Citrus Sinensis ID: 019536

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------34
Protein Sequence
MLSSLNIKRKSSGEAADSNMVRNEKLLLQKLIATFNGKRNPIRAFSAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLSVV
Secondary Structure (PSIPRED)
cccHHHHHHcccHHHHHHHHHHcccHHHHHHHHHccccccccccccHHHHHHHHccccccccccccccEEEEEEEEccccEEEEEEEccccccccHHHHHHHHHHHHHcccccccccEEcEEcccccEEEEEEEcccccHHHHccccccHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccEEEccccccccccccHHHHHHccccccccccHHHHHHHHHHHcccccccccccccccccHHHHHHHHHHcccccccccccccccccccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHHccc
Secondary Structure Prediction (SSPRO)
ccHHHHHHHHccccccccccccccccccHHHHcccccccccccEEcHHHHHHHHccccHHcccccccccEEEEEEccccccEEEEEEEccccccccHHHHHHHHHHHHHHHcHHHHHEEEEEEccccEEEEEEEcccccHHHHHcccccHHHHHHHHHHHHHHHHHHHHHccccEEEEcccHcHEEccccccccHcHcccEEEccccccEEEEEEEEEccccccHHHHHccccccccHHHHHHHEEEHHHccccccccccccccHHHHHHHHHHHHHHcccHHHHccHHHcccccccccHHHHHHHHHHHHHHHcccHcccccHHHHHHHHHcccEEcc
Coil and Loop (DISEMBL)
mlsslnikrkssgeaadsnMVRNEKLLLQKLIATfngkrnpirafSAKDLKkatnnydlhkviqsdtsyrlfegtlvdqdrpisvmkfhdnstlddveYCFNNIVFSSQMKHKNILKLIGCcletelptlvfesvkygtlrgfsfaslliAPRIKIAMEIANAVAYLhvgfdrpiVFRCIKASnvlldenysaklhdfslsvsipegethVREEFIKgaygfiapeyfatssfnemcDVYSFGAFLCELLTGcnvlefkgngndddLTVLEYAKKSIennrfgaivdpifdednsfpgkeeKLQSLGQLMYKClskspehrplMVDVAKQLRQMYLSVV
Flexible Loop (DISEMBL)
mlsslnikrkssgeaadsnmvrNEKLLLQKLIAtfngkrnpirafsakdlkkatnnydlhkviqsdtsyrLFEGtlvdqdrpiSVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIennrfgaivdPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLSVV
Low Complexity Region (SEG)
MLSSLNIKRKSSGEAADSNMVRNEKLLLQKLIATFNGKRNPIRAFSAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLSVV
Disordered region (IsUnstruct)
************************KLLLQKLIATFNGKRNPIRAFSAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFD****************QLMYKCL*************************
Disordered Region (DISOPRED)
*******************************************AFSAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNV************TVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYL***
Disordered Region (DISEMBL)
***************ADSNMVRNEKLLLQKLIATFNGKRNPIRAFSAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLSVV
Disordered Region (DISPRO)
ML**LNIKRK****************************RNPIRAFSAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS**
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MLSSLNIKRKSSGEAADSNMVRNEKLLLQKLIATFNGKRNPIRAFSAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLSVV
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	339	2.2.26 [Sep-21-2011]
Q8RY17	751	Wall-associated receptor	no	no	0.890	0.402	0.35	3e-45
Q9LMT9	764	Putative wall-associated	no	no	0.893	0.396	0.353	9e-45
Q9LSV3	433	Putative wall-associated	no	no	0.828	0.648	0.347	2e-44
Q9M092	786	Wall-associated receptor	no	no	0.899	0.388	0.340	5e-44
Q9S9M2	761	Wall-associated receptor	no	no	0.893	0.398	0.351	7e-43
Q9S9M5	730	Wall-associated receptor	no	no	0.884	0.410	0.350	8e-43
Q9LN59	788	Putative wall-associated	no	no	0.882	0.379	0.336	9e-43
Q9S9M3	730	Wall-associated receptor	no	no	0.890	0.413	0.336	2e-42
Q7X8C5	748	Wall-associated receptor	no	no	0.905	0.410	0.352	2e-42
Q0WNY5	793	Wall-associated receptor	no	no	0.899	0.384	0.337	3e-42

>sp|Q8RY17|WAKLI_ARATH Wall-associated receptor kinase-like 22 OS=Arabidopsis thaliana GN=WAKL22 PE=2 SV=1

 Score =  182 bits (463), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 112/320 (35%), Positives = 185/320 (57%), Gaps = 18/320 (5%)

Query: 22  RNEKLLLQKLIATFNGKRNPIRAFSAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDR 81
           RN  LLL++ + T  G     + FS+K+L+KAT+N+++++V+       +++G LVD  R
Sbjct: 386 RNGGLLLKQQLTTRGGNVQSSKIFSSKELEKATDNFNMNRVLGQGGQGTVYKGMLVD-GR 444

Query: 82  PISVMKFHDNSTLDD--VEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGT 139
            ++V +   +  LD+  VE   N +   SQ+ H+NI+KL+GCCLETE+P LV+E +  G 
Sbjct: 445 IVAVKR---SKVLDEDKVEEFINEVGVLSQINHRNIVKLMGCCLETEVPILVYEHIPNGD 501

Query: 140 L-----RGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAK 194
           L           ++    R++I++EIA A+AYLH     P+  R +K +N+LLDE Y AK
Sbjct: 502 LFKRLHHDSDDYTMTWDVRLRISVEIAGALAYLHSAASTPVYHRDVKTTNILLDEKYRAK 561

Query: 195 LHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCN 254
           + DF  S SI   +TH+    + G +G++ PEYF TS F +  DVYSFG  L EL+TG  
Sbjct: 562 VSDFGTSRSINVDQTHL-TTLVAGTFGYLDPEYFQTSQFTDKSDVYSFGVVLVELITGEK 620

Query: 255 VLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCL 314
              F     +++  ++ +  ++++ NR   IVD    E  +     E++ ++ +L  +CL
Sbjct: 621 --PFSVMRPEENRGLVSHFNEAMKQNRVLDIVDSRIKEGCTL----EQVLAVAKLARRCL 674

Query: 315 SKSPEHRPLMVDVAKQLRQM 334
           S   + RP M +V+ +L ++
Sbjct: 675 SLKGKKRPNMREVSVELERI 694

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Required during plant's response to pathogen infection.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: -

>sp|Q9LMT9|WAKLL_ARATH Putative wall-associated receptor kinase-like 13 OS=Arabidopsis thaliana GN=WAKL13 PE=2 SV=1

 Score =  181 bits (458), Expect = 9e-45,   Method: Compositional matrix adjust.
 Identities = 113/320 (35%), Positives = 181/320 (56%), Gaps = 17/320 (5%)

Query: 22  RNEKLLLQKLIATFNGKRNPIRAFSAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDR 81
           RN  LLLQ+ + T  G+    + FS+++L+KAT+N++ ++VI       +++G LVD  R
Sbjct: 419 RNGGLLLQQQLNTTQGRVEKTKLFSSRELEKATDNFNDNRVIGQGGQGTVYKGMLVD-GR 477

Query: 82  PISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL- 140
            ++V K  +    D ++   N ++  SQ+ H++++KL+GCCLETE+P LV+E +  G L 
Sbjct: 478 SVAVKK-SNVVDEDKLQEFINEVIILSQINHRHVVKLLGCCLETEVPILVYEFIPNGNLF 536

Query: 141 ----RGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLH 196
                 F   + L   R++IA++I+ A +YLH     PI  R IK++N+LLDE Y AK+ 
Sbjct: 537 QHLHEEFDDYTALWGVRMRIAVDISGAFSYLHTAACSPIYHRDIKSTNILLDEKYRAKVS 596

Query: 197 DFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCN-V 255
           DF  S S+    TH     I G  G++ PEY+ +S F E  DVYSFG  L EL+TG   V
Sbjct: 597 DFGTSRSVSIDHTH-WTTVISGTVGYVDPEYYGSSHFTEKSDVYSFGVVLVELITGEKPV 655

Query: 256 LEFKGNGNDDDLTVL-EYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCL 314
           +         ++T L +Y + ++  NR   I+D     D     K E++ ++  L  +CL
Sbjct: 656 ITLS---ETQEITGLADYFRLAMRENRLFEIIDARIRNDC----KLEQVIAVANLALRCL 708

Query: 315 SKSPEHRPLMVDVAKQLRQM 334
            K+ + RP M +V+  L ++
Sbjct: 709 KKTGKTRPDMREVSTALERI 728

Putative serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9LSV3|WAKLS_ARATH Putative wall-associated receptor kinase-like 16 OS=Arabidopsis thaliana GN=WAKL16 PE=3 SV=1

 Score =  179 bits (455), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 104/299 (34%), Positives = 167/299 (55%), Gaps = 18/299 (6%)

Query: 43  RAFSAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQD-RPISVMKFHDNSTLDDVEYCF 101
           + F+ +D+K+ATN YD+ +++     + +++G L D     I   +  DN   + VE   
Sbjct: 94  KIFTEEDMKEATNGYDVSRILGQGGQWTVYKGILPDNSIVAIKKTRLGDN---NQVEQFI 150

Query: 102 NNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL----RGFSF-ASLLIAPRIKI 156
           N ++  SQ+ H+N++KL+GCCLETE+P LV+E +  G+L     G  F +SL    R++I
Sbjct: 151 NEVLVLSQINHRNVVKLLGCCLETEVPLLVYEFITGGSLFDHLHGSMFVSSLTWEHRLEI 210

Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI 216
           A+E+A A+AYLH G   PI+ R IK  N+LLDEN +AK+ DF  S   P  +  +    +
Sbjct: 211 AIEVAGAIAYLHSGASIPIIHRDIKTENILLDENLTAKVADFGASKLKPMDKEQLT-TMV 269

Query: 217 KGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKS 276
           +G  G++ PEY+ T   NE  DVYSFG  L EL++G   L F+       L  + Y   +
Sbjct: 270 QGTLGYLDPEYYTTWLLNEKSDVYSFGVVLMELISGQKALCFERPETSKHL--VSYFVLA 327

Query: 277 IENNRFGAIV-DPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQM 334
            + NR   I+ D + +E+N     + ++    ++  +C     E RP M++VA +L  +
Sbjct: 328 TKENRLHEIIDDQVLNEEN-----QREIHEAARVAVECTRLKGEERPRMIEVAAELETL 381

Putative serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9M092|WAKLM_ARATH Wall-associated receptor kinase-like 17 OS=Arabidopsis thaliana GN=WAKL17 PE=3 SV=2

 Score =  178 bits (452), Expect = 5e-44,   Method: Compositional matrix adjust.
 Identities = 110/323 (34%), Positives = 182/323 (56%), Gaps = 18/323 (5%)

Query: 23  NEKLLLQKLIATFNGKRNPIRAFSAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRP 82
           N  LLLQ+ + T  G     R F++K+L+KAT N+  ++V+       +++G LVD  R 
Sbjct: 410 NGGLLLQQELNTRQGVVEKARIFTSKELEKATENFSENRVLGHGGQGTVYKGMLVD-GRT 468

Query: 83  ISVMKFHDNSTLDD--VEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL 140
           ++V K   +  +D+  ++   N +V  SQ+ H++++KL+GCCLETE+P LV+E +  G L
Sbjct: 469 VAVKK---SKVIDEDKLQEFINEVVILSQINHRHVVKLLGCCLETEVPILVYEFIINGNL 525

Query: 141 ------RGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAK 194
                       +++   R++IA++IA A++YLH     PI  R IK++N+LLDE Y AK
Sbjct: 526 FKHIHEEEADDYTMIWGMRLRIAVDIAGALSYLHSAASSPIYHRDIKSTNILLDEKYRAK 585

Query: 195 LHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCN 254
           + DF  S S+   +TH     I G  G++ PEY+ +S + E  DVYSFG  L EL+TG  
Sbjct: 586 VADFGTSRSVTIDQTH-WTTVISGTVGYVDPEYYRSSQYTEKSDVYSFGVILAELITGDK 644

Query: 255 VLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCL 314
            +    N   + + + E+ + +++  R   I+D    +D+    K E++ ++  L  KCL
Sbjct: 645 PVIMVQN-TQEIIALAEHFRVAMKERRLSDIMDARIRDDS----KPEQVMAVANLAMKCL 699

Query: 315 SKSPEHRPLMVDVAKQLRQMYLS 337
           S    +RP M +V  +L ++  S
Sbjct: 700 SSRGRNRPNMREVFTELERICTS 722

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9S9M2|WAKLD_ARATH Wall-associated receptor kinase-like 4 OS=Arabidopsis thaliana GN=WAKL4 PE=2 SV=2

 Score =  174 bits (442), Expect = 7e-43,   Method: Compositional matrix adjust.
 Identities = 112/319 (35%), Positives = 181/319 (56%), Gaps = 16/319 (5%)

Query: 22  RNEKLLLQKLIATFNGKRNPIRAFSAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDR 81
           RN  +LL++ +A   G     + FS+ +L+KAT+N++ ++V+       +++G LVD   
Sbjct: 389 RNGGMLLKQQLARKEGNVEMSKIFSSNELEKATDNFNTNRVLGQGGQGTVYKGMLVDGR- 447

Query: 82  PISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYG--- 138
            I  +K       D VE   N +V  +Q+ H+NI+KL+GCCLETE+P LV+E V  G   
Sbjct: 448 -IVAVKRSKAMDEDKVEEFINEVVVLAQINHRNIVKLLGCCLETEVPVLVYEFVPNGDLC 506

Query: 139 -TLRGFSFASLLIAP-RIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLH 196
             LR      ++    R+ IA+EIA A++YLH     PI  R IK +N+LLDE Y  K+ 
Sbjct: 507 KRLRDECDDYIMTWEVRLHIAIEIAGALSYLHSAASFPIYHRDIKTTNILLDEKYQVKVS 566

Query: 197 DFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVL 256
           DF  S S+   +TH+  + + G +G++ PEYF +S F +  DVYSFG  L EL+TG N  
Sbjct: 567 DFGTSRSVTIDQTHLTTQ-VAGTFGYVDPEYFQSSKFTDKSDVYSFGVVLVELITGKN-- 623

Query: 257 EFKGNGNDDDLTVLEYAKKSIENNRFGAIVDP-IFDEDNSFPGKEEKLQSLGQLMYKCLS 315
                 ++++     +   +++ NRF  IVD  I DE N      +++ ++ +L  +CL+
Sbjct: 624 PSSRVQSEENRGFAAHFVAAVKENRFLDIVDERIKDECNL-----DQVMAVAKLAKRCLN 678

Query: 316 KSPEHRPLMVDVAKQLRQM 334
           +  + RP M +V+ +L ++
Sbjct: 679 RKGKKRPNMREVSVELERI 697

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Plays a role in plant mineral nutrients response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9S9M5|WAKLA_ARATH Wall-associated receptor kinase-like 1 OS=Arabidopsis thaliana GN=WAKL1 PE=1 SV=1

 Score =  174 bits (441), Expect = 8e-43,   Method: Compositional matrix adjust.
 Identities = 113/322 (35%), Positives = 180/322 (55%), Gaps = 22/322 (6%)

Query: 22  RNEKLLLQKLIATFNGKRNPIRAFSAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDR 81
           RN  LLL++ + T +G     + FS+K+L+KAT+N+ + +V+       +++G LVD   
Sbjct: 394 RNGGLLLKQQLTTKDGNVEMSKIFSSKELRKATDNFSIDRVLGQGGQGTVYKGMLVDGS- 452

Query: 82  PISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL- 140
            I  +K       D +E   N IV  SQ+ H+NI+KL+GCCLETE+P LV+E +  G L 
Sbjct: 453 -IVAVKRSKVVDEDKMEEFINEIVLLSQINHRNIVKLLGCCLETEVPILVYEYIPNGDLF 511

Query: 141 -RGFSFA---SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLH 196
            R    +   ++    R++IA+EIA A+ Y+H     PI  R IK +N+LLDE Y AK+ 
Sbjct: 512 KRLHDESDDYTMTWEVRLRIAIEIAGALTYMHSAASFPIFHRDIKTTNILLDEKYRAKVS 571

Query: 197 DFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG---- 252
           DF  S S+   +TH+    + G +G++ PEYF +S +    DVYSFG  L EL+TG    
Sbjct: 572 DFGTSRSVTLDQTHL-TTLVAGTFGYMDPEYFLSSQYTHKSDVYSFGVVLVELITGEKPL 630

Query: 253 CNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYK 312
             V   +G G      +  +  ++++ NR    V  I D       K E++ ++ +L  K
Sbjct: 631 SRVRSEEGRG------LATHFLEAMKENR----VIDIIDIRIKDESKLEQVMAVAKLARK 680

Query: 313 CLSKSPEHRPLMVDVAKQLRQM 334
           CL++  ++RP M +V+ +L ++
Sbjct: 681 CLNRKGKNRPNMKEVSNELERI 702

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9LN59|WAKLK_ARATH Putative wall-associated receptor kinase-like 11 OS=Arabidopsis thaliana GN=WAKL11 PE=3 SV=2

 Score =  174 bits (441), Expect = 9e-43,   Method: Compositional matrix adjust.
 Identities = 111/330 (33%), Positives = 176/330 (53%), Gaps = 31/330 (9%)

Query: 22  RNEKLLLQKLIATFNGKRNPIRAFSAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDR 81
           RN  LLLQ+ + T  G     R FS+++L+KAT+N+   +++       +++G LVD  R
Sbjct: 416 RNGGLLLQQQLNTNKGNVEKTRIFSSRELEKATDNFSESRILGQGGQGTVYKGMLVD-GR 474

Query: 82  PISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLR 141
            ++V K       D +E   N +V  SQ+ H++++KL+GCCLETE+PTLV+E +  G L 
Sbjct: 475 TVAVKK-SKVVDEDKLEEFINEVVILSQINHRHVVKLLGCCLETEVPTLVYEFIPNGNL- 532

Query: 142 GFSFA-------SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAK 194
            F          +     R++IA++IA A++YLH     PI  R IK++N+LLDE Y  K
Sbjct: 533 -FQHIHEESDDYTKTWGMRLRIAVDIAGALSYLHSAASSPIYHRDIKSTNILLDEKYRTK 591

Query: 195 LHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG-- 252
           + DF  S S+    TH     I G  G++ PEY+ +S + +  DVYSFG  L EL+TG  
Sbjct: 592 VSDFGTSRSVTIDHTH-WTTVISGTVGYVDPEYYGSSQYTDKSDVYSFGVVLVELITGEK 650

Query: 253 -----CNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLG 307
                 N  E +G        + ++ + +++ NRF  I+D    +      K E++ ++ 
Sbjct: 651 PVITVSNSQEIRG--------LADHFRVAMKENRFFEIMDARIRDG----CKPEQVMAVA 698

Query: 308 QLMYKCLSKSPEHRPLMVDVAKQLRQMYLS 337
            L  +CL+   + RP M  V   L ++  S
Sbjct: 699 NLARRCLNSKGKKRPCMRKVFTDLEKILAS 728

Putative serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9S9M3|WAKLC_ARATH Wall-associated receptor kinase-like 3 OS=Arabidopsis thaliana GN=WAKL3 PE=2 SV=2

 Score =  173 bits (438), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 107/318 (33%), Positives = 180/318 (56%), Gaps = 16/318 (5%)

Query: 22  RNEKLLLQKLIATFNGKRNPIRAFSAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDR 81
           RN  LLL++ + T +G     + FS+++L+KAT+N+ + +V+       +++  LVD   
Sbjct: 393 RNGGLLLKQQLTTKDGSVEMSKIFSSRELEKATDNFSIDRVLGQGGQGTVYKRMLVDGS- 451

Query: 82  PISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL- 140
            I  +K       D +E   N IV  SQ+ H+NI+KL+GCCLETE+P LV+E +  G L 
Sbjct: 452 -IVAVKRSKVVDEDKMEEFINEIVLLSQINHRNIVKLLGCCLETEVPILVYEYIPNGDLF 510

Query: 141 ----RGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLH 196
                 +    +    R++IA+EIA A++Y+H     PI  R IK +N+LLDE Y AK+ 
Sbjct: 511 KRLHDEYDDYMMTWEVRLRIAVEIAGALSYMHSAASFPIFHRDIKTTNILLDEKYRAKIS 570

Query: 197 DFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVL 256
           DF  S S+   +TH+    + G +G++ PEYF +S +    DVYSFG  L EL+TG   +
Sbjct: 571 DFGTSRSVATDQTHL-TTLVAGTFGYMDPEYFLSSQYTHKSDVYSFGVVLVELITGEKPM 629

Query: 257 EFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSK 316
                 +++ + +  Y  ++++ NR   I+D I  +D S     +++ ++ +L  +CL++
Sbjct: 630 SRV--RSEEGIGLATYFLEAMKENRAVDIID-IRIKDES-----KQVMAVAKLARRCLNR 681

Query: 317 SPEHRPLMVDVAKQLRQM 334
               RP M +V+ +L ++
Sbjct: 682 KGNKRPNMREVSIKLERI 699

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q7X8C5|WAKLB_ARATH Wall-associated receptor kinase-like 2 OS=Arabidopsis thaliana GN=WAKL2 PE=2 SV=1

 Score =  172 bits (437), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 113/321 (35%), Positives = 175/321 (54%), Gaps = 14/321 (4%)

Query: 22  RNEKLLLQKLIATFNGKRNPIRAFSAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDR 81
           RN  +LL++ +A   G     R FS+ +L+KAT+N++ ++V+       +++G LVD   
Sbjct: 381 RNGGMLLKQQLARKEGNVEMSRIFSSHELEKATDNFNKNRVLGQGGQGTVYKGMLVDGR- 439

Query: 82  PISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL- 140
            I  +K       D VE   N +V  +Q+ H+NI+KL+GCCLETE+P LV+E V  G L 
Sbjct: 440 -IVAVKRSKAVDEDRVEEFINEVVVLAQINHRNIVKLLGCCLETEVPVLVYEFVPNGDLC 498

Query: 141 -RGFSFA---SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLH 196
            R    +   ++    R+ IA+EIA A++YLH     PI  R IK +N+LLDE   AK+ 
Sbjct: 499 KRLHDESDDYTMTWEVRLHIAIEIAGALSYLHSAASFPIYHRDIKTTNILLDERNRAKVS 558

Query: 197 DFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVL 256
           DF  S S+   +TH+  + + G +G++ PEYF +S F E  DVYSFG  L ELLTG    
Sbjct: 559 DFGTSRSVTIDQTHLTTQ-VAGTFGYVDPEYFQSSKFTEKSDVYSFGVVLVELLTG-EKP 616

Query: 257 EFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSK 316
             +    ++      + +   EN     + D I DE N      +++ S+  L  +CL++
Sbjct: 617 SSRVRSEENRGLAAHFVEAVKENRVLDIVDDRIKDECNM-----DQVMSVANLARRCLNR 671

Query: 317 SPEHRPLMVDVAKQLRQMYLS 337
             + RP M +V+ +L  +  S
Sbjct: 672 KGKKRPNMREVSIELEMIRSS 692

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q0WNY5|WAKLN_ARATH Wall-associated receptor kinase-like 18 OS=Arabidopsis thaliana GN=WAKL18 PE=2 SV=1

 Score =  172 bits (437), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 109/323 (33%), Positives = 177/323 (54%), Gaps = 18/323 (5%)

Query: 23  NEKLLLQKLIATFNGKRNPIRAFSAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRP 82
           N  LLL + + T  G     R F++++L+KAT N+  ++V+       +++G LVD  R 
Sbjct: 419 NGGLLLLQELNTREGYVEKTRVFNSRELEKATENFSENRVLGHGGQGTVYKGMLVD-GRT 477

Query: 83  ISVMKFH--DNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL 140
           ++V K    D   L +     N +V  SQ+ H++++KL+GCCLETE+P LV+E +  G L
Sbjct: 478 VAVKKSKVIDEDKLQEF---INEVVILSQINHRHVVKLLGCCLETEVPMLVYEFIINGNL 534

Query: 141 RGFSFA------SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAK 194
                       ++L   R++IA++IA A++YLH     PI  R IK++N+LLDE Y AK
Sbjct: 535 FKHIHEEESDDYTMLWGMRLRIAVDIAGALSYLHSSASSPIYHRDIKSTNILLDEKYRAK 594

Query: 195 LHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCN 254
           + DF  S S+   +TH     I G  G++ PEY+ +S + E  DVYSFG  L EL+TG  
Sbjct: 595 VADFGTSRSVTIDQTH-WTTVISGTVGYVDPEYYQSSQYTEKSDVYSFGVILAELITGDK 653

Query: 255 VLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCL 314
            +    N   + + + E+ + +++  R   I+D     D     K E++ ++ ++  KCL
Sbjct: 654 PVIMVQN-TQEIVALAEHFRVAMKEKRLTDIIDARIRND----CKPEQVMAVAKVAMKCL 708

Query: 315 SKSPEHRPLMVDVAKQLRQMYLS 337
           S   + RP M +V  +L ++  S
Sbjct: 709 SSKGKKRPNMREVFTELERICTS 731

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	339
255582635	331	receptor protein kinase, putative [Ricin	0.905	0.927	0.503	9e-83
224123144	344	predicted protein [Populus trichocarpa]	0.932	0.918	0.474	5e-82
255542656	331	serine-threonine protein kinase, plant-t	0.923	0.945	0.437	4e-68
255542662	330	serine-threonine protein kinase, plant-t	0.911	0.936	0.445	1e-63
255542658	356	serine-threonine protein kinase, plant-t	0.926	0.882	0.409	1e-61
255542668	307	serine-threonine protein kinase, plant-t	0.781	0.863	0.429	1e-53
359493231	497	PREDICTED: inactive serine/threonine-pro	0.911	0.621	0.370	3e-51
297820570	353	kinase family protein [Arabidopsis lyrat	0.917	0.881	0.357	9e-51
296081092	1111	unnamed protein product [Vitis vinifera]	0.911	0.278	0.370	1e-50
22331843	355	putative protein kinase [Arabidopsis tha	0.911	0.870	0.368	1e-49

>gi|255582635|ref|XP_002532098.1| receptor protein kinase, putative [Ricinus communis] gi|223528232|gb|EEF30288.1| receptor protein kinase, putative [Ricinus communis]

 Score =  313 bits (801), Expect = 9e-83,   Method: Compositional matrix adjust.
 Identities = 161/320 (50%), Positives = 226/320 (70%), Gaps = 13/320 (4%)

Query: 23  NEKLLLQKLIATFNGKRNPIRAFSAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRP 82
           N ++LL+KLIA+ +G+ NPIR FSA +L +AT++YD  K+I  D+ Y+L+ G L   +R 
Sbjct: 15  NGRMLLEKLIASCDGRCNPIRIFSADELSRATDDYDPRKIITQDSGYKLYNGLL--HERT 72

Query: 83  ISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLETELPTLVFESVKYGTLR 141
           ISV KF D S  +  +YC+N+I+F++QM KHKN LKL+GCCLET++P LVFE ++YGTL 
Sbjct: 73  ISVKKFKDKS--EQYKYCYNDIMFATQMSKHKNFLKLLGCCLETQIPVLVFEPIEYGTLA 130

Query: 142 GFSFAS-------LLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAK 194
           G  +         LL   R+KIA+EIANAV+YLH  F RPIVFR IK  N+ LDE + AK
Sbjct: 131 GRLYGPNKTLYQPLLWRHRLKIAVEIANAVSYLHTAFSRPIVFRNIKPLNIFLDECHVAK 190

Query: 195 LHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCN 254
           L DFSL+VSIPEGE+HV++  + GA+G IAPEY  TS FNE  DVY+FG FL  LLTG  
Sbjct: 191 LSDFSLAVSIPEGESHVKD-MLAGAWGLIAPEYAKTSCFNESQDVYNFGVFLLMLLTGQK 249

Query: 255 VLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCL 314
           V++       ++L ++++ KK I ++RF   VD I   + S P K+++LQ+   L ++C+
Sbjct: 250 VVDSYRPQAGEELGLVDHVKKFIADDRFYETVDSIILGEGSLPEKDQQLQAFTLLSFRCI 309

Query: 315 SKSPEHRPLMVDVAKQLRQM 334
           S++ E RP+M+DVAK+LR++
Sbjct: 310 SEADEDRPMMIDVAKELRKI 329

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224123144|ref|XP_002319005.1| predicted protein [Populus trichocarpa] gi|222857381|gb|EEE94928.1| predicted protein [Populus trichocarpa]

 Score =  310 bits (795), Expect = 5e-82,   Method: Compositional matrix adjust.
 Identities = 157/331 (47%), Positives = 229/331 (69%), Gaps = 15/331 (4%)

Query: 17  DSNMVRNEKLLLQKLIATFNGKRNPIRAFSAKDLKKATNNYDLHKVIQSDTSYRLFEGTL 76
           ++  ++N   LL+KL+   +GK N IR+FSA +LKKATNNYD  K++  D+ Y+L++G L
Sbjct: 16  ETAFIKNGSKLLEKLVDICDGKCNSIRSFSATELKKATNNYDPQKILTGDSGYKLYKGFL 75

Query: 77  VDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMK-HKNILKLIGCCLETELPTLVFESV 135
             Q RP+SV KF D+   +  EYCFN+IV++S+M  HK+ +KL+GCCLE  +P LVFE V
Sbjct: 76  --QGRPVSVKKFKDDD--EQYEYCFNDIVYASKMSVHKSFMKLLGCCLEARIPILVFEYV 131

Query: 136 KYGTLRGFSFAS-------LLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLD 188
              TL  F + S       LL  PR KIAM++ANAVA+LH  F +PIVFR IK  N+LLD
Sbjct: 132 GDWTLSDFLWGSEEARCQPLLWIPRSKIAMDMANAVAFLHAAFSKPIVFRNIKPLNILLD 191

Query: 189 ENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCE 248
           +N+ AKL DFS+S+SIP+GE+HVR+  + GA G IAPEY  T +FNE  DV++FG FL  
Sbjct: 192 DNHEAKLSDFSISISIPKGESHVRDS-VAGATGLIAPEYLTTGNFNEKQDVFNFGVFLLV 250

Query: 249 LLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQ 308
           LL+G  V++F  +  + ++ + ++ KK IE++RF  ++D     + ++PGKE++LQ+   
Sbjct: 251 LLSGQMVVDF--SRPEKEILLQDHVKKCIEDDRFNKVIDSTIIAEGTWPGKEQQLQAYTA 308

Query: 309 LMYKCLSKSPEHRPLMVDVAKQLRQMYLSVV 339
           L  +C+S+  E RP M+DV+K+LR++Y S +
Sbjct: 309 LSLRCISELAEDRPTMIDVSKELRKIYWSAI 339

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255542656|ref|XP_002512391.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223548352|gb|EEF49843.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  264 bits (675), Expect = 4e-68,   Method: Compositional matrix adjust.
 Identities = 141/322 (43%), Positives = 206/322 (63%), Gaps = 9/322 (2%)

Query: 20  MVRNEKLLLQKLIATFNGKRNPIRAFSAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQ 79
           ++RN + LL+K +A  NG+ NP+R FS K+L+ ATN+Y  H V   D + RL++G +  +
Sbjct: 14  LMRNGRSLLEKSVALNNGRGNPVRCFSVKELQNATNSYSQHNVFYIDGTCRLYKGLI--R 71

Query: 80  DRPISVMKFHDNSTLDDVEYCFNNIVFSSQMK-HKNILKLIGCCLETELPTLVFESVKYG 138
           DRP+ V K+      +D     ++IV +S+M  H+N+LKL+GCCLE+E+P  VFE  + G
Sbjct: 72  DRPVIVKKYDYKHPSEDP---VSDIVIASEMSVHRNVLKLLGCCLESEIPIPVFEYAEKG 128

Query: 139 TLRGF-SFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHD 197
           TL  +    +LL   R+KIA+++A+ +AYLH  F RPIV R I  +++LLDE+ +AK+  
Sbjct: 129 TLEDYVQKTALLWKDRLKIAVDVASVIAYLHTAFPRPIVHRDISLASILLDEDCAAKVTG 188

Query: 198 FSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLE 257
           FSLS+SIPEGETH+ +E + G  G++APEYF    FNE  DVYSFG  L  LLTG   + 
Sbjct: 189 FSLSISIPEGETHIEDE-VAGTIGYVAPEYFMKRMFNEKIDVYSFGVVLLVLLTGHGPIL 247

Query: 258 FKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKS 317
                N+    V+ + +  I+N RF  I+DP   E+  +P KE++L+S   L  +C  K 
Sbjct: 248 RSPTTNESHALVV-FVEAKIKNERFNEIIDPAILEEGPWPEKEQQLKSFLTLAMQCTRKD 306

Query: 318 PEHRPLMVDVAKQLRQMYLSVV 339
            E RP + DVAKQLR +Y S++
Sbjct: 307 EEDRPEITDVAKQLRHIYHSLM 328

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255542662|ref|XP_002512394.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223548355|gb|EEF49846.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  249 bits (636), Expect = 1e-63,   Method: Compositional matrix adjust.
 Identities = 144/323 (44%), Positives = 192/323 (59%), Gaps = 14/323 (4%)

Query: 23  NEKLLLQKLIATFNGKRNPIRAFSAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRP 82
           N   LL+K +A  NG+ NPIR FS+++L+KAT NY+  +V++ D  + L++G L  QDRP
Sbjct: 10  NGSKLLEKSVAFCNGRCNPIRNFSSEELEKATRNYNEKQVLKLDGYFELYKGFL--QDRP 67

Query: 83  ISVMKFHDNSTLDDVEYCFNNIVFSSQMK-HKNILKLIGCCLETELPTLVFESVKYGTLR 141
           + V KF +       +   N IV++S M  H N +KL+GCCLET  P LVFES K  TL 
Sbjct: 68  VIVKKFLEVGV---EQLAINEIVYASAMSVHINSIKLLGCCLETPSPILVFESAKEKTLA 124

Query: 142 GF-------SFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAK 194
                     F  +    R+KI  +IAN V Y+H  F RPIV R IKASN+LLDE+Y AK
Sbjct: 125 DRIIDRNDDHFEPVKWKLRLKIVADIANVVVYIHTAFPRPIVHRNIKASNILLDEDYVAK 184

Query: 195 LHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCN 254
           L DFSL VSIPEG++ VR+  + G  G IA E  AT  FNE  DVYSFG  L  +LTG  
Sbjct: 185 LSDFSLCVSIPEGKSRVRD-IMAGTMGLIASESLATGYFNEKSDVYSFGVVLLVVLTGQR 243

Query: 255 VLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCL 314
             +F      +   ++ + KK IE   F  +VDPI   + +   K ++L+    L  +C+
Sbjct: 244 SFDFSRTETGEQFLLVNHVKKHIETGGFKEMVDPIIVAEEAGNRKGQELEDFRDLALRCI 303

Query: 315 SKSPEHRPLMVDVAKQLRQMYLS 337
             S E RP M++VAKQLR +YLS
Sbjct: 304 HDSAEERPTMIEVAKQLRHIYLS 326

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255542658|ref|XP_002512392.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223548353|gb|EEF49844.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  243 bits (619), Expect = 1e-61,   Method: Compositional matrix adjust.
 Identities = 143/349 (40%), Positives = 209/349 (59%), Gaps = 35/349 (10%)

Query: 17  DSNMVRNEKLLLQKLIATFNGKRNPIRAFSAKDLKKATNNYDLHKVIQSDTSYRLFEGTL 76
           ++ ++RN  +LL+K IA  NG+ NPIR FS  +L+ ATN+Y  + VI     + L++G L
Sbjct: 13  ETALMRNGGILLEKSIAFNNGRGNPIRWFSVDELQTATNSYSQNNVIYEGGWHTLYKGFL 72

Query: 77  VDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLETELPTLVFESV 135
             +DRP+ V ++ +N  + +     N+IVF+S+M +HKN+LKL+GCCLE+E+P LVFE  
Sbjct: 73  --RDRPVIVKRYRNN--IHERVCPINDIVFASEMSRHKNVLKLLGCCLESEIPILVFEYA 128

Query: 136 KYGTLRGF-------SFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLD 188
           + G L+ +       SF  LL   R+KIA++ AN +AYLH    RP+V R I  SN+ LD
Sbjct: 129 EKGKLQDYIYKTDSASFRPLLWKSRLKIAVDAANVIAYLHTACPRPVVHRDITLSNIWLD 188

Query: 189 ENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCE 248
           E+Y AK+ DF++S+SI EGETH+ E+F+ G  G+ APEY  +  FNE  DV+SFG  L  
Sbjct: 189 EDYVAKVTDFTVSMSILEGETHI-EDFVLGTCGYAAPEYVRSGIFNEKIDVFSFGVLLLV 247

Query: 249 LLTGCNVLEFKGNGND-----------DDLTV---LEYAKKSIEN------NRFGAIVDP 288
           LLT  +   F+GN  +             L V   L   K+ +E        +    +DP
Sbjct: 248 LLT--DQKPFQGNWENILKDARFDEIIGSLIVEKGLWSEKEQLETFLTRTRQKLDLTIDP 305

Query: 289 IFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS 337
           I  E+  +P KE++L++   L  +C+    E+RP + DVAKQLR  YLS
Sbjct: 306 IIVEEGPWPEKEQQLKAFLMLGVQCIDPDEENRPEITDVAKQLRHFYLS 354

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255542668|ref|XP_002512397.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223548358|gb|EEF49849.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  216 bits (550), Expect = 1e-53,   Method: Compositional matrix adjust.
 Identities = 118/275 (42%), Positives = 176/275 (64%), Gaps = 10/275 (3%)

Query: 70  RLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMK-HKNILKLIGCCLETELP 128
           RL E ++   +  + V K++  S ++D     N+IVF+S+M  HKN+LKL+GCCLE+++P
Sbjct: 35  RLLEKSIALNNGRVIVKKYYWASDMEDP---INDIVFASEMSVHKNVLKLLGCCLESKIP 91

Query: 129 TLVFESVKYGTLRGFSF----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASN 184
            LVFE  + G L+ + +    ASLL   R++IA+++A+ ++YLH  F RPIV R I  SN
Sbjct: 92  ILVFECAQKGILKDYFYKTDSASLLWQIRLRIAVDVASVISYLHSAFPRPIVHRDITLSN 151

Query: 185 VLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGA 244
           +LLDE+Y AK+  FSLS+SIPEG+TH+ +E + G  G++AP YF T  FNE  DVYSFG 
Sbjct: 152 ILLDEDYIAKVTGFSLSMSIPEGKTHIEDEVV-GTPGYLAPAYFKTLMFNEKIDVYSFGV 210

Query: 245 FLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQ 304
            L  LLTG   +           +++ + K+ IE+ RF  I+DP+  E+  +P KE +L+
Sbjct: 211 LLLVLLTGQQPI-LHSPTTTARYSLVNFVKEKIEDERFDEIIDPVILEEGPWPEKERQLE 269

Query: 305 SLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLSVV 339
               L  +C  ++ E RP + DVAKQLR +Y S++
Sbjct: 270 IFLTLAMQCTHENEEDRPEITDVAKQLRHIYHSLI 304

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359493231|ref|XP_002265528.2| PREDICTED: inactive serine/threonine-protein kinase At1g67470-like [Vitis vinifera]

 Score =  208 bits (529), Expect = 3e-51,   Method: Compositional matrix adjust.
 Identities = 121/327 (37%), Positives = 187/327 (57%), Gaps = 18/327 (5%)

Query: 21  VRNEKLLLQKLIATFNGKRNPIRAFSAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQD 80
           ++N  LLL+KL+++ NG+ NPIR FS K+L++ATN Y+   +    T    ++G+L  + 
Sbjct: 10  LKNGSLLLEKLVSSLNGRSNPIRNFSIKELEQATNKYNSSLIFDRWTYSEWYKGSL--EG 67

Query: 81  RPISVMKFHDNSTLDD--VEYCFNNIVFSSQMK-HKNILKLIGCCLETELPTLVFE---- 133
           R +SV KFH    +DD  +E     I F++Q+  HKN+LKL GCCLET+ P LV+E    
Sbjct: 68  RFVSVRKFH--PVIDDAFLERVIKEITFATQLSAHKNVLKLFGCCLETQTPVLVYEYPVN 125

Query: 134 ------SVKYGTLRGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLL 187
                  V + +  G S   L    R++I+ +IA+ +AYLH  F R I+ R +  S   L
Sbjct: 126 GVVPLYDVIHPSTDGKSRQRLPWKSRLRISGDIAHVIAYLHTAFPRAIIHREVTLSFFFL 185

Query: 188 DENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLC 247
           DE+   KL +F  ++++PEG  +V +  + G  GFIAPEY  T    E  DV+SFG  L 
Sbjct: 186 DEDCVPKLSNFFFAIALPEGRKYVVDG-VMGIEGFIAPEYEMTGMVTEKVDVFSFGKLLL 244

Query: 248 ELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLG 307
           ELLTG   ++F   GND +L + +  K  +E++     VD           +E +L ++ 
Sbjct: 245 ELLTGRRTIDFGPLGNDGELLLQDCIKTYVEDHELDGFVDASILPRGGEIHEELQLLAVT 304

Query: 308 QLMYKCLSKSPEHRPLMVDVAKQLRQM 334
           +L  +C+  + E RP MV++AK+LR++
Sbjct: 305 KLALRCIMTAAEQRPTMVEIAKELRRI 331

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297820570|ref|XP_002878168.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297324006|gb|EFH54427.1| kinase family protein [Arabidopsis lyrata subsp. lyrata]

 Score =  206 bits (525), Expect = 9e-51,   Method: Compositional matrix adjust.
 Identities = 117/327 (35%), Positives = 189/327 (57%), Gaps = 16/327 (4%)

Query: 23  NEKLLLQKLIATFNGKRNPIRAFSAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRP 82
           N  + L +L+A  NGK  PIR+FS + + KATNN+D    +  D  Y+ + G +  +DR 
Sbjct: 28  NGSIFLTELVADCNGKSIPIRSFSPEQILKATNNFDSSCFVSQDVYYKWYRGQI--EDRS 85

Query: 83  ISVMKFHDNSTLDD---VEYCFNNIVFSSQMK-HKNILKLIGCCLETELPTLVFESVKYG 138
             + +F ++        V+  +N+IV S++M  H N L+L+GCCLE   P LVFE  +YG
Sbjct: 86  YMIKRFSEDEITGKRHRVKEVYNDIVLSARMSNHSNFLQLLGCCLEFPFPVLVFEFAEYG 145

Query: 139 TL--RGFSFAS-----LLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENY 191
            L  RG    +     L  + R+KI  EIANAV+YLH+ F + I+ R +K  +V LD+N+
Sbjct: 146 ALNQRGGIMVNGEEYLLPWSVRLKIGKEIANAVSYLHMAFPKIIIHRDVKPMHVFLDKNW 205

Query: 192 SAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT 251
           +AKL D S S+S+PEG++ +  E++ G +G++ P Y  TS   E  DVYSFG     +LT
Sbjct: 206 TAKLSDLSFSISLPEGKSRIEAEWVLGTFGYLDPLYHKTSFVTEYTDVYSFGICFLVILT 265

Query: 252 GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMY 311
           G   +    +G  D   +L Y +   EN +   ++DP+  +D +  G+  ++++   L  
Sbjct: 266 GKPAIITISDG--DLQGILSYVRGLCENGKLDEVIDPMLMKDIT-SGQRLQVEACVVLAL 322

Query: 312 KCLSKSPEHRPLMVDVAKQLRQMYLSV 338
           +C  +  E+RP ++ VAK+L+++  S+
Sbjct: 323 RCCEERDEYRPKVIQVAKELKRIEASL 349

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|296081092|emb|CBI18286.3| unnamed protein product [Vitis vinifera]

 Score =  206 bits (525), Expect = 1e-50,   Method: Compositional matrix adjust.
 Identities = 121/327 (37%), Positives = 187/327 (57%), Gaps = 18/327 (5%)

Query: 21  VRNEKLLLQKLIATFNGKRNPIRAFSAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQD 80
           ++N  LLL+KL+++ NG+ NPIR FS K+L++ATN Y+   +    T    ++G+L  + 
Sbjct: 624 LKNGSLLLEKLVSSLNGRSNPIRNFSIKELEQATNKYNSSLIFDRWTYSEWYKGSL--EG 681

Query: 81  RPISVMKFHDNSTLDD--VEYCFNNIVFSSQMK-HKNILKLIGCCLETELPTLVFE---- 133
           R +SV KFH    +DD  +E     I F++Q+  HKN+LKL GCCLET+ P LV+E    
Sbjct: 682 RFVSVRKFH--PVIDDAFLERVIKEITFATQLSAHKNVLKLFGCCLETQTPVLVYEYPVN 739

Query: 134 ------SVKYGTLRGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLL 187
                  V + +  G S   L    R++I+ +IA+ +AYLH  F R I+ R +  S   L
Sbjct: 740 GVVPLYDVIHPSTDGKSRQRLPWKSRLRISGDIAHVIAYLHTAFPRAIIHREVTLSFFFL 799

Query: 188 DENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLC 247
           DE+   KL +F  ++++PEG  +V +  + G  GFIAPEY  T    E  DV+SFG  L 
Sbjct: 800 DEDCVPKLSNFFFAIALPEGRKYVVDG-VMGIEGFIAPEYEMTGMVTEKVDVFSFGKLLL 858

Query: 248 ELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLG 307
           ELLTG   ++F   GND +L + +  K  +E++     VD           +E +L ++ 
Sbjct: 859 ELLTGRRTIDFGPLGNDGELLLQDCIKTYVEDHELDGFVDASILPRGGEIHEELQLLAVT 918

Query: 308 QLMYKCLSKSPEHRPLMVDVAKQLRQM 334
           +L  +C+  + E RP MV++AK+LR++
Sbjct: 919 KLALRCIMTAAEQRPTMVEIAKELRRI 945

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|22331843|ref|NP_191332.2| putative protein kinase [Arabidopsis thaliana] gi|18086365|gb|AAL57644.1| AT3g57730/F15B8_80 [Arabidopsis thaliana] gi|21700831|gb|AAM70539.1| AT3g57730/F15B8_80 [Arabidopsis thaliana] gi|332646170|gb|AEE79691.1| putative protein kinase [Arabidopsis thaliana]

 Score =  203 bits (516), Expect = 1e-49,   Method: Compositional matrix adjust.
 Identities = 119/323 (36%), Positives = 190/323 (58%), Gaps = 14/323 (4%)

Query: 21  VRNEKLLLQKLIATFNGKRNPIRAFSAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQD 80
           + N  + L++LI   NGK  PIR+F++  ++KAT N+DL   +  +  Y  ++G +  +D
Sbjct: 31  LENGSIFLKELIVDCNGKSIPIRSFTSSQIRKATKNFDLSCFVAEEGFYIWYKGVI--ED 88

Query: 81  RPISVMKFHDNSTLD-DVEYCFNNIVFSSQMK-HKNILKLIGCCLETELPTLVFESVKYG 138
           R   + +F +    D  V   + +IV S++M  H N LKL+GCCLE   P LVFE  ++G
Sbjct: 89  RSYMIKRFSEYKVTDYRVSEVYKDIVLSARMSNHNNFLKLLGCCLEFPFPVLVFEFAEHG 148

Query: 139 TLR---GFSF---ASLL-IAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENY 191
            L    G +     SLL ++ R+KI  EIANA+AYLH+ F + I++R +K  +V LD N+
Sbjct: 149 VLNYRGGITVNGEESLLPLSLRLKIGKEIANALAYLHMAFPKIIIYRDVKPLHVFLDNNW 208

Query: 192 SAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT 251
           +AKL D S S+S+ EG++ +  E + G YG++ P YFAT    E  DVYSFG FL  ++T
Sbjct: 209 TAKLSDLSFSISLEEGKSQIEAEDVLGTYGYLDPLYFATRIVTEYTDVYSFGVFLMVVIT 268

Query: 252 GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMY 311
           G +V  F G+ +   + +L Y K   EN +   IV P+  ++ +   +  ++++   L  
Sbjct: 269 GISVY-FTGS-DGYPVGILGYMKGLAENGKLNEIVYPMIMKEMT-SAQRLQVEACVLLAL 325

Query: 312 KCLSKSPEHRPLMVDVAKQLRQM 334
           +C  +  E RP M+ VAK+L+++
Sbjct: 326 RCCEERVEDRPKMIQVAKELKRI 348

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	339
TAIR|locus:2076671	355	AT3G57730 [Arabidopsis thalian	0.949	0.907	0.360	3.1e-51
TAIR|locus:2076586	351	AT3G57710 [Arabidopsis thalian	0.917	0.886	0.360	9.5e-50
TAIR|locus:2076681	359	AT3G57720 [Arabidopsis thalian	0.949	0.896	0.367	1.2e-49
TAIR|locus:2076596	340	AT3G57700 [Arabidopsis thalian	0.941	0.938	0.381	4.1e-49
TAIR|locus:2076646	334	AT3G57750 [Arabidopsis thalian	0.896	0.910	0.373	4.1e-49
TAIR|locus:2019893	751	RFO1 "RESISTANCE TO FUSARIUM O	0.890	0.402	0.353	1.1e-43
TAIR|locus:2200552	730	WAKL1 "wall associated kinase-	0.941	0.436	0.348	1.2e-43
TAIR|locus:2126316	786	AT4G31100 [Arabidopsis thalian	0.902	0.389	0.342	2.4e-43
TAIR|locus:2094468	433	AT3G25490 [Arabidopsis thalian	0.873	0.683	0.340	3.5e-43
TAIR|locus:2030988	764	AT1G17910 [Arabidopsis thalian	0.893	0.396	0.353	7.2e-43

TAIR|locus:2076671 AT3G57730 [Arabidopsis thaliana (taxid:3702)]

 Score = 532 (192.3 bits), Expect = 3.1e-51, P = 3.1e-51
 Identities = 121/336 (36%), Positives = 194/336 (57%)

Query:     8 KRKSSGEAADSNMVRNEKLLLQKLIATFNGKRNPIRAFSAKDLKKATNNYDLHKVIQSDT 67
             K+K      +   + N  + L++LI   NGK  PIR+F++  ++KAT N+DL   +  + 
Sbjct:    18 KKKEKSMKKERWFLENGSIFLKELIVDCNGKSIPIRSFTSSQIRKATKNFDLSCFVAEEG 77

Query:    68 SYRLFEGTLVDQDRPISVMKFHDNSTLD-DVEYCFNNIVFSSQMK-HKNILKLIGCCLET 125
              Y  ++G +  +DR   + +F +    D  V   + +IV S++M  H N LKL+GCCLE 
Sbjct:    78 FYIWYKGVI--EDRSYMIKRFSEYKVTDYRVSEVYKDIVLSARMSNHNNFLKLLGCCLEF 135

Query:   126 ELPTLVFESVKYGTLR---GFSF---ASLL-IAPRIKIAMEIANAVAYLHVGFDRPIVFR 178
               P LVFE  ++G L    G +     SLL ++ R+KI  EIANA+AYLH+ F + I++R
Sbjct:   136 PFPVLVFEFAEHGVLNYRGGITVNGEESLLPLSLRLKIGKEIANALAYLHMAFPKIIIYR 195

Query:   179 CIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCD 238
              +K  +V LD N++AKL D S S+S+ EG++ +  E + G YG++ P YFAT    E  D
Sbjct:   196 DVKPLHVFLDNNWTAKLSDLSFSISLEEGKSQIEAEDVLGTYGYLDPLYFATRIVTEYTD 255

Query:   239 VYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPG 298
             VYSFG FL  ++TG +V  F G+ +   + +L Y K   EN +   IV P+  ++ +   
Sbjct:   256 VYSFGVFLMVVITGISVY-FTGS-DGYPVGILGYMKGLAENGKLNEIVYPMIMKEMT-SA 312

Query:   299 KEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQM 334
             +  ++++   L  +C  +  E RP M+ VAK+L+++
Sbjct:   313 QRLQVEACVLLALRCCEERVEDRPKMIQVAKELKRI 348

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2076586 AT3G57710 [Arabidopsis thaliana (taxid:3702)]

 Score = 518 (187.4 bits), Expect = 9.5e-50, P = 9.5e-50
 Identities = 118/327 (36%), Positives = 187/327 (57%)

Query:    23 NEKLLLQKLIATFNGKRNPIRAFSAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRP 82
             N  + L++L+A  NGK  PIR+FS + + KATNN+D    +  D  Y+ + G +  +DR 
Sbjct:    26 NGSIFLRELVADCNGKSIPIRSFSPEQILKATNNFDSSCFVSQDVYYKWYRGEI--EDRS 83

Query:    83 ISVMKFHDNSTLDD---VEYCFNNIVFSSQMK-HKNILKLIGCCLETELPTLVFESVKYG 138
               + +F ++        V+  +N+IV S++M  H N L+L+GCCLE   P LVFE  ++G
Sbjct:    84 YMIKRFSEDEITGKRHRVKEVYNDIVLSARMSNHSNFLQLLGCCLEFPFPVLVFEFAEHG 143

Query:   139 TL--RGFSFA----SLLI-APRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENY 191
              +  RG        SLL  + R+KI  EIANAV YLH  F + I+ R +K  +V LD+N+
Sbjct:   144 AMNQRGGVIVNGEESLLPWSVRLKIGKEIANAVTYLHTAFPKIIIHRDVKPMHVFLDKNW 203

Query:   192 SAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT 251
             +AKL D S S+S+PEG++ +  E++ G +G+I P Y  T    E  DVYSFG  L  ++T
Sbjct:   204 TAKLSDLSFSISLPEGKSRIEAEWVLGTFGYIDPLYHKTCFVTEYTDVYSFGICLLVIIT 263

Query:   252 GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMY 311
             G   +    +G  D   +L   ++  EN +   ++DP   +D +  G+  ++++   L  
Sbjct:   264 GKPAIMTISDG--DLQGILSLVRELCENGKLDEVIDPRLMKDIT-SGQRLQVEACVVLAL 320

Query:   312 KCLSKSPEHRPLMVDVAKQLRQMYLSV 338
             +C  +  E RP M+ VAK+L+Q+  S+
Sbjct:   321 RCCKERDEDRPKMIQVAKELKQIEASL 347

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2076681 AT3G57720 [Arabidopsis thaliana (taxid:3702)]

 Score = 517 (187.1 bits), Expect = 1.2e-49, P = 1.2e-49
 Identities = 124/337 (36%), Positives = 186/337 (55%)

Query:     8 KRKSSGEAADSNMVRNEKLLLQKLIATFNGKRNPIRAFSAKDLKKATNNYDLHKVIQSDT 67
             K K      +   + N  + L++LIA  NGK  PIR FS+  + KAT+N+     + ++ 
Sbjct:    21 KEKEKDIQEEKWFLDNGSIFLKELIADCNGKSIPIRNFSSDQILKATSNFGSSCFVTAEG 80

Query:    68 SYRLFEGTLVDQDRPISVMKFHDNS-TLDDVEYCFNNIVFSSQMK-HKNILKLIGCCLET 125
              Y  ++G +  +DR   + +F +   T   V   +N IV S++M  H N LKLIG CLE 
Sbjct:    81 FYVWYKGII--EDRSYMIKRFSEYKVTQYRVAEVYNEIVLSARMSNHNNFLKLIGFCLEF 138

Query:   126 ELPTLVFESVKYGTL--RGFSFAS--LLIAP---RIKIAMEIANAVAYLHVGFDRPIVFR 178
              LP LVFE  ++G L  RG    +   +I P   R+KI  EIANAV YLH+ F + ++ R
Sbjct:   139 SLPVLVFEYAEHGVLNHRGGVIVNGEEVILPLSLRLKIGKEIANAVTYLHMAFPKILIHR 198

Query:   179 CIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCD 238
              IK  NV LDEN++ KL DFS+S+++PEG++ +  E ++G  G++ P Y+ T    E  D
Sbjct:   199 HIKPRNVFLDENWTPKLSDFSISINLPEGKSRIEVECVQGTIGYLDPVYYTTKMVTEYTD 258

Query:   239 VYSFGAFLCELLTGCNVLEFKGNGNDDDLT-VLEYAKKSIENNRFGAIVDPIFDEDNSFP 297
             VYSFG FL  +LTG   L      +D D   +  Y K   EN +   ++DP   ED +  
Sbjct:   259 VYSFGVFLMVILTGKPALA--STSSDGDYKHIASYVKGFHENGQLDGVIDPKVMEDITSA 316

Query:   298 GKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQM 334
              K   +++   L  +C     E+RP M+ +AK+L+Q+
Sbjct:   317 QKVH-VEACVVLALRCCELRDENRPKMIQIAKELKQI 352

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2076596 AT3G57700 [Arabidopsis thaliana (taxid:3702)]

 Score = 512 (185.3 bits), Expect = 4.1e-49, P = 4.1e-49
 Identities = 129/338 (38%), Positives = 194/338 (57%)

Query:     8 KRKSSGEAADSNMVRNEKLLLQKLIATFNGKRNPIRAFSAKDLKKATNNYDLHKVIQSDT 67
             K+K   +  + N+ +N  LLL++LIAT  G  NPIR FS+  + +ATN++D + VI  D 
Sbjct:     7 KKKKQKKEEEINLQKNGSLLLEELIATSGGIYNPIRTFSSDQILQATNHFDWNYVISEDR 66

Query:    68 SYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMK-HKNILKLIGCCLETE 126
              +  ++G +  ++RP+ + KF D S  D   + + +I  SS M  HKN+LKL+GCCLE  
Sbjct:    67 -FVWYKGMI--ENRPVLIKKFQDCSVFDADNF-YRDIAVSSLMSSHKNVLKLLGCCLEFP 122

Query:   127 LPTLVFESVKYGTLRGFSFASLLIA--P---RIKIAMEIANAVAYLHVGFDRPIVFRCIK 181
              P LV E  ++G L         +   P   R++IA EIA+AVAYLH  F R I+ R +K
Sbjct:   123 RPVLVCEYPEHGALNCIRCGKEGVRSFPWNVRLRIAKEIADAVAYLHTEFPRTIIHRDLK 182

Query:   182 ASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYS 241
              +N+ LDEN+SAKL  FSLS+ +PEGET V +   + +  +I P+YF T    E  D+YS
Sbjct:   183 LANIFLDENWSAKLSSFSLSIVLPEGETGVNDMVCRTS-SYIEPDYFNTGLVTENVDIYS 241

Query:   242 FGAFLCELLTGCNVLEFKGNGNDDDLTVLE-YAKKSIENNRFGAIVDP-IFDEDNSFPGK 299
              G  +  +LTG +  E+        L VL  Y  K +E      ++DP I D  +    K
Sbjct:   242 LGIIMLIILTGKS--EYNSEVAVY-LPVLPVYVGKFLERGLLTELIDPSILDSTSDDIPK 298

Query:   300 EEKLQ--SLGQLMYKCLSKSP-EHRPLMVDVAKQLRQM 334
               +LQ  +  +L ++C+   P E+ P M+DVAK+L+++
Sbjct:   299 HSRLQMEAFIELAFRCVRFRPGENVPRMIDVAKELKKI 336

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0009693 "ethylene biosynthetic process" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0045088 "regulation of innate immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2076646 AT3G57750 [Arabidopsis thaliana (taxid:3702)]

 Score = 512 (185.3 bits), Expect = 4.1e-49, P = 4.1e-49
 Identities = 121/324 (37%), Positives = 196/324 (60%)

Query:    21 VRNEKLLLQKLIATFNGKRNPIRAFSAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQD 80
             ++N  +LL++LIA+F+GK NPIR FS+  + KAT+N+   ++I S   +  ++G +  ++
Sbjct:    13 LKNGGILLEELIASFDGKTNPIRCFSSDQILKATDNFSESRIISSWGYFIWYKGVI--EE 70

Query:    81 RPISVMKFHDNSTLDDVEYCFNNIVFSSQMK-HKNILKLIGCCLETELPTLVFESVKYGT 139
             R +S+ K+  +  L      + +I  SSQM  HKN LKLIGCCLE +LP LV E  ++G 
Sbjct:    71 RQVSIKKW-SSQNLSSFTEAYRDISVSSQMSGHKNALKLIGCCLEFDLPALVCEYTEHGP 129

Query:   140 L-RGFSFASLLIAP---RIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKL 195
             L R    +S ++ P   R+KIA EIA++V YLH  F   IV R I  +N+ +DEN++AKL
Sbjct:   130 LNRDGGLSSGVVLPWKVRLKIAKEIASSVTYLHTAFPETIVHRNINPTNIFIDENWTAKL 189

Query:   196 HDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNV 255
              DF   V+IPEGE +V ++ +KG  GF+ P+Y+ T    E  D+YSFG  +  LL+G   
Sbjct:   190 SDFWFCVAIPEGELYVEDD-VKGVIGFVDPDYYWTMKVTEKVDIYSFGVVMLVLLSG-RA 247

Query:   256 LEFKGNGNDD-DLTVLEYAKKSIENNRFGAIVDP-IFDE---DNSFPGKEEKLQSLGQLM 310
               F  NG D+  +++ ++  + +E   F  IVD  I+++   D+    +  ++++  +L 
Sbjct:   248 AVF--NGPDEAPMSLNDHVSEVMEKGEFDEIVDKEIWNDLGGDDDLVLRRSQVKAFLRLA 305

Query:   311 YKCLSKSPEHRPL--MVDVAKQLR 332
              +C+    E  P+  M++VAK+L+
Sbjct:   306 LRCVRYKKED-PVSGMLEVAKELK 328

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009693 "ethylene biosynthetic process" evidence=RCA

GO:0015824 "proline transport" evidence=RCA

TAIR|locus:2019893 RFO1 "RESISTANCE TO FUSARIUM OXYSPORUM 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 466 (169.1 bits), Expect = 1.1e-43, P = 1.1e-43
 Identities = 113/320 (35%), Positives = 186/320 (58%)

Query:    22 RNEKLLLQKLIATFNGKRNPIRAFSAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDR 81
             RN  LLL++ + T  G     + FS+K+L+KAT+N+++++V+       +++G LVD  R
Sbjct:   386 RNGGLLLKQQLTTRGGNVQSSKIFSSKELEKATDNFNMNRVLGQGGQGTVYKGMLVD-GR 444

Query:    82 PISVMKFHDNSTLDD--VEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGT 139
              ++V +   +  LD+  VE   N +   SQ+ H+NI+KL+GCCLETE+P LV+E +  G 
Sbjct:   445 IVAVKR---SKVLDEDKVEEFINEVGVLSQINHRNIVKLMGCCLETEVPILVYEHIPNGD 501

Query:   140 L-RGFSFAS----LLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAK 194
             L +     S    +    R++I++EIA A+AYLH     P+  R +K +N+LLDE Y AK
Sbjct:   502 LFKRLHHDSDDYTMTWDVRLRISVEIAGALAYLHSAASTPVYHRDVKTTNILLDEKYRAK 561

Query:   195 LHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCN 254
             + DF  S SI   +TH+    + G +G++ PEYF TS F +  DVYSFG  L EL+TG  
Sbjct:   562 VSDFGTSRSINVDQTHLTT-LVAGTFGYLDPEYFQTSQFTDKSDVYSFGVVLVELITGEK 620

Query:   255 VLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCL 314
                F     +++  ++ +  ++++ NR   IVD    E  +     E++ ++ +L  +CL
Sbjct:   621 --PFSVMRPEENRGLVSHFNEAMKQNRVLDIVDSRIKEGCTL----EQVLAVAKLARRCL 674

Query:   315 SKSPEHRPLMVDVAKQLRQM 334
             S   + RP M +V+ +L ++
Sbjct:   675 SLKGKKRPNMREVSVELERI 694

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005618 "cell wall" evidence=ISS

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016021 "integral to membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009620 "response to fungus" evidence=IMP

TAIR|locus:2200552 WAKL1 "wall associated kinase-like 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 465 (168.7 bits), Expect = 1.2e-43, P = 1.2e-43
 Identities = 116/333 (34%), Positives = 187/333 (56%)

Query:     7 IKRKSSGEAADSNMVRNEKLLLQKLIATFNGKRNPIRAFSAKDLKKATNNYDLHKVIQSD 66
             IK++ +   +     RN  LLL++ + T +G     + FS+K+L+KAT+N+ + +V+   
Sbjct:   379 IKKRRNINRSKKFFKRNGGLLLKQQLTTKDGNVEMSKIFSSKELRKATDNFSIDRVLGQG 438

Query:    67 TSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETE 126
                 +++G LVD    I  +K       D +E   N IV  SQ+ H+NI+KL+GCCLETE
Sbjct:   439 GQGTVYKGMLVDGS--IVAVKRSKVVDEDKMEEFINEIVLLSQINHRNIVKLLGCCLETE 496

Query:   127 LPTLVFESVKYGTL-RGFSFAS----LLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIK 181
             +P LV+E +  G L +     S    +    R++IA+EIA A+ Y+H     PI  R IK
Sbjct:   497 VPILVYEYIPNGDLFKRLHDESDDYTMTWEVRLRIAIEIAGALTYMHSAASFPIFHRDIK 556

Query:   182 ASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYS 241
              +N+LLDE Y AK+ DF  S S+   +TH+    + G +G++ PEYF +S +    DVYS
Sbjct:   557 TTNILLDEKYRAKVSDFGTSRSVTLDQTHLTT-LVAGTFGYMDPEYFLSSQYTHKSDVYS 615

Query:   242 FGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEE 301
             FG  L EL+TG   L    +     L    +  ++++ NR   I+D I  +D S   K E
Sbjct:   616 FGVVLVELITGEKPLSRVRSEEGRGLAT--HFLEAMKENRVIDIID-IRIKDES---KLE 669

Query:   302 KLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQM 334
             ++ ++ +L  KCL++  ++RP M +V+ +L ++
Sbjct:   670 QVMAVAKLARKCLNRKGKNRPNMKEVSNELERI 702

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005618 "cell wall" evidence=ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016021 "integral to membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2126316 AT4G31100 [Arabidopsis thaliana (taxid:3702)]

 Score = 464 (168.4 bits), Expect = 2.4e-43, P = 2.4e-43
 Identities = 111/324 (34%), Positives = 183/324 (56%)

Query:    22 RNEKLLLQKLIATFNGKRNPIRAFSAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDR 81
             RN  LLLQ+ + T  G     R F++K+L+KAT N+  ++V+       +++G LVD  R
Sbjct:   409 RNGGLLLQQELNTRQGVVEKARIFTSKELEKATENFSENRVLGHGGQGTVYKGMLVD-GR 467

Query:    82 PISVMKFHDNSTLDD--VEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGT 139
              ++V K   +  +D+  ++   N +V  SQ+ H++++KL+GCCLETE+P LV+E +  G 
Sbjct:   468 TVAVKK---SKVIDEDKLQEFINEVVILSQINHRHVVKLLGCCLETEVPILVYEFIINGN 524

Query:   140 L------RGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSA 193
             L            +++   R++IA++IA A++YLH     PI  R IK++N+LLDE Y A
Sbjct:   525 LFKHIHEEEADDYTMIWGMRLRIAVDIAGALSYLHSAASSPIYHRDIKSTNILLDEKYRA 584

Query:   194 KLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGC 253
             K+ DF  S S+   +TH     I G  G++ PEY+ +S + E  DVYSFG  L EL+TG 
Sbjct:   585 KVADFGTSRSVTIDQTHWTT-VISGTVGYVDPEYYRSSQYTEKSDVYSFGVILAELITGD 643

Query:   254 NVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKC 313
               +    N   + + + E+ + +++  R   I+D    +D+    K E++ ++  L  KC
Sbjct:   644 KPVIMVQN-TQEIIALAEHFRVAMKERRLSDIMDARIRDDS----KPEQVMAVANLAMKC 698

Query:   314 LSKSPEHRPLMVDVAKQLRQMYLS 337
             LS    +RP M +V  +L ++  S
Sbjct:   699 LSSRGRNRPNMREVFTELERICTS 722

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016021 "integral to membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2094468 AT3G25490 [Arabidopsis thaliana (taxid:3702)]

 Score = 456 (165.6 bits), Expect = 3.5e-43, P = 3.5e-43
 Identities = 108/317 (34%), Positives = 174/317 (54%)

Query:    26 LLLQKLIATFNGKRN-PIRAFSAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDR-PI 83
             +L+++L     G  N   + F+ +D+K+ATN YD+ +++     + +++G L D     I
Sbjct:    78 MLIERLSGA--GSSNIDFKIFTEEDMKEATNGYDVSRILGQGGQWTVYKGILPDNSIVAI 135

Query:    84 SVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL--- 140
                +  DN+    VE   N ++  SQ+ H+N++KL+GCCLETE+P LV+E +  G+L   
Sbjct:   136 KKTRLGDNN---QVEQFINEVLVLSQINHRNVVKLLGCCLETEVPLLVYEFITGGSLFDH 192

Query:   141 -RGFSFASLLI-APRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDF 198
               G  F S L    R++IA+E+A A+AYLH G   PI+ R IK  N+LLDEN +AK+ DF
Sbjct:   193 LHGSMFVSSLTWEHRLEIAIEVAGAIAYLHSGASIPIIHRDIKTENILLDENLTAKVADF 252

Query:   199 SLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEF 258
               S   P  +  +    ++G  G++ PEY+ T   NE  DVYSFG  L EL++G   L F
Sbjct:   253 GASKLKPMDKEQLTT-MVQGTLGYLDPEYYTTWLLNEKSDVYSFGVVLMELISGQKALCF 311

Query:   259 KGNGNDDDLTVLEYAKKSIENNRFGAIVDP-IFDEDNSFPGKEEKLQSLGQLMYKCLSKS 317
             +       L  + Y   + + NR   I+D  + +E+N     + ++    ++  +C    
Sbjct:   312 ERPETSKHL--VSYFVLATKENRLHEIIDDQVLNEEN-----QREIHEAARVAVECTRLK 364

Query:   318 PEHRPLMVDVAKQLRQM 334
              E RP M++VA +L  +
Sbjct:   365 GEERPRMIEVAAELETL 381

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2030988 AT1G17910 [Arabidopsis thaliana (taxid:3702)]

 Score = 459 (166.6 bits), Expect = 7.2e-43, P = 7.2e-43
 Identities = 113/320 (35%), Positives = 181/320 (56%)

Query:    22 RNEKLLLQKLIATFNGKRNPIRAFSAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDR 81
             RN  LLLQ+ + T  G+    + FS+++L+KAT+N++ ++VI       +++G LVD  R
Sbjct:   419 RNGGLLLQQQLNTTQGRVEKTKLFSSRELEKATDNFNDNRVIGQGGQGTVYKGMLVD-GR 477

Query:    82 PISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL- 140
              ++V K +     D ++   N ++  SQ+ H++++KL+GCCLETE+P LV+E +  G L 
Sbjct:   478 SVAVKKSNVVDE-DKLQEFINEVIILSQINHRHVVKLLGCCLETEVPILVYEFIPNGNLF 536

Query:   141 ----RGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLH 196
                   F   + L   R++IA++I+ A +YLH     PI  R IK++N+LLDE Y AK+ 
Sbjct:   537 QHLHEEFDDYTALWGVRMRIAVDISGAFSYLHTAACSPIYHRDIKSTNILLDEKYRAKVS 596

Query:   197 DFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCN-V 255
             DF  S S+    TH     I G  G++ PEY+ +S F E  DVYSFG  L EL+TG   V
Sbjct:   597 DFGTSRSVSIDHTHWTT-VISGTVGYVDPEYYGSSHFTEKSDVYSFGVVLVELITGEKPV 655

Query:   256 LEFKGNGNDDDLTVL-EYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCL 314
             +         ++T L +Y + ++  NR   I+D     D     K E++ ++  L  +CL
Sbjct:   656 ITLS---ETQEITGLADYFRLAMRENRLFEIIDARIRNDC----KLEQVIAVANLALRCL 708

Query:   315 SKSPEHRPLMVDVAKQLRQM 334
              K+ + RP M +V+  L ++
Sbjct:   709 KKTGKTRPDMREVSTALERI 728

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016021 "integral to membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

No EC number assignment, probably not an enzyme!

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: fgenesh4_pm.C_LG_XIII000087 hypothetical protein (344 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	339
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	4e-27
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-26
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-26
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	4e-23
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	5e-23
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-22
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-20
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	6e-16
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	3e-15
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	4e-15
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	5e-15
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	6e-15
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-14
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	4e-14
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	6e-14
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-13
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-13
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	1e-12
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-12
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-12
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-12
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-12
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	7e-12
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	7e-12
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-11
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-11
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	3e-11
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	4e-11
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	4e-11
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	5e-11
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	7e-11
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-10
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-10
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	3e-10
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	4e-10
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	5e-10
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	8e-10
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	8e-10
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-09
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-09
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-09
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	2e-09
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	3e-09
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	3e-09
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	4e-09
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	4e-09
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	4e-09
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	4e-09
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	5e-09
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	5e-09
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	5e-09
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	6e-09
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	6e-09
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	7e-09
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-08
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-08
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-08
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-08
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-08
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-08
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-08
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-08
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	3e-08
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	3e-08
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	4e-08
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	4e-08
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	4e-08
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	4e-08
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	4e-08
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	6e-08
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	6e-08
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	6e-08
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	6e-08
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	6e-08
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	7e-08
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	8e-08
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	8e-08
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	9e-08
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-07
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-07
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	1e-07
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-07
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-07
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-07
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-07
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-07
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-07
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-07
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-07
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-07
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-07
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	3e-07
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-07
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-07
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	3e-07
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	3e-07
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	3e-07
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	4e-07
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	4e-07
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	4e-07
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	4e-07
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	4e-07
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	4e-07
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	5e-07
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	5e-07
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	5e-07
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	7e-07
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	8e-07
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	8e-07
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	8e-07
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-06
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-06
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-06
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-06
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-06
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-06
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-06
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-06
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-06
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-06
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-06
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-06
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-06
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-06
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	3e-06
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	3e-06
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	3e-06
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	4e-06
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	4e-06
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	4e-06
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	4e-06
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	5e-06
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	6e-06
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	6e-06
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	6e-06
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	6e-06
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	7e-06
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	8e-06
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	9e-06
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	9e-06
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	9e-06
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-05
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-05
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-05
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	1e-05
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-05
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-05
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-05
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-05
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-05
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-05
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	1e-05
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-05
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-05
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-05
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-05
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-05
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-05
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-05
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-05
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	3e-05
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-05
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	3e-05
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	4e-05
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	4e-05
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	5e-05
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	5e-05
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	5e-05
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	5e-05
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	6e-05
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	6e-05
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	7e-05
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	7e-05
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	7e-05
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-04
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-04
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-04
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	1e-04
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-04
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-04
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-04
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-04
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-04
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-04
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-04
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-04
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-04
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-04
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	3e-04
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-04
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	3e-04
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	3e-04
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-04
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	3e-04
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	4e-04
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	4e-04
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	4e-04
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	5e-04
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	5e-04
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	5e-04
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	5e-04
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	5e-04
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	5e-04
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	5e-04
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	6e-04
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	6e-04
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	8e-04
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	8e-04
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	0.001
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	0.001
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	0.001
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	0.001
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	0.001
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	0.001
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	0.001
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	0.001
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	0.001
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	0.002
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	0.002
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	0.002
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	0.002
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	0.002
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	0.002
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	0.002
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	0.003
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	0.003
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	0.003
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	0.004
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	0.004
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	0.004
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	0.004

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  106 bits (268), Expect = 4e-27
 Identities = 60/232 (25%), Positives = 95/232 (40%), Gaps = 38/232 (16%)

Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPR--------IKIAME 159
            ++ H N++KL+G C E E   +V E ++ G L  +     L   R        +  A++
Sbjct: 56  RKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSY-----LRKNRPKLSLSDLLSFALQ 110

Query: 160 IANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGA 219
           IA  + YL     +  + R + A N L+ EN   K+ DF LS  + + + + R+   K  
Sbjct: 111 IARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY-RKRGGKLP 166

Query: 220 YGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIEN 279
             ++APE      F    DV+SFG  L E+ T       +      +  VLEY K     
Sbjct: 167 IRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLG----EQPYPGMSNEEVLEYLKN---G 219

Query: 280 NRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQL 331
            R               P        L  LM +C ++ PE RP   ++ + L
Sbjct: 220 YR------------LPQP--PNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  105 bits (265), Expect = 1e-26
 Identities = 59/245 (24%), Positives = 99/245 (40%), Gaps = 53/245 (21%)

Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF-----------SFASLLIAPRIKI 156
            ++ H N+++L+G C E E   LV E ++ G L  +             ++L +   +  
Sbjct: 51  KKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSF 110

Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEF- 215
           A++IA  + YL     +  V R + A N L+ E+   K+ DF LS  + + + + ++   
Sbjct: 111 AIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGG 167

Query: 216 ---IKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGC-----NVLEFKGNGNDDDL 267
              I+    ++APE      F    DV+SFG  L E+ T        +          + 
Sbjct: 168 KLPIR----WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL---------SNE 214

Query: 268 TVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDV 327
            VLEY +K     R               P  E     L +LM  C    PE RP   ++
Sbjct: 215 EVLEYLRK---GYR------------LPKP--EYCPDELYELMLSCWQLDPEDRPTFSEL 257

Query: 328 AKQLR 332
            ++L 
Sbjct: 258 VERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  105 bits (264), Expect = 1e-26
 Identities = 62/231 (26%), Positives = 95/231 (41%), Gaps = 35/231 (15%)

Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF----SFASLLIAPRIKIAMEIANA 163
            ++ H NI+KL+G C E E   +V E +  G L  +        L ++  +  A++IA  
Sbjct: 56  RKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARG 115

Query: 164 VAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFI 223
           + YL     +  + R + A N L+ EN   K+ DF LS  + + + +     +KG    I
Sbjct: 116 MEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYK----VKGGKLPI 168

Query: 224 ---APEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENN 280
              APE      F    DV+SFG  L E+ T              +  VLEY KK     
Sbjct: 169 RWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPY----PGMSNAEVLEYLKK---GY 221

Query: 281 RFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQL 331
           R               P        L +LM +C ++ PE RP   ++ + L
Sbjct: 222 R------------LPKP--PNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 96.0 bits (240), Expect = 4e-23
 Identities = 62/227 (27%), Positives = 99/227 (43%), Gaps = 27/227 (11%)

Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANAV 164
            ++ H NI++L+G C + E   +V E +  G L  F       L +   +++A++IA  +
Sbjct: 56  KKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGM 115

Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIA 224
            YL     +  V R + A N L+ EN   K+ DF LS  I E + + +    K    ++A
Sbjct: 116 EYLE---SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMA 172

Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA 284
           PE      F    DV+SFG  L E+ T      + G  N++   VLE  +   +  R   
Sbjct: 173 PESLKDGKFTSKSDVWSFGVLLWEIFTLGEQ-PYPGMSNEE---VLELLE---DGYR--- 222

Query: 285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQL 331
                       P  E     L +LM +C +  PE RP   ++ + L
Sbjct: 223 ---------LPRP--ENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score = 94.6 bits (236), Expect = 5e-23
 Identities = 46/183 (25%), Positives = 78/183 (42%), Gaps = 10/183 (5%)

Query: 72  FEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLV 131
           +        + +++       +   +E     I    ++ H NI+KL G   +     LV
Sbjct: 10  YLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLV 69

Query: 132 FESVKYGTLRGF--SFASLLIAPRI-KIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLD 188
            E  + G+L+         L    I +I ++I   + YLH      I+ R +K  N+LLD
Sbjct: 70  MEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLD 126

Query: 189 E-NYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPE-YFATSSFNEMCDVYSFGAFL 246
             N   KL DF LS  +   ++ ++   I G   ++APE       ++E  D++S G  L
Sbjct: 127 SDNGKVKLADFGLSKLLTSDKSLLKT--IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVIL 184

Query: 247 CEL 249
            EL
Sbjct: 185 YEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score = 94.1 bits (235), Expect = 2e-22
 Identities = 60/222 (27%), Positives = 88/222 (39%), Gaps = 37/222 (16%)

Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRI-------KIAMEI 160
            ++KH NI++L     + +   LV E  + G L       LL                +I
Sbjct: 52  KKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLF-----DLLKKRGRLSEDEARFYLRQI 106

Query: 161 ANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAY 220
            +A+ YLH    + IV R +K  N+LLDE+   KL DF L+  +  GE      F+ G  
Sbjct: 107 LSALEYLH---SKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK--LTTFV-GTP 160

Query: 221 GFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENN 280
            ++APE      + +  D++S G  L ELLTG     F G+    +L             
Sbjct: 161 EYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPP--FPGDDQLLEL------------- 205

Query: 281 RFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
            F  I  P             + +    L+ K L K PE R 
Sbjct: 206 -FKKIGKPKPPFPPPEWDISPEAKD---LIRKLLVKDPEKRL 243

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score = 88.5 bits (220), Expect = 3e-20
 Identities = 63/220 (28%), Positives = 90/220 (40%), Gaps = 32/220 (14%)

Query: 110 MKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPR--IKIAMEIANAVAYL 167
           + H NI++LI    + +   LV E  + G L  +      ++     KIA++I   + YL
Sbjct: 55  LSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYL 114

Query: 168 HVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPE- 226
           H      I+ R +K  N+LLDEN   K+ DF L+  +    +     F+ G   ++APE 
Sbjct: 115 H---SNGIIHRDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFV-GTPWYMAPEV 169

Query: 227 ----YFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRF 282
                          DV+S G  L ELLTG     F G    D L ++            
Sbjct: 170 LLGGNGYGPK----VDVWSLGVILYELLTGKPP--FSGENILDQLQLIRRILGP------ 217

Query: 283 GAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
                  FDE     G EE       L+ KCL+K P  RP
Sbjct: 218 ----PLEFDEPKWSSGSEE----AKDLIKKCLNKDPSKRP 249

Length = 260

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 76.5 bits (188), Expect = 6e-16
 Identities = 54/153 (35%), Positives = 80/153 (52%), Gaps = 19/153 (12%)

Query: 112 HKNILKLIGCCLET--ELPTLVFESVKYGTLRGF------SFASLLIAPRIKIAMEIANA 163
           H+NI+K  GCC E   +   L+ E V  G+LR +      + A LL+      A +I   
Sbjct: 65  HENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLL-----FAQQICEG 119

Query: 164 VAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH--VREEFIKGAYG 221
           +AYLH    +  + R + A NVLLD +   K+ DF L+ ++PEG  +  VRE+     + 
Sbjct: 120 MAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 176

Query: 222 FIAPEYFATSSFNEMCDVYSFGAFLCELLTGCN 254
           + A E    + F+   DV+SFG  L ELLT C+
Sbjct: 177 Y-AVECLKENKFSYASDVWSFGVTLYELLTHCD 208

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 75.0 bits (184), Expect = 3e-15
 Identities = 62/255 (24%), Positives = 103/255 (40%), Gaps = 56/255 (21%)

Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPR--------------- 153
           Q+ H +++KL G C +     L+ E  KYG+LR F   S  + P                
Sbjct: 59  QVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDN 118

Query: 154 -----------IKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSV 202
                      I  A +I+  + YL    +  +V R + A NVL+ E    K+ DF LS 
Sbjct: 119 PDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARNVLVAEGRKMKISDFGLSR 175

Query: 203 SIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGN 261
            + E +++V+    +    ++A E      +    DV+SFG  L E++T G N   + G 
Sbjct: 176 DVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN--PYPGI 233

Query: 262 GNDDDLTVLE--YAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPE 319
             +    +L+  Y  +  EN                        + +  LM  C  + P+
Sbjct: 234 APERLFNLLKTGYRMERPENCS----------------------EEMYNLMLTCWKQEPD 271

Query: 320 HRPLMVDVAKQLRQM 334
            RP   D++K+L +M
Sbjct: 272 KRPTFADISKELEKM 286

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 73.7 bits (181), Expect = 4e-15
 Identities = 72/279 (25%), Positives = 123/279 (44%), Gaps = 39/279 (13%)

Query: 71  LFEGTLVDQD---RPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETE- 126
           ++ GTL+D D      +V   +  + L++VE      +      H N+L L+G CL +E 
Sbjct: 11  VYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEG 70

Query: 127 LPTLVFESVKYGTLRGFSFASLLIAPRIK----IAMEIANAVAYLHVGFDRPIVFRCIKA 182
            P +V   +K+G LR F   S    P +K      +++A  + YL     +  V R + A
Sbjct: 71  SPLVVLPYMKHGDLRNF-IRSETHNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAA 126

Query: 183 SNVLLDENYSAKLHDFSLSVSIPEGETH-VREEFIKGA---YGFIAPEYFATSSFNEMCD 238
            N +LDE+++ K+ DF L+  I + E + V      GA     ++A E   T  F    D
Sbjct: 127 RNCMLDESFTVKVADFGLARDIYDKEYYSVHNH--TGAKLPVKWMALESLQTQKFTTKSD 184

Query: 239 VYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPG 298
           V+SFG  L EL+T       +G     D+   +     ++  R   ++ P +  D     
Sbjct: 185 VWSFGVLLWELMT-------RGAPPYPDVDSFDITVYLLQGRR---LLQPEYCPD----- 229

Query: 299 KEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS 337
                  L ++M  C    PE RP   ++  ++ Q++ +
Sbjct: 230 ------PLYEVMLSCWHPKPEMRPTFSELVSRIEQIFST 262

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 73.4 bits (181), Expect = 5e-15
 Identities = 63/255 (24%), Positives = 96/255 (37%), Gaps = 42/255 (16%)

Query: 83  ISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLR- 141
           I V+K     + +  E   N I    + KH NI+K  G  L+ +   +V E    G+L+ 
Sbjct: 30  IKVIKL---ESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKD 86

Query: 142 -----GFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLH 196
                  +     IA    +  E+   + YLH      I+ R IKA+N+LL  +   KL 
Sbjct: 87  LLKSTNQTLTESQIA---YVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLI 140

Query: 197 DFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVL 256
           DF LS  + + +   R   + G   ++APE      ++   D++S G    EL  G    
Sbjct: 141 DFGLSAQLSDTKA--RNTMV-GTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPY 197

Query: 257 EFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSK 316
                     +  L             A   P    +      E         + KCL K
Sbjct: 198 -----SELPPMKALFKI----------ATNGPPGLRNPEKWSDE-----FKDFLKKCLQK 237

Query: 317 SPEHRPLMVDVAKQL 331
           +PE RP     A+QL
Sbjct: 238 NPEKRP----TAEQL 248

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 73.6 bits (181), Expect = 6e-15
 Identities = 43/151 (28%), Positives = 71/151 (47%), Gaps = 15/151 (9%)

Query: 112 HKNILKLIGCCLETELPT--LVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANAVAY 166
           H+NI+K  G C +    +  L+ E +  G+LR +       + +   +  + +I   + Y
Sbjct: 65  HENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDY 124

Query: 167 LHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH--VRE--EFIKGAYGF 222
           L     +  + R + A N+L++     K+ DF L+  +PE + +  V+E  E     Y  
Sbjct: 125 LG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-- 179

Query: 223 IAPEYFATSSFNEMCDVYSFGAFLCELLTGC 253
            APE   TS F+   DV+SFG  L EL T  
Sbjct: 180 -APECLRTSKFSSASDVWSFGVTLYELFTYG 209

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 73.7 bits (181), Expect = 2e-14
 Identities = 64/229 (27%), Positives = 100/229 (43%), Gaps = 25/229 (10%)

Query: 109 QMKHKNILKLIGCCLETELPTLVFESVK----YGTLRGFSFASLLIAPRIKIAMEIANAV 164
           +++H NI+KLIG C   +   L+ E ++       LR  S+       R KIA+ IA A+
Sbjct: 739 KLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRNLSWER-----RRKIAIGIAKAL 793

Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIA 224
            +LH      +V   +    +++D      L      +S+P       + FI  AY  +A
Sbjct: 794 RFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL-----RLSLPGLLCTDTKCFISSAY--VA 846

Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLTGCNV--LEFKGNGNDDDLTVLEYAKKSIENNRF 282
           PE   T    E  D+Y FG  L ELLTG +    EF  +G     +++E+A+    +   
Sbjct: 847 PETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHG-----SIVEWARYCYSDCHL 901

Query: 283 GAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQL 331
              +DP    D S    + ++  +  L   C +  P  RP   DV K L
Sbjct: 902 DMWIDPSIRGDVSV--NQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948

Length = 968

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score = 71.0 bits (175), Expect = 4e-14
 Identities = 48/161 (29%), Positives = 74/161 (45%), Gaps = 13/161 (8%)

Query: 108 SQMKHKNILKLIGCCLETELPTL-VF-ESVKYGTLRGF--SFASL---LIAPRIKIAMEI 160
           S ++H NI++  G   + E  TL +F E V  G+L      F  L   +I    K   +I
Sbjct: 54  SSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVI---RKYTRQI 110

Query: 161 ANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAY 220
              +AYLH      IV R IK +N+L+D +   KL DF  +  + + ET      ++G  
Sbjct: 111 LEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTP 167

Query: 221 GFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGN 261
            ++APE      +    D++S G  + E+ TG       GN
Sbjct: 168 YWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN 208

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 71.7 bits (174), Expect = 6e-14
 Identities = 60/232 (25%), Positives = 90/232 (38%), Gaps = 26/232 (11%)

Query: 112 HKNILKLIGCCLETELPTLVFESVKYGTLR-----GFSFASLLIAPRIKIAMEIANAVAY 166
             NI+KL     +     LV E V  G+L            L  +  + I  +I +A+ Y
Sbjct: 57  PPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEY 116

Query: 167 LHVGFDRPIVFRCIKASNVLLDENYS-AKLHDFSLSVSIPEGETHVREEFIK----GAYG 221
           LH    + I+ R IK  N+LLD +    KL DF L+  +P+  +      +     G  G
Sbjct: 117 LH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPG 173

Query: 222 FIAPEYFATSSFNEMC---DVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIE 278
           ++APE     S        D++S G  L ELLTG    E + N +    T+     K I 
Sbjct: 174 YMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTL-----KIIL 228

Query: 279 NNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ 330
                    P      S    E   ++   L+ K L+K P++R         
Sbjct: 229 ELPT-----PSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275

Length = 384

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 69.3 bits (170), Expect = 1e-13
 Identities = 58/228 (25%), Positives = 96/228 (42%), Gaps = 31/228 (13%)

Query: 110 MKHKNILKLIGCCLETELPTLVFESVKYG----TLRGFSFASLLIAPRIKIAMEIANAVA 165
           + H+N+++L G  L   L  +V E    G     LR  +    LI+     A++IAN + 
Sbjct: 53  LDHENLIRLYGVVLTHPL-MMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMR 111

Query: 166 YLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEF-IKGAYGFIA 224
           YL     +  + R + A N+LL  +   K+ DF L  ++P+ E H   E  +K  + + A
Sbjct: 112 YLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCA 168

Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKG-NGNDDDLTVLEYAKKSIENNRFG 283
           PE   T +F+   DV+ FG  L E+ T      + G +G+                    
Sbjct: 169 PESLRTRTFSHASDVWMFGVTLWEMFTYGE-EPWAGLSGSQ------------------- 208

Query: 284 AIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQL 331
            I+  I  E       E   Q +  +M +C + +P  RP    + + L
Sbjct: 209 -ILKKIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 69.5 bits (170), Expect = 1e-13
 Identities = 62/247 (25%), Positives = 97/247 (39%), Gaps = 38/247 (15%)

Query: 90  DNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETE------LPTLVFESVKYGTLRGF 143
           D  T  ++E   +         H N++KLIG C E         P ++   +K+G L  F
Sbjct: 38  DIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSF 97

Query: 144 SFASLL-IAPR-------IKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKL 195
              S L   P        +K  ++IA  + YL    +R  + R + A N +L E+ +  +
Sbjct: 98  LLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCV 154

Query: 196 HDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNV 255
            DF LS  I  G+ + +    K    +IA E  A   +    DV++FG  + E+ T    
Sbjct: 155 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATR-GQ 213

Query: 256 LEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLS 315
             + G  N +   + +Y       NR                  E+ L  L  LMY C  
Sbjct: 214 TPYPGVENHE---IYDYL---RHGNRLKQ--------------PEDCLDELYDLMYSCWR 253

Query: 316 KSPEHRP 322
             P+ RP
Sbjct: 254 ADPKDRP 260

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 67.1 bits (164), Expect = 1e-12
 Identities = 69/276 (25%), Positives = 109/276 (39%), Gaps = 44/276 (15%)

Query: 72  FEGTLVDQDRP---ISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELP 128
           ++G  +  +     ++V    + ++    E          Q  H +I+KLIG    TE P
Sbjct: 23  YQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVI--TENP 80

Query: 129 T-LVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASN 184
             +V E    G LR +   +  SL +A  I  + +++ A+AYL     +  V R I A N
Sbjct: 81  VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARN 137

Query: 185 VLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYG-----FIAPEYFATSSFNEMCDV 239
           VL+      KL DF LS  + +      E + K + G     ++APE      F    DV
Sbjct: 138 VLVSSPDCVKLGDFGLSRYLED------ESYYKASKGKLPIKWMAPESINFRRFTSASDV 191

Query: 240 YSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGK 299
           + FG  + E+L    V  F+G  N+D +  +E                         P  
Sbjct: 192 WMFGVCMWEILM-LGVKPFQGVKNNDVIGRIE--------------------NGERLPMP 230

Query: 300 EEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMY 335
                +L  LM KC +  P  RP   ++  QL  + 
Sbjct: 231 PNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 66.5 bits (162), Expect = 1e-12
 Identities = 58/254 (22%), Positives = 107/254 (42%), Gaps = 38/254 (14%)

Query: 96  DVEYCFNNIVFSSQMKHKNILKLIGCCLETE------LPTLVFESVKYGTLRGFSFAS-- 147
           D+E          +  H N++KLIG  L +       +P ++   +K+G L  F   S  
Sbjct: 44  DIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRI 103

Query: 148 ------LLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLS 201
                 L +   ++  ++IA+ + YL     +  + R + A N +L+EN +  + DF LS
Sbjct: 104 GEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLS 160

Query: 202 VSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGN 261
             I  G+ + +    K    ++A E  A + +    DV++FG  + E++T      + G 
Sbjct: 161 KKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQT-PYAGV 219

Query: 262 GNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHR 321
            N +   +  Y    I+ NR                   + L+ + +LM +C S  P+ R
Sbjct: 220 ENSE---IYNYL---IKGNRLKQ--------------PPDCLEDVYELMCQCWSPEPKCR 259

Query: 322 PLMVDVAKQLRQMY 335
           P    +  QL  ++
Sbjct: 260 PSFQHLRDQLELIW 273

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 66.3 bits (162), Expect = 1e-12
 Identities = 40/146 (27%), Positives = 72/146 (49%), Gaps = 12/146 (8%)

Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTL----RGFSFASLLIAPRIKIAMEIANA 163
           + ++H N+++L+G  L+     +V E +  G+L    R    A + +A ++  A+++   
Sbjct: 55  TTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEG 114

Query: 164 VAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFI 223
           + YL    ++  V R + A NVL+ E+  AK+ DF L+      E    ++  K    + 
Sbjct: 115 MEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLA-----KEASQGQDSGKLPVKWT 166

Query: 224 APEYFATSSFNEMCDVYSFGAFLCEL 249
           APE      F+   DV+SFG  L E+
Sbjct: 167 APEALREKKFSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 66.0 bits (161), Expect = 2e-12
 Identities = 65/272 (23%), Positives = 106/272 (38%), Gaps = 44/272 (16%)

Query: 71  LFEGTLVDQD------RPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLE 124
           ++EGT  D          ++V      +T  + +         S   H NI+KL+G CL 
Sbjct: 11  VYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL 70

Query: 125 TELPTLVFESVKYGT----LRG-----FSFASLLIAPRIKIAMEIANAVAYLHVGFDRPI 175
            E   ++ E ++ G     LR      F    L +   + I +++A    YL        
Sbjct: 71  NEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHF 127

Query: 176 VFRCIKASNVLLDE-NYSA----KLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFAT 230
           + R + A N L+ E  Y A    K+ DF L+  I + + + +E        ++APE    
Sbjct: 128 IHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLD 187

Query: 231 SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIF 290
             F    DV+SFG  + E+LT      +    N +   VL++          G +  P  
Sbjct: 188 GKFTTQSDVWSFGVLMWEILTLGQ-QPYPALNNQE---VLQHVTAG------GRLQKP-- 235

Query: 291 DEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
               + P K      + QLM  C ++ P  RP
Sbjct: 236 ---ENCPDK------IYQLMTNCWAQDPSERP 258

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 65.8 bits (161), Expect = 2e-12
 Identities = 60/218 (27%), Positives = 91/218 (41%), Gaps = 29/218 (13%)

Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF----SFASLLIAPRIKIAMEIANAV 164
           +++H  +++L   C E E   +V E +  G+L  F        L +   + +A +IA  +
Sbjct: 57  KLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGM 116

Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIA 224
           AYL     R  + R + A N+L+ EN   K+ DF L+  I + E   RE   K    + A
Sbjct: 117 AYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREG-AKFPIKWTA 172

Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA 284
           PE      F    DV+SFG  L E++T   V  + G  N + L  +E   +         
Sbjct: 173 PEAANYGRFTIKSDVWSFGILLTEIVTYGRV-PYPGMTNREVLEQVERGYR--------- 222

Query: 285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
                       P      + L  LM +C  K PE RP
Sbjct: 223 -----------MPRPPNCPEELYDLMLQCWDKDPEERP 249

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 64.4 bits (157), Expect = 7e-12
 Identities = 53/217 (24%), Positives = 95/217 (43%), Gaps = 30/217 (13%)

Query: 110 MKHKNILKLIGCCLETELPTLVFESVKYGTLRGF----SFASLLIAPRIKIAMEIANAVA 165
           ++HK+++ L   C   E   ++ E ++ G+L  F        L +A  I +A ++A  +A
Sbjct: 59  LRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMA 118

Query: 166 YLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAP 225
           YL    ++  + R + A N+L+ E+   K+ DF L+  I E + ++  +  K  Y + AP
Sbjct: 119 YLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKE-DVYLSSD-KKIPYKWTAP 173

Query: 226 EYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAI 285
           E  +  +F+   DV+SFG  L E+ T                    Y +          +
Sbjct: 174 EAASHGTFSTKSDVWSFGILLYEMFT--------------------YGQVPYPGMNNHEV 213

Query: 286 VDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
            D I       P   +  Q + ++M +C +  PE RP
Sbjct: 214 YDQI-TAGYRMPCPAKCPQEIYKIMLECWAAEPEDRP 249

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 64.3 bits (157), Expect = 7e-12
 Identities = 60/239 (25%), Positives = 91/239 (38%), Gaps = 44/239 (18%)

Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIKI------AMEIA 161
           +Q+ H  I++LIG C    L  LV E    G L  +    L     I +      A ++A
Sbjct: 51  AQLDHPCIVRLIGVCKGEPL-MLVMELAPLGPLLKY----LKKRREIPVSDLKELAHQVA 105

Query: 162 NAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEF-----I 216
             +AYL     +  V R + A NVLL   + AK+ DF +S ++  G  + R        +
Sbjct: 106 MGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPL 162

Query: 217 KGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKS 276
           K    + APE      F+   DV+S+G  L E  +                    Y +  
Sbjct: 163 K----WYAPECINYGKFSSKSDVWSYGVTLWEAFS---------------YGAKPYGEMK 203

Query: 277 IENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMY 335
                 GA V  + +     P  EE  Q +  +M  C    PE RP   ++    R+  
Sbjct: 204 ------GAEVIAMLESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 63.8 bits (156), Expect = 1e-11
 Identities = 41/150 (27%), Positives = 74/150 (49%), Gaps = 13/150 (8%)

Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF-----SFASLLIAPRIKIAMEIAN 162
             +KH NI+K IG    ++   ++ E  + G+LR        F   L+A  +    ++  
Sbjct: 54  KNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVY---QVLQ 110

Query: 163 AVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGF 222
            +AYLH   ++ ++ R IKA+N+L  ++   KL DF ++  +   +    +  + G   +
Sbjct: 111 GLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKL--NDVSKDDASVVGTPYW 165

Query: 223 IAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
           +APE    S  +   D++S G  + ELLTG
Sbjct: 166 MAPEVIEMSGASTASDIWSLGCTVIELLTG 195

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 63.9 bits (155), Expect = 1e-11
 Identities = 63/258 (24%), Positives = 106/258 (41%), Gaps = 44/258 (17%)

Query: 93  TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETE------LPTLVFESVKYGTLRGFSFA 146
           T  ++E   +  V   +  H N+++LIG CL+T        P ++   +K+G L  F   
Sbjct: 40  TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLY 99

Query: 147 SLL-----IAPR---IKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDF 198
           S L       P    +K   +IA+ + YL     +  + R + A N +L+EN +  + DF
Sbjct: 100 SRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADF 156

Query: 199 SLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEF 258
            LS  I  G+ + +    K    +IA E  A   +    DV+SFG  + E+ T       
Sbjct: 157 GLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIAT------- 209

Query: 259 KGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFD---EDNSFPGKEEKLQSLGQLMYKCLS 315
           +G          +     +EN+        I+D   + N      + L  L  LM  C  
Sbjct: 210 RG----------QTPYPGVENSE-------IYDYLRQGNRLKQPPDCLDGLYSLMSSCWL 252

Query: 316 KSPEHRPLMVDVAKQLRQ 333
            +P+ RP    +  +L +
Sbjct: 253 LNPKDRPSFETLRCELEK 270

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 62.5 bits (152), Expect = 3e-11
 Identities = 53/226 (23%), Positives = 94/226 (41%), Gaps = 27/226 (11%)

Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANAVA 165
           Q  H NI+KLIG C++ +   +V E V  G+L  F       L +   ++++++ A  + 
Sbjct: 48  QYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGME 107

Query: 166 YLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAP 225
           YL     +  + R + A N L+ EN   K+ DF +S     G   V +   +    + AP
Sbjct: 108 YLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAP 164

Query: 226 EYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAI 285
           E      +    DV+S+G  L E  +      + G  N          ++ IE+      
Sbjct: 165 EALNYGRYTSESDVWSYGILLWETFSL-GDTPYPGMSNQQ-------TRERIESG----- 211

Query: 286 VDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQL 331
                      P  +   + + +LM +C +  PE+RP   ++  +L
Sbjct: 212 --------YRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNEL 249

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 62.2 bits (151), Expect = 4e-11
 Identities = 42/147 (28%), Positives = 74/147 (50%), Gaps = 8/147 (5%)

Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTL----RGFSFASLLIAPRIKIAMEIANAV 164
           ++KH N+++L+G C       ++ E + YG L    R  +   +     + +A +I++A+
Sbjct: 58  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAM 117

Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIA 224
            YL     +  + R + A N L+ EN+  K+ DF LS  +  G+T+      K    + A
Sbjct: 118 EYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTA 173

Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLT 251
           PE  A + F+   DV++FG  L E+ T
Sbjct: 174 PESLAYNKFSIKSDVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 62.1 bits (151), Expect = 4e-11
 Identities = 46/147 (31%), Positives = 76/147 (51%), Gaps = 8/147 (5%)

Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGT----LRGFSFASLLIAPRIKIAMEIANAV 164
           +++H  +++L   C   E   +V E +KYG+    L+G +  +L +   I +A ++A+ +
Sbjct: 57  KLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGM 116

Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIA 224
           AYL     +  + R + A NVL+ EN   K+ DF L+  I E     RE   K    + A
Sbjct: 117 AYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREG-AKFPIKWTA 172

Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLT 251
           PE    + F+   DV+SFG  L E++T
Sbjct: 173 PEAALYNRFSIKSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 62.2 bits (151), Expect = 5e-11
 Identities = 40/158 (25%), Positives = 79/158 (50%), Gaps = 15/158 (9%)

Query: 104 IVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF-----SFASLLIAPRIKIAM 158
           I    +++H+NI++ +G  L+ +   +  E V  G++        +F   L+   ++   
Sbjct: 57  IALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVR--- 113

Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLS----VSIPEGETHVREE 214
           +I   + YLH   +R I+ R IK +N+L+D     K+ DF +S     +    +T+    
Sbjct: 114 QILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARP 170

Query: 215 FIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
            ++G+  ++APE    +S+    D++S G  + E+LTG
Sbjct: 171 SLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTG 208

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 61.6 bits (149), Expect = 7e-11
 Identities = 60/218 (27%), Positives = 95/218 (43%), Gaps = 30/218 (13%)

Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF---SFASLLIAPR-IKIAMEIANAV 164
           +++H+ +++L     E  +  +V E +  G+L  F        L  P+ + +A +IA+ +
Sbjct: 57  KLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGM 115

Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIA 224
           AY+        V R ++A+N+L+ EN   K+ DF L+  I + E   R+   K    + A
Sbjct: 116 AYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTA 171

Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA 284
           PE      F    DV+SFG  L EL T   V  + G  N + L  +E   +         
Sbjct: 172 PEAALYGRFTIKSDVWSFGILLTELTTKGRV-PYPGMVNREVLDQVERGYR--------- 221

Query: 285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
                       P   E  +SL  LM +C  K PE RP
Sbjct: 222 -----------MPCPPECPESLHDLMCQCWRKEPEERP 248

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 61.1 bits (148), Expect = 1e-10
 Identities = 44/149 (29%), Positives = 70/149 (46%), Gaps = 9/149 (6%)

Query: 110 MKHKNILKLIGCCLETELPTLVFESVKYGTLRGF--SFASLLIAPRIKIAMEIANAVAYL 167
           +KH NI++ +G CL+    ++  E V  G++      F  L      K   +I + VAYL
Sbjct: 59  LKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYL 118

Query: 168 HVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHV-REEFIKGAYG---FI 223
           H   +  +V R IK +NV+L  N   KL DF  +  +     H      +K  +G   ++
Sbjct: 119 H---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWM 175

Query: 224 APEYFATSSFNEMCDVYSFGAFLCELLTG 252
           APE    S +    D++S G  + E+ TG
Sbjct: 176 APEVINESGYGRKSDIWSIGCTVFEMATG 204

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 61.3 bits (149), Expect = 1e-10
 Identities = 41/163 (25%), Positives = 76/163 (46%), Gaps = 10/163 (6%)

Query: 95  DDVEYCFNNIVFSSQMKH---KNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIA 151
           DDV      +   SQ++     NI K  G  L+     ++ E  + G++R    A  +  
Sbjct: 41  DDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAE 100

Query: 152 PRIKIAM-EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH 210
             I + + E+  A+ Y+H      ++ R IKA+N+L+    + KL DF ++  + +  + 
Sbjct: 101 KYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN-SS 156

Query: 211 VREEFIKGAYGFIAPEYFAT-SSFNEMCDVYSFGAFLCELLTG 252
            R  F+   Y ++APE       ++   D++S G  + E+ TG
Sbjct: 157 KRSTFVGTPY-WMAPEVITEGKYYDTKADIWSLGITIYEMATG 198

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 59.5 bits (145), Expect = 3e-10
 Identities = 46/175 (26%), Positives = 68/175 (38%), Gaps = 31/175 (17%)

Query: 149 LIAPRIK-IAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEG 207
               R +  A EI  A+ YLH      I++R +K  N+LLD +   KL DF L+  +   
Sbjct: 90  FSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSE 146

Query: 208 ETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDL 267
            +     F  G   ++APE      + +  D +S G  L E+LTG     F         
Sbjct: 147 GSRTNT-FC-GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGK--PPF--------- 193

Query: 268 TVLEYAKKSIENNRFGAIVDPIFDEDNSFP-GKEEKLQSLGQLMYKCLSKSPEHR 321
               YA+   E      I + I  +   FP     + +    L+   L K P  R
Sbjct: 194 ----YAEDRKE------IYEKILKDPLRFPEFLSPEARD---LISGLLQKDPTKR 235

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 59.7 bits (145), Expect = 4e-10
 Identities = 51/208 (24%), Positives = 95/208 (45%), Gaps = 18/208 (8%)

Query: 59  LHKVIQSDTSYRLFEGTLVDQD----RPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKN 114
           L  ++Q  T  R+F G L+D+       + V    D+++   V            + H+N
Sbjct: 10  LSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQN 69

Query: 115 ILKLIGCCLE-TELPTLVFESVKYGTLRGF----------SFASLLIAPRIKIAMEIANA 163
           IL ++  C+E  E P +++  + +G L+ F          +  +L     + +A++IA  
Sbjct: 70  ILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACG 129

Query: 164 VAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFI 223
           ++YLH    R ++ + I A N ++DE    K+ D +LS  +   + H   +       ++
Sbjct: 130 MSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWM 186

Query: 224 APEYFATSSFNEMCDVYSFGAFLCELLT 251
           A E      ++   DV+SFG  L EL+T
Sbjct: 187 ALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 58.7 bits (143), Expect = 5e-10
 Identities = 63/251 (25%), Positives = 97/251 (38%), Gaps = 45/251 (17%)

Query: 85  VMKFHD--NSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL-- 140
           V+K  D  N +  + E   N +    ++ H NI+K      E     +V E    G L  
Sbjct: 29  VLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQ 88

Query: 141 -------RGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSA 193
                   G  F    I   +   +++  A+ YLH    R I+ R IK  N+ L  N   
Sbjct: 89  KIKKQKKEGKPFPEEQI---LDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLV 142

Query: 194 KLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGC 253
           KL DF +S  +      + +  +   Y +++PE      +N   D++S G  L EL T  
Sbjct: 143 KLGDFGIS-KVLSSTVDLAKTVVGTPY-YLSPELCQNKPYNYKSDIWSLGCVLYELCT-- 198

Query: 254 NVLE--FKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMY 311
             L+  F+G        +LE A K ++         PI    + +         L  L+ 
Sbjct: 199 --LKHPFEGE------NLLELALKILKGQ-----YPPI---PSQYS------SELRNLVS 236

Query: 312 KCLSKSPEHRP 322
             L K PE RP
Sbjct: 237 SLLQKDPEERP 247

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 58.5 bits (141), Expect = 8e-10
 Identities = 53/217 (24%), Positives = 92/217 (42%), Gaps = 29/217 (13%)

Query: 110 MKHKNILKLIGCCLETELPTLVFESVKYGTLRGF---SFASLLIAPR-IKIAMEIANAVA 165
           ++H  +++L     + E   ++ E +  G+L  F        ++ P+ I  + +IA  +A
Sbjct: 58  LQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMA 117

Query: 166 YLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAP 225
           Y+     +  + R ++A+NVL+ E+   K+ DF L+  I + E   RE   K    + AP
Sbjct: 118 YIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREG-AKFPIKWTAP 173

Query: 226 EYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAI 285
           E     SF    DV+SFG  L E++T   +  + G  N D ++ L+   +          
Sbjct: 174 EAINFGSFTIKSDVWSFGILLYEIVTYGKI-PYPGMSNSDVMSALQRGYR---------- 222

Query: 286 VDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
                      P  E     L  +M  C  +  E RP
Sbjct: 223 ----------MPRMENCPDELYDIMKTCWKEKAEERP 249

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 58.6 bits (142), Expect = 8e-10
 Identities = 51/211 (24%), Positives = 87/211 (41%), Gaps = 37/211 (17%)

Query: 70  RLFEGTLVDQDRP-----ISVMKFHDNSTLDDVEYCFNNI-VFSSQMKHKNILKLIGCCL 123
           ++ +   V  D P     ++V    D++T  D+    + + +     KHKNI+ L+G C 
Sbjct: 27  QVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86

Query: 124 ETELPTLVFESVKYGTLRGFSFA----------SLLIAPRIKI--------AMEIANAVA 165
           +     +V E   +G LR F  A               P   +        A ++A  + 
Sbjct: 87  QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGME 146

Query: 166 YLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYG---- 221
           +L     +  + R + A NVL+ E++  K+ DF L+  I     H  + + K   G    
Sbjct: 147 FLA---SKKCIHRDLAARNVLVTEDHVMKIADFGLARDI-----HHIDYYRKTTNGRLPV 198

Query: 222 -FIAPEYFATSSFNEMCDVYSFGAFLCELLT 251
            ++APE      +    DV+SFG  L E+ T
Sbjct: 199 KWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 57.4 bits (139), Expect = 2e-09
 Identities = 59/267 (22%), Positives = 110/267 (41%), Gaps = 56/267 (20%)

Query: 78  DQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKY 137
           + +  +++   ++N+++ +     N      +    ++++L+G     +   +V E +  
Sbjct: 34  EPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAK 93

Query: 138 GTLRGF--------SFASLLIAPR----IKIAMEIANAVAYLHVGFDRPIVFRCIKASNV 185
           G L+ +             L  P     I++A EIA+ +AYL     +  V R + A N 
Sbjct: 94  GDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNC 150

Query: 186 LLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYG-----FIAPE-----YFATSSFNE 235
           ++ E+ + K+ DF ++  I E      + + KG  G     ++APE      F T S   
Sbjct: 151 MVAEDLTVKIGDFGMTRDIYE-----TDYYRKGGKGLLPVRWMAPESLKDGVFTTKS--- 202

Query: 236 MCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNS 295
             DV+SFG  L E+ T      ++G  N++   VL++          G  +D        
Sbjct: 203 --DVWSFGVVLWEMAT-LAEQPYQGLSNEE---VLKFVID-------GGHLDL------- 242

Query: 296 FPGKEEKLQSLGQLMYKCLSKSPEHRP 322
               E     L +LM  C   +P+ RP
Sbjct: 243 ---PENCPDKLLELMRMCWQYNPKMRP 266

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 57.2 bits (139), Expect = 2e-09
 Identities = 49/206 (23%), Positives = 77/206 (37%), Gaps = 28/206 (13%)

Query: 130 LVFESVKYGTLRGFSFASLLIAPRI--KIAMEIANAVAYLHVGFDRPIVFRCIKASNVLL 187
           +V E +  G+L         I   +   IA +I   + YLH    R I+ R IK SN+L+
Sbjct: 76  IVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHT--KRHIIHRDIKPSNLLI 133

Query: 188 DENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLC 247
           +     K+ DF +S  + E        F+ G   +++PE     S++   D++S G  L 
Sbjct: 134 NSKGEVKIADFGISKVL-ENTLDQCNTFV-GTVTYMSPERIQGESYSYAADIWSLGLTLL 191

Query: 248 ELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLG 307
           E   G                  ++         F  ++  I D        EE      
Sbjct: 192 ECALG------------------KFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFR 233

Query: 308 QLMYKCLSKSPEHRPLMVDVAKQLRQ 333
             +  CL K P+ RP     A +L Q
Sbjct: 234 DFISACLQKDPKKRPS----AAELLQ 255

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 57.4 bits (139), Expect = 2e-09
 Identities = 44/172 (25%), Positives = 68/172 (39%), Gaps = 28/172 (16%)

Query: 155 KIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREE 214
           K+ + I  A+ YL       ++ R +K SN+LLD + + KL DF +S  + + +   R  
Sbjct: 118 KMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS- 174

Query: 215 FIKGAYGFIAPEYF----ATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
              G   ++APE          ++   DV+S G  L EL TG    +F       +  VL
Sbjct: 175 --AGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATG----QFPYKNCKTEFEVL 228

Query: 271 EYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
                         I+    +E  S P  E         +  CL+K    RP
Sbjct: 229 T------------KILQ---EEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRP 265

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 57.1 bits (138), Expect = 2e-09
 Identities = 49/182 (26%), Positives = 82/182 (45%), Gaps = 23/182 (12%)

Query: 85  VMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF- 143
           V+K   +   D + + F      SQ+ HK+++KL G C+  E   +V E VK+G L  F 
Sbjct: 34  VLKVLGSDHRDSLAF-FETASLMSQLSHKHLVKLYGVCVRDE-NIMVEEYVKFGPLDVFL 91

Query: 144 --SFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLL-----DENYS--AK 194
                ++ +  ++ +A ++A+A+ YL    D+ +V   +   N+L+     +E Y    K
Sbjct: 92  HREKNNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIK 148

Query: 195 LHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYF--ATSSFNEMCDVYSFGAFLCELLTG 252
           L D    + I       R E I     +IAPE      +S     D +SFG  L E+ + 
Sbjct: 149 LSD--PGIPITVLSREERVERIP----WIAPECIRNGQASLTIAADKWSFGTTLLEICSN 202

Query: 253 CN 254
             
Sbjct: 203 GE 204

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 56.7 bits (137), Expect = 3e-09
 Identities = 61/247 (24%), Positives = 97/247 (39%), Gaps = 43/247 (17%)

Query: 108 SQMKHKNILKLIGCCLETELPT--LVFESVKYGTLRGF---------SFASLLIAPRIKI 156
             ++H NI+K  G C         LV E + YG+LR +             LL A +I  
Sbjct: 60  KSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICK 119

Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEG-ETHVREEF 215
            ME   +  Y+H         R +   N+L++     K+ DF L+  +P+  E +   E 
Sbjct: 120 GMEYLGSKRYVH---------RDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREP 170

Query: 216 IKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNV--------LEFKGNGNDDDL 267
            +    + APE    S F+   DV+SFG  L EL T  +         +   GN     +
Sbjct: 171 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQM 230

Query: 268 TVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDV 327
            V    +    N R  A   P        PG   ++ +   +M +C +  P  RP   ++
Sbjct: 231 IVYHLIELLKNNGRLPA---P--------PGCPAEIYA---IMKECWNNDPSQRPSFSEL 276

Query: 328 AKQLRQM 334
           A Q+  +
Sbjct: 277 ALQVEAI 283

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 56.5 bits (136), Expect = 3e-09
 Identities = 59/233 (25%), Positives = 100/233 (42%), Gaps = 42/233 (18%)

Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTL-------RG-FSFASLLIAPRIKIAMEI 160
           ++ H  +++L G C E     LVFE +++G L       RG FS  +LL      + +++
Sbjct: 55  KLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLL-----GMCLDV 109

Query: 161 ANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAY 220
              +AYL       ++ R + A N L+ EN   K+ DF ++  + + + +      K   
Sbjct: 110 CEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLD-DQYTSSTGTKFPV 165

Query: 221 GFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENN 280
            + +PE F+ S ++   DV+SFG  + E                    V    K   EN 
Sbjct: 166 KWSSPEVFSFSKYSSKSDVWSFGVLMWE--------------------VFSEGKTPYENR 205

Query: 281 RFGAIVDPIFDEDNSFPGKEEKL--QSLGQLMYKCLSKSPEHRPLMVDVAKQL 331
               +V+ I   +  F   + +L  QS+ +LM  C  + PE RP    +  QL
Sbjct: 206 SNSEVVETI---NAGFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 56.5 bits (136), Expect = 4e-09
 Identities = 58/241 (24%), Positives = 101/241 (41%), Gaps = 34/241 (14%)

Query: 109 QMKHKNILKLIGCCLET--ELPTLVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANA 163
            + H+NI+K  G C E       L+ E +  G+L+ +   +   + +  ++K A++I   
Sbjct: 62  NLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKG 121

Query: 164 VAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH--VREEFIKGAYG 221
           + YL     R  V R + A NVL++  +  K+ DF L+ +I   + +  V+++     + 
Sbjct: 122 MDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFW 178

Query: 222 FIAPEYFATSSFNEMCDVYSFGAFLCELLTGCN--------VLEFKGNGNDDDLTVLEYA 273
           + APE    S F    DV+SFG  L ELLT C+         L+  G      +TV    
Sbjct: 179 Y-APECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGP-THGQMTVTRLV 236

Query: 274 KKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQ 333
           +              + +E    P      + + QLM KC    P  R    ++ +    
Sbjct: 237 R--------------VLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA 282

Query: 334 M 334
           +
Sbjct: 283 I 283

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 56.3 bits (136), Expect = 4e-09
 Identities = 47/170 (27%), Positives = 69/170 (40%), Gaps = 22/170 (12%)

Query: 155 KIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE--THVR 212
           KIA  +   ++YLH    R I+ R IK SN+LL      KL DF +S     GE    + 
Sbjct: 109 KIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVS-----GELVNSLA 160

Query: 213 EEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEY 272
             F   ++ ++APE      ++   DV+S G  L E+         +G      + +L Y
Sbjct: 161 GTFTGTSF-YMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSY 219

Query: 273 AKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
               I N     + D   +  N     EE        + +CL K P  RP
Sbjct: 220 ----IVNMPNPELKD---EPGNGIKWSEE----FKDFIKQCLEKDPTRRP 258

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 56.3 bits (137), Expect = 4e-09
 Identities = 47/177 (26%), Positives = 73/177 (41%), Gaps = 40/177 (22%)

Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF--SFASLLIAPRIK-IAMEIANAVA 165
           ++KH NI+KL+          LVFE      L+ +       L    IK I  ++   +A
Sbjct: 54  ELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLA 112

Query: 166 YLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLS--VSIPEGE-THV------REEFI 216
           Y H      I+ R +K  N+L++ +   KL DF L+    IP    TH       R    
Sbjct: 113 YCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYR---- 165

Query: 217 KGAYGFIAPE------YFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDL 267
                  APE      +++T+      D++S G    E++TG  +  F G+   D L
Sbjct: 166 -------APEILLGSKHYSTA-----VDIWSVGCIFAEMITGKPL--FPGDSEIDQL 208

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 56.2 bits (135), Expect = 4e-09
 Identities = 57/229 (24%), Positives = 97/229 (42%), Gaps = 34/229 (14%)

Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANAVA 165
           Q  H NI+KLIG C + +   +V E V  G    F       L     +K A++ A  +A
Sbjct: 48  QYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMA 107

Query: 166 YLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEG---ETHVREEFIKGAYGF 222
           YL     +  + R + A N L+ EN   K+ DF +S    +G    + +++  IK    +
Sbjct: 108 YLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIK----W 160

Query: 223 IAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRF 282
            APE      ++   DV+S+G  L E  +   V  + G  N       + A++ +E    
Sbjct: 161 TAPEALNYGRYSSESDVWSYGILLWETFS-LGVCPYPGMTN-------QQAREQVEKGYR 212

Query: 283 GAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQL 331
            +      D+             + ++M +C    PE+RP   ++ K+L
Sbjct: 213 MSCPQKCPDD-------------VYKVMQRCWDYKPENRPKFSELQKEL 248

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 56.6 bits (136), Expect = 5e-09
 Identities = 61/247 (24%), Positives = 98/247 (39%), Gaps = 55/247 (22%)

Query: 111 KHKNILKLIGCCLETELPTLVFESVKYGTLRGF-----------SFA-------SLLIAP 152
            H NI+ L+G C       +  E   YG L  F           +FA       +L    
Sbjct: 61  HHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQ 120

Query: 153 RIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVR 212
            ++ A ++A  + YL    ++  + R + A NVL+ EN ++K+ DF LS     GE    
Sbjct: 121 LLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLASKIADFGLS----RGE---- 169

Query: 213 EEFIKGAYGFIAPEYFATSSFN-----EMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDL 267
           E ++K   G +   + A  S N        DV+SFG  L E+++        G      +
Sbjct: 170 EVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS-------LGGTPYCGM 222

Query: 268 TVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDV 327
           T  E  +K  +  R   +  P   +D  +           +LM +C    P  RP    +
Sbjct: 223 TCAELYEKLPQGYR---MEKPRNCDDEVY-----------ELMRQCWRDRPYERPPFAQI 268

Query: 328 AKQLRQM 334
           + QL +M
Sbjct: 269 SVQLSRM 275

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 56.0 bits (135), Expect = 5e-09
 Identities = 54/258 (20%), Positives = 99/258 (38%), Gaps = 41/258 (15%)

Query: 86  MKFHDNSTLDDVEYC---FNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRG 142
           + +  N++ +  E        I   +++ H +I++++G   E     L  E      + G
Sbjct: 33  VTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVE-----WMAG 87

Query: 143 FSFASLLI-------APRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDEN-YSAK 194
            S + LL        A  I    ++   ++YLH   +  I+ R +K +N+L+D      +
Sbjct: 88  GSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLR 144

Query: 195 LHDFSLSVSIPEGETHVRE---EFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT 251
           + DF  +  +    T   E   + + G   F+APE      +   CDV+S G  + E+ T
Sbjct: 145 IADFGAAARLAAKGTGAGEFQGQLL-GTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMAT 203

Query: 252 GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMY 311
                  K   N +  +           N   A++  I     +    E     L  +  
Sbjct: 204 A------KPPWNAEKHS-----------NHL-ALIFKIASATTAPSIPEHLSPGLRDVTL 245

Query: 312 KCLSKSPEHRPLMVDVAK 329
           +CL   PE RP   ++ K
Sbjct: 246 RCLELQPEDRPPSRELLK 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 56.2 bits (136), Expect = 5e-09
 Identities = 50/181 (27%), Positives = 81/181 (44%), Gaps = 26/181 (14%)

Query: 90  DNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLR-------- 141
           D+ + +D++     I+ S Q++H NIL  +   +      +V   + YG+          
Sbjct: 36  DSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFP 95

Query: 142 -GFSFASLLIAPRIKIAMEIANAVAYLH-VGFDRPIVFRCIKASNVLLDENYSAKLHDFS 199
            G     L IA  +K   ++ NA+ Y+H  GF    + R +KAS++LL  +    L    
Sbjct: 96  EGLP--ELAIAFILK---DVLNALDYIHSKGF----IHRSVKASHILLSGDGKVVLSGLR 146

Query: 200 LSVS-IPEGETH-VREEFIKGA---YGFIAPE--YFATSSFNEMCDVYSFGAFLCELLTG 252
            SVS I  G+   V  +F K +     +++PE        +NE  D+YS G   CEL  G
Sbjct: 147 YSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANG 206

Query: 253 C 253
            
Sbjct: 207 H 207

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 56.0 bits (135), Expect = 6e-09
 Identities = 30/98 (30%), Positives = 46/98 (46%), Gaps = 9/98 (9%)

Query: 155 KIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREE 214
           +   E+   V  LH    R I+ R IK  N+L+D+    KL DF LS +         ++
Sbjct: 101 QYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNG-----LENKK 152

Query: 215 FIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
           F+ G   ++APE       ++M D +S G  + E L G
Sbjct: 153 FV-GTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFG 189

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 55.9 bits (135), Expect = 6e-09
 Identities = 51/212 (24%), Positives = 88/212 (41%), Gaps = 42/212 (19%)

Query: 70  RLFEGTL----VDQDRPISVMKFHDNSTLDDVEYCFNNIV-FSSQMKHKNILKLIGCCLE 124
           ++F G       + D+ +  +K    +  +D    F       +  +H+NI+K  G C E
Sbjct: 20  KVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTE 79

Query: 125 TELPTLVFESVKYGTLRGF-----SFASLLIAPR-----------IKIAMEIANAVAYLH 168
            + P +VFE +++G L  F       A+ L +P            ++IA++IA+ + YL 
Sbjct: 80  GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA 139

Query: 169 VGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSI-------PEGETH--VREEFIKGA 219
               +  V R +   N L+  +   K+ DF +S  +         G T   +R       
Sbjct: 140 S---QHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIR------- 189

Query: 220 YGFIAPEYFATSSFNEMCDVYSFGAFLCELLT 251
             ++ PE      F    DV+SFG  L E+ T
Sbjct: 190 --WMPPESIMYRKFTTESDVWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 55.5 bits (134), Expect = 7e-09
 Identities = 35/148 (23%), Positives = 68/148 (45%), Gaps = 13/148 (8%)

Query: 110 MKHKNILKLIGCCLETELPTLVFESVKYGTLRGF------SFASLLIAPRIKIAMEIANA 163
           + H ++++L+G CL +    L+ + +  G L  +      +  S  +   +   ++IA  
Sbjct: 66  VDHPHVVRLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYL---LNWCVQIAKG 121

Query: 164 VAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFI 223
           ++YL    ++ +V R + A NVL+      K+ DF L+  +   E     E  K    ++
Sbjct: 122 MSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWM 178

Query: 224 APEYFATSSFNEMCDVYSFGAFLCELLT 251
           A E      +    DV+S+G  + EL+T
Sbjct: 179 ALESILHRIYTHKSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 55.0 bits (133), Expect = 1e-08
 Identities = 29/101 (28%), Positives = 46/101 (45%), Gaps = 7/101 (6%)

Query: 153 RIKIAM-EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHV 211
           ++K  + EI  A+ YLH    + I+ R IK  N+LLDE     + DF+++  +       
Sbjct: 101 QVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTT 157

Query: 212 REEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
                 G  G++APE      ++   D +S G    E L G
Sbjct: 158 S---TSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRG 195

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 54.7 bits (132), Expect = 1e-08
 Identities = 45/153 (29%), Positives = 71/153 (46%), Gaps = 19/153 (12%)

Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLL----IAPRIKIAM---EI 160
           S+++H NI++ +G   E +   +  E V  G     S A LL      P   I +   +I
Sbjct: 57  SKLQHPNIVQYLGTEREEDNLYIFLELVPGG-----SLAKLLKKYGSFPEPVIRLYTRQI 111

Query: 161 ANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAY 220
              + YLH   DR  V R IK +N+L+D N   KL DF ++  +         +  KG+ 
Sbjct: 112 LLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQV---VEFSFAKSFKGSP 165

Query: 221 GFIAPEYFA-TSSFNEMCDVYSFGAFLCELLTG 252
            ++APE  A    +    D++S G  + E+ TG
Sbjct: 166 YWMAPEVIAQQGGYGLAADIWSLGCTVLEMATG 198

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 54.6 bits (131), Expect = 1e-08
 Identities = 39/148 (26%), Positives = 74/148 (50%), Gaps = 13/148 (8%)

Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF----SFASLLIAPRIKIAMEIANA 163
           +++ HKN+++L+G  L   L  +V E +  G L  F      A + +   ++ ++++A  
Sbjct: 54  TKLHHKNLVRLLGVILHNGL-YIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEG 112

Query: 164 VAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFI 223
           + YL     + +V R + A N+L+ E+  AK+ DF L+     G  + +   +K    + 
Sbjct: 113 MEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLP-VK----WT 164

Query: 224 APEYFATSSFNEMCDVYSFGAFLCELLT 251
           APE      F+   DV+S+G  L E+ +
Sbjct: 165 APEALKHKKFSSKSDVWSYGVLLWEVFS 192

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 54.7 bits (131), Expect = 1e-08
 Identities = 46/162 (28%), Positives = 71/162 (43%), Gaps = 12/162 (7%)

Query: 95  DDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGT----LRGFSFASLLI 150
           D++E     I   SQ     + K  G  L+     ++ E +  G+    LR   F    I
Sbjct: 44  DEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQI 103

Query: 151 APRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH 210
           A  +K   EI   + YLH       + R IKA+NVLL E    KL DF ++  + +  T 
Sbjct: 104 ATMLK---EILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQ 155

Query: 211 VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
           ++     G   ++APE    S+++   D++S G    EL  G
Sbjct: 156 IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKG 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 54.7 bits (131), Expect = 2e-08
 Identities = 59/246 (23%), Positives = 95/246 (38%), Gaps = 55/246 (22%)

Query: 112 HKNILKLIGCCLETELPTLVFESVKYGTLRGF-----------SFA-------SLLIAPR 153
           H NI+ L+G C       L  E   +G L  F           +FA       +L     
Sbjct: 55  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 114

Query: 154 IKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVRE 213
           +  A ++A  + YL     +  + R + A N+L+ ENY AK+ DF LS     G+    E
Sbjct: 115 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLS----RGQ----E 163

Query: 214 EFIKGAYGFIAPEYFATSSFN-----EMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLT 268
            ++K   G +   + A  S N        DV+S+G  L E+++        G      +T
Sbjct: 164 VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS-------LGGTPYCGMT 216

Query: 269 VLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVA 328
             E  +K  +  R   +  P+  +D  +            LM +C  + P  RP    + 
Sbjct: 217 CAELYEKLPQGYR---LEKPLNCDDEVY-----------DLMRQCWREKPYERPSFAQIL 262

Query: 329 KQLRQM 334
             L +M
Sbjct: 263 VSLNRM 268

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 54.3 bits (131), Expect = 2e-08
 Identities = 48/182 (26%), Positives = 75/182 (41%), Gaps = 25/182 (13%)

Query: 85  VMKFHDN--STLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRG 142
            ++  DN   T+ ++      +     +KH N++K  G  +  E   +  E    GTL  
Sbjct: 32  EIRIQDNDPKTIKEIADEMKVL---ELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTL-- 86

Query: 143 FSFASLLIAPRI-------KIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKL 195
                LL   RI          +++   +AYLH      IV R IK +N+ LD N   KL
Sbjct: 87  ---EELLEHGRILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKL 140

Query: 196 HDFSLSVSIPEGETHVREEF--IKGAYGFIAPEYFATSSFNE---MCDVYSFGAFLCELL 250
            DF  +V +    T + EE   + G   ++APE              D++S G  + E+ 
Sbjct: 141 GDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMA 200

Query: 251 TG 252
           TG
Sbjct: 201 TG 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 47/207 (22%), Positives = 87/207 (42%), Gaps = 35/207 (16%)

Query: 73  EGTLVDQDRP-----ISVMKFHDNSTLDDVEYCFNNIVFSSQM-----KHKNILKLIGCC 122
           E   +D+D+P     ++V    D++T  D+    +++V   +M     KHKNI+ L+G C
Sbjct: 35  EALGIDKDKPKEAVTVAVKMLKDDATEKDL----SDLVSEMEMMKMIGKHKNIINLLGAC 90

Query: 123 LETELPTLVFESVKYGTLRGFSFA------------------SLLIAPRIKIAMEIANAV 164
            +     ++ E    G LR +  A                   +     +    ++A  +
Sbjct: 91  TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGM 150

Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIA 224
            YL     +  + R + A NVL+ EN   K+ DF L+  +   + + +    +    ++A
Sbjct: 151 EYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMA 207

Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLT 251
           PE      +    DV+SFG  + E+ T
Sbjct: 208 PEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 54.2 bits (131), Expect = 2e-08
 Identities = 57/218 (26%), Positives = 88/218 (40%), Gaps = 37/218 (16%)

Query: 50  LKKATNNYDLHKVIQSDTSYRLFEGTLVDQDR--PISVMKF-HDNSTLDDVEYCFNNIV- 105
           L   T  ++L +VI   T  ++++       +   I +M    D       EY   NI+ 
Sbjct: 1   LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEY---NILR 57

Query: 106 -FSSQMKHKNILKLIGCCLETELPT------LVFESVKYGTLRGFSFASLLIAPRIK--- 155
            +S+   H NI    G  ++   P       LV E    G++            R+K   
Sbjct: 58  KYSN---HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEW 114

Query: 156 ---IAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLS--VSIPEGETH 210
              I  E    +AYLH   +  ++ R IK  N+LL +N   KL DF +S  +    G   
Sbjct: 115 IAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGR-- 169

Query: 211 VREEFIKGAYGFIAPEYFA-----TSSFNEMCDVYSFG 243
            R  FI   Y ++APE  A      +S++   DV+S G
Sbjct: 170 -RNTFIGTPY-WMAPEVIACDEQPDASYDARSDVWSLG 205

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 53.9 bits (129), Expect = 3e-08
 Identities = 56/218 (25%), Positives = 94/218 (43%), Gaps = 30/218 (13%)

Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF----SFASLLIAPRIKIAMEIANAV 164
           +++H  ++ L     E  +  +V E +  G+L  F        L +   + +A +IA+ +
Sbjct: 57  KLRHDKLVPLYAVVSEEPI-YIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGM 115

Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIA 224
           AY+        + R ++A+N+L+ +N   K+ DF L+  I + E   R+   K    + A
Sbjct: 116 AYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQG-AKFPIKWTA 171

Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA 284
           PE      F    DV+SFG  L EL+T   V  + G  N +   VLE  ++         
Sbjct: 172 PEAALYGRFTIKSDVWSFGILLTELVTKGRV-PYPGMVNRE---VLEQVERGYR------ 221

Query: 285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
                       P  +   +SL +LM  C  K P+ RP
Sbjct: 222 -----------MPCPQGCPESLHELMKLCWKKDPDERP 248

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 53.5 bits (129), Expect = 3e-08
 Identities = 49/162 (30%), Positives = 77/162 (47%), Gaps = 21/162 (12%)

Query: 104 IVFSSQMKHKNILK-----LIGCCLETELPTL----VFESVKYGTLRGFSFASLLIAPRI 154
           +   SQ  H N++K     ++G  L   +P L    + + +K    RG      +IA  +
Sbjct: 50  VQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGG-LDEAIIATVL 108

Query: 155 KIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEG---ETHV 211
           K   E+   + YLH       + R IKA N+LL E+ S K+ DF +S S+ +G      V
Sbjct: 109 K---EVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKV 162

Query: 212 REEFIKGAYGFIAPEYFAT-SSFNEMCDVYSFGAFLCELLTG 252
           R+ F+ G   ++APE       ++   D++SFG    EL TG
Sbjct: 163 RKTFV-GTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATG 203

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 53.3 bits (128), Expect = 4e-08
 Identities = 47/163 (28%), Positives = 70/163 (42%), Gaps = 25/163 (15%)

Query: 104 IVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIA---------PRI 154
           I   S +KH+NI++ +G   E     +  E V  G+L     ++LL +           I
Sbjct: 56  IALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSL-----SALLRSKWGPLKDNEQTI 110

Query: 155 KI-AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSA--KLHDFSLSVSIPEGETHV 211
                +I   + YLH   D  IV R IK  NVL++  YS   K+ DF  S  +  G    
Sbjct: 111 IFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVN-TYSGVVKISDFGTSKRLA-GINPC 165

Query: 212 REEFIKGAYGFIAPEYF--ATSSFNEMCDVYSFGAFLCELLTG 252
            E F  G   ++APE        +    D++S G  + E+ TG
Sbjct: 166 TETF-TGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATG 207

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 53.1 bits (127), Expect = 4e-08
 Identities = 54/218 (24%), Positives = 95/218 (43%), Gaps = 30/218 (13%)

Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF----SFASLLIAPRIKIAMEIANAV 164
           +++H  +++L     E  +  +V E +  G+L  F       +L +   + +A ++A  +
Sbjct: 57  KLRHDKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGM 115

Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIA 224
           AY+        + R ++++N+L+ +    K+ DF L+  I + E   R+   K    + A
Sbjct: 116 AYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQG-AKFPIKWTA 171

Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA 284
           PE      F    DV+SFG  L EL+T   V  + G  N +   VLE  ++         
Sbjct: 172 PEAALYGRFTIKSDVWSFGILLTELVTKGRV-PYPGMNNRE---VLEQVERGYR------ 221

Query: 285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
                       P  ++   SL +LM +C  K PE RP
Sbjct: 222 -----------MPCPQDCPISLHELMLQCWKKDPEERP 248

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 53.3 bits (128), Expect = 4e-08
 Identities = 38/113 (33%), Positives = 50/113 (44%), Gaps = 7/113 (6%)

Query: 153 RIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVR 212
           R+ IA EI  A+ +LH      I++R IK  N+LLD      L DF LS      E    
Sbjct: 108 RVYIA-EIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERA 163

Query: 213 EEFIKGAYGFIAPEYFATSS--FNEMCDVYSFGAFLCELLTGCNVLEFKGNGN 263
             F  G   ++APE     S   ++  D +S G    ELLTG +     G  N
Sbjct: 164 YSFC-GTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN 215

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 53.3 bits (128), Expect = 4e-08
 Identities = 55/219 (25%), Positives = 95/219 (43%), Gaps = 32/219 (14%)

Query: 109 QMKHKNILKLIGCCLETELPT-LVFESVKYGTLRGF----SFASLLIAPRIKIAMEIANA 163
           Q++H  +++L      T+ P  ++ E ++ G+L  F        L I   I +A +IA  
Sbjct: 57  QLQHPRLVRLYAVV--TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEG 114

Query: 164 VAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFI 223
           +A++     +  + R ++A+N+L+ E    K+ DF L+  I + E   RE   K    + 
Sbjct: 115 MAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREG-AKFPIKWT 170

Query: 224 APEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFG 283
           APE     +F    DV+SFG  L E++T   +  + G  N + +  LE   +        
Sbjct: 171 APEAINYGTFTIKSDVWSFGILLTEIVTYGRI-PYPGMTNPEVIQNLERGYR-------- 221

Query: 284 AIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
                        P  +   + L +LM  C  + PE RP
Sbjct: 222 ------------MPRPDNCPEELYELMRLCWKEKPEERP 248

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 53.2 bits (128), Expect = 4e-08
 Identities = 57/238 (23%), Positives = 93/238 (39%), Gaps = 37/238 (15%)

Query: 102 NNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL-------RGFSFASLLIAPRI 154
           N IV  S ++H NI+      ++     +  E    GTL       +G  F   ++   +
Sbjct: 48  NEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMV---L 104

Query: 155 KIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREE 214
               +I +AV+Y+H      I+ R IK  N+ L +    KL DF +S  I   E  + E 
Sbjct: 105 WYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGIS-KILGSEYSMAET 160

Query: 215 FIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAK 274
            +   Y +++PE      +N   D+++ G  L ELLT                      K
Sbjct: 161 VVGTPY-YMSPELCQGVKYNFKSDIWALGCVLYELLT---------------------LK 198

Query: 275 KSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLR 332
           ++ +      +V  I  + N  P        L  L++  L + PE RP   +V  Q  
Sbjct: 199 RTFDATNPLNLVVKIV-QGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPL 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 53.0 bits (128), Expect = 6e-08
 Identities = 40/175 (22%), Positives = 71/175 (40%), Gaps = 16/175 (9%)

Query: 83  ISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL-- 140
           I  M+        + E   N I+     KH NI+      L  +   +V E +  G+L  
Sbjct: 49  IKKMRLRK----QNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTD 104

Query: 141 --RGFSFASLLIAPRIK-IAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHD 197
                     +  P+I  +  E+   + YLH    + ++ R IK+ N+LL ++ S KL D
Sbjct: 105 IITQNFVR--MNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLAD 159

Query: 198 FSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
           F  +  + +     +   + G   ++APE      +    D++S G    E+  G
Sbjct: 160 FGFAAQLTKE--KSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 52.5 bits (126), Expect = 6e-08
 Identities = 60/266 (22%), Positives = 103/266 (38%), Gaps = 48/266 (18%)

Query: 80  DRPISVMKFHDNSTLD--DVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKY 137
           D+ +  MK  D S ++  + E   +     +++    I++     L+     +V E  + 
Sbjct: 24  DKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAEN 83

Query: 138 GTLRGFSFASLLIAPR---------IKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLD 188
           G L       LL   R          +  ++I   +A+LH    + I+ R IK+ N+ LD
Sbjct: 84  GDLH-----KLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLD 135

Query: 189 ENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCE 248
              + K+ D  ++  +   +       I G   +++PE      +NE  DV++ G  L E
Sbjct: 136 AYDNVKIGDLGVAKLL--SDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYE 193

Query: 249 LLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKL-QSLG 307
             TG                     K   + N  GA++  I      FP   +   Q L 
Sbjct: 194 CCTG---------------------KHPFDANNQGALILKII--RGVFPPVSQMYSQQLA 230

Query: 308 QLMYKCLSKSPEHRPLMVDVAKQLRQ 333
           QL+ +CL+K    RP   D  + LR 
Sbjct: 231 QLIDQCLTKDYRQRP---DTFQLLRN 253

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 52.8 bits (126), Expect = 6e-08
 Identities = 42/159 (26%), Positives = 71/159 (44%), Gaps = 18/159 (11%)

Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFA----SLLIAP----------- 152
           + ++H++I+K  G C+E +   +VFE +K+G L  F  A    ++L+A            
Sbjct: 62  TNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQ 121

Query: 153 RIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVR 212
            + IA +IA  + YL     +  V R +   N L+ EN   K+ DF +S  +   + +  
Sbjct: 122 MLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRV 178

Query: 213 EEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT 251
                    ++ PE      F    DV+S G  L E+ T
Sbjct: 179 GGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 52.7 bits (126), Expect = 6e-08
 Identities = 47/163 (28%), Positives = 71/163 (43%), Gaps = 16/163 (9%)

Query: 95  DDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF-----SFASLL 149
           DD       I    + KH NI+   G  L  E   +  E    G+L+         + L 
Sbjct: 48  DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQ 107

Query: 150 IAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGET 209
           IA    +  E    +AYLH    +  + R IK +N+LL +N   KL DF ++  I     
Sbjct: 108 IA---YVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKI-TATI 160

Query: 210 HVREEFIKGAYGFIAPEYFATSS---FNEMCDVYSFGAFLCEL 249
             R+ FI   Y ++APE  A      +N++CD+++ G    EL
Sbjct: 161 AKRKSFIGTPY-WMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 53.1 bits (127), Expect = 6e-08
 Identities = 50/207 (24%), Positives = 89/207 (42%), Gaps = 35/207 (16%)

Query: 73  EGTLVDQDRP-----ISVMKFHDNSTLDDVEYCFNNIVFSSQM-----KHKNILKLIGCC 122
           E   +D+D+P     ++V    D++T  D+    +++V   +M     KHKNI+ L+G C
Sbjct: 32  EAIGIDKDKPNKPVTVAVKMLKDDATDKDL----SDLVSEMEMMKMIGKHKNIINLLGAC 87

Query: 123 LETELPTLVFESVKYGTLRGF-----------SF-------ASLLIAPRIKIAMEIANAV 164
            +     ++ E    G LR +           SF         L     +  A ++A  +
Sbjct: 88  TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGM 147

Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIA 224
            YL     +  + R + A NVL+ E+   K+ DF L+  +   + + +    +    ++A
Sbjct: 148 EYLA---SQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMA 204

Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLT 251
           PE      +    DV+SFG  L E+ T
Sbjct: 205 PEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 52.5 bits (126), Expect = 7e-08
 Identities = 44/220 (20%), Positives = 85/220 (38%), Gaps = 34/220 (15%)

Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF------SFASLLIAPRIKIAMEIAN 162
           ++ H N+++L G C +     +V E +  G L  +         +  +   + +  ++  
Sbjct: 55  KLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWL---LDMCSDVCE 111

Query: 163 AVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGF 222
           A+ YL        + R + A N L+ E+   K+ DF L+  + + + +   +  K    +
Sbjct: 112 AMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ-YTSSQGTKFPVKW 167

Query: 223 IAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRF 282
             PE F  S F+   DV+SFG  + E+ +    + ++   N     V+E         R 
Sbjct: 168 APPEVFDYSRFSSKSDVWSFGVLMWEVFS-EGKMPYERFSN---SEVVESVSAGYRLYRP 223

Query: 283 GAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
                 ++                  +MY C  + PE RP
Sbjct: 224 KLAPTEVY-----------------TIMYSCWHEKPEDRP 246

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 52.6 bits (127), Expect = 8e-08
 Identities = 36/166 (21%), Positives = 57/166 (34%), Gaps = 33/166 (19%)

Query: 112 HKNILKLIGCCLETELPTLVFESVKYGTL-------RGFSFASLLIAPRIKIAMEIANAV 164
           H  I+KL     + E    V E    G L                       A EI  A+
Sbjct: 61  HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRF-----YAAEILLAL 115

Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLS-----VSIPEGETHVREEFIKGA 219
            YLH    + I+ R +K  N+LLD++   K+ DF  +      S PE             
Sbjct: 116 EYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQI 172

Query: 220 YG-------------FIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
                          +++PE        +  D+++ G  + ++LTG
Sbjct: 173 EKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTG 218

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 52.3 bits (126), Expect = 8e-08
 Identities = 52/232 (22%), Positives = 91/232 (39%), Gaps = 33/232 (14%)

Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF------SFASLLIAPRIKIAMEIAN 162
           Q  H NI++L G   ++    ++ E ++ G+L  F       F    +   + +   IA+
Sbjct: 61  QFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQL---VGMLRGIAS 117

Query: 163 AVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGF 222
            + YL    +   V R + A N+L++ N   K+ DF LS  + + E     +  K    +
Sbjct: 118 GMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRW 174

Query: 223 IAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRF 282
            APE  A   F    DV+SFG  + E                    V+ Y ++   +   
Sbjct: 175 TAPEAIAYRKFTSASDVWSFGIVMWE--------------------VMSYGERPYWDMSN 214

Query: 283 GAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQM 334
             ++  + ++    P   +   +L QLM  C  K    RP    +   L +M
Sbjct: 215 QDVIKAV-EDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 52.7 bits (126), Expect = 9e-08
 Identities = 49/203 (24%), Positives = 85/203 (41%), Gaps = 27/203 (13%)

Query: 73  EGTLVDQDRP-----ISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLETE 126
           E   +D+ RP     ++V    DN+T  D+    + +     + KHKNI+ L+G C +  
Sbjct: 32  EAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91

Query: 127 LPTLVFESVKYGTLRGFSFA------------------SLLIAPRIKIAMEIANAVAYLH 168
              ++ E    G LR F  A                   L     +  A ++A  + YL 
Sbjct: 92  PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE 151

Query: 169 VGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYF 228
               R  + R + A NVL+ E+   K+ DF L+  + + + + +    +    ++APE  
Sbjct: 152 ---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEAL 208

Query: 229 ATSSFNEMCDVYSFGAFLCELLT 251
               +    DV+SFG  + E+ T
Sbjct: 209 FDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 51.9 bits (124), Expect = 1e-07
 Identities = 43/169 (25%), Positives = 71/169 (42%), Gaps = 25/169 (14%)

Query: 154 IKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVRE 213
           I  + +IA  +A++     R  + R ++A+N+L+  +   K+ DF L+  I + E +   
Sbjct: 105 IDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-YTAR 160

Query: 214 EFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYA 273
           E  K    + APE     SF    DV+SFG  L E++T   +  + G  N + +  LE  
Sbjct: 161 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRI-PYPGMSNPEVIRALERG 219

Query: 274 KKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
            +                     P  E   + L  +M +C    PE RP
Sbjct: 220 YR--------------------MPRPENCPEELYNIMMRCWKNRPEERP 248

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 52.0 bits (124), Expect = 1e-07
 Identities = 47/175 (26%), Positives = 74/175 (42%), Gaps = 19/175 (10%)

Query: 83  ISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRG 142
           I V+K         V+     I+     KH NI+   G  L  +   +  E    G+L+ 
Sbjct: 39  IKVIKLEPGEDFAVVQ---QEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQD 95

Query: 143 F-----SFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHD 197
                   +   IA    ++ E    + YLH    +  + R IK +N+LL +N   KL D
Sbjct: 96  IYHVTGPLSESQIA---YVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLAD 149

Query: 198 FSLSVSIPEGETHVREEFIKGAYGFIAPEYFATS---SFNEMCDVYSFGAFLCEL 249
           F +S  I       R+ FI   Y ++APE  A      +N++CD+++ G    EL
Sbjct: 150 FGVSAQI-TATIAKRKSFIGTPY-WMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 52.1 bits (125), Expect = 1e-07
 Identities = 57/250 (22%), Positives = 99/250 (39%), Gaps = 48/250 (19%)

Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF----------SFASLLIAPR---- 153
           ++  H NI+KL+G C   +   L+FE + YG L  F          S +    + R    
Sbjct: 63  AEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGL 122

Query: 154 ----------IKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVS 203
                     + IA ++A  +AYL    +R  V R +   N L+ EN   K+ DF LS +
Sbjct: 123 NPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRN 179

Query: 204 IPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGN 263
           I   + +   E       ++ PE    + +    DV+++G  L E+ +   +  + G  +
Sbjct: 180 IYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS-YGMQPYYGMAH 238

Query: 264 DDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPL 323
           ++   V+ Y +                 + N     +     L  LM  C SK P  RP 
Sbjct: 239 EE---VIYYVR-----------------DGNVLSCPDNCPLELYNLMRLCWSKLPSDRPS 278

Query: 324 MVDVAKQLRQ 333
              + + L++
Sbjct: 279 FASINRILQR 288

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 52.1 bits (125), Expect = 1e-07
 Identities = 37/160 (23%), Positives = 75/160 (46%), Gaps = 14/160 (8%)

Query: 98  EYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIK-I 156
           E  FN +V     +H NI+++    L  +   +V E ++ G L      + +   +I  +
Sbjct: 61  ELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATV 120

Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDF----SLSVSIPEGETHVR 212
            + +  A+++LH    + ++ R IK+ ++LL  +   KL DF     +S  +P      R
Sbjct: 121 CLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR-----R 172

Query: 213 EEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
           +  +   Y ++APE  +   +    D++S G  + E++ G
Sbjct: 173 KSLVGTPY-WMAPEVISRLPYGTEVDIWSLGIMVIEMVDG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 51.9 bits (124), Expect = 1e-07
 Identities = 43/155 (27%), Positives = 69/155 (44%), Gaps = 18/155 (11%)

Query: 112 HKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIA--PRIKIAMEIANAVA---Y 166
           H NI+ L+G C       L  E   +G L  F   S ++   P   IA   A+ ++    
Sbjct: 67  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126

Query: 167 LHVGFD----------RPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI 216
           LH   D          +  + R + A N+L+ ENY AK+ DF LS      E +V++   
Sbjct: 127 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG---QEVYVKKTMG 183

Query: 217 KGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT 251
           +    ++A E    S +    DV+S+G  L E+++
Sbjct: 184 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 51.5 bits (124), Expect = 1e-07
 Identities = 33/94 (35%), Positives = 47/94 (50%), Gaps = 8/94 (8%)

Query: 160 IANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE-THVREEFIKG 218
           +  A  YLH   +R I++R +K  N+LLD N   KL DF  +  +  G+ T     F  G
Sbjct: 102 VVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT---FC-G 154

Query: 219 AYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
              ++APE      ++   D +S G  L ELLTG
Sbjct: 155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTG 188

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 51.5 bits (123), Expect = 2e-07
 Identities = 28/99 (28%), Positives = 51/99 (51%), Gaps = 6/99 (6%)

Query: 154 IKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVRE 213
           I  + +I   + +LH      IV+R +K  NVLLD+  + +L D  L+V + +G+T  + 
Sbjct: 98  IHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQR 154

Query: 214 EFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
               G  G++APE      ++   D ++ G  + E++ G
Sbjct: 155 ---AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAG 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 51.3 bits (123), Expect = 2e-07
 Identities = 48/206 (23%), Positives = 86/206 (41%), Gaps = 14/206 (6%)

Query: 55  NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFH----DNSTLDDVEYCFNNIVFSSQM 110
            N+   K++      R++    VD  R ++V +         T  +V      I     +
Sbjct: 2   TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61

Query: 111 KHKNILKLIGCCLETELPTLVFESVKYGTLRGF--SFASLLIAPRIKIAMEIANAVAYLH 168
           +H+ I++  GC  + E  ++  E +  G+++    ++ +L      K   +I   V YLH
Sbjct: 62  QHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLH 121

Query: 169 VGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYG---FIAP 225
                 IV R IK +N+L D   + KL DF  S  +           +K   G   +++P
Sbjct: 122 ---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ--TICSSGTGMKSVTGTPYWMSP 176

Query: 226 EYFATSSFNEMCDVYSFGAFLCELLT 251
           E  +   +    DV+S G  + E+LT
Sbjct: 177 EVISGEGYGRKADVWSVGCTVVEMLT 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 51.5 bits (123), Expect = 2e-07
 Identities = 46/185 (24%), Positives = 83/185 (44%), Gaps = 34/185 (18%)

Query: 154 IKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVRE 213
           I++A EIA+ +AYL+    +  V R + A N ++  +++ K+ DF ++  I E      +
Sbjct: 122 IQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE-----TD 173

Query: 214 EFIKGAYGFI-----APEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLT 268
            + KG  G +     APE      F    D++SFG  L E +T      ++G  N+    
Sbjct: 174 YYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWE-ITSLAEQPYQGLSNEQ--- 229

Query: 269 VLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVA 328
           VL++          G +  P    DN      E++  L ++   C   +P+ RP  +++ 
Sbjct: 230 VLKFVMDG------GYLDQP----DNC----PERVTDLMRM---CWQFNPKMRPTFLEIV 272

Query: 329 KQLRQ 333
             L+ 
Sbjct: 273 NLLKD 277

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 51.1 bits (123), Expect = 2e-07
 Identities = 44/129 (34%), Positives = 56/129 (43%), Gaps = 20/129 (15%)

Query: 140 LRGFSFASLLI--------APRIKIAMEIANAVAYLH-VGFDRPIVFRCIKASNVLLDEN 190
           L G   ASLL           RI IA EI  A+ YLH  G    I+ R +K  N+L+D N
Sbjct: 75  LPGGDLASLLENVGSLDEDVARIYIA-EIVLALEYLHSNG----IIHRDLKPDNILIDSN 129

Query: 191 YSAKLHDFSLS------VSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGA 244
              KL DF LS        I   +    ++ I G   +IAPE       ++  D +S G 
Sbjct: 130 GHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGC 189

Query: 245 FLCELLTGC 253
            L E L G 
Sbjct: 190 ILYEFLVGI 198

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 51.5 bits (123), Expect = 2e-07
 Identities = 39/162 (24%), Positives = 69/162 (42%), Gaps = 21/162 (12%)

Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF------------------SFASLL 149
           + ++H++I+K  G C + +   +VFE +K+G L  F                  +   L 
Sbjct: 62  TNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 121

Query: 150 IAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGET 209
           ++  + IA +IA+ + YL     +  V R +   N L+  N   K+ DF +S  +   + 
Sbjct: 122 LSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY 178

Query: 210 HVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT 251
           +           ++ PE      F    DV+SFG  L E+ T
Sbjct: 179 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 51.2 bits (122), Expect = 2e-07
 Identities = 57/255 (22%), Positives = 93/255 (36%), Gaps = 27/255 (10%)

Query: 71  LFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTL 130
           +F G L   + P++V    +    D             Q  H NI++LIG C + +   +
Sbjct: 11  VFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI 70

Query: 131 VFESVKYGTLRGF---SFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLL 187
           V E V+ G    F       L +   I++    A  + YL     +  + R + A N L+
Sbjct: 71  VMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLV 127

Query: 188 DENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLC 247
            E    K+ DF +S    +G         +    + APE      ++   DV+SFG  L 
Sbjct: 128 TEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLW 187

Query: 248 ELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLG 307
           E  +               L  + YA  S +  R         ++    P  E    ++ 
Sbjct: 188 EAFS---------------LGAVPYANLSNQQTR------EAIEQGVRLPCPELCPDAVY 226

Query: 308 QLMYKCLSKSPEHRP 322
           +LM +C    P  RP
Sbjct: 227 RLMERCWEYDPGQRP 241

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 51.3 bits (123), Expect = 2e-07
 Identities = 42/123 (34%), Positives = 61/123 (49%), Gaps = 21/123 (17%)

Query: 159 EIANAVAYLH-VGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIK 217
           E+A A+ +LH +G    I++R +K  N+LLDE    KL DF LS    + E        K
Sbjct: 106 ELALALDHLHSLG----IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--------K 153

Query: 218 GAYGF------IAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLE 271
            AY F      +APE        +  D +SFG  + E+LTG   L F+G    + +T++ 
Sbjct: 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG--SLPFQGKDRKETMTMIL 211

Query: 272 YAK 274
            AK
Sbjct: 212 KAK 214

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 51.1 bits (122), Expect = 3e-07
 Identities = 28/78 (35%), Positives = 42/78 (53%), Gaps = 3/78 (3%)

Query: 175 IVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFN 234
           IV+R +K  N+LLD+    ++ D  L+V IPEGET VR     G  G++APE      + 
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-VRGRV--GTVGYMAPEVINNEKYT 179

Query: 235 EMCDVYSFGAFLCELLTG 252
              D +  G  + E++ G
Sbjct: 180 FSPDWWGLGCLIYEMIQG 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 50.9 bits (122), Expect = 3e-07
 Identities = 58/259 (22%), Positives = 97/259 (37%), Gaps = 60/259 (23%)

Query: 101 FNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF----------------- 143
                  S ++H NI+ L+G C + +   ++FE + +G L  F                 
Sbjct: 56  RQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDE 115

Query: 144 SFASLLIAPR-IKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSV 202
           +  S L     + IA++IA  + YL        V R + A N L+ E  + K+ DF LS 
Sbjct: 116 TVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGLTVKISDFGLSR 172

Query: 203 SIPEGETH---------VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGC 253
            I   + +         VR         ++ PE      F    D++SFG  L E+ +  
Sbjct: 173 DIYSADYYRVQSKSLLPVR---------WMPPEAILYGKFTTESDIWSFGVVLWEIFS-Y 222

Query: 254 NVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKC 313
            +  + G  N +   V+E  +                      P  E+    +  LM +C
Sbjct: 223 GLQPYYGFSNQE---VIEMIRSRQ-----------------LLPCPEDCPARVYALMIEC 262

Query: 314 LSKSPEHRPLMVDVAKQLR 332
            ++ P  RP   D+  +LR
Sbjct: 263 WNEIPARRPRFKDIHTRLR 281

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 50.8 bits (121), Expect = 3e-07
 Identities = 32/99 (32%), Positives = 50/99 (50%), Gaps = 12/99 (12%)

Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI 216
           A EI   +  LH      IV+R +K  N+LLD++   ++ D  L+V +PEG+T      I
Sbjct: 108 AAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT------I 158

Query: 217 K---GAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
           K   G  G++APE      +    D ++ G  L E++ G
Sbjct: 159 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAG 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 50.8 bits (121), Expect = 3e-07
 Identities = 38/156 (24%), Positives = 74/156 (47%), Gaps = 6/156 (3%)

Query: 98  EYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIKIA 157
           E  FN +V     +H+N++++    L  E   ++ E ++ G L      + L   +I   
Sbjct: 63  ELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATV 122

Query: 158 ME-IANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI 216
            E +  A+ YLH    + ++ R IK+ ++LL  +   KL DF     I + +   R+  +
Sbjct: 123 CESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK-DVPKRKSLV 178

Query: 217 KGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
              Y ++APE  + + +    D++S G  + E++ G
Sbjct: 179 GTPY-WMAPEVISRTPYGTEVDIWSLGIMVIEMVDG 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 50.6 bits (121), Expect = 3e-07
 Identities = 29/97 (29%), Positives = 50/97 (51%), Gaps = 8/97 (8%)

Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE-THVREEF 215
           A +I   + +LH    R IV+R +K  NVLLD++ + ++ D  L+V +  G+    R   
Sbjct: 101 AAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGR--- 154

Query: 216 IKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
             G  G++APE      ++   D ++ G  L E++ G
Sbjct: 155 -AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAG 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 50.8 bits (121), Expect = 3e-07
 Identities = 60/248 (24%), Positives = 109/248 (43%), Gaps = 51/248 (20%)

Query: 107 SSQMKHKN---ILKLIGCCLETELPTLV-FESVKYGTLRGF------------SFASLLI 150
           +S MK  N   +++L+G   + + PTLV  E +  G L+ +              A   +
Sbjct: 60  ASVMKEFNCHHVVRLLGVVSQGQ-PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSL 118

Query: 151 APRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH 210
              I++A EIA+ +AYL+       V R + A N ++ E+++ K+ DF ++  I E    
Sbjct: 119 KKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE---- 171

Query: 211 VREEFIKGAYG-----FIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDD 265
             + + KG  G     +++PE      F    DV+SFG  L E+ T      ++G  N+ 
Sbjct: 172 -TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE-QPYQGMSNEQ 229

Query: 266 DLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMV 325
            L             RF  +   + D+ ++ P        L +LM  C   +P+ RP  +
Sbjct: 230 VL-------------RF-VMEGGLLDKPDNCP------DMLFELMRMCWQYNPKMRPSFL 269

Query: 326 DVAKQLRQ 333
           ++   +++
Sbjct: 270 EIISSIKE 277

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 50.8 bits (122), Expect = 4e-07
 Identities = 52/182 (28%), Positives = 76/182 (41%), Gaps = 26/182 (14%)

Query: 95  DDVEYCFNNI-VFSSQMKHKNILKLIGCCLET-ELPTLVFESVKYGTL-------RGFSF 145
           DDVE       V +   KH  + +L   C +T +    V E V  G L         F  
Sbjct: 37  DDVECTMTEKRVLALAGKHPFLTQLH-SCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFD- 94

Query: 146 ASLLIAPRIKI-AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSI 204
                 PR +  A EI   + +LH   +R I++R +K  NVLLD     K+ DF +    
Sbjct: 95  -----EPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMC--- 143

Query: 205 PEGETH-VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGN 263
            EG    V      G   +IAPE  +   +    D ++ G  L E+L G +   F+G+  
Sbjct: 144 KEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQS--PFEGDDE 201

Query: 264 DD 265
           D+
Sbjct: 202 DE 203

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 50.4 bits (120), Expect = 4e-07
 Identities = 48/205 (23%), Positives = 84/205 (40%), Gaps = 27/205 (13%)

Query: 71  LFEGTLVDQDRPISVMKFHDNSTLDDV-EYCFNNIVFSSQM-----KHKNILKLIGCCLE 124
           + E   +D+++P  V K        D  E   ++++   +M     KHKNI+ L+G C +
Sbjct: 36  MAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95

Query: 125 TELPTLVFESVKYGTLRGFSFA------------------SLLIAPRIKIAMEIANAVAY 166
                ++ E    G LR +  A                   L     +  A ++A  + Y
Sbjct: 96  DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEY 155

Query: 167 LHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPE 226
           L     +  + R + A NVL+ E+   K+ DF L+  I   + + +    +    ++APE
Sbjct: 156 LA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPE 212

Query: 227 YFATSSFNEMCDVYSFGAFLCELLT 251
                 +    DV+SFG  L E+ T
Sbjct: 213 ALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 50.4 bits (120), Expect = 4e-07
 Identities = 41/161 (25%), Positives = 78/161 (48%), Gaps = 19/161 (11%)

Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF--------------SFASLLIAPR 153
           S++K+ NI++L+G C+  +   ++ E ++ G L  F              +  S+ IA  
Sbjct: 72  SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131

Query: 154 IKIAMEIANAVAYL-HVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVR 212
           + +A++IA+ + YL  + F    V R +   N L+  +Y+ K+ DF +S ++  G+ +  
Sbjct: 132 LYMAVQIASGMKYLASLNF----VHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRI 187

Query: 213 EEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGC 253
           +        ++A E      F    DV++FG  L E+ T C
Sbjct: 188 QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLC 228

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 50.6 bits (121), Expect = 4e-07
 Identities = 35/96 (36%), Positives = 50/96 (52%), Gaps = 9/96 (9%)

Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSL-SVSIPEGE-THVREEFI 216
           EI+ A+ +LH    + I++R +K  N+LLD     KL DF L   SI EG  TH      
Sbjct: 108 EISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT----F 160

Query: 217 KGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
            G   ++APE    S   +  D +S GA + ++LTG
Sbjct: 161 CGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTG 196

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 50.2 bits (121), Expect = 4e-07
 Identities = 26/102 (25%), Positives = 45/102 (44%), Gaps = 19/102 (18%)

Query: 109 QMKHKNILKLIGCCLETELPT--LVFESVKYGTLRGFSFASLLIAPRIKIAM-------- 158
           +++H NI++L          +  +VFE + +          LL +P +K           
Sbjct: 54  KLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH------DLTGLLDSPEVKFTESQIKCYMK 107

Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSL 200
           ++   + YLH      I+ R IK SN+L++ +   KL DF L
Sbjct: 108 QLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGL 146

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 50.1 bits (120), Expect = 4e-07
 Identities = 55/236 (23%), Positives = 94/236 (39%), Gaps = 36/236 (15%)

Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF---------SFASLLIAPRIKIAM 158
           S+  H+NI++LIG   E     ++ E +  G L+ F           +SL +   +  A 
Sbjct: 64  SKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCAR 123

Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLD---ENYSAKLHDFSLSVSIPEGETHVREEF 215
           ++A    YL    +   + R I A N LL        AK+ DF ++  I     + +   
Sbjct: 124 DVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGR 180

Query: 216 IKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKK 275
                 ++ PE F    F    DV+SFG  L E+ +    + + G  N +   V+E+   
Sbjct: 181 AMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS-LGYMPYPGRTNQE---VMEFVTG 236

Query: 276 SIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQL 331
                  G  +DP        PG       + ++M  C   +PE RP    + +++
Sbjct: 237 -------GGRLDP----PKGCPG------PVYRIMTDCWQHTPEDRPNFATILERI 275

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 50.0 bits (119), Expect = 5e-07
 Identities = 43/150 (28%), Positives = 73/150 (48%), Gaps = 19/150 (12%)

Query: 108 SQMKHKNILKLIGCCLETELPT-LVFESVKYGTL------RGFSFASLLIAPR-IKIAME 159
           +Q++H N+++L+G  +E +    +V E +  G+L      RG    S+L     +K +++
Sbjct: 54  TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG---RSVLGGDCLLKFSLD 110

Query: 160 IANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGA 219
           +  A+ YL        V R + A NVL+ E+  AK+ DF L+      E    ++  K  
Sbjct: 111 VCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLT-----KEASSTQDTGKLP 162

Query: 220 YGFIAPEYFATSSFNEMCDVYSFGAFLCEL 249
             + APE      F+   DV+SFG  L E+
Sbjct: 163 VKWTAPEALREKKFSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 49.9 bits (119), Expect = 5e-07
 Identities = 55/232 (23%), Positives = 89/232 (38%), Gaps = 32/232 (13%)

Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANAVA 165
           Q  H NI+ L G   +++   +V E ++ G+L  F         +   + +   IA+ + 
Sbjct: 61  QFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMK 120

Query: 166 YLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSI---PEGETHVREEFIKGAYGF 222
           YL    D   V R + A N+L++ N   K+ DF LS  +   PE     R   I     +
Sbjct: 121 YLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRW 175

Query: 223 IAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRF 282
            APE  A   F    DV+S+G  + E                    V+ Y ++       
Sbjct: 176 TAPEAIAYRKFTSASDVWSYGIVMWE--------------------VMSYGERPYWEMSN 215

Query: 283 GAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQM 334
             ++  I +E    P   +   +L QLM  C  K    RP    +   L ++
Sbjct: 216 QDVIKAI-EEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 50.0 bits (119), Expect = 5e-07
 Identities = 37/159 (23%), Positives = 65/159 (40%), Gaps = 20/159 (12%)

Query: 110 MKHKNILKLIGCCLETELPTLVFESVKYGTLRGF-----------------SFASLLIAP 152
           ++H++I++  G C E     +VFE +++G L  F                 +   L +  
Sbjct: 64  LQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQ 123

Query: 153 RIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVR 212
            + IA +IA+ + YL        V R +   N L+ +    K+ DF +S  I   + +  
Sbjct: 124 MLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRV 180

Query: 213 EEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT 251
                    ++ PE      F    D++SFG  L E+ T
Sbjct: 181 GGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 49.8 bits (119), Expect = 7e-07
 Identities = 56/236 (23%), Positives = 95/236 (40%), Gaps = 37/236 (15%)

Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFAS-----------LLIAPRIKI 156
            ++ HKN+++L+G C E E   ++ E    G L+ F  A+           L    ++ +
Sbjct: 63  RKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVAL 122

Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE-THVREEF 215
             +IA  + +L        V R + A N L+      K+   SLS  +   E   +R   
Sbjct: 123 CTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNAL 179

Query: 216 IKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKK 275
           I     ++APE      F+   DV+SFG  + E+ T    L F G  +++ L  L+    
Sbjct: 180 I--PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQ-GELPFYGLSDEEVLNRLQ--AG 234

Query: 276 SIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQL 331
            +E                  P  E     L +LM +C + +P+ RP   ++   L
Sbjct: 235 KLE-----------------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 49.6 bits (119), Expect = 8e-07
 Identities = 57/247 (23%), Positives = 93/247 (37%), Gaps = 38/247 (15%)

Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF--SFASLLIAPRIKIAMEIANAVAY 166
           Q++H+NI+ L           LVFE V+   L     S   L          ++  A+AY
Sbjct: 56  QLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAY 115

Query: 167 LHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPE 226
            H      I+ R IK  N+L+ E+   KL DF  + ++         +++   + + APE
Sbjct: 116 CH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRW-YRAPE 171

Query: 227 YF-ATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDL--------------TVLE 271
                +++ +  DV++ G  + ELL G   L F G+ + D L                L 
Sbjct: 172 LLVGDTNYGKPVDVWAIGCIMAELLDG-EPL-FPGDSDIDQLYLIQKCLGPLPPSHQELF 229

Query: 272 YAKKSIENNRF-GAIVDPIFDEDN---SFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDV 327
            +     N RF G         ++    +PGK          +  CL   P+ R      
Sbjct: 230 SS-----NPRFAGVAFPEPSQPESLERRYPGKVSSP--ALDFLKACLRMDPKERLT---- 278

Query: 328 AKQLRQM 334
             +L Q 
Sbjct: 279 CDELLQH 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 49.3 bits (117), Expect = 8e-07
 Identities = 47/175 (26%), Positives = 74/175 (42%), Gaps = 27/175 (15%)

Query: 156 IAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEF 215
           I  EI   + YLH       + R IKA+NVLL E+   KL DF ++  +   +T ++   
Sbjct: 106 ILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNT 160

Query: 216 IKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKK 275
             G   ++APE    S+++   D++S G    EL         KG     +L  ++    
Sbjct: 161 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELA--------KGEPPHSELHPMKVLFL 212

Query: 276 SIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ 330
             +NN       P  + + S P KE         +  CL+K P  RP   ++ K 
Sbjct: 213 IPKNN------PPTLEGNYSKPLKE--------FVEACLNKEPSFRPTAKELLKH 253

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 49.5 bits (118), Expect = 8e-07
 Identities = 28/97 (28%), Positives = 50/97 (51%), Gaps = 8/97 (8%)

Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI 216
           A EI   + ++H  F   +V+R +K +N+LLDE+   ++ D  L+    + + H      
Sbjct: 103 AAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---- 155

Query: 217 KGAYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTG 252
            G +G++APE      +++   D +S G  L +LL G
Sbjct: 156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 49.3 bits (117), Expect = 1e-06
 Identities = 36/156 (23%), Positives = 74/156 (47%), Gaps = 6/156 (3%)

Query: 98  EYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRI-KI 156
           E  FN +V      H+N++ +    L  +   +V E ++ G L      + +   +I  +
Sbjct: 64  ELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATV 123

Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI 216
            + +  A++YLH   ++ ++ R IK+ ++LL  +   KL DF     + + E   R+  +
Sbjct: 124 CLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK-EVPKRKSLV 179

Query: 217 KGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
              Y ++APE  +   +    D++S G  + E++ G
Sbjct: 180 GTPY-WMAPEVISRLPYGTEVDIWSLGIMVIEMIDG 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 48.8 bits (116), Expect = 1e-06
 Identities = 51/179 (28%), Positives = 79/179 (44%), Gaps = 30/179 (16%)

Query: 158 MEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIK 217
           ++IA A+ YLH   ++ I+ R +K  NV L      K+ D  ++  + E +  +    I 
Sbjct: 109 VQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIA-RVLENQCDMASTLIG 164

Query: 218 GAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSI 277
             Y +++PE F+   +N   DV++ G  + E+ T       K   N  D+  L Y  + I
Sbjct: 165 TPY-YMSPELFSNKPYNYKSDVWALGCCVYEMAT------LKHAFNAKDMNSLVY--RII 215

Query: 278 ENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYL 336
           E         P   +D S          LG+L+   LSK PE RP    V   LRQ Y+
Sbjct: 216 EGKL------PPMPKDYS--------PELGELIATMLSKRPEKRP---SVKSILRQPYI 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 30/96 (31%), Positives = 47/96 (48%), Gaps = 6/96 (6%)

Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI 216
           A EI   +  LH       V+R +K  N+LLD+    ++ D  L+V IPEGE+ +R    
Sbjct: 108 AAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES-IRGRV- 162

Query: 217 KGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
            G  G++APE      +    D +  G  + E++ G
Sbjct: 163 -GTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEG 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 59/242 (24%), Positives = 97/242 (40%), Gaps = 52/242 (21%)

Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF------SFASLLIAPRIKIAMEIAN 162
           Q  H NI++L G   + +   ++ E ++ G L  +       F+S  +   ++    IA 
Sbjct: 62  QFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIAA 118

Query: 163 AVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYG- 221
            + YL    D   V R + A N+L++ N   K+ DF LS         V E+  +G Y  
Sbjct: 119 GMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLS--------RVLEDDPEGTYTT 167

Query: 222 --------FIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYA 273
                   + APE  A   F    DV+SFG  + E+++        G     D++  E  
Sbjct: 168 SGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMS-------FGERPYWDMSNHEVM 220

Query: 274 KKSIENNRFGAIVD-PIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLR 332
           K   +  R  A +D P                ++ QLM +C  +    RP  VD+   L 
Sbjct: 221 KAINDGFRLPAPMDCP---------------SAVYQLMLQCWQQDRARRPRFVDIVNLLD 265

Query: 333 QM 334
           ++
Sbjct: 266 KL 267

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 49.1 bits (117), Expect = 1e-06
 Identities = 55/183 (30%), Positives = 77/183 (42%), Gaps = 25/183 (13%)

Query: 95  DDVEYCFNNIVFSSQMKHKNILKLIGCCLET-ELPTLVFESVKYGTL-------RGFSFA 146
           DDVE         S  ++   L  + CC +T +    V E V  G L       R F   
Sbjct: 37  DDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD-- 94

Query: 147 SLLIAPRIKI-AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSL-SVSI 204
                 R +  A EI +A+ +LH   D+ I++R +K  NVLLD     KL DF +    I
Sbjct: 95  ----EARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 147

Query: 205 PEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGND 264
             G+T        G   +IAPE      +    D ++ G  L E+L G    E +   N+
Sbjct: 148 FNGKT---TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAE---NE 201

Query: 265 DDL 267
           DDL
Sbjct: 202 DDL 204

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 48.8 bits (116), Expect = 1e-06
 Identities = 53/230 (23%), Positives = 92/230 (40%), Gaps = 28/230 (12%)

Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPR--IKIAMEIANAVAY 166
           Q+ +  I+++IG C E E   LV E  + G L  F   +  +  +   ++  +++  + Y
Sbjct: 52  QLDNPYIVRMIGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKY 110

Query: 167 LHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI-KGAYGFIAP 225
           L    +   V R + A NVLL   + AK+ DF LS ++   E + + +   K    + AP
Sbjct: 111 LE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAP 167

Query: 226 EYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAI 285
           E      F+   DV+SFG  + E  +                    Y +K  +  + G  
Sbjct: 168 ECMNYYKFSSKSDVWSFGVLMWEAFS--------------------YGQKPYKGMK-GNE 206

Query: 286 VDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMY 335
           V  + +        +     +  LM  C +   + RP    V  +LR  Y
Sbjct: 207 VTQMIESGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNYY 256

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 48.8 bits (116), Expect = 1e-06
 Identities = 28/97 (28%), Positives = 52/97 (53%), Gaps = 8/97 (8%)

Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI 216
           A EI   + ++H   +R +V+R +K +N+LLDE+   ++ D  L+    + + H      
Sbjct: 103 ATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---- 155

Query: 217 KGAYGFIAPEYFAT-SSFNEMCDVYSFGAFLCELLTG 252
            G +G++APE     ++++   D +S G  L +LL G
Sbjct: 156 VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 49.0 bits (117), Expect = 1e-06
 Identities = 36/109 (33%), Positives = 53/109 (48%), Gaps = 7/109 (6%)

Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI 216
           A EI   + +LH    + I++R +K  NVLLD++   K+ DF +      GE   +    
Sbjct: 102 AAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG--KASTF 156

Query: 217 KGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDD 265
            G   +IAPE      +NE  D +SFG  L E+L G +   F G   D+
Sbjct: 157 CGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQS--PFHGEDEDE 203

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 48.4 bits (116), Expect = 2e-06
 Identities = 46/170 (27%), Positives = 72/170 (42%), Gaps = 22/170 (12%)

Query: 92  STLDDVEYCFNNIVFSSQMKHKNILKLIGCCLE-TELPTL--------VFESVKYGTLRG 142
              D++E     I F SQ +   I K  G  L+ ++L  +          + +K G L  
Sbjct: 38  EAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDE 97

Query: 143 FSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSV 202
              A         I  E+   + YLH   +   + R IKA+N+LL E    KL DF +S 
Sbjct: 98  TYIAF--------ILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSG 146

Query: 203 SIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
            +    +  R  F+   + ++APE    S ++E  D++S G    EL  G
Sbjct: 147 QLTSTMSK-RNTFVGTPF-WMAPEVIKQSGYDEKADIWSLGITAIELAKG 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 48.8 bits (117), Expect = 2e-06
 Identities = 49/193 (25%), Positives = 70/193 (36%), Gaps = 53/193 (27%)

Query: 157 AMEIANAVAYLHV-GFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEF 215
           A E+  A+ YLH+ G    IV+R +K  N+LL E+    L DF LS         V +  
Sbjct: 109 AAEVLLALEYLHLLG----IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKAL 164

Query: 216 IKGAYG---------------------------FIAPEYFATSSFNEMCDVYSFGAFLCE 248
            KG+                             +IAPE  +        D ++ G  L E
Sbjct: 165 RKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYE 224

Query: 249 LLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQ 308
           +L G     FKG+  D          ++  N         I  ++ +FPG      S   
Sbjct: 225 MLYGTT--PFKGSNRD----------ETFSN---------ILKKEVTFPGSPPVSSSARD 263

Query: 309 LMYKCLSKSPEHR 321
           L+ K L K P  R
Sbjct: 264 LIRKLLVKDPSKR 276

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 48.7 bits (116), Expect = 2e-06
 Identities = 26/94 (27%), Positives = 50/94 (53%), Gaps = 5/94 (5%)

Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI 216
             +I + + +LH    R I++R +K  NVLLD + + ++ D  L+V + +G++  +    
Sbjct: 103 TAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKG--Y 157

Query: 217 KGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELL 250
            G  GF+APE      ++   D ++ G  L E++
Sbjct: 158 AGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMI 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 48.5 bits (115), Expect = 2e-06
 Identities = 35/107 (32%), Positives = 48/107 (44%), Gaps = 6/107 (5%)

Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           EI  A+ +LH      I++R IK  N+LLD N    L DF LS    E E   R     G
Sbjct: 113 EIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCG 168

Query: 219 AYGFIAPEYFA--TSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGN 263
              ++AP+         ++  D +S G  + ELLTG +     G  N
Sbjct: 169 TIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN 215

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 48.5 bits (115), Expect = 2e-06
 Identities = 35/156 (22%), Positives = 74/156 (47%), Gaps = 6/156 (3%)

Query: 98  EYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIK-I 156
           E  FN +V     +H+N++++    L  +   +V E ++ G L      + +   +I  +
Sbjct: 62  ELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAV 121

Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI 216
            + +  A++ LH    + ++ R IK+ ++LL  +   KL DF     + + E   R+  +
Sbjct: 122 CLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK-EVPRRKSLV 177

Query: 217 KGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
              Y ++APE  +   +    D++S G  + E++ G
Sbjct: 178 GTPY-WMAPELISRLPYGPEVDIWSLGIMVIEMVDG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 48.5 bits (115), Expect = 2e-06
 Identities = 54/244 (22%), Positives = 95/244 (38%), Gaps = 43/244 (17%)

Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSF-------------------ASL 148
           +++ H NI+ L+G   + +   ++FE +  G L  F                     +SL
Sbjct: 62  AELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSL 121

Query: 149 LIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE 208
                + IA++IA  + YL   F    V + + A N+L+ E    K+ D  LS  I   +
Sbjct: 122 DHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSAD 178

Query: 209 THVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLT 268
            +  +        ++ PE      F+   D++SFG  L E+ +   +  + G  N +   
Sbjct: 179 YYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS-FGLQPYYGFSNQE--- 234

Query: 269 VLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVA 328
           V+E  +K                     P  E+    +  LM +C  + P  RP   D+ 
Sbjct: 235 VIEMVRKR-----------------QLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIH 277

Query: 329 KQLR 332
            +LR
Sbjct: 278 TRLR 281

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 48.0 bits (114), Expect = 3e-06
 Identities = 59/249 (23%), Positives = 103/249 (41%), Gaps = 53/249 (21%)

Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF-----------------SFASLLI 150
           S++K  NI++L+G C++ +   ++ E ++ G L  F                   A  L 
Sbjct: 74  SRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLP 133

Query: 151 APR----IKIAMEIANAVAYLH-VGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIP 205
           A      + +A++IA+ + YL  + F    V R +   N L+ EN + K+ DF +S ++ 
Sbjct: 134 AISYSSLLHVALQIASGMKYLSSLNF----VHRDLATRNCLVGENLTIKIADFGMSRNLY 189

Query: 206 EGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDD 265
            G+ +  +        ++A E      F    DV++FG  L E+L  C    + G   D+
Sbjct: 190 AGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPY-GELTDE 248

Query: 266 DLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKL-------QSLGQLMYKCLSKSP 318
            +         IEN          F +     G++  L       Q L +LM +C S+  
Sbjct: 249 QV---------IEN------AGEFFRDQ----GRQVYLFRPPPCPQGLYELMLQCWSRDC 289

Query: 319 EHRPLMVDV 327
             RP   D+
Sbjct: 290 RERPSFSDI 298

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 47.3 bits (112), Expect = 3e-06
 Identities = 56/238 (23%), Positives = 91/238 (38%), Gaps = 37/238 (15%)

Query: 106 FSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIKIAMEIANAVA 165
              Q+ +  I+++IG C E E   LV E    G L  F     L   + +I +   N V 
Sbjct: 48  IMHQLDNPYIVRMIGVC-EAEALMLVMEMASGGPLNKF-----LSGKKDEITVS--NVVE 99

Query: 166 YLH---VGF----DRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVR-EEFIK 217
            +H   +G      +  V R + A NVLL   + AK+ DF LS ++   +++ +     K
Sbjct: 100 LMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGK 159

Query: 218 GAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSI 277
               + APE      F+   DV+S+G  + E  +                    Y +K  
Sbjct: 160 WPLKWYAPECINFRKFSSRSDVWSYGITMWEAFS--------------------YGQKPY 199

Query: 278 ENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMY 335
           +  + G  V    ++        E    +  LM  C     E RP    V +++R  Y
Sbjct: 200 KKMK-GPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTYY 256

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 47.8 bits (113), Expect = 3e-06
 Identities = 42/162 (25%), Positives = 77/162 (47%), Gaps = 14/162 (8%)

Query: 96  DVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF------SFASLL 149
           +VE+    ++ +S M H ++++L+G CL   +  LV + + +G L  +      +  S L
Sbjct: 53  NVEFMDEALIMAS-MDHPHLVRLLGVCLSPTI-QLVTQLMPHGCLLDYVHEHKDNIGSQL 110

Query: 150 IAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGET 209
           +   +   ++IA  + YL    +R +V R + A NVL+      K+ DF L+  +   E 
Sbjct: 111 L---LNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK 164

Query: 210 HVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT 251
               +  K    ++A E      F    DV+S+G  + EL+T
Sbjct: 165 EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 47.3 bits (113), Expect = 4e-06
 Identities = 28/88 (31%), Positives = 39/88 (44%), Gaps = 5/88 (5%)

Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIA 224
            YLH       + R IKA N+LL+E   AKL DF +S          R   I   + ++A
Sbjct: 113 EYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVS-GQLTDTMAKRNTVIGTPF-WMA 167

Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLTG 252
           PE      +N   D++S G    E+  G
Sbjct: 168 PEVIQEIGYNNKADIWSLGITAIEMAEG 195

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 47.4 bits (112), Expect = 4e-06
 Identities = 40/156 (25%), Positives = 69/156 (44%), Gaps = 6/156 (3%)

Query: 98  EYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIK-I 156
           E   N I+   ++K+ NI+  +   L  +   +V E +  G+L      + +   +I  +
Sbjct: 61  ELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAV 120

Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI 216
             E   A+ +LH      ++ R IK+ NVLL  + S KL DF     I   E   R   +
Sbjct: 121 CRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP-EQSKRSTMV 176

Query: 217 KGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
              Y ++APE     ++    D++S G    E++ G
Sbjct: 177 GTPY-WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 47.3 bits (113), Expect = 4e-06
 Identities = 49/180 (27%), Positives = 78/180 (43%), Gaps = 28/180 (15%)

Query: 83  ISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFE-----SVK- 136
           I V+K       + ++     I    + +H NI+   G  L  +   +V E     S++ 
Sbjct: 33  IKVIKLEPGDDFEIIQ---QEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQD 89

Query: 137 -YGTLRGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKL 195
            Y   RG   + L IA    +  E    +AYLH   +   + R IK +N+LL E+   KL
Sbjct: 90  IYQVTRG-PLSELQIA---YVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKL 142

Query: 196 HDFSLSVSIPEGETHV---REEFIKGAYGFIAPEYFA---TSSFNEMCDVYSFGAFLCEL 249
            DF +S  +    T     R+ FI   Y ++APE  A      ++  CD+++ G    EL
Sbjct: 143 ADFGVSAQL----TATIAKRKSFIGTPY-WMAPEVAAVERKGGYDGKCDIWALGITAIEL 197

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 47.4 bits (112), Expect = 4e-06
 Identities = 39/156 (25%), Positives = 68/156 (43%), Gaps = 6/156 (3%)

Query: 98  EYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIK-I 156
           E   N I+   + K+ NI+  +   L  +   +V E +  G+L      + +   +I  +
Sbjct: 62  ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV 121

Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI 216
             E   A+ +LH      ++ R IK+ N+LL  + S KL DF     I   E   R   +
Sbjct: 122 CRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP-EQSKRSTMV 177

Query: 217 KGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
              Y ++APE     ++    D++S G    E++ G
Sbjct: 178 GTPY-WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 47.0 bits (111), Expect = 5e-06
 Identities = 40/149 (26%), Positives = 71/149 (47%), Gaps = 12/149 (8%)

Query: 110 MKHKNILKLIGCCLETELPTLV--FESVKYGTLRG--FSFASLLIAPRIKIAMEIANAVA 165
           ++H+ I++  GC  +    TL    E +  G+++    ++ +L  +   K   +I   ++
Sbjct: 61  LQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMS 120

Query: 166 YLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLS---VSIPEGETHVREEFIKGAYGF 222
           YLH      IV R IK +N+L D   + KL DF  S    +I    T +R   + G   +
Sbjct: 121 YLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS--VTGTPYW 175

Query: 223 IAPEYFATSSFNEMCDVYSFGAFLCELLT 251
           ++PE  +   +    DV+S G  + E+LT
Sbjct: 176 MSPEVISGEGYGRKADVWSLGCTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 46.9 bits (111), Expect = 6e-06
 Identities = 31/96 (32%), Positives = 46/96 (47%), Gaps = 5/96 (5%)

Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI 216
           A EI   + +LH    + IV+R +K  N+LLD +   K+ DF +      G+   +    
Sbjct: 102 AAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--KTCTF 156

Query: 217 KGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
            G   +IAPE      +N   D +SFG  L E+L G
Sbjct: 157 CGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 47.1 bits (112), Expect = 6e-06
 Identities = 33/97 (34%), Positives = 50/97 (51%), Gaps = 7/97 (7%)

Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSL-SVSIPEGETHVREEF 215
           A EIA  + +LH    + I++R +K  NV+LD     K+ DF +   +I  G+T     F
Sbjct: 107 AAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT--TRTF 161

Query: 216 IKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
             G   +IAPE  A   + +  D ++FG  L E+L G
Sbjct: 162 C-GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 197

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 46.6 bits (110), Expect = 6e-06
 Identities = 65/287 (22%), Positives = 114/287 (39%), Gaps = 35/287 (12%)

Query: 56  NYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDV--EYCFNNIVFSSQMKHK 113
           N+ + K I       ++  T +    P+++ K      +D      C   I    Q+ H 
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 114 NILKLIGCCLETELPTLVFESVKYGTL----RGFSFASLLIAPRI--KIAMEIANAVAYL 167
           N++K     +E     +V E    G L    + F     LI  +   K  +++ +A+ ++
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122

Query: 168 HVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEY 227
           H    R ++ R IK +NV +      KL D  L        T      + G   +++PE 
Sbjct: 123 H---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPER 177

Query: 228 FATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVD 287
              + +N   D++S G  L E+      L+    G+  +L  L    K IE   +     
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAA----LQSPFYGDKMNLYSL---CKKIEQCDY----P 226

Query: 288 PIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP---LMVDVAKQL 331
           P+  +  S        + L QL+  C++  PE RP    + DVAK++
Sbjct: 227 PLPSDHYS--------EELRQLVNMCINPDPEKRPDITYVYDVAKRM 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 46.6 bits (110), Expect = 6e-06
 Identities = 49/175 (28%), Positives = 74/175 (42%), Gaps = 27/175 (15%)

Query: 156 IAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEF 215
           I  EI   + YLH   +R I  R IKA+NVLL E    KL DF ++  +   +T ++   
Sbjct: 106 ILREILKGLDYLHS--ERKI-HRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNT 160

Query: 216 IKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKK 275
             G   ++APE    S+++   D++S G    EL         KG   + DL  +     
Sbjct: 161 FVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELA--------KGEPPNSDLHPMRVLFL 212

Query: 276 SIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ 330
             +N+       P  +   S P KE         +  CL+K P  RP   ++ K 
Sbjct: 213 IPKNS------PPTLEGQYSKPFKE--------FVEACLNKDPRFRPTAKELLKH 253

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 46.6 bits (110), Expect = 7e-06
 Identities = 62/289 (21%), Positives = 116/289 (40%), Gaps = 32/289 (11%)

Query: 56  NYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDV--EYCFNNIVFSSQMKHK 113
           N+ + K I       ++  T +   +P+++ K      +D    + C   I    Q+ H 
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 114 NILKLIGCCLETELPTLVFESVKYGTL----RGFSFASLLIAPRI--KIAMEIANAVAYL 167
           N++K +   +E     +V E    G L    + F     LI  R   K  +++ +AV ++
Sbjct: 63  NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122

Query: 168 HVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEY 227
           H    R ++ R IK +NV +      KL D  L       +T      +   Y +++PE 
Sbjct: 123 H---SRRVMHRDIKPANVFITATGVVKLGDLGLG-RFFSSKTTAAHSLVGTPY-YMSPER 177

Query: 228 FATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVD 287
              + +N   D++S G  L E+      L+    G  D + +    +K IE   +  +  
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMA----ALQSPFYG--DKMNLFSLCQK-IEQCDYPPL-- 228

Query: 288 PIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYL 336
                       E   + L +L+  C+   P+ RP +  V +  +QM++
Sbjct: 229 ----------PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMHV 267

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 46.4 bits (110), Expect = 8e-06
 Identities = 40/156 (25%), Positives = 68/156 (43%), Gaps = 6/156 (3%)

Query: 98  EYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIK-I 156
           E   N I+   + KH NI+  +   L  +   +V E +  G+L      + +   +I  +
Sbjct: 61  ELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV 120

Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI 216
             E   A+ +LH      ++ R IK+ N+LL  + S KL DF     I   E   R   +
Sbjct: 121 CRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP-EQSKRSTMV 176

Query: 217 KGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
              Y ++APE     ++    D++S G    E++ G
Sbjct: 177 GTPY-WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 46.4 bits (110), Expect = 9e-06
 Identities = 32/96 (33%), Positives = 48/96 (50%), Gaps = 6/96 (6%)

Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI 216
           A EI   +  LH      IV+R +K  N+LLD+    ++ D  L+V IPEGET +R    
Sbjct: 108 AAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-IRGRV- 162

Query: 217 KGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
            G  G++APE      +    D +  G  + E++ G
Sbjct: 163 -GTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEG 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 46.3 bits (110), Expect = 9e-06
 Identities = 48/209 (22%), Positives = 85/209 (40%), Gaps = 28/209 (13%)

Query: 56  NYDLHKVIQSDTSYRLFEGTLVDQDR------PISVMKFHDNSTLDDVEYCFNNIVFSSQ 109
           + +  K + + T    F    + +DR       + VM   +   L   ++  N      +
Sbjct: 2   DLERIKTVGTGT----FGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKE 57

Query: 110 MKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIKIAM------EIANA 163
           + H  I++L     +     ++ E V  G L    F+ L  + R   +       EI  A
Sbjct: 58  VSHPFIIRLFWTEHDQRFLYMLMEYVPGGEL----FSYLRNSGRFSNSTGLFYASEIVCA 113

Query: 164 VAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFI 223
           + YLH    + IV+R +K  N+LLD+    KL DF  +      +   R   + G   ++
Sbjct: 114 LEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFA-----KKLRDRTWTLCGTPEYL 165

Query: 224 APEYFATSSFNEMCDVYSFGAFLCELLTG 252
           APE   +   N+  D ++ G  + E+L G
Sbjct: 166 APEVIQSKGHNKAVDWWALGILIYEMLVG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 46.6 bits (110), Expect = 9e-06
 Identities = 32/117 (27%), Positives = 56/117 (47%), Gaps = 7/117 (5%)

Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSL-SVSIPEGETHVREEF 215
           + EI+ A+ YLH   +R I++R +K  NVLLD     KL D+ +    +  G+T      
Sbjct: 102 SAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TST 155

Query: 216 IKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEY 272
             G   +IAPE      +    D ++ G  + E++ G +  +  G+ ++ D    +Y
Sbjct: 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDY 212

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 46.2 bits (110), Expect = 1e-05
 Identities = 43/178 (24%), Positives = 70/178 (39%), Gaps = 46/178 (25%)

Query: 104 IVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF------------------SF 145
           +   S++   NI +L+G C       ++ E ++ G L  F                  SF
Sbjct: 70  VKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSF 129

Query: 146 ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIP 205
           ++LL      +A +IA+ + YL        V R +   N L+ +NY+ K+ DF +S    
Sbjct: 130 STLL-----YMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMS---- 177

Query: 206 EGETHVREEFIKGAYG----------FIAPEYFATSSFNEMCDVYSFGAFLCELLTGC 253
                 R  +    Y           ++A E      F    DV++FG  L E+LT C
Sbjct: 178 ------RNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLC 229

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 46.1 bits (110), Expect = 1e-05
 Identities = 27/105 (25%), Positives = 49/105 (46%), Gaps = 12/105 (11%)

Query: 154 IKIAMEIANAVAYLHVGFD--RPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEG---- 207
            +I  ++  A+   H   D    ++ R +K +N+ LD N + KL DF L+  +       
Sbjct: 108 WRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFA 167

Query: 208 ETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
           +T+V      G   +++PE     S++E  D++S G  + EL   
Sbjct: 168 KTYV------GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCAL 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 46.1 bits (109), Expect = 1e-05
 Identities = 34/104 (32%), Positives = 48/104 (46%), Gaps = 10/104 (9%)

Query: 152 PRIKI-AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVS--IPEGE 208
           PR +  A E+A+A+ YLH      I++R +K  N+LLD      L DF L      PE  
Sbjct: 96  PRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET 152

Query: 209 THVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
           T        G   ++APE      ++   D +  GA L E+L G
Sbjct: 153 TST----FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 45.6 bits (108), Expect = 1e-05
 Identities = 36/101 (35%), Positives = 48/101 (47%), Gaps = 8/101 (7%)

Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI 216
           A E+  A+  LH      IV R +  +N+LLD+    +L  FS      E E     E +
Sbjct: 91  AAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFS---RWSEVEDSCDGEAV 144

Query: 217 KGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLE 257
           +  Y   APE    S   E CD +S GA L ELLTG  ++E
Sbjct: 145 ENMY--CAPEVGGISEETEACDWWSLGAILFELLTGKTLVE 183

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 45.9 bits (109), Expect = 1e-05
 Identities = 38/146 (26%), Positives = 65/146 (44%), Gaps = 11/146 (7%)

Query: 112 HKNILKLIGCCLETELPTLVFESVKYGTLRGF------SFASLLIAPRIKIAMEIANAVA 165
           H+NI+ L+G C       ++ E   YG L  F      SF +L     +  + ++A  +A
Sbjct: 98  HENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTL--EDLLSFSYQVAKGMA 155

Query: 166 YLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAP 225
           +L     +  + R + A NVLL      K+ DF L+  I     +V +   +    ++AP
Sbjct: 156 FLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAP 212

Query: 226 EYFATSSFNEMCDVYSFGAFLCELLT 251
           E      +    DV+S+G  L E+ +
Sbjct: 213 ESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 45.6 bits (108), Expect = 1e-05
 Identities = 52/232 (22%), Positives = 90/232 (38%), Gaps = 30/232 (12%)

Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANAVA 165
           Q  H NI+ L G   ++    ++ E ++ G L  F   +     +   + +   IA  + 
Sbjct: 61  QFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMK 120

Query: 166 YLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE---THVREEFIKGAYGF 222
           YL    +   V R + A N+L++ N   K+ DF LS  + +     T+      K    +
Sbjct: 121 YLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRW 177

Query: 223 IAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRF 282
            APE  A   F    DV+S+G  + E                    V+ Y ++   +   
Sbjct: 178 TAPEAIAYRKFTSASDVWSYGIVMWE--------------------VMSYGERPYWDMSN 217

Query: 283 GAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQM 334
             +++ I ++D   P   +   +L QLM  C  K    RP    +   L +M
Sbjct: 218 QDVINAI-EQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 45.9 bits (109), Expect = 1e-05
 Identities = 62/293 (21%), Positives = 114/293 (38%), Gaps = 38/293 (12%)

Query: 54  TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFH-----DNSTLDDVEYCFNNIVFSS 108
             N+ + K I       +++   +   R +++ K       D     D   C   I    
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQD---CLKEIDLLK 57

Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTL----RGFSFASLLIAPRI--KIAMEIAN 162
           Q+ H N++K +   +E     +V E    G L    + F     LI  R   K  +++ +
Sbjct: 58  QLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCS 117

Query: 163 AVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGF 222
           A+ ++H    + I+ R IK +NV +      KL D  L       +T      +   Y +
Sbjct: 118 ALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS-KTTAAHSLVGTPY-Y 172

Query: 223 IAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRF 282
           ++PE    + +N   D++S G  L E+        F G    D + +    KK IE   +
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEM--AALQSPFYG----DKMNLYSLCKK-IEKCDY 225

Query: 283 GAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMY 335
             +    + E+            L  L+ +C++  PE RP +  V +  ++M+
Sbjct: 226 PPLPADHYSEE------------LRDLVSRCINPDPEKRPDISYVLQVAKEMH 266

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 45.7 bits (108), Expect = 1e-05
 Identities = 59/237 (24%), Positives = 98/237 (41%), Gaps = 38/237 (16%)

Query: 102 NNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL-------RGFSFASLLIAPRI 154
             ++  ++MKH NI+       E     +V E    G L       RG  F+   I   +
Sbjct: 48  KEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQI---L 104

Query: 155 KIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDEN-YSAKLHDFSLSVSIPEGETHVRE 213
              ++I+  + ++H   DR I+ R IK+ N+ L +N   AKL DF ++  + +    +  
Sbjct: 105 SWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND-SMELAY 160

Query: 214 EFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYA 273
             +   Y +++PE      +N   D++S G  L EL T    L+    GN+    VL+  
Sbjct: 161 TCVGTPY-YLSPEICQNRPYNNKTDIWSLGCVLYELCT----LKHPFEGNNLHQLVLK-- 213

Query: 274 KKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ 330
              I    F  I           P     L+SL   ++K    SP  RP +  + K+
Sbjct: 214 ---ICQGYFAPIS----------PNFSRDLRSLISQLFKV---SPRDRPSITSILKR 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 45.6 bits (108), Expect = 1e-05
 Identities = 54/230 (23%), Positives = 98/230 (42%), Gaps = 40/230 (17%)

Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASL------LIAPRI-KIAMEIA 161
           Q++H NI++     LE +   +V + ++ G   G  F SL          RI  I +++ 
Sbjct: 65  QLRHPNIVRYYKTFLENDRLYIVMDLIE-GAPLGEHFNSLKEKKQRFTEERIWNIFVQMV 123

Query: 162 NAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYG 221
            A+ YLH   ++ IV R +  +N++L E+    + DF L+      +    E  +    G
Sbjct: 124 LALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLA------KQKQPESKLTSVVG 175

Query: 222 FI---APEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIE 278
            I    PE      + E  DV++FG  L ++ T      +  N       +L  A K +E
Sbjct: 176 TILYSCPEIVKNEPYGEKADVWAFGCILYQMCT-LQPPFYSTN-------MLSLATKIVE 227

Query: 279 NNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVA 328
                A+ +P+ +   S        + +  ++  CL+   E RP ++ V+
Sbjct: 228 -----AVYEPLPEGMYS--------EDVTDVITSCLTPDAEARPDIIQVS 264

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 45.4 bits (108), Expect = 1e-05
 Identities = 42/170 (24%), Positives = 69/170 (40%), Gaps = 26/170 (15%)

Query: 155 KIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE--THVR 212
           KIA+ +   + YLH      I+ R +K SN+L++     KL DF +S     G+    + 
Sbjct: 104 KIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVS-----GQLVNSLA 156

Query: 213 EEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEY 272
           + F+ G   ++APE    + ++   D++S G  L EL TG      + +  D    +L+Y
Sbjct: 157 KTFV-GTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQY 215

Query: 273 AKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
                           I +E        +        +  CL K P  RP
Sbjct: 216 ----------------IVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERP 249

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 45.6 bits (108), Expect = 1e-05
 Identities = 56/250 (22%), Positives = 107/250 (42%), Gaps = 44/250 (17%)

Query: 85  VMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF- 143
           ++K  D S  +  E  F      SQ+ HK+++   G C+  +   +V E VK+G+L  + 
Sbjct: 31  LLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYL 90

Query: 144 --SFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLL----DENYSA---- 193
             +   + I+ ++++A ++A A+ +L    D+ +    + A NVLL    D         
Sbjct: 91  KKNKNLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFI 147

Query: 194 KLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTG 252
           KL D  +S+++      + +E +     ++ PE      + +   D +SFG  L E+ + 
Sbjct: 148 KLSDPGISITV------LPKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFS- 200

Query: 253 CNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYK 312
                    G D  L+ L+  KK              +++ +  P    K   L  L+ +
Sbjct: 201 ---------GGDKPLSALDSQKKLQ-----------FYEDRHQLPAP--KWTELANLINQ 238

Query: 313 CLSKSPEHRP 322
           C+   P+ RP
Sbjct: 239 CMDYEPDFRP 248

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 46.4 bits (110), Expect = 1e-05
 Identities = 41/162 (25%), Positives = 70/162 (43%), Gaps = 16/162 (9%)

Query: 108 SQMKHKNILKLI--GCCLETELPTLVFESVKYGTLRGFSFASLLIAP--RIKIAMEIANA 163
           +++ H NI+ L+  G      L   VFE V   TLR    A   +      ++ +++ +A
Sbjct: 33  ARLYHPNIVALLDSGEA-PPGLLFAVFEYVPGRTLREVLAADGALPAGETGRLMLQVLDA 91

Query: 164 VAYLHVGFDRPIVFRCIKASNVLL---DENYSAKLHDFSLSVSIPEGE-----THVREEF 215
           +A  H   ++ IV R +K  N+++        AK+ DF +   +P        T  R   
Sbjct: 92  LACAH---NQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTE 148

Query: 216 IKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLE 257
           + G   + APE           D+Y++G    E LTG  V++
Sbjct: 149 VLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVVQ 190

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 45.5 bits (108), Expect = 1e-05
 Identities = 42/156 (26%), Positives = 66/156 (42%), Gaps = 25/156 (16%)

Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTL--------RGFSFASLLIAPRIKIAM- 158
           S+ KH NI+ L           ++ E    G L        RG +       P+I+    
Sbjct: 57  SECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLT------EPQIRYVCR 110

Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           ++  A+ +LH      ++ R +KA N+LL  +   KL DF +S          R+ FI  
Sbjct: 111 QMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKS-TLQKRDTFIGT 166

Query: 219 AYGFIAPEYFATSSF-----NEMCDVYSFGAFLCEL 249
            Y ++APE  A  +F     +   D++S G  L EL
Sbjct: 167 PY-WMAPEVVACETFKDNPYDYKADIWSLGITLIEL 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 45.7 bits (108), Expect = 2e-05
 Identities = 49/166 (29%), Positives = 68/166 (40%), Gaps = 28/166 (16%)

Query: 159 EIANAVAYLH-VGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIK 217
           EI  A+ +LH +G    IV+R IK  N+LLD      L DF LS      E      F  
Sbjct: 113 EIILALEHLHKLG----IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFC- 167

Query: 218 GAYGFIAPEYF-ATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKS 276
           G   ++APE         +  D +S G  + ELLTG +    +G  N    T  E +++ 
Sbjct: 168 GTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN----TQSEVSRR- 222

Query: 277 IENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQ-LMYKCLSKSPEHR 321
                       I   D  FP     +    Q L++K L K P+ R
Sbjct: 223 ------------ILKCDPPFP---SFIGPEAQDLLHKLLRKDPKKR 253

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 45.7 bits (109), Expect = 2e-05
 Identities = 34/146 (23%), Positives = 52/146 (35%), Gaps = 40/146 (27%)

Query: 135 VKYGTLRGFSFASLLIAPRIKIAMEIANAVAYLH-VGFDRPIVFRCIKASNVLLDENYSA 193
           ++         A   IA       E+  A+  +H +GF    + R IK  N+L+D +   
Sbjct: 93  IRKDVFPE-ETARFYIA-------ELVLALDSVHKLGF----IHRDIKPDNILIDADGHI 140

Query: 194 KLHDFSLSVSIPEG---------------------------ETHVREEFIKGAYGFIAPE 226
           KL DF L   + +                            +  VR     G   +IAPE
Sbjct: 141 KLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPE 200

Query: 227 YFATSSFNEMCDVYSFGAFLCELLTG 252
               + +   CD +S G  L E+L G
Sbjct: 201 VLRGTPYGLECDWWSLGVILYEMLYG 226

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 35/107 (32%), Positives = 48/107 (44%), Gaps = 10/107 (9%)

Query: 149 LIAPRIKI-AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVS--IP 205
            + PR +  A EIA+A+ YLH      IV+R +K  N+LLD      L DF L       
Sbjct: 93  FLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 149

Query: 206 EGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
            G T        G   ++APE      ++   D +  GA L E+L G
Sbjct: 150 NGTTST----FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 45.4 bits (107), Expect = 2e-05
 Identities = 57/223 (25%), Positives = 97/223 (43%), Gaps = 31/223 (13%)

Query: 50  LKKATNNYDLHKVIQSDTSYRLFEGTLVD--QDRPISVMKFHDNSTLDDVEYCFNNIVFS 107
           L+     ++L +V+ + T  ++++G  V   Q   I VM   ++   ++++   N +   
Sbjct: 11  LRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIKLEINMLKKY 69

Query: 108 SQMKHKNILKLIGCCLETELPT------LVFESVKYGTL-------RGFSFASLLIAPRI 154
           S   H+NI    G  ++   P       LV E    G++       +G +     IA   
Sbjct: 70  SH--HRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIA--- 124

Query: 155 KIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREE 214
            I  EI   +A+LH      ++ R IK  NVLL EN   KL DF +S  + +     R  
Sbjct: 125 YICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL-DRTVGRRNT 180

Query: 215 FIKGAYGFIAPEYFAT-----SSFNEMCDVYSFGAFLCELLTG 252
           FI   Y ++APE  A      ++++   D++S G    E+  G
Sbjct: 181 FIGTPY-WMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 45.2 bits (107), Expect = 2e-05
 Identities = 41/171 (23%), Positives = 79/171 (46%), Gaps = 13/171 (7%)

Query: 89  HDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGT----LRGFS 144
           HD+   D V+   + I     + H NI++ +G     E  ++  E V  G+    LR + 
Sbjct: 44  HDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYG 103

Query: 145 -FASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVS 203
            F   L+        ++   +AYLH    + I+ R +KA N+L+D +   K+ DF +S  
Sbjct: 104 RFEEQLVR---FFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKK 157

Query: 204 IPEGETHVREEFIKGAYGFIAPEYFATS--SFNEMCDVYSFGAFLCELLTG 252
             +   + +   ++G+  ++APE   +    ++   D++S G  + E+  G
Sbjct: 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAG 208

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 45.0 bits (106), Expect = 2e-05
 Identities = 52/207 (25%), Positives = 91/207 (43%), Gaps = 16/207 (7%)

Query: 56  NYDLHKVIQSDTSYRLFEGTLVDQDRPISV--MKFHDNS--TLDDVEYCFNNIVFSSQMK 111
           N+ L K++      R++     D  R ++V  ++F   S  T  +V      I     + 
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62

Query: 112 HKNILKLIGCCLETELPTL--VFESVKYGTLRG--FSFASLLIAPRIKIAMEIANAVAYL 167
           H+ I++  GC  +    TL    E +  G+++    S+ +L      K   +I   V+YL
Sbjct: 63  HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYL 122

Query: 168 HVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLS---VSIPEGETHVREEFIKGAYGFIA 224
           H      IV R IK +N+L D   + KL DF  S    +I    T ++   + G   +++
Sbjct: 123 HSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS--VTGTPYWMS 177

Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLT 251
           PE  +   +    D++S G  + E+LT
Sbjct: 178 PEVISGEGYGRKADIWSVGCTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 45.0 bits (106), Expect = 3e-05
 Identities = 35/111 (31%), Positives = 55/111 (49%), Gaps = 11/111 (9%)

Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSL-SVSIPEGETHVREEF 215
           A EIA  + +LH    + I++R +K  NV+LD     K+ DF +   ++ +G   V  + 
Sbjct: 107 AAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG---VTTKT 160

Query: 216 IKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDD 266
             G   +IAPE  A   + +  D ++FG  L E+L G    E    G D+D
Sbjct: 161 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE----GEDED 207

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 44.8 bits (107), Expect = 3e-05
 Identities = 26/97 (26%), Positives = 47/97 (48%), Gaps = 8/97 (8%)

Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI 216
           A ++  A+ YLH      IV+R +K  N+LLD +   K+ DF  +  +    T+     +
Sbjct: 107 AAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-TYT----L 158

Query: 217 KGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGC 253
            G   ++APE   +  + +  D ++ G  + E+L G 
Sbjct: 159 CGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGY 195

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 44.6 bits (105), Expect = 3e-05
 Identities = 34/105 (32%), Positives = 49/105 (46%), Gaps = 12/105 (11%)

Query: 152 PRIKI-AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSL---SVSIPEG 207
           PR +  A EIA+A+ YLH      IV+R +K  N+LLD      L DF L    ++  + 
Sbjct: 96  PRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT 152

Query: 208 ETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
            T        G   ++APE      ++   D +  GA L E+L G
Sbjct: 153 TTT-----FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 44.3 bits (105), Expect = 4e-05
 Identities = 34/101 (33%), Positives = 52/101 (51%), Gaps = 8/101 (7%)

Query: 155 KIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREE 214
           KIA+    A+ YL    +  I+ R +K SN+LLD N + KL DF +S  + +     R+ 
Sbjct: 111 KIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRD- 167

Query: 215 FIKGAYGFIAPEYFATSS---FNEMCDVYSFGAFLCELLTG 252
              G   ++APE    S+   ++   DV+S G  L E+ TG
Sbjct: 168 --AGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATG 206

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 44.3 bits (104), Expect = 4e-05
 Identities = 39/156 (25%), Positives = 68/156 (43%), Gaps = 6/156 (3%)

Query: 98  EYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIK-I 156
           E   N I+   + K+ NI+  +   L  +   +V E +  G+L      + +   +I  +
Sbjct: 61  ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV 120

Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI 216
             E   A+ +LH      ++ R IK+ N+LL  + S KL DF     I   E   R   +
Sbjct: 121 CRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP-EQSKRSTMV 176

Query: 217 KGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
              Y ++APE     ++    D++S G    E++ G
Sbjct: 177 GTPY-WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 44.2 bits (104), Expect = 5e-05
 Identities = 30/97 (30%), Positives = 48/97 (49%), Gaps = 7/97 (7%)

Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSL-SVSIPEGETHVREEF 215
           A EI+  + +LH    R I++R +K  NV+LD     K+ DF +    + +G   V    
Sbjct: 107 AAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG---VTTRT 160

Query: 216 IKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
             G   +IAPE  A   + +  D +++G  L E+L G
Sbjct: 161 FCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAG 197

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 44.1 bits (104), Expect = 5e-05
 Identities = 39/166 (23%), Positives = 64/166 (38%), Gaps = 34/166 (20%)

Query: 173 RPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSS 232
           R  + R + A N+LL EN   K+ DF L+  I +   +VR+   +    ++APE      
Sbjct: 192 RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKV 251

Query: 233 FNEMCDVYSFGAFLCELLT-------GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAI 285
           +    DV+SFG  L E+ +       G  + E             E+ ++  E  R  A 
Sbjct: 252 YTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-------------EFCRRLKEGTRMRA- 297

Query: 286 VDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQL 331
                         E     +  +M  C   +PE RP   ++ + L
Sbjct: 298 -------------PEYATPEIYSIMLDCWHNNPEDRPTFSELVEIL 330

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 44.2 bits (104), Expect = 5e-05
 Identities = 33/109 (30%), Positives = 51/109 (46%), Gaps = 7/109 (6%)

Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI 216
           A EI   + +LH    + I++R +K  NV+LD +   K+ DF +      G+   R    
Sbjct: 102 AAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN--RASTF 156

Query: 217 KGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDD 265
            G   +IAPE      +    D +SFG  L E+L G +   F G+  D+
Sbjct: 157 CGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQS--PFHGDDEDE 203

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 44.2 bits (104), Expect = 5e-05
 Identities = 25/79 (31%), Positives = 40/79 (50%)

Query: 173 RPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSS 232
           R  + R + A N+LL EN   K+ DF L+  I +   +VR+   +    ++APE      
Sbjct: 193 RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKV 252

Query: 233 FNEMCDVYSFGAFLCELLT 251
           +    DV+SFG  L E+ +
Sbjct: 253 YTTQSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 44.0 bits (104), Expect = 6e-05
 Identities = 26/94 (27%), Positives = 44/94 (46%), Gaps = 8/94 (8%)

Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           E+  A  YLH    + I++R +K  N+LLD     K+ DF  +  +P+     R   + G
Sbjct: 126 ELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD-----RTFTLCG 177

Query: 219 AYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
              ++APE   +    +  D ++ G  L E + G
Sbjct: 178 TPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 43.4 bits (102), Expect = 6e-05
 Identities = 59/230 (25%), Positives = 96/230 (41%), Gaps = 51/230 (22%)

Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSF--ASLLIAP-RIKIAMEIANAVA 165
           Q+ HK+I+ L G C+      +V E V++G L  F    + +L  P + K+A ++A+A++
Sbjct: 60  QVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALS 119

Query: 166 YLHVGFDRPIVFRCIKASNVLL-----DENYSA--KLHDFSLSVSIPEGETHVREEFIKG 218
           YL    D+ +V   +   N+LL     D       KL D  + +++       R+E ++ 
Sbjct: 120 YLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLS-----RQECVE- 170

Query: 219 AYGFIAPEYFA-TSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSI 277
              +IAPE    + + +   D +SFG  L E+   C    + G     D       K   
Sbjct: 171 RIPWIAPECVEDSKNLSIAADKWSFGTTLWEI---C----YNGEIPLKD-------KTLA 216

Query: 278 ENNRFGA----IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPL 323
           E  RF      +V P   E             L  LM  C++  P  RP 
Sbjct: 217 EKERFYEGQCMLVTPSCKE-------------LADLMTHCMNYDPNQRPF 253

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 43.6 bits (103), Expect = 7e-05
 Identities = 44/170 (25%), Positives = 69/170 (40%), Gaps = 20/170 (11%)

Query: 155 KIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE--THVR 212
           KIA+ +   + YL+      I+ R IK SN+L++     KL DF +S     GE    + 
Sbjct: 107 KIAVAVVEGLTYLY--NVHRIMHRDIKPSNILVNSRGQIKLCDFGVS-----GELINSIA 159

Query: 213 EEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEY 272
           + F+ G   +++PE      +    DV+S G  + EL  G     F  +  DDD      
Sbjct: 160 DTFV-GTSTYMSPERIQGGKYTVKSDVWSLGISIIELALG--KFPFAFSNIDDDGQD--- 213

Query: 273 AKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
               I +     ++  I  E        +  + L   +  CL K P  RP
Sbjct: 214 DPMGILD-----LLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERP 258

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 43.3 bits (102), Expect = 7e-05
 Identities = 46/222 (20%), Positives = 86/222 (38%), Gaps = 38/222 (17%)

Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTL--------RGFSFASLLIAPRIKIAMEI 160
           ++ H+ +++L G C +     +V E +  G L        + F  + LL     ++  ++
Sbjct: 55  KLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLL-----EMCKDV 109

Query: 161 ANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAY 220
              +AYL     +  + R + A N L+D+    K+ DF LS  + + E +      K   
Sbjct: 110 CEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE-YTSSVGSKFPV 165

Query: 221 GFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENN 280
            +  PE    S F+   DV++FG  + E+ +        G    +     E  +K  +  
Sbjct: 166 RWSPPEVLLYSKFSSKSDVWAFGVLMWEVYS-------LGKMPYERFNNSETVEKVSQGL 218

Query: 281 RFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
           R   +  P    +  +            +MY C  +  E RP
Sbjct: 219 R---LYRPHLASEKVY-----------AIMYSCWHEKAEERP 246

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 43.7 bits (103), Expect = 7e-05
 Identities = 32/117 (27%), Positives = 55/117 (47%), Gaps = 7/117 (5%)

Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSL-SVSIPEGETHVREEF 215
           + EI+ A+ +LH   +R I++R +K  NVLLD     KL D+ +    I  G+T      
Sbjct: 102 SAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT---TST 155

Query: 216 IKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEY 272
             G   +IAPE      +    D ++ G  + E++ G +  +  G  ++ D    +Y
Sbjct: 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDY 212

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 43.1 bits (101), Expect = 1e-04
 Identities = 47/190 (24%), Positives = 81/190 (42%), Gaps = 5/190 (2%)

Query: 83  ISVMKFHDNSTLDDV-EYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLR 141
           +++ KF D+   ++V E     +     +K +NI++L           LVFE V+   L 
Sbjct: 29  VAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLE 88

Query: 142 GFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLS 201
                   + P  K+   I   +  +H      IV R IK  N+L+  N   KL DF  +
Sbjct: 89  LLEEMPNGVPPE-KVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFA 147

Query: 202 VSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGN 261
            ++ EG      E++   + + +PE    + + +  D++S G  L EL  G  +  F G 
Sbjct: 148 RNLSEGSNANYTEYVATRW-YRSPELLLGAPYGKAVDMWSVGCILGELSDGQPL--FPGE 204

Query: 262 GNDDDLTVLE 271
              D L  ++
Sbjct: 205 SEIDQLFTIQ 214

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 43.1 bits (101), Expect = 1e-04
 Identities = 27/95 (28%), Positives = 49/95 (51%), Gaps = 6/95 (6%)

Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSL-SVSIPEGETHVREEFIK 217
           EI +A+ YLH   ++ +V+R +K  N++LD++   K+ DF L    I +G T    +   
Sbjct: 103 EIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM---KTFC 157

Query: 218 GAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
           G   ++APE    + +    D +  G  + E++ G
Sbjct: 158 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 43.2 bits (102), Expect = 1e-04
 Identities = 30/100 (30%), Positives = 49/100 (49%), Gaps = 10/100 (10%)

Query: 158 MEIANAVAYLH-VGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI 216
            E+  A+  +H +GF    + R +K  N+LLD++   KL DF   + + +    VR +  
Sbjct: 149 AEVVLALDAIHSMGF----IHRDVKPDNMLLDKSGHLKLADFGTCMKM-DANGMVRCDTA 203

Query: 217 KGAYGFIAPEYFATSS----FNEMCDVYSFGAFLCELLTG 252
            G   +I+PE   +      +   CD +S G FL E+L G
Sbjct: 204 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 42.6 bits (100), Expect = 1e-04
 Identities = 41/165 (24%), Positives = 78/165 (47%), Gaps = 28/165 (16%)

Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF------------------SFASLL 149
           S++K  NI++L+  C+ ++   ++ E ++ G L  F                  S+++L 
Sbjct: 74  SRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL- 132

Query: 150 IAPRIKIAMEIANAVAYL-HVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE 208
               I +A +IA+ + YL  + F    V R +   N L+ +NY+ K+ DF +S ++  G+
Sbjct: 133 ----IFMATQIASGMKYLSSLNF----VHRDLATRNCLVGKNYTIKIADFGMSRNLYSGD 184

Query: 209 THVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGC 253
            +  +        +++ E      F    DV++FG  L E+LT C
Sbjct: 185 YYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLC 229

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 42.9 bits (101), Expect = 2e-04
 Identities = 34/102 (33%), Positives = 47/102 (46%), Gaps = 6/102 (5%)

Query: 152 PRIKI-AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH 210
           PR +  A EIA+A+ YLH      I++R +K  N+LLD      L DF L     E    
Sbjct: 96  PRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK- 151

Query: 211 VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
               F  G   ++APE      ++   D +  GA L E+L G
Sbjct: 152 TTSTFC-GTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 40/159 (25%), Positives = 65/159 (40%), Gaps = 20/159 (12%)

Query: 173 RPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSS 232
           R  + R + A N+LL EN   K+ DF L+  I +   +VR+   +    ++APE      
Sbjct: 198 RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV 257

Query: 233 FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDE 292
           +    DV+SFG  L E+ +      + G   D+     E+ ++  E  R  A        
Sbjct: 258 YTIQSDVWSFGVLLWEIFS-LGASPYPGVKIDE-----EFCRRLKEGTRMRA-------P 304

Query: 293 DNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQL 331
           D + P        + Q M  C    P  RP   ++ + L
Sbjct: 305 DYTTP-------EMYQTMLDCWHGEPSQRPTFSELVEHL 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 42.9 bits (101), Expect = 2e-04
 Identities = 32/95 (33%), Positives = 48/95 (50%), Gaps = 15/95 (15%)

Query: 163 AVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLS------VSIPEGETHVREEFI 216
           AV ++H    + ++ R IK++N+LL  N   KL DF  S      VS   G T     F 
Sbjct: 155 AVHHVH---SKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRT-----FC 206

Query: 217 KGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT 251
              Y ++APE +    +++  D++S G  L ELLT
Sbjct: 207 GTPY-YVAPEIWRRKPYSKKADMFSLGVLLYELLT 240

Length = 496

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 50/180 (27%), Positives = 71/180 (39%), Gaps = 30/180 (16%)

Query: 83  ISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRG 142
           +  M +    T +  +     + F  Q+KH N ++  GC L+     LV E         
Sbjct: 51  VKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYC------- 103

Query: 143 FSFASLLIAPRIKIAMEIANA---------VAYLHVGFDRPIVFRCIKASNVLLDENYSA 193
              AS L+    K   E+  A         +AYLH      ++ R IKA N+LL E    
Sbjct: 104 LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQV 160

Query: 194 KLHDF-SLSVSIPEGETHVREEFIKGAYGFIAPEYFAT---SSFNEMCDVYSFGAFLCEL 249
           KL DF S S S P         F+   Y ++APE         ++   DV+S G    EL
Sbjct: 161 KLADFGSASKSSPA------NSFVGTPY-WMAPEVILAMDEGQYDGKVDVWSLGITCIEL 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 42.4 bits (99), Expect = 2e-04
 Identities = 32/102 (31%), Positives = 49/102 (48%), Gaps = 10/102 (9%)

Query: 156 IAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEF 215
           I  EI   +++LH      ++ R IK  NVLL EN   KL DF +S  + +     R  F
Sbjct: 116 ICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL-DRTVGRRNTF 171

Query: 216 IKGAYGFIAPEYFAT-----SSFNEMCDVYSFGAFLCELLTG 252
           I   Y ++APE  A      ++++   D++S G    E+  G
Sbjct: 172 IGTPY-WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 42.0 bits (99), Expect = 2e-04
 Identities = 33/106 (31%), Positives = 50/106 (47%), Gaps = 17/106 (16%)

Query: 155 KIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREE 214
           KIA+ I  A+ YLH      ++ R +K SNVL++ N   KL DF +S        ++ + 
Sbjct: 107 KIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGIS-------GYLVDS 157

Query: 215 FIK----GAYGFIAPEYF----ATSSFNEMCDVYSFGAFLCELLTG 252
             K    G   ++APE          ++   DV+S G  + EL TG
Sbjct: 158 VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATG 203

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 42.1 bits (99), Expect = 2e-04
 Identities = 37/153 (24%), Positives = 69/153 (45%), Gaps = 24/153 (15%)

Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGT-LRGFSFASLLIAPRIK------IAMEIA 161
            ++H+NI+ L      +++     E + + T L G     LL +  ++         +I 
Sbjct: 65  HLRHENIISL------SDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQIL 118

Query: 162 NAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLS-VSIPEGETHVREEFIKGAY 220
             + Y+H      +V R +K SN+L++EN   K+ DF L+ +  P+   +V   + +   
Sbjct: 119 RGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRYYR--- 172

Query: 221 GFIAPEYFAT-SSFNEMCDVYSFGAFLCELLTG 252
              APE   T   ++   D++S G    E+L G
Sbjct: 173 ---APEIMLTWQKYDVEVDIWSAGCIFAEMLEG 202

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 41.9 bits (98), Expect = 2e-04
 Identities = 37/149 (24%), Positives = 68/149 (45%), Gaps = 12/149 (8%)

Query: 110 MKHKNILKLIGCCLETELP--TLVFESVKYGTLRG--FSFASLLIAPRIKIAMEIANAVA 165
           ++H  I++  GC  + E    ++  E +  G+++    ++ +L      +   +I   V+
Sbjct: 61  LRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVS 120

Query: 166 YLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPE---GETHVREEFIKGAYGF 222
           YLH      IV R IK +N+L D   + KL DF  S  I       T ++   + G   +
Sbjct: 121 YLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS--VTGTPYW 175

Query: 223 IAPEYFATSSFNEMCDVYSFGAFLCELLT 251
           ++PE  +   +    DV+S    + E+LT
Sbjct: 176 MSPEVISGEGYGRKADVWSVACTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 42.0 bits (99), Expect = 2e-04
 Identities = 57/244 (23%), Positives = 95/244 (38%), Gaps = 34/244 (13%)

Query: 83  ISVMKFHDNSTLDDVE--YCFNNI-VFSSQMKHKNILKLIGCCLETELPTLVFESVKYGT 139
           I  +K  D    D+VE   C   I   ++  +H  ++ L  C    +    V E    G 
Sbjct: 29  IKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGD 88

Query: 140 LRGFSFASLLIAPRIKI-AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDF 198
           L       +   PR    A  +   + YLH   +  IV+R +K  N+LLD     K+ DF
Sbjct: 89  LMMHIHTDVFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADF 145

Query: 199 SLSVSIPEGETHV-REEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLE 257
            L     EG     R     G   F+APE    +S+    D +  G  + E+L G +   
Sbjct: 146 GLC---KEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGES--P 200

Query: 258 FKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKS 317
           F G+  ++                   + D I +++  +P      +++  +M + L ++
Sbjct: 201 FPGDDEEE-------------------VFDSIVNDEVRYPR-FLSREAIS-IMRRLLRRN 239

Query: 318 PEHR 321
           PE R
Sbjct: 240 PERR 243

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 41.9 bits (98), Expect = 2e-04
 Identities = 29/95 (30%), Positives = 48/95 (50%), Gaps = 7/95 (7%)

Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSL-SVSIPEGETHVREEFIK 217
           EI +A+ YLH    R +V+R IK  N++LD++   K+ DF L    I +G T    +   
Sbjct: 103 EIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM---KTFC 156

Query: 218 GAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
           G   ++APE    + +    D +  G  + E++ G
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 191

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 41.9 bits (98), Expect = 3e-04
 Identities = 29/97 (29%), Positives = 47/97 (48%), Gaps = 7/97 (7%)

Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSL-SVSIPEGETHVREEF 215
           A EI  A+ +LH   +R I++R +K  NVLLD +   KL D+ +    +  G+T      
Sbjct: 102 AAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT---TST 155

Query: 216 IKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
             G   +IAPE      +    D ++ G  + E++ G
Sbjct: 156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAG 192

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 42.0 bits (98), Expect = 3e-04
 Identities = 29/95 (30%), Positives = 47/95 (49%), Gaps = 7/95 (7%)

Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVRE-EFIK 217
           EI +A+ YLH G    IV+R +K  N++LD++   K+ DF L     EG T     +   
Sbjct: 103 EIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLC---KEGITDAATMKTFC 156

Query: 218 GAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
           G   ++APE    + +    D +  G  + E++ G
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 191

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 41.8 bits (98), Expect = 3e-04
 Identities = 33/181 (18%), Positives = 75/181 (41%), Gaps = 17/181 (9%)

Query: 85  VMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF- 143
           V +   ++T D+       +    ++ H N+L+ +G C+E+    LV E    G L+ + 
Sbjct: 27  VKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYL 86

Query: 144 ----SFASLLIAPRI--KIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHD 197
                  + +    +  ++A E+A+ + +LH       +   +   N  L  + S K+ D
Sbjct: 87  RSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGD 143

Query: 198 FSLSVSIPEGETHVREEFIKGAYGFIAPEY-------FATSSFNEMCDVYSFGAFLCELL 250
           + L++     + ++ ++       ++APE               +  +++S G  + EL 
Sbjct: 144 YGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELF 203

Query: 251 T 251
           T
Sbjct: 204 T 204

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 41.9 bits (98), Expect = 3e-04
 Identities = 36/147 (24%), Positives = 67/147 (45%), Gaps = 7/147 (4%)

Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASL-LIAPR--IKIAMEIANAV 164
           + + + ++ +L+G CL T    L+ + + +G L  +       I  +  +   ++IA  +
Sbjct: 64  ASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 122

Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIA 224
            YL    +R +V R + A NVL+      K+ DF L+  +   E     E  K    ++A
Sbjct: 123 NYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMA 179

Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLT 251
            E      +    DV+S+G  + EL+T
Sbjct: 180 LESILHRIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 41.5 bits (97), Expect = 3e-04
 Identities = 45/177 (25%), Positives = 74/177 (41%), Gaps = 29/177 (16%)

Query: 95  DDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPT-----LVFESVKYGTL--------- 140
           +++E  +N  +  +   H N++K  G   + ++       LV E    G++         
Sbjct: 59  EEIEAEYN--ILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLK 116

Query: 141 RGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSL 200
           RG      +IA    I  E    + +LHV      + R +K +N+LL      KL DF +
Sbjct: 117 RGERMEEPIIA---YILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGV 170

Query: 201 SVSIPEGETHVREEFIKGAYGFIAPEYFAT-----SSFNEMCDVYSFGAFLCELLTG 252
           S  +    T +R     G   ++APE  A      S+++  CDV+S G    EL  G
Sbjct: 171 SAQLTS--TRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 42.0 bits (98), Expect = 3e-04
 Identities = 45/171 (26%), Positives = 71/171 (41%), Gaps = 34/171 (19%)

Query: 99  YCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSF------------- 145
              N I+   ++ H+NILK+           L  E+  Y   + + F             
Sbjct: 209 QLENEILALGRLNHENILKI--------EEILRSEANTYMITQKYDFDLYSFMYDEAFDW 260

Query: 146 --ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVS 203
               LL   R  I  ++  AV Y+H   D+ ++ R IK  N+ L+ +    L DF  +  
Sbjct: 261 KDRPLLKQTR-AIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFG-TAM 315

Query: 204 IPEGETHVREEFIKGAYGFIA---PEYFATSSFNEMCDVYSFGAFLCELLT 251
             E E   RE F  G  G +A   PE  A   + E+ D++S G  L ++L+
Sbjct: 316 PFEKE---REAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 41.5 bits (97), Expect = 4e-04
 Identities = 37/178 (20%), Positives = 77/178 (43%), Gaps = 17/178 (9%)

Query: 82  PISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL- 140
           P+++    D S     +   ++++    + H  I++L+G C    L  LV +    G+L 
Sbjct: 38  PVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGASL-QLVTQLSPLGSLL 96

Query: 141 ------RGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAK 194
                 R       L+       ++IA  + YL    +  +V R + A N+LL  +   +
Sbjct: 97  DHVRQHRDSLDPQRLL----NWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQ 149

Query: 195 LHDFSLS-VSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT 251
           + DF ++ +  P+ + +   E  K    ++A E      +    DV+S+G  + E+++
Sbjct: 150 IADFGVADLLYPDDKKYFYSE-HKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 41.5 bits (97), Expect = 4e-04
 Identities = 36/129 (27%), Positives = 58/129 (44%), Gaps = 18/129 (13%)

Query: 125 TELPTLVFES--VKYGTLRGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKA 182
           T   TL+ ES  + Y  L GFS+             ++AN + +L     +  V R + A
Sbjct: 224 TRRDTLINESPALSYMDLVGFSY-------------QVANGMEFLA---SKNCVHRDLAA 267

Query: 183 SNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSF 242
            NVL+ E    K+ DF L+  I     ++ +        ++APE    + +  + DV+SF
Sbjct: 268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSF 327

Query: 243 GAFLCELLT 251
           G  L E+ T
Sbjct: 328 GILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 41.2 bits (97), Expect = 4e-04
 Identities = 38/157 (24%), Positives = 70/157 (44%), Gaps = 26/157 (16%)

Query: 109 QMKHKNILKL----IGCCLETELPTLVFESVKYGTLRGFSFASLL-------IAPRIK-I 156
            ++H NI++L    +G  L++    LV E  +         ASLL          ++K +
Sbjct: 62  NLRHPNIVELKEVVVGKHLDSIF--LVMEYCEQ------DLASLLDNMPTPFSESQVKCL 113

Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI 216
            +++   + YLH   +  I+ R +K SN+LL +    K+ DF L+ +       +  + +
Sbjct: 114 MLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV 170

Query: 217 KGAYGFIAPE-YFATSSFNEMCDVYSFGAFLCELLTG 252
              Y   APE     +++    D+++ G  L ELL  
Sbjct: 171 TLWYR--APELLLGCTTYTTAIDMWAVGCILAELLAH 205

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 40.8 bits (96), Expect = 5e-04
 Identities = 58/259 (22%), Positives = 110/259 (42%), Gaps = 21/259 (8%)

Query: 78  DQDRPISVMKFHDNSTLDDV-EYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVK 136
           +  + +++ KF ++     V +     I    Q++H+N++ LI      +   LVFE V 
Sbjct: 24  ETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVD 83

Query: 137 YGTLRGFS-FASLLIAPRI-KIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAK 194
           +  L     + + L   R+ K   +I   + + H      I+ R IK  N+L+ ++   K
Sbjct: 84  HTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVK 140

Query: 195 LHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYF-ATSSFNEMCDVYSFGAFLCELLTGC 253
           L DF  + ++      V  +++   + + APE     + +    D+++ G  + E+LTG 
Sbjct: 141 LCDFGFARTL-AAPGEVYTDYVATRW-YRAPELLVGDTKYGRAVDIWAVGCLVTEMLTG- 197

Query: 254 NVLEFKGNGNDDDL--------TVLEYAKKSIENNRFGAIVD-PIFDEDNSFPGKEEKLQ 304
             L F G+ + D L         ++   ++  + N   A +  P   E      +  KL 
Sbjct: 198 EPL-FPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLS 256

Query: 305 SLG-QLMYKCLSKSPEHRP 322
            L   L  +CL   P+ RP
Sbjct: 257 GLVLDLAKQCLRIDPDDRP 275

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 41.3 bits (97), Expect = 5e-04
 Identities = 19/46 (41%), Positives = 29/46 (63%), Gaps = 3/46 (6%)

Query: 156 IAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLS 201
           +A +I + +AYLH    R IV R IK SN+L++   + K+ DF +S
Sbjct: 173 VARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVS 215

Length = 353

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 41.3 bits (97), Expect = 5e-04
 Identities = 35/158 (22%), Positives = 68/158 (43%), Gaps = 17/158 (10%)

Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIK-IAMEIANAVAYL 167
           ++KH+NI+ L+   +E +   LV + +     +       L   ++K I ++I N +  L
Sbjct: 76  EIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVL 135

Query: 168 HVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLS---VSIPEGETHVREEFIKG------ 218
           H       + R +  +N+ ++     K+ DF L+      P  +T  ++E ++       
Sbjct: 136 H---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTS 192

Query: 219 ---AYGFIAPE-YFATSSFNEMCDVYSFGAFLCELLTG 252
                 + APE       ++   D++S G    ELLTG
Sbjct: 193 KVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG 230

Length = 335

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 40.8 bits (95), Expect = 5e-04
 Identities = 33/107 (30%), Positives = 52/107 (48%), Gaps = 11/107 (10%)

Query: 149 LIAPRIK-IAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEG 207
           L  P+I+ I  ++  A+ YLH      I+ R +KA NVLL  +   KL DF +S    + 
Sbjct: 107 LTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK- 162

Query: 208 ETHVREEFIKGAYGFIAPEY-----FATSSFNEMCDVYSFGAFLCEL 249
               R+ FI   Y ++APE         + ++   D++S G  L E+
Sbjct: 163 TLQRRDSFIGTPY-WMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 40.7 bits (95), Expect = 5e-04
 Identities = 67/253 (26%), Positives = 106/253 (41%), Gaps = 51/253 (20%)

Query: 85  VMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL---- 140
           V+K  D S  D     F      SQ+ H ++  + G C+      +V E V++G L    
Sbjct: 48  VLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCL 107

Query: 141 ---RGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLL-----DENYS 192
              +G     + +A +I +A ++A+A++YL    D+ +V   + A N+LL      E  S
Sbjct: 108 RKEKG----RVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEGTS 160

Query: 193 A--KLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFAT-SSFNEMCDVYSFGAFLCEL 249
              KL D  +S +    E  V  E I     +IAPE     +S +   D +SFG  L E+
Sbjct: 161 PFIKLSDPGVSFTALSREERV--ERIP----WIAPECVPGGNSLSTAADKWSFGTTLLEI 214

Query: 250 LTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQL 309
              C    F G        V    +   E  RF       +++ +  P  E   + L  L
Sbjct: 215 ---C----FDGE-------VPLKERTPSEKERF-------YEKKHRLP--EPSCKELATL 251

Query: 310 MYKCLSKSPEHRP 322
           + +CL+  P  RP
Sbjct: 252 ISQCLTYEPTQRP 264

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 41.1 bits (96), Expect = 5e-04
 Identities = 24/79 (30%), Positives = 41/79 (51%), Gaps = 5/79 (6%)

Query: 175 IVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFN 234
           IV+R +K  N+LLD++   K+ DF  +  + +  T+     + G   +IAPE        
Sbjct: 152 IVYRDLKPENLLLDKDGFIKMTDFGFA-KVVDTRTYT----LCGTPEYIAPEILLNVGHG 206

Query: 235 EMCDVYSFGAFLCELLTGC 253
           +  D ++ G F+ E+L GC
Sbjct: 207 KAADWWTLGIFIYEILVGC 225

Length = 340

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 40.6 bits (95), Expect = 5e-04
 Identities = 41/173 (23%), Positives = 70/173 (40%), Gaps = 31/173 (17%)

Query: 155 KIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPE--GETHVR 212
           +IA+ +   + YL   +   I+ R +K SN+L++     KL DF +S  +     +T+V 
Sbjct: 99  RIAVAVVKGLTYL---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV- 154

Query: 213 EEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEF---KGNGNDDDLTV 269
                G   ++APE  +   +    DV+S G    EL  G     F   +   N   L  
Sbjct: 155 -----GTNAYMAPERISGEQYGIHSDVWSLGISFMELALG----RFPYPQIQKNQGSLMP 205

Query: 270 LEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
           L+             ++  I DED       +  +     + +C+ K P+ RP
Sbjct: 206 LQ-------------LLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERP 245

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 40.8 bits (95), Expect = 6e-04
 Identities = 51/220 (23%), Positives = 95/220 (43%), Gaps = 20/220 (9%)

Query: 48  KDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHD--NSTLDDVEYCFNNIV 105
           + L   T+ +++ + I   T  ++++ T   +D  ++ +K  D  +   +++E  +N  +
Sbjct: 15  ESLGDPTDTWEIIETIGKGTYGKVYKVT-NKKDGSLAAVKILDPISDVDEEIEAEYN--I 71

Query: 106 FSSQMKHKNILKLIGCCLETELPT-----LVFESVKYGTLRGFSFASLLIAPRIK---IA 157
             S   H N++K  G   + +        LV E    G++       L+   R+    I+
Sbjct: 72  LQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMIS 131

Query: 158 MEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIK 217
             +  A+  L    +  I+ R +K +N+LL      KL DF +S  +    T +R     
Sbjct: 132 YILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT--STRLRRNTSV 189

Query: 218 GAYGFIAPEYFAT-----SSFNEMCDVYSFGAFLCELLTG 252
           G   ++APE  A       S++  CDV+S G    EL  G
Sbjct: 190 GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 40.9 bits (96), Expect = 6e-04
 Identities = 47/229 (20%), Positives = 93/229 (40%), Gaps = 34/229 (14%)

Query: 40  NPIRAFSAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEY 99
           N I+   + D+ K T+      +I+ +    +++G   +++  I   K         ++ 
Sbjct: 10  NDIKCIESDDIDKYTS-----VLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDI 64

Query: 100 CFNNIVFSSQMKHKNILKLIGCCLET--ELP--TLVFESVKYGTLRGF--SFASLLIAPR 153
             N I    ++   NILK+ G  ++   +LP  +L+ E    G LR        L    +
Sbjct: 65  TENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTK 124

Query: 154 IKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKL--HDFSLSVSIPEGETHV 211
           + +A++    +  L+   ++P  ++ + + + L+ ENY  K+  H     +S P  +   
Sbjct: 125 LDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKN-- 180

Query: 212 REEFIKGAYGFIAPEYFAT-------SSFNEMCDVYSFGAFLCELLTGC 253
                     F+   YF+        S +    D+YS G  L E+ TG 
Sbjct: 181 --------VNFMV--YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGK 219

Length = 283

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 40.1 bits (94), Expect = 8e-04
 Identities = 23/98 (23%), Positives = 48/98 (48%), Gaps = 7/98 (7%)

Query: 155 KIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREE 214
           +I +++   +  LH   ++ I+ R +K++N+LL  N   K+ D  +S  + +     +  
Sbjct: 107 RIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQ-- 161

Query: 215 FIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
              G   ++APE +    ++   D++S G  L E+ T 
Sbjct: 162 --IGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATF 197

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 40.2 bits (94), Expect = 8e-04
 Identities = 34/104 (32%), Positives = 46/104 (44%), Gaps = 16/104 (15%)

Query: 163 AVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLS--------VSIPEG--ETHVR 212
           A+ YLH   +  IV R +K  N+L+      KL DF LS         ++ EG  E   R
Sbjct: 113 ALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169

Query: 213 EEFIKGAYG---FIAPEYFATSSFNEMCDVYSFGAFLCELLTGC 253
           E   K   G   +IAPE      + +  D ++ G  L E L GC
Sbjct: 170 EFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGC 213

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 40.4 bits (94), Expect = 0.001
 Identities = 29/113 (25%), Positives = 42/113 (37%), Gaps = 39/113 (34%)

Query: 176 VFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIK------------------ 217
           + R IK  N+LLD     KL DF L   + +     R EF +                  
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH---RTEFYRNLTHNPPSDFSFQNMNSK 179

Query: 218 ------------------GAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
                             G   +IAPE F  + +N++CD +S G  + E+L G
Sbjct: 180 RKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 40.3 bits (95), Expect = 0.001
 Identities = 38/151 (25%), Positives = 59/151 (39%), Gaps = 22/151 (14%)

Query: 110 MKHKNILKLIGCCLETELPTLVFES--------VKYGTLRGFSFASLLIAPRIK-IAMEI 160
           +KH NI+ L+          LVFE         +K  ++        L    IK   +  
Sbjct: 59  LKHPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIV-------LTPADIKSYMLMT 111

Query: 161 ANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAY 220
              + YLH      I+ R +K +N+L+  +   KL DF L+ S       +  + +   Y
Sbjct: 112 LRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWY 168

Query: 221 GFIAPE-YFATSSFNEMCDVYSFGAFLCELL 250
              APE  F    +    D++S G    ELL
Sbjct: 169 R--APELLFGARHYGVGVDMWSVGCIFAELL 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 40.4 bits (94), Expect = 0.001
 Identities = 29/113 (25%), Positives = 42/113 (37%), Gaps = 39/113 (34%)

Query: 176 VFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIK------------------ 217
           + R IK  N+LLD     KL DF L   + +     R EF +                  
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH---RTEFYRNLNHSLPSDFTFQNMNSK 179

Query: 218 ------------------GAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
                             G   +IAPE F  + +N++CD +S G  + E+L G
Sbjct: 180 RKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 40.0 bits (93), Expect = 0.001
 Identities = 26/98 (26%), Positives = 49/98 (50%), Gaps = 6/98 (6%)

Query: 155 KIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREE 214
           K+++ +   +AYL       I+ R +K SN+L++     KL DF +S  + +    +   
Sbjct: 107 KVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANS 161

Query: 215 FIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
           F+ G   +++PE    + ++   D++S G  L EL  G
Sbjct: 162 FV-GTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIG 198

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 39.9 bits (94), Expect = 0.001
 Identities = 30/102 (29%), Positives = 54/102 (52%), Gaps = 9/102 (8%)

Query: 156 IAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE----THV 211
           I  ++  A+ Y+H G    ++ R +K SN+LL+ +   KL DF L+ S+ E E      V
Sbjct: 112 IMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPV 168

Query: 212 REEFIKGAYGFIAPE-YFATSSFNEMCDVYSFGAFLCELLTG 252
             +++   + + APE    ++ + +  D++S G  L E+L G
Sbjct: 169 LTDYVATRW-YRAPEILLGSTRYTKGVDMWSVGCILGEMLLG 209

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 40.0 bits (94), Expect = 0.001
 Identities = 35/154 (22%), Positives = 61/154 (39%), Gaps = 11/154 (7%)

Query: 104 IVFSSQMKHKNILKLIGCCLETELPTLVFESVK---YGTLRGFSFASLLIAPRIK-IAME 159
           I      +H  ++KL+          LV E +       LR       L   ++K     
Sbjct: 50  IKALQACQHPYVVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERP--LPEAQVKSYMRM 107

Query: 160 IANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGA 219
           +   VAY+H      I+ R +K +N+L+  +   K+ DF L+    E E  +    +   
Sbjct: 108 LLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-AT 163

Query: 220 YGFIAPE-YFATSSFNEMCDVYSFGAFLCELLTG 252
             + APE  +    ++   D+++ G    ELL G
Sbjct: 164 RWYRAPELLYGARKYDPGVDLWAVGCIFAELLNG 197

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 39.8 bits (93), Expect = 0.001
 Identities = 35/142 (24%), Positives = 54/142 (38%), Gaps = 47/142 (33%)

Query: 153 RIKIAMEIANAVAYLH-VGFDRPIVFRCIKASNVLLDENYSAKLHDFSL----------- 200
           R  IA E+  A+  +H +GF    + R IK  N+L+D +   KL DF L           
Sbjct: 104 RFYIA-ELTCAIESVHKMGF----IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158

Query: 201 -----------SVSIPEGETHVREEFIK-------------------GAYGFIAPEYFAT 230
                      S+   E  + +    +K                   G   +IAPE    
Sbjct: 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR 218

Query: 231 SSFNEMCDVYSFGAFLCELLTG 252
           + + ++CD +S G  L E+L G
Sbjct: 219 TGYTQLCDWWSVGVILYEMLVG 240

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 39.5 bits (92), Expect = 0.001
 Identities = 41/167 (24%), Positives = 67/167 (40%), Gaps = 30/167 (17%)

Query: 164 VAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFI 223
           V Y+H    R I+ R +KA N+ L  N   K+ DF +S  +  G   +   F    Y ++
Sbjct: 119 VHYMHQ---RRILHRDLKAKNIFLKNNL-LKIGDFGVS-RLLMGSCDLATTFTGTPY-YM 172

Query: 224 APEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFG 283
           +PE      ++   D++S G  L E+                    L +A    E   F 
Sbjct: 173 SPEALKHQGYDSKSDIWSLGCILYEM------------------CCLAHA---FEGQNFL 211

Query: 284 AIVDPIFDEDN-SFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK 329
           ++V  I +    S P  E   + L  +M   L+K P  RP   ++ +
Sbjct: 212 SVVLRIVEGPTPSLP--ETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 39.2 bits (91), Expect = 0.001
 Identities = 42/167 (25%), Positives = 68/167 (40%), Gaps = 23/167 (13%)

Query: 96  DVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL-------RGFSFASL 148
            VE      V  ++MKH NI+             +V E    G L       RG  F   
Sbjct: 41  AVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPED 100

Query: 149 LIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFS----LSVSI 204
            I   ++  +++   V ++H   ++ ++ R IK+ N+ L +N   KL DF     L+   
Sbjct: 101 TI---LQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG 154

Query: 205 PEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT 251
               T+V      G   ++ PE +    +N   D++S G  L EL T
Sbjct: 155 AYACTYV------GTPYYVPPEIWENMPYNNKSDIWSLGCILYELCT 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 39.6 bits (92), Expect = 0.002
 Identities = 31/99 (31%), Positives = 50/99 (50%), Gaps = 10/99 (10%)

Query: 159 EIANAVAYLH-VGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIK 217
           E+  A+  +H +GF    + R +K  N+LLD++   KL DF   + + + E  VR +   
Sbjct: 150 EVVLALDAIHSMGF----IHRDVKPDNMLLDKSGHLKLADFGTCMKMNK-EGMVRCDTAV 204

Query: 218 GAYGFIAPEYFATSS----FNEMCDVYSFGAFLCELLTG 252
           G   +I+PE   +      +   CD +S G FL E+L G
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 39.4 bits (92), Expect = 0.002
 Identities = 28/95 (29%), Positives = 48/95 (50%), Gaps = 7/95 (7%)

Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSL-SVSIPEGETHVREEFIK 217
           EI +A+ YLH      +V+R +K  N++LD++   K+ DF L    I +G T   + F  
Sbjct: 103 EIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFC- 156

Query: 218 GAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
           G   ++APE    + +    D +  G  + E++ G
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 191

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 39.2 bits (91), Expect = 0.002
 Identities = 55/238 (23%), Positives = 90/238 (37%), Gaps = 58/238 (24%)

Query: 115 ILKLIGCCLETELPTLVFESVKYGTLRGFSFASL-LIAPR--IKIAMEIANAVAYLHVGF 171
           + +L+G CL T    LV + + YG L  +   +   I  +  +   ++IA  ++YL    
Sbjct: 71  VCRLLGICL-TSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE--- 126

Query: 172 DRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATS 231
           +  +V R + A NVL+      K+ DF L+  +   ET    +  K    ++A E     
Sbjct: 127 EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHR 186

Query: 232 SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFD 291
            F    DV+S+G  + EL+T                              FGA   P   
Sbjct: 187 RFTHQSDVWSYGVTVWELMT------------------------------FGA--KPY-- 212

Query: 292 EDNSFPGKE-----EKLQSLGQ----------LMYKCLSKSPEHRPLMVDVAKQLRQM 334
             +  P +E     EK + L Q          +M KC     E RP   ++  +  +M
Sbjct: 213 --DGIPAREIPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM 268

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 39.2 bits (91), Expect = 0.002
 Identities = 44/182 (24%), Positives = 76/182 (41%), Gaps = 16/182 (8%)

Query: 79  QDRPISVM---KFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESV 135
           Q++   V+   K  D  + +++E     I   +   H NI+KL+          ++ E  
Sbjct: 25  QNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84

Query: 136 KYGTLRG--FSFASLLIAPRIKIA-MEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYS 192
             G +          L  P+I++   +   A+ YLH   +  I+ R +KA N+L   +  
Sbjct: 85  AGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGD 141

Query: 193 AKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSS-----FNEMCDVYSFGAFLC 247
            KL DF +S          R+ FI   Y ++APE     +     ++   DV+S G  L 
Sbjct: 142 IKLADFGVSAKNTR-TIQRRDSFIGTPY-WMAPEVVMCETSKDRPYDYKADVWSLGITLI 199

Query: 248 EL 249
           E+
Sbjct: 200 EM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 39.1 bits (91), Expect = 0.002
 Identities = 52/264 (19%), Positives = 94/264 (35%), Gaps = 38/264 (14%)

Query: 79  QDRPISVMKFHDNSTLDDVEYCF-NNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKY 137
           ++ P+++       + D     F    +   Q  H NI++L G         +V E +  
Sbjct: 32  RELPVAIHTLRAGCS-DKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSN 90

Query: 138 GTLRGF---SFASLLIAPRIKIAMEIANAVAYL-HVGFDRPIVFRCIKASNVLLDENYSA 193
           G L  F       L+    + +   +A+ + YL  +G+    V + + A  VL++ +   
Sbjct: 91  GALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGY----VHKGLAAHKVLVNSDLVC 146

Query: 194 KLHDFSLSVSIPEGETHVREEFIKGAYGFI--APEYFATSSFNEMCDVYSFGAFLCELLT 251
           K+  F     + E ++      + G    +  APE      F+   DV+SFG  + E   
Sbjct: 147 KISGFR---RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWE--- 200

Query: 252 GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDN-SFPGKEEKLQSLGQLM 310
                            V+ Y ++   +     ++  +  ED    P        L QLM
Sbjct: 201 -----------------VMSYGERPYWDMSGQDVIKAV--EDGFRLPAPRNCPNLLHQLM 241

Query: 311 YKCLSKSPEHRPLMVDVAKQLRQM 334
             C  K    RP    +   L +M
Sbjct: 242 LDCWQKERGERPRFSQIHSILSKM 265

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 39.3 bits (92), Expect = 0.002
 Identities = 41/164 (25%), Positives = 68/164 (41%), Gaps = 26/164 (15%)

Query: 159 EIANAVAYLH-VGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIK 217
           E+  AV  LH +G     + R +K  N L+D +   KL DF LS  I           + 
Sbjct: 109 EMFEAVDALHELG----YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YANSVV 159

Query: 218 GAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSI 277
           G+  ++APE      ++   D +S G  L E L G     F G+  ++    L+Y K+++
Sbjct: 160 GSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFP--PFSGSTPNETWENLKYWKETL 217

Query: 278 ENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHR 321
           +         P++D+       E        L+ K ++  P  R
Sbjct: 218 QR--------PVYDDPRFNLSDE-----AWDLITKLIN-DPSRR 247

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 39.0 bits (91), Expect = 0.002
 Identities = 57/228 (25%), Positives = 93/228 (40%), Gaps = 43/228 (18%)

Query: 48  KDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFS 107
           K   + T      K I  D      EGT     R IS+MK                    
Sbjct: 18  KGRNRTTGEIVALKEIHLDAE----EGTPSTAIREISLMK-------------------- 53

Query: 108 SQMKHKNILKLIGCC-LETELPTLVFESV-----KYGTLRGFSFASLLIAPRIKIAM-EI 160
            ++KH+NI++L      E +L  LVFE +     KY    G   A  L    +K    ++
Sbjct: 54  -ELKHENIVRLHDVIHTENKL-MLVFEYMDKDLKKYMDTHGVRGA--LDPNTVKSFTYQL 109

Query: 161 ANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAY 220
              +A+ H   +  ++ R +K  N+L+++    KL DF L+ +          E +   Y
Sbjct: 110 LKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWY 166

Query: 221 GFIAPEYFATS-SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDL 267
              AP+    S +++   D++S G  + E++TG  +  F G  N+D L
Sbjct: 167 R--APDVLLGSRTYSTSIDIWSVGCIMAEMITGRPL--FPGTNNEDQL 210

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 38.8 bits (90), Expect = 0.003
 Identities = 26/82 (31%), Positives = 41/82 (50%), Gaps = 5/82 (6%)

Query: 175 IVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSS-- 232
           ++ R +K  N+LLD++   KL DF   + + E    VR +   G   +I+PE   +    
Sbjct: 163 LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE-TGMVRCDTAVGTPDYISPEVLKSQGGD 221

Query: 233 --FNEMCDVYSFGAFLCELLTG 252
             +   CD +S G FL E+L G
Sbjct: 222 GYYGRECDWWSVGVFLFEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 38.5 bits (89), Expect = 0.003
 Identities = 48/180 (26%), Positives = 71/180 (39%), Gaps = 30/180 (16%)

Query: 83  ISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRG 142
           I  M +    + +  +     + F  ++KH N ++  GC L      LV E         
Sbjct: 55  IKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYC------- 107

Query: 143 FSFASLLIAPRIKIAMEIANA---------VAYLHVGFDRPIVFRCIKASNVLLDENYSA 193
              AS L+    K   E+  A         +AYLH      ++ R IKA N+LL E    
Sbjct: 108 LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQV 164

Query: 194 KLHDF-SLSVSIPEGETHVREEFIKGAYGFIAPEYFAT---SSFNEMCDVYSFGAFLCEL 249
           KL DF S S++ P         F+   Y ++APE         ++   DV+S G    EL
Sbjct: 165 KLADFGSASIASPA------NSFVGTPY-WMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 38.6 bits (90), Expect = 0.003
 Identities = 39/151 (25%), Positives = 59/151 (39%), Gaps = 25/151 (16%)

Query: 176 VFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYF-----AT 230
           V R IK  NVLLD+N   +L DF   + +    T V+     G   +I+PE         
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT-VQSNVAVGTPDYISPEILQAMEDGK 182

Query: 231 SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIF 290
             +   CD +S G  + E+L G                   YA+  +E   +G I++   
Sbjct: 183 GRYGPECDWWSLGVCMYEMLYG---------------ETPFYAESLVET--YGKIMN--H 223

Query: 291 DEDNSFPGKEEKLQSLGQLMYKCLSKSPEHR 321
            E   FP     +    + + + L  SPE R
Sbjct: 224 KEHFQFPPDVTDVSEEAKDLIRRLICSPETR 254

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 38.5 bits (89), Expect = 0.004
 Identities = 45/178 (25%), Positives = 71/178 (39%), Gaps = 26/178 (14%)

Query: 83  ISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRG 142
           I  M +    + +  +     + F  +++H N ++  GC L      LV E        G
Sbjct: 45  IKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC-----LG 99

Query: 143 FSFASLLIAPRIKIAMEIA-------NAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKL 195
            +   L +  +    +EIA         +AYLH      ++ R +KA N+LL E    KL
Sbjct: 100 SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKL 156

Query: 196 HDF-SLSVSIPEGETHVREEFIKGAYGFIAPEYFAT---SSFNEMCDVYSFGAFLCEL 249
            DF S S+  P         F+   Y ++APE         ++   DV+S G    EL
Sbjct: 157 GDFGSASIMAPA------NXFVGTPY-WMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 38.5 bits (89), Expect = 0.004
 Identities = 30/119 (25%), Positives = 55/119 (46%), Gaps = 23/119 (19%)

Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           +I   + Y+H      I+ R +K SN+ ++E+   K+ DF L+        H  +E    
Sbjct: 128 QILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-------RHTDDEMT-- 175

Query: 219 AYGFIAPEYFATSS-------FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
             G++A  ++           +N+  D++S G  + ELLTG  +  F G  + D L ++
Sbjct: 176 --GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL--FPGTDHIDQLKLI 230

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 38.2 bits (89), Expect = 0.004
 Identities = 26/100 (26%), Positives = 47/100 (47%), Gaps = 10/100 (10%)

Query: 155 KIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH--VR 212
           KI++ +   + YL       I+ R +K SN+L++     KL DF +S     G+    + 
Sbjct: 103 KISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMA 155

Query: 213 EEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
             F+ G   +++PE    + +    D++S G  L E+  G
Sbjct: 156 NSFV-GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIG 194

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 38.1 bits (89), Expect = 0.004
 Identities = 30/118 (25%), Positives = 51/118 (43%), Gaps = 27/118 (22%)

Query: 109 QMKHKNILKLIGCCLETELPT--------LVFESVKYGTLRGFSFASLLIAPRIKIAME- 159
            +KH+N++ LI  C     P         LVFE  ++        A LL    +K  +  
Sbjct: 67  LLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH------DLAGLLSNKNVKFTLSE 120

Query: 160 -------IANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLS--VSIPEGE 208
                  + N + Y+H      I+ R +KA+N+L+ ++   KL DF L+   S+ +  
Sbjct: 121 IKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNS 175

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	339
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.98
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
PRK09188	365	serine/threonine protein kinase; Provisional	99.95
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.94
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.93
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.93
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.92
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.92
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.91
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.9
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.89
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.89
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.88
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.87
PRK12274	218	serine/threonine protein kinase; Provisional	99.87
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.87
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.87
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.86
PRK10345	210	hypothetical protein; Provisional	99.85
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.85
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.84
PRK14879	211	serine/threonine protein kinase; Provisional	99.84
smart00090	237	RIO RIO-like kinase.	99.83
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.83
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.8
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.8
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.78
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.75
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.73
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.73
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.7
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.58
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.53
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.48
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.48
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.47
KOG1243	690	consensus Protein kinase [General function predict	99.47
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.47
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.44
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.41
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.31
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.29
KOG3087	229	consensus Serine/threonine protein kinase [General	99.2
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.16
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.15
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.07
COG4248	637	Uncharacterized protein with protein kinase and he	98.92
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.88
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.87
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.78
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.67
PRK09902	216	hypothetical protein; Provisional	98.67
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.5
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.45
PLN02876	822	acyl-CoA dehydrogenase	98.45
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.43
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.41
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.39
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.32
PF01636	239	APH: Phosphotransferase enzyme family This family	98.31
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.18
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.15
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.13
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.13
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.1
PRK10593	297	hypothetical protein; Provisional	97.93
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.88
PRK05231	319	homoserine kinase; Provisional	97.82
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.79
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.76
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.74
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.74
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.5
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.34
KOG2270	520	consensus Serine/threonine protein kinase involved	97.33
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.26
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.26
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.15
PLN02236	344	choline kinase	96.93
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.63
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.53
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.52
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.51
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.41
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.38
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.37
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.3
PLN02756	418	S-methyl-5-thioribose kinase	96.22
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.96
KOG1093	725	consensus Predicted protein kinase (contains TBC a	95.82
PRK12396	409	5-methylribose kinase; Reviewed	95.76
COG2334	331	Putative homoserine kinase type II (protein kinase	95.24
PTZ00384	383	choline kinase; Provisional	95.14
KOG1236	565	consensus Predicted unusual protein kinase [Genera	94.78
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	94.78
PRK06148	1013	hypothetical protein; Provisional	94.51
PRK11768	325	serine/threonine protein kinase; Provisional	94.39

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-54  Score=395.42  Aligned_cols=287  Identities=36%  Similarity=0.629  Sum_probs=245.6

Q ss_pred             CcccccHHHHHHHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeee
Q 019536           41 PIRAFSAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIG  120 (339)
Q Consensus        41 ~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~  120 (339)
                      ....|++.++..+|++|...+.||+|+||.||+|... ++..||||++....... ..+|.+|+.++.+++|||+|+|+|
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlG  138 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLG  138 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEE
Confidence            5778999999999999999999999999999999997 55999999887765432 455999999999999999999999


Q ss_pred             eeeeCC-ccEEEEEeccCCcccccccc----CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEE
Q 019536          121 CCLETE-LPTLVFESVKYGTLRGFSFA----SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKL  195 (339)
Q Consensus       121 ~~~~~~-~~~lv~e~~~~g~L~~~~~~----~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl  195 (339)
                      ||.+++ ..+||+||+++|+|.+++..    .++|..+++|+.++|.||+|||.....+|+|||||+.|||+|+++.+||
T Consensus       139 yC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl  218 (361)
T KOG1187|consen  139 YCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL  218 (361)
T ss_pred             EEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence            999998 49999999999999999872    7899999999999999999999766667999999999999999999999


Q ss_pred             ecCCCccccCC-CCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHH
Q 019536          196 HDFSLSVSIPE-GETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAK  274 (339)
Q Consensus       196 ~dfg~a~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~  274 (339)
                      +|||+|+..+. ....... . .||.+|+|||++..+..+.++||||||+++.|+++|+.+.+...  .........|..
T Consensus       219 sDFGLa~~~~~~~~~~~~~-~-~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~--~~~~~~l~~w~~  294 (361)
T KOG1187|consen  219 SDFGLAKLGPEGDTSVSTT-V-MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSR--PRGELSLVEWAK  294 (361)
T ss_pred             cCccCcccCCccccceeee-c-CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCC--CcccccHHHHHH
Confidence            99999976654 2222111 1 79999999999999999999999999999999999998876433  223344888888


Q ss_pred             HHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 019536          275 KSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMY  335 (339)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~  335 (339)
                      .......+..++|+.+... ..+. ......+..+..+|++.+|++||+|.+|++.|+.+.
T Consensus       295 ~~~~~~~~~eiiD~~l~~~-~~~~-~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~  353 (361)
T KOG1187|consen  295 PLLEEGKLREIVDPRLKEG-EYPD-EKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL  353 (361)
T ss_pred             HHHHCcchhheeCCCccCC-CCCh-HHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence            8888889999999987641 1111 145667899999999999999999999999997664

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-54  Score=372.77  Aligned_cols=254  Identities=19%  Similarity=0.227  Sum_probs=216.0

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCc-cEEEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETEL-PTLVFE  133 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~-~~lv~e  133 (339)
                      ++.+....||+|..|+||++.++.+++.+|+|.+..........++.+|+++++..+|||||.++|+|..... .+++||
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE  158 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME  158 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence            3566679999999999999999999999999999777666777889999999999999999999999999885 999999


Q ss_pred             eccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCcee
Q 019536          134 SVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHV  211 (339)
Q Consensus       134 ~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~  211 (339)
                      ||++|+|++++.  +.+++...-.++.+|++||.|||+  ..+|+||||||+|||++..|.+||||||.++.+.+.    
T Consensus       159 YMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----  232 (364)
T KOG0581|consen  159 YMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----  232 (364)
T ss_pred             hcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh----
Confidence            999999999987  689999999999999999999994  389999999999999999999999999999887655    


Q ss_pred             eecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCccc
Q 019536          212 REEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFD  291 (339)
Q Consensus       212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (339)
                      .+.+.+||..|||||.+.+..|+.++||||||++++|+.+|+.||............+...+-.   +            
T Consensus       233 ~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~---~------------  297 (364)
T KOG0581|consen  233 IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD---E------------  297 (364)
T ss_pred             hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc---C------------
Confidence            2225789999999999999999999999999999999999999987542323233332222111   0            


Q ss_pred             CCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          292 EDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       292 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      +....|.. .+++++++++..||++||.+|||+.|++++
T Consensus       298 ppP~lP~~-~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  298 PPPRLPEG-EFSPEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             CCCCCCcc-cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            11122221 488899999999999999999999999873

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-53  Score=390.51  Aligned_cols=248  Identities=23%  Similarity=0.331  Sum_probs=215.3

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC--ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS--TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVF  132 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  132 (339)
                      ..|...+.||+|||+.+|.+++..+|..||+|++.+..  .....+...+||+|.++|+|||||+++++|++.++.|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            56999999999999999999998899999999998742  2355677889999999999999999999999999999999


Q ss_pred             EeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCce
Q 019536          133 ESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH  210 (339)
Q Consensus       133 e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~  210 (339)
                      |+|+.++|..++.  ..+++.+++.++.||+.||.|||   +.+|+|||||..|++++++..+||+|||+|+.+..+...
T Consensus        98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Er  174 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGER  174 (592)
T ss_pred             EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeecCcccc
Confidence            9999999999987  78999999999999999999999   999999999999999999999999999999998765332


Q ss_pred             eeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcc
Q 019536          211 VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIF  290 (339)
Q Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (339)
                      ..  +.+||+.|.|||++....++..+||||+||+||.|+.|++||+..         .++.....++.           
T Consensus       175 k~--TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk---------~vkety~~Ik~-----------  232 (592)
T KOG0575|consen  175 KK--TLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK---------TVKETYNKIKL-----------  232 (592)
T ss_pred             cc--eecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc---------hHHHHHHHHHh-----------
Confidence            22  478999999999999999999999999999999999999999622         12222222221           


Q ss_pred             cCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          291 DEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                       .+..+|  ...+.++++||.++|+.||.+|||+.+|+.+
T Consensus       233 -~~Y~~P--~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  233 -NEYSMP--SHLSAEAKDLIRKLLRPNPSERPSLDEVLDH  269 (592)
T ss_pred             -cCcccc--cccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence             122233  3677789999999999999999999999863

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.2e-53  Score=360.31  Aligned_cols=268  Identities=19%  Similarity=0.266  Sum_probs=214.7

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCCh-hhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTL-DDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFE  133 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  133 (339)
                      +.|+...++|+|+||.||+++++++|+.||||++...... ...+..++|+++|++++|+|+|.++++|.....++||||
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            4688889999999999999999999999999999876543 334557799999999999999999999999999999999


Q ss_pred             eccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCcee
Q 019536          134 SVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHV  211 (339)
Q Consensus       134 ~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~  211 (339)
                      ||+..-|.++-.  ..++...+.+++.|++.|+.|+|   +++++||||||+|||++.+|.+||||||+|+.+.......
T Consensus        82 ~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~Y  158 (396)
T KOG0593|consen   82 YCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNY  158 (396)
T ss_pred             ecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchh
Confidence            998876665533  67888889999999999999999   9999999999999999999999999999999987433322


Q ss_pred             eeccccccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhc---------Cc
Q 019536          212 REEFIKGAYGFIAPEYFAT-SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIEN---------NR  281 (339)
Q Consensus       212 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------~~  281 (339)
                      +  -.+.|..|+|||++.| ..|+.++||||+||++.||++|.+.|  +|.++.+++..+........+         ..
T Consensus       159 T--DYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~--PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~  234 (396)
T KOG0593|consen  159 T--DYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLW--PGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPF  234 (396)
T ss_pred             h--hhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCC--CCcchHHHHHHHHHHHcccCHHHHHHhccCCc
Confidence            2  2468899999999988 58999999999999999999999995  566666666665544332222         11


Q ss_pred             ccccccCcccCCCCCCC-cHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          282 FGAIVDPIFDEDNSFPG-KEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       282 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                      +..+.-|......+.+. -+..+.-+.+|+++||+.||.+|+|..+++.
T Consensus       235 F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  235 FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            22221111111111100 0245567899999999999999999999986

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.2e-53  Score=371.93  Aligned_cols=253  Identities=21%  Similarity=0.254  Sum_probs=207.6

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCCh------hhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCc
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTL------DDVEYCFNNIVFSSQMKHKNILKLIGCCLETEL  127 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~  127 (339)
                      .+.|.+.+.+|+|+||.|-+|..+.+++.||||++++.-..      .....+.+|+++|++++|||||++.+++...+.
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds  250 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS  250 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence            36788899999999999999999999999999999875221      133446799999999999999999999999999


Q ss_pred             cEEEEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCC---CceEEecCCCcc
Q 019536          128 PTLVFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDEN---YSAKLHDFSLSV  202 (339)
Q Consensus       128 ~~lv~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~---~~~kl~dfg~a~  202 (339)
                      .|+||||++||+|.+.+-  ..+.+.....++.|++.|+.|||   +.||+||||||+|||+..+   ..+||+|||+|+
T Consensus       251 ~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK  327 (475)
T KOG0615|consen  251 SYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDFGLAK  327 (475)
T ss_pred             eEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEecccchhh
Confidence            999999999999999976  67888888999999999999999   9999999999999999766   789999999999


Q ss_pred             ccCCCCceeeecccccccccccccccccCCC---CcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhc
Q 019536          203 SIPEGETHVREEFIKGAYGFIAPEYFATSSF---NEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIEN  279 (339)
Q Consensus       203 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  279 (339)
                      .......   ..+.+||+.|.|||++.+..+   ..++|+||+||++|-+++|.+||.....    .....+    .+..
T Consensus       328 ~~g~~sf---m~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~----~~sl~e----QI~~  396 (475)
T KOG0615|consen  328 VSGEGSF---MKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYT----DPSLKE----QILK  396 (475)
T ss_pred             cccccee---hhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccC----CccHHH----HHhc
Confidence            8764433   335789999999999987653   3588999999999999999999852211    111111    1111


Q ss_pred             CcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          280 NRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      +.+.          ...+.+...+++..+||.+||..||++|||+.|+|++
T Consensus       397 G~y~----------f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h  437 (475)
T KOG0615|consen  397 GRYA----------FGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH  437 (475)
T ss_pred             Cccc----------ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence            1110          1112334778899999999999999999999999863

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-52  Score=374.64  Aligned_cols=257  Identities=26%  Similarity=0.406  Sum_probs=211.0

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCee-EEEEEeccCCC-hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC-ccEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRP-ISVMKFHDNST-LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETE-LPTL  130 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~-vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~-~~~l  130 (339)
                      ...+...+.||+|+||+||+|.+.  |.. ||||++..... ....+.|.+|+.+|.+++|||||+|+|+|.+.. ..++
T Consensus        40 ~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~i  117 (362)
T KOG0192|consen   40 PDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCI  117 (362)
T ss_pred             hHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEE
Confidence            344555667999999999999994  555 99999987642 223678999999999999999999999999987 7899


Q ss_pred             EEEeccCCccccccc----cCCChHHHHHHHHHHHHHHHHHhcCCCCC-eEEccCCCCCEEeCCCC-ceEEecCCCcccc
Q 019536          131 VFESVKYGTLRGFSF----ASLLIAPRIKIAMEIANAVAYLHVGFDRP-IVFRCIKASNVLLDENY-SAKLHDFSLSVSI  204 (339)
Q Consensus       131 v~e~~~~g~L~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~-i~H~dlk~~Nil~~~~~-~~kl~dfg~a~~~  204 (339)
                      ||||+++|+|..++.    ..+++..++.++.||+.|+.|||   +.+ ||||||||+|||++.++ ++||+|||+++..
T Consensus       118 VtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~  194 (362)
T KOG0192|consen  118 VTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREK  194 (362)
T ss_pred             EEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceee
Confidence            999999999999984    57999999999999999999999   888 99999999999999997 9999999999876


Q ss_pred             CCCCceeeecccccccccccccccc--cCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcc
Q 019536          205 PEGETHVREEFIKGAYGFIAPEYFA--TSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRF  282 (339)
Q Consensus       205 ~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (339)
                      .....  ..+...||+.|||||++.  ...|+.++||||||+++|||+||+.||.....        .+.......... 
T Consensus       195 ~~~~~--~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~--------~~~~~~v~~~~~-  263 (362)
T KOG0192|consen  195 VISKT--SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP--------VQVASAVVVGGL-  263 (362)
T ss_pred             ccccc--cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHhcCC-
Confidence            54321  111357999999999999  56899999999999999999999999863322        222222222211 


Q ss_pred             cccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhc
Q 019536          283 GAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLSV  338 (339)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~~  338 (339)
                                  +.+.+..+++.+..||.+||+.||..||++.+|+..|+.+...+
T Consensus       264 ------------Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~  307 (362)
T KOG0192|consen  264 ------------RPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHI  307 (362)
T ss_pred             ------------CCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence                        11112236678999999999999999999999999999887643

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4e-52  Score=364.20  Aligned_cols=250  Identities=22%  Similarity=0.341  Sum_probs=205.3

Q ss_pred             HhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 019536           53 ATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS-TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLV  131 (339)
Q Consensus        53 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  131 (339)
                      ..++|...+.||.|+|++||+|+++.++..||||.+.... .....+....|+.+|+.++|||||++++++..++..|||
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV   87 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV   87 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence            4578999999999999999999999999999999998764 445667788999999999999999999999999999999


Q ss_pred             EEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCC------CceEEecCCCccc
Q 019536          132 FESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDEN------YSAKLHDFSLSVS  203 (339)
Q Consensus       132 ~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~------~~~kl~dfg~a~~  203 (339)
                      ||||.||+|.+++.  +.+++.++..++.|++.||++||   +++|+||||||+|||++..      -.+||+|||+|+.
T Consensus        88 MEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~  164 (429)
T KOG0595|consen   88 MEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF  164 (429)
T ss_pred             EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence            99999999999997  57999999999999999999999   9999999999999999764      4589999999999


Q ss_pred             cCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCccc
Q 019536          204 IPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFG  283 (339)
Q Consensus       204 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (339)
                      +......   .+.+|++-|||||++....|+.|+|+||+|+++|++++|++||....        ..+............
T Consensus       165 L~~~~~a---~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t--------~~eL~~~~~k~~~~~  233 (429)
T KOG0595|consen  165 LQPGSMA---ETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET--------PKELLLYIKKGNEIV  233 (429)
T ss_pred             CCchhHH---HHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC--------HHHHHHHHhcccccc
Confidence            8755432   25789999999999999999999999999999999999999986221        222222211111110


Q ss_pred             ccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 019536          284 AIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVA  328 (339)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il  328 (339)
                                  ...+...+..+.+|+...++.+|.+|.++.+-.
T Consensus       234 ------------~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~  266 (429)
T KOG0595|consen  234 ------------PVLPAELSNPLRELLISLLQRNPKDRISFEDFF  266 (429)
T ss_pred             ------------CchhhhccCchhhhhhHHHhcCccccCchHHhh
Confidence                        011123344456777777788877777765543

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-51  Score=357.23  Aligned_cols=242  Identities=24%  Similarity=0.297  Sum_probs=205.8

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC--hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST--LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLV  131 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  131 (339)
                      .++|++.++||.|+||.||.++..++++.+|+|++++...  ........+|..+|..++||+||.++-.|++...+|||
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            4789999999999999999999999999999999988632  24577788999999999999999999999999999999


Q ss_pred             EEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCc
Q 019536          132 FESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGET  209 (339)
Q Consensus       132 ~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~  209 (339)
                      +||+.||.|.-++.  +.+++..+..++.+|+.||.|||   +++|+||||||+|||+|.+|.++|+|||+++.......
T Consensus       104 ld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~  180 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD  180 (357)
T ss_pred             EeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCC
Confidence            99999999999987  67899999999999999999999   99999999999999999999999999999986544432


Q ss_pred             eeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCc
Q 019536          210 HVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPI  289 (339)
Q Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (339)
                        .+.+.+||+.|||||++.+.+|+..+|+||+|+++|||++|.+||....        ..+...+...           
T Consensus       181 --~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~--------~~~~~~~I~~-----------  239 (357)
T KOG0598|consen  181 --ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED--------VKKMYDKILK-----------  239 (357)
T ss_pred             --ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc--------HHHHHHHHhc-----------
Confidence              2225789999999999999999999999999999999999999975221        1111111111           


Q ss_pred             ccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCC
Q 019536          290 FDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP  322 (339)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp  322 (339)
                        .....+ +...+.+.+++++++|..||++|.
T Consensus       240 --~k~~~~-p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  240 --GKLPLP-PGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             --CcCCCC-CccCCHHHHHHHHHHhccCHHHhc
Confidence              111111 123667899999999999999996

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-51  Score=368.61  Aligned_cols=261  Identities=24%  Similarity=0.351  Sum_probs=219.3

Q ss_pred             HHHHHHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCc
Q 019536           48 KDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETEL  127 (339)
Q Consensus        48 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~  127 (339)
                      +.++.....+...+.||+|-||.||.|.+. ....||+|.++...  ...+.|.+|+++|++|+|+|||+++|+|..+..
T Consensus       199 d~wei~r~~l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~--m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~p  275 (468)
T KOG0197|consen  199 DPWEIPREELKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGS--MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEP  275 (468)
T ss_pred             CCeeecHHHHHHHHHhcCCccceEEEEEEc-CCCcccceEEeccc--cChhHHHHHHHHHHhCcccCeEEEEEEEecCCc
Confidence            334444456777899999999999999995 34589999998763  456778899999999999999999999999889


Q ss_pred             cEEEEEeccCCccccccc----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccc
Q 019536          128 PTLVFESVKYGTLRGFSF----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVS  203 (339)
Q Consensus       128 ~~lv~e~~~~g~L~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~  203 (339)
                      ++|||||++.|+|.+++.    ..+...+.+.++.|||+|++||+   ++++|||||.++|||++++..+||+|||+|+.
T Consensus       276 iyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~  352 (468)
T KOG0197|consen  276 IYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARL  352 (468)
T ss_pred             eEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccc
Confidence            999999999999999997    46788888999999999999999   99999999999999999999999999999996


Q ss_pred             cCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCcc
Q 019536          204 IPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRF  282 (339)
Q Consensus       204 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (339)
                      ..++...... ...-...|.|||.+....|+.+||||||||+|||++| |+.|++        ++...+.+...-+    
T Consensus       353 ~~d~~Y~~~~-~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~--------~msn~ev~~~le~----  419 (468)
T KOG0197|consen  353 IGDDEYTASE-GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYP--------GMSNEEVLELLER----  419 (468)
T ss_pred             cCCCceeecC-CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCC--------CCCHHHHHHHHhc----
Confidence            5554443222 2334567999999999999999999999999999998 777764        3333333333222    


Q ss_pred             cccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          283 GAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                                ..++|.|..++.++.++|..||+.+|++|||+..+...|+.+...
T Consensus       420 ----------GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~  464 (468)
T KOG0197|consen  420 ----------GYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS  464 (468)
T ss_pred             ----------cCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence                      344577778999999999999999999999999999999988753

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.3e-52  Score=346.65  Aligned_cols=255  Identities=21%  Similarity=0.316  Sum_probs=209.3

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC-ChhhHHHHHHHHHHHHhcCCCceeeeee-eeeeCCc-cEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS-TLDDVEYCFNNIVFSSQMKHKNILKLIG-CCLETEL-PTL  130 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~~~~-~~~~~~~-~~l  130 (339)
                      ..+|+++++||.|+||+||++....+|..+|.|.++-+. .....+....|+.+|++|+|||||++++ .+.+++. ++|
T Consensus        18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni   97 (375)
T KOG0591|consen   18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI   97 (375)
T ss_pred             HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence            356889999999999999999999999999999988442 2245567789999999999999999999 5555555 899


Q ss_pred             EEEeccCCccccccc------cCCChHHHHHHHHHHHHHHHHHhcCCCCC--eEEccCCCCCEEeCCCCceEEecCCCcc
Q 019536          131 VFESVKYGTLRGFSF------ASLLIAPRIKIAMEIANAVAYLHVGFDRP--IVFRCIKASNVLLDENYSAKLHDFSLSV  202 (339)
Q Consensus       131 v~e~~~~g~L~~~~~------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~dlk~~Nil~~~~~~~kl~dfg~a~  202 (339)
                      |||||..|+|...+.      ..+++.++++++.|++.||.++|... .+  |+||||||.||+++.+|.+||+|||+++
T Consensus        98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r  176 (375)
T KOG0591|consen   98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGR  176 (375)
T ss_pred             HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHh
Confidence            999999999999876      57999999999999999999999311 44  9999999999999999999999999999


Q ss_pred             ccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcc
Q 019536          203 SIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRF  282 (339)
Q Consensus       203 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (339)
                      .+....+.  ....+||+.||+||.+.+.+|+.++||||+||++|||+.-.+||..  .   ....+    .+.+.++.+
T Consensus       177 ~l~s~~tf--A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g--~---n~~~L----~~KI~qgd~  245 (375)
T KOG0591|consen  177 FLSSKTTF--AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYG--D---NLLSL----CKKIEQGDY  245 (375)
T ss_pred             HhcchhHH--HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccc--c---cHHHH----HHHHHcCCC
Confidence            98665443  3357899999999999999999999999999999999999999752  2   12222    222333322


Q ss_pred             cccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 019536          283 GAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLR  332 (339)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~  332 (339)
                      .           +.|. ...+..+..|+..|+..||+.||+...++..+.
T Consensus       246 ~-----------~~p~-~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~  283 (375)
T KOG0591|consen  246 P-----------PLPD-EHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ  283 (375)
T ss_pred             C-----------CCcH-HHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence            1           1121 467889999999999999999999655555443

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=2.2e-50  Score=334.87  Aligned_cols=268  Identities=19%  Similarity=0.242  Sum_probs=218.9

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhH-HHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDV-EYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFE  133 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  133 (339)
                      .+|...+++|+|+||.||+|++..+|+.||||+++.....+.. -...+|+++|+.++|+||+.++++|.+.+...||+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            4688889999999999999999999999999999887543333 446799999999999999999999999999999999


Q ss_pred             eccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCce
Q 019536          134 SVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH  210 (339)
Q Consensus       134 ~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~  210 (339)
                      |++. +|...+.   ..+...++..++.++++|++|||   .+.|+||||||.|+|++++|.+||+|||+|+.+......
T Consensus        82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~  157 (318)
T KOG0659|consen   82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI  157 (318)
T ss_pred             eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence            9964 7888876   35677788899999999999999   999999999999999999999999999999998765544


Q ss_pred             eeecccccccccccccccccC-CCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccc---
Q 019536          211 VREEFIKGAYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIV---  286 (339)
Q Consensus       211 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  286 (339)
                      ...  .+-|..|+|||.+-|. .|+..+||||.||+++||+.|.+.  ++|+.+.+++..+..+...+....+..+.   
T Consensus       158 ~~~--~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~--fpG~sDidQL~~If~~LGTP~~~~WP~~~~lp  233 (318)
T KOG0659|consen  158 QTH--QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPF--FPGDSDIDQLSKIFRALGTPTPDQWPEMTSLP  233 (318)
T ss_pred             ccc--ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCC--CCCCchHHHHHHHHHHcCCCCcccCccccccc
Confidence            332  3578889999998776 699999999999999999998776  56887777777777666665555443331   


Q ss_pred             cCcccCCCCCCC----cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          287 DPIFDEDNSFPG----KEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       287 ~~~~~~~~~~~~----~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      |-.--...+.|.    -+..++.+.+|+.+||.+||.+|+|+.|++++
T Consensus       234 dY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  234 DYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             cHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            111111111111    12356678999999999999999999999874

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.1e-50  Score=361.31  Aligned_cols=270  Identities=20%  Similarity=0.268  Sum_probs=215.8

Q ss_pred             HhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhH-HHHHHHHHHHHhcCCCceeeeeeeeeeC--CccE
Q 019536           53 ATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDV-EYCFNNIVFSSQMKHKNILKLIGCCLET--ELPT  129 (339)
Q Consensus        53 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~e~~~l~~l~H~niv~~~~~~~~~--~~~~  129 (339)
                      ..+.|+..++||+|+||.||+|++..+|+.||+|++.-....... .-..+||.||++|.||||++|.+...+.  ..+|
T Consensus       115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY  194 (560)
T KOG0600|consen  115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY  194 (560)
T ss_pred             chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence            346799999999999999999999999999999999876543333 4455999999999999999999998876  6899


Q ss_pred             EEEEeccCCcccccccc---CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCC
Q 019536          130 LVFESVKYGTLRGFSFA---SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPE  206 (339)
Q Consensus       130 lv~e~~~~g~L~~~~~~---~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~  206 (339)
                      ||||||++ +|..++..   .+++.++..++.|++.||+|||   .++|+|||||..|||+|.+|.+||+|||+|+.+..
T Consensus       195 lVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~  270 (560)
T KOG0600|consen  195 LVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTP  270 (560)
T ss_pred             EEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeeccC
Confidence            99999987 77777663   6889999999999999999999   99999999999999999999999999999998876


Q ss_pred             CCceeeecccccccccccccccccC-CCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCccc--
Q 019536          207 GETHVREEFIKGAYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFG--  283 (339)
Q Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  283 (339)
                      ......+ ..+-|..|+|||++.|. .|+.++|+||.|||+.||+.|++.|  .|..+.+++..+..+...+....|.  
T Consensus       271 ~~~~~~T-~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~--~G~tEveQl~kIfklcGSP~e~~W~~~  347 (560)
T KOG0600|consen  271 SGSAPYT-SRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPIL--QGRTEVEQLHKIFKLCGSPTEDYWPVS  347 (560)
T ss_pred             CCCcccc-cceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCc--CCccHHHHHHHHHHHhCCCChhccccc
Confidence            5544322 35679999999999886 6999999999999999999999995  4555555666555555444444333  


Q ss_pred             ccccC-cccCCCCCCCc-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          284 AIVDP-IFDEDNSFPGK-----EEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       284 ~~~~~-~~~~~~~~~~~-----~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                      ++... .+....+.+..     ...+....+|+..+|..||.+|.||.++|+
T Consensus       348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            11110 11111111110     123567889999999999999999999886

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-50  Score=360.95  Aligned_cols=254  Identities=21%  Similarity=0.300  Sum_probs=213.4

Q ss_pred             HHHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC--hhhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCc
Q 019536           51 KKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST--LDDVEYCFNNIVFSSQM-KHKNILKLIGCCLETEL  127 (339)
Q Consensus        51 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~  127 (339)
                      ++...+|..++.||.|+|++|++|+.+.+++.||||++.+..-  ....+.+..|-.+|.+| .||.|++|+--|.+...
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            5556899999999999999999999999999999999987632  24456778899999999 89999999999999999


Q ss_pred             cEEEEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccC
Q 019536          128 PTLVFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIP  205 (339)
Q Consensus       128 ~~lv~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~  205 (339)
                      +|.|+||+++|+|.+++.  +.+++...+.++.+|+.||+|||   ++|||||||||+|||+|+++.+||.|||.|+.+.
T Consensus       149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~  225 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKILS  225 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccccCC
Confidence            999999999999999997  78888888999999999999999   9999999999999999999999999999998876


Q ss_pred             CCCce-----------eeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHH
Q 019536          206 EGETH-----------VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAK  274 (339)
Q Consensus       206 ~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~  274 (339)
                      +....           ......+||..|.+||+|.....+..+|+|+|||++|+|+.|++||....+  .   ...+   
T Consensus       226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne--y---liFq---  297 (604)
T KOG0592|consen  226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE--Y---LIFQ---  297 (604)
T ss_pred             hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH--H---HHHH---
Confidence            43221           111357899999999999999999999999999999999999999863222  1   1111   


Q ss_pred             HHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          275 KSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                               +|+    .-+..+|  +..++.+.+|+.++|..||.+|+|+.+|-++
T Consensus       298 ---------kI~----~l~y~fp--~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  298 ---------KIQ----ALDYEFP--EGFPEDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             ---------HHH----HhcccCC--CCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence                     111    1111222  2455689999999999999999999888764

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2e-49  Score=333.81  Aligned_cols=237  Identities=22%  Similarity=0.288  Sum_probs=207.9

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC--ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS--TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLV  131 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  131 (339)
                      .++|+..+.||.|+||+|..++.+.+|..+|+|++.+..  ...+.+...+|..+|+.+.||+++++++.|.+.+.+++|
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv  122 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV  122 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence            367888999999999999999999999999999998763  235677788999999999999999999999999999999


Q ss_pred             EEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCc
Q 019536          132 FESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGET  209 (339)
Q Consensus       132 ~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~  209 (339)
                      |||.+||.|..++.  +++++..++.++.||+.||+|||   +++|++|||||+|||+|++|.+||.|||.|+.+... +
T Consensus       123 meyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-T  198 (355)
T KOG0616|consen  123 MEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-T  198 (355)
T ss_pred             EeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEecCc-E
Confidence            99999999999998  58999999999999999999999   999999999999999999999999999999988654 2


Q ss_pred             eeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCc
Q 019536          210 HVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPI  289 (339)
Q Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (339)
                          .+.+||+.|+|||.+...+|+.++|.|||||++|||+.|.+||.....                     .++.+.+
T Consensus       199 ----~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~---------------------~~iY~KI  253 (355)
T KOG0616|consen  199 ----WTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP---------------------IQIYEKI  253 (355)
T ss_pred             ----EEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh---------------------HHHHHHH
Confidence                257899999999999999999999999999999999999999852221                     1122333


Q ss_pred             ccCCCCCCCcHHHHHHHHHHHHHhhccCCCCC
Q 019536          290 FDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHR  321 (339)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~R  321 (339)
                      +..+..+|.  ..+.++++|+.++|+.|-.+|
T Consensus       254 ~~~~v~fP~--~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  254 LEGKVKFPS--YFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             HhCcccCCc--ccCHHHHHHHHHHHhhhhHhh
Confidence            334444443  567789999999999999999

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.3e-49  Score=337.44  Aligned_cols=271  Identities=17%  Similarity=0.212  Sum_probs=220.0

Q ss_pred             HHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHH-HHHHHHHHHHhcCCCceeeeeeeeeeC--Ccc
Q 019536           52 KATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVE-YCFNNIVFSSQMKHKNILKLIGCCLET--ELP  128 (339)
Q Consensus        52 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~-~~~~e~~~l~~l~H~niv~~~~~~~~~--~~~  128 (339)
                      +..++|+.++.|++|+||.||+|++..++..||+|+++-........ .-++||.+|.+++|||||.+-.+....  +.+
T Consensus        73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i  152 (419)
T KOG0663|consen   73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKI  152 (419)
T ss_pred             ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence            34467899999999999999999999999999999998764333332 346999999999999999998887653  458


Q ss_pred             EEEEEeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccC
Q 019536          129 TLVFESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIP  205 (339)
Q Consensus       129 ~lv~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~  205 (339)
                      |+|||||++ +|..++.   .++...++..++.|++.|+.|||   ...|+|||||++|+|++..|.+|++|||+|+.+.
T Consensus       153 y~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg  228 (419)
T KOG0663|consen  153 YIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREYG  228 (419)
T ss_pred             eeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhhc
Confidence            999999987 5555544   68899999999999999999999   8999999999999999999999999999999987


Q ss_pred             CCCceeeecccccccccccccccccC-CCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccc
Q 019536          206 EGETHVREEFIKGAYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA  284 (339)
Q Consensus       206 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (339)
                      ......+  ..+-|..|+|||.+.+. .|++++|+||+||++.|++++++.|  +|....+++..+...........+..
T Consensus       229 sp~k~~T--~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf--~G~sE~dQl~~If~llGtPte~iwpg  304 (419)
T KOG0663|consen  229 SPLKPYT--PLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLF--PGKSEIDQLDKIFKLLGTPSEAIWPG  304 (419)
T ss_pred             CCcccCc--ceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCC--CCCchHHHHHHHHHHhCCCccccCCC
Confidence            7654433  35679999999999886 5999999999999999999999995  56677777777777766666655555


Q ss_pred             cccCcccCCCCCCCc-----------HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          285 IVDPIFDEDNSFPGK-----------EEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       285 ~~~~~~~~~~~~~~~-----------~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      +.+........++..           ...++...+|+..+|.+||.+|.||.|.|++
T Consensus       305 ~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h  361 (419)
T KOG0663|consen  305 YSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH  361 (419)
T ss_pred             ccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence            543322221121111           0134678899999999999999999999864

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-50  Score=356.78  Aligned_cols=269  Identities=16%  Similarity=0.216  Sum_probs=213.3

Q ss_pred             HhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcC-CCceeeeeeeeeeCC-ccEE
Q 019536           53 ATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMK-HKNILKLIGCCLETE-LPTL  130 (339)
Q Consensus        53 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~~~~~~~~~~-~~~l  130 (339)
                      ..++|.+.++||.|+||+||+|+...+|..||||+++..-...+..--++|++.|+++. ||||+++.+++.+.+ .+++
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f   87 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF   87 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence            34789999999999999999999999999999999988754344444569999999998 999999999999988 8999


Q ss_pred             EEEeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCC
Q 019536          131 VFESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEG  207 (339)
Q Consensus       131 v~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~  207 (339)
                      |||||+. +|.+++.   ..+++..+..|+.||+.||+|+|   .+|+.|||+||+|||+..+..+||+|||+||.+...
T Consensus        88 VfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk  163 (538)
T KOG0661|consen   88 VFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREVRSK  163 (538)
T ss_pred             eHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEecccccccccccC
Confidence            9999964 7888876   57899999999999999999999   999999999999999998899999999999988765


Q ss_pred             Cceeeeccccccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccc--
Q 019536          208 ETHVREEFIKGAYGFIAPEYFAT-SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA--  284 (339)
Q Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  284 (339)
                      ....   -.+.|..|+|||++.. ..|+.++||||+||+++|+.+-++.|+  |..+.+++..+-.+........+..  
T Consensus       164 pPYT---eYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFP--G~sE~Dqi~KIc~VLGtP~~~~~~eg~  238 (538)
T KOG0661|consen  164 PPYT---EYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFP--GASEIDQIYKICEVLGTPDKDSWPEGY  238 (538)
T ss_pred             CCcc---hhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCC--CCcHHHHHHHHHHHhCCCccccchhHH
Confidence            5432   2468999999999865 469999999999999999999999964  5555555433322222222111111  


Q ss_pred             ----cccCcccCCCCCCCc---HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          285 ----IVDPIFDEDNSFPGK---EEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       285 ----~~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                          .+.-.++.....+..   +.++.++.++|.+|++|||.+||||.+++++
T Consensus       239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence                111111111111110   2367789999999999999999999999873

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.7e-49  Score=359.20  Aligned_cols=246  Identities=21%  Similarity=0.301  Sum_probs=213.8

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS-TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFE  133 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  133 (339)
                      ++|.+.+.||+|+||+||+|+.+.+.+.||+|.+.+.. ...+...+.+|++|++.++|||||.++++|+...+.|+|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            57888999999999999999999999999999998764 33567778899999999999999999999999999999999


Q ss_pred             eccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCcee
Q 019536          134 SVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHV  211 (339)
Q Consensus       134 ~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~  211 (339)
                      ||.| +|..++.  ..++++.+..++.+++.||.|||   +.+|+|||+||.|||++.+|.+|++|||+|+....+... 
T Consensus        82 ~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~v-  156 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSV-  156 (808)
T ss_pred             hhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhcccCcee-
Confidence            9976 9999987  78999999999999999999999   999999999999999999999999999999987664432 


Q ss_pred             eecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCccc
Q 019536          212 REEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFD  291 (339)
Q Consensus       212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (339)
                      .+ .+.||+-|||||++.+.+|+..+|+||+||++||+++|++||...        ...             +++..+..
T Consensus       157 lt-sikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~--------si~-------------~Lv~~I~~  214 (808)
T KOG0597|consen  157 LT-SIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR--------SIT-------------QLVKSILK  214 (808)
T ss_pred             ee-eccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH--------HHH-------------HHHHHHhc
Confidence            22 578999999999999999999999999999999999999998411        111             11222333


Q ss_pred             CCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          292 EDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       292 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                      ++..+|  ...+..+..++..+|++||..|.|..+++.
T Consensus       215 d~v~~p--~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  215 DPVKPP--STASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             CCCCCc--ccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence            333333  377888999999999999999999999875

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-48  Score=355.45  Aligned_cols=250  Identities=21%  Similarity=0.320  Sum_probs=214.5

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFES  134 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  134 (339)
                      ..|....+||+|+.|.||.|....+++.||||++..... ...+-+++|+.+|+..+|+|||.+++.+..++.+|+||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q-~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy  351 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ-PKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY  351 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccC-CchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence            467778899999999999999999999999999987643 3456678999999999999999999999999999999999


Q ss_pred             ccCCccccccc-cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceeee
Q 019536          135 VKYGTLRGFSF-ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVRE  213 (339)
Q Consensus       135 ~~~g~L~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~  213 (339)
                      ++||+|.|... ..+++.++..|+.+++.||+|||   .++|+|||||.+|||++.+|.+||.|||++..+.....  ..
T Consensus       352 m~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--KR  426 (550)
T KOG0578|consen  352 MEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--KR  426 (550)
T ss_pred             cCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeeccccccC--cc
Confidence            99999999987 56899999999999999999999   99999999999999999999999999999988766544  33


Q ss_pred             cccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCC
Q 019536          214 EFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDED  293 (339)
Q Consensus       214 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (339)
                      ...+||+.|||||+.....|++++||||||++++||+.|.+||-. .+       .+..++....++.            
T Consensus       427 ~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln-E~-------PlrAlyLIa~ng~------------  486 (550)
T KOG0578|consen  427 STMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN-EN-------PLRALYLIATNGT------------  486 (550)
T ss_pred             ccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC-CC-------hHHHHHHHhhcCC------------
Confidence            357899999999999999999999999999999999999999742 11       1222222222221            


Q ss_pred             CCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          294 NSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       294 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      ..+..++..+..+++++.+||+.||++|+|+.++|++
T Consensus       487 P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  487 PKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             CCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence            2223345778899999999999999999999999973

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=3.4e-48  Score=354.46  Aligned_cols=261  Identities=21%  Similarity=0.365  Sum_probs=205.9

Q ss_pred             HhcCcccCCceeccCCeeEEEEEEc-----CCCeeEEEEEeccCCChhhHHHHHHHHHHHHhc-CCCceeeeeeeeeeC-
Q 019536           53 ATNNYDLHKVIQSDTSYRLFEGTLV-----DQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLET-  125 (339)
Q Consensus        53 ~~~~~~~~~~ig~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~-  125 (339)
                      ..++|++.+.||+|+||.||+|.+.     .++..||+|++...........+.+|+.++..+ +||||++++++|... 
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN   84 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence            3468999999999999999999852     345689999997655445567788999999999 899999999998764 


Q ss_pred             CccEEEEEeccCCcccccccc-----------------------------------------------------------
Q 019536          126 ELPTLVFESVKYGTLRGFSFA-----------------------------------------------------------  146 (339)
Q Consensus       126 ~~~~lv~e~~~~g~L~~~~~~-----------------------------------------------------------  146 (339)
                      +..++||||+++|+|.+++..                                                           
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence            457899999999999877641                                                           


Q ss_pred             -----CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceeeecccccccc
Q 019536          147 -----SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYG  221 (339)
Q Consensus       147 -----~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~gt~~  221 (339)
                           .+++.....++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++...............++..
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~  241 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK  241 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence                 2566777889999999999999   89999999999999999999999999999986644332222223345678


Q ss_pred             cccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCCCCCCCcH
Q 019536          222 FIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKE  300 (339)
Q Consensus       222 y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (339)
                      |+|||++.+..++.++|||||||++|||++ |..||.......    ..    ......+..             .+.+.
T Consensus       242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~----~~----~~~~~~~~~-------------~~~~~  300 (338)
T cd05102         242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE----EF----CQRLKDGTR-------------MRAPE  300 (338)
T ss_pred             ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH----HH----HHHHhcCCC-------------CCCCC
Confidence            999999998899999999999999999997 999976322110    01    111111110             01112


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          301 EKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       301 ~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                      ..+..+.+|+.+||+.||++|||+.++++.|+++..+
T Consensus       301 ~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~~  337 (338)
T cd05102         301 NATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQE  337 (338)
T ss_pred             CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            3456799999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-47  Score=339.44  Aligned_cols=265  Identities=20%  Similarity=0.303  Sum_probs=215.0

Q ss_pred             HHHHHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCcc
Q 019536           49 DLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELP  128 (339)
Q Consensus        49 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~  128 (339)
                      ++....++|++.+.||.|..++||+|.....+..||||++.........+.+.+|++.++.++||||++++.+|..+..+
T Consensus        20 ~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~L   99 (516)
T KOG0582|consen   20 EFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSEL   99 (516)
T ss_pred             cCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEeccee
Confidence            34445578999999999999999999999999999999999876656788999999999999999999999999999999


Q ss_pred             EEEEEeccCCccccccc----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCcccc
Q 019536          129 TLVFESVKYGTLRGFSF----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSI  204 (339)
Q Consensus       129 ~lv~e~~~~g~L~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~  204 (339)
                      |+||.||.+|++.+++.    ..+.+..+..|++++++||.|||   .+|.||||+|+.|||++.+|.+||+|||.+..+
T Consensus       100 WvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l  176 (516)
T KOG0582|consen  100 WVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASL  176 (516)
T ss_pred             EEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeee
Confidence            99999999999999987    45777778889999999999999   999999999999999999999999999987665


Q ss_pred             CCCCceee-e-cccccccccccccccccC--CCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcC
Q 019536          205 PEGETHVR-E-EFIKGAYGFIAPEYFATS--SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENN  280 (339)
Q Consensus       205 ~~~~~~~~-~-~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  280 (339)
                      -....... . .+.+||++|||||++...  .|+.|+||||||++..||.+|..||.-.        ...+.+...+.+.
T Consensus       177 ~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~--------pPmkvLl~tLqn~  248 (516)
T KOG0582|consen  177 FDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKY--------PPMKVLLLTLQND  248 (516)
T ss_pred             cccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccC--------ChHHHHHHHhcCC
Confidence            44332211 1 356899999999997654  6999999999999999999999998632        2222222222211


Q ss_pred             cccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          281 RFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                      .. ...-...    ........+.++++++..||+.||++|||+.++++
T Consensus       249 pp-~~~t~~~----~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  249 PP-TLLTSGL----DKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             CC-CcccccC----ChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            11 0000000    01112345678999999999999999999999987

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-48  Score=355.74  Aligned_cols=270  Identities=23%  Similarity=0.351  Sum_probs=218.0

Q ss_pred             ccccHHHHHHHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccC-CChhhHHHHHHHHHHHHhcCCCceeeeeee
Q 019536           43 RAFSAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDN-STLDDVEYCFNNIVFSSQMKHKNILKLIGC  121 (339)
Q Consensus        43 ~~~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~~~~~  121 (339)
                      ...+.++|....+...+...||+|.||+||+|.+.++   ||||.++.. ...+..+.|++|+..+++-+|.||+-|.|+
T Consensus       380 ~s~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~  456 (678)
T KOG0193|consen  380 ASDSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGA  456 (678)
T ss_pred             CCccccccccCHHHhhccceeccccccceeecccccc---eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehh
Confidence            3345578888889999999999999999999999765   999999876 445678999999999999999999999999


Q ss_pred             eeeCCccEEEEEeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecC
Q 019536          122 CLETELPTLVFESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDF  198 (339)
Q Consensus       122 ~~~~~~~~lv~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~df  198 (339)
                      |..++. .||+.+|+|.+|..++.   ..+.+.+.+.|+.||+.|+.|||   .++|||||||..||++.+++++||.||
T Consensus       457 ~~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDF  532 (678)
T KOG0193|consen  457 CMNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDF  532 (678)
T ss_pred             hcCCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecc
Confidence            999887 99999999999999987   57888899999999999999999   999999999999999999999999999


Q ss_pred             CCccccCCCCceeeeccccccccccccccccc---CCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHH
Q 019536          199 SLSVSIPEGETHVREEFIKGAYGFIAPEYFAT---SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKK  275 (339)
Q Consensus       199 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  275 (339)
                      |++..-.............|+..|||||++..   .+|+..+||||||+++|||++|.-||. .+..+  +.-       
T Consensus       533 GLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~d--qIi-------  602 (678)
T KOG0193|consen  533 GLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRD--QII-------  602 (678)
T ss_pred             cceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChh--heE-------
Confidence            99865332222122223567888999999863   479999999999999999999999986 22211  000       


Q ss_pred             HhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          276 SIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                       +.-++  ...-    .+.. .....+.+++++|+..||.++|++||.+.+|+..|+.+..+
T Consensus       603 -fmVGr--G~l~----pd~s-~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~  656 (678)
T KOG0193|consen  603 -FMVGR--GYLM----PDLS-KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS  656 (678)
T ss_pred             -EEecc--cccC----ccch-hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence             00000  0000    0000 01135677999999999999999999999999999988763

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-47  Score=338.02  Aligned_cols=254  Identities=21%  Similarity=0.265  Sum_probs=204.0

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC--ccEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETE--LPTLV  131 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~--~~~lv  131 (339)
                      ..++...+.||.|+||+||.+....+|...|||.+....... .+.+.+|+.+|++++|||||+++|......  .++++
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~   94 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF   94 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence            456788899999999999999999889999999987764322 666889999999999999999999855444  68999


Q ss_pred             EEeccCCccccccc--c-CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCC-CCceEEecCCCccccCCC
Q 019536          132 FESVKYGTLRGFSF--A-SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDE-NYSAKLHDFSLSVSIPEG  207 (339)
Q Consensus       132 ~e~~~~g~L~~~~~--~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~-~~~~kl~dfg~a~~~~~~  207 (339)
                      |||+++|+|.+++.  + .+++..++.+.+||+.||.|||   +++++||||||+|||++. ++.+||+|||++......
T Consensus        95 mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~  171 (313)
T KOG0198|consen   95 MEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESK  171 (313)
T ss_pred             eeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence            99999999999987  3 5899999999999999999999   999999999999999999 799999999998876531


Q ss_pred             -CceeeecccccccccccccccccC-CCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCccccc
Q 019536          208 -ETHVREEFIKGAYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAI  285 (339)
Q Consensus       208 -~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (339)
                       ..........||+.|||||++..+ ....++||||+||++.||+||++||...       ..........-.....   
T Consensus       172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-------~~~~~~~~~ig~~~~~---  241 (313)
T KOG0198|consen  172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-------FEEAEALLLIGREDSL---  241 (313)
T ss_pred             cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-------cchHHHHHHHhccCCC---
Confidence             111122246799999999999853 3335999999999999999999998632       1111111111111110   


Q ss_pred             ccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 019536          286 VDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQL  331 (339)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L  331 (339)
                                .+.+...+...++++.+|+..||++||||.++|++-
T Consensus       242 ----------P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp  277 (313)
T KOG0198|consen  242 ----------PEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP  277 (313)
T ss_pred             ----------CCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence                      022335677899999999999999999999999864

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-47  Score=349.02  Aligned_cols=249  Identities=23%  Similarity=0.304  Sum_probs=208.1

Q ss_pred             HHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC----hhhHHHHHHHHHHHHhcC-CCceeeeeeeeeeCC
Q 019536           52 KATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST----LDDVEYCFNNIVFSSQMK-HKNILKLIGCCLETE  126 (339)
Q Consensus        52 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~e~~~l~~l~-H~niv~~~~~~~~~~  126 (339)
                      ...+.|.+.+.||+|+||+|+.|....++..||+|.+.....    ....+.+.+|+.+++.++ ||||+++++++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            456899999999999999999999999999999997766411    123455668999999998 999999999999999


Q ss_pred             ccEEEEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCC-CceEEecCCCccc
Q 019536          127 LPTLVFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDEN-YSAKLHDFSLSVS  203 (339)
Q Consensus       127 ~~~lv~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~-~~~kl~dfg~a~~  203 (339)
                      .+++||||+.+|+|.+++.  +++.+.....++.|++.|++|||   +.+|+||||||+|||++.+ +.+||+|||+++.
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~  170 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLSAI  170 (370)
T ss_pred             eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence            9999999999999999987  67888899999999999999999   9999999999999999999 9999999999988


Q ss_pred             cC-CCCceeeecccccccccccccccccCC-CC-cccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcC
Q 019536          204 IP-EGETHVREEFIKGAYGFIAPEYFATSS-FN-EMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENN  280 (339)
Q Consensus       204 ~~-~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  280 (339)
                      .. ....   ....+||+.|+|||++.+.. |+ .++||||+||++|.|++|+.||....        .... ...+.. 
T Consensus       171 ~~~~~~~---l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~--------~~~l-~~ki~~-  237 (370)
T KOG0583|consen  171 SPGEDGL---LKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN--------VPNL-YRKIRK-  237 (370)
T ss_pred             cCCCCCc---ccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc--------HHHH-HHHHhc-
Confidence            74 2222   22578999999999999988 87 78999999999999999999987411        1111 111111 


Q ss_pred             cccccccCcccCCCCCCCcHHH-HHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          281 RFGAIVDPIFDEDNSFPGKEEK-LQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                                 ....+|.  .. +.++++|+.+||..||.+|+|+.+|+.
T Consensus       238 -----------~~~~~p~--~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~  274 (370)
T KOG0583|consen  238 -----------GEFKIPS--YLLSPEARSLIEKMLVPDPSTRITLLEILE  274 (370)
T ss_pred             -----------CCccCCC--CcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence                       1222232  33 778999999999999999999999984

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.6e-47  Score=345.43  Aligned_cols=253  Identities=20%  Similarity=0.241  Sum_probs=208.0

Q ss_pred             HhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC--hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 019536           53 ATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST--LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTL  130 (339)
Q Consensus        53 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  130 (339)
                      ..++|+++..||+|+||.||.|+.+++|..+|+|++++...  ..+++.+..|-.+|....+|.||+++-.|++...+||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            44799999999999999999999999999999999988633  3567888999999999999999999999999999999


Q ss_pred             EEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCC-
Q 019536          131 VFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEG-  207 (339)
Q Consensus       131 v~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~-  207 (339)
                      ||||+|||++..++.  ..+++.++..++.+++.|++-+|   +.|+|||||||+|+|+|..|.+||+||||+..+... 
T Consensus       219 iMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~  295 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKH  295 (550)
T ss_pred             EEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccchhhhhh
Confidence            999999999999987  78999999999999999999999   999999999999999999999999999998543210 


Q ss_pred             ---------------------Cce----ee-------------------ecccccccccccccccccCCCCcccchHHHH
Q 019536          208 ---------------------ETH----VR-------------------EEFIKGAYGFIAPEYFATSSFNEMCDVYSFG  243 (339)
Q Consensus       208 ---------------------~~~----~~-------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG  243 (339)
                                           ...    ..                   ....+|||.|+|||++.+..|+..+|+||+|
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG  375 (550)
T KOG0605|consen  296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLG  375 (550)
T ss_pred             hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHH
Confidence                                 000    00                   0124699999999999999999999999999


Q ss_pred             HHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCC
Q 019536          244 AFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPL  323 (339)
Q Consensus       244 ~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps  323 (339)
                      ||||||+.|.+||.  ++..   ......+...              .....+|.....+.++.+||.+||. ||++|.-
T Consensus       376 ~ImyEmLvGyPPF~--s~tp---~~T~rkI~nw--------------r~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG  435 (550)
T KOG0605|consen  376 CIMYEMLVGYPPFC--SETP---QETYRKIVNW--------------RETLKFPEEVDLSDEAKDLITRLLC-DPENRLG  435 (550)
T ss_pred             HHHHHHHhCCCCCC--CCCH---HHHHHHHHHH--------------hhhccCCCcCcccHHHHHHHHHHhc-CHHHhcC
Confidence            99999999999975  2221   1111111111              1122334444566889999999999 9999975


Q ss_pred             ---HHHHH
Q 019536          324 ---MVDVA  328 (339)
Q Consensus       324 ---~~~il  328 (339)
                         +.||-
T Consensus       436 ~~G~~EIK  443 (550)
T KOG0605|consen  436 SKGAEEIK  443 (550)
T ss_pred             cccHHHHh
Confidence               55543

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.2e-47  Score=350.31  Aligned_cols=248  Identities=20%  Similarity=0.241  Sum_probs=212.1

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC--hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST--LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLV  131 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  131 (339)
                      .+-|.+++.||.|+.|.|-.|++..+|+.+|||++.+...  ......+.+|+.||+-+.|||++++++++++...+|||
T Consensus        11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv   90 (786)
T KOG0588|consen   11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV   90 (786)
T ss_pred             ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence            3668899999999999999999999999999999987632  23345577999999999999999999999999999999


Q ss_pred             EEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCc
Q 019536          132 FESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGET  209 (339)
Q Consensus       132 ~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~  209 (339)
                      .||+++|.|++++.  +++++.+...+++||+.|+.|||   ..+|+||||||+|+|+|..+.+||+|||+|..-..+..
T Consensus        91 lEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gkl  167 (786)
T KOG0588|consen   91 LEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKL  167 (786)
T ss_pred             EEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeecccCCcc
Confidence            99999999999986  78999999999999999999999   89999999999999999999999999999976555443


Q ss_pred             eeeecccccccccccccccccCCCC-cccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccC
Q 019536          210 HVREEFIKGAYGFIAPEYFATSSFN-EMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDP  288 (339)
Q Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (339)
                      ..   +.||+++|.|||++.|.+|+ .++||||.||++|.|++|+.||+   +++      +..+......+.       
T Consensus       168 Le---TSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd---DdN------ir~LLlKV~~G~-------  228 (786)
T KOG0588|consen  168 LE---TSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD---DDN------IRVLLLKVQRGV-------  228 (786)
T ss_pred             cc---ccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC---Ccc------HHHHHHHHHcCc-------
Confidence            32   46899999999999999997 78999999999999999999986   111      111111112222       


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          289 IFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                           +  ..|...+.++.+|+.+||..||++|+|++||+++
T Consensus       229 -----f--~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH  263 (786)
T KOG0588|consen  229 -----F--EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH  263 (786)
T ss_pred             -----c--cCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence                 2  2335778889999999999999999999999985

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=3e-47  Score=360.94  Aligned_cols=260  Identities=22%  Similarity=0.314  Sum_probs=217.0

Q ss_pred             HHhcCcccCCceeccCCeeEEEEEEcC-----CCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC
Q 019536           52 KATNNYDLHKVIQSDTSYRLFEGTLVD-----QDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETE  126 (339)
Q Consensus        52 ~~~~~~~~~~~ig~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~  126 (339)
                      ....+....+.||+|+||.||+|+..+     +...||||.++.....+...+|.+|+.+++.++|||||+|+|+|.+++
T Consensus       483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~  562 (774)
T KOG1026|consen  483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGD  562 (774)
T ss_pred             echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence            334566778999999999999999753     345799999999888778899999999999999999999999999999


Q ss_pred             ccEEEEEeccCCccccccc------------cC----CChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCC
Q 019536          127 LPTLVFESVKYGTLRGFSF------------AS----LLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDEN  190 (339)
Q Consensus       127 ~~~lv~e~~~~g~L~~~~~------------~~----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~  190 (339)
                      ..++|||||..|+|.+++.            ..    +...+.+.|+.|||.|+.||-   +...+||||..+|+|++++
T Consensus       563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~  639 (774)
T KOG1026|consen  563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGEN  639 (774)
T ss_pred             eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccc
Confidence            9999999999999999976            12    667788999999999999999   8999999999999999999


Q ss_pred             CceEEecCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhH
Q 019536          191 YSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTV  269 (339)
Q Consensus       191 ~~~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~  269 (339)
                      ..+||+|||+++..-....+.......-..+|||||.+..+.|+++||||||||++||+++ |+.|+....+        
T Consensus       640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn--------  711 (774)
T KOG1026|consen  640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN--------  711 (774)
T ss_pred             eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch--------
Confidence            9999999999987644443322212223578999999999999999999999999999998 8888653222        


Q ss_pred             HHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 019536          270 LEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYL  336 (339)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~  336 (339)
                      .+.+.... .+.             -++.|+.++.++.+||..||+..|++|||+.||-..|.....
T Consensus       712 ~EVIe~i~-~g~-------------lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~  764 (774)
T KOG1026|consen  712 QEVIECIR-AGQ-------------LLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ  764 (774)
T ss_pred             HHHHHHHH-cCC-------------cccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence            22222211 111             145667888999999999999999999999999999988754

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-47  Score=338.78  Aligned_cols=249  Identities=20%  Similarity=0.235  Sum_probs=211.8

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFES  134 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  134 (339)
                      ..|+..+.||.|+||.||+|.+..+++.||+|++.........+.+.+|+.+|.+++++||.+++|.+..+..++++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            45777799999999999999999999999999999987778889999999999999999999999999999999999999


Q ss_pred             ccCCcccccccc-C-CChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceee
Q 019536          135 VKYGTLRGFSFA-S-LLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVR  212 (339)
Q Consensus       135 ~~~g~L~~~~~~-~-~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~  212 (339)
                      |.||++.+.+.. . +.+....-++++++.||.|||   ..+.+|||||+.|||+..+|.+||+|||.+..+....... 
T Consensus        93 ~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr-  168 (467)
T KOG0201|consen   93 CGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR-  168 (467)
T ss_pred             hcCcchhhhhccCCCCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeechhhcc-
Confidence            999999999883 3 366666778999999999999   8999999999999999999999999999988776544332 


Q ss_pred             ecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccC
Q 019536          213 EEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDE  292 (339)
Q Consensus       213 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (339)
                       ...+||+.|||||++.+..|+.++||||||++.+||.+|.+|+.......                  ...    .+..
T Consensus       169 -~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr------------------vlf----lIpk  225 (467)
T KOG0201|consen  169 -KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR------------------VLF----LIPK  225 (467)
T ss_pred             -ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce------------------EEE----eccC
Confidence             35789999999999998899999999999999999999999975332210                  000    1111


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          293 DNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       293 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      ..+..-...++..+++++..||.+||+.||||.+++++
T Consensus       226 ~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  226 SAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             CCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence            11111112567789999999999999999999999974

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=5.6e-46  Score=331.53  Aligned_cols=245  Identities=18%  Similarity=0.243  Sum_probs=198.7

Q ss_pred             CceeccCCeeEEEEEEcCCCeeEEEEEeccCCCh--hhHHHHHHHHHHHHhcCCCceeeeeeeeee----CCccEEEEEe
Q 019536           61 KVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTL--DDVEYCFNNIVFSSQMKHKNILKLIGCCLE----TELPTLVFES  134 (339)
Q Consensus        61 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~~~~~~~~----~~~~~lv~e~  134 (339)
                      ..||+|++|.||+|.+  +|+.||+|.+......  ...+.+.+|+.++++++||||++++|++.+    ....++||||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            6799999999999999  7899999998765321  224678899999999999999999999977    3467899999


Q ss_pred             ccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCC-CCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCcee
Q 019536          135 VKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFD-RPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHV  211 (339)
Q Consensus       135 ~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~  211 (339)
                      +++|+|.+++.  ..+++.....++.+++.||.|||   . .+++||||||+||+++.++.+||+|||+++.+.....  
T Consensus       104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~~--  178 (283)
T PHA02988        104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLY---KYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPF--  178 (283)
T ss_pred             CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHH---hcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccccc--
Confidence            99999999986  56788889999999999999999   6 4889999999999999999999999999876544322  


Q ss_pred             eeccccccccccccccccc--CCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCc
Q 019536          212 REEFIKGAYGFIAPEYFAT--SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPI  289 (339)
Q Consensus       212 ~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (339)
                         ...|+..|+|||++.+  ..++.++|||||||++|||++|+.||....        ..+.........         
T Consensus       179 ---~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~--------~~~~~~~i~~~~---------  238 (283)
T PHA02988        179 ---KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT--------TKEIYDLIINKN---------  238 (283)
T ss_pred             ---cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHhcC---------
Confidence               2457889999999976  679999999999999999999999985221        111111111110         


Q ss_pred             ccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 019536          290 FDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYL  336 (339)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~  336 (339)
                          ...+.+..++..+.+|+.+||+.||++|||+.++++.|+.++.
T Consensus       239 ----~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~  281 (283)
T PHA02988        239 ----NSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF  281 (283)
T ss_pred             ----CCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence                0111112355679999999999999999999999999998764

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-47  Score=329.97  Aligned_cols=272  Identities=18%  Similarity=0.198  Sum_probs=210.7

Q ss_pred             HhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccC-CChhhHHHHHHHHHHHHhcCCCceeeeeeeeee-----CC
Q 019536           53 ATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDN-STLDDVEYCFNNIVFSSQMKHKNILKLIGCCLE-----TE  126 (339)
Q Consensus        53 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~-----~~  126 (339)
                      ....|...+.||.|+||.|+++.+..+|..||||++... ......++..+|+++|+.++|+||+.+++++..     -+
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~   99 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN   99 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence            345677689999999999999999999999999998854 444667888999999999999999999999875     34


Q ss_pred             ccEEEEEeccCCccccccc-c-CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCcccc
Q 019536          127 LPTLVFESVKYGTLRGFSF-A-SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSI  204 (339)
Q Consensus       127 ~~~lv~e~~~~g~L~~~~~-~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~  204 (339)
                      ..|+|+|+| +.+|...+. + .+....+..++.|+++||.|+|   +.+|+||||||.|++++.++.+|++|||+|+..
T Consensus       100 DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~  175 (359)
T KOG0660|consen  100 DVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGLARYL  175 (359)
T ss_pred             eeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccccceeec
Confidence            579999999 568888887 3 3888888999999999999999   999999999999999999999999999999988


Q ss_pred             CCCCceeeecccccccccccccccc-cCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCccc
Q 019536          205 PEGETHVREEFIKGAYGFIAPEYFA-TSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFG  283 (339)
Q Consensus       205 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (339)
                      .........+..+.|..|+|||++. ...|+.++||||+||+++||++|++.|+  |.+..+++.++....+.+....+.
T Consensus       176 ~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFp--G~d~v~Ql~lI~~~lGtP~~e~l~  253 (359)
T KOG0660|consen  176 DKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFP--GKDYVHQLQLILELLGTPSEEDLQ  253 (359)
T ss_pred             cccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCC--CCchHHHHHHHHHhcCCCCHHHHH
Confidence            6432222222356789999999875 4579999999999999999999999964  555544555444433333222222


Q ss_pred             ccccC-------cccCCCCCCCc---HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          284 AIVDP-------IFDEDNSFPGK---EEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       284 ~~~~~-------~~~~~~~~~~~---~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      .+-..       ..+.....|-.   +..++.+.+|+.+||..||.+|+|++|++.+
T Consensus       254 ~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  254 KIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             HhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            21100       01111111100   1345678999999999999999999999873

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-47  Score=346.82  Aligned_cols=253  Identities=21%  Similarity=0.314  Sum_probs=213.0

Q ss_pred             HHHHHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCcc
Q 019536           49 DLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELP  128 (339)
Q Consensus        49 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~  128 (339)
                      .|+...+....++-+|+|+.|.||.|++  .++.||||+++.-        -..+|+-|++|+||||+.|.|+|.....+
T Consensus       118 ~WeiPFe~IsELeWlGSGaQGAVF~Grl--~netVAVKKV~el--------kETdIKHLRkLkH~NII~FkGVCtqsPcy  187 (904)
T KOG4721|consen  118 LWEIPFEEISELEWLGSGAQGAVFLGRL--HNETVAVKKVREL--------KETDIKHLRKLKHPNIITFKGVCTQSPCY  187 (904)
T ss_pred             hccCCHHHhhhhhhhccCcccceeeeec--cCceehhHHHhhh--------hhhhHHHHHhccCcceeeEeeeecCCcee
Confidence            3444455556678899999999999999  6889999998532        12678999999999999999999999999


Q ss_pred             EEEEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCC
Q 019536          129 TLVFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPE  206 (339)
Q Consensus       129 ~lv~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~  206 (339)
                      |||||||..|-|...+.  ..+.....+.+..+||.|+.|||   ...|||||||.-|||++.+..+||+|||-++.+.+
T Consensus       188 CIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~  264 (904)
T KOG4721|consen  188 CIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSD  264 (904)
T ss_pred             EEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhhhh
Confidence            99999999999999998  45666777889999999999999   89999999999999999999999999999988766


Q ss_pred             CCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccc
Q 019536          207 GETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIV  286 (339)
Q Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (339)
                      ..+..   .+.||..|||||++...+.+.|+|||||||++|||+||..||......                     .|+
T Consensus       265 ~STkM---SFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss---------------------AII  320 (904)
T KOG4721|consen  265 KSTKM---SFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS---------------------AII  320 (904)
T ss_pred             hhhhh---hhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh---------------------eeE
Confidence            53322   578999999999999999999999999999999999999997522211                     122


Q ss_pred             cCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhc
Q 019536          287 DPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLSV  338 (339)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~~  338 (339)
                      -..-.....+|.|+.+++.++=|++.||+-.|..|||+++|+.+|+-...++
T Consensus       321 wGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pel  372 (904)
T KOG4721|consen  321 WGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPEL  372 (904)
T ss_pred             EeccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHH
Confidence            2222333456777788999999999999999999999999999998655444

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.3e-45  Score=332.58  Aligned_cols=262  Identities=20%  Similarity=0.312  Sum_probs=202.5

Q ss_pred             cCcccCCceeccCCeeEEEEEEcC----------------CCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeee
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVD----------------QDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKL  118 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~----------------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~  118 (339)
                      ++|.+.+.||+|+||.||+|.+..                ++..||+|.+...........+.+|+.++..++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            678999999999999999998642                3457999998876554566778999999999999999999


Q ss_pred             eeeeeeCCccEEEEEeccCCcccccccc---------------------CCChHHHHHHHHHHHHHHHHHhcCCCCCeEE
Q 019536          119 IGCCLETELPTLVFESVKYGTLRGFSFA---------------------SLLIAPRIKIAMEIANAVAYLHVGFDRPIVF  177 (339)
Q Consensus       119 ~~~~~~~~~~~lv~e~~~~g~L~~~~~~---------------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H  177 (339)
                      ++++.+.+..++||||+++|+|.+++..                     .+++.....++.|++.||.|||   +.+|+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCccc
Confidence            9999999999999999999999887641                     2566778899999999999999   899999


Q ss_pred             ccCCCCCEEeCCCCceEEecCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccc
Q 019536          178 RCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLE  257 (339)
Q Consensus       178 ~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~  257 (339)
                      |||||+||+++.++.+||+|||+++.+.............++..|+|||++.+..++.++||||||+++|+|+++..+.+
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            99999999999999999999999987654433222223445778999999988889999999999999999997543333


Q ss_pred             cCCCCCCCchhHHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 019536          258 FKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLR  332 (339)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~  332 (339)
                      +.+...   ................ ...         ...++.++..+.+|+.+||+.||++|||+.+|.+.|+
T Consensus       242 ~~~~~~---~~~~~~~~~~~~~~~~-~~~---------~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         242 YGELTD---EQVIENAGEFFRDQGR-QVY---------LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCcCCH---HHHHHHHHHHhhhccc-ccc---------ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            332221   1111111111111100 000         0011134457899999999999999999999998886

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-46  Score=333.48  Aligned_cols=257  Identities=24%  Similarity=0.298  Sum_probs=209.4

Q ss_pred             HHHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCCh-------------hhHHHHHHHHHHHHhcCCCceee
Q 019536           51 KKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTL-------------DDVEYCFNNIVFSSQMKHKNILK  117 (339)
Q Consensus        51 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~e~~~l~~l~H~niv~  117 (339)
                      .+..+.|++...||+|.||.|-+|....+++.||||++.+....             ...+...+|+.+|++++|||||+
T Consensus        93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~  172 (576)
T KOG0585|consen   93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK  172 (576)
T ss_pred             ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence            34558999999999999999999999999999999999764321             12467889999999999999999


Q ss_pred             eeeeeeeC--CccEEEEEeccCCccccccc-cC-CChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCce
Q 019536          118 LIGCCLET--ELPTLVFESVKYGTLRGFSF-AS-LLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSA  193 (339)
Q Consensus       118 ~~~~~~~~--~~~~lv~e~~~~g~L~~~~~-~~-~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~  193 (339)
                      |+++..+.  +.+|||+|||..|.+...-. .. +.+.++++|+++++.||+|||   .++|+||||||.|+|++++|++
T Consensus       173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~~~g~V  249 (576)
T KOG0585|consen  173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLSSDGTV  249 (576)
T ss_pred             EEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEcCCCcE
Confidence            99999874  56899999999998865533 44 889999999999999999999   9999999999999999999999


Q ss_pred             EEecCCCccccCCCC---ceeeecccccccccccccccccC---CC-CcccchHHHHHHHHHHHhCCCccccCCCCCCCc
Q 019536          194 KLHDFSLSVSIPEGE---THVREEFIKGAYGFIAPEYFATS---SF-NEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDD  266 (339)
Q Consensus       194 kl~dfg~a~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~---~~-~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~  266 (339)
                      ||+|||.+..+....   .........||+.|+|||.+.++   .| +.+.||||+||++|.|+.|+.||-  ++.    
T Consensus       250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~--~~~----  323 (576)
T KOG0585|consen  250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFF--DDF----  323 (576)
T ss_pred             EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcc--cch----
Confidence            999999987663221   11111136799999999999873   33 378899999999999999999974  111    


Q ss_pred             hhHHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 019536          267 LTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQL  331 (339)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L  331 (339)
                                     ..++.+.+......+|...+..+.+++||.+||.+||++|++..+|..+.
T Consensus       324 ---------------~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp  373 (576)
T KOG0585|consen  324 ---------------ELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP  373 (576)
T ss_pred             ---------------HHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence                           11123344445556666556788999999999999999999999987654

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=4.9e-46  Score=344.37  Aligned_cols=262  Identities=20%  Similarity=0.311  Sum_probs=207.0

Q ss_pred             HHHHhcCcccCCceeccCCeeEEEEEEcC-----CCeeEEEEEeccCCChhhHHHHHHHHHHHHhc-CCCceeeeeeeee
Q 019536           50 LKKATNNYDLHKVIQSDTSYRLFEGTLVD-----QDRPISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCCL  123 (339)
Q Consensus        50 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~  123 (339)
                      |....++|++.+.||+|+||.||+|....     ++..||+|++.........+.+.+|+.+++.+ +||||++++++|.
T Consensus        33 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~  112 (374)
T cd05106          33 WEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACT  112 (374)
T ss_pred             ccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence            33445689999999999999999998643     33579999998765445567788999999999 8999999999999


Q ss_pred             eCCccEEEEEeccCCcccccccc---------------------------------------------------------
Q 019536          124 ETELPTLVFESVKYGTLRGFSFA---------------------------------------------------------  146 (339)
Q Consensus       124 ~~~~~~lv~e~~~~g~L~~~~~~---------------------------------------------------------  146 (339)
                      +++..++||||+++|+|.+++..                                                         
T Consensus       113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (374)
T cd05106         113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS  192 (374)
T ss_pred             CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence            99999999999999999887531                                                         


Q ss_pred             ---------------CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCcee
Q 019536          147 ---------------SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHV  211 (339)
Q Consensus       147 ---------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~  211 (339)
                                     ++++..++.++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++.........
T Consensus       193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~  269 (374)
T cd05106         193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV  269 (374)
T ss_pred             ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCccee
Confidence                           3566778899999999999999   8999999999999999999999999999998765433222


Q ss_pred             eecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcc
Q 019536          212 REEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIF  290 (339)
Q Consensus       212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (339)
                      ......++..|+|||++.+..++.++|||||||++|+|++ |+.||.......        ..........         
T Consensus       270 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--------~~~~~~~~~~---------  332 (374)
T cd05106         270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--------KFYKMVKRGY---------  332 (374)
T ss_pred             eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--------HHHHHHHccc---------
Confidence            2222335567999999988899999999999999999997 999985321110        0011111100         


Q ss_pred             cCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 019536          291 DEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMY  335 (339)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~  335 (339)
                          ..+.+...+.++.+++.+||+.||++|||+.+|++.|+++.
T Consensus       333 ----~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         333 ----QMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             ----CccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence                00011123457999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-46  Score=345.01  Aligned_cols=245  Identities=22%  Similarity=0.317  Sum_probs=214.1

Q ss_pred             HHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC--hhhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCcc
Q 019536           52 KATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST--LDDVEYCFNNIVFSSQM-KHKNILKLIGCCLETELP  128 (339)
Q Consensus        52 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~  128 (339)
                      ...++|.+.++||.|+||.|+.+..+.+++.+|||.+++...  .++.+..+.|..|+... +||.++.++.+|+..+++
T Consensus       365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l  444 (694)
T KOG0694|consen  365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL  444 (694)
T ss_pred             ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence            345789999999999999999999999999999999998743  35678888999888877 599999999999999999


Q ss_pred             EEEEEeccCCccccccc-cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCC
Q 019536          129 TLVFESVKYGTLRGFSF-ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEG  207 (339)
Q Consensus       129 ~lv~e~~~~g~L~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~  207 (339)
                      |.||||+.||++..+.. ..+++..+..++..|+.||+|||   +++||+||||.+|||+|..|.+||+|||+++..-..
T Consensus       445 ~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~  521 (694)
T KOG0694|consen  445 FFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ  521 (694)
T ss_pred             EEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEecccccccccCCC
Confidence            99999999999777766 78999999999999999999999   999999999999999999999999999999865422


Q ss_pred             CceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCccccccc
Q 019536          208 ETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVD  287 (339)
Q Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (339)
                      ..  .+.+.+||+.|+|||++.+..|+.++|+|||||+||||+.|..||+  |+++                   ..++|
T Consensus       522 g~--~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~--gddE-------------------ee~Fd  578 (694)
T KOG0694|consen  522 GD--RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFP--GDDE-------------------EEVFD  578 (694)
T ss_pred             CC--ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCC--CCCH-------------------HHHHH
Confidence            22  4447899999999999999999999999999999999999999975  3332                   22455


Q ss_pred             CcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCH
Q 019536          288 PIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLM  324 (339)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~  324 (339)
                      .+...+..+|.  ..+.+..+||+++|..+|++|.-+
T Consensus       579 sI~~d~~~yP~--~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  579 SIVNDEVRYPR--FLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             HHhcCCCCCCC--cccHHHHHHHHHHhccCcccccCC
Confidence            56666666664  577889999999999999999865

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-46  Score=365.00  Aligned_cols=258  Identities=26%  Similarity=0.409  Sum_probs=217.7

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCe-----eEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDR-----PISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPT  129 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~  129 (339)
                      .+.+..+.||+|.||.||.|...+...     .||+|.+......+....|++|..+|+.++|||||+++|+|.+....+
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~  771 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL  771 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence            566778899999999999999875433     499999999888888999999999999999999999999999999999


Q ss_pred             EEEEeccCCccccccc---------cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCC
Q 019536          130 LVFESVKYGTLRGFSF---------ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSL  200 (339)
Q Consensus       130 lv~e~~~~g~L~~~~~---------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~  200 (339)
                      |++|||++|+|..+++         ..+.+.+.+.++.|||+|+.||+   +++.|||||..+|+|++....+||+|||+
T Consensus       772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFGl  848 (1025)
T KOG1095|consen  772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFGL  848 (1025)
T ss_pred             EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccch
Confidence            9999999999999987         34788889999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhc
Q 019536          201 SVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIEN  279 (339)
Q Consensus       201 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  279 (339)
                      |+-+-............-...|||||.+....|+.++|||||||++||+++ |..||+...+        .+........
T Consensus       849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n--------~~v~~~~~~g  920 (1025)
T KOG1095|consen  849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN--------FEVLLDVLEG  920 (1025)
T ss_pred             hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch--------HHHHHHHHhC
Confidence            995544444332211123467999999999999999999999999999999 8888753322        2222222333


Q ss_pred             CcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          280 NRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                      +              +++.|..++..+.++|..||+.+|++||++..|++.+..+...
T Consensus       921 g--------------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~  964 (1025)
T KOG1095|consen  921 G--------------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA  964 (1025)
T ss_pred             C--------------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence            2              3345567888899999999999999999999999999988754

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=4.8e-46  Score=344.65  Aligned_cols=261  Identities=20%  Similarity=0.299  Sum_probs=205.6

Q ss_pred             HHHHhcCcccCCceeccCCeeEEEEEE-----cCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhc-CCCceeeeeeeee
Q 019536           50 LKKATNNYDLHKVIQSDTSYRLFEGTL-----VDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCCL  123 (339)
Q Consensus        50 ~~~~~~~~~~~~~ig~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~  123 (339)
                      +....++|++.+.||+|+||+||+|..     .+++..||+|+++........+.+.+|+.++..+ +||||++++++|.
T Consensus        30 ~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~  109 (375)
T cd05104          30 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACT  109 (375)
T ss_pred             cccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence            344456899999999999999999974     3456789999997654445567788999999999 8999999999999


Q ss_pred             eCCccEEEEEeccCCcccccccc---------------------------------------------------------
Q 019536          124 ETELPTLVFESVKYGTLRGFSFA---------------------------------------------------------  146 (339)
Q Consensus       124 ~~~~~~lv~e~~~~g~L~~~~~~---------------------------------------------------------  146 (339)
                      +++..++||||+++|+|.+++..                                                         
T Consensus       110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  189 (375)
T cd05104         110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV  189 (375)
T ss_pred             cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence            99999999999999999877631                                                         


Q ss_pred             --------------------CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCC
Q 019536          147 --------------------SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPE  206 (339)
Q Consensus       147 --------------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~  206 (339)
                                          .+++..+..++.||+.||.|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~  266 (375)
T cd05104         190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRN  266 (375)
T ss_pred             ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccC
Confidence                                3566778889999999999999   89999999999999999999999999999987654


Q ss_pred             CCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCccccc
Q 019536          207 GETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAI  285 (339)
Q Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (339)
                      ...........++..|+|||++.+..++.++|||||||++|+|++ |..||......    ..    .......+..   
T Consensus       267 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~----~~----~~~~~~~~~~---  335 (375)
T cd05104         267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD----SK----FYKMIKEGYR---  335 (375)
T ss_pred             cccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch----HH----HHHHHHhCcc---
Confidence            332221112334567999999999999999999999999999998 88887532111    01    1111111100   


Q ss_pred             ccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 019536          286 VDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQM  334 (339)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l  334 (339)
                                .+.+...+.++.+|+.+||+.||++|||+.+|++.|++.
T Consensus       336 ----------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         336 ----------MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             ----------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence                      001112345789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=5.1e-46  Score=332.21  Aligned_cols=270  Identities=20%  Similarity=0.246  Sum_probs=204.6

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC-hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST-LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFE  133 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  133 (339)
                      ++|++.+.||+|+||+||+|++..+++.||+|++..... ....+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            478999999999999999999998999999999876532 2345667899999999999999999999999999999999


Q ss_pred             eccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCcee
Q 019536          134 SVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHV  211 (339)
Q Consensus       134 ~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~  211 (339)
                      |++++++..+..  ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++.........
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  157 (287)
T cd07848          81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN  157 (287)
T ss_pred             cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccc
Confidence            999987766543  46888889999999999999999   8999999999999999999999999999998764432211


Q ss_pred             eecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHH---------HhhcCcc
Q 019536          212 REEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKK---------SIENNRF  282 (339)
Q Consensus       212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~---------~~~~~~~  282 (339)
                      . ....|+..|+|||++.+..++.++|+||+||++|+|++|++||.....  .+..........         .......
T Consensus       158 ~-~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07848         158 Y-TEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESE--IDQLFTIQKVLGPLPAEQMKLFYSNPRF  234 (287)
T ss_pred             c-cccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence            1 134688999999999988899999999999999999999999853221  111111111000         0000000


Q ss_pred             cccccCcccCCCCC--CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          283 GAIVDPIFDEDNSF--PGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       283 ~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      .....+........  ......+.++.+|+.+||+.||++|||+.+++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h  284 (287)
T cd07848         235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH  284 (287)
T ss_pred             cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            00000000000000  0001245679999999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.1e-45  Score=326.63  Aligned_cols=255  Identities=20%  Similarity=0.295  Sum_probs=205.9

Q ss_pred             hcCcccCCceeccCCeeEEEEEEc---CCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLV---DQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTL  130 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  130 (339)
                      .++|++.+.||+|+||.||+|.+.   ..+..||+|.++..........+.+|+..++.++||||+++++++..++..++
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            357899999999999999999875   35678999999876554556678899999999999999999999999999999


Q ss_pred             EEEeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCC
Q 019536          131 VFESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEG  207 (339)
Q Consensus       131 v~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~  207 (339)
                      ||||+++|+|.+++.   ..+++..++.++.|++.||+|||   +.+++||||||+||+++.++.++++|||.+......
T Consensus        84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~  160 (266)
T cd05064          84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE  160 (266)
T ss_pred             EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence            999999999998875   35788999999999999999999   999999999999999999999999999987654322


Q ss_pred             CceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCcccccc
Q 019536          208 ETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIV  286 (339)
Q Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (339)
                      ... ......++..|+|||++.+..++.++|||||||++|++++ |..||.....     .....    .....      
T Consensus       161 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~-----~~~~~----~~~~~------  224 (266)
T cd05064         161 AIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG-----QDVIK----AVEDG------  224 (266)
T ss_pred             chh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH-----HHHHH----HHHCC------
Confidence            211 1112334567999999998999999999999999999775 9999753211     11111    11111      


Q ss_pred             cCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 019536          287 DPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQM  334 (339)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l  334 (339)
                             ...|.+..++..+.+++.+||+.+|++|||+.+|++.|+++
T Consensus       225 -------~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         225 -------FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             -------CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence                   01122234556799999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=7.4e-46  Score=331.59  Aligned_cols=268  Identities=16%  Similarity=0.196  Sum_probs=201.1

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFES  134 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  134 (339)
                      ++|++.+.||.|+||+||+|....++..||+|++...........+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            57999999999999999999999899999999987654334455677999999999999999999999999999999999


Q ss_pred             ccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCcee
Q 019536          135 VKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHV  211 (339)
Q Consensus       135 ~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~  211 (339)
                      +++ +|.+++.   ..++...+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.........
T Consensus        85 ~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~  160 (288)
T cd07871          85 LDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTY  160 (288)
T ss_pred             CCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCccc
Confidence            975 8877764   34678888999999999999999   8999999999999999999999999999987654322211


Q ss_pred             eeccccccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccC--
Q 019536          212 REEFIKGAYGFIAPEYFAT-SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDP--  288 (339)
Q Consensus       212 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  288 (339)
                        ....+++.|+|||++.+ ..++.++||||+||++|+|++|++||...  ...+................+..+...  
T Consensus       161 --~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07871         161 --SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGS--TVKEELHLIFRLLGTPTEETWPGITSNEE  236 (288)
T ss_pred             --cCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHHHhCCCChHHhhccccchh
Confidence              13457889999999865 46899999999999999999999997532  111111111111000001111111000  


Q ss_pred             ----cccCCCCCC---CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          289 ----IFDEDNSFP---GKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       289 ----~~~~~~~~~---~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                          .++.....+   .....+.++.+|+.+||++||.+|||+.|++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h  285 (288)
T cd07871         237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH  285 (288)
T ss_pred             hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                000000000   001234578999999999999999999999863

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-46  Score=333.87  Aligned_cols=245  Identities=20%  Similarity=0.243  Sum_probs=202.3

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC--ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS--TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVF  132 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  132 (339)
                      ++|++.+.||+|+||.||+|....+++.||+|++....  .....+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            47899999999999999999999899999999987542  1234566789999999999999999999999999999999


Q ss_pred             EeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCce
Q 019536          133 ESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH  210 (339)
Q Consensus       133 e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~  210 (339)
                      ||+++|+|.+++.  ..+++.....++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++....... 
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~-  156 (291)
T cd05612          81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTW-  156 (291)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCcc-
Confidence            9999999999876  56788888999999999999999   99999999999999999999999999999877643221 


Q ss_pred             eeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcc
Q 019536          211 VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIF  290 (339)
Q Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (339)
                          ...||+.|+|||++.+..++.++|||||||++|+|++|+.||.....        ........ ..          
T Consensus       157 ----~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~--------~~~~~~i~-~~----------  213 (291)
T cd05612         157 ----TLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP--------FGIYEKIL-AG----------  213 (291)
T ss_pred             ----cccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHH-hC----------
Confidence                34689999999999988999999999999999999999999752211        11111111 11          


Q ss_pred             cCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 019536          291 DEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPL-----MVDVAKQ  330 (339)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps-----~~~il~~  330 (339)
                        ...+|  ...+..+.+|+.+||+.||.+||+     +.+++++
T Consensus       214 --~~~~~--~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         214 --KLEFP--RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             --CcCCC--ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence              11111  123557899999999999999995     8888764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.2e-45  Score=320.14  Aligned_cols=269  Identities=18%  Similarity=0.232  Sum_probs=208.1

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChh-hHHHHHHHHHHHHhcCCCc-eeeeeeeeeeCC-----
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLD-DVEYCFNNIVFSSQMKHKN-ILKLIGCCLETE-----  126 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~H~n-iv~~~~~~~~~~-----  126 (339)
                      ...|...++||+|+||+||+|+...+|+.||+|++......+ ......+|+.+++.++|+| |+++++++...+     
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            355777788999999999999999999999999998764422 2345679999999999999 999999998877     


Q ss_pred             -ccEEEEEeccCCcccccccc------CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCC
Q 019536          127 -LPTLVFESVKYGTLRGFSFA------SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFS  199 (339)
Q Consensus       127 -~~~lv~e~~~~g~L~~~~~~------~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg  199 (339)
                       .+++||||++ -+|..++..      .++...+..++.|++.||+|||   +.+|+||||||+|||++++|.+||+|||
T Consensus        90 ~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   90 GKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             ceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccc
Confidence             7899999995 478777651      4666778899999999999999   9999999999999999999999999999


Q ss_pred             CccccCCCCceeeecccccccccccccccccC-CCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhh
Q 019536          200 LSVSIPEGETHVREEFIKGAYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIE  278 (339)
Q Consensus       200 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  278 (339)
                      +|+...-+.....  ...+|..|+|||++.+. .|+..+||||+||+++||+++++.|+  |..+.++...+......+.
T Consensus       166 lAra~~ip~~~yt--~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFp--G~se~~ql~~If~~lGtP~  241 (323)
T KOG0594|consen  166 LARAFSIPMRTYT--PEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFP--GDSEIDQLFRIFRLLGTPN  241 (323)
T ss_pred             hHHHhcCCccccc--ccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCC--CCcHHHHHHHHHHHcCCCC
Confidence            9997764333222  35688889999999887 79999999999999999999998865  4444444444444444333


Q ss_pred             cCccccccc-CcccCC-CCCCCcHHH-------HHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          279 NNRFGAIVD-PIFDED-NSFPGKEEK-------LQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       279 ~~~~~~~~~-~~~~~~-~~~~~~~~~-------~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      ...+..+.. +..... ..++.+...       ..+..+++.+||+++|.+|.|+..++.+
T Consensus       242 e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  242 EKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             ccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            333332211 111100 111111111       2478899999999999999999999875

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=2.2e-45  Score=332.79  Aligned_cols=256  Identities=19%  Similarity=0.325  Sum_probs=206.0

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCe----eEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDR----PISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTL  130 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  130 (339)
                      .+|++.+.||+|+||.||+|.+..++.    .||+|.+.........+.+.+|+.+++.++||||++++|+|... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            569999999999999999999865555    48999987655445567788999999999999999999999875 4679


Q ss_pred             EEEeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCC
Q 019536          131 VFESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEG  207 (339)
Q Consensus       131 v~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~  207 (339)
                      |+||+++|+|.+++.   ..+++...+.++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++.+...
T Consensus        86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~  162 (316)
T cd05108          86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD  162 (316)
T ss_pred             eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEccccccccccCC
Confidence            999999999999876   35788888999999999999999   899999999999999999999999999999877654


Q ss_pred             CceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCcccccc
Q 019536          208 ETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIV  286 (339)
Q Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (339)
                      ..........++..|+|||++.+..++.++||||||+++|||++ |+.||....        ..+. ......       
T Consensus       163 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~--------~~~~-~~~~~~-------  226 (316)
T cd05108         163 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--------ASEI-SSILEK-------  226 (316)
T ss_pred             CcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC--------HHHH-HHHHhC-------
Confidence            43332222334678999999998999999999999999999997 999875211        1111 111111       


Q ss_pred             cCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 019536          287 DPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYL  336 (339)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~  336 (339)
                            ....|.+..++.++.+++.+||+.+|++|||+.+++..|..+..
T Consensus       227 ------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~  270 (316)
T cd05108         227 ------GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  270 (316)
T ss_pred             ------CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence                  01112122344578999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9.3e-46  Score=324.47  Aligned_cols=251  Identities=22%  Similarity=0.290  Sum_probs=210.5

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC--hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST--LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVF  132 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  132 (339)
                      ++|++.+.||+|.-|+||.+...+++..+|+|++.+...  .....+...|-+||+.++||.+++|++.++.+...||||
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            578888999999999999999999999999999988632  345677788999999999999999999999999999999


Q ss_pred             EeccCCccccccc----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCC--
Q 019536          133 ESVKYGTLRGFSF----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPE--  206 (339)
Q Consensus       133 e~~~~g~L~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~--  206 (339)
                      |||+||+|..+.+    ..+++..+..++.+++.||+|||   ..|||+|||||+|||+-++|.+.|+||.++.....  
T Consensus       157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~P  233 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP  233 (459)
T ss_pred             ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence            9999999988876    57899999999999999999999   99999999999999999999999999998643211  


Q ss_pred             -------------------------------CCc---------------------eeeecccccccccccccccccCCCC
Q 019536          207 -------------------------------GET---------------------HVREEFIKGAYGFIAPEYFATSSFN  234 (339)
Q Consensus       207 -------------------------------~~~---------------------~~~~~~~~gt~~y~aPE~~~~~~~~  234 (339)
                                                     ...                     .......+||-.|+|||++.|...+
T Consensus       234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg  313 (459)
T KOG0610|consen  234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG  313 (459)
T ss_pred             eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence                                           000                     0011235789999999999999999


Q ss_pred             cccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhh
Q 019536          235 EMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCL  314 (339)
Q Consensus       235 ~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  314 (339)
                      .++|+|+|||++|||+.|+.||...++..  .                   +-.++..+..+|..+..+..++|||+++|
T Consensus       314 sAVDWWtfGIflYEmLyG~TPFKG~~~~~--T-------------------l~NIv~~~l~Fp~~~~vs~~akDLIr~LL  372 (459)
T KOG0610|consen  314 SAVDWWTFGIFLYEMLYGTTPFKGSNNKE--T-------------------LRNIVGQPLKFPEEPEVSSAAKDLIRKLL  372 (459)
T ss_pred             chhhHHHHHHHHHHHHhCCCCcCCCCchh--h-------------------HHHHhcCCCcCCCCCcchhHHHHHHHHHh
Confidence            99999999999999999999976444322  1                   12233445556665677789999999999


Q ss_pred             ccCCCCCCC----HHHHHH
Q 019536          315 SKSPEHRPL----MVDVAK  329 (339)
Q Consensus       315 ~~dP~~Rps----~~~il~  329 (339)
                      .+||++|.-    |.||-+
T Consensus       373 vKdP~kRlg~~rGA~eIK~  391 (459)
T KOG0610|consen  373 VKDPSKRLGSKRGAAEIKR  391 (459)
T ss_pred             ccChhhhhccccchHHhhc
Confidence            999999998    666644

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.1e-44  Score=330.39  Aligned_cols=264  Identities=16%  Similarity=0.223  Sum_probs=206.9

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFE  133 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  133 (339)
                      .++|++.+.||+|+||.||++.+..++..+|+|.+...........+.+|+.+++.++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            36899999999999999999999999999999998876544556778899999999999999999999999999999999


Q ss_pred             eccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCC-CeEEccCCCCCEEeCCCCceEEecCCCccccCCCCce
Q 019536          134 SVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDR-PIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH  210 (339)
Q Consensus       134 ~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~  210 (339)
                      |+++|+|.+++.  ..+++..+..++.|++.||.|||   +. +|+||||||+||+++.++.+||+|||++..+..... 
T Consensus        84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  159 (331)
T cd06649          84 HMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLR---EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA-  159 (331)
T ss_pred             cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHh---hcCCEEcCCCChhhEEEcCCCcEEEccCccccccccccc-
Confidence            999999999886  46788888999999999999999   64 699999999999999999999999999876643221 


Q ss_pred             eeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhc---Cccc----
Q 019536          211 VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIEN---NRFG----  283 (339)
Q Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~----  283 (339)
                         ....|+..|+|||++.+..++.++|||||||++|+|++|+.||......     ............   ....    
T Consensus       160 ---~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~  231 (331)
T cd06649         160 ---NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAK-----ELEAIFGRPVVDGEEGEPHSISP  231 (331)
T ss_pred             ---ccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHhcccccccccCCccccCc
Confidence               1346899999999999889999999999999999999999998532110     011000000000   0000    


Q ss_pred             -----------------------ccccCcccCC-CCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          284 -----------------------AIVDPIFDED-NSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       284 -----------------------~~~~~~~~~~-~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                                             ...+...... ...+ ....+.++.+|+.+||++||++|||+.+++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         232 RPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLP-NGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             ccccccccccccccccccchhHHHHHHHHHhCCCcCCC-CccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                                   0000000000 0001 11345679999999999999999999999875

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.1e-46  Score=326.53  Aligned_cols=262  Identities=19%  Similarity=0.259  Sum_probs=202.2

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC-----cc
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETE-----LP  128 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~-----~~  128 (339)
                      .-.|...+++|+|+||.||.|....++..||||++.....     .-.+|+++|+.+.|||||++.-+|....     ..
T Consensus        23 ~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l   97 (364)
T KOG0658|consen   23 EISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL   97 (364)
T ss_pred             EEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence            3468888999999999999999999999999999876532     2237999999999999999998886422     35


Q ss_pred             EEEEEeccCCccccccc------cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCC-CceEEecCCCc
Q 019536          129 TLVFESVKYGTLRGFSF------ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDEN-YSAKLHDFSLS  201 (339)
Q Consensus       129 ~lv~e~~~~g~L~~~~~------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~-~~~kl~dfg~a  201 (339)
                      .+||||+|. +|...+.      ..++.-.+.-+..||++||.|||   +.+|+||||||.|+|+|.+ |.+||||||.|
T Consensus        98 nlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSA  173 (364)
T KOG0658|consen   98 NLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSA  173 (364)
T ss_pred             HHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCcc
Confidence            699999986 7776665      56777778889999999999999   8999999999999999965 89999999999


Q ss_pred             cccCCCCceeeecccccccccccccccccC-CCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcC
Q 019536          202 VSIPEGETHVREEFIKGAYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENN  280 (339)
Q Consensus       202 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  280 (339)
                      +.+..++...   ....|..|+|||++.|. .|+.+.||||.||++.||+-|++.|  +|++..+++..+-.+...+...
T Consensus       174 K~L~~~epni---SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plF--pG~s~~dQL~eIik~lG~Pt~e  248 (364)
T KOG0658|consen  174 KVLVKGEPNI---SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLF--PGDSSVDQLVEIIKVLGTPTRE  248 (364)
T ss_pred             eeeccCCCce---eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCccc--CCCCHHHHHHHHHHHhCCCCHH
Confidence            9987765442   23457789999998876 6999999999999999999999995  4566555655554444433222


Q ss_pred             ccccc-------ccCcccCCC-CCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          281 RFGAI-------VDPIFDEDN-SFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       281 ~~~~~-------~~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                      ....+       ..+.+.... ..-.....+++..+|+.++|+++|.+|.++.+++.
T Consensus       249 ~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  249 DIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             HHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence            21111       011111100 00011234568899999999999999999999886

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=7.9e-46  Score=337.57  Aligned_cols=246  Identities=17%  Similarity=0.242  Sum_probs=202.9

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC--ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS--TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLV  131 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  131 (339)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++....  .....+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence            367999999999999999999999999999999987542  123456688999999999999999999999999999999


Q ss_pred             EEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCc
Q 019536          132 FESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGET  209 (339)
Q Consensus       132 ~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~  209 (339)
                      |||+++|+|.+++.  ..++...+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus        97 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  173 (329)
T PTZ00263         97 LEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTF  173 (329)
T ss_pred             EcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCcc
Confidence            99999999998876  46788888889999999999999   99999999999999999999999999999987644322


Q ss_pred             eeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCc
Q 019536          210 HVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPI  289 (339)
Q Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (339)
                           ...||+.|+|||++.+..++.++|||||||++|+|++|+.||....        ....... ...+.        
T Consensus       174 -----~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~--------~~~~~~~-i~~~~--------  231 (329)
T PTZ00263        174 -----TLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT--------PFRIYEK-ILAGR--------  231 (329)
T ss_pred             -----eecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC--------HHHHHHH-HhcCC--------
Confidence                 2468999999999999999999999999999999999999974211        1111111 11111        


Q ss_pred             ccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 019536          290 FDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPL-----MVDVAKQ  330 (339)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps-----~~~il~~  330 (339)
                          ..+|  ...+..+.+|+.+||+.||.+||+     +.+++.+
T Consensus       232 ----~~~p--~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        232 ----LKFP--NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             ----cCCC--CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence                1111  123456899999999999999997     5777653

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-46  Score=342.87  Aligned_cols=270  Identities=24%  Similarity=0.371  Sum_probs=218.0

Q ss_pred             cccccHHHHHHHhcCcccCCceeccCCeeEEEEEEcCCC----eeEEEEEecc--CCChhhHHHHHHHHHHHHhcCCCce
Q 019536           42 IRAFSAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQD----RPISVMKFHD--NSTLDDVEYCFNNIVFSSQMKHKNI  115 (339)
Q Consensus        42 ~~~~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~----~~vavK~~~~--~~~~~~~~~~~~e~~~l~~l~H~ni  115 (339)
                      .++...+.|+..-++-.+.++||+|+||.||+|.....+    ..||+|....  ........++++|.++|++++||||
T Consensus       144 ~~PI~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NV  223 (474)
T KOG0194|consen  144 KRPIPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNV  223 (474)
T ss_pred             cccccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCE
Confidence            344555566666677778899999999999999987532    2389999885  3455778889999999999999999


Q ss_pred             eeeeeeeeeCCccEEEEEeccCCcccccccc---CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCc
Q 019536          116 LKLIGCCLETELPTLVFESVKYGTLRGFSFA---SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYS  192 (339)
Q Consensus       116 v~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~---~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~  192 (339)
                      |+++|++.....++||||+|.||+|.+++..   .++..+++.++.+.+.||+|||   +++++||||..+|+|++.++.
T Consensus       224 Vr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~  300 (474)
T KOG0194|consen  224 VRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGV  300 (474)
T ss_pred             EEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCe
Confidence            9999999999999999999999999999982   5899999999999999999999   999999999999999999999


Q ss_pred             eEEecCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHH
Q 019536          193 AKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLE  271 (339)
Q Consensus       193 ~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~  271 (339)
                      +||+|||+++.-..  .........-...|+|||.+....|+.++|||||||++||+++ |..||+.        ....+
T Consensus       301 vKISDFGLs~~~~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g--------~~~~~  370 (474)
T KOG0194|consen  301 VKISDFGLSRAGSQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPG--------MKNYE  370 (474)
T ss_pred             EEeCccccccCCcc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCC--------CCHHH
Confidence            99999999876431  1111101234578999999999999999999999999999998 7888652        22222


Q ss_pred             HHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          272 YAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                      ...+...+             ..+.+.+...+..+..++.+||..||++||||.++.+.|+.+...
T Consensus       371 v~~kI~~~-------------~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~  423 (474)
T KOG0194|consen  371 VKAKIVKN-------------GYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKK  423 (474)
T ss_pred             HHHHHHhc-------------CccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhc
Confidence            22222121             122233335566788999999999999999999999999988753

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=5.4e-45  Score=325.56  Aligned_cols=250  Identities=18%  Similarity=0.259  Sum_probs=201.2

Q ss_pred             CcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC--hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 019536           56 NYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST--LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFE  133 (339)
Q Consensus        56 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  133 (339)
                      .|+..+.||+|+||+||+|....+++.||+|.+.....  ......+.+|+.+++.++|+||+++++++.+++..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            37778999999999999999998999999999875432  1334557799999999999999999999999999999999


Q ss_pred             eccCCccccccc----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCc
Q 019536          134 SVKYGTLRGFSF----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGET  209 (339)
Q Consensus       134 ~~~~g~L~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~  209 (339)
                      |+++|+|.+++.    ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.++|+|||++........
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET  157 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence            999999987764    35788888999999999999999   99999999999999999999999999999987644322


Q ss_pred             eeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCc
Q 019536          210 HVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPI  289 (339)
Q Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (339)
                      .   ....||..|+|||++.+..++.++||||+||++|+|++|+.||.......     ..+..........        
T Consensus       158 ~---~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-----~~~~~~~~~~~~~--------  221 (285)
T cd05631         158 V---RGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV-----KREEVDRRVKEDQ--------  221 (285)
T ss_pred             e---cCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch-----hHHHHHHHhhccc--------
Confidence            1   13468999999999999999999999999999999999999986332211     0111111111100        


Q ss_pred             ccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 019536          290 FDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPL-----MVDVAKQ  330 (339)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps-----~~~il~~  330 (339)
                          .  +.+...+..+.+|+.+||+.||.+||+     +.+++++
T Consensus       222 ----~--~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  261 (285)
T cd05631         222 ----E--EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH  261 (285)
T ss_pred             ----c--cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence                0  111234567899999999999999997     7888763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=4.1e-45  Score=325.64  Aligned_cols=255  Identities=23%  Similarity=0.375  Sum_probs=206.5

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCC-----eeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQD-----RPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPT  129 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~  129 (339)
                      ++|++.+.||+|+||.||+|.....+     ..||+|.+...........+.+|+.+++.++||||+++++++.+....+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            47888999999999999999986554     6899999876655455677889999999999999999999999999999


Q ss_pred             EEEEeccCCccccccc------------------cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCC
Q 019536          130 LVFESVKYGTLRGFSF------------------ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENY  191 (339)
Q Consensus       130 lv~e~~~~g~L~~~~~------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~  191 (339)
                      ++|||+++|+|.+++.                  ..+++.....++.|++.||.|||   +.+++|+||||+||+++.++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCCC
Confidence            9999999999988874                  23667788899999999999999   89999999999999999999


Q ss_pred             ceEEecCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHH
Q 019536          192 SAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVL  270 (339)
Q Consensus       192 ~~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~  270 (339)
                      .++|+|||+++...............+++.|+|||++.+..++.++|+|||||++|||++ |..||.....     ....
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~-----~~~~  236 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN-----QEVI  236 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH-----HHHH
Confidence            999999999876544332222223456788999999988889999999999999999998 9999752211     1111


Q ss_pred             HHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 019536          271 EYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQM  334 (339)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l  334 (339)
                          .......             ..+.+..++.++.+|+.+||+.||.+|||+.+|++.|+++
T Consensus       237 ----~~i~~~~-------------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~  283 (283)
T cd05048         237 ----EMIRSRQ-------------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW  283 (283)
T ss_pred             ----HHHHcCC-------------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence                1111111             0111234567899999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.8e-45  Score=334.47  Aligned_cols=241  Identities=17%  Similarity=0.208  Sum_probs=197.1

Q ss_pred             CceeccCCeeEEEEEEcCCCeeEEEEEeccCC--ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeccCC
Q 019536           61 KVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS--TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYG  138 (339)
Q Consensus        61 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g  138 (339)
                      +.||+|+||.||+|....+++.||+|++....  .......+.+|+.+++.++||||+++++++..++..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999999899999999987642  2234566788999999999999999999999999999999999999


Q ss_pred             ccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceeeeccc
Q 019536          139 TLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI  216 (339)
Q Consensus       139 ~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~~~~  216 (339)
                      +|.+++.  ..+++..+..++.||+.||.|||   +.+|+||||||+||+++.++.+||+|||+++........  ....
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~--~~~~  155 (323)
T cd05571          81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTF  155 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCc--ccce
Confidence            9988875  56788888999999999999999   999999999999999999999999999998754322221  1235


Q ss_pred             ccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCCCCC
Q 019536          217 KGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSF  296 (339)
Q Consensus       217 ~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (339)
                      .||+.|+|||++.+..++.++||||+||++|+|++|+.||....     .....    ......            ...+
T Consensus       156 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~-----~~~~~----~~~~~~------------~~~~  214 (323)
T cd05571         156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----HEKLF----ELILME------------EIRF  214 (323)
T ss_pred             ecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC-----HHHHH----HHHHcC------------CCCC
Confidence            68999999999999999999999999999999999999984211     01111    111110            1111


Q ss_pred             CCcHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 019536          297 PGKEEKLQSLGQLMYKCLSKSPEHRP-----LMVDVAK  329 (339)
Q Consensus       297 ~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~il~  329 (339)
                      |  ...+.++.+|+.+||+.||++||     ++.++++
T Consensus       215 p--~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         215 P--RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             C--CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            1  23456799999999999999999     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=5e-45  Score=339.42  Aligned_cols=263  Identities=19%  Similarity=0.312  Sum_probs=208.2

Q ss_pred             HHHHhcCcccCCceeccCCeeEEEEEEcCC-----CeeEEEEEeccCCChhhHHHHHHHHHHHHhcC-CCceeeeeeeee
Q 019536           50 LKKATNNYDLHKVIQSDTSYRLFEGTLVDQ-----DRPISVMKFHDNSTLDDVEYCFNNIVFSSQMK-HKNILKLIGCCL  123 (339)
Q Consensus        50 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~~~~~~~  123 (339)
                      +....++|.+.+.||+|+||.||+|.+...     +..||||++.........+.+.+|+.+++.+. ||||++++++|.
T Consensus        32 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~  111 (400)
T cd05105          32 WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACT  111 (400)
T ss_pred             eeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence            344467899999999999999999987432     34799999977655455677899999999995 999999999999


Q ss_pred             eCCccEEEEEeccCCcccccccc---------------------------------------------------------
Q 019536          124 ETELPTLVFESVKYGTLRGFSFA---------------------------------------------------------  146 (339)
Q Consensus       124 ~~~~~~lv~e~~~~g~L~~~~~~---------------------------------------------------------  146 (339)
                      +.+..++|||||++|+|.+++..                                                         
T Consensus       112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (400)
T cd05105         112 KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM  191 (400)
T ss_pred             cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence            99999999999999999876531                                                         


Q ss_pred             -----------------------------------------CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCE
Q 019536          147 -----------------------------------------SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNV  185 (339)
Q Consensus       147 -----------------------------------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Ni  185 (339)
                                                               .+++..+..++.|++.||.|||   +.+|+||||||+||
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Ni  268 (400)
T cd05105         192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNV  268 (400)
T ss_pred             hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhE
Confidence                                                     2556677889999999999999   89999999999999


Q ss_pred             EeCCCCceEEecCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCC
Q 019536          186 LLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGND  264 (339)
Q Consensus       186 l~~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~  264 (339)
                      +++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||....... 
T Consensus       269 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~-  347 (400)
T cd05105         269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS-  347 (400)
T ss_pred             EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH-
Confidence            999999999999999987644332222223346678999999988899999999999999999997 888875321110 


Q ss_pred             CchhHHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 019536          265 DDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYL  336 (339)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~  336 (339)
                             .........             ...+.+...+..+.+++.+||+.||++|||+.+|.+.|+++.+
T Consensus       348 -------~~~~~~~~~-------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         348 -------TFYNKIKSG-------------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             -------HHHHHHhcC-------------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence                   001111111             0111122455679999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.9e-46  Score=306.07  Aligned_cols=247  Identities=20%  Similarity=0.300  Sum_probs=207.9

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC--hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST--LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLV  131 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  131 (339)
                      .++|++++.+|.|-||.||.|+.+.++-.||+|++.+..-  ......+.+|++|.+.|+||||++++++|.+....||+
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            4789999999999999999999999999999999876521  12345677999999999999999999999999999999


Q ss_pred             EEeccCCccccccc----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCC
Q 019536          132 FESVKYGTLRGFSF----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEG  207 (339)
Q Consensus       132 ~e~~~~g~L~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~  207 (339)
                      +||.+.|++...+.    ..+.+.....+..|+|.||.|+|   .++|+||||||+|+|++..+.+|++|||.+..-+.+
T Consensus       101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~  177 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSN  177 (281)
T ss_pred             EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeecCCC
Confidence            99999999988876    45778888899999999999999   999999999999999999999999999998665432


Q ss_pred             CceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCccccccc
Q 019536          208 ETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVD  287 (339)
Q Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (339)
                      .    ..+.+||..|.+||+..+..++..+|+|++|++.||++.|.+||.....+     .....+.+            
T Consensus       178 k----R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~-----etYkrI~k------------  236 (281)
T KOG0580|consen  178 K----RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS-----ETYKRIRK------------  236 (281)
T ss_pred             C----ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH-----HHHHHHHH------------
Confidence            2    22578999999999999999999999999999999999999998633211     11111111            


Q ss_pred             CcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          288 PIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                          -+..+|  ...+..++++|.+||..+|.+|.+..|++++
T Consensus       237 ----~~~~~p--~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  237 ----VDLKFP--STISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             ----ccccCC--cccChhHHHHHHHHhccCccccccHHHHhhh
Confidence                111122  3566789999999999999999999999875

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=4.6e-45  Score=333.45  Aligned_cols=260  Identities=20%  Similarity=0.355  Sum_probs=206.1

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcC-----CCeeEEEEEeccCCChhhHHHHHHHHHHHHhc-CCCceeeeeeeeee-CC
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVD-----QDRPISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLE-TE  126 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~-~~  126 (339)
                      .++|++.+.||+|+||.||+|....     +++.||+|++.........+.+..|+.++.++ +|+||++++++|.. +.
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            4579999999999999999997543     35789999997655445566788999999999 89999999998865 45


Q ss_pred             ccEEEEEeccCCccccccc-------------------------------------------------------------
Q 019536          127 LPTLVFESVKYGTLRGFSF-------------------------------------------------------------  145 (339)
Q Consensus       127 ~~~lv~e~~~~g~L~~~~~-------------------------------------------------------------  145 (339)
                      ..+++|||+++|+|.+++.                                                             
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            6789999999999987763                                                             


Q ss_pred             --cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceeeecccccccccc
Q 019536          146 --ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFI  223 (339)
Q Consensus       146 --~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~  223 (339)
                        ..+++..+..++.||+.||.|||   +.+|+||||||+||+++.++.++|+|||+++.+.............++..|+
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence              15678888999999999999999   8999999999999999999999999999998765433322222344567899


Q ss_pred             cccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCCCCCCCcHHH
Q 019536          224 APEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEK  302 (339)
Q Consensus       224 aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (339)
                      |||++.+..++.++|||||||++|+|++ |..||.......        ...........             ...+...
T Consensus       243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~--------~~~~~~~~~~~-------------~~~~~~~  301 (337)
T cd05054         243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--------EFCRRLKEGTR-------------MRAPEYA  301 (337)
T ss_pred             CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH--------HHHHHHhccCC-------------CCCCccC
Confidence            9999999999999999999999999997 999975321110        01111111100             0111234


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          303 LQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       303 ~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                      +.++.+++.+||+.+|++|||+.++++.|+++..+
T Consensus       302 ~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~~  336 (337)
T cd05054         302 TPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQE  336 (337)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            46799999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-47  Score=352.58  Aligned_cols=258  Identities=22%  Similarity=0.309  Sum_probs=224.2

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCC---eeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQD---RPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLV  131 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  131 (339)
                      ....+.++||.|.||.||+|+.+..+   ..||||.++...+.....+|+.|..||.+++||||++|.|+.......+||
T Consensus       629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi  708 (996)
T KOG0196|consen  629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII  708 (996)
T ss_pred             hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence            46778899999999999999998666   479999999998888899999999999999999999999999999999999


Q ss_pred             EEeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCC
Q 019536          132 FESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE  208 (339)
Q Consensus       132 ~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~  208 (339)
                      .|||++|+|+.+++   +.+...+.+.++++|+.|+.||-   +.+.+||||..+|||++++-.+|++|||+++.+.++.
T Consensus       709 TEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~  785 (996)
T KOG0196|consen  709 TEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  785 (996)
T ss_pred             hhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheeeccceEEEeccccceeecccCC
Confidence            99999999999997   56888889999999999999999   9999999999999999999999999999999886654


Q ss_pred             -ceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCcccccc
Q 019536          209 -THVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIV  286 (339)
Q Consensus       209 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (339)
                       ....+....-..+|.|||.+....++.++||||+|++|||.++ |..||....+        .+.+.            
T Consensus       786 ~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN--------QdVIk------------  845 (996)
T KOG0196|consen  786 EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN--------QDVIK------------  845 (996)
T ss_pred             CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch--------HHHHH------------
Confidence             2222222222468999999999999999999999999999876 8888764333        22211            


Q ss_pred             cCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          287 DPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                        .+.+...+|.|++++..+.+||..||++|..+||.+.+|+..|.+|+++
T Consensus       846 --aIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn  894 (996)
T KOG0196|consen  846 --AIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN  894 (996)
T ss_pred             --HHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence              2233456677889999999999999999999999999999999999853

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.1e-44  Score=330.44  Aligned_cols=198  Identities=15%  Similarity=0.226  Sum_probs=176.1

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFE  133 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  133 (339)
                      .++|++.+.||+|+||.||+|.+..++..+|+|.+...........+.+|+++++.++||||++++++|.+++..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            37899999999999999999999989999999998766444556778899999999999999999999999999999999


Q ss_pred             eccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCC-CCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCce
Q 019536          134 SVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFD-RPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH  210 (339)
Q Consensus       134 ~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~  210 (339)
                      |+++|+|.+++.  ..++......++.|++.||.|||   + .+|+|+||||+||+++.++.+||+|||++........ 
T Consensus        84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~-  159 (333)
T cd06650          84 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA-  159 (333)
T ss_pred             cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhcc-
Confidence            999999999886  46788888899999999999999   5 4799999999999999999999999999876533221 


Q ss_pred             eeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCcccc
Q 019536          211 VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEF  258 (339)
Q Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~  258 (339)
                         ....|+..|+|||++.+..++.++|+|||||++|+|++|+.||..
T Consensus       160 ---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~  204 (333)
T cd06650         160 ---NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP  204 (333)
T ss_pred             ---ccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence               134688999999999988899999999999999999999999853

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.3e-45  Score=322.64  Aligned_cols=249  Identities=20%  Similarity=0.296  Sum_probs=212.4

Q ss_pred             HhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC--hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 019536           53 ATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST--LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTL  130 (339)
Q Consensus        53 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  130 (339)
                      ...+|++.+.+|.|+||.|-+|..+..|+.||||.+++...  .++.-.+.+|++||+.|+||||+.++.+|++.+.+.|
T Consensus        51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi  130 (668)
T KOG0611|consen   51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI  130 (668)
T ss_pred             hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence            34689999999999999999999988999999999887633  3556678899999999999999999999999999999


Q ss_pred             EEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCC
Q 019536          131 VFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE  208 (339)
Q Consensus       131 v~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~  208 (339)
                      ||||..+|.|.|++.  +.+++.+...+++||+.|+.|+|   .++++|||||.+|||+|.++++||+|||++..+....
T Consensus       131 vMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k  207 (668)
T KOG0611|consen  131 VMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK  207 (668)
T ss_pred             EEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhhcccc
Confidence            999999999999997  78999999999999999999999   9999999999999999999999999999998887665


Q ss_pred             ceeeecccccccccccccccccCCCC-cccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCccccccc
Q 019536          209 THVREEFIKGAYGFIAPEYFATSSFN-EMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVD  287 (339)
Q Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (339)
                      ...   +++|++-|.+||.++|.+|. +.+|.||||+++|.|+.|..||+...  .       ..+-+.+..+.+   .+
T Consensus       208 fLq---TFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D--h-------k~lvrQIs~GaY---rE  272 (668)
T KOG0611|consen  208 FLQ---TFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD--H-------KRLVRQISRGAY---RE  272 (668)
T ss_pred             HHH---HhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch--H-------HHHHHHhhcccc---cC
Confidence            443   57899999999999999986 78999999999999999999976321  1       111222222222   11


Q ss_pred             CcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 019536          288 PIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQL  331 (339)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L  331 (339)
                      +            ..+..+.-||+.||..+|++|.|..+|..+-
T Consensus       273 P------------~~PSdA~gLIRwmLmVNP~RRATieDiAsHW  304 (668)
T KOG0611|consen  273 P------------ETPSDASGLIRWMLMVNPERRATIEDIASHW  304 (668)
T ss_pred             C------------CCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence            1            2223477899999999999999999998754

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-45  Score=334.61  Aligned_cols=253  Identities=20%  Similarity=0.253  Sum_probs=204.6

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC--hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST--LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVF  132 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  132 (339)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.....  ......+.+|+.++..++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            478999999999999999999998999999999876421  234566789999999999999999999999999999999


Q ss_pred             EeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCce
Q 019536          133 ESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH  210 (339)
Q Consensus       133 e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~  210 (339)
                      ||+++|+|.+++.  ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++.....   
T Consensus        81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~---  154 (333)
T cd05600          81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTY---  154 (333)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCcccccc---
Confidence            9999999999986  56788888999999999999999   899999999999999999999999999998765441   


Q ss_pred             eeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcc
Q 019536          211 VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIF  290 (339)
Q Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (339)
                        .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.....     ............  .   +..+..
T Consensus       155 --~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-----~~~~~~i~~~~~--~---~~~~~~  222 (333)
T cd05600         155 --ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP-----NETWENLKYWKE--T---LQRPVY  222 (333)
T ss_pred             --cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH-----HHHHHHHHhccc--c---ccCCCC
Confidence              1135689999999999988999999999999999999999999853211     111111110000  0   000000


Q ss_pred             cCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          291 DEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      .    .+ ....+.++.+|+.+||+.+|.+|||+.+++++
T Consensus       223 ~----~~-~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         223 D----DP-RFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             C----cc-ccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            0    00 01345678999999999999999999999875

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.8e-45  Score=330.84  Aligned_cols=249  Identities=20%  Similarity=0.269  Sum_probs=213.1

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC-hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCc-cEEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST-LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETEL-PTLVF  132 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~-~~lv~  132 (339)
                      ++|..++.||.|+||.++..+.+.++..|++|++..... ........+|+.++++++|||||.+.+.|.+++. .+|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            679999999999999999999999999999999877632 3444577899999999999999999999999888 99999


Q ss_pred             EeccCCccccccc----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCC
Q 019536          133 ESVKYGTLRGFSF----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE  208 (339)
Q Consensus       133 e~~~~g~L~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~  208 (339)
                      +||+||++.+.+.    ..+++..+..++.|++.|+.|||   +++|+|||||+.||+++.++.+||.|||+|+.+....
T Consensus        84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~  160 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED  160 (426)
T ss_pred             eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence            9999999999986    35788889999999999999999   9999999999999999999999999999999987665


Q ss_pred             ceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccC
Q 019536          209 THVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDP  288 (339)
Q Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (339)
                      ..  .....||+.|++||.+.+.+|+.++|||||||++|||++-+++|.....     ..++.   +...          
T Consensus       161 ~~--a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m-----~~Li~---ki~~----------  220 (426)
T KOG0589|consen  161 SL--ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM-----SELIL---KINR----------  220 (426)
T ss_pred             hh--hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch-----HHHHH---HHhh----------
Confidence            22  2247899999999999999999999999999999999999999752211     11111   1111          


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          289 IFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                         . .-.|.+...+.+++.|+..||+.+|+.||++.++|.+
T Consensus       221 ---~-~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  221 ---G-LYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             ---c-cCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence               1 1124455788899999999999999999999999985

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-45  Score=345.43  Aligned_cols=256  Identities=22%  Similarity=0.272  Sum_probs=212.9

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcC-CCceeeeeeeee-e---C---
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMK-HKNILKLIGCCL-E---T---  125 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~~~~~~~-~---~---  125 (339)
                      ..++++.+.|.+|||+.||.|.+...|..||+|++-.. .......+.+|+.+|+.|. |+|||.+++... .   .   
T Consensus        36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~  114 (738)
T KOG1989|consen   36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV  114 (738)
T ss_pred             CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence            35788899999999999999999977799999998776 4477888999999999996 999999999432 1   1   


Q ss_pred             CccEEEEEeccCCccccccc----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCc
Q 019536          126 ELPTLVFESVKYGTLRGFSF----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLS  201 (339)
Q Consensus       126 ~~~~lv~e~~~~g~L~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a  201 (339)
                      ...+|.||||++|.|-|++.    ..|.+.++++|+.|+++|+.+||.- ..+|||||||-||||++.+|..||||||.|
T Consensus       115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSa  193 (738)
T KOG1989|consen  115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSA  193 (738)
T ss_pred             eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccc
Confidence            24679999999999999986    5699999999999999999999933 456999999999999999999999999998


Q ss_pred             cccCCCC-ceee------eccccccccccccccc---ccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHH
Q 019536          202 VSIPEGE-THVR------EEFIKGAYGFIAPEYF---ATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLE  271 (339)
Q Consensus       202 ~~~~~~~-~~~~------~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~  271 (339)
                      +.-.... ....      .-....|+.|+|||++   .+.+.+.|+|||||||+||-|+....||+..|..         
T Consensus       194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l---------  264 (738)
T KOG1989|consen  194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL---------  264 (738)
T ss_pred             ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce---------
Confidence            6532221 1100      0013468899999986   4668899999999999999999999999744331         


Q ss_pred             HHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 019536          272 YAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYL  336 (339)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~  336 (339)
                                      .++.....+|..+.++..+++||..||+.||.+||++.+++..+.+|..
T Consensus       265 ----------------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~  313 (738)
T KOG1989|consen  265 ----------------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN  313 (738)
T ss_pred             ----------------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence                            2445566677767899999999999999999999999999999988864

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-45  Score=330.41  Aligned_cols=239  Identities=20%  Similarity=0.242  Sum_probs=194.5

Q ss_pred             eeccCCeeEEEEEEcCCCeeEEEEEeccCC--ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeccCCcc
Q 019536           63 IQSDTSYRLFEGTLVDQDRPISVMKFHDNS--TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL  140 (339)
Q Consensus        63 ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L  140 (339)
                      ||+|+||.||+|.+..+++.||+|.+....  .......+.+|+.+++.++||||+++++++.+++..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999999899999999987532  224456678999999999999999999999999999999999999999


Q ss_pred             ccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceeeeccccc
Q 019536          141 RGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG  218 (339)
Q Consensus       141 ~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~g  218 (339)
                      .+++.  ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++........  .....|
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g  155 (312)
T cd05585          81 FHHLQREGRFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK--TNTFCG  155 (312)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCc--cccccC
Confidence            98875  56888899999999999999999   999999999999999999999999999998764332221  223568


Q ss_pred             ccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCCCCCCC
Q 019536          219 AYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPG  298 (339)
Q Consensus       219 t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (339)
                      |+.|+|||++.+..++.++||||+||++|+|++|+.||....        ..+.......             ....+| 
T Consensus       156 t~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~--------~~~~~~~~~~-------------~~~~~~-  213 (312)
T cd05585         156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN--------VNEMYRKILQ-------------EPLRFP-  213 (312)
T ss_pred             CcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC--------HHHHHHHHHc-------------CCCCCC-
Confidence            999999999999999999999999999999999999985211        1111111111             111111 


Q ss_pred             cHHHHHHHHHHHHHhhccCCCCCCC---HHHHHH
Q 019536          299 KEEKLQSLGQLMYKCLSKSPEHRPL---MVDVAK  329 (339)
Q Consensus       299 ~~~~~~~~~~li~~cl~~dP~~Rps---~~~il~  329 (339)
                       ...+..+.+++.+||+.||++||+   +.+++.
T Consensus       214 -~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~  246 (312)
T cd05585         214 -DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN  246 (312)
T ss_pred             -CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence             234567899999999999999985   555554

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.1e-44  Score=319.06  Aligned_cols=248  Identities=30%  Similarity=0.470  Sum_probs=195.2

Q ss_pred             cCCceeccCCeeEEEEEEc----CCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 019536           59 LHKVIQSDTSYRLFEGTLV----DQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFES  134 (339)
Q Consensus        59 ~~~~ig~G~~g~V~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  134 (339)
                      +.+.||.|.||.||+|.+.    ..+..|+||.++........+.+.+|++.+++++||||++++|+|...+..++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            4578999999999999997    456789999997765556688899999999999999999999999988889999999


Q ss_pred             ccCCcccccccc----CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCce
Q 019536          135 VKYGTLRGFSFA----SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH  210 (339)
Q Consensus       135 ~~~g~L~~~~~~----~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~  210 (339)
                      +++|+|.+++..    .+++..+..++.|++.||.|||   +.+++|+||+++||++++++.+||+|||++.........
T Consensus        83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred             cccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccccc
Confidence            999999999873    5888999999999999999999   899999999999999999999999999998876333333


Q ss_pred             eeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCc
Q 019536          211 VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPI  289 (339)
Q Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (339)
                      ...........|+|||.+.+..++.++||||||+++||+++ |+.||...        ...+..........        
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~--------~~~~~~~~~~~~~~--------  223 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY--------DNEEIIEKLKQGQR--------  223 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS--------CHHHHHHHHHTTEE--------
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccc--------cccccccccccccc--------
Confidence            22223456778999999998899999999999999999999 67886422        11222222211111        


Q ss_pred             ccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 019536          290 FDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQL  331 (339)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L  331 (339)
                            .+.+..++..+.+++.+||+.||++|||+.+|++.|
T Consensus       224 ------~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  224 ------LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             ------TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ------ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence                  111223456789999999999999999999999986

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=5e-45  Score=333.40  Aligned_cols=246  Identities=22%  Similarity=0.308  Sum_probs=201.4

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCC-eeEEEEEeccCC--ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQD-RPISVMKFHDNS--TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTL  130 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~-~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  130 (339)
                      .++|++.+.||+|+||.||+|.+..++ ..||+|++....  .....+.+.+|+.+++.++||||+++++++.+++..++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            467999999999999999999876554 689999986532  22345668899999999999999999999999999999


Q ss_pred             EEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCC
Q 019536          131 VFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE  208 (339)
Q Consensus       131 v~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~  208 (339)
                      ||||+++|+|.+++.  ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus       109 v~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~~  185 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRT  185 (340)
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCCc
Confidence            999999999999886  46888888999999999999999   9999999999999999999999999999998764322


Q ss_pred             ceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccC
Q 019536          209 THVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDP  288 (339)
Q Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (339)
                      .     ...||+.|+|||++.+..++.++|+||+||++|+|++|+.||.....        ...... ....        
T Consensus       186 ~-----~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~--------~~~~~~-i~~~--------  243 (340)
T PTZ00426        186 Y-----TLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP--------LLIYQK-ILEG--------  243 (340)
T ss_pred             c-----eecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH--------HHHHHH-HhcC--------
Confidence            1     35689999999999988899999999999999999999999852211        111111 1111        


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 019536          289 IFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP-----LMVDVAKQ  330 (339)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~il~~  330 (339)
                          ...+|  ...+..+.+++.+||+.||++|+     |+.+++++
T Consensus       244 ----~~~~p--~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        244 ----IIYFP--KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             ----CCCCC--CCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence                01111  13445789999999999999995     88888764

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=2.3e-44  Score=327.89  Aligned_cols=250  Identities=20%  Similarity=0.272  Sum_probs=198.8

Q ss_pred             CceeccCCeeEEEEEEcCCCeeEEEEEeccCC--ChhhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCccEEEEEeccC
Q 019536           61 KVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS--TLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLETELPTLVFESVKY  137 (339)
Q Consensus        61 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~  137 (339)
                      +.||+|+||.||+|....+++.||+|++....  .......+.+|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999999999999999997642  223455677899999888 799999999999999999999999999


Q ss_pred             Cccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceeeecc
Q 019536          138 GTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEF  215 (339)
Q Consensus       138 g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~~~  215 (339)
                      |+|.+++.  ..+++..+..++.|++.||.|||   +++|+||||||+||+++.++.+||+|||+++.......  ....
T Consensus        81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~--~~~~  155 (329)
T cd05588          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--TTST  155 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccCCC--cccc
Confidence            99988875  57899999999999999999999   99999999999999999999999999999875322221  1123


Q ss_pred             cccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCCCC
Q 019536          216 IKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNS  295 (339)
Q Consensus       216 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (339)
                      ..||..|+|||++.+..++.++|+||+||++|+|++|+.||...+....................            ...
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~------------~~~  223 (329)
T cd05588         156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK------------QIR  223 (329)
T ss_pred             ccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC------------CCC
Confidence            56899999999999999999999999999999999999999754433211111112222211111            111


Q ss_pred             CCCcHHHHHHHHHHHHHhhccCCCCCCC------HHHHHH
Q 019536          296 FPGKEEKLQSLGQLMYKCLSKSPEHRPL------MVDVAK  329 (339)
Q Consensus       296 ~~~~~~~~~~~~~li~~cl~~dP~~Rps------~~~il~  329 (339)
                      .|  ...+..+.+++.+||+.||.+|||      +.++++
T Consensus       224 ~p--~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         224 IP--RSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             CC--CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence            12  234557899999999999999998      566654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.2e-44  Score=329.62  Aligned_cols=242  Identities=19%  Similarity=0.217  Sum_probs=197.9

Q ss_pred             CceeccCCeeEEEEEEcCCCeeEEEEEeccCC--ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeccCC
Q 019536           61 KVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS--TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYG  138 (339)
Q Consensus        61 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g  138 (339)
                      +.||+|+||.||++....+++.||+|++....  .......+.+|+.+++.++||||+++++++.+++..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46899999999999999999999999997642  2244567789999999999999999999999999999999999999


Q ss_pred             ccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceeeeccc
Q 019536          139 TLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI  216 (339)
Q Consensus       139 ~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~~~~  216 (339)
                      +|.+++.  ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++........  ....
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~--~~~~  155 (328)
T cd05593          81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAAT--MKTF  155 (328)
T ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccc--cccc
Confidence            9988875  46888899999999999999999   999999999999999999999999999998754332221  1235


Q ss_pred             ccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCCCCC
Q 019536          217 KGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSF  296 (339)
Q Consensus       217 ~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (339)
                      .||+.|+|||++.+..++.++||||+||++|+|++|+.||.....        ...... ..            .....+
T Consensus       156 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~--------~~~~~~-~~------------~~~~~~  214 (328)
T cd05593         156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------EKLFEL-IL------------MEDIKF  214 (328)
T ss_pred             cCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH--------HHHHHH-hc------------cCCccC
Confidence            689999999999988999999999999999999999999852211        111111 00            011111


Q ss_pred             CCcHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 019536          297 PGKEEKLQSLGQLMYKCLSKSPEHRP-----LMVDVAKQ  330 (339)
Q Consensus       297 ~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~il~~  330 (339)
                      |  ...+..+.+++.+||+.||++||     ++.+++++
T Consensus       215 p--~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         215 P--RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             C--CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            1  23456789999999999999997     88998864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.6e-44  Score=325.35  Aligned_cols=266  Identities=17%  Similarity=0.217  Sum_probs=199.7

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFE  133 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  133 (339)
                      .++|++.+.||+|+||+||+|....+++.||+|++...........+.+|+.+++.++||||+++++++.++...++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            37899999999999999999999989999999998765443444567789999999999999999999999999999999


Q ss_pred             eccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCce
Q 019536          134 SVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH  210 (339)
Q Consensus       134 ~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~  210 (339)
                      |++ ++|.+++.   ..++...+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++........
T Consensus        84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  159 (303)
T cd07869          84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHT  159 (303)
T ss_pred             CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCcc
Confidence            996 56666654   45788888999999999999999   999999999999999999999999999998755332221


Q ss_pred             eeecccccccccccccccccC-CCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhc---Ccccccc
Q 019536          211 VREEFIKGAYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIEN---NRFGAIV  286 (339)
Q Consensus       211 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~  286 (339)
                        .....+|+.|+|||++.+. .++.++||||+||++|+|++|+.||....+    ..............   ..+....
T Consensus       160 --~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~  233 (303)
T cd07869         160 --YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD----IQDQLERIFLVLGTPNEDTWPGVH  233 (303)
T ss_pred             --CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc----HHHHHHHHHHHhCCCChhhccchh
Confidence              1134578999999998654 588999999999999999999999863221    11111111111100   0000000


Q ss_pred             c-Ccc-cCCCCC--CCc-------HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          287 D-PIF-DEDNSF--PGK-------EEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       287 ~-~~~-~~~~~~--~~~-------~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                      . +.. ......  +..       ...+..+.+|+.+||+.||++|||+.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence            0 000 000000  000       012356889999999999999999999986

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=3.6e-44  Score=316.80  Aligned_cols=256  Identities=23%  Similarity=0.325  Sum_probs=207.6

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCC---CeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQ---DRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLV  131 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  131 (339)
                      ++|++.+.||+|+||+||+|.+...   ...||+|.+...........+.+|+.+++.++||||+++++++.+++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            5789999999999999999998643   4579999987765545567788999999999999999999999999999999


Q ss_pred             EEeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCC
Q 019536          132 FESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE  208 (339)
Q Consensus       132 ~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~  208 (339)
                      |||+++++|.+++.   ..+++..+..++.|++.||.|||   +.+|+|+||||+||+++.++.++|+|||+++.+....
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~  160 (266)
T cd05033          84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE  160 (266)
T ss_pred             EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence            99999999999875   36788999999999999999999   8999999999999999999999999999998875322


Q ss_pred             ceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCccccccc
Q 019536          209 THVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVD  287 (339)
Q Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (339)
                      .........++..|+|||.+.+..++.++|+||||+++|++++ |..||....        ..+.. ......       
T Consensus       161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~--------~~~~~-~~~~~~-------  224 (266)
T cd05033         161 ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS--------NQDVI-KAVEDG-------  224 (266)
T ss_pred             cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC--------HHHHH-HHHHcC-------
Confidence            2222222344678999999998899999999999999999998 988874211        11111 111110       


Q ss_pred             CcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 019536          288 PIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMY  335 (339)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~  335 (339)
                            ...+.+...+..+.+++.+||+.+|++|||+.+|++.|++++
T Consensus       225 ------~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~~  266 (266)
T cd05033         225 ------YRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI  266 (266)
T ss_pred             ------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence                  001111234567899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=3.8e-44  Score=318.59  Aligned_cols=256  Identities=18%  Similarity=0.316  Sum_probs=202.4

Q ss_pred             HhcCcccCCceeccCCeeEEEEEEcC-----CCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCc
Q 019536           53 ATNNYDLHKVIQSDTSYRLFEGTLVD-----QDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETEL  127 (339)
Q Consensus        53 ~~~~~~~~~~ig~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~  127 (339)
                      ..++|++.+.||+|+||.||+|.+.+     ++..||+|++...........+.+|+.+++.++||||+++++++.++..
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            46789999999999999999998642     3567999998765443455668899999999999999999999999999


Q ss_pred             cEEEEEeccCCcccccccc------------CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEE
Q 019536          128 PTLVFESVKYGTLRGFSFA------------SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKL  195 (339)
Q Consensus       128 ~~lv~e~~~~g~L~~~~~~------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl  195 (339)
                      .++||||+++|+|.+++..            .+++..+..++.|++.||.|||   +.+++|+||||+||++++++.++|
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEEE
Confidence            9999999999999988752            2456677889999999999999   899999999999999999999999


Q ss_pred             ecCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHH
Q 019536          196 HDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAK  274 (339)
Q Consensus       196 ~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~  274 (339)
                      +|||+++...............++..|+|||++.+..++.++|+|||||++|+|++ |..||.....        .... 
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~--------~~~~-  231 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN--------EQVL-  231 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHH-
Confidence            99999876644333222112345678999999998889999999999999999999 6778642211        1111 


Q ss_pred             HHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 019536          275 KSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQ  333 (339)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~  333 (339)
                      .........             +.+...+..+.+++.+||+.||++|||+.++++.|++
T Consensus       232 ~~~~~~~~~-------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         232 RFVMEGGLL-------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             HHHHcCCcC-------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            111111100             0111344578999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=3.5e-44  Score=326.67  Aligned_cols=245  Identities=21%  Similarity=0.285  Sum_probs=195.5

Q ss_pred             CceeccCCeeEEEEEEcCCCeeEEEEEeccCC--ChhhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCccEEEEEeccC
Q 019536           61 KVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS--TLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLETELPTLVFESVKY  137 (339)
Q Consensus        61 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~  137 (339)
                      +.||+|+||.||+|....+++.||+|++....  .......+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999999999999999998642  223456677898888776 899999999999999999999999999


Q ss_pred             Cccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceeeecc
Q 019536          138 GTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEF  215 (339)
Q Consensus       138 g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~~~  215 (339)
                      |+|..++.  ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++........  ...
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~--~~~  155 (329)
T cd05618          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TST  155 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCc--ccc
Confidence            99988765  57888999999999999999999   899999999999999999999999999998754322211  123


Q ss_pred             cccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCCCC
Q 019536          216 IKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNS  295 (339)
Q Consensus       216 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (339)
                      ..||..|+|||++.+..++.++|+|||||++|+|++|+.||...+...........+........            ...
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~------------~~~  223 (329)
T cd05618         156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK------------QIR  223 (329)
T ss_pred             ccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC------------CCC
Confidence            56899999999999999999999999999999999999998644333222222222222211111            111


Q ss_pred             CCCcHHHHHHHHHHHHHhhccCCCCCCCH
Q 019536          296 FPGKEEKLQSLGQLMYKCLSKSPEHRPLM  324 (339)
Q Consensus       296 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~  324 (339)
                      .|  ...+..+.+++.+||+.||++|||+
T Consensus       224 ~p--~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         224 IP--RSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             CC--CCCCHHHHHHHHHHhcCCHHHcCCC
Confidence            12  1345578899999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=4.6e-44  Score=329.08  Aligned_cols=250  Identities=18%  Similarity=0.211  Sum_probs=198.1

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFES  134 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  134 (339)
                      ++|+..+.||+|+||+||+|.+..+++.||||++...........+.+|+.+++.++|+||+++++++.+++..++||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            56777899999999999999999899999999997655445567788999999999999999999999999999999999


Q ss_pred             ccCCccccccccCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceeeec
Q 019536          135 VKYGTLRGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREE  214 (339)
Q Consensus       135 ~~~g~L~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~~  214 (339)
                      +++|+|.+..  .........++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+......  ..
T Consensus       154 ~~~~~L~~~~--~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~--~~  226 (353)
T PLN00034        154 MDGGSLEGTH--IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP--CN  226 (353)
T ss_pred             CCCCcccccc--cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceeccccccc--cc
Confidence            9999987653  3456667789999999999999   899999999999999999999999999998876433221  11


Q ss_pred             ccccccccccccccccC-----CCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCc
Q 019536          215 FIKGAYGFIAPEYFATS-----SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPI  289 (339)
Q Consensus       215 ~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (339)
                      ...||..|+|||++...     ..+.++|||||||++|+|++|+.||......  +......   ......         
T Consensus       227 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~--~~~~~~~---~~~~~~---------  292 (353)
T PLN00034        227 SSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG--DWASLMC---AICMSQ---------  292 (353)
T ss_pred             ccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc--cHHHHHH---HHhccC---------
Confidence            34689999999987532     2456899999999999999999998622211  1111110   000000         


Q ss_pred             ccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          290 FDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                           ....+...+.++.+|+.+||+.||++|||+.|++++
T Consensus       293 -----~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        293 -----PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             -----CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                 001112445679999999999999999999999874

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.1e-43  Score=317.55  Aligned_cols=258  Identities=22%  Similarity=0.315  Sum_probs=207.1

Q ss_pred             hcCcccCCceeccCCeeEEEEEEc-----CCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCcc
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLV-----DQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELP  128 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~  128 (339)
                      .++|.+.+.||+|+||.||++...     .++..+|+|.+..... .....+.+|+.+++.++||||+++++++..++..
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASD-NARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL   82 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCH-HHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence            367899999999999999999852     3456799998876543 4566788999999999999999999999999999


Q ss_pred             EEEEEeccCCccccccc---------------cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCce
Q 019536          129 TLVFESVKYGTLRGFSF---------------ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSA  193 (339)
Q Consensus       129 ~lv~e~~~~g~L~~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~  193 (339)
                      ++||||+++++|.+++.               ..+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~  159 (288)
T cd05093          83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLV  159 (288)
T ss_pred             EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcE
Confidence            99999999999988874               13788899999999999999999   8999999999999999999999


Q ss_pred             EEecCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHH
Q 019536          194 KLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEY  272 (339)
Q Consensus       194 kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~  272 (339)
                      +|+|||+++...............++..|+|||++.+..++.++|+|||||++|+|++ |..||.....        ...
T Consensus       160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~--------~~~  231 (288)
T cd05093         160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--------NEV  231 (288)
T ss_pred             EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------HHH
Confidence            9999999876644332222222345678999999998899999999999999999998 8888742211        111


Q ss_pred             HHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          273 AKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                      ... ...+...             +.+...+.++.+|+.+||+.||.+|||+.++++.|+++..+
T Consensus       232 ~~~-i~~~~~~-------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         232 IEC-ITQGRVL-------------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             HHH-HHcCCcC-------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence            111 1111110             00112345799999999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=5.8e-45  Score=303.78  Aligned_cols=254  Identities=21%  Similarity=0.312  Sum_probs=211.8

Q ss_pred             HHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCCh-------hhHHHHHHHHHHHHhc-CCCceeeeeeeee
Q 019536           52 KATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTL-------DDVEYCFNNIVFSSQM-KHKNILKLIGCCL  123 (339)
Q Consensus        52 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~e~~~l~~l-~H~niv~~~~~~~  123 (339)
                      ...+.|...+.+|.|..++|.++....++..+|+|++....+.       .-.+.-.+|+.||+++ .||||+.+.++++
T Consensus        14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye   93 (411)
T KOG0599|consen   14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE   93 (411)
T ss_pred             hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence            3456788889999999999999999999999999998764321       2234556899999999 6999999999999


Q ss_pred             eCCccEEEEEeccCCcccccccc--CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCc
Q 019536          124 ETELPTLVFESVKYGTLRGFSFA--SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLS  201 (339)
Q Consensus       124 ~~~~~~lv~e~~~~g~L~~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a  201 (339)
                      .+.+.++|+|.|+.|.|.|++..  .+++.....|++|+..|++|||   ..+|+||||||+|||++++..+||+|||.|
T Consensus        94 s~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isDFGFa  170 (411)
T KOG0599|consen   94 SDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISDFGFA  170 (411)
T ss_pred             CcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEecccee
Confidence            99999999999999999999984  5677778899999999999999   999999999999999999999999999999


Q ss_pred             cccCCCCceeeecccccccccccccccc------cCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHH
Q 019536          202 VSIPEGETHVREEFIKGAYGFIAPEYFA------TSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKK  275 (339)
Q Consensus       202 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  275 (339)
                      +.+..+....   -.+||++|+|||.+.      ...|+..+|+||.|++||.|+.|.+||..         ..+.....
T Consensus       171 ~~l~~GekLr---elCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH---------RkQmlMLR  238 (411)
T KOG0599|consen  171 CQLEPGEKLR---ELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH---------RKQMLMLR  238 (411)
T ss_pred             eccCCchhHH---HhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH---------HHHHHHHH
Confidence            9998876543   468999999999875      34689999999999999999999999851         11112222


Q ss_pred             HhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          276 SIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      .+..+.+          +..-|.....+..+++||.+||+.||.+|.|+.|+|.+
T Consensus       239 ~ImeGky----------qF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH  283 (411)
T KOG0599|consen  239 MIMEGKY----------QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH  283 (411)
T ss_pred             HHHhccc----------ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence            3333322          12234445778889999999999999999999999873

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=4.7e-44  Score=318.48  Aligned_cols=257  Identities=18%  Similarity=0.270  Sum_probs=203.4

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCe----eEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDR----PISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTL  130 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  130 (339)
                      ++|++.+.||.|+||+||+|.+..++.    .+++|.+...........+..|+.+++.+.||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            568888999999999999999976665    4778887654443445677788889999999999999999864 45789


Q ss_pred             EEEeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCC
Q 019536          131 VFESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEG  207 (339)
Q Consensus       131 v~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~  207 (339)
                      ++||+++|+|.+++.   ..+++.....++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++.+...
T Consensus        86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~  162 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD  162 (279)
T ss_pred             EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence            999999999999985   46788899999999999999999   899999999999999999999999999999876544


Q ss_pred             CceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCcccccc
Q 019536          208 ETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIV  286 (339)
Q Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (339)
                      ..........++..|+|||++.+..++.++||||||+++||+++ |+.||.....     ....    .....+.     
T Consensus       163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-----~~~~----~~~~~~~-----  228 (279)
T cd05111         163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP-----HEVP----DLLEKGE-----  228 (279)
T ss_pred             CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH-----HHHH----HHHHCCC-----
Confidence            33222223456778999999998899999999999999999998 9988742211     1111    1111111     


Q ss_pred             cCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          287 DPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                              ..+.+..++..+.+++.+||..||++|||+.++++.|..+.+.
T Consensus       229 --------~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~  271 (279)
T cd05111         229 --------RLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD  271 (279)
T ss_pred             --------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence                    0011112344688899999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.3e-44  Score=328.76  Aligned_cols=242  Identities=20%  Similarity=0.230  Sum_probs=196.7

Q ss_pred             CceeccCCeeEEEEEEcCCCeeEEEEEeccCC--ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeccCC
Q 019536           61 KVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS--TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYG  138 (339)
Q Consensus        61 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g  138 (339)
                      +.||+|+||.||++....+|..||+|++....  .......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46999999999999999899999999987642  2234556778999999999999999999999999999999999999


Q ss_pred             ccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceeeeccc
Q 019536          139 TLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI  216 (339)
Q Consensus       139 ~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~~~~  216 (339)
                      +|..++.  ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++........  ....
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~--~~~~  155 (323)
T cd05595          81 ELFFHLSRERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTF  155 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCc--cccc
Confidence            9988775  46888899999999999999999   899999999999999999999999999998754332221  1235


Q ss_pred             ccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCCCCC
Q 019536          217 KGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSF  296 (339)
Q Consensus       217 ~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (339)
                      .||+.|+|||++.+..++.++|||||||++|+|++|+.||.....     .....   . ...            ....+
T Consensus       156 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~-----~~~~~---~-~~~------------~~~~~  214 (323)
T cd05595         156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----ERLFE---L-ILM------------EEIRF  214 (323)
T ss_pred             cCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH-----HHHHH---H-Hhc------------CCCCC
Confidence            689999999999988999999999999999999999999752211     01111   0 000            01111


Q ss_pred             CCcHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 019536          297 PGKEEKLQSLGQLMYKCLSKSPEHRP-----LMVDVAKQ  330 (339)
Q Consensus       297 ~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~il~~  330 (339)
                      |  ...+.++.+++.+||+.||++||     ++.+++++
T Consensus       215 p--~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h  251 (323)
T cd05595         215 P--RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  251 (323)
T ss_pred             C--CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence            1  23456789999999999999998     88888763

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-47  Score=310.62  Aligned_cols=253  Identities=21%  Similarity=0.291  Sum_probs=205.8

Q ss_pred             HhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccC-CChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 019536           53 ATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDN-STLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLV  131 (339)
Q Consensus        53 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  131 (339)
                      .++.|++.+.||+|.|+.|+++....+|+.+|+|+++.. -...+.+.+.+|+.|-+.++||||+++.+........|+|
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv   88 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   88 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence            357788999999999999999999999999999987654 2224678888999999999999999999999999999999


Q ss_pred             EEeccCCcccccccc--CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCC---CceEEecCCCccccCC
Q 019536          132 FESVKYGTLRGFSFA--SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDEN---YSAKLHDFSLSVSIPE  206 (339)
Q Consensus       132 ~e~~~~g~L~~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~---~~~kl~dfg~a~~~~~  206 (339)
                      ||++.||+|..-+-.  ..++..+..+++||++||.|+|   .++|+|||+||+|+++.+.   --+||+|||+|..+..
T Consensus        89 Fe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~  165 (355)
T KOG0033|consen   89 FDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND  165 (355)
T ss_pred             EecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEEEeCC
Confidence            999999998766543  3455556679999999999999   9999999999999999643   3489999999988873


Q ss_pred             CCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccc
Q 019536          207 GETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIV  286 (339)
Q Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (339)
                      ....   ....||++|||||++...+|+..+|||+-|+++|-|+.|++||..  ..       ...+...+..+..    
T Consensus       166 g~~~---~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~--~~-------~~rlye~I~~g~y----  229 (355)
T KOG0033|consen  166 GEAW---HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD--ED-------QHRLYEQIKAGAY----  229 (355)
T ss_pred             cccc---ccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC--cc-------HHHHHHHHhcccc----
Confidence            3322   256899999999999999999999999999999999999999852  11       1111222222211    


Q ss_pred             cCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          287 DPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                            +.+.|..+..+++.++|+++||..||.+|+|+.|+|++
T Consensus       230 ------d~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H  267 (355)
T KOG0033|consen  230 ------DYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH  267 (355)
T ss_pred             ------CCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence                  11223334677899999999999999999999999864

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=3.1e-44  Score=320.14  Aligned_cols=254  Identities=22%  Similarity=0.351  Sum_probs=203.7

Q ss_pred             cCcccCCceeccCCeeEEEEEEc----CCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLV----DQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTL  130 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  130 (339)
                      ++|++.+.||+|+||+||+|...    ..+..|++|.+...........+.+|+.+++.++||||+++++++..++..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            56888899999999999999863    35578999999865554556778899999999999999999999999999999


Q ss_pred             EEEeccCCccccccc-------------------cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCC
Q 019536          131 VFESVKYGTLRGFSF-------------------ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENY  191 (339)
Q Consensus       131 v~e~~~~g~L~~~~~-------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~  191 (339)
                      ||||+++|+|.+++.                   ..+++...+.++.|++.||.|||   +++++||||||+||+++.++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCCC
Confidence            999999999988863                   23667778889999999999999   89999999999999999999


Q ss_pred             ceEEecCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHH
Q 019536          192 SAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVL  270 (339)
Q Consensus       192 ~~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~  270 (339)
                      .+||+|||+++...............++..|+|||++.+..++.++|+||||+++|+|++ |..||.....     ....
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~-----~~~~  236 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN-----QEVI  236 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-----HHHH
Confidence            999999999987654432222223345677999999988889999999999999999998 8888742211     1111


Q ss_pred             HHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 019536          271 EYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQ  333 (339)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~  333 (339)
                      +..    ....             ..+.+...+..+.+++.+||+.||++||++.+|++.|..
T Consensus       237 ~~~----~~~~-------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         237 EMV----RKRQ-------------LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HHH----HcCC-------------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            111    1110             011112345578999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=7.3e-44  Score=339.70  Aligned_cols=248  Identities=19%  Similarity=0.212  Sum_probs=201.4

Q ss_pred             CcccCCceeccCCeeEEEEEEcCC-CeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 019536           56 NYDLHKVIQSDTSYRLFEGTLVDQ-DRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFES  134 (339)
Q Consensus        56 ~~~~~~~ig~G~~g~V~~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  134 (339)
                      .|.+.+.||.|++|.||.|....+ +..||+|.+..... .....+.+|+.+++.++||||+++++++..++..+|||||
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~  146 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDE-RQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY  146 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence            499999999999999999998777 78888887654432 4455677899999999999999999999999999999999


Q ss_pred             ccCCccccccc------cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCC
Q 019536          135 VKYGTLRGFSF------ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE  208 (339)
Q Consensus       135 ~~~g~L~~~~~------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~  208 (339)
                      +++|+|.+++.      ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+....
T Consensus       147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~  223 (478)
T PTZ00267        147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV  223 (478)
T ss_pred             CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence            99999988764      24777888889999999999999   8999999999999999999999999999998765443


Q ss_pred             ceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccC
Q 019536          209 THVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDP  288 (339)
Q Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (339)
                      .........||+.|+|||++.+..++.++|||||||++|+|++|+.||....        ..+........ ..    . 
T Consensus       224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~--------~~~~~~~~~~~-~~----~-  289 (478)
T PTZ00267        224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS--------QREIMQQVLYG-KY----D-  289 (478)
T ss_pred             ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhC-CC----C-
Confidence            2222234568999999999999899999999999999999999999975221        11111111111 00    0 


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          289 IFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                              +.+...+..+.+++.+||+.||++|||+.+++.
T Consensus       290 --------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        290 --------PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             --------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence                    111234567999999999999999999999975

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=2.7e-44  Score=319.76  Aligned_cols=255  Identities=22%  Similarity=0.357  Sum_probs=205.1

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcC-----CCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCcc
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVD-----QDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELP  128 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~  128 (339)
                      .++|.+.+.||+|+||.||+|....     ++..||+|.+.........+.+.+|+++++.++||||+++++++..+...
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            3568889999999999999998743     35789999998765544667899999999999999999999999999999


Q ss_pred             EEEEEeccCCccccccc----------------cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCc
Q 019536          129 TLVFESVKYGTLRGFSF----------------ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYS  192 (339)
Q Consensus       129 ~lv~e~~~~g~L~~~~~----------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~  192 (339)
                      ++||||+++++|.+++.                ..+++.....++.|++.||.|||   +.+++||||||+||+++.++.
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~  160 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCe
Confidence            99999999999998875                23677788899999999999999   899999999999999999999


Q ss_pred             eEEecCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHH
Q 019536          193 AKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLE  271 (339)
Q Consensus       193 ~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~  271 (339)
                      +||+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |+.||.....     .....
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~-----~~~~~  235 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN-----EEVIE  235 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHH
Confidence            99999999876543322211223345678999999999999999999999999999998 9999752211     11111


Q ss_pred             HHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 019536          272 YAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQ  333 (339)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~  333 (339)
                          ....+...             +.+...+..+.+++.+||+.||++|||+.|+++.|++
T Consensus       236 ----~~~~~~~~-------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         236 ----CITQGRLL-------------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             ----HHHcCCcC-------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence                11111110             0011345679999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=3.9e-44  Score=313.99  Aligned_cols=247  Identities=24%  Similarity=0.360  Sum_probs=198.1

Q ss_pred             CceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeccCCcc
Q 019536           61 KVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL  140 (339)
Q Consensus        61 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L  140 (339)
                      +.||+|+||.||+|.+..++..||+|.+...........+.+|+.+++.++||||+++++++...+..++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            46899999999999999899999999987655445567789999999999999999999999999999999999999999


Q ss_pred             ccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceeeecccc
Q 019536          141 RGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIK  217 (339)
Q Consensus       141 ~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~  217 (339)
                      .+++.   ..+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||++................
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  157 (252)
T cd05084          81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ  157 (252)
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence            99875   35788889999999999999999   8999999999999999999999999999987654322111111112


Q ss_pred             cccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCCCCC
Q 019536          218 GAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSF  296 (339)
Q Consensus       218 gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (339)
                      .+..|+|||.+.+..++.++|+||||+++|++++ |..||.....        .. ........             ...
T Consensus       158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~--------~~-~~~~~~~~-------------~~~  215 (252)
T cd05084         158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN--------QQ-TREAIEQG-------------VRL  215 (252)
T ss_pred             CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH--------HH-HHHHHHcC-------------CCC
Confidence            3456999999988889999999999999999997 8888742111        00 11111110             001


Q ss_pred             CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 019536          297 PGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLR  332 (339)
Q Consensus       297 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~  332 (339)
                      +.+...+..+.+|+.+||+.+|++|||+.++++.|.
T Consensus       216 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         216 PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            111234567899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=4.7e-44  Score=315.64  Aligned_cols=253  Identities=21%  Similarity=0.347  Sum_probs=205.6

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFES  134 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  134 (339)
                      .+|++.+.||.|++|.||+|.+..++..||+|.+....  .....+.+|+.+++.++||||+++++++..++..++||||
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   83 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc--hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence            46888899999999999999999889999999987543  3456788999999999999999999999999999999999


Q ss_pred             ccCCccccccc----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCce
Q 019536          135 VKYGTLRGFSF----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH  210 (339)
Q Consensus       135 ~~~g~L~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~  210 (339)
                      +++++|.+++.    ..+++..++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++.........
T Consensus        84 ~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~  160 (263)
T cd05052          84 MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT  160 (263)
T ss_pred             CCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence            99999999875    35788888999999999999999   899999999999999999999999999998776543221


Q ss_pred             eeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCc
Q 019536          211 VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPI  289 (339)
Q Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (339)
                      . .....++..|+|||.+.+..++.++|||||||++|+|++ |..||+..  .      ..+.... .....        
T Consensus       161 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~--~------~~~~~~~-~~~~~--------  222 (263)
T cd05052         161 A-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--D------LSQVYEL-LEKGY--------  222 (263)
T ss_pred             c-cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC--C------HHHHHHH-HHCCC--------
Confidence            1 111223567999999998899999999999999999998 88887421  1      1111111 11100        


Q ss_pred             ccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 019536          290 FDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMY  335 (339)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~  335 (339)
                           ..+.+...+.++.+++.+||+.||++|||+.++++.|+.++
T Consensus       223 -----~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  263 (263)
T cd05052         223 -----RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETMF  263 (263)
T ss_pred             -----CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhhC
Confidence                 00111234567999999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=6.3e-44  Score=317.50  Aligned_cols=257  Identities=20%  Similarity=0.316  Sum_probs=206.0

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCe----eEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDR----PISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPT  129 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~  129 (339)
                      .++|++.+.||+|+||+||+|.+..++.    .||+|.+...........+.+|+.+++.++||||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence            3678899999999999999999876665    48999987665545567788999999999999999999999754 468


Q ss_pred             EEEEeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCC
Q 019536          130 LVFESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPE  206 (339)
Q Consensus       130 lv~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~  206 (339)
                      +++||+++|+|.+++.   ..+++..++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++.+..
T Consensus        85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~  161 (279)
T cd05109          85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI  161 (279)
T ss_pred             EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence            9999999999999875   35788999999999999999999   89999999999999999999999999999987754


Q ss_pred             CCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCccccc
Q 019536          207 GETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAI  285 (339)
Q Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (339)
                      ...........++..|+|||.+.+..++.++|||||||++|||++ |..||.....     ...    ........    
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----~~~----~~~~~~~~----  228 (279)
T cd05109         162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA-----REI----PDLLEKGE----  228 (279)
T ss_pred             ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----HHH----HHHHHCCC----
Confidence            333222212334677999999988889999999999999999998 8888742111     001    11111110    


Q ss_pred             ccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 019536          286 VDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYL  336 (339)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~  336 (339)
                               ..+.+...+.++.+++.+||+.||++|||+.++++.|+++..
T Consensus       229 ---------~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05109         229 ---------RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR  270 (279)
T ss_pred             ---------cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence                     111122445678999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=3.2e-44  Score=321.57  Aligned_cols=261  Identities=23%  Similarity=0.343  Sum_probs=208.1

Q ss_pred             HHHHhcCcccCCceeccCCeeEEEEEEcCC-----CeeEEEEEeccCCChhhHHHHHHHHHHHHhc-CCCceeeeeeeee
Q 019536           50 LKKATNNYDLHKVIQSDTSYRLFEGTLVDQ-----DRPISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCCL  123 (339)
Q Consensus        50 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~  123 (339)
                      +....++|++.+.||+|+||.||+|.....     ...+|+|.+...........+.+|+.++..+ +||||+++++++.
T Consensus         7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   86 (293)
T cd05053           7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT   86 (293)
T ss_pred             cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence            344457799999999999999999998643     3789999988765445567788999999999 8999999999999


Q ss_pred             eCCccEEEEEeccCCccccccc------------------cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCE
Q 019536          124 ETELPTLVFESVKYGTLRGFSF------------------ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNV  185 (339)
Q Consensus       124 ~~~~~~lv~e~~~~g~L~~~~~------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Ni  185 (339)
                      .++..+++|||+++|+|.+++.                  ..+++..++.++.|++.||.|||   +.+|+||||||+||
T Consensus        87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Ni  163 (293)
T cd05053          87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNV  163 (293)
T ss_pred             CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeE
Confidence            9999999999999999988863                  34677888999999999999999   89999999999999


Q ss_pred             EeCCCCceEEecCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCC
Q 019536          186 LLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGND  264 (339)
Q Consensus       186 l~~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~  264 (339)
                      +++.++.+||+|||+++.+.............++..|+|||++.+..++.++|||||||++|++++ |..||....    
T Consensus       164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~----  239 (293)
T cd05053         164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP----  239 (293)
T ss_pred             EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC----
Confidence            999999999999999987654332222222234567999999988899999999999999999997 888864211    


Q ss_pred             CchhHHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 019536          265 DDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMY  335 (339)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~  335 (339)
                          ..+. ........             ..+.+...+..+.+|+.+||+.||++|||+.++++.|+++.
T Consensus       240 ----~~~~-~~~~~~~~-------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         240 ----VEEL-FKLLKEGY-------------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             ----HHHH-HHHHHcCC-------------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence                1111 11111110             00111234557899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=7.7e-44  Score=318.75  Aligned_cols=257  Identities=25%  Similarity=0.397  Sum_probs=205.2

Q ss_pred             CcccCCceeccCCeeEEEEEEcC-----CCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 019536           56 NYDLHKVIQSDTSYRLFEGTLVD-----QDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTL  130 (339)
Q Consensus        56 ~~~~~~~ig~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  130 (339)
                      +|++.+.||+|+||.||+|....     ....+++|.+...........+.+|+.+++.++||||++++++|..++..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            47888999999999999998742     2357899988766554556778899999999999999999999999999999


Q ss_pred             EEEeccCCccccccc--------------------------cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCC
Q 019536          131 VFESVKYGTLRGFSF--------------------------ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASN  184 (339)
Q Consensus       131 v~e~~~~g~L~~~~~--------------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~N  184 (339)
                      |+||+++|+|.+++.                          ..+++...+.++.|++.||.|||   +.+++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhhe
Confidence            999999999988754                          23667788899999999999999   8999999999999


Q ss_pred             EEeCCCCceEEecCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCC
Q 019536          185 VLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGN  263 (339)
Q Consensus       185 il~~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~  263 (339)
                      |+++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||....   
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~---  234 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA---  234 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC---
Confidence            9999999999999999876544332222223345678999999988889999999999999999998 988874211   


Q ss_pred             CCchhHHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          264 DDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                        .....+.    ....             ...+.+...+.++.+++.+||+.+|++|||+.++++.|+++..+
T Consensus       235 --~~~~~~~----~~~~-------------~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~  289 (290)
T cd05045         235 --PERLFNL----LKTG-------------YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK  289 (290)
T ss_pred             --HHHHHHH----HhCC-------------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence              1111111    1110             00111123456799999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.1e-44  Score=330.58  Aligned_cols=263  Identities=19%  Similarity=0.195  Sum_probs=197.3

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFES  134 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  134 (339)
                      .+|++.+.||.|+||.||+|.+..+++.||+|...       ...+.+|+.+++.++||||+++++++..+...++|+|+
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            57999999999999999999999999999999753       23466899999999999999999999999999999999


Q ss_pred             ccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceee
Q 019536          135 VKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVR  212 (339)
Q Consensus       135 ~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~  212 (339)
                      +. ++|..++.  ..+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+|+........ .
T Consensus       165 ~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~-~  239 (391)
T PHA03212        165 YK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN-K  239 (391)
T ss_pred             CC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCccccccccccc-c
Confidence            95 67777764  56888899999999999999999   899999999999999999999999999998754322111 1


Q ss_pred             ecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCC--chhHHHHHHHHhh--cCc-------
Q 019536          213 EEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDD--DLTVLEYAKKSIE--NNR-------  281 (339)
Q Consensus       213 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~--~~~-------  281 (339)
                      .....||+.|+|||++.+..++.++||||+||++|+|++|+.||.........  .............  ...       
T Consensus       240 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~  319 (391)
T PHA03212        240 YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQA  319 (391)
T ss_pred             cccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhH
Confidence            12356899999999999989999999999999999999999886322111100  0001110000000  000       


Q ss_pred             -ccccc----cCcccCCCCCCCc---HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          282 -FGAIV----DPIFDEDNSFPGK---EEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       282 -~~~~~----~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                       +..+.    ..........+..   ...+.++.+|+.+||++||++|||+.|+++
T Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        320 NLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence             00000    0000000001111   134567899999999999999999999986

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1e-44  Score=335.18  Aligned_cols=255  Identities=18%  Similarity=0.227  Sum_probs=204.4

Q ss_pred             HhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC--ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 019536           53 ATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS--TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTL  130 (339)
Q Consensus        53 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  130 (339)
                      ..++|++.+.||+|+||.||+|....++..||+|++....  .......+.+|+.+++.++||||+++++++.+++..++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            4578999999999999999999999999999999986531  12334557789999999999999999999999999999


Q ss_pred             EEEeccCCccccccc-cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCc
Q 019536          131 VFESVKYGTLRGFSF-ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGET  209 (339)
Q Consensus       131 v~e~~~~g~L~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~  209 (339)
                      ||||+++|+|.+++. ..++...+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||++........
T Consensus       121 v~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~  197 (370)
T cd05596         121 VMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM  197 (370)
T ss_pred             EEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc
Confidence            999999999999876 46788888899999999999999   89999999999999999999999999999877644322


Q ss_pred             eeeecccccccccccccccccC----CCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCccccc
Q 019536          210 HVREEFIKGAYGFIAPEYFATS----SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAI  285 (339)
Q Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (339)
                      . ......||+.|+|||++.+.    .++.++|+|||||++|+|++|+.||.....        ...........     
T Consensus       198 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--------~~~~~~i~~~~-----  263 (370)
T cd05596         198 V-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--------VGTYSKIMDHK-----  263 (370)
T ss_pred             c-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH--------HHHHHHHHcCC-----
Confidence            1 11235689999999998653    378999999999999999999999852211        11111111100     


Q ss_pred             ccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 019536          286 VDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEH--RPLMVDVAKQ  330 (339)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~--Rps~~~il~~  330 (339)
                            ....+|.....+.++.+|+.+||+.+|.+  |+|+.+++++
T Consensus       264 ------~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         264 ------NSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             ------CcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence                  01112222245668999999999999998  9999999864

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=3.2e-44  Score=333.38  Aligned_cols=253  Identities=17%  Similarity=0.196  Sum_probs=199.5

Q ss_pred             CcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC--ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 019536           56 NYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS--TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFE  133 (339)
Q Consensus        56 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  133 (339)
                      .|++.+.||+|+||+||+|.+..+++.||+|++....  .......+.+|+.+++.++||||+++++++.+++..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5888999999999999999999999999999997642  22445678899999999999999999999999999999999


Q ss_pred             eccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCc--
Q 019536          134 SVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGET--  209 (339)
Q Consensus       134 ~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~--  209 (339)
                      |+++|+|.+++.  ..+++..+..++.|++.||.|||   ..+|+||||||+|||++.++.+||+|||+++.+.....  
T Consensus        82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~  158 (381)
T cd05626          82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK  158 (381)
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence            999999999875  46788888889999999999999   89999999999999999999999999999764321000  


Q ss_pred             -------------------------------------------eeeecccccccccccccccccCCCCcccchHHHHHHH
Q 019536          210 -------------------------------------------HVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFL  246 (339)
Q Consensus       210 -------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l  246 (339)
                                                                 ........||+.|+|||++.+..++.++|||||||++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il  238 (381)
T cd05626         159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL  238 (381)
T ss_pred             cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHH
Confidence                                                       0001134689999999999988999999999999999


Q ss_pred             HHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHH--hhccCCCCCCCH
Q 019536          247 CELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYK--CLSKSPEHRPLM  324 (339)
Q Consensus       247 ~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~--cl~~dP~~Rps~  324 (339)
                      |||++|+.||.....        ...........           .....|.....+.++.+|+.+  |+..+|..||++
T Consensus       239 ~elltG~~Pf~~~~~--------~~~~~~i~~~~-----------~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~  299 (381)
T cd05626         239 FEMLVGQPPFLAPTP--------TETQLKVINWE-----------NTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGA  299 (381)
T ss_pred             HHHHhCCCCCcCCCH--------HHHHHHHHccc-----------cccCCCCCCCCCHHHHHHHHHHccCcccccCCCCH
Confidence            999999999853211        01111111000           001112222345678899988  445566669999


Q ss_pred             HHHHHH
Q 019536          325 VDVAKQ  330 (339)
Q Consensus       325 ~~il~~  330 (339)
                      .+++.+
T Consensus       300 ~~~l~h  305 (381)
T cd05626         300 DDIKAH  305 (381)
T ss_pred             HHHhcC
Confidence            999874

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-44  Score=325.90  Aligned_cols=253  Identities=23%  Similarity=0.266  Sum_probs=213.1

Q ss_pred             HhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCCh--hhHHHHHHHHHHHHhcC-CCceeeeeeeeeeCCccE
Q 019536           53 ATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTL--DDVEYCFNNIVFSSQMK-HKNILKLIGCCLETELPT  129 (339)
Q Consensus        53 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~-H~niv~~~~~~~~~~~~~  129 (339)
                      ....|++.+.||.|.||.||+++...+|+.+|+|.+.+....  ...+.+.+|+.+|+++. |||||.+.+++++....+
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            346799999999999999999999999999999999876432  34577889999999998 999999999999999999


Q ss_pred             EEEEeccCCccccccccC-CChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCC----CceEEecCCCcccc
Q 019536          130 LVFESVKYGTLRGFSFAS-LLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDEN----YSAKLHDFSLSVSI  204 (339)
Q Consensus       130 lv~e~~~~g~L~~~~~~~-~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~----~~~kl~dfg~a~~~  204 (339)
                      +|||+|.||.|.+.+... +++..+..++.|++.++.|||   +.+|+||||||+|+|+...    +.+|++|||+|...
T Consensus       113 lvmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~  189 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI  189 (382)
T ss_pred             EEEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence            999999999999998866 999999999999999999999   9999999999999999643    47999999999988


Q ss_pred             CCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccc
Q 019536          205 PEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA  284 (339)
Q Consensus       205 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (339)
                      .....   ....+||+.|+|||++.+..|+..+||||+|+++|.|++|.+||.......    ...     ....+.+  
T Consensus       190 ~~~~~---~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~----~~~-----~i~~~~~--  255 (382)
T KOG0032|consen  190 KPGER---LHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFE----IFL-----AILRGDF--  255 (382)
T ss_pred             cCCce---EeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhH----HHH-----HHHcCCC--
Confidence            76322   225789999999999999999999999999999999999999986332211    111     1111111  


Q ss_pred             cccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                              ....+.....+..+++++.+||..||.+|+|+.+++++
T Consensus       256 --------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  256 --------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             --------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence                    11222334678899999999999999999999999985

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2.9e-44  Score=326.63  Aligned_cols=245  Identities=20%  Similarity=0.269  Sum_probs=195.7

Q ss_pred             cccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC--ChhhHHHHHHHHHHH---HhcCCCceeeeeeeeeeCCccEEE
Q 019536           57 YDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS--TLDDVEYCFNNIVFS---SQMKHKNILKLIGCCLETELPTLV  131 (339)
Q Consensus        57 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l---~~l~H~niv~~~~~~~~~~~~~lv  131 (339)
                      |.+.+.||+|+||.||+|.+..+++.||||++....  .....+.+.+|+.++   +.++||||+++++++.+++..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            677889999999999999999899999999997542  123345566776655   566799999999999999999999


Q ss_pred             EEeccCCccccccc-cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCce
Q 019536          132 FESVKYGTLRGFSF-ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH  210 (339)
Q Consensus       132 ~e~~~~g~L~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~  210 (339)
                      |||+++|+|..++. ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++........
T Consensus        81 ~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~  157 (324)
T cd05589          81 MEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR  157 (324)
T ss_pred             EcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCc
Confidence            99999999988876 57899999999999999999999   899999999999999999999999999998754322221


Q ss_pred             eeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcc
Q 019536          211 VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIF  290 (339)
Q Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (339)
                        .....|++.|+|||++.+..++.++|+|||||++|+|++|+.||.....        ........ ..          
T Consensus       158 --~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~--------~~~~~~i~-~~----------  216 (324)
T cd05589         158 --TSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE--------EEVFDSIV-ND----------  216 (324)
T ss_pred             --ccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH--------HHHHHHHH-hC----------
Confidence              1235689999999999998999999999999999999999999752211        11111111 11          


Q ss_pred             cCCCCCCCcHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 019536          291 DEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP-----LMVDVAK  329 (339)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~il~  329 (339)
                        ....|  ...+..+.+++.+||+.||.+||     ++.++++
T Consensus       217 --~~~~p--~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         217 --EVRYP--RFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             --CCCCC--CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence              01111  13455788999999999999999     5666665

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=6.2e-44  Score=314.32  Aligned_cols=252  Identities=22%  Similarity=0.330  Sum_probs=203.7

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFE  133 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  133 (339)
                      .++|++.++||+|++|.||+|... ++..||+|.+....  ...+.+.+|+.+++.++|+||+++++++.+++..++|||
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT--MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE   81 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc--hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence            467999999999999999999975 56779999876543  345678899999999999999999999999999999999


Q ss_pred             eccCCccccccc----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCc
Q 019536          134 SVKYGTLRGFSF----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGET  209 (339)
Q Consensus       134 ~~~~g~L~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~  209 (339)
                      |+++|+|.+++.    ..+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||+++.......
T Consensus        82 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05072          82 YMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY  158 (261)
T ss_pred             cCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence            999999999875    35778888899999999999999   89999999999999999999999999999987654332


Q ss_pred             eeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCcccccccC
Q 019536          210 HVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDP  288 (339)
Q Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (339)
                      .. .....++..|+|||++.+..++.++|+|||||++|+|++ |+.||.....        ...... ....        
T Consensus       159 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~--------~~~~~~-~~~~--------  220 (261)
T cd05072         159 TA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN--------SDVMSA-LQRG--------  220 (261)
T ss_pred             ec-cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH--------HHHHHH-HHcC--------
Confidence            21 112345677999999988889999999999999999998 8988752111        111111 1110        


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 019536          289 IFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQM  334 (339)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l  334 (339)
                           ...+.....+..+.+++.+||+.+|++|||+.++.+.|+++
T Consensus       221 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         221 -----YRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             -----CCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence                 00111123445789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.7e-45  Score=333.42  Aligned_cols=253  Identities=21%  Similarity=0.256  Sum_probs=205.4

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC--ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS--TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVF  132 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  132 (339)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++....  .......+.+|+.++..++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            47899999999999999999999899999999987642  1134566789999999999999999999999999999999


Q ss_pred             EeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCC--
Q 019536          133 ESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE--  208 (339)
Q Consensus       133 e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~--  208 (339)
                      ||+++|+|.+++.  ..++...+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||++.......  
T Consensus        81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~  157 (350)
T cd05573          81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR  157 (350)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence            9999999999886  46888999999999999999999   8999999999999999999999999999987765433  


Q ss_pred             -------------------------ceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCC
Q 019536          209 -------------------------THVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGN  263 (339)
Q Consensus       209 -------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~  263 (339)
                                               .........||+.|+|||++.+..++.++|||||||++|+|++|+.||....   
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~---  234 (350)
T cd05573         158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT---  234 (350)
T ss_pred             cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC---
Confidence                                     0011123568999999999999999999999999999999999999985322   


Q ss_pred             CCchhHHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCC-HHHHHHH
Q 019536          264 DDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPL-MVDVAKQ  330 (339)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps-~~~il~~  330 (339)
                           ...........           ......|.....+..+.+|+.+||. ||.+||+ +.+++++
T Consensus       235 -----~~~~~~~i~~~-----------~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         235 -----LQETYNKIINW-----------KESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             -----HHHHHHHHhcc-----------CCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence                 11111111110           0011112222345679999999998 9999999 9999874

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.1e-43  Score=338.99  Aligned_cols=257  Identities=20%  Similarity=0.262  Sum_probs=206.5

Q ss_pred             HHHHHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC-
Q 019536           49 DLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS-TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETE-  126 (339)
Q Consensus        49 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~-  126 (339)
                      +.....++|.+.+.||+|+||+||+|.+..+++.||||++.... .......+.+|+.++..++|+||+++.+.+...+ 
T Consensus        26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~  105 (496)
T PTZ00283         26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP  105 (496)
T ss_pred             cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence            34455689999999999999999999999899999999987653 3345567889999999999999999988775432 


Q ss_pred             -------ccEEEEEeccCCccccccc------cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCce
Q 019536          127 -------LPTLVFESVKYGTLRGFSF------ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSA  193 (339)
Q Consensus       127 -------~~~lv~e~~~~g~L~~~~~------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~  193 (339)
                             ..++||||+++|+|.+++.      ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+
T Consensus       106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~v  182 (496)
T PTZ00283        106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLV  182 (496)
T ss_pred             cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCE
Confidence                   3679999999999998874      35788888999999999999999   8999999999999999999999


Q ss_pred             EEecCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHH
Q 019536          194 KLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYA  273 (339)
Q Consensus       194 kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~  273 (339)
                      ||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|+|++|+.||....        .....
T Consensus       183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~--------~~~~~  254 (496)
T PTZ00283        183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN--------MEEVM  254 (496)
T ss_pred             EEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC--------HHHHH
Confidence            9999999987654322222224578999999999999999999999999999999999999985211        11111


Q ss_pred             HHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          274 KKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      ..... ...    .         +.+...+.++.+++.+||+.||.+|||+.+++.+
T Consensus       255 ~~~~~-~~~----~---------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        255 HKTLA-GRY----D---------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             HHHhc-CCC----C---------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            11111 100    0         1122455679999999999999999999999864

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=2e-44  Score=333.33  Aligned_cols=262  Identities=18%  Similarity=0.219  Sum_probs=207.6

Q ss_pred             CcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcC-C-----CceeeeeeeeeeCCccE
Q 019536           56 NYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMK-H-----KNILKLIGCCLETELPT  129 (339)
Q Consensus        56 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-H-----~niv~~~~~~~~~~~~~  129 (339)
                      +|++.+.||+|+||.|.+|.+..+++.||||++++..  .-..+...|+.+|..++ |     -|+|+++++|...++.|
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k--~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc  264 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK--RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC  264 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh--HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence            7899999999999999999999999999999998753  33455668999999996 4     38999999999999999


Q ss_pred             EEEEeccCCccccccc----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCC--CceEEecCCCccc
Q 019536          130 LVFESVKYGTLRGFSF----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDEN--YSAKLHDFSLSVS  203 (339)
Q Consensus       130 lv~e~~~~g~L~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~--~~~kl~dfg~a~~  203 (339)
                      ||+|.+ .-+|.+++.    ..++...++.++.||+.||.+||   ..+|||+||||+|||+...  ..+||+|||.|+.
T Consensus       265 iVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~  340 (586)
T KOG0667|consen  265 IVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCF  340 (586)
T ss_pred             eeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEecccccc
Confidence            999999 458999987    56889999999999999999999   9999999999999999643  4699999999988


Q ss_pred             cCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcc-
Q 019536          204 IPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRF-  282 (339)
Q Consensus       204 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-  282 (339)
                      ......     ....+..|+|||++.|.+|+.+.|||||||+++||++|.+.|  +|+.+.+++..+......+....+ 
T Consensus       341 ~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLf--pG~ne~DQl~~I~e~lG~Pp~~mL~  413 (586)
T KOG0667|consen  341 ESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLF--PGDNEYDQLARIIEVLGLPPPKMLD  413 (586)
T ss_pred             cCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCcccc--CCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            755443     235677899999999999999999999999999999998884  566666666655554443221110 


Q ss_pred             -----cccccC-----------cc----------------cCCCCCC-Cc-------H-HHHHHHHHHHHHhhccCCCCC
Q 019536          283 -----GAIVDP-----------IF----------------DEDNSFP-GK-------E-EKLQSLGQLMYKCLSKSPEHR  321 (339)
Q Consensus       283 -----~~~~~~-----------~~----------------~~~~~~~-~~-------~-~~~~~~~~li~~cl~~dP~~R  321 (339)
                           .++++.           ..                ......| ..       . .....+.+++.+||++||.+|
T Consensus       414 ~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R  493 (586)
T KOG0667|consen  414 TAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAER  493 (586)
T ss_pred             hccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhc
Confidence                 111111           00                0001111 10       1 234568999999999999999


Q ss_pred             CCHHHHHHH
Q 019536          322 PLMVDVAKQ  330 (339)
Q Consensus       322 ps~~~il~~  330 (339)
                      +|+.+++++
T Consensus       494 ~tp~qal~H  502 (586)
T KOG0667|consen  494 ITPAQALNH  502 (586)
T ss_pred             CCHHHHhcC
Confidence            999999874

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-44  Score=329.00  Aligned_cols=255  Identities=25%  Similarity=0.377  Sum_probs=219.8

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCC----CeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQ----DRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTL  130 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  130 (339)
                      ...+..++||.|.||.||+|.+...    .-.||||.-+.+.+....+.|+.|..+|+.++||||++++|+|.+.. .|+
T Consensus       389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P-~Wi  467 (974)
T KOG4257|consen  389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQP-MWI  467 (974)
T ss_pred             hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccc-eeE
Confidence            3445567899999999999998633    34799999998888788999999999999999999999999998764 689


Q ss_pred             EEEeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCC
Q 019536          131 VFESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEG  207 (339)
Q Consensus       131 v~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~  207 (339)
                      |||.++.|.|..++.   ..++..+...++.||+.||.|||   +++.+||||..+|||+.+...+||+|||+++.+.+.
T Consensus       468 vmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~  544 (974)
T KOG4257|consen  468 VMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDD  544 (974)
T ss_pred             EEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence            999999999999987   57888888999999999999999   999999999999999999999999999999999776


Q ss_pred             CceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCcccccc
Q 019536          208 ETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIV  286 (339)
Q Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (339)
                      ..+... ...-..-|||||.++...++.++|||-|||.|||++. |..||....+.+                      +
T Consensus       545 ~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD----------------------V  601 (974)
T KOG4257|consen  545 AYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD----------------------V  601 (974)
T ss_pred             chhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc----------------------e
Confidence            655433 3334567999999999999999999999999999887 999986544332                      1


Q ss_pred             cCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 019536          287 DPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYL  336 (339)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~  336 (339)
                      --.+....++|.|+.|++.+..|+.+||.+||.+||.+.+|...|..++.
T Consensus       602 I~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  602 IGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             EEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence            12233445667788999999999999999999999999999999998875

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.3e-43  Score=316.01  Aligned_cols=254  Identities=19%  Similarity=0.293  Sum_probs=202.6

Q ss_pred             cCcccCCceeccCCeeEEEEEEcC-----CCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVD-----QDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPT  129 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~  129 (339)
                      .+|.+.+.||.|+||.||+|.+..     .+..||+|++.........+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~   84 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS   84 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence            457778999999999999998753     357899999986654344567889999999999999999999999999999


Q ss_pred             EEEEeccCCccccccc------------------cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCC
Q 019536          130 LVFESVKYGTLRGFSF------------------ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENY  191 (339)
Q Consensus       130 lv~e~~~~g~L~~~~~------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~  191 (339)
                      +++||+++++|.+++.                  ..+++..+..++.|++.||.|||   +.+|+||||||.||+++.++
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~  161 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKL  161 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCC
Confidence            9999999999988863                  23677778899999999999999   89999999999999999999


Q ss_pred             ceEEecCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHH
Q 019536          192 SAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVL  270 (339)
Q Consensus       192 ~~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~  270 (339)
                      .+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||....        ..
T Consensus       162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~--------~~  233 (283)
T cd05091         162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS--------NQ  233 (283)
T ss_pred             ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC--------HH
Confidence            999999999887644332222223345678999999988889999999999999999998 777764211        11


Q ss_pred             HHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 019536          271 EYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQ  333 (339)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~  333 (339)
                      +....... ...             .+.+..++..+.+|+.+||+.+|.+|||+.+|+..|++
T Consensus       234 ~~~~~i~~-~~~-------------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         234 DVIEMIRN-RQV-------------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HHHHHHHc-CCc-------------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            11111111 110             01122455678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-43  Score=313.09  Aligned_cols=253  Identities=25%  Similarity=0.418  Sum_probs=200.7

Q ss_pred             cccCCceeccCCeeEEEEEEcCC---CeeEEEEEeccCC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCc-----
Q 019536           57 YDLHKVIQSDTSYRLFEGTLVDQ---DRPISVMKFHDNS-TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETEL-----  127 (339)
Q Consensus        57 ~~~~~~ig~G~~g~V~~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~-----  127 (339)
                      |++.+.||+|+||.||+|....+   +..||+|++.... .......+.+|+.+++.++||||+++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            57789999999999999998653   3789999987643 23456778899999999999999999999876554     


Q ss_pred             -cEEEEEeccCCccccccc--------cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecC
Q 019536          128 -PTLVFESVKYGTLRGFSF--------ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDF  198 (339)
Q Consensus       128 -~~lv~e~~~~g~L~~~~~--------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~df  198 (339)
                       .++|+||+++|+|.+++.        ..+++.....++.|++.||.|||   +.+++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCc
Confidence             789999999999988863        25788888999999999999999   899999999999999999999999999


Q ss_pred             CCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHh
Q 019536          199 SLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSI  277 (339)
Q Consensus       199 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~  277 (339)
                      |+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.....     ....+   .. 
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~-----~~~~~---~~-  228 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN-----HEIYD---YL-  228 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH-----HHHHH---HH-
Confidence            99987654433222212334667999999988889999999999999999999 8888642211     11111   11 


Q ss_pred             hcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 019536          278 ENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQM  334 (339)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l  334 (339)
                      .....             .+.+...+..+.+++.+||+.||++|||+.++++.|+++
T Consensus       229 ~~~~~-------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         229 RHGNR-------------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             HcCCC-------------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            11110             011123456799999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=6.3e-44  Score=331.93  Aligned_cols=262  Identities=21%  Similarity=0.305  Sum_probs=206.6

Q ss_pred             HHHHhcCcccCCceeccCCeeEEEEEEcC-----CCeeEEEEEeccCCChhhHHHHHHHHHHHHhcC-CCceeeeeeeee
Q 019536           50 LKKATNNYDLHKVIQSDTSYRLFEGTLVD-----QDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMK-HKNILKLIGCCL  123 (339)
Q Consensus        50 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~~~~~~~  123 (339)
                      +....++|.+.+.||+|+||.||+|.+.+     .+..||+|++.........+.+.+|+.++..+. ||||++++++|.
T Consensus        32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~  111 (401)
T cd05107          32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT  111 (401)
T ss_pred             ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence            45556789999999999999999999642     456899999987644444567889999999997 999999999999


Q ss_pred             eCCccEEEEEeccCCcccccccc---------------------------------------------------------
Q 019536          124 ETELPTLVFESVKYGTLRGFSFA---------------------------------------------------------  146 (339)
Q Consensus       124 ~~~~~~lv~e~~~~g~L~~~~~~---------------------------------------------------------  146 (339)
                      ..+..++||||+++|+|.+++..                                                         
T Consensus       112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (401)
T cd05107         112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP  191 (401)
T ss_pred             cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence            99999999999999999887631                                                         


Q ss_pred             -------------------------------------------CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCC
Q 019536          147 -------------------------------------------SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKAS  183 (339)
Q Consensus       147 -------------------------------------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~  183 (339)
                                                                 .+++...+.++.|++.||.|||   +.+++||||||+
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~  268 (401)
T cd05107         192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAAR  268 (401)
T ss_pred             hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcc
Confidence                                                       2455567789999999999999   899999999999


Q ss_pred             CEEeCCCCceEEecCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCC
Q 019536          184 NVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNG  262 (339)
Q Consensus       184 Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~  262 (339)
                      |||++.++.+||+|||+++...............++..|+|||++.+..++.++|+||||+++|||++ |..||..... 
T Consensus       269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~-  347 (401)
T cd05107         269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM-  347 (401)
T ss_pred             eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc-
Confidence            99999999999999999986543322111112346788999999988889999999999999999998 8888753211 


Q ss_pred             CCCchhHHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 019536          263 NDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMY  335 (339)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~  335 (339)
                             .+........+.             ..+.+...+..+.+|+.+||+.+|++||++.+|++.|++++
T Consensus       348 -------~~~~~~~~~~~~-------------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         348 -------NEQFYNAIKRGY-------------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             -------hHHHHHHHHcCC-------------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence                   111111111110             00111234567999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=2.2e-44  Score=327.57  Aligned_cols=242  Identities=18%  Similarity=0.215  Sum_probs=196.4

Q ss_pred             CceeccCCeeEEEEEEcCCCeeEEEEEeccCC--ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeccCC
Q 019536           61 KVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS--TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYG  138 (339)
Q Consensus        61 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g  138 (339)
                      +.||+|+||.||++....+++.||+|.+....  .......+.+|+.++..++||||+++.+++.+.+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46899999999999999899999999987642  2234566778999999999999999999999999999999999999


Q ss_pred             ccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCC-CCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceeeecc
Q 019536          139 TLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFD-RPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEF  215 (339)
Q Consensus       139 ~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~~~  215 (339)
                      +|..++.  ..+++..+..++.|++.||.|||   + .+|+||||||+|||++.++.+||+|||+++.........  ..
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~--~~  155 (325)
T cd05594          81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM--KT  155 (325)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccc--cc
Confidence            9988875  56888899999999999999999   7 799999999999999999999999999987543322211  13


Q ss_pred             cccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCCCC
Q 019536          216 IKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNS  295 (339)
Q Consensus       216 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (339)
                      ..||+.|+|||++.+..++.++|||||||++|+|++|+.||.....        ... .......            ...
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~--------~~~-~~~i~~~------------~~~  214 (325)
T cd05594         156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------EKL-FELILME------------EIR  214 (325)
T ss_pred             ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH--------HHH-HHHHhcC------------CCC
Confidence            5689999999999988999999999999999999999999852211        011 1111110            111


Q ss_pred             CCCcHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 019536          296 FPGKEEKLQSLGQLMYKCLSKSPEHRP-----LMVDVAKQ  330 (339)
Q Consensus       296 ~~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~il~~  330 (339)
                      +|  ...+..+.+|+.+||+.||++|+     ++.+++++
T Consensus       215 ~p--~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         215 FP--RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             CC--CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            11  13455789999999999999997     89998864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-44  Score=329.87  Aligned_cols=252  Identities=19%  Similarity=0.229  Sum_probs=201.7

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC--ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS--TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVF  132 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  132 (339)
                      ++|++.+.||+|+||+||+|....+++.||||++....  .......+.+|+.++..++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47899999999999999999999999999999997542  1234456778999999999999999999999999999999


Q ss_pred             EeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCce
Q 019536          133 ESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH  210 (339)
Q Consensus       133 e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~  210 (339)
                      ||+++|+|.+++.  ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.++|+|||+++.+......
T Consensus        81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~  157 (364)
T cd05599          81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT  157 (364)
T ss_pred             CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence            9999999999875  56888899999999999999999   999999999999999999999999999998765322100


Q ss_pred             e------------------------------------eecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCC
Q 019536          211 V------------------------------------REEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCN  254 (339)
Q Consensus       211 ~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~  254 (339)
                      .                                    .....+||+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~  237 (364)
T cd05599         158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP  237 (364)
T ss_pred             cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence            0                                    0012358999999999998899999999999999999999999


Q ss_pred             ccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCC---HHHHHH
Q 019536          255 VLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPL---MVDVAK  329 (339)
Q Consensus       255 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps---~~~il~  329 (339)
                      ||....        ..+.........           .....|.....+..+.+|+.+||. +|.+|++   +.+++.
T Consensus       238 Pf~~~~--------~~~~~~~i~~~~-----------~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         238 PFCSDN--------PQETYRKIINWK-----------ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             CCCCCC--------HHHHHHHHHcCC-----------CccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            985221        111111111100           011112222345678999999997 9999998   888876

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-44  Score=333.80  Aligned_cols=253  Identities=19%  Similarity=0.214  Sum_probs=199.7

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC--ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS--TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVF  132 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  132 (339)
                      ++|++.+.||+|+||.||++....+++.||+|++....  .......+.+|+.+++.++||||+++++++.+++..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            47899999999999999999999999999999986532  2234566789999999999999999999999999999999


Q ss_pred             EeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCce
Q 019536          133 ESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH  210 (339)
Q Consensus       133 e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~  210 (339)
                      ||+++|+|.+++.  ..++...+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+......
T Consensus        81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  157 (377)
T cd05629          81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS  157 (377)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence            9999999998875  56788888899999999999999   999999999999999999999999999998643211000


Q ss_pred             ---------------------------------------------eeecccccccccccccccccCCCCcccchHHHHHH
Q 019536          211 ---------------------------------------------VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAF  245 (339)
Q Consensus       211 ---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~  245 (339)
                                                                   .......||+.|+|||++.+..++.++|||||||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi  237 (377)
T cd05629         158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI  237 (377)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchh
Confidence                                                         00002358999999999998899999999999999


Q ss_pred             HHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCC---C
Q 019536          246 LCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHR---P  322 (339)
Q Consensus       246 l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~R---p  322 (339)
                      +|||++|..||.....     ....   ......           .....+|.....+.++.+|+.+||. +|.+|   +
T Consensus       238 l~elltG~~Pf~~~~~-----~~~~---~~i~~~-----------~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~  297 (377)
T cd05629         238 MFECLIGWPPFCSENS-----HETY---RKIINW-----------RETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRG  297 (377)
T ss_pred             hhhhhcCCCCCCCCCH-----HHHH---HHHHcc-----------CCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCC
Confidence            9999999999852211     1111   111100           0011122222345678999999998 77765   5


Q ss_pred             CHHHHHHH
Q 019536          323 LMVDVAKQ  330 (339)
Q Consensus       323 s~~~il~~  330 (339)
                      |+.+++.+
T Consensus       298 ~~~~~l~h  305 (377)
T cd05629         298 GAHEIKSH  305 (377)
T ss_pred             CHHHHhcC
Confidence            99998874

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.7e-43  Score=318.39  Aligned_cols=259  Identities=21%  Similarity=0.310  Sum_probs=207.3

Q ss_pred             HHhcCcccCCceeccCCeeEEEEEEc-----CCCeeEEEEEeccCCChhhHHHHHHHHHHHHhc-CCCceeeeeeeeeeC
Q 019536           52 KATNNYDLHKVIQSDTSYRLFEGTLV-----DQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLET  125 (339)
Q Consensus        52 ~~~~~~~~~~~ig~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~  125 (339)
                      -..++|.+.+.||+|+||.||+|...     .++..||+|.+.........+.+.+|+.+++++ +||||+++++++...
T Consensus        32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  111 (302)
T cd05055          32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG  111 (302)
T ss_pred             ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence            34468999999999999999999852     345689999987665445567788999999999 799999999999999


Q ss_pred             CccEEEEEeccCCcccccccc----CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCc
Q 019536          126 ELPTLVFESVKYGTLRGFSFA----SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLS  201 (339)
Q Consensus       126 ~~~~lv~e~~~~g~L~~~~~~----~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a  201 (339)
                      +..++||||+++|+|.+++..    .+++.+...++.|++.||.|||   +.+|+|+||||+||+++.++.++++|||++
T Consensus       112 ~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~  188 (302)
T cd05055         112 GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLA  188 (302)
T ss_pred             CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCccc
Confidence            999999999999999998752    2788999999999999999999   899999999999999999999999999999


Q ss_pred             cccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcC
Q 019536          202 VSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENN  280 (339)
Q Consensus       202 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  280 (339)
                      +...............++..|+|||.+.+..++.++||||+||++|+|++ |..||......        ..........
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~--------~~~~~~~~~~  260 (302)
T cd05055         189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD--------SKFYKLIKEG  260 (302)
T ss_pred             ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch--------HHHHHHHHcC
Confidence            87654432222222345678999999988899999999999999999998 99987522110        0111111111


Q ss_pred             cccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 019536          281 RFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQM  334 (339)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l  334 (339)
                      .             ..+.+...+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus       261 ~-------------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         261 Y-------------RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             C-------------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            0             0001112345799999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.1e-43  Score=315.72  Aligned_cols=255  Identities=22%  Similarity=0.327  Sum_probs=202.9

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcC-----CCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCcc
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVD-----QDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELP  128 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~  128 (339)
                      +++|++.+.||+|++|.||+|.+..     .+..||+|.+...........+.+|+.+++.++|+||+++++++.+.+..
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            4679999999999999999999976     67899999887655445556788999999999999999999999999899


Q ss_pred             EEEEEeccCCcccccccc---------CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCC---ceEEe
Q 019536          129 TLVFESVKYGTLRGFSFA---------SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENY---SAKLH  196 (339)
Q Consensus       129 ~lv~e~~~~g~L~~~~~~---------~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~---~~kl~  196 (339)
                      ++||||+++++|.+++..         .+++..++.++.||+.||.|||   +.+++||||||+||+++.++   .+||+
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEec
Confidence            999999999999998752         4788888999999999999999   89999999999999998654   58999


Q ss_pred             cCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHH
Q 019536          197 DFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKK  275 (339)
Q Consensus       197 dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~  275 (339)
                      |||+++................+..|+|||++.+..++.++|||||||++|+|++ |..||.....        .+....
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~--------~~~~~~  233 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN--------QEVMEF  233 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHH
Confidence            9999987643322111112233567999999988889999999999999999997 9888752211        111111


Q ss_pred             HhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 019536          276 SIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQ  333 (339)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~  333 (339)
                      ......              .+.+...+..+.+++.+||+.+|++|||+.+|+++|++
T Consensus       234 ~~~~~~--------------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~  277 (277)
T cd05036         234 VTGGGR--------------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY  277 (277)
T ss_pred             HHcCCc--------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence            111100              01112344578999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2.6e-43  Score=311.27  Aligned_cols=257  Identities=21%  Similarity=0.332  Sum_probs=207.7

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC--ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS--TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVF  132 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  132 (339)
                      ++|++.+.||+|+||.||+|....+++.||+|.+....  .......+.+|+.+++.++||||+++++++.+.+..++|+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            57999999999999999999999899999999876532  2244566889999999999999999999999999999999


Q ss_pred             EeccCCccccccc------cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCC
Q 019536          133 ESVKYGTLRGFSF------ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPE  206 (339)
Q Consensus       133 e~~~~g~L~~~~~------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~  206 (339)
                      ||+++|+|.+++.      ..++...+..++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            9999999988763      34678888999999999999999   89999999999999999999999999999887654


Q ss_pred             CCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccc
Q 019536          207 GETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIV  286 (339)
Q Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (339)
                      .....  ....++..|+|||.+.+..++.++|+||+|+++|+|++|+.||.....      ........ ......    
T Consensus       159 ~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~------~~~~~~~~-~~~~~~----  225 (267)
T cd08228         159 KTTAA--HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM------NLFSLCQK-IEQCDY----  225 (267)
T ss_pred             hhHHH--hcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc------cHHHHHHH-HhcCCC----
Confidence            33211  124578889999999888899999999999999999999999742211      11111111 111000    


Q ss_pred             cCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 019536          287 DPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMY  335 (339)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~  335 (339)
                             .+.+ ....+..+.+++.+||+.+|++|||+.++++.|+.+.
T Consensus       226 -------~~~~-~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         226 -------PPLP-TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             -------CCCC-hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence                   0001 1234567999999999999999999999999998863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=3.1e-43  Score=313.21  Aligned_cols=253  Identities=16%  Similarity=0.247  Sum_probs=203.0

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFES  134 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  134 (339)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+...........+.+|+.++++++||||+++++++..++..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            36888899999999999999998899999999987654445566788999999999999999999999999999999999


Q ss_pred             ccCCccccccccCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceeeec
Q 019536          135 VKYGTLRGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREE  214 (339)
Q Consensus       135 ~~~g~L~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~~  214 (339)
                      +++++|..+  ..+++.....++.|++.||.|||   +.+|+|+||||+||+++.++.++|+|||++........    .
T Consensus        81 ~~~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~----~  151 (279)
T cd06619          81 MDGGSLDVY--RKIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIA----K  151 (279)
T ss_pred             CCCCChHHh--hcCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccccc----c
Confidence            999998655  45678888899999999999999   99999999999999999999999999999876643322    1


Q ss_pred             ccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCCC
Q 019536          215 FIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDN  294 (339)
Q Consensus       215 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (339)
                      ...++..|+|||++.+..++.++|+||||+++|+|++|+.||.......... .......... ....           .
T Consensus       152 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~-~~~~-----------~  218 (279)
T cd06619         152 TYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL-MPLQLLQCIV-DEDP-----------P  218 (279)
T ss_pred             CCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccccc-chHHHHHHHh-ccCC-----------C
Confidence            3468889999999998899999999999999999999999985322211111 1111111100 0000           0


Q ss_pred             CCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          295 SFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       295 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      ..+. ...+.++.+++.+||+.+|++||++.+++++
T Consensus       219 ~~~~-~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         219 VLPV-GQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             CCCC-CcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            0011 1244578999999999999999999999875

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.6e-43  Score=316.96  Aligned_cols=257  Identities=22%  Similarity=0.318  Sum_probs=205.8

Q ss_pred             cCcccCCceeccCCeeEEEEEEcC-----CCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVD-----QDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPT  129 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~  129 (339)
                      .+|.+.+.||+|+||.||+|....     ++..+++|.+..... .....+.+|+.+++.++||||+++++++..++..+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL-AARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI   83 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH-HHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence            468888999999999999998642     456788998865433 44567889999999999999999999999999999


Q ss_pred             EEEEeccCCcccccccc------------------CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCC
Q 019536          130 LVFESVKYGTLRGFSFA------------------SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENY  191 (339)
Q Consensus       130 lv~e~~~~g~L~~~~~~------------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~  191 (339)
                      +||||+++++|.+++..                  .+++..++.++.|++.||.|||   +++|+||||||+||+++.++
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~  160 (291)
T cd05094          84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANL  160 (291)
T ss_pred             EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCC
Confidence            99999999999998742                  2678889999999999999999   99999999999999999999


Q ss_pred             ceEEecCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHH
Q 019536          192 SAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVL  270 (339)
Q Consensus       192 ~~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~  270 (339)
                      .++|+|||+++...............++..|+|||++.+..++.++||||||+++|+|++ |+.||.....     ....
T Consensus       161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-----~~~~  235 (291)
T cd05094         161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN-----TEVI  235 (291)
T ss_pred             cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----HHHH
Confidence            999999999876544332222223446788999999998899999999999999999998 9999743211     0111


Q ss_pred             HHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          271 EYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                      +    ....+...        .     .+..++..+.+++.+||+.||++|||+.++++.|+++...
T Consensus       236 ~----~~~~~~~~--------~-----~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         236 E----CITQGRVL--------E-----RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             H----HHhCCCCC--------C-----CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence            1    11111110        0     0113445789999999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.6e-44  Score=316.40  Aligned_cols=254  Identities=21%  Similarity=0.326  Sum_probs=204.5

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCC-----CeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCcc
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQ-----DRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELP  128 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~  128 (339)
                      .++|++.+.||+|+||.||+|.....     +..||+|.+...........+.+|+.+++.++||||+++++++..+...
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            46889999999999999999998643     3789999987665545566788999999999999999999999999999


Q ss_pred             EEEEEeccCCcccccccc------------CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEe
Q 019536          129 TLVFESVKYGTLRGFSFA------------SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLH  196 (339)
Q Consensus       129 ~lv~e~~~~g~L~~~~~~------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~  196 (339)
                      ++||||+++|+|.+++..            .+++..++.++.|++.||.|||   +.+++||||||+||+++.++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEEC
Confidence            999999999999988752            2566788899999999999999   8999999999999999999999999


Q ss_pred             cCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHH
Q 019536          197 DFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKK  275 (339)
Q Consensus       197 dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~  275 (339)
                      |||+++.+.............++..|+|||.+.+..++.++|||||||++|++++ |..||.....     .....    
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-----~~~~~----  232 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN-----EEVLK----  232 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH-----HHHHH----
Confidence            9999887654332222223346778999999988889999999999999999998 8888742111     11111    


Q ss_pred             HhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 019536          276 SIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLR  332 (339)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~  332 (339)
                      .......             .+.+...+..+.+++.+||+.+|++|||+.+++..|+
T Consensus       233 ~~~~~~~-------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         233 FVIDGGH-------------LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             HHhcCCC-------------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            1111100             0111133567999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.4e-43  Score=319.17  Aligned_cols=255  Identities=21%  Similarity=0.316  Sum_probs=202.5

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCe--eEEEEEeccCCChhhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCccEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDR--PISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLETELPTL  130 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~~l  130 (339)
                      .++|++.+.||+|+||.||+|.+..++.  .+|+|.+...........+.+|+.++.++ +||||+++++++.+++..++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            4688999999999999999999876665  46888776554445567788999999999 89999999999999999999


Q ss_pred             EEEeccCCcccccccc------------------CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCc
Q 019536          131 VFESVKYGTLRGFSFA------------------SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYS  192 (339)
Q Consensus       131 v~e~~~~g~L~~~~~~------------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~  192 (339)
                      ||||+++|+|.+++..                  .+++.+++.++.|++.||+|||   +.+++||||||+|||++.++.
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~  162 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYV  162 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCc
Confidence            9999999999988741                  3678888999999999999999   999999999999999999999


Q ss_pred             eEEecCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHH
Q 019536          193 AKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLE  271 (339)
Q Consensus       193 ~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~  271 (339)
                      +||+|||+++.......   .....++..|+|||++.+..++.++|||||||++|+|++ |..||.....        .+
T Consensus       163 ~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--------~~  231 (303)
T cd05088         163 AKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--------AE  231 (303)
T ss_pred             EEeCccccCcccchhhh---cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh--------HH
Confidence            99999999864321111   111234567999999988889999999999999999998 9998742211        11


Q ss_pred             HHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 019536          272 YAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYL  336 (339)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~  336 (339)
                      .... .....             ..+.+...+..+.+|+.+||+.+|++|||+.+++..|+.+..
T Consensus       232 ~~~~-~~~~~-------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~  282 (303)
T cd05088         232 LYEK-LPQGY-------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  282 (303)
T ss_pred             HHHH-HhcCC-------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            1111 11100             001111234578999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.2e-43  Score=327.74  Aligned_cols=256  Identities=18%  Similarity=0.242  Sum_probs=203.5

Q ss_pred             HHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC--ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccE
Q 019536           52 KATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS--TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPT  129 (339)
Q Consensus        52 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~  129 (339)
                      ...++|++.+.||+|+||.||++....+++.||+|.+....  .......+.+|+.+++.++||||+++++++.+++..+
T Consensus        40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~  119 (370)
T cd05621          40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY  119 (370)
T ss_pred             CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence            34578999999999999999999999999999999986531  2233455778999999999999999999999999999


Q ss_pred             EEEEeccCCccccccc-cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCC
Q 019536          130 LVFESVKYGTLRGFSF-ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE  208 (339)
Q Consensus       130 lv~e~~~~g~L~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~  208 (339)
                      +||||+++|+|.+++. ..++...+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+|.......
T Consensus       120 lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~  196 (370)
T cd05621         120 MVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG  196 (370)
T ss_pred             EEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccceecccCC
Confidence            9999999999999886 46788888999999999999999   9999999999999999999999999999998764433


Q ss_pred             ceeeecccccccccccccccccCC----CCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccc
Q 019536          209 THVREEFIKGAYGFIAPEYFATSS----FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA  284 (339)
Q Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (339)
                      .. ......||+.|+|||++.+..    ++.++|+||+||++|+|++|+.||....        .............   
T Consensus       197 ~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~--------~~~~~~~i~~~~~---  264 (370)
T cd05621         197 MV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS--------LVGTYSKIMDHKN---  264 (370)
T ss_pred             ce-ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCc---
Confidence            22 122456999999999987543    7889999999999999999999985221        1111111111100   


Q ss_pred             cccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 019536          285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEH--RPLMVDVAKQ  330 (339)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~--Rps~~~il~~  330 (339)
                              ...+|.....+..+++++..||+.+|.+  |+|+.+++++
T Consensus       265 --------~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         265 --------SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             --------ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence                    1112222245667899999999865544  8899999875

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=4.5e-44  Score=326.18  Aligned_cols=252  Identities=17%  Similarity=0.163  Sum_probs=203.5

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC--hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST--LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVF  132 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  132 (339)
                      ++|++.+.||+|+||+||+|....+++.||+|++.....  ......+.+|+.+++.++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            478999999999999999999999999999999976422  234556778999999999999999999999999999999


Q ss_pred             EeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCc
Q 019536          133 ESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGET  209 (339)
Q Consensus       133 e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~  209 (339)
                      ||+++|+|.+++.   ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||++..+.....
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  157 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM  157 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence            9999999999885   46888888999999999999999   99999999999999999999999999999987655433


Q ss_pred             eeeecccccccccccccccc------cCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCccc
Q 019536          210 HVREEFIKGAYGFIAPEYFA------TSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFG  283 (339)
Q Consensus       210 ~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (339)
                      . ......||+.|+|||++.      +..++.++|||||||++|+|++|+.||.....        ............  
T Consensus       158 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~--------~~~~~~i~~~~~--  226 (330)
T cd05601         158 V-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS--------AKTYNNIMNFQR--  226 (330)
T ss_pred             e-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH--------HHHHHHHHcCCC--
Confidence            2 222346899999999986      45678999999999999999999999852211        111111111100  


Q ss_pred             ccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          284 AIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                               ...+|.....+..+.+|+.+||+ +|.+|||+.+++.+
T Consensus       227 ---------~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         227 ---------FLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             ---------ccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence                     11122222355678999999998 99999999998853

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=7.9e-44  Score=323.76  Aligned_cols=241  Identities=21%  Similarity=0.277  Sum_probs=194.7

Q ss_pred             CcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC--ChhhHHHHHHHHHHHHhcCC-CceeeeeeeeeeCCccEEEE
Q 019536           56 NYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS--TLDDVEYCFNNIVFSSQMKH-KNILKLIGCCLETELPTLVF  132 (339)
Q Consensus        56 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H-~niv~~~~~~~~~~~~~lv~  132 (339)
                      +|++.+.||+|+||.||+|....+++.||+|++....  .....+.+..|..++..+.| ++|+.+++++.+.+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            5888999999999999999999899999999987642  22445667889999999976 46888999999999999999


Q ss_pred             EeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCce
Q 019536          133 ESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH  210 (339)
Q Consensus       133 e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~  210 (339)
                      ||+++|+|.+++.  ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++........
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~  157 (324)
T cd05587          81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT  157 (324)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCc
Confidence            9999999988875  46788889999999999999999   899999999999999999999999999998754322221


Q ss_pred             eeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcc
Q 019536          211 VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIF  290 (339)
Q Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (339)
                        .....||+.|+|||++.+..++.++|+||+||++|+|++|+.||.....     ....   .. ....          
T Consensus       158 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-----~~~~---~~-i~~~----------  216 (324)
T cd05587         158 --TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE-----DELF---QS-IMEH----------  216 (324)
T ss_pred             --eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-----HHHH---HH-HHcC----------
Confidence              1235689999999999999999999999999999999999999852211     1111   11 1110          


Q ss_pred             cCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCH
Q 019536          291 DEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLM  324 (339)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~  324 (339)
                        ...+|  ...+..+.+++.+||+.||.+|+++
T Consensus       217 --~~~~~--~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         217 --NVSYP--KSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             --CCCCC--CCCCHHHHHHHHHHhhcCHHHcCCC
Confidence              01111  1345578999999999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=5.3e-44  Score=326.53  Aligned_cols=268  Identities=17%  Similarity=0.241  Sum_probs=196.6

Q ss_pred             CcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC-----ccE
Q 019536           56 NYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS-TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETE-----LPT  129 (339)
Q Consensus        56 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~-----~~~  129 (339)
                      +|++.+.||+|+||.||+|.+..++..||+|++.... .......+.+|+.+++.++||||+++++++...+     ..+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            5888999999999999999999899999999987532 2234556889999999999999999999886432     479


Q ss_pred             EEEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCC
Q 019536          130 LVFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEG  207 (339)
Q Consensus       130 lv~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~  207 (339)
                      +||||++ ++|.+++.  ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus        81 lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  156 (338)
T cd07859          81 VVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFND  156 (338)
T ss_pred             EEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence            9999995 67877765  46888999999999999999999   899999999999999999999999999998765332


Q ss_pred             Cce-eeeccccccccccccccccc--CCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHH--------H
Q 019536          208 ETH-VREEFIKGAYGFIAPEYFAT--SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKK--------S  276 (339)
Q Consensus       208 ~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~--------~  276 (339)
                      ... .......||..|+|||++.+  ..++.++|||||||++|+|++|++||.....  ......+.....        .
T Consensus       157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~  234 (338)
T cd07859         157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV--VHQLDLITDLLGTPSPETISR  234 (338)
T ss_pred             cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCCh--HHHHHHHHHHhCCCCHHHHHH
Confidence            211 11123468999999999876  5789999999999999999999999753211  111100000000        0


Q ss_pred             hhcCcccccccCcccCCCCCCCc---HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          277 IENNRFGAIVDPIFDEDNSFPGK---EEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      ............ +......+..   ...+..+.+++.+||+.||++|||+.+++++
T Consensus       235 i~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         235 VRNEKARRYLSS-MRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             hhhhhHHHHHHh-hcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            000000000000 0000000000   1234568899999999999999999999864

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=7.9e-44  Score=328.71  Aligned_cols=254  Identities=19%  Similarity=0.212  Sum_probs=198.3

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC--hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST--LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVF  132 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  132 (339)
                      ++|++.+.||+|+||+||+|....+++.||+|++.....  ......+.+|+.++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            478999999999999999999998999999999975421  233456778999999999999999999999999999999


Q ss_pred             EeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCce
Q 019536          133 ESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH  210 (339)
Q Consensus       133 e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~  210 (339)
                      ||+++|+|.+++.  ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+......
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~  157 (363)
T cd05628          81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT  157 (363)
T ss_pred             cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence            9999999999875  56888999999999999999999   999999999999999999999999999998765321100


Q ss_pred             ---------------------------------eeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccc
Q 019536          211 ---------------------------------VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLE  257 (339)
Q Consensus       211 ---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~  257 (339)
                                                       ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~  237 (363)
T cd05628         158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC  237 (363)
T ss_pred             cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence                                             00113469999999999999999999999999999999999999985


Q ss_pred             cCCCCCCCchhHHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhc--cCCCCCCCHHHHHHH
Q 019536          258 FKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLS--KSPEHRPLMVDVAKQ  330 (339)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~--~dP~~Rps~~~il~~  330 (339)
                      ...        ..+....... ..          ....+|.....+.++.+++.+++.  .++..||++.+|+++
T Consensus       238 ~~~--------~~~~~~~i~~-~~----------~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         238 SET--------PQETYKKVMN-WK----------ETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             CCC--------HHHHHHHHHc-Cc----------CcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            221        1111111110 00          001112111244578888887554  233346899999875

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=6.6e-44  Score=323.70  Aligned_cols=236  Identities=24%  Similarity=0.287  Sum_probs=191.6

Q ss_pred             CceeccCCeeEEEEEEcCCCeeEEEEEeccCC--ChhhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCccEEEEEeccC
Q 019536           61 KVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS--TLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLETELPTLVFESVKY  137 (339)
Q Consensus        61 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~  137 (339)
                      +.||+|+||+||+|....+++.||+|++....  .......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46899999999999999899999999987542  223456677888888776 799999999999999999999999999


Q ss_pred             Cccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceeeecc
Q 019536          138 GTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEF  215 (339)
Q Consensus       138 g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~~~  215 (339)
                      |+|.+++.  ..++...+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++........  ...
T Consensus        81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~--~~~  155 (320)
T cd05590          81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--TST  155 (320)
T ss_pred             chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCc--ccc
Confidence            99988875  56888889999999999999999   999999999999999999999999999998754322221  123


Q ss_pred             cccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCCCC
Q 019536          216 IKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNS  295 (339)
Q Consensus       216 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (339)
                      ..||+.|+|||++.+..++.++||||+||++|+|++|+.||.....        ...... ....            ...
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~--------~~~~~~-i~~~------------~~~  214 (320)
T cd05590         156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE--------DDLFEA-ILND------------EVV  214 (320)
T ss_pred             cccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH--------HHHHHH-HhcC------------CCC
Confidence            5689999999999988999999999999999999999999853211        111111 1111            111


Q ss_pred             CCCcHHHHHHHHHHHHHhhccCCCCCCCH
Q 019536          296 FPGKEEKLQSLGQLMYKCLSKSPEHRPLM  324 (339)
Q Consensus       296 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~  324 (339)
                      .|  ...+.++.+++.+||+.||++||++
T Consensus       215 ~~--~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         215 YP--TWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             CC--CCCCHHHHHHHHHHcccCHHHCCCC
Confidence            11  1345678999999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=8.6e-43  Score=308.80  Aligned_cols=253  Identities=26%  Similarity=0.382  Sum_probs=198.7

Q ss_pred             cccCCceeccCCeeEEEEEEcCCCe--eEEEEEeccCC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeC------Cc
Q 019536           57 YDLHKVIQSDTSYRLFEGTLVDQDR--PISVMKFHDNS-TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLET------EL  127 (339)
Q Consensus        57 ~~~~~~ig~G~~g~V~~~~~~~~~~--~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~------~~  127 (339)
                      |.+.+.||+|+||.||+|.+..++.  .+|+|.+.... .....+.+.+|+.+++.++||||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            4567899999999999999876664  68999887642 334567788999999999999999999987532      24


Q ss_pred             cEEEEEeccCCccccccc--------cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCC
Q 019536          128 PTLVFESVKYGTLRGFSF--------ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFS  199 (339)
Q Consensus       128 ~~lv~e~~~~g~L~~~~~--------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg  199 (339)
                      .+++|||+++|+|.+++.        ..+++.....++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCC
Confidence            689999999999988752        23678888999999999999999   8999999999999999999999999999


Q ss_pred             CccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhh
Q 019536          200 LSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIE  278 (339)
Q Consensus       200 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  278 (339)
                      +++...............++..|+|||++.+..++.++|+||||+++|+|++ |+.||...  ..      .. ......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~--~~------~~-~~~~~~  228 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGV--EN------SE-IYDYLR  228 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCC--CH------HH-HHHHHH
Confidence            9987654433222222345678999999998899999999999999999999 78887421  11      11 111111


Q ss_pred             cCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 019536          279 NNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQM  334 (339)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l  334 (339)
                      .+..             .+.+...+..+.+++.+||+.||++|||+.++++.|+++
T Consensus       229 ~~~~-------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         229 QGNR-------------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             cCCC-------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            1110             011123445689999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=5.5e-43  Score=307.52  Aligned_cols=248  Identities=19%  Similarity=0.301  Sum_probs=198.9

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFES  134 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  134 (339)
                      ++|++.+.||+|+||.||+|... .+..+|+|.+....  .....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   80 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGA--MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF   80 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCC--ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence            46888899999999999999886 45689999876543  2345688999999999999999999999999999999999


Q ss_pred             ccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCcee
Q 019536          135 VKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHV  211 (339)
Q Consensus       135 ~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~  211 (339)
                      +++|+|.+++.   ..+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+|++|||.++.........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05114          81 MENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS  157 (256)
T ss_pred             CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence            99999998875   35788889999999999999999   8999999999999999999999999999987664433221


Q ss_pred             eecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcc
Q 019536          212 REEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIF  290 (339)
Q Consensus       212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (339)
                      . ....++..|+|||++.+..++.++|+||||+++|+|++ |+.||....        ..+..........         
T Consensus       158 ~-~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~--------~~~~~~~i~~~~~---------  219 (256)
T cd05114         158 S-SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS--------NYEVVEMISRGFR---------  219 (256)
T ss_pred             c-CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC--------HHHHHHHHHCCCC---------
Confidence            1 12234567999999988889999999999999999999 888874221        1111111111110         


Q ss_pred             cCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 019536          291 DEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQL  331 (339)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L  331 (339)
                           .+.+...+..+.+++.+||+.+|++|||+.++++.|
T Consensus       220 -----~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         220 -----LYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             -----CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence                 011112345789999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=9.3e-44  Score=321.17  Aligned_cols=267  Identities=17%  Similarity=0.202  Sum_probs=199.9

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFES  134 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  134 (339)
                      ++|.+.+.||+|+||+||+|.+..++..||+|.+...........+.+|+.+++.++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            57999999999999999999999899999999987654434445677899999999999999999999999999999999


Q ss_pred             ccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCcee
Q 019536          135 VKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHV  211 (339)
Q Consensus       135 ~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~  211 (339)
                      +++ +|.+++.   ..++...+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++.........
T Consensus        86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  161 (309)
T cd07872          86 LDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTY  161 (309)
T ss_pred             CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCCcccc
Confidence            975 6766654   34778888899999999999999   8999999999999999999999999999987654332211


Q ss_pred             eeccccccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCccccccc---
Q 019536          212 REEFIKGAYGFIAPEYFAT-SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVD---  287 (339)
Q Consensus       212 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  287 (339)
                        ....++..|+|||++.+ ..++.++||||+||++|+|++|+.||......  +................+..+..   
T Consensus       162 --~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07872         162 --SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVE--DELHLIFRLLGTPTEETWPGISSNDE  237 (309)
T ss_pred             --ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCCHHHHhhhcchhh
Confidence              12457889999998865 46889999999999999999999998532211  11111111000000000000000   


Q ss_pred             ------CcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          288 ------PIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       288 ------~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                            +..............+.++.+|+.+||+.||.+|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence                  000000000011134567899999999999999999999987

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1e-42  Score=309.85  Aligned_cols=260  Identities=24%  Similarity=0.386  Sum_probs=209.3

Q ss_pred             HhcCcccCCceeccCCeeEEEEEEcC----CCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeee-CCc
Q 019536           53 ATNNYDLHKVIQSDTSYRLFEGTLVD----QDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLE-TEL  127 (339)
Q Consensus        53 ~~~~~~~~~~ig~G~~g~V~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~-~~~  127 (339)
                      ..++|++.+.||+|+||.||+|.+..    .+..|++|.+...........+.+|+.+++.++||||+++++++.. +..
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            35789999999999999999999875    2588999998766555667778899999999999999999998876 567


Q ss_pred             cEEEEEeccCCccccccc----------cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEec
Q 019536          128 PTLVFESVKYGTLRGFSF----------ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHD  197 (339)
Q Consensus       128 ~~lv~e~~~~g~L~~~~~----------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~d  197 (339)
                      .++++||+++|+|.+++.          ..+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.+|++|
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECC
Confidence            899999999999998874          24778888999999999999999   89999999999999999999999999


Q ss_pred             CCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHH
Q 019536          198 FSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKS  276 (339)
Q Consensus       198 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~  276 (339)
                      ||+++.+.............++..|+|||++.+..++.++||||||+++|++++ |+.||....     .   ...... 
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-----~---~~~~~~-  231 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID-----P---FEMAAY-  231 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC-----H---HHHHHH-
Confidence            999987654433322223345678999999988889999999999999999998 999974211     1   111111 


Q ss_pred             hhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          277 IENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                      .....             ..+.+..++.++.+++.+||+.||++|||+.++++.|+.+...
T Consensus       232 ~~~~~-------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~  279 (280)
T cd05043         232 LKDGY-------------RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ  279 (280)
T ss_pred             HHcCC-------------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence            11110             0111123445789999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-44  Score=294.64  Aligned_cols=260  Identities=20%  Similarity=0.250  Sum_probs=212.5

Q ss_pred             HhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC-----c
Q 019536           53 ATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETE-----L  127 (339)
Q Consensus        53 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~-----~  127 (339)
                      ..++|.+.+.+|+|||+-||.+....++..+|+|++.-.. .++.+..++|+...++++|||+++++++...+.     .
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~   97 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE   97 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence            3478999999999999999999998999999999987665 377888999999999999999999999886543     3


Q ss_pred             cEEEEEeccCCccccccc------cCCChHHHHHHHHHHHHHHHHHhcCCCCC--eEEccCCCCCEEeCCCCceEEecCC
Q 019536          128 PTLVFESVKYGTLRGFSF------ASLLIAPRIKIAMEIANAVAYLHVGFDRP--IVFRCIKASNVLLDENYSAKLHDFS  199 (339)
Q Consensus       128 ~~lv~e~~~~g~L~~~~~------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~dlk~~Nil~~~~~~~kl~dfg  199 (339)
                      .||+++|...|+|.+.+.      ..+++.+.+.|+.++++||.+||   +..  ..||||||.|||+++.+.+++.|||
T Consensus        98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH---~~~~~yAH~DiKP~NILls~~~~~vl~D~G  174 (302)
T KOG2345|consen   98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALH---EKEPPYAHRDIKPANILLSDSGLPVLMDLG  174 (302)
T ss_pred             EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHh---ccCCcccccCCCcceeEecCCCceEEEecc
Confidence            899999999999999876      36889999999999999999999   555  9999999999999999999999999


Q ss_pred             CccccCCCCceee-------ecccccccccccccccccC---CCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhH
Q 019536          200 LSVSIPEGETHVR-------EEFIKGAYGFIAPEYFATS---SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTV  269 (339)
Q Consensus       200 ~a~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~  269 (339)
                      .++..+-.-....       -.....|..|+|||++.-.   ..+.++|||||||++|+|+.|..||+..-.        
T Consensus       175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~--------  246 (302)
T KOG2345|consen  175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ--------  246 (302)
T ss_pred             CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh--------
Confidence            9876532111000       0012357889999998754   456899999999999999999999862111        


Q ss_pred             HHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 019536          270 LEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMY  335 (339)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~  335 (339)
                              ..+   .+.-.....+..+|..+..++.+.++++.||+.||.+||++.+++..++.+.
T Consensus       247 --------~Gg---SlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  247 --------QGG---SLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             --------cCC---eEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence                    111   1222233445566666668889999999999999999999999999998874

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2.2e-43  Score=310.78  Aligned_cols=254  Identities=22%  Similarity=0.348  Sum_probs=207.3

Q ss_pred             HHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 019536           52 KATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLV  131 (339)
Q Consensus        52 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  131 (339)
                      +...+|++.+.||.|+||.||+|.+.. +..+++|.+..... .....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (261)
T cd05148           3 RPREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL-LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII   80 (261)
T ss_pred             CcHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch-hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence            345679999999999999999999986 89999999876543 3456688999999999999999999999999999999


Q ss_pred             EEeccCCccccccc----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCC
Q 019536          132 FESVKYGTLRGFSF----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEG  207 (339)
Q Consensus       132 ~e~~~~g~L~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~  207 (339)
                      |||+++|+|.+++.    ..+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.+||+|||.+......
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~  157 (261)
T cd05148          81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKED  157 (261)
T ss_pred             EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence            99999999999986    35788889999999999999999   899999999999999999999999999998776443


Q ss_pred             CceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCcccccc
Q 019536          208 ETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIV  286 (339)
Q Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (339)
                      .....  ...++..|+|||.+.+..++.++|+||||+++|+|++ |+.||....        ..+........       
T Consensus       158 ~~~~~--~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~--------~~~~~~~~~~~-------  220 (261)
T cd05148         158 VYLSS--DKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN--------NHEVYDQITAG-------  220 (261)
T ss_pred             ccccc--CCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC--------HHHHHHHHHhC-------
Confidence            22211  2345678999999988889999999999999999998 888874221        11111111110       


Q ss_pred             cCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 019536          287 DPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQM  334 (339)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l  334 (339)
                             ...+.+...+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus       221 -------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         221 -------YRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             -------CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence                   01111224556789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=8.6e-44  Score=323.11  Aligned_cols=242  Identities=19%  Similarity=0.247  Sum_probs=195.1

Q ss_pred             CceeccCCeeEEEEEEcCCCeeEEEEEeccCC--ChhhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCccEEEEEeccC
Q 019536           61 KVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS--TLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLETELPTLVFESVKY  137 (339)
Q Consensus        61 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~  137 (339)
                      +.||+|+||.||+|.+..+++.||+|++....  .......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46899999999999999899999999987642  223455677888888866 899999999999999999999999999


Q ss_pred             Cccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceeeecc
Q 019536          138 GTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEF  215 (339)
Q Consensus       138 g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~~~  215 (339)
                      |+|...+.  ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++........  ...
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~--~~~  155 (321)
T cd05591          81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTT  155 (321)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccCCcc--ccc
Confidence            99988875  56788888999999999999999   899999999999999999999999999998764332221  123


Q ss_pred             cccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCCCC
Q 019536          216 IKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNS  295 (339)
Q Consensus       216 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (339)
                      ..||+.|+|||++.+..++.++||||+||++|+|++|+.||.....        ......... .            ...
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~--------~~~~~~i~~-~------------~~~  214 (321)
T cd05591         156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE--------DDLFESILH-D------------DVL  214 (321)
T ss_pred             cccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH--------HHHHHHHHc-C------------CCC
Confidence            5689999999999988999999999999999999999999853211        111111111 0            111


Q ss_pred             CCCcHHHHHHHHHHHHHhhccCCCCCC-------CHHHHHHH
Q 019536          296 FPGKEEKLQSLGQLMYKCLSKSPEHRP-------LMVDVAKQ  330 (339)
Q Consensus       296 ~~~~~~~~~~~~~li~~cl~~dP~~Rp-------s~~~il~~  330 (339)
                      .|  ...+.++.+++.+||+.||++||       ++.+++++
T Consensus       215 ~p--~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         215 YP--VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             CC--CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            11  12445789999999999999999       77777753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=5.7e-44  Score=331.88  Aligned_cols=251  Identities=18%  Similarity=0.221  Sum_probs=198.2

Q ss_pred             CcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC--ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 019536           56 NYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS--TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFE  133 (339)
Q Consensus        56 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  133 (339)
                      .|++.+.||+|+||+||+|....+++.||+|++....  .......+.+|+.+++.++||||+++++++.+++..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5888999999999999999999999999999987542  12345678899999999999999999999999999999999


Q ss_pred             eccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCC---
Q 019536          134 SVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE---  208 (339)
Q Consensus       134 ~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~---  208 (339)
                      |+++|+|.+++.  ..++...+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+....   
T Consensus        82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~  158 (382)
T cd05625          82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK  158 (382)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence            999999998875  45788888899999999999999   8999999999999999999999999999975432100   


Q ss_pred             ------------------------------------------ceeeecccccccccccccccccCCCCcccchHHHHHHH
Q 019536          209 ------------------------------------------THVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFL  246 (339)
Q Consensus       209 ------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l  246 (339)
                                                                .........||+.|+|||++.+..|+.++||||+||++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil  238 (382)
T cd05625         159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL  238 (382)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHH
Confidence                                                      00001124689999999999999999999999999999


Q ss_pred             HHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCC---
Q 019536          247 CELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPL---  323 (339)
Q Consensus       247 ~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps---  323 (339)
                      |||++|+.||.....        .+........           ......|.....+.++.+++.+|+ .+|.+|++   
T Consensus       239 ~elltG~~Pf~~~~~--------~~~~~~i~~~-----------~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~  298 (382)
T cd05625         239 YEMLVGQPPFLAQTP--------LETQMKVINW-----------QTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNG  298 (382)
T ss_pred             HHHHhCCCCCCCCCH--------HHHHHHHHcc-----------CCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCC
Confidence            999999999852211        1111111100           001112222244567888888876 59999997   


Q ss_pred             HHHHHH
Q 019536          324 MVDVAK  329 (339)
Q Consensus       324 ~~~il~  329 (339)
                      +.+++.
T Consensus       299 ~~ei~~  304 (382)
T cd05625         299 ADEIKA  304 (382)
T ss_pred             HHHHhc
Confidence            887765

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=5e-43  Score=312.37  Aligned_cols=269  Identities=24%  Similarity=0.344  Sum_probs=204.0

Q ss_pred             cccCCceeccCCeeEEEEEE----cCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeC--CccEE
Q 019536           57 YDLHKVIQSDTSYRLFEGTL----VDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLET--ELPTL  130 (339)
Q Consensus        57 ~~~~~~ig~G~~g~V~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~--~~~~l  130 (339)
                      |++.+.||.|+||+||.+..    ..++..||+|.+...........+.+|+.+++.++||||+++++++...  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            38889999999999988653    3467899999987664434567788999999999999999999998753  35789


Q ss_pred             EEEeccCCccccccc-cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCc
Q 019536          131 VFESVKYGTLRGFSF-ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGET  209 (339)
Q Consensus       131 v~e~~~~g~L~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~  209 (339)
                      ||||+++|+|.+++. ..+++..+..++.|++.||.|||   +.+++||||||+||+++.++.++|+|||+++.......
T Consensus        86 v~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~  162 (283)
T cd05080          86 IMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE  162 (283)
T ss_pred             EecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeecccccccCCcch
Confidence            999999999999876 57899999999999999999999   89999999999999999999999999999887654322


Q ss_pred             eee-ecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccC
Q 019536          210 HVR-EEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDP  288 (339)
Q Consensus       210 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (339)
                      ... .....++..|+|||.+.+..++.++||||||+++|+|++|+.|+........+   .............+....+ 
T Consensus       163 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~-  238 (283)
T cd05080         163 YYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEE---MIGPKQGQMTVVRLIELLE-  238 (283)
T ss_pred             hhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhh---hhcccccccchhhhhhhhh-
Confidence            111 11223456799999998888999999999999999999999997533211000   0000000000000000011 


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 019536          289 IFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMY  335 (339)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~  335 (339)
                         .....+.+...+..+.+++.+||+.||++|||+.++++.|+.+-
T Consensus       239 ---~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         239 ---RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             ---cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence               01111222345568999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.1e-43  Score=322.63  Aligned_cols=241  Identities=20%  Similarity=0.267  Sum_probs=195.0

Q ss_pred             CcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC--hhhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCccEEEE
Q 019536           56 NYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST--LDDVEYCFNNIVFSSQM-KHKNILKLIGCCLETELPTLVF  132 (339)
Q Consensus        56 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~~lv~  132 (339)
                      +|.+.+.||+|+||.||+|.+..+++.||+|.+.....  ......+..|..++..+ +|++|+.+++++.+.+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            57889999999999999999998999999999876421  23345566788888777 6899999999999999999999


Q ss_pred             EeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCce
Q 019536          133 ESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH  210 (339)
Q Consensus       133 e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~  210 (339)
                      ||+++|+|.+++.  ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++........
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~  157 (323)
T cd05616          81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT  157 (323)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCc
Confidence            9999999988875  56888899999999999999999   899999999999999999999999999998754322221


Q ss_pred             eeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcc
Q 019536          211 VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIF  290 (339)
Q Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (339)
                        .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.....     ....   .... ..          
T Consensus       158 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~-----~~~~---~~i~-~~----------  216 (323)
T cd05616         158 --TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-----DELF---QSIM-EH----------  216 (323)
T ss_pred             --cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH-----HHHH---HHHH-hC----------
Confidence              1235689999999999999999999999999999999999999853211     1111   1111 11          


Q ss_pred             cCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCH
Q 019536          291 DEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLM  324 (339)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~  324 (339)
                        ...+|  ...+.++.+++.+||+.||++|+++
T Consensus       217 --~~~~p--~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         217 --NVAYP--KSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             --CCCCC--CcCCHHHHHHHHHHcccCHHhcCCC
Confidence              11111  1345678999999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=8.5e-43  Score=314.14  Aligned_cols=260  Identities=21%  Similarity=0.325  Sum_probs=206.9

Q ss_pred             HHhcCcccCCceeccCCeeEEEEEEc-------CCCeeEEEEEeccCCChhhHHHHHHHHHHHHhc-CCCceeeeeeeee
Q 019536           52 KATNNYDLHKVIQSDTSYRLFEGTLV-------DQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCCL  123 (339)
Q Consensus        52 ~~~~~~~~~~~ig~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~  123 (339)
                      ...++|.+.+.||+|+||.||.|...       .++..||+|.+...........+.+|+.+++.+ +||||+++++++.
T Consensus        12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   91 (304)
T cd05101          12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT   91 (304)
T ss_pred             ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence            34578899999999999999999753       234579999987654445667788999999999 8999999999999


Q ss_pred             eCCccEEEEEeccCCcccccccc------------------CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCE
Q 019536          124 ETELPTLVFESVKYGTLRGFSFA------------------SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNV  185 (339)
Q Consensus       124 ~~~~~~lv~e~~~~g~L~~~~~~------------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Ni  185 (339)
                      .....++||||+++|+|.+++..                  .+++.++..++.|++.||.|||   +.+++||||||+||
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Ni  168 (304)
T cd05101          92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNV  168 (304)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceE
Confidence            99999999999999999988642                  3567778889999999999999   89999999999999


Q ss_pred             EeCCCCceEEecCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCC
Q 019536          186 LLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGND  264 (339)
Q Consensus       186 l~~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~  264 (339)
                      +++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|++++ |..||...     
T Consensus       169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-----  243 (304)
T cd05101         169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-----  243 (304)
T ss_pred             EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC-----
Confidence            999999999999999987654333222222345677999999988889999999999999999998 77776421     


Q ss_pred             CchhHHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 019536          265 DDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYL  336 (339)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~  336 (339)
                         ...+..... .....             ...+..++..+.+|+.+||+.+|++|||+.++++.|+++..
T Consensus       244 ---~~~~~~~~~-~~~~~-------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~  298 (304)
T cd05101         244 ---PVEELFKLL-KEGHR-------------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT  298 (304)
T ss_pred             ---CHHHHHHHH-HcCCc-------------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence               111111111 11110             01112345679999999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2.5e-43  Score=322.87  Aligned_cols=260  Identities=20%  Similarity=0.336  Sum_probs=202.8

Q ss_pred             hcCcccCCceeccCCeeEEEEEEc-----CCCeeEEEEEeccCCChhhHHHHHHHHHHHHhc-CCCceeeeeeeeee-CC
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLV-----DQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLE-TE  126 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~-~~  126 (339)
                      .++|.+.+.||+|+||.||+|.+.     .+++.||||++...........+.+|+.++..+ +||||++++++|.. +.
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            467999999999999999999853     357899999997655445567788999999999 78999999998865 45


Q ss_pred             ccEEEEEeccCCcccccccc------------------------------------------------------------
Q 019536          127 LPTLVFESVKYGTLRGFSFA------------------------------------------------------------  146 (339)
Q Consensus       127 ~~~lv~e~~~~g~L~~~~~~------------------------------------------------------------  146 (339)
                      ..++||||+++|+|.+++..                                                            
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            67899999999999887641                                                            


Q ss_pred             ---------CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceeeecccc
Q 019536          147 ---------SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIK  217 (339)
Q Consensus       147 ---------~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~  217 (339)
                               .+++.....++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++...............
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                     2466677889999999999999   8999999999999999999999999999987764332222221233


Q ss_pred             cccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCCCCC
Q 019536          218 GAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSF  296 (339)
Q Consensus       218 gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (339)
                      ++..|+|||++.+..++.++|+||||+++|++++ |..||......    ..    ..........             .
T Consensus       243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----~~----~~~~~~~~~~-------------~  301 (343)
T cd05103         243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID----EE----FCRRLKEGTR-------------M  301 (343)
T ss_pred             CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc----HH----HHHHHhccCC-------------C
Confidence            5667999999988899999999999999999997 88887532111    00    1111111110             0


Q ss_pred             CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          297 PGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       297 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                      +.+...+..+.+++..||+.||++|||+.+|++.|+.+.+.
T Consensus       302 ~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~  342 (343)
T cd05103         302 RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  342 (343)
T ss_pred             CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            01112334689999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=5.1e-43  Score=309.51  Aligned_cols=254  Identities=22%  Similarity=0.285  Sum_probs=202.5

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFE  133 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  133 (339)
                      .++|++.+.||+|+||.||+|....+++.||+|++..... .....+.+|+.+++.++||||+++++++..++..++|||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e   86 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG-DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME   86 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc-chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence            3579999999999999999999988999999999875533 345567799999999999999999999999999999999


Q ss_pred             eccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCcee
Q 019536          134 SVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHV  211 (339)
Q Consensus       134 ~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~  211 (339)
                      |+++++|.+++.  ..+++..+..++.|++.||.|||   +.+|+||||+|+||+++.++.++|+|||++..+...... 
T Consensus        87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~-  162 (267)
T cd06646          87 YCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK-  162 (267)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeecccccc-
Confidence            999999998875  56788888999999999999999   899999999999999999999999999998876432211 


Q ss_pred             eecccccccccccccccc---cCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccC
Q 019536          212 REEFIKGAYGFIAPEYFA---TSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDP  288 (339)
Q Consensus       212 ~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (339)
                       .....++..|+|||.+.   ...++.++|+||+||++|+|++|+.||........        .         ..+...
T Consensus       163 -~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~--------~---------~~~~~~  224 (267)
T cd06646         163 -RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--------L---------FLMSKS  224 (267)
T ss_pred             -cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh--------h---------eeeecC
Confidence             11345788999999884   34578899999999999999999999742211100        0         000000


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 019536          289 IFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQL  331 (339)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L  331 (339)
                      .+. ....+.....+..+.+++.+||+.||++|||+.+|++.|
T Consensus       225 ~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         225 NFQ-PPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             CCC-CCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            000 001111123456899999999999999999999998754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-43  Score=313.70  Aligned_cols=250  Identities=18%  Similarity=0.268  Sum_probs=201.0

Q ss_pred             CcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC--hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 019536           56 NYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST--LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFE  133 (339)
Q Consensus        56 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  133 (339)
                      .|++.++||+|+||+||++....+++.||+|++.....  ......+.+|+.+++.++||||+++++++.+++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            47888999999999999999988899999999875422  1233557789999999999999999999999999999999


Q ss_pred             eccCCccccccc----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCc
Q 019536          134 SVKYGTLRGFSF----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGET  209 (339)
Q Consensus       134 ~~~~g~L~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~  209 (339)
                      |+++|+|.+++.    ..+++..+..++.|++.||.|||   +.+++||||||+||++++++.++|+|||+++.......
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  157 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET  157 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence            999999987764    35788899999999999999999   89999999999999999999999999999887644332


Q ss_pred             eeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCc
Q 019536          210 HVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPI  289 (339)
Q Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (339)
                      .   ....|+..|+|||++.+..++.++|+||+||++|++++|+.||.....  .   ...+..........        
T Consensus       158 ~---~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~--~---~~~~~~~~~~~~~~--------  221 (285)
T cd05605         158 I---RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE--K---VKREEVERRVKEDQ--------  221 (285)
T ss_pred             c---ccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCch--h---hHHHHHHHHhhhcc--------
Confidence            1   134688999999999888899999999999999999999999853211  1   11111111111100        


Q ss_pred             ccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 019536          290 FDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP-----LMVDVAKQ  330 (339)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~il~~  330 (339)
                          ..  .+...+..+.+|+.+||+.||++||     ++.+++++
T Consensus       222 ----~~--~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         222 ----EE--YSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             ----cc--cCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence                01  1123556789999999999999999     88888653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2.8e-43  Score=318.80  Aligned_cols=261  Identities=22%  Similarity=0.326  Sum_probs=205.9

Q ss_pred             HHhcCcccCCceeccCCeeEEEEEEc-------CCCeeEEEEEeccCCChhhHHHHHHHHHHHHhc-CCCceeeeeeeee
Q 019536           52 KATNNYDLHKVIQSDTSYRLFEGTLV-------DQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCCL  123 (339)
Q Consensus        52 ~~~~~~~~~~~ig~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~  123 (339)
                      ...++|.+.+.||+|+||.||+|...       .....+|+|.+...........+.+|+.+++.+ +||||+++++++.
T Consensus         9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   88 (314)
T cd05099           9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT   88 (314)
T ss_pred             ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence            34468899999999999999999763       234579999988665545667788999999999 6999999999999


Q ss_pred             eCCccEEEEEeccCCcccccccc------------------CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCE
Q 019536          124 ETELPTLVFESVKYGTLRGFSFA------------------SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNV  185 (339)
Q Consensus       124 ~~~~~~lv~e~~~~g~L~~~~~~------------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Ni  185 (339)
                      +.+..++||||+++|+|.+++..                  .+++..+..++.|++.||.|||   +.+++||||||+||
T Consensus        89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Ni  165 (314)
T cd05099          89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNV  165 (314)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeE
Confidence            99999999999999999988742                  3677888899999999999999   89999999999999


Q ss_pred             EeCCCCceEEecCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCC
Q 019536          186 LLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGND  264 (339)
Q Consensus       186 l~~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~  264 (339)
                      +++.++.+||+|||+++...............++..|+|||++.+..++.++|+||||+++|+|++ |..||....    
T Consensus       166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~----  241 (314)
T cd05099         166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP----  241 (314)
T ss_pred             EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC----
Confidence            999999999999999987644322211112234457999999988889999999999999999999 888864211    


Q ss_pred             CchhHHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          265 DDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                       ......    .......             ...+...+.++.+++.+||+.||++|||+.++++.|.++...
T Consensus       242 -~~~~~~----~~~~~~~-------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~  296 (314)
T cd05099         242 -VEELFK----LLREGHR-------------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA  296 (314)
T ss_pred             -HHHHHH----HHHcCCC-------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence             111111    1111100             011123445788999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=2.7e-43  Score=316.40  Aligned_cols=254  Identities=21%  Similarity=0.317  Sum_probs=202.1

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCe--eEEEEEeccCCChhhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCccEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDR--PISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLETELPTLV  131 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~~lv  131 (339)
                      ++|++.+.||+|+||.||+|....++.  .+++|.++........+.+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            578999999999999999999876664  47888877544445567788999999999 799999999999999999999


Q ss_pred             EEeccCCcccccccc------------------CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCce
Q 019536          132 FESVKYGTLRGFSFA------------------SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSA  193 (339)
Q Consensus       132 ~e~~~~g~L~~~~~~------------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~  193 (339)
                      +||+++|+|.+++..                  .+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeE
Confidence            999999999888742                  3677888999999999999999   8999999999999999999999


Q ss_pred             EEecCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHH
Q 019536          194 KLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEY  272 (339)
Q Consensus       194 kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~  272 (339)
                      ||+|||++.......   .......+..|+|||++.+..++.++|||||||++|+|++ |..||.....        ...
T Consensus       159 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~--------~~~  227 (297)
T cd05089         159 KIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC--------AEL  227 (297)
T ss_pred             EECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH--------HHH
Confidence            999999986432211   1111223456999999988899999999999999999997 9999742211        111


Q ss_pred             HHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 019536          273 AKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYL  336 (339)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~  336 (339)
                      .......              ...+.+...+..+.+|+.+||+.+|.+|||+.++++.|+.+..
T Consensus       228 ~~~~~~~--------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~  277 (297)
T cd05089         228 YEKLPQG--------------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE  277 (297)
T ss_pred             HHHHhcC--------------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            1111110              0001112345678999999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.8e-43  Score=318.98  Aligned_cols=260  Identities=22%  Similarity=0.320  Sum_probs=206.2

Q ss_pred             HhcCcccCCceeccCCeeEEEEEEcC-------CCeeEEEEEeccCCChhhHHHHHHHHHHHHhc-CCCceeeeeeeeee
Q 019536           53 ATNNYDLHKVIQSDTSYRLFEGTLVD-------QDRPISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLE  124 (339)
Q Consensus        53 ~~~~~~~~~~ig~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~  124 (339)
                      ..++|.+.+.||+|+||.||.|...+       +...+|+|.+...........+.+|+.+++.+ +||||+++++++..
T Consensus        16 ~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (307)
T cd05098          16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ   95 (307)
T ss_pred             ehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence            34789999999999999999998643       23469999988654445567788999999999 79999999999999


Q ss_pred             CCccEEEEEeccCCcccccccc------------------CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEE
Q 019536          125 TELPTLVFESVKYGTLRGFSFA------------------SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVL  186 (339)
Q Consensus       125 ~~~~~lv~e~~~~g~L~~~~~~------------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil  186 (339)
                      ++..++||||+++|+|.+++..                  .+++..++.++.|++.||+|||   +.+++||||||+||+
T Consensus        96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nil  172 (307)
T cd05098          96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVL  172 (307)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheE
Confidence            9999999999999999988752                  3677888999999999999999   899999999999999


Q ss_pred             eCCCCceEEecCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCC
Q 019536          187 LDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDD  265 (339)
Q Consensus       187 ~~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~  265 (339)
                      ++.++.+||+|||+++...............++..|+|||++.+..++.++|+|||||++|+|++ |..||....     
T Consensus       173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~-----  247 (307)
T cd05098         173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-----  247 (307)
T ss_pred             EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC-----
Confidence            99999999999999876643222111112234567999999988889999999999999999998 888864211     


Q ss_pred             chhHHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          266 DLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                         ..+ .........             ..+.+...+.++.+|+.+||+.+|++|||+.++++.|+++...
T Consensus       248 ---~~~-~~~~~~~~~-------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~  302 (307)
T cd05098         248 ---VEE-LFKLLKEGH-------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL  302 (307)
T ss_pred             ---HHH-HHHHHHcCC-------------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence               111 111111110             0111123456789999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=7.1e-43  Score=312.25  Aligned_cols=259  Identities=19%  Similarity=0.312  Sum_probs=202.9

Q ss_pred             HHhcCcccCCceeccCCeeEEEEEEcC-----CCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC
Q 019536           52 KATNNYDLHKVIQSDTSYRLFEGTLVD-----QDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETE  126 (339)
Q Consensus        52 ~~~~~~~~~~~ig~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~  126 (339)
                      ...++|++.+.||+|+||.||+|...+     .+..||+|.+...........+.+|+.+++.++||||+++++++.+++
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ   82 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            346789999999999999999997642     355899999876554445566889999999999999999999999999


Q ss_pred             ccEEEEEeccCCcccccccc------------CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceE
Q 019536          127 LPTLVFESVKYGTLRGFSFA------------SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAK  194 (339)
Q Consensus       127 ~~~lv~e~~~~g~L~~~~~~------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~k  194 (339)
                      ..++||||+++|+|.+++..            .........++.|++.||.|||   +++|+||||||+||+++.++.++
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~  159 (288)
T cd05061          83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVK  159 (288)
T ss_pred             CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEE
Confidence            99999999999999999752            2245567889999999999999   99999999999999999999999


Q ss_pred             EecCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHH
Q 019536          195 LHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYA  273 (339)
Q Consensus       195 l~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~  273 (339)
                      |+|||+++...............++..|+|||.+.+..++.++|+|||||++|+|++ |..||....        ..+..
T Consensus       160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~--------~~~~~  231 (288)
T cd05061         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS--------NEQVL  231 (288)
T ss_pred             ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCC--------HHHHH
Confidence            999999876544332211112234677999999988899999999999999999998 777864211        11111


Q ss_pred             HHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 019536          274 KKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMY  335 (339)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~  335 (339)
                      .........              +.+...+..+.+++.+||+.||++|||+.++++.|.+..
T Consensus       232 ~~~~~~~~~--------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         232 KFVMDGGYL--------------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             HHHHcCCCC--------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence            111111100              011133457999999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.7e-43  Score=314.50  Aligned_cols=261  Identities=21%  Similarity=0.280  Sum_probs=201.1

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCC--------------CeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeee
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQ--------------DRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLI  119 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~--------------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~  119 (339)
                      .++|++.+.||+|+||.||.+...+.              ...||+|.+...........+.+|+++++.++|||+++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            36799999999999999999987532              2358999998765545567788999999999999999999


Q ss_pred             eeeeeCCccEEEEEeccCCcccccccc--------------CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCE
Q 019536          120 GCCLETELPTLVFESVKYGTLRGFSFA--------------SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNV  185 (339)
Q Consensus       120 ~~~~~~~~~~lv~e~~~~g~L~~~~~~--------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Ni  185 (339)
                      +++...+..++||||+++++|.+++..              .+++..+..++.|++.||.|||   +.+++|+||||+||
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Ni  160 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNC  160 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhE
Confidence            999999999999999999999888641              3577788899999999999999   89999999999999


Q ss_pred             EeCCCCceEEecCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhC--CCccccCCCCC
Q 019536          186 LLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG--CNVLEFKGNGN  263 (339)
Q Consensus       186 l~~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g--~~p~~~~~~~~  263 (339)
                      +++.++.+||+|||+++.+.............++..|+|||++.+..++.++|+|||||++|+|+++  ..||.  ....
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~--~~~~  238 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYS--LLSD  238 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCc--ccCh
Confidence            9999999999999998766443322222223456789999999888899999999999999999984  44543  2111


Q ss_pred             CCchhHHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 019536          264 DDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLR  332 (339)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~  332 (339)
                         ................ ...         ...+...+..+.+|+.+||+.||++|||+.+|++.|.
T Consensus       239 ---~~~~~~~~~~~~~~~~-~~~---------~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         239 ---EQVIENTGEFFRNQGR-QIY---------LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             ---HHHHHHHHHhhhhccc-ccc---------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence               1111111111111000 000         0011123457999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=3.2e-43  Score=314.64  Aligned_cols=263  Identities=17%  Similarity=0.248  Sum_probs=193.5

Q ss_pred             cCcccCCceeccCCeeEEEEEEcC-CCeeEEEEEeccCCCh-hhHHHHHHHHHHHHhc---CCCceeeeeeeeee-----
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVD-QDRPISVMKFHDNSTL-DDVEYCFNNIVFSSQM---KHKNILKLIGCCLE-----  124 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l---~H~niv~~~~~~~~-----  124 (339)
                      ++|++.+.||+|+||+||+|.+.. +++.||+|.+...... .....+.+|+.+++.+   .||||++++++|..     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            478999999999999999999853 4688999998764322 2234556777777665   69999999999852     


Q ss_pred             CCccEEEEEeccCCccccccc----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCC
Q 019536          125 TELPTLVFESVKYGTLRGFSF----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSL  200 (339)
Q Consensus       125 ~~~~~lv~e~~~~g~L~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~  200 (339)
                      ....++||||++ ++|.+++.    ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGL  156 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence            445899999996 57877764    34788899999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHh---
Q 019536          201 SVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSI---  277 (339)
Q Consensus       201 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~---  277 (339)
                      ++.......   .....||..|+|||++.+..++.++|||||||++|+|++|++||.....  .   ..........   
T Consensus       157 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~--~---~~~~~i~~~~~~~  228 (290)
T cd07862         157 ARIYSFQMA---LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD--V---DQLGKILDVIGLP  228 (290)
T ss_pred             eEeccCCcc---cccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCH--H---HHHHHHHHHhCCC
Confidence            976644321   1235689999999999888999999999999999999999999753221  1   1111111100   


Q ss_pred             hcCcccc---cccCcccCCCCCCC---cHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          278 ENNRFGA---IVDPIFDEDNSFPG---KEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       278 ~~~~~~~---~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                      ....+..   +....+......+.   ....+..+.+|+.+||+.||++|||+.++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         229 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             ChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            0000000   00000000000000   0123457889999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.8e-43  Score=320.29  Aligned_cols=241  Identities=24%  Similarity=0.297  Sum_probs=191.8

Q ss_pred             CceeccCCeeEEEEEEcCCCeeEEEEEeccCC--ChhhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCccEEEEEeccC
Q 019536           61 KVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS--TLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLETELPTLVFESVKY  137 (339)
Q Consensus        61 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~  137 (339)
                      +.||+|+||.||+|....+++.||+|.+....  .....+.+..|..++... +||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999999899999999987642  123345556677777654 899999999999999999999999999


Q ss_pred             Cccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceeeecc
Q 019536          138 GTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEF  215 (339)
Q Consensus       138 g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~~~  215 (339)
                      |+|.+++.  ..++...+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++.......  ....
T Consensus        81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~--~~~~  155 (316)
T cd05592          81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG--KAST  155 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC--cccc
Confidence            99988875  56888889999999999999999   89999999999999999999999999999876533222  1224


Q ss_pred             cccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCCCC
Q 019536          216 IKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNS  295 (339)
Q Consensus       216 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (339)
                      ..||+.|+|||++.+..++.++|||||||++|+|++|+.||.....        .+.... ....            ...
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~--------~~~~~~-i~~~------------~~~  214 (316)
T cd05592         156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE--------DELFDS-ILND------------RPH  214 (316)
T ss_pred             ccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH--------HHHHHH-HHcC------------CCC
Confidence            5689999999999988999999999999999999999999853211        111111 1110            001


Q ss_pred             CCCcHHHHHHHHHHHHHhhccCCCCCCCHH-HHHH
Q 019536          296 FPGKEEKLQSLGQLMYKCLSKSPEHRPLMV-DVAK  329 (339)
Q Consensus       296 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~-~il~  329 (339)
                      .|  ...+..+.+++.+||+.||++||++. ++++
T Consensus       215 ~~--~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05592         215 FP--RWISKEAKDCLSKLFERDPTKRLGVDGDIRQ  247 (316)
T ss_pred             CC--CCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence            11  13455788999999999999999875 5543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=2.2e-43  Score=314.30  Aligned_cols=244  Identities=18%  Similarity=0.267  Sum_probs=195.4

Q ss_pred             eeccCCeeEEEEEEcCCCeeEEEEEeccCCC--hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeccCCcc
Q 019536           63 IQSDTSYRLFEGTLVDQDRPISVMKFHDNST--LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL  140 (339)
Q Consensus        63 ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L  140 (339)
                      ||+|+||+||++.+..+++.||+|++.....  ....+.+..|+.+++.++||||+++.+++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            6999999999999998999999999875422  12345677899999999999999999999999999999999999999


Q ss_pred             ccccc------cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceeeec
Q 019536          141 RGFSF------ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREE  214 (339)
Q Consensus       141 ~~~~~------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~~  214 (339)
                      .+++.      ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.++|+|||++..+......  ..
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--cc
Confidence            87652      35788889999999999999999   899999999999999999999999999998766543322  11


Q ss_pred             ccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCCC
Q 019536          215 FIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDN  294 (339)
Q Consensus       215 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (339)
                      ...||+.|+|||++.+..++.++|+|||||++|+|++|+.||...+...    ........             ......
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~----~~~~~~~~-------------~~~~~~  218 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV----ENKELKQR-------------ILNDSV  218 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch----hHHHHHHh-------------hcccCC
Confidence            3468899999999999999999999999999999999999986432211    00000000             000111


Q ss_pred             CCCCcHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 019536          295 SFPGKEEKLQSLGQLMYKCLSKSPEHRP-----LMVDVAKQ  330 (339)
Q Consensus       295 ~~~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~il~~  330 (339)
                      ..  +...+..+.+++.+||+.||++||     ++.+++++
T Consensus       219 ~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         219 TY--PDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             CC--cccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence            11  123556789999999999999999     67777753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.5e-43  Score=321.88  Aligned_cols=241  Identities=22%  Similarity=0.249  Sum_probs=193.6

Q ss_pred             CceeccCCeeEEEEEEc---CCCeeEEEEEeccCC---ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 019536           61 KVIQSDTSYRLFEGTLV---DQDRPISVMKFHDNS---TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFES  134 (339)
Q Consensus        61 ~~ig~G~~g~V~~~~~~---~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  134 (339)
                      +.||+|+||.||++...   .+++.||+|.+....   .......+.+|+.+++.++||||+++++++..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            67999999999999864   468899999987532   113345567899999999999999999999999999999999


Q ss_pred             ccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceee
Q 019536          135 VKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVR  212 (339)
Q Consensus       135 ~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~  212 (339)
                      +++|+|.+++.  ..++...+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++........  
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--  156 (323)
T cd05584          82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTV--  156 (323)
T ss_pred             CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCc--
Confidence            99999998875  45677888889999999999999   999999999999999999999999999998754332221  


Q ss_pred             ecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccC
Q 019536          213 EEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDE  292 (339)
Q Consensus       213 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (339)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|+.||....        .......... .            
T Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~--------~~~~~~~~~~-~------------  215 (323)
T cd05584         157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN--------RKKTIDKILK-G------------  215 (323)
T ss_pred             ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC--------HHHHHHHHHc-C------------
Confidence            123568999999999998889999999999999999999999985221        1111111111 1            


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 019536          293 DNSFPGKEEKLQSLGQLMYKCLSKSPEHRP-----LMVDVAK  329 (339)
Q Consensus       293 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~il~  329 (339)
                      ....  +...+..+.+++.+||+.||++||     ++.++++
T Consensus       216 ~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         216 KLNL--PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             CCCC--CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence            0111  123455789999999999999999     7888776

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=2.4e-43  Score=321.69  Aligned_cols=252  Identities=23%  Similarity=0.271  Sum_probs=198.9

Q ss_pred             CcccCCceeccCCeeEEEEEEc---CCCeeEEEEEeccCC---ChhhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCcc
Q 019536           56 NYDLHKVIQSDTSYRLFEGTLV---DQDRPISVMKFHDNS---TLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLETELP  128 (339)
Q Consensus        56 ~~~~~~~ig~G~~g~V~~~~~~---~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~  128 (339)
                      +|++.+.||+|+||+||++...   .+++.||+|++....   .....+.+.+|+.++..+ +||||+++++++...+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            5888999999999999999874   468899999987532   113345677899999999 599999999999999999


Q ss_pred             EEEEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCC
Q 019536          129 TLVFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPE  206 (339)
Q Consensus       129 ~lv~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~  206 (339)
                      ++||||+++|+|.+++.  ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+..
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~  157 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS  157 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence            99999999999998875  56888899999999999999999   89999999999999999999999999999986544


Q ss_pred             CCceeeecccccccccccccccccC-CCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCccccc
Q 019536          207 GETHVREEFIKGAYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAI  285 (339)
Q Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (339)
                      ...... ....||..|+|||++.+. .++.++|||||||++|+|++|+.||...+...  ...  . .......      
T Consensus       158 ~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--~~~--~-~~~~~~~------  225 (332)
T cd05614         158 EEKERT-YSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN--TQS--E-VSRRILK------  225 (332)
T ss_pred             cCCCcc-ccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCC--CHH--H-HHHHHhc------
Confidence            332211 135689999999999865 47899999999999999999999986433221  111  1 1111100      


Q ss_pred             ccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 019536          286 VDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP-----LMVDVAKQ  330 (339)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~il~~  330 (339)
                            .....  +...+..+.+++.+||+.||++||     ++.+++++
T Consensus       226 ------~~~~~--~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         226 ------CDPPF--PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             ------CCCCC--CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence                  00111  123456789999999999999999     67777753

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2.8e-43  Score=325.58  Aligned_cols=260  Identities=18%  Similarity=0.241  Sum_probs=204.9

Q ss_pred             HHHHHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC--ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC
Q 019536           49 DLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS--TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETE  126 (339)
Q Consensus        49 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~  126 (339)
                      ++....++|++.+.||+|+||.||+|.+..+++.||+|.+....  .......+.+|+.+++.++||||+++++++.+++
T Consensus        37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~  116 (371)
T cd05622          37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR  116 (371)
T ss_pred             hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence            34445589999999999999999999999999999999986532  1233455778999999999999999999999999


Q ss_pred             ccEEEEEeccCCccccccc-cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccC
Q 019536          127 LPTLVFESVKYGTLRGFSF-ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIP  205 (339)
Q Consensus       127 ~~~lv~e~~~~g~L~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~  205 (339)
                      ..++||||+++|+|.+++. ..++...+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus       117 ~~~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~  193 (371)
T cd05622         117 YLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN  193 (371)
T ss_pred             EEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcC
Confidence            9999999999999998876 46788888889999999999999   9999999999999999999999999999998765


Q ss_pred             CCCceeeecccccccccccccccccC----CCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCc
Q 019536          206 EGETHVREEFIKGAYGFIAPEYFATS----SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNR  281 (339)
Q Consensus       206 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (339)
                      ..... ......||+.|+|||++.+.    .++.++||||+||++|+|++|+.||.....        ........... 
T Consensus       194 ~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--------~~~~~~i~~~~-  263 (371)
T cd05622         194 KEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--------VGTYSKIMNHK-  263 (371)
T ss_pred             cCCcc-cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH--------HHHHHHHHcCC-
Confidence            43322 12245699999999998754    378999999999999999999999852211        11111111100 


Q ss_pred             ccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHHH
Q 019536          282 FGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEH--RPLMVDVAKQL  331 (339)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~--Rps~~~il~~L  331 (339)
                                ....+|.....+..+.+++..||+.++.+  |+++.+++++.
T Consensus       264 ----------~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         264 ----------NSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             ----------CcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence                      01122333345668999999999844433  78999988753

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=6.2e-43  Score=307.58  Aligned_cols=248  Identities=21%  Similarity=0.305  Sum_probs=196.8

Q ss_pred             ceeccCCeeEEEEEEc--CCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeccCCc
Q 019536           62 VIQSDTSYRLFEGTLV--DQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGT  139 (339)
Q Consensus        62 ~ig~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~  139 (339)
                      .||+|+||.||+|.+.  ..+..||+|.+.........+.+.+|+.++++++||||+++++++.. +..++||||+++|+
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence            4899999999999875  44567999998776554556778899999999999999999999864 46799999999999


Q ss_pred             cccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceee-ecc
Q 019536          140 LRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVR-EEF  215 (339)
Q Consensus       140 L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~-~~~  215 (339)
                      |.+++.   ..+++..++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++........... ...
T Consensus        81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  157 (257)
T cd05115          81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA  157 (257)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence            999875   46889999999999999999999   89999999999999999999999999999976644332211 111


Q ss_pred             cccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCCC
Q 019536          216 IKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDN  294 (339)
Q Consensus       216 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (339)
                      ..++..|+|||.+.+..++.++|+||||+++|++++ |..||.....        ..... ....+.             
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~~~-~~~~~~-------------  215 (257)
T cd05115         158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG--------PEVMS-FIEQGK-------------  215 (257)
T ss_pred             CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH--------HHHHH-HHHCCC-------------
Confidence            223567999999988889999999999999999996 9999752211        11111 111110             


Q ss_pred             CCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 019536          295 SFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMY  335 (339)
Q Consensus       295 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~  335 (339)
                      ..+.+...+.++.+++.+||+.+|++||++.+|.+.|++++
T Consensus       216 ~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~~  256 (257)
T cd05115         216 RLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTYY  256 (257)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhhc
Confidence            00111234567999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=9.5e-43  Score=311.33  Aligned_cols=255  Identities=24%  Similarity=0.344  Sum_probs=203.5

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcC-----CCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCcc
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVD-----QDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELP  128 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~  128 (339)
                      .++|++.+.||.|+||.||+|....     ++..||+|.+...........+.+|+.+++.+.||||+++++++.+++..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            4679999999999999999998743     57889999988665545567788999999999999999999999999999


Q ss_pred             EEEEEeccCCcccccccc------------------------CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCC
Q 019536          129 TLVFESVKYGTLRGFSFA------------------------SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASN  184 (339)
Q Consensus       129 ~lv~e~~~~g~L~~~~~~------------------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~N  184 (339)
                      ++||||+++|+|.+++..                        .+++..++.++.|++.||.|||   ..+++||||||.|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHhh
Confidence            999999999999888741                        3567778899999999999999   8999999999999


Q ss_pred             EEeCCCCceEEecCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCC
Q 019536          185 VLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGN  263 (339)
Q Consensus       185 il~~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~  263 (339)
                      |+++.++.++|+|||+++.+..............+..|+|||++.+..++.++|+|||||++|+|++ |..||...    
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~----  236 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM----  236 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC----
Confidence            9999999999999999876543322111112234567999999988899999999999999999997 77776311    


Q ss_pred             CCchhHHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 019536          264 DDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQ  333 (339)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~  333 (339)
                          ...+.... ......             .+.+...+.++.+++.+||+.||++|||+.|+++.|++
T Consensus       237 ----~~~~~~~~-~~~~~~-------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         237 ----AHEEVIYY-VRDGNV-------------LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             ----CHHHHHHH-HhcCCC-------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence                11111111 111110             01112345679999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.6e-43  Score=320.83  Aligned_cols=241  Identities=24%  Similarity=0.302  Sum_probs=195.0

Q ss_pred             CceeccCCeeEEEEEEcCCCeeEEEEEeccCC--ChhhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCccEEEEEeccC
Q 019536           61 KVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS--TLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLETELPTLVFESVKY  137 (339)
Q Consensus        61 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~  137 (339)
                      +.||+|+||+||+|.+..++..||+|++....  .......+.+|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999999899999999987642  123455677888988888 799999999999999999999999999


Q ss_pred             Cccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceeeecc
Q 019536          138 GTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEF  215 (339)
Q Consensus       138 g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~~~  215 (339)
                      |+|.+++.  ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++........  ...
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~  155 (318)
T cd05570          81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TST  155 (318)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCc--ccc
Confidence            99988875  46889999999999999999999   999999999999999999999999999998653222211  113


Q ss_pred             cccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCCCC
Q 019536          216 IKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNS  295 (339)
Q Consensus       216 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (339)
                      ..|+..|+|||++.+..++.++|+|||||++|+|++|+.||.....        .... ......            ...
T Consensus       156 ~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~--------~~~~-~~i~~~------------~~~  214 (318)
T cd05570         156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE--------DELF-QSILED------------EVR  214 (318)
T ss_pred             eecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH--------HHHH-HHHHcC------------CCC
Confidence            4689999999999999999999999999999999999999852211        1111 111111            111


Q ss_pred             CCCcHHHHHHHHHHHHHhhccCCCCCCCH-----HHHHH
Q 019536          296 FPGKEEKLQSLGQLMYKCLSKSPEHRPLM-----VDVAK  329 (339)
Q Consensus       296 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~-----~~il~  329 (339)
                      .|  ...+..+.+|+.+||+.||.+|||+     .++++
T Consensus       215 ~~--~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         215 YP--RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             CC--CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence            11  1345578999999999999999999     77765

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=5.7e-43  Score=309.37  Aligned_cols=256  Identities=23%  Similarity=0.333  Sum_probs=205.6

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCe---eEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDR---PISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTL  130 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  130 (339)
                      .++|+..+.||+|+||.||+|....++.   .+|+|.+.........+.+.+|+.+++.++||||+++.+++.+.+..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            3578889999999999999999875544   7999998766444556778899999999999999999999999999999


Q ss_pred             EEEeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCC
Q 019536          131 VFESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEG  207 (339)
Q Consensus       131 v~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~  207 (339)
                      ||||+++++|.+++.   ..+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.+|++|||++......
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  160 (268)
T cd05063          84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD  160 (268)
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence            999999999999875   45788899999999999999999   899999999999999999999999999998766443


Q ss_pred             Cceee-ecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCccccc
Q 019536          208 ETHVR-EEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAI  285 (339)
Q Consensus       208 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (339)
                      ..... ......+..|+|||++.+..++.++|+|||||++|++++ |+.||.....        .+ ........     
T Consensus       161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~--------~~-~~~~i~~~-----  226 (268)
T cd05063         161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN--------HE-VMKAINDG-----  226 (268)
T ss_pred             cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH--------HH-HHHHHhcC-----
Confidence            22111 111223457999999988889999999999999999997 9999742211        11 11111110     


Q ss_pred             ccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 019536          286 VDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQM  334 (339)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l  334 (339)
                              ...|.+...+.++.+++.+||+.+|++||++.+|++.|+++
T Consensus       227 --------~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         227 --------FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             --------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                    01122223456789999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=6.1e-43  Score=309.19  Aligned_cols=255  Identities=24%  Similarity=0.337  Sum_probs=205.0

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCC---eeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQD---RPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLV  131 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  131 (339)
                      ++|++.+.||+|+||.||+|....++   ..+|+|.+...........+.+|+.+++.++||||+++++++.+++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            57889999999999999999886433   479999987655445567788999999999999999999999999999999


Q ss_pred             EEeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCC
Q 019536          132 FESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE  208 (339)
Q Consensus       132 ~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~  208 (339)
                      |||+++++|.+++.   ..+++.+...++.|++.||.|||   +.+++||||||+||+++.++.++++|||++.......
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd05066          84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  160 (267)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence            99999999999976   35788888999999999999999   8999999999999999999999999999998765433


Q ss_pred             ceee-ecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCcccccc
Q 019536          209 THVR-EEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIV  286 (339)
Q Consensus       209 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (339)
                      .... .....++..|+|||++.+..++.++|+||||+++|++++ |..||......     ....   . ....      
T Consensus       161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~-----~~~~---~-~~~~------  225 (267)
T cd05066         161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ-----DVIK---A-IEEG------  225 (267)
T ss_pred             ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH-----HHHH---H-HhCC------
Confidence            2211 111223567999999998889999999999999999886 99997532110     1111   1 1110      


Q ss_pred             cCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 019536          287 DPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQM  334 (339)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l  334 (339)
                             ...|.+...+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus       226 -------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         226 -------YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             -------CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence                   01111223455789999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=3.8e-43  Score=323.74  Aligned_cols=268  Identities=19%  Similarity=0.251  Sum_probs=200.6

Q ss_pred             HhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC-----
Q 019536           53 ATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS-TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETE-----  126 (339)
Q Consensus        53 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~-----  126 (339)
                      ..++|++.+.||+|+||.||+|.+..++..||+|++.... .......+.+|+.+++.++||||+++++++....     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            4589999999999999999999999899999999987542 2244567789999999999999999999986543     


Q ss_pred             -ccEEEEEeccCCccccccccCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccC
Q 019536          127 -LPTLVFESVKYGTLRGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIP  205 (339)
Q Consensus       127 -~~~lv~e~~~~g~L~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~  205 (339)
                       ..++||||+++ +|.+.+...++...+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++...
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~  174 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIHMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC  174 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHhccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence             46899999975 565666667888888999999999999999   8999999999999999999999999999987653


Q ss_pred             CCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchh------------HHHH-
Q 019536          206 EGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLT------------VLEY-  272 (339)
Q Consensus       206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~------------~~~~-  272 (339)
                      .....   ....||..|+|||++.+..++.++||||+||++|+|++|+.||.....  .+...            .... 
T Consensus       175 ~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~  249 (359)
T cd07876         175 TNFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDH--IDQWNKVIEQLGTPSAEFMNRL  249 (359)
T ss_pred             cCccC---CCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHhcCCCcHHHHHHH
Confidence            32211   134688999999999999999999999999999999999999863221  00000            0000 


Q ss_pred             ---HHHHhh-cCccccc-ccCcccCCCCCCC----cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          273 ---AKKSIE-NNRFGAI-VDPIFDEDNSFPG----KEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       273 ---~~~~~~-~~~~~~~-~~~~~~~~~~~~~----~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                         ...... ......+ ....+. ...++.    ....+..+.+|+.+||+.||++|||+.|++.+
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         250 QPTVRNYVENRPQYPGISFEELFP-DWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             HHHHHHHHhhCCCCCCcchhhhcc-ccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence               000000 0000000 000000 000110    11234578999999999999999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.6e-43  Score=309.57  Aligned_cols=252  Identities=24%  Similarity=0.355  Sum_probs=202.9

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFE  133 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  133 (339)
                      .++|++.+.||.|++|.||+|.+. ++..||+|.+....  ...+.+.+|+.++++++||||+++++++...+..++|||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGT--MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE   81 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCc--ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence            467999999999999999999976 56789999987643  234668899999999999999999999999999999999


Q ss_pred             eccCCccccccc----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCc
Q 019536          134 SVKYGTLRGFSF----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGET  209 (339)
Q Consensus       134 ~~~~g~L~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~  209 (339)
                      |+++++|.+++.    ..+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||+++.......
T Consensus        82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05068          82 LMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY  158 (261)
T ss_pred             cccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence            999999999975    25788899999999999999999   89999999999999999999999999999987653322


Q ss_pred             eeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCcccccccC
Q 019536          210 HVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDP  288 (339)
Q Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (339)
                      .. ......+..|+|||++.+..++.++|+||||+++|+|++ |+.||....        .... .......        
T Consensus       159 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--------~~~~-~~~~~~~--------  220 (261)
T cd05068         159 EA-REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT--------NAEV-LQQVDQG--------  220 (261)
T ss_pred             cc-cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC--------HHHH-HHHHHcC--------
Confidence            11 111223457999999988899999999999999999999 988874211        1111 1111110        


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 019536          289 IFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQM  334 (339)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l  334 (339)
                           ...+.+...+..+.+++.+||+.+|++||++.++++.|+++
T Consensus       221 -----~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         221 -----YRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             -----CCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence                 00111123456799999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=4.7e-43  Score=311.77  Aligned_cols=245  Identities=18%  Similarity=0.264  Sum_probs=193.7

Q ss_pred             eeccCCeeEEEEEEcCCCeeEEEEEeccCCC--hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeccCCcc
Q 019536           63 IQSDTSYRLFEGTLVDQDRPISVMKFHDNST--LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL  140 (339)
Q Consensus        63 ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L  140 (339)
                      ||+|+||+||++....+|+.||+|++.....  ......+..|+.+++.++||||+++++++.++...++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            6999999999999998999999999865321  12234456799999999999999999999999999999999999999


Q ss_pred             ccccc----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceeeeccc
Q 019536          141 RGFSF----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI  216 (339)
Q Consensus       141 ~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~~~~  216 (339)
                      .+++.    ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.++|+|||++.........   ...
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~---~~~  154 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI---TQR  154 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCcee---ecc
Confidence            88764    35778888899999999999999   899999999999999999999999999998776543321   134


Q ss_pred             ccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCCCCC
Q 019536          217 KGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSF  296 (339)
Q Consensus       217 ~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (339)
                      .|+..|+|||++.+..++.++|+||+||++|+|++|+.||......    ............ .            ....
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~----~~~~~~~~~~~~-~------------~~~~  217 (277)
T cd05607         155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK----VAKEELKRRTLE-D------------EVKF  217 (277)
T ss_pred             CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch----hhHHHHHHHhhc-c------------cccc
Confidence            6889999999999888999999999999999999999997532211    111111111110 0            0000


Q ss_pred             CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 019536          297 PGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQL  331 (339)
Q Consensus       297 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L  331 (339)
                      + ....+.++.+|+.+||+.||++||++.|+++.+
T Consensus       218 ~-~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         218 E-HQNFTEESKDICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             c-cccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence            1 013455789999999999999999997766443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-44  Score=330.66  Aligned_cols=243  Identities=23%  Similarity=0.351  Sum_probs=206.0

Q ss_pred             CceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeccCCcc
Q 019536           61 KVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL  140 (339)
Q Consensus        61 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L  140 (339)
                      -++|.|+||+||-|++.++...+|||.+..... +..+-...|+.+.++++|.|||+++|+|.+++++-+.||-.|||+|
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekds-r~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL  659 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS-REVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL  659 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccccc-hhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence            369999999999999999999999999877655 5566678999999999999999999999999999999999999999


Q ss_pred             ccccc---cCC--ChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeC-CCCceEEecCCCccccCCCCceeeec
Q 019536          141 RGFSF---ASL--LIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLD-ENYSAKLHDFSLSVSIPEGETHVREE  214 (339)
Q Consensus       141 ~~~~~---~~~--~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~-~~~~~kl~dfg~a~~~~~~~~~~~~~  214 (339)
                      .+++.   +++  .+.+.-.+-.||++||.|||   .+.|+|||||-+|+|++ -.|.+||+|||-++.+..-+  ..+.
T Consensus       660 SsLLrskWGPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin--P~TE  734 (1226)
T KOG4279|consen  660 SSLLRSKWGPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN--PCTE  734 (1226)
T ss_pred             HHHHHhccCCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhccCC--cccc
Confidence            99987   555  56677789999999999999   89999999999999996 57899999999988774322  2344


Q ss_pred             ccccccccccccccccC--CCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccC
Q 019536          215 FIKGAYGFIAPEYFATS--SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDE  292 (339)
Q Consensus       215 ~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (339)
                      +..||..|||||++..+  .|+.++|||||||++.||.||++||...|......          ++-+.+          
T Consensus       735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM----------FkVGmy----------  794 (1226)
T KOG4279|consen  735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM----------FKVGMY----------  794 (1226)
T ss_pred             ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh----------hhhcce----------
Confidence            67899999999999765  49999999999999999999999997666543111          111111          


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          293 DNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       293 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                      ....|.|+..+.+++.+|.+|+.+||.+||||.+++.
T Consensus       795 KvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  795 KVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             ecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            1223566789999999999999999999999999985

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=9.6e-43  Score=312.36  Aligned_cols=261  Identities=20%  Similarity=0.288  Sum_probs=205.2

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCC----------------eeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceee
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQD----------------RPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILK  117 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~----------------~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~  117 (339)
                      .++|++.+.||+|+||.||+|.....+                ..||+|.+.........+.+.+|+.+++.++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            468999999999999999999876433                5689999887765566778899999999999999999


Q ss_pred             eeeeeeeCCccEEEEEeccCCcccccccc-------------CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCC
Q 019536          118 LIGCCLETELPTLVFESVKYGTLRGFSFA-------------SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASN  184 (339)
Q Consensus       118 ~~~~~~~~~~~~lv~e~~~~g~L~~~~~~-------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~N  184 (339)
                      +++++..++..++||||+++++|.+++..             .+++..++.++.|++.||.|||   +.+++|+||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhc
Confidence            99999999999999999999999988752             4788888999999999999999   8999999999999


Q ss_pred             EEeCCCCceEEecCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh--CCCccccCCCC
Q 019536          185 VLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT--GCNVLEFKGNG  262 (339)
Q Consensus       185 il~~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~--g~~p~~~~~~~  262 (339)
                      |+++.++.++|+|||+++...............++..|+|||++.+..++.++|||||||++|+|++  |..||...  .
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~--~  238 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL--T  238 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc--C
Confidence            9999999999999999876544332222223456778999999988889999999999999999998  55565321  1


Q ss_pred             CCCchhHHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 019536          263 NDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLR  332 (339)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~  332 (339)
                         ................          .....+.+...+.++.+++.+||+.||++|||+.+|++.|+
T Consensus       239 ---~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         239 ---DQQVIENAGHFFRDDG----------RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             ---hHHHHHHHHhcccccc----------ccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence               1111111111111100          00011112234467999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-44  Score=328.51  Aligned_cols=244  Identities=22%  Similarity=0.293  Sum_probs=202.9

Q ss_pred             CcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC--ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 019536           56 NYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS--TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFE  133 (339)
Q Consensus        56 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  133 (339)
                      .|+.++.||.|+||.||-|++..+...||||++.-..  ......+++.|+.+|.++.|||++.+-|||......|||||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            4666789999999999999999999999999986543  23556789999999999999999999999999999999999


Q ss_pred             eccCCcccccc---ccCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCce
Q 019536          134 SVKYGTLRGFS---FASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH  210 (339)
Q Consensus       134 ~~~~g~L~~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~  210 (339)
                      ||- |+-.|++   ..++.+-++..|..+.+.||.|||   +.+.||||||..|||+++.|.+||+|||.|....+.+  
T Consensus       107 YCl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn--  180 (948)
T KOG0577|consen  107 YCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN--  180 (948)
T ss_pred             HHh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcCchh--
Confidence            995 4555554   478888889999999999999999   9999999999999999999999999999987665443  


Q ss_pred             eeeccccccccccccccccc---CCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCccccccc
Q 019536          211 VREEFIKGAYGFIAPEYFAT---SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVD  287 (339)
Q Consensus       211 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (339)
                          .++||+.|||||++..   +.|+-++||||+|+++.||...++|+...        +....++. +..+       
T Consensus       181 ----sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM--------NAMSALYH-IAQN-------  240 (948)
T KOG0577|consen  181 ----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM--------NAMSALYH-IAQN-------  240 (948)
T ss_pred             ----cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc--------hHHHHHHH-HHhc-------
Confidence                4689999999999864   57999999999999999999999997422        11111222 1111       


Q ss_pred             CcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          288 PIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                          +...++ ...++..++.++..||++-|++|||+.+++++
T Consensus       241 ----esPtLq-s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  241 ----ESPTLQ-SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             ----CCCCCC-CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence                112222 24889999999999999999999999999874

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=5.7e-44  Score=331.22  Aligned_cols=253  Identities=17%  Similarity=0.194  Sum_probs=199.1

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC--hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST--LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVF  132 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  132 (339)
                      ++|++.+.||+|+||.||+|....+++.||+|++.....  ......+.+|+.+++.++||||+++++.+.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            478999999999999999999999999999999865321  134566789999999999999999999999999999999


Q ss_pred             EeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCC--
Q 019536          133 ESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE--  208 (339)
Q Consensus       133 e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~--  208 (339)
                      ||+++|+|.+++.  ..++......++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+|..+....  
T Consensus        81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~  157 (376)
T cd05598          81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  157 (376)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence            9999999999886  45778888889999999999999   9999999999999999999999999999975331000  


Q ss_pred             ---------------------------------------ceeeecccccccccccccccccCCCCcccchHHHHHHHHHH
Q 019536          209 ---------------------------------------THVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCEL  249 (339)
Q Consensus       209 ---------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el  249 (339)
                                                             .........||+.|+|||++.+..++.++|||||||++|+|
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel  237 (376)
T cd05598         158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM  237 (376)
T ss_pred             cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence                                                   00001124689999999999999999999999999999999


Q ss_pred             HhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCC---CHHH
Q 019536          250 LTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP---LMVD  326 (339)
Q Consensus       250 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp---s~~~  326 (339)
                      ++|+.||.....        .+....... ..          .....|.....+..+.+++.+|+ .+|.+|+   |+.+
T Consensus       238 l~G~~Pf~~~~~--------~~~~~~i~~-~~----------~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~e  297 (376)
T cd05598         238 LVGQPPFLADTP--------AETQLKVIN-WE----------TTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADE  297 (376)
T ss_pred             hhCCCCCCCCCH--------HHHHHHHhc-cC----------ccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHH
Confidence            999999853221        111111100 00          00111111234557888999876 5999999   8888


Q ss_pred             HHHH
Q 019536          327 VAKQ  330 (339)
Q Consensus       327 il~~  330 (339)
                      ++.+
T Consensus       298 ll~h  301 (376)
T cd05598         298 IKAH  301 (376)
T ss_pred             HhCC
Confidence            8864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=2e-42  Score=305.40  Aligned_cols=257  Identities=21%  Similarity=0.326  Sum_probs=208.7

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC--ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS--TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVF  132 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  132 (339)
                      ++|++.+.||+|++|.||+|....+++.||+|.++...  .....+.+.+|+.++++++|+|++++++++.+++..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            68999999999999999999999899999999886432  2234567889999999999999999999999999999999


Q ss_pred             EeccCCccccccc------cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCC
Q 019536          133 ESVKYGTLRGFSF------ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPE  206 (339)
Q Consensus       133 e~~~~g~L~~~~~------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~  206 (339)
                      ||+++|+|.+++.      ..++...+..++.+++.||.|||   +.+++|+||+|+||+++.++.++++|||++..+..
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            9999999988764      34788888999999999999999   89999999999999999999999999999876644


Q ss_pred             CCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccc
Q 019536          207 GETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIV  286 (339)
Q Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (339)
                      .....  ....++..|+|||.+.+..++.++|+||||+++|+|++|+.||.....      ........ ......    
T Consensus       159 ~~~~~--~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~-~~~~~~----  225 (267)
T cd08224         159 KTTAA--HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM------NLYSLCKK-IEKCDY----  225 (267)
T ss_pred             CCccc--ceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc------cHHHHHhh-hhcCCC----
Confidence            32221  124578889999999888899999999999999999999999742221      11111111 111100    


Q ss_pred             cCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 019536          287 DPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMY  335 (339)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~  335 (339)
                             .+.|. ...+..+.+++.+||..+|++|||+.+|++.|+++.
T Consensus       226 -------~~~~~-~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         226 -------PPLPA-DHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             -------CCCCh-hhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence                   01111 144567899999999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.3e-42  Score=304.78  Aligned_cols=248  Identities=19%  Similarity=0.244  Sum_probs=203.8

Q ss_pred             CcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEec
Q 019536           56 NYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESV  135 (339)
Q Consensus        56 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  135 (339)
                      +|++.+.||.|+||.||++.+..+++.+|+|.+.........+.+.+|+.+++.++||||+++++++.+++..++||||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            57888999999999999999998999999999876544456677889999999999999999999999999999999999


Q ss_pred             cCCccccccc----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCcee
Q 019536          136 KYGTLRGFSF----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHV  211 (339)
Q Consensus       136 ~~g~L~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~  211 (339)
                      ++|+|.+++.    ..++......++.|++.||.|||   +.+|+|+||||+||+++.++.++++|||.++.........
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~  157 (255)
T cd08219          81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYA  157 (255)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeeccccccc
Confidence            9999988764    34778888999999999999999   8999999999999999999999999999987765433221


Q ss_pred             eecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCccc
Q 019536          212 REEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFD  291 (339)
Q Consensus       212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (339)
                        ....++..|+|||++.+..++.++|+||||+++|+|++|+.||....        ........ ......        
T Consensus       158 --~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~--------~~~~~~~~-~~~~~~--------  218 (255)
T cd08219         158 --CTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS--------WKNLILKV-CQGSYK--------  218 (255)
T ss_pred             --ccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC--------HHHHHHHH-hcCCCC--------
Confidence              13458888999999988889999999999999999999999975211        11111111 111110        


Q ss_pred             CCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          292 EDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       292 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                           +.+...+..+.+++.+||+.||++|||+.+++.+
T Consensus       219 -----~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         219 -----PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             -----CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence                 1112345578999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.6e-43  Score=309.90  Aligned_cols=256  Identities=19%  Similarity=0.317  Sum_probs=206.9

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCe----eEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDR----PISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTL  130 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  130 (339)
                      .+|++.+.||+|+||.||+|....++.    .+|+|.............+.+|+.+++.++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            578889999999999999999876554    6899988776554566778899999999999999999999987 67899


Q ss_pred             EEEeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCC
Q 019536          131 VFESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEG  207 (339)
Q Consensus       131 v~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~  207 (339)
                      ||||+++|+|.+++.   ..+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||+++.+...
T Consensus        86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~  162 (279)
T cd05057          86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD  162 (279)
T ss_pred             EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence            999999999999875   35788999999999999999999   899999999999999999999999999999877644


Q ss_pred             CceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCcccccc
Q 019536          208 ETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIV  286 (339)
Q Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (339)
                      ..........++..|+|||.+....++.++|+||||+++|++++ |+.||....        ..+.........      
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--------~~~~~~~~~~~~------  228 (279)
T cd05057         163 EKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP--------AVEIPDLLEKGE------  228 (279)
T ss_pred             ccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC--------HHHHHHHHhCCC------
Confidence            33322222234567999999988889999999999999999998 999975321        111111111110      


Q ss_pred             cCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 019536          287 DPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYL  336 (339)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~  336 (339)
                              ..+.+..++..+.+++.+||..||++|||+.++++.|.++..
T Consensus       229 --------~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         229 --------RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             --------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                    111122344568899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=8.8e-43  Score=307.93  Aligned_cols=257  Identities=21%  Similarity=0.311  Sum_probs=208.2

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC--hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST--LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVF  132 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  132 (339)
                      ++|++.+.||+|++|.||+|....++..+++|.+.....  ......+.+|+.+++.++||||+++++++.+++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            578889999999999999999988999999998865322  234567889999999999999999999999999999999


Q ss_pred             EeccCCccccccc------cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCC
Q 019536          133 ESVKYGTLRGFSF------ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPE  206 (339)
Q Consensus       133 e~~~~g~L~~~~~------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~  206 (339)
                      ||+++++|.+++.      ..+++..++.++.|++.||.|||   +.+++|+||||+||+++.++.++++|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            9999999988764      34788889999999999999999   99999999999999999999999999999876644


Q ss_pred             CCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccc
Q 019536          207 GETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIV  286 (339)
Q Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (339)
                      .....  ....++..|+|||++.+..++.++|+||||+++|+|++|..||......      ....... .....     
T Consensus       159 ~~~~~--~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~-~~~~~-----  224 (267)
T cd08229         159 KTTAA--HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LYSLCKK-IEQCD-----  224 (267)
T ss_pred             CCccc--ccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch------HHHHhhh-hhcCC-----
Confidence            33221  1345788899999998888999999999999999999999997422111      1111110 00000     


Q ss_pred             cCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 019536          287 DPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMY  335 (339)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~  335 (339)
                      .      .+.+ +...+..+.+++.+||+.||++|||+.+|++.++++.
T Consensus       225 ~------~~~~-~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         225 Y------PPLP-SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             C------CCCC-cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence            0      0001 1245668999999999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-45  Score=310.37  Aligned_cols=248  Identities=20%  Similarity=0.275  Sum_probs=214.2

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFES  134 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  134 (339)
                      .-|.++.++|+|+||+||+|.++..|..+|||++...   .+.+.+..|+.|+.+...|++|+++|.+.....+|+||||
T Consensus        33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~---sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY  109 (502)
T KOG0574|consen   33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD---TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY  109 (502)
T ss_pred             HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc---chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence            3477788999999999999999999999999998765   5678889999999999999999999999999999999999


Q ss_pred             ccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCcee
Q 019536          135 VKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHV  211 (339)
Q Consensus       135 ~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~  211 (339)
                      |.-|++.+++.   ..+.+.++..++...++||+|||   ...-+|||||..|||++-+|..||+|||.|..+.+.-.  
T Consensus       110 CGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA--  184 (502)
T KOG0574|consen  110 CGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA--  184 (502)
T ss_pred             cCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhhhHH--
Confidence            99999999986   67889999999999999999999   88899999999999999999999999999877654322  


Q ss_pred             eecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCccc
Q 019536          212 REEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFD  291 (339)
Q Consensus       212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (339)
                      ...++.||+.|||||++..-.|+.++||||+|++..||..|++||..-+.                    +..++--.-.
T Consensus       185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHP--------------------MRAIFMIPT~  244 (502)
T KOG0574|consen  185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHP--------------------MRAIFMIPTK  244 (502)
T ss_pred             hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccc--------------------cceeEeccCC
Confidence            12246799999999999999999999999999999999999999863322                    1122211122


Q ss_pred             CCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          292 EDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       292 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      ....+..|+.++.++.++++.||-..|++|-|+.+++++
T Consensus       245 PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  245 PPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             CCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            334455678999999999999999999999999998874

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=3.9e-43  Score=318.06  Aligned_cols=241  Identities=22%  Similarity=0.297  Sum_probs=192.3

Q ss_pred             CceeccCCeeEEEEEEcCCCeeEEEEEeccCC--ChhhHHHHHHHHHHHHh-cCCCceeeeeeeeeeCCccEEEEEeccC
Q 019536           61 KVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS--TLDDVEYCFNNIVFSSQ-MKHKNILKLIGCCLETELPTLVFESVKY  137 (339)
Q Consensus        61 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~-l~H~niv~~~~~~~~~~~~~lv~e~~~~  137 (339)
                      +.||+|+||.||+|.+..+++.||+|.+....  .......+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999999899999999987642  11334556678777775 4899999999999999999999999999


Q ss_pred             Cccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceeeecc
Q 019536          138 GTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEF  215 (339)
Q Consensus       138 g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~~~  215 (339)
                      |+|.+++.  ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++........  ...
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~  155 (316)
T cd05619          81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK--TCT  155 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCc--eee
Confidence            99998886  46888899999999999999999   899999999999999999999999999998754322211  113


Q ss_pred             cccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCCCC
Q 019536          216 IKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNS  295 (339)
Q Consensus       216 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (339)
                      ..||..|+|||++.+..++.++|+||+||++|+|++|+.||.....     ......    .....            ..
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-----~~~~~~----i~~~~------------~~  214 (316)
T cd05619         156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE-----EELFQS----IRMDN------------PC  214 (316)
T ss_pred             ecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH-----HHHHHH----HHhCC------------CC
Confidence            5689999999999988999999999999999999999999752211     111111    11000            01


Q ss_pred             CCCcHHHHHHHHHHHHHhhccCCCCCCCHH-HHHH
Q 019536          296 FPGKEEKLQSLGQLMYKCLSKSPEHRPLMV-DVAK  329 (339)
Q Consensus       296 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~-~il~  329 (339)
                      .|  ...+..+.+++.+||+.||++||++. +++.
T Consensus       215 ~~--~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         215 YP--RWLTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             CC--ccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence            11  13445789999999999999999997 5543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=7.6e-43  Score=311.39  Aligned_cols=263  Identities=22%  Similarity=0.304  Sum_probs=204.8

Q ss_pred             cCcccCCceeccCCeeEEEEEE----cCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeC--Ccc
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTL----VDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLET--ELP  128 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~--~~~  128 (339)
                      ..|++.+.||+|+||.||.+.+    ..++..||+|.+...........+.+|+.+++.++||||+++.+++.+.  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            4578899999999999999985    3467899999987665545567788999999999999999999998875  568


Q ss_pred             EEEEEeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccC
Q 019536          129 TLVFESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIP  205 (339)
Q Consensus       129 ~lv~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~  205 (339)
                      ++||||+++++|.+++.   ..+++..+..++.|++.||.|||   +.+++||||||+||+++.++.++|+|||+++.+.
T Consensus        84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE  160 (284)
T ss_pred             EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCccccccc
Confidence            89999999999999875   35788999999999999999999   9999999999999999999999999999998765


Q ss_pred             CCCcee-eecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCC-------CCchhHHHHHHHHh
Q 019536          206 EGETHV-REEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGN-------DDDLTVLEYAKKSI  277 (339)
Q Consensus       206 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~-------~~~~~~~~~~~~~~  277 (339)
                      ...... ......++..|+|||++.+..++.++||||||+++|+|++++.|+.......       ...... .......
T Consensus       161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  239 (284)
T cd05079         161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTV-TRLVRVL  239 (284)
T ss_pred             cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccH-HHHHHHH
Confidence            433221 1123446677999999988889999999999999999999876642211000       000000 0000000


Q ss_pred             hcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 019536          278 ENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQM  334 (339)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l  334 (339)
                      ...             ...+.+...+..+.+|+.+||+.+|++|||+.++++.|+.+
T Consensus       240 ~~~-------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         240 EEG-------------KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HcC-------------ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            000             11112224556899999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=5.6e-43  Score=309.68  Aligned_cols=255  Identities=22%  Similarity=0.313  Sum_probs=204.1

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCe---eEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDR---PISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLV  131 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  131 (339)
                      ++|.+.+.||+|+||.||+|....++.   .||+|.+...........+.+|+.+++.++||||+++++++.++...++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            458889999999999999999876554   69999987665545667899999999999999999999999999999999


Q ss_pred             EEeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCC
Q 019536          132 FESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE  208 (339)
Q Consensus       132 ~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~  208 (339)
                      |||+++|+|.+++.   ..+++..++.++.|++.||.|||   +.+++|+||||+||+++.++.++++|||++.......
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~  160 (269)
T cd05065          84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  160 (269)
T ss_pred             EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence            99999999998875   45788889999999999999999   8999999999999999999999999999987654432


Q ss_pred             ceeeecc-c--ccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCcccc
Q 019536          209 THVREEF-I--KGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA  284 (339)
Q Consensus       209 ~~~~~~~-~--~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (339)
                      ....... .  ..+..|+|||.+.+..++.++|+||+||++||+++ |..||.....     .......   ...     
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~-----~~~~~~i---~~~-----  227 (269)
T cd05065         161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-----QDVINAI---EQD-----  227 (269)
T ss_pred             cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH-----HHHHHHH---HcC-----
Confidence            2111101 1  12356999999998899999999999999999886 9998742211     1111111   000     


Q ss_pred             cccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 019536          285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQM  334 (339)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l  334 (339)
                               ...|.+...+..+.+++.+||+.+|++||++.+|+..|+++
T Consensus       228 ---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         228 ---------YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             ---------CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                     01122224455789999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2.8e-43  Score=318.97  Aligned_cols=240  Identities=21%  Similarity=0.277  Sum_probs=191.7

Q ss_pred             CceeccCCeeEEEEEEcCCCeeEEEEEeccCCC--hhhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCccEEEEEeccC
Q 019536           61 KVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST--LDDVEYCFNNIVFSSQM-KHKNILKLIGCCLETELPTLVFESVKY  137 (339)
Q Consensus        61 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~  137 (339)
                      +.||+|+||.||+|.+..++..||+|.+.....  .........|..++... +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            469999999999999999999999999876421  13345566788877654 899999999999999999999999999


Q ss_pred             Cccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceeeecc
Q 019536          138 GTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEF  215 (339)
Q Consensus       138 g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~~~  215 (339)
                      |+|.+++.  ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.++|+|||+++........  ...
T Consensus        81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~  155 (316)
T cd05620          81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--AST  155 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCc--eec
Confidence            99988875  46788888999999999999999   899999999999999999999999999998753222221  123


Q ss_pred             cccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCCCC
Q 019536          216 IKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNS  295 (339)
Q Consensus       216 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (339)
                      ..||..|+|||++.+..++.++||||+||++|+|++|+.||.....     ....+    ......            ..
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~-----~~~~~----~~~~~~------------~~  214 (316)
T cd05620         156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-----DELFE----SIRVDT------------PH  214 (316)
T ss_pred             cCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-----HHHHH----HHHhCC------------CC
Confidence            5689999999999999999999999999999999999999852211     11111    111100            01


Q ss_pred             CCCcHHHHHHHHHHHHHhhccCCCCCCCHH-HHH
Q 019536          296 FPGKEEKLQSLGQLMYKCLSKSPEHRPLMV-DVA  328 (339)
Q Consensus       296 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~-~il  328 (339)
                      .|  ...+.++.+++.+||+.||++||++. +++
T Consensus       215 ~~--~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         215 YP--RWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             CC--CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            11  12445789999999999999999984 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=8.1e-43  Score=311.10  Aligned_cols=270  Identities=20%  Similarity=0.309  Sum_probs=202.5

Q ss_pred             hcCcccCCceeccCCeeEEEEEE----cCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeee--CCc
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTL----VDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLE--TEL  127 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~--~~~  127 (339)
                      ..+|++.+.||+|+||+||+|..    ..++..||+|++..... .....+.+|+.+++.++||||+++++++..  ...
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTA-EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN   81 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCH-HHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence            35788999999999999999984    34678999999876543 556778899999999999999999998754  346


Q ss_pred             cEEEEEeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCcccc
Q 019536          128 PTLVFESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSI  204 (339)
Q Consensus       128 ~~lv~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~  204 (339)
                      .++||||+++|+|.+++.   ..+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++..
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~  158 (284)
T cd05081          82 LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVL  158 (284)
T ss_pred             eEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCcccccc
Confidence            789999999999999875   35788899999999999999999   899999999999999999999999999999876


Q ss_pred             CCCCceee-ecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhc-Ccc
Q 019536          205 PEGETHVR-EEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIEN-NRF  282 (339)
Q Consensus       205 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~  282 (339)
                      ........ .....++..|+|||++.+..++.++|+||||+++|||++|..|+.......      .......... ...
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~------~~~~~~~~~~~~~~  232 (284)
T cd05081         159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEF------MRMMGNDKQGQMIV  232 (284)
T ss_pred             cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhh------hhhcccccccccch
Confidence            54332211 111223445999999988889999999999999999999877643221100      0000000000 000


Q ss_pred             cccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 019536          283 GAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQM  334 (339)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l  334 (339)
                      ..+. .........+.+...+..+.+|+.+||+.+|++|||+.+|++.|+.+
T Consensus       233 ~~~~-~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         233 YHLI-ELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHHH-HHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            0000 00011111122224556799999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.5e-42  Score=308.83  Aligned_cols=252  Identities=20%  Similarity=0.293  Sum_probs=200.8

Q ss_pred             cCcccCCceeccCCeeEEEEEEc-----CCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLV-----DQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPT  129 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~  129 (339)
                      .+|....+||+|+||.||++...     .++..+|+|.+..... .....+.+|+.+++.++|+||+++++++.+++..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE-SARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL   83 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCH-HHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence            56888899999999999999753     3466899998765433 55677889999999999999999999999999999


Q ss_pred             EEEEeccCCcccccccc-----------------CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCc
Q 019536          130 LVFESVKYGTLRGFSFA-----------------SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYS  192 (339)
Q Consensus       130 lv~e~~~~g~L~~~~~~-----------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~  192 (339)
                      +||||+++|+|.+++..                 .+++..+..++.|++.||.|||   +.+++||||||+||++++++.
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~  160 (280)
T cd05092          84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLV  160 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCC
Confidence            99999999999988752                 3678888999999999999999   999999999999999999999


Q ss_pred             eEEecCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHH
Q 019536          193 AKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLE  271 (339)
Q Consensus       193 ~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~  271 (339)
                      +||+|||+++...............+++.|+|||++.+..++.++|||||||++|+|++ |++||.....        ..
T Consensus       161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--------~~  232 (280)
T cd05092         161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN--------TE  232 (280)
T ss_pred             EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH--------HH
Confidence            99999999876544332222222335678999999998999999999999999999998 8888742111        11


Q ss_pred             HHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 019536          272 YAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLR  332 (339)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~  332 (339)
                      ..........              ...+...+..+.+|+.+||+.||++||++.+|++.|+
T Consensus       233 ~~~~~~~~~~--------------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         233 AIECITQGRE--------------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             HHHHHHcCcc--------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence            1111111000              0111134457899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1e-42  Score=312.53  Aligned_cols=250  Identities=19%  Similarity=0.280  Sum_probs=204.7

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFES  134 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  134 (339)
                      .+|++.+.||+|++|.||+|....+++.|++|.+..... ...+.+.+|+.+++.+.||||+++++.+..+...++||||
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~   98 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc-chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence            589999999999999999999988999999999876544 3456788999999999999999999999999999999999


Q ss_pred             ccCCccccccc-cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceeee
Q 019536          135 VKYGTLRGFSF-ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVRE  213 (339)
Q Consensus       135 ~~~g~L~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~  213 (339)
                      +++++|.+++. ..+++.++..++.|++.||.|||   +.+|+|+||||+||+++.++.++|+|||++..........  
T Consensus        99 ~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~--  173 (296)
T cd06654          99 LAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--  173 (296)
T ss_pred             cCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhcccccccc--
Confidence            99999999886 45788889999999999999999   8999999999999999999999999999987654332211  


Q ss_pred             cccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCC
Q 019536          214 EFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDED  293 (339)
Q Consensus       214 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (339)
                      ....++..|+|||.+.+..++.++|+|||||++|+|++|+.||.....        ............            
T Consensus       174 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~--------~~~~~~~~~~~~------------  233 (296)
T cd06654         174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP--------LRALYLIATNGT------------  233 (296)
T ss_pred             CcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH--------HHhHHHHhcCCC------------
Confidence            124578899999999888899999999999999999999999853211        010000000000            


Q ss_pred             CCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          294 NSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       294 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      ...+.+...+..+.+++.+||..||++|||+.++++.
T Consensus       234 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         234 PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             CCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence            0111122455678999999999999999999999873

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.6e-42  Score=311.19  Aligned_cols=261  Identities=20%  Similarity=0.289  Sum_probs=201.0

Q ss_pred             cCcccCCceeccCCeeEEEEEEcC----------------CCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeee
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVD----------------QDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKL  118 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~----------------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~  118 (339)
                      ++|++.+.||+|+||.||++...+                ++..+|+|.+...........+.+|+.+++.++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            579999999999999999986432                3457999998766544556788999999999999999999


Q ss_pred             eeeeeeCCccEEEEEeccCCcccccccc-------------CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCE
Q 019536          119 IGCCLETELPTLVFESVKYGTLRGFSFA-------------SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNV  185 (339)
Q Consensus       119 ~~~~~~~~~~~lv~e~~~~g~L~~~~~~-------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Ni  185 (339)
                      ++++..++..++||||+++|+|.+++..             .+++.+...++.|++.||.|||   +.+++|+||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChheE
Confidence            9999999999999999999999988752             2556778899999999999999   89999999999999


Q ss_pred             EeCCCCceEEecCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh--CCCccccCCCCC
Q 019536          186 LLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT--GCNVLEFKGNGN  263 (339)
Q Consensus       186 l~~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~--g~~p~~~~~~~~  263 (339)
                      +++.++.++|+|||+++.+.............++..|+|||+..+..++.++|+|||||++|||++  |..||..  ...
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~--~~~  239 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ--LSD  239 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccc--cCh
Confidence            999999999999999876644332221212334677999999888889999999999999999998  5566532  111


Q ss_pred             CCchhHHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 019536          264 DDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQ  333 (339)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~  333 (339)
                         ................          ....+.+..++..+.+|+.+||+.||++|||+.+|++.|++
T Consensus       240 ---~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         240 ---EQVIENTGEFFRDQGR----------QVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             ---HHHHHHHHHHHhhccc----------cccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence               1111111111111000          00111122344679999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=3.8e-43  Score=331.23  Aligned_cols=262  Identities=18%  Similarity=0.271  Sum_probs=190.6

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeC--------
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLET--------  125 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~--------  125 (339)
                      ..+|++.+.||+|+||.||+|....+++.||||++....     ....+|+.+++.++||||+++++++...        
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence            467999999999999999999999899999999986532     2234799999999999999998876432        


Q ss_pred             CccEEEEEeccCCccccccc------cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCC-ceEEecC
Q 019536          126 ELPTLVFESVKYGTLRGFSF------ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENY-SAKLHDF  198 (339)
Q Consensus       126 ~~~~lv~e~~~~g~L~~~~~------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~-~~kl~df  198 (339)
                      ..+++||||+++ +|.+++.      ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++ .+||+||
T Consensus       140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeecc
Confidence            246799999985 5555442      46888889999999999999999   89999999999999998664 6999999


Q ss_pred             CCccccCCCCceeeecccccccccccccccccC-CCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHh
Q 019536          199 SLSVSIPEGETHVREEFIKGAYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSI  277 (339)
Q Consensus       199 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  277 (339)
                      |+|+.+.......   ...||+.|+|||++.+. .|+.++||||+||++|+|++|++||...  ...+............
T Consensus       216 Gla~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~--~~~~~~~~i~~~~~~p  290 (440)
T PTZ00036        216 GSAKNLLAGQRSV---SYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQ--SSVDQLVRIIQVLGTP  290 (440)
T ss_pred             ccchhccCCCCcc---cCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC--ChHHHHHHHHHHhCCC
Confidence            9998765433221   24678999999998764 6999999999999999999999997532  2111111111000000


Q ss_pred             hc-------CcccccccCcc-cCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          278 EN-------NRFGAIVDPIF-DEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       278 ~~-------~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                      ..       ..+..+.-+.. ........+...+.++.+|+.+||++||.+|||+.|++.
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence            00       00000000000 000000001123467899999999999999999999985

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=2.2e-42  Score=312.03  Aligned_cols=263  Identities=16%  Similarity=0.234  Sum_probs=204.3

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFES  134 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  134 (339)
                      ++|++.+.||+|+||.||++.+..++..+|+|.+...........+.+|++++++++||||+++++++.+++..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            46899999999999999999999899999999987654444556788999999999999999999999999999999999


Q ss_pred             ccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCC-CCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCcee
Q 019536          135 VKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFD-RPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHV  211 (339)
Q Consensus       135 ~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~  211 (339)
                      +++++|.+++.  ..+++..+..++.|++.||.|||   + .+++|+||||+||+++.++.++|+|||++........  
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--  155 (308)
T cd06615          81 MDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--  155 (308)
T ss_pred             cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hhCCEEECCCChHHEEEecCCcEEEccCCCccccccccc--
Confidence            99999999986  56788889999999999999999   6 5899999999999999999999999999876533221  


Q ss_pred             eecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCccc--------
Q 019536          212 REEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFG--------  283 (339)
Q Consensus       212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------  283 (339)
                        ....++..|+|||++.+..++.++|+||||+++|+|++|+.||......     ................        
T Consensus       156 --~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~  228 (308)
T cd06615         156 --NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK-----ELEAMFGRPVSEGEAKESHRPVSG  228 (308)
T ss_pred             --ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh-----hHHHhhcCccccccccCCcccccC
Confidence              1346788999999998888999999999999999999999997522110     0000000000000000        


Q ss_pred             ------------ccccCcccC-CCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          284 ------------AIVDPIFDE-DNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       284 ------------~~~~~~~~~-~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                                  ...+..... ....|.. ..+.++.+++.+||+.||++|||+.+++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         229 HPPDSPRPMAIFELLDYIVNEPPPKLPSG-AFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             CCCCccchhhHHHHHHHHhcCCCccCcCc-ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                        000000000 0011111 245679999999999999999999999875

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.1e-42  Score=316.62  Aligned_cols=243  Identities=21%  Similarity=0.265  Sum_probs=194.3

Q ss_pred             CceeccCCeeEEEEEEcCCCeeEEEEEeccCCC--hhhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCccEEEEEeccC
Q 019536           61 KVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST--LDDVEYCFNNIVFSSQM-KHKNILKLIGCCLETELPTLVFESVKY  137 (339)
Q Consensus        61 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~  137 (339)
                      +.||+|+||.||+|....+++.||+|++.....  ....+.+.+|+.++.++ +||||+.+++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            469999999999999999999999999986422  23456678899999888 699999999999999999999999999


Q ss_pred             Cccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceeeecc
Q 019536          138 GTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEF  215 (339)
Q Consensus       138 g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~~~  215 (339)
                      |+|..++.  ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++........  ...
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~--~~~  155 (327)
T cd05617          81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT--TST  155 (327)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCc--eec
Confidence            99988775  57899999999999999999999   899999999999999999999999999998753322211  123


Q ss_pred             cccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCCCC
Q 019536          216 IKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNS  295 (339)
Q Consensus       216 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (339)
                      ..||+.|+|||++.+..++.++|||||||++|+|++|+.||.......  ...............            ...
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~~~------------~~~  221 (327)
T cd05617         156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNP--DMNTEDYLFQVILEK------------PIR  221 (327)
T ss_pred             ccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCc--ccccHHHHHHHHHhC------------CCC
Confidence            568999999999999999999999999999999999999986432221  111111111111111            111


Q ss_pred             CCCcHHHHHHHHHHHHHhhccCCCCCCCH
Q 019536          296 FPGKEEKLQSLGQLMYKCLSKSPEHRPLM  324 (339)
Q Consensus       296 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~  324 (339)
                      .|  ...+..+.+++.+||+.||++|+++
T Consensus       222 ~p--~~~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         222 IP--RFLSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             CC--CCCCHHHHHHHHHHhccCHHHcCCC
Confidence            11  2344578899999999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=6e-43  Score=307.46  Aligned_cols=249  Identities=18%  Similarity=0.286  Sum_probs=199.4

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFES  134 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  134 (339)
                      ++|.+.+.||+|+||+||.|.+. .+..+|+|.+....  ...+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS--MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEY   80 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCc--ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEc
Confidence            46888899999999999999886 44569999887543  2346688999999999999999999999999899999999


Q ss_pred             ccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCcee
Q 019536          135 VKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHV  211 (339)
Q Consensus       135 ~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~  211 (339)
                      +++|+|.+++.   ..+++..++.++.|++.||.|||   +.+++|+||||.||+++.++.+||+|||.++........ 
T Consensus        81 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~-  156 (256)
T cd05113          81 MSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT-  156 (256)
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCcee-
Confidence            99999999875   35788889999999999999999   899999999999999999999999999998766443322 


Q ss_pred             eecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcc
Q 019536          212 REEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIF  290 (339)
Q Consensus       212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (339)
                      ......++..|+|||++.+..++.++|+||||+++|+|++ |+.||.....        ...... ......        
T Consensus       157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--------~~~~~~-~~~~~~--------  219 (256)
T cd05113         157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN--------SETVEK-VSQGLR--------  219 (256)
T ss_pred             ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH--------HHHHHH-HhcCCC--------
Confidence            1112235567999999988889999999999999999998 9888752221        111111 111100        


Q ss_pred             cCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 019536          291 DEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLR  332 (339)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~  332 (339)
                           .+.+...+..+.+++.+||+.||.+|||+.+|++.|+
T Consensus       220 -----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         220 -----LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             -----CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence                 0011123467899999999999999999999998774

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.3e-42  Score=305.49  Aligned_cols=248  Identities=22%  Similarity=0.299  Sum_probs=196.9

Q ss_pred             ceeccCCeeEEEEEE--cCCCeeEEEEEeccCCC-hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeccCC
Q 019536           62 VIQSDTSYRLFEGTL--VDQDRPISVMKFHDNST-LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYG  138 (339)
Q Consensus        62 ~ig~G~~g~V~~~~~--~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g  138 (339)
                      .||+|+||.||+|.+  ..++..+|+|++..... ....+.+.+|+.+++.+.||||+++++++.. +..++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence            589999999999975  35678999999875533 2345678899999999999999999999864 4678999999999


Q ss_pred             ccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceeee-cc
Q 019536          139 TLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVRE-EF  215 (339)
Q Consensus       139 ~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~-~~  215 (339)
                      +|.+++.  ..+++.....++.|++.||.|||   +.+++||||||.||+++.++.+||+|||+++........... ..
T Consensus        81 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  157 (257)
T cd05116          81 PLNKFLQKNKHVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH  157 (257)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCC
Confidence            9999876  46788899999999999999999   899999999999999999999999999999876554332211 12


Q ss_pred             cccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCCC
Q 019536          216 IKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDN  294 (339)
Q Consensus       216 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (339)
                      ..++..|+|||.+.+..++.++|+|||||++|||++ |+.||.....     .....   . ...+.             
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----~~~~~---~-i~~~~-------------  215 (257)
T cd05116         158 GKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG-----NEVTQ---M-IESGE-------------  215 (257)
T ss_pred             CCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHH---H-HHCCC-------------
Confidence            234578999999988889999999999999999998 9999752211     11111   1 11111             


Q ss_pred             CCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 019536          295 SFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMY  335 (339)
Q Consensus       295 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~  335 (339)
                      ..+.+...+.++.++|.+||+.||++|||+.+|.+.|++.+
T Consensus       216 ~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~~  256 (257)
T cd05116         216 RMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNYY  256 (257)
T ss_pred             CCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhccc
Confidence            01111234567899999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-42  Score=305.80  Aligned_cols=252  Identities=19%  Similarity=0.243  Sum_probs=202.5

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC----hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST----LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTL  130 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  130 (339)
                      ++|.+.+.||+|++|.||.|....+++.||+|.+.....    ......+.+|+.++++++||||+++++++.+++..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            578999999999999999999988999999999875422    1234567899999999999999999999999999999


Q ss_pred             EEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCC
Q 019536          131 VFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE  208 (339)
Q Consensus       131 v~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~  208 (339)
                      |+||+++++|.+++.  ..++......++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||+++......
T Consensus        82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~  158 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC  158 (263)
T ss_pred             EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence            999999999998876  46788888899999999999999   9999999999999999999999999999987654322


Q ss_pred             ceee-ecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCccccccc
Q 019536          209 THVR-EEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVD  287 (339)
Q Consensus       209 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (339)
                      .... .....++..|+|||++.+..++.++|+||+|+++|++++|+.||...  .   ..   ...........      
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~--~---~~---~~~~~~~~~~~------  224 (263)
T cd06625         159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEF--E---AM---AAIFKIATQPT------  224 (263)
T ss_pred             cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCcccc--c---hH---HHHHHHhccCC------
Confidence            1111 01245778899999999888999999999999999999999997421  1   11   11111110000      


Q ss_pred             CcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          288 PIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                             ..+.+...+..+.+++.+||+.+|++|||+.++++.
T Consensus       225 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         225 -------NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             -------CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence                   001112345578999999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-43  Score=315.52  Aligned_cols=247  Identities=20%  Similarity=0.258  Sum_probs=213.2

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC-hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST-LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVF  132 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  132 (339)
                      .+-|.+.+.||+|-|+.|-.|++.-+|..||||++.+... .-....+++|+..|+.++|||||++|++......+|||+
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL   96 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL   96 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence            4678899999999999999999999999999999987533 234566889999999999999999999999999999999


Q ss_pred             EeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEe-CCCCceEEecCCCccccCCCC
Q 019536          133 ESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLL-DENYSAKLHDFSLSVSIPEGE  208 (339)
Q Consensus       133 e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~-~~~~~~kl~dfg~a~~~~~~~  208 (339)
                      |.-++|+|.|++.   ..+.++-..+++.||+.|+.|+|   +..++||||||+|+.+ .+-|-+||.|||++..+.+..
T Consensus        97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~  173 (864)
T KOG4717|consen   97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK  173 (864)
T ss_pred             EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence            9999999999986   67888899999999999999999   9999999999999876 567899999999999887766


Q ss_pred             ceeeecccccccccccccccccCCCC-cccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCccccccc
Q 019536          209 THVREEFIKGAYGFIAPEYFATSSFN-EMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVD  287 (339)
Q Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (339)
                      ...   ..+|+..|-|||.+.|..|+ +++|||||||++|.|++|++||+...+.+.                 +..|+|
T Consensus       174 kL~---TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET-----------------LTmImD  233 (864)
T KOG4717|consen  174 KLT---TSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET-----------------LTMIMD  233 (864)
T ss_pred             hhh---cccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh-----------------hhhhhc
Confidence            543   46899999999999999998 789999999999999999999975554431                 111222


Q ss_pred             CcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          288 PIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                      -    ..  ..|...+.++++||..||..||++|.|.++|+.
T Consensus       234 C----KY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  234 C----KY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             c----cc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence            1    12  223478889999999999999999999999875

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=2.7e-43  Score=320.08  Aligned_cols=237  Identities=22%  Similarity=0.221  Sum_probs=188.9

Q ss_pred             CceeccCCeeEEEEEEcCCCeeEEEEEeccCCC--hhhHHHHHHHHH-HHHhcCCCceeeeeeeeeeCCccEEEEEeccC
Q 019536           61 KVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST--LDDVEYCFNNIV-FSSQMKHKNILKLIGCCLETELPTLVFESVKY  137 (339)
Q Consensus        61 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~-~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~  137 (339)
                      +.||+|+||+||+|.+..+++.||+|++.....  ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            469999999999999999999999999875421  123344555544 56789999999999999999999999999999


Q ss_pred             Cccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceeeecc
Q 019536          138 GTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEF  215 (339)
Q Consensus       138 g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~~~  215 (339)
                      |+|..++.  ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++........  ...
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~--~~~  155 (323)
T cd05575          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TST  155 (323)
T ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCc--ccc
Confidence            99988875  46788888899999999999999   899999999999999999999999999998754322221  123


Q ss_pred             cccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCCCC
Q 019536          216 IKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNS  295 (339)
Q Consensus       216 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (339)
                      ..||+.|+|||++.+..++.++|||||||++|+|++|+.||....        ..+...... ..            ...
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~--------~~~~~~~i~-~~------------~~~  214 (323)
T cd05575         156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD--------TAEMYDNIL-NK------------PLR  214 (323)
T ss_pred             ccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC--------HHHHHHHHH-cC------------CCC
Confidence            568999999999999899999999999999999999999985221        111111111 00            001


Q ss_pred             CCCcHHHHHHHHHHHHHhhccCCCCCCCHH
Q 019536          296 FPGKEEKLQSLGQLMYKCLSKSPEHRPLMV  325 (339)
Q Consensus       296 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~  325 (339)
                      .  +...+..+.+++.+||+.||.+||++.
T Consensus       215 ~--~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         215 L--KPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             C--CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            1  113356789999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-42  Score=304.95  Aligned_cols=249  Identities=24%  Similarity=0.357  Sum_probs=199.4

Q ss_pred             CceeccCCeeEEEEEEcCCC---eeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeccC
Q 019536           61 KVIQSDTSYRLFEGTLVDQD---RPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKY  137 (339)
Q Consensus        61 ~~ig~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~  137 (339)
                      +.||+|+||.||+|.+...+   ..+|+|.+.........+.+.+|+.+++.+.||||+++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            47999999999999886555   7899999887655445677889999999999999999999876 4467999999999


Q ss_pred             Cccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceeee-c
Q 019536          138 GTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVRE-E  214 (339)
Q Consensus       138 g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~-~  214 (339)
                      |+|.+++.  ..+++..+..++.|++.||.|||   ..+++|+||||+||+++.++.+||+|||+++........... .
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~  156 (257)
T cd05060          80 GPLLKYLKKRREIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT  156 (257)
T ss_pred             CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCccccccc
Confidence            99999886  45888899999999999999999   899999999999999999999999999999876544332211 1


Q ss_pred             ccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCC
Q 019536          215 FIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDED  293 (339)
Q Consensus       215 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (339)
                      ...++..|+|||.+.+..++.++|+||||+++|++++ |..||....     .......    .....            
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~-----~~~~~~~----~~~~~------------  215 (257)
T cd05060         157 AGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK-----GAEVIAM----LESGE------------  215 (257)
T ss_pred             CccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCC-----HHHHHHH----HHcCC------------
Confidence            1223467999999988889999999999999999998 999975221     1111111    11110            


Q ss_pred             CCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 019536          294 NSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMY  335 (339)
Q Consensus       294 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~  335 (339)
                       ..+.+...+..+.+++.+||+.+|++|||+.++++.|+++.
T Consensus       216 -~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         216 -RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             -cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence             01112234567899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-42  Score=307.31  Aligned_cols=247  Identities=21%  Similarity=0.315  Sum_probs=195.8

Q ss_pred             CceeccCCeeEEEEEEcCCCe--eEEEEEeccCCChhhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCccEEEEEeccC
Q 019536           61 KVIQSDTSYRLFEGTLVDQDR--PISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLETELPTLVFESVKY  137 (339)
Q Consensus        61 ~~ig~G~~g~V~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~  137 (339)
                      +.||+|+||.||+|.+.+++.  .+++|.+.........+.+.+|+.++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            368999999999999987765  56888887554445567788999999999 899999999999999999999999999


Q ss_pred             Ccccccccc------------------CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCC
Q 019536          138 GTLRGFSFA------------------SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFS  199 (339)
Q Consensus       138 g~L~~~~~~------------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg  199 (339)
                      |+|.+++..                  .+++.++..++.|++.||+|||   +.+++||||||+||+++.++.+|++|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCC
Confidence            999888742                  3678888999999999999999   8999999999999999999999999999


Q ss_pred             CccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhh
Q 019536          200 LSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIE  278 (339)
Q Consensus       200 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  278 (339)
                      ++........   ......+..|+|||++.+..++.++|+||||+++|+|++ |..||.....        .........
T Consensus       158 l~~~~~~~~~---~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~--------~~~~~~~~~  226 (270)
T cd05047         158 LSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--------AELYEKLPQ  226 (270)
T ss_pred             Cccccchhhh---ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH--------HHHHHHHhC
Confidence            9854321111   111223567999999988889999999999999999997 9999742111        111111111


Q ss_pred             cCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 019536          279 NNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMY  335 (339)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~  335 (339)
                      ..              ..+.+...+.++.+|+.+||+.||.+|||+.+++..|+++.
T Consensus       227 ~~--------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         227 GY--------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             CC--------------CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            00              00111133457899999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=9e-43  Score=306.22  Aligned_cols=248  Identities=21%  Similarity=0.316  Sum_probs=198.6

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFES  134 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  134 (339)
                      .+|++.+.||+|+||.||+|.+. ++..+|+|.+.....  ....+.+|+.+++.++||||+++++++...+..++||||
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM--SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEY   80 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC--CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEec
Confidence            35888999999999999999886 567899999865432  335678899999999999999999999999999999999


Q ss_pred             ccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCcee
Q 019536          135 VKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHV  211 (339)
Q Consensus       135 ~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~  211 (339)
                      +++++|.+++.   ..+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++.........
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~  157 (256)
T cd05059          81 MANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS  157 (256)
T ss_pred             CCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence            99999999875   35788889999999999999999   8999999999999999999999999999987664332211


Q ss_pred             eecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcc
Q 019536          212 REEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIF  290 (339)
Q Consensus       212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (339)
                      . ....++..|+|||.+.+..++.++|+||||+++|++++ |+.||......     ....   . ....          
T Consensus       158 ~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~~~---~-~~~~----------  217 (256)
T cd05059         158 S-QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS-----EVVE---S-VSAG----------  217 (256)
T ss_pred             c-CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH-----HHHH---H-HHcC----------
Confidence            1 11223457999999998899999999999999999998 78887532111     1111   1 1100          


Q ss_pred             cCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 019536          291 DEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQL  331 (339)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L  331 (339)
                         ...+.+...+.++.+++.+||+.+|++|||+.++++.|
T Consensus       218 ---~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         218 ---YRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             ---CcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence               00111123456799999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=4.4e-42  Score=304.14  Aligned_cols=256  Identities=26%  Similarity=0.357  Sum_probs=205.7

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCC---CeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQ---DRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLV  131 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  131 (339)
                      ++|.+.+.||+|+||.||+|.+.+.   ...|++|...........+.+.+|+.+++.++||||+++++++.+. ..++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN-PVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC-CcEEE
Confidence            5688899999999999999997643   4579999987765445667889999999999999999999998764 57899


Q ss_pred             EEeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCC
Q 019536          132 FESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE  208 (339)
Q Consensus       132 ~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~  208 (339)
                      |||+++|+|.+++.   ..+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.++++|||+++......
T Consensus        85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  161 (270)
T cd05056          85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES  161 (270)
T ss_pred             EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence            99999999999986   35788899999999999999999   8999999999999999999999999999987765443


Q ss_pred             ceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCccccccc
Q 019536          209 THVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVD  287 (339)
Q Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (339)
                      ....+ ...++..|+|||.+.+..++.++|+||||+++|++++ |..||......        +.... .....      
T Consensus       162 ~~~~~-~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~--------~~~~~-~~~~~------  225 (270)
T cd05056         162 YYKAS-KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN--------DVIGR-IENGE------  225 (270)
T ss_pred             ceecC-CCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH--------HHHHH-HHcCC------
Confidence            22211 2234567999999988889999999999999999986 99997522111        11111 11110      


Q ss_pred             CcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          288 PIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                             ..+.+...+..+.+++.+||..+|++|||+.++++.|+++..+
T Consensus       226 -------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~  268 (270)
T cd05056         226 -------RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE  268 (270)
T ss_pred             -------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence                   0111224456799999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=2.8e-42  Score=314.86  Aligned_cols=261  Identities=21%  Similarity=0.329  Sum_probs=205.7

Q ss_pred             HHHhcCcccCCceeccCCeeEEEEEEcC-------CCeeEEEEEeccCCChhhHHHHHHHHHHHHhc-CCCceeeeeeee
Q 019536           51 KKATNNYDLHKVIQSDTSYRLFEGTLVD-------QDRPISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCC  122 (339)
Q Consensus        51 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~  122 (339)
                      +....+|++.+.||+|+||.||.|....       .+..||+|.+...........+.+|+.+++++ +||||++++++|
T Consensus         8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (334)
T cd05100           8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC   87 (334)
T ss_pred             ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence            3344679999999999999999998643       22468999887654445567888999999999 899999999999


Q ss_pred             eeCCccEEEEEeccCCcccccccc------------------CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCC
Q 019536          123 LETELPTLVFESVKYGTLRGFSFA------------------SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASN  184 (339)
Q Consensus       123 ~~~~~~~lv~e~~~~g~L~~~~~~------------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~N  184 (339)
                      ..++..++++||+++|+|.+++..                  .+++.+++.++.|++.||.|||   +.+++||||||+|
T Consensus        88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~N  164 (334)
T cd05100          88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARN  164 (334)
T ss_pred             ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccce
Confidence            999999999999999999988642                  3667788889999999999999   8999999999999


Q ss_pred             EEeCCCCceEEecCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCC
Q 019536          185 VLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGN  263 (339)
Q Consensus       185 il~~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~  263 (339)
                      |+++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|+|++ |..||...    
T Consensus       165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~----  240 (334)
T cd05100         165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI----  240 (334)
T ss_pred             EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC----
Confidence            9999999999999999877644322211212334567999999998899999999999999999998 78886421    


Q ss_pred             CCchhHHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 019536          264 DDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYL  336 (339)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~  336 (339)
                          ...+.. .......             ..+.+...+..+.+++.+||+.+|++|||+.++++.|+++..
T Consensus       241 ----~~~~~~-~~~~~~~-------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~  295 (334)
T cd05100         241 ----PVEELF-KLLKEGH-------------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT  295 (334)
T ss_pred             ----CHHHHH-HHHHcCC-------------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence                111111 1111110             001112344578899999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=8.5e-43  Score=313.72  Aligned_cols=264  Identities=17%  Similarity=0.195  Sum_probs=200.0

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFES  134 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  134 (339)
                      ++|++.+.||.|+||.||+|.+..++..||+|.+...........+.+|+.+++.++||||+++++++...+..++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            67999999999999999999998899999999987654434455677899999999999999999999999999999999


Q ss_pred             ccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCcee
Q 019536          135 VKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHV  211 (339)
Q Consensus       135 ~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~  211 (339)
                      ++ ++|.+++.   ..+++..+..++.|++.||.|||   +.+|+|+||||+||+++.++.++|+|||++..........
T Consensus        86 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  161 (301)
T cd07873          86 LD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY  161 (301)
T ss_pred             cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcc
Confidence            97 57777664   45788888999999999999999   8999999999999999999999999999987654322211


Q ss_pred             eecccccccccccccccccC-CCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHH---hhcCccccccc
Q 019536          212 REEFIKGAYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKS---IENNRFGAIVD  287 (339)
Q Consensus       212 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  287 (339)
                        ....++..|+|||++.+. .++.++|||||||++|+|++|++||.....     ..........   .....+..+..
T Consensus       162 --~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~  234 (301)
T cd07873         162 --SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV-----EEQLHFIFRILGTPTEETWPGILS  234 (301)
T ss_pred             --cccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHcCCCChhhchhhhc
Confidence              123468889999998654 578899999999999999999999853211     1111111111   01111111111


Q ss_pred             CcccCCCCCC---------CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          288 PIFDEDNSFP---------GKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       288 ~~~~~~~~~~---------~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                      .........|         .....+..+.+|+.+||+.||.+|||+.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         235 NEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             cccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            0000000000         00134557899999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.1e-42  Score=313.25  Aligned_cols=256  Identities=21%  Similarity=0.331  Sum_probs=203.1

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCe----eEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDR----PISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTL  130 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  130 (339)
                      ++|+..+.||+|+||.||+|.+..++.    .||+|.+...........+.+|+.+++.++||||++++++|... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            568888999999999999999876665    57888887655444455688999999999999999999999765 4679


Q ss_pred             EEEeccCCcccccccc---CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCC
Q 019536          131 VFESVKYGTLRGFSFA---SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEG  207 (339)
Q Consensus       131 v~e~~~~g~L~~~~~~---~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~  207 (339)
                      ++||+++|+|.+++..   .+++..+..++.|++.||.|||   +.+|+|+||||+||+++.++.+||+|||+++.....
T Consensus        86 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~  162 (303)
T cd05110          86 VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD  162 (303)
T ss_pred             eehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEccccccccccCc
Confidence            9999999999998763   5788888999999999999999   899999999999999999999999999999876544


Q ss_pred             CceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCcccccc
Q 019536          208 ETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIV  286 (339)
Q Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (339)
                      ..........++..|+|||++.+..++.++||||||+++|++++ |+.||.....     ...    ........     
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~-----~~~----~~~~~~~~-----  228 (303)
T cd05110         163 EKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT-----REI----PDLLEKGE-----  228 (303)
T ss_pred             ccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH-----HHH----HHHHHCCC-----
Confidence            33222223345678999999998899999999999999999997 8888742110     011    11111110     


Q ss_pred             cCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 019536          287 DPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYL  336 (339)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~  336 (339)
                              ..+.+..++..+.+++.+||..+|++||++.++++.|+++..
T Consensus       229 --------~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~  270 (303)
T cd05110         229 --------RLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR  270 (303)
T ss_pred             --------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                    011112334578999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=2e-42  Score=305.22  Aligned_cols=252  Identities=25%  Similarity=0.337  Sum_probs=200.7

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFE  133 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  133 (339)
                      .++|++.++||+|+||+||+|.+.++ ..||+|++.....  ..+.+.+|+.+++.++||||+++++++.+ +..++|||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e   80 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE   80 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc--CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEE
Confidence            36799999999999999999988644 5699999876432  34568899999999999999999998754 45789999


Q ss_pred             eccCCcccccccc----CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCc
Q 019536          134 SVKYGTLRGFSFA----SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGET  209 (339)
Q Consensus       134 ~~~~g~L~~~~~~----~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~  209 (339)
                      |+++|+|.+++..    .+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||.++.+.....
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~  157 (262)
T cd05071          81 YMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  157 (262)
T ss_pred             cCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence            9999999998862    4678888999999999999999   89999999999999999999999999999977654332


Q ss_pred             eeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCcccccccC
Q 019536          210 HVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDP  288 (339)
Q Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (339)
                      .. .....++..|+|||+..+..++.++|+||||+++|++++ |..||.....        ...... ....        
T Consensus       158 ~~-~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~--------~~~~~~-~~~~--------  219 (262)
T cd05071         158 TA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------REVLDQ-VERG--------  219 (262)
T ss_pred             cc-ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh--------HHHHHH-HhcC--------
Confidence            21 112345677999999988889999999999999999999 7778642211        010111 1000        


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 019536          289 IFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMY  335 (339)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~  335 (339)
                           ...+.+...+..+.+++.+||+.||++|||+.++++.|+..+
T Consensus       220 -----~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~  261 (262)
T cd05071         220 -----YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  261 (262)
T ss_pred             -----CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence                 011122245567899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=6.6e-42  Score=300.25  Aligned_cols=248  Identities=20%  Similarity=0.296  Sum_probs=203.7

Q ss_pred             CcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 019536           56 NYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS-TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFES  134 (339)
Q Consensus        56 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  134 (339)
                      +|++.+.||+|++|.||+|....++..|++|.+.... .......+.+|+.+++.++||||+++++++.+++..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4788899999999999999999899999999987542 235567788999999999999999999999999999999999


Q ss_pred             ccCCccccccc----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCce
Q 019536          135 VKYGTLRGFSF----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH  210 (339)
Q Consensus       135 ~~~g~L~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~  210 (339)
                      +++++|.+++.    ..++...+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||+++........
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~  157 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF  157 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence            99999999875    35778888899999999999999   899999999999999999999999999998876544322


Q ss_pred             eeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcc
Q 019536          211 VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIF  290 (339)
Q Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (339)
                      .  ....|+..|+|||++.+..++.++|+||||+++|+|++|+.||.....        ........ .....       
T Consensus       158 ~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~-~~~~~-------  219 (256)
T cd08529         158 A--NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ--------GALILKII-RGVFP-------  219 (256)
T ss_pred             h--hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHH-cCCCC-------
Confidence            1  234578889999999988899999999999999999999999753221        11111111 11100       


Q ss_pred             cCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          291 DEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                            +.+...+..+.+++.+||+.+|++||++.++++.
T Consensus       220 ------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         220 ------PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             ------CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence                  1111345679999999999999999999999864

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2.7e-42  Score=318.60  Aligned_cols=266  Identities=17%  Similarity=0.207  Sum_probs=200.8

Q ss_pred             HhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeC------
Q 019536           53 ATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS-TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLET------  125 (339)
Q Consensus        53 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~------  125 (339)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            4588999999999999999999999899999999987642 224456678999999999999999999987643      


Q ss_pred             CccEEEEEeccCCccccccccCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccC
Q 019536          126 ELPTLVFESVKYGTLRGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIP  205 (339)
Q Consensus       126 ~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~  205 (339)
                      ...++||||+++ +|.+.+...++......++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++...
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~  177 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  177 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHHhcCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence            346999999965 666666677888888999999999999999   8999999999999999999999999999997654


Q ss_pred             CCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHH---------
Q 019536          206 EGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKS---------  276 (339)
Q Consensus       206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~---------  276 (339)
                      .....   ....+|..|+|||++.+..++.++|||||||++|+|++|+.||.....     ..........         
T Consensus       178 ~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~~~  249 (364)
T cd07875         178 TSFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH-----IDQWNKVIEQLGTPCPEFM  249 (364)
T ss_pred             CCCcc---cCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHhcCCCCHHHH
Confidence            43221   134688999999999999999999999999999999999999853221     1111100000         


Q ss_pred             ----------hhc-CcccccccCcccCCCCCCC----cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          277 ----------IEN-NRFGAIVDPIFDEDNSFPG----KEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       277 ----------~~~-~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                                ... .................+.    .......+.+|+.+||+.||.+|||+.+++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                      000 0000000000000000010    01224578999999999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-43  Score=321.60  Aligned_cols=262  Identities=22%  Similarity=0.358  Sum_probs=218.5

Q ss_pred             HHHHHHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCc
Q 019536           48 KDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETEL  127 (339)
Q Consensus        48 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~  127 (339)
                      ++|+-...+....++||-|.||.||.|.|+.....||||.++.+.  ...++|+.|..+|+.++|||+|+++|+|.....
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt--MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP  337 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP  337 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc--hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence            567766778888899999999999999999899999999987653  668899999999999999999999999999999


Q ss_pred             cEEEEEeccCCcccccccc----CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccc
Q 019536          128 PTLVFESVKYGTLRGFSFA----SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVS  203 (339)
Q Consensus       128 ~~lv~e~~~~g~L~~~~~~----~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~  203 (339)
                      +|||+|||..|+|.+++..    -++.-..+.++.||..|+.||.   .++.|||||..+|+|+.++..+|++|||+++.
T Consensus       338 FYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRl  414 (1157)
T KOG4278|consen  338 FYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRL  414 (1157)
T ss_pred             eEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhh
Confidence            9999999999999999872    3444455688999999999999   99999999999999999999999999999998


Q ss_pred             cCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCcc
Q 019536          204 IPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRF  282 (339)
Q Consensus       204 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (339)
                      +..+.... .....-..-|.|||-+....++.++|||+|||++||+.| |-.||+        +.++.+. +....    
T Consensus       415 MtgDTYTA-HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYP--------GidlSqV-Y~LLE----  480 (1157)
T KOG4278|consen  415 MTGDTYTA-HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYP--------GIDLSQV-YGLLE----  480 (1157)
T ss_pred             hcCCceec-ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCC--------CccHHHH-HHHHh----
Confidence            86654332 112233567999999999999999999999999999998 666654        2222221 11111    


Q ss_pred             cccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          283 GAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                               ....+..+++|++.+.+||..||+|.|.+||+++||-+.++.|+.+
T Consensus       481 ---------kgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~  526 (1157)
T KOG4278|consen  481 ---------KGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS  526 (1157)
T ss_pred             ---------ccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence                     1223344567888999999999999999999999999999999854

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.5e-42  Score=321.23  Aligned_cols=265  Identities=18%  Similarity=0.220  Sum_probs=197.8

Q ss_pred             CcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC-----ccE
Q 019536           56 NYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS-TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETE-----LPT  129 (339)
Q Consensus        56 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~-----~~~  129 (339)
                      +|++.+.||+|+||.||+|.+..+++.||+|++.... .......+.+|+.+++.++||||+++++++...+     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            5788999999999999999998899999999986542 2234567889999999999999999999998776     789


Q ss_pred             EEEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCC
Q 019536          130 LVFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEG  207 (339)
Q Consensus       130 lv~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~  207 (339)
                      +|+||++ ++|.+.+.  ..++...+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus        81 lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~  156 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD  156 (372)
T ss_pred             EEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence            9999996 56666654  56888899999999999999999   899999999999999999999999999999765433


Q ss_pred             CceeeecccccccccccccccccC-CCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCccccc-
Q 019536          208 ETHVREEFIKGAYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAI-  285 (339)
Q Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  285 (339)
                      ..... ....++..|+|||++.+. .++.++||||+||++|+|++|+.||.....  ......+   ...........+ 
T Consensus       157 ~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~~~~~i---~~~~g~~~~~~~~  230 (372)
T cd07853         157 ESKHM-TQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSP--IQQLDLI---TDLLGTPSLEAMR  230 (372)
T ss_pred             ccccC-CCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCH--HHHHHHH---HHHcCCCCHHHHH
Confidence            22111 124578889999998875 588999999999999999999999853221  1111111   000000000000 


Q ss_pred             ------ccCcccCCCCCC-------CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          286 ------VDPIFDEDNSFP-------GKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       286 ------~~~~~~~~~~~~-------~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                            ...........+       .....+.++.+|+.+||+.||++|||+.+++.+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         231 SACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             HhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence                  000000000000       011235678999999999999999999999864

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.6e-42  Score=325.16  Aligned_cols=266  Identities=17%  Similarity=0.218  Sum_probs=197.9

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFE  133 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  133 (339)
                      ...|.+.+.||+|+||.||+|.+..+++.||||....       ..+.+|+.++++++|+||+++++++..++..++|||
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e  240 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP  240 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence            3579999999999999999999998999999996422       235689999999999999999999999999999999


Q ss_pred             eccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCce
Q 019536          134 SVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH  210 (339)
Q Consensus       134 ~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~  210 (339)
                      ++. ++|.+++.   ..+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+......
T Consensus       241 ~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~  316 (461)
T PHA03211        241 KYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST  316 (461)
T ss_pred             ccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence            995 67777764   35889999999999999999999   899999999999999999999999999999876443222


Q ss_pred             eeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCch---hHHHHHHHH-hhcCcccccc
Q 019536          211 VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDL---TVLEYAKKS-IENNRFGAIV  286 (339)
Q Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~---~~~~~~~~~-~~~~~~~~~~  286 (339)
                      .......||..|+|||++.+..++.++|||||||++|||++|..|+...........   .....+... .....+....
T Consensus       317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~  396 (461)
T PHA03211        317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA  396 (461)
T ss_pred             ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence            222235689999999999999999999999999999999998876532221111111   111111110 0000000000


Q ss_pred             c------------CcccCCCC---CCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          287 D------------PIFDEDNS---FPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       287 ~------------~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      .            ........   +......+..+.+|+.+||+.||.+|||+.|+|++
T Consensus       397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            0            00000000   11001223468899999999999999999999974

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=6.6e-43  Score=317.52  Aligned_cols=241  Identities=20%  Similarity=0.275  Sum_probs=194.1

Q ss_pred             CcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC--ChhhHHHHHHHHHHHHhcC-CCceeeeeeeeeeCCccEEEE
Q 019536           56 NYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS--TLDDVEYCFNNIVFSSQMK-HKNILKLIGCCLETELPTLVF  132 (339)
Q Consensus        56 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~-H~niv~~~~~~~~~~~~~lv~  132 (339)
                      +|+..+.||+|+||+||+|....+++.||+|++....  .....+.+..|..++..+. |++|+++.+++.+.+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            4677899999999999999999999999999987542  1234456778888888885 578888999999999999999


Q ss_pred             EeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCce
Q 019536          133 ESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH  210 (339)
Q Consensus       133 e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~  210 (339)
                      ||+++|+|.+++.  ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++........
T Consensus        81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~  157 (323)
T cd05615          81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT  157 (323)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCcc
Confidence            9999999998876  56889999999999999999999   899999999999999999999999999998754332221


Q ss_pred             eeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcc
Q 019536          211 VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIF  290 (339)
Q Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (339)
                        .....||+.|+|||++.+..++.++|+||+||++|+|++|+.||.....     ....   ..... .          
T Consensus       158 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-----~~~~---~~i~~-~----------  216 (323)
T cd05615         158 --TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-----DELF---QSIME-H----------  216 (323)
T ss_pred             --ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH-----HHHH---HHHHh-C----------
Confidence              1235689999999999988999999999999999999999999752211     1111   11111 0          


Q ss_pred             cCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCH
Q 019536          291 DEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLM  324 (339)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~  324 (339)
                        ....|  ...+..+.+++.+||+.+|.+|+++
T Consensus       217 --~~~~p--~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         217 --NVSYP--KSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             --CCCCC--ccCCHHHHHHHHHHcccCHhhCCCC
Confidence              01111  1344578999999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=2.1e-42  Score=318.29  Aligned_cols=267  Identities=18%  Similarity=0.223  Sum_probs=201.7

Q ss_pred             HHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC----
Q 019536           52 KATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS-TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETE----  126 (339)
Q Consensus        52 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~----  126 (339)
                      ...++|++.+.||+|+||.||++.+..+++.||+|++.... .......+.+|+.+++.++||||+++++++....    
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            45689999999999999999999998899999999987643 2244567789999999999999999999986543    


Q ss_pred             --ccEEEEEeccCCccccccccCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCcccc
Q 019536          127 --LPTLVFESVKYGTLRGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSI  204 (339)
Q Consensus       127 --~~~lv~e~~~~g~L~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~  204 (339)
                        ..++||||+++ ++.+.+...++...+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++..
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~  169 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  169 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHhhcCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCcccccC
Confidence              46899999965 566666667888888999999999999999   999999999999999999999999999999765


Q ss_pred             CCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHH---------
Q 019536          205 PEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKK---------  275 (339)
Q Consensus       205 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~---------  275 (339)
                      ......   ....||..|+|||++.+..++.++|||||||++|+|++|+.||....  .   .........         
T Consensus       170 ~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--~---~~~~~~~~~~~~~~~~~~  241 (355)
T cd07874         170 GTSFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD--Y---IDQWNKVIEQLGTPCPEF  241 (355)
T ss_pred             CCcccc---CCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--H---HHHHHHHHHHhCCCCHHH
Confidence            433221   13468899999999998899999999999999999999999985321  1   111100000         


Q ss_pred             ----------Hhhc-CcccccccCcccCCCCCC----CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          276 ----------SIEN-NRFGAIVDPIFDEDNSFP----GKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       276 ----------~~~~-~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                                .... .....+..+.......++    .....+..+.+|+.+||+.||++|||+.|++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                      0000 000000000000000011    011234578999999999999999999999985

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=4.8e-43  Score=318.74  Aligned_cols=241  Identities=22%  Similarity=0.226  Sum_probs=189.7

Q ss_pred             CceeccCCeeEEEEEEcCCCeeEEEEEeccCCC--hhhHHHHHHHH-HHHHhcCCCceeeeeeeeeeCCccEEEEEeccC
Q 019536           61 KVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST--LDDVEYCFNNI-VFSSQMKHKNILKLIGCCLETELPTLVFESVKY  137 (339)
Q Consensus        61 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~-~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~  137 (339)
                      +.||+|+||+||+|.+..+++.||+|++.....  ......+..|. .+++.++||||+++++++.+++..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            469999999999999998999999999875321  12233444454 456788999999999999999999999999999


Q ss_pred             Cccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceeeecc
Q 019536          138 GTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEF  215 (339)
Q Consensus       138 g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~~~  215 (339)
                      |+|.+++.  ..++......++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++........  ...
T Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~--~~~  155 (325)
T cd05602          81 GELFYHLQRERCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT--TST  155 (325)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCC--ccc
Confidence            99998876  45777888889999999999999   999999999999999999999999999998754332221  123


Q ss_pred             cccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCCCC
Q 019536          216 IKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNS  295 (339)
Q Consensus       216 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (339)
                      ..||+.|+|||++.+..++.++||||+||++|+|++|+.||.....        .+....... ..            . 
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~i~~-~~------------~-  213 (325)
T cd05602         156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT--------AEMYDNILN-KP------------L-  213 (325)
T ss_pred             ccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH--------HHHHHHHHh-CC------------c-
Confidence            5689999999999999999999999999999999999999852211        111111110 00            0 


Q ss_pred             CCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          296 FPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       296 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                       ..+...+..+.+++.+||+.||.+||++.+.+.
T Consensus       214 -~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~  246 (325)
T cd05602         214 -QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFM  246 (325)
T ss_pred             -CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence             011134557899999999999999999875443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=3.1e-43  Score=324.46  Aligned_cols=252  Identities=19%  Similarity=0.231  Sum_probs=198.6

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC--ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS--TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVF  132 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  132 (339)
                      ++|++.+.||+|+||+||++....+++.||+|++....  .......+.+|+.++..++||||+++++++.+++..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46889999999999999999999999999999987532  1234566788999999999999999999999999999999


Q ss_pred             EeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCce
Q 019536          133 ESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH  210 (339)
Q Consensus       133 e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~  210 (339)
                      ||+++|+|.+++.  ..++...+..++.|++.||.|||   +.+|+||||||+|||++.++.++|+|||+++.+......
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~  157 (360)
T cd05627          81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT  157 (360)
T ss_pred             eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence            9999999999875  56888889999999999999999   999999999999999999999999999998754321100


Q ss_pred             ---------------------------------eeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccc
Q 019536          211 ---------------------------------VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLE  257 (339)
Q Consensus       211 ---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~  257 (339)
                                                       .......||+.|+|||++.+..++.++|+|||||++|+|++|+.||.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~  237 (360)
T cd05627         158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC  237 (360)
T ss_pred             ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence                                             00112468999999999999999999999999999999999999985


Q ss_pred             cCCCCCCCchhHHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCC---HHHHHH
Q 019536          258 FKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPL---MVDVAK  329 (339)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps---~~~il~  329 (339)
                      ....        ......... ..          ....+|.....+..+.+|+.+|+. ||.+|++   +.++++
T Consensus       238 ~~~~--------~~~~~~i~~-~~----------~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~  292 (360)
T cd05627         238 SETP--------QETYRKVMN-WK----------ETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKS  292 (360)
T ss_pred             CCCH--------HHHHHHHHc-CC----------CceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhc
Confidence            3211        111111110 00          001111111245678899998774 9999985   566654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=3.2e-42  Score=301.44  Aligned_cols=245  Identities=24%  Similarity=0.364  Sum_probs=196.2

Q ss_pred             CceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeccCCcc
Q 019536           61 KVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL  140 (339)
Q Consensus        61 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L  140 (339)
                      ++||+|+||.||+|... ++..+|+|.+...........+.+|+.+++.++||||+++++++...+..++||||+++++|
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   79 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF   79 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence            36899999999999865 68899999987765545556788999999999999999999999999999999999999999


Q ss_pred             ccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceeeecccc
Q 019536          141 RGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIK  217 (339)
Q Consensus       141 ~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~  217 (339)
                      .+++.   ..+.+..+..++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||++.......... .....
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~~~~  155 (250)
T cd05085          80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS-SGLKQ  155 (250)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceecccccccc-CCCCC
Confidence            98875   35788888999999999999999   8999999999999999999999999999987643322211 11223


Q ss_pred             cccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCCCCC
Q 019536          218 GAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSF  296 (339)
Q Consensus       218 gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (339)
                      ++..|+|||++.+..++.++|+||||+++|++++ |..||.....     .....   . ......             .
T Consensus       156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~-----~~~~~---~-~~~~~~-------------~  213 (250)
T cd05085         156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN-----QQARE---Q-VEKGYR-------------M  213 (250)
T ss_pred             CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH-----HHHHH---H-HHcCCC-------------C
Confidence            4567999999988889999999999999999998 9889752211     11111   1 111100             0


Q ss_pred             CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 019536          297 PGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLR  332 (339)
Q Consensus       297 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~  332 (339)
                      ..+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus       214 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         214 SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            001134457999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.7e-43  Score=319.43  Aligned_cols=238  Identities=21%  Similarity=0.218  Sum_probs=192.1

Q ss_pred             CceeccCCeeEEEEEEc---CCCeeEEEEEeccCCC-hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEecc
Q 019536           61 KVIQSDTSYRLFEGTLV---DQDRPISVMKFHDNST-LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVK  136 (339)
Q Consensus        61 ~~ig~G~~g~V~~~~~~---~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~  136 (339)
                      +.||+|+||.||++...   .++..||+|++..... ......+.+|+.++++++||||+++++++.+++..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            67999999999998863   5788999999876422 1234556789999999999999999999999999999999999


Q ss_pred             CCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceeeec
Q 019536          137 YGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREE  214 (339)
Q Consensus       137 ~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~~  214 (339)
                      +|+|.+++.  ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++........  ..
T Consensus        82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~--~~  156 (318)
T cd05582          82 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AY  156 (318)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCc--ee
Confidence            999988875  45888999999999999999999   899999999999999999999999999998765443221  11


Q ss_pred             ccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCCC
Q 019536          215 FIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDN  294 (339)
Q Consensus       215 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (339)
                      ...||..|+|||++.+..++.++|||||||++|+|++|+.||.....        ........ ...            .
T Consensus       157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~--------~~~~~~i~-~~~------------~  215 (318)
T cd05582         157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR--------KETMTMIL-KAK------------L  215 (318)
T ss_pred             cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH--------HHHHHHHH-cCC------------C
Confidence            35689999999999988899999999999999999999999852211        11111111 110            1


Q ss_pred             CCCCcHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 019536          295 SFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVD  326 (339)
Q Consensus       295 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~  326 (339)
                      ..|  ...+..+.+|+.+||+.||++|||+.+
T Consensus       216 ~~p--~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         216 GMP--QFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCC--CCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            111  234567899999999999999999554

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.3e-42  Score=309.91  Aligned_cols=258  Identities=18%  Similarity=0.275  Sum_probs=206.7

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFES  134 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  134 (339)
                      ++|++.+.||+|+||+||+|....++..||+|++...........+.+|+++++.++||||+++++++...+..++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            57888999999999999999998889999999987665445567788999999999999999999999999999999999


Q ss_pred             ccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceee
Q 019536          135 VKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVR  212 (339)
Q Consensus       135 ~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~  212 (339)
                      +++++|.+++.  +.+++..+..++.+++.||.|||+  ..+++|+||+|+||+++.++.++|+|||++........   
T Consensus        85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~---  159 (284)
T cd06620          85 MDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIA---  159 (284)
T ss_pred             CCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhcc---
Confidence            99999988875  467888999999999999999993  25899999999999999999999999999865533221   


Q ss_pred             ecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCC---CchhHHHHHHHHhhcCcccccccCc
Q 019536          213 EEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGND---DDLTVLEYAKKSIENNRFGAIVDPI  289 (339)
Q Consensus       213 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~  289 (339)
                       ....|+..|+|||++.+..++.++|+|||||++|++++|+.||........   ................         
T Consensus       160 -~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------  229 (284)
T cd06620         160 -DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP---------  229 (284)
T ss_pred             -CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc---------
Confidence             134688999999999888899999999999999999999999864332111   1111111111111100         


Q ss_pred             ccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 019536          290 FDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQL  331 (339)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L  331 (339)
                         ....+ ....+..+.+|+.+||+.||++|||+.+++++.
T Consensus       230 ---~~~~~-~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         230 ---PPRLP-SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             ---CCCCC-chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence               00011 113456789999999999999999999999753

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=3.3e-42  Score=309.39  Aligned_cols=249  Identities=18%  Similarity=0.271  Sum_probs=204.3

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFES  134 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  134 (339)
                      ++|++.+.||+|++|.||+|....+++.||+|.+..... ...+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   97 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   97 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc-chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence            689999999999999999999988999999999876544 3456678999999999999999999999999999999999


Q ss_pred             ccCCccccccc-cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceeee
Q 019536          135 VKYGTLRGFSF-ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVRE  213 (339)
Q Consensus       135 ~~~g~L~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~  213 (339)
                      +++++|.+++. ..+++..+..++.|++.||.|||   +.+++||||||+||+++.++.++|+|||++..........  
T Consensus        98 ~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~--  172 (297)
T cd06656          98 LAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--  172 (297)
T ss_pred             cCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCc--
Confidence            99999999876 56788889999999999999999   8999999999999999999999999999987654433211  


Q ss_pred             cccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCC
Q 019536          214 EFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDED  293 (339)
Q Consensus       214 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (339)
                      ....++..|+|||.+.+..++.++|+|||||++|++++|+.||.......  ..      .....            ...
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~--~~------~~~~~------------~~~  232 (297)
T cd06656         173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR--AL------YLIAT------------NGT  232 (297)
T ss_pred             CcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcch--he------eeecc------------CCC
Confidence            13457888999999998889999999999999999999999985321110  00      00000            000


Q ss_pred             CCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          294 NSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       294 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                      .....+...+..+.+++.+||+.+|++|||+.++++
T Consensus       233 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         233 PELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            011112244567899999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=2e-42  Score=304.60  Aligned_cols=251  Identities=24%  Similarity=0.341  Sum_probs=201.0

Q ss_pred             HhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 019536           53 ATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVF  132 (339)
Q Consensus        53 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  132 (339)
                      ..++|++.++||+|+||.||+|... +++.||+|.+.....  ....+.+|+.+++.++||||+++++++. .+..++||
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~   79 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM--SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIIT   79 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC--cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEE
Confidence            3467999999999999999999876 678899999876543  3467889999999999999999999874 45689999


Q ss_pred             EeccCCccccccc----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCC
Q 019536          133 ESVKYGTLRGFSF----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE  208 (339)
Q Consensus       133 e~~~~g~L~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~  208 (339)
                      ||+++++|.+++.    ..+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||++.......
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05067          80 EYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE  156 (260)
T ss_pred             EcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence            9999999998875    35788888999999999999999   8999999999999999999999999999987765332


Q ss_pred             ceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCccccccc
Q 019536          209 THVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVD  287 (339)
Q Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (339)
                      ... .....++..|+|||++.+..++.++|+||||+++|++++ |+.||.....     .......    ....      
T Consensus       157 ~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----~~~~~~~----~~~~------  220 (260)
T cd05067         157 YTA-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN-----PEVIQNL----ERGY------  220 (260)
T ss_pred             ccc-ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh-----HHHHHHH----HcCC------
Confidence            221 112345678999999988889999999999999999998 9999752211     1111111    1100      


Q ss_pred             CcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 019536          288 PIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQ  333 (339)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~  333 (339)
                             ..+.+...+.++.+++.+||+.+|++|||+.+++..|+.
T Consensus       221 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         221 -------RMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             -------CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence                   001112344579999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=3.1e-42  Score=307.11  Aligned_cols=248  Identities=17%  Similarity=0.216  Sum_probs=199.1

Q ss_pred             cccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEecc
Q 019536           57 YDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVK  136 (339)
Q Consensus        57 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~  136 (339)
                      |++.+.||+|+||.||+|.+..++..+++|.+..... ...+.+.+|+.+++.++||||+++++++..++..++|+||++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~   85 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSE-EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA   85 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCH-HHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence            6778899999999999999998999999999865533 456778899999999999999999999999999999999999


Q ss_pred             CCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceeee
Q 019536          137 YGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVRE  213 (339)
Q Consensus       137 ~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~  213 (339)
                      +|+|..++.   ..+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+|++|||++.........  .
T Consensus        86 ~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~--~  160 (282)
T cd06643          86 GGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR--R  160 (282)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEccccccccccccccc--c
Confidence            999988764   46888999999999999999999   899999999999999999999999999998765432211  1


Q ss_pred             cccccccccccccccc-----cCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccC
Q 019536          214 EFIKGAYGFIAPEYFA-----TSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDP  288 (339)
Q Consensus       214 ~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (339)
                      ....++..|+|||++.     +..++.++|+||+||++|+|++|++||....        .......... ...      
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~--------~~~~~~~~~~-~~~------  225 (282)
T cd06643         161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN--------PMRVLLKIAK-SEP------  225 (282)
T ss_pred             ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC--------HHHHHHHHhh-cCC------
Confidence            1346888999999984     3457889999999999999999999975211        1111111110 000      


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          289 IFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                           ...+.+...+..+.+++.+||+.||.+|||+.+++++
T Consensus       226 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         226 -----PTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             -----CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                 0001112345679999999999999999999998863

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-42  Score=305.08  Aligned_cols=249  Identities=24%  Similarity=0.305  Sum_probs=205.7

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFES  134 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  134 (339)
                      ++|++.+.||.|++|.||+|.+..++..||+|.+...........+.+|+.+++.++|+||+++++++.++...++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            46888999999999999999999899999999987665445567788999999999999999999999999999999999


Q ss_pred             ccCCcccccccc-CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceeee
Q 019536          135 VKYGTLRGFSFA-SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVRE  213 (339)
Q Consensus       135 ~~~g~L~~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~  213 (339)
                      +++++|.+++.. .+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||+++........  .
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~--~  155 (274)
T cd06609          81 CGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK--R  155 (274)
T ss_pred             eCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeecccccc--c
Confidence            999999999874 6889999999999999999999   899999999999999999999999999999877543221  1


Q ss_pred             cccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCC
Q 019536          214 EFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDED  293 (339)
Q Consensus       214 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (339)
                      ....++..|+|||++.+..++.++|+||||+++|+|++|+.||.....     .....   . ......     +     
T Consensus       156 ~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~-----~~~~~---~-~~~~~~-----~-----  216 (274)
T cd06609         156 NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP-----MRVLF---L-IPKNNP-----P-----  216 (274)
T ss_pred             ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch-----HHHHH---H-hhhcCC-----C-----
Confidence            134678889999999988899999999999999999999999752211     11111   1 000000     0     


Q ss_pred             CCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          294 NSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       294 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                       ..+. ...+..+.+++.+||+.||++|||+.++++
T Consensus       217 -~~~~-~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         217 -SLEG-NKFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             -CCcc-cccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence             0011 014557899999999999999999999976

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.6e-42  Score=321.59  Aligned_cols=265  Identities=20%  Similarity=0.226  Sum_probs=199.8

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcC--CCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVD--QDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLV  131 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  131 (339)
                      ..+|.+.+.||.|+||.||++...+  .+..|++|.+...      ....+|+.+++.++||||+++++++...+..++|
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv  164 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG------KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV  164 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence            4579999999999999999998643  4578999988653      2245899999999999999999999999999999


Q ss_pred             EEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCc
Q 019536          132 FESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGET  209 (339)
Q Consensus       132 ~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~  209 (339)
                      ||++. ++|.+++.  ..+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.++|+|||+++.+.....
T Consensus       165 ~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~  240 (392)
T PHA03207        165 MPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD  240 (392)
T ss_pred             ehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence            99995 57777764  56899999999999999999999   89999999999999999999999999999987655433


Q ss_pred             eeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcc--cc---
Q 019536          210 HVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRF--GA---  284 (339)
Q Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~---  284 (339)
                      ........||..|+|||++.+..|+.++|||||||++|+|++|+.||.......  .................  ..   
T Consensus       241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~--~~~~l~~i~~~~~~~~~~~~~~~~  318 (392)
T PHA03207        241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKS--SSSQLRSIIRCMQVHPLEFPQNGS  318 (392)
T ss_pred             cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCC--cHHHHHHHHHHhccCccccCCccc
Confidence            333334578999999999999999999999999999999999999975433221  11111111111100000  00   


Q ss_pred             ------c--ccCcccCCCCCCC---cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          285 ------I--VDPIFDEDNSFPG---KEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       285 ------~--~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                            +  ...........|.   ....+.++.+++.+||+.||++|||+.+++.+
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence                  0  0000000011110   01234568899999999999999999999874

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.1e-41  Score=299.99  Aligned_cols=251  Identities=26%  Similarity=0.417  Sum_probs=193.7

Q ss_pred             CceeccCCeeEEEEEEcC---CCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeee-eCCccEEEEEecc
Q 019536           61 KVIQSDTSYRLFEGTLVD---QDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCL-ETELPTLVFESVK  136 (339)
Q Consensus        61 ~~ig~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~-~~~~~~lv~e~~~  136 (339)
                      +.||+|+||.||+|.+.+   .+..||+|.+.........+.+.+|+.+++.++||||+++++++. .++..++||||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            468999999999998753   346799999865444455677889999999999999999999876 4556899999999


Q ss_pred             CCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCcee--
Q 019536          137 YGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHV--  211 (339)
Q Consensus       137 ~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~--  211 (339)
                      +|+|.+++.   ....+.....++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++.........  
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~  157 (262)
T cd05058          81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH  157 (262)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence            999999975   33566777889999999999999   8999999999999999999999999999987654322111  


Q ss_pred             eecccccccccccccccccCCCCcccchHHHHHHHHHHHhC-CCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcc
Q 019536          212 REEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG-CNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIF  290 (339)
Q Consensus       212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (339)
                      ......++..|+|||.+.+..++.++|||||||++|||++| .+||..  .      ........... +.         
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~--~------~~~~~~~~~~~-~~---------  219 (262)
T cd05058         158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD--V------DSFDITVYLLQ-GR---------  219 (262)
T ss_pred             ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCC--C------CHHHHHHHHhc-CC---------
Confidence            11123356679999999888899999999999999999995 445431  1      11111111111 00         


Q ss_pred             cCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 019536          291 DEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYL  336 (339)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~  336 (339)
                          ..+.+...+..+.+++.+||+.+|++||++.++++.|++++.
T Consensus       220 ----~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         220 ----RLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             ----CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence                011111334578999999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2.2e-42  Score=304.32  Aligned_cols=250  Identities=24%  Similarity=0.361  Sum_probs=199.8

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFE  133 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  133 (339)
                      .++|++.+.||+|+||.||+|... .+..+|+|.+.....  ..+.+.+|+.++++++|+|++++++++.. +..++|||
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e   80 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM--SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTE   80 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC--CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEE
Confidence            357899999999999999999876 567799999876533  34568899999999999999999998854 55789999


Q ss_pred             eccCCccccccc----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCc
Q 019536          134 SVKYGTLRGFSF----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGET  209 (339)
Q Consensus       134 ~~~~g~L~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~  209 (339)
                      |+++++|.+++.    ..+++..+..++.|++.||.|||   +.+++||||||+||+++.++.++|+|||++..+.....
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05070          81 YMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY  157 (260)
T ss_pred             ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence            999999999875    34788889999999999999999   89999999999999999999999999999987654332


Q ss_pred             eeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCcccccccC
Q 019536          210 HVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDP  288 (339)
Q Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (339)
                      .... ...++..|+|||++.+..++.++|+||||+++|+|++ |..||....     ......   . ....        
T Consensus       158 ~~~~-~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~-----~~~~~~---~-~~~~--------  219 (260)
T cd05070         158 TARQ-GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN-----NREVLE---Q-VERG--------  219 (260)
T ss_pred             cccc-CCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH---H-HHcC--------
Confidence            2111 2234567999999988889999999999999999999 888874211     111111   1 1110        


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 019536          289 IFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQ  333 (339)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~  333 (339)
                           ...+.+...+..+.+|+.+||+.+|++|||++++.+.|++
T Consensus       220 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         220 -----YRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             -----CCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                 0111122445679999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=3.5e-42  Score=339.03  Aligned_cols=259  Identities=17%  Similarity=0.228  Sum_probs=203.0

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC--hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST--LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVF  132 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  132 (339)
                      ++|++.++||+|+||.||+|.+..+++.||+|++.....  ....+++.+|+.+++.++||||+++++++.+++..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            679999999999999999999998999999999876422  234567889999999999999999999999999999999


Q ss_pred             EeccCCccccccc-------------cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCC
Q 019536          133 ESVKYGTLRGFSF-------------ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFS  199 (339)
Q Consensus       133 e~~~~g~L~~~~~-------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg  199 (339)
                      ||+++|+|.+++.             ...++...+.++.|++.||+|||   +.+|+||||||+||+++.++.++|+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecC
Confidence            9999999988764             12345567889999999999999   8999999999999999999999999999


Q ss_pred             CccccCCCCc----------------eeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCC
Q 019536          200 LSVSIPEGET----------------HVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGN  263 (339)
Q Consensus       200 ~a~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~  263 (339)
                      +++.......                ........||+.|+|||++.+..++.++||||+||++|+|++|+.||.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            9976621110                001112468999999999999999999999999999999999999985311100


Q ss_pred             CCchhHHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHHHHh
Q 019536          264 DDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP-LMVDVAKQLRQMYL  336 (339)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-s~~~il~~L~~l~~  336 (339)
                           ..   ..    ..   +..+     .........+..+.+++.+||+.||++|| +++++++.|+....
T Consensus       239 -----i~---~~----~~---i~~P-----~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq  292 (932)
T PRK13184        239 -----IS---YR----DV---ILSP-----IEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ  292 (932)
T ss_pred             -----hh---hh----hh---ccCh-----hhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence                 00   00    00   0000     00000113445788999999999999996 57777777877643

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=5.2e-42  Score=306.30  Aligned_cols=249  Identities=18%  Similarity=0.270  Sum_probs=199.6

Q ss_pred             CcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCCh--hhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 019536           56 NYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTL--DDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFE  133 (339)
Q Consensus        56 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  133 (339)
                      .|+..+.||+|+||+||+|.+..+++.||+|.+......  .....+.+|+.+++.++|+||+.+++.+.+++..++|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            367788999999999999999999999999998764321  223456789999999999999999999999999999999


Q ss_pred             eccCCccccccc----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCc
Q 019536          134 SVKYGTLRGFSF----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGET  209 (339)
Q Consensus       134 ~~~~g~L~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~  209 (339)
                      |+++++|.+++.    ..++...+..++.|++.||.|||   +.+|+||||||+||+++.++.++|+|||++........
T Consensus        81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  157 (285)
T cd05630          81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT  157 (285)
T ss_pred             ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence            999999988874    35788889999999999999999   89999999999999999999999999999876543332


Q ss_pred             eeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCc
Q 019536          210 HVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPI  289 (339)
Q Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (339)
                      ..   ...|+..|+|||++.+..++.++|+||+|+++|+|++|+.||......  ......   ........      . 
T Consensus       158 ~~---~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~--~~~~~~---~~~~~~~~------~-  222 (285)
T cd05630         158 IK---GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK--IKREEV---ERLVKEVQ------E-  222 (285)
T ss_pred             cc---CCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCcc--chHHHH---Hhhhhhhh------h-
Confidence            11   246889999999999889999999999999999999999998532111  000000   10000000      0 


Q ss_pred             ccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 019536          290 FDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPL-----MVDVAK  329 (339)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps-----~~~il~  329 (339)
                           ..  +...+..+.+|+.+||+.||++|||     +.++++
T Consensus       223 -----~~--~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         223 -----EY--SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             -----hc--CccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence                 00  1133456899999999999999999     888887

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=6.5e-42  Score=302.97  Aligned_cols=251  Identities=20%  Similarity=0.260  Sum_probs=190.5

Q ss_pred             CceeccCCeeEEEEEEcC--CCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeccCC
Q 019536           61 KVIQSDTSYRLFEGTLVD--QDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYG  138 (339)
Q Consensus        61 ~~ig~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g  138 (339)
                      +.||+|+||.||+|....  ++..+|+|.+...........+.+|+.+++.++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            368999999999998653  456799999877654445567889999999999999999999999999999999999999


Q ss_pred             cccccccc-------CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCcee
Q 019536          139 TLRGFSFA-------SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHV  211 (339)
Q Consensus       139 ~L~~~~~~-------~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~  211 (339)
                      +|.+++..       ..++..+..++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||+++.........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            99988752       3455667789999999999999   8999999999999999999999999999987654433322


Q ss_pred             eecccccccccccccccccC-------CCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCccc
Q 019536          212 REEFIKGAYGFIAPEYFATS-------SFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFG  283 (339)
Q Consensus       212 ~~~~~~gt~~y~aPE~~~~~-------~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (339)
                      ......++..|+|||++.+.       .++.++|+||||+++|+|++ |+.||......        +.......... .
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~--------~~~~~~~~~~~-~  228 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE--------QVLTYTVREQQ-L  228 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH--------HHHHHHhhccc-C
Confidence            22234567889999998542       35789999999999999996 99998532211        11111111100 0


Q ss_pred             ccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 019536          284 AIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLR  332 (339)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~  332 (339)
                      .+.++.    ..    ...+..+.+++..|| .+|++|||+.+|+..|+
T Consensus       229 ~~~~~~----~~----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         229 KLPKPR----LK----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCCCc----cC----CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            011110    00    123446888999999 68999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.6e-42  Score=300.06  Aligned_cols=246  Identities=24%  Similarity=0.370  Sum_probs=198.5

Q ss_pred             CceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeccCCcc
Q 019536           61 KVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL  140 (339)
Q Consensus        61 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L  140 (339)
                      +.||+|++|.||+|.+.. ++.|++|.+...........+.+|+.++++++||||+++++++.+....++||||+++++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l   79 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL   79 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence            468999999999999976 9999999988765544667788999999999999999999999999999999999999999


Q ss_pred             ccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceeeecccc
Q 019536          141 RGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIK  217 (339)
Q Consensus       141 ~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~  217 (339)
                      .+++.   ..+++..+..++.+++.||.|||   +.+++||||+|+||+++.++.++|+|||.+................
T Consensus        80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~  156 (251)
T cd05041          80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ  156 (251)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence            99874   45788888999999999999999   8999999999999999999999999999987654322221111223


Q ss_pred             cccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCCCCC
Q 019536          218 GAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSF  296 (339)
Q Consensus       218 gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (339)
                      .+..|+|||.+.+..++.++|+||||+++|+|++ |..||.....        ..... .....             ...
T Consensus       157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~--------~~~~~-~~~~~-------------~~~  214 (251)
T cd05041         157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN--------QQTRE-RIESG-------------YRM  214 (251)
T ss_pred             ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH--------HHHHH-HHhcC-------------CCC
Confidence            3567999999988899999999999999999999 7877642211        01001 11100             011


Q ss_pred             CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 019536          297 PGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLR  332 (339)
Q Consensus       297 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~  332 (339)
                      +.+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus       215 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         215 PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             CCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            112244567999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=8.5e-43  Score=316.61  Aligned_cols=237  Identities=22%  Similarity=0.241  Sum_probs=187.9

Q ss_pred             CceeccCCeeEEEEEEcCCCeeEEEEEeccCCC--hhhHHHHHHHHH-HHHhcCCCceeeeeeeeeeCCccEEEEEeccC
Q 019536           61 KVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST--LDDVEYCFNNIV-FSSQMKHKNILKLIGCCLETELPTLVFESVKY  137 (339)
Q Consensus        61 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~-~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~  137 (339)
                      +.||+|+||.||+|.+..+++.||+|++.....  ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            469999999999999998999999999875421  123344555554 67889999999999999999999999999999


Q ss_pred             Cccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceeeecc
Q 019536          138 GTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEF  215 (339)
Q Consensus       138 g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~~~  215 (339)
                      |+|...+.  ..++...+..++.||+.||.|||   +.+|+||||||+||+++.++.+||+|||+++.......  ....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~  155 (321)
T cd05603          81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--TTST  155 (321)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC--cccc
Confidence            99988775  46788888889999999999999   89999999999999999999999999999875422221  1123


Q ss_pred             cccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCCCC
Q 019536          216 IKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNS  295 (339)
Q Consensus       216 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (339)
                      ..||+.|+|||++.+..++.++|||||||++|+|++|+.||....        .........             .....
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--------~~~~~~~i~-------------~~~~~  214 (321)
T cd05603         156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD--------VSQMYDNIL-------------HKPLQ  214 (321)
T ss_pred             ccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC--------HHHHHHHHh-------------cCCCC
Confidence            568999999999998899999999999999999999999985221        111111110             00111


Q ss_pred             CCCcHHHHHHHHHHHHHhhccCCCCCCCHH
Q 019536          296 FPGKEEKLQSLGQLMYKCLSKSPEHRPLMV  325 (339)
Q Consensus       296 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~  325 (339)
                      .|  ...+..+.+++.+||+.||.+||++.
T Consensus       215 ~~--~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         215 LP--GGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CC--CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            11  23455789999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=3.4e-42  Score=302.46  Aligned_cols=245  Identities=21%  Similarity=0.321  Sum_probs=197.0

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeee-eCCccEEEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCL-ETELPTLVFE  133 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~-~~~~~~lv~e  133 (339)
                      .+|++.+.||+|+||.||+|..  .+..||+|.+....   ..+.+.+|+.+++.++|+|++++++++. +++..++|||
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE   80 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCc---hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEE
Confidence            5789999999999999999987  57889999986543   3456889999999999999999999764 4567899999


Q ss_pred             eccCCcccccccc----CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCc
Q 019536          134 SVKYGTLRGFSFA----SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGET  209 (339)
Q Consensus       134 ~~~~g~L~~~~~~----~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~  209 (339)
                      |+++++|.+++..    .+++..++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  157 (256)
T cd05082          81 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD  157 (256)
T ss_pred             CCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceeccccCC
Confidence            9999999998752    3778888999999999999999   89999999999999999999999999999876533221


Q ss_pred             eeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCcccccccC
Q 019536          210 HVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDP  288 (339)
Q Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (339)
                           ...++..|+|||++.+..++.++|||||||++|+|++ |+.||....        ....... .....       
T Consensus       158 -----~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~--------~~~~~~~-~~~~~-------  216 (256)
T cd05082         158 -----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--------LKDVVPR-VEKGY-------  216 (256)
T ss_pred             -----CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHH-HhcCC-------
Confidence                 2234567999999988889999999999999999997 888875221        1111111 11110       


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 019536          289 IFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQM  334 (339)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l  334 (339)
                            ....+...+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus       217 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         217 ------KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             ------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence                  0011123456789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=6.7e-43  Score=317.80  Aligned_cols=241  Identities=21%  Similarity=0.199  Sum_probs=190.6

Q ss_pred             CceeccCCeeEEEEEEcCCCeeEEEEEeccCC--ChhhHHHHHHHHH-HHHhcCCCceeeeeeeeeeCCccEEEEEeccC
Q 019536           61 KVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS--TLDDVEYCFNNIV-FSSQMKHKNILKLIGCCLETELPTLVFESVKY  137 (339)
Q Consensus        61 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~-~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~  137 (339)
                      +.||+|+||+||+|....+|+.||+|++....  .......+..|.. +++.++||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999999899999999987542  1133345556654 56789999999999999999999999999999


Q ss_pred             Cccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceeeecc
Q 019536          138 GTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEF  215 (339)
Q Consensus       138 g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~~~  215 (339)
                      |+|..++.  ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++........  ...
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~--~~~  155 (325)
T cd05604          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--TTT  155 (325)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCC--ccc
Confidence            99988775  56888889999999999999999   899999999999999999999999999998754322211  123


Q ss_pred             cccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCCCC
Q 019536          216 IKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNS  295 (339)
Q Consensus       216 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (339)
                      ..||..|+|||++.+..++.++|||||||++|+|++|+.||....        ..+........ .            ..
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~--------~~~~~~~~~~~-~------------~~  214 (325)
T cd05604         156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD--------VAEMYDNILHK-P------------LV  214 (325)
T ss_pred             ccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC--------HHHHHHHHHcC-C------------cc
Confidence            568999999999999999999999999999999999999985221        11111111110 0            00


Q ss_pred             CCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          296 FPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       296 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                      .  +...+..+.+++.+||+.||++||++.+.++
T Consensus       215 ~--~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~  246 (325)
T cd05604         215 L--RPGASLTAWSILEELLEKDRQRRLGAKEDFL  246 (325)
T ss_pred             C--CCCCCHHHHHHHHHHhccCHHhcCCCCCCHH
Confidence            0  1134456889999999999999998864333

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-43  Score=316.57  Aligned_cols=263  Identities=21%  Similarity=0.295  Sum_probs=216.1

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFE  133 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  133 (339)
                      .+...+.++||+|.||.|..+... .+..||+|.++.........+|..|+++|.+++||||++++|+|..++.+++++|
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E  615 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE  615 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence            467788899999999999999985 3699999999998887778999999999999999999999999999999999999


Q ss_pred             eccCCccccccccC----CChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCc
Q 019536          134 SVKYGTLRGFSFAS----LLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGET  209 (339)
Q Consensus       134 ~~~~g~L~~~~~~~----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~  209 (339)
                      |+++|+|.+++...    +.-...+.|+.||+.|++||.   +.+++|||+.+.|+|++.++++||+|||+++.+-....
T Consensus       616 YmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y  692 (807)
T KOG1094|consen  616 YMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY  692 (807)
T ss_pred             HHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccCCc
Confidence            99999999998732    233445679999999999999   99999999999999999999999999999997766666


Q ss_pred             eeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh--CCCccccCCCCCCCchhHHHHHHHHhhcCccccccc
Q 019536          210 HVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT--GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVD  287 (339)
Q Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (339)
                      +......+-..+|||||.+.-+.+++++|+|+||+++||+++  ...||....++     ...+...........     
T Consensus       693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e-----~vven~~~~~~~~~~-----  762 (807)
T KOG1094|consen  693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE-----QVVENAGEFFRDQGR-----  762 (807)
T ss_pred             eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH-----HHHHhhhhhcCCCCc-----
Confidence            554444556789999999999999999999999999999876  55676533221     122222222222211     


Q ss_pred             CcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 019536          288 PIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMY  335 (339)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~  335 (339)
                           ..-++.|..++..+.++|.+||+.|-.+|||++++...|.+..
T Consensus       763 -----~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~  805 (807)
T KOG1094|consen  763 -----QVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA  805 (807)
T ss_pred             -----ceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence                 1112334467778999999999999999999999999887654

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=7.7e-42  Score=306.11  Aligned_cols=249  Identities=18%  Similarity=0.234  Sum_probs=200.7

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFES  134 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  134 (339)
                      +.|++.+.||.|+||.||+|....++..+++|.+..... ...+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   90 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSE-EELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF   90 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCH-HHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence            679999999999999999999998899999999876543 5567788999999999999999999999999999999999


Q ss_pred             ccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCcee
Q 019536          135 VKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHV  211 (339)
Q Consensus       135 ~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~  211 (339)
                      +++++|..++.   ..+++..+..++.|++.||.|||   +.+++||||||+||+++.++.++|+|||++......... 
T Consensus        91 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~-  166 (292)
T cd06644          91 CPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR-  166 (292)
T ss_pred             CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceeccccccc-
Confidence            99999987764   46788999999999999999999   899999999999999999999999999998754332211 


Q ss_pred             eecccccccccccccccc-----cCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccc
Q 019536          212 REEFIKGAYGFIAPEYFA-----TSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIV  286 (339)
Q Consensus       212 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (339)
                       .....++..|+|||++.     ...++.++|+|||||++|+|++|..||.....        ...........      
T Consensus       167 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--------~~~~~~~~~~~------  231 (292)
T cd06644         167 -RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP--------MRVLLKIAKSE------  231 (292)
T ss_pred             -cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH--------HHHHHHHhcCC------
Confidence             11345788899999985     34578899999999999999999999752211        11111111100      


Q ss_pred             cCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          287 DPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                            ....+.+...+.++.+++.+||+.+|++||++.++++
T Consensus       232 ------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         232 ------PPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             ------CccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence                  0011112244567899999999999999999999986

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.1e-41  Score=302.75  Aligned_cols=249  Identities=22%  Similarity=0.268  Sum_probs=205.3

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFES  134 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  134 (339)
                      ..|+..+.||+|+||.||+|.+..++..||+|.+...........+.+|+.+++.+.||||+++++++.+++..++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            45778899999999999999998889999999987665445667788999999999999999999999999999999999


Q ss_pred             ccCCccccccc-cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceeee
Q 019536          135 VKYGTLRGFSF-ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVRE  213 (339)
Q Consensus       135 ~~~g~L~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~  213 (339)
                      +++|+|.+++. ..++......++.|++.||.|||   +.+++|+||+|+||+++.++.++++|||++.........  .
T Consensus        84 ~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~--~  158 (277)
T cd06640          84 LGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK--R  158 (277)
T ss_pred             CCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCccc--c
Confidence            99999999876 56788888899999999999999   899999999999999999999999999998776443321  1


Q ss_pred             cccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCC
Q 019536          214 EFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDED  293 (339)
Q Consensus       214 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (339)
                      ....++..|+|||++.+..++.++|+||||+++|+|++|+.||.....     ....   .. .....            
T Consensus       159 ~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~-----~~~~---~~-~~~~~------------  217 (277)
T cd06640         159 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHP-----MRVL---FL-IPKNN------------  217 (277)
T ss_pred             ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcCh-----HhHh---hh-hhcCC------------
Confidence            134578889999999888899999999999999999999999752211     0000   00 00000            


Q ss_pred             CCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          294 NSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       294 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                       ....+...+..+.+++.+||+.+|++||++.+++..
T Consensus       218 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         218 -PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             -CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence             001122456779999999999999999999999875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4.2e-42  Score=306.07  Aligned_cols=265  Identities=20%  Similarity=0.277  Sum_probs=206.4

Q ss_pred             cCcccCCceeccCCeeEEEEEEcC----CCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeee--CCcc
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVD----QDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLE--TELP  128 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~--~~~~  128 (339)
                      ..|++.+.||+|+||.||+|....    ++..||+|.+...........+.+|+.+++.+.||||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            467888999999999999999753    4789999999876543356778999999999999999999999887  5678


Q ss_pred             EEEEEeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccC
Q 019536          129 TLVFESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIP  205 (339)
Q Consensus       129 ~lv~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~  205 (339)
                      ++||||+++++|.+++.   ..+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||++....
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLP  160 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence            99999999999999986   24888999999999999999999   8999999999999999999999999999998775


Q ss_pred             CCCceee-ecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCch------hHHHHHHHHhh
Q 019536          206 EGETHVR-EEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDL------TVLEYAKKSIE  278 (339)
Q Consensus       206 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~------~~~~~~~~~~~  278 (339)
                      ....... .....++..|+|||.+.+..++.++|+||||+++|+|++|+.|+...........      ...........
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd05038         161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK  240 (284)
T ss_pred             cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence            3322211 1122345569999999888899999999999999999999988643221110000      00000011110


Q ss_pred             cCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 019536          279 NNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMY  335 (339)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~  335 (339)
                                   .....+.+..++.++.+++.+||+.+|++|||+.+|++.|++++
T Consensus       241 -------------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~  284 (284)
T cd05038         241 -------------EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR  284 (284)
T ss_pred             -------------cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence                         01111222234467999999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.4e-42  Score=301.71  Aligned_cols=247  Identities=22%  Similarity=0.369  Sum_probs=202.3

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFE  133 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  133 (339)
                      .++|++.+.||.|+||.||+|..  .|+.||+|.+.....  ..+.+.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   80 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTE   80 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEE
Confidence            46789999999999999999988  588999999976543  46778899999999999999999999999899999999


Q ss_pred             eccCCcccccccc----CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCc
Q 019536          134 SVKYGTLRGFSFA----SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGET  209 (339)
Q Consensus       134 ~~~~g~L~~~~~~----~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~  209 (339)
                      |+++++|.+++..    .+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||.++.......
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~  157 (256)
T cd05039          81 YMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD  157 (256)
T ss_pred             ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEcccccccccccccc
Confidence            9999999998752    5788999999999999999999   99999999999999999999999999999877633221


Q ss_pred             eeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCcccccccC
Q 019536          210 HVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDP  288 (339)
Q Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (339)
                           ....+..|+|||++.+..++.++|+||||+++|++++ |..||....        ... .........       
T Consensus       158 -----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--------~~~-~~~~~~~~~-------  216 (256)
T cd05039         158 -----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--------LKD-VVPHVEKGY-------  216 (256)
T ss_pred             -----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC--------HHH-HHHHHhcCC-------
Confidence                 2234567999999988889999999999999999997 988874221        111 111111100       


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 019536          289 IFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQM  334 (339)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l  334 (339)
                            ....+...+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus       217 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         217 ------RMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             ------CCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence                  0001113446789999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=3.6e-42  Score=305.91  Aligned_cols=248  Identities=22%  Similarity=0.267  Sum_probs=202.6

Q ss_pred             CcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEec
Q 019536           56 NYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESV  135 (339)
Q Consensus        56 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  135 (339)
                      .|+..+.||+|+||.||+|.+..++..||+|.+.........+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            46677889999999999999988899999999876554455677889999999999999999999999999999999999


Q ss_pred             cCCccccccc-cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceeeec
Q 019536          136 KYGTLRGFSF-ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREE  214 (339)
Q Consensus       136 ~~g~L~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~~  214 (339)
                      ++++|.+++. ..+++..+..++.|++.|+.|||   +.+++|+||+|+||+++.++.++++|||++..+......  ..
T Consensus        85 ~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~--~~  159 (277)
T cd06642          85 GGGSALDLLKPGPLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK--RN  159 (277)
T ss_pred             CCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcchh--hh
Confidence            9999998876 56788888999999999999999   899999999999999999999999999998776543221  11


Q ss_pred             ccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCCC
Q 019536          215 FIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDN  294 (339)
Q Consensus       215 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (339)
                      ...++..|+|||++.+..++.++|+||||+++|+|++|+.|+......     ...   . ......     .+      
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-----~~~---~-~~~~~~-----~~------  219 (277)
T cd06642         160 TFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM-----RVL---F-LIPKNS-----PP------  219 (277)
T ss_pred             cccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh-----hHH---h-hhhcCC-----CC------
Confidence            245788899999999888999999999999999999999997421110     000   0 000000     00      


Q ss_pred             CCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          295 SFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       295 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                        ......+..+.+++.+||+.+|++|||+.+++.+
T Consensus       220 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         220 --TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             --CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence              0111345678999999999999999999999983

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-41  Score=298.26  Aligned_cols=247  Identities=24%  Similarity=0.386  Sum_probs=202.7

Q ss_pred             CceeccCCeeEEEEEEcCC---CeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeccC
Q 019536           61 KVIQSDTSYRLFEGTLVDQ---DRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKY  137 (339)
Q Consensus        61 ~~ig~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~  137 (339)
                      +.||+|+||.||+|.....   +..|++|.+...........+.+|+..+..++|+||+++++++.++...++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            4689999999999999865   8899999998765544567888999999999999999999999999999999999999


Q ss_pred             Cccccccc-----------cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCC
Q 019536          138 GTLRGFSF-----------ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPE  206 (339)
Q Consensus       138 g~L~~~~~-----------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~  206 (339)
                      ++|.+++.           ..+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence            99999875           34788899999999999999999   99999999999999999999999999999987765


Q ss_pred             CCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCccccc
Q 019536          207 GETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAI  285 (339)
Q Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (339)
                      ...........++..|+|||.+.+..++.++|+||+|+++|+|++ |..||....        ...........      
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--------~~~~~~~~~~~------  223 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS--------NEEVLEYLRKG------  223 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC--------HHHHHHHHHcC------
Confidence            432222223457888999999988889999999999999999999 688875331        11111111111      


Q ss_pred             ccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 019536          286 VDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLR  332 (339)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~  332 (339)
                              ...+.+...+.++.+++.+||+.+|++|||+.++++.|+
T Consensus       224 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         224 --------YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             --------CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                    011112244668999999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=2.5e-42  Score=305.32  Aligned_cols=248  Identities=25%  Similarity=0.377  Sum_probs=197.0

Q ss_pred             CceeccCCeeEEEEEEcCCC------eeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 019536           61 KVIQSDTSYRLFEGTLVDQD------RPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFES  134 (339)
Q Consensus        61 ~~ig~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  134 (339)
                      +.||+|+||.||+|...+..      ..+|+|.+...........+.+|+.+++.++||||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            36899999999999986433      689999887655445567788999999999999999999999999999999999


Q ss_pred             ccCCccccccc---------cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCC-----ceEEecCCC
Q 019536          135 VKYGTLRGFSF---------ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENY-----SAKLHDFSL  200 (339)
Q Consensus       135 ~~~g~L~~~~~---------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~-----~~kl~dfg~  200 (339)
                      +++++|.+++.         ..+++..+..++.|++.||.|||   +.+++|+||||+||+++.++     .++++|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            99999998875         23677888899999999999999   89999999999999999877     899999999


Q ss_pred             ccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhc
Q 019536          201 SVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIEN  279 (339)
Q Consensus       201 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  279 (339)
                      ++...............++..|+|||++.+..++.++|||||||++|+|++ |+.||.....     ....   .. ...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~-----~~~~---~~-~~~  228 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN-----QEVL---QH-VTA  228 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH-----HHHH---HH-Hhc
Confidence            876543322211112345678999999998899999999999999999998 9999752211     1111   11 111


Q ss_pred             CcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 019536          280 NRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQ  333 (339)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~  333 (339)
                      ..             ....+...+..+.+++.+||+.+|++|||+.++++.|++
T Consensus       229 ~~-------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         229 GG-------------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             CC-------------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            00             011112455678999999999999999999999998863

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=3.4e-42  Score=304.23  Aligned_cols=252  Identities=21%  Similarity=0.289  Sum_probs=200.9

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFES  134 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  134 (339)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+..... .....+.+|+.+++.++||||+++++++..++..++||||
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~   87 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG-EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF   87 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence            578888999999999999999998999999999876543 4455678899999999999999999999999999999999


Q ss_pred             ccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceee
Q 019536          135 VKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVR  212 (339)
Q Consensus       135 ~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~  212 (339)
                      +++++|.+++.  ..+++.++..++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||++.........  
T Consensus        88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~--  162 (267)
T cd06645          88 CGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAK--  162 (267)
T ss_pred             cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccc--
Confidence            99999999875  56888999999999999999999   899999999999999999999999999998765432211  


Q ss_pred             ecccccccccccccccc---cCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCc
Q 019536          213 EEFIKGAYGFIAPEYFA---TSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPI  289 (339)
Q Consensus       213 ~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (339)
                      .....|+..|+|||++.   ...++.++|+||+||++|+|++|+.||.......     .   ...... ..   ...+.
T Consensus       163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~-----~---~~~~~~-~~---~~~~~  230 (267)
T cd06645         163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR-----A---LFLMTK-SN---FQPPK  230 (267)
T ss_pred             cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh-----h---HHhhhc-cC---CCCCc
Confidence            12346889999999974   4468899999999999999999999974222100     0   000000 00   00000


Q ss_pred             ccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          290 FDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      ..      .....+..+.+++.+||+.+|++|||+.+++++
T Consensus       231 ~~------~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         231 LK------DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             cc------ccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence            00      011234568899999999999999999998763

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=3.6e-42  Score=308.95  Aligned_cols=249  Identities=20%  Similarity=0.293  Sum_probs=204.1

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFES  134 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  134 (339)
                      .+|++.+.||.|++|+||+|.+..+++.|++|.+..... ...+.+.+|+.+++.++||||+++++++..++..++|+||
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   97 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ-PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY   97 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC-chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence            569999999999999999999988999999999876543 4456788999999999999999999999999999999999


Q ss_pred             ccCCccccccc-cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceeee
Q 019536          135 VKYGTLRGFSF-ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVRE  213 (339)
Q Consensus       135 ~~~g~L~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~  213 (339)
                      +++++|..++. ..+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++.........  .
T Consensus        98 ~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~--~  172 (296)
T cd06655          98 LAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK--R  172 (296)
T ss_pred             cCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhccccccc--C
Confidence            99999998876 46889999999999999999999   899999999999999999999999999998765443221  1


Q ss_pred             cccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCC
Q 019536          214 EFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDED  293 (339)
Q Consensus       214 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (339)
                      ....++..|+|||.+.+..++.++|+|||||++|++++|+.||.....        ............            
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~--------~~~~~~~~~~~~------------  232 (296)
T cd06655         173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP--------LRALYLIATNGT------------  232 (296)
T ss_pred             CCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhcCC------------
Confidence            134578899999999888899999999999999999999999753211        111111111100            


Q ss_pred             CCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          294 NSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       294 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                      .....+...+..+.+++.+||..||++|||+.+++.
T Consensus       233 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         233 PELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             cccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            001111234557889999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.1e-42  Score=312.23  Aligned_cols=253  Identities=18%  Similarity=0.204  Sum_probs=198.3

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC--ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS--TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVF  132 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  132 (339)
                      ++|++.+.||+|+||+||++....+++.||+|++....  .....+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            47899999999999999999999899999999987531  1234456788999999999999999999999999999999


Q ss_pred             EeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCc
Q 019536          133 ESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGET  209 (339)
Q Consensus       133 e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~  209 (339)
                      ||+++|+|.+++.   ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||++..+.....
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  157 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT  157 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence            9999999999875   46888889999999999999999   99999999999999999999999999999876644332


Q ss_pred             eeeeccccccccccccccccc-----CCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccc
Q 019536          210 HVREEFIKGAYGFIAPEYFAT-----SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA  284 (339)
Q Consensus       210 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (339)
                      .. .....||+.|+|||++..     ..++.++||||+||++|+|++|+.||....        ..+..........   
T Consensus       158 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~--------~~~~~~~i~~~~~---  225 (331)
T cd05597         158 VQ-SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES--------LVETYGKIMNHKE---  225 (331)
T ss_pred             cc-ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC--------HHHHHHHHHcCCC---
Confidence            21 113468999999999863     457889999999999999999999975211        1111111111000   


Q ss_pred             cccCcccCCCCCC-CcHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 019536          285 IVDPIFDEDNSFP-GKEEKLQSLGQLMYKCLSKSPEH--RPLMVDVAKQ  330 (339)
Q Consensus       285 ~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~dP~~--Rps~~~il~~  330 (339)
                              ....+ .....+..+.+++.+||..++++  |+++.+++++
T Consensus       226 --------~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         226 --------HFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             --------cccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence                    00011 11134567899999988664443  7899998875

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=5.6e-42  Score=306.21  Aligned_cols=262  Identities=19%  Similarity=0.223  Sum_probs=192.5

Q ss_pred             CcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChh-hHHHHHHHHHHHHhc---CCCceeeeeeeeeeC-----C
Q 019536           56 NYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLD-DVEYCFNNIVFSSQM---KHKNILKLIGCCLET-----E  126 (339)
Q Consensus        56 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l---~H~niv~~~~~~~~~-----~  126 (339)
                      +|++.+.||+|+||+||+|.+..+++.||+|.+....... ....+.+|+.+++.+   .||||+++++++...     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            5888999999999999999999999999999987643212 223455677776655   699999999998642     3


Q ss_pred             ccEEEEEeccCCccccccc----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCcc
Q 019536          127 LPTLVFESVKYGTLRGFSF----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSV  202 (339)
Q Consensus       127 ~~~lv~e~~~~g~L~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~  202 (339)
                      ..++||||+++ +|.+++.    ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~~~  156 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLAR  156 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCccc
Confidence            57899999974 7777664    34788899999999999999999   8999999999999999999999999999987


Q ss_pred             ccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHh---hc
Q 019536          203 SIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSI---EN  279 (339)
Q Consensus       203 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~  279 (339)
                      ........   ....+|..|+|||++.+..++.++||||+||++|+|++|++||....  .   ...........   ..
T Consensus       157 ~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~--~---~~~~~~~~~~~~~~~~  228 (288)
T cd07863         157 IYSCQMAL---TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS--E---ADQLGKIFDLIGLPPE  228 (288)
T ss_pred             cccCcccC---CCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCC--H---HHHHHHHHHHhCCCCh
Confidence            76433221   12457889999999998899999999999999999999999974221  1   11111111110   00


Q ss_pred             Cccccc---ccCcccCCCCCC---CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          280 NRFGAI---VDPIFDEDNSFP---GKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       280 ~~~~~~---~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                      ..+...   ....+......+   .....+..+.+++.+||+.||++|||+.+++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         229 DDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             hhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            000000   000000000000   00134567899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=3.7e-42  Score=307.09  Aligned_cols=260  Identities=21%  Similarity=0.242  Sum_probs=203.7

Q ss_pred             ccHHHHHHHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhc-CCCceeeeeeeee
Q 019536           45 FSAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCCL  123 (339)
Q Consensus        45 ~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~  123 (339)
                      +.++.+....++|++.+.||+|+||.||+|....+++.+|+|.+....  .....+.+|+.+++.+ +||||+++++++.
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   85 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH--DIDEEIEAEYNILKALSDHPNVVKFYGMYY   85 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc--chHHHHHHHHHHHHHHhcCCCeeeeeeeee
Confidence            455667778899999999999999999999999899999999876532  2235577899999999 6999999999884


Q ss_pred             -----eCCccEEEEEeccCCccccccc------cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCc
Q 019536          124 -----ETELPTLVFESVKYGTLRGFSF------ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYS  192 (339)
Q Consensus       124 -----~~~~~~lv~e~~~~g~L~~~~~------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~  192 (339)
                           .++..++||||+++++|.+++.      ..+++..+..++.|++.||.|||   +.+++||||||+||+++.++.
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~  162 (286)
T cd06638          86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGG  162 (286)
T ss_pred             ecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCC
Confidence                 3456899999999999988753      35777888899999999999999   899999999999999999999


Q ss_pred             eEEecCCCccccCCCCceeeeccccccccccccccccc-----CCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCch
Q 019536          193 AKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFAT-----SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDL  267 (339)
Q Consensus       193 ~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~  267 (339)
                      ++|+|||+++........  .....|+..|+|||++..     ..++.++|+||+||++|+|++|+.||.....      
T Consensus       163 ~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~------  234 (286)
T cd06638         163 VKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP------  234 (286)
T ss_pred             EEEccCCceeecccCCCc--cccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch------
Confidence            999999998776443221  113468899999999853     4578899999999999999999999753211      


Q ss_pred             hHHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 019536          268 TVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQL  331 (339)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L  331 (339)
                        ......... ..           ......+...+..+.+++.+||+.||++|||+.+|+++.
T Consensus       235 --~~~~~~~~~-~~-----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         235 --MRALFKIPR-NP-----------PPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             --hHHHhhccc-cC-----------CCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence              000000000 00           000111122345789999999999999999999999753

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4e-42  Score=315.03  Aligned_cols=265  Identities=17%  Similarity=0.213  Sum_probs=198.3

Q ss_pred             HHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC-hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeC-----
Q 019536           52 KATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST-LDDVEYCFNNIVFSSQMKHKNILKLIGCCLET-----  125 (339)
Q Consensus        52 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~-----  125 (339)
                      ...++|++.+.||.|+||+||+|.+..+++.||+|++..... ......+.+|+.+++.++||||+++++++...     
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            345789999999999999999999988999999999876422 23445677999999999999999999988643     


Q ss_pred             -CccEEEEEeccCCccccccc-cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccc
Q 019536          126 -ELPTLVFESVKYGTLRGFSF-ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVS  203 (339)
Q Consensus       126 -~~~~lv~e~~~~g~L~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~  203 (339)
                       ...++++|++ +++|.+++. ..++...+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~  167 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQ  167 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCCcccee
Confidence             3468999988 778887765 57899999999999999999999   89999999999999999999999999999987


Q ss_pred             cCCCCceeeeccccccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCc-
Q 019536          204 IPEGETHVREEFIKGAYGFIAPEYFAT-SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNR-  281 (339)
Q Consensus       204 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-  281 (339)
                      ......     ...||..|+|||++.+ ..++.++||||+||++|+|++|+.||.....     ............... 
T Consensus       168 ~~~~~~-----~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~~~~~~~~~~~  237 (343)
T cd07878         168 ADDEMT-----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDY-----IDQLKRIMEVVGTPSP  237 (343)
T ss_pred             cCCCcC-----CccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHHHhCCCCH
Confidence            644321     3468899999999876 4688999999999999999999999753211     111111110000000 


Q ss_pred             --cccccc----CcccCCCCCCCc------HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          282 --FGAIVD----PIFDEDNSFPGK------EEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       282 --~~~~~~----~~~~~~~~~~~~------~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                        ...+..    .........+..      ...++.+.+|+.+||+.||++|||+.+++.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         238 EVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             HHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence              000000    000000000000      0123457899999999999999999999864

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-42  Score=306.00  Aligned_cols=251  Identities=19%  Similarity=0.258  Sum_probs=203.1

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFE  133 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  133 (339)
                      .++|++.+.||.|++|.||+|....++..||+|.+..... ...+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESE-EELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE   82 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCH-HHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence            3679999999999999999999988899999999876533 556778899999999999999999999999999999999


Q ss_pred             eccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCce
Q 019536          134 SVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH  210 (339)
Q Consensus       134 ~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~  210 (339)
                      |+++++|.+++.   ..+++..+..++.|++.||.|||   +.+|+|+||+|+||+++.++.++|+|||++.........
T Consensus        83 ~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~  159 (280)
T cd06611          83 FCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK  159 (280)
T ss_pred             ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhcccccc
Confidence            999999998875   45889999999999999999999   899999999999999999999999999998765433221


Q ss_pred             eeecccccccccccccccc-----cCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCccccc
Q 019536          211 VREEFIKGAYGFIAPEYFA-----TSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAI  285 (339)
Q Consensus       211 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (339)
                        .....++..|+|||++.     +..++.++|+||+|+++|+|++|+.||....        ......... ....   
T Consensus       160 --~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~-~~~~---  225 (280)
T cd06611         160 --RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELN--------PMRVLLKIL-KSEP---  225 (280)
T ss_pred             --cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCC--------HHHHHHHHh-cCCC---
Confidence              11346888999999975     3457789999999999999999999975221        111111111 1100   


Q ss_pred             ccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          286 VDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                              .....+..++..+.+++.+||+.+|.+|||+.+++++
T Consensus       226 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         226 --------PTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             --------CCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence                    0111122455678999999999999999999999874

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=3.5e-42  Score=304.94  Aligned_cols=251  Identities=21%  Similarity=0.270  Sum_probs=198.4

Q ss_pred             HHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhc-CCCceeeeeeeeeeC-----
Q 019536           52 KATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLET-----  125 (339)
Q Consensus        52 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~-----  125 (339)
                      .+++.|++.+.||+|+||.||+|....+++.||+|.+....  .....+.+|+.++..+ +||||+++++++...     
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM   80 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC--ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence            35678999999999999999999999899999999987543  3345678999999998 799999999998753     


Q ss_pred             -CccEEEEEeccCCccccccc----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCC
Q 019536          126 -ELPTLVFESVKYGTLRGFSF----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSL  200 (339)
Q Consensus       126 -~~~~lv~e~~~~g~L~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~  200 (339)
                       ...++||||+++|+|.+++.    ..+++..+..++.|++.||.|||   +.+|+|+||+|+||+++.++.++|+|||+
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg~  157 (272)
T cd06637          81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGV  157 (272)
T ss_pred             CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCCC
Confidence             35789999999999999876    34788888999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCCCceeeecccccccccccccccc-----cCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHH
Q 019536          201 SVSIPEGETHVREEFIKGAYGFIAPEYFA-----TSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKK  275 (339)
Q Consensus       201 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  275 (339)
                      +.........  .....|+..|+|||++.     +..++.++|+||+||++|+|++|+.||.....        ......
T Consensus       158 ~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~--------~~~~~~  227 (272)
T cd06637         158 SAQLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP--------MRALFL  227 (272)
T ss_pred             ceeccccccc--CCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH--------HHHHHH
Confidence            8765432221  12356888999999986     33588899999999999999999999742111        110011


Q ss_pred             HhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          276 SIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      ... .....            ......+..+.+|+.+||+.||.+|||+.+++++
T Consensus       228 ~~~-~~~~~------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  269 (272)
T cd06637         228 IPR-NPAPR------------LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH  269 (272)
T ss_pred             Hhc-CCCCC------------CCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence            010 00000            0011344578999999999999999999999863

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1e-41  Score=304.34  Aligned_cols=251  Identities=14%  Similarity=0.214  Sum_probs=201.9

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFES  134 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  134 (339)
                      ++|++.+.||+|+||.||+|.+..++..||+|.+...........+.+|+.++++++||||+++++++..++..++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            46889999999999999999998899999999987654434557788999999999999999999999999999999999


Q ss_pred             ccCCcccccccc-----CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCc
Q 019536          135 VKYGTLRGFSFA-----SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGET  209 (339)
Q Consensus       135 ~~~g~L~~~~~~-----~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~  209 (339)
                      +++++|..++..     .+++..+..++.|++.||.|||+  +.+++|+||||+||+++.++.++|+|||++..+.....
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  158 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA  158 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCcc
Confidence            999999888764     68889999999999999999993  25899999999999999999999999999876643322


Q ss_pred             eeeecccccccccccccccccC------CCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCccc
Q 019536          210 HVREEFIKGAYGFIAPEYFATS------SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFG  283 (339)
Q Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (339)
                      .    ...++..|+|||++.+.      .++.++|+||+||++|+|++|+.||.....     ............ ... 
T Consensus       159 ~----~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~~-~~~-  227 (286)
T cd06622         159 K----TNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY-----ANIFAQLSAIVD-GDP-  227 (286)
T ss_pred             c----cCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch-----hhHHHHHHHHhh-cCC-
Confidence            1    34578889999998554      357899999999999999999999852211     111111111010 000 


Q ss_pred             ccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          284 AIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                                .  ..+...+.++.+++.+||+.+|++||++.+++..
T Consensus       228 ----------~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         228 ----------P--TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             ----------C--CCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence                      0  1112466789999999999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1e-41  Score=301.51  Aligned_cols=255  Identities=20%  Similarity=0.307  Sum_probs=201.6

Q ss_pred             HHHHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccE
Q 019536           50 LKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPT  129 (339)
Q Consensus        50 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~  129 (339)
                      ++..++++.....||+|+||.||+|.+..++..|++|.+..... ...+.+.+|+.+++.++|+||+++++++..++..+
T Consensus         3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (268)
T cd06624           3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDS-RYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK   81 (268)
T ss_pred             cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCH-HHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence            45566777777899999999999999988899999999876543 45667889999999999999999999999999999


Q ss_pred             EEEEeccCCcccccccc---CC--ChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCC-CCceEEecCCCccc
Q 019536          130 LVFESVKYGTLRGFSFA---SL--LIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDE-NYSAKLHDFSLSVS  203 (339)
Q Consensus       130 lv~e~~~~g~L~~~~~~---~~--~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~-~~~~kl~dfg~a~~  203 (339)
                      +|+||+++++|.+++..   .+  +...+..++.|++.||.|||   +.+|+||||||+||+++. ++.++|+|||++..
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~  158 (268)
T cd06624          82 IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKR  158 (268)
T ss_pred             EEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence            99999999999998762   34  66777889999999999999   899999999999999976 67899999999876


Q ss_pred             cCCCCceeeecccccccccccccccccCC--CCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCc
Q 019536          204 IPEGETHVREEFIKGAYGFIAPEYFATSS--FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNR  281 (339)
Q Consensus       204 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (339)
                      .......  .....++..|+|||++.+..  ++.++|+||+|+++|+|++|+.||.......     .........    
T Consensus       159 ~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~-----~~~~~~~~~----  227 (268)
T cd06624         159 LAGINPC--TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ-----AAMFKVGMF----  227 (268)
T ss_pred             cccCCCc--cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh-----hhHhhhhhh----
Confidence            5432221  11235788999999986643  7899999999999999999999975322111     000000000    


Q ss_pred             ccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          282 FGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                               ......  +...+..+.+++.+||+.+|++|||+.+++.+
T Consensus       228 ---------~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         228 ---------KIHPEI--PESLSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             ---------ccCCCC--CcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence                     000011  12345678999999999999999999999864

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2e-41  Score=308.39  Aligned_cols=264  Identities=17%  Similarity=0.246  Sum_probs=194.8

Q ss_pred             cCCceecc--CCeeEEEEEEcCCCeeEEEEEeccCCC-hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEec
Q 019536           59 LHKVIQSD--TSYRLFEGTLVDQDRPISVMKFHDNST-LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESV  135 (339)
Q Consensus        59 ~~~~ig~G--~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  135 (339)
                      +.++||.|  +|++||++....+|+.||+|++..... ......+.+|+.+++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            46789999  688999999999999999999976532 234456778999999999999999999999999999999999


Q ss_pred             cCCccccccc----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCce-
Q 019536          136 KYGTLRGFSF----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH-  210 (339)
Q Consensus       136 ~~g~L~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~-  210 (339)
                      ++|+|.+++.    ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.++++||+.+......... 
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~  158 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL  158 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence            9999999874    34788889999999999999999   899999999999999999999999999865443221110 


Q ss_pred             ----eeeccccccccccccccccc--CCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhh------
Q 019536          211 ----VREEFIKGAYGFIAPEYFAT--SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIE------  278 (339)
Q Consensus       211 ----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------  278 (339)
                          .......++..|+|||++.+  ..++.++|||||||++|+|++|+.||.......    ...........      
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----~~~~~~~~~~~~~~~~~  234 (327)
T cd08227         159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ----MLLEKLNGTVPCLLDTT  234 (327)
T ss_pred             cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH----HHHHHhcCCcccccccc
Confidence                01112346778999999976  458999999999999999999999985322111    00000000000      


Q ss_pred             ---cCcc-----cccccCcccC-------------CCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          279 ---NNRF-----GAIVDPIFDE-------------DNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       279 ---~~~~-----~~~~~~~~~~-------------~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                         ...+     ....+.....             ....+.....+..+.+|+.+||+.||++|||+.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             chhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence               0000     0000000000             0001111234568999999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.1e-41  Score=298.75  Aligned_cols=247  Identities=20%  Similarity=0.288  Sum_probs=203.7

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFES  134 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  134 (339)
                      ++|++.+.||+|++|.||+|....++..+++|.+....   ..+.+.+|+.+++.++||||+++++++.++...++++||
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~   79 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE---DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY   79 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH---HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence            67999999999999999999998888999999987542   267788999999999999999999999999999999999


Q ss_pred             ccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCcee
Q 019536          135 VKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHV  211 (339)
Q Consensus       135 ~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~  211 (339)
                      +++++|.+++.   ..+++.....++.|++.||.|||   +.+++|+||+|.||+++.++.++|+|||++......... 
T Consensus        80 ~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~-  155 (256)
T cd06612          80 CGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK-  155 (256)
T ss_pred             CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccCccc-
Confidence            99999999874   46788999999999999999999   899999999999999999999999999998876543321 


Q ss_pred             eecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCccc
Q 019536          212 REEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFD  291 (339)
Q Consensus       212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (339)
                       .....++..|+|||++.+..++.++||||||+++|+|++|+.||.......        .... ....           
T Consensus       156 -~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~--------~~~~-~~~~-----------  214 (256)
T cd06612         156 -RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR--------AIFM-IPNK-----------  214 (256)
T ss_pred             -cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh--------hhhh-hccC-----------
Confidence             113457888999999988899999999999999999999999975321110        0000 0000           


Q ss_pred             CCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          292 EDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       292 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                      .......+...+..+.+++.+||+.||++|||+.++++
T Consensus       215 ~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         215 PPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             CCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            00011112245567999999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1e-41  Score=300.18  Aligned_cols=249  Identities=24%  Similarity=0.334  Sum_probs=197.6

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFES  134 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  134 (339)
                      ++|.+...||+|++|.||+|.+... ..+|+|.+....  ...+.+.+|+.+++.++|||++++++++.. +..++||||
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~   81 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT--MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEF   81 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC--ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEc
Confidence            5688999999999999999988644 469999876543  234668899999999999999999998854 567899999


Q ss_pred             ccCCcccccccc----CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCce
Q 019536          135 VKYGTLRGFSFA----SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH  210 (339)
Q Consensus       135 ~~~g~L~~~~~~----~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~  210 (339)
                      +++|+|.+++..    .+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||+++........
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05069          82 MGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence            999999988752    3678888999999999999999   899999999999999999999999999999776443221


Q ss_pred             eeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCc
Q 019536          211 VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPI  289 (339)
Q Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (339)
                      . .....++..|+|||+..+..++.++|+||||+++|+|++ |+.||....  .   .....   . ....         
T Consensus       159 ~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--~---~~~~~---~-~~~~---------  219 (260)
T cd05069         159 A-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMV--N---REVLE---Q-VERG---------  219 (260)
T ss_pred             c-cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCC--H---HHHHH---H-HHcC---------
Confidence            1 112345677999999988889999999999999999999 888875211  1   01111   1 1110         


Q ss_pred             ccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 019536          290 FDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQ  333 (339)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~  333 (339)
                          ...+.+...+..+.+++.+||+.||++|||+.+|++.|++
T Consensus       220 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         220 ----YRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             ----CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence                0011122455679999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=5.9e-42  Score=305.92  Aligned_cols=249  Identities=17%  Similarity=0.239  Sum_probs=198.4

Q ss_pred             cccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCCh--hhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 019536           57 YDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTL--DDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFES  134 (339)
Q Consensus        57 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  134 (339)
                      |+..+.||+|+||+||+|.+..+++.||+|.+......  .....+.+|+.+++.++|+||+.+.+++..++..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            66778999999999999999999999999998764321  2234567899999999999999999999999999999999


Q ss_pred             ccCCccccccc----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCce
Q 019536          135 VKYGTLRGFSF----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH  210 (339)
Q Consensus       135 ~~~g~L~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~  210 (339)
                      +++++|.+++.    ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.++|+|||++.........
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~  158 (285)
T cd05632          82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESI  158 (285)
T ss_pred             ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcc
Confidence            99999987764    35889999999999999999999   899999999999999999999999999998765433221


Q ss_pred             eeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcc
Q 019536          211 VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIF  290 (339)
Q Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (339)
                         ....|+..|+|||++.+..++.++|+||+|+++|+|++|+.||......     ...+...........        
T Consensus       159 ---~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~-----~~~~~~~~~~~~~~~--------  222 (285)
T cd05632         159 ---RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEK-----VKREEVDRRVLETEE--------  222 (285)
T ss_pred             ---cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHhhhcccc--------
Confidence               1346899999999998889999999999999999999999998522110     001111111111000        


Q ss_pred             cCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 019536          291 DEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPL-----MVDVAKQ  330 (339)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps-----~~~il~~  330 (339)
                          .  .+...+..+.+|+.+||+.||++||+     +.+++.+
T Consensus       223 ----~--~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         223 ----V--YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             ----c--cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence                0  01134456889999999999999999     6677663

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.4e-41  Score=300.84  Aligned_cols=250  Identities=18%  Similarity=0.258  Sum_probs=187.7

Q ss_pred             ceeccCCeeEEEEEEcC--CCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeccCCc
Q 019536           62 VIQSDTSYRLFEGTLVD--QDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGT  139 (339)
Q Consensus        62 ~ig~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~  139 (339)
                      .||+|+||.||+|....  ....+++|.+...........+.+|+.+++.++||||+++++++.+.+..++||||+++|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            68999999999997542  3457888887665444555678899999999999999999999999999999999999999


Q ss_pred             ccccccc-------CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceee
Q 019536          140 LRGFSFA-------SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVR  212 (339)
Q Consensus       140 L~~~~~~-------~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~  212 (339)
                      |.+++..       ..++.....++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++...........
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            9998752       2355667889999999999999   89999999999999999999999999999865433322222


Q ss_pred             eccccccccccccccccc-------CCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCcccc
Q 019536          213 EEFIKGAYGFIAPEYFAT-------SSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA  284 (339)
Q Consensus       213 ~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (339)
                      .....++..|+|||++..       ..++.++|||||||++|+|++ |..||.....        .+.......... ..
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--------~~~~~~~~~~~~-~~  229 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD--------EQVLKQVVREQD-IK  229 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH--------HHHHHHHhhccC-cc
Confidence            223345677999998743       356789999999999999999 7777642211        111111111110 01


Q ss_pred             cccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 019536          285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLR  332 (339)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~  332 (339)
                      +..+.        .+...+..+.+++..|| .||++|||+.+|++.|.
T Consensus       230 ~~~~~--------~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         230 LPKPQ--------LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CCCCc--------ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            11111        11234456788999999 59999999999998873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.4e-41  Score=303.20  Aligned_cols=266  Identities=19%  Similarity=0.252  Sum_probs=201.3

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC-hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST-LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFE  133 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  133 (339)
                      ++|+....||+|++|.||+|.+..+++.||+|++..... ....+.+.+|+.+++.++|||++++++++..++..++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            468899999999999999999998899999999865432 2234567799999999999999999999999999999999


Q ss_pred             eccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCcee
Q 019536          134 SVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHV  211 (339)
Q Consensus       134 ~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~  211 (339)
                      |+++++|..+..  ..+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||++..........
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~  157 (286)
T cd07847          81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY  157 (286)
T ss_pred             ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCCCcccc
Confidence            999998887765  46888899999999999999999   8999999999999999999999999999998765443211


Q ss_pred             eeccccccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhc---Cc---c--
Q 019536          212 REEFIKGAYGFIAPEYFAT-SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIEN---NR---F--  282 (339)
Q Consensus       212 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~---~--  282 (339)
                        ....++..|+|||++.+ ..++.++|+||||+++|+|++|+.||.....  .+   ...........   ..   +  
T Consensus       158 --~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~--~~---~~~~~~~~~~~~~~~~~~~~~~  230 (286)
T cd07847         158 --TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSD--VD---QLYLIRKTLGDLIPRHQQIFST  230 (286)
T ss_pred             --cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCCh--HH---HHHHHHHHhCCCChHHhhhccc
Confidence              12357788999999876 4588999999999999999999999753221  11   11111110000   00   0  


Q ss_pred             cccccCc-ccCCCCCCC----cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          283 GAIVDPI-FDEDNSFPG----KEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       283 ~~~~~~~-~~~~~~~~~----~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      ....... .......+.    ....+..+.+|+.+||+.||++|||+.+++.+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~  283 (286)
T cd07847         231 NQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH  283 (286)
T ss_pred             ccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence            0000000 000000000    01235678999999999999999999999853

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=9.7e-42  Score=302.63  Aligned_cols=254  Identities=20%  Similarity=0.303  Sum_probs=201.5

Q ss_pred             cCcccCCceeccCCeeEEEEEEcC-----CCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVD-----QDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPT  129 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~  129 (339)
                      ++|++...||.|+||.||+|....     +.+.|++|.+.........+.+.+|+.++++++||||+++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            578899999999999999999753     346799998876544335677899999999999999999999999989999


Q ss_pred             EEEEeccCCccccccc--c---------CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecC
Q 019536          130 LVFESVKYGTLRGFSF--A---------SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDF  198 (339)
Q Consensus       130 lv~e~~~~g~L~~~~~--~---------~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~df  198 (339)
                      +||||+++|+|.+++.  .         .+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.++++||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEccc
Confidence            9999999999999875  2         5788999999999999999999   899999999999999999999999999


Q ss_pred             CCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHh
Q 019536          199 SLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSI  277 (339)
Q Consensus       199 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~  277 (339)
                      |++......... ......++..|+|||.+.+..++.++||||||+++|++++ |..||....  .      ...... .
T Consensus       162 ~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~--~------~~~~~~-~  231 (275)
T cd05046         162 SLSKDVYNSEYY-KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS--D------EEVLNR-L  231 (275)
T ss_pred             ccccccCccccc-ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccc--h------HHHHHH-H
Confidence            998654332211 1112345677999999988888999999999999999998 777764211  1      111111 1


Q ss_pred             hcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 019536          278 ENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQ  333 (339)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~  333 (339)
                      .....            .++.+...+..+.+++.+||+.+|++|||+.+++..|.+
T Consensus       232 ~~~~~------------~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~  275 (275)
T cd05046         232 QAGKL------------ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE  275 (275)
T ss_pred             HcCCc------------CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence            11110            011112344579999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.8e-42  Score=314.60  Aligned_cols=189  Identities=18%  Similarity=0.290  Sum_probs=164.0

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFE  133 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  133 (339)
                      ..+|++.+.||+|+||.||+|....++..||+|......       ...|+.+++.++||||+++++++..++..++|||
T Consensus        65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~-------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  137 (357)
T PHA03209         65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT-------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP  137 (357)
T ss_pred             hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc-------cHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence            467999999999999999999999889999999854332       2468999999999999999999999999999999


Q ss_pred             eccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCce
Q 019536          134 SVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH  210 (339)
Q Consensus       134 ~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~  210 (339)
                      ++. ++|.+++.   ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++........
T Consensus       138 ~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  213 (357)
T PHA03209        138 HYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAF  213 (357)
T ss_pred             ccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccccccCccc
Confidence            995 57777764   46889999999999999999999   899999999999999999999999999998754322211


Q ss_pred             eeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCcc
Q 019536          211 VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVL  256 (339)
Q Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~  256 (339)
                         ....||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus       214 ---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        214 ---LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             ---ccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence               1346899999999999999999999999999999999865554

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.1e-41  Score=299.28  Aligned_cols=247  Identities=24%  Similarity=0.368  Sum_probs=197.5

Q ss_pred             CceeccCCeeEEEEEEcC-CC--eeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeccC
Q 019536           61 KVIQSDTSYRLFEGTLVD-QD--RPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKY  137 (339)
Q Consensus        61 ~~ig~G~~g~V~~~~~~~-~~--~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~  137 (339)
                      +.||+|++|.||+|.+.. .+  ..||+|.+.........+.+.+|+.++++++||||+++++.+.+ ...++|+||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999999864 23  36999998876554566788899999999999999999999988 888999999999


Q ss_pred             Ccccccccc----CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCcee-e
Q 019536          138 GTLRGFSFA----SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHV-R  212 (339)
Q Consensus       138 g~L~~~~~~----~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~-~  212 (339)
                      |+|.+++..    .+++.....++.|++.||.|||   +.+++|+||+|+||+++.++.+||+|||+++.+....... .
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  156 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM  156 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence            999998752    4688888999999999999999   8999999999999999999999999999998775432221 1


Q ss_pred             ecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCccc
Q 019536          213 EEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFD  291 (339)
Q Consensus       213 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (339)
                      .....++..|+|||++.+..++.++|+|||||++|+|++ |+.||....        ..+.........           
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--------~~~~~~~~~~~~-----------  217 (257)
T cd05040         157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLS--------GSQILKKIDKEG-----------  217 (257)
T ss_pred             ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHHhcC-----------
Confidence            112446778999999998899999999999999999998 999974221        111111111100           


Q ss_pred             CCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 019536          292 EDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLR  332 (339)
Q Consensus       292 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~  332 (339)
                        ...+.+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus       218 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         218 --ERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             --CcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence              001111234467999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=3.5e-42  Score=313.80  Aligned_cols=253  Identities=18%  Similarity=0.206  Sum_probs=198.8

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC--ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS--TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVF  132 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  132 (339)
                      ++|++.+.||+|+||+||++....+++.||+|.+....  .......+.+|..++..++|+||+++++++.+.+..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47899999999999999999999899999999987531  1133455778999999999999999999999999999999


Q ss_pred             EeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCc
Q 019536          133 ESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGET  209 (339)
Q Consensus       133 e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~  209 (339)
                      ||+++|+|.+++.   ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  157 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT  157 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence            9999999999985   46788888899999999999999   99999999999999999999999999999977654333


Q ss_pred             eeeeccccccccccccccccc-----CCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccc
Q 019536          210 HVREEFIKGAYGFIAPEYFAT-----SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA  284 (339)
Q Consensus       210 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (339)
                      .. .....||+.|+|||++.+     ..++.++|+||+||++|+|++|+.||....        ..+..........   
T Consensus       158 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~--------~~~~~~~i~~~~~---  225 (331)
T cd05624         158 VQ-SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES--------LVETYGKIMNHEE---  225 (331)
T ss_pred             ee-eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC--------HHHHHHHHHcCCC---
Confidence            21 223568999999999875     457889999999999999999999985211        1111111111000   


Q ss_pred             cccCcccCCCCCCC-cHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 019536          285 IVDPIFDEDNSFPG-KEEKLQSLGQLMYKCLSKSPEH--RPLMVDVAKQ  330 (339)
Q Consensus       285 ~~~~~~~~~~~~~~-~~~~~~~~~~li~~cl~~dP~~--Rps~~~il~~  330 (339)
                              ...+|. ....+..+.+++.+||..++++  |+++.+++++
T Consensus       226 --------~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         226 --------RFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             --------cccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence                    001111 1134567999999999876654  4688888764

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=4.6e-42  Score=301.76  Aligned_cols=252  Identities=29%  Similarity=0.390  Sum_probs=201.0

Q ss_pred             cccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhH-HHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEec
Q 019536           57 YDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDV-EYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESV  135 (339)
Q Consensus        57 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  135 (339)
                      |++.+.||+|+||+||++....+++.||+|++......... ....+|+.+++.++||||+++++++.+....++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            67788999999999999999999999999999887543322 23456999999999999999999999999999999999


Q ss_pred             cCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceeee
Q 019536          136 KYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVRE  213 (339)
Q Consensus       136 ~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~  213 (339)
                      ++++|.+++.  ..++...+..++.|++.||.+||   +.+++|+||||+||+++.++.++|+|||.+........  ..
T Consensus        81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~--~~  155 (260)
T PF00069_consen   81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNE--NF  155 (260)
T ss_dssp             TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTS--EB
T ss_pred             ccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccc--cc
Confidence            9999999886  78899999999999999999999   89999999999999999999999999999876422222  12


Q ss_pred             cccccccccccccccc-cCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccC
Q 019536          214 EFIKGAYGFIAPEYFA-TSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDE  292 (339)
Q Consensus       214 ~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (339)
                      ....++..|+|||++. +..++.++|+||+|+++|+|++|..||...     ....................        
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~-----~~~~~~~~~~~~~~~~~~~~--------  222 (260)
T PF00069_consen  156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES-----NSDDQLEIIEKILKRPLPSS--------  222 (260)
T ss_dssp             SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS-----SHHHHHHHHHHHHHTHHHHH--------
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccc-----cchhhhhhhhhccccccccc--------
Confidence            2356788999999998 788999999999999999999999997633     01111111111111000000        


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          293 DNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       293 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                         ..........+.+++.+||+.||++|||+.++++
T Consensus       223 ---~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  223 ---SQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             ---TTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             ---ccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               0000011367999999999999999999999986

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=8.8e-42  Score=300.60  Aligned_cols=252  Identities=24%  Similarity=0.351  Sum_probs=201.0

Q ss_pred             HhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 019536           53 ATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVF  132 (339)
Q Consensus        53 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  132 (339)
                      ..++|++.+.||+|+||.||+|... .+..+++|.+....  ...+.+.+|+.+++.++|+||+++.+++.+ ...+++|
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~   79 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT   79 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh--hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEE
Confidence            3478999999999999999999865 56679999887542  345678899999999999999999999887 6789999


Q ss_pred             EeccCCcccccccc----CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCC
Q 019536          133 ESVKYGTLRGFSFA----SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE  208 (339)
Q Consensus       133 e~~~~g~L~~~~~~----~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~  208 (339)
                      ||+++|+|.+++..    .+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.+||+|||.+..+....
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  156 (260)
T cd05073          80 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE  156 (260)
T ss_pred             EeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence            99999999998752    4677888899999999999999   8999999999999999999999999999987765433


Q ss_pred             ceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCccccccc
Q 019536          209 THVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVD  287 (339)
Q Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (339)
                      .... ....++..|+|||++.+..++.++|+||||+++|++++ |+.||.....     .....    .....       
T Consensus       157 ~~~~-~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~-----~~~~~----~~~~~-------  219 (260)
T cd05073         157 YTAR-EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN-----PEVIR----ALERG-------  219 (260)
T ss_pred             cccc-cCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH-----HHHHH----HHhCC-------
Confidence            2211 12335567999999988889999999999999999998 8888752211     11111    11111       


Q ss_pred             CcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 019536          288 PIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQM  334 (339)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l  334 (339)
                            ...+.+...+.++.+++.+||+.+|++||++.++++.|+.+
T Consensus       220 ------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~  260 (260)
T cd05073         220 ------YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF  260 (260)
T ss_pred             ------CCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence                  01111123445799999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2.4e-41  Score=306.38  Aligned_cols=194  Identities=17%  Similarity=0.259  Sum_probs=158.3

Q ss_pred             CCceeccCCeeEEEEEEc--CCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeee--CCccEEEEEec
Q 019536           60 HKVIQSDTSYRLFEGTLV--DQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLE--TELPTLVFESV  135 (339)
Q Consensus        60 ~~~ig~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~--~~~~~lv~e~~  135 (339)
                      .++||+|+||+||+|...  .+++.||+|.+.....   ...+.+|+.+++.++||||+++++++..  +...++||||+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~   82 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA   82 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC---cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence            468999999999999975  3668999999875432   2446789999999999999999999864  45678999999


Q ss_pred             cCCccccccc-----------cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEe----CCCCceEEecCCC
Q 019536          136 KYGTLRGFSF-----------ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLL----DENYSAKLHDFSL  200 (339)
Q Consensus       136 ~~g~L~~~~~-----------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~----~~~~~~kl~dfg~  200 (339)
                      ++ +|.+++.           ..++...+..++.|++.||.|||   +.+|+||||||+|||+    +.++.+||+|||+
T Consensus        83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07868          83 EH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             CC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence            64 6655542           24788888999999999999999   8999999999999999    4567899999999


Q ss_pred             ccccCCCCce-eeecccccccccccccccccC-CCCcccchHHHHHHHHHHHhCCCccccCC
Q 019536          201 SVSIPEGETH-VREEFIKGAYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTGCNVLEFKG  260 (339)
Q Consensus       201 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~  260 (339)
                      ++.+...... .......+|+.|+|||++.+. .++.++||||+||++|+|++|++||....
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  220 (317)
T cd07868         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence            9876543221 112235689999999998774 58999999999999999999999986433

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=5.1e-41  Score=296.65  Aligned_cols=249  Identities=20%  Similarity=0.313  Sum_probs=200.1

Q ss_pred             CcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCCh--------hhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCc
Q 019536           56 NYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTL--------DDVEYCFNNIVFSSQMKHKNILKLIGCCLETEL  127 (339)
Q Consensus        56 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~  127 (339)
                      +|.+...||+|++|.||+|....++..+|+|.+......        ...+.+.+|+.+++.++||||+++++++.+.+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            477889999999999999999888999999988764321        123567789999999999999999999999999


Q ss_pred             cEEEEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccC
Q 019536          128 PTLVFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIP  205 (339)
Q Consensus       128 ~~lv~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~  205 (339)
                      .++||||+++++|.+++.  ..++...+..++.|++.||.|||   +.+++||||+|+||+++.++.++|+|||.++...
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~  157 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLE  157 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence            999999999999999886  46788888899999999999999   8999999999999999999999999999988765


Q ss_pred             CCCcee----eecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCc
Q 019536          206 EGETHV----REEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNR  281 (339)
Q Consensus       206 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (339)
                      ......    ......|+..|+|||.+.+..++.++|+||+|+++|+|++|+.||.....        ......... . 
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~-~-  227 (267)
T cd06628         158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ--------LQAIFKIGE-N-  227 (267)
T ss_pred             cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH--------HHHHHHHhc-c-
Confidence            321110    11123578889999999888899999999999999999999999853211        111111000 0 


Q ss_pred             ccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          282 FGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                          ..+      ..  +...+..+.+++.+||+.||++||++.+|++
T Consensus       228 ----~~~------~~--~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         228 ----ASP------EI--PSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             ----CCC------cC--CcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence                000      01  1134567899999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.5e-41  Score=299.63  Aligned_cols=238  Identities=23%  Similarity=0.349  Sum_probs=185.8

Q ss_pred             CceeccCCeeEEEEEEcCC------------CeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCcc
Q 019536           61 KVIQSDTSYRLFEGTLVDQ------------DRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELP  128 (339)
Q Consensus        61 ~~ig~G~~g~V~~~~~~~~------------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~  128 (339)
                      +.||.|+||.||+|.....            ...|++|.+..... .....+.+|+.+++.++||||+++++++......
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~-~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~   79 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHR-DISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN   79 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhh-hHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence            4689999999999986422            23688888765432 4455678899999999999999999999999899


Q ss_pred             EEEEEeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCc-------eEEecC
Q 019536          129 TLVFESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYS-------AKLHDF  198 (339)
Q Consensus       129 ~lv~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~-------~kl~df  198 (339)
                      ++||||+++|+|..++.   ..+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.       ++++||
T Consensus        80 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~  156 (262)
T cd05077          80 IMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP  156 (262)
T ss_pred             EEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence            99999999999988875   35788899999999999999999   999999999999999986654       899999


Q ss_pred             CCccccCCCCceeeecccccccccccccccc-cCCCCcccchHHHHHHHHHHH-hCCCccccCCCCCCCchhHHHHHHHH
Q 019536          199 SLSVSIPEGETHVREEFIKGAYGFIAPEYFA-TSSFNEMCDVYSFGAFLCELL-TGCNVLEFKGNGNDDDLTVLEYAKKS  276 (339)
Q Consensus       199 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~~l~el~-~g~~p~~~~~~~~~~~~~~~~~~~~~  276 (339)
                      |++.......      ...++..|+|||.+. +..++.++|||||||++|+|+ .|..||.....        .+. ...
T Consensus       157 g~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--------~~~-~~~  221 (262)
T cd05077         157 GIPITVLSRQ------ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL--------AEK-ERF  221 (262)
T ss_pred             CCCccccCcc------cccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch--------hHH-HHH
Confidence            9986553322      235778899999987 457899999999999999998 57777542110        000 000


Q ss_pred             hhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 019536          277 IENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLR  332 (339)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~  332 (339)
                      .. ...        .  ..    .....++.+|+.+||+.||++||++.+|++.|+
T Consensus       222 ~~-~~~--------~--~~----~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         222 YE-GQC--------M--LV----TPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             Hh-cCc--------c--CC----CCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence            00 000        0  00    122356899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-42  Score=316.55  Aligned_cols=240  Identities=19%  Similarity=0.208  Sum_probs=187.2

Q ss_pred             eeccCCeeEEEEEEcCCCeeEEEEEeccCCC--hhhHHHHHHHHHHHHhc---CCCceeeeeeeeeeCCccEEEEEeccC
Q 019536           63 IQSDTSYRLFEGTLVDQDRPISVMKFHDNST--LDDVEYCFNNIVFSSQM---KHKNILKLIGCCLETELPTLVFESVKY  137 (339)
Q Consensus        63 ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l---~H~niv~~~~~~~~~~~~~lv~e~~~~  137 (339)
                      ||+|+||+||+|.+..+++.||+|++.....  ......+..|..++...   .||||+.+++++.+.+..++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            6999999999999998999999999865321  12334455676766655   699999999999999999999999999


Q ss_pred             Cccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceeeecc
Q 019536          138 GTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEF  215 (339)
Q Consensus       138 g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~~~  215 (339)
                      |+|.+++.  ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.++|+|||+++........  ...
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~--~~~  155 (330)
T cd05586          81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT--TNT  155 (330)
T ss_pred             ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCC--ccC
Confidence            99988875  56888899999999999999999   899999999999999999999999999998764332221  123


Q ss_pred             cccccccccccccccC-CCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCCC
Q 019536          216 IKGAYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDN  294 (339)
Q Consensus       216 ~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (339)
                      ..||..|+|||++.+. .++.++||||+||++|+|++|+.||....        ..+. ........            .
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~--------~~~~-~~~i~~~~------------~  214 (330)
T cd05586         156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED--------TQQM-YRNIAFGK------------V  214 (330)
T ss_pred             ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC--------HHHH-HHHHHcCC------------C
Confidence            5689999999998765 48899999999999999999999974211        1111 11111110            1


Q ss_pred             CCCCcHHHHHHHHHHHHHhhccCCCCCCC----HHHHHH
Q 019536          295 SFPGKEEKLQSLGQLMYKCLSKSPEHRPL----MVDVAK  329 (339)
Q Consensus       295 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps----~~~il~  329 (339)
                      .+|. ...+..+.+++.+||+.||++||+    +.++++
T Consensus       215 ~~~~-~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         215 RFPK-NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             CCCC-ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence            1111 124557899999999999999984    556554

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.4e-41  Score=309.93  Aligned_cols=253  Identities=18%  Similarity=0.210  Sum_probs=198.8

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC--ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS--TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVF  132 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  132 (339)
                      ++|++.+.||+|+||+||++....+++.+|+|.+.+..  .......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            47899999999999999999999899999999986531  1123345778999999999999999999999999999999


Q ss_pred             EeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCc
Q 019536          133 ESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGET  209 (339)
Q Consensus       133 e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~  209 (339)
                      ||+++|+|.+++.   ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||++..+.....
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~  157 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT  157 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence            9999999999985   46788888999999999999999   99999999999999999999999999999876543332


Q ss_pred             eeeecccccccccccccccc-----cCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccc
Q 019536          210 HVREEFIKGAYGFIAPEYFA-----TSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA  284 (339)
Q Consensus       210 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (339)
                      . ......||+.|+|||++.     ...++.++|||||||++|+|++|+.||....        ..+..........   
T Consensus       158 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~--------~~~~~~~i~~~~~---  225 (332)
T cd05623         158 V-QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES--------LVETYGKIMNHKE---  225 (332)
T ss_pred             c-eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC--------HHHHHHHHhCCCc---
Confidence            2 122356899999999986     3458899999999999999999999985221        1111111111100   


Q ss_pred             cccCcccCCCCCCC-cHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 019536          285 IVDPIFDEDNSFPG-KEEKLQSLGQLMYKCLSKSPEH--RPLMVDVAKQ  330 (339)
Q Consensus       285 ~~~~~~~~~~~~~~-~~~~~~~~~~li~~cl~~dP~~--Rps~~~il~~  330 (339)
                              ...+|. ....+..+.+|+.+||..+|.+  |+++.+++++
T Consensus       226 --------~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         226 --------RFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             --------cccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence                    001111 1234667999999999765554  6899998875

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.9e-42  Score=300.49  Aligned_cols=252  Identities=26%  Similarity=0.367  Sum_probs=202.8

Q ss_pred             HhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 019536           53 ATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVF  132 (339)
Q Consensus        53 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  132 (339)
                      ..++|++.+.||+|+||.||+|... +++.||+|.+....  .....+.+|+.+++.++||||+++++++......++||
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT--MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT   80 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCc--cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence            3578999999999999999999976 56789999987643  23466889999999999999999999999988999999


Q ss_pred             EeccCCccccccc----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCC
Q 019536          133 ESVKYGTLRGFSF----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE  208 (339)
Q Consensus       133 e~~~~g~L~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~  208 (339)
                      ||+++++|.+++.    ..+++..+..++.|++.|+.|||   +.+++|+||||+||+++.++.++++|||+++.+....
T Consensus        81 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~  157 (261)
T cd05034          81 EYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE  157 (261)
T ss_pred             eccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence            9999999999875    35788889999999999999999   8999999999999999999999999999987765422


Q ss_pred             ceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCccccccc
Q 019536          209 THVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVD  287 (339)
Q Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (339)
                      ..... ...++..|+|||.+.+..++.++|+||+|+++|++++ |+.||...  ..   .....   .....        
T Consensus       158 ~~~~~-~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~--~~---~~~~~---~~~~~--------  220 (261)
T cd05034         158 YTARE-GAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM--TN---REVLE---QVERG--------  220 (261)
T ss_pred             hhhhh-ccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC--CH---HHHHH---HHHcC--------
Confidence            21111 1224567999999998889999999999999999998 99887421  11   11111   11110        


Q ss_pred             CcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 019536          288 PIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQ  333 (339)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~  333 (339)
                            ...+.+...+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus       221 ------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         221 ------YRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             ------CCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence                  0011112335578999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=5.1e-41  Score=294.80  Aligned_cols=249  Identities=22%  Similarity=0.251  Sum_probs=204.4

Q ss_pred             CcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 019536           56 NYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS-TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFES  134 (339)
Q Consensus        56 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  134 (339)
                      +|+..+.||.|+||.||.+....++..+++|.+.... .......+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            5888999999999999999999999999999987543 335566788999999999999999999999999999999999


Q ss_pred             ccCCcccccccc----CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCce
Q 019536          135 VKYGTLRGFSFA----SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH  210 (339)
Q Consensus       135 ~~~g~L~~~~~~----~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~  210 (339)
                      +++|+|.+++..    .++...+..++.|++.||.|||   +.+++|+||+|+||+++.++.+||+|||++.........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~  157 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSM  157 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEccccccc
Confidence            999999998863    4788888999999999999999   899999999999999999999999999998776443321


Q ss_pred             eeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcc
Q 019536          211 VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIF  290 (339)
Q Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (339)
                        .....++..|+|||++.+..++.++|+||||+++|+|++|..||....        ..+...... ...+.       
T Consensus       158 --~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~--------~~~~~~~~~-~~~~~-------  219 (256)
T cd08221         158 --AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN--------PLNLVVKIV-QGNYT-------  219 (256)
T ss_pred             --ccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHH-cCCCC-------
Confidence              123568899999999988888999999999999999999999975211        111111111 11110       


Q ss_pred             cCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 019536          291 DEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQL  331 (339)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L  331 (339)
                            +.+...+..+.+++.+||+.+|.+|||+.++++.+
T Consensus       220 ------~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         220 ------PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             ------CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence                  11124456799999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=6.6e-42  Score=325.86  Aligned_cols=267  Identities=13%  Similarity=0.161  Sum_probs=192.5

Q ss_pred             HHHHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCC------Cceeeeeeeee
Q 019536           50 LKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKH------KNILKLIGCCL  123 (339)
Q Consensus        50 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H------~niv~~~~~~~  123 (339)
                      +...+++|++.+.||+|+||+||+|.+..+++.||||++....  .....+..|+.++..++|      ++++.+++++.
T Consensus       124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~  201 (467)
T PTZ00284        124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP--KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ  201 (467)
T ss_pred             cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch--hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence            3445688999999999999999999998899999999986532  223345567777777654      45888999887


Q ss_pred             eC-CccEEEEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCC-CCeEEccCCCCCEEeCCCC--------
Q 019536          124 ET-ELPTLVFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFD-RPIVFRCIKASNVLLDENY--------  191 (339)
Q Consensus       124 ~~-~~~~lv~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~i~H~dlk~~Nil~~~~~--------  191 (339)
                      .. ...++|||++ +++|.+++.  ..+++..+..++.||+.||.|||   + .+|+||||||+|||++.++        
T Consensus       202 ~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NILl~~~~~~~~~~~~  277 (467)
T PTZ00284        202 NETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENILMETSDTVVDPVTN  277 (467)
T ss_pred             cCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEecCCcccccccc
Confidence            64 5688999998 677877765  56888999999999999999999   7 5999999999999998665        


Q ss_pred             --------ceEEecCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCC
Q 019536          192 --------SAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGN  263 (339)
Q Consensus       192 --------~~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~  263 (339)
                              .+||+|||.+.......     ....||+.|+|||++.+..|+.++|||||||++|||++|+.||....  .
T Consensus       278 ~~~~~~~~~vkl~DfG~~~~~~~~~-----~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~--~  350 (467)
T PTZ00284        278 RALPPDPCRVRICDLGGCCDERHSR-----TAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD--N  350 (467)
T ss_pred             cccCCCCceEEECCCCccccCcccc-----ccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--h
Confidence                    49999999875432221     13578999999999999999999999999999999999999985322  1


Q ss_pred             CCchhHHHHHHHHhhcC--------cccccccC------cccCC-------CCCCCcHHHHHHHHHHHHHhhccCCCCCC
Q 019536          264 DDDLTVLEYAKKSIENN--------RFGAIVDP------IFDED-------NSFPGKEEKLQSLGQLMYKCLSKSPEHRP  322 (339)
Q Consensus       264 ~~~~~~~~~~~~~~~~~--------~~~~~~~~------~~~~~-------~~~~~~~~~~~~~~~li~~cl~~dP~~Rp  322 (339)
                      .+....+......+...        ....+.+.      .....       ............+.+||.+||++||++||
T Consensus       351 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~  430 (467)
T PTZ00284        351 LEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRL  430 (467)
T ss_pred             HHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCC
Confidence            11111111110000000        00000000      00000       00000001235678999999999999999


Q ss_pred             CHHHHHH
Q 019536          323 LMVDVAK  329 (339)
Q Consensus       323 s~~~il~  329 (339)
                      |+.|+++
T Consensus       431 ta~e~L~  437 (467)
T PTZ00284        431 NARQMTT  437 (467)
T ss_pred             CHHHHhc
Confidence            9999997

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.3e-41  Score=300.01  Aligned_cols=253  Identities=18%  Similarity=0.251  Sum_probs=205.9

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFES  134 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  134 (339)
                      ++|+..+.||.|++|.||++....+++.+++|.+...........+.+|+.+++.++||||+++++++..++..++|+||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            46788899999999999999999899999999988765545667788999999999999999999999999999999999


Q ss_pred             ccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCC-CCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCce
Q 019536          135 VKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFD-RPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH  210 (339)
Q Consensus       135 ~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~  210 (339)
                      +++++|.+++.   ..++......++.|++.||.|||   + .+++|+||+|+||+++.++.++|+|||.+.........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~  157 (265)
T cd06605          81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK  157 (265)
T ss_pred             cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh
Confidence            99999999886   56788888899999999999999   8 99999999999999999999999999998765332211


Q ss_pred             eeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcc
Q 019536          211 VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIF  290 (339)
Q Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (339)
                          ...++..|+|||.+.+..++.++|+||+|+++|++++|+.||........   ..............         
T Consensus       158 ----~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~---------  221 (265)
T cd06605         158 ----TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD---GIFELLQYIVNEPP---------  221 (265)
T ss_pred             ----cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc---cHHHHHHHHhcCCC---------
Confidence                14578889999999988999999999999999999999999853322111   11111111111100         


Q ss_pred             cCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          291 DEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                         ...+. ...+..+.++|.+||..||++|||+.+++..
T Consensus       222 ---~~~~~-~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         222 ---PRLPS-GKFSPDFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             ---CCCCh-hhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence               00111 1255679999999999999999999999863

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=6e-42  Score=305.40  Aligned_cols=265  Identities=17%  Similarity=0.220  Sum_probs=197.2

Q ss_pred             CcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCCh-hhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 019536           56 NYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTL-DDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFES  134 (339)
Q Consensus        56 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  134 (339)
                      +|++.+.||+|+||.||+|.+..+|..||+|.+...... .....+.+|+.+++.++||||+++++++.+.+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            478889999999999999999999999999998754321 2235567899999999999999999999999999999999


Q ss_pred             ccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCcee
Q 019536          135 VKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHV  211 (339)
Q Consensus       135 ~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~  211 (339)
                      +++ +|.+++.   ..+++..+..++.||+.||.|||   +.+|+||||||+||+++.++.++|+|||+++.+.......
T Consensus        81 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~  156 (284)
T cd07839          81 CDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCY  156 (284)
T ss_pred             CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCc
Confidence            974 6666553   46888999999999999999999   8999999999999999999999999999987654332211


Q ss_pred             eecccccccccccccccccC-CCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhc---Ccc---cc
Q 019536          212 REEFIKGAYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIEN---NRF---GA  284 (339)
Q Consensus       212 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~---~~  284 (339)
                        ....++..|+|||++.+. .++.++||||+||++|+|++|..|+. .+....   ............   ..+   ..
T Consensus       157 --~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~-~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  230 (284)
T cd07839         157 --SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF-PGNDVD---DQLKRIFRLLGTPTEESWPGVSK  230 (284)
T ss_pred             --CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCc-CCCCHH---HHHHHHHHHhCCCChHHhHHhhh
Confidence              123567889999998765 47899999999999999999998863 222211   111111111000   000   00


Q ss_pred             cccC----cccCCCCC-CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          285 IVDP----IFDEDNSF-PGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       285 ~~~~----~~~~~~~~-~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      +.+.    .......+ +.....+.++.+++.+||+.||.+|||+.+++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h  281 (284)
T cd07839         231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH  281 (284)
T ss_pred             cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence            0000    00000000 0011345678999999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=3.7e-41  Score=297.20  Aligned_cols=256  Identities=22%  Similarity=0.335  Sum_probs=205.4

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFES  134 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  134 (339)
                      ++|++.+.||.|++|+||+|....++..+++|++...........+.+|+.+++.++|+||+++++.+..++..++|+|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            47899999999999999999998889999999997665445667788999999999999999999999999999999999


Q ss_pred             ccCCccccccc-----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCc
Q 019536          135 VKYGTLRGFSF-----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGET  209 (339)
Q Consensus       135 ~~~g~L~~~~~-----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~  209 (339)
                      +++++|.+++.     ..+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++..+.....
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            99999999875     24788888999999999999999   99999999999999999999999999999877654432


Q ss_pred             ee--eecccccccccccccccccC-CCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccc
Q 019536          210 HV--REEFIKGAYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIV  286 (339)
Q Consensus       210 ~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (339)
                      ..  ......++..|+|||++... .++.++|+||||+++|+|++|+.||......        +.........      
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~--------~~~~~~~~~~------  223 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM--------KVLMLTLQND------  223 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh--------hhHHHHhcCC------
Confidence            21  11234688899999998776 7889999999999999999999997522110        1111111100      


Q ss_pred             cCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          287 DPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      .+......   .....+..+.+++.+||+.||++|||+.+++++
T Consensus       224 ~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         224 PPSLETGA---DYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             CCCcCCcc---ccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            00000000   011445678999999999999999999999863

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.7e-41  Score=294.46  Aligned_cols=252  Identities=22%  Similarity=0.312  Sum_probs=204.4

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFE  133 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  133 (339)
                      .++|++.+.||.|+||.||+|....++..+++|.+..... .....+.+|+.+++.++||||+++++++.+++..+++||
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e   80 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG-DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME   80 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch-hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence            3678999999999999999999988889999999876543 356778899999999999999999999999999999999


Q ss_pred             eccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCce
Q 019536          134 SVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH  210 (339)
Q Consensus       134 ~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~  210 (339)
                      |+++++|.+++.   ..++...+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++.........
T Consensus        81 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~  157 (262)
T cd06613          81 YCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAK  157 (262)
T ss_pred             CCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhhhhc
Confidence            999999998875   46888889999999999999999   899999999999999999999999999998766443211


Q ss_pred             eeecccccccccccccccccC---CCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCccccccc
Q 019536          211 VREEFIKGAYGFIAPEYFATS---SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVD  287 (339)
Q Consensus       211 ~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (339)
                        .....++..|+|||.+.+.   .++.++|+||||+++|+|++|+.||.....        .......... .+   ..
T Consensus       158 --~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~--------~~~~~~~~~~-~~---~~  223 (262)
T cd06613         158 --RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHP--------MRALFLISKS-NF---PP  223 (262)
T ss_pred             --cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhc-cC---CC
Confidence              1134578889999999776   788999999999999999999999752211        1111110000 00   00


Q ss_pred             CcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          288 PIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                            .........+.++.+++.+||..+|.+|||+.+|+.
T Consensus       224 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         224 ------PKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             ------ccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                  001112245678999999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=6.2e-41  Score=297.01  Aligned_cols=255  Identities=19%  Similarity=0.260  Sum_probs=198.9

Q ss_pred             CcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCCh---------hhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC
Q 019536           56 NYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTL---------DDVEYCFNNIVFSSQMKHKNILKLIGCCLETE  126 (339)
Q Consensus        56 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~  126 (339)
                      +|.+.+.||+|++|.||+|....+++.||+|.+......         ...+.+.+|+.+++.++|||++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            477889999999999999999888999999988643110         12346778999999999999999999999999


Q ss_pred             ccEEEEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCcccc
Q 019536          127 LPTLVFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSI  204 (339)
Q Consensus       127 ~~~lv~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~  204 (339)
                      ..++||||+++|+|.+++.  ..++...+..++.|++.||.|||   +.+++|+||+|+||+++.++.++++|||+++..
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~  158 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKS  158 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeeccccccc
Confidence            9999999999999998876  46778888889999999999999   899999999999999999999999999998765


Q ss_pred             CCCCceeeecccccccccccccccccCC--CCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcc
Q 019536          205 PEGETHVREEFIKGAYGFIAPEYFATSS--FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRF  282 (339)
Q Consensus       205 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (339)
                      .............++..|+|||++....  ++.++|+||||+++|++++|..||....        ..............
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~--------~~~~~~~~~~~~~~  230 (272)
T cd06629         159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE--------AIAAMFKLGNKRSA  230 (272)
T ss_pred             cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcc--------hHHHHHHhhccccC
Confidence            4322211122345788999999987654  8899999999999999999999974111        11111111111000


Q ss_pred             cccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          283 GAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                           ..+...    .....+..+.+++.+||+.||++|||+.+++++
T Consensus       231 -----~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         231 -----PPIPPD----VSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             -----CcCCcc----ccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence                 000000    011345679999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=3.4e-41  Score=302.17  Aligned_cols=251  Identities=19%  Similarity=0.279  Sum_probs=204.8

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFE  133 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  133 (339)
                      .++|.+.+.||+|+||.||+|....++..|++|.+..... ...+.+.+|+.+++.++||||+++++++..++..++|+|
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e   96 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ-PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVME   96 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc-hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEe
Confidence            4789999999999999999999888899999999865433 345678899999999999999999999999999999999


Q ss_pred             eccCCccccccc-cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceee
Q 019536          134 SVKYGTLRGFSF-ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVR  212 (339)
Q Consensus       134 ~~~~g~L~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~  212 (339)
                      |+++++|.+++. ..+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++.......... 
T Consensus        97 ~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~-  172 (293)
T cd06647          97 YLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-  172 (293)
T ss_pred             cCCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccccc-
Confidence            999999999886 46788888999999999999999   9999999999999999999999999999987664433221 


Q ss_pred             ecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccC
Q 019536          213 EEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDE  292 (339)
Q Consensus       213 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (339)
                       ....+++.|+|||.+.+..++.++|+||||+++|++++|+.||.......  ...      ....            ..
T Consensus       173 -~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~--~~~------~~~~------------~~  231 (293)
T cd06647         173 -STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR--ALY------LIAT------------NG  231 (293)
T ss_pred             -ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhh--hee------ehhc------------CC
Confidence             13457888999999988889999999999999999999999985221110  000      0000            00


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          293 DNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       293 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      ....+.+...+..+.+++.+||+.+|++||++.+++.+
T Consensus       232 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         232 TPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            11112222345678999999999999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.7e-41  Score=335.60  Aligned_cols=255  Identities=19%  Similarity=0.242  Sum_probs=199.5

Q ss_pred             HHHHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeeee--CC
Q 019536           50 LKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS-TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLE--TE  126 (339)
Q Consensus        50 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~--~~  126 (339)
                      .....++|.+.+.||.|+||+||+|.+..++..||+|.+.... .......+..|+.+++.++||||++++++|.+  ..
T Consensus         8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~   87 (1021)
T PTZ00266          8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ   87 (1021)
T ss_pred             CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence            3445689999999999999999999999999999999987543 22445678899999999999999999998865  35


Q ss_pred             ccEEEEEeccCCccccccc------cCCChHHHHHHHHHHHHHHHHHhcCC----CCCeEEccCCCCCEEeCC-------
Q 019536          127 LPTLVFESVKYGTLRGFSF------ASLLIAPRIKIAMEIANAVAYLHVGF----DRPIVFRCIKASNVLLDE-------  189 (339)
Q Consensus       127 ~~~lv~e~~~~g~L~~~~~------~~~~~~~~~~i~~~i~~~l~~LH~~~----~~~i~H~dlk~~Nil~~~-------  189 (339)
                      .+||||||+++|+|.+++.      ..+++..++.|+.||+.||.|||...    ..+|+||||||+|||++.       
T Consensus        88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~  167 (1021)
T PTZ00266         88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK  167 (1021)
T ss_pred             EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence            6899999999999998875      36889999999999999999999311    145999999999999964       


Q ss_pred             ----------CCceEEecCCCccccCCCCceeeeccccccccccccccccc--CCCCcccchHHHHHHHHHHHhCCCccc
Q 019536          190 ----------NYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFAT--SSFNEMCDVYSFGAFLCELLTGCNVLE  257 (339)
Q Consensus       190 ----------~~~~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~g~~p~~  257 (339)
                                .+.+||+|||++..+......   ....||+.|+|||++.+  ..++.++|||||||++|+|++|+.||.
T Consensus       168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~---~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~  244 (1021)
T PTZ00266        168 ITAQANNLNGRPIAKIGDFGLSKNIGIESMA---HSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH  244 (1021)
T ss_pred             ccccccccCCCCceEEccCCccccccccccc---cccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence                      235899999999776443221   13468999999999864  458899999999999999999999985


Q ss_pred             cCCCCCCCchhHHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          258 FKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                      ....    .....   .. ....             ...|. ...+..+.+||..||+.+|.+|||+.+++.
T Consensus       245 ~~~~----~~qli---~~-lk~~-------------p~lpi-~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        245 KANN----FSQLI---SE-LKRG-------------PDLPI-KGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             cCCc----HHHHH---HH-HhcC-------------CCCCc-CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            2211    11111   11 1100             00111 123457899999999999999999999985

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.9e-41  Score=298.94  Aligned_cols=237  Identities=24%  Similarity=0.334  Sum_probs=184.9

Q ss_pred             ceeccCCeeEEEEEEcCC------------------------CeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceee
Q 019536           62 VIQSDTSYRLFEGTLVDQ------------------------DRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILK  117 (339)
Q Consensus        62 ~ig~G~~g~V~~~~~~~~------------------------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~  117 (339)
                      .||+|+||.||+|....+                        ...|++|.+..... .....+.+|+.+++.++||||++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~-~~~~~~~~~~~~~~~l~h~niv~   80 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR-DIALAFFETASLMSQVSHIHLAF   80 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH-HHHHHHHHHHHHHhcCCCCCeee
Confidence            689999999999985321                        23688898865433 34566888999999999999999


Q ss_pred             eeeeeeeCCccEEEEEeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCC---
Q 019536          118 LIGCCLETELPTLVFESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENY---  191 (339)
Q Consensus       118 ~~~~~~~~~~~~lv~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~---  191 (339)
                      ++++|.+++..++||||+++|+|..++.   ..+++..+..++.|++.||.|||   +.+|+||||||+||+++..+   
T Consensus        81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~~~~~  157 (274)
T cd05076          81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAE  157 (274)
T ss_pred             EEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEeccCccc
Confidence            9999999999999999999999988874   46788999999999999999999   89999999999999997543   


Q ss_pred             ----ceEEecCCCccccCCCCceeeeccccccccccccccccc-CCCCcccchHHHHHHHHHHH-hCCCccccCCCCCCC
Q 019536          192 ----SAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFAT-SSFNEMCDVYSFGAFLCELL-TGCNVLEFKGNGNDD  265 (339)
Q Consensus       192 ----~~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~-~g~~p~~~~~~~~~~  265 (339)
                          .+|++|||++.......      ...++..|+|||.+.+ ..++.++|+||||+++||++ +|+.||.......  
T Consensus       158 ~~~~~~kl~d~g~~~~~~~~~------~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--  229 (274)
T cd05076         158 GTSPFIKLSDPGVSFTALSRE------ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE--  229 (274)
T ss_pred             CccceeeecCCcccccccccc------ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH--
Confidence                47999999876543222      1346778999998875 46899999999999999985 6888875322110  


Q ss_pred             chhHHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 019536          266 DLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLR  332 (339)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~  332 (339)
                         ....    ...             ....|.  .....+.+++.+||+.+|++|||+.+|++.|.
T Consensus       230 ---~~~~----~~~-------------~~~~~~--~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         230 ---KERF----YEK-------------KHRLPE--PSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             ---HHHH----HHh-------------ccCCCC--CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence               1010    000             000111  12236889999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=7.9e-41  Score=293.67  Aligned_cols=248  Identities=21%  Similarity=0.274  Sum_probs=200.4

Q ss_pred             CcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeeee-CCccEEEEE
Q 019536           56 NYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS-TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLE-TELPTLVFE  133 (339)
Q Consensus        56 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~-~~~~~lv~e  133 (339)
                      +|++.+.||.|++|.||.+....+++.||+|++.... .....+.+.+|+.++++++|+|++++.+.+.. +...++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4888999999999999999998889999999987643 22445668899999999999999999998764 446789999


Q ss_pred             eccCCccccccc----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCc
Q 019536          134 SVKYGTLRGFSF----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGET  209 (339)
Q Consensus       134 ~~~~g~L~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~  209 (339)
                      |+++++|.+++.    ..+++.++..++.+++.|+.|||   +.+++|+||||+||+++.++.++|+|||++........
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~  157 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD  157 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence            999999988875    35788999999999999999999   99999999999999999999999999999877644322


Q ss_pred             eeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCc
Q 019536          210 HVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPI  289 (339)
Q Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (339)
                      .  .....+++.|+|||++.+..++.++|+||+|++++++++|+.||....        ......... .....      
T Consensus       158 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~--------~~~~~~~~~-~~~~~------  220 (257)
T cd08223         158 M--ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD--------MNSLVYRII-EGKLP------  220 (257)
T ss_pred             c--cccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC--------HHHHHHHHH-hcCCC------
Confidence            1  113457889999999998889999999999999999999999975211        111111111 11110      


Q ss_pred             ccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          290 FDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                             +.+...+..+.+++.+||+.||++|||+.+++++
T Consensus       221 -------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         221 -------PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             -------CCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence                   1112455679999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=8.7e-41  Score=296.12  Aligned_cols=254  Identities=24%  Similarity=0.387  Sum_probs=198.3

Q ss_pred             cccCCceeccCCeeEEEEEEc---CCCeeEEEEEeccCC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC------
Q 019536           57 YDLHKVIQSDTSYRLFEGTLV---DQDRPISVMKFHDNS-TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETE------  126 (339)
Q Consensus        57 ~~~~~~ig~G~~g~V~~~~~~---~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~------  126 (339)
                      |.+.+.||+|+||.||+|.+.   .+++.||+|.+.... .....+.+.+|+.+++.++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            567889999999999999864   357899999987653 2345677889999999999999999999886532      


Q ss_pred             ccEEEEEeccCCccccccc--------cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecC
Q 019536          127 LPTLVFESVKYGTLRGFSF--------ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDF  198 (339)
Q Consensus       127 ~~~lv~e~~~~g~L~~~~~--------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~df  198 (339)
                      ..++++||+++|+|.+++.        ..++......++.|++.||+|||   +.+|+||||||+||+++.++.+|++||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcc
Confidence            2478999999999987753        14677888999999999999999   899999999999999999999999999


Q ss_pred             CCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHh
Q 019536          199 SLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSI  277 (339)
Q Consensus       199 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~  277 (339)
                      |+++...............++..|++||.+.+..++.++|||||||++|+|++ |++||...  .      .........
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~--~------~~~~~~~~~  229 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGV--E------NSEIYNYLI  229 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCC--C------HHHHHHHHH
Confidence            99987654332222222345567999999988889999999999999999999 88886421  1      111111111


Q ss_pred             hcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 019536          278 ENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMY  335 (339)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~  335 (339)
                      .....              +.+...+..+.+++.+||+.+|++|||+.++++.|++++
T Consensus       230 ~~~~~--------------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~~  273 (273)
T cd05074         230 KGNRL--------------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELIW  273 (273)
T ss_pred             cCCcC--------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence            11000              011134457999999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=3.4e-41  Score=300.62  Aligned_cols=264  Identities=17%  Similarity=0.185  Sum_probs=195.8

Q ss_pred             CcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC-hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 019536           56 NYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST-LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFES  134 (339)
Q Consensus        56 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  134 (339)
                      +|++.+.||+|++|.||+|....++..||+|++..... ......+.+|+.+++.++||||+++++++.+++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            57888999999999999999988999999999875432 22345677999999999999999999999999999999999


Q ss_pred             ccCCccccccc-----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCc
Q 019536          135 VKYGTLRGFSF-----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGET  209 (339)
Q Consensus       135 ~~~g~L~~~~~-----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~  209 (339)
                      ++ ++|.+++.     ..++...+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  156 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR  156 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence            97 57777654     35788888999999999999999   89999999999999999999999999999876543322


Q ss_pred             eeeecccccccccccccccccC-CCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHH--hhcCcccc--
Q 019536          210 HVREEFIKGAYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKS--IENNRFGA--  284 (339)
Q Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~--  284 (339)
                      ..  ....++..|+|||++.+. .++.++|+|||||++|+|++|++||......  +  .........  .....+..  
T Consensus       157 ~~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~--~--~~~~~~~~~~~~~~~~~~~~~  230 (285)
T cd07861         157 VY--THEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEI--D--QLFRIFRILGTPTEDVWPGVT  230 (285)
T ss_pred             cc--cCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHH--H--HHHHHHHHhCCCChhhhhcch
Confidence            11  123467889999988654 5789999999999999999999997522110  0  000000000  00000000  


Q ss_pred             -c--ccCcccC---CCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          285 -I--VDPIFDE---DNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       285 -~--~~~~~~~---~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                       +  .......   ..........+.++.+++.+||+.||++|||+.+|++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         231 SLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             hhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence             0  0000000   0000000124567889999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.6e-41  Score=297.60  Aligned_cols=248  Identities=21%  Similarity=0.297  Sum_probs=201.6

Q ss_pred             CcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcC---CCceeeeeeeeeeCCccEEEE
Q 019536           56 NYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMK---HKNILKLIGCCLETELPTLVF  132 (339)
Q Consensus        56 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~---H~niv~~~~~~~~~~~~~lv~  132 (339)
                      .|+..+.||+|+||.||+|.+..+++.||+|.+.........+.+.+|+.+++.++   |||++++++++.++...++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            57888999999999999999988999999999876654456677889999999996   999999999999999999999


Q ss_pred             EeccCCccccccc-cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCcee
Q 019536          133 ESVKYGTLRGFSF-ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHV  211 (339)
Q Consensus       133 e~~~~g~L~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~  211 (339)
                      ||+++++|.+++. ..+++.....++.|++.||.|||   +.+|+|+||+|+||+++.++.++|+|||++..+.......
T Consensus        82 e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06917          82 EYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR  158 (277)
T ss_pred             ecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcccc
Confidence            9999999998876 46788889999999999999999   8999999999999999999999999999988765543221


Q ss_pred             eecccccccccccccccccC-CCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcc
Q 019536          212 REEFIKGAYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIF  290 (339)
Q Consensus       212 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (339)
                        ....|+..|+|||.+.+. .++.++|+||||+++|+|++|+.||.....        ..... .....     ..+  
T Consensus       159 --~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~--------~~~~~-~~~~~-----~~~--  220 (277)
T cd06917         159 --STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA--------FRAMM-LIPKS-----KPP--  220 (277)
T ss_pred             --ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh--------hhhhh-ccccC-----CCC--
Confidence              134688899999988654 578999999999999999999999752211        00000 00000     000  


Q ss_pred             cCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          291 DEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                          ..+. ...+.++.+++.+||+.||++||++.+++.
T Consensus       221 ----~~~~-~~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         221 ----RLED-NGYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             ----CCCc-ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence                1111 124457999999999999999999999986

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=2.2e-41  Score=302.91  Aligned_cols=259  Identities=22%  Similarity=0.239  Sum_probs=203.6

Q ss_pred             ccHHHHHHHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhc-CCCceeeeeeeee
Q 019536           45 FSAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCCL  123 (339)
Q Consensus        45 ~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~  123 (339)
                      ++..++...+++|++.+.||+|+||.||+|....+++.+|+|.+....  .....+.+|+.++..+ +|||++++++++.
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   89 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS--DVDEEIEAEYNILQSLPNHPNVVKFYGMFY   89 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc--cHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence            455677778899999999999999999999999899999999986542  2345567899999998 8999999999987


Q ss_pred             eC-----CccEEEEEeccCCccccccc------cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCc
Q 019536          124 ET-----ELPTLVFESVKYGTLRGFSF------ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYS  192 (339)
Q Consensus       124 ~~-----~~~~lv~e~~~~g~L~~~~~------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~  192 (339)
                      ..     +..++||||+++|+|.+++.      ..+++..++.++.|++.||.|||   +.+++|+||||+||+++.++.
T Consensus        90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~  166 (291)
T cd06639          90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGG  166 (291)
T ss_pred             eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCC
Confidence            53     35799999999999988763      46788889999999999999999   899999999999999999999


Q ss_pred             eEEecCCCccccCCCCceeeecccccccccccccccccC-----CCCcccchHHHHHHHHHHHhCCCccccCCCCCCCch
Q 019536          193 AKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATS-----SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDL  267 (339)
Q Consensus       193 ~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~  267 (339)
                      +||+|||++..........  ....++..|+|||++...     .++.++|+|||||++|+|++|+.||....       
T Consensus       167 ~kl~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~-------  237 (291)
T cd06639         167 VKLVDFGVSAQLTSTRLRR--NTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH-------  237 (291)
T ss_pred             EEEeecccchhcccccccc--cCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCc-------
Confidence            9999999987654332211  124578889999998643     36789999999999999999999975211       


Q ss_pred             hHHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          268 TVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                       ........... ...           ....+......+.+++.+||+.+|++|||+.+++.+
T Consensus       238 -~~~~~~~~~~~-~~~-----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         238 -PVKTLFKIPRN-PPP-----------TLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             -HHHHHHHHhcC-CCC-----------CCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence             11111111111 000           001112344579999999999999999999999863

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.6e-41  Score=298.71  Aligned_cols=238  Identities=22%  Similarity=0.380  Sum_probs=187.1

Q ss_pred             CceeccCCeeEEEEEEcCCCe-------eEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 019536           61 KVIQSDTSYRLFEGTLVDQDR-------PISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFE  133 (339)
Q Consensus        61 ~~ig~G~~g~V~~~~~~~~~~-------~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  133 (339)
                      +.||+|+||+||+|.....+.       .|++|.+..... ...+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e   79 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHR-NYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE   79 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhH-HHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence            468999999999999865443       488888754432 445678899999999999999999999999999999999


Q ss_pred             eccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCc--------eEEecCCCcc
Q 019536          134 SVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYS--------AKLHDFSLSV  202 (339)
Q Consensus       134 ~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~--------~kl~dfg~a~  202 (339)
                      |+++|+|.+++.   ..+++..++.++.|++.||.|||   +++|+||||||+||+++.++.        ++++|||.+.
T Consensus        80 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~  156 (258)
T cd05078          80 YVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI  156 (258)
T ss_pred             cCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence            999999999985   34788888999999999999999   999999999999999987654        6999999986


Q ss_pred             ccCCCCceeeecccccccccccccccccC-CCCcccchHHHHHHHHHHHhCC-CccccCCCCCCCchhHHHHHHHHhhcC
Q 019536          203 SIPEGETHVREEFIKGAYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTGC-NVLEFKGNGNDDDLTVLEYAKKSIENN  280 (339)
Q Consensus       203 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~  280 (339)
                      ......      ...++..|+|||++.+. .++.++|+||||+++|+|++|. .|+....        ....... ... 
T Consensus       157 ~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~--------~~~~~~~-~~~-  220 (258)
T cd05078         157 TVLPKE------ILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALD--------SQKKLQF-YED-  220 (258)
T ss_pred             ccCCch------hccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhcc--------HHHHHHH-HHc-
Confidence            553322      24578889999999864 5789999999999999999985 4432111        1111100 000 


Q ss_pred             cccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 019536          281 RFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLR  332 (339)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~  332 (339)
                                  ....|.  ....++.+|+.+||+.||++|||+.+|++.|+
T Consensus       221 ------------~~~~~~--~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         221 ------------RHQLPA--PKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             ------------cccCCC--CCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                        001111  22346899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.2e-40  Score=297.83  Aligned_cols=257  Identities=20%  Similarity=0.249  Sum_probs=202.7

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeee--CCccEEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLE--TELPTLVF  132 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~--~~~~~lv~  132 (339)
                      ++|...+.||.|++|.||+|.+..+++.+|+|.+...........+.+|+++++.++||||++++++|.+  .+..++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            4678889999999999999999889999999999866544556778899999999999999999999865  34689999


Q ss_pred             EeccCCccccccc------cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCC
Q 019536          133 ESVKYGTLRGFSF------ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPE  206 (339)
Q Consensus       133 e~~~~g~L~~~~~------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~  206 (339)
                      ||+++++|.+++.      ..++......++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            9999999988753      34677888899999999999999   89999999999999999999999999999865533


Q ss_pred             CCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccc
Q 019536          207 GETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIV  286 (339)
Q Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (339)
                      ....    ...++..|+|||.+.+..++.++|+||+|+++|+|++|+.||...............+..    ......+ 
T Consensus       158 ~~~~----~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~-  228 (287)
T cd06621         158 SLAG----TFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV----NMPNPEL-  228 (287)
T ss_pred             cccc----cccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHh----cCCchhh-
Confidence            2221    234678899999998889999999999999999999999998644321111122211111    1010000 


Q ss_pred             cCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          287 DPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                          ...  .+.....++.+.+++.+||+.+|++|||+.|+++
T Consensus       229 ----~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         229 ----KDE--PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             ----ccC--CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence                000  0111134667999999999999999999999987

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=3.4e-41  Score=300.31  Aligned_cols=256  Identities=23%  Similarity=0.279  Sum_probs=200.9

Q ss_pred             cHHHHHHHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhc-CCCceeeeeeeeee
Q 019536           46 SAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLE  124 (339)
Q Consensus        46 ~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~  124 (339)
                      +..++....+.|++.+.||+|+||.||+|.+..+++.+|+|.+....  .....+..|+.+++.+ +||||+++++++..
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   84 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE--DEEEEIKLEINMLKKYSHHRNIATYYGAFIK   84 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh--HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence            45566667789999999999999999999999899999999986543  3345677899999888 79999999999853


Q ss_pred             ------CCccEEEEEeccCCccccccc----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceE
Q 019536          125 ------TELPTLVFESVKYGTLRGFSF----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAK  194 (339)
Q Consensus       125 ------~~~~~lv~e~~~~g~L~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~k  194 (339)
                            .+..+++|||+++|+|.+++.    ..+++..+..++.|++.||.|||   +.+|+|+||+|+||+++.++.++
T Consensus        85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~~  161 (282)
T cd06636          85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVK  161 (282)
T ss_pred             ccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEE
Confidence                  456799999999999998875    34677778889999999999999   89999999999999999999999


Q ss_pred             EecCCCccccCCCCceeeecccccccccccccccc-----cCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhH
Q 019536          195 LHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFA-----TSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTV  269 (339)
Q Consensus       195 l~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~  269 (339)
                      |+|||++.........  .....|+..|+|||++.     +..++.++|+|||||++|+|++|+.||.....     ...
T Consensus       162 l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~-----~~~  234 (282)
T cd06636         162 LVDFGVSAQLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP-----MRA  234 (282)
T ss_pred             EeeCcchhhhhccccC--CCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCH-----Hhh
Confidence            9999998765432211  11356888999999986     34578899999999999999999999742211     000


Q ss_pred             HHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          270 LEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                      .   ..... ..     ..      . ......+..+.+++.+||+.||.+|||+.+|++
T Consensus       235 ~---~~~~~-~~-----~~------~-~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         235 L---FLIPR-NP-----PP------K-LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             h---hhHhh-CC-----CC------C-CcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            0   00000 00     00      0 001134567999999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=7e-41  Score=295.86  Aligned_cols=250  Identities=20%  Similarity=0.267  Sum_probs=196.7

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC----hhhHHHHHHHHHHHHhcCCCceeeeeeeeee--CCcc
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST----LDDVEYCFNNIVFSSQMKHKNILKLIGCCLE--TELP  128 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~--~~~~  128 (339)
                      .+|+..+.||+|+||.||+|....++..|++|++.....    ......+.+|+.+++.++||||+++++++.+  +...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            478999999999999999999988999999999865421    2344667899999999999999999999875  3567


Q ss_pred             EEEEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCC
Q 019536          129 TLVFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPE  206 (339)
Q Consensus       129 ~lv~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~  206 (339)
                      ++++||+++++|.+++.  ..++......++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||+++.+..
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~  158 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT  158 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence            89999999999998876  45788888899999999999999   89999999999999999999999999999876543


Q ss_pred             CCce-eeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCccccc
Q 019536          207 GETH-VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAI  285 (339)
Q Consensus       207 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (339)
                      .... .......++..|+|||++.+..++.++|+||+||++|++++|+.||...        ..............    
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~--------~~~~~~~~~~~~~~----  226 (266)
T cd06651         159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY--------EAMAAIFKIATQPT----  226 (266)
T ss_pred             ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCcccc--------chHHHHHHHhcCCC----
Confidence            2111 1111245788999999998888999999999999999999999997521        11111111110000    


Q ss_pred             ccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          286 VDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                       .      ...  +...+..+.+++ .||..+|++|||+.+|++
T Consensus       227 -~------~~~--~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         227 -N------PQL--PSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             -C------CCC--chhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence             0      011  123445677888 688899999999999986

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.7e-42  Score=308.35  Aligned_cols=250  Identities=21%  Similarity=0.250  Sum_probs=199.0

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEecc-CCChhhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCccEEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHD-NSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLETELPTLVF  132 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~~lv~  132 (339)
                      ..|++.+.||+||.+.||++... +.+.||+|++.. ....+....+.+|+.+|.+| .|.+||++++|-..++.+|+||
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm  439 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM  439 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence            57999999999999999999886 556677776554 34556778899999999999 5899999999999999999999


Q ss_pred             EeccCCcccccccc---CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCc
Q 019536          133 ESVKYGTLRGFSFA---SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGET  209 (339)
Q Consensus       133 e~~~~g~L~~~~~~---~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~  209 (339)
                      ||- ..+|..++..   ..+...+..+..|++.++.++|   ..||||.||||.|+|+- .|.+||+|||.|..+..+.+
T Consensus       440 E~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTT  514 (677)
T KOG0596|consen  440 ECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTT  514 (677)
T ss_pred             ecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEE-eeeEEeeeechhcccCcccc
Confidence            986 4588888762   2332367889999999999999   99999999999999987 47899999999999988887


Q ss_pred             eeeecccccccccccccccccCC-----------CCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhh
Q 019536          210 HVREEFIKGAYGFIAPEYFATSS-----------FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIE  278 (339)
Q Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  278 (339)
                      .......+||+.||+||.+....           .+.++||||+||++|+|+.|++||....       ....       
T Consensus       515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-------n~~a-------  580 (677)
T KOG0596|consen  515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-------NQIA-------  580 (677)
T ss_pred             ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-------HHHH-------
Confidence            77777789999999999886432           4578999999999999999999986211       1111       


Q ss_pred             cCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          279 NNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                        .+..+.++..  .+.+|..+. ..++.++|+.||++||.+|||..++|+
T Consensus       581 --Kl~aI~~P~~--~Iefp~~~~-~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  581 --KLHAITDPNH--EIEFPDIPE-NDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             --HHHhhcCCCc--cccccCCCC-chHHHHHHHHHHhcCcccCCCcHHHhc
Confidence              1222333311  112222111 113899999999999999999999986

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-41  Score=301.42  Aligned_cols=265  Identities=16%  Similarity=0.213  Sum_probs=196.8

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFES  134 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  134 (339)
                      ++|++.+.||+|++|.||+|....+++.||+|.+...........+.+|+.+++.++||||+++++++.+++..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            67999999999999999999998889999999987654323334567899999999999999999999999999999999


Q ss_pred             ccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCcee
Q 019536          135 VKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHV  211 (339)
Q Consensus       135 ~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~  211 (339)
                      +++ +|.+++.   ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++.........
T Consensus        85 ~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~  160 (291)
T cd07844          85 LDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTY  160 (291)
T ss_pred             CCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCCCccc
Confidence            974 8887764   35788888999999999999999   8999999999999999999999999999987543322111


Q ss_pred             eeccccccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhh---cCccccccc
Q 019536          212 REEFIKGAYGFIAPEYFAT-SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIE---NNRFGAIVD  287 (339)
Q Consensus       212 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  287 (339)
                      .  ...++..|+|||++.+ ..++.++||||+|+++|+|++|+.||.....    .............   ...+..+..
T Consensus       161 ~--~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~  234 (291)
T cd07844         161 S--NEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTD----VEDQLHKIFRVLGTPTEETWPGVSS  234 (291)
T ss_pred             c--ccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCcc----HHHHHHHHHHhcCCCChhhhhhhhh
Confidence            1  2246778999999876 4588999999999999999999999853221    1111111111100   000000000


Q ss_pred             C--cccCCCCC--CCc-----HHH--HHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          288 P--IFDEDNSF--PGK-----EEK--LQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       288 ~--~~~~~~~~--~~~-----~~~--~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                      .  ........  +.+     ...  ...+.+++.+||+.+|++|||+.+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence            0  00000000  000     011  256789999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=2.4e-40  Score=292.83  Aligned_cols=250  Identities=18%  Similarity=0.247  Sum_probs=185.9

Q ss_pred             ceeccCCeeEEEEEEcCC--CeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeccCCc
Q 019536           62 VIQSDTSYRLFEGTLVDQ--DRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGT  139 (339)
Q Consensus        62 ~ig~G~~g~V~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~  139 (339)
                      .||+|+||+||+|.....  ...+++|.+.........+.+.+|+.+++.++||||++++++|.+....++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            589999999999986433  235667777655444556788999999999999999999999999999999999999999


Q ss_pred             ccccccc------CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceeee
Q 019536          140 LRGFSFA------SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVRE  213 (339)
Q Consensus       140 L~~~~~~------~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~  213 (339)
                      |.+++..      ..+......++.|++.||.|||   +.+++||||||+|||++.++.++|+|||++............
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            9988752      3455666789999999999999   899999999999999999999999999997643222111111


Q ss_pred             ccccccccccccccccc-------CCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCccccc
Q 019536          214 EFIKGAYGFIAPEYFAT-------SSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAI  285 (339)
Q Consensus       214 ~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (339)
                      ....++..|+|||++..       ..++.++||||||+++|||++ |..||...  .      ..+.......... ..+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~--~------~~~~~~~~~~~~~-~~~  229 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHL--S------DREVLNHVIKDQQ-VKL  229 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC--C------HHHHHHHHHhhcc-ccc
Confidence            23457888999998743       245789999999999999997 45665321  1      1111111111111 111


Q ss_pred             ccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 019536          286 VDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLR  332 (339)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~  332 (339)
                      .++.+.        ...+..+.+++..|| .+|++|||+.+|++.|.
T Consensus       230 ~~~~~~--------~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         230 FKPQLE--------LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CCCccC--------CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            111111        124456888999999 67999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.3e-40  Score=343.07  Aligned_cols=265  Identities=23%  Similarity=0.325  Sum_probs=211.3

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFE  133 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  133 (339)
                      ...|...+.||+|+||.||+|....++..||+|++.....     ....|++.+++++|||||+++|+|.+++..++|||
T Consensus       689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E  763 (968)
T PLN00113        689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE  763 (968)
T ss_pred             HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence            4567788999999999999999988999999999865432     11246888999999999999999999999999999


Q ss_pred             eccCCccccccccCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceeee
Q 019536          134 SVKYGTLRGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVRE  213 (339)
Q Consensus       134 ~~~~g~L~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~  213 (339)
                      |+++|+|.+++. .+++..+..++.|++.||+|||+..+.+|+|||+||+||+++.++..++. ||.+.......     
T Consensus       764 y~~~g~L~~~l~-~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~~-----  836 (968)
T PLN00113        764 YIEGKNLSEVLR-NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDT-----  836 (968)
T ss_pred             CCCCCcHHHHHh-cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccCC-----
Confidence            999999999985 58899999999999999999996556799999999999999998888775 66543332211     


Q ss_pred             cccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCC
Q 019536          214 EFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDED  293 (339)
Q Consensus       214 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (339)
                       ...+|..|+|||++.+..++.++|||||||++|||++|+.||.....   ......++............+.++.+...
T Consensus       837 -~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  912 (968)
T PLN00113        837 -KCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG---VHGSIVEWARYCYSDCHLDMWIDPSIRGD  912 (968)
T ss_pred             -CccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC---CCCcHHHHHHHhcCccchhheeCccccCC
Confidence             23578899999999999999999999999999999999999842211   12234445444444444444555554433


Q ss_pred             CCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 019536          294 NSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYL  336 (339)
Q Consensus       294 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~  336 (339)
                      ..  .......++.+++.+||+.||++||||.+|++.|+++..
T Consensus       913 ~~--~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        913 VS--VNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             CC--ccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence            22  223455678899999999999999999999999999875

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=2.6e-41  Score=296.48  Aligned_cols=243  Identities=22%  Similarity=0.367  Sum_probs=195.3

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFES  134 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  134 (339)
                      ++|++.+.||+|+||.||+|..  +++.||+|.+....   ..+.+.+|+.+++.++|||++++++++..+. .++||||
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~---~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~v~e~   79 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV---TAQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYIVMEL   79 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc---hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC-cEEEEEC
Confidence            5689999999999999999976  78889999986542   3456889999999999999999999987654 6999999


Q ss_pred             ccCCccccccc----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCce
Q 019536          135 VKYGTLRGFSF----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH  210 (339)
Q Consensus       135 ~~~g~L~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~  210 (339)
                      +++++|.+++.    ..+++..+..++.|++.||.|||   +.+++||||||+||+++.++.++|+|||++........ 
T Consensus        80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~-  155 (254)
T cd05083          80 MSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVD-  155 (254)
T ss_pred             CCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceeccccCC-
Confidence            99999998875    24688888999999999999999   89999999999999999999999999999876432211 


Q ss_pred             eeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCc
Q 019536          211 VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPI  289 (339)
Q Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (339)
                          ....+..|+|||.+.+..++.++|+||||+++|+|++ |+.||....        ..+.. .......        
T Consensus       156 ----~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~--------~~~~~-~~~~~~~--------  214 (254)
T cd05083         156 ----NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS--------LKEVK-ECVEKGY--------  214 (254)
T ss_pred             ----CCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC--------HHHHH-HHHhCCC--------
Confidence                1234567999999988889999999999999999997 888875221        11111 1111110        


Q ss_pred             ccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 019536          290 FDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQ  333 (339)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~  333 (339)
                           ..+.+...+..+.+++.+||+.+|++|||+.++++.|++
T Consensus       215 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         215 -----RMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             -----CCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence                 001112345678999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=9.5e-41  Score=293.09  Aligned_cols=248  Identities=19%  Similarity=0.240  Sum_probs=202.2

Q ss_pred             CcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 019536           56 NYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS-TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFES  134 (339)
Q Consensus        56 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  134 (339)
                      +|++.+.||+|+||.+|.+....+++.||+|.+.... .......+.+|+.+++.++||||+++++++.+.+..++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            5888999999999999999999899999999987542 224456788999999999999999999999999999999999


Q ss_pred             ccCCccccccc----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCce
Q 019536          135 VKYGTLRGFSF----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH  210 (339)
Q Consensus       135 ~~~g~L~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~  210 (339)
                      +++++|.+++.    ..+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++++|||++.........
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~  157 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL  157 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh
Confidence            99999988875    24688888999999999999999   899999999999999999999999999998776443221


Q ss_pred             eeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcc
Q 019536          211 VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIF  290 (339)
Q Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (339)
                      .  ....|+..|+|||++.+..++.++|+|||||+++++++|+.||....        ........... ..        
T Consensus       158 ~--~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~--------~~~~~~~~~~~-~~--------  218 (256)
T cd08218         158 A--RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN--------MKNLVLKIIRG-SY--------  218 (256)
T ss_pred             h--hhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC--------HHHHHHHHhcC-CC--------
Confidence            1  12357888999999988889999999999999999999999975211        11111111111 00        


Q ss_pred             cCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          291 DEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                           .+.+...+.++.+++.+||+.+|++||++.+|+++
T Consensus       219 -----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         219 -----PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             -----CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence                 01112345679999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=3.5e-41  Score=295.86  Aligned_cols=249  Identities=22%  Similarity=0.354  Sum_probs=198.8

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFES  134 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  134 (339)
                      .+|++.+.||+|+||.||+|.+. .+..+|+|.+.....  ....+.+|+.++++++|||++++++++......++||||
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM--SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF   80 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC--CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence            46888899999999999999886 477899998875432  245688999999999999999999999999999999999


Q ss_pred             ccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCcee
Q 019536          135 VKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHV  211 (339)
Q Consensus       135 ~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~  211 (339)
                      +++++|.+++.   ..+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||.++........ 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-  156 (256)
T cd05112          81 MEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT-  156 (256)
T ss_pred             CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCccc-
Confidence            99999998875   35788888999999999999999   899999999999999999999999999998765433221 


Q ss_pred             eecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcc
Q 019536          212 REEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIF  290 (339)
Q Consensus       212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (339)
                      ......++..|+|||++.+..++.++|+||+|+++|+|++ |+.||.....        ............         
T Consensus       157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~~~~~~---------  219 (256)
T cd05112         157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN--------SEVVETINAGFR---------  219 (256)
T ss_pred             ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH--------HHHHHHHhCCCC---------
Confidence            1112234568999999988889999999999999999998 8888752211        111111111000         


Q ss_pred             cCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 019536          291 DEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLR  332 (339)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~  332 (339)
                           ...+...+..+.+|+.+||+.+|++|||+.++++.|.
T Consensus       220 -----~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         220 -----LYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             -----CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence                 0001123457999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=5.4e-41  Score=296.28  Aligned_cols=250  Identities=22%  Similarity=0.307  Sum_probs=198.0

Q ss_pred             CcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC-----hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 019536           56 NYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST-----LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTL  130 (339)
Q Consensus        56 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  130 (339)
                      +|++.+.||+|+||+||+|... +++.+|+|.+.....     ......+.+|+.+++.++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI   79 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence            4788999999999999999875 788999998865421     1234567899999999999999999999999999999


Q ss_pred             EEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCC
Q 019536          131 VFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE  208 (339)
Q Consensus       131 v~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~  208 (339)
                      |+||+++++|.+++.  ..+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus        80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  156 (265)
T cd06631          80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG  156 (265)
T ss_pred             EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence            999999999999876  46788888899999999999999   8999999999999999999999999999987653211


Q ss_pred             c----eeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccc
Q 019536          209 T----HVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA  284 (339)
Q Consensus       209 ~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (339)
                      .    ........++..|+|||++.+..++.++|+||+|+++|++++|+.||.....     ........  ......  
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~~--~~~~~~--  227 (265)
T cd06631         157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR-----LAAMFYIG--AHRGLM--  227 (265)
T ss_pred             ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCCh-----HHHHHHhh--hccCCC--
Confidence            1    1111134578899999999988899999999999999999999999852111     11100000  000000  


Q ss_pred             cccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                         +        +.+...+.++.+++.+||+.+|++|||+.+++.
T Consensus       228 ---~--------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         228 ---P--------RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             ---C--------CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence               0        011234567899999999999999999999975

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=3.9e-41  Score=303.48  Aligned_cols=255  Identities=18%  Similarity=0.217  Sum_probs=200.9

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC--hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST--LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVF  132 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  132 (339)
                      ++|++.+.||+|+||.||++....+++.|++|.+.....  ......+.+|+.+++.++||||+++++.+..++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            478899999999999999999999999999999876532  234566779999999999999999999999999999999


Q ss_pred             EeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCc-
Q 019536          133 ESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGET-  209 (339)
Q Consensus       133 e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~-  209 (339)
                      ||+++++|.+++.  ..+++.....++.|++.||.|||   +.+++||||||+||+++.++.++++|||+++....... 
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~  157 (305)
T cd05609          81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT  157 (305)
T ss_pred             ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence            9999999999986  56788888899999999999999   89999999999999999999999999998864211100 


Q ss_pred             ------------eeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHh
Q 019536          210 ------------HVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSI  277 (339)
Q Consensus       210 ------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  277 (339)
                                  ........++..|+|||.+.+..++.++|+|||||++|++++|..||..  ..      ..+......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~--~~------~~~~~~~~~  229 (305)
T cd05609         158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG--DT------PEELFGQVI  229 (305)
T ss_pred             cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCC--CC------HHHHHHHHH
Confidence                        0011123567889999999888899999999999999999999999742  11      111111111


Q ss_pred             hcCcccccccCcccCCCCCCC-cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 019536          278 ENNRFGAIVDPIFDEDNSFPG-KEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQ  333 (339)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~  333 (339)
                      .. .            ...|. ....+..+.+++.+||+.||++|||+.++.+.|+.
T Consensus       230 ~~-~------------~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         230 SD-D------------IEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             hc-c------------cCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            10 0            00010 01344568999999999999999997666666654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.5e-41  Score=304.46  Aligned_cols=249  Identities=18%  Similarity=0.290  Sum_probs=199.9

Q ss_pred             CcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEec
Q 019536           56 NYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESV  135 (339)
Q Consensus        56 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  135 (339)
                      .|.....||+|+||.||++....++..||||.+..... ...+.+.+|+.+++.++||||+++++.+..++..++||||+
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~  101 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQ-QRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL  101 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchH-HHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence            34445779999999999999988899999999865433 44566889999999999999999999999999999999999


Q ss_pred             cCCccccccc-cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceeeec
Q 019536          136 KYGTLRGFSF-ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREE  214 (339)
Q Consensus       136 ~~g~L~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~~  214 (339)
                      ++++|.+++. ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.++|+|||++..........  .
T Consensus       102 ~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~--~  176 (292)
T cd06658         102 EGGALTDIVTHTRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR--K  176 (292)
T ss_pred             CCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccC--c
Confidence            9999998875 56788899999999999999999   8999999999999999999999999999987654322211  1


Q ss_pred             ccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCCC
Q 019536          215 FIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDN  294 (339)
Q Consensus       215 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (339)
                      ...++..|+|||++.+..++.++|+||||+++|+|++|+.||....     ..........    .     ....     
T Consensus       177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~-----~~~~~~~~~~----~-----~~~~-----  237 (292)
T cd06658         177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEP-----PLQAMRRIRD----N-----LPPR-----  237 (292)
T ss_pred             eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHh----c-----CCCc-----
Confidence            3457889999999988889999999999999999999999975211     1111111100    0     0000     


Q ss_pred             CCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          295 SFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       295 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                       .+.....+..+.+++.+||..||++|||+.+++++
T Consensus       238 -~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         238 -VKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             -cccccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence             01111344578899999999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=9.1e-41  Score=294.90  Aligned_cols=251  Identities=19%  Similarity=0.235  Sum_probs=198.1

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC----ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeC--Ccc
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS----TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLET--ELP  128 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~--~~~  128 (339)
                      .+|++.+.||+|+||.||.|.+..++..||+|.+....    .......+.+|+.+++.++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            47889999999999999999999899999999886432    123456788999999999999999999998764  467


Q ss_pred             EEEEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCC
Q 019536          129 TLVFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPE  206 (339)
Q Consensus       129 ~lv~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~  206 (339)
                      ++||||+++++|.+++.  ..++......++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||+++....
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~  158 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQT  158 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence            89999999999999875  45778888899999999999999   89999999999999999999999999999876543


Q ss_pred             CCce-eeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCccccc
Q 019536          207 GETH-VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAI  285 (339)
Q Consensus       207 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (339)
                      .... .......++..|+|||++.+..++.++|+||||+++|+|++|+.||....        .............    
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~--------~~~~~~~~~~~~~----  226 (265)
T cd06652         159 ICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFE--------AMAAIFKIATQPT----  226 (265)
T ss_pred             ccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccc--------hHHHHHHHhcCCC----
Confidence            2111 01113457889999999988889999999999999999999999975211        1111111110000    


Q ss_pred             ccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          286 VDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                               ....+...+..+.+++.+||. +|++|||+.+++++
T Consensus       227 ---------~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~  261 (265)
T cd06652         227 ---------NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH  261 (265)
T ss_pred             ---------CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence                     001123455678899999995 99999999999863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.1e-40  Score=297.02  Aligned_cols=248  Identities=19%  Similarity=0.278  Sum_probs=193.5

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHH-HHhcCCCceeeeeeeeeeCCccEEEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVF-SSQMKHKNILKLIGCCLETELPTLVFE  133 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~-l~~l~H~niv~~~~~~~~~~~~~lv~e  133 (339)
                      ++|++.+.||+|+||.||+|.+..+|..||+|++...........+..|+.+ ++.++||||+++++++..++..++|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            4789999999999999999999989999999998765433444556667664 666799999999999999999999999


Q ss_pred             eccCCccccccc------cCCChHHHHHHHHHHHHHHHHHhcCCCC-CeEEccCCCCCEEeCCCCceEEecCCCccccCC
Q 019536          134 SVKYGTLRGFSF------ASLLIAPRIKIAMEIANAVAYLHVGFDR-PIVFRCIKASNVLLDENYSAKLHDFSLSVSIPE  206 (339)
Q Consensus       134 ~~~~g~L~~~~~------~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~  206 (339)
                      |++ |+|.+++.      ..+++..+..++.|++.||.|||   +. +++||||||+||+++.++.+||+|||++.....
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            996 56666543      35788889999999999999999   76 999999999999999999999999999876543


Q ss_pred             CCceeeeccccccccccccccccc----CCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcc
Q 019536          207 GETHVREEFIKGAYGFIAPEYFAT----SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRF  282 (339)
Q Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (339)
                      ....   ....++..|+|||++.+    ..++.++|+||+||++|+|++|+.||.....    ...   .......... 
T Consensus       157 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~~---~~~~~~~~~~-  225 (283)
T cd06617         157 SVAK---TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT----PFQ---QLKQVVEEPS-  225 (283)
T ss_pred             cccc---ccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc----CHH---HHHHHHhcCC-
Confidence            2211   12457888999998865    4578899999999999999999999742111    111   1111111000 


Q ss_pred             cccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          283 GAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                                 ...|. ...+.++.+++.+||+.+|++|||+.++++
T Consensus       226 -----------~~~~~-~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         226 -----------PQLPA-EKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             -----------CCCCc-cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                       00111 134567999999999999999999999987

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=7.8e-41  Score=293.93  Aligned_cols=236  Identities=23%  Similarity=0.371  Sum_probs=187.7

Q ss_pred             CceeccCCeeEEEEEEcCCC----------eeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 019536           61 KVIQSDTSYRLFEGTLVDQD----------RPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTL  130 (339)
Q Consensus        61 ~~ig~G~~g~V~~~~~~~~~----------~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  130 (339)
                      +.||+|+||.||+|.+..++          ..+++|.+..... . ...+.+|+.+++.++||||+++++++.. ...++
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~-~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l   77 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR-D-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIM   77 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh-h-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEE
Confidence            46899999999999998666          3578887765433 2 6778899999999999999999999988 77899


Q ss_pred             EEEeccCCccccccc--c-CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCC-------ceEEecCCC
Q 019536          131 VFESVKYGTLRGFSF--A-SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENY-------SAKLHDFSL  200 (339)
Q Consensus       131 v~e~~~~g~L~~~~~--~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~-------~~kl~dfg~  200 (339)
                      ||||+++|+|.+++.  . .+++..+..++.|++.||.|||   +.+|+||||||+||+++.++       .+||+|||+
T Consensus        78 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~  154 (259)
T cd05037          78 VEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI  154 (259)
T ss_pred             EEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence            999999999999986  2 5788889999999999999999   89999999999999999887       799999999


Q ss_pred             ccccCCCCceeeecccccccccccccccccC--CCCcccchHHHHHHHHHHHhC-CCccccCCCCCCCchhHHHHHHHHh
Q 019536          201 SVSIPEGETHVREEFIKGAYGFIAPEYFATS--SFNEMCDVYSFGAFLCELLTG-CNVLEFKGNGNDDDLTVLEYAKKSI  277 (339)
Q Consensus       201 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~~l~el~~g-~~p~~~~~~~~~~~~~~~~~~~~~~  277 (339)
                      +.......      ...++..|+|||++.+.  .++.++|+||||+++|+|++| ..||......        .......
T Consensus       155 a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~--------~~~~~~~  220 (259)
T cd05037         155 PITVLSRE------ERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS--------EKERFYQ  220 (259)
T ss_pred             cccccccc------ccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch--------hHHHHHh
Confidence            87654421      23466789999999876  788999999999999999994 6665322110        0000000


Q ss_pred             hcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 019536          278 ENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLR  332 (339)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~  332 (339)
                      ...              ..+.+  ....+.+++.+||+.+|.+|||+.++++.|+
T Consensus       221 ~~~--------------~~~~~--~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         221 DQH--------------RLPMP--DCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             cCC--------------CCCCC--CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            000              01111  1157899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-41  Score=316.22  Aligned_cols=274  Identities=19%  Similarity=0.263  Sum_probs=211.3

Q ss_pred             CcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC------ccE
Q 019536           56 NYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETE------LPT  129 (339)
Q Consensus        56 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~------~~~  129 (339)
                      .+...+.+|+|+||.||+|+.+.+|+.||||.++........+...+|+++|++++|||||+++++-.+..      ...
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence            34556889999999999999999999999999998776678888999999999999999999999876654      468


Q ss_pred             EEEEeccCCccccccc-----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeC--CCC--ceEEecCCC
Q 019536          130 LVFESVKYGTLRGFSF-----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLD--ENY--SAKLHDFSL  200 (339)
Q Consensus       130 lv~e~~~~g~L~~~~~-----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~--~~~--~~kl~dfg~  200 (339)
                      +|||||.+|+|+..+.     ..+++.+.+.++.+++.||.|||   .++|+||||||.||++-  .+|  ..||+|||.
T Consensus        94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            9999999999999987     36999999999999999999999   99999999999999983  333  479999999


Q ss_pred             ccccCCCCceeeeccccccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhc
Q 019536          201 SVSIPEGETHVREEFIKGAYGFIAPEYFAT-SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIEN  279 (339)
Q Consensus       201 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  279 (339)
                      |+.++++...   ....||..|++||++.. ..|+..+|.|||||++|+.+||..||.-.+.... -.. ..+.....+.
T Consensus       171 Arel~d~s~~---~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~-~~~-~~~~~~tkkp  245 (732)
T KOG4250|consen  171 ARELDDNSLF---TSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKN-NKE-IMWHIITKKP  245 (732)
T ss_pred             cccCCCCCee---eeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccc-cch-hhhhhhccCC
Confidence            9999877632   25789999999999984 7899999999999999999999999864333210 000 1111111111


Q ss_pred             CcccccccC----cccCCCCCCCc----HHHHHHHHHHHHHhhccCCCCCC--CHHHHHHHHHHHHhh
Q 019536          280 NRFGAIVDP----IFDEDNSFPGK----EEKLQSLGQLMYKCLSKSPEHRP--LMVDVAKQLRQMYLS  337 (339)
Q Consensus       280 ~~~~~~~~~----~~~~~~~~~~~----~~~~~~~~~li~~cl~~dP~~Rp--s~~~il~~L~~l~~~  337 (339)
                      ....-...+    .+.....+|.+    ......+..++..+|+++|++|-  .+.+....+..|...
T Consensus       246 ~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~  313 (732)
T KOG4250|consen  246 SGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL  313 (732)
T ss_pred             CceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence            000000111    11122223332    24455677889999999999998  777777777776543

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1e-41  Score=268.46  Aligned_cols=267  Identities=19%  Similarity=0.264  Sum_probs=212.3

Q ss_pred             CcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhh-HHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 019536           56 NYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDD-VEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFES  134 (339)
Q Consensus        56 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  134 (339)
                      +|...++||+|+||+||+|+..++++.||+|.+......+. .....+|+.+++.+.|.|||+++++.-.+..+-+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            56667899999999999999999999999999987654343 35678999999999999999999999999999999999


Q ss_pred             ccCCcccccc---ccCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCcee
Q 019536          135 VKYGTLRGFS---FASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHV  211 (339)
Q Consensus       135 ~~~g~L~~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~  211 (339)
                      |.. +|..+.   .+.++...+..++.|+++||.++|   +.+++|||+||.|.|++.+|.+|++|||+|+.+.-.....
T Consensus        83 cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgipvrcy  158 (292)
T KOG0662|consen   83 CDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCY  158 (292)
T ss_pred             hhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEee
Confidence            954 666554   477888999999999999999999   9999999999999999999999999999999887655333


Q ss_pred             eecccccccccccccccccC-CCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCccccccc-C
Q 019536          212 REEFIKGAYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVD-P  288 (339)
Q Consensus       212 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  288 (339)
                      .  ..+-|..|++|.++-|. -|+++.|+||.||++.|+.. |++.  |+|.+-.+++..+.+.........+..+.. +
T Consensus       159 s--aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrpl--fpg~dvddqlkrif~~lg~p~ed~wps~t~lp  234 (292)
T KOG0662|consen  159 S--AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL--FPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLP  234 (292)
T ss_pred             e--ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCC--CCCCcHHHHHHHHHHHhCCCccccCCccccCC
Confidence            2  34568899999998776 59999999999999999997 5555  567776677777766666555544433321 1


Q ss_pred             cccCCCCCCCc---H----HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          289 IFDEDNSFPGK---E----EKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       289 ~~~~~~~~~~~---~----~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      ....-..+|..   .    .....-++|+.++|.-+|..|++++++++.
T Consensus       235 dyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh  283 (292)
T KOG0662|consen  235 DYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH  283 (292)
T ss_pred             CCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence            11111111111   1    222345799999999999999999998763

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2.4e-40  Score=290.41  Aligned_cols=249  Identities=26%  Similarity=0.408  Sum_probs=201.4

Q ss_pred             cccCCceeccCCeeEEEEEEcCCC----eeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 019536           57 YDLHKVIQSDTSYRLFEGTLVDQD----RPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVF  132 (339)
Q Consensus        57 ~~~~~~ig~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  132 (339)
                      +++.+.||.|+||.||+|.+...+    ..||+|.+...........+.+|+.++..++|+||+++++++.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            456789999999999999998766    8999999977655446778889999999999999999999999999999999


Q ss_pred             EeccCCccccccc--cC--CChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCC
Q 019536          133 ESVKYGTLRGFSF--AS--LLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE  208 (339)
Q Consensus       133 e~~~~g~L~~~~~--~~--~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~  208 (339)
                      ||+++++|.+++.  ..  +++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||+++......
T Consensus        81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  157 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD  157 (258)
T ss_pred             eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence            9999999999886  22  889999999999999999999   8999999999999999999999999999987765543


Q ss_pred             ceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCccccccc
Q 019536          209 THVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVD  287 (339)
Q Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (339)
                      ..... ...++..|+|||.+.+..++.++|+||+|+++++|++ |.+||...     .......   ... ....     
T Consensus       158 ~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~-----~~~~~~~---~~~-~~~~-----  222 (258)
T smart00219      158 YYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM-----SNEEVLE---YLK-KGYR-----  222 (258)
T ss_pred             ccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-----CHHHHHH---HHh-cCCC-----
Confidence            22211 1236788999999988889999999999999999998 77776421     1111111   111 1100     


Q ss_pred             CcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 019536          288 PIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQL  331 (339)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L  331 (339)
                              .+.+...+.++.+++.+||..||++|||+.++++.|
T Consensus       223 --------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      223 --------LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             --------CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                    011123456799999999999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.1e-40  Score=296.45  Aligned_cols=248  Identities=22%  Similarity=0.290  Sum_probs=202.7

Q ss_pred             CcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEec
Q 019536           56 NYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESV  135 (339)
Q Consensus        56 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  135 (339)
                      -|+..+.||.|+||.||+|....++..||+|.+...........+.+|+.+++.++||||+++++++.+++..++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            47778899999999999999988899999999876544455677889999999999999999999999999999999999


Q ss_pred             cCCccccccc-cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceeeec
Q 019536          136 KYGTLRGFSF-ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREE  214 (339)
Q Consensus       136 ~~g~L~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~~  214 (339)
                      ++++|.+++. ..+++.....++.|++.|+.|||   +.+++|+||+|.||+++.++.++++|||++..+......  ..
T Consensus        85 ~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~--~~  159 (277)
T cd06641          85 GGGSALDLLEPGPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK--RN  159 (277)
T ss_pred             CCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccchhh--hc
Confidence            9999998876 56788889999999999999999   899999999999999999999999999998766443221  11


Q ss_pred             ccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCCC
Q 019536          215 FIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDN  294 (339)
Q Consensus       215 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (339)
                      ...++..|+|||.+.+..++.++|+||+||++|+|++|..||.....        ...... ......     +      
T Consensus       160 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~--------~~~~~~-~~~~~~-----~------  219 (277)
T cd06641         160 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP--------MKVLFL-IPKNNP-----P------  219 (277)
T ss_pred             cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch--------HHHHHH-HhcCCC-----C------
Confidence            34578889999999888889999999999999999999999742111        111111 111100     0      


Q ss_pred             CCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          295 SFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       295 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      ..  +...+..+.+++.+||+.+|.+||++.+++.+
T Consensus       220 ~~--~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         220 TL--EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             CC--CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            00  11344578999999999999999999999984

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-41  Score=297.03  Aligned_cols=251  Identities=23%  Similarity=0.280  Sum_probs=199.9

Q ss_pred             HHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCC----
Q 019536           52 KATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLETE----  126 (339)
Q Consensus        52 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~----  126 (339)
                      ..+++|++.+.||+|++|.||+|....+++.+++|.+.....  ..+.+.+|+.+++.+ .|+||+++++++....    
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED--EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN   80 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence            456899999999999999999999988899999999876542  346688999999999 7999999999997654    


Q ss_pred             --ccEEEEEeccCCccccccc------cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecC
Q 019536          127 --LPTLVFESVKYGTLRGFSF------ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDF  198 (339)
Q Consensus       127 --~~~lv~e~~~~g~L~~~~~------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~df  198 (339)
                        ..++||||+++++|.+++.      ..+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+||
T Consensus        81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~  157 (275)
T cd06608          81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDF  157 (275)
T ss_pred             ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCC
Confidence              4799999999999988864      36788888999999999999999   999999999999999999999999999


Q ss_pred             CCccccCCCCceeeeccccccccccccccccc-----CCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHH
Q 019536          199 SLSVSIPEGETHVREEFIKGAYGFIAPEYFAT-----SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYA  273 (339)
Q Consensus       199 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~  273 (339)
                      |++.........  .....++..|+|||++..     ..++.++||||+|+++|++++|+.||.....     .   ...
T Consensus       158 ~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~---~~~  227 (275)
T cd06608         158 GVSAQLDSTLGR--RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP-----M---RAL  227 (275)
T ss_pred             ccceecccchhh--hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch-----H---HHH
Confidence            998765433221  113458889999998753     3467889999999999999999999852111     1   111


Q ss_pred             HHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          274 KKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                      ..... ...           .....+..++..+.+|+.+||+.||++|||+.++++
T Consensus       228 ~~~~~-~~~-----------~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         228 FKIPR-NPP-----------PTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             HHhhc-cCC-----------CCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            11111 000           011122245668999999999999999999999986

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-41  Score=303.49  Aligned_cols=251  Identities=22%  Similarity=0.282  Sum_probs=201.9

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCCh--hhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTL--DDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVF  132 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  132 (339)
                      ++|++.+.||+|++|+||+|....+++.||+|.+......  .....+.+|+.+++.++||||+++++.+.++...++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            4688899999999999999999988999999999875432  25567889999999999999999999999999999999


Q ss_pred             EeccCCccccccc----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCC
Q 019536          133 ESVKYGTLRGFSF----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE  208 (339)
Q Consensus       133 e~~~~g~L~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~  208 (339)
                      ||+.+++|.+++.    ..+++.....++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||++.......
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  157 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP  157 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence            9999999999875    35788888899999999999999   8999999999999999999999999999986543221


Q ss_pred             cee---------------------------eecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCC
Q 019536          209 THV---------------------------REEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGN  261 (339)
Q Consensus       209 ~~~---------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~  261 (339)
                      ...                           ......|+..|+|||++.+..++.++||||||+++|+|++|+.||.....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~  237 (316)
T cd05574         158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR  237 (316)
T ss_pred             cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence            100                           01123578889999999988899999999999999999999999753221


Q ss_pred             CCCCchhHHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCC----HHHHHH
Q 019536          262 GNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPL----MVDVAK  329 (339)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps----~~~il~  329 (339)
                      .        .......             .....++.....+..+.+++.+||+.||++|||    +.+++.
T Consensus       238 ~--------~~~~~~~-------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         238 D--------ETFSNIL-------------KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             H--------HHHHHHh-------------cCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            1        0001100             011111222235668999999999999999999    777665

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.8e-41  Score=302.47  Aligned_cols=266  Identities=18%  Similarity=0.244  Sum_probs=201.4

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCCh-hhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTL-DDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFE  133 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  133 (339)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++...... ...+.+.+|+.+++.++||||+++++++.+++..++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            4688999999999999999999888999999998765332 234567899999999999999999999999999999999


Q ss_pred             eccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCcee
Q 019536          134 SVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHV  211 (339)
Q Consensus       134 ~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~  211 (339)
                      |+++++|..+..  ..+++..+..++.|++.||.|||   +.+++|+||+|+||++++++.++|+|||++..+.......
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~  157 (286)
T cd07846          81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY  157 (286)
T ss_pred             cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcccc
Confidence            999998887764  35788999999999999999999   8999999999999999999999999999987764433221


Q ss_pred             eecccccccccccccccccC-CCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcC--cccc----
Q 019536          212 REEFIKGAYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENN--RFGA----  284 (339)
Q Consensus       212 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~----  284 (339)
                        ....++..|+|||++.+. .++.++||||||+++|+|++|++||....  .   .............-  ....    
T Consensus       158 --~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~--~---~~~~~~~~~~~~~~~~~~~~~~~~  230 (286)
T cd07846         158 --TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDS--D---IDQLYHIIKCLGNLIPRHQEIFQK  230 (286)
T ss_pred             --CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCc--h---HHHHHHHHHHhCCCchhhHHHhcc
Confidence              124578889999998754 57889999999999999999998875221  1   11111111000000  0000    


Q ss_pred             --cccCcccCCCCCC-----CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          285 --IVDPIFDEDNSFP-----GKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       285 --~~~~~~~~~~~~~-----~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                        +.+.........+     .....+..+.+++.+||+.+|++||++.++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         231 NPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             chHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence              0000000000000     011345679999999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.6e-40  Score=300.82  Aligned_cols=192  Identities=17%  Similarity=0.258  Sum_probs=156.7

Q ss_pred             CCceeccCCeeEEEEEEcC--CCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeee--CCccEEEEEec
Q 019536           60 HKVIQSDTSYRLFEGTLVD--QDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLE--TELPTLVFESV  135 (339)
Q Consensus        60 ~~~ig~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~--~~~~~lv~e~~  135 (339)
                      ..+||+|+||+||+|...+  ++..||+|.+.....   ...+.+|+.+++.++||||+++++++..  +...++||||+
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~   82 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI---SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA   82 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC---cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence            3689999999999999753  567899999876432   3456789999999999999999999854  45678999999


Q ss_pred             cCCccccccc-----------cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEe----CCCCceEEecCCC
Q 019536          136 KYGTLRGFSF-----------ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLL----DENYSAKLHDFSL  200 (339)
Q Consensus       136 ~~g~L~~~~~-----------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~----~~~~~~kl~dfg~  200 (339)
                      ++ +|.+++.           ..+++..+..++.|++.||.|||   +.+|+||||||+||++    +.++.+||+|||+
T Consensus        83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07867          83 EH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             CC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence            75 5555432           24677888899999999999999   8999999999999999    5667899999999


Q ss_pred             ccccCCCCce-eeecccccccccccccccccC-CCCcccchHHHHHHHHHHHhCCCcccc
Q 019536          201 SVSIPEGETH-VREEFIKGAYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTGCNVLEF  258 (339)
Q Consensus       201 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~  258 (339)
                      ++........ .......+|..|+|||++.+. .++.++||||+||++|+|++|++||..
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~  218 (317)
T cd07867         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence            9876543221 111234688999999998764 588999999999999999999999864

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=3.9e-40  Score=290.15  Aligned_cols=252  Identities=19%  Similarity=0.262  Sum_probs=208.3

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFES  134 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  134 (339)
                      ++|++.+.||+|++|.||+|....+++.|++|++...........+.+|+..+..++|+||+++++++..++..++||||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            46889999999999999999999899999999998765445567788999999999999999999999999999999999


Q ss_pred             ccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCC-CCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCcee
Q 019536          135 VKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFD-RPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHV  211 (339)
Q Consensus       135 ~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~  211 (339)
                      +++++|.+++.  ..++...+..++.|++.|+.|||   + .+++|+||+|+||+++.++.++|+|||.+..........
T Consensus        81 ~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~  157 (264)
T cd06623          81 MDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC  157 (264)
T ss_pred             cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcc
Confidence            99999999986  57888899999999999999999   8 999999999999999999999999999988765433321


Q ss_pred             eecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCccc
Q 019536          212 REEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFD  291 (339)
Q Consensus       212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (339)
                        ....++..|+|||.+.+..++.++|+||||+++|+|++|+.||......  .......   .......          
T Consensus       158 --~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~~~~~~~---~~~~~~~----------  220 (264)
T cd06623         158 --NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP--SFFELMQ---AICDGPP----------  220 (264)
T ss_pred             --cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc--CHHHHHH---HHhcCCC----------
Confidence              1245788899999998888999999999999999999999998644321  1111111   1111000          


Q ss_pred             CCCCCCCcHH-HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          292 EDNSFPGKEE-KLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       292 ~~~~~~~~~~-~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                          .+.+.. .+..+.+++.+||+.+|++|||+.++++.
T Consensus       221 ----~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         221 ----PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             ----CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                011112 45679999999999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.1e-40  Score=294.88  Aligned_cols=250  Identities=18%  Similarity=0.304  Sum_probs=198.9

Q ss_pred             CcccCCceeccCCeeEEEEEEcC-CCeeEEEEEeccCC---------ChhhHHHHHHHHHHHHh-cCCCceeeeeeeeee
Q 019536           56 NYDLHKVIQSDTSYRLFEGTLVD-QDRPISVMKFHDNS---------TLDDVEYCFNNIVFSSQ-MKHKNILKLIGCCLE  124 (339)
Q Consensus        56 ~~~~~~~ig~G~~g~V~~~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~~e~~~l~~-l~H~niv~~~~~~~~  124 (339)
                      +|++.+.||+|+||.||+|.... .++.+|+|.+....         .......+.+|+.++.. ++||||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47888999999999999999986 67899999875421         12344567788887765 799999999999999


Q ss_pred             CCccEEEEEeccCCccccccc------cCCChHHHHHHHHHHHHHHHHHhcCCC-CCeEEccCCCCCEEeCCCCceEEec
Q 019536          125 TELPTLVFESVKYGTLRGFSF------ASLLIAPRIKIAMEIANAVAYLHVGFD-RPIVFRCIKASNVLLDENYSAKLHD  197 (339)
Q Consensus       125 ~~~~~lv~e~~~~g~L~~~~~------~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~i~H~dlk~~Nil~~~~~~~kl~d  197 (339)
                      ++..++||||+++++|.+++.      ..++...++.++.|++.||.|||   . .+++|+||+|+||+++.++.++|+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~i~H~dl~~~nil~~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLH---KEKRIVHRDLTPNNIMLGEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhc---cCCceeecCCCHHHEEECCCCcEEEec
Confidence            999999999999999988763      35788888999999999999999   5 6799999999999999999999999


Q ss_pred             CCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHh
Q 019536          198 FSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSI  277 (339)
Q Consensus       198 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  277 (339)
                      ||.+........   .....++..|+|||++.+..++.++|+||||+++|+|++|+.||....        ........ 
T Consensus       158 fg~~~~~~~~~~---~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~--------~~~~~~~~-  225 (269)
T cd08528         158 FGLAKQKQPESK---LTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN--------MLSLATKI-  225 (269)
T ss_pred             ccceeecccccc---cccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC--------HHHHHHHH-
Confidence            999877654431   123568889999999998889999999999999999999999974211        11111111 


Q ss_pred             hcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 019536          278 ENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLR  332 (339)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~  332 (339)
                      .....    .+       .+ ....+..+.+++.+||+.||++|||+.++..++.
T Consensus       226 ~~~~~----~~-------~~-~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         226 VEAVY----EP-------LP-EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             hhccC----Cc-------CC-cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            11110    00       00 1123457899999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=4.3e-41  Score=302.15  Aligned_cols=248  Identities=17%  Similarity=0.282  Sum_probs=199.6

Q ss_pred             cccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEecc
Q 019536           57 YDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVK  136 (339)
Q Consensus        57 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~  136 (339)
                      |.....||+|+||.||+|....++..||+|.+..... ...+.+.+|+.+++.++||||+++++++..++..++|+||++
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~  101 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ-QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQ  101 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc-chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCC
Confidence            3445689999999999999988899999999865433 345667899999999999999999999999999999999999


Q ss_pred             CCccccccc-cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceeeecc
Q 019536          137 YGTLRGFSF-ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEF  215 (339)
Q Consensus       137 ~g~L~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~~~  215 (339)
                      +++|..++. ..+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++.........  ...
T Consensus       102 ~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~--~~~  176 (297)
T cd06659         102 GGALTDIVSQTRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKS  176 (297)
T ss_pred             CCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhccccccc--ccc
Confidence            999988776 46788899999999999999999   899999999999999999999999999998765443221  113


Q ss_pred             cccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCCCC
Q 019536          216 IKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNS  295 (339)
Q Consensus       216 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (339)
                      ..++..|+|||++.+..++.++|+|||||++|+|++|+.||.....     .......    .....     .      .
T Consensus       177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-----~~~~~~~----~~~~~-----~------~  236 (297)
T cd06659         177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP-----VQAMKRL----RDSPP-----P------K  236 (297)
T ss_pred             eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHH----hccCC-----C------C
Confidence            4688999999999988899999999999999999999999752211     1111111    10000     0      0


Q ss_pred             CCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          296 FPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       296 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      .......+..+.+++.+||+.+|++|||+.++++.
T Consensus       237 ~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         237 LKNAHKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             ccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            00111334568899999999999999999999873

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=8.1e-41  Score=299.24  Aligned_cols=244  Identities=20%  Similarity=0.280  Sum_probs=201.2

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC--ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS--TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVF  132 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  132 (339)
                      ++|++.+.||+|++|.||++.+..+++.||+|.+....  .....+.+.+|++++++++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            47889999999999999999999899999999987542  1234567889999999999999999999999999999999


Q ss_pred             EeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCce
Q 019536          133 ESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH  210 (339)
Q Consensus       133 e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~  210 (339)
                      ||+++++|.+++.  ..++...+..++.|++.||.|||   +.+++|+||+|.||+++.++.+||+|||++.......  
T Consensus        81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~--  155 (290)
T cd05580          81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT--  155 (290)
T ss_pred             ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCCC--
Confidence            9999999999875  56888889999999999999999   8999999999999999999999999999987765441  


Q ss_pred             eeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcc
Q 019536          211 VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIF  290 (339)
Q Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (339)
                         ....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||....     ......   . ...+.         
T Consensus       156 ---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~---~-~~~~~---------  214 (290)
T cd05580         156 ---YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN-----PIQIYE---K-ILEGK---------  214 (290)
T ss_pred             ---CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC-----HHHHHH---H-HhcCC---------
Confidence               13468889999999988888999999999999999999999975222     011111   1 11110         


Q ss_pred             cCCCCCCCcHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 019536          291 DEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP-----LMVDVAK  329 (339)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~il~  329 (339)
                         ...|  ...+..+.+++.+||+.||.+|+     ++.++++
T Consensus       215 ---~~~~--~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         215 ---VRFP--SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             ---ccCC--ccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence               1111  12355789999999999999999     7777764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-41  Score=313.47  Aligned_cols=250  Identities=23%  Similarity=0.345  Sum_probs=207.8

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCC---CeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQ---DRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLV  131 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  131 (339)
                      +...+.++||+|.||.|++|.|...   ...||||.+..........+|++|+.+|.+|+|||+++|||+..+ ....+|
T Consensus       110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV  188 (1039)
T KOG0199|consen  110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV  188 (1039)
T ss_pred             HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence            3445568999999999999999743   357999999988765688999999999999999999999999998 567899


Q ss_pred             EEeccCCccccccc----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCC
Q 019536          132 FESVKYGTLRGFSF----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEG  207 (339)
Q Consensus       132 ~e~~~~g~L~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~  207 (339)
                      ||.++.|+|.+.+.    ..+.......++.|||.|+.||.   ++++|||||..+|+|+.....+||+|||+.+.+..+
T Consensus       189 ~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~n  265 (1039)
T KOG0199|consen  189 FELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGEN  265 (1039)
T ss_pred             hhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence            99999999999886    45777778889999999999999   999999999999999999999999999999998876


Q ss_pred             Cceeeec-ccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCccccc
Q 019536          208 ETHVREE-FIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAI  285 (339)
Q Consensus       208 ~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (339)
                      ...+... ...-.+.|+|||.+....|+.++|+|+|||++|||++ |..||....        -.+.+..          
T Consensus       266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~--------g~qIL~~----------  327 (1039)
T KOG0199|consen  266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR--------GIQILKN----------  327 (1039)
T ss_pred             CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC--------HHHHHHh----------
Confidence            6554321 1223457999999999999999999999999999998 667764221        1222221          


Q ss_pred             ccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          286 VDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                          +.....++.+..+++.+.++|..||...|++|||+.+|.+.
T Consensus       328 ----iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~  368 (1039)
T KOG0199|consen  328 ----IDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED  368 (1039)
T ss_pred             ----ccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence                12333456667899999999999999999999999999743

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.8e-40  Score=292.41  Aligned_cols=252  Identities=20%  Similarity=0.290  Sum_probs=203.4

Q ss_pred             CcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCCh-hhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 019536           56 NYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTL-DDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFES  134 (339)
Q Consensus        56 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  134 (339)
                      +|++.+.||+|+||.||+|....+++.|++|.+...... .....+.+|+.+++.++|+||+++++++.+.+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            588889999999999999999888999999998766432 4677788999999999999999999999999999999999


Q ss_pred             ccCCcccccccc--CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceee
Q 019536          135 VKYGTLRGFSFA--SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVR  212 (339)
Q Consensus       135 ~~~g~L~~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~  212 (339)
                      +++++|.+++..  .+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.+||+|||++...........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~  157 (264)
T cd06626          81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG  157 (264)
T ss_pred             CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence            999999999864  4788888999999999999999   89999999999999999999999999999887654332211


Q ss_pred             --ecccccccccccccccccCC---CCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCccccccc
Q 019536          213 --EEFIKGAYGFIAPEYFATSS---FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVD  287 (339)
Q Consensus       213 --~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (339)
                        .....++..|+|||++.+..   ++.++|+||||+++|++++|+.||.....       .......... .       
T Consensus       158 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~-------~~~~~~~~~~-~-------  222 (264)
T cd06626         158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN-------EFQIMFHVGA-G-------  222 (264)
T ss_pred             ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc-------hHHHHHHHhc-C-------
Confidence              11245778899999998766   88999999999999999999999852211       1111111000 0       


Q ss_pred             CcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          288 PIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                          .....|.....+..+.+++.+||+.+|++|||+.+++.
T Consensus       223 ----~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         223 ----HKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             ----CCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                01111222233567889999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=3e-40  Score=289.74  Aligned_cols=247  Identities=21%  Similarity=0.291  Sum_probs=200.5

Q ss_pred             CcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 019536           56 NYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS-TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFES  134 (339)
Q Consensus        56 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  134 (339)
                      +|+..+.||+|++|.||++....++..+|+|.+.... .......+.+|+.+++.++||||+++++.+..++..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            5888999999999999999998899999999987653 224566788999999999999999999999999999999999


Q ss_pred             ccCCccccccc----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCC-CceEEecCCCccccCCCCc
Q 019536          135 VKYGTLRGFSF----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDEN-YSAKLHDFSLSVSIPEGET  209 (339)
Q Consensus       135 ~~~g~L~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~-~~~kl~dfg~a~~~~~~~~  209 (339)
                      +++++|.+++.    ..+++..+..++.+++.||.|||   +++++|+||+|+||+++.+ +.++++|||.+........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK  157 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence            99999999885    24788888999999999999999   8999999999999999854 4689999999987654432


Q ss_pred             eeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCc
Q 019536          210 HVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPI  289 (339)
Q Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (339)
                      ..   ...++..|+|||.+.+..++.++|+||||+++|+|++|+.||.....     ....   ..... ....      
T Consensus       158 ~~---~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~-----~~~~---~~~~~-~~~~------  219 (256)
T cd08220         158 AY---TVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL-----PALV---LKIMS-GTFA------  219 (256)
T ss_pred             cc---ccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch-----HHHH---HHHHh-cCCC------
Confidence            21   24578899999999988899999999999999999999999742211     1111   11110 0000      


Q ss_pred             ccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          290 FDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                             +.+...+..+.+++.+||+.+|++|||+.+++.+
T Consensus       220 -------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         220 -------PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             -------CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence                   0111345578999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.7e-40  Score=289.29  Aligned_cols=247  Identities=23%  Similarity=0.294  Sum_probs=200.1

Q ss_pred             CcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC----hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 019536           56 NYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST----LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLV  131 (339)
Q Consensus        56 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  131 (339)
                      +|+..+.||+|++|.||+|....++..|++|.+.....    ....+.+.+|+.+++.++|+||+++++++.+++..++|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            47788999999999999999988899999999865432    23456788999999999999999999999999999999


Q ss_pred             EEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCc
Q 019536          132 FESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGET  209 (339)
Q Consensus       132 ~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~  209 (339)
                      +||+++++|.+++.  ..+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.+||+|||++........
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~  157 (258)
T cd06632          81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF  157 (258)
T ss_pred             EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceecccccc
Confidence            99999999999876  45788888899999999999999   89999999999999999999999999999876644331


Q ss_pred             eeeecccccccccccccccccCC-CCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccC
Q 019536          210 HVREEFIKGAYGFIAPEYFATSS-FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDP  288 (339)
Q Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (339)
                         .....++..|+|||.+.... ++.++|+||||+++|+|++|+.||....        ...............     
T Consensus       158 ---~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~--------~~~~~~~~~~~~~~~-----  221 (258)
T cd06632         158 ---AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE--------GVAAVFKIGRSKELP-----  221 (258)
T ss_pred             ---ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc--------HHHHHHHHHhcccCC-----
Confidence               11345788899999987766 8999999999999999999999975221        111111111100000     


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          289 IFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                            .  .+...+..+.+++.+||+.+|++|||+.+++.
T Consensus       222 ------~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         222 ------P--IPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             ------C--cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence                  0  01134567899999999999999999999986

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.2e-40  Score=297.19  Aligned_cols=265  Identities=17%  Similarity=0.202  Sum_probs=201.3

Q ss_pred             CcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC-hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 019536           56 NYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST-LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFES  134 (339)
Q Consensus        56 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  134 (339)
                      +|++.+.||+|++|.||+|.+..++..|++|++..... ......+.+|+.+++.++||||+++++++.+++..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            58889999999999999999988999999999876543 23456788999999999999999999999999999999999


Q ss_pred             ccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCcee
Q 019536          135 VKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHV  211 (339)
Q Consensus       135 ~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~  211 (339)
                      + +++|.+++.   ..+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||++......... 
T Consensus        81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~-  155 (286)
T cd07832          81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR-  155 (286)
T ss_pred             c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC-
Confidence            9 999998864   46888999999999999999999   899999999999999999999999999998876543321 


Q ss_pred             eecccccccccccccccccC-CCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcC---c------
Q 019536          212 REEFIKGAYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENN---R------  281 (339)
Q Consensus       212 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~------  281 (339)
                      ......++..|+|||++.+. .++.++||||+|+++|+|++|.+||..  ..+   ..............   .      
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~--~~~---~~~~~~~~~~~~~~~~~~~~~~~~  230 (286)
T cd07832         156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPG--END---IEQLAIVFRTLGTPNEETWPGLTS  230 (286)
T ss_pred             ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCC--CCH---HHHHHHHHHHcCCCChHHHhhccC
Confidence            11134578899999998654 468999999999999999999777642  211   11111111110000   0      


Q ss_pred             ccccccCcccCCCCCC---CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          282 FGAIVDPIFDEDNSFP---GKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       282 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      +..............+   .....+..+.+++.+||+.||++|||+.+++.+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            0000000000000000   001234688999999999999999999999864

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=9.5e-41  Score=298.06  Aligned_cols=266  Identities=20%  Similarity=0.277  Sum_probs=202.4

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC-hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST-LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFE  133 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  133 (339)
                      ++|++.+.||+|++|.||+|.+..+++.|++|++..... ....+.+.+|+.+++.++|+||+++++++..++..++|||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            468899999999999999999998899999999876432 2345678899999999999999999999999999999999


Q ss_pred             eccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCcee
Q 019536          134 SVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHV  211 (339)
Q Consensus       134 ~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~  211 (339)
                      |++++.+..+..  ..++...+..++.|++.||.|||   ..+++|+||+|+||+++.++.+||+|||++..........
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~  157 (288)
T cd07833          81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASP  157 (288)
T ss_pred             cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccc
Confidence            999887776554  45788889999999999999999   8999999999999999999999999999988765543211


Q ss_pred             eecccccccccccccccccC-CCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhh---cCccccc-c
Q 019536          212 REEFIKGAYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIE---NNRFGAI-V  286 (339)
Q Consensus       212 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~-~  286 (339)
                      .. ...++..|+|||++.+. .++.++|+||||+++|+|++|+.||.....     ............   ....... .
T Consensus       158 ~~-~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~  231 (288)
T cd07833         158 LT-DYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSD-----IDQLYLIQKCLGPLPPSHQELFSS  231 (288)
T ss_pred             cc-CcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHhCCCCHHHhhhccc
Confidence            11 24577889999999888 789999999999999999999999753221     111111111000   0000000 0


Q ss_pred             cCcccC----CCCCC------CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          287 DPIFDE----DNSFP------GKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       287 ~~~~~~----~~~~~------~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                      ++....    ....+      .+...+..+.+++.+||+.+|++|||+.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         232 NPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             CccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            000000    00000      01123677999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.1e-41  Score=308.59  Aligned_cols=253  Identities=21%  Similarity=0.253  Sum_probs=214.4

Q ss_pred             HHHHHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC-hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCc
Q 019536           49 DLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST-LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETEL  127 (339)
Q Consensus        49 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~  127 (339)
                      +.......|.+...||+|.|+.|..|....++..||||.+.+... ......+.+|+++|+.++|||||+++.+......
T Consensus        50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~  129 (596)
T KOG0586|consen   50 DDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEAT  129 (596)
T ss_pred             cccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecce
Confidence            334566899999999999999999999999999999999988643 2334558899999999999999999999999999


Q ss_pred             cEEEEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccC
Q 019536          128 PTLVFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIP  205 (339)
Q Consensus       128 ~~lv~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~  205 (339)
                      +|+||||+.+|.+++++.  +......+..++.|++.|++|||   ++.|+|||||++|+|++.+..+||+|||++..+.
T Consensus       130 lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~  206 (596)
T KOG0586|consen  130 LYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFD  206 (596)
T ss_pred             eEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeec
Confidence            999999999999999987  56666778889999999999999   9999999999999999999999999999999887


Q ss_pred             CCCceeeecccccccccccccccccCCCC-cccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccc
Q 019536          206 EGETHVREEFIKGAYGFIAPEYFATSSFN-EMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA  284 (339)
Q Consensus       206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (339)
                      ......   ..+|++.|.|||++.+..|+ +.+|+||+|+++|.|+.|..||+...                     +..
T Consensus       207 ~~~~lq---t~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~---------------------lk~  262 (596)
T KOG0586|consen  207 YGLMLQ---TFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN---------------------LKE  262 (596)
T ss_pred             cccccc---ccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc---------------------ccc
Confidence            554432   57899999999999999886 78999999999999999999986221                     111


Q ss_pred             cccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      +-++.+......|.  ..+.++.+|++++|..+|.+|++++++.+.
T Consensus       263 Lr~rvl~gk~rIp~--~ms~dce~lLrk~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  263 LRPRVLRGKYRIPF--YMSCDCEDLLRKFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             ccchheeeeecccc--eeechhHHHHHHhhccCccccCCHHHhhhh
Confidence            22233333333332  345578999999999999999999999764

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.3e-41  Score=288.39  Aligned_cols=275  Identities=18%  Similarity=0.215  Sum_probs=202.3

Q ss_pred             HHhcCcccCCceeccCCeeEEEEEEcCCC----eeEEEEEeccCCChh-hHHHHHHHHHHHHhcCCCceeeeeeeeee-C
Q 019536           52 KATNNYDLHKVIQSDTSYRLFEGTLVDQD----RPISVMKFHDNSTLD-DVEYCFNNIVFSSQMKHKNILKLIGCCLE-T  125 (339)
Q Consensus        52 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~~~~~~~~-~  125 (339)
                      .....|+....||+|+||.||+|+...++    +.+|||+++...... ......+|+.+++.++|||++.+..++.. +
T Consensus        21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d  100 (438)
T KOG0666|consen   21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD  100 (438)
T ss_pred             HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence            33467999999999999999999765443    378999998763222 23456799999999999999999999988 7


Q ss_pred             CccEEEEEeccCCccccccc-------cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCC----CceE
Q 019536          126 ELPTLVFESVKYGTLRGFSF-------ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDEN----YSAK  194 (339)
Q Consensus       126 ~~~~lv~e~~~~g~L~~~~~-------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~----~~~k  194 (339)
                      ...++++||.++ +|..++.       ..++...+..|++||+.|+.|||   ++-|+||||||.|||+..+    |.+|
T Consensus       101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VK  176 (438)
T KOG0666|consen  101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVK  176 (438)
T ss_pred             ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeE
Confidence            788999999987 5666654       46788889999999999999999   8999999999999999877    8999


Q ss_pred             EecCCCccccCCCCcee-eecccccccccccccccccC-CCCcccchHHHHHHHHHHHhCCCccccCCCCCC-------C
Q 019536          195 LHDFSLSVSIPEGETHV-REEFIKGAYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGND-------D  265 (339)
Q Consensus       195 l~dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~-------~  265 (339)
                      |+|||+|+.+.+.-... ....++-|..|+|||++.|. .|+.++|+||+||++.||++-.+.|......-.       +
T Consensus       177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~d  256 (438)
T KOG0666|consen  177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHD  256 (438)
T ss_pred             eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHH
Confidence            99999999987654332 23346678999999999886 599999999999999999999988754322111       2


Q ss_pred             chhHHHHHHHHhhcCccccccc-Ccc-------c----CCCCCCCc----HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          266 DLTVLEYAKKSIENNRFGAIVD-PIF-------D----EDNSFPGK----EEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~-~~~-------~----~~~~~~~~----~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                      ++..+..+...+....+..+.. +..       .    .+..++..    ...+++..+|+.++|++||-+|+|+.++++
T Consensus       257 Ql~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle  336 (438)
T KOG0666|consen  257 QLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE  336 (438)
T ss_pred             HHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc
Confidence            2222222222222222221110 000       0    00000000    011234789999999999999999999987


Q ss_pred             H
Q 019536          330 Q  330 (339)
Q Consensus       330 ~  330 (339)
                      +
T Consensus       337 h  337 (438)
T KOG0666|consen  337 H  337 (438)
T ss_pred             c
Confidence            4

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=2.4e-40  Score=296.25  Aligned_cols=266  Identities=15%  Similarity=0.160  Sum_probs=196.5

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFE  133 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  133 (339)
                      +++|.+.+.||+|+||.||+|....++..||+|.+...........+.+|+.+++.++|+||+++.+++.+++..++|||
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e   83 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE   83 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence            57899999999999999999999889999999998765443334466789999999999999999999999999999999


Q ss_pred             eccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCce
Q 019536          134 SVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH  210 (339)
Q Consensus       134 ~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~  210 (339)
                      |++ +++.+++.   ..++...+..++.|++.||.|||   +.+|+|+||||+||+++.++.++|+|||+++........
T Consensus        84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  159 (291)
T cd07870          84 YMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT  159 (291)
T ss_pred             ccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC
Confidence            996 56655543   34677788889999999999999   899999999999999999999999999998764332211


Q ss_pred             eeecccccccccccccccccC-CCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHh---hcC------
Q 019536          211 VREEFIKGAYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSI---ENN------  280 (339)
Q Consensus       211 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~------  280 (339)
                      .  ....++..|+|||++.+. .++.++|+||||+++|+|++|+.||.....    ............   ...      
T Consensus       160 ~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~  233 (291)
T cd07870         160 Y--SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSD----VFEQLEKIWTVLGVPTEDTWPGVS  233 (291)
T ss_pred             C--CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchh----HHHHHHHHHHHcCCCChhhhhhhh
Confidence            1  123468889999998764 578899999999999999999999853221    111111110000   000      


Q ss_pred             cccccccCcccCCCCCC-----CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          281 RFGAIVDPIFDEDNSFP-----GKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       281 ~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                      .................     ........+.+++.+||+.||.+|||+.+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence            00000000000000000     00012357889999999999999999999875

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.4e-40  Score=305.99  Aligned_cols=269  Identities=18%  Similarity=0.225  Sum_probs=201.1

Q ss_pred             HhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeC------
Q 019536           53 ATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS-TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLET------  125 (339)
Q Consensus        53 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~------  125 (339)
                      ..++|+..+.||+|+||.||+|....+++.||+|.+.... .......+.+|+.+++.++||||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            4588999999999999999999999899999999986542 223456677899999999999999999998643      


Q ss_pred             CccEEEEEeccCCccccccccCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccC
Q 019536          126 ELPTLVFESVKYGTLRGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIP  205 (339)
Q Consensus       126 ~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~  205 (339)
                      ...++||||++ ++|.+.+...++......++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++...
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~  169 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQMDLDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  169 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhhcCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence            34699999996 5777777666888888999999999999999   8999999999999999999999999999998764


Q ss_pred             CCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHH------------HHH
Q 019536          206 EGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL------------EYA  273 (339)
Q Consensus       206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~------------~~~  273 (339)
                      ....   .....++..|+|||.+.+..++.++||||+||++|+|++|+.||.....  ......+            ...
T Consensus       170 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~  244 (353)
T cd07850         170 TSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDH--IDQWNKIIEQLGTPSDEFMSRL  244 (353)
T ss_pred             CCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCH--HHHHHHHHHhcCCCCHHHHHHh
Confidence            4322   1124578889999999999999999999999999999999999753221  0000000            000


Q ss_pred             ----HHHhhcC------cccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          274 ----KKSIENN------RFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       274 ----~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                          .......      .+..+.................+..+.+++.+||+.||++|||+.+++.+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         245 QPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             hhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                0000000      00000000000000000011345678999999999999999999999863

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=3.2e-40  Score=297.79  Aligned_cols=245  Identities=21%  Similarity=0.284  Sum_probs=196.4

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC--ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS--TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVF  132 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  132 (339)
                      ..|...+.||+|+||+||+|....+++.||+|++....  .......+.+|+.+++.++||||+++.++|.+++..++||
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            45888999999999999999998889999999986542  2244567889999999999999999999999999999999


Q ss_pred             EeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCc
Q 019536          133 ESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGET  209 (339)
Q Consensus       133 e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~  209 (339)
                      ||++ |++.+++.   ..+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++....... 
T Consensus        95 e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~-  169 (307)
T cd06607          95 EYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN-  169 (307)
T ss_pred             HhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecCCCC-
Confidence            9997 45555543   56888899999999999999999   8999999999999999999999999999987654332 


Q ss_pred             eeeecccccccccccccccc---cCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccc
Q 019536          210 HVREEFIKGAYGFIAPEYFA---TSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIV  286 (339)
Q Consensus       210 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (339)
                           ...++..|+|||++.   ...++.++||||||+++|+|++|+.||....        ............      
T Consensus       170 -----~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~--------~~~~~~~~~~~~------  230 (307)
T cd06607         170 -----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--------AMSALYHIAQND------  230 (307)
T ss_pred             -----CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCcc--------HHHHHHHHhcCC------
Confidence                 235778899999874   3568899999999999999999999974211        111111111000      


Q ss_pred             cCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          287 DPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                            ....+ ...++..+.+++.+||+.||++|||+.+|+.+
T Consensus       231 ------~~~~~-~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         231 ------SPTLS-SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             ------CCCCC-chhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence                  00111 12456689999999999999999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.5e-40  Score=292.34  Aligned_cols=253  Identities=19%  Similarity=0.298  Sum_probs=201.3

Q ss_pred             CcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC-----hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 019536           56 NYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST-----LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTL  130 (339)
Q Consensus        56 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  130 (339)
                      +|+..+.||+|++|.||+|....++..||+|.+.....     ....+.+.+|+.+++.++|+||+++++++.+++..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            47888999999999999999988999999999875431     1235678899999999999999999999999999999


Q ss_pred             EEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCC-ceEEecCCCccccCCC
Q 019536          131 VFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENY-SAKLHDFSLSVSIPEG  207 (339)
Q Consensus       131 v~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~-~~kl~dfg~a~~~~~~  207 (339)
                      |+||+++++|.+++.  ..+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++ .++|+|||.+......
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~  157 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK  157 (268)
T ss_pred             EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence            999999999999885  56788888999999999999999   89999999999999998775 5999999998776543


Q ss_pred             Cce--eeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCccccc
Q 019536          208 ETH--VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAI  285 (339)
Q Consensus       208 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (339)
                      ...  .......++..|+|||++.+..++.++|+||+|+++|++++|..||......  ...   ..........     
T Consensus       158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~---~~~~~~~~~~-----  227 (268)
T cd06630         158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS--NHL---ALIFKIASAT-----  227 (268)
T ss_pred             cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc--chH---HHHHHHhccC-----
Confidence            211  1111345788999999998888999999999999999999999997522111  111   1110000000     


Q ss_pred             ccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          286 VDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                              .....+...+..+.+++.+||+.+|.+|||+.++++
T Consensus       228 --------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         228 --------TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             --------CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence                    000112245567999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.3e-41  Score=312.37  Aligned_cols=242  Identities=20%  Similarity=0.341  Sum_probs=197.7

Q ss_pred             ccCCceeccCCeeEEEEEEcCCCeeEEEEEecc---CCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCc--cEEEE
Q 019536           58 DLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHD---NSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETEL--PTLVF  132 (339)
Q Consensus        58 ~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~--~~lv~  132 (339)
                      ....+||.|+|-+||+|.+..+|..||-=.++.   .......++|..|+.+|+.|+||||++++.+|.+...  +.+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            345789999999999999988898887533322   2334567899999999999999999999999998665  77999


Q ss_pred             EeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCC-CCceEEecCCCccccCCCCc
Q 019536          133 ESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDE-NYSAKLHDFSLSVSIPEGET  209 (339)
Q Consensus       133 e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~-~~~~kl~dfg~a~~~~~~~~  209 (339)
                      |.+..|+|+.|..  +.........|++||++||.|||++ ..+|+|||||.+||+++. .|.+||+|+|+|+.......
T Consensus       123 EL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~a  201 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHA  201 (632)
T ss_pred             ecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcccc
Confidence            9999999999987  6788888889999999999999976 688999999999999985 48899999999988755433


Q ss_pred             eeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHh---hcCcccccc
Q 019536          210 HVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSI---ENNRFGAIV  286 (339)
Q Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  286 (339)
                      .    .+.|||.|||||++. ..|+..+||||||+.|.||+|+..||....+       .++.-.+..   ++..+.++-
T Consensus       202 k----svIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n-------~AQIYKKV~SGiKP~sl~kV~  269 (632)
T KOG0584|consen  202 K----SVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN-------PAQIYKKVTSGIKPAALSKVK  269 (632)
T ss_pred             c----eeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC-------HHHHHHHHHcCCCHHHhhccC
Confidence            2    468999999999996 8899999999999999999999999863322       222222222   222222222


Q ss_pred             cCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          287 DPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                                      .+++++||.+||.. ..+|||+.|+|+
T Consensus       270 ----------------dPevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  270 ----------------DPEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             ----------------CHHHHHHHHHHhcC-chhccCHHHHhh
Confidence                            23799999999999 999999999987

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-42  Score=313.75  Aligned_cols=250  Identities=18%  Similarity=0.282  Sum_probs=207.9

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFES  134 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  134 (339)
                      +.+.+.-.+|.|+||.||+|..+.++..-|.|++..... ...+.++-|+.||+...||+||++++.|...+.+|++.||
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkse-EELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF  110 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSE-EELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF  110 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccch-hHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence            445666788999999999999998887788888766554 6788899999999999999999999999999999999999


Q ss_pred             ccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCcee
Q 019536          135 VKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHV  211 (339)
Q Consensus       135 ~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~  211 (339)
                      |+||..+.++.   ..+.++++..++.|++.||.|||   +++|||||||..|||++-+|.++|+|||.+.....  +..
T Consensus       111 C~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~q  185 (1187)
T KOG0579|consen  111 CGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TRQ  185 (1187)
T ss_pred             cCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccchh--HHh
Confidence            99999888865   78999999999999999999999   99999999999999999999999999999765422  222


Q ss_pred             eecccccccccccccccc-----cCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccc
Q 019536          212 REEFIKGAYGFIAPEYFA-----TSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIV  286 (339)
Q Consensus       212 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (339)
                      ....+.||+.|||||+..     ..+|+.++||||||+++.||..+.+|..        .+.....+.+..+.       
T Consensus       186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHh--------elnpMRVllKiaKS-------  250 (1187)
T KOG0579|consen  186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHH--------ELNPMRVLLKIAKS-------  250 (1187)
T ss_pred             hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcc--------ccchHHHHHHHhhc-------
Confidence            334678999999999864     5689999999999999999999999854        22222222222221       


Q ss_pred             cCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          287 DPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                           +...+-.|+.++.++.+++.+||..||..||++.+++++
T Consensus       251 -----ePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H  289 (1187)
T KOG0579|consen  251 -----EPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH  289 (1187)
T ss_pred             -----CCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence                 122233456888899999999999999999999999874

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=3.8e-40  Score=294.41  Aligned_cols=253  Identities=20%  Similarity=0.244  Sum_probs=196.6

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcC-CCceeeeeeeeeeCCccEEEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMK-HKNILKLIGCCLETELPTLVFE  133 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~~~~~~~~~~~~~lv~e  133 (339)
                      ++|+..+.||+|+||.||++.+..+++.||+|++...........+.+|+.++.++. ||||+++++++..++..+++||
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e   83 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME   83 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence            356667899999999999999999999999999886554455667889999999996 9999999999999888999999


Q ss_pred             eccCCcccccc-------ccCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCC
Q 019536          134 SVKYGTLRGFS-------FASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPE  206 (339)
Q Consensus       134 ~~~~g~L~~~~-------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~  206 (339)
                      |++. ++.++.       ...+++..+..++.|++.||+|||+  ..+++||||||+||+++.++.++|+|||+++.+..
T Consensus        84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  160 (288)
T cd06616          84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD  160 (288)
T ss_pred             cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence            9864 444332       2468888999999999999999993  35899999999999999999999999999876544


Q ss_pred             CCceeeecccccccccccccccccC---CCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCccc
Q 019536          207 GETHVREEFIKGAYGFIAPEYFATS---SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFG  283 (339)
Q Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (339)
                      .....   ...|+..|+|||++.+.   .++.++|+||+||++|+|++|+.||....       ...+.........   
T Consensus       161 ~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-------~~~~~~~~~~~~~---  227 (288)
T cd06616         161 SIAKT---RDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-------SVFDQLTQVVKGD---  227 (288)
T ss_pred             CCccc---cccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-------hHHHHHhhhcCCC---
Confidence            32211   23578889999999766   68899999999999999999999985221       1111111111100   


Q ss_pred             ccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          284 AIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                         .+.+..    ..+...+.++.+|+.+||+.||++|||+.+|+++
T Consensus       228 ---~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         228 ---PPILSN----SEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             ---CCcCCC----cCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               011111    1112356679999999999999999999999874

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=4.6e-40  Score=289.55  Aligned_cols=251  Identities=17%  Similarity=0.254  Sum_probs=201.9

Q ss_pred             CcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeeee--CCccEEEE
Q 019536           56 NYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS-TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLE--TELPTLVF  132 (339)
Q Consensus        56 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~--~~~~~lv~  132 (339)
                      +|++.+.||.|+||.||++....++..||+|.+.... .....+.+.+|+.+++.++||||+++++++..  +...+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            5788899999999999999999899999999987543 23445678899999999999999999998764  45678999


Q ss_pred             EeccCCccccccc------cCCChHHHHHHHHHHHHHHHHHhcCC--CCCeEEccCCCCCEEeCCCCceEEecCCCcccc
Q 019536          133 ESVKYGTLRGFSF------ASLLIAPRIKIAMEIANAVAYLHVGF--DRPIVFRCIKASNVLLDENYSAKLHDFSLSVSI  204 (339)
Q Consensus       133 e~~~~g~L~~~~~------~~~~~~~~~~i~~~i~~~l~~LH~~~--~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~  204 (339)
                      ||+++++|.+++.      ..+++..++.++.|++.||.|||...  +.+++|+||+|+||+++.++.+||+|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            9999999998874      46788889999999999999999332  567999999999999999999999999999877


Q ss_pred             CCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccc
Q 019536          205 PEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA  284 (339)
Q Consensus       205 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (339)
                      .......  ....++..|+|||++.+..++.++|+||||+++|+|++|+.||.....     ...    .......... 
T Consensus       161 ~~~~~~~--~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~----~~~~~~~~~~-  228 (265)
T cd08217         161 GHDSSFA--KTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ-----LQL----ASKIKEGKFR-  228 (265)
T ss_pred             cCCcccc--cccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH-----HHH----HHHHhcCCCC-
Confidence            5544211  134688899999999888899999999999999999999999753211     111    1111111110 


Q ss_pred             cccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                                  +.+...+..+.+++.+||+.+|++|||+.+|+++
T Consensus       229 ------------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         229 ------------RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             ------------CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                        1112455679999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=3.8e-40  Score=295.91  Aligned_cols=264  Identities=19%  Similarity=0.190  Sum_probs=199.3

Q ss_pred             CcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCCh----hhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 019536           56 NYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTL----DDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLV  131 (339)
Q Consensus        56 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  131 (339)
                      +|++.+.||+|++|.||+|.+..+++.||+|++......    .....+.+|+.+++.++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            478889999999999999999888999999999765432    2234567899999999999999999999999999999


Q ss_pred             EEeccCCcccccccc---CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCC
Q 019536          132 FESVKYGTLRGFSFA---SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE  208 (339)
Q Consensus       132 ~e~~~~g~L~~~~~~---~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~  208 (339)
                      |||+ +|+|.+++..   .+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||+++......
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  156 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN  156 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence            9999 8999988862   5788899999999999999999   8999999999999999999999999999988765432


Q ss_pred             ceeeeccccccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcC---cc--
Q 019536          209 THVREEFIKGAYGFIAPEYFAT-SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENN---RF--  282 (339)
Q Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~--  282 (339)
                      ....  ...++..|+|||.+.+ ..++.++|+|||||++|+|++|.+||..  ...   ..............   .+  
T Consensus       157 ~~~~--~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~--~~~---~~~~~~~~~~~~~~~~~~~~~  229 (298)
T cd07841         157 RKMT--HQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPG--DSD---IDQLGKIFEALGTPTEENWPG  229 (298)
T ss_pred             cccc--ccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccC--Ccc---HHHHHHHHHHcCCCchhhhhh
Confidence            2111  2346778999998865 4678999999999999999999777642  221   11111111111000   00  


Q ss_pred             -cccccCccc-CCCCCC---CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          283 -GAIVDPIFD-EDNSFP---GKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       283 -~~~~~~~~~-~~~~~~---~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                       ....+.... .....+   .....+..+.+++.+||++||++|||+.+++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence             000000000 000000   001345678999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.1e-39  Score=291.24  Aligned_cols=248  Identities=19%  Similarity=0.290  Sum_probs=199.4

Q ss_pred             CcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEec
Q 019536           56 NYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESV  135 (339)
Q Consensus        56 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  135 (339)
                      .|...+.||+|++|.||+|....++..+++|++..... ...+.+.+|+.+++.++||||+++++++..++..++|+||+
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~   98 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFL   98 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch-hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEecc
Confidence            34555799999999999999988899999999865433 34566889999999999999999999999999999999999


Q ss_pred             cCCccccccc-cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceeeec
Q 019536          136 KYGTLRGFSF-ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREE  214 (339)
Q Consensus       136 ~~g~L~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~~  214 (339)
                      ++++|.+++. ..++...+..++.|++.||.|||   +.+++||||+|+||+++.++.++|+|||.+..........  .
T Consensus        99 ~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~--~  173 (285)
T cd06648          99 EGGALTDIVTHTRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRR--K  173 (285)
T ss_pred             CCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCccc--c
Confidence            9999998876 46788888999999999999999   8999999999999999999999999999877654332211  1


Q ss_pred             ccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCCC
Q 019536          215 FIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDN  294 (339)
Q Consensus       215 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (339)
                      ...|+..|+|||++.+..++.++|+||||+++|+|++|+.||....     .....   ..... ...     +.     
T Consensus       174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~-----~~~~~---~~~~~-~~~-----~~-----  234 (285)
T cd06648         174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP-----PLQAM---KRIRD-NLP-----PK-----  234 (285)
T ss_pred             cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC-----HHHHH---HHHHh-cCC-----CC-----
Confidence            2458889999999988889999999999999999999999974211     11111   11111 000     00     


Q ss_pred             CCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          295 SFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       295 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                       ...+...+..+.+++.+||+.+|++|||+.++++
T Consensus       235 -~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         235 -LKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             -CcccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence             0011124457999999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=2.8e-40  Score=296.13  Aligned_cols=261  Identities=19%  Similarity=0.221  Sum_probs=198.1

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCCh-hhHHHHHHHHHHHHhcCCCceeeeeeeeeeC--CccEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTL-DDVEYCFNNIVFSSQMKHKNILKLIGCCLET--ELPTLV  131 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~--~~~~lv  131 (339)
                      ++|++.+.||.|+||.||+|.+..+++.+++|.+...... .....+.+|+.++++++||||+++++++...  +..++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            5789999999999999999999988999999998765332 2234567899999999999999999999877  889999


Q ss_pred             EEeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCC
Q 019536          132 FESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE  208 (339)
Q Consensus       132 ~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~  208 (339)
                      +||++ ++|.+++.   ..+++.....++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||++.......
T Consensus        85 ~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  160 (293)
T cd07843          85 MEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL  160 (293)
T ss_pred             ehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence            99997 48877764   34788999999999999999999   8999999999999999999999999999988765542


Q ss_pred             ceeeecccccccccccccccccC-CCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhh---cCccc-
Q 019536          209 THVREEFIKGAYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIE---NNRFG-  283 (339)
Q Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~-  283 (339)
                      ...  ....++..|+|||.+.+. .++.++|+||+|+++|+|++|.+||.....     ............   ...+. 
T Consensus       161 ~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~-----~~~~~~~~~~~~~~~~~~~~~  233 (293)
T cd07843         161 KPY--TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSE-----IDQLNKIFKLLGTPTEKIWPG  233 (293)
T ss_pred             ccc--ccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHHHhCCCchHHHHH
Confidence            211  123567889999998764 468999999999999999999999753221     111111111000   00000 


Q ss_pred             -------------ccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          284 -------------AIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       284 -------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                                   ......+.  ..++.. ..+..+.+++.+||+.||++|||+.|++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~-~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         234 FSELPGAKKKTFTKYPYNQLR--KKFPAL-SLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             hhccchhcccccccccchhhh--cccccc-CCChHHHHHHHHHhccCccccCCHHHHhc
Confidence                         00000000  001110 13567899999999999999999999986

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=4.1e-40  Score=297.36  Aligned_cols=266  Identities=17%  Similarity=0.201  Sum_probs=196.6

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChh-hHHHHHHHHHHHHhcCCCceeeeeeeeeeC--CccEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLD-DVEYCFNNIVFSSQMKHKNILKLIGCCLET--ELPTL  130 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~~~~~~~~~--~~~~l  130 (339)
                      .++|++.+.||.|+||.||+|.+..+|..||+|++....... ....+.+|+.++++++|+||+++++++.+.  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            478999999999999999999999899999999987543222 233456899999999999999999998765  45799


Q ss_pred             EEEeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCC
Q 019536          131 VFESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEG  207 (339)
Q Consensus       131 v~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~  207 (339)
                      ||||+++ +|.+++.   ..+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++......
T Consensus        86 v~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~  161 (309)
T cd07845          86 VMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP  161 (309)
T ss_pred             EEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence            9999965 6766654   46888999999999999999999   899999999999999999999999999998876543


Q ss_pred             Cceeeeccccccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhh---cCccc
Q 019536          208 ETHVREEFIKGAYGFIAPEYFAT-SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIE---NNRFG  283 (339)
Q Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~  283 (339)
                      .....  ...++..|+|||++.+ ..++.++|+||+||++|+|++|++||....  .   ............   ...+.
T Consensus       162 ~~~~~--~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~--~---~~~~~~~~~~~~~~~~~~~~  234 (309)
T cd07845         162 AKPMT--PKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKS--E---IEQLDLIIQLLGTPNESIWP  234 (309)
T ss_pred             cCCCC--cccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCC--H---HHHHHHHHHhcCCCChhhch
Confidence            22211  2335778999999865 458899999999999999999999975221  1   111111111100   00000


Q ss_pred             ccccCccc-----CCCCCCC----cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          284 AIVDPIFD-----EDNSFPG----KEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       284 ~~~~~~~~-----~~~~~~~----~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      .+......     .......    ....+..+.++|.+||++||++|||+.+++.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         235 GFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             hhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            00000000     0000000    01235678899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1e-39  Score=290.95  Aligned_cols=263  Identities=17%  Similarity=0.227  Sum_probs=198.5

Q ss_pred             CcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEec
Q 019536           56 NYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESV  135 (339)
Q Consensus        56 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  135 (339)
                      +|++.+.||.|++|.||+|.+..++..||+|++...........+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            58889999999999999999998999999999987654344566778999999999999999999999999999999999


Q ss_pred             cCCccccccc-----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCce
Q 019536          136 KYGTLRGFSF-----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH  210 (339)
Q Consensus       136 ~~g~L~~~~~-----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~  210 (339)
                      ++ +|.+++.     ..+++..+..++.|++.||.|||   +.+++|+||+|+||++++++.++++|||+++........
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~  156 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT  156 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc
Confidence            85 7777654     34788899999999999999999   899999999999999999999999999998765433221


Q ss_pred             eeecccccccccccccccccC-CCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHh---hcCcccccc
Q 019536          211 VREEFIKGAYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSI---ENNRFGAIV  286 (339)
Q Consensus       211 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  286 (339)
                      .  ....++..|++||++.+. .++.++|+||+|+++|++++|+.||.....     ...........   ....+..+.
T Consensus       157 ~--~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~  229 (284)
T cd07836         157 F--SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNN-----EDQLLKIFRIMGTPTESTWPGIS  229 (284)
T ss_pred             c--ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc-----HHHHHHHHHHhCCCChhhHHHHh
Confidence            1  123467889999998664 578999999999999999999999753221     11111111000   000000000


Q ss_pred             c-CcccCCCCCC-------CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          287 D-PIFDEDNSFP-------GKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       287 ~-~~~~~~~~~~-------~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                      . +.+....+..       ..+..+..+.+++.+||+.||.+||++.++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         230 QLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             cCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            0 0000000000       00123457889999999999999999999985

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=5.2e-40  Score=292.41  Aligned_cols=261  Identities=17%  Similarity=0.181  Sum_probs=193.7

Q ss_pred             cccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcC-CCceeeeeeeeeeC--CccEEEEE
Q 019536           57 YDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMK-HKNILKLIGCCLET--ELPTLVFE  133 (339)
Q Consensus        57 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~~~~~~~~~--~~~~lv~e  133 (339)
                      |++.+.||+|+||.||+|....++..||+|++.............+|+.++.++. |||++++++++.++  +..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            6678899999999999999998999999999876533233334567888898885 99999999999987  88999999


Q ss_pred             eccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCce
Q 019536          134 SVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH  210 (339)
Q Consensus       134 ~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~  210 (339)
                      |+++ +|.+.+.   ..+++..+..++.|++.||.|||   +.+++||||+|+||+++. +.+||+|||+++........
T Consensus        81 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~  155 (282)
T cd07831          81 LMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY  155 (282)
T ss_pred             cCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecccccccccCCCc
Confidence            9974 6666654   35789999999999999999999   899999999999999999 99999999999876443322


Q ss_pred             eeeccccccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCc--cccccc
Q 019536          211 VREEFIKGAYGFIAPEYFAT-SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNR--FGAIVD  287 (339)
Q Consensus       211 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  287 (339)
                      .   ...++..|+|||++.+ ..++.++|+||+||++|+|++|+.||.....     ...............  +.....
T Consensus       156 ~---~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~  227 (282)
T cd07831         156 T---EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE-----LDQIAKIHDVLGTPDAEVLKKFR  227 (282)
T ss_pred             C---CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH-----HHHHHHHHHHcCCCCHHHHHhhc
Confidence            1   2357888999997654 4578899999999999999999999753221     111111111000000  000000


Q ss_pred             CcccCCCCCCC---------cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          288 PIFDEDNSFPG---------KEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       288 ~~~~~~~~~~~---------~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      ........+|.         ....+..+.+++.+||+.+|++|||+.+++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             ccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence            00000000110         11346789999999999999999999999863

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=5.3e-40  Score=296.29  Aligned_cols=272  Identities=19%  Similarity=0.220  Sum_probs=195.6

Q ss_pred             HhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCCh-hhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCc----
Q 019536           53 ATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTL-DDVEYCFNNIVFSSQMKHKNILKLIGCCLETEL----  127 (339)
Q Consensus        53 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~----  127 (339)
                      ..++|++.+.||+|+||.||+|....+++.||+|.+...... .....+.+|+.+++.++||||+++++++.....    
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR   89 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence            346799999999999999999999989999999998654322 223456689999999999999999999876543    


Q ss_pred             ----cEEEEEeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCC
Q 019536          128 ----PTLVFESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSL  200 (339)
Q Consensus       128 ----~~lv~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~  200 (339)
                          .++||||+++ +|.+.+.   ..+++.++..++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||+
T Consensus        90 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~  165 (310)
T cd07865          90 YKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGL  165 (310)
T ss_pred             CCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcCCC
Confidence                4999999964 6666654   25789999999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCCCce--eeecccccccccccccccccC-CCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHh
Q 019536          201 SVSIPEGETH--VREEFIKGAYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSI  277 (339)
Q Consensus       201 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  277 (339)
                      +.........  .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...  ................
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~--~~~~~~~~~~~~~~~~  243 (310)
T cd07865         166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGN--TEQHQLTLISQLCGSI  243 (310)
T ss_pred             cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHHHhCCC
Confidence            8766443221  111124567889999988765 4788999999999999999999997522  1111111111111000


Q ss_pred             hcCcccccccCcccCCCCCCC-----------cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          278 ENNRFGAIVDPIFDEDNSFPG-----------KEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      ....+..............+.           +...+..+.+|+.+||+.||++|||+.+++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h  307 (310)
T cd07865         244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH  307 (310)
T ss_pred             ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence            000000000000000000000           00123467899999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.4e-39  Score=294.95  Aligned_cols=246  Identities=21%  Similarity=0.254  Sum_probs=196.5

Q ss_pred             CcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC--ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 019536           56 NYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS--TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFE  133 (339)
Q Consensus        56 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  133 (339)
                      .|+..+.||+|+||.||+|....++..||+|.+....  .......+.+|+.+++.++|||++++++++.+++..++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            3778899999999999999998899999999987542  22344678899999999999999999999999999999999


Q ss_pred             eccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCce
Q 019536          134 SVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH  210 (339)
Q Consensus       134 ~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~  210 (339)
                      |+++ +|.+.+.   ..+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++.......  
T Consensus       106 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~~--  179 (317)
T cd06635         106 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPAN--  179 (317)
T ss_pred             CCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCCcc--
Confidence            9975 6666553   56788899999999999999999   8999999999999999999999999999986554322  


Q ss_pred             eeecccccccccccccccc---cCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCccccccc
Q 019536          211 VREEFIKGAYGFIAPEYFA---TSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVD  287 (339)
Q Consensus       211 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (339)
                          ...++..|+|||++.   +..++.++|+|||||++|+|++|+.||...        ..............      
T Consensus       180 ----~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~--------~~~~~~~~~~~~~~------  241 (317)
T cd06635         180 ----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM--------NAMSALYHIAQNES------  241 (317)
T ss_pred             ----cccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCc--------cHHHHHHHHHhccC------
Confidence                235788899999974   456889999999999999999999997421        11111111111110      


Q ss_pred             CcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 019536          288 PIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLR  332 (339)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~  332 (339)
                             ........+..+.+++.+||+.+|++||++.++++.+.
T Consensus       242 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~  279 (317)
T cd06635         242 -------PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF  279 (317)
T ss_pred             -------CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence                   00111245567999999999999999999999998654

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=8.8e-40  Score=288.05  Aligned_cols=242  Identities=22%  Similarity=0.275  Sum_probs=196.0

Q ss_pred             eeccCCeeEEEEEEcCCCeeEEEEEeccCCC--hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeccCCcc
Q 019536           63 IQSDTSYRLFEGTLVDQDRPISVMKFHDNST--LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL  140 (339)
Q Consensus        63 ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L  140 (339)
                      ||.|++|.||+|.+..++..|++|.+.....  ....+.+.+|+.+++.++||||+++++++.+++..++|+||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            6899999999999988899999999876432  23456788999999999999999999999999999999999999999


Q ss_pred             ccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceeeeccccc
Q 019536          141 RGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG  218 (339)
Q Consensus       141 ~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~g  218 (339)
                      .+++.  ..++...+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++.........   ....+
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~---~~~~~  154 (262)
T cd05572          81 WTILRDRGLFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKT---WTFCG  154 (262)
T ss_pred             HHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccccc---ccccC
Confidence            99986  45788888899999999999999   899999999999999999999999999998876543211   13457


Q ss_pred             ccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCCCCCCC
Q 019536          219 AYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPG  298 (339)
Q Consensus       219 t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (339)
                      +..|+|||.+.+..++.++|+||+|+++|++++|..||.....   +   ............           .....| 
T Consensus       155 ~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~---~~~~~~~~~~~~-----------~~~~~~-  216 (262)
T cd05572         155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE---D---PMEIYNDILKGN-----------GKLEFP-  216 (262)
T ss_pred             CcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC---C---HHHHHHHHhccC-----------CCCCCC-
Confidence            8889999999888899999999999999999999999853321   0   111111111000           011111 


Q ss_pred             cHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 019536          299 KEEKLQSLGQLMYKCLSKSPEHRPL-----MVDVAK  329 (339)
Q Consensus       299 ~~~~~~~~~~li~~cl~~dP~~Rps-----~~~il~  329 (339)
                       ...+.++.+++.+||+.+|++||+     +.|+++
T Consensus       217 -~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         217 -NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             -cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence             123567999999999999999999     777765

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=2.5e-40  Score=294.92  Aligned_cols=265  Identities=15%  Similarity=0.192  Sum_probs=196.2

Q ss_pred             CcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC-hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 019536           56 NYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST-LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFES  134 (339)
Q Consensus        56 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  134 (339)
                      +|+..+.||.|++|.||+|....++..||||++..... ......+.+|+.++++++||||+++++++.+++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            58889999999999999999988999999999875432 22345688999999999999999999999999999999999


Q ss_pred             ccCCccccccc----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCce
Q 019536          135 VKYGTLRGFSF----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH  210 (339)
Q Consensus       135 ~~~g~L~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~  210 (339)
                      ++ ++|..++.    ..+++..+..++.|++.||+|||   ..+++|+||+|+||+++.++.+||+|||+++........
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~  156 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT  156 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc
Confidence            96 57777654    45788889999999999999999   899999999999999999999999999998765433221


Q ss_pred             eeecccccccccccccccccCC-CCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHH--hhcCccc---c
Q 019536          211 VREEFIKGAYGFIAPEYFATSS-FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKS--IENNRFG---A  284 (339)
Q Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~---~  284 (339)
                      ..  ...++..|+|||++.+.. ++.++|+||||+++|+|++|+.||.....    ...........  .....+.   .
T Consensus       157 ~~--~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~  230 (284)
T cd07860         157 YT--HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE----IDQLFRIFRTLGTPDEVVWPGVTS  230 (284)
T ss_pred             cc--cccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHHHHhCCCChhhhhhhhH
Confidence            11  234678899999887654 68899999999999999999999753211    11111111000  0000000   0


Q ss_pred             cc--cCcccCCCCC---CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          285 IV--DPIFDEDNSF---PGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       285 ~~--~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      +.  ...+......   ......+..+.+++.+||+.||++|||+.+++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  281 (284)
T cd07860         231 LPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH  281 (284)
T ss_pred             HHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence            00  0000000000   0001234568899999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-40  Score=303.63  Aligned_cols=268  Identities=18%  Similarity=0.192  Sum_probs=198.7

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC-----cc
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETE-----LP  128 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~-----~~  128 (339)
                      +++|++.+.||+|+||.||+|.+..++..||+|++...........+.+|+.+++.++||||+++++++....     ..
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            4789999999999999999999998999999999875444345567889999999999999999999876543     47


Q ss_pred             EEEEEeccCCccccccc-cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCC
Q 019536          129 TLVFESVKYGTLRGFSF-ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEG  207 (339)
Q Consensus       129 ~lv~e~~~~g~L~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~  207 (339)
                      ++|+||+++ +|...+. ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||++......
T Consensus        84 ~lv~e~~~~-~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~  159 (336)
T cd07849          84 YIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE  159 (336)
T ss_pred             EEEehhccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence            899999964 6666655 57889999999999999999999   899999999999999999999999999998765432


Q ss_pred             Ccee-eeccccccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhc---Ccc
Q 019536          208 ETHV-REEFIKGAYGFIAPEYFAT-SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIEN---NRF  282 (339)
Q Consensus       208 ~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~  282 (339)
                      .... ......|+..|+|||.+.+ ..++.++|+||+||++|+|++|+.||.....     .............   ..+
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~-----~~~~~~~~~~~~~~~~~~~  234 (336)
T cd07849         160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY-----LHQLNLILGVLGTPSQEDL  234 (336)
T ss_pred             ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHcCCCCHHHH
Confidence            2111 1112457889999998754 4688999999999999999999999853211     1111111000000   000


Q ss_pred             cccccC-------cccCCCCCCCc---HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          283 GAIVDP-------IFDEDNSFPGK---EEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       283 ~~~~~~-------~~~~~~~~~~~---~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      ..+...       ........+..   +..+..+.+++.+||+.||++|||+.+++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            000000       00000000000   1235678999999999999999999999875

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=5.8e-40  Score=288.53  Aligned_cols=247  Identities=19%  Similarity=0.227  Sum_probs=201.6

Q ss_pred             CcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC--hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 019536           56 NYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST--LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFE  133 (339)
Q Consensus        56 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  133 (339)
                      +|++.+.||.|+||.||+|.+..++..||+|.+.....  ......+.+|+.++++++||||+++++++.+++..++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            58889999999999999999988899999999876432  2456778899999999999999999999999999999999


Q ss_pred             eccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCcee
Q 019536          134 SVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHV  211 (339)
Q Consensus       134 ~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~  211 (339)
                      |+++++|.+++.  ..++......++.|++.||.|||   +.+++|+||+|+||++++++.++|+|||.+......... 
T Consensus        81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-  156 (258)
T cd05578          81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT-  156 (258)
T ss_pred             CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCccc-
Confidence            999999999886  36888889999999999999999   899999999999999999999999999998776544321 


Q ss_pred             eecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCccc
Q 019536          212 REEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFD  291 (339)
Q Consensus       212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (339)
                        ....++..|+|||.+.+..++.++|+||+|+++|+|++|..||......      ............           
T Consensus       157 --~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~~-----------  217 (258)
T cd05578         157 --TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT------IRDQIRAKQETA-----------  217 (258)
T ss_pred             --cccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc------HHHHHHHHhccc-----------
Confidence              1345788899999998888999999999999999999999997533221      011111111100           


Q ss_pred             CCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCH--HHHH
Q 019536          292 EDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLM--VDVA  328 (339)
Q Consensus       292 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~--~~il  328 (339)
                         ..+.+...+..+.+++.+||+.||.+||++  .|++
T Consensus       218 ---~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         218 ---DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             ---cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence               001112345679999999999999999999  6655

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-41  Score=286.86  Aligned_cols=240  Identities=21%  Similarity=0.258  Sum_probs=203.9

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC--hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST--LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVF  132 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  132 (339)
                      ++|..++++|+|+||.|-.++.+.+++.+|+|++++...  ......-+.|-++|+..+||.+..+--.|+..+.+|.||
T Consensus       168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM  247 (516)
T KOG0690|consen  168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM  247 (516)
T ss_pred             chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence            789999999999999999999999999999999988632  345566778999999999999999999999999999999


Q ss_pred             EeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCce
Q 019536          133 ESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH  210 (339)
Q Consensus       133 e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~  210 (339)
                      ||..||.|.-++.  ..+++.....+-..|+.||.|||   +.+|+.||||.+|+|+|++|.+||.|||+++.-..... 
T Consensus       248 eyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~-  323 (516)
T KOG0690|consen  248 EYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGD-  323 (516)
T ss_pred             EEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhcccccc-
Confidence            9999999998887  56777778889999999999999   89999999999999999999999999999875443332 


Q ss_pred             eeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcc
Q 019536          211 VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIF  290 (339)
Q Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (339)
                       ++...+||+.|+|||++....|+.++|+|.+||+||||++|+.||.....                     .++++-++
T Consensus       324 -t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh---------------------~kLFeLIl  381 (516)
T KOG0690|consen  324 -TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH---------------------EKLFELIL  381 (516)
T ss_pred             -eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch---------------------hHHHHHHH
Confidence             33368999999999999999999999999999999999999999742211                     11222233


Q ss_pred             cCCCCCCCcHHHHHHHHHHHHHhhccCCCCCC
Q 019536          291 DEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP  322 (339)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp  322 (339)
                      .++..+|.  ..+++++.|+..+|..||.+|.
T Consensus       382 ~ed~kFPr--~ls~eAktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  382 MEDLKFPR--TLSPEAKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             hhhccCCc--cCCHHHHHHHHHHhhcChHhhc
Confidence            33444443  5667899999999999999995

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-41  Score=296.73  Aligned_cols=246  Identities=20%  Similarity=0.281  Sum_probs=206.0

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC--hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST--LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVF  132 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  132 (339)
                      +.|..-++||.|+||.||-+....+|+.+|.|++.+...  .....-.++|-.+|..++.+.||.+--+|+..+.+|||+
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL  264 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL  264 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence            578888999999999999999999999999999876522  234455779999999999999999999999999999999


Q ss_pred             EeccCCccccccc----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCC
Q 019536          133 ESVKYGTLRGFSF----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE  208 (339)
Q Consensus       133 e~~~~g~L~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~  208 (339)
                      ..|.||+|.-++.    ..+++...+.++.+|+.||++||   ..+||.|||||+|||+|+.|.++|+|+|+|..+....
T Consensus       265 tlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~  341 (591)
T KOG0986|consen  265 TLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK  341 (591)
T ss_pred             EeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEecCCCC
Confidence            9999999998876    46889999999999999999999   9999999999999999999999999999999887766


Q ss_pred             ceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccC
Q 019536          209 THVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDP  288 (339)
Q Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (339)
                      ...   ..+||.+|||||++.+..|+.++|+||+||++|||+.|+.||.......    ...+....             
T Consensus       342 ~~~---~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv----k~eEvdrr-------------  401 (591)
T KOG0986|consen  342 PIR---GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV----KREEVDRR-------------  401 (591)
T ss_pred             ccc---cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh----hHHHHHHH-------------
Confidence            543   3479999999999999999999999999999999999999986332211    11111111             


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHH
Q 019536          289 IFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMV  325 (339)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~  325 (339)
                      .+.....++  ...++++++|...+|+.||++|.-.+
T Consensus       402 ~~~~~~ey~--~kFS~eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  402 TLEDPEEYS--DKFSEEAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             Hhcchhhcc--cccCHHHHHHHHHHHccCHHHhccCC
Confidence            111122222  46788999999999999999997654

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=8.2e-40  Score=287.09  Aligned_cols=248  Identities=21%  Similarity=0.288  Sum_probs=199.8

Q ss_pred             CcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC-hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 019536           56 NYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST-LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFES  134 (339)
Q Consensus        56 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  134 (339)
                      +|++.+.||.|+||.||+|....++..+|+|.+..... ....+.+.+|+.+++.++|+||+++++.+.+++..++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            57888999999999999999998999999999876422 13445677999999999999999999999999999999999


Q ss_pred             ccCCcccccccc----CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCC-ceEEecCCCccccCCCCc
Q 019536          135 VKYGTLRGFSFA----SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENY-SAKLHDFSLSVSIPEGET  209 (339)
Q Consensus       135 ~~~g~L~~~~~~----~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~-~~kl~dfg~a~~~~~~~~  209 (339)
                      +++++|.+++..    .+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++ .++++|||.+........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME  157 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence            999999988752    4688889999999999999999   89999999999999998875 469999999887654332


Q ss_pred             eeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCc
Q 019536          210 HVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPI  289 (339)
Q Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (339)
                      ..  ....|+..|+|||++.+..++.++|+||||+++|++++|..||....        ..+...... ....    .  
T Consensus       158 ~~--~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~-~~~~----~--  220 (257)
T cd08225         158 LA--YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN--------LHQLVLKIC-QGYF----A--  220 (257)
T ss_pred             cc--cccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc--------HHHHHHHHh-cccC----C--
Confidence            21  12457888999999988889999999999999999999999974221        111111111 1111    0  


Q ss_pred             ccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          290 FDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                             +.....+..+.+++.+||+.+|++|||+.+++++
T Consensus       221 -------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         221 -------PISPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             -------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence                   0011334579999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.4e-39  Score=290.47  Aligned_cols=250  Identities=21%  Similarity=0.319  Sum_probs=203.9

Q ss_pred             HhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 019536           53 ATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVF  132 (339)
Q Consensus        53 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  132 (339)
                      .++.|+....||+|++|.||+|.+..++..|++|++.....  ..+.+.+|+.+++.++|+|++++++++...+..++|+
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   94 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM   94 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence            45678889999999999999999988899999999976543  4567889999999999999999999999999999999


Q ss_pred             EeccCCcccccccc---CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCc
Q 019536          133 ESVKYGTLRGFSFA---SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGET  209 (339)
Q Consensus       133 e~~~~g~L~~~~~~---~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~  209 (339)
                      ||+++++|.+++..   .+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++........
T Consensus        95 e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  171 (286)
T cd06614          95 EYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS  171 (286)
T ss_pred             eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence            99999999999872   6888999999999999999999   89999999999999999999999999999766543321


Q ss_pred             eeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCc
Q 019536          210 HVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPI  289 (339)
Q Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (339)
                      .  .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||.....     ....   ..... ...       
T Consensus       172 ~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~-----~~~~---~~~~~-~~~-------  233 (286)
T cd06614         172 K--RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP-----LRAL---FLITT-KGI-------  233 (286)
T ss_pred             h--hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH-----HHHH---HHHHh-cCC-------
Confidence            1  1134577889999999888899999999999999999999999742111     1111   11000 000       


Q ss_pred             ccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          290 FDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                          ...+....++..+.+++.+||+.+|.+|||+.++++
T Consensus       234 ----~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         234 ----PPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             ----CCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence                011111234567999999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=2e-39  Score=283.09  Aligned_cols=248  Identities=23%  Similarity=0.334  Sum_probs=203.8

Q ss_pred             CcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEec
Q 019536           56 NYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESV  135 (339)
Q Consensus        56 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  135 (339)
                      +|+..+.||+|++|.||++....++..+++|++..... .....+.+|+.+++.++|||++++++++..++..++++||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~   79 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC   79 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence            47888999999999999999988899999999987654 45677889999999999999999999999999999999999


Q ss_pred             cCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceee
Q 019536          136 KYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVR  212 (339)
Q Consensus       136 ~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~  212 (339)
                      ++++|.+++.   ..+++..+..++.|++.||.|||   ..+++|+||+|+||+++.++.++|+|||.+........   
T Consensus        80 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---  153 (253)
T cd05122          80 SGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---  153 (253)
T ss_pred             CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---
Confidence            9999998875   36788999999999999999999   89999999999999999999999999999877655432   


Q ss_pred             ecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccC
Q 019536          213 EEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDE  292 (339)
Q Consensus       213 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (339)
                      .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||.....     .....   .... ....         
T Consensus       154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~---~~~~-~~~~---------  215 (253)
T cd05122         154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP-----MKALF---KIAT-NGPP---------  215 (253)
T ss_pred             ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch-----HHHHH---HHHh-cCCC---------
Confidence            1134678899999999888889999999999999999999999752211     11111   1000 1000         


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          293 DNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       293 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                        ..+....++..+.+++.+||+.||++|||+.+++++
T Consensus       216 --~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         216 --GLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             --CcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence              011111235679999999999999999999999863

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1e-39  Score=290.60  Aligned_cols=242  Identities=16%  Similarity=0.217  Sum_probs=187.8

Q ss_pred             ceeccCCeeEEEEEEcCCCeeEEEEEeccCCCh--hhHHHHHHHHHHHH---hcCCCceeeeeeeeeeCCccEEEEEecc
Q 019536           62 VIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTL--DDVEYCFNNIVFSS---QMKHKNILKLIGCCLETELPTLVFESVK  136 (339)
Q Consensus        62 ~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~---~l~H~niv~~~~~~~~~~~~~lv~e~~~  136 (339)
                      .||+|+||.||++....+++.+|+|.+......  .....+.+|..+++   ...||||+.+++++..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            489999999999999889999999998764321  22233445544333   3479999999999999999999999999


Q ss_pred             CCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceeeec
Q 019536          137 YGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREE  214 (339)
Q Consensus       137 ~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~~  214 (339)
                      +|+|.+++.  ..+++.....++.|++.||.|||   +.+|+||||||+||+++.++.++|+|||++........    .
T Consensus        81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~----~  153 (279)
T cd05633          81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP----H  153 (279)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc----c
Confidence            999988875  56899999999999999999999   89999999999999999999999999999876543222    1


Q ss_pred             ccccccccccccccc-cCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCC
Q 019536          215 FIKGAYGFIAPEYFA-TSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDED  293 (339)
Q Consensus       215 ~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (339)
                      ...|+..|+|||.+. +..++.++|+||+||++|+|++|..||.......  ..    ........            ..
T Consensus       154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~----~~~~~~~~------------~~  215 (279)
T cd05633         154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--KH----EIDRMTLT------------VN  215 (279)
T ss_pred             CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC--HH----HHHHHhhc------------CC
Confidence            245889999999986 4568999999999999999999999985332211  00    01100000            00


Q ss_pred             CCCCCcHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 019536          294 NSFPGKEEKLQSLGQLMYKCLSKSPEHRP-----LMVDVAKQ  330 (339)
Q Consensus       294 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~il~~  330 (339)
                      ...  +...+..+.+++.+||+.||++||     |+.+++++
T Consensus       216 ~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         216 VEL--PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             cCC--ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            011  123556799999999999999999     59888774

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-39  Score=292.81  Aligned_cols=269  Identities=17%  Similarity=0.254  Sum_probs=196.3

Q ss_pred             CcccCCceeccCCeeEEEEEEcC--CCeeEEEEEeccCC--ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeC--CccE
Q 019536           56 NYDLHKVIQSDTSYRLFEGTLVD--QDRPISVMKFHDNS--TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLET--ELPT  129 (339)
Q Consensus        56 ~~~~~~~ig~G~~g~V~~~~~~~--~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~--~~~~  129 (339)
                      .|++.+.||+|++|.||+|....  ++..||+|.+....  .....+.+.+|+.+++.++||||+++++++.+.  +..+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            47888999999999999999987  78999999988742  113345677899999999999999999999988  7899


Q ss_pred             EEEEeccCCccccccc-------cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCC----CCceEEecC
Q 019536          130 LVFESVKYGTLRGFSF-------ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDE----NYSAKLHDF  198 (339)
Q Consensus       130 lv~e~~~~g~L~~~~~-------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~----~~~~kl~df  198 (339)
                      +||||+++ ++.+++.       ..++...+..++.|++.||.|||   +.+|+||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999975 5554432       25778888999999999999999   899999999999999999    899999999


Q ss_pred             CCccccCCCCc-eeeecccccccccccccccccC-CCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchh----HHHH
Q 019536          199 SLSVSIPEGET-HVREEFIKGAYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLT----VLEY  272 (339)
Q Consensus       199 g~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~----~~~~  272 (339)
                      |+++....... ........++..|+|||++.+. .++.++|+||||+++|+|++|++||............    ....
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            99887654332 1112234578889999988764 5889999999999999999999998644332210000    0000


Q ss_pred             HHHHhh------------cCcccccccCcccCCCCCCCc---------HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          273 AKKSIE------------NNRFGAIVDPIFDEDNSFPGK---------EEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       273 ~~~~~~------------~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      ......            ...+....+..  .....+..         ...+..+.+++.+||++||++|||+.+++++
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~  313 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDF--KTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH  313 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhc--cCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            000000            00000000000  00011100         0233568899999999999999999999853

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=2.7e-39  Score=286.02  Aligned_cols=249  Identities=18%  Similarity=0.205  Sum_probs=195.1

Q ss_pred             HHHHHHHhcCcccCCce--eccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhc-CCCceeeeeeeee
Q 019536           47 AKDLKKATNNYDLHKVI--QSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCCL  123 (339)
Q Consensus        47 ~~~~~~~~~~~~~~~~i--g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~  123 (339)
                      ..+.....++|++.+.+  |+|+||.||++....++..+|+|.+....... .     |+.....+ +||||+++++++.
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-~-----e~~~~~~~~~h~~iv~~~~~~~   79 (267)
T PHA03390          6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-I-----EPMVHQLMKDNPNFIKLYYSVT   79 (267)
T ss_pred             HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-h-----hHHHHHHhhcCCCEEEEEEEEe
Confidence            34455556788887777  99999999999999999999999987543211 1     22222222 7999999999999


Q ss_pred             eCCccEEEEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCC-ceEEecCCC
Q 019536          124 ETELPTLVFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENY-SAKLHDFSL  200 (339)
Q Consensus       124 ~~~~~~lv~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~-~~kl~dfg~  200 (339)
                      ..+..++||||+++|+|.+++.  ..+++..+..++.|++.||.|||   +.+++||||||+||+++.++ .++++|||+
T Consensus        80 ~~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~dfg~  156 (267)
T PHA03390         80 TLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGL  156 (267)
T ss_pred             cCCeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecCcc
Confidence            9999999999999999999886  36889999999999999999999   89999999999999999888 999999999


Q ss_pred             ccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcC
Q 019536          201 SVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENN  280 (339)
Q Consensus       201 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  280 (339)
                      ++......      ...++..|+|||++.+..++.++|+||+|+++|+|++|+.||.......   ..........  . 
T Consensus       157 ~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~--~-  224 (267)
T PHA03390        157 CKIIGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE---LDLESLLKRQ--Q-  224 (267)
T ss_pred             ceecCCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch---hhHHHHHHhh--c-
Confidence            87664332      2357889999999998899999999999999999999999986322211   1111111111  0 


Q ss_pred             cccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCC-HHHHHH
Q 019536          281 RFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPL-MVDVAK  329 (339)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps-~~~il~  329 (339)
                                 ..  .+.+...+..+.+++.+||+.+|.+||+ +.++++
T Consensus       225 -----------~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        225 -----------KK--LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             -----------cc--CCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence                       00  0111245667999999999999999996 588875

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.9e-39  Score=291.00  Aligned_cols=257  Identities=12%  Similarity=0.093  Sum_probs=183.5

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCC---CeeEEEEEeccCCChhhH----------HHHHHHHHHHHhcCCCceeeeeee
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQ---DRPISVMKFHDNSTLDDV----------EYCFNNIVFSSQMKHKNILKLIGC  121 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~----------~~~~~e~~~l~~l~H~niv~~~~~  121 (339)
                      ++|.+.+.||+|+||+||+|...++   +..+|+|...........          .....+...+..+.|+|+++++++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            6899999999999999999998766   566777754332211111          111223344556789999999998


Q ss_pred             eeeCC----ccEEEEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEE
Q 019536          122 CLETE----LPTLVFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKL  195 (339)
Q Consensus       122 ~~~~~----~~~lv~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl  195 (339)
                      +....    ..++++|++.. ++.+.+.  ...+...+..++.|++.||.|||   +.+|+||||||+|||++.++.++|
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~~~~l  167 (294)
T PHA02882         92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGYI  167 (294)
T ss_pred             eeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCcEEE
Confidence            76543    33677777643 4444443  24567778899999999999999   899999999999999999999999


Q ss_pred             ecCCCccccCCCCce-----eeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHH
Q 019536          196 HDFSLSVSIPEGETH-----VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL  270 (339)
Q Consensus       196 ~dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~  270 (339)
                      +|||+|+.+......     .......||+.|+|||+..+..++.++||||+||++|+|++|+.||...+.... .....
T Consensus       168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~-~~~~~  246 (294)
T PHA02882        168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN-LIHAA  246 (294)
T ss_pred             EEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH-HHHHh
Confidence            999999876432211     111134689999999999999999999999999999999999999864422110 01000


Q ss_pred             HH-HHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 019536          271 EY-AKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQL  331 (339)
Q Consensus       271 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L  331 (339)
                      .. .........            ...+   ..+..+.+++..||+.+|++||++.++++.|
T Consensus       247 ~~~~~~~~~~~~------------~~~~---~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        247 KCDFIKRLHEGK------------IKIK---NANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             HHHHHHHhhhhh------------hccC---CCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            00 001111110            0011   2345789999999999999999999999876

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=4.5e-39  Score=293.01  Aligned_cols=262  Identities=19%  Similarity=0.238  Sum_probs=191.9

Q ss_pred             Cceecc--CCeeEEEEEEcCCCeeEEEEEeccCC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeccC
Q 019536           61 KVIQSD--TSYRLFEGTLVDQDRPISVMKFHDNS-TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKY  137 (339)
Q Consensus        61 ~~ig~G--~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~  137 (339)
                      ..||.|  +||+||.+.+..+++.||+|.+.... .....+.+.+|+.+++.++||||++++++|..++..++|+||+++
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            456666  89999999999899999999987643 223456788999999999999999999999999999999999999


Q ss_pred             Cccccccc----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCce---
Q 019536          138 GTLRGFSF----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH---  210 (339)
Q Consensus       138 g~L~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~---  210 (339)
                      ++|.+++.    ..+++..+..++.|++.||+|||   +.+++||||||+||+++.++.++++||+.+.........   
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (328)
T cd08226          84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV  160 (328)
T ss_pred             CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence            99998876    34778888899999999999999   899999999999999999999999999865433221110   


Q ss_pred             --eeecccccccccccccccccC--CCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHH----------
Q 019536          211 --VREEFIKGAYGFIAPEYFATS--SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKS----------  276 (339)
Q Consensus       211 --~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~----------  276 (339)
                        .......++..|+|||++.+.  .++.++||||+||++|+|++|+.||......    ..........          
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~  236 (328)
T cd08226         161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT----QMLLQKLKGPPYSPLDITTF  236 (328)
T ss_pred             cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH----HHHHHHhcCCCCCCcccccc
Confidence              001112345679999999764  4789999999999999999999998532110    0000000000          


Q ss_pred             ------hhcC---cccccccC---------cccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          277 ------IENN---RFGAIVDP---------IFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       277 ------~~~~---~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                            ....   ....+.+.         ........+.....+..+.+|+.+||+.||++|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             chhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence                  0000   00000000         00011112223356778999999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.3e-39  Score=291.95  Aligned_cols=264  Identities=16%  Similarity=0.131  Sum_probs=194.0

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCCh-hhHHHHHHHHHHHHhcC-CCceeeeeeeeeeCCc-----
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTL-DDVEYCFNNIVFSSQMK-HKNILKLIGCCLETEL-----  127 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~-H~niv~~~~~~~~~~~-----  127 (339)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+...... .....+.+|+.+++.+. ||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            4689999999999999999999989999999998664321 23456788999999994 6999999999987665     


Q ss_pred             cEEEEEeccCCccccccc-------cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCC-CCceEEecCC
Q 019536          128 PTLVFESVKYGTLRGFSF-------ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDE-NYSAKLHDFS  199 (339)
Q Consensus       128 ~~lv~e~~~~g~L~~~~~-------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~-~~~~kl~dfg  199 (339)
                      .++||||+++ +|.+++.       ..+++..+..++.||+.||.|||   +.+++||||+|+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeecc
Confidence            7999999985 7777653       24688889999999999999999   899999999999999998 8899999999


Q ss_pred             CccccCCCCceeeeccccccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhh
Q 019536          200 LSVSIPEGETHVREEFIKGAYGFIAPEYFAT-SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIE  278 (339)
Q Consensus       200 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  278 (339)
                      +++.+........  ...+++.|+|||++.+ ..++.++|+||||+++|+|++|..||.....     ............
T Consensus       157 ~~~~~~~~~~~~~--~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~-----~~~~~~~~~~~~  229 (295)
T cd07837         157 LGRAFSIPVKSYT--HEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSE-----LQQLLHIFKLLG  229 (295)
T ss_pred             cceecCCCccccC--CcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH-----HHHHHHHHHHhC
Confidence            9876543222111  2346788999998865 4578999999999999999999999753211     111111111000


Q ss_pred             ---cCcccccccC---cccCCCCCCC----cHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          279 ---NNRFGAIVDP---IFDEDNSFPG----KEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       279 ---~~~~~~~~~~---~~~~~~~~~~----~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                         ...+......   ..........    ....+..+.++|.+||+.||++|||+.+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         230 TPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             CCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence               0000000000   0000000000    0124567899999999999999999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-41  Score=278.52  Aligned_cols=251  Identities=20%  Similarity=0.287  Sum_probs=202.1

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCccEEEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLETELPTLVFE  133 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e  133 (339)
                      ++.+.+..+|+|+.|+|++++...+|...|||.+......+..++++..+.++..- ..|+||+-+|+|..+...++.||
T Consensus        92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe  171 (391)
T KOG0983|consen   92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME  171 (391)
T ss_pred             HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence            45666788999999999999999999999999999887778888888888877655 48999999999999998899999


Q ss_pred             eccCCccccc---cccCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCce
Q 019536          134 SVKYGTLRGF---SFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH  210 (339)
Q Consensus       134 ~~~~g~L~~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~  210 (339)
                      .|.. .++.+   +..++|+...=++...+++||.||-+  +.+|+|||+||+|||+|+.|.+|+||||++..+.+....
T Consensus       172 lMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh  248 (391)
T KOG0983|consen  172 LMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH  248 (391)
T ss_pred             HHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeeccccc
Confidence            8743 34333   34778877777888999999999996  789999999999999999999999999999877655433


Q ss_pred             eeeccccccccccccccccc---CCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCccccccc
Q 019536          211 VREEFIKGAYGFIAPEYFAT---SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVD  287 (339)
Q Consensus       211 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (339)
                      .   ...|.+.|||||.+.-   ..|+.++||||||++++||.||..||.....+    .....            ++++
T Consensus       249 t---rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td----Fe~lt------------kvln  309 (391)
T KOG0983|consen  249 T---RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD----FEVLT------------KVLN  309 (391)
T ss_pred             c---cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc----HHHHH------------HHHh
Confidence            2   3468899999999853   46999999999999999999999997632221    11111            1111


Q ss_pred             CcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          288 PIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                         .+...+|....++..+.+++..||++|+.+||...+++++
T Consensus       310 ---~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  310 ---EEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             ---cCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence               1123344445678899999999999999999999999863

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-40  Score=294.61  Aligned_cols=272  Identities=21%  Similarity=0.300  Sum_probs=209.3

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHh--cCCCceeeeeeeeeeCC----c
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQ--MKHKNILKLIGCCLETE----L  127 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~--l~H~niv~~~~~~~~~~----~  127 (339)
                      ....++..+||+|.||.||+|..  +++.||||++..    +..+.|.+|-.|.+.  ++|+||++|+++-..+.    .
T Consensus       209 l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~e  282 (534)
T KOG3653|consen  209 LDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPE----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRME  282 (534)
T ss_pred             CCchhhHHHhhcCccceeehhhc--cCceeEEEecCH----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccc
Confidence            35566778999999999999999  679999999975    556778888777765  48999999999987655    7


Q ss_pred             cEEEEEeccCCccccccc-cCCChHHHHHHHHHHHHHHHHHhcCC------CCCeEEccCCCCCEEeCCCCceEEecCCC
Q 019536          128 PTLVFESVKYGTLRGFSF-ASLLIAPRIKIAMEIANAVAYLHVGF------DRPIVFRCIKASNVLLDENYSAKLHDFSL  200 (339)
Q Consensus       128 ~~lv~e~~~~g~L~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~------~~~i~H~dlk~~Nil~~~~~~~kl~dfg~  200 (339)
                      ++||+||.+.|+|.+++. ..++|....+++..+++||+|||+..      +.+|+|||||..|||+.+++++.|+|||+
T Consensus       283 ywLVt~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL  362 (534)
T KOG3653|consen  283 YWLVTEFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL  362 (534)
T ss_pred             eeEEeeeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence            899999999999999998 67899999999999999999999433      56799999999999999999999999999


Q ss_pred             ccccCCCCceeeecccccccccccccccccCC-CC-----cccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHH
Q 019536          201 SVSIPEGETHVREEFIKGAYGFIAPEYFATSS-FN-----EMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAK  274 (339)
Q Consensus       201 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~  274 (339)
                      |..+............+||.+|||||++.+.. +.     .+.||||+|.++||++++...+. ++.....++.....+.
T Consensus       363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~-~~~vp~Yqlpfe~evG  441 (534)
T KOG3653|consen  363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDAD-PGPVPEYQLPFEAEVG  441 (534)
T ss_pred             eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhccccc-CCCCCcccCchhHHhc
Confidence            99987765554444578999999999997653 22     46899999999999999876653 2433333333332222


Q ss_pred             HHhhcCccccc-----ccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 019536          275 KSIENNRFGAI-----VDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMY  335 (339)
Q Consensus       275 ~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~  335 (339)
                      ..+.-+.+..+     ..|.++..  +.. ......+.+.+..||..||+.|.|+.-+.+++.++.
T Consensus       442 ~hPt~e~mq~~VV~kK~RP~~p~~--W~~-h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~  504 (534)
T KOG3653|consen  442 NHPTLEEMQELVVRKKQRPKIPDA--WRK-HAGMAVLCETIEECWDHDAEARLTAGCVEERMAELM  504 (534)
T ss_pred             CCCCHHHHHHHHHhhccCCCChhh--hhc-CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence            21111111111     01111110  000 133456899999999999999999999999998876

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-40  Score=280.99  Aligned_cols=249  Identities=20%  Similarity=0.245  Sum_probs=200.2

Q ss_pred             HhcCcccC-CceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhc-CCCceeeeeeeeeeC----C
Q 019536           53 ATNNYDLH-KVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLET----E  126 (339)
Q Consensus        53 ~~~~~~~~-~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~----~  126 (339)
                      .+++|++. .+||-|-.|.|-.+..+.+++.+|+|++..      .+...+|+++.-.. .|||||++++++.+.    .
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk  132 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD------SPKARREVELHWMASGHPHIVSIIDVYENSYQGRK  132 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc------CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence            45677764 678999999999999999999999999854      34566888877555 699999999998753    3


Q ss_pred             ccEEEEEeccCCccccccc----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeC---CCCceEEecCC
Q 019536          127 LPTLVFESVKYGTLRGFSF----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLD---ENYSAKLHDFS  199 (339)
Q Consensus       127 ~~~lv~e~~~~g~L~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~---~~~~~kl~dfg  199 (339)
                      .+.+|||.++||.|...+.    ..+++.++..|+.||..|+.|||   +.+|.||||||+|+|..   .|..+||+|||
T Consensus       133 cLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDfG  209 (400)
T KOG0604|consen  133 CLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDFG  209 (400)
T ss_pred             eeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEecccc
Confidence            4679999999999998886    45888999999999999999999   99999999999999996   45679999999


Q ss_pred             CccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhc
Q 019536          200 LSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIEN  279 (339)
Q Consensus       200 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  279 (339)
                      +|+.-..+....   +.+-|+.|.|||++....|+..+|+||+||+||-|++|.+||-........     --..     
T Consensus       210 FAK~t~~~~~L~---TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ais-----pgMk-----  276 (400)
T KOG0604|consen  210 FAKETQEPGDLM---TPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-----PGMK-----  276 (400)
T ss_pred             cccccCCCcccc---CCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCC-----hhHH-----
Confidence            998765433322   456799999999999889999999999999999999999998432221100     0001     


Q ss_pred             CcccccccCcccCCCCCC--CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          280 NRFGAIVDPIFDEDNSFP--GKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                             ..+...+..+|  .+...++..+++|+++|..+|.+|.|+.+++.+
T Consensus       277 -------~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h  322 (400)
T KOG0604|consen  277 -------RRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH  322 (400)
T ss_pred             -------hHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence                   11222334444  345678999999999999999999999998763

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=2.8e-39  Score=295.51  Aligned_cols=272  Identities=20%  Similarity=0.260  Sum_probs=198.8

Q ss_pred             HhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccC-CChhhHHHHHHHHHHHHhc-CCCceeeeeeeeeeC--Ccc
Q 019536           53 ATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDN-STLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLET--ELP  128 (339)
Q Consensus        53 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~--~~~  128 (339)
                      ..++|++.+.||+|+||.||+|.+..++..+|+|++... ........+.+|+.+++++ +||||++++++|...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            457899999999999999999999888999999988653 2223445677899999999 999999999998653  467


Q ss_pred             EEEEEeccCCccccccc-cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCC
Q 019536          129 TLVFESVKYGTLRGFSF-ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEG  207 (339)
Q Consensus       129 ~lv~e~~~~g~L~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~  207 (339)
                      ++||||++ ++|..++. ..+++..+..++.|++.||.|||   +.+|+|+||||+||+++.++.+||+|||++......
T Consensus        85 ~lv~e~~~-~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~  160 (337)
T cd07852          85 YLVFEYME-TDLHAVIRANILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL  160 (337)
T ss_pred             EEEecccc-cCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence            99999997 58887775 46778888889999999999999   899999999999999999999999999998876543


Q ss_pred             Cce---eeeccccccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHH-------
Q 019536          208 ETH---VREEFIKGAYGFIAPEYFAT-SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKS-------  276 (339)
Q Consensus       208 ~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-------  276 (339)
                      ...   .......|+..|+|||++.+ ..++.++|+||||+++|+|++|+.||......  ............       
T Consensus       161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~  238 (337)
T cd07852         161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTL--NQLEKIIEVIGPPSAEDIE  238 (337)
T ss_pred             cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCCHHHHH
Confidence            321   11123457889999998765 45789999999999999999999997532211  100000000000       


Q ss_pred             -hhcCcccccccCcccCCCC-C-CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          277 -IENNRFGAIVDPIFDEDNS-F-PGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       277 -~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                       ........+.+........ . ......+.++.+++.+||+.||++|||+.++++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         239 SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence             0000000001100000000 0 0001245678999999999999999999999974

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=7.6e-39  Score=280.52  Aligned_cols=252  Identities=21%  Similarity=0.274  Sum_probs=205.3

Q ss_pred             CcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC-hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeC--CccEEEE
Q 019536           56 NYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST-LDDVEYCFNNIVFSSQMKHKNILKLIGCCLET--ELPTLVF  132 (339)
Q Consensus        56 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~--~~~~lv~  132 (339)
                      +|+..+.||+|++|.||+|....++..|++|++..... ....+.+.+|+.++++++||||+++++.+.+.  +..++|+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            47788999999999999999998899999999876532 24567788999999999999999999999988  8899999


Q ss_pred             EeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCce
Q 019536          133 ESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH  210 (339)
Q Consensus       133 e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~  210 (339)
                      ||+++++|.+++.  ..+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||.+.........
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  157 (260)
T cd06606          81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG  157 (260)
T ss_pred             EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence            9999999999876  46888999999999999999999   899999999999999999999999999998877654421


Q ss_pred             eeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcc
Q 019536          211 VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIF  290 (339)
Q Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (339)
                      .......++..|+|||.+.+..++.++|+||||+++++|++|..||....       ...............        
T Consensus       158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~--------  222 (260)
T cd06606         158 EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-------NPMAALYKIGSSGEP--------  222 (260)
T ss_pred             ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------chHHHHHhccccCCC--------
Confidence            11123567889999999988889999999999999999999999975332       111111111100000        


Q ss_pred             cCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          291 DEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                           .+.+...+..+.+++.+||+.+|++|||+.+++.+
T Consensus       223 -----~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~  257 (260)
T cd06606         223 -----PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH  257 (260)
T ss_pred             -----cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence                 01112345689999999999999999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.8e-40  Score=299.73  Aligned_cols=261  Identities=18%  Similarity=0.216  Sum_probs=195.4

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC-hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC------c
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST-LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETE------L  127 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~------~  127 (339)
                      ++|.+.+.||+|+||.||+|.+..++..||+|++..... ......+.+|+.+++.++||||+++++++....      .
T Consensus        15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   94 (342)
T cd07879          15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD   94 (342)
T ss_pred             cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence            789999999999999999999988899999999876432 223456789999999999999999999987543      3


Q ss_pred             cEEEEEeccCCccccccccCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCC
Q 019536          128 PTLVFESVKYGTLRGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEG  207 (339)
Q Consensus       128 ~~lv~e~~~~g~L~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~  207 (339)
                      .++|+||+.. +|..+....+++..+..++.|++.||.|||   +.+++||||||+||+++.++.++|+|||+++.....
T Consensus        95 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~  170 (342)
T cd07879          95 FYLVMPYMQT-DLQKIMGHPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE  170 (342)
T ss_pred             EEEEeccccc-CHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC
Confidence            5899999964 676666567899999999999999999999   899999999999999999999999999998765332


Q ss_pred             Cceeeeccccccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHh---------
Q 019536          208 ETHVREEFIKGAYGFIAPEYFAT-SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSI---------  277 (339)
Q Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------  277 (339)
                      ..     ...++..|+|||++.+ ..++.++|+|||||++|+|++|+.||....     ............         
T Consensus       171 ~~-----~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~-----~~~~~~~~~~~~~~~~~~~~~  240 (342)
T cd07879         171 MT-----GYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD-----YLDQLTQILKVTGVPGPEFVQ  240 (342)
T ss_pred             CC-----CceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHhcCCCCHHHHH
Confidence            21     2357788999999876 468899999999999999999999985321     111111111000         


Q ss_pred             --hcCccccccc--CcccCCCCCC-CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          278 --ENNRFGAIVD--PIFDEDNSFP-GKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       278 --~~~~~~~~~~--~~~~~~~~~~-~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                        ..........  +... ...+. .....+..+.+|+.+||+.||++|||+.+++.+
T Consensus       241 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h  297 (342)
T cd07879         241 KLEDKAAKSYIKSLPKYP-RKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH  297 (342)
T ss_pred             HhcccchHHHHhhcCCcc-cchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence              0000000000  0000 00000 001234568899999999999999999999864

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=4.4e-39  Score=288.90  Aligned_cols=252  Identities=20%  Similarity=0.275  Sum_probs=195.7

Q ss_pred             HhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCccEEE
Q 019536           53 ATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLETELPTLV  131 (339)
Q Consensus        53 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~~lv  131 (339)
                      ..++|++.+.||+|++|.||+|.+..+++.||||.+...........+..|+.++... .||||+++++++.++...++|
T Consensus        13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v   92 (296)
T cd06618          13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC   92 (296)
T ss_pred             CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence            3477899999999999999999998889999999997654434455667787766666 499999999999999999999


Q ss_pred             EEeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCC-CCeEEccCCCCCEEeCCCCceEEecCCCccccCCC
Q 019536          132 FESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFD-RPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEG  207 (339)
Q Consensus       132 ~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~  207 (339)
                      |||++ +++.++..   ..+++..+..++.|++.||.|||   + .+|+||||+|+||++++++.+||+|||++..+...
T Consensus        93 ~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~  168 (296)
T cd06618          93 MELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLK---EKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS  168 (296)
T ss_pred             eeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hhCCEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence            99985 45555543   56888888999999999999999   6 58999999999999999999999999998766443


Q ss_pred             CceeeecccccccccccccccccCC----CCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCccc
Q 019536          208 ETHVREEFIKGAYGFIAPEYFATSS----FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFG  283 (339)
Q Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (339)
                      ....   ...++..|+|||.+.+..    ++.++|+||||+++|+|++|+.||.....       ..+..........  
T Consensus       169 ~~~~---~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~~~~~~~~~~~--  236 (296)
T cd06618         169 KAKT---RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT-------EFEVLTKILQEEP--  236 (296)
T ss_pred             Cccc---CCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh-------HHHHHHHHhcCCC--
Confidence            2221   234678899999987554    78899999999999999999999752111       0111111111110  


Q ss_pred             ccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          284 AIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                                ...+.....+.++.+|+.+||+.||++|||+.+++++
T Consensus       237 ----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         237 ----------PSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             ----------CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                      0011111244579999999999999999999999875

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2.3e-39  Score=287.88  Aligned_cols=242  Identities=19%  Similarity=0.261  Sum_probs=192.0

Q ss_pred             eeccCCeeEEEEEEcCCCeeEEEEEeccCCC--hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeccCCcc
Q 019536           63 IQSDTSYRLFEGTLVDQDRPISVMKFHDNST--LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL  140 (339)
Q Consensus        63 ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L  140 (339)
                      ||+|+||+||++....+++.||+|.+.....  ......+.+|+.+++.++||||+++++++...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            6899999999999988999999999875421  13345567899999999999999999999999999999999999999


Q ss_pred             ccccc--c--CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceeeeccc
Q 019536          141 RGFSF--A--SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI  216 (339)
Q Consensus       141 ~~~~~--~--~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~~~~  216 (339)
                      .+++.  .  .+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||.+.........   ...
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~---~~~  154 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKI---KGR  154 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCcc---ccc
Confidence            98875  2  5788888999999999999999   899999999999999999999999999998765432221   124


Q ss_pred             ccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCCCCC
Q 019536          217 KGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSF  296 (339)
Q Consensus       217 ~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (339)
                      .++..|+|||++.+..++.++|+||+|+++|+|++|+.||.......    .. .......            .......
T Consensus       155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~-~~~~~~~------------~~~~~~~  217 (277)
T cd05577         155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV----EK-EELKRRT------------LEMAVEY  217 (277)
T ss_pred             cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccc----cH-HHHHhcc------------ccccccC
Confidence            57788999999988889999999999999999999999985332211    00 0000000            0001111


Q ss_pred             CCcHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 019536          297 PGKEEKLQSLGQLMYKCLSKSPEHRP-----LMVDVAK  329 (339)
Q Consensus       297 ~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~il~  329 (339)
                        +...+..+.+++.+||+.||++||     ++.+++.
T Consensus       218 --~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         218 --PDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             --CccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence              123456789999999999999999     6666654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-40  Score=282.89  Aligned_cols=267  Identities=21%  Similarity=0.279  Sum_probs=211.3

Q ss_pred             cHHHHHHHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhc-CCCceeeeeeeeee
Q 019536           46 SAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLE  124 (339)
Q Consensus        46 ~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~  124 (339)
                      .+.|+.+.|+     +.+|+|+|+.|-.+....+|..||||++.+... ....++.+|++++.+. .|+||++++++|++
T Consensus        74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~g-HsR~RvfREVe~f~~Cqgh~nilqLiefFEd  147 (463)
T KOG0607|consen   74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPG-HSRSRVFREVETFYQCQGHKNILQLIEFFED  147 (463)
T ss_pred             hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCc-hHHHHHHHHHHHHHHhcCCccHHHHHHHhcc
Confidence            4556666655     469999999999999999999999999998865 6788899999999999 59999999999999


Q ss_pred             CCccEEEEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCC---ceEEecCC
Q 019536          125 TELPTLVFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENY---SAKLHDFS  199 (339)
Q Consensus       125 ~~~~~lv~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~---~~kl~dfg  199 (339)
                      +..+|||||-|.||+|..++.  ..+.+.++..+..+|+.||.+||   .+||.||||||+|||.....   -+||+||.
T Consensus       148 d~~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCDfD  224 (463)
T KOG0607|consen  148 DTRFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICDFD  224 (463)
T ss_pred             cceEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeeccc
Confidence            999999999999999998887  57888999999999999999999   99999999999999986543   37999999


Q ss_pred             CccccCCCC-----ceeeecccccccccccccccc---c--CCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCch--
Q 019536          200 LSVSIPEGE-----THVREEFIKGAYGFIAPEYFA---T--SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDL--  267 (339)
Q Consensus       200 ~a~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~---~--~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~--  267 (339)
                      ++.....+.     ......+.+|+..|||||+..   +  ..|+.++|.||||+++|-|++|++||......+..+.  
T Consensus       225 LgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrG  304 (463)
T KOG0607|consen  225 LGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRG  304 (463)
T ss_pred             cccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCC
Confidence            864332111     111122467889999999753   3  3589999999999999999999999976555544332  


Q ss_pred             hHHHHHHHHhhcCcccccccCcccCCCCCCCc--HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          268 TVLEYAKKSIENNRFGAIVDPIFDEDNSFPGK--EEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                      ..+...+..        +++++-.....+|..  ..++.+.++|++.+|..|+.+|.++.+++.
T Consensus       305 e~Cr~CQ~~--------LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  305 EVCRVCQNK--------LFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             CccHHHHHH--------HHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            222222221        112222233445533  356889999999999999999999998876

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-39  Score=284.31  Aligned_cols=251  Identities=19%  Similarity=0.219  Sum_probs=198.2

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC----ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeC--Ccc
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS----TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLET--ELP  128 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~--~~~  128 (339)
                      .+|++.+.||+|+||.||+|.+..++..||+|.+....    .......+.+|+.++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            47899999999999999999999899999999875431    223456788999999999999999999998764  457


Q ss_pred             EEEEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCC
Q 019536          129 TLVFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPE  206 (339)
Q Consensus       129 ~lv~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~  206 (339)
                      ++|+||+++++|.+++.  ..+++.....++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||+++....
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  158 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQT  158 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence            89999999999998875  45788888999999999999999   89999999999999999999999999999876533


Q ss_pred             CCc-eeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCccccc
Q 019536          207 GET-HVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAI  285 (339)
Q Consensus       207 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (339)
                      ... ........++..|+|||++.+..++.++|+|||||++|++++|+.||....     ..   ...........    
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~---~~~~~~~~~~~----  226 (264)
T cd06653         159 ICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYE-----AM---AAIFKIATQPT----  226 (264)
T ss_pred             ccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccC-----HH---HHHHHHHcCCC----
Confidence            111 011113457889999999988889999999999999999999999975211     11   11111110000    


Q ss_pred             ccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          286 VDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                             ..  ..+...+..+.+++.+||+ +|..|||+.+++.+
T Consensus       227 -------~~--~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~  261 (264)
T cd06653         227 -------KP--MLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH  261 (264)
T ss_pred             -------CC--CCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence                   00  1122456679999999999 57999999988763

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=2e-39  Score=293.43  Aligned_cols=256  Identities=20%  Similarity=0.289  Sum_probs=189.2

Q ss_pred             CCeeEEEEEEcCCCeeEEEEEeccC-CChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeccCCccccccc
Q 019536           67 TSYRLFEGTLVDQDRPISVMKFHDN-STLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSF  145 (339)
Q Consensus        67 ~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~  145 (339)
                      +++.||.+....+++.||+|++... ........+.+|+.+++.++||||+++++++.+.+..+++|||+++|+|.+++.
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~   91 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK   91 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence            4455566666658999999999765 333566788999999999999999999999999999999999999999998876


Q ss_pred             ----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCce-----eeeccc
Q 019536          146 ----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH-----VREEFI  216 (339)
Q Consensus       146 ----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~-----~~~~~~  216 (339)
                          ..++......++.|++.||.|||   +.+|+||||||+||+++.++.+|++|||.+..+......     ......
T Consensus        92 ~~~~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~  168 (314)
T cd08216          92 THFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSS  168 (314)
T ss_pred             HhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccc
Confidence                34778888899999999999999   899999999999999999999999999988655332110     111134


Q ss_pred             ccccccccccccccC--CCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhh-----------cCccc
Q 019536          217 KGAYGFIAPEYFATS--SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIE-----------NNRFG  283 (339)
Q Consensus       217 ~gt~~y~aPE~~~~~--~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~  283 (339)
                      .++..|+|||++.+.  .++.++|+||+||++|+|++|+.||.....    .....+.......           .....
T Consensus       169 ~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (314)
T cd08216         169 VKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPA----TQMLLEKVRGTVPCLLDKSTYPLYEDSMS  244 (314)
T ss_pred             cccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhccCccccccCchhhhcCCcC
Confidence            467789999998763  588999999999999999999999853211    0111111100000           00000


Q ss_pred             c----cccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          284 A----IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       284 ~----~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                      .    ..++........+.....+..+.+++.+||++||++|||+.++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         245 QSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             cccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence            0    011111111112222345678899999999999999999999987

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.7e-39  Score=290.99  Aligned_cols=244  Identities=18%  Similarity=0.299  Sum_probs=197.1

Q ss_pred             CCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeccCCc
Q 019536           60 HKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGT  139 (339)
Q Consensus        60 ~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~  139 (339)
                      ..+||+|+||.||+|....++..||+|++..... .....+.+|+.+++.++|+||+++++++..++..++||||+++++
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  103 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA  103 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccch-hHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence            3679999999999999998999999999865433 445668899999999999999999999999999999999999999


Q ss_pred             cccccc-cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceeeeccccc
Q 019536          140 LRGFSF-ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG  218 (339)
Q Consensus       140 L~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~g  218 (339)
                      |.+++. ..+++.....++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++..........  ....+
T Consensus       104 L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~--~~~~~  178 (292)
T cd06657         104 LTDIVTHTRMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR--KSLVG  178 (292)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceecccccccc--ccccc
Confidence            998875 46788888999999999999999   8999999999999999999999999999987654432211  13457


Q ss_pred             ccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCCCCCCC
Q 019536          219 AYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPG  298 (339)
Q Consensus       219 t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (339)
                      +..|+|||.+.+..++.++|+||+|+++|+|++|..||..  ...   .........    ..     ..      ..+.
T Consensus       179 ~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~--~~~---~~~~~~~~~----~~-----~~------~~~~  238 (292)
T cd06657         179 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN--EPP---LKAMKMIRD----NL-----PP------KLKN  238 (292)
T ss_pred             CccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC--CCH---HHHHHHHHh----hC-----Cc------ccCC
Confidence            8899999999888889999999999999999999999742  111   111111110    00     00      0011


Q ss_pred             cHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          299 KEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       299 ~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                      ....+..+.+++.+||+.||.+||++.+++.
T Consensus       239 ~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         239 LHKVSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             cccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            1133456889999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=3.1e-39  Score=290.44  Aligned_cols=268  Identities=18%  Similarity=0.207  Sum_probs=198.0

Q ss_pred             HHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC-hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC----
Q 019536           52 KATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST-LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETE----  126 (339)
Q Consensus        52 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~----  126 (339)
                      ...++|++.+.||+|+||+||+|....+++.||+|.+..... ......+.+|+.+++.++||||+++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            456889999999999999999999998899999999876532 233456678999999999999999999987654    


Q ss_pred             ------ccEEEEEeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEec
Q 019536          127 ------LPTLVFESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHD  197 (339)
Q Consensus       127 ------~~~lv~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~d  197 (339)
                            ..++|+||+++ ++.+.+.   ..+++..+..++.|++.||.|||   +.+|+|+||+|+||+++.++.+||+|
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl~d  159 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLAD  159 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEeCc
Confidence                  78999999986 5555544   35788999999999999999999   89999999999999999999999999


Q ss_pred             CCCccccCCCCceeeecccccccccccccccccC-CCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHH
Q 019536          198 FSLSVSIPEGETHVREEFIKGAYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKS  276 (339)
Q Consensus       198 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  276 (339)
                      ||++.......... .....++..|+|||.+.+. .++.++||||+||++|+|++|++||...  ..   ..........
T Consensus       160 fg~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~--~~---~~~~~~~~~~  233 (302)
T cd07864         160 FGLARLYNSEESRP-YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQAN--QE---LAQLELISRL  233 (302)
T ss_pred             ccccccccCCcccc-cccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC--Ch---HHHHHHHHHH
Confidence            99988765433211 1123457789999988654 5789999999999999999999997522  11   1122111111


Q ss_pred             hhc---CcccccccCccc------CC---CCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          277 IEN---NRFGAIVDPIFD------ED---NSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       277 ~~~---~~~~~~~~~~~~------~~---~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                      ...   ..+..+......      ..   .........+..+.+++.+||+.||.+|||+.+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         234 CGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             hCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            111   001100000000      00   000001123567899999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.2e-39  Score=286.92  Aligned_cols=246  Identities=23%  Similarity=0.230  Sum_probs=195.1

Q ss_pred             eeccCCeeEEEEEEcCCCeeEEEEEeccCCC--hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeccCCcc
Q 019536           63 IQSDTSYRLFEGTLVDQDRPISVMKFHDNST--LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL  140 (339)
Q Consensus        63 ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L  140 (339)
                      ||.|+||.||++.+..+++.+++|.+.....  ......+.+|+.+++.++||||+++++.+..++..++|+||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            6899999999999998899999999876432  24456788999999999999999999999999999999999999999


Q ss_pred             ccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCc------eee
Q 019536          141 RGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGET------HVR  212 (339)
Q Consensus       141 ~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~------~~~  212 (339)
                      .+++.  ..+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++........      ...
T Consensus        81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~  157 (265)
T cd05579          81 ASLLENVGSLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE  157 (265)
T ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence            98876  46788899999999999999999   89999999999999999999999999999876543311      011


Q ss_pred             ecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccC
Q 019536          213 EEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDE  292 (339)
Q Consensus       213 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (339)
                      .....++..|+|||...+..++.++|+||||+++|++++|..||....        .......... .            
T Consensus       158 ~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~--------~~~~~~~~~~-~------------  216 (265)
T cd05579         158 DKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET--------PEEIFQNILN-G------------  216 (265)
T ss_pred             ccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHhc-C------------
Confidence            123457788999999988888999999999999999999999975221        1111111110 0            


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 019536          293 DNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLR  332 (339)
Q Consensus       293 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~  332 (339)
                      ...+|.....+..+.+++.+||+.+|.+|||+..+.+.|+
T Consensus       217 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         217 KIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             CcCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence            1111111123567899999999999999999955554443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.4e-39  Score=297.07  Aligned_cols=271  Identities=15%  Similarity=0.188  Sum_probs=199.8

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC-hhhHHHHHHHHHHHHhcCCCceeeeeeeeee----CCcc
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST-LDDVEYCFNNIVFSSQMKHKNILKLIGCCLE----TELP  128 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~----~~~~  128 (339)
                      .++|++.+.||+|++|.||+|....++..||+|++..... ......+.+|+.+++.++||||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            3789999999999999999999999999999999876532 2345667789999999999999999998763    3467


Q ss_pred             EEEEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCC
Q 019536          129 TLVFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPE  206 (339)
Q Consensus       129 ~lv~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~  206 (339)
                      ++||||+. |+|.+++.  ..+++..+..++.|++.||.|||   ..+|+||||||+||+++.++.+||+|||++.....
T Consensus        84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  159 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSS  159 (334)
T ss_pred             EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccceeecc
Confidence            99999995 68888875  56788999999999999999999   89999999999999999999999999999876543


Q ss_pred             CCcee--eeccccccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCccc
Q 019536          207 GETHV--REEFIKGAYGFIAPEYFAT-SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFG  283 (339)
Q Consensus       207 ~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (339)
                      .....  ......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.....  ..................+.
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~--~~~~~~~~~~~g~~~~~~~~  237 (334)
T cd07855         160 SPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNY--VHQLKLILSVLGSPSEEVLN  237 (334)
T ss_pred             cCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCCh--HHHHHHHHHHhCCChhHhhh
Confidence            32211  1113467889999999865 4588999999999999999999999853211  11111100000000000000


Q ss_pred             ccccC-------cccCCCCCCCc---HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          284 AIVDP-------IFDEDNSFPGK---EEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       284 ~~~~~-------~~~~~~~~~~~---~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      .+...       ........+..   ...+..+.+++.+||+.+|++|||+.+++.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            00000       00011111100   1245679999999999999999999998873

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-39  Score=312.09  Aligned_cols=272  Identities=18%  Similarity=0.223  Sum_probs=185.6

Q ss_pred             HhcCcccCCceeccCCeeEEEEEEcCCCe-eEEEEE--------------eccC--CChhhHHHHHHHHHHHHhcCCCce
Q 019536           53 ATNNYDLHKVIQSDTSYRLFEGTLVDQDR-PISVMK--------------FHDN--STLDDVEYCFNNIVFSSQMKHKNI  115 (339)
Q Consensus        53 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~-~vavK~--------------~~~~--~~~~~~~~~~~e~~~l~~l~H~ni  115 (339)
                      ..++|++.+.||+|+||+||++....... ..++|.              +.+.  ........+.+|+.+++.++||||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            45789999999999999999987643221 111111              1100  111234567899999999999999


Q ss_pred             eeeeeeeeeCCccEEEEEeccCCccccccc-c------CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeC
Q 019536          116 LKLIGCCLETELPTLVFESVKYGTLRGFSF-A------SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLD  188 (339)
Q Consensus       116 v~~~~~~~~~~~~~lv~e~~~~g~L~~~~~-~------~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~  188 (339)
                      +++++++.+.+..++|+|++.+ +|.+++. .      .........++.|++.||.|||   +++|+||||||+|||++
T Consensus       226 v~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl~  301 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLN  301 (501)
T ss_pred             CcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEC
Confidence            9999999999999999999954 5555543 1      2234556789999999999999   89999999999999999


Q ss_pred             CCCceEEecCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchh
Q 019536          189 ENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLT  268 (339)
Q Consensus       189 ~~~~~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~  268 (339)
                      .++.+||+|||+++.+....... .....||..|+|||++.+..++.++|||||||++|||++|..++...+... ....
T Consensus       302 ~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~-~~~~  379 (501)
T PHA03210        302 CDGKIVLGDFGTAMPFEKEREAF-DYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGK-PGKQ  379 (501)
T ss_pred             CCCCEEEEeCCCceecCcccccc-cccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCC-HHHH
Confidence            99999999999998775433221 113568999999999999999999999999999999999875432222111 1111


Q ss_pred             HHHHHHHHh-hcCccc-------cccc-CcccCC-CCCCC---cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          269 VLEYAKKSI-ENNRFG-------AIVD-PIFDED-NSFPG---KEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       269 ~~~~~~~~~-~~~~~~-------~~~~-~~~~~~-~~~~~---~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      ..+...... ....+.       .+++ ..+... ...+.   ....+..+.+++.+||++||++|||+.|++.+
T Consensus       380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            111111000 000000       0000 000000 00000   00123457889999999999999999999873

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-39  Score=286.19  Aligned_cols=264  Identities=18%  Similarity=0.217  Sum_probs=197.8

Q ss_pred             cccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeC--CccEEEEE
Q 019536           57 YDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS-TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLET--ELPTLVFE  133 (339)
Q Consensus        57 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~--~~~~lv~e  133 (339)
                      |++.+.||+|++|.||+|....++..+|+|++.... .......+.+|+.+++.++|||++++++++.+.  +..++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            677889999999999999999889999999998763 223445678999999999999999999999988  78999999


Q ss_pred             eccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCce
Q 019536          134 SVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH  210 (339)
Q Consensus       134 ~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~  210 (339)
                      |+++ +|.+++.   ..+++..+..++.|++.||.|||   ..+++|+||+|+||+++.++.++|+|||++.........
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~  156 (287)
T cd07840          81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA  156 (287)
T ss_pred             cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence            9975 7777765   35888889999999999999999   899999999999999999999999999998876544321


Q ss_pred             eeeccccccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhh---cCcccccc
Q 019536          211 VREEFIKGAYGFIAPEYFAT-SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIE---NNRFGAIV  286 (339)
Q Consensus       211 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~  286 (339)
                      . .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.....     ............   ...+..+.
T Consensus       157 ~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~  230 (287)
T cd07840         157 D-YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE-----LEQLEKIFELCGSPTDENWPGVS  230 (287)
T ss_pred             c-ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHHHhCCCchhhccccc
Confidence            1 112346778999998765 3578999999999999999999999752221     111111111110   11111110


Q ss_pred             cC----cccCCCCCCCc-----HH-HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          287 DP----IFDEDNSFPGK-----EE-KLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       287 ~~----~~~~~~~~~~~-----~~-~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      +.    ........+..     .. .+..+.+++.+||+.+|++|||+.++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             cchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            00    00000000000     01 25678999999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=6.1e-39  Score=289.64  Aligned_cols=245  Identities=20%  Similarity=0.260  Sum_probs=194.7

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccC--CChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDN--STLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVF  132 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  132 (339)
                      ..|+..+.||+|++|.||+|....++..+|+|.+...  ........+.+|+.+++.++|+|++++.+++......++||
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            4477788999999999999999888999999998653  22234566789999999999999999999999999999999


Q ss_pred             EeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCc
Q 019536          133 ESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGET  209 (339)
Q Consensus       133 e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~  209 (339)
                      ||+. |++.+++.   ..++...+..++.|++.||.|||   +.+++||||+|+||+++.++.++|+|||++....... 
T Consensus        95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-  169 (308)
T cd06634          95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN-  169 (308)
T ss_pred             EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecCcc-
Confidence            9996 57666553   45788888999999999999999   8999999999999999999999999999987654322 


Q ss_pred             eeeecccccccccccccccc---cCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccc
Q 019536          210 HVREEFIKGAYGFIAPEYFA---TSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIV  286 (339)
Q Consensus       210 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (339)
                           ...++..|+|||++.   ...++.++|||||||++|+|++|+.||....        .............     
T Consensus       170 -----~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--------~~~~~~~~~~~~~-----  231 (308)
T cd06634         170 -----XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--------AMSALYHIAQNES-----  231 (308)
T ss_pred             -----cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcccc--------HHHHHHHHhhcCC-----
Confidence                 245788899999974   3457889999999999999999999974211        1111111111000     


Q ss_pred             cCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          287 DPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                              ........+..+.+|+.+||+.+|++||++.++++.
T Consensus       232 --------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~  267 (308)
T cd06634         232 --------PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (308)
T ss_pred             --------CCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence                    000112455678999999999999999999999875

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-39  Score=284.49  Aligned_cols=244  Identities=20%  Similarity=0.175  Sum_probs=189.1

Q ss_pred             CceeccCCeeEEEEEEcCCCeeEEEEEeccCCC--hhhHHHHHHHHHH-HHhcCCCceeeeeeeeeeCCccEEEEEeccC
Q 019536           61 KVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST--LDDVEYCFNNIVF-SSQMKHKNILKLIGCCLETELPTLVFESVKY  137 (339)
Q Consensus        61 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~-l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~  137 (339)
                      +.||+|+||.||+|....+++.||+|.+.....  ......+..|..+ .....|||++++++++..++..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            568999999999999988999999999875422  1223334455444 4455899999999999999999999999999


Q ss_pred             Cccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceeeecc
Q 019536          138 GTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEF  215 (339)
Q Consensus       138 g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~~~  215 (339)
                      ++|.+++.  ..+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++.......      .
T Consensus        82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~------~  152 (260)
T cd05611          82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK------K  152 (260)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccccc------c
Confidence            99999886  56888999999999999999999   8999999999999999999999999999987643311      2


Q ss_pred             cccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCCCC
Q 019536          216 IKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNS  295 (339)
Q Consensus       216 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (339)
                      ..++..|+|||.+.+..++.++|+||+|+++|+|++|..||.....     ....   .. ......        ...  
T Consensus       153 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~---~~-~~~~~~--------~~~--  213 (260)
T cd05611         153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP-----DAVF---DN-ILSRRI--------NWP--  213 (260)
T ss_pred             CCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH-----HHHH---HH-HHhccc--------CCC--
Confidence            4578889999999888889999999999999999999999752111     1111   11 111000        000  


Q ss_pred             CCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 019536          296 FPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLR  332 (339)
Q Consensus       296 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~  332 (339)
                      .......+..+.+++.+||+.+|++|||+.++.+.|.
T Consensus       214 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~  250 (260)
T cd05611         214 EEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS  250 (260)
T ss_pred             CcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence            0011134567999999999999999998765555443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=5e-39  Score=281.67  Aligned_cols=248  Identities=23%  Similarity=0.310  Sum_probs=203.6

Q ss_pred             CcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC-hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 019536           56 NYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST-LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFES  134 (339)
Q Consensus        56 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  134 (339)
                      +|++.+.||.|++|.||++.+..++..+++|++..... ......+.+|+++++.++|||++++.+.+..++..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            57888999999999999999988899999999876533 24556788999999999999999999999999999999999


Q ss_pred             ccCCccccccc------cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCC
Q 019536          135 VKYGTLRGFSF------ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE  208 (339)
Q Consensus       135 ~~~g~L~~~~~------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~  208 (339)
                      +++++|.+++.      ..++......++.+++.||.|||   +.+++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            99999988875      45788889999999999999999   8999999999999999999999999999987765543


Q ss_pred             ceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccC
Q 019536          209 THVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDP  288 (339)
Q Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (339)
                      ..  .....++..|+|||.+.+..++.++|+||+|+++++|++|+.||....        .......... ....     
T Consensus       158 ~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~--------~~~~~~~~~~-~~~~-----  221 (258)
T cd08215         158 DL--AKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN--------LLELALKILK-GQYP-----  221 (258)
T ss_pred             ce--ecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc--------HHHHHHHHhc-CCCC-----
Confidence            21  223467888999999988889999999999999999999999975322        1111111111 1110     


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          289 IFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                              +.+...+..+.+++.+||+.+|++|||+.++++.
T Consensus       222 --------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         222 --------PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             --------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                    1111344578999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.2e-42  Score=282.35  Aligned_cols=271  Identities=19%  Similarity=0.265  Sum_probs=207.4

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChh-hHHHHHHHHHHHHhcCCCceeeeeeeeeeC-------
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLD-DVEYCFNNIVFSSQMKHKNILKLIGCCLET-------  125 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~~~~~~~~~-------  125 (339)
                      .+.|+...+||+|+||.||+|+...+|+.||+|++.-..... --....+|+.+|..+.|+|++.+++.|...       
T Consensus        16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~   95 (376)
T KOG0669|consen   16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD   95 (376)
T ss_pred             chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence            356777889999999999999999999999999765432222 234567999999999999999999998632       


Q ss_pred             -CccEEEEEeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCc
Q 019536          126 -ELPTLVFESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLS  201 (339)
Q Consensus       126 -~~~~lv~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a  201 (339)
                       ..+++||.+|++ +|..++.   ..++..++.+++.++++||.|+|   ...|+|||+|++|+|++.+|.+||+|||++
T Consensus        96 r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFGla  171 (376)
T KOG0669|consen   96 RATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFGLA  171 (376)
T ss_pred             cceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeeccccc
Confidence             247999999976 6767665   46888999999999999999999   899999999999999999999999999999


Q ss_pred             cccCCCCceeee--cccccccccccccccccC-CCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhh
Q 019536          202 VSIPEGETHVRE--EFIKGAYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIE  278 (339)
Q Consensus       202 ~~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  278 (339)
                      +.+.........  +..+-|..|++||.+.|. .|+++.|||+.||++.||++|.+.+.  ++.+..++..+..+...+.
T Consensus       172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimq--gnteqqql~~Is~LcGs~t  249 (376)
T KOG0669|consen  172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQ--GNTEQQQLHLISQLCGSIT  249 (376)
T ss_pred             cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCcccc--CChHHHHHHHHHHHhccCC
Confidence            877544332221  123458899999999886 59999999999999999999998854  5555555555555555554


Q ss_pred             cCcccccccCcccCCCC---CCC-----------cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          279 NNRFGAIVDPIFDEDNS---FPG-----------KEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       279 ~~~~~~~~~~~~~~~~~---~~~-----------~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      ...+.....-.+.....   .|.           +-...+...+|+.++|..||.+|+++.+++.+
T Consensus       250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh  315 (376)
T KOG0669|consen  250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH  315 (376)
T ss_pred             cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence            44443332211111110   111           00123478899999999999999999999864

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=2.9e-39  Score=283.32  Aligned_cols=246  Identities=18%  Similarity=0.276  Sum_probs=202.4

Q ss_pred             CcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 019536           56 NYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS-TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFES  134 (339)
Q Consensus        56 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  134 (339)
                      +|++.+.||.|++|.||++....++..+++|.+.... .......+.+|+.+++.++|+||+++.+++.++...++|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            5788899999999999999998899999999987643 224456678899999999999999999999999999999999


Q ss_pred             ccCCccccccc------cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCC
Q 019536          135 VKYGTLRGFSF------ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE  208 (339)
Q Consensus       135 ~~~g~L~~~~~------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~  208 (339)
                      +++++|.+++.      ..+++..+..++.|++.||.|||   +.+++|+||+|.||+++.++.+||+|||++.......
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~  157 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM  157 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence            99999998874      35788888999999999999999   9999999999999999999999999999998775542


Q ss_pred             ceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccC
Q 019536          209 THVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDP  288 (339)
Q Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (339)
                      ..    ...++..|+|||.+.+..++.++|+||+|+++|+|++|+.||.....        ... ..........     
T Consensus       158 ~~----~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--------~~~-~~~~~~~~~~-----  219 (256)
T cd08530         158 AK----TQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM--------QDL-RYKVQRGKYP-----  219 (256)
T ss_pred             cc----cccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHH-HHHHhcCCCC-----
Confidence            11    24578889999999888899999999999999999999999753211        111 1111111110     


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          289 IFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                              +.+...+..+.+++.+||+.+|++|||+.++++.
T Consensus       220 --------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         220 --------PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             --------CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence                    1112456679999999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-39  Score=288.70  Aligned_cols=264  Identities=17%  Similarity=0.187  Sum_probs=196.3

Q ss_pred             cccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCCh-hhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEec
Q 019536           57 YDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTL-DDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESV  135 (339)
Q Consensus        57 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  135 (339)
                      |++.+.||.|++|.||+|.+..+|..||+|++...... .....+.+|+.+++.++|||++++++++.+++..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            67789999999999999999889999999998765322 23456789999999999999999999999999999999999


Q ss_pred             cCCcccccccc----CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCcee
Q 019536          136 KYGTLRGFSFA----SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHV  211 (339)
Q Consensus       136 ~~g~L~~~~~~----~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~  211 (339)
                      + ++|.+++..    .+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++..........
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~  156 (283)
T cd07835          81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY  156 (283)
T ss_pred             C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcccc
Confidence            5 688887652    5788999999999999999999   8999999999999999999999999999987654332211


Q ss_pred             eecccccccccccccccccC-CCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHH--hhcCcc---ccc
Q 019536          212 REEFIKGAYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKS--IENNRF---GAI  285 (339)
Q Consensus       212 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~---~~~  285 (339)
                      .  ...++..|+|||++.+. .++.++|+||||+++|+|++|+.||......    ..........  .....+   ..+
T Consensus       157 ~--~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~  230 (283)
T cd07835         157 T--HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI----DQLFRIFRTLGTPDEDVWPGVTSL  230 (283)
T ss_pred             C--ccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHHhCCCChHHhhhhhhc
Confidence            1  23467889999988664 5789999999999999999999997532210    0111100000  000000   000


Q ss_pred             cc--CcccCC---CCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          286 VD--PIFDED---NSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       286 ~~--~~~~~~---~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      .+  ..+...   .........+..+.+++.+||+.||++|||+.++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         231 PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             hhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            00  000000   0000011334578899999999999999999999853

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-41  Score=328.28  Aligned_cols=256  Identities=18%  Similarity=0.221  Sum_probs=207.3

Q ss_pred             HHHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC-hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccE
Q 019536           51 KKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST-LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPT  129 (339)
Q Consensus        51 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~  129 (339)
                      ...+-+++....||.|.||.||.|...++|.-.|+|-+.-... ....+.+.+|..++..+.|||+|+++|+-.+.+..+
T Consensus      1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred             ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence            3455688889999999999999999999999999998766532 344566779999999999999999999999999999


Q ss_pred             EEEEeccCCcccccccc--CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCC
Q 019536          130 LVFESVKYGTLRGFSFA--SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEG  207 (339)
Q Consensus       130 lv~e~~~~g~L~~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~  207 (339)
                      |.||||++|+|.+.+..  ..++.....+..|++.|+.|||   +.||||||+||+||+++.+|.+|++|||.|..+..+
T Consensus      1311 IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred             HHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEecCc
Confidence            99999999999999873  3566556678899999999999   999999999999999999999999999999887655


Q ss_pred             Cce--eeecccccccccccccccccC---CCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcc
Q 019536          208 ETH--VREEFIKGAYGFIAPEYFATS---SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRF  282 (339)
Q Consensus       208 ~~~--~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (339)
                      ...  .......||+.|||||++.+.   ....+.||||+||++.||+||+.||....++-       ...++.-.    
T Consensus      1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~-------aIMy~V~~---- 1456 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW-------AIMYHVAA---- 1456 (1509)
T ss_pred             hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh-------HHHhHHhc----
Confidence            311  111246799999999999764   45688999999999999999999986333211       11111111    


Q ss_pred             cccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          283 GAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                              ....  +.|+..+.+-++++..||+.||+.|-++.|+++.
T Consensus      1457 --------gh~P--q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1457 --------GHKP--QIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             --------cCCC--CCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence                    1111  2334578889999999999999999999888764

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-38  Score=277.07  Aligned_cols=247  Identities=21%  Similarity=0.343  Sum_probs=202.8

Q ss_pred             CcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC-hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 019536           56 NYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST-LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFES  134 (339)
Q Consensus        56 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  134 (339)
                      +|++.+.||+|++|.||+|....+++.|++|.+..... ....+.+.+|+.+++.++|||++++++++.+++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            57888999999999999999988899999999977643 13557788999999999999999999999999999999999


Q ss_pred             ccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceee
Q 019536          135 VKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVR  212 (339)
Q Consensus       135 ~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~  212 (339)
                      +++++|.+++.  ..+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||.+.........  
T Consensus        81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~--  155 (254)
T cd06627          81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--  155 (254)
T ss_pred             CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc--
Confidence            99999998876  46888899999999999999999   999999999999999999999999999999876554332  


Q ss_pred             ecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccC
Q 019536          213 EEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDE  292 (339)
Q Consensus       213 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (339)
                      .....++..|+|||.+.+..++.++|+||+|+++|+|++|+.||.....        ......... ...          
T Consensus       156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~--------~~~~~~~~~-~~~----------  216 (254)
T cd06627         156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP--------MAALFRIVQ-DDH----------  216 (254)
T ss_pred             ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH--------HHHHHHHhc-cCC----------
Confidence            1134578889999999888889999999999999999999999752210        111111000 000          


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          293 DNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       293 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                       .  +.+...+..+.+++.+||+.+|++|||+.+++.
T Consensus       217 -~--~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         217 -P--PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             -C--CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence             0  011134557899999999999999999999875

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=8e-39  Score=285.02  Aligned_cols=262  Identities=17%  Similarity=0.177  Sum_probs=196.0

Q ss_pred             cccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcC-CCceeeeeeeeeeCCccEEEEEec
Q 019536           57 YDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMK-HKNILKLIGCCLETELPTLVFESV  135 (339)
Q Consensus        57 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~~  135 (339)
                      |++.+.||+|++|+||+|....+++.|++|++.............+|+..++.++ ||||+++++++.+++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            6778999999999999999988899999999876543233344567999999998 999999999999999999999999


Q ss_pred             cCCccccccc----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCcee
Q 019536          136 KYGTLRGFSF----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHV  211 (339)
Q Consensus       136 ~~g~L~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~  211 (339)
                       +|+|.+++.    ..+++..+..++.|++.+|.|||   +++++|+||+|+||+++.++.++|+|||++..........
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~  156 (283)
T cd07830          81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYT  156 (283)
T ss_pred             -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcC
Confidence             788887765    25788899999999999999999   8999999999999999999999999999987664432211


Q ss_pred             eeccccccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhc---------Cc
Q 019536          212 REEFIKGAYGFIAPEYFAT-SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIEN---------NR  281 (339)
Q Consensus       212 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------~~  281 (339)
                         ...++..|+|||++.+ ..++.++|+||||+++++|++|++||.......     ...........         ..
T Consensus       157 ---~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~  228 (283)
T cd07830         157 ---DYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEID-----QLYKICSVLGTPTKQDWPEGYK  228 (283)
T ss_pred             ---CCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHH-----HHHHHHHhcCCCChhhhhhHhh
Confidence               2357888999998854 457899999999999999999999975332111     11000000000         00


Q ss_pred             ccccccCcccCCCCCC---CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          282 FGAIVDPIFDEDNSFP---GKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       282 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      .....+..........   .....+..+.+++.+||+.||++|||+.|++.+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         229 LASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             hhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            0000000000000000   000124578999999999999999999999763

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.9e-39  Score=296.60  Aligned_cols=270  Identities=17%  Similarity=0.201  Sum_probs=200.4

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeC-----Cc
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS-TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLET-----EL  127 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~-----~~  127 (339)
                      .++|.+.+.||.|+||+||+|....++..||+|.+.... .......+.+|+.+++.++||||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            467999999999999999999999899999999987542 223455677899999999999999999988654     34


Q ss_pred             cEEEEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccC
Q 019536          128 PTLVFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIP  205 (339)
Q Consensus       128 ~~lv~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~  205 (339)
                      .++|+||+. ++|.+++.  ..++...+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++...
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~  159 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTS  159 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCccccccC
Confidence            799999996 67777764  56888899999999999999999   8999999999999999999999999999988764


Q ss_pred             CCCceeeeccccccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhh---cCc
Q 019536          206 EGETHVREEFIKGAYGFIAPEYFAT-SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIE---NNR  281 (339)
Q Consensus       206 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~  281 (339)
                      ......  ....++..|+|||.+.. ..++.++|+|||||++|+|++|++||....     .............   ...
T Consensus       160 ~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-----~~~~~~~~~~~~~~~~~~~  232 (337)
T cd07858         160 EKGDFM--TEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKD-----YVHQLKLITELLGSPSEED  232 (337)
T ss_pred             CCcccc--cccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCC-----hHHHHHHHHHHhCCCChHH
Confidence            432111  12457888999998865 468899999999999999999999975321     1111111111000   000


Q ss_pred             ccccccCc-------ccCCCCCC---CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHHH
Q 019536          282 FGAIVDPI-------FDEDNSFP---GKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ--LRQM  334 (339)
Q Consensus       282 ~~~~~~~~-------~~~~~~~~---~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~--L~~l  334 (339)
                      ...+.+..       .......+   .....+..+.+++.+||+.+|++|||+.+++++  +..+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         233 LGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             hhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence            00000000       00000000   011345678999999999999999999999986  5544

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=4.6e-39  Score=288.36  Aligned_cols=263  Identities=17%  Similarity=0.186  Sum_probs=193.7

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCCh-hhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTL-DDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFE  133 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  133 (339)
                      ++|++.+.||.|++|+||+|.+..+++.||+|.+...... .....+.+|+.+++.++||||+++++++.+++..++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            5789999999999999999999889999999998654322 334567899999999999999999999999999999999


Q ss_pred             eccCCcccccccc----CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCC-CCceEEecCCCccccCCCC
Q 019536          134 SVKYGTLRGFSFA----SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDE-NYSAKLHDFSLSVSIPEGE  208 (339)
Q Consensus       134 ~~~~g~L~~~~~~----~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~-~~~~kl~dfg~a~~~~~~~  208 (339)
                      |++ ++|.+++..    .+++..+..++.||+.||.|||   +.+++|+||+|+||+++. ++.+||+|||++.......
T Consensus        82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~  157 (294)
T PLN00009         82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV  157 (294)
T ss_pred             ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence            996 467666542    2466777889999999999999   899999999999999985 5579999999987654332


Q ss_pred             ceeeecccccccccccccccccC-CCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhc---Ccccc
Q 019536          209 THVREEFIKGAYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIEN---NRFGA  284 (339)
Q Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~  284 (339)
                      ...  ....++..|+|||++.+. .++.++|+||+|+++|+|++|+.||.....     .............   ..+..
T Consensus       158 ~~~--~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~-----~~~~~~~~~~~~~~~~~~~~~  230 (294)
T PLN00009        158 RTF--THEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSE-----IDELFKIFRILGTPNEETWPG  230 (294)
T ss_pred             ccc--ccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHhCCCChhhccc
Confidence            211  123467889999998664 578999999999999999999999753211     1111111110000   00000


Q ss_pred             ---ccc--CcccCCCCCCC----cHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          285 ---IVD--PIFDEDNSFPG----KEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       285 ---~~~--~~~~~~~~~~~----~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                         +.+  .... ......    ....+..+.+++.+||+.+|++||++.++++
T Consensus       231 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        231 VTSLPDYKSAFP-KWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             cccchhhhhhcc-cCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence               000  0000 000000    0123456899999999999999999999986

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-40  Score=308.81  Aligned_cols=255  Identities=20%  Similarity=0.315  Sum_probs=216.4

Q ss_pred             cccCCceeccCCeeEEEEEEcCCCe----eEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 019536           57 YDLHKVIQSDTSYRLFEGTLVDQDR----PISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVF  132 (339)
Q Consensus        57 ~~~~~~ig~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  132 (339)
                      ....++||+|+||+||+|.+.-.|.    +||||++......+...+++.|+-.|.+++|||+++++|+|.... +.||+
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt  776 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT  776 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence            3446899999999999999975554    789999988777677888999999999999999999999998776 78999


Q ss_pred             EeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCc
Q 019536          133 ESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGET  209 (339)
Q Consensus       133 e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~  209 (339)
                      +|+|.|+|.++.+   ..+.....+.|..||++|+.|||   .++++||||..+|+|+.+...+|+.|||+|+.+..+..
T Consensus       777 q~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~  853 (1177)
T KOG1025|consen  777 QLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK  853 (1177)
T ss_pred             HhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence            9999999999986   57778888999999999999999   99999999999999999999999999999999988877


Q ss_pred             eeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCcccccccC
Q 019536          210 HVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDP  288 (339)
Q Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (339)
                      ........-.+.|||-|.+....|+.++|||||||++||++| |..|+......        + +...+           
T Consensus       854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~--------e-I~dll-----------  913 (1177)
T KOG1025|consen  854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE--------E-IPDLL-----------  913 (1177)
T ss_pred             cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH--------H-hhHHH-----------
Confidence            766555555677999999999999999999999999999998 88886532221        1 11111           


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          289 IFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                        ....+++.|+.++.++.-+|.+||..|+..||++.++..++.++.++
T Consensus       914 --e~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard  960 (1177)
T KOG1025|consen  914 --EKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD  960 (1177)
T ss_pred             --hccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence              11223455567888999999999999999999999999999988754

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-39  Score=286.06  Aligned_cols=262  Identities=18%  Similarity=0.180  Sum_probs=199.6

Q ss_pred             cccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCCh-hhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEec
Q 019536           57 YDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTL-DDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESV  135 (339)
Q Consensus        57 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  135 (339)
                      |++.+.||+|++|.||+|....+++.+++|++...... .....+.+|+.+++.++|+||+++++++.+++..++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            56788999999999999999889999999998765432 34567789999999999999999999999999999999999


Q ss_pred             cCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceee
Q 019536          136 KYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVR  212 (339)
Q Consensus       136 ~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~  212 (339)
                      ++ +|.+++.   ..+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||.+...........
T Consensus        81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~  156 (283)
T cd05118          81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYT  156 (283)
T ss_pred             CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccccc
Confidence            75 7777665   36788899999999999999999   89999999999999999999999999999877655431111


Q ss_pred             ecccccccccccccccccC-CCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhh---cCccccccc-
Q 019536          213 EEFIKGAYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIE---NNRFGAIVD-  287 (339)
Q Consensus       213 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~-  287 (339)
                        ...++..|+|||.+.+. .++.++|+||+|+++|+|++|+.||.....     ............   ...+..+.+ 
T Consensus       157 --~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~  229 (283)
T cd05118         157 --HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE-----IDQLFKIFRTLGTPDPEVWPKFTSL  229 (283)
T ss_pred             --CccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHcCCCchHhcccchhh
Confidence              23477789999998776 788999999999999999999999753221     111111111000   000111100 


Q ss_pred             -----CcccCCCCCC---CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          288 -----PIFDEDNSFP---GKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       288 -----~~~~~~~~~~---~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                           ..+......+   .....+..+.+++.+||+.||.+||++.+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence                 0000000000   01235678999999999999999999999986

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=9.3e-39  Score=284.27  Aligned_cols=242  Identities=17%  Similarity=0.239  Sum_probs=188.2

Q ss_pred             ceeccCCeeEEEEEEcCCCeeEEEEEeccCCCh--hhHHHHHHHH---HHHHhcCCCceeeeeeeeeeCCccEEEEEecc
Q 019536           62 VIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTL--DDVEYCFNNI---VFSSQMKHKNILKLIGCCLETELPTLVFESVK  136 (339)
Q Consensus        62 ~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~---~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~  136 (339)
                      .||+|+||.||+|....+++.||+|.+......  .....+..|.   .+++...||||+++++++.+.+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999999888999999998764321  2222233443   34455679999999999999999999999999


Q ss_pred             CCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceeeec
Q 019536          137 YGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREE  214 (339)
Q Consensus       137 ~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~~  214 (339)
                      +|+|.+++.  ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.++|+|||++..+......    
T Consensus        81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~~----  153 (278)
T cd05606          81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH----  153 (278)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCCc----
Confidence            999988875  46889999999999999999999   899999999999999999999999999998765433221    


Q ss_pred             ccccccccccccccccC-CCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCC
Q 019536          215 FIKGAYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDED  293 (339)
Q Consensus       215 ~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (339)
                      ...|+..|+|||++.+. .++.++|+||+|+++|+|++|+.||.......  ...    .......            ..
T Consensus       154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~--~~~----~~~~~~~------------~~  215 (278)
T cd05606         154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--KHE----IDRMTLT------------MA  215 (278)
T ss_pred             CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccc--hHH----HHHHhhc------------cC
Confidence            34688999999998754 68999999999999999999999985332111  000    0000000            01


Q ss_pred             CCCCCcHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 019536          294 NSFPGKEEKLQSLGQLMYKCLSKSPEHRP-----LMVDVAKQ  330 (339)
Q Consensus       294 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~il~~  330 (339)
                      ...|  ...+..+.+++.+||..+|.+||     ++.+++++
T Consensus       216 ~~~~--~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~  255 (278)
T cd05606         216 VELP--DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH  255 (278)
T ss_pred             CCCC--CcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence            1111  13356799999999999999999     99999863

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6e-39  Score=294.18  Aligned_cols=273  Identities=17%  Similarity=0.201  Sum_probs=201.9

Q ss_pred             cccHHHHHHHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC-ChhhHHHHHHHHHHHHhcCCCceeeeeeee
Q 019536           44 AFSAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS-TLDDVEYCFNNIVFSSQMKHKNILKLIGCC  122 (339)
Q Consensus        44 ~~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~~~~~~  122 (339)
                      .....++...+++|++.+.||+|+||.||+|.+..++..||+|++.... .....+.+.+|+.++++++||||+++++++
T Consensus         6 ~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~   85 (345)
T cd07877           6 QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVF   85 (345)
T ss_pred             hhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeee
Confidence            3445566677899999999999999999999998899999999987642 223356678899999999999999999988


Q ss_pred             eeC------CccEEEEEeccCCccccccc-cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEE
Q 019536          123 LET------ELPTLVFESVKYGTLRGFSF-ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKL  195 (339)
Q Consensus       123 ~~~------~~~~lv~e~~~~g~L~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl  195 (339)
                      ...      +..+++++++ +++|.+++. ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||
T Consensus        86 ~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl  161 (345)
T cd07877          86 TPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI  161 (345)
T ss_pred             eecccccccccEEEEehhc-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCEEE
Confidence            643      3467888877 778877765 46888999999999999999999   899999999999999999999999


Q ss_pred             ecCCCccccCCCCceeeeccccccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHH
Q 019536          196 HDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFAT-SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAK  274 (339)
Q Consensus       196 ~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~  274 (339)
                      +|||+++.......     ...++..|+|||++.+ ..++.++|+||+||++|+|++|+.||.....     ........
T Consensus       162 ~dfg~~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~-----~~~~~~~~  231 (345)
T cd07877         162 LDFGLARHTDDEMT-----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH-----IDQLKLIL  231 (345)
T ss_pred             eccccccccccccc-----ccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHH
Confidence            99999876533221     2457888999999866 4688999999999999999999999753211     11111110


Q ss_pred             HHh---hcCcccccccC-------cccC--CCCCC-CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          275 KSI---ENNRFGAIVDP-------IFDE--DNSFP-GKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       275 ~~~---~~~~~~~~~~~-------~~~~--~~~~~-~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      ...   .......+.+.       ....  ...+. .....+..+.+++.+||+.||.+|||+.+++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         232 RLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             HHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence            000   00000000000       0000  00000 000134568999999999999999999999863

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=4.7e-38  Score=284.46  Aligned_cols=243  Identities=22%  Similarity=0.283  Sum_probs=192.2

Q ss_pred             cccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC--hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 019536           57 YDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST--LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFES  134 (339)
Q Consensus        57 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  134 (339)
                      |...+.||+|+||+||+|....++..|++|++.....  ......+.+|+.+++.++|||++++++++.+++..++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            6667889999999999999988999999999875422  23446678999999999999999999999999999999999


Q ss_pred             ccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCcee
Q 019536          135 VKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHV  211 (339)
Q Consensus       135 ~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~  211 (339)
                      ++ |++.+++.   ..+++.++..++.|++.||.|||   +.+++|+||+|+||+++.++.+||+|||++.......   
T Consensus       103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~~---  175 (313)
T cd06633         103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPAN---  175 (313)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccCCCC---
Confidence            96 46666553   46788889999999999999999   8999999999999999999999999999986432221   


Q ss_pred             eecccccccccccccccc---cCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccC
Q 019536          212 REEFIKGAYGFIAPEYFA---TSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDP  288 (339)
Q Consensus       212 ~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (339)
                         ...|+..|+|||++.   +..++.++|+||||+++|+|++|..||....        ............ ...    
T Consensus       176 ---~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~--------~~~~~~~~~~~~-~~~----  239 (313)
T cd06633         176 ---SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--------AMSALYHIAQND-SPT----  239 (313)
T ss_pred             ---CccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHHhcC-CCC----
Confidence               345788899999984   3568889999999999999999999974211        111111111110 000    


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          289 IFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                             .+ ....+..+.+++.+||+.+|++||++.+++.+
T Consensus       240 -------~~-~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         240 -------LQ-SNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             -------CC-ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                   00 11234568999999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=2.3e-39  Score=315.42  Aligned_cols=255  Identities=19%  Similarity=0.279  Sum_probs=197.5

Q ss_pred             HHHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeC-----
Q 019536           51 KKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLET-----  125 (339)
Q Consensus        51 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~-----  125 (339)
                      .+...+|+....||+||||.||+++.+-+|+.||||++...........+.+|+.++++|+|||||+++..+.+.     
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~  554 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT  554 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence            567789999999999999999999999999999999998876556667788999999999999999998766110     


Q ss_pred             --------------------------------------------------------------------------------
Q 019536          126 --------------------------------------------------------------------------------  125 (339)
Q Consensus       126 --------------------------------------------------------------------------------  125 (339)
                                                                                                      
T Consensus       555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS  634 (1351)
T KOG1035|consen  555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS  634 (1351)
T ss_pred             cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence                                                                                            


Q ss_pred             ----------------------------------CccEEEEEeccCCccccccccCCC---hHHHHHHHHHHHHHHHHHh
Q 019536          126 ----------------------------------ELPTLVFESVKYGTLRGFSFASLL---IAPRIKIAMEIANAVAYLH  168 (339)
Q Consensus       126 ----------------------------------~~~~lv~e~~~~g~L~~~~~~~~~---~~~~~~i~~~i~~~l~~LH  168 (339)
                                                        ..+||-||||+..++.+++.....   ....++++++|++||.|+|
T Consensus       635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH  714 (1351)
T KOG1035|consen  635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH  714 (1351)
T ss_pred             ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH
Confidence                                              024788999999888888874333   4566889999999999999


Q ss_pred             cCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccC----------------CCCceeeecccccccccccccccccCC
Q 019536          169 VGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIP----------------EGETHVREEFIKGAYGFIAPEYFATSS  232 (339)
Q Consensus       169 ~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~~~~  232 (339)
                         +.|||||||||.||++++++.+||+|||+|+...                ........+..+||.-|+|||++.+..
T Consensus       715 ---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~  791 (1351)
T KOG1035|consen  715 ---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS  791 (1351)
T ss_pred             ---hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence               9999999999999999999999999999998721                001111223567999999999997654


Q ss_pred             ---CCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHH
Q 019536          233 ---FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQL  309 (339)
Q Consensus       233 ---~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  309 (339)
                         |+.|+||||+|++++||+.   ||.       ..++.+..+.... .+.        ++....+..  .....-+.+
T Consensus       792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~-------TsMERa~iL~~LR-~g~--------iP~~~~f~~--~~~~~e~sl  850 (1351)
T KOG1035|consen  792 SNKYNSKIDMYSLGIVLFEMLY---PFG-------TSMERASILTNLR-KGS--------IPEPADFFD--PEHPEEASL  850 (1351)
T ss_pred             cccccchhhhHHHHHHHHHHhc---cCC-------chHHHHHHHHhcc-cCC--------CCCCccccc--ccchHHHHH
Confidence               9999999999999999985   443       1333444333322 221        111111111  122245689


Q ss_pred             HHHhhccCCCCCCCHHHHHH
Q 019536          310 MYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       310 i~~cl~~dP~~Rps~~~il~  329 (339)
                      |..|++.||.+||||.|+|.
T Consensus       851 I~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  851 IRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             HHHHhcCCCccCCCHHHHhh
Confidence            99999999999999999986

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-40  Score=286.35  Aligned_cols=264  Identities=18%  Similarity=0.222  Sum_probs=204.1

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcC--CC----ceeeeeeeeeeCCc
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMK--HK----NILKLIGCCLETEL  127 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~--H~----niv~~~~~~~~~~~  127 (339)
                      +++|.+...+|+|+||.|-.+.+..++..||||+++...  .-.+..+-|+..|.++.  -|    -+|.+.+||.-.++
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~--kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh  165 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD--KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH  165 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH--HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence            789999999999999999999999999999999987643  33456678999999993  23    27888899999999


Q ss_pred             cEEEEEeccCCccccccc----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCC--------------
Q 019536          128 PTLVFESVKYGTLRGFSF----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDE--------------  189 (339)
Q Consensus       128 ~~lv~e~~~~g~L~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~--------------  189 (339)
                      .|+|+|.+ |.++.+++.    .+++...+..++.|++.++.+||   +.+++|.||||+|||+.+              
T Consensus       166 iCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~k~~~~  241 (415)
T KOG0671|consen  166 ICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNPKKKVC  241 (415)
T ss_pred             eEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEeccCCccc
Confidence            99999998 568889987    46899999999999999999999   999999999999999932              


Q ss_pred             ------CCceEEecCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCC
Q 019536          190 ------NYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGN  263 (339)
Q Consensus       190 ------~~~~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~  263 (339)
                            +..++++|||.|+.......     .++.|.+|+|||++.+.+++.++||||+||++.|+.+|...|+...  +
T Consensus       242 ~~r~~ks~~I~vIDFGsAtf~~e~hs-----~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe--n  314 (415)
T KOG0671|consen  242 FIRPLKSTAIKVIDFGSATFDHEHHS-----TIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHE--N  314 (415)
T ss_pred             eeccCCCcceEEEecCCcceeccCcc-----eeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCC--c
Confidence                  23489999999987654442     4678999999999999999999999999999999999999976443  4


Q ss_pred             CCchhHHHHHHHHhhcCccccc-------------ccCcccC------CCCCC------CcHHHHHHHHHHHHHhhccCC
Q 019536          264 DDDLTVLEYAKKSIENNRFGAI-------------VDPIFDE------DNSFP------GKEEKLQSLGQLMYKCLSKSP  318 (339)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~------~~~~~------~~~~~~~~~~~li~~cl~~dP  318 (339)
                      .+.+...+.+...+.......-             .+.....      +.+.|      ........+.+|+.+||.+||
T Consensus       315 ~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP  394 (415)
T KOG0671|consen  315 LEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDP  394 (415)
T ss_pred             HHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCc
Confidence            4444444333322211111000             0000000      00111      011334568999999999999


Q ss_pred             CCCCCHHHHHHH
Q 019536          319 EHRPLMVDVAKQ  330 (339)
Q Consensus       319 ~~Rps~~~il~~  330 (339)
                      .+|+|+.|++.+
T Consensus       395 ~~RiTl~EAL~H  406 (415)
T KOG0671|consen  395 ARRITLREALSH  406 (415)
T ss_pred             cccccHHHHhcC
Confidence            999999999863

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=8.5e-39  Score=284.06  Aligned_cols=249  Identities=19%  Similarity=0.250  Sum_probs=202.3

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC--ChhhHHHHHHHHHHHHhcC-CCceeeeeeeeeeCCccEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS--TLDDVEYCFNNIVFSSQMK-HKNILKLIGCCLETELPTLV  131 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~-H~niv~~~~~~~~~~~~~lv  131 (339)
                      ++|.+.+.||+|++|.||+|....++..|++|++....  .......+.+|..+++++. ||||+++++++.+++..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            47899999999999999999999899999999987632  2234566789999999998 99999999999999999999


Q ss_pred             EEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCc
Q 019536          132 FESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGET  209 (339)
Q Consensus       132 ~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~  209 (339)
                      |||+++++|.+++.  ..+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++++|||++........
T Consensus        81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~  157 (280)
T cd05581          81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS  157 (280)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence            99999999999886  46899999999999999999999   89999999999999999999999999999876644321


Q ss_pred             e------------------eeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHH
Q 019536          210 H------------------VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLE  271 (339)
Q Consensus       210 ~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~  271 (339)
                      .                  .......++..|+|||++.+..++.++|+||+|++++++++|+.||.....        ..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~  229 (280)
T cd05581         158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE--------YL  229 (280)
T ss_pred             cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH--------HH
Confidence            1                  112234577889999999888899999999999999999999999763321        01


Q ss_pred             HHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCH----HHHHH
Q 019536          272 YAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLM----VDVAK  329 (339)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~----~~il~  329 (339)
                      ...... ..            ..  ..+...+..+.+++.+||+.+|.+|||+    .+++.
T Consensus       230 ~~~~~~-~~------------~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         230 TFQKIL-KL------------EY--SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             HHHHHH-hc------------CC--CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            111111 00            00  1112335678999999999999999999    77765

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-38  Score=308.47  Aligned_cols=262  Identities=23%  Similarity=0.332  Sum_probs=213.7

Q ss_pred             HHHHHhcCcccCCceeccCCeeEEEEEEcC-------CCeeEEEEEeccCCChhhHHHHHHHHHHHHhc-CCCceeeeee
Q 019536           49 DLKKATNNYDLHKVIQSDTSYRLFEGTLVD-------QDRPISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIG  120 (339)
Q Consensus        49 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~  120 (339)
                      .|+...++..+.+.+|+|.||.|++|....       ....||||.++......+.+.+..|+.+|+.+ .||||+.++|
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG  369 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG  369 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence            455556677778899999999999998641       14579999999887767888899999999999 6999999999


Q ss_pred             eeeeCCccEEEEEeccCCccccccc-cC-----------------CChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCC
Q 019536          121 CCLETELPTLVFESVKYGTLRGFSF-AS-----------------LLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKA  182 (339)
Q Consensus       121 ~~~~~~~~~lv~e~~~~g~L~~~~~-~~-----------------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~  182 (339)
                      +|...+..++|+||+..|+|..++. .+                 +...+.+.++.||+.|++||+   +.+++||||..
T Consensus       370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAa  446 (609)
T KOG0200|consen  370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAA  446 (609)
T ss_pred             eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhh
Confidence            9999999999999999999999986 33                 777888999999999999999   99999999999


Q ss_pred             CCEEeCCCCceEEecCCCccccCCCCceeeeccccc--ccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccC
Q 019536          183 SNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG--AYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFK  259 (339)
Q Consensus       183 ~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~  259 (339)
                      +|||+.++..+|++|||+|+........... ...+  ...|||||.+....|+.++||||||+++||+++ |..||+..
T Consensus       447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~-~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~  525 (609)
T KOG0200|consen  447 RNVLITKNKVIKIADFGLARDHYNKDYYRTK-SSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI  525 (609)
T ss_pred             hhEEecCCCEEEEccccceeccCCCCceEec-CCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC
Confidence            9999999999999999999976665544322 1222  345999999999999999999999999999998 77886421


Q ss_pred             CCCCCCchhHHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 019536          260 GNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMY  335 (339)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~  335 (339)
                      .       ...+. ....+.+             .....|..++.++.++|..||+.+|++||++.++.+.++++.
T Consensus       526 ~-------~~~~l-~~~l~~G-------------~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l  580 (609)
T KOG0200|consen  526 P-------PTEEL-LEFLKEG-------------NRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL  580 (609)
T ss_pred             C-------cHHHH-HHHHhcC-------------CCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence            1       01111 1122222             122334466788999999999999999999999999999864

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-40  Score=318.64  Aligned_cols=257  Identities=21%  Similarity=0.265  Sum_probs=211.0

Q ss_pred             HHHHHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCCh--hhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC
Q 019536           49 DLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTL--DDVEYCFNNIVFSSQMKHKNILKLIGCCLETE  126 (339)
Q Consensus        49 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~  126 (339)
                      ++.-..++|.++++||.|+||.|..++.+++++.||.|++++....  ....-|..|-.+|..-..+=|+.+.-.|++.+
T Consensus        69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~  148 (1317)
T KOG0612|consen   69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER  148 (1317)
T ss_pred             HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence            3444458999999999999999999999999999999999885321  33455778888999888999999999999999


Q ss_pred             ccEEEEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCcccc
Q 019536          127 LPTLVFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSI  204 (339)
Q Consensus       127 ~~~lv~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~  204 (339)
                      ++|+||||++||+|-.++.  ..+|+.++..++..|+.||.-||   +.|.|||||||+|||+|..|.+||+|||.+-.+
T Consensus       149 ~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGsClkm  225 (1317)
T KOG0612|consen  149 YLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKM  225 (1317)
T ss_pred             ceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchhHHhc
Confidence            9999999999999998886  46899999999999999999999   999999999999999999999999999998888


Q ss_pred             CCCCceeeecccccccccccccccc----c-CCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhc
Q 019536          205 PEGETHVREEFIKGAYGFIAPEYFA----T-SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIEN  279 (339)
Q Consensus       205 ~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  279 (339)
                      ..+.... ....+|||.|.+||++.    + +.|++.+|+||+||++|||+.|..||.  .+      .+++ .      
T Consensus       226 ~~dG~V~-s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFY--ad------slve-T------  289 (1317)
T KOG0612|consen  226 DADGTVR-SSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFY--AD------SLVE-T------  289 (1317)
T ss_pred             CCCCcEE-eccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcch--HH------HHHH-H------
Confidence            7666543 33678999999999985    3 468999999999999999999999984  11      1111 1      


Q ss_pred             CcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCC---HHHHHH
Q 019536          280 NRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPL---MVDVAK  329 (339)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps---~~~il~  329 (339)
                        +.+|++.  .....+|.....+.++++||.+.+. +|+.|..   +.++-.
T Consensus       290 --Y~KIm~h--k~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~  337 (1317)
T KOG0612|consen  290 --YGKIMNH--KESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN  337 (1317)
T ss_pred             --HHHHhch--hhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence              1222222  2234556445678899999998875 6777776   666644

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-38  Score=280.52  Aligned_cols=292  Identities=19%  Similarity=0.267  Sum_probs=211.0

Q ss_pred             HhhhHHHHHHHHhhCCCCCCcccccHHHHHHHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHH
Q 019536           22 RNEKLLLQKLIATFNGKRNPIRAFSAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCF  101 (339)
Q Consensus        22 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~  101 (339)
                      .+++..+++++.....++...- ..+---........+.+.||+|.||.||+|.+  .|..||||++..    .+.+.+.
T Consensus       179 ~~~~stl~Dll~~~~tSGSGSG-lplLVQRTiarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~s----rdE~SWf  251 (513)
T KOG2052|consen  179 LAGDSTLKDLLDDLETSGSGSG-LPLLVQRTIARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSS----RDERSWF  251 (513)
T ss_pred             ccCCccHHHHHHhhccCCCCCC-chhHhHHhhhheeEEEEEecCccccceeeccc--cCCceEEEEecc----cchhhhh
Confidence            4445556777755443322211 11111133347788899999999999999999  688999999976    3456667


Q ss_pred             HHHHHHHh--cCCCceeeeeeeeeeCC----ccEEEEEeccCCccccccc-cCCChHHHHHHHHHHHHHHHHHhc-----
Q 019536          102 NNIVFSSQ--MKHKNILKLIGCCLETE----LPTLVFESVKYGTLRGFSF-ASLLIAPRIKIAMEIANAVAYLHV-----  169 (339)
Q Consensus       102 ~e~~~l~~--l~H~niv~~~~~~~~~~----~~~lv~e~~~~g~L~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~-----  169 (339)
                      +|.+|...  ++|+||+.|++.=..++    .+|||.+|.++|+|.|++. ..++....++++..+|.||+|||.     
T Consensus       252 rEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GT  331 (513)
T KOG2052|consen  252 RETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGT  331 (513)
T ss_pred             hHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcC
Confidence            77777654  59999999998865543    3689999999999999998 578888889999999999999992     


Q ss_pred             CCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCC--ceeeecccccccccccccccccCC----CC--cccchHH
Q 019536          170 GFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE--THVREEFIKGAYGFIAPEYFATSS----FN--EMCDVYS  241 (339)
Q Consensus       170 ~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~----~~--~~~Diws  241 (339)
                      ..+..|.|||||..|||+.+++.+-|+|+|+|.......  ........+||-+|||||++....    +.  ..+||||
T Consensus       332 qgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYa  411 (513)
T KOG2052|consen  332 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYA  411 (513)
T ss_pred             CCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHH
Confidence            235679999999999999999999999999997765542  222333568999999999996542    22  4689999


Q ss_pred             HHHHHHHHHhCC----------CccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCCCCCCCc-----HHHHHHH
Q 019536          242 FGAFLCELLTGC----------NVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGK-----EEKLQSL  306 (339)
Q Consensus       242 lG~~l~el~~g~----------~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~  306 (339)
                      ||.++||+..+.          .||...-+.                +..+.+..+-....+.....+     ......+
T Consensus       412 fgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~----------------DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m  475 (513)
T KOG2052|consen  412 FGLVLWEIARRCESGGIVEEYQLPYYDVVPS----------------DPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVM  475 (513)
T ss_pred             HHHHHHHHHHHhhcCCEehhhcCCcccCCCC----------------CCCHHHHhcceeecccCCCCCcccccCHHHHHH
Confidence            999999998643          233211111                111111111111111111111     2455678


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 019536          307 GQLMYKCLSKSPEHRPLMVDVAKQLRQMYL  336 (339)
Q Consensus       307 ~~li~~cl~~dP~~Rps~~~il~~L~~l~~  336 (339)
                      .+||+.||..+|..|.|+-.|-+.|.++.+
T Consensus       476 ~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  476 AKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             HHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence            899999999999999999999999999874

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.1e-38  Score=290.45  Aligned_cols=266  Identities=18%  Similarity=0.188  Sum_probs=199.6

Q ss_pred             HHHHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeeee-CCc
Q 019536           50 LKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS-TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLE-TEL  127 (339)
Q Consensus        50 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~-~~~  127 (339)
                      +...+++|++.+.||.|+||.||+|....++..||+|++.... .......+.+|+.+++.++||||+++.+++.. ...
T Consensus         5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   84 (328)
T cd07856           5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED   84 (328)
T ss_pred             eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence            3446789999999999999999999999999999999886542 22345667799999999999999999999876 557


Q ss_pred             cEEEEEeccCCccccccc-cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCC
Q 019536          128 PTLVFESVKYGTLRGFSF-ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPE  206 (339)
Q Consensus       128 ~~lv~e~~~~g~L~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~  206 (339)
                      .++++||+ +++|..++. ..++......++.|++.||.|||   +.+|+||||+|.||+++.++.++|+|||++.....
T Consensus        85 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~  160 (328)
T cd07856          85 IYFVTELL-GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQDP  160 (328)
T ss_pred             EEEEeehh-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCccccccccCC
Confidence            88999998 568887775 46788888889999999999999   89999999999999999999999999999875433


Q ss_pred             CCceeeeccccccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhh-------
Q 019536          207 GETHVREEFIKGAYGFIAPEYFAT-SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIE-------  278 (339)
Q Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------  278 (339)
                      ...     ...++..|+|||.+.+ ..++.++|+||+|+++|+|++|+.||.....     ............       
T Consensus       161 ~~~-----~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~-----~~~~~~~~~~~~~~~~~~~  230 (328)
T cd07856         161 QMT-----GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDH-----VNQFSIITDLLGTPPDDVI  230 (328)
T ss_pred             CcC-----CCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHhCCCCHHHH
Confidence            221     2356788999998866 5689999999999999999999999753221     011000000000       


Q ss_pred             ----cCcccccccCcccCCCCCCCc---HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          279 ----NNRFGAIVDPIFDEDNSFPGK---EEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       279 ----~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                          ......+.. ........|..   ...+..+.+++.+||+.+|++|||+.+++..
T Consensus       231 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         231 NTICSENTLRFVQ-SLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             HhccchhhHHHHh-hccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                000000000 00001111111   1234679999999999999999999999864

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=3.1e-38  Score=282.41  Aligned_cols=251  Identities=22%  Similarity=0.289  Sum_probs=195.5

Q ss_pred             CcccCCceeccCCeeEEEEEEc---CCCeeEEEEEeccCCC---hhhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCcc
Q 019536           56 NYDLHKVIQSDTSYRLFEGTLV---DQDRPISVMKFHDNST---LDDVEYCFNNIVFSSQM-KHKNILKLIGCCLETELP  128 (339)
Q Consensus        56 ~~~~~~~ig~G~~g~V~~~~~~---~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~  128 (339)
                      +|++.+.||+|+||.||.+...   .+|..||+|.+.....   ....+.+.+|+.++..+ +|+||+.+++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            4788899999999999999874   4788999999875321   12346677899999999 699999999999999999


Q ss_pred             EEEEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCC
Q 019536          129 TLVFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPE  206 (339)
Q Consensus       129 ~lv~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~  206 (339)
                      ++||||+++++|.+++.  ..++......++.|++.||.|||   +.+++||||+|+||+++.++.+||+|||++.....
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  157 (290)
T cd05613          81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE  157 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence            99999999999999875  45778888889999999999999   89999999999999999999999999999877644


Q ss_pred             CCceeeecccccccccccccccccC--CCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccc
Q 019536          207 GETHVREEFIKGAYGFIAPEYFATS--SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA  284 (339)
Q Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (339)
                      .... ......|+..|+|||.+.+.  .++.++|+||||+++|+|++|..||...+...    ............     
T Consensus       158 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~----~~~~~~~~~~~~-----  227 (290)
T cd05613         158 DEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN----SQAEISRRILKS-----  227 (290)
T ss_pred             cccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc----cHHHHHHHhhcc-----
Confidence            3221 11134578899999998753  46789999999999999999999985432211    111111111000     


Q ss_pred             cccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 019536          285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP-----LMVDVAK  329 (339)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~il~  329 (339)
                              ..  +.+...+..+.+++.+||+.||++||     ++.+++.
T Consensus       228 --------~~--~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         228 --------EP--PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             --------CC--CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence                    00  11123445788999999999999997     6677765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=8e-38  Score=278.90  Aligned_cols=261  Identities=20%  Similarity=0.214  Sum_probs=193.6

Q ss_pred             cccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCCh-hhHHHHHHHHHHHHhc---CCCceeeeeeeeeeCCc-----
Q 019536           57 YDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTL-DDVEYCFNNIVFSSQM---KHKNILKLIGCCLETEL-----  127 (339)
Q Consensus        57 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l---~H~niv~~~~~~~~~~~-----  127 (339)
                      |++.+.||+|+||.||+|.+..++..||+|.+...... .....+.+|+.+++++   .|||++++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            66788999999999999999888999999999754332 2234566788777666   59999999999988776     


Q ss_pred             cEEEEEeccCCccccccc----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccc
Q 019536          128 PTLVFESVKYGTLRGFSF----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVS  203 (339)
Q Consensus       128 ~~lv~e~~~~g~L~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~  203 (339)
                      .+++|||+++ +|.+++.    ..+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++..
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~  156 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARI  156 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCccee
Confidence            8999999974 7777654    25788999999999999999999   89999999999999999999999999999877


Q ss_pred             cCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCccc
Q 019536          204 IPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFG  283 (339)
Q Consensus       204 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (339)
                      ........   ...++..|+|||++.+..++.++|+|||||++|+|++|++||.....     .................
T Consensus       157 ~~~~~~~~---~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~  228 (287)
T cd07838         157 YSFEMALT---SVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE-----ADQLDKIFDVIGLPSEE  228 (287)
T ss_pred             ccCCcccc---cccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh-----HHHHHHHHHHcCCCChH
Confidence            64433211   23467889999999988899999999999999999999988753211     11111111100000000


Q ss_pred             cccc------CcccCCCCCC---CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          284 AIVD------PIFDEDNSFP---GKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       284 ~~~~------~~~~~~~~~~---~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                      .+..      ..+......+   .....+..+.+++.+||+.||.+||++.+++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         229 EWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             hcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence            0000      0000000000   00134567889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.3e-38  Score=284.66  Aligned_cols=257  Identities=21%  Similarity=0.253  Sum_probs=200.3

Q ss_pred             CcccCCceeccCCeeEEEEEEc---CCCeeEEEEEeccCCC---hhhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCcc
Q 019536           56 NYDLHKVIQSDTSYRLFEGTLV---DQDRPISVMKFHDNST---LDDVEYCFNNIVFSSQM-KHKNILKLIGCCLETELP  128 (339)
Q Consensus        56 ~~~~~~~ig~G~~g~V~~~~~~---~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~  128 (339)
                      +|++.+.||+|++|.||++...   .++..||+|.+.....   ....+.+.+|+.++.++ +||||+++++++..+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4778899999999999999864   3568899999875321   13345678999999999 599999999999999999


Q ss_pred             EEEEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCC
Q 019536          129 TLVFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPE  206 (339)
Q Consensus       129 ~lv~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~  206 (339)
                      ++||||+++|+|.+++.  ..+++.....++.|++.||.|||   ..+++|+||+|.||+++.++.++|+|||+++.+..
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  157 (288)
T cd05583          81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA  157 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence            99999999999998875  45778888899999999999999   89999999999999999999999999999877654


Q ss_pred             CCceeeecccccccccccccccccCC--CCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccc
Q 019536          207 GETHVREEFIKGAYGFIAPEYFATSS--FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA  284 (339)
Q Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (339)
                      ..... .....++..|+|||.+.+..  .+.++|+||||+++|+|++|..||...+...    ............     
T Consensus       158 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~----~~~~~~~~~~~~-----  227 (288)
T cd05583         158 EEEER-AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN----SQSEISRRILKS-----  227 (288)
T ss_pred             ccccc-cccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc----hHHHHHHHHHcc-----
Confidence            33221 11345788999999987654  7789999999999999999999985332211    111111111100     


Q ss_pred             cccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 019536          285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMY  335 (339)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~  335 (339)
                              .  .+.+...+..+.+++.+||+.||++|||+.++.+.|+..+
T Consensus       228 --------~--~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~  268 (288)
T cd05583         228 --------K--PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPF  268 (288)
T ss_pred             --------C--CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcc
Confidence                    0  0111234457899999999999999999988877776543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2.7e-38  Score=288.66  Aligned_cols=267  Identities=17%  Similarity=0.199  Sum_probs=195.6

Q ss_pred             cCcc-cCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhh-------------HHHHHHHHHHHHhcCCCceeeeee
Q 019536           55 NNYD-LHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDD-------------VEYCFNNIVFSSQMKHKNILKLIG  120 (339)
Q Consensus        55 ~~~~-~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-------------~~~~~~e~~~l~~l~H~niv~~~~  120 (339)
                      ++|. +.+.||+|+||+||+|.+..+++.||+|++........             ...+.+|+.+++.++||||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            5565 45779999999999999988999999999876432110             124678999999999999999999


Q ss_pred             eeeeCCccEEEEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecC
Q 019536          121 CCLETELPTLVFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDF  198 (339)
Q Consensus       121 ~~~~~~~~~lv~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~df  198 (339)
                      ++..++..++||||++ |+|.+++.  ..++......++.|++.||.|||   +.+++|+||+|+||+++.++.++|+||
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~kl~df  163 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADF  163 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEEECCc
Confidence            9999999999999996 68888775  46788889999999999999999   899999999999999999999999999


Q ss_pred             CCccccCCCCc------------eeeecccccccccccccccccC-CCCcccchHHHHHHHHHHHhCCCccccCCCCCCC
Q 019536          199 SLSVSIPEGET------------HVREEFIKGAYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDD  265 (339)
Q Consensus       199 g~a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~  265 (339)
                      |+++.......            ........++..|+|||++.+. .++.++|+||+||++|+|++|+.||.....    
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~----  239 (335)
T PTZ00024        164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE----  239 (335)
T ss_pred             cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH----
Confidence            99876641110            0011123457789999998764 478999999999999999999999753321    


Q ss_pred             chhHHHHHHHHhhcCc---cccccc-CcccC-CCCCCC-----cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          266 DLTVLEYAKKSIENNR---FGAIVD-PIFDE-DNSFPG-----KEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       266 ~~~~~~~~~~~~~~~~---~~~~~~-~~~~~-~~~~~~-----~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                       ...............   +..... +.... ....+.     ....+..+.+++.+||+.+|++|||+.+++.+
T Consensus       240 -~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~  313 (335)
T PTZ00024        240 -IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH  313 (335)
T ss_pred             -HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence             111111111111000   000000 00000 000000     01235678899999999999999999999863

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.7e-38  Score=290.92  Aligned_cols=264  Identities=17%  Similarity=0.156  Sum_probs=197.2

Q ss_pred             HHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC-hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC----
Q 019536           52 KATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST-LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETE----  126 (339)
Q Consensus        52 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~----  126 (339)
                      ...++|++.+.||+|+||.||+|....++..||+|++..... ......+.+|+.+++.++||||+++++++..+.    
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07880          12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR   91 (343)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence            346789999999999999999999998999999999865422 233456789999999999999999999987654    


Q ss_pred             --ccEEEEEeccCCccccccc-cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccc
Q 019536          127 --LPTLVFESVKYGTLRGFSF-ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVS  203 (339)
Q Consensus       127 --~~~lv~e~~~~g~L~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~  203 (339)
                        ..++||||+ +++|.+++. ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.++++|||++..
T Consensus        92 ~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~  167 (343)
T cd07880          92 FHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ  167 (343)
T ss_pred             cceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccccc
Confidence              348999999 678887775 57899999999999999999999   89999999999999999999999999999876


Q ss_pred             cCCCCceeeeccccccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhc---
Q 019536          204 IPEGETHVREEFIKGAYGFIAPEYFAT-SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIEN---  279 (339)
Q Consensus       204 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---  279 (339)
                      ......     ...++..|+|||++.+ ..++.++|+||+|+++|++++|+.||.....     .............   
T Consensus       168 ~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~~~~  237 (343)
T cd07880         168 TDSEMT-----GYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDH-----LDQLMEIMKVTGTPSK  237 (343)
T ss_pred             cccCcc-----ccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHhcCCCCH
Confidence            543221     2457888999999876 3588999999999999999999999752211     0010000000000   


Q ss_pred             --------CcccccccCcccC-CCCCC-CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          280 --------NRFGAIVDPIFDE-DNSFP-GKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       280 --------~~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                              ............. ...+. .....+..+.+++.+||+.||++|||+.+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         238 EFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             HHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                    0000000000000 00000 00123456889999999999999999999984

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=4.5e-38  Score=276.85  Aligned_cols=247  Identities=18%  Similarity=0.232  Sum_probs=194.5

Q ss_pred             CcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC----ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 019536           56 NYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS----TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLV  131 (339)
Q Consensus        56 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  131 (339)
                      +|.+.+.||+|+||.||++.+...+..+++|.++...    .......+.+|+.+++.++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            5888999999999999999998766666666655421    123344567899999999999999999999999999999


Q ss_pred             EEeccCCccccccc------cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccC
Q 019536          132 FESVKYGTLRGFSF------ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIP  205 (339)
Q Consensus       132 ~e~~~~g~L~~~~~------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~  205 (339)
                      +||+++++|.+++.      ..+++...+.++.|++.||.|||   +.+++|+||+|+||+++. +.++|+|||.+....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeecC
Confidence            99999999988763      45788889999999999999999   899999999999999975 569999999987764


Q ss_pred             CCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCccccc
Q 019536          206 EGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAI  285 (339)
Q Consensus       206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (339)
                      ......  ....++..|+|||.+.+..++.++|+||+|+++|+|++|..||....        .......... ...   
T Consensus       157 ~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~--------~~~~~~~~~~-~~~---  222 (260)
T cd08222         157 GSCDLA--TTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN--------FLSVVLRIVE-GPT---  222 (260)
T ss_pred             CCcccc--cCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc--------HHHHHHHHHc-CCC---
Confidence            433221  13457888999999988888999999999999999999999974211        1111111111 100   


Q ss_pred             ccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          286 VDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                              ..  .+...+.++.+++.+||+.+|++||++.++++.
T Consensus       223 --------~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         223 --------PS--LPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             --------CC--CcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence                    00  112456689999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.9e-39  Score=291.22  Aligned_cols=268  Identities=19%  Similarity=0.214  Sum_probs=200.6

Q ss_pred             CcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC-hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC-----ccE
Q 019536           56 NYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST-LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETE-----LPT  129 (339)
Q Consensus        56 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~-----~~~  129 (339)
                      +|++.+.||.|++|.||+|....++..||+|++..... ....+.+.+|+.+++.++||||+++.+++....     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            58889999999999999999988899999999876532 345567889999999999999999999998775     789


Q ss_pred             EEEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCC
Q 019536          130 LVFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEG  207 (339)
Q Consensus       130 lv~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~  207 (339)
                      +||||++ ++|.+++.  ..+++..+..++.|++.||.|||   +.+|+|+||||.||+++.++.++|+|||++......
T Consensus        81 lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~  156 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD  156 (330)
T ss_pred             EEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence            9999997 47777765  36788889999999999999999   899999999999999999999999999998876554


Q ss_pred             Cce-eeecccccccccccccccccC-CCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcC-----
Q 019536          208 ETH-VREEFIKGAYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENN-----  280 (339)
Q Consensus       208 ~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----  280 (339)
                      ... .......++..|+|||++.+. .++.++|+||+|+++|+|++|++||......  ................     
T Consensus       157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~  234 (330)
T cd07834         157 EDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI--DQLNLIVEVLGTPSEEDLKFI  234 (330)
T ss_pred             ccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH--HHHHHHHHhcCCCChhHhhhc
Confidence            310 011134578889999999887 7899999999999999999999997533211  0000000000000000     


Q ss_pred             ---cccccccCcccCCCCCC---CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          281 ---RFGAIVDPIFDEDNSFP---GKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       281 ---~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                         ........ .......+   .....+..+.+++.+||+++|.+|||+.+++.+
T Consensus       235 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         235 TSEKARNYLKS-LPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             cccchhhHHhh-cccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence               00000000 00000000   001245678999999999999999999999974

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=2.9e-38  Score=285.07  Aligned_cols=266  Identities=18%  Similarity=0.211  Sum_probs=193.6

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCCh-hhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC------
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTL-DDVEYCFNNIVFSSQMKHKNILKLIGCCLETE------  126 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~------  126 (339)
                      .++|++.+.||+|+||.||+|....+++.+|+|++...... .....+.+|+.+++.++||||+++++++.+..      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            57899999999999999999999989999999998654322 22345678999999999999999999876543      


Q ss_pred             --ccEEEEEeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCc
Q 019536          127 --LPTLVFESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLS  201 (339)
Q Consensus       127 --~~~lv~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a  201 (339)
                        ..++|+||+++ ++...+.   ..+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||++
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~  162 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLA  162 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence              45899999975 4554443   46888999999999999999999   899999999999999999999999999998


Q ss_pred             cccCCCCcee---------eecccccccccccccccccC-CCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHH
Q 019536          202 VSIPEGETHV---------REEFIKGAYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLE  271 (339)
Q Consensus       202 ~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~  271 (339)
                      +.........         ......++..|+|||++.+. .++.++|||||||++|+|++|++||.....     .....
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~-----~~~~~  237 (311)
T cd07866         163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSD-----IDQLH  237 (311)
T ss_pred             hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCH-----HHHHH
Confidence            7654322111         11123567889999988654 588999999999999999999999752211     11111


Q ss_pred             HHHHHh---hcCccc------ccccCcccCCCCCCCc----HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          272 YAKKSI---ENNRFG------AIVDPIFDEDNSFPGK----EEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       272 ~~~~~~---~~~~~~------~~~~~~~~~~~~~~~~----~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                      ......   ....+.      ...+.......+ +..    ......+.+++.+||+.||.+|||+.+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         238 LIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYP-RTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHHHHhCCCChhhchhhhhcccccccccCCCCC-ccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            111110   000000      000000000000 000    112356889999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.1e-38  Score=292.18  Aligned_cols=266  Identities=15%  Similarity=0.199  Sum_probs=194.2

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeC--------
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLET--------  125 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~--------  125 (339)
                      .++|.+.+.||.|+||.||+|....++..||+|++..... ...+.+.+|+.+++.++||||+++++++...        
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV   82 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence            3789999999999999999999998999999999876544 4556788999999999999999999876543        


Q ss_pred             ------CccEEEEEeccCCccccccc-cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeC-CCCceEEec
Q 019536          126 ------ELPTLVFESVKYGTLRGFSF-ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLD-ENYSAKLHD  197 (339)
Q Consensus       126 ------~~~~lv~e~~~~g~L~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~-~~~~~kl~d  197 (339)
                            ...++||||++ ++|.+++. ..+++..+..++.|++.||.|||   +.+++||||||+||+++ .++.++++|
T Consensus        83 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~kl~d  158 (342)
T cd07854          83 GSLTELNSVYIVQEYME-TDLANVLEQGPLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGD  158 (342)
T ss_pred             ccccccceEEEEeeccc-ccHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceEEECC
Confidence                  35789999997 57877765 56889999999999999999999   89999999999999997 456789999


Q ss_pred             CCCccccCCCCcee-eeccccccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHH
Q 019536          198 FSLSVSIPEGETHV-REEFIKGAYGFIAPEYFAT-SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKK  275 (339)
Q Consensus       198 fg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  275 (339)
                      ||+++.+....... ......++..|+|||++.+ ..++.++|+|||||++|+|++|+.||.....     .........
T Consensus       159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~-----~~~~~~~~~  233 (342)
T cd07854         159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHE-----LEQMQLILE  233 (342)
T ss_pred             cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHH
Confidence            99987653321111 1112346788999998754 4688999999999999999999999852211     111110000


Q ss_pred             Hhh---cCccccc---ccCccc---CCCCCCC---cHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          276 SIE---NNRFGAI---VDPIFD---EDNSFPG---KEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       276 ~~~---~~~~~~~---~~~~~~---~~~~~~~---~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                      ...   .......   ......   .....+.   ....+.++.+++.+||+.||++|||+.+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         234 SVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             hcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence            000   0000000   000000   0000000   0123467889999999999999999999985

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1e-37  Score=284.64  Aligned_cols=265  Identities=18%  Similarity=0.212  Sum_probs=192.3

Q ss_pred             CcccCCceeccCCeeEEEEEEcCC--CeeEEEEEeccCCC-hhhHHHHHHHHHHHHhc-CCCceeeeeeeeeeC----Cc
Q 019536           56 NYDLHKVIQSDTSYRLFEGTLVDQ--DRPISVMKFHDNST-LDDVEYCFNNIVFSSQM-KHKNILKLIGCCLET----EL  127 (339)
Q Consensus        56 ~~~~~~~ig~G~~g~V~~~~~~~~--~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~----~~  127 (339)
                      +|++.+.||+|+||.||++....+  +..||+|++..... ......+.+|+.+++.+ .||||+++++.+...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            477889999999999999999877  88999999875422 23356678899999999 599999999976432    35


Q ss_pred             cEEEEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccC
Q 019536          128 PTLVFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIP  205 (339)
Q Consensus       128 ~~lv~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~  205 (339)
                      .++++||+. ++|.+++.  ..+++..+..++.|++.||.|||   ..+|+||||||+||+++.++.++|+|||+++.+.
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~  156 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFS  156 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence            688899886 57877765  56788899999999999999999   8999999999999999999999999999998765


Q ss_pred             CCCcee--eeccccccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHh---hc
Q 019536          206 EGETHV--REEFIKGAYGFIAPEYFAT-SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSI---EN  279 (339)
Q Consensus       206 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~  279 (339)
                      ......  ......|+..|+|||++.+ ..++.++|+||+|+++|++++|++||.....     ...........   ..
T Consensus       157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~~~~  231 (332)
T cd07857         157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDY-----VDQLNQILQVLGTPDE  231 (332)
T ss_pred             cccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCH-----HHHHHHHHHHhCCCCH
Confidence            432211  1113468889999998765 4689999999999999999999999753221     11111000000   00


Q ss_pred             CcccccccC-------ccc--CCCCCCC-cHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          280 NRFGAIVDP-------IFD--EDNSFPG-KEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       280 ~~~~~~~~~-------~~~--~~~~~~~-~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                      ..+..+..+       ...  ....++. ....+..+.+++.+||+.||++|||+.+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         232 ETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             HHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            000000000       000  0000000 0123457899999999999999999999875

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=5e-38  Score=279.53  Aligned_cols=262  Identities=19%  Similarity=0.212  Sum_probs=197.9

Q ss_pred             cccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC-hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEec
Q 019536           57 YDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST-LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESV  135 (339)
Q Consensus        57 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  135 (339)
                      |+..+.||+|++|.||+|....+++.||+|.+..... ....+.+.+|+.+++.++|+|++++++++.+.+..++|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            5677899999999999999998899999999987542 233466778999999999999999999999999999999999


Q ss_pred             cCCcccccccc---CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceee
Q 019536          136 KYGTLRGFSFA---SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVR  212 (339)
Q Consensus       136 ~~g~L~~~~~~---~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~  212 (339)
                      + ++|.+++..   .+++..+..++.|++.||.|||   +.+|+|+||+|+||+++.++.++|+|||+++..........
T Consensus        81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~  156 (282)
T cd07829          81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYT  156 (282)
T ss_pred             C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccC
Confidence            7 589888763   5888999999999999999999   89999999999999999999999999999877644332111


Q ss_pred             ecccccccccccccccccC-CCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHh---hcCccccc---
Q 019536          213 EEFIKGAYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSI---ENNRFGAI---  285 (339)
Q Consensus       213 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~---  285 (339)
                        ...++..|+|||.+.+. .++.++|+||||+++|++++|+.||....  .   ...........   ....+..+   
T Consensus       157 --~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~--~---~~~~~~~~~~~~~~~~~~~~~~~~~  229 (282)
T cd07829         157 --HEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDS--E---IDQLFKIFQILGTPTEESWPGVTKL  229 (282)
T ss_pred             --ccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCcc--H---HHHHHHHHHHhCCCcHHHHHhhccc
Confidence              23456779999998766 78899999999999999999998874221  1   11111111100   00000000   


Q ss_pred             --ccCcccCCCCCCC---cHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          286 --VDPIFDEDNSFPG---KEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       286 --~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                        .+.........+.   ....+..+.+++.+||+.||++||++.+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         230 PDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             ccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence              0000000000000   0122567999999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-39  Score=290.61  Aligned_cols=243  Identities=21%  Similarity=0.228  Sum_probs=198.3

Q ss_pred             CCceeccCCeeEEEEEEcCCCeeEEEEEeccCC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeccCC
Q 019536           60 HKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS-TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYG  138 (339)
Q Consensus        60 ~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g  138 (339)
                      .+++|+|.||+||-|..+.+|+.||||++.+-. .....+...+|+.||..++||.||.+-..|+..+..++|||-+.|.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            479999999999999999999999999998753 2245577889999999999999999999999999999999999554


Q ss_pred             ccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCC---CceEEecCCCccccCCCCceee
Q 019536          139 TLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDEN---YSAKLHDFSLSVSIPEGETHVR  212 (339)
Q Consensus       139 ~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~---~~~kl~dfg~a~~~~~~~~~~~  212 (339)
                      -|.-++.   +++++.....++.||+.||.|||   .++|+|+||||+|+|+.+.   -.+||||||.|+..+...... 
T Consensus       649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRr-  724 (888)
T KOG4236|consen  649 MLEMILSSEKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRR-  724 (888)
T ss_pred             HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhh-
Confidence            3443333   68898888899999999999999   9999999999999999754   358999999999987765432 


Q ss_pred             ecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccC
Q 019536          213 EEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDE  292 (339)
Q Consensus       213 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (339)
                        ..+||+.|+|||++....|+.+-|+||+|+++|--++|..||.  .+++  -.+.+       .+..+   +-+    
T Consensus       725 --sVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFN--EdEd--IndQI-------QNAaF---MyP----  784 (888)
T KOG4236|consen  725 --SVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFN--EDED--INDQI-------QNAAF---MYP----  784 (888)
T ss_pred             --hhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCC--Cccc--hhHHh-------hcccc---ccC----
Confidence              5789999999999999999999999999999999999999974  2211  11111       11111   111    


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          293 DNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       293 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                      ..  | +.+.+..+.+||..+|+..-.+|.|.+.-+.
T Consensus       785 p~--P-W~eis~~AidlIn~LLqVkm~kRysvdk~ls  818 (888)
T KOG4236|consen  785 PN--P-WSEISPEAIDLINNLLQVKMRKRYSVDKSLS  818 (888)
T ss_pred             CC--c-hhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence            11  1 2467788999999999999999999887665

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=6.3e-39  Score=261.50  Aligned_cols=265  Identities=18%  Similarity=0.268  Sum_probs=207.4

Q ss_pred             HhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcC-CCceeeeeeeeeeC--CccE
Q 019536           53 ATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMK-HKNILKLIGCCLET--ELPT  129 (339)
Q Consensus        53 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~~~~~~~~~--~~~~  129 (339)
                      ..++|++.+++|.|.++.||.|....++..++||.+++.    ....+.+|+.||..+. ||||+++++...+.  ..+.
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV----kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa  111 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV----KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS  111 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH----HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence            347899999999999999999999889999999999763    3466789999999996 99999999999875  4578


Q ss_pred             EEEEeccCCccccccccCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCC-CCceEEecCCCccccCCCC
Q 019536          130 LVFESVKYGTLRGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDE-NYSAKLHDFSLSVSIPEGE  208 (339)
Q Consensus       130 lv~e~~~~g~L~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~-~~~~kl~dfg~a~~~~~~~  208 (339)
                      |++||+.+.+...+. ..++..++..++.+++.||.|||   +.||+|||+||.|+++|. .-.++|+|+|+|....+..
T Consensus       112 LiFE~v~n~Dfk~ly-~tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~  187 (338)
T KOG0668|consen  112 LIFEYVNNTDFKQLY-PTLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  187 (338)
T ss_pred             hHhhhhccccHHHHh-hhhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhcCCCc
Confidence            999999887765543 56666777889999999999999   999999999999999985 4569999999999887766


Q ss_pred             ceeeecccccccccccccccccC-CCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHH------hhcC-
Q 019536          209 THVREEFIKGAYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKS------IENN-  280 (339)
Q Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~------~~~~-  280 (339)
                      ...   ..+.+..|..||++..- .|+.+-|+|||||+++.|+..+.|| |.|.++.+++-.+......      .... 
T Consensus       188 eYn---VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepF-FhG~dN~DQLVkIakVLGt~el~~Yl~KY~  263 (338)
T KOG0668|consen  188 EYN---VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF-FHGHDNYDQLVKIAKVLGTDELYAYLNKYQ  263 (338)
T ss_pred             eee---eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcc-cCCCCCHHHHHHHHHHhChHHHHHHHHHHc
Confidence            543   34567778999998764 5889999999999999999999999 7898888877655443221      1111 


Q ss_pred             -----cccccccCcccCC-CCC--CC-cHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          281 -----RFGAIVDPIFDED-NSF--PG-KEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       281 -----~~~~~~~~~~~~~-~~~--~~-~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                           .+..++....... ..+  +. ....++++.+|+.++|.+|.++|+||.|++.
T Consensus       264 i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  264 IDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             cCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence                 1111111110000 001  00 1123478999999999999999999999876

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=9.2e-38  Score=307.90  Aligned_cols=146  Identities=21%  Similarity=0.204  Sum_probs=132.6

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC--ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS--TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLV  131 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  131 (339)
                      .++|.+.+.||+|+||+||+|.+..+++.||+|++....  .......+.+|+.+++.++||||+++++++...+..++|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            468999999999999999999999899999999987642  223346678999999999999999999999999999999


Q ss_pred             EEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCcc
Q 019536          132 FESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSV  202 (339)
Q Consensus       132 ~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~  202 (339)
                      |||+++++|.+++.  ..+++..++.++.||+.||.|||   ..+|+||||||+|||++.++.+||+|||+++
T Consensus        83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999999875  56788888999999999999999   8999999999999999999999999999975

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.8e-38  Score=288.69  Aligned_cols=263  Identities=17%  Similarity=0.221  Sum_probs=197.8

Q ss_pred             HhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCc----
Q 019536           53 ATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS-TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETEL----  127 (339)
Q Consensus        53 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~----  127 (339)
                      ..++|++...||+|++|.||+|....++..||+|++.... .......+.+|+.+++.++||||+++.+++...+.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            4578999999999999999999999899999999986542 22344667789999999999999999998876554    


Q ss_pred             --cEEEEEeccCCccccccc-cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCcccc
Q 019536          128 --PTLVFESVKYGTLRGFSF-ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSI  204 (339)
Q Consensus       128 --~~lv~e~~~~g~L~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~  204 (339)
                        .++|+||+ +++|.+++. ..+++..+..++.|++.||.|||   +.+|+||||+|+||+++.++.++|+|||++...
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~  168 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHT  168 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEccccccccc
Confidence              89999999 568888876 47899999999999999999999   899999999999999999999999999998766


Q ss_pred             CCCCceeeecccccccccccccccccC-CCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhc----
Q 019536          205 PEGETHVREEFIKGAYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIEN----  279 (339)
Q Consensus       205 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----  279 (339)
                      .....     ...++..|+|||.+.+. .++.++|+||+|+++|++++|+.||....  .   .............    
T Consensus       169 ~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~--~---~~~~~~i~~~~~~~~~~  238 (343)
T cd07851         169 DDEMT-----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSD--H---IDQLKRIMNLVGTPDEE  238 (343)
T ss_pred             ccccc-----CCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC--h---HHHHHHHHHhcCCCCHH
Confidence            44321     24578889999998653 67899999999999999999999975221  1   1111111000000    


Q ss_pred             -------CcccccccCc-ccCCCCCCC-cHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          280 -------NRFGAIVDPI-FDEDNSFPG-KEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       280 -------~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                             .....+.... ......++. ....+..+.+++.+||+.||++|||+.+|+.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             HHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence                   0000000000 000000000 0123567999999999999999999999976

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.1e-37  Score=270.97  Aligned_cols=218  Identities=21%  Similarity=0.170  Sum_probs=176.5

Q ss_pred             cCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeccCCccccccc
Q 019536           66 DTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSF  145 (339)
Q Consensus        66 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~  145 (339)
                      |.+|.||++.+..+++.||+|++....      .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   77 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS   77 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence            899999999999999999999987642      12345455556679999999999999999999999999999988875


Q ss_pred             --cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceeeecccccccccc
Q 019536          146 --ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFI  223 (339)
Q Consensus       146 --~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~  223 (339)
                        ..+++.....++.|++.||.|||   +.+++||||||+||+++.++.++++|||.+........     ...++..|+
T Consensus        78 ~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~-----~~~~~~~y~  149 (237)
T cd05576          78 KFLNIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCD-----GEAVENMYC  149 (237)
T ss_pred             HhcCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhccccccc-----cCCcCcccc
Confidence              46888889999999999999999   89999999999999999999999999998766543221     234566799


Q ss_pred             cccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCCCCCCCcHHHH
Q 019536          224 APEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKL  303 (339)
Q Consensus       224 aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (339)
                      |||.+.+..++.++|+||+|+++|+|++|+.|+.......                           ........+...+
T Consensus       150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~---------------------------~~~~~~~~~~~~~  202 (237)
T cd05576         150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI---------------------------NTHTTLNIPEWVS  202 (237)
T ss_pred             CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc---------------------------ccccccCCcccCC
Confidence            9999988889999999999999999999998864211100                           0000001112345


Q ss_pred             HHHHHHHHHhhccCCCCCCCH
Q 019536          304 QSLGQLMYKCLSKSPEHRPLM  324 (339)
Q Consensus       304 ~~~~~li~~cl~~dP~~Rps~  324 (339)
                      ..+.+++.+||+.||++||++
T Consensus       203 ~~~~~li~~~l~~dp~~R~~~  223 (237)
T cd05576         203 EEARSLLQQLLQFNPTERLGA  223 (237)
T ss_pred             HHHHHHHHHHccCCHHHhcCC
Confidence            678999999999999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-37  Score=271.99  Aligned_cols=236  Identities=23%  Similarity=0.256  Sum_probs=192.4

Q ss_pred             eeccCCeeEEEEEEcCCCeeEEEEEeccCCC--hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeccCCcc
Q 019536           63 IQSDTSYRLFEGTLVDQDRPISVMKFHDNST--LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL  140 (339)
Q Consensus        63 ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L  140 (339)
                      ||.|+||.||++....+++.+++|.+.....  ......+.+|+.+++.++||||+++++.+..++..++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            6899999999999988899999999876533  23556788999999999999999999999999999999999999999


Q ss_pred             ccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceeeeccccc
Q 019536          141 RGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG  218 (339)
Q Consensus       141 ~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~g  218 (339)
                      .+++.  ..+++.....++.|++.||.|||   +.+++|+||+|.||+++.++.++|+|||++.........  .....+
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~  155 (250)
T cd05123          81 FSHLSKEGRFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSR--TNTFCG  155 (250)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCc--ccCCcC
Confidence            99886  36788899999999999999999   899999999999999999999999999998776443211  123567


Q ss_pred             ccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCCCCCCC
Q 019536          219 AYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPG  298 (339)
Q Consensus       219 t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (339)
                      +..|+|||...+...+.++|+||||+++|++++|..||.....        ......... .            ....  
T Consensus       156 ~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--------~~~~~~~~~-~------------~~~~--  212 (250)
T cd05123         156 TPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--------KEIYEKILK-D------------PLRF--  212 (250)
T ss_pred             CccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHhc-C------------CCCC--
Confidence            8889999999888889999999999999999999999742211        111111110 0            1111  


Q ss_pred             cHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 019536          299 KEEKLQSLGQLMYKCLSKSPEHRPLMVD  326 (339)
Q Consensus       299 ~~~~~~~~~~li~~cl~~dP~~Rps~~~  326 (339)
                      +...+..+.+++.+||..||++|||+.+
T Consensus       213 ~~~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         213 PEFLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence            1123567899999999999999999943

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-38  Score=290.99  Aligned_cols=240  Identities=22%  Similarity=0.270  Sum_probs=196.1

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCccEEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLETELPTLVF  132 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~~lv~  132 (339)
                      ++.|.+...+|.|+|+.|-.+....+++..++|++.+...     ...+|+.++... +||||+++.+.+.++...|+||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~  395 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM  395 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheecccccc-----ccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence            5789999999999999999999999999999999987621     122566555444 7999999999999999999999


Q ss_pred             EeccCCccccccc-cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEe-CCCCceEEecCCCccccCCCCce
Q 019536          133 ESVKYGTLRGFSF-ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLL-DENYSAKLHDFSLSVSIPEGETH  210 (339)
Q Consensus       133 e~~~~g~L~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~-~~~~~~kl~dfg~a~~~~~~~~~  210 (339)
                      |.+.++.+.+.+. .......+..|+.+|+.|+.|||   .+|++||||||+|||+ ++.+.++|+|||.++.+...   
T Consensus       396 e~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~---  469 (612)
T KOG0603|consen  396 ELLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS---  469 (612)
T ss_pred             hhccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhCchh---
Confidence            9999998877765 33333666789999999999999   9999999999999999 68999999999999887665   


Q ss_pred             eeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcc
Q 019536          211 VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIF  290 (339)
Q Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (339)
                        ....+-|..|.|||++....|+.++|+||||+++|+|++|+.||.....+        ..+...+..+.+        
T Consensus       470 --~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--------~ei~~~i~~~~~--------  531 (612)
T KOG0603|consen  470 --CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--------IEIHTRIQMPKF--------  531 (612)
T ss_pred             --hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--------HHHHHhhcCCcc--------
Confidence              11345678899999999889999999999999999999999998643332        111111111111        


Q ss_pred             cCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          291 DEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                              ....+..+++|+.+||+.||.+||++.++..+
T Consensus       532 --------s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h  563 (612)
T KOG0603|consen  532 --------SECVSDEAKDLLQQLLQVDPALRLGADEIGAH  563 (612)
T ss_pred             --------ccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence                    13567789999999999999999999998764

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-37  Score=292.86  Aligned_cols=252  Identities=21%  Similarity=0.256  Sum_probs=206.5

Q ss_pred             HHHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhc-CCCceeeeeeeee-----e
Q 019536           51 KKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCCL-----E  124 (339)
Q Consensus        51 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~-----~  124 (339)
                      ..-++-|++.++||.|.+|.||+++...+++..|+|+.......  .+++..|..+++.. .|||++.++|++.     .
T Consensus        15 pdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~--deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~   92 (953)
T KOG0587|consen   15 PDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE--EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGN   92 (953)
T ss_pred             CCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc--cHHHHHHHHHHHhccCCCCcceEEEEEEEecCCC
Confidence            34467899999999999999999999999999999998876542  34455777888877 6999999999986     3


Q ss_pred             CCccEEEEEeccCCccccccc----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCC
Q 019536          125 TELPTLVFESVKYGTLRGFSF----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSL  200 (339)
Q Consensus       125 ~~~~~lv~e~~~~g~L~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~  200 (339)
                      ++.+|||||||.+|+..|+..    .++.+..+..|+..++.|+.+||   ...++|||+|-.|||++.++.+||+|||.
T Consensus        93 ~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKLvDFGv  169 (953)
T KOG0587|consen   93 GDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKLVDFGV  169 (953)
T ss_pred             CCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEEeeeee
Confidence            567999999999999999876    57788888899999999999999   89999999999999999999999999999


Q ss_pred             ccccCCCCceeeecccccccccccccccccC-----CCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHH
Q 019536          201 SVSIPEGETHVREEFIKGAYGFIAPEYFATS-----SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKK  275 (339)
Q Consensus       201 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  275 (339)
                      +..+.....  ...+..||+.|||||++...     .|+..+|+||||++..||.-|.+|+..+..-             
T Consensus       170 SaQldsT~g--rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm-------------  234 (953)
T KOG0587|consen  170 SAQLDSTVG--RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM-------------  234 (953)
T ss_pred             eeeeecccc--cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh-------------
Confidence            877654322  22256799999999998643     4788999999999999999999997633321             


Q ss_pred             HhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          276 SIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                             ..++.....+...+..+..+++++.++|..||..|-++||++.++++
T Consensus       235 -------raLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  235 -------RALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             -------hhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence                   11111111222333445789999999999999999999999999886

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-37  Score=274.20  Aligned_cols=263  Identities=20%  Similarity=0.260  Sum_probs=206.1

Q ss_pred             HHHHHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChh------hHHHHHHHHHHHHhcCCCceeeeeeee
Q 019536           49 DLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLD------DVEYCFNNIVFSSQMKHKNILKLIGCC  122 (339)
Q Consensus        49 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~e~~~l~~l~H~niv~~~~~~  122 (339)
                      +-....++|-++.++|.|||+.||+|.+....+.||||+-.....+.      -.+...+|-.|.+.|.||.||+++++|
T Consensus       457 DHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyf  536 (775)
T KOG1151|consen  457 DHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYF  536 (775)
T ss_pred             cCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeee
Confidence            33455578999999999999999999999999999999865543222      235567899999999999999999998


Q ss_pred             e-eCCccEEEEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCC---CCceEEe
Q 019536          123 L-ETELPTLVFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDE---NYSAKLH  196 (339)
Q Consensus       123 ~-~~~~~~lv~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~---~~~~kl~  196 (339)
                      . +.+.+|-|+|||+|.+|+-++.  ..+++.++..|+.||+.||.||.+- +.+|||-||||.|||+..   -|.+||.
T Consensus       537 slDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKIT  615 (775)
T KOG1151|consen  537 SLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKIT  615 (775)
T ss_pred             eeccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEee
Confidence            6 5667899999999999998887  5678888999999999999999954 688999999999999953   4679999


Q ss_pred             cCCCccccCCCCce-----eeecccccccccccccccccC----CCCcccchHHHHHHHHHHHhCCCccccCCCCCCCch
Q 019536          197 DFSLSVSIPEGETH-----VREEFIKGAYGFIAPEYFATS----SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDL  267 (339)
Q Consensus       197 dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~  267 (339)
                      |||+++.+..+...     ..+....||..|++||.+.-+    ..+.++||||+||++|..+.|+.||.....    + 
T Consensus       616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs----Q-  690 (775)
T KOG1151|consen  616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS----Q-  690 (775)
T ss_pred             ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh----H-
Confidence            99999988664332     223346799999999987533    478999999999999999999999852211    1 


Q ss_pred             hHHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          268 TVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                        ...+..    ...   +.   .....+|..+..+.++.++|++||++.-++|.+..++..
T Consensus       691 --QdILqe----NTI---lk---AtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  691 --QDILQE----NTI---LK---ATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             --HHHHhh----hch---hc---ceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence              111111    000   00   112344544567778999999999999999999888764

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-38  Score=274.12  Aligned_cols=242  Identities=22%  Similarity=0.321  Sum_probs=199.8

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCCh--hhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCccEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTL--DDVEYCFNNIVFSSQM-KHKNILKLIGCCLETELPTL  130 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~~l  130 (339)
                      ..+|..+.+||.|+||.|-.|..+++...+|||++++....  .+.+--+.|-++|+.. +-|.++++..+|+.-+.+|.
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF  427 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF  427 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence            35788889999999999999999999999999999886432  3344456777777766 57899999999999999999


Q ss_pred             EEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCC
Q 019536          131 VFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE  208 (339)
Q Consensus       131 v~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~  208 (339)
                      ||||+.||+|--.+.  +.+.+..++.++.+|+-||-+||   +++|+.||||.+|||++..|.+||+|||+++.-....
T Consensus       428 VMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~  504 (683)
T KOG0696|consen  428 VMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDG  504 (683)
T ss_pred             EEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeecccccccccCC
Confidence            999999999988876  67888889999999999999999   9999999999999999999999999999987543333


Q ss_pred             ceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccC
Q 019536          209 THVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDP  288 (339)
Q Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (339)
                      .  ++.+.+||+.|+|||.+...+|+.++|+||+||++|||+.|++||+  |+++.+               .+..|.+ 
T Consensus       505 ~--TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFd--GeDE~e---------------lF~aI~e-  564 (683)
T KOG0696|consen  505 V--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD--GEDEDE---------------LFQAIME-  564 (683)
T ss_pred             c--ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCC--CCCHHH---------------HHHHHHH-
Confidence            2  3335889999999999999999999999999999999999999975  332211               1111122 


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCC
Q 019536          289 IFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPL  323 (339)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps  323 (339)
                         .+..+|.  ..+.++.++....|...|.+|..
T Consensus       565 ---hnvsyPK--slSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  565 ---HNVSYPK--SLSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             ---ccCcCcc--cccHHHHHHHHHHhhcCCccccC
Confidence               2223332  56778889999999999999964

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-38  Score=281.03  Aligned_cols=242  Identities=19%  Similarity=0.247  Sum_probs=205.7

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC--ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS--TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVF  132 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  132 (339)
                      .+++....+|-|+||.|=.+..+.....+|+|++++..  ...+.+.+..|-.||...+.|.||++|--|.+....|++|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            56777889999999999999997666668999887752  2356778889999999999999999999999999999999


Q ss_pred             EeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCce
Q 019536          133 ESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH  210 (339)
Q Consensus       133 e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~  210 (339)
                      |-|-||.|...+.  +.+...+...++..+++|++|||   .++||.|||||+|++++.+|.+||.|||+|+.+..+...
T Consensus       500 EaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KT  576 (732)
T KOG0614|consen  500 EACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKT  576 (732)
T ss_pred             HhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhccCCce
Confidence            9999999999987  67888888999999999999999   999999999999999999999999999999998877654


Q ss_pred             eeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcc
Q 019536          211 VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIF  290 (339)
Q Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (339)
                      .   +.+||+.|.|||.+.....+.++|.||||+++|||++|.+||...     +++.....+.+-++...         
T Consensus       577 w---TFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~-----dpmktYn~ILkGid~i~---------  639 (732)
T KOG0614|consen  577 W---TFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGV-----DPMKTYNLILKGIDKIE---------  639 (732)
T ss_pred             e---eecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCC-----chHHHHHHHHhhhhhhh---------
Confidence            4   578999999999999999999999999999999999999997532     23333333333222221         


Q ss_pred             cCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCC
Q 019536          291 DEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPL  323 (339)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps  323 (339)
                           +|  ........+||+++...+|.+|.-
T Consensus       640 -----~P--r~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  640 -----FP--RRITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             -----cc--cccchhHHHHHHHHHhcCcHhhhc
Confidence                 22  245567889999999999999975

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-38  Score=263.22  Aligned_cols=252  Identities=19%  Similarity=0.197  Sum_probs=194.8

Q ss_pred             CcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHH-HhcCCCceeeeeeeeeeCCccEEEEEe
Q 019536           56 NYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFS-SQMKHKNILKLIGCCLETELPTLVFES  134 (339)
Q Consensus        56 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l-~~l~H~niv~~~~~~~~~~~~~lv~e~  134 (339)
                      +.+.+..||.|+||+|++-.++..|+..|||+++......+..+++.|.... +.-+.||||+++|.+-..+..|+-||.
T Consensus        65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL  144 (361)
T KOG1006|consen   65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL  144 (361)
T ss_pred             hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence            3444578999999999999999999999999999877667778888888754 555799999999999888889999999


Q ss_pred             ccCCccccccc-------cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCC
Q 019536          135 VKYGTLRGFSF-------ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEG  207 (339)
Q Consensus       135 ~~~g~L~~~~~-------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~  207 (339)
                      |+ .+|..+..       ..+++.-.-.|..-.+.||.||-.  ...|+|||+||+|||++..|.+||||||.+..+..+
T Consensus       145 Md-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S  221 (361)
T KOG1006|consen  145 MD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS  221 (361)
T ss_pred             Hh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHHH
Confidence            94 46655532       567777766788888999999986  678999999999999999999999999998665443


Q ss_pred             Cceeeeccccccccccccccccc--CCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCccccc
Q 019536          208 ETHVREEFIKGAYGFIAPEYFAT--SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAI  285 (339)
Q Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (339)
                      -..   +.-.|..+|||||.+..  ..|+.++|+||||+++||+.||+.|+.       .+....+.+..... +....+
T Consensus       222 iAk---T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr-------~w~svfeql~~Vv~-gdpp~l  290 (361)
T KOG1006|consen  222 IAK---TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYR-------KWDSVFEQLCQVVI-GDPPIL  290 (361)
T ss_pred             HHh---hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcc-------hHHHHHHHHHHHHc-CCCCee
Confidence            211   13457888999999853  359999999999999999999999975       12223332222211 111111


Q ss_pred             ccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          286 VDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                      .     .+.   .....+..+..++..||.+|..+||+..++++
T Consensus       291 ~-----~~~---~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  291 L-----FDK---ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             c-----Ccc---cccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence            1     000   01245678999999999999999999998875

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-36  Score=256.21  Aligned_cols=250  Identities=21%  Similarity=0.282  Sum_probs=206.2

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccC--CChhhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCccEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDN--STLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLETELPTL  130 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~~l  130 (339)
                      .++|.++++||.|+|+.|..++.+.+.+.+|+|++++.  ...++.++...|-.+..+. +||.+|-+..+|+....++.
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            47899999999999999999999999999999999875  3335677888888877766 79999999999999999999


Q ss_pred             EEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCC
Q 019536          131 VFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE  208 (339)
Q Consensus       131 v~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~  208 (339)
                      |.||.+||+|--++.  +.+|++.+..+...|..||.|||   +.||+.||||.+|+|+|..|.+||.|+|.++.-..+.
T Consensus       329 vieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~l~~g  405 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPG  405 (593)
T ss_pred             EEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcCCCCC
Confidence            999999999988876  67999999999999999999999   9999999999999999999999999999987543332


Q ss_pred             ceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccC
Q 019536          209 THVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDP  288 (339)
Q Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (339)
                      .  .+.+.+||+.|.|||.+.+..|..++|+|++|++|+||+.|+.||+..|..+.+. +...++...+-          
T Consensus       406 d--~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~-ntedylfqvil----------  472 (593)
T KOG0695|consen  406 D--TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDM-NTEDYLFQVIL----------  472 (593)
T ss_pred             c--ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCccc-chhHHHHHHHh----------
Confidence            2  2336889999999999999999999999999999999999999999877555332 22222222111          


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCC
Q 019536          289 IFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPL  323 (339)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps  323 (339)
                        ..+...|.  ..+-.+..+++..|++||.+|..
T Consensus       473 --ekqiripr--slsvkas~vlkgflnkdp~erlg  503 (593)
T KOG0695|consen  473 --EKQIRIPR--SLSVKASHVLKGFLNKDPKERLG  503 (593)
T ss_pred             --hhcccccc--eeehhhHHHHHHhhcCCcHHhcC
Confidence              11222222  22334667899999999999954

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-37  Score=259.84  Aligned_cols=269  Identities=17%  Similarity=0.227  Sum_probs=199.9

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccC-CChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC-----cc
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDN-STLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETE-----LP  128 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~-----~~  128 (339)
                      .+.+..+.||-|+||.||..++..+|+.||+|++... ......+++.+|+++|..++|.|++..++...-..     .+
T Consensus        53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi  132 (449)
T KOG0664|consen   53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL  132 (449)
T ss_pred             ccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence            4567789999999999999999999999999998764 22345678899999999999999999998876543     35


Q ss_pred             EEEEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCC
Q 019536          129 TLVFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPE  206 (339)
Q Consensus       129 ~lv~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~  206 (339)
                      |+++|.+. .+|..++-  ..++.+.+.-++.||++||.|||   +.+|+||||||.|.|+++|+.+||+|||+|+....
T Consensus       133 YV~TELmQ-SDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~  208 (449)
T KOG0664|consen  133 YVLTELMQ-SDLHKIIVSPQALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ  208 (449)
T ss_pred             HHHHHHHH-hhhhheeccCCCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccch
Confidence            78888884 47777765  56777888889999999999999   99999999999999999999999999999998765


Q ss_pred             CCceeeecccccccccccccccccC-CCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhc------
Q 019536          207 GETHVREEFIKGAYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIEN------  279 (339)
Q Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~------  279 (339)
                      +.....+ ..+-|-.|+|||.+.|. .|+.++||||+||++.|++.++-.|...+.-  .+++.+..+......      
T Consensus       209 d~~~hMT-qEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~Pi--qQL~lItdLLGTPs~EaMr~A  285 (449)
T KOG0664|consen  209 RDRLNMT-HEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPI--EQLQMIIDLLGTPSQEAMKYA  285 (449)
T ss_pred             hhhhhhH-HHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChH--HHHHHHHHHhCCCcHHHHHHH
Confidence            5443222 34567889999999986 5999999999999999999888887644332  233322222211111      


Q ss_pred             --Cccccccc-----CcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          280 --NRFGAIVD-----PIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       280 --~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                        +....++.     +....-.....+.....+..+++.+++.+||.+|.+..+++..
T Consensus       286 CEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~  343 (449)
T KOG0664|consen  286 CEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQH  343 (449)
T ss_pred             hhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccc
Confidence              00000000     0000001111111333466789999999999999999888764

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=3.5e-35  Score=283.21  Aligned_cols=263  Identities=16%  Similarity=0.146  Sum_probs=168.0

Q ss_pred             HhcCcccCCceeccCCeeEEEEEEcCC----CeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeee------e
Q 019536           53 ATNNYDLHKVIQSDTSYRLFEGTLVDQ----DRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGC------C  122 (339)
Q Consensus        53 ~~~~~~~~~~ig~G~~g~V~~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~------~  122 (339)
                      ..++|++.+.||+|+||.||+|.+..+    +..||+|++.....   .+...++  .+....+.++..++..      +
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~---~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~  204 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA---VEIWMNE--RVRRACPNSCADFVYGFLEPVSS  204 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch---hHHHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence            557999999999999999999999888    89999999865322   1212222  1112222233322222      2


Q ss_pred             eeCCccEEEEEeccCCccccccccC-CC---------------------hHHHHHHHHHHHHHHHHHhcCCCCCeEEccC
Q 019536          123 LETELPTLVFESVKYGTLRGFSFAS-LL---------------------IAPRIKIAMEIANAVAYLHVGFDRPIVFRCI  180 (339)
Q Consensus       123 ~~~~~~~lv~e~~~~g~L~~~~~~~-~~---------------------~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dl  180 (339)
                      ..+...++|+||+++++|.+++... .+                     ...+..++.|++.||.|||   +.+|+||||
T Consensus       205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDL  281 (566)
T PLN03225        205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDV  281 (566)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcC
Confidence            4566789999999999998886521 11                     1224568999999999999   899999999


Q ss_pred             CCCCEEeCC-CCceEEecCCCccccCCCCceeeecccccccccccccccccC----------------------CCCccc
Q 019536          181 KASNVLLDE-NYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATS----------------------SFNEMC  237 (339)
Q Consensus       181 k~~Nil~~~-~~~~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~  237 (339)
                      ||+|||++. ++.+||+|||+|+.+........ ....+++.|+|||.+...                      .++.++
T Consensus       282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~-~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~  360 (566)
T PLN03225        282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIP-KEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF  360 (566)
T ss_pred             CHHHEEEeCCCCcEEEEeCCCccccccccccCC-cccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence            999999985 57899999999986644332221 235688999999966422                      234467


Q ss_pred             chHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHH-hhcCcccccccCcccCCC--CCCCcHHHHHHHHHHHHHhh
Q 019536          238 DVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKS-IENNRFGAIVDPIFDEDN--SFPGKEEKLQSLGQLMYKCL  314 (339)
Q Consensus       238 DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~cl  314 (339)
                      ||||+||++|||+++..++.    ..  ........... .....+.....+......  .+...........+|+.+||
T Consensus       361 DVwSlGviL~el~~~~~~~~----~~--~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL  434 (566)
T PLN03225        361 DIYSAGLIFLQMAFPNLRSD----SN--LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMM  434 (566)
T ss_pred             ccHHHHHHHHHHHhCcCCCc----hH--HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHc
Confidence            99999999999998654421    10  00000000000 000000011111100000  00000011224568999999


Q ss_pred             ccCCCCCCCHHHHHHH
Q 019536          315 SKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       315 ~~dP~~Rps~~~il~~  330 (339)
                      +.||++|||+.+++++
T Consensus       435 ~~dP~kR~ta~e~L~H  450 (566)
T PLN03225        435 RFKGRQRISAKAALAH  450 (566)
T ss_pred             cCCcccCCCHHHHhCC
Confidence            9999999999999874

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=6.7e-35  Score=252.68  Aligned_cols=238  Identities=24%  Similarity=0.304  Sum_probs=191.8

Q ss_pred             CCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeccCCcccccccc
Q 019536           67 TSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFA  146 (339)
Q Consensus        67 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~  146 (339)
                      +||.||+|....++..+++|++.........+.+.+|+..++.++|+||+++++++..+...++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999998889999999998765433367888999999999999999999999999999999999999999998762


Q ss_pred             --CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceeeeccccccccccc
Q 019536          147 --SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIA  224 (339)
Q Consensus       147 --~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~a  224 (339)
                        .++......++.+++.++.|||   ..+++|+||+|.||+++.++.++++|||.+........   .....++..|++
T Consensus        81 ~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~  154 (244)
T smart00220       81 RGRLSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGL---LTTFVGTPEYMA  154 (244)
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeeccccc---cccccCCcCCCC
Confidence              3788889999999999999999   89999999999999999999999999999887655321   113457888999


Q ss_pred             ccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHH
Q 019536          225 PEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQ  304 (339)
Q Consensus       225 PE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (339)
                      ||.+.+..++.++|+||+|++++++++|..||.....    .....    .........        ..   +.....+.
T Consensus       155 pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~----~~~~~----~~~~~~~~~--------~~---~~~~~~~~  215 (244)
T smart00220      155 PEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ----LLELF----KKIGKPKPP--------FP---PPEWKISP  215 (244)
T ss_pred             HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc----HHHHH----HHHhccCCC--------Cc---cccccCCH
Confidence            9999888889999999999999999999999753211    01111    111111100        00   00001445


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          305 SLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       305 ~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                      .+.+++.+||..+|++||++.++++
T Consensus       216 ~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      216 EAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHHHHHccCCchhccCHHHHhh
Confidence            7999999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-35  Score=271.50  Aligned_cols=202  Identities=18%  Similarity=0.241  Sum_probs=176.6

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC--hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST--LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVF  132 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  132 (339)
                      .-|...+.||-|+||.|+.++..++...||.|.+.+...  .+....+..|-.||+.-..+=||+|+-.|.+.+.+|+||
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM  708 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM  708 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence            458888999999999999999999999999999987643  345677889999999999999999999999999999999


Q ss_pred             EeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccC--CCC
Q 019536          133 ESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIP--EGE  208 (339)
Q Consensus       133 e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~--~~~  208 (339)
                      +|++||++-.++.  +-++++-++.++.++.+|+++.|   ..|.|||||||+|||||.+|.+||.|||+++-+.  .+.
T Consensus       709 dYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds  785 (1034)
T KOG0608|consen  709 DYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  785 (1034)
T ss_pred             eccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccccceecccc
Confidence            9999999988876  67888888899999999999999   9999999999999999999999999999986541  000


Q ss_pred             c--------------------------------------eeeecccccccccccccccccCCCCcccchHHHHHHHHHHH
Q 019536          209 T--------------------------------------HVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELL  250 (339)
Q Consensus       209 ~--------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~  250 (339)
                      .                                      .+.....+||+.|+|||++....|+..+|+||.||++|||+
T Consensus       786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~  865 (1034)
T KOG0608|consen  786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEML  865 (1034)
T ss_pred             ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHh
Confidence            0                                      01122357999999999999999999999999999999999


Q ss_pred             hCCCccccC
Q 019536          251 TGCNVLEFK  259 (339)
Q Consensus       251 ~g~~p~~~~  259 (339)
                      .|++||...
T Consensus       866 ~g~~pf~~~  874 (1034)
T KOG0608|consen  866 VGQPPFLAD  874 (1034)
T ss_pred             hCCCCccCC
Confidence            999998643

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-36  Score=254.56  Aligned_cols=266  Identities=20%  Similarity=0.241  Sum_probs=201.4

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccC-CChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC------c
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDN-STLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETE------L  127 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~------~  127 (339)
                      .+|.-+..+|.|.. .|..+.+.-.+++||+|++... ......++..+|..++..+.|+||++++.++.-..      .
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            57888889999998 8889988889999999998765 22345677889999999999999999999997543      4


Q ss_pred             cEEEEEeccCCccccccccCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCC
Q 019536          128 PTLVFESVKYGTLRGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEG  207 (339)
Q Consensus       128 ~~lv~e~~~~g~L~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~  207 (339)
                      .|+|||++ .++|...+.-.++-.+...++.|++.|+.|||   +.+|+||||||+||++..++.+|+.|||+|+.-...
T Consensus        96 ~y~v~e~m-~~nl~~vi~~elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~  171 (369)
T KOG0665|consen   96 VYLVMELM-DANLCQVILMELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD  171 (369)
T ss_pred             HHHHHHhh-hhHHHHHHHHhcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhhcccCcc
Confidence            68999999 46888877777777888899999999999999   999999999999999999999999999999875443


Q ss_pred             CceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHh----------
Q 019536          208 ETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSI----------  277 (339)
Q Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~----------  277 (339)
                         ...+-.+.|..|.|||++.+..|...+||||+||++.||++|+-.|.  |....++...+.......          
T Consensus       172 ---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~--g~d~idQ~~ki~~~lgtpd~~F~~qL~~  246 (369)
T KOG0665|consen  172 ---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFP--GKDHIDQWNKIIEQLGTPDPSFMKQLQP  246 (369)
T ss_pred             ---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEec--CchHHHHHHHHHHHhcCCCHHHHHHhhH
Confidence               11223567888999999999999999999999999999999999875  433333222211111110          


Q ss_pred             ------h-cCcccccccCcccCCCCCCCc----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          278 ------E-NNRFGAIVDPIFDEDNSFPGK----EEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       278 ------~-~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                            . ..+...+.-+..-++.-++..    .-....+++++.+||-.||++|.|++++|.+
T Consensus       247 ~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  247 TVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             HHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence                  0 001111111111112222211    1234568899999999999999999999864

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-36  Score=283.74  Aligned_cols=241  Identities=22%  Similarity=0.347  Sum_probs=186.7

Q ss_pred             cccCCceeccCCee-EEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCccEEEEEe
Q 019536           57 YDLHKVIQSDTSYR-LFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLETELPTLVFES  134 (339)
Q Consensus        57 ~~~~~~ig~G~~g~-V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~  134 (339)
                      |.-.+++|.|+.|+ ||+|.+  .|+.||||++..    .....+.+|+..|..- +|||||++++.-.+..+.||..|.
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~----e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalEL  584 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLE----EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALEL  584 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee--CCceehHHHHhh----HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehH
Confidence            44556788888775 899999  899999999864    3345667999999887 699999999999999999999999


Q ss_pred             ccCCccccccccC-CCh-----HHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCC---C--CceEEecCCCccc
Q 019536          135 VKYGTLRGFSFAS-LLI-----APRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDE---N--YSAKLHDFSLSVS  203 (339)
Q Consensus       135 ~~~g~L~~~~~~~-~~~-----~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~---~--~~~kl~dfg~a~~  203 (339)
                      |. -+|.+++... ...     -..+.++.|++.||++||   +.+|+||||||.|||++.   +  ..++|+|||+++.
T Consensus       585 C~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk  660 (903)
T KOG1027|consen  585 CA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKK  660 (903)
T ss_pred             hh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccc
Confidence            94 5899998753 111     234678999999999999   999999999999999976   3  4689999999999


Q ss_pred             cCCCCcee-eecccccccccccccccccCCCCcccchHHHHHHHHHHHhC-CCccccCCCCCCCchhHHHHHHHHhhcCc
Q 019536          204 IPEGETHV-REEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG-CNVLEFKGNGNDDDLTVLEYAKKSIENNR  281 (339)
Q Consensus       204 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (339)
                      +..+.... ......||-+|+|||++....-+.++||||+||++|+.++| .+||...-..+         ......+..
T Consensus       661 l~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~---------~NIl~~~~~  731 (903)
T KOG1027|consen  661 LAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ---------ANILTGNYT  731 (903)
T ss_pred             cCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh---------hhhhcCccc
Confidence            87665442 23457799999999999998888899999999999998885 88985221110         000000011


Q ss_pred             ccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          282 FGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                      +..+        .  +. ..+  ++.+||.+|+++||..||+|.+|+.
T Consensus       732 L~~L--------~--~~-~d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  732 LVHL--------E--PL-PDC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             eeee--------c--cC-chH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence            1000        0  11 122  7899999999999999999999985

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.9e-34  Score=270.76  Aligned_cols=263  Identities=16%  Similarity=0.152  Sum_probs=178.4

Q ss_pred             HhcCcccCCceeccCCeeEEEEEEc----------------CCCeeEEEEEeccCCChhhH--------------HHHHH
Q 019536           53 ATNNYDLHKVIQSDTSYRLFEGTLV----------------DQDRPISVMKFHDNSTLDDV--------------EYCFN  102 (339)
Q Consensus        53 ~~~~~~~~~~ig~G~~g~V~~~~~~----------------~~~~~vavK~~~~~~~~~~~--------------~~~~~  102 (339)
                      ..++|++.++||+|+||+||+|...                ..++.||||++..... ...              +....
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~-~~~~~fl~e~~~~~~~~e~~~v  221 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQ-GVRQDFLKTGTLAKGSAETGMV  221 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccch-hhHHHHHhhhhhhhcccchhHH
Confidence            4679999999999999999999752                2446799999865322 111              22334


Q ss_pred             HHHHHHhcCCCce-----eeeeeeeee--------CCccEEEEEeccCCcccccccc-----------------------
Q 019536          103 NIVFSSQMKHKNI-----LKLIGCCLE--------TELPTLVFESVKYGTLRGFSFA-----------------------  146 (339)
Q Consensus       103 e~~~l~~l~H~ni-----v~~~~~~~~--------~~~~~lv~e~~~~g~L~~~~~~-----------------------  146 (339)
                      |+..+.+++|.++     ++++++|..        .+..+|||||+++|+|.+++..                       
T Consensus       222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~  301 (507)
T PLN03224        222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM  301 (507)
T ss_pred             HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence            6777777766554     677887753        3457999999999999887642                       


Q ss_pred             ---CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceeeecccccccccc
Q 019536          147 ---SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFI  223 (339)
Q Consensus       147 ---~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~  223 (339)
                         .+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++......... .....+|+.|+
T Consensus       302 ~~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~g~~tp~Y~  377 (507)
T PLN03224        302 PQDKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN-PLYGMLDPRYS  377 (507)
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccC-ccccCCCccee
Confidence               1245567789999999999999   8999999999999999999999999999987654322211 11233478999


Q ss_pred             cccccccCC--------------------CC--cccchHHHHHHHHHHHhCCC-ccccCCCCCCCchhHHHHHHHHhhcC
Q 019536          224 APEYFATSS--------------------FN--EMCDVYSFGAFLCELLTGCN-VLEFKGNGNDDDLTVLEYAKKSIENN  280 (339)
Q Consensus       224 aPE~~~~~~--------------------~~--~~~DiwslG~~l~el~~g~~-p~~~~~~~~~~~~~~~~~~~~~~~~~  280 (339)
                      |||.+....                    |+  .++|+||+||++++|++|.. ||......+.+ ..........++. 
T Consensus       378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~-~~~~~~~~~~~r~-  455 (507)
T PLN03224        378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTE-LRQYDNDLNRWRM-  455 (507)
T ss_pred             ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhH-HhhccchHHHHHh-
Confidence            999875432                    22  24799999999999999874 54311100000 0000000000000 


Q ss_pred             cccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCC---CCCCCHHHHHHH
Q 019536          281 RFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSP---EHRPLMVDVAKQ  330 (339)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP---~~Rps~~~il~~  330 (339)
                              .......++.....+....+|+.+||..+|   .+|+|+.|++++
T Consensus       456 --------~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H  500 (507)
T PLN03224        456 --------YKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH  500 (507)
T ss_pred             --------hcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence                    000111122222455679999999999876   689999999864

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-35  Score=253.57  Aligned_cols=263  Identities=21%  Similarity=0.333  Sum_probs=214.1

Q ss_pred             HHHHHhcCcccCCceeccCCeeEEEEEEcCCC-----eeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeee
Q 019536           49 DLKKATNNYDLHKVIQSDTSYRLFEGTLVDQD-----RPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCL  123 (339)
Q Consensus        49 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~  123 (339)
                      ++.....+++....+.+|+||.||.|.+.+.+     +.|-+|.++.....-+...++.|.-++..+.|||+..+.+++.
T Consensus       278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~i  357 (563)
T KOG1024|consen  278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSI  357 (563)
T ss_pred             hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence            44455577888899999999999999776433     4577888888777677888999999999999999999999987


Q ss_pred             e-CCccEEEEEeccCCccccccc----------cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCc
Q 019536          124 E-TELPTLVFESVKYGTLRGFSF----------ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYS  192 (339)
Q Consensus       124 ~-~~~~~lv~e~~~~g~L~~~~~----------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~  192 (339)
                      + ...++..+.++.-|+|..++.          +.+.-.+.+.++.|++.|++|||   +.+++|.||..+|+++++.-.
T Consensus       358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~Lq  434 (563)
T KOG1024|consen  358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQLQ  434 (563)
T ss_pred             eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhhee
Confidence            5 567889999999999999976          23455566779999999999999   999999999999999999999


Q ss_pred             eEEecCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHH
Q 019536          193 AKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLE  271 (339)
Q Consensus       193 ~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~  271 (339)
                      +||+|=.+++-+-+....+..+.......||+||.+....|+.++|+||||+++|||++ |+.|+.        ..+..+
T Consensus       435 VkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Pya--------eIDPfE  506 (563)
T KOG1024|consen  435 VKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYA--------EIDPFE  506 (563)
T ss_pred             EEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCcc--------ccCHHH
Confidence            99999999998766666555444556678999999999999999999999999999998 888864        222333


Q ss_pred             HHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 019536          272 YAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYL  336 (339)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~  336 (339)
                      ......+..++              ..|.++++++..+|.-||+.+|++|||+.+++.-|.+...
T Consensus       507 m~~ylkdGyRl--------------aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~  557 (563)
T KOG1024|consen  507 MEHYLKDGYRL--------------AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHT  557 (563)
T ss_pred             HHHHHhcccee--------------cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence            22222222222              2234677889999999999999999999999999987653

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-34  Score=254.85  Aligned_cols=128  Identities=17%  Similarity=0.240  Sum_probs=112.3

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcC-----C---Cceeeeeeeeee--
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMK-----H---KNILKLIGCCLE--  124 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-----H---~niv~~~~~~~~--  124 (339)
                      ++|.+.++||.|-|++||.+.+.++.+.||+|+++...  .-.+..+.||.+|++++     |   .+||+|++.|..  
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq--hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG  155 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ--HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG  155 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh--HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence            68999999999999999999999999999999997653  44567789999999984     3   369999999974  


Q ss_pred             --CCccEEEEEeccCCccccccc----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEe
Q 019536          125 --TELPTLVFESVKYGTLRGFSF----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLL  187 (339)
Q Consensus       125 --~~~~~lv~e~~~~g~L~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~  187 (339)
                        +.+.|+|+|++ |.+|..++.    +.++...+..|+.||+.||.|||.  .++|||.||||+|||+
T Consensus       156 pNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl  221 (590)
T KOG1290|consen  156 PNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLL  221 (590)
T ss_pred             CCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeee
Confidence              56799999999 556666654    679999999999999999999997  8899999999999999

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=5e-35  Score=263.10  Aligned_cols=267  Identities=21%  Similarity=0.224  Sum_probs=203.4

Q ss_pred             HHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcC------CCceeeeeeeeeeC
Q 019536           52 KATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMK------HKNILKLIGCCLET  125 (339)
Q Consensus        52 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~------H~niv~~~~~~~~~  125 (339)
                      ...++|.+....|+|-|++|..|.+...|..||||++.+...  -...=+.|++||++|.      --|+++|+-.|...
T Consensus       429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~--M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk  506 (752)
T KOG0670|consen  429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV--MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK  506 (752)
T ss_pred             hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH--HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence            445789989999999999999999998999999999987643  2234458999999995      24799999999999


Q ss_pred             CccEEEEEeccCCccccccc-----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCC-CceEEecCC
Q 019536          126 ELPTLVFESVKYGTLRGFSF-----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDEN-YSAKLHDFS  199 (339)
Q Consensus       126 ~~~~lv~e~~~~g~L~~~~~-----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~-~~~kl~dfg  199 (339)
                      +++|||||.+ .-+|.+.+.     -.+....+..++.|+..||.+|-   .++|+|.||||.|||+++. ..+||||||
T Consensus       507 nHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iLKLCDfG  582 (752)
T KOG0670|consen  507 NHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNILKLCDFG  582 (752)
T ss_pred             ceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcceeeeccCc
Confidence            9999999988 457888876     34677788899999999999999   9999999999999999865 568999999


Q ss_pred             CccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhc
Q 019536          200 LSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIEN  279 (339)
Q Consensus       200 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  279 (339)
                      .|-....+....    ..-+..|.|||.+.|.+|+...|+||+||++|||.||+-.|+...+.  ..+.+...+...+.+
T Consensus       583 SA~~~~eneitP----YLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN--~MLrl~me~KGk~p~  656 (752)
T KOG0670|consen  583 SASFASENEITP----YLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNN--QMLRLFMELKGKFPN  656 (752)
T ss_pred             cccccccccccH----HHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcH--HHHHHHHHhcCCCcH
Confidence            997776554321    23455699999999999999999999999999999999997644332  233333222222111


Q ss_pred             Cc--ccccccCccc------------------------------------CCCCCCCc-HHHHHHHHHHHHHhhccCCCC
Q 019536          280 NR--FGAIVDPIFD------------------------------------EDNSFPGK-EEKLQSLGQLMYKCLSKSPEH  320 (339)
Q Consensus       280 ~~--~~~~~~~~~~------------------------------------~~~~~~~~-~~~~~~~~~li~~cl~~dP~~  320 (339)
                      ..  -.++.|..+.                                    ....+|.. .....++.+|+.+||..||++
T Consensus       657 KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~K  736 (752)
T KOG0670|consen  657 KMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEK  736 (752)
T ss_pred             HHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhh
Confidence            00  0111111111                                    11112221 245678999999999999999


Q ss_pred             CCCHHHHHHH
Q 019536          321 RPLMVDVAKQ  330 (339)
Q Consensus       321 Rps~~~il~~  330 (339)
                      |.|..++|++
T Consensus       737 Rit~nqAL~H  746 (752)
T KOG0670|consen  737 RITVNQALKH  746 (752)
T ss_pred             cCCHHHHhcC
Confidence            9999999864

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-35  Score=269.36  Aligned_cols=252  Identities=21%  Similarity=0.260  Sum_probs=207.5

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFE  133 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  133 (339)
                      .++|+...+||+|+||.||+++++.++...|+|.++.... .+..-..+|+-+++..+|||||.++|.+...+..++.||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~-dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME   92 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG-DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME   92 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCC-ccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence            4789999999999999999999999999999999988766 667778899999999999999999999999999999999


Q ss_pred             eccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCcee
Q 019536          134 SVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHV  211 (339)
Q Consensus       134 ~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~  211 (339)
                      ||.+|+|.+...  .++.+.+...+++..+.||.|||   +.+-+|||||-.||+++..|.+|++|||.+..+...-  .
T Consensus        93 ycgggslQdiy~~TgplselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqitati--~  167 (829)
T KOG0576|consen   93 YCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI--A  167 (829)
T ss_pred             ecCCCcccceeeecccchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhhhh--h
Confidence            999999999877  67777888889999999999999   9999999999999999999999999999976554322  1


Q ss_pred             eecccccccccccccccc---cCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccC
Q 019536          212 REEFIKGAYGFIAPEYFA---TSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDP  288 (339)
Q Consensus       212 ~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (339)
                      ......||+.|||||+..   .+.|...+|+|++|+...|+..-++|.....     ++   . ...         ++-.
T Consensus       168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlh-----pm---r-~l~---------LmTk  229 (829)
T KOG0576|consen  168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLH-----PM---R-ALF---------LMTK  229 (829)
T ss_pred             hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccc-----hH---H-HHH---------Hhhc
Confidence            222467999999999874   4579999999999999999988777642111     11   1 111         1111


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          289 IFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                      ...+...+.....+++.+.++++.||..+|++|||++.++.
T Consensus       230 S~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  230 SGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             cCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            22222333344578889999999999999999999988765

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-34  Score=227.98  Aligned_cols=202  Identities=15%  Similarity=0.198  Sum_probs=170.5

Q ss_pred             HHHHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHH-HhcCCCceeeeeeeeeeCCcc
Q 019536           50 LKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFS-SQMKHKNILKLIGCCLETELP  128 (339)
Q Consensus        50 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l-~~l~H~niv~~~~~~~~~~~~  128 (339)
                      ++...++......||.|++|.|=+-++..+|...|+|.+......+...+.++|+.+. +....|.+|.|+|........
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv  120 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV  120 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence            4444566677789999999999999999999999999998876667778888998865 455899999999998888889


Q ss_pred             EEEEEeccCCccccccc------cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCcc
Q 019536          129 TLVFESVKYGTLRGFSF------ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSV  202 (339)
Q Consensus       129 ~lv~e~~~~g~L~~~~~------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~  202 (339)
                      ++.||.|. -+|..+..      ..+++...=+|+..++.||.|||+  ...++|||+||.|||++.+|.+|+||||.+-
T Consensus       121 wIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG  197 (282)
T KOG0984|consen  121 WICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISG  197 (282)
T ss_pred             EEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccce
Confidence            99999995 46766643      467777777899999999999997  7889999999999999999999999999998


Q ss_pred             ccCCCCceeeeccccccccccccccccc----CCCCcccchHHHHHHHHHHHhCCCccc
Q 019536          203 SIPEGETHVREEFIKGAYGFIAPEYFAT----SSFNEMCDVYSFGAFLCELLTGCNVLE  257 (339)
Q Consensus       203 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~~l~el~~g~~p~~  257 (339)
                      .+.++-...   .-.|.-.|||||.+..    ..|+.++||||||+++.||.+++.||+
T Consensus       198 ~L~dSiAkt---~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~  253 (282)
T KOG0984|consen  198 YLVDSIAKT---MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYE  253 (282)
T ss_pred             eehhhhHHH---HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccc
Confidence            775543221   2346778999998753    369999999999999999999999986

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=1.2e-31  Score=226.79  Aligned_cols=210  Identities=26%  Similarity=0.407  Sum_probs=183.8

Q ss_pred             eeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeccCCcccc
Q 019536           63 IQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRG  142 (339)
Q Consensus        63 ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L~~  142 (339)
                      ||+|++|.||++....+++.+++|++.........+.+.+|+..++.+.|++++++++++......++++|++++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            68999999999999877999999999876543245778899999999999999999999999889999999999999999


Q ss_pred             cccc---CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCC-CCceEEecCCCccccCCCCceeeeccccc
Q 019536          143 FSFA---SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDE-NYSAKLHDFSLSVSIPEGETHVREEFIKG  218 (339)
Q Consensus       143 ~~~~---~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~-~~~~kl~dfg~a~~~~~~~~~~~~~~~~g  218 (339)
                      ++..   .++...+..++.+++.++.+||   +.+++|+||+|.||+++. ++.++|+|||.+........  ......+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~  155 (215)
T cd00180          81 LLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVG  155 (215)
T ss_pred             HHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccC
Confidence            9864   5888899999999999999999   899999999999999998 89999999999877654431  1112456


Q ss_pred             ccccccccccccC-CCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCCCCCC
Q 019536          219 AYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFP  297 (339)
Q Consensus       219 t~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (339)
                      ...|++||.+... .++.+.|+|++|++++++                                                
T Consensus       156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------  187 (215)
T cd00180         156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------  187 (215)
T ss_pred             CCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------
Confidence            7789999999877 788999999999999998                                                


Q ss_pred             CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 019536          298 GKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQL  331 (339)
Q Consensus       298 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L  331 (339)
                            ..+.+++.+|++.+|++||++.++++.+
T Consensus       188 ------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 ------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             ------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                  1478899999999999999999998753

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=2e-33  Score=255.65  Aligned_cols=196  Identities=20%  Similarity=0.240  Sum_probs=170.7

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCCh-------hhHHHHHHHHHHHHhcC---CCceeeeeeeee
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTL-------DDVEYCFNNIVFSSQMK---HKNILKLIGCCL  123 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~e~~~l~~l~---H~niv~~~~~~~  123 (339)
                      ..+|+....+|.|+||.|+.|.++.+...|+||.+.+....       ...-.+--|++||+.++   |+||++++++|+
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE  639 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE  639 (772)
T ss_pred             cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence            46799999999999999999999999899999988764221       11122346999999997   999999999999


Q ss_pred             eCCccEEEEEec-cCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCC
Q 019536          124 ETELPTLVFESV-KYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSL  200 (339)
Q Consensus       124 ~~~~~~lv~e~~-~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~  200 (339)
                      +++++||+||-. ++.+|++++.  .++.+.....|+.||+.|+++||   +.+|+|||||-+|+.++.+|-+||+|||.
T Consensus       640 ddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~klidfgs  716 (772)
T KOG1152|consen  640 DDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLIDFGS  716 (772)
T ss_pred             cCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEeeccc
Confidence            999999999986 4557888886  68899999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCceeeecccccccccccccccccCCCC-cccchHHHHHHHHHHHhCCCcc
Q 019536          201 SVSIPEGETHVREEFIKGAYGFIAPEYFATSSFN-EMCDVYSFGAFLCELLTGCNVL  256 (339)
Q Consensus       201 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~~l~el~~g~~p~  256 (339)
                      |.........    ..+||..|.|||++.|..|- ..-|||++|+++|.++....||
T Consensus       717 aa~~ksgpfd----~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy  769 (772)
T KOG1152|consen  717 AAYTKSGPFD----VFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY  769 (772)
T ss_pred             hhhhcCCCcc----eeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence            8776555443    57899999999999999886 5679999999999999888886

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.98  E-value=7.6e-33  Score=244.01  Aligned_cols=274  Identities=22%  Similarity=0.278  Sum_probs=200.4

Q ss_pred             HHHHHhcCcccCCceeccCCeeEEEEEEcC---CCeeEEEEEeccCCChhhHHHHHHHHHHHHhc-CCCceeeeeeeeee
Q 019536           49 DLKKATNNYDLHKVIQSDTSYRLFEGTLVD---QDRPISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLE  124 (339)
Q Consensus        49 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~  124 (339)
                      .+....+.|..+++||.|+|++||++.+..   ..+.||+|.+.....   ..++.+|+++|..+ .+.||+.+.+++..
T Consensus        30 ~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~---p~ri~~El~~L~~~gG~~ni~~~~~~~rn  106 (418)
T KOG1167|consen   30 DIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS---PSRILNELEMLYRLGGSDNIIKLNGCFRN  106 (418)
T ss_pred             hhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC---chHHHHHHHHHHHhccchhhhcchhhhcc
Confidence            344555789999999999999999999876   678999999877644   45678999999999 58999999999999


Q ss_pred             CCccEEEEEeccCCccccccccCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCC-CCceEEecCCCccc
Q 019536          125 TELPTLVFESVKYGTLRGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDE-NYSAKLHDFSLSVS  203 (339)
Q Consensus       125 ~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~-~~~~kl~dfg~a~~  203 (339)
                      ++...+|+||+++....++. ..++......+++.++.||.++|   .+||+|||+||.|+|++. .+.-.|+|||+|..
T Consensus       107 nd~v~ivlp~~~H~~f~~l~-~~l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~  182 (418)
T KOG1167|consen  107 NDQVAIVLPYFEHDRFRDLY-RSLSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQR  182 (418)
T ss_pred             CCeeEEEecccCccCHHHHH-hcCCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechhHHH
Confidence            99999999999998887776 45668888899999999999999   999999999999999974 45679999999862


Q ss_pred             cCCCC---------------------------------cee---------eecccccccccccccccccC-CCCcccchH
Q 019536          204 IPEGE---------------------------------THV---------REEFIKGAYGFIAPEYFATS-SFNEMCDVY  240 (339)
Q Consensus       204 ~~~~~---------------------------------~~~---------~~~~~~gt~~y~aPE~~~~~-~~~~~~Diw  240 (339)
                      .....                                 ...         ......||++|+|||++... ..++++|||
T Consensus       183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiw  262 (418)
T KOG1167|consen  183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIW  262 (418)
T ss_pred             HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcccee
Confidence            11000                                 000         01124589999999998765 478999999


Q ss_pred             HHHHHHHHHHhCCCccccCCCCCCCchh-HHHHHHHH-hhc--Ccccc--ccc---------------Cc----ccC-C-
Q 019536          241 SFGAFLCELLTGCNVLEFKGNGNDDDLT-VLEYAKKS-IEN--NRFGA--IVD---------------PI----FDE-D-  293 (339)
Q Consensus       241 slG~~l~el~~g~~p~~~~~~~~~~~~~-~~~~~~~~-~~~--~~~~~--~~~---------------~~----~~~-~-  293 (339)
                      |.|+++..+++++.||. ....+.+-+. .+...... ++.  ...+.  +.+               ..    +.. . 
T Consensus       263 s~GVI~Lslls~~~PFf-~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q  341 (418)
T KOG1167|consen  263 SAGVILLSLLSRRYPFF-KAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQ  341 (418)
T ss_pred             eccceeehhhccccccc-cCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccc
Confidence            99999999999999984 4433332222 21111110 000  00000  011               00    000 0 


Q ss_pred             ---CCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          294 ---NSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       294 ---~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                         .........+..+.+|+.+||+.||.+|+|++++|++
T Consensus       342 ~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH  381 (418)
T KOG1167|consen  342 PNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH  381 (418)
T ss_pred             cceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence               0001111234578999999999999999999999873

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.1e-32  Score=227.47  Aligned_cols=268  Identities=19%  Similarity=0.229  Sum_probs=201.9

Q ss_pred             ccHHHHHHH--hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhc-CCCceeeeee-
Q 019536           45 FSAKDLKKA--TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIG-  120 (339)
Q Consensus        45 ~~~~~~~~~--~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~-  120 (339)
                      +...|+++.  .+.|.+.+.+|+|-||.+-.+.+++++..+++|-+....+  ...+|.+|...--.| .|.||+.-++ 
T Consensus        12 I~~~el~kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t--t~~dF~rEfhY~~~Ls~H~hIi~tY~v   89 (378)
T KOG1345|consen   12 IPMEELKKVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT--TQADFVREFHYSFFLSPHQHIIDTYEV   89 (378)
T ss_pred             cccccccccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh--hHHHHHHHhccceeeccchhhhHHHHH
Confidence            334444433  3789999999999999999999999999999999877643  457788998766566 5899997775 


Q ss_pred             eeeeCCccEEEEEeccCCccccccc-cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeC--CCCceEEec
Q 019536          121 CCLETELPTLVFESVKYGTLRGFSF-ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLD--ENYSAKLHD  197 (339)
Q Consensus       121 ~~~~~~~~~lv~e~~~~g~L~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~--~~~~~kl~d  197 (339)
                      .|+..+.+..++||+|.|+|..-+. ..+-+.....++.|++.|+.|+|   +++++|||||.+|||+-  ....+||||
T Consensus        90 aFqt~d~YvF~qE~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcD  166 (378)
T KOG1345|consen   90 AFQTSDAYVFVQEFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCD  166 (378)
T ss_pred             HhhcCceEEEeeccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeee
Confidence            4777788889999999999988876 56777788899999999999999   99999999999999983  345799999


Q ss_pred             CCCccccCCCCceeeecccccccccccccccccC-----CCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHH
Q 019536          198 FSLSVSIPEGETHVREEFIKGAYGFIAPEYFATS-----SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEY  272 (339)
Q Consensus       198 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~  272 (339)
                      ||+.+..+....     ....+..|.+||++...     ...+.+|+|.||++++.+++|+.|++-....+.....-.+|
T Consensus       167 FG~t~k~g~tV~-----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w  241 (378)
T KOG1345|consen  167 FGLTRKVGTTVK-----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQW  241 (378)
T ss_pred             cccccccCceeh-----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHH
Confidence            999876543221     23456679999987532     24688999999999999999999997444333322222222


Q ss_pred             HHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          273 AKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                      .....          +..+...     ...++.+..+.++-|..+|++|-...++.+...+.|.+
T Consensus       242 ~~rk~----------~~~P~~F-----~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E  291 (378)
T KOG1345|consen  242 LKRKN----------PALPKKF-----NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE  291 (378)
T ss_pred             hcccC----------ccCchhh-----cccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence            22211          1111111     13456788899999999999998888887777766643

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=6.3e-30  Score=219.34  Aligned_cols=197  Identities=27%  Similarity=0.335  Sum_probs=171.0

Q ss_pred             cccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEecc
Q 019536           57 YDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVK  136 (339)
Q Consensus        57 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~  136 (339)
                      |.+.+.||+|++|+||+|....++..+++|.+.........+.+.+|+..++.++|+|++++++++......++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            56778999999999999999888899999999876442256788899999999999999999999999899999999999


Q ss_pred             CCccccccc--cC-CChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceeee
Q 019536          137 YGTLRGFSF--AS-LLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVRE  213 (339)
Q Consensus       137 ~g~L~~~~~--~~-~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~  213 (339)
                      +++|.+++.  .. +++.....++.+++.++.+||   +.+++|+|++|.||+++.++.++|+|||.+......... ..
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-~~  156 (225)
T smart00221       81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-LL  156 (225)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-cc
Confidence            999999876  23 788888999999999999999   889999999999999999999999999998877554310 11


Q ss_pred             ccccccccccccccc-ccCCCCcccchHHHHHHHHHHHhCCCccc
Q 019536          214 EFIKGAYGFIAPEYF-ATSSFNEMCDVYSFGAFLCELLTGCNVLE  257 (339)
Q Consensus       214 ~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~~l~el~~g~~p~~  257 (339)
                      ....++..|++||.+ ....++.++|+|+||+++++|++|+.||.
T Consensus       157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~  201 (225)
T smart00221      157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS  201 (225)
T ss_pred             cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence            124567789999998 66678889999999999999999999984

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.96  E-value=2.3e-29  Score=253.79  Aligned_cols=195  Identities=18%  Similarity=0.206  Sum_probs=138.3

Q ss_pred             HhcCC-Cceeeeeeee-------eeCCccEEEEEeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeE
Q 019536          108 SQMKH-KNILKLIGCC-------LETELPTLVFESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIV  176 (339)
Q Consensus       108 ~~l~H-~niv~~~~~~-------~~~~~~~lv~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~  176 (339)
                      +.++| +||++++++|       .++..++.++|++ +++|.+++.   ..++..+++.++.||+.||.|||   +++|+
T Consensus        27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~gIv  102 (793)
T PLN00181         27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAH---SQGIV  102 (793)
T ss_pred             chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHH---hCCee
Confidence            34556 6888888887       3334567888987 569999985   35888999999999999999999   99999


Q ss_pred             EccCCCCCEEeCC-------------------CCceEEecCCCccccCCCCc--------------eeeecccccccccc
Q 019536          177 FRCIKASNVLLDE-------------------NYSAKLHDFSLSVSIPEGET--------------HVREEFIKGAYGFI  223 (339)
Q Consensus       177 H~dlk~~Nil~~~-------------------~~~~kl~dfg~a~~~~~~~~--------------~~~~~~~~gt~~y~  223 (339)
                      ||||||+|||++.                   ++.+|++|||+++.......              ........||+.|+
T Consensus       103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~  182 (793)
T PLN00181        103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT  182 (793)
T ss_pred             eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence            9999999999954                   44566777777654321000              00011235788899


Q ss_pred             cccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCCCCCCCcHHHH
Q 019536          224 APEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKL  303 (339)
Q Consensus       224 aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (339)
                      |||++.+..|+.++|||||||++|||++|.+|+....       ........    .    ...+         ......
T Consensus       183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-------~~~~~~~~----~----~~~~---------~~~~~~  238 (793)
T PLN00181        183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-------RTMSSLRH----R----VLPP---------QILLNW  238 (793)
T ss_pred             ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-------HHHHHHHH----h----hcCh---------hhhhcC
Confidence            9999999999999999999999999999887753110       01110000    0    0000         000112


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          304 QSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       304 ~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      ....+++.+||+.+|.+|||+.+|+++
T Consensus       239 ~~~~~~~~~~L~~~P~~Rps~~eil~h  265 (793)
T PLN00181        239 PKEASFCLWLLHPEPSCRPSMSELLQS  265 (793)
T ss_pred             HHHHHHHHHhCCCChhhCcChHHHhhc
Confidence            345688999999999999999999863

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=6e-28  Score=199.93  Aligned_cols=167  Identities=20%  Similarity=0.198  Sum_probs=124.9

Q ss_pred             Cccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceeeec
Q 019536          138 GTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREE  214 (339)
Q Consensus       138 g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~~  214 (339)
                      |+|.+++.   ..+++..++.++.|++.||.|||   +.+      ||+||+++.++.+|+  ||+++......      
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------   63 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ------   63 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeecccc------
Confidence            57777775   35899999999999999999999   665      999999999999999  99987654322      


Q ss_pred             ccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCCC
Q 019536          215 FIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDN  294 (339)
Q Consensus       215 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (339)
                       ..||+.|+|||++.+..|+.++|||||||++|||++|+.||.....    ................         ..  
T Consensus        64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~----~~~~~~~~~~~~~~~~---------~~--  127 (176)
T smart00750       64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE----LSAILEILLNGMPADD---------PR--  127 (176)
T ss_pred             -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch----hcHHHHHHHHHhccCC---------cc--
Confidence             2578999999999999999999999999999999999999753211    1111111111110000         00  


Q ss_pred             CCCCcHHHHH--HHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          295 SFPGKEEKLQ--SLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       295 ~~~~~~~~~~--~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                      ..+.+.....  .+.+++.+||+.||.+|||+.++++++..+..+
T Consensus       128 ~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~  172 (176)
T smart00750      128 DRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE  172 (176)
T ss_pred             ccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence            0011223333  699999999999999999999999999877654

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.95  E-value=5.2e-27  Score=212.93  Aligned_cols=167  Identities=14%  Similarity=0.050  Sum_probs=131.6

Q ss_pred             HHHhcCcccCCceeccCCeeEEEEEEcC-CCeeEEEEEeccCC----ChhhHHHHHHHHHHHHhcCCCceee-eeeeeee
Q 019536           51 KKATNNYDLHKVIQSDTSYRLFEGTLVD-QDRPISVMKFHDNS----TLDDVEYCFNNIVFSSQMKHKNILK-LIGCCLE  124 (339)
Q Consensus        51 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~H~niv~-~~~~~~~  124 (339)
                      ....++|.+.+.||+|+||+||+|.+.. +++.||||+.....    .......+.+|+.+++.++|+|++. ++++   
T Consensus        14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---   90 (365)
T PRK09188         14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---   90 (365)
T ss_pred             ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence            4456789999999999999999998875 67888999875431    2233566889999999999999985 4432   


Q ss_pred             CCccEEEEEeccCCccccccccCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccC-CCCCEEeCCCCceEEecCCCccc
Q 019536          125 TELPTLVFESVKYGTLRGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCI-KASNVLLDENYSAKLHDFSLSVS  203 (339)
Q Consensus       125 ~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dl-k~~Nil~~~~~~~kl~dfg~a~~  203 (339)
                       +..++||||+++++|....  ...   ...++.|++.||.|||   +.+|+|||| ||+|||++.++.+||+|||+|+.
T Consensus        91 -~~~~LVmE~~~G~~L~~~~--~~~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~  161 (365)
T PRK09188         91 -GKDGLVRGWTEGVPLHLAR--PHG---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVIDFQLASV  161 (365)
T ss_pred             -CCcEEEEEccCCCCHHHhC--ccc---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEECcccee
Confidence             4579999999999996321  111   2467899999999999   899999999 99999999999999999999987


Q ss_pred             cCCCCceee------ecccccccccccccccc
Q 019536          204 IPEGETHVR------EEFIKGAYGFIAPEYFA  229 (339)
Q Consensus       204 ~~~~~~~~~------~~~~~gt~~y~aPE~~~  229 (339)
                      +........      -....+++.|+|||.+.
T Consensus       162 ~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~  193 (365)
T PRK09188        162 FRRRGALYRIAAYEDLRHLLKHKRTYAPDALT  193 (365)
T ss_pred             cccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence            755432211      12456788899999885

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.94  E-value=1.6e-27  Score=229.67  Aligned_cols=254  Identities=16%  Similarity=0.161  Sum_probs=191.6

Q ss_pred             ccCCceeccCCeeEEEEEEcCCCeeEEEEEec----cCCChhhH-HHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 019536           58 DLHKVIQSDTSYRLFEGTLVDQDRPISVMKFH----DNSTLDDV-EYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVF  132 (339)
Q Consensus        58 ~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~----~~~~~~~~-~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  132 (339)
                      ....++|.|++|.|+...........+.|.+.    ........ ..+..|..+-..+.|||++..+..+.+.....-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            45688999999988888877666656666543    22221222 22556777888899999988888887766666669


Q ss_pred             EeccCCcccccccc--CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCce
Q 019536          133 ESVKYGTLRGFSFA--SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH  210 (339)
Q Consensus       133 e~~~~g~L~~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~  210 (339)
                      |||++ +|..++..  .+...++-.++.|++.|+.|+|   ..||.|||+|++|+++..+|.+|++|||.+..+...-..
T Consensus       401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~  476 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK  476 (601)
T ss_pred             hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeeccCcch
Confidence            99999 99998875  6888888899999999999999   999999999999999999999999999998776543322


Q ss_pred             --eeecccccccccccccccccCCCCc-ccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCccccccc
Q 019536          211 --VREEFIKGAYGFIAPEYFATSSFNE-MCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVD  287 (339)
Q Consensus       211 --~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (339)
                        ......+|+.+|+|||++.+..|++ .+||||.|+++..|.+|+.||..+...+...        ......      +
T Consensus       477 ~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~--------~~~~~~------~  542 (601)
T KOG0590|consen  477 NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF--------KTNNYS------D  542 (601)
T ss_pred             hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch--------hhhccc------c
Confidence              3334578999999999999999985 5899999999999999999987555443221        000000      0


Q ss_pred             CcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          288 PIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                      ..-......+.....+.+.+.+|.+||+.||.+|.|+.+|++
T Consensus       543 ~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  543 QRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             ccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            000001111112345667889999999999999999999987

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.93  E-value=4.5e-24  Score=192.23  Aligned_cols=258  Identities=24%  Similarity=0.314  Sum_probs=195.7

Q ss_pred             cccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChh--hHHHHHHHHHHHHhcCCC-ceeeeeeeeeeCCccEEEEE
Q 019536           57 YDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLD--DVEYCFNNIVFSSQMKHK-NILKLIGCCLETELPTLVFE  133 (339)
Q Consensus        57 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~H~-niv~~~~~~~~~~~~~lv~e  133 (339)
                      |.+...||.|+||.||.+.+.   ..+++|.+.......  ....+.+|+.+++.+.|+ +++++.+.+......+++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~   78 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME   78 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence            677789999999999999996   778999988765543  477889999999999988 79999999977777899999


Q ss_pred             eccCCcccccccc-----CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCC-ceEEecCCCccccCCC
Q 019536          134 SVKYGTLRGFSFA-----SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENY-SAKLHDFSLSVSIPEG  207 (339)
Q Consensus       134 ~~~~g~L~~~~~~-----~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~-~~kl~dfg~a~~~~~~  207 (339)
                      ++.++++.+++..     .+.......++.|++.++.|+|   ..+++|||+||+||+++..+ .++++|||.++.+...
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~  155 (384)
T COG0515          79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP  155 (384)
T ss_pred             cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence            9999999966652     5788888999999999999999   89999999999999999888 7999999999866543


Q ss_pred             Ccee----eeccccccccccccccccc---CCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcC
Q 019536          208 ETHV----REEFIKGAYGFIAPEYFAT---SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENN  280 (339)
Q Consensus       208 ~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  280 (339)
                      ....    ......|+..|+|||.+.+   ..++...|+||+|++++++++|..||...... ................ 
T Consensus       156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~-~~~~~~~~~~~~~~~~-  233 (384)
T COG0515         156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS-SATSQTLKIILELPTP-  233 (384)
T ss_pred             CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc-ccHHHHHHHHHhcCCc-
Confidence            3221    1235679999999999987   57889999999999999999999996533321 0001111111111100 


Q ss_pred             cccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          281 RFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      ..    ........  +  ......+.+++..|+..+|..|.++.+....
T Consensus       234 ~~----~~~~~~~~--~--~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         234 SL----ASPLSPSN--P--ELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             cc----ccccCccc--c--chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            00    00000000  0  1223568899999999999999998877653

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=2.3e-24  Score=195.52  Aligned_cols=259  Identities=16%  Similarity=0.131  Sum_probs=193.0

Q ss_pred             CcccCCceeccCCeeEEEEEEcCCC-eeEEEEEeccCCChhhHHHHHHHHHHHHhcCC----Cceeeeeeee-eeCCccE
Q 019536           56 NYDLHKVIQSDTSYRLFEGTLVDQD-RPISVMKFHDNSTLDDVEYCFNNIVFSSQMKH----KNILKLIGCC-LETELPT  129 (339)
Q Consensus        56 ~~~~~~~ig~G~~g~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H----~niv~~~~~~-~~~~~~~  129 (339)
                      +|.+.+.||+|+||.||.|.+..++ ..+|+|.-......... .+..|..++..+..    +++..+++.. ..+...+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~   97 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNF   97 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeE
Confidence            8999999999999999999997664 57888877664332222 56688888888863    5888999888 4777889


Q ss_pred             EEEEeccCCccccccc----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCC-----CceEEecCCC
Q 019536          130 LVFESVKYGTLRGFSF----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDEN-----YSAKLHDFSL  200 (339)
Q Consensus       130 lv~e~~~~g~L~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~-----~~~kl~dfg~  200 (339)
                      +||+.+ |.+|.++..    +.++..+...++.|++.+|.+||   +.|++||||||.|+++...     ..+.+.|||+
T Consensus        98 iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl  173 (322)
T KOG1164|consen   98 IVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL  173 (322)
T ss_pred             EEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence            999998 788988763    57899999999999999999999   9999999999999999854     4689999999


Q ss_pred             cc--ccCCCCce----e-e-ecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHH
Q 019536          201 SV--SIPEGETH----V-R-EEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEY  272 (339)
Q Consensus       201 a~--~~~~~~~~----~-~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~  272 (339)
                      |+  .+......    . . .....||..|+++..-.+...+.+.|+||++.++.++..|..|+........     ...
T Consensus       174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-----~~~  248 (322)
T KOG1164|consen  174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-----KSK  248 (322)
T ss_pred             CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-----HHH
Confidence            98  33222111    0 1 1234599999999999999999999999999999999999988753322111     111


Q ss_pred             HHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          273 AKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                      ..........    ..       .  ....+..+.++...+-..+...+|....+...|.....+
T Consensus       249 ~~~~~~~~~~----~~-------~--~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~  300 (322)
T KOG1164|consen  249 FEKDPRKLLT----DR-------F--GDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS  300 (322)
T ss_pred             HHHHhhhhcc----cc-------c--cCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence            1111111100    00       0  012233566777777779999999999999988777643

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.92  E-value=4.6e-26  Score=190.89  Aligned_cols=246  Identities=19%  Similarity=0.254  Sum_probs=183.5

Q ss_pred             CcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 019536           56 NYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS-TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFES  134 (339)
Q Consensus        56 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  134 (339)
                      +..+..+|...-.|..|+|++.  |..+++|++.... +......|..|.-.|+.+.||||..++|.|.....+.++..|
T Consensus       191 ~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~  268 (448)
T KOG0195|consen  191 SLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQY  268 (448)
T ss_pred             hhhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeee
Confidence            3444567888889999999995  4445556655432 223445688889899999999999999999999999999999


Q ss_pred             ccCCcccccccc----CCChHHHHHHHHHHHHHHHHHhcCCCCCeE-EccCCCCCEEeCCCCceEEe--cCCCccccCCC
Q 019536          135 VKYGTLRGFSFA----SLLIAPRIKIAMEIANAVAYLHVGFDRPIV-FRCIKASNVLLDENYSAKLH--DFSLSVSIPEG  207 (339)
Q Consensus       135 ~~~g~L~~~~~~----~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~-H~dlk~~Nil~~~~~~~kl~--dfg~a~~~~~~  207 (339)
                      +|.|+|...+..    ..+-.+.++++.++++|+.|||+  -.+++ --.|....+++|++.+.+|+  |--++  +  .
T Consensus       269 mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhs--lep~ipr~~lns~hvmidedltarismad~kfs--f--q  342 (448)
T KOG0195|consen  269 MPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHS--LEPMIPRFYLNSKHVMIDEDLTARISMADTKFS--F--Q  342 (448)
T ss_pred             ccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhh--cchhhhhhhcccceEEecchhhhheecccceee--e--e
Confidence            999999998873    24567889999999999999995  23344 44688999999998887664  32211  1  1


Q ss_pred             CceeeecccccccccccccccccCCCC---cccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccc
Q 019536          208 ETHVREEFIKGAYGFIAPEYFATSSFN---EMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA  284 (339)
Q Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (339)
                      ..     ...-.+.||+||.+...+-+   .++|+|||.+++||+.|...||..-++-+.        ..+..       
T Consensus       343 e~-----gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec--------gmkia-------  402 (448)
T KOG0195|consen  343 EV-----GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC--------GMKIA-------  402 (448)
T ss_pred             cc-----ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh--------hhhhh-------
Confidence            11     12345779999999876643   679999999999999999999864333221        11111       


Q ss_pred             cccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 019536          285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMY  335 (339)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~  335 (339)
                            .+......|++.+..+..||.-|++.||.+||.+..|+--|++|+
T Consensus       403 ------leglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  403 ------LEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             ------hccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence                  111122234477788999999999999999999999999999986

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=8.6e-25  Score=180.23  Aligned_cols=262  Identities=14%  Similarity=0.130  Sum_probs=193.9

Q ss_pred             HhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCC-CceeeeeeeeeeCCccEEE
Q 019536           53 ATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKH-KNILKLIGCCLETELPTLV  131 (339)
Q Consensus        53 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H-~niv~~~~~~~~~~~~~lv  131 (339)
                      ..+.|.++++||+|+||.+|.|....+|..||||.-+....   ......|..+...++| ..|..+..+..+...-.+|
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~---hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV   89 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK---HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV   89 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC---CcchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence            35889999999999999999999999999999998766543   3445578888888875 5777778888888888999


Q ss_pred             EEeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCC---CceEEecCCCccccC
Q 019536          132 FESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDEN---YSAKLHDFSLSVSIP  205 (339)
Q Consensus       132 ~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~---~~~kl~dfg~a~~~~  205 (339)
                      |+.+ |.+|.++..   ..+++.+++-++-|++.-++|+|   ..+.+||||||+|+|..-+   ..+.++|||+|+.+.
T Consensus        90 MdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~  165 (341)
T KOG1163|consen   90 MDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR  165 (341)
T ss_pred             eecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchhhhc
Confidence            9998 778877754   78999999999999999999999   8999999999999998633   358899999998875


Q ss_pred             CCCce-----eeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcC
Q 019536          206 EGETH-----VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENN  280 (339)
Q Consensus       206 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  280 (339)
                      +..+.     .......||.+|.+--...+...+..-|+-|+|.++.++-.|..||+..-...        ..+++    
T Consensus       166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~t--------k~QKy----  233 (341)
T KOG1163|consen  166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAAT--------KKQKY----  233 (341)
T ss_pred             cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhh--------HHHHH----
Confidence            53322     12224678999988877767777888999999999988889999987432221        11111    


Q ss_pred             cccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 019536          281 RFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYL  336 (339)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~  336 (339)
                        .+|.+........ .-..+.+.++.-.+.-|-..--++-|+..-+-+.+.-+..
T Consensus       234 --EkI~EkK~s~~ie-~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr  286 (341)
T KOG1163|consen  234 --EKISEKKMSTPIE-VLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFR  286 (341)
T ss_pred             --HHHHHhhcCCCHH-HHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHh
Confidence              0011110000000 0012445677778888888888888887666555544443

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=2e-23  Score=179.46  Aligned_cols=258  Identities=14%  Similarity=0.143  Sum_probs=194.0

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCccEEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLETELPTLVF  132 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~~lv~  132 (339)
                      .-+|.+.++||+|+||.+|.|+..-++++||||.-...+   ....+..|....+.| ..++|..++-+..++-+-.||+
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS---~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi  103 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS---EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI  103 (449)
T ss_pred             cccceeccccccCcceeeecccccccCceEEEEeccccC---CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence            357999999999999999999999999999999755443   344555677777777 5689999888888888888999


Q ss_pred             EeccCCccccc---cccCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCC-----CceEEecCCCcccc
Q 019536          133 ESVKYGTLRGF---SFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDEN-----YSAKLHDFSLSVSI  204 (339)
Q Consensus       133 e~~~~g~L~~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~-----~~~kl~dfg~a~~~  204 (339)
                      |.+ |.+|+|+   +.+.++..++.-++.|++.-++|+|   ++.+|.|||||+|+||...     ..+.++|||+|+.+
T Consensus       104 dLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y  179 (449)
T KOG1165|consen  104 DLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY  179 (449)
T ss_pred             hhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence            998 6676655   4589999999999999999999999   9999999999999999743     34899999999988


Q ss_pred             CCCCce-----eeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhc
Q 019536          205 PEGETH-----VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIEN  279 (339)
Q Consensus       205 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  279 (339)
                      .+..+.     .......||.+||+--.-.|...+.+-|+-|+|-++.+.+-|..||...-...      .+  .++   
T Consensus       180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~t------nK--~kY---  248 (449)
T KOG1165|consen  180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADT------NK--EKY---  248 (449)
T ss_pred             cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcc------hH--HHH---
Confidence            665432     12224679999999998888899999999999999999999999987433222      00  010   


Q ss_pred             CcccccccCcccCCCCCCC---cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 019536          280 NRFGAIVDPIFDEDNSFPG---KEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYL  336 (339)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~  336 (339)
                         ++|-+.    ....|.   ..+.+.++..-+.-.-+.+-.+-|+.+-+-..+..+.+
T Consensus       249 ---eKIGe~----Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvld  301 (449)
T KOG1165|consen  249 ---EKIGET----KRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLD  301 (449)
T ss_pred             ---HHhccc----cccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence               111110    000110   12445667777776667777788887766666555543

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.90  E-value=1.9e-23  Score=174.62  Aligned_cols=138  Identities=14%  Similarity=0.107  Sum_probs=107.9

Q ss_pred             CCceeccCCeeEEEEEEcCCCeeEEEEEeccCCCh-hh------------------------HHHHHHHHHHHHhcCCCc
Q 019536           60 HKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTL-DD------------------------VEYCFNNIVFSSQMKHKN  114 (339)
Q Consensus        60 ~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~------------------------~~~~~~e~~~l~~l~H~n  114 (339)
                      ...||+|++|.||+|... +|+.||+|+++..... ..                        .....+|+.++..+.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            468999999999999997 8999999999765221 01                        112235999999998877


Q ss_pred             eeeeeeeeeeCCccEEEEEeccCCcccccc--ccCCChHHHHHHHHHHHHHHHHH-hcCCCCCeEEccCCCCCEEeCCCC
Q 019536          115 ILKLIGCCLETELPTLVFESVKYGTLRGFS--FASLLIAPRIKIAMEIANAVAYL-HVGFDRPIVFRCIKASNVLLDENY  191 (339)
Q Consensus       115 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~--~~~~~~~~~~~i~~~i~~~l~~L-H~~~~~~i~H~dlk~~Nil~~~~~  191 (339)
                      +.....+.. . ..++||||++++++....  ...++......++.|++.+|.|+ |   +.+|+||||||+||+++ ++
T Consensus        81 v~~p~~~~~-~-~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli~-~~  154 (190)
T cd05147          81 IPCPEPILL-K-SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLYH-DG  154 (190)
T ss_pred             CCCCcEEEe-c-CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEE-CC
Confidence            643332222 2 238999999988776542  25678888899999999999999 7   88999999999999998 47


Q ss_pred             ceEEecCCCcccc
Q 019536          192 SAKLHDFSLSVSI  204 (339)
Q Consensus       192 ~~kl~dfg~a~~~  204 (339)
                      .++|+|||+|...
T Consensus       155 ~v~LiDFG~a~~~  167 (190)
T cd05147         155 KLYIIDVSQSVEH  167 (190)
T ss_pred             cEEEEEccccccC
Confidence            8999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.89  E-value=2.6e-23  Score=176.21  Aligned_cols=172  Identities=12%  Similarity=0.085  Sum_probs=133.0

Q ss_pred             HhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCCh--hhHHH------HHHHHHHHHhcCCCceeeeeeeeee
Q 019536           53 ATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTL--DDVEY------CFNNIVFSSQMKHKNILKLIGCCLE  124 (339)
Q Consensus        53 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~------~~~e~~~l~~l~H~niv~~~~~~~~  124 (339)
                      ..++|...+++|.|+||.||....  ++..+|+|.+.+....  .....      +.+|+..+.++.||+|..+.+++..
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            358999999999999999999755  5778999999765331  22222      5689999999999999999888664


Q ss_pred             C--------CccEEEEEeccCCccccccccCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEe
Q 019536          125 T--------ELPTLVFESVKYGTLRGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLH  196 (339)
Q Consensus       125 ~--------~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~  196 (339)
                      .        +..+|||||++|.+|.++..  ++.    ....+++.++..+|   ..|++|||++|.|++++.++ ++++
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~g-i~li  176 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMPE--ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKNG-LRII  176 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhhh--ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCCC-EEEE
Confidence            3        35789999999999987732  222    35669999999999   99999999999999999888 9999


Q ss_pred             cCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHH
Q 019536          197 DFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELL  250 (339)
Q Consensus       197 dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~  250 (339)
                      |||...........              ..++....|+.++|+||||+++..+.
T Consensus       177 Dfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        177 DLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             ECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence            99987554221110              11334455778899999999876554

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.89  E-value=2.6e-22  Score=168.21  Aligned_cols=140  Identities=10%  Similarity=0.057  Sum_probs=110.8

Q ss_pred             CCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChh-------------------------hHHHHHHHHHHHHhcCCCc
Q 019536           60 HKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLD-------------------------DVEYCFNNIVFSSQMKHKN  114 (339)
Q Consensus        60 ~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------------------------~~~~~~~e~~~l~~l~H~n  114 (339)
                      ...||+|++|+||+|.+. +|+.||||+++......                         ....+.+|...+.++.|++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            568999999999999987 89999999988753110                         0123457899999999998


Q ss_pred             eeeeeeeeeeCCccEEEEEeccCCccccc-cc-cCCChHHHHHHHHHHHHHHHHHhcCCC-CCeEEccCCCCCEEeCCCC
Q 019536          115 ILKLIGCCLETELPTLVFESVKYGTLRGF-SF-ASLLIAPRIKIAMEIANAVAYLHVGFD-RPIVFRCIKASNVLLDENY  191 (339)
Q Consensus       115 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~-~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~i~H~dlk~~Nil~~~~~  191 (339)
                      +.....+....  .+|||||++++++... +. ..++......++.|++.++.++|   . .||+||||||+||+++ ++
T Consensus        81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NIll~-~~  154 (190)
T cd05145          81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNILYH-DG  154 (190)
T ss_pred             CCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhEEEE-CC
Confidence            75444333322  4899999998855433 22 45667788899999999999999   7 9999999999999999 78


Q ss_pred             ceEEecCCCccccCC
Q 019536          192 SAKLHDFSLSVSIPE  206 (339)
Q Consensus       192 ~~kl~dfg~a~~~~~  206 (339)
                      .++|+|||++.....
T Consensus       155 ~~~liDFG~a~~~~~  169 (190)
T cd05145         155 KPYIIDVSQAVELDH  169 (190)
T ss_pred             CEEEEEcccceecCC
Confidence            999999999976644

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.88  E-value=2.3e-23  Score=202.52  Aligned_cols=246  Identities=19%  Similarity=0.210  Sum_probs=175.8

Q ss_pred             CcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHH---HHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 019536           56 NYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYC---FNNIVFSSQMKHKNILKLIGCCLETELPTLVF  132 (339)
Q Consensus        56 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~---~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  132 (339)
                      ++...+.+|++.|=.|.+|.++ .|. |+||++-+....-....+   +.|++ ...++|||.+.+.-+-..+...|||=
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR  100 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR  100 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence            6778899999999999999996 555 889998776433334444   34455 55568999999988877777788888


Q ss_pred             EeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCcc--ccCCCC
Q 019536          133 ESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSV--SIPEGE  208 (339)
Q Consensus       133 e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~--~~~~~~  208 (339)
                      +|..+ +|.|.+.  ..+..-+..-|+.|++.||..+|   ..+|+|+|||.+|||+++-..+.|+||..=+  .++.++
T Consensus       101 qyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN  176 (1431)
T KOG1240|consen  101 QYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN  176 (1431)
T ss_pred             HHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence            88855 7888876  34555566779999999999999   9999999999999999998899999997532  233222


Q ss_pred             ce---eeecccccccccccccccccC----------C-CCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHH
Q 019536          209 TH---VREEFIKGAYGFIAPEYFATS----------S-FNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYA  273 (339)
Q Consensus       209 ~~---~~~~~~~gt~~y~aPE~~~~~----------~-~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~  273 (339)
                      ..   ...++.....+|.|||.+...          + .+++-||||+||+++||++ |++||...        .+    
T Consensus       177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS--------QL----  244 (1431)
T KOG1240|consen  177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS--------QL----  244 (1431)
T ss_pred             cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH--------HH----
Confidence            11   111122234569999987531          1 4567899999999999988 68887521        11    


Q ss_pred             HHHhhcCc--ccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 019536          274 KKSIENNR--FGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLR  332 (339)
Q Consensus       274 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~  332 (339)
                      ..+...+.  ..++++.            -....++.++..|++.||.+|.||++.|+.-.
T Consensus       245 ~aYr~~~~~~~e~~Le~------------Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yr  293 (1431)
T KOG1240|consen  245 LAYRSGNADDPEQLLEK------------IEDVSLRNLILSMIQRDPSKRLSAEDYLQKYR  293 (1431)
T ss_pred             HhHhccCccCHHHHHHh------------CcCccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence            11111110  1111111            01125889999999999999999999998743

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.87  E-value=4.9e-22  Score=183.91  Aligned_cols=215  Identities=25%  Similarity=0.377  Sum_probs=157.1

Q ss_pred             HHhcCCCceeeeeeeeeeCCccEEEEEeccCCcccccccc---CCChHHHHHHHHHHHHHHHHHhcCCCCCe-EEccCCC
Q 019536          107 SSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFA---SLLIAPRIKIAMEIANAVAYLHVGFDRPI-VFRCIKA  182 (339)
Q Consensus       107 l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~---~~~~~~~~~i~~~i~~~l~~LH~~~~~~i-~H~dlk~  182 (339)
                      |+.+.|.|+.+|+|.+.++...+.|++||..|+|.|.+..   .+++.....++++++.||.|||   ..+| .|+.+++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh---~s~i~~hg~l~s   77 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLH---NSPIGYHGALKS   77 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHh---cCcceeeeeecc
Confidence            3578999999999999999999999999999999999873   4555666778999999999999   4445 8999999


Q ss_pred             CCEEeCCCCceEEecCCCccccCCCCceeeecccccccccccccccccC---C----CCcccchHHHHHHHHHHHhCCCc
Q 019536          183 SNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATS---S----FNEMCDVYSFGAFLCELLTGCNV  255 (339)
Q Consensus       183 ~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~----~~~~~DiwslG~~l~el~~g~~p  255 (339)
                      .|++++..+.+|+.|||+.................-..-|.|||.+.+.   .    -+.+.|+||||++++|+++.+.|
T Consensus        78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~  157 (484)
T KOG1023|consen   78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP  157 (484)
T ss_pred             ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence            9999999999999999997665421111111112234559999998763   1    35779999999999999999999


Q ss_pred             cccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 019536          256 LEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMY  335 (339)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~  335 (339)
                      |+........ ...+..+..   .+  .....|.+...      .+..+.+..++.+||..+|..||++.+|-..++.+.
T Consensus       158 ~~~~~~~~~~-~eii~~~~~---~~--~~~~rP~i~~~------~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~  225 (484)
T KOG1023|consen  158 FDLRNLVEDP-DEIILRVKK---GG--SNPFRPSIELL------NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN  225 (484)
T ss_pred             cccccccCCh-HHHHHHHHh---cC--CCCcCcchhhh------hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence            8754433322 223322222   01  11111111110      123336889999999999999999999998887765


Q ss_pred             h
Q 019536          336 L  336 (339)
Q Consensus       336 ~  336 (339)
                      .
T Consensus       226 ~  226 (484)
T KOG1023|consen  226 K  226 (484)
T ss_pred             c
Confidence            3

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.87  E-value=1.4e-21  Score=162.24  Aligned_cols=190  Identities=12%  Similarity=-0.010  Sum_probs=138.3

Q ss_pred             ccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhh---HHHHHHHHHHHHhcC-CCceeeeeeeeeeCCccEEEEE
Q 019536           58 DLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDD---VEYCFNNIVFSSQMK-HKNILKLIGCCLETELPTLVFE  133 (339)
Q Consensus        58 ~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~e~~~l~~l~-H~niv~~~~~~~~~~~~~lv~e  133 (339)
                      .+...+++|+||+|+.+..  .+.+++.+.+........   ...+.+|+++|+++. |+++++++++    +..+++||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme   78 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS   78 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence            3567899999999997766  678888887766543211   224779999999995 5889999886    34689999


Q ss_pred             eccCCccccccccCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccC-CCCCEEeCCCCceEEecCCCccccCCCCce--
Q 019536          134 SVKYGTLRGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCI-KASNVLLDENYSAKLHDFSLSVSIPEGETH--  210 (339)
Q Consensus       134 ~~~~g~L~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dl-k~~Nil~~~~~~~kl~dfg~a~~~~~~~~~--  210 (339)
                      |++|.+|......     ....++.|++.+|.++|   ..||+|||| ||+|||++.++.++|+|||+|.........  
T Consensus        79 yI~G~~L~~~~~~-----~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r  150 (218)
T PRK12274         79 YLAGAAMYQRPPR-----GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR  150 (218)
T ss_pred             eecCccHHhhhhh-----hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence            9999888654321     12457889999999999   999999999 799999999999999999999865443310  


Q ss_pred             --ee-------ecccccccccccccccccC-CCC-cccchHHHHHHHHHHHhCCCccccCCC
Q 019536          211 --VR-------EEFIKGAYGFIAPEYFATS-SFN-EMCDVYSFGAFLCELLTGCNVLEFKGN  261 (339)
Q Consensus       211 --~~-------~~~~~gt~~y~aPE~~~~~-~~~-~~~DiwslG~~l~el~~g~~p~~~~~~  261 (339)
                        ..       ......++.|++|+.-.-. ..+ ...+.++-|+.+|.++||..++...++
T Consensus       151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~  212 (218)
T PRK12274        151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE  212 (218)
T ss_pred             HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence              00       0012234556666543221 233 456777999999999999988654433

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.87  E-value=2.2e-22  Score=176.88  Aligned_cols=197  Identities=21%  Similarity=0.277  Sum_probs=136.3

Q ss_pred             CCCceeeeeeeeeeC---------------------------CccEEEEEeccCCccccccc-cCCChHHHHHHHHHHHH
Q 019536          111 KHKNILKLIGCCLET---------------------------ELPTLVFESVKYGTLRGFSF-ASLLIAPRIKIAMEIAN  162 (339)
Q Consensus       111 ~H~niv~~~~~~~~~---------------------------~~~~lv~e~~~~g~L~~~~~-~~~~~~~~~~i~~~i~~  162 (339)
                      .|||||++.++|.+.                           ..+|+||..++. +|.+++- ...+.....-++.|+++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~~s~r~~~~~laQlLE  352 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRHRSYRTGRVILAQLLE  352 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCCCchHHHHHHHHHHHH
Confidence            499999999988543                           246889887754 7887775 45566667778999999


Q ss_pred             HHHHHhcCCCCCeEEccCCCCCEEe--CCCC--ceEEecCCCccccCCCCce--ee-ec-ccccccccccccccccCC--
Q 019536          163 AVAYLHVGFDRPIVFRCIKASNVLL--DENY--SAKLHDFSLSVSIPEGETH--VR-EE-FIKGAYGFIAPEYFATSS--  232 (339)
Q Consensus       163 ~l~~LH~~~~~~i~H~dlk~~Nil~--~~~~--~~kl~dfg~a~~~~~~~~~--~~-~~-~~~gt~~y~aPE~~~~~~--  232 (339)
                      |+.|||   ..+|.|||+|.+|||+  +.++  .+.++|||++-.-......  .. .. ...|....||||+....+  
T Consensus       353 av~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp  429 (598)
T KOG4158|consen  353 AVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGP  429 (598)
T ss_pred             HHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCC
Confidence            999999   9999999999999998  3443  4789999986432221100  00 00 123566689999986432  


Q ss_pred             ---C-CcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHH
Q 019536          233 ---F-NEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQ  308 (339)
Q Consensus       233 ---~-~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (339)
                         . -.++|.|+.|.+.||++....||-..|+-.-+   ...     ..+.++             .+.++.++..+++
T Consensus       430 ~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~---~r~-----Yqe~qL-------------Palp~~vpp~~rq  488 (598)
T KOG4158|consen  430 NAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLD---TRT-----YQESQL-------------PALPSRVPPVARQ  488 (598)
T ss_pred             ceeeccchhhhhhhhhhHHHHhccCCcccccchheec---hhh-----hhhhhC-------------CCCcccCChHHHH
Confidence               1 26799999999999999999997533322111   000     111111             1123355667999


Q ss_pred             HHHHhhccCCCCCCCHHHHHHHHH
Q 019536          309 LMYKCLSKSPEHRPLMVDVAKQLR  332 (339)
Q Consensus       309 li~~cl~~dP~~Rps~~~il~~L~  332 (339)
                      ++..+|+.||.+|+|.+-+...|+
T Consensus       489 lV~~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  489 LVFDLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             HHHHHhcCCccccCCccHHHhHHH
Confidence            999999999999999876665543

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.87  E-value=2.9e-22  Score=174.76  Aligned_cols=230  Identities=20%  Similarity=0.211  Sum_probs=146.0

Q ss_pred             CcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC--ChhhHHHHHHHHHHHHhcCC----------Cceeeeeeeee
Q 019536           56 NYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS--TLDDVEYCFNNIVFSSQMKH----------KNILKLIGCCL  123 (339)
Q Consensus        56 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H----------~niv~~~~~~~  123 (339)
                      .+.....||.|+++.||.+++.++|+.+|+|++....  .....+.+.+|.-....+.+          -.++--++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            4566788999999999999999999999999876543  23456667666544444322          11221122211


Q ss_pred             ---------eC---C-----ccEEEEEeccCCccccccc-----cC----CChHHHHHHHHHHHHHHHHHhcCCCCCeEE
Q 019536          124 ---------ET---E-----LPTLVFESVKYGTLRGFSF-----AS----LLIAPRIKIAMEIANAVAYLHVGFDRPIVF  177 (339)
Q Consensus       124 ---------~~---~-----~~~lv~e~~~~g~L~~~~~-----~~----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H  177 (339)
                               ..   +     ..+++|+-+ .++|.+++.     ..    +....++.+..|++..+++||   ..|++|
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVH  168 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVH  168 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEE
T ss_pred             EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEe
Confidence                     11   1     235677777 467777654     11    223334556789999999999   999999


Q ss_pred             ccCCCCCEEeCCCCceEEecCCCccccCCCCceeeecccccccccccccccccC--------CCCcccchHHHHHHHHHH
Q 019536          178 RCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATS--------SFNEMCDVYSFGAFLCEL  249 (339)
Q Consensus       178 ~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~DiwslG~~l~el  249 (339)
                      +||+|+|++++.+|.+.|+||+.....+.  ...   ....+..|.+||.....        .++.+.|.|++|+++|.|
T Consensus       169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~--~~~---~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l  243 (288)
T PF14531_consen  169 GDIKPENFLLDQDGGVFLGDFSSLVRAGT--RYR---CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL  243 (288)
T ss_dssp             ST-SGGGEEE-TTS-EEE--GGGEEETTE--EEE---GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred             cccceeeEEEcCCCCEEEcChHHHeecCc--eee---ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence            99999999999999999999987655432  111   12345678999977432        478899999999999999


Q ss_pred             HhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCC
Q 019536          250 LTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHR  321 (339)
Q Consensus       250 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~R  321 (339)
                      ++|..||..........                     ..+..     + ...++.++.||..+|+++|.+|
T Consensus       244 WC~~lPf~~~~~~~~~~---------------------~~f~~-----C-~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  244 WCGRLPFGLSSPEADPE---------------------WDFSR-----C-RDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHSS-STCCCGGGSTSG---------------------GGGTT-----S-S---HHHHHHHHHHT-SSGGGS
T ss_pred             HHccCCCCCCCcccccc---------------------ccchh-----c-CCcCHHHHHHHHHHccCCcccC
Confidence            99999986433222110                     01111     1 1566779999999999999988

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.86  E-value=3.7e-23  Score=191.67  Aligned_cols=225  Identities=21%  Similarity=0.183  Sum_probs=179.6

Q ss_pred             ceeccCCeeEEEEEE---cCCCeeEEEEEeccCCCh-hhHHHHHHHHHHHHhcC-CCceeeeeeeeeeCCccEEEEEecc
Q 019536           62 VIQSDTSYRLFEGTL---VDQDRPISVMKFHDNSTL-DDVEYCFNNIVFSSQMK-HKNILKLIGCCLETELPTLVFESVK  136 (339)
Q Consensus        62 ~ig~G~~g~V~~~~~---~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~~~  136 (339)
                      ++|+|+||.|+.+.-   .+.+.-+|.|...+.... ........|..++..++ ||.+|++.-.++.+...+++++|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            468999999886643   346677888887765321 11224557888888886 9999999999999999999999999


Q ss_pred             CCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceeeec
Q 019536          137 YGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREE  214 (339)
Q Consensus       137 ~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~~  214 (339)
                      +|.|...+.  ..+.+.....+...++-+++++|   +.+|+|||+|++||+++.+|.+++.|||+++..-.....    
T Consensus        81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~----  153 (612)
T KOG0603|consen   81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA----  153 (612)
T ss_pred             cchhhhccccCCchHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc----
Confidence            999988876  34566667788999999999999   999999999999999999999999999999876554432    


Q ss_pred             ccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCCC
Q 019536          215 FIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDN  294 (339)
Q Consensus       215 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (339)
                        +||..|||||+++  ....++|.||||+++++|++|..||..         .....                +...  
T Consensus       154 --cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~---------~~~~~----------------Il~~--  202 (612)
T KOG0603|consen  154 --CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG---------DTMKR----------------ILKA--  202 (612)
T ss_pred             --ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch---------HHHHH----------------Hhhh--
Confidence              6899999999997  677889999999999999999999852         11111                1111  


Q ss_pred             CCCCcHHHHHHHHHHHHHhhccCCCCCCCH
Q 019536          295 SFPGKEEKLQSLGQLMYKCLSKSPEHRPLM  324 (339)
Q Consensus       295 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~  324 (339)
                      .++.+...+..+.+++..++..+|.+|.-.
T Consensus       203 ~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  203 ELEMPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             ccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            123345777889999999999999999754

>PRK10345 hypothetical protein; Provisional

Probab=99.85  E-value=6.6e-21  Score=160.88  Aligned_cols=136  Identities=10%  Similarity=0.079  Sum_probs=106.5

Q ss_pred             cccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhc-----CCCceeeeeeeeeeCC---c-
Q 019536           57 YDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQM-----KHKNILKLIGCCLETE---L-  127 (339)
Q Consensus        57 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-----~H~niv~~~~~~~~~~---~-  127 (339)
                      +.-...||+|+||.||.  +..++.. +||+...... ...+.+.+|+.+++.+     .||||++++|++.++.   . 
T Consensus         4 L~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~-~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v   79 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD-GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV   79 (210)
T ss_pred             cCCcceecCCCceEEEE--CCCCcCe-EEEEEecccc-chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence            34467899999999996  5545555 6888876433 3456788999999999     5799999999998863   3 


Q ss_pred             cEEEEEe--ccCCcccccccc-CCChHHHHHHHHHHHHHH-HHHhcCCCCCeEEccCCCCCEEeCC----CCceEEecCC
Q 019536          128 PTLVFES--VKYGTLRGFSFA-SLLIAPRIKIAMEIANAV-AYLHVGFDRPIVFRCIKASNVLLDE----NYSAKLHDFS  199 (339)
Q Consensus       128 ~~lv~e~--~~~g~L~~~~~~-~~~~~~~~~i~~~i~~~l-~~LH~~~~~~i~H~dlk~~Nil~~~----~~~~kl~dfg  199 (339)
                      ..+|+||  +++|+|.+++.. .+++.  ..++.+++.++ +|||   +.+|+||||||+|||++.    ++.++|+||+
T Consensus        80 ~~~I~e~~G~~~~tL~~~l~~~~~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~  154 (210)
T PRK10345         80 YDVIADFDGKPSITLTEFAEQCRYEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVCDNI  154 (210)
T ss_pred             EEEEecCCCCcchhHHHHHHcccccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence            3478999  568999999874 33333  45678888888 9999   999999999999999974    3479999955


Q ss_pred             Cc
Q 019536          200 LS  201 (339)
Q Consensus       200 ~a  201 (339)
                      .+
T Consensus       155 G~  156 (210)
T PRK10345        155 GE  156 (210)
T ss_pred             CC
Confidence            43

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.85  E-value=1.9e-22  Score=183.56  Aligned_cols=168  Identities=25%  Similarity=0.341  Sum_probs=123.0

Q ss_pred             cEEEEEeccCCccccccc-----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCcc
Q 019536          128 PTLVFESVKYGTLRGFSF-----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSV  202 (339)
Q Consensus       128 ~~lv~e~~~~g~L~~~~~-----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~  202 (339)
                      +|+.|++|...+|.+++.     ...++.....++.|++.|++|      ++.+|+|+||.||++..+..+||.|||+..
T Consensus       331 lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~t  404 (516)
T KOG1033|consen  331 LYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLVT  404 (516)
T ss_pred             hhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhee
Confidence            468888888888888886     245666677899999999998      678999999999999999999999999987


Q ss_pred             ccCCCCc----eeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHh
Q 019536          203 SIPEGET----HVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSI  277 (339)
Q Consensus       203 ~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~  277 (339)
                      ......+    ....+...||..||+||.+.+..|+.++||||||++++|++. -...|..                   
T Consensus       405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er-------------------  465 (516)
T KOG1033|consen  405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER-------------------  465 (516)
T ss_pred             ecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH-------------------
Confidence            7655441    112224579999999999999999999999999999999997 2222211                   


Q ss_pred             hcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 019536          278 ENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVD  326 (339)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~  326 (339)
                       -..+..+-+..+++....     ..+.-..|+.++|...|.+||++.+
T Consensus       466 -~~t~~d~r~g~ip~~~~~-----d~p~e~~ll~~lls~~p~~RP~~~~  508 (516)
T KOG1033|consen  466 -IATLTDIRDGIIPPEFLQ-----DYPEEYTLLQQLLSPSPEERPSAIE  508 (516)
T ss_pred             -HHhhhhhhcCCCChHHhh-----cCcHHHHHHHHhcCCCcccCchHHH
Confidence             011112222222211111     1123457999999999999995443

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.84  E-value=1.1e-20  Score=186.55  Aligned_cols=197  Identities=17%  Similarity=0.189  Sum_probs=155.2

Q ss_pred             HHHHHHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcC---CCceeeeeeeeee
Q 019536           48 KDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMK---HKNILKLIGCCLE  124 (339)
Q Consensus        48 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~---H~niv~~~~~~~~  124 (339)
                      .+++.....|.+.+.||.|+||+||.|...+ |+.||+|+-++...++-    .--.+++.+|+   -+.|+.+..+..-
T Consensus       691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEf----YI~~q~~~RLk~~~~~~~~~~~~a~~~  765 (974)
T KOG1166|consen  691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEF----YICLQVMERLKPQMLPSIMHISSAHVF  765 (974)
T ss_pred             ceeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceee----eehHHHHHhhchhhhcchHHHHHHHcc
Confidence            3455556789999999999999999999985 99999999877654321    11123333343   2345555556566


Q ss_pred             CCccEEEEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeC-------CCCceEE
Q 019536          125 TELPTLVFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLD-------ENYSAKL  195 (339)
Q Consensus       125 ~~~~~lv~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~-------~~~~~kl  195 (339)
                      .+..+||+||.+.|+|.+++.  +.+++.-++.++.|++.-+++||   ..+|||+||||+|.|+.       .+..++|
T Consensus       766 ~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~l  842 (974)
T KOG1166|consen  766 QNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYL  842 (974)
T ss_pred             CCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEE
Confidence            667789999999999999998  56788888999999999999999   99999999999999994       2345899


Q ss_pred             ecCCCccc---cCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCc
Q 019536          196 HDFSLSVS---IPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNV  255 (339)
Q Consensus       196 ~dfg~a~~---~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p  255 (339)
                      +|||.|--   +++..   .-....+|-.+-++|+..|.+++..+|.|.+.-+++.|+.|+..
T Consensus       843 IDfG~siDm~lfp~~~---~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  843 IDFGRSIDMKLFPDGT---KFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             EecccceeeeEcCCCc---EEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence            99998743   23332   22245678889999999999999999999999999999999754

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.84  E-value=6.8e-20  Score=156.19  Aligned_cols=135  Identities=16%  Similarity=0.156  Sum_probs=113.1

Q ss_pred             CceeccCCeeEEEEEEcCCCeeEEEEEeccCCCh-h------hHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 019536           61 KVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTL-D------DVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFE  133 (339)
Q Consensus        61 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~------~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  133 (339)
                      +.||+|++|.||+|..  .|..+++|+....... .      ....+.+|+.++..+.|++++....++.+.+..++|||
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e   79 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME   79 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence            5799999999999988  6778889986643221 1      12457789999999999998877777777778899999


Q ss_pred             eccCCccccccccCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccc
Q 019536          134 SVKYGTLRGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVS  203 (339)
Q Consensus       134 ~~~~g~L~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~  203 (339)
                      |++|++|.+++....+  ....++.+++.+|.++|   ..+++|+|++|.||+++ ++.++++|||+++.
T Consensus        80 ~~~G~~L~~~~~~~~~--~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         80 YIEGEPLKDLINSNGM--EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EeCCcCHHHHHHhccH--HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999988754332  67789999999999999   99999999999999999 78899999998754

>smart00090 RIO RIO-like kinase

Probab=99.83  E-value=5.8e-20  Score=158.74  Aligned_cols=142  Identities=12%  Similarity=0.085  Sum_probs=111.2

Q ss_pred             cCcccCCceeccCCeeEEEEE-EcCCCeeEEEEEeccCCCh-------------------h----hHHHHHHHHHHHHhc
Q 019536           55 NNYDLHKVIQSDTSYRLFEGT-LVDQDRPISVMKFHDNSTL-------------------D----DVEYCFNNIVFSSQM  110 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~-~~~~~~~vavK~~~~~~~~-------------------~----~~~~~~~e~~~l~~l  110 (339)
                      ..|.+.+.||+|++|.||+|. ...+|+.||+|++......                   .    ....+.+|+.++..+
T Consensus        28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L  107 (237)
T smart00090       28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL  107 (237)
T ss_pred             chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            358899999999999999998 5568999999998754210                   0    112356899999999


Q ss_pred             CCC--ceeeeeeeeeeCCccEEEEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCC-eEEccCCCCCE
Q 019536          111 KHK--NILKLIGCCLETELPTLVFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRP-IVFRCIKASNV  185 (339)
Q Consensus       111 ~H~--niv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~-i~H~dlk~~Ni  185 (339)
                      .+.  .+.+++++   . ..++||||+++++|.....  ..........++.|++.++.+||   ..+ ++||||||+||
T Consensus       108 ~~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dikp~NI  180 (237)
T smart00090      108 YEAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLY---KEGELVHGDLSEYNI  180 (237)
T ss_pred             HhcCCCCCeeeEe---c-CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCChhhE
Confidence            753  33444443   2 3489999999988876653  33444456789999999999999   899 99999999999


Q ss_pred             EeCCCCceEEecCCCcccc
Q 019536          186 LLDENYSAKLHDFSLSVSI  204 (339)
Q Consensus       186 l~~~~~~~kl~dfg~a~~~  204 (339)
                      +++ ++.++|+|||.+...
T Consensus       181 li~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      181 LVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             EEE-CCCEEEEEChhhhcc
Confidence            999 789999999998654

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.83  E-value=2.7e-21  Score=187.93  Aligned_cols=208  Identities=20%  Similarity=0.290  Sum_probs=146.8

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFE  133 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  133 (339)
                      -.+|...+.|..|+||.||..+++.+.+++|+| +++..      .+.+.  ++.....|.+|                 
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~------lilRn--ilt~a~npfvv-----------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQN------LILRN--ILTFAGNPFVV-----------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhc-ccccc------hhhhc--cccccCCccee-----------------
Confidence            378999999999999999999999889999994 44321      11111  33333444443                 


Q ss_pred             eccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCce-
Q 019536          134 SVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH-  210 (339)
Q Consensus       134 ~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~-  210 (339)
                          |+=...+.  +.++..        ++.+++|||   +.+|+|||+||+|.++..-|.+|+.|||+++........ 
T Consensus       136 ----gDc~tllk~~g~lPvd--------mvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn  200 (1205)
T KOG0606|consen  136 ----GDCATLLKNIGPLPVD--------MVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN  200 (1205)
T ss_pred             ----chhhhhcccCCCCcch--------hhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence                22223333  244433        278899999   999999999999999999999999999997653221111 


Q ss_pred             ------------eeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhh
Q 019536          211 ------------VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIE  278 (339)
Q Consensus       211 ------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  278 (339)
                                  ......+||+.|.|||++....|+..+|+|++|+++||.+.|+.||.....+                
T Consensus       201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpe----------------  264 (1205)
T KOG0606|consen  201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE----------------  264 (1205)
T ss_pred             hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHH----------------
Confidence                        1122368999999999999999999999999999999999999997522111                


Q ss_pred             cCcccccccCcccCCCCCCCc-HHHHHHHHHHHHHhhccCCCCCCC
Q 019536          279 NNRFGAIVDPIFDEDNSFPGK-EEKLQSLGQLMYKCLSKSPEHRPL  323 (339)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~cl~~dP~~Rps  323 (339)
                           .++...+.....||.. .....++++++.++|+.+|..|.-
T Consensus       265 -----elfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlg  305 (1205)
T KOG0606|consen  265 -----ELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLG  305 (1205)
T ss_pred             -----HHHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhcc
Confidence                 1112222222222221 234467999999999999999953

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.80  E-value=6.1e-19  Score=148.84  Aligned_cols=147  Identities=14%  Similarity=0.069  Sum_probs=113.5

Q ss_pred             HHHHHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCCh---------------------hhHHHHHHHHHHH
Q 019536           49 DLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTL---------------------DDVEYCFNNIVFS  107 (339)
Q Consensus        49 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---------------------~~~~~~~~e~~~l  107 (339)
                      ++......|.+.+.||+|+||.||+|... +|+.||||++......                     .....+.+|..++
T Consensus         9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   87 (198)
T cd05144           9 TLVKRGVVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL   87 (198)
T ss_pred             HHHHcCchhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence            34444445888899999999999999885 7999999987653210                     0112356788899


Q ss_pred             HhcCCCc--eeeeeeeeeeCCccEEEEEeccCCccccccccCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCE
Q 019536          108 SQMKHKN--ILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNV  185 (339)
Q Consensus       108 ~~l~H~n--iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Ni  185 (339)
                      ..+.|++  ++..++.    ...++||||+++++|......    .....++.+++.++.++|   ..+++|+||+|.||
T Consensus        88 ~~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~----~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~p~Ni  156 (198)
T cd05144          88 KALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL----EDPEEVLDEILEEIVKAY---KHGIIHGDLSEFNI  156 (198)
T ss_pred             HHHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc----ccHHHHHHHHHHHHHHHH---HCCCCcCCCCcccE
Confidence            9998774  4444442    345899999999998766431    334578899999999999   89999999999999


Q ss_pred             EeCCCCceEEecCCCccccCCC
Q 019536          186 LLDENYSAKLHDFSLSVSIPEG  207 (339)
Q Consensus       186 l~~~~~~~kl~dfg~a~~~~~~  207 (339)
                      +++.++.++|+|||.+..+...
T Consensus       157 ll~~~~~~~liDfg~~~~~~~~  178 (198)
T cd05144         157 LVDDDEKIYIIDWPQMVSTDHP  178 (198)
T ss_pred             EEcCCCcEEEEECCccccCCCc
Confidence            9999999999999998766543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.80  E-value=5.1e-19  Score=149.44  Aligned_cols=131  Identities=18%  Similarity=0.151  Sum_probs=105.8

Q ss_pred             ceeccCCeeEEEEEEcCCCeeEEEEEeccCCCh-------hhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 019536           62 VIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTL-------DDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFES  134 (339)
Q Consensus        62 ~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  134 (339)
                      .||+|++|.||+|..  ++..+++|........       .....+.+|+.++..+.|+++.....++.+.+..++||||
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   78 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY   78 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence            489999999999996  6788999986543211       1235577899999999988765555555566677899999


Q ss_pred             ccCCccccccccCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccc
Q 019536          135 VKYGTLRGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVS  203 (339)
Q Consensus       135 ~~~g~L~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~  203 (339)
                      ++|++|.+++.....     .++.+++.+|.+||   ..+++|+|++|.||+++ ++.++++|||+++.
T Consensus        79 ~~g~~l~~~~~~~~~-----~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        79 IEGKPLKDVIEEGND-----ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             ECCccHHHHHhhcHH-----HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            999999887643211     78999999999999   99999999999999999 78999999998755

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.78  E-value=1.2e-18  Score=168.35  Aligned_cols=138  Identities=15%  Similarity=0.118  Sum_probs=111.2

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccC--CC-----hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCc
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDN--ST-----LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETEL  127 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~--~~-----~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~  127 (339)
                      ..|...+.||+|+||+||+|.+...  .+++|+....  ..     ....+++.+|+.+++.++|++++....++.+...
T Consensus       333 ~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~  410 (535)
T PRK09605        333 RRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE  410 (535)
T ss_pred             cccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence            4556789999999999999998543  3334432211  11     0123567899999999999999988888877777


Q ss_pred             cEEEEEeccCCccccccccCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCcccc
Q 019536          128 PTLVFESVKYGTLRGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSI  204 (339)
Q Consensus       128 ~~lv~e~~~~g~L~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~  204 (339)
                      .++||||+++++|.+++.      ....++.+++.+|.|||   +.+++|||+||+||++ .++.++|+|||+++..
T Consensus       411 ~~lv~E~~~g~~L~~~l~------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        411 KTIVMEYIGGKDLKDVLE------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             CEEEEEecCCCcHHHHHH------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence            899999999999988764      45678999999999999   9999999999999999 5778999999998653

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.75  E-value=6e-18  Score=141.38  Aligned_cols=138  Identities=13%  Similarity=0.109  Sum_probs=99.5

Q ss_pred             CCceeccCCeeEEEEEEcCCCeeEEEEEeccCCCh-hhHHH----------------------HHHHHHHHHhcCCCc--
Q 019536           60 HKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTL-DDVEY----------------------CFNNIVFSSQMKHKN--  114 (339)
Q Consensus        60 ~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~----------------------~~~e~~~l~~l~H~n--  114 (339)
                      .+.||+|+||+||+|.+. +++.||||++...... .....                      ...|...+..+.+..  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            568999999999999986 7899999998764221 11111                      124555666664332  


Q ss_pred             eeeeeeeeeeCCccEEEEEeccCCccccccccCCCh-HHHHHHHHHHHHHHHHHhcCCC-CCeEEccCCCCCEEeCCCCc
Q 019536          115 ILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLI-APRIKIAMEIANAVAYLHVGFD-RPIVFRCIKASNVLLDENYS  192 (339)
Q Consensus       115 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~-~~~~~i~~~i~~~l~~LH~~~~-~~i~H~dlk~~Nil~~~~~~  192 (339)
                      +.+.+++    ...++||||++++.+.......... .....++.+++.++.++|   . .+|+|+||||+||+++ ++.
T Consensus        81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nili~-~~~  152 (187)
T cd05119          81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLLEDPEELYDQILELMRKLY---REAGLVHGDLSEYNILVD-DGK  152 (187)
T ss_pred             CCceEec----CCCEEEEEEeCCCCccChhhhhhhhcccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEEEE-CCc
Confidence            4444443    2358999999996543322211111 566789999999999999   7 9999999999999999 889


Q ss_pred             eEEecCCCccccCC
Q 019536          193 AKLHDFSLSVSIPE  206 (339)
Q Consensus       193 ~kl~dfg~a~~~~~  206 (339)
                      ++++|||.+.....
T Consensus       153 ~~liDfg~a~~~~~  166 (187)
T cd05119         153 VYIIDVPQAVEIDH  166 (187)
T ss_pred             EEEEECcccccccC
Confidence            99999999865533

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.73  E-value=7.3e-17  Score=129.37  Aligned_cols=135  Identities=13%  Similarity=0.074  Sum_probs=113.4

Q ss_pred             cCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCC--CceeeeeeeeeeCCccEEEEEecc
Q 019536           59 LHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKH--KNILKLIGCCLETELPTLVFESVK  136 (339)
Q Consensus        59 ~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H--~niv~~~~~~~~~~~~~lv~e~~~  136 (339)
                      +.+.||+|.++.||++...  +..+++|.......   ...+.+|+.++..++|  .++++++++...++..+++|||++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~   76 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIE   76 (155)
T ss_pred             cceecccccccceEEEEec--CCeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecC
Confidence            4578999999999999984  47899999866533   4567899999999976  589999999888888999999999


Q ss_pred             CCccccccccCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccc
Q 019536          137 YGTLRGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVS  203 (339)
Q Consensus       137 ~g~L~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~  203 (339)
                      ++++..+     +......++.+++.++.++|.....+++|+|++|.||++++.+.++++|||.++.
T Consensus        77 g~~~~~~-----~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          77 GETLDEV-----SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             CeecccC-----CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            8888665     5566677899999999999943225799999999999999989999999998754

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.73  E-value=3.7e-19  Score=171.94  Aligned_cols=256  Identities=18%  Similarity=0.172  Sum_probs=196.7

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcC-CCeeEEEEEeccCC-ChhhHHHHHHHHHHHHhcC-CCceeeeeeeeeeCCccEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVD-QDRPISVMKFHDNS-TLDDVEYCFNNIVFSSQMK-HKNILKLIGCCLETELPTL  130 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~-H~niv~~~~~~~~~~~~~l  130 (339)
                      ...|.+.+.||+|+|+.|-...... ....+|.|.+.... ..........|..+-+.+. |+|++.+++...+.+..++
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            4678888899999999998887743 44567777766553 2234455556888888886 9999999999999999999


Q ss_pred             EEEeccCCcccccc-cc---CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCC-ceEEecCCCccccC
Q 019536          131 VFESVKYGTLRGFS-FA---SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENY-SAKLHDFSLSVSIP  205 (339)
Q Consensus       131 v~e~~~~g~L~~~~-~~---~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~-~~kl~dfg~a~~~~  205 (339)
                      .++|..+|++.+.+ ..   ..+....-.++.|+..++.|+|.  ..++.|+|+||+|.+++..+ .++++|||+|..+.
T Consensus        99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~  176 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYR  176 (601)
T ss_pred             ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence            99999999999888 42   45666777899999999999995  57899999999999999999 99999999999887


Q ss_pred             C-CCceeeeccccc-ccccccccccccCC-CCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcc
Q 019536          206 E-GETHVREEFIKG-AYGFIAPEYFATSS-FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRF  282 (339)
Q Consensus       206 ~-~~~~~~~~~~~g-t~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (339)
                      . +.........+| ++.|+|||...+.. .....|+||.|+++..+++|..|+.+..........              
T Consensus       177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~--------------  242 (601)
T KOG0590|consen  177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSS--------------  242 (601)
T ss_pred             ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccccee--------------
Confidence            7 555544445678 99999999998864 457899999999999999999998765554422111              


Q ss_pred             cccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          283 GAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                        +....  ................+++.+++..+|..|.+..++..
T Consensus       243 --~~~~~--~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  243 --WKSNK--GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             --ecccc--cccccCccccCChhhhhcccccccCCchhccccccccc
Confidence              11110  00001111234456788999999999999999877643

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.70  E-value=2e-16  Score=136.99  Aligned_cols=136  Identities=15%  Similarity=0.123  Sum_probs=104.6

Q ss_pred             CCcee-ccCCeeEEEEEEcCCCeeEEEEEeccCCC------------hhhHHHHHHHHHHHHhcCCCce--eeeeeeeee
Q 019536           60 HKVIQ-SDTSYRLFEGTLVDQDRPISVMKFHDNST------------LDDVEYCFNNIVFSSQMKHKNI--LKLIGCCLE  124 (339)
Q Consensus        60 ~~~ig-~G~~g~V~~~~~~~~~~~vavK~~~~~~~------------~~~~~~~~~e~~~l~~l~H~ni--v~~~~~~~~  124 (339)
                      ...|| .|+.|+||.+..  .+..+++|.+.....            ......+.+|+.++..+.|++|  +..+++...
T Consensus        36 ~~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~  113 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV  113 (239)
T ss_pred             CceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence            35687 899999999988  477899998854211            1223567889999999998875  677776543


Q ss_pred             CC-c---cEEEEEeccC-Ccccccccc-CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecC
Q 019536          125 TE-L---PTLVFESVKY-GTLRGFSFA-SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDF  198 (339)
Q Consensus       125 ~~-~---~~lv~e~~~~-g~L~~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~df  198 (339)
                      .. .   .++|||++++ .+|.+++.. .++.    ..+.+++.+|.+||   ..||+||||||.|||++.++.++|+||
T Consensus       114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~~~l~~----~~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~LIDf  186 (239)
T PRK01723        114 RHGLFYRADILIERIEGARDLVALLQEAPLSE----EQWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWLIDF  186 (239)
T ss_pred             ecCcceeeeEEEEecCCCCCHHHHHhcCCCCH----HHHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEEEEC
Confidence            22 2   2599999997 688877653 3333    24678999999999   999999999999999998889999999


Q ss_pred             CCcccc
Q 019536          199 SLSVSI  204 (339)
Q Consensus       199 g~a~~~  204 (339)
                      |.++..
T Consensus       187 g~~~~~  192 (239)
T PRK01723        187 DRGELR  192 (239)
T ss_pred             CCcccC
Confidence            987653

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.58  E-value=1.9e-14  Score=135.08  Aligned_cols=142  Identities=11%  Similarity=0.070  Sum_probs=99.2

Q ss_pred             CCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhH---------------------------------------HHH
Q 019536           60 HKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDV---------------------------------------EYC  100 (339)
Q Consensus        60 ~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~---------------------------------------~~~  100 (339)
                      .+.||+|++|.||+|+.. +|+.||||+.++.....-.                                       -++
T Consensus       122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf  200 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL  200 (437)
T ss_pred             CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence            367999999999999987 7899999998765321100                                       023


Q ss_pred             HHHHHHHHhcC----CCceeeeeeeee-eCCccEEEEEeccCCcccccccc-CCChHHHHHHHHHHHH-HHHHHhcCCCC
Q 019536          101 FNNIVFSSQMK----HKNILKLIGCCL-ETELPTLVFESVKYGTLRGFSFA-SLLIAPRIKIAMEIAN-AVAYLHVGFDR  173 (339)
Q Consensus       101 ~~e~~~l~~l~----H~niv~~~~~~~-~~~~~~lv~e~~~~g~L~~~~~~-~~~~~~~~~i~~~i~~-~l~~LH~~~~~  173 (339)
                      .+|...+..+.    |.+-+.+-.++. .....+|||||++|++|.++... .... ....++..++. .+..+|   ..
T Consensus       201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~-~~~~ia~~~~~~~l~ql~---~~  276 (437)
T TIGR01982       201 RREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL-DRKALAENLARSFLNQVL---RD  276 (437)
T ss_pred             HHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC-CHHHHHHHHHHHHHHHHH---hC
Confidence            44555444442    333333333332 23446899999999999887541 1111 23456666665 468889   89


Q ss_pred             CeEEccCCCCCEEeCCCCceEEecCCCccccCC
Q 019536          174 PIVFRCIKASNVLLDENYSAKLHDFSLSVSIPE  206 (339)
Q Consensus       174 ~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~  206 (339)
                      |++|+|++|.||+++.++.++++|||++..+..
T Consensus       277 g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       277 GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            999999999999999999999999999877754

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.53  E-value=9.1e-15  Score=136.02  Aligned_cols=248  Identities=16%  Similarity=0.180  Sum_probs=181.9

Q ss_pred             cCcccCCceec--cCCeeEEEEEE--cCCCeeEEEEEeccCCC-hhhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCcc
Q 019536           55 NNYDLHKVIQS--DTSYRLFEGTL--VDQDRPISVMKFHDNST-LDDVEYCFNNIVFSSQM-KHKNILKLIGCCLETELP  128 (339)
Q Consensus        55 ~~~~~~~~ig~--G~~g~V~~~~~--~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~  128 (339)
                      ..+.+...+|.  |.+|.||.+..  ..++..+|+|+-+.... ......-++|+...+.+ .|+|.++....++.++..
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l  193 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL  193 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence            55677788999  99999999998  77888999998554422 23334445777777777 599999999999999999


Q ss_pred             EEEEEeccCCccccccc---cCCChHHHHHHHHHHHH----HHHHHhcCCCCCeEEccCCCCCEEeCCC-CceEEecCCC
Q 019536          129 TLVFESVKYGTLRGFSF---ASLLIAPRIKIAMEIAN----AVAYLHVGFDRPIVFRCIKASNVLLDEN-YSAKLHDFSL  200 (339)
Q Consensus       129 ~lv~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~----~l~~LH~~~~~~i~H~dlk~~Nil~~~~-~~~kl~dfg~  200 (339)
                      ++-+|+|. .+|..+..   ..++....+..+.+...    ||.++|   ..+++|-|+||.||+...+ ..+++.|||+
T Consensus       194 fiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~df~~  269 (524)
T KOG0601|consen  194 FIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTDFGL  269 (524)
T ss_pred             eeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecCCcce
Confidence            99999995 67877765   34677777788888888    999999   9999999999999999988 7899999999


Q ss_pred             ccccCCCCceee---ecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHh
Q 019536          201 SVSIPEGETHVR---EEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSI  277 (339)
Q Consensus       201 a~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  277 (339)
                      ...+........   .....|...|++||.+. +.++...|+||+|.++.+..++-.++. .+...              
T Consensus       270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~-~g~~~--------------  333 (524)
T KOG0601|consen  270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPS-VGKNS--------------  333 (524)
T ss_pred             eEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhccccc-CCCCC--------------
Confidence            887765542211   11124666799999885 567888999999999999988876643 11101              


Q ss_pred             hcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          278 ENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                         .|.++...-+....    ...-+.++...+..+++.+|-.|++++.+..
T Consensus       334 ---~W~~~r~~~ip~e~----~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  334 ---SWSQLRQGYIPLEF----CEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             ---CccccccccCchhh----hcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence               00000000000000    0122345666889999999999999877654

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.48  E-value=3.2e-14  Score=123.11  Aligned_cols=199  Identities=21%  Similarity=0.259  Sum_probs=133.2

Q ss_pred             HHHhcCCCceeeeeeeeeeCC-----ccEEEEEeccCCccccccc------cCCChHHHHHHHHHHHHHHHHHhcCCCCC
Q 019536          106 FSSQMKHKNILKLIGCCLETE-----LPTLVFESVKYGTLRGFSF------ASLLIAPRIKIAMEIANAVAYLHVGFDRP  174 (339)
Q Consensus       106 ~l~~l~H~niv~~~~~~~~~~-----~~~lv~e~~~~g~L~~~~~------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~  174 (339)
                      -+-++.|.|||++..++.+..     ...++.||+..|++..+++      ..+......+++.||+.||.|||+ ++..
T Consensus       120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~Pp  198 (458)
T KOG1266|consen  120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDPP  198 (458)
T ss_pred             HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCCc
Confidence            344567999999999987543     3578899999999999987      345666667899999999999994 4788


Q ss_pred             eEEccCCCCCEEeCCCCceEEecCCCccccC--CCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhC
Q 019536          175 IVFRCIKASNVLLDENYSAKLHDFSLSVSIP--EGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG  252 (339)
Q Consensus       175 i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~--~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g  252 (339)
                      |+|+++..+.|++..+|.+|+.--.-.....  ............+-++|.+||.-.....+.++|||+||....+|..+
T Consensus       199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail  278 (458)
T KOG1266|consen  199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL  278 (458)
T ss_pred             cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence            9999999999999999888875322110000  00000011123456789999987666778899999999988998876


Q ss_pred             CCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          253 CNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       253 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      .---   ++.. ......+.....+            +.         .....-++++.+|++..|+.||+|++++.+
T Consensus       279 Eiq~---tnse-S~~~~ee~ia~~i------------~~---------len~lqr~~i~kcl~~eP~~rp~ar~llfH  331 (458)
T KOG1266|consen  279 EIQS---TNSE-SKVEVEENIANVI------------IG---------LENGLQRGSITKCLEGEPNGRPDARLLLFH  331 (458)
T ss_pred             eecc---CCCc-ceeehhhhhhhhe------------ee---------ccCccccCcCcccccCCCCCCcchhhhhcC
Confidence            4321   1111 0111111000000            00         000113468999999999999999998864

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.48  E-value=3.7e-13  Score=110.42  Aligned_cols=126  Identities=17%  Similarity=0.067  Sum_probs=94.8

Q ss_pred             CceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCce-eeeeeeeeeCCccEEEEEeccCCc
Q 019536           61 KVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNI-LKLIGCCLETELPTLVFESVKYGT  139 (339)
Q Consensus        61 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~ni-v~~~~~~~~~~~~~lv~e~~~~g~  139 (339)
                      +.++.|.++.||++..  .+..|++|.......  ....+.+|+.+++.+.+.++ .+++.+..  ...++||||+++.+
T Consensus         4 ~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~   77 (170)
T cd05151           4 SPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTE--LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSE   77 (170)
T ss_pred             eecCCcccCceEEEEE--CCeEEEEEeCCCCcc--cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCc
Confidence            5678899999999987  578899998765432  12335688999988865554 45555433  33579999999988


Q ss_pred             cccccccCCChHHHHHHHHHHHHHHHHHhcCCCCC-----eEEccCCCCCEEeCCCCceEEecCCCcc
Q 019536          140 LRGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRP-----IVFRCIKASNVLLDENYSAKLHDFSLSV  202 (339)
Q Consensus       140 L~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~-----i~H~dlk~~Nil~~~~~~~kl~dfg~a~  202 (339)
                      +....      .....++.+++.+|..||   ..+     ++|+|++|.||+++ ++.++++|||.+.
T Consensus        78 l~~~~------~~~~~~~~~l~~~l~~LH---~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          78 LLTED------FSDPENLEKIAKLLKKLH---SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             ccccc------ccCHHHHHHHHHHHHHHh---CCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            86541      111346789999999999   666     59999999999999 6689999999874

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.47  E-value=1.2e-13  Score=131.47  Aligned_cols=146  Identities=12%  Similarity=0.114  Sum_probs=95.3

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChh---------------------------------hHH--
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLD---------------------------------DVE--   98 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---------------------------------~~~--   98 (339)
                      ..+|+. +.||+|++|+||+|+.+++|+.||||+.++.....                                 ...  
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            346776 78999999999999998779999999998652110                                 011  


Q ss_pred             ----HHHHHHHHHHhcC----CCceeeeeeeeee-CCccEEEEEeccCCccccccc---cCCChHHHHHHHHHHHHH-HH
Q 019536           99 ----YCFNNIVFSSQMK----HKNILKLIGCCLE-TELPTLVFESVKYGTLRGFSF---ASLLIAPRIKIAMEIANA-VA  165 (339)
Q Consensus        99 ----~~~~e~~~l~~l~----H~niv~~~~~~~~-~~~~~lv~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~-l~  165 (339)
                          ++.+|...+.++.    +.+.+.+-.++.+ ....+|||||++|+.+.++..   ......   .++...+.. +.
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~---~la~~~v~~~~~  274 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMK---LLAERGVEVFFT  274 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHH---HHHHHHHHHHHH
Confidence                1234444443332    3333443333332 344679999999999977522   112111   122222221 23


Q ss_pred             HHhcCCCCCeEEccCCCCCEEeCCCC----ceEEecCCCccccCC
Q 019536          166 YLHVGFDRPIVFRCIKASNVLLDENY----SAKLHDFSLSVSIPE  206 (339)
Q Consensus       166 ~LH~~~~~~i~H~dlk~~Nil~~~~~----~~kl~dfg~a~~~~~  206 (339)
                      .+.   ..|++|+|++|.||+++.++    .++++|||++..++.
T Consensus       275 Qif---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        275 QVF---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHH---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            344   68899999999999999887    899999999877754

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.47  E-value=1.4e-12  Score=122.83  Aligned_cols=170  Identities=21%  Similarity=0.228  Sum_probs=127.0

Q ss_pred             EEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeccCCccccccccCCChHH
Q 019536           73 EGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAP  152 (339)
Q Consensus        73 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~  152 (339)
                      .|..+.++.+|.|+.++.... ...+...+.++-|+.++||||+++++.+...+..|||+|.+.  .|..++.. +....
T Consensus        30 ~~t~k~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-l~~~~  105 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-LGKEE  105 (690)
T ss_pred             ccceeccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-hHHHH
Confidence            577778999999999887655 445667788999999999999999999999999999999874  34333331 12333


Q ss_pred             HHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceeeecccccccccccccccccCC
Q 019536          153 RIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSS  232 (339)
Q Consensus       153 ~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  232 (339)
                      +..-+.||+.||.|||.  .++++|+++.-..++++..|..||++|.++.....-...  ......-..|..|+-.....
T Consensus       106 v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~--~~~~~~~~s~~~P~~~~~s~  181 (690)
T KOG1243|consen  106 VCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAP--AKSLYLIESFDDPEEIDPSE  181 (690)
T ss_pred             HHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcc--cccchhhhcccChhhcCccc
Confidence            44568899999999986  789999999999999999999999999987544322210  00111122355665432221


Q ss_pred             CCcccchHHHHHHHHHHHhC
Q 019536          233 FNEMCDVYSFGAFLCELLTG  252 (339)
Q Consensus       233 ~~~~~DiwslG~~l~el~~g  252 (339)
                        -..|.|-|||++++++.|
T Consensus       182 --~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  182 --WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             --cchhhhhHHHHHHHHhCc
Confidence              357999999999999998

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.47  E-value=3.7e-14  Score=132.01  Aligned_cols=257  Identities=16%  Similarity=0.186  Sum_probs=184.5

Q ss_pred             ccccHHH-HHHHhcCcccCCceeccCCeeEEEEEEc-CCCeeEEEEEeccCCChhh-HHHHHHHHHHHHhc-CCCceeee
Q 019536           43 RAFSAKD-LKKATNNYDLHKVIQSDTSYRLFEGTLV-DQDRPISVMKFHDNSTLDD-VEYCFNNIVFSSQM-KHKNILKL  118 (339)
Q Consensus        43 ~~~~~~~-~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~-~~~~~~e~~~l~~l-~H~niv~~  118 (339)
                      +.+...+ ....+.+|..+..||.|.|+.|+..... .++..|++|.+.+...... ...-..|+.+...+ .|.+++.+
T Consensus       252 ~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~  331 (524)
T KOG0601|consen  252 NIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGK  331 (524)
T ss_pred             heecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCC
Confidence            3344444 3455678999999999999999998866 6788999998877643222 22234677766666 68999999


Q ss_pred             eeeeeeCCccEEEEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCC-CceEE
Q 019536          119 IGCCLETELPTLVFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDEN-YSAKL  195 (339)
Q Consensus       119 ~~~~~~~~~~~lv~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~-~~~kl  195 (339)
                      +..+......++-.|||.++++.....  ..+....++.+..|++.++.++|   ++.++|+|+||.||++..+ +..++
T Consensus       332 ~~~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~  408 (524)
T KOG0601|consen  332 NSSWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKL  408 (524)
T ss_pred             CCCccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhc
Confidence            888888888889999999998766653  56777778899999999999999   9999999999999999876 77899


Q ss_pred             ecCCCccccCCCCceeeecccccccccc--cccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHH
Q 019536          196 HDFSLSVSIPEGETHVREEFIKGAYGFI--APEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYA  273 (339)
Q Consensus       196 ~dfg~a~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~  273 (339)
                      .|||+++.+......     ..+..++.  +|.......+..++|++|||..+.+.++|...-+ .+..           
T Consensus       409 ~~~~~~t~~~~~~~~-----~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~-~~~~-----------  471 (524)
T KOG0601|consen  409 GDFGCWTRLAFSSGV-----FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSE-SGVQ-----------  471 (524)
T ss_pred             cccccccccceeccc-----ccccccccccchhhccccccccccccccccccccccccCcccCc-cccc-----------
Confidence            999998754332221     22333344  4555556678899999999999999998765421 1110           


Q ss_pred             HHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 019536          274 KKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQ  333 (339)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~  333 (339)
                              +..+    ....  .|........+..+...+...++..||++.++....+-
T Consensus       472 --------~~~i----~~~~--~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~  517 (524)
T KOG0601|consen  472 --------SLTI----RSGD--TPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF  517 (524)
T ss_pred             --------ceee----eccc--ccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence                    0000    0110  11111333567788999999999999999888765543

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.44  E-value=3.9e-12  Score=105.75  Aligned_cols=138  Identities=12%  Similarity=0.037  Sum_probs=99.2

Q ss_pred             CCceeccCCeeEEEEEEcC------CCeeEEEEEeccCCC---------------------hhhHHH----HHHHHHHHH
Q 019536           60 HKVIQSDTSYRLFEGTLVD------QDRPISVMKFHDNST---------------------LDDVEY----CFNNIVFSS  108 (339)
Q Consensus        60 ~~~ig~G~~g~V~~~~~~~------~~~~vavK~~~~~~~---------------------~~~~~~----~~~e~~~l~  108 (339)
                      .-.||+|--+.||.|...+      .+..+|||+++....                     ......    ..+|...|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3579999999999998653      357899998753211                     001122    338999999


Q ss_pred             hcC--CCceeeeeeeeeeCCccEEEEEeccCCccccc-cc-cCCChHHHHHHHHHHHHHHHHH-hcCCCCCeEEccCCCC
Q 019536          109 QMK--HKNILKLIGCCLETELPTLVFESVKYGTLRGF-SF-ASLLIAPRIKIAMEIANAVAYL-HVGFDRPIVFRCIKAS  183 (339)
Q Consensus       109 ~l~--H~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~-~~-~~~~~~~~~~i~~~i~~~l~~L-H~~~~~~i~H~dlk~~  183 (339)
                      ++.  .-++...+++    ..-+|||||+.++.+... +. ..++......+..+++.+|..+ |   ..+++|+||++.
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGDLs~~  154 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYK---ECNLVHADLSEY  154 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHH
Confidence            884  3567777765    345799999976543222 11 2334445567889999999988 8   899999999999


Q ss_pred             CEEeCCCCceEEecCCCccccC
Q 019536          184 NVLLDENYSAKLHDFSLSVSIP  205 (339)
Q Consensus       184 Nil~~~~~~~kl~dfg~a~~~~  205 (339)
                      ||++. ++.+.++|||.|....
T Consensus       155 NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         155 NMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             HEEEE-CCcEEEEECCCceeCC
Confidence            99997 4679999999876543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.41  E-value=5.6e-14  Score=137.63  Aligned_cols=249  Identities=18%  Similarity=0.199  Sum_probs=180.6

Q ss_pred             HhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccC--CChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 019536           53 ATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDN--STLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTL  130 (339)
Q Consensus        53 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  130 (339)
                      ..+.+.+.+-+.+|+++.++.+.-...+...++|.....  ......+....+-.++-..++|-+++..-.+......+|
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L  881 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL  881 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence            446788888888999999999887766644444443322  111233444445444445567888877766666777899


Q ss_pred             EEEeccCCcccccccc--CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccC---
Q 019536          131 VFESVKYGTLRGFSFA--SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIP---  205 (339)
Q Consensus       131 v~e~~~~g~L~~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~---  205 (339)
                      |++|..+++|...+..  .............+..+++|||   ...+.|+|++|.|++...++..++.|||......   
T Consensus       882 ~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~  958 (1205)
T KOG0606|consen  882 VGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIP  958 (1205)
T ss_pred             hhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCcccccccccccc
Confidence            9999999888877763  3444445567778889999999   7779999999999999999999999998422210   


Q ss_pred             ------------------CC----Cce----eeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccC
Q 019536          206 ------------------EG----ETH----VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFK  259 (339)
Q Consensus       206 ------------------~~----~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~  259 (339)
                                        ..    ...    .......+|+.|.+||.+.+......+|+|++|++++|.++|.+||...
T Consensus       959 p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen  959 PTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred             CcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCc
Confidence                              00    000    0122356899999999999999999999999999999999999997522


Q ss_pred             CCCCCCchhHHHHHHHHhhcCcccccccCcccCCCCCC-CcHHHHHHHHHHHHHhhccCCCCCCCHH
Q 019536          260 GNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFP-GKEEKLQSLGQLMYKCLSKSPEHRPLMV  325 (339)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~dP~~Rps~~  325 (339)
                      .                     ..++++.++....++| .+...+.++.+++...+..+|.+|..+.
T Consensus      1039 t---------------------pq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1039 T---------------------PQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             c---------------------hhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            2                     2334455556666666 3445677899999999999999998765

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.31  E-value=4.5e-11  Score=102.30  Aligned_cols=142  Identities=18%  Similarity=0.158  Sum_probs=109.2

Q ss_pred             CceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCC--CceeeeeeeeeeCC---ccEEEEEec
Q 019536           61 KVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKH--KNILKLIGCCLETE---LPTLVFESV  135 (339)
Q Consensus        61 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H--~niv~~~~~~~~~~---~~~lv~e~~  135 (339)
                      +.|+.|..+.||++... +|..+++|.............+.+|..+++.+.+  .++.+++.+.....   ..++||||+
T Consensus         4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i   82 (223)
T cd05154           4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV   82 (223)
T ss_pred             eecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence            56889999999999885 3688999987654321234567799999999965  44677787776542   568999999


Q ss_pred             cCCccccccc-cCCChHHHHHHHHHHHHHHHHHhcCC-------------------------------------------
Q 019536          136 KYGTLRGFSF-ASLLIAPRIKIAMEIANAVAYLHVGF-------------------------------------------  171 (339)
Q Consensus       136 ~~g~L~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~-------------------------------------------  171 (339)
                      +|.++.+... ..++......++.+++.+|..||+..                                           
T Consensus        83 ~G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (223)
T cd05154          83 DGRVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLR  162 (223)
T ss_pred             CCEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHH
Confidence            9998887664 45666777788888888888888321                                           


Q ss_pred             ----------CCCeEEccCCCCCEEeCC--CCceEEecCCCccc
Q 019536          172 ----------DRPIVFRCIKASNVLLDE--NYSAKLHDFSLSVS  203 (339)
Q Consensus       172 ----------~~~i~H~dlk~~Nil~~~--~~~~kl~dfg~a~~  203 (339)
                                ...++|+|+.+.||+++.  ++.+.++||+.+..
T Consensus       163 ~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         163 WLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                      245799999999999998  56789999998743

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.29  E-value=4.5e-11  Score=96.43  Aligned_cols=132  Identities=16%  Similarity=0.163  Sum_probs=97.9

Q ss_pred             CceeccCCeeEEEEEEcCCCeeEEEEE-eccCCChhh------HHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 019536           61 KVIQSDTSYRLFEGTLVDQDRPISVMK-FHDNSTLDD------VEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFE  133 (339)
Q Consensus        61 ~~ig~G~~g~V~~~~~~~~~~~vavK~-~~~~~~~~~------~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  133 (339)
                      ..+++|+-+.++.+.+  .|..+.+|. +.+......      ..+-.+|..++.++.--.|..-.-+..+.+...|+||
T Consensus         2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me   79 (204)
T COG3642           2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME   79 (204)
T ss_pred             chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence            4678999999999977  454555554 333222121      2445689999988865444444445556667789999


Q ss_pred             eccCCccccccccCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccc
Q 019536          134 SVKYGTLRGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVS  203 (339)
Q Consensus       134 ~~~~g~L~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~  203 (339)
                      |++|..|.+.+...     ...++..+-.-+.-||   ..+|+|+||.++||++.... +.++|||++..
T Consensus        80 ~I~G~~lkd~l~~~-----~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          80 YIEGELLKDALEEA-----RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             EeCChhHHHHHHhc-----chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            99999998887644     2457778888889999   99999999999999998654 99999999853

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.20  E-value=2.2e-10  Score=92.18  Aligned_cols=140  Identities=17%  Similarity=0.187  Sum_probs=101.1

Q ss_pred             cCCceeccCCeeEEEEEEcCCCeeEEEEE-eccCCChh------hHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 019536           59 LHKVIQSDTSYRLFEGTLVDQDRPISVMK-FHDNSTLD------DVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLV  131 (339)
Q Consensus        59 ~~~~ig~G~~g~V~~~~~~~~~~~vavK~-~~~~~~~~------~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  131 (339)
                      ....|.||+-+.|+++.+  .|+.+.||. +.+.....      ...+-.+|++++.++.--.|.--.-++.+...-.|+
T Consensus        11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~   88 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY   88 (229)
T ss_pred             cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence            567899999999999999  688877774 33322211      235567899999888644443333355566667899


Q ss_pred             EEeccC-Cccccccc---cCCChHHH-HHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCC---ceEEecCCCccc
Q 019536          132 FESVKY-GTLRGFSF---ASLLIAPR-IKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENY---SAKLHDFSLSVS  203 (339)
Q Consensus       132 ~e~~~~-g~L~~~~~---~~~~~~~~-~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~---~~kl~dfg~a~~  203 (339)
                      |||+++ .++.+++.   ..-..+.. ..++..|-..+.-||   ..+|+|+||..+||++..++   .+.++|||++..
T Consensus        89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            999977 46777765   22222222 568889999999999   99999999999999986554   358999999743

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.16  E-value=8.1e-10  Score=91.54  Aligned_cols=126  Identities=16%  Similarity=0.145  Sum_probs=83.6

Q ss_pred             eEEEEEEcCCCeeEEEEEeccCCCh-------------------------hhHHHHHHHHHHHHhcCCC--ceeeeeeee
Q 019536           70 RLFEGTLVDQDRPISVMKFHDNSTL-------------------------DDVEYCFNNIVFSSQMKHK--NILKLIGCC  122 (339)
Q Consensus        70 ~V~~~~~~~~~~~vavK~~~~~~~~-------------------------~~~~~~~~e~~~l~~l~H~--niv~~~~~~  122 (339)
                      .||.|... +|..+|+|........                         ....+..+|...|..+..-  ++.+.+++.
T Consensus         1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            48999886 7889999998643110                         0124467899999999654  567776553


Q ss_pred             eeCCccEEEEEecc--CCccccccccCCChHHHHHHHHHHHHHHHH-HhcCCCCCeEEccCCCCCEEeCCCCceEEecCC
Q 019536          123 LETELPTLVFESVK--YGTLRGFSFASLLIAPRIKIAMEIANAVAY-LHVGFDRPIVFRCIKASNVLLDENYSAKLHDFS  199 (339)
Q Consensus       123 ~~~~~~~lv~e~~~--~g~L~~~~~~~~~~~~~~~i~~~i~~~l~~-LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg  199 (339)
                          .-+|||||++  |..+..+....+.......++.+++..+.. +|   ..||+|+||.+.||+++.+ .+.++|||
T Consensus        80 ----~~~ivME~I~~~G~~~~~l~~~~~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~iIDf~  151 (188)
T PF01163_consen   80 ----RNVIVMEYIGEDGVPLPRLKDVDLSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVYIIDFG  151 (188)
T ss_dssp             ----TTEEEEE--EETTEEGGCHHHCGGGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEEE--GT
T ss_pred             ----CCEEEEEecCCCccchhhHHhccccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEEEEecC
Confidence                3479999998  555555443333344556677888885544 68   8999999999999999977 89999999


Q ss_pred             Ccccc
Q 019536          200 LSVSI  204 (339)
Q Consensus       200 ~a~~~  204 (339)
                      .+...
T Consensus       152 qav~~  156 (188)
T PF01163_consen  152 QAVDS  156 (188)
T ss_dssp             TEEET
T ss_pred             cceec
Confidence            87544

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.15  E-value=7.6e-10  Score=97.09  Aligned_cols=137  Identities=10%  Similarity=0.008  Sum_probs=98.9

Q ss_pred             CceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhH----------HHHHHHHHHHHhcCCCc--eeeeeeeeee----
Q 019536           61 KVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDV----------EYCFNNIVFSSQMKHKN--ILKLIGCCLE----  124 (339)
Q Consensus        61 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~----------~~~~~e~~~l~~l~H~n--iv~~~~~~~~----  124 (339)
                      +.+-......|+++..  .|+.|.||...........          ..+.+|...+..+...+  .+..+++.+.    
T Consensus        28 e~v~~~~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~  105 (268)
T PRK15123         28 EVFRELEGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP  105 (268)
T ss_pred             cEEecCCCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence            4455445556778766  6789999987554321111          13678888888874333  3445555543    


Q ss_pred             -CCccEEEEEeccCC-ccccccc----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCC-------CC
Q 019536          125 -TELPTLVFESVKYG-TLRGFSF----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDE-------NY  191 (339)
Q Consensus       125 -~~~~~lv~e~~~~g-~L~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~-------~~  191 (339)
                       ....+||+|++++. +|.+++.    ...+......++.+++..+.-||   ..||+|+|+++.|||++.       +.
T Consensus       106 ~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~  182 (268)
T PRK15123        106 ATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDL  182 (268)
T ss_pred             ccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCc
Confidence             22467999999876 7887764    33445566789999999999999   999999999999999975       46


Q ss_pred             ceEEecCCCcc
Q 019536          192 SAKLHDFSLSV  202 (339)
Q Consensus       192 ~~kl~dfg~a~  202 (339)
                      .+.++||+.++
T Consensus       183 ~~~LIDl~r~~  193 (268)
T PRK15123        183 KLSVIDLHRAQ  193 (268)
T ss_pred             eEEEEECCccc
Confidence            78999999874

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.07  E-value=7.4e-09  Score=95.44  Aligned_cols=163  Identities=13%  Similarity=0.166  Sum_probs=122.4

Q ss_pred             CeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeee----eCCccEEEEEeccC-Ccccc
Q 019536           68 SYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCL----ETELPTLVFESVKY-GTLRG  142 (339)
Q Consensus        68 ~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~----~~~~~~lv~e~~~~-g~L~~  142 (339)
                      -.+.|++...-+|..|++|+++.... ........-++.++++.|+|+|.|-+++.    .+..+++|++|.|+ ++|.+
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~-~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRD-QSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccc-cCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            45789999999999999999954322 22212224577889999999999999887    34567899999987 46666


Q ss_pred             ccc-----------------cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccC
Q 019536          143 FSF-----------------ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIP  205 (339)
Q Consensus       143 ~~~-----------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~  205 (339)
                      ...                 ...++...|.++.|+..||.++|   +.|+.-+-|.+.+|+++.+.+++|+.-|....+.
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence            532                 23566778999999999999999   8898889999999999988888888777655443


Q ss_pred             CCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCC
Q 019536          206 EGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGC  253 (339)
Q Consensus       206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~  253 (339)
                      .+...                .+.   --.+-|.=.||.++..|.+|.
T Consensus       445 ~d~~~----------------~le---~~Qq~D~~~lG~ll~aLAt~~  473 (655)
T KOG3741|consen  445 EDPTE----------------PLE---SQQQNDLRDLGLLLLALATGT  473 (655)
T ss_pred             CCCCc----------------chh---HHhhhhHHHHHHHHHHHhhcc
Confidence            33210                011   123468889999999999985

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.92  E-value=2.2e-07  Score=84.06  Aligned_cols=264  Identities=14%  Similarity=0.084  Sum_probs=159.2

Q ss_pred             ccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhc-CCCceeeeeeeee------e-CCccE
Q 019536           58 DLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCCL------E-TELPT  129 (339)
Q Consensus        58 ~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~------~-~~~~~  129 (339)
                      ...+.+|+|+.+.+|..-..   +..+.|+++........    +-+..|... .||-+-.=+.+=.      + +...-
T Consensus        14 ~~gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa~~a----qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iG   86 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPAAQA----QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIG   86 (637)
T ss_pred             CCCccccCCccceeeecchh---hchhheeecCCCchHHH----HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeE
Confidence            45678999999999975442   22345777765432211    223333433 5664322122211      1 11134


Q ss_pred             EEEEeccCC-ccccccc--------cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCC
Q 019536          130 LVFESVKYG-TLRGFSF--------ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSL  200 (339)
Q Consensus       130 lv~e~~~~g-~L~~~~~--------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~  200 (339)
                      +.|..+++- .+..+..        ....|...+..++.++.+..-||   ..|.+-+|+.++|+|++.++.+.|.|=..
T Consensus        87 flmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsDs  163 (637)
T COG4248          87 FLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSDS  163 (637)
T ss_pred             EecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcccc
Confidence            566666543 2333322        23567888899999999999999   88999999999999999999999997543


Q ss_pred             ccccCCCCceeeecccccccccccccccc-----cCCCCcccchHHHHHHHHHHHhC-CCccccCCCCCCCchhHHHHHH
Q 019536          201 SVSIPEGETHVREEFIKGAYGFIAPEYFA-----TSSFNEMCDVYSFGAFLCELLTG-CNVLEFKGNGNDDDLTVLEYAK  274 (339)
Q Consensus       201 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~el~~g-~~p~~~~~~~~~~~~~~~~~~~  274 (339)
                      -..- .+.....  ..+|...|.+||.-.     +-.-+...|.|.+|+++++++.| ++||..-...........    
T Consensus       164 fqi~-~ng~~~~--cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E----  236 (637)
T COG4248         164 FQIN-ANGTLHL--CPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE----  236 (637)
T ss_pred             eeec-cCCceEe--cccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch----
Confidence            2221 2222222  467889999999754     23345778999999999999886 999864221111111110    


Q ss_pred             HHhhcCccccccc---CcccCCCCCCCcHHHHHHHHHHHHHhhccC--CCCCCCHHHHHHHHHHHHhhcC
Q 019536          275 KSIENNRFGAIVD---PIFDEDNSFPGKEEKLQSLGQLMYKCLSKS--PEHRPLMVDVAKQLRQMYLSVV  339 (339)
Q Consensus       275 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~li~~cl~~d--P~~Rps~~~il~~L~~l~~~~~  339 (339)
                      ..+..+.+..-.+   ........+|- .....++..|..+|+..-  +.-|||+..-+..|..+.++++
T Consensus       237 ~~Ia~g~f~ya~~~~~g~~p~P~~~P~-~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~  305 (637)
T COG4248         237 TDIAHGRFAYASDQRRGLKPPPRSIPL-SMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLK  305 (637)
T ss_pred             hhhhcceeeechhccCCCCCCCCCCCh-hhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhh
Confidence            0111111111111   11111122221 244567778888888754  5689999999999998887763

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.88  E-value=2e-08  Score=85.99  Aligned_cols=142  Identities=15%  Similarity=0.051  Sum_probs=100.7

Q ss_pred             HHHHHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCCh---------------------hhHHHHHHHHHHH
Q 019536           49 DLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTL---------------------DDVEYCFNNIVFS  107 (339)
Q Consensus        49 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---------------------~~~~~~~~e~~~l  107 (339)
                      .+.....-+.+...||.|.-+.||.|... .|.++|||.-+...+.                     -......+|..+|
T Consensus        85 ~l~~r~~ve~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L  163 (304)
T COG0478          85 ALVKRGIVEAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEAL  163 (304)
T ss_pred             HHHHcChHHhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHH
Confidence            33333345677899999999999999997 7899999965432110                     0123456899999


Q ss_pred             HhcCCC--ceeeeeeeeeeCCccEEEEEeccCCccccccccCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCE
Q 019536          108 SQMKHK--NILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNV  185 (339)
Q Consensus       108 ~~l~H~--niv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Ni  185 (339)
                      .+|.-.  .+.+.+++-    .-.+||||++|-.|...-.   .....-.++..|+.-+.-+-   ..|++|+|+++-||
T Consensus       164 ~~L~~~G~~VP~P~~~n----RHaVvMe~ieG~eL~~~r~---~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNI  233 (304)
T COG0478         164 QRLYPEGVKVPKPIAWN----RHAVVMEYIEGVELYRLRL---DVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNI  233 (304)
T ss_pred             HHhhhcCCCCCCccccc----cceeeeehcccceeecccC---cccCHHHHHHHHHHHHHHHH---HcCccccCCchheE
Confidence            998543  566666543    3479999999877655432   23333445555666555555   58899999999999


Q ss_pred             EeCCCCceEEecCCCc
Q 019536          186 LLDENYSAKLHDFSLS  201 (339)
Q Consensus       186 l~~~~~~~kl~dfg~a  201 (339)
                      +++++|.+.++||=-+
T Consensus       234 lV~~dg~~~vIDwPQ~  249 (304)
T COG0478         234 LVTEDGDIVVIDWPQA  249 (304)
T ss_pred             EEecCCCEEEEeCccc
Confidence            9999999999999644

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.87  E-value=5.2e-10  Score=106.20  Aligned_cols=150  Identities=20%  Similarity=0.330  Sum_probs=102.9

Q ss_pred             HHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceeeec-------cccccccccccccccc
Q 019536          158 MEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREE-------FIKGAYGFIAPEYFAT  230 (339)
Q Consensus       158 ~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~~-------~~~gt~~y~aPE~~~~  230 (339)
                      .+++.|+.|+|.  +.++||++|.|++|.++.++..|++.|+.+.............       .......|.|||++.+
T Consensus       106 ~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            455599999996  7889999999999999999999999999876544322111110       1223456999999998


Q ss_pred             CCCCcccchHHHHHHHHHHH-hCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHH
Q 019536          231 SSFNEMCDVYSFGAFLCELL-TGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQL  309 (339)
Q Consensus       231 ~~~~~~~DiwslG~~l~el~-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  309 (339)
                      ...+.++|++|+|+++|.+. .|+..+...+........      ....        +     -..+-.....+.++++=
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~------~~~~--------~-----~~~~~~s~~~p~el~~~  244 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFS------RNLL--------N-----AGAFGYSNNLPSELRES  244 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhh------hccc--------c-----cccccccccCcHHHHHH
Confidence            88889999999999999998 566655433322211000      0000        0     00001113455678899


Q ss_pred             HHHhhccCCCCCCCHHHHH
Q 019536          310 MYKCLSKSPEHRPLMVDVA  328 (339)
Q Consensus       310 i~~cl~~dP~~Rps~~~il  328 (339)
                      +.+++..++.-||++..+.
T Consensus       245 l~k~l~~~~~~rp~~~~l~  263 (700)
T KOG2137|consen  245 LKKLLNGDSAVRPTLDLLL  263 (700)
T ss_pred             HHHHhcCCcccCcchhhhh
Confidence            9999999999999776654

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.78  E-value=6.6e-08  Score=81.94  Aligned_cols=132  Identities=15%  Similarity=0.055  Sum_probs=92.8

Q ss_pred             eeEEEEEEc---CCCeeEEEEEeccCCCh------hhHHHHHHHHHHHHhcCC--CceeeeeeeeeeCC----ccEEEEE
Q 019536           69 YRLFEGTLV---DQDRPISVMKFHDNSTL------DDVEYCFNNIVFSSQMKH--KNILKLIGCCLETE----LPTLVFE  133 (339)
Q Consensus        69 g~V~~~~~~---~~~~~vavK~~~~~~~~------~~~~~~~~e~~~l~~l~H--~niv~~~~~~~~~~----~~~lv~e  133 (339)
                      +.++.+...   ..++.+-+|........      -......+|...+..+..  =.+++.+++.....    ..+||+|
T Consensus        18 ~~~~~~~~~~~~~~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite   97 (206)
T PF06293_consen   18 RGGWFGVQRVVDLVGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITE   97 (206)
T ss_pred             ceEEEEEEccccccceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEE
Confidence            344544443   24556666654332111      133456788887777743  23556666665532    3479999


Q ss_pred             eccCC-cccccccc--CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCC---ceEEecCCCccc
Q 019536          134 SVKYG-TLRGFSFA--SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENY---SAKLHDFSLSVS  203 (339)
Q Consensus       134 ~~~~g-~L~~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~---~~kl~dfg~a~~  203 (339)
                      ++++. +|.+++..  ..+......++.+++..+.-||   ..||+|+|+++.|||++.+.   .+.++||+.++.
T Consensus        98 ~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen   98 ALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             eCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            99874 78888763  3555667789999999999999   99999999999999999876   799999997654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.67  E-value=6.3e-07  Score=76.14  Aligned_cols=155  Identities=11%  Similarity=0.094  Sum_probs=102.5

Q ss_pred             ccccHHHHHHHhcCcccCCcee---ccCCeeEEEEEEcCCCeeEEEEEeccCCChh-----------------------h
Q 019536           43 RAFSAKDLKKATNNYDLHKVIQ---SDTSYRLFEGTLVDQDRPISVMKFHDNSTLD-----------------------D   96 (339)
Q Consensus        43 ~~~~~~~~~~~~~~~~~~~~ig---~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----------------------~   96 (339)
                      ...+...+....+...+....|   +|.-+.||+|... ++..+|+|++......-                       .
T Consensus        33 D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~-~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv  111 (268)
T COG1718          33 DKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETG-DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLV  111 (268)
T ss_pred             hhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccC-CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHH
Confidence            3456677777777777776666   5556689999874 78899999987542210                       1


Q ss_pred             HHHHHHHHHHHHhcC--CCceeeeeeeeeeCCccEEEEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCC
Q 019536           97 VEYCFNNIVFSSQMK--HKNILKLIGCCLETELPTLVFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFD  172 (339)
Q Consensus        97 ~~~~~~e~~~l~~l~--H~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~  172 (339)
                      ..+...|+.-|+++.  +-.+.+-+++.    .-.|||||+.......-..  -.+...+...+..+++..+.-|-.  .
T Consensus       112 ~~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~--~  185 (268)
T COG1718         112 FAWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYK--E  185 (268)
T ss_pred             HHHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHH--h
Confidence            123346777776663  33444445443    2469999996542111111  122222466677788888766662  4


Q ss_pred             CCeEEccCCCCCEEeCCCCceEEecCCCccccC
Q 019536          173 RPIVFRCIKASNVLLDENYSAKLHDFSLSVSIP  205 (339)
Q Consensus       173 ~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~  205 (339)
                      .+++|+||+.-|||+. ++.+.++|||-|....
T Consensus       186 a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         186 AGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             cCcccccchhhheEEE-CCeEEEEECccccccC
Confidence            8999999999999999 7899999999876543

>PRK09902 hypothetical protein; Provisional

Probab=98.67  E-value=5.1e-07  Score=75.53  Aligned_cols=135  Identities=10%  Similarity=0.034  Sum_probs=98.9

Q ss_pred             eeccCCeeEEEEEEcCCCeeEEEEEeccC--CC---hhhHHHHHHHHHHHHhcCCC--ceeeeeeeee-eC----CccEE
Q 019536           63 IQSDTSYRLFEGTLVDQDRPISVMKFHDN--ST---LDDVEYCFNNIVFSSQMKHK--NILKLIGCCL-ET----ELPTL  130 (339)
Q Consensus        63 ig~G~~g~V~~~~~~~~~~~vavK~~~~~--~~---~~~~~~~~~e~~~l~~l~H~--niv~~~~~~~-~~----~~~~l  130 (339)
                      -|.||.+-|++...  .|..+-+|+-.+-  .+   +.....|.+|+..+..+..-  .+.+.+ ++. ..    -..+|
T Consensus        26 ~~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L  102 (216)
T PRK09902         26 YRRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL  102 (216)
T ss_pred             cCCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence            45688889999887  4556888876421  11   24678899999999988532  344555 332 11    12579


Q ss_pred             EEEeccC-Cccccccc----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCc--eEEecCCCccc
Q 019536          131 VFESVKY-GTLRGFSF----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYS--AKLHDFSLSVS  203 (339)
Q Consensus       131 v~e~~~~-g~L~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~--~kl~dfg~a~~  203 (339)
                      |+|-+++ -+|.+++.    ...+...+..++.+++..+.-||   ..|+.|+|+-+.||+++.++.  ++++||.-++.
T Consensus       103 VTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        103 VTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            9998754 46777764    23456667789999999999999   999999999999999986666  99999987643

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.50  E-value=1.4e-06  Score=82.97  Aligned_cols=143  Identities=12%  Similarity=0.072  Sum_probs=93.3

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhH-------------------------------------
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDV-------------------------------------   97 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-------------------------------------   97 (339)
                      ..|.. .-|++++-|.||+|+.+ +|+.||||+.+++....-.                                     
T Consensus       126 ~eF~~-~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~  203 (517)
T COG0661         126 SEFEP-EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLR  203 (517)
T ss_pred             HHcCC-CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHH
Confidence            44543 68899999999999998 5999999998875332100                                     


Q ss_pred             --HHHHHHHHHHHhcC-----CCceeeeeeeeee-CCccEEEEEeccCCccccccc---cCCChHHHHHHHHHHHHH-HH
Q 019536           98 --EYCFNNIVFSSQMK-----HKNILKLIGCCLE-TELPTLVFESVKYGTLRGFSF---ASLLIAPRIKIAMEIANA-VA  165 (339)
Q Consensus        98 --~~~~~e~~~l~~l~-----H~niv~~~~~~~~-~~~~~lv~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~-l~  165 (339)
                        -++.+|...+.+++     .++ +.+-.++.+ .....|+|||++|-.+.+...   ...+...   ++..++.+ +.
T Consensus       204 ~ElDy~~EA~n~~~~~~nf~~~~~-v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~---ia~~~~~~f~~  279 (517)
T COG0661         204 EELDYRREAANAERFRENFKDDPD-VYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKE---LAELLVRAFLR  279 (517)
T ss_pred             HHhCHHHHHHHHHHHHHHcCCCCC-eEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHH---HHHHHHHHHHH
Confidence              01133444333332     222 233333332 345679999999988888743   3344222   33333332 22


Q ss_pred             HHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCC
Q 019536          166 YLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPE  206 (339)
Q Consensus       166 ~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~  206 (339)
                      .+-   ..|..|.|.-|.||+++.+|.+-+.|||+...+.+
T Consensus       280 q~~---~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         280 QLL---RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             HHH---hcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            333   56899999999999999999999999999877654

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.45  E-value=2.7e-08  Score=93.94  Aligned_cols=183  Identities=13%  Similarity=0.012  Sum_probs=131.9

Q ss_pred             CcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCc-eeeeeeeeeeCCccEEEEEe
Q 019536           56 NYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKN-ILKLIGCCLETELPTLVFES  134 (339)
Q Consensus        56 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~n-iv~~~~~~~~~~~~~lv~e~  134 (339)
                      .+...+-++.|+.+.+++.+...+...+ .+.+...      ....-++++|.+++||| .+..++.+...+..++++++
T Consensus       243 ws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i  315 (829)
T KOG0576|consen  243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRI  315 (829)
T ss_pred             chHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhh
Confidence            3444455678889999988775433333 4544332      33456889999999999 77888888888889999999


Q ss_pred             ccCC-ccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCce
Q 019536          135 VKYG-TLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH  210 (339)
Q Consensus       135 ~~~g-~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~  210 (339)
                      +.+| +-.....   -.+..-+...+.+.-.++++++|   +..=+|+|    ||+..+ +..+..||+....+....  
T Consensus       316 ~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~---~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--  385 (829)
T KOG0576|consen  316 CSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELH---SSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--  385 (829)
T ss_pred             hcCCccccccCChhhHhhhhhhhhhhhhhhcccccccc---cccccCcc----cccccc-cccccccccCCcccCccc--
Confidence            9887 3222221   12222233456777788999999   55567888    777664 678999999887665543  


Q ss_pred             eeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCcc
Q 019536          211 VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVL  256 (339)
Q Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~  256 (339)
                       ......+++.++|||+.....+....|.|++|.-..++.-|-+|-
T Consensus       386 -~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  386 -KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             -ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence             222467899999999999999999999999998777777777664

>PLN02876 acyl-CoA dehydrogenase

Probab=98.45  E-value=4.2e-06  Score=85.38  Aligned_cols=82  Identities=10%  Similarity=0.057  Sum_probs=58.5

Q ss_pred             CCceeccCCeeEEEEEEcCCC--eeEEEEEeccCCChhhHHHHHHHHHHHHhcC-CCce--eeeeeeeeeC---CccEEE
Q 019536           60 HKVIQSDTSYRLFEGTLVDQD--RPISVMKFHDNSTLDDVEYCFNNIVFSSQMK-HKNI--LKLIGCCLET---ELPTLV  131 (339)
Q Consensus        60 ~~~ig~G~~g~V~~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-H~ni--v~~~~~~~~~---~~~~lv  131 (339)
                      ...++.|.+..+|.......+  ..+++|+............+.+|..+++.+. |+++  .+++.+|.+.   +..++|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            466788999999998775332  4677777654432233456779999999995 6665  7888888764   457899


Q ss_pred             EEeccCCccc
Q 019536          132 FESVKYGTLR  141 (339)
Q Consensus       132 ~e~~~~g~L~  141 (339)
                      |||++|..+.
T Consensus       123 ME~v~G~~~~  132 (822)
T PLN02876        123 MEYLEGRIFV  132 (822)
T ss_pred             EEecCCcccC
Confidence            9999886543

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.43  E-value=4.7e-06  Score=71.57  Aligned_cols=134  Identities=7%  Similarity=-0.053  Sum_probs=83.5

Q ss_pred             CceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCc--eeeeeeeeeeCCccEEEEEeccCC
Q 019536           61 KVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKN--ILKLIGCCLETELPTLVFESVKYG  138 (339)
Q Consensus        61 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~n--iv~~~~~~~~~~~~~lv~e~~~~g  138 (339)
                      ..||+|..+.||+.    .+..+++|.......   .....+|.++++.+..-.  +.+.+++..+++...+|||+++|.
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~---~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~   79 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFD---KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK   79 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCCC---HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence            57899999999983    244677888765432   344578999998885433  467788887777788999999886


Q ss_pred             c-cccccc--------------------c-----CCChHHHH-HHHH----------HHHHH-HHHHhc-CCCCCeEEcc
Q 019536          139 T-LRGFSF--------------------A-----SLLIAPRI-KIAM----------EIANA-VAYLHV-GFDRPIVFRC  179 (339)
Q Consensus       139 ~-L~~~~~--------------------~-----~~~~~~~~-~i~~----------~i~~~-l~~LH~-~~~~~i~H~d  179 (339)
                      + +.....                    .     ..+..... .+..          .+... ..+|.. .....++|+|
T Consensus        80 ~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD  159 (226)
T TIGR02172        80 RSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD  159 (226)
T ss_pred             cchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence            3 111110                    0     01111100 0000          01111 122221 1134578999


Q ss_pred             CCCCCEEeCCCCceEEecCCCcc
Q 019536          180 IKASNVLLDENYSAKLHDFSLSV  202 (339)
Q Consensus       180 lk~~Nil~~~~~~~kl~dfg~a~  202 (339)
                      +.|.||+++.++ +.++||+.+.
T Consensus       160 ~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       160 FQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCCCcEEEcCCC-cEEEechhcC
Confidence            999999999887 9999999764

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.41  E-value=1.7e-05  Score=66.01  Aligned_cols=98  Identities=21%  Similarity=0.209  Sum_probs=81.7

Q ss_pred             HHHHHHHhcCC-CceeeeeeeeeeCCccEEEEEeccCCcccccc----c-cCCChHHHHHHHHHHHHHHHHHhcCCCCCe
Q 019536          102 NNIVFSSQMKH-KNILKLIGCCLETELPTLVFESVKYGTLRGFS----F-ASLLIAPRIKIAMEIANAVAYLHVGFDRPI  175 (339)
Q Consensus       102 ~e~~~l~~l~H-~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~~----~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i  175 (339)
                      +|.-++..+++ +++++++|+|-    .++|.||.+.+++.+..    . ...+|..+.+|+.+++..+.++++.....+
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~   83 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF   83 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence            68888888976 69999999994    36799999887664321    1 357899999999999999999997666778


Q ss_pred             EEccCCCCCEEeCCCCceEEecCCCccc
Q 019536          176 VFRCIKASNVLLDENYSAKLHDFSLSVS  203 (339)
Q Consensus       176 ~H~dlk~~Nil~~~~~~~kl~dfg~a~~  203 (339)
                      .-.|++++|+-+++++.+|++|...+-.
T Consensus        84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   84 YLCDVSPDNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             EEeecchHHeEEeCCCcEEEEechhcch
Confidence            8999999999999999999999987543

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.39  E-value=5.5e-06  Score=72.07  Aligned_cols=134  Identities=10%  Similarity=-0.047  Sum_probs=81.9

Q ss_pred             eeccCC-eeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcC-CCceeeeeeeeeeCCccEEEEEeccCCcc
Q 019536           63 IQSDTS-YRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMK-HKNILKLIGCCLETELPTLVFESVKYGTL  140 (339)
Q Consensus        63 ig~G~~-g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~g~L  140 (339)
                      |..|.. ..||+....  +..+.+|......    .....+|+.+++.+. +--+.+++++...++..++|||+++|.++
T Consensus         6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l   79 (244)
T cd05150           6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGP----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA   79 (244)
T ss_pred             cCCCCCcCeEEEEcCC--CCcEEEEecCCCc----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence            444544 788998763  4677788775542    234557888888773 44466788887776678999999999776


Q ss_pred             ccccc------------------cCC-----ChH----HHHHHHH--------------------HHHHHHHHHh----c
Q 019536          141 RGFSF------------------ASL-----LIA----PRIKIAM--------------------EIANAVAYLH----V  169 (339)
Q Consensus       141 ~~~~~------------------~~~-----~~~----~~~~i~~--------------------~i~~~l~~LH----~  169 (339)
                      .....                  ..+     +..    .......                    .+...+..|-    .
T Consensus        80 ~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  159 (244)
T cd05150          80 AALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPA  159 (244)
T ss_pred             hHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCC
Confidence            54310                  011     100    0000000                    0111112221    0


Q ss_pred             CCCCCeEEccCCCCCEEeCCCCceEEecCCCcc
Q 019536          170 GFDRPIVFRCIKASNVLLDENYSAKLHDFSLSV  202 (339)
Q Consensus       170 ~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~  202 (339)
                      .....++|+|+.|.|||++.++...|+||+.+.
T Consensus       160 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         160 EEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             cCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            113458999999999999987778899999763

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.32  E-value=1.7e-05  Score=66.80  Aligned_cols=137  Identities=14%  Similarity=0.108  Sum_probs=89.4

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhh--HHHH------HHHHHHHHhcC---CCceeeeeeee
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDD--VEYC------FNNIVFSSQMK---HKNILKLIGCC  122 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--~~~~------~~e~~~l~~l~---H~niv~~~~~~  122 (339)
                      .++|...+++.......|.+-..  +|..+.+|.........+  ...|      .+.+..+..+.   -.....++.+.
T Consensus        30 ~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   30 DNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             hCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            46788888887777666666666  788999998776543211  1111      23333333332   22233333333


Q ss_pred             ee-----CCccEEEEEeccCCccccccccCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEec
Q 019536          123 LE-----TELPTLVFESVKYGTLRGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHD  197 (339)
Q Consensus       123 ~~-----~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~d  197 (339)
                      ..     ....+++|||++|..|.+...  ++.    .+...++.++.-+|   ..|+.|+|..|.|++++.+ .++++|
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~--i~e----~~~~ki~~~ikqlH---~~G~~HGD~hpgNFlv~~~-~i~iID  177 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED--IDE----DLAEKIVEAIKQLH---KHGFYHGDPHPGNFLVSNN-GIRIID  177 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh--cCH----HHHHHHHHHHHHHH---HcCCccCCCCcCcEEEECC-cEEEEE
Confidence            22     223468999999988876632  221    24566778899999   9999999999999999855 499999


Q ss_pred             CCCcc
Q 019536          198 FSLSV  202 (339)
Q Consensus       198 fg~a~  202 (339)
                      |+..+
T Consensus       178 ~~~k~  182 (229)
T PF06176_consen  178 TQGKR  182 (229)
T ss_pred             Ccccc
Confidence            98653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.31  E-value=9.1e-06  Score=69.77  Aligned_cols=136  Identities=14%  Similarity=0.159  Sum_probs=81.0

Q ss_pred             CceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCC--ceeeeeeeeee---CCccEEEEEec
Q 019536           61 KVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHK--NILKLIGCCLE---TELPTLVFESV  135 (339)
Q Consensus        61 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~--niv~~~~~~~~---~~~~~lv~e~~  135 (339)
                      +.++.|..+.||.....+  ..+++|.....   .....+.+|..++..+...  .+.+++.....   ....+++|+++
T Consensus         3 ~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~---~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i   77 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD--GRYVLKFYRPP---DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI   77 (239)
T ss_dssp             EEEEESSSSEEEEEEETT--SEEEEEEESSH---HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred             ccCCCCCeeeEEEEEECC--cEEEEEEeCCC---CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence            568899999999999853  58889987653   3456677888888888432  35677765433   33468999999


Q ss_pred             cCCccccc----------------cc----c-----CCChHHH--H-------HH------------HHHHHH-HHHHHh
Q 019536          136 KYGTLRGF----------------SF----A-----SLLIAPR--I-------KI------------AMEIAN-AVAYLH  168 (339)
Q Consensus       136 ~~g~L~~~----------------~~----~-----~~~~~~~--~-------~i------------~~~i~~-~l~~LH  168 (339)
                      ++.++...                +.    .     .......  .       ..            ...+.. .+..++
T Consensus        78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (239)
T PF01636_consen   78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE  157 (239)
T ss_dssp             SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence            99887770                00    0     0010000  0       00            111222 222222


Q ss_pred             ----cCCCCCeEEccCCCCCEEeC-CCCceEEecCCCc
Q 019536          169 ----VGFDRPIVFRCIKASNVLLD-ENYSAKLHDFSLS  201 (339)
Q Consensus       169 ----~~~~~~i~H~dlk~~Nil~~-~~~~~kl~dfg~a  201 (339)
                          ......++|+|+.|.||+++ +++.+-++||+.+
T Consensus       158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a  195 (239)
T PF01636_consen  158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDA  195 (239)
T ss_dssp             HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-
T ss_pred             hhhccCCCcEEEEeccccccceeeeccceeEEEecccc
Confidence                11256799999999999999 6666689999875

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.18  E-value=1.9e-05  Score=75.16  Aligned_cols=140  Identities=11%  Similarity=0.036  Sum_probs=89.0

Q ss_pred             CceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhH------------------------------------HHHHHHH
Q 019536           61 KVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDV------------------------------------EYCFNNI  104 (339)
Q Consensus        61 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~------------------------------------~~~~~e~  104 (339)
                      +.||..+.|.||+|+.+ +|+.||||+-++.-.....                                    -+|.+|.
T Consensus       167 ~piaaASlaQVhrA~L~-~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLK-NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEEec-CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            68999999999999999 5999999998765332100                                    0123333


Q ss_pred             HH----HHhcCCCce---eeeeeeeee-CCccEEEEEeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCC
Q 019536          105 VF----SSQMKHKNI---LKLIGCCLE-TELPTLVFESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDR  173 (339)
Q Consensus       105 ~~----l~~l~H~ni---v~~~~~~~~-~~~~~lv~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~  173 (339)
                      +-    .+.+.|-+.   |.+-.++.+ .....|+|||++|..+.|.-.   ..++...+..-+.+...-+  +-   ..
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~q--If---~~  320 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQ--IF---KT  320 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHH--HH---hc
Confidence            32    223345551   112222222 234679999999988777643   4455444333333332222  22   46


Q ss_pred             CeEEccCCCCCEEeCC----CCceEEecCCCccccCC
Q 019536          174 PIVFRCIKASNVLLDE----NYSAKLHDFSLSVSIPE  206 (339)
Q Consensus       174 ~i~H~dlk~~Nil~~~----~~~~kl~dfg~a~~~~~  206 (339)
                      |.+|+|=-|-||++..    ++.+.+.|||+...+..
T Consensus       321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             CCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            7999999999999983    67799999999876544

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.15  E-value=3.4e-05  Score=64.15  Aligned_cols=127  Identities=20%  Similarity=0.198  Sum_probs=92.0

Q ss_pred             hcCcccCCceeccCC-eeEEEEEEcCCCeeEEEEEecc---CCCh-----------------hhHHHHHHHHHHHHhcC-
Q 019536           54 TNNYDLHKVIQSDTS-YRLFEGTLVDQDRPISVMKFHD---NSTL-----------------DDVEYCFNNIVFSSQMK-  111 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~-g~V~~~~~~~~~~~vavK~~~~---~~~~-----------------~~~~~~~~e~~~l~~l~-  111 (339)
                      +.+++..+.||.|.. |.||++..  +|+.+|+|.+..   ....                 ...+-|..|.+...+|+ 
T Consensus        36 ~~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke  113 (207)
T PF13095_consen   36 GDDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKE  113 (207)
T ss_pred             CCcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHh
Confidence            378999999999999 99999999  788999999322   1100                 11234778888777774 


Q ss_pred             --CCce--eeeeeeeeeC------------------CccEEEEEeccCCccccccccCCChHHHHHHHHHHHHHHHHHhc
Q 019536          112 --HKNI--LKLIGCCLET------------------ELPTLVFESVKYGTLRGFSFASLLIAPRIKIAMEIANAVAYLHV  169 (339)
Q Consensus       112 --H~ni--v~~~~~~~~~------------------~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~i~~~i~~~l~~LH~  169 (339)
                        +.++  |+.+||..-.                  ....||.||.+...       .+    ...-+.+|.+-+..+| 
T Consensus       114 ~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------~~----~~~~~~~~~~dl~~~~-  181 (207)
T PF13095_consen  114 AGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------PL----QIRDIPQMLRDLKILH-  181 (207)
T ss_pred             ccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------cc----chhHHHHHHHHHHHHH-
Confidence              4456  8889987322                  12357888776543       11    1234567888889999 


Q ss_pred             CCCCCeEEccCCCCCEEeCCCCceEEecCCCc
Q 019536          170 GFDRPIVFRCIKASNVLLDENYSAKLHDFSLS  201 (339)
Q Consensus       170 ~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a  201 (339)
                        ..||+-+|+++.|..   +  -+|+|||.+
T Consensus       182 --k~gI~~~Dv~~~ny~---~--G~lvDfs~~  206 (207)
T PF13095_consen  182 --KLGIVPRDVKPRNYR---G--GKLVDFSSS  206 (207)
T ss_pred             --HCCeeeccCcccccc---C--CEEEecccC
Confidence              999999999999986   2  399999864

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.13  E-value=2.2e-05  Score=63.42  Aligned_cols=130  Identities=9%  Similarity=0.047  Sum_probs=89.3

Q ss_pred             cccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCcee-eeeeeeeeCCccEEEEEec
Q 019536           57 YDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNIL-KLIGCCLETELPTLVFESV  135 (339)
Q Consensus        57 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv-~~~~~~~~~~~~~lv~e~~  135 (339)
                      ......|+.|++|.||+|.+  .|..+|+|+-..++.   ...+..|.++|..+.-.++. +++.+-.+    ++.|||+
T Consensus        24 ~~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds~---r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i   94 (201)
T COG2112          24 LRVEKELAKGTTSVVYLGEW--RGGEVALKVRRRDSP---RRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYI   94 (201)
T ss_pred             hhhhhhhhcccccEEEEeec--cCceEEEEEecCCcc---hhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhh
Confidence            34457899999999999999  677899998766543   45566899999988765553 45544332    3569999


Q ss_pred             cCCccccccccCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCC-CCCEEeCCCCceEEecCCCccc
Q 019536          136 KYGTLRGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIK-ASNVLLDENYSAKLHDFSLSVS  203 (339)
Q Consensus       136 ~~g~L~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk-~~Nil~~~~~~~kl~dfg~a~~  203 (339)
                      .|-.|.+.-... .    .+-+..+++.---|-   ..||-|..|. |...++..++.+.|+||..|+.
T Consensus        95 ~G~~L~~~~~~~-~----rk~l~~vlE~a~~LD---~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          95 DGRPLGKLEIGG-D----RKHLLRVLEKAYKLD---RLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             cCcchhhhhhcc-c----HHHHHHHHHHHHHHH---HhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            987886664322 1    223344455534444   6778888875 4555555566899999998863

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.13  E-value=6.4e-05  Score=62.92  Aligned_cols=132  Identities=16%  Similarity=0.175  Sum_probs=87.8

Q ss_pred             cCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC---------------ChhhHHHHHHHHHHHHhcC------CCceee
Q 019536           59 LHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS---------------TLDDVEYCFNNIVFSSQMK------HKNILK  117 (339)
Q Consensus        59 ~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---------------~~~~~~~~~~e~~~l~~l~------H~niv~  117 (339)
                      -...||+|+.-.||.--   .+....||+.....               .........+|+.....+.      +.+|.+
T Consensus         5 ~~~~i~~G~~R~cy~HP---~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r   81 (199)
T PF10707_consen    5 ESDLIAQGGERDCYQHP---DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPR   81 (199)
T ss_pred             CCcccccCCCceEEECC---CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccccc
Confidence            35689999999988743   33446688877654               0012345566766655555      889999


Q ss_pred             eeeeeeeCCccEEEEEeccCC------cccccccc-CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCC
Q 019536          118 LIGCCLETELPTLVFESVKYG------TLRGFSFA-SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDEN  190 (339)
Q Consensus       118 ~~~~~~~~~~~~lv~e~~~~g------~L~~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~  190 (339)
                      ++|+.+++--.-+|+|.+.+.      +|.+++.. .++. .....+.++   ..||-   ...|+.+|++|.||++...
T Consensus        82 ~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~-~~~~~L~~f---~~~l~---~~~Iv~~dl~~~NIv~~~~  154 (199)
T PF10707_consen   82 FYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGGLTE-ELRQALDEF---KRYLL---DHHIVIRDLNPHNIVVQRR  154 (199)
T ss_pred             EeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCCccH-HHHHHHHHH---HHHHH---HcCCeecCCCcccEEEEec
Confidence            999999988888999987543      35555542 3333 333333333   35555   6779999999999999532


Q ss_pred             ---C-ceEEec-CCC
Q 019536          191 ---Y-SAKLHD-FSL  200 (339)
Q Consensus       191 ---~-~~kl~d-fg~  200 (339)
                         . .+.|+| ||.
T Consensus       155 ~~~~~~lvlIDG~G~  169 (199)
T PF10707_consen  155 DSGEFRLVLIDGLGE  169 (199)
T ss_pred             CCCceEEEEEeCCCC
Confidence               2 577887 554

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.10  E-value=5.4e-05  Score=65.50  Aligned_cols=75  Identities=11%  Similarity=0.007  Sum_probs=45.6

Q ss_pred             CceeccCCe-eEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCC---ceeeeeeeeeeC---CccEEEEE
Q 019536           61 KVIQSDTSY-RLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHK---NILKLIGCCLET---ELPTLVFE  133 (339)
Q Consensus        61 ~~ig~G~~g-~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~---niv~~~~~~~~~---~~~~lv~e  133 (339)
                      +.|+.|+.. .||+.     +..+.+|.....   .....+.+|..++..+...   -+.++++.....   ...+++|+
T Consensus         3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~~---~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~   74 (235)
T cd05155           3 EPVDSGGTDNATFRL-----GDDMSVRLPSAA---GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYR   74 (235)
T ss_pred             eeccCCCcccceEEc-----CCceEEEcCCcc---chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEE
Confidence            456766666 48875     124566765432   2344677899988887532   344555544332   23588999


Q ss_pred             eccCCccccc
Q 019536          134 SVKYGTLRGF  143 (339)
Q Consensus       134 ~~~~g~L~~~  143 (339)
                      +++|.++.+.
T Consensus        75 ~i~G~~l~~~   84 (235)
T cd05155          75 WLEGETATAA   84 (235)
T ss_pred             eecCCCCCcc
Confidence            9999877533

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PRK10593 hypothetical protein; Provisional

Probab=97.93  E-value=0.00034  Score=62.72  Aligned_cols=76  Identities=11%  Similarity=-0.018  Sum_probs=54.4

Q ss_pred             CCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCC---CceeeeeeeeeeC---CccEEEEE
Q 019536           60 HKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKH---KNILKLIGCCLET---ELPTLVFE  133 (339)
Q Consensus        60 ~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H---~niv~~~~~~~~~---~~~~lv~e  133 (339)
                      .+.||.|..+.||..... ++ .+.+|..+...   ....+.+|...|+.+.-   -.+.+++++|..+   +..+||||
T Consensus        19 ~~~i~~G~~~~vy~~~~~-~~-~~~~k~~~~~~---~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE   93 (297)
T PRK10593         19 VECISEQPYAALWALYDS-QG-NPMPLMARSFS---TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE   93 (297)
T ss_pred             eeecCCccceeEEEEEcC-CC-CEEEEEecccc---cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence            467999999999998763 23 46566644321   22466789988888842   3678888887643   56799999


Q ss_pred             eccCCcc
Q 019536          134 SVKYGTL  140 (339)
Q Consensus       134 ~~~~g~L  140 (339)
                      +++++++
T Consensus        94 ~i~G~~~  100 (297)
T PRK10593         94 RLRGVSV  100 (297)
T ss_pred             ccCCEec
Confidence            9998765

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.88  E-value=4e-05  Score=77.65  Aligned_cols=191  Identities=19%  Similarity=0.212  Sum_probs=127.7

Q ss_pred             HHHHHHHhcCCCceeeeeeeeeeCCc----cEEEEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCe
Q 019536          102 NNIVFSSQMKHKNILKLIGCCLETEL----PTLVFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPI  175 (339)
Q Consensus       102 ~e~~~l~~l~H~niv~~~~~~~~~~~----~~lv~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i  175 (339)
                      -|...+..+.|+|++.+++|-.....    ..+..|+|..-++...+.  ...+..+.+.+..++.+||.|+|   +...
T Consensus       231 ~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h---~~~l  307 (1351)
T KOG1035|consen  231 IELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLH---SLSL  307 (1351)
T ss_pred             HHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHH---Hhcc
Confidence            45667788899999999998765432    234557887777777776  67888888889999999999999   5544


Q ss_pred             EEccCCCC---CEEeCCCCceEEe--cCCCccccCCCCceeeecccccccccccccccccCCCCc--ccchHHHHHHHHH
Q 019536          176 VFRCIKAS---NVLLDENYSAKLH--DFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNE--MCDVYSFGAFLCE  248 (339)
Q Consensus       176 ~H~dlk~~---Nil~~~~~~~kl~--dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~DiwslG~~l~e  248 (339)
                      .|.-+...   +--.+..+.....  ||+.++.++.......   ...+..+.+||......+..  ..|+|.+|.....
T Consensus       308 ~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~---~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~  384 (1351)
T KOG1035|consen  308 EHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS---DLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQ  384 (1351)
T ss_pred             ceeEEecccccccccCccceeecchhhhcccccCCCcccchh---hcCccccccccccccccchhhhhhHHHHHHHHHhh
Confidence            44444333   3333445556666  8888777665443321   22334477888877666554  4799999999999


Q ss_pred             HHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 019536          249 LLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVA  328 (339)
Q Consensus       249 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il  328 (339)
                      +..|..+-....                    ....+++.            .......+...+|+.-++++|+++.+++
T Consensus       385 ~~~~~~i~~~~~--------------------~~~~~l~~------------~~~~~~~d~~~~~~~~~~~~Rl~~~~ll  432 (1351)
T KOG1035|consen  385 LSQGEDISEKSA--------------------VPVSLLDV------------LSTSELLDALPKCLDEDSEERLSALELL  432 (1351)
T ss_pred             hhhcCccccccc--------------------chhhhhcc------------ccchhhhhhhhhhcchhhhhccchhhhh
Confidence            888755421000                    00000000            1111467888999999999999999988


Q ss_pred             HH
Q 019536          329 KQ  330 (339)
Q Consensus       329 ~~  330 (339)
                      ..
T Consensus       433 ~~  434 (1351)
T KOG1035|consen  433 TH  434 (1351)
T ss_pred             hc
Confidence            74

>PRK05231 homoserine kinase; Provisional

Probab=97.82  E-value=0.00098  Score=60.38  Aligned_cols=153  Identities=15%  Similarity=0.106  Sum_probs=82.0

Q ss_pred             cccHHHHHHHhcCccc-----CCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCC--cee
Q 019536           44 AFSAKDLKKATNNYDL-----HKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHK--NIL  116 (339)
Q Consensus        44 ~~~~~~~~~~~~~~~~-----~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~--niv  116 (339)
                      ..+.+++......|.+     .+.|+.|...++|.....  +..+++|++. ...   .+....|..++..+...  .+.
T Consensus         6 ~ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~--~g~~vLK~~~-~~~---~~~l~~~~~~l~~L~~~glpvP   79 (319)
T PRK05231          6 DVSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTT--QGEYVLTLFE-RLT---AEDLPFFLGLMQHLAARGVPVP   79 (319)
T ss_pred             cCCHHHHHHHHHhcCCchhhccchhccccccceEEEEeC--CCcEEEEEec-cCC---hHHhHHHHHHHHHHHHCCCCCC
Confidence            3455555555455544     244566777789988763  3367888876 222   22233455555555311  233


Q ss_pred             eeeee------eeeCCccEEEEEeccCCcccccc--------------c---cCC--------C--h-HHHH--------
Q 019536          117 KLIGC------CLETELPTLVFESVKYGTLRGFS--------------F---ASL--------L--I-APRI--------  154 (339)
Q Consensus       117 ~~~~~------~~~~~~~~lv~e~~~~g~L~~~~--------------~---~~~--------~--~-~~~~--------  154 (339)
                      +.+..      ....+..++++||++|..+....              .   ..+        .  + ....        
T Consensus        80 ~~i~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  159 (319)
T PRK05231         80 APVARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLA  159 (319)
T ss_pred             cceeCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccC
Confidence            44421      12245578999999987543210              0   001        0  1 0100        


Q ss_pred             ----HHHHH-HHHHHHHHhcC----CCCCeEEccCCCCCEEeCCCCceEEecCCCcc
Q 019536          155 ----KIAME-IANAVAYLHVG----FDRPIVFRCIKASNVLLDENYSAKLHDFSLSV  202 (339)
Q Consensus       155 ----~i~~~-i~~~l~~LH~~----~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~  202 (339)
                          ..+.+ +...+..+...    ...+++|+|+.|.||+++.+...-++||+.+.
T Consensus       160 ~~~~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        160 DEQAALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             hhHHHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence                01111 11112222210    24579999999999999976656899999864

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.79  E-value=0.00035  Score=61.26  Aligned_cols=134  Identities=10%  Similarity=-0.029  Sum_probs=76.3

Q ss_pred             ceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCce-eeeeeeeeeCCccEEEEEeccCCcc
Q 019536           62 VIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNI-LKLIGCCLETELPTLVFESVKYGTL  140 (339)
Q Consensus        62 ~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~ni-v~~~~~~~~~~~~~lv~e~~~~g~L  140 (339)
                      .+..|-...+|+...  ++..+++|........-. -...+|..+++.+....+ .+++..+.    .++|+||++|..+
T Consensus         3 ~~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~   75 (256)
T TIGR02721         3 TLSGGLTNRSWRIEH--PGISFVWRPQSPVCKALG-VDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVI   75 (256)
T ss_pred             cCCCcCcCCeEEEEe--CCccEEEeeCCccccccc-CcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccc
Confidence            345677888998874  567788887554322111 124578888888853323 34454432    3689999998776


Q ss_pred             ccc-------cc---------c-------CCChHHH-HHHHHHH---------HHHHHHHhc-----CCCCCeEEccCCC
Q 019536          141 RGF-------SF---------A-------SLLIAPR-IKIAMEI---------ANAVAYLHV-----GFDRPIVFRCIKA  182 (339)
Q Consensus       141 ~~~-------~~---------~-------~~~~~~~-~~i~~~i---------~~~l~~LH~-----~~~~~i~H~dlk~  182 (339)
                      ...       ..         .       .+..... ..+..++         ...+..+-.     .....++|+|+.|
T Consensus        76 ~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~  155 (256)
T TIGR02721        76 TLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHA  155 (256)
T ss_pred             ccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCc
Confidence            432       00         0       1111111 1111111         111221211     1123589999999


Q ss_pred             CCEEeCCCCceEEecCCCccc
Q 019536          183 SNVLLDENYSAKLHDFSLSVS  203 (339)
Q Consensus       183 ~Nil~~~~~~~kl~dfg~a~~  203 (339)
                      .||+++.++ +.++||+.|..
T Consensus       156 ~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       156 YNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             CcEEEeCCC-CEEEeccccCc
Confidence            999999877 78999998743

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.76  E-value=0.00049  Score=59.34  Aligned_cols=75  Identities=12%  Similarity=0.105  Sum_probs=47.1

Q ss_pred             CceeccCCeeEEEEEEcC-CCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCC-CceeeeeeeeeeCCccEEEEEeccCC
Q 019536           61 KVIQSDTSYRLFEGTLVD-QDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKH-KNILKLIGCCLETELPTLVFESVKYG  138 (339)
Q Consensus        61 ~~ig~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H-~niv~~~~~~~~~~~~~lv~e~~~~g  138 (339)
                      +.+..|-...+|+....+ .+..|++|....... . .....+|+.+++.+.. .-.+++++.+. +   .++|||++|.
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~-~---~~l~e~i~G~   77 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-L-IIDRERELRIHKLLSKHGLAPKLYATFQ-N---GLIYEFIPGR   77 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-c-eecHHHHHHHHHHHHhCCCCCeEEEEeC-C---cEEEEeeCCC
Confidence            356677788999987642 256788887654322 1 1223378888888843 33445555433 2   3799999987


Q ss_pred             ccc
Q 019536          139 TLR  141 (339)
Q Consensus       139 ~L~  141 (339)
                      ++.
T Consensus        78 ~l~   80 (235)
T cd05157          78 TLE   80 (235)
T ss_pred             cCC
Confidence            653

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.74  E-value=0.001  Score=59.93  Aligned_cols=152  Identities=14%  Similarity=0.160  Sum_probs=85.8

Q ss_pred             cHHHHHHHhcCccc-----CCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCC--ceeee
Q 019536           46 SAKDLKKATNNYDL-----HKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHK--NILKL  118 (339)
Q Consensus        46 ~~~~~~~~~~~~~~-----~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~--niv~~  118 (339)
                      +.+++......|.+     ...++.|....+|....  ++..+.+|.+.....   .+....|..++..+...  .+.++
T Consensus         8 ~~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t--~~~~~vLK~~~~~~~---~~~i~~e~~~l~~L~~~g~pvp~~   82 (307)
T TIGR00938         8 SDEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTT--DVGRYILTLYEKRVK---AEELPFFLALTTHLAARGLPVPKP   82 (307)
T ss_pred             CHHHHHHHHHhcCCCCceeccccCCccccceEEEEe--CCCcEEEEEecCCCC---HHHHHHHHHHHHHHHHCCCCCCcc
Confidence            34445444445544     34566676678998765  334577887755322   23344667777776422  24455


Q ss_pred             eeee------eeCCccEEEEEeccCCcccccc----c-------------cCCC--------hH---HHH----------
Q 019536          119 IGCC------LETELPTLVFESVKYGTLRGFS----F-------------ASLL--------IA---PRI----------  154 (339)
Q Consensus       119 ~~~~------~~~~~~~lv~e~~~~g~L~~~~----~-------------~~~~--------~~---~~~----------  154 (339)
                      +...      ..++..++++||++|.++....    .             ..++        ..   ...          
T Consensus        83 i~t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l  162 (307)
T TIGR00938        83 VKSRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQL  162 (307)
T ss_pred             ccCCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhccccc
Confidence            4422      1234568999999986543110    0             1110        00   000          


Q ss_pred             --HHHHHHHHHHHHHhc----CCCCCeEEccCCCCCEEeCCCCceEEecCCCcc
Q 019536          155 --KIAMEIANAVAYLHV----GFDRPIVFRCIKASNVLLDENYSAKLHDFSLSV  202 (339)
Q Consensus       155 --~i~~~i~~~l~~LH~----~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~  202 (339)
                        .....+...++++..    ....+++|+|+.+.|++++.++...++||+.+.
T Consensus       163 ~~~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       163 EAHMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             CHHHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence              001122334454531    114789999999999999988877899999763

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.74  E-value=0.0005  Score=61.56  Aligned_cols=137  Identities=13%  Similarity=0.081  Sum_probs=81.6

Q ss_pred             CCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCC--ceeeeeeee------eeCCccEEE
Q 019536           60 HKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHK--NILKLIGCC------LETELPTLV  131 (339)
Q Consensus        60 ~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~--niv~~~~~~------~~~~~~~lv  131 (339)
                      .+.|..|....+|+...  ++..+++|.....    .......|+.++..+.+.  .+.+++...      ..++..+.|
T Consensus        19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~----~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l   92 (296)
T cd05153          19 FEGISAGIENTNYFVTT--DSGRYVLTLFEKV----SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAAL   92 (296)
T ss_pred             eecccCccccceEEEEe--CCCcEEEEEcCCC----ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEE
Confidence            34566777788998865  4457888887642    234455777777777433  244554421      223456899


Q ss_pred             EEeccCCcccccc----c-------------cCC----------ChHHHH----------HHHHHHHHHHHHHhc----C
Q 019536          132 FESVKYGTLRGFS----F-------------ASL----------LIAPRI----------KIAMEIANAVAYLHV----G  170 (339)
Q Consensus       132 ~e~~~~g~L~~~~----~-------------~~~----------~~~~~~----------~i~~~i~~~l~~LH~----~  170 (339)
                      ++|++|..+...-    .             ..+          .+....          .....+..++.++..    .
T Consensus        93 ~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~  172 (296)
T cd05153          93 VEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSD  172 (296)
T ss_pred             EEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhc
Confidence            9999987764310    0             000          010000          011112333444441    1


Q ss_pred             CCCCeEEccCCCCCEEeCCCCceEEecCCCcc
Q 019536          171 FDRPIVFRCIKASNVLLDENYSAKLHDFSLSV  202 (339)
Q Consensus       171 ~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~  202 (339)
                      ...+++|+|+.|.|++++.++.+.|+||+.+.
T Consensus       173 ~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         173 LPRGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            13569999999999999988778899999764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.50  E-value=0.0032  Score=58.53  Aligned_cols=77  Identities=12%  Similarity=-0.015  Sum_probs=54.1

Q ss_pred             CceeccCCeeEEEEEEcCCCeeEEEEEeccC------CChhhHHHHHHHHHHHHhcC---CCceeeeeeeeeeCCccEEE
Q 019536           61 KVIQSDTSYRLFEGTLVDQDRPISVMKFHDN------STLDDVEYCFNNIVFSSQMK---HKNILKLIGCCLETELPTLV  131 (339)
Q Consensus        61 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~~~~~e~~~l~~l~---H~niv~~~~~~~~~~~~~lv  131 (339)
                      +.||.|....||++...+.++.|.||.-.+.      ......++...|...|..+.   -.++++++.+.  ....++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEEE
Confidence            5789999999999999643368999985422      11234566777888887762   34677788773  3456899


Q ss_pred             EEeccCCc
Q 019536          132 FESVKYGT  139 (339)
Q Consensus       132 ~e~~~~g~  139 (339)
                      |||+++..
T Consensus       110 ME~L~~~~  117 (401)
T PRK09550        110 MEDLSDHK  117 (401)
T ss_pred             EecCCCcc
Confidence            99998643

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.34  E-value=0.0019  Score=57.98  Aligned_cols=75  Identities=16%  Similarity=0.153  Sum_probs=47.2

Q ss_pred             ceeccCCeeEEEEEEcC------CCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCc-eeeeeeeeeeCCccEEEEEe
Q 019536           62 VIQSDTSYRLFEGTLVD------QDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKN-ILKLIGCCLETELPTLVFES  134 (339)
Q Consensus        62 ~ig~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~n-iv~~~~~~~~~~~~~lv~e~  134 (339)
                      .+..|-...+|+.....      .++.+++|......  .......+|..++..+.... ..++++++.+    .+|+||
T Consensus         5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~--~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~   78 (302)
T cd05156           5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV--ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF   78 (302)
T ss_pred             EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC--cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence            45556667889887643      25788888876542  22234457888888874322 3456666542    258999


Q ss_pred             ccCCcccc
Q 019536          135 VKYGTLRG  142 (339)
Q Consensus       135 ~~~g~L~~  142 (339)
                      ++|.++..
T Consensus        79 i~G~~l~~   86 (302)
T cd05156          79 IPSRTLTT   86 (302)
T ss_pred             eCCCcCCH
Confidence            98877643

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.33  E-value=0.0044  Score=56.13  Aligned_cols=140  Identities=13%  Similarity=0.080  Sum_probs=87.4

Q ss_pred             cCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC-----------------------hh--hHHHHHHHHHHHHhcCCC
Q 019536           59 LHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST-----------------------LD--DVEYCFNNIVFSSQMKHK  113 (339)
Q Consensus        59 ~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----------------------~~--~~~~~~~e~~~l~~l~H~  113 (339)
                      +.-.|..|.-+.||.+... +|..+|||+++...-                       +.  ..-+...|+.-|++++..
T Consensus       148 inGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a  226 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA  226 (520)
T ss_pred             cccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence            3456788999999999886 788899998753210                       00  112234677777777544


Q ss_pred             ceeeeeeeeeeCCccEEEEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCC
Q 019536          114 NILKLIGCCLETELPTLVFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENY  191 (339)
Q Consensus       114 niv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~  191 (339)
                      .|.----.....  -.|||+|+.......-..  ..++...+..+-.+++.-+.-|-.  .+++||.||.--|+|+- +|
T Consensus       227 GIP~PePIlLk~--hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~--~c~LVHADLSEfN~Lyh-dG  301 (520)
T KOG2270|consen  227 GIPCPEPILLKN--HVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQ--KCRLVHADLSEFNLLYH-DG  301 (520)
T ss_pred             CCCCCCceeeec--ceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHH--HhceeccchhhhhheEE-CC
Confidence            432111111111  259999995332211111  345555555566666666654443  78899999999999876 57


Q ss_pred             ceEEecCCCcccc
Q 019536          192 SAKLHDFSLSVSI  204 (339)
Q Consensus       192 ~~kl~dfg~a~~~  204 (339)
                      .+.++|.+-+...
T Consensus       302 ~lyiIDVSQSVE~  314 (520)
T KOG2270|consen  302 KLYIIDVSQSVEH  314 (520)
T ss_pred             EEEEEEccccccC
Confidence            8999999876443

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.26  E-value=0.0085  Score=53.83  Aligned_cols=142  Identities=15%  Similarity=0.085  Sum_probs=84.6

Q ss_pred             cCCceeccCCeeEEEEEEcCCCeeEEEEEecc-CCChhhHHHHHHHHHHHHhcCC--CceeeeeeeeeeCC--ccEEEEE
Q 019536           59 LHKVIQSDTSYRLFEGTLVDQDRPISVMKFHD-NSTLDDVEYCFNNIVFSSQMKH--KNILKLIGCCLETE--LPTLVFE  133 (339)
Q Consensus        59 ~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~~~e~~~l~~l~H--~niv~~~~~~~~~~--~~~lv~e  133 (339)
                      +.+.+..|..-.+|....  +++.+.+. ... ...........+|..+++.+.-  --+...+++|.++.  ..+.||+
T Consensus        29 ~v~~~~~G~sn~t~~~~~--~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~  105 (321)
T COG3173          29 IVEEISGGWSNDTFRLGD--TGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVME  105 (321)
T ss_pred             eeeeccCCcccceEEEec--CCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEE
Confidence            334443344334555444  36777777 221 2222445556678888877742  23556788888776  6799999


Q ss_pred             eccCCccccccccCCChHHHHHHH-HHHHHHHHHHh--------------------------------------------
Q 019536          134 SVKYGTLRGFSFASLLIAPRIKIA-MEIANAVAYLH--------------------------------------------  168 (339)
Q Consensus       134 ~~~~g~L~~~~~~~~~~~~~~~i~-~~i~~~l~~LH--------------------------------------------  168 (339)
                      |++|..+..........   ..++ ..++..|.-||                                            
T Consensus       106 ~veGe~~~~~~~~~~~~---~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~  182 (321)
T COG3173         106 WVEGEVVWSALPPESLG---RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADR  182 (321)
T ss_pred             EecceeccCcCCcccch---HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHH
Confidence            99985443332211100   0111 23333344444                                            


Q ss_pred             ------cCC-----CCCeEEccCCCCCEEeCCCCceEEecCCCccccCC
Q 019536          169 ------VGF-----DRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPE  206 (339)
Q Consensus       169 ------~~~-----~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~  206 (339)
                            +..     ...++|+|+.+.|++++..+-+-+.||+++..-++
T Consensus       183 ~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP  231 (321)
T COG3173         183 LIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP  231 (321)
T ss_pred             HHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence                  111     23589999999999999888899999999866433

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.26  E-value=0.00048  Score=61.12  Aligned_cols=134  Identities=11%  Similarity=0.067  Sum_probs=91.3

Q ss_pred             CcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC-------------------hh--hHHHHHHHHHHHHhcC-CC
Q 019536           56 NYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST-------------------LD--DVEYCFNNIVFSSQMK-HK  113 (339)
Q Consensus        56 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------------------~~--~~~~~~~e~~~l~~l~-H~  113 (339)
                      -+.+.+.||-|.-+.||.+-+. .|.+.++|.-..+.+                   +.  ..-...+|+..|+.|. |.
T Consensus        93 v~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g  171 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG  171 (465)
T ss_pred             hhhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence            4788999999999999999886 678777775332211                   11  1123457888888884 32


Q ss_pred             -ceeeeeeeeeeCCccEEEEEeccCCccccccccCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCc
Q 019536          114 -NILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYS  192 (339)
Q Consensus       114 -niv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~  192 (339)
                       -+.+.++++    .-++|||++.+-+|.....- ....   .+...++.-+--|.   ..|+||+|..--||++..++.
T Consensus       172 fpVPkpiD~~----RH~Vvmelv~g~Pl~~v~~v-~d~~---~ly~~lm~~Iv~la---~~GlIHgDFNEFNimv~dd~~  240 (465)
T KOG2268|consen  172 FPVPKPIDHN----RHCVVMELVDGYPLRQVRHV-EDPP---TLYDDLMGLIVRLA---NHGLIHGDFNEFNIMVKDDDK  240 (465)
T ss_pred             CCCCCccccc----ceeeHHHhhcccceeeeeec-CChH---HHHHHHHHHHHHHH---HcCceecccchheeEEecCCC
Confidence             244445443    45799999988887666421 1111   22333333344555   789999999999999999999


Q ss_pred             eEEecCCCc
Q 019536          193 AKLHDFSLS  201 (339)
Q Consensus       193 ~kl~dfg~a  201 (339)
                      ++++||=-.
T Consensus       241 i~vIDFPQm  249 (465)
T KOG2268|consen  241 IVVIDFPQM  249 (465)
T ss_pred             EEEeechHh
Confidence            999999754

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.15  E-value=0.0098  Score=52.72  Aligned_cols=31  Identities=19%  Similarity=0.323  Sum_probs=25.3

Q ss_pred             CCeEEccCCCCCEEeCCCCc-eEEecCCCccc
Q 019536          173 RPIVFRCIKASNVLLDENYS-AKLHDFSLSVS  203 (339)
Q Consensus       173 ~~i~H~dlk~~Nil~~~~~~-~kl~dfg~a~~  203 (339)
                      ..++|+|+.+.||+++.++. .-|+||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            34899999999999997454 56999998744

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PLN02236 choline kinase

Probab=96.93  E-value=0.013  Score=53.75  Aligned_cols=135  Identities=15%  Similarity=0.125  Sum_probs=77.6

Q ss_pred             ceeccCCeeEEEEEEcC----CCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCce-eeeeeeeeeCCccEEEEEecc
Q 019536           62 VIQSDTSYRLFEGTLVD----QDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNI-LKLIGCCLETELPTLVFESVK  136 (339)
Q Consensus        62 ~ig~G~~g~V~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~ni-v~~~~~~~~~~~~~lv~e~~~  136 (339)
                      .+..|-.-.+|+....+    .++.|.++....... .... ..+|..+++.+...++ .++++.+..+    .|.||++
T Consensus        43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~-~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~  116 (344)
T PLN02236         43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE-LFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH  116 (344)
T ss_pred             EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC-eeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence            44457777899987532    246788888765432 2222 2578888888853333 4666666433    5899998


Q ss_pred             CCccccc-------cc-----------c-------CCChHHHHHHHHH-----------------HHHHHHHH----hc-
Q 019536          137 YGTLRGF-------SF-----------A-------SLLIAPRIKIAME-----------------IANAVAYL----HV-  169 (339)
Q Consensus       137 ~g~L~~~-------~~-----------~-------~~~~~~~~~i~~~-----------------i~~~l~~L----H~-  169 (339)
                      +.++...       ..           .       ...+.....++.+                 +...+..|    .. 
T Consensus       117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~  196 (344)
T PLN02236        117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD  196 (344)
T ss_pred             CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence            7665421       00           0       0111222122211                 11111111    11 


Q ss_pred             CCCCCeEEccCCCCCEEeCC-CCceEEecCCCcc
Q 019536          170 GFDRPIVFRCIKASNVLLDE-NYSAKLHDFSLSV  202 (339)
Q Consensus       170 ~~~~~i~H~dlk~~Nil~~~-~~~~kl~dfg~a~  202 (339)
                      .....++|+|+++.||++++ ++.+.++||..|.
T Consensus       197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence            11346899999999999976 4679999999874

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.63  E-value=0.015  Score=49.15  Aligned_cols=103  Identities=15%  Similarity=0.095  Sum_probs=66.0

Q ss_pred             eEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeccCCccccccccCCChHHHHHHHHHHH
Q 019536           82 PISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIKIAMEIA  161 (339)
Q Consensus        82 ~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~i~~~i~  161 (339)
                      +..+|++..-.-.-...-+.++..++++++  .|+++..-  ++-.+-++.|+|-....       .+    ..++.-=+
T Consensus        87 ~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i-------~~----~N~i~agi  151 (308)
T PF07387_consen   87 PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI-------NF----SNFITAGI  151 (308)
T ss_pred             hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc-------ch----hHHHHHhH
Confidence            455666654332113345678888888885  47777621  22234477888843211       11    11222224


Q ss_pred             HHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCC
Q 019536          162 NAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSL  200 (339)
Q Consensus       162 ~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~  200 (339)
                      ++|.-.|++ ..+.+|+|..|+||+-|+.|.+||.|=+.
T Consensus       152 ~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~  189 (308)
T PF07387_consen  152 KDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVC  189 (308)
T ss_pred             HHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhh
Confidence            667888854 67899999999999999999999999774

The function of this family is unknown.

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.53  E-value=0.033  Score=49.60  Aligned_cols=73  Identities=8%  Similarity=0.001  Sum_probs=45.6

Q ss_pred             CCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhc---CCCceeeeeeeeeeCCccEEEEEecc
Q 019536           60 HKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQM---KHKNILKLIGCCLETELPTLVFESVK  136 (339)
Q Consensus        60 ~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l---~H~niv~~~~~~~~~~~~~lv~e~~~  136 (339)
                      .+.|+.|....+|+..  .+++.+.||.-..    .....|..|..-|+.|   .--.+++++++....+..+||+||++
T Consensus        22 ~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~----~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~   95 (288)
T PF03881_consen   22 IEPVSGGDINEAYRLD--TDGGSYFVKVNSE----SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE   95 (288)
T ss_dssp             EEEE--SSSSEEEEEE--TTS-EEEEEEEEG----GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred             eEecCCCChhheEEEE--CCCccEEEEecCh----hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence            3567888888888877  4788899998763    2234456777777777   34467788998887777799999998


Q ss_pred             CC
Q 019536          137 YG  138 (339)
Q Consensus       137 ~g  138 (339)
                      .+
T Consensus        96 ~~   97 (288)
T PF03881_consen   96 MG   97 (288)
T ss_dssp             --
T ss_pred             CC
Confidence            87

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.52  E-value=0.03  Score=51.00  Aligned_cols=74  Identities=15%  Similarity=0.152  Sum_probs=45.3

Q ss_pred             CceeccCCeeEEEEEEcCC---CeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCce-eeeeeeeeeCCccEEEEEecc
Q 019536           61 KVIQSDTSYRLFEGTLVDQ---DRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNI-LKLIGCCLETELPTLVFESVK  136 (339)
Q Consensus        61 ~~ig~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~ni-v~~~~~~~~~~~~~lv~e~~~  136 (339)
                      +.+..|-.-.+|+....+.   +..|.++....... . .-...+|..+++.+..-++ .++++++..+    +|.+|++
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~-~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~   93 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-Y-VIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFIN   93 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-e-EechHHHHHHHHHHHhcCCCCceeEEeCCc----Eeehhhc
Confidence            3444466777888876432   23788888765422 1 2223478888888854444 4666666322    5899997


Q ss_pred             CCcc
Q 019536          137 YGTL  140 (339)
Q Consensus       137 ~g~L  140 (339)
                      +.++
T Consensus        94 g~~l   97 (330)
T PLN02421         94 ARTL   97 (330)
T ss_pred             CCCC
Confidence            7665

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.51  E-value=0.00019  Score=74.87  Aligned_cols=153  Identities=12%  Similarity=-0.081  Sum_probs=105.3

Q ss_pred             HHHHHHHhcCCCceeeeeeeeee--CCccEEEEEeccCCccccccccC------CChHHHHHHHHHHHHHHHHHhcCC--
Q 019536          102 NNIVFSSQMKHKNILKLIGCCLE--TELPTLVFESVKYGTLRGFSFAS------LLIAPRIKIAMEIANAVAYLHVGF--  171 (339)
Q Consensus       102 ~e~~~l~~l~H~niv~~~~~~~~--~~~~~lv~e~~~~g~L~~~~~~~------~~~~~~~~i~~~i~~~l~~LH~~~--  171 (339)
                      .|...++...|+++.....=...  ....+.+++|+.+|.+...+...      +....+.....+.+.+..-+|...  
T Consensus      1278 ~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnl 1357 (2724)
T KOG1826|consen 1278 SERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNL 1357 (2724)
T ss_pred             hhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccC
Confidence            34445556689888766544332  23457899999999998887522      222223333333355555555322  


Q ss_pred             CCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh
Q 019536          172 DRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT  251 (339)
Q Consensus       172 ~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~  251 (339)
                      +.-.+|++||+-|.++..+..+|+.++|+.+...+....  .....+++-|++|+..+.-.++.++|+|..|+.+|+..-
T Consensus      1358 g~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf--~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~ 1435 (2724)
T KOG1826|consen 1358 GNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSF--FGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSD 1435 (2724)
T ss_pred             CccchhhhhhhhccceecCCcccccccccccccCchHhh--hhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhc
Confidence            333689999999999999999999999998833322221  113456777899998888889988999999999999988


Q ss_pred             CCCcc
Q 019536          252 GCNVL  256 (339)
Q Consensus       252 g~~p~  256 (339)
                      |..+|
T Consensus      1436 ~n~~f 1440 (2724)
T KOG1826|consen 1436 GNAYF 1440 (2724)
T ss_pred             ccHHH
Confidence            87765

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.41  E-value=0.045  Score=50.05  Aligned_cols=75  Identities=12%  Similarity=0.006  Sum_probs=48.6

Q ss_pred             ceeccCCeeEEEEEEcCCCeeEEEEEecc------CCChhhHHHHHHHHHHHHhcC--CC-ceeeeeeeeeeCCccEEEE
Q 019536           62 VIQSDTSYRLFEGTLVDQDRPISVMKFHD------NSTLDDVEYCFNNIVFSSQMK--HK-NILKLIGCCLETELPTLVF  132 (339)
Q Consensus        62 ~ig~G~~g~V~~~~~~~~~~~vavK~~~~------~~~~~~~~~~~~e~~~l~~l~--H~-niv~~~~~~~~~~~~~lv~  132 (339)
                      .||.|.-.-||++...+.++.|.||.-.+      ...+-..++..-|...|+...  -| .+++++.+  +.....+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            47888889999999854346899997542      122344566667777776652  23 45555544  444456899


Q ss_pred             EeccCC
Q 019536          133 ESVKYG  138 (339)
Q Consensus       133 e~~~~g  138 (339)
                      |+++..
T Consensus        80 EdL~~~   85 (370)
T TIGR01767        80 EDLSHH   85 (370)
T ss_pred             hhCccc
Confidence            998653

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.38  E-value=0.11  Score=46.74  Aligned_cols=29  Identities=21%  Similarity=0.252  Sum_probs=25.2

Q ss_pred             CCCeEEccCCCCCEEeCCCCceEEecCCCc
Q 019536          172 DRPIVFRCIKASNVLLDENYSAKLHDFSLS  201 (339)
Q Consensus       172 ~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a  201 (339)
                      ..+++|+|+.+.|++++. +.+.++||+.+
T Consensus       186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~  214 (313)
T TIGR02906       186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYC  214 (313)
T ss_pred             cCceEcCCCCcccEEEeC-CcEEEEECccc
Confidence            367899999999999987 56889999965

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.37  E-value=0.064  Score=48.38  Aligned_cols=32  Identities=19%  Similarity=0.204  Sum_probs=28.1

Q ss_pred             CCCeEEccCCCCCEEeCCCCceEEecCCCccc
Q 019536          172 DRPIVFRCIKASNVLLDENYSAKLHDFSLSVS  203 (339)
Q Consensus       172 ~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~  203 (339)
                      ..+++|+|+.+.|++++.++.+.++||..++.
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            45799999999999999988999999987643

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.30  E-value=0.019  Score=48.61  Aligned_cols=30  Identities=20%  Similarity=0.319  Sum_probs=20.9

Q ss_pred             CCeEEccCCCCCEEe-CCCCceEEecCCCcc
Q 019536          173 RPIVFRCIKASNVLL-DENYSAKLHDFSLSV  202 (339)
Q Consensus       173 ~~i~H~dlk~~Nil~-~~~~~~kl~dfg~a~  202 (339)
                      ..++|+|+.+.||++ +.++.++++||..|.
T Consensus       143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~  173 (211)
T PF01633_consen  143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAG  173 (211)
T ss_dssp             EEEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred             ceEeeccCccccEEeccCCCeEEEecHHHHh
Confidence            457899999999999 788999999999863

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.22  E-value=0.1  Score=48.68  Aligned_cols=74  Identities=3%  Similarity=-0.123  Sum_probs=50.4

Q ss_pred             CCceeccCCeeEEEEEEcCCCeeEEEEEeccCC------ChhhHHHHHHHHHHHHhcC---CCceeeeeeeeeeCCccEE
Q 019536           60 HKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS------TLDDVEYCFNNIVFSSQMK---HKNILKLIGCCLETELPTL  130 (339)
Q Consensus        60 ~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~~e~~~l~~l~---H~niv~~~~~~~~~~~~~l  130 (339)
                      .+.||.|....||+...  .+..+.||+-....      .+....+...|...|+.+.   ..++.+++.++.+.  .++
T Consensus        37 ~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~--~vl  112 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTM--ALI  112 (418)
T ss_pred             EEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCC--CEE
Confidence            45678888889999876  34568899865221      1124455556666666553   35788899988744  578


Q ss_pred             EEEeccC
Q 019536          131 VFESVKY  137 (339)
Q Consensus       131 v~e~~~~  137 (339)
                      +||++++
T Consensus       113 vME~L~~  119 (418)
T PLN02756        113 GMRYLEP  119 (418)
T ss_pred             EEeecCC
Confidence            9999977

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.96  E-value=0.056  Score=49.15  Aligned_cols=104  Identities=15%  Similarity=0.128  Sum_probs=68.7

Q ss_pred             CccEEEEEeccCCccccccccCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccC
Q 019536          126 ELPTLVFESVKYGTLRGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIP  205 (339)
Q Consensus       126 ~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~  205 (339)
                      ...|++|++- |+++.-.  ..-.+.+...++++.+.-+.-+..  .-..-|||+...|||++ .|.+.|+||-+++.-.
T Consensus       299 ~y~yl~~kdh-gt~is~i--k~~~~~e~lsff~s~~sil~~lek--kf~fehrnlt~~niLId-~GnvtLIDfklsRl~~  372 (488)
T COG5072         299 LYLYLHFKDH-GTPISII--KADRSEEELSFFWSCISILDILEK--KFPFEHRNLTLDNILID-EGNVTLIDFKLSRLSY  372 (488)
T ss_pred             eEEEEEEecC-Cceeeee--ecccHHHHHHHHHHHHHHHhhhhh--cCCcccccccccceeee-cCceEEEEeeeeeccc
Confidence            3456777765 4444222  455677888899888887777774  45678999999999999 8999999999998432


Q ss_pred             CCCceeeecccccccccccccccccCCCCcccchHHHH
Q 019536          206 EGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFG  243 (339)
Q Consensus       206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG  243 (339)
                      .+. .      ..-...--|-.+.|.. +...+||-+-
T Consensus       373 ~q~-~------isy~rldhp~lF~G~d-d~QFeIYrlM  402 (488)
T COG5072         373 SQG-I------ISYNRLDHPDLFNGVD-DYQFEIYRLM  402 (488)
T ss_pred             CCc-e------eeccccCchhhhcCcc-ceeeeHHHHH
Confidence            221 1      1111223455555433 5666777543

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=95.82  E-value=0.01  Score=55.97  Aligned_cols=48  Identities=13%  Similarity=0.138  Sum_probs=36.7

Q ss_pred             HHHHHHHHHHHHhcCCCceeeeeeeeee-CCccEEEEEeccCCccccccc
Q 019536           97 VEYCFNNIVFSSQMKHKNILKLIGCCLE-TELPTLVFESVKYGTLRGFSF  145 (339)
Q Consensus        97 ~~~~~~e~~~l~~l~H~niv~~~~~~~~-~~~~~lv~e~~~~g~L~~~~~  145 (339)
                      ...+....++++.+.|+|.-.++++... .....+|+|++ +-+|.++..
T Consensus        26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~   74 (725)
T KOG1093|consen   26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILK   74 (725)
T ss_pred             HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHH
Confidence            4456677889999999999999888764 33467899999 557777764

>PRK12396 5-methylribose kinase; Reviewed

Probab=95.76  E-value=0.67  Score=43.09  Aligned_cols=76  Identities=11%  Similarity=-0.049  Sum_probs=50.5

Q ss_pred             CCceeccCCeeEEEEEEcCCCeeEEEEEecc-----CCChhhHHHHHHHHHHHHhcC--CC-ceeeeeeeeeeCCccEEE
Q 019536           60 HKVIQSDTSYRLFEGTLVDQDRPISVMKFHD-----NSTLDDVEYCFNNIVFSSQMK--HK-NILKLIGCCLETELPTLV  131 (339)
Q Consensus        60 ~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~~~e~~~l~~l~--H~-niv~~~~~~~~~~~~~lv  131 (339)
                      .+.||.|.-.-||++.....++.|+||.-.+     .+.+-..++..-|...|+...  -| ++++++.+  +.....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            3578989999999999853457799997443     122345677777877777653  23 45556654  34445688


Q ss_pred             EEeccC
Q 019536          132 FESVKY  137 (339)
Q Consensus       132 ~e~~~~  137 (339)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            998854

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=95.24  E-value=0.61  Score=42.41  Aligned_cols=135  Identities=16%  Similarity=0.108  Sum_probs=75.9

Q ss_pred             ceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCc------eeeeeee----eeeCCccEEE
Q 019536           62 VIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKN------ILKLIGC----CLETELPTLV  131 (339)
Q Consensus        62 ~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~n------iv~~~~~----~~~~~~~~lv  131 (339)
                      .|.+ .--.+|.....  +..+++|.+.....   ...+.-|+..+..+.-..      +.++=|-    ...+...+-|
T Consensus        33 ~l~s-~eN~~f~~~~~--~g~~iLki~~~~~~---~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~l  106 (331)
T COG2334          33 GLNS-EENSNFRVQTE--DGRYILKIYRPGWT---RAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAAL  106 (331)
T ss_pred             cccc-ccCceEEEEec--CCCeEEEEecCCCC---HHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEE
Confidence            3444 44568888774  33448888877622   333445666676663111      2222222    1122366789


Q ss_pred             EEeccCCcccc-ccc-----------------c-----------CCChHH---H----------HHHHHHHHHHHHHHhc
Q 019536          132 FESVKYGTLRG-FSF-----------------A-----------SLLIAP---R----------IKIAMEIANAVAYLHV  169 (339)
Q Consensus       132 ~e~~~~g~L~~-~~~-----------------~-----------~~~~~~---~----------~~i~~~i~~~l~~LH~  169 (339)
                      ++|++|..+.. ...                 .           ...|..   .          .....++...+..+.+
T Consensus       107 f~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~  186 (331)
T COG2334         107 FEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLA  186 (331)
T ss_pred             EEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHh
Confidence            99999988872 210                 0           122220   0          0123334444444431


Q ss_pred             CC-----CCC--eEEccCCCCCEEeCCCC-ceEEecCCCcc
Q 019536          170 GF-----DRP--IVFRCIKASNVLLDENY-SAKLHDFSLSV  202 (339)
Q Consensus       170 ~~-----~~~--i~H~dlk~~Nil~~~~~-~~kl~dfg~a~  202 (339)
                      .-     ..+  +||+|+-|.||+++.+. .+.++||+-+.
T Consensus       187 ~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         187 RLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             hchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence            11     233  99999999999999877 48999999763

>PTZ00384 choline kinase; Provisional

Probab=95.14  E-value=0.3  Score=45.45  Aligned_cols=75  Identities=20%  Similarity=0.185  Sum_probs=44.7

Q ss_pred             CceeccCCeeEEEEEEcCCC-e-----eEEEEEeccCCChhhHHHHHHHHHHHHhcCCCce-eeeeeeeeeCCccEEEEE
Q 019536           61 KVIQSDTSYRLFEGTLVDQD-R-----PISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNI-LKLIGCCLETELPTLVFE  133 (339)
Q Consensus        61 ~~ig~G~~g~V~~~~~~~~~-~-----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~ni-v~~~~~~~~~~~~~lv~e  133 (339)
                      +.|..|-...+|++...+.. .     .|.+..... .. ...-.-.+|+.+++.+...++ .++++.+..    .++.|
T Consensus        56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~-~~-~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~e  129 (383)
T PTZ00384         56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST-YN-SLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQE  129 (383)
T ss_pred             EEeCCcccceEEEEEecCCCCCccccceEEEEeccC-CC-ceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEE
Confidence            34555778889998764321 2     244443322 11 111223478899999865444 566666643    48999


Q ss_pred             eccCCccc
Q 019536          134 SVKYGTLR  141 (339)
Q Consensus       134 ~~~~g~L~  141 (339)
                      |++|-+|.
T Consensus       130 fIeGr~l~  137 (383)
T PTZ00384        130 WVEGNTMG  137 (383)
T ss_pred             EeccccCC
Confidence            99987664

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=94.78  E-value=0.094  Score=48.43  Aligned_cols=59  Identities=22%  Similarity=0.042  Sum_probs=41.2

Q ss_pred             EEEEEeccCCccccccc-cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCC
Q 019536          129 TLVFESVKYGTLRGFSF-ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDE  189 (339)
Q Consensus       129 ~lv~e~~~~g~L~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~  189 (339)
                      .||-+|.+|-++..++. ...++.-+..++.-.+.|+..+-.  -.+.+|.|+.|.||++-.
T Consensus       321 vl~E~~~~Gl~v~~~v~~~~~pe~l~kkva~lg~~AllkMl~--vDNFvHaDlHPGNVlirf  380 (565)
T KOG1236|consen  321 VLVETYERGLSVLRFVKWKSQPEALVKKVAKLGVNALLKMLI--VDNFVHADLHPGNVLIRF  380 (565)
T ss_pred             eeeeeccccccHHhhhhcccChHHHHHHHHHHHHHHHHHHHH--hhcceecccCCCcEEEEe
Confidence            45666777777777766 455655666677767777643331  567999999999999853

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=94.78  E-value=0.58  Score=40.04  Aligned_cols=69  Identities=14%  Similarity=0.090  Sum_probs=47.0

Q ss_pred             eeEEEEEEcCC-CeeEEEEEeccCCChhhHHHHHHHHHHHHhc---CCCceeeeeeeeeeCCccEEEEEeccCCccc
Q 019536           69 YRLFEGTLVDQ-DRPISVMKFHDNSTLDDVEYCFNNIVFSSQM---KHKNILKLIGCCLETELPTLVFESVKYGTLR  141 (339)
Q Consensus        69 g~V~~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l---~H~niv~~~~~~~~~~~~~lv~e~~~~g~L~  141 (339)
                      |.|..|....+ ..++-+|+-..    ....-|..|+.=|..+   +.-++.+++.+-.+.++.|||+||++.|.+.
T Consensus        27 G~inea~~v~dg~~~~FvK~n~~----~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d   99 (286)
T COG3001          27 GDINEAWRLRDGTDPFFVKCNQR----EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD   99 (286)
T ss_pred             ccccceeEeecCCcceEEEecch----hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence            44555544433 45677776432    3345566776666555   3456778888888889999999999998776

>PRK06148 hypothetical protein; Provisional

Probab=94.51  E-value=0.78  Score=48.38  Aligned_cols=32  Identities=22%  Similarity=0.310  Sum_probs=26.2

Q ss_pred             CCCeEEccCCCCCEEeCCCC--ceE-EecCCCccc
Q 019536          172 DRPIVFRCIKASNVLLDENY--SAK-LHDFSLSVS  203 (339)
Q Consensus       172 ~~~i~H~dlk~~Nil~~~~~--~~k-l~dfg~a~~  203 (339)
                      ..++||+|+.+.||+++.++  .+. |+|||-+..
T Consensus       202 p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        202 PAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             CcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            46799999999999999775  454 999998643

>PRK11768 serine/threonine protein kinase; Provisional

Probab=94.39  E-value=3.6  Score=37.32  Aligned_cols=97  Identities=8%  Similarity=0.095  Sum_probs=53.5

Q ss_pred             CCcccccHHHHHHHhcCcccC-----CceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCC-
Q 019536           40 NPIRAFSAKDLKKATNNYDLH-----KVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHK-  113 (339)
Q Consensus        40 ~~~~~~~~~~~~~~~~~~~~~-----~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~-  113 (339)
                      +++..++.+.+..+...+-+.     ..+ .+.-..||..... ++..+++|......  .....+..|+..+..+... 
T Consensus         6 ~~~~~l~p~~~~~a~~~~g~~~~~~~~~l-~s~eN~vy~v~~~-~~~~~vlKv~r~~~--~~~~~i~~E~~~l~~L~~~g   81 (325)
T PRK11768          6 FPFQTLTPDLILDALESLGLRVDGRLLAL-NSYENRVYQFGDE-DGRRVVAKFYRPER--WSDAQILEEHAFALELAEAE   81 (325)
T ss_pred             CCCCCCChHHHHHHHHHcCCCCccceEee-ccccceEEEEecC-CCCEEEEEEcCccc--CCHHHHHHHHHHHHHHHHCC
Confidence            345556666665555544332     122 2344568888764 56678889876432  2344555677777666321 


Q ss_pred             -ceeeee---e--eeeeCCccEEEEEeccCCcc
Q 019536          114 -NILKLI---G--CCLETELPTLVFESVKYGTL  140 (339)
Q Consensus       114 -niv~~~---~--~~~~~~~~~lv~e~~~~g~L  140 (339)
                       .++...   |  ....++..+.|+++++|...
T Consensus        82 ipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~~  114 (325)
T PRK11768         82 IPVVAPLAFNGQTLHEHQGFRFALFPRRGGRAP  114 (325)
T ss_pred             CCCCCCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence             122211   1  12224567789999987654

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	339
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		5e-31
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-30
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		5e-26
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		5e-25
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		7e-15
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-14
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		3e-14
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		3e-14
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-14
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-14
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		7e-14
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-13
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-13
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-13
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		3e-13
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-13
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		3e-13
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-13
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		3e-13
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-13
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		5e-13
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		5e-13
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		6e-13
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		7e-13
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		7e-13
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		7e-13
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		7e-13
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		7e-13
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		8e-13
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		8e-13
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		8e-13
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		8e-13
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		8e-13
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		9e-13
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-12
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-12
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-12
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-12
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		3e-12
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-12
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-12
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		4e-12
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-12
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		4e-12
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		5e-12
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		5e-12
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		5e-12
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		6e-12
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		7e-12
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		7e-12
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		7e-12
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		7e-12
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		8e-12
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		8e-12
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		8e-12
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		9e-12
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-11
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-11
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-11
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		4e-11
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		4e-11
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		4e-11
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		4e-11
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		4e-11
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		4e-11
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		4e-11
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		5e-11
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		6e-11
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		6e-11
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		6e-11
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		6e-11
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		6e-11
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		6e-11
2pl0_A	289	Lck Bound To Imatinib Length = 289		7e-11
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		7e-11
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		9e-11
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-10
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-10
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-10
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-10
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-10
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-10
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-10
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-10
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-10
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-10
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-10
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-10
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-10
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-10
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-10
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-10
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-10
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-10
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-10
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-10
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-10
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-10
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		3e-10
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		3e-10
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		3e-10
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		3e-10
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-10
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		3e-10
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		4e-10
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		4e-10
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		4e-10
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-10
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		4e-10
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		5e-10
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		5e-10
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		5e-10
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		6e-10
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		8e-10
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		8e-10
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		8e-10
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		9e-10
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		9e-10
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		9e-10
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		9e-10
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-09
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-09
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		1e-09
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-09
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		1e-09
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-09
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-09
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-09
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-09
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-09
3a4o_X	286	Lyn Kinase Domain Length = 286		4e-09
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		4e-09
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-09
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		4e-09
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-09
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-09
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		6e-09
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		6e-09
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		7e-09
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		7e-09
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		7e-09
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		7e-09
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		8e-09
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		8e-09
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		8e-09
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		8e-09
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		8e-09
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		9e-09
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		9e-09
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		9e-09
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		9e-09
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		9e-09
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		9e-09
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-08
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-08
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-08
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-08
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-08
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-08
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-08
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-08
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-08
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-08
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-08
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-08
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-08
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-08
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-08
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-08
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-08
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		1e-08
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-08
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-08
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-08
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-08
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-08
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-08
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-08
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-08
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-08
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-08
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-08
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-08
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-08
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-08
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-08
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-08
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-08
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-08
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-08
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-08
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-08
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-08
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-08
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-08
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-08
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-08
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-08
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-08
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-08
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		3e-08
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-08
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-08
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		3e-08
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-08
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-08
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-08
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-08
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		3e-08
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		3e-08
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-08
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		4e-08
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-08
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		4e-08
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-08
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		4e-08
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		4e-08
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		4e-08
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		4e-08
4h58_A	275	Braf In Complex With Compound 3 Length = 275		4e-08
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		4e-08
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		4e-08
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-08
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		4e-08
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		4e-08
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		5e-08
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		5e-08
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-08
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		5e-08
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		5e-08
1fvr_A	327	Tie2 Kinase Domain Length = 327		5e-08
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-08
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		6e-08
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		6e-08
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		6e-08
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		6e-08
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		6e-08
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		6e-08
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		6e-08
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		6e-08
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		6e-08
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		6e-08
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		6e-08
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		7e-08
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		7e-08
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		7e-08
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		7e-08
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		8e-08
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		8e-08
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		8e-08
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		8e-08
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		8e-08
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		8e-08
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		9e-08
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		9e-08
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		9e-08
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-08
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		9e-08
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-07
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-07
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-07
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		1e-07
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-07
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-07
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-07
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-07
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-07
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-07
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-07
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-07
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-07
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-07
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-07
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-07
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-07
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-07
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-07
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-07
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-07
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-07
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-07
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-07
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-07
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-07
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-07
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-07
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-07
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-07
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-07
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-07
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-07
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-07
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-07
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-07
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-07
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-07
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-07
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-07
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		2e-07
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-07
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-07
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-07
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-07
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		3e-07
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		3e-07
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		3e-07
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		3e-07
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-07
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-07
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-07
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		3e-07
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-07
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-07
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		4e-07
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-07
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		4e-07
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-07
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		4e-07
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		4e-07
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		4e-07
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		5e-07
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-07
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		5e-07
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		5e-07
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		5e-07
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		5e-07
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		5e-07
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		5e-07
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		5e-07
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		5e-07
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		5e-07
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		5e-07
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		5e-07
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		5e-07
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		5e-07
3a7f_A	303	Human Mst3 Kinase Length = 303		5e-07
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		5e-07
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		6e-07
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		6e-07
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		6e-07
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		6e-07
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		6e-07
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-07
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		6e-07
4fie_A	423	Full-Length Human Pak4 Length = 423		6e-07
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		6e-07
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		6e-07
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		6e-07
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		7e-07
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		7e-07
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		7e-07
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		7e-07
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		7e-07
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		7e-07
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		7e-07
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		7e-07
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		7e-07
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		8e-07
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		8e-07
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		8e-07
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-07
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		9e-07
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		9e-07
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-06
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		1e-06
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-06
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		1e-06
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-06
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-06
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-06
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-06
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-06
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-06
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-06
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-06
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-06
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		2e-06
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-06
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-06
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-06
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-06
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-06
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-06
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-06
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-06
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-06
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-06
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-06
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-06
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-06
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-06
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-06
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		3e-06
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-06
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-06
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		3e-06
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		3e-06
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		3e-06
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-06
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		3e-06
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		3e-06
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		3e-06
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		4e-06
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		4e-06
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		4e-06
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		4e-06
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		4e-06
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		4e-06
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		4e-06
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		4e-06
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		5e-06
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		6e-06
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		6e-06
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		6e-06
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		7e-06
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		7e-06
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		7e-06
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		7e-06
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		7e-06
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		8e-06
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		8e-06
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		8e-06
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		9e-06
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		1e-05
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-05
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-05
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-05
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-05
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-05
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-05
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-05
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-05
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-05
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-05
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		1e-05
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-05
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-05
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-05
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-05
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-05
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-05
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-05
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-05
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-05
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		1e-05
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-05
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		1e-05
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-05
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-05
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-05
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-05
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-05
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-05
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-05
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-05
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-05
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-05
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-05
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-05
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-05
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-05
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-05
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-05
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-05
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-05
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-05
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-05
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-05
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-05
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-05
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-05
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-05
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-05
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-05
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-05
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		2e-05
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-05
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-05
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-05
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-05
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-05
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-05
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-05
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-05
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-05
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-05
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-05
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-05
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		3e-05
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		3e-05
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		3e-05
3kk9_A	282	Camkii Substrate Complex B Length = 282		3e-05
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-05
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		3e-05
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		3e-05
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-05
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		3e-05
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		3e-05
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		3e-05
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		3e-05
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-05
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		4e-05
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		4e-05
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		4e-05
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		4e-05
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		4e-05
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		4e-05
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		4e-05
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		4e-05
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		4e-05
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-05
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		5e-05
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		5e-05
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		5e-05
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		5e-05
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		5e-05
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		5e-05
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		5e-05
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-05
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-05
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-05
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		5e-05
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		5e-05
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		5e-05
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		5e-05
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		5e-05
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		5e-05
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		5e-05
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		5e-05
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		6e-05
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		6e-05
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		6e-05
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		6e-05
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		7e-05
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		7e-05
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		7e-05
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		7e-05
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		8e-05
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		8e-05
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		8e-05
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		8e-05
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		8e-05
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		8e-05
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		8e-05
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		8e-05
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		8e-05
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		9e-05
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		9e-05
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		9e-05
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		9e-05
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		9e-05
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		9e-05
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		9e-05
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		9e-05
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		9e-05
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		9e-05
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		9e-05
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-04
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-04
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-04
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		1e-04
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-04
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-04
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-04
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-04
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-04
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-04
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		1e-04
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-04
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-04
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-04
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-04
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-04
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-04
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-04
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-04
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-04
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-04
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-04
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-04
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-04
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-04
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-04
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-04
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-04
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-04
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-04
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-04
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-04
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-04
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-04
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-04
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-04
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-04
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-04
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-04
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-04
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-04
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-04
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-04
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-04
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-04
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-04
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-04
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-04
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-04
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-04
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-04
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-04
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-04
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-04
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-04
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-04
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-04
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-04
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-04
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-04
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-04
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-04
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-04
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-04
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-04
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		3e-04
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		3e-04
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		3e-04
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		3e-04
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		3e-04
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-04
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		3e-04
3hec_A	348	P38 In Complex With Imatinib Length = 348		3e-04
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		3e-04
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-04
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		3e-04
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-04
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		3e-04
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		3e-04
2oza_B	366	Structure Of P38alpha Complex Length = 366		3e-04
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		3e-04
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		3e-04
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		3e-04
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		3e-04
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		3e-04
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-04
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		3e-04
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-04
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		3e-04
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		3e-04
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		3e-04
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-04
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-04
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		3e-04
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-04
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		4e-04
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		4e-04
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-04
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		4e-04
3soa_A	444	Full-Length Human Camkii Length = 444		4e-04
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		4e-04
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-04
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		4e-04
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		5e-04
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-04
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		5e-04
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		5e-04
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		5e-04
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		5e-04
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		6e-04
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		7e-04
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		8e-04
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		9e-04
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		9e-04

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  131 bits (330), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 86/296 (29%), Positives = 150/296 (50%), Gaps = 12/296 (4%)
Query: 42  IRAFSAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCF 101
           ++ FS ++L+ A++N+    ++      ++++G L D    ++V +  +  T        
Sbjct: 17  LKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLAD-GXLVAVKRLKEERTQGGELQFQ 75
Query: 102 NNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL------RGFSFASLLIAPRIK 155
             +   S   H+N+L+L G C+      LV+  +  G++      R  S   L    R +
Sbjct: 76  TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 135
Query: 156 IAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEF 215
           IA+  A  +AYLH   D  I+ R +KA+N+LLDE + A + DF L+  +   + HV    
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXA- 194
Query: 216 IKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKK 275
           ++G  G IAPEY +T   +E  DV+ +G  L EL+TG    +     NDDD+ +L++ K 
Sbjct: 195 VRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254
Query: 276 SIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQL 331
            ++  +  A+VD   D   ++  K+E+++ L Q+   C   SP  RP M +V + L
Sbjct: 255 LLKEKKLEALVD--VDLQGNY--KDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 85/296 (28%), Positives = 149/296 (50%), Gaps = 12/296 (4%)
Query: 42  IRAFSAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCF 101
           ++ FS ++L+ A++N+    ++      ++++G L D    ++V +  +           
Sbjct: 25  LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTL-VAVKRLKEERXQGGELQFQ 83
Query: 102 NNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL------RGFSFASLLIAPRIK 155
             +   S   H+N+L+L G C+      LV+  +  G++      R  S   L    R +
Sbjct: 84  TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 143
Query: 156 IAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEF 215
           IA+  A  +AYLH   D  I+ R +KA+N+LLDE + A + DF L+  +   + HV    
Sbjct: 144 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXA- 202
Query: 216 IKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKK 275
           ++G  G IAPEY +T   +E  DV+ +G  L EL+TG    +     NDDD+ +L++ K 
Sbjct: 203 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 262
Query: 276 SIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQL 331
            ++  +  A+VD   D   ++  K+E+++ L Q+   C   SP  RP M +V + L
Sbjct: 263 LLKEKKLEALVD--VDLQGNY--KDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 314

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 93/290 (32%), Positives = 142/290 (48%), Gaps = 19/290 (6%)
Query: 49  DLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSS 108
           DL++ATNN+D   +I      ++++G L D  +    +K     +   +E     I   S
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAK--VALKRRTPESSQGIEEFETEIETLS 90
Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLL------IAPRIKIAMEIAN 162
             +H +++ LIG C E     L+++ ++ G L+   + S L         R++I +  A 
Sbjct: 91  FCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR 150
Query: 163 AVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPE-GETHVREEFIKGAYG 221
            + YLH    R I+ R +K+ N+LLDEN+  K+ DF +S    E G+TH+    +KG  G
Sbjct: 151 GLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHL-XXVVKGTLG 206
Query: 222 FIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNR 281
           +I PEYF      E  DVYSFG  L E+L  C       +   + + + E+A +S  N +
Sbjct: 207 YIDPEYFIKGRLTEKSDVYSFGVVLFEVL--CARSAIVQSLPREMVNLAEWAVESHNNGQ 264
Query: 282 FGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQL 331
              IVDP    D   P   E L+  G    KCL+ S E RP M DV  +L
Sbjct: 265 LEQIVDPNL-ADKIRP---ESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  111 bits (278), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 92/290 (31%), Positives = 141/290 (48%), Gaps = 19/290 (6%)
Query: 49  DLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSS 108
           DL++ATNN+D   +I      ++++G L D  +    +K     +   +E     I   S
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAK--VALKRRTPESSQGIEEFETEIETLS 90
Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLL------IAPRIKIAMEIAN 162
             +H +++ LIG C E     L+++ ++ G L+   + S L         R++I +  A 
Sbjct: 91  FCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR 150
Query: 163 AVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPE-GETHVREEFIKGAYG 221
            + YLH    R I+ R +K+ N+LLDEN+  K+ DF +S    E  +TH+    +KG  G
Sbjct: 151 GLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHL-XXVVKGTLG 206
Query: 222 FIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNR 281
           +I PEYF      E  DVYSFG  L E+L  C       +   + + + E+A +S  N +
Sbjct: 207 YIDPEYFIKGRLTEKSDVYSFGVVLFEVL--CARSAIVQSLPREMVNLAEWAVESHNNGQ 264
Query: 282 FGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQL 331
              IVDP    D   P   E L+  G    KCL+ S E RP M DV  +L
Sbjct: 265 LEQIVDPNL-ADKIRP---ESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 69/235 (29%), Positives = 106/235 (45%), Gaps = 38/235 (16%)
Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIKI--AMEIANAVA 165
           + +KH NI+ L G CL+     LV E  + G L     +   I P I +  A++IA  + 
Sbjct: 61  AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRV-LSGKRIPPDILVNWAVQIARGMN 119
Query: 166 YLHVGFDRPIVFRCIKASNVLLDE--------NYSAKLHDFSLSVSIPEGETHVREEF-I 216
           YLH     PI+ R +K+SN+L+ +        N   K+ DF L+      E H   +   
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA-----REWHRTTKMSA 174
Query: 217 KGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKS 276
            GAY ++APE    S F++  DV+S+G  L ELLTG   + F+G    D L V       
Sbjct: 175 AGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTG--EVPFRG---IDGLAV------- 222
Query: 277 IENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQL 331
                +G  ++ +     + P      +   +LM  C +  P  RP   ++  QL
Sbjct: 223 ----AYGVAMNKL-----ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQL 268

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/150 (35%), Positives = 79/150 (52%), Gaps = 9/150 (6%)
Query: 110 MKHKNILKLIGCCLETELPTL--VFESVKYGTLRGF-SFASLLIAPRIKIAMEIANAVAY 166
           + H++I+K  GCC +    +L  V E V  G+LR +    S+ +A  +  A +I   +AY
Sbjct: 90  LYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAY 149
Query: 167 LHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGET--HVREEFIKGAYGFIA 224
           LH    +  + R + A NVLLD +   K+ DF L+ ++PEG     VRE+     + + A
Sbjct: 150 LHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWY-A 205
Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLTGCN 254
           PE      F    DV+SFG  L ELLT C+
Sbjct: 206 PECLKEYKFYYASDVWSFGVTLYELLTHCD 235

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 53/150 (35%), Positives = 80/150 (53%), Gaps = 9/150 (6%)
Query: 110 MKHKNILKLIGCCLETELPTL--VFESVKYGTLRGF-SFASLLIAPRIKIAMEIANAVAY 166
           + H++I+K  GCC +    +L  V E V  G+LR +    S+ +A  +  A +I   +AY
Sbjct: 73  LYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAY 132
Query: 167 LHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH--VREEFIKGAYGFIA 224
           LH    +  + R + A NVLLD +   K+ DF L+ ++PEG  +  VRE+     + + A
Sbjct: 133 LHA---QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-A 188
Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLTGCN 254
           PE      F    DV+SFG  L ELLT C+
Sbjct: 189 PECLKEYKFYYASDVWSFGVTLYELLTHCD 218

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 53/150 (35%), Positives = 80/150 (53%), Gaps = 9/150 (6%)
Query: 110 MKHKNILKLIGCCLETELPTL--VFESVKYGTLRGF-SFASLLIAPRIKIAMEIANAVAY 166
           + H++I+K  GCC +    +L  V E V  G+LR +    S+ +A  +  A +I   +AY
Sbjct: 73  LYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAY 132
Query: 167 LHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH--VREEFIKGAYGFIA 224
           LH    +  + R + A NVLLD +   K+ DF L+ ++PEG  +  VRE+     + + A
Sbjct: 133 LH---SQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-A 188
Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLTGCN 254
           PE      F    DV+SFG  L ELLT C+
Sbjct: 189 PECLKEYKFYYASDVWSFGVTLYELLTHCD 218

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 54/155 (34%), Positives = 79/155 (50%), Gaps = 19/155 (12%)
Query: 110 MKHKNILKLIGCCLETELPT--LVFESVKYGTLRGF------SFASLLIAPRIKIAMEIA 161
           + H++I+K  GCC +    +  LV E V  G+LR +        A LL+      A +I 
Sbjct: 67  LYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLL-----FAQQIC 121
Query: 162 NAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH--VREEFIKGA 219
             +AYLH    +  + R + A NVLLD +   K+ DF L+ ++PEG  +  VRE+     
Sbjct: 122 EGMAYLHA---QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV 178
Query: 220 YGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCN 254
           + + APE      F    DV+SFG  L ELLT C+
Sbjct: 179 FWY-APECLKECKFYYASDVWSFGVTLYELLTYCD 212

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 54/155 (34%), Positives = 79/155 (50%), Gaps = 19/155 (12%)
Query: 110 MKHKNILKLIGCCLETELPT--LVFESVKYGTLRGF------SFASLLIAPRIKIAMEIA 161
           + H++I+K  GCC +    +  LV E V  G+LR +        A LL+      A +I 
Sbjct: 68  LYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLL-----FAQQIC 122
Query: 162 NAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH--VREEFIKGA 219
             +AYLH    +  + R + A NVLLD +   K+ DF L+ ++PEG  +  VRE+     
Sbjct: 123 EGMAYLHA---QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV 179
Query: 220 YGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCN 254
           + + APE      F    DV+SFG  L ELLT C+
Sbjct: 180 FWY-APECLKECKFYYASDVWSFGVTLYELLTYCD 213

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 63/279 (22%), Positives = 116/279 (41%), Gaps = 52/279 (18%)
Query: 83  ISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRG 142
           ++V    +N++  ++    +      Q+ H +++KL G C +     L+ E  KYG+LRG
Sbjct: 56  VAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRG 115
Query: 143 FSFASLLIAPR--------------------------IKIAMEIANAVAYLHVGFDRPIV 176
           F   S  + P                           I  A +I+  + YL    +  +V
Sbjct: 116 FLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLV 172
Query: 177 FRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEM 236
            R + A N+L+ E    K+ DF LS  + E +++V+    +    ++A E      +   
Sbjct: 173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQ 232
Query: 237 CDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNS 295
            DV+SFG  L E++T G N   + G   +    +L+   +             +   DN 
Sbjct: 233 SDVWSFGVLLWEIVTLGGN--PYPGIPPERLFNLLKTGHR-------------MERPDNC 277
Query: 296 FPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQM 334
                   + + +LM +C  + P+ RP+  D++K L +M
Sbjct: 278 S-------EEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/279 (22%), Positives = 115/279 (41%), Gaps = 52/279 (18%)
Query: 83  ISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRG 142
           ++V    +N++  ++    +      Q+ H +++KL G C +     L+ E  KYG+LRG
Sbjct: 56  VAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRG 115
Query: 143 FSFASLLIAPR--------------------------IKIAMEIANAVAYLHVGFDRPIV 176
           F   S  + P                           I  A +I+  + YL    +  +V
Sbjct: 116 FLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMSLV 172
Query: 177 FRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEM 236
            R + A N+L+ E    K+ DF LS  + E ++ V+    +    ++A E      +   
Sbjct: 173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQ 232
Query: 237 CDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNS 295
            DV+SFG  L E++T G N   + G   +    +L+   +             +   DN 
Sbjct: 233 SDVWSFGVLLWEIVTLGGN--PYPGIPPERLFNLLKTGHR-------------MERPDNC 277
Query: 296 FPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQM 334
                   + + +LM +C  + P+ RP+  D++K L +M
Sbjct: 278 S-------EEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/279 (22%), Positives = 115/279 (41%), Gaps = 52/279 (18%)
Query: 83  ISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRG 142
           ++V    +N++  ++    +      Q+ H +++KL G C +     L+ E  KYG+LRG
Sbjct: 56  VAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRG 115
Query: 143 FSFASLLIAPR--------------------------IKIAMEIANAVAYLHVGFDRPIV 176
           F   S  + P                           I  A +I+  + YL    +  +V
Sbjct: 116 FLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLV 172
Query: 177 FRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEM 236
            R + A N+L+ E    K+ DF LS  + E ++ V+    +    ++A E      +   
Sbjct: 173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQ 232
Query: 237 CDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNS 295
            DV+SFG  L E++T G N   + G   +    +L+   +             +   DN 
Sbjct: 233 SDVWSFGVLLWEIVTLGGN--PYPGIPPERLFNLLKTGHR-------------MERPDNC 277
Query: 296 FPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQM 334
                   + + +LM +C  + P+ RP+  D++K L +M
Sbjct: 278 S-------EEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 78/292 (26%), Positives = 118/292 (40%), Gaps = 32/292 (10%)
Query: 46  SAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPI--SVMKFHDNSTLDDVEYCF-N 102
           S +D +      +L + I       + +G  +  + P     +K   N T D V   F  
Sbjct: 6   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ 65
Query: 103 NIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFA---SLLIAPRIKIAME 159
             +   Q  H +I+KLIG   E  +  ++ E    G LR F      SL +A  I  A +
Sbjct: 66  EALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQ 124
Query: 160 IANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGA 219
           ++ A+AYL     +  V R I A NVL+  N   KL DF LS  + E  T+ +    K  
Sbjct: 125 LSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLP 180
Query: 220 YGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIEN 279
             ++APE      F    DV+ FG  + E+L    V  F+G  N+D +  +E  ++    
Sbjct: 181 IKWMAPESINFRRFTSASDVWMFGVCMWEILMH-GVKPFQGVKNNDVIGRIENGER---- 235
Query: 280 NRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQL 331
                            P       +L  LM KC +  P  RP   ++  QL
Sbjct: 236 ----------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQL 271

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 78/292 (26%), Positives = 118/292 (40%), Gaps = 32/292 (10%)
Query: 46  SAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPI--SVMKFHDNSTLDDVEYCF-N 102
           S +D +      +L + I       + +G  +  + P     +K   N T D V   F  
Sbjct: 29  STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ 88
Query: 103 NIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFA---SLLIAPRIKIAME 159
             +   Q  H +I+KLIG   E  +  ++ E    G LR F      SL +A  I  A +
Sbjct: 89  EALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQ 147
Query: 160 IANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGA 219
           ++ A+AYL     +  V R I A NVL+  N   KL DF LS  + E  T+ +    K  
Sbjct: 148 LSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLP 203
Query: 220 YGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIEN 279
             ++APE      F    DV+ FG  + E+L    V  F+G  N+D +  +E  ++    
Sbjct: 204 IKWMAPESINFRRFTSASDVWMFGVCMWEILMH-GVKPFQGVKNNDVIGRIENGER---- 258
Query: 280 NRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQL 331
                            P       +L  LM KC +  P  RP   ++  QL
Sbjct: 259 ----------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQL 294

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 78/292 (26%), Positives = 118/292 (40%), Gaps = 32/292 (10%)
Query: 46  SAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISV--MKFHDNSTLDDVEYCF-N 102
           S +D +      +L + I       + +G  +  + P     +K   N T D V   F  
Sbjct: 1   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQ 60
Query: 103 NIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFA---SLLIAPRIKIAME 159
             +   Q  H +I+KLIG   E  +  ++ E    G LR F      SL +A  I  A +
Sbjct: 61  EALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQ 119
Query: 160 IANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGA 219
           ++ A+AYL     +  V R I A NVL+  N   KL DF LS  + E  T+ +    K  
Sbjct: 120 LSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLP 175
Query: 220 YGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIEN 279
             ++APE      F    DV+ FG  + E+L    V  F+G  N+D +  +E  ++    
Sbjct: 176 IKWMAPESINFRRFTSASDVWMFGVCMWEILMH-GVKPFQGVKNNDVIGRIENGER---- 230
Query: 280 NRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQL 331
                            P       +L  LM KC +  P  RP   ++  QL
Sbjct: 231 ----------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQL 266

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 78/292 (26%), Positives = 118/292 (40%), Gaps = 32/292 (10%)
Query: 46  SAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPI--SVMKFHDNSTLDDVEYCF-N 102
           S +D +      +L + I       + +G  +  + P     +K   N T D V   F  
Sbjct: 1   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ 60
Query: 103 NIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF---SFASLLIAPRIKIAME 159
             +   Q  H +I+KLIG   E  +  ++ E    G LR F      SL +A  I  A +
Sbjct: 61  EALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQ 119
Query: 160 IANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGA 219
           ++ A+AYL     +  V R I A NVL+  N   KL DF LS  + E  T+ +    K  
Sbjct: 120 LSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLP 175
Query: 220 YGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIEN 279
             ++APE      F    DV+ FG  + E+L    V  F+G  N+D +  +E  ++    
Sbjct: 176 IKWMAPESINFRRFTSASDVWMFGVCMWEILMH-GVKPFQGVKNNDVIGRIENGER---- 230
Query: 280 NRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQL 331
                            P       +L  LM KC +  P  RP   ++  QL
Sbjct: 231 ----------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQL 266

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 78/292 (26%), Positives = 118/292 (40%), Gaps = 32/292 (10%)
Query: 46  SAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPI--SVMKFHDNSTLDDVEYCF-N 102
           S +D +      +L + I       + +G  +  + P     +K   N T D V   F  
Sbjct: 4   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ 63
Query: 103 NIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF---SFASLLIAPRIKIAME 159
             +   Q  H +I+KLIG   E  +  ++ E    G LR F      SL +A  I  A +
Sbjct: 64  EALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQ 122
Query: 160 IANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGA 219
           ++ A+AYL     +  V R I A NVL+  N   KL DF LS  + E  T+ +    K  
Sbjct: 123 LSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLP 178
Query: 220 YGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIEN 279
             ++APE      F    DV+ FG  + E+L    V  F+G  N+D +  +E  ++    
Sbjct: 179 IKWMAPESINFRRFTSASDVWMFGVCMWEILMH-GVKPFQGVKNNDVIGRIENGER---- 233
Query: 280 NRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQL 331
                            P       +L  LM KC +  P  RP   ++  QL
Sbjct: 234 ----------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQL 269

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 78/292 (26%), Positives = 118/292 (40%), Gaps = 32/292 (10%)
Query: 46  SAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPI--SVMKFHDNSTLDDVEYCF-N 102
           S +D +      +L + I       + +G  +  + P     +K   N T D V   F  
Sbjct: 3   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ 62
Query: 103 NIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF---SFASLLIAPRIKIAME 159
             +   Q  H +I+KLIG   E  +  ++ E    G LR F      SL +A  I  A +
Sbjct: 63  EALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQ 121
Query: 160 IANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGA 219
           ++ A+AYL     +  V R I A NVL+  N   KL DF LS  + E  T+ +    K  
Sbjct: 122 LSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLP 177
Query: 220 YGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIEN 279
             ++APE      F    DV+ FG  + E+L    V  F+G  N+D +  +E  ++    
Sbjct: 178 IKWMAPESINFRRFTSASDVWMFGVCMWEILMH-GVKPFQGVKNNDVIGRIENGER---- 232
Query: 280 NRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQL 331
                            P       +L  LM KC +  P  RP   ++  QL
Sbjct: 233 ----------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQL 268

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 78/292 (26%), Positives = 118/292 (40%), Gaps = 32/292 (10%)
Query: 46  SAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISV--MKFHDNSTLDDVEYCF-N 102
           S +D +      +L + I       + +G  +  + P     +K   N T D V   F  
Sbjct: 381 STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQ 440
Query: 103 NIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFA---SLLIAPRIKIAME 159
             +   Q  H +I+KLIG   E  +  ++ E    G LR F      SL +A  I  A +
Sbjct: 441 EALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQ 499
Query: 160 IANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGA 219
           ++ A+AYL     +  V R I A NVL+  N   KL DF LS  + E  T+ +    K  
Sbjct: 500 LSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLP 555
Query: 220 YGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIEN 279
             ++APE      F    DV+ FG  + E+L    V  F+G  N+D +  +E  ++    
Sbjct: 556 IKWMAPESINFRRFTSASDVWMFGVCMWEILMH-GVKPFQGVKNNDVIGRIENGER---- 610
Query: 280 NRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQL 331
                            P       +L  LM KC +  P  RP   ++  QL
Sbjct: 611 ----------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQL 646

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 78/292 (26%), Positives = 117/292 (40%), Gaps = 32/292 (10%)
Query: 46  SAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISV--MKFHDNSTLDDV-EYCFN 102
           S +D +      +L + I       + +G  +  + P     +K   N T D V E    
Sbjct: 1   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQ 60
Query: 103 NIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFA---SLLIAPRIKIAME 159
             +   Q  H +I+KLIG   E  +  ++ E    G LR F      SL +A  I  A +
Sbjct: 61  EALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQ 119
Query: 160 IANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGA 219
           ++ A+AYL     +  V R I A NVL+  N   KL DF LS  + E  T  +    K  
Sbjct: 120 LSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTXXKASKGKLP 175
Query: 220 YGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIEN 279
             ++APE      F    DV+ FG  + E+L    V  F+G  N+D +  +E  ++    
Sbjct: 176 IKWMAPESINFRRFTSASDVWMFGVCMWEILMH-GVKPFQGVKNNDVIGRIENGER---- 230
Query: 280 NRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQL 331
                            P       +L  LM KC +  P  RP   ++  QL
Sbjct: 231 ----------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQL 266

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/239 (26%), Positives = 102/239 (42%), Gaps = 45/239 (18%)
Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF-----SFASLLIAPRIKIAMEIAN 162
           S++ H NI+KL G CL      LV E  + G+L               A  +   ++ + 
Sbjct: 57  SRVNHPNIVKLYGACLNPV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQ 114
Query: 163 AVAYLHVGFDRPIVFRCIKASNVLLDENYSA-KLHDFSLSVSIPEGETHVREEFIKGAYG 221
            VAYLH    + ++ R +K  N+LL    +  K+ DF  +  I   +TH+     KG+  
Sbjct: 115 GVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI---QTHMTNN--KGSAA 169
Query: 222 FIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNR 281
           ++APE F  S+++E CDV+S+G  L E++T                              
Sbjct: 170 WMAPEVFEGSNYSEKCDVFSWGIILWEVIT--------------------------RRKP 203
Query: 282 FGAIVDPIFD-----EDNSFPGKEEKL-QSLGQLMYKCLSKSPEHRPLMVDVAKQLRQM 334
           F  I  P F       + + P   + L + +  LM +C SK P  RP M ++ K +  +
Sbjct: 204 FDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL 262

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/239 (26%), Positives = 102/239 (42%), Gaps = 45/239 (18%)
Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF-----SFASLLIAPRIKIAMEIAN 162
           S++ H NI+KL G CL      LV E  + G+L               A  +   ++ + 
Sbjct: 56  SRVNHPNIVKLYGACLNPV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQ 113
Query: 163 AVAYLHVGFDRPIVFRCIKASNVLLDENYSA-KLHDFSLSVSIPEGETHVREEFIKGAYG 221
            VAYLH    + ++ R +K  N+LL    +  K+ DF  +  I   +TH+     KG+  
Sbjct: 114 GVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI---QTHMTNN--KGSAA 168
Query: 222 FIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNR 281
           ++APE F  S+++E CDV+S+G  L E++T                              
Sbjct: 169 WMAPEVFEGSNYSEKCDVFSWGIILWEVIT--------------------------RRKP 202
Query: 282 FGAIVDPIFD-----EDNSFPGKEEKL-QSLGQLMYKCLSKSPEHRPLMVDVAKQLRQM 334
           F  I  P F       + + P   + L + +  LM +C SK P  RP M ++ K +  +
Sbjct: 203 FDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL 261

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 72/250 (28%), Positives = 104/250 (41%), Gaps = 30/250 (12%)
Query: 86  MKFHDNSTLDDV-EYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF- 143
           +K   N T D V E      +   Q  H +I+KLIG   E  +  ++ E    G LR F 
Sbjct: 40  IKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFL 98
Query: 144 --SFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLS 201
                SL +A  I  A +++ A+AYL     +  V R I A NVL+  N   KL DF LS
Sbjct: 99  QVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLS 155
Query: 202 VSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGN 261
             + E  T+ +    K    ++APE      F    DV+ FG  + E+L    V  F+G 
Sbjct: 156 RYM-EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMH-GVKPFQGV 213
Query: 262 GNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHR 321
            N+D +  +E  ++                     P       +L  LM KC +  P  R
Sbjct: 214 KNNDVIGRIENGER--------------------LPMPPNCPPTLYSLMTKCWAYDPSRR 253
Query: 322 PLMVDVAKQL 331
           P   ++  QL
Sbjct: 254 PRFTELKAQL 263

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 64/278 (23%), Positives = 118/278 (42%), Gaps = 33/278 (11%)
Query: 71  LFEGTLVDQDRP---ISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETE- 126
           ++ GTL+D D      +V   +  + + +V       +      H N+L L+G CL +E 
Sbjct: 46  VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 105
Query: 127 LPTLVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKAS 183
            P +V   +K+G LR F      +  +   I   +++A  + YL     +  V R + A 
Sbjct: 106 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAAR 162
Query: 184 NVLLDENYSAKLHDFSLSVSIPEGETHV--REEFIKGAYGFIAPEYFATSSFNEMCDVYS 241
           N +LDE ++ K+ DF L+  + + E +    +   K    ++A E   T  F    DV+S
Sbjct: 163 NCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWS 222
Query: 242 FGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEE 301
           FG  L EL+T       +G     D+   +     ++  R   ++ P +  D        
Sbjct: 223 FGVLLWELMT-------RGAPPYPDVNTFDITVYLLQGRR---LLQPEYCPD-------- 264
Query: 302 KLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLSVV 339
               L ++M KC     E RP   ++  ++  ++ + +
Sbjct: 265 ---PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 299

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 64/274 (23%), Positives = 116/274 (42%), Gaps = 33/274 (12%)
Query: 71  LFEGTLVDQDRP---ISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETE- 126
           ++ GTL+D D      +V   +  + + +V       +      H N+L L+G CL +E 
Sbjct: 64  VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 123
Query: 127 LPTLVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKAS 183
            P +V   +K+G LR F      +  +   I   +++A  + YL     +  V R + A 
Sbjct: 124 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAAR 180
Query: 184 NVLLDENYSAKLHDFSLSVSIPEGETHV--REEFIKGAYGFIAPEYFATSSFNEMCDVYS 241
           N +LDE ++ K+ DF L+  + + E +    +   K    ++A E   T  F    DV+S
Sbjct: 181 NCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWS 240
Query: 242 FGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEE 301
           FG  L EL+T       +G     D+   +     ++  R   ++ P +  D        
Sbjct: 241 FGVLLWELMT-------RGAPPYPDVNTFDITVYLLQGRR---LLQPEYCPD-------- 282
Query: 302 KLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMY 335
               L ++M KC     E RP   ++  ++  ++
Sbjct: 283 ---PLYEVMLKCWHPKAEMRPSFSELVSRISAIF 313

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 64/278 (23%), Positives = 118/278 (42%), Gaps = 33/278 (11%)
Query: 71  LFEGTLVDQDRP---ISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETE- 126
           ++ GTL+D D      +V   +  + + +V       +      H N+L L+G CL +E 
Sbjct: 38  VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 97
Query: 127 LPTLVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKAS 183
            P +V   +K+G LR F      +  +   I   +++A  + YL     +  V R + A 
Sbjct: 98  SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAAR 154
Query: 184 NVLLDENYSAKLHDFSLSVSIPEGETHV--REEFIKGAYGFIAPEYFATSSFNEMCDVYS 241
           N +LDE ++ K+ DF L+  + + E +    +   K    ++A E   T  F    DV+S
Sbjct: 155 NCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWS 214
Query: 242 FGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEE 301
           FG  L EL+T       +G     D+   +     ++  R   ++ P +  D        
Sbjct: 215 FGVLLWELMT-------RGAPPYPDVNTFDITVYLLQGRR---LLQPEYCPD-------- 256
Query: 302 KLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLSVV 339
               L ++M KC     E RP   ++  ++  ++ + +
Sbjct: 257 ---PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 291

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 64/278 (23%), Positives = 118/278 (42%), Gaps = 33/278 (11%)
Query: 71  LFEGTLVDQDRP---ISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETE- 126
           ++ GTL+D D      +V   +  + + +V       +      H N+L L+G CL +E 
Sbjct: 41  VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 100
Query: 127 LPTLVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKAS 183
            P +V   +K+G LR F      +  +   I   +++A  + YL     +  V R + A 
Sbjct: 101 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAAR 157
Query: 184 NVLLDENYSAKLHDFSLSVSIPEGETHV--REEFIKGAYGFIAPEYFATSSFNEMCDVYS 241
           N +LDE ++ K+ DF L+  + + E +    +   K    ++A E   T  F    DV+S
Sbjct: 158 NCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWS 217
Query: 242 FGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEE 301
           FG  L EL+T       +G     D+   +     ++  R   ++ P +  D        
Sbjct: 218 FGVLLWELMT-------RGAPPYPDVNTFDITVYLLQGRR---LLQPEYCPD-------- 259
Query: 302 KLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLSVV 339
               L ++M KC     E RP   ++  ++  ++ + +
Sbjct: 260 ---PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 92/210 (43%), Gaps = 29/210 (13%)
Query: 104 IVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL-----RGFSFASLLIAPRIKIAM 158
           +    +++H NI+  +G   +    ++V E +  G+L     +  +   L    R+ +A 
Sbjct: 85  VAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAY 144
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           ++A  + YLH   + PIV R +K+ N+L+D+ Y+ K+ DF LS    +  T +  +   G
Sbjct: 145 DVAKGMNYLH-NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAG 201
Query: 219 AYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-------------------GCNVLEFK 259
              ++APE       NE  DVYSFG  L EL T                    C  LE  
Sbjct: 202 TPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIP 261
Query: 260 GNGNDDDLTVLE--YAKKSIENNRFGAIVD 287
            N N     ++E  +  +  +   F  I+D
Sbjct: 262 RNLNPQVAAIIEGCWTNEPWKRPSFATIMD 291

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 64/274 (23%), Positives = 116/274 (42%), Gaps = 33/274 (12%)
Query: 71  LFEGTLVDQDRP---ISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETE- 126
           ++ GTL+D D      +V   +  + + +V       +      H N+L L+G CL +E 
Sbjct: 65  VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 124
Query: 127 LPTLVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKAS 183
            P +V   +K+G LR F      +  +   I   +++A  + YL     +  V R + A 
Sbjct: 125 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAAR 181
Query: 184 NVLLDENYSAKLHDFSLSVSIPEGETHV--REEFIKGAYGFIAPEYFATSSFNEMCDVYS 241
           N +LDE ++ K+ DF L+  + + E +    +   K    ++A E   T  F    DV+S
Sbjct: 182 NCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWS 241
Query: 242 FGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEE 301
           FG  L EL+T       +G     D+   +     ++  R   ++ P +  D        
Sbjct: 242 FGVLLWELMT-------RGAPPYPDVNTFDITVYLLQGRR---LLQPEYCPD-------- 283
Query: 302 KLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMY 335
               L ++M KC     E RP   ++  ++  ++
Sbjct: 284 ---PLYEVMLKCWHPKAEMRPSFSELVSRISAIF 314

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 64/278 (23%), Positives = 118/278 (42%), Gaps = 33/278 (11%)
Query: 71  LFEGTLVDQDRP---ISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETE- 126
           ++ GTL+D D      +V   +  + + +V       +      H N+L L+G CL +E 
Sbjct: 45  VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 104
Query: 127 LPTLVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKAS 183
            P +V   +K+G LR F      +  +   I   +++A  + YL     +  V R + A 
Sbjct: 105 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAAR 161
Query: 184 NVLLDENYSAKLHDFSLSVSIPEGETHV--REEFIKGAYGFIAPEYFATSSFNEMCDVYS 241
           N +LDE ++ K+ DF L+  + + E +    +   K    ++A E   T  F    DV+S
Sbjct: 162 NCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWS 221
Query: 242 FGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEE 301
           FG  L EL+T       +G     D+   +     ++  R   ++ P +  D        
Sbjct: 222 FGVLLWELMT-------RGAPPYPDVNTFDITVYLLQGRR---LLQPEYCPD-------- 263
Query: 302 KLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLSVV 339
               L ++M KC     E RP   ++  ++  ++ + +
Sbjct: 264 ---PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 298

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 64/278 (23%), Positives = 118/278 (42%), Gaps = 33/278 (11%)
Query: 71  LFEGTLVDQDRP---ISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETE- 126
           ++ GTL+D D      +V   +  + + +V       +      H N+L L+G CL +E 
Sbjct: 44  VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 103
Query: 127 LPTLVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKAS 183
            P +V   +K+G LR F      +  +   I   +++A  + YL     +  V R + A 
Sbjct: 104 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAAR 160
Query: 184 NVLLDENYSAKLHDFSLSVSIPEGETHV--REEFIKGAYGFIAPEYFATSSFNEMCDVYS 241
           N +LDE ++ K+ DF L+  + + E +    +   K    ++A E   T  F    DV+S
Sbjct: 161 NCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWS 220
Query: 242 FGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEE 301
           FG  L EL+T       +G     D+   +     ++  R   ++ P +  D        
Sbjct: 221 FGVLLWELMT-------RGAPPYPDVNTFDITVYLLQGRR---LLQPEYCPD-------- 262
Query: 302 KLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLSVV 339
               L ++M KC     E RP   ++  ++  ++ + +
Sbjct: 263 ---PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 297

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 64/278 (23%), Positives = 118/278 (42%), Gaps = 33/278 (11%)
Query: 71  LFEGTLVDQDRP---ISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETE- 126
           ++ GTL+D D      +V   +  + + +V       +      H N+L L+G CL +E 
Sbjct: 43  VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 102
Query: 127 LPTLVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKAS 183
            P +V   +K+G LR F      +  +   I   +++A  + YL     +  V R + A 
Sbjct: 103 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAAR 159
Query: 184 NVLLDENYSAKLHDFSLSVSIPEGETHV--REEFIKGAYGFIAPEYFATSSFNEMCDVYS 241
           N +LDE ++ K+ DF L+  + + E +    +   K    ++A E   T  F    DV+S
Sbjct: 160 NCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWS 219
Query: 242 FGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEE 301
           FG  L EL+T       +G     D+   +     ++  R   ++ P +  D        
Sbjct: 220 FGVLLWELMT-------RGAPPYPDVNTFDITVYLLQGRR---LLQPEYCPD-------- 261
Query: 302 KLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLSVV 339
               L ++M KC     E RP   ++  ++  ++ + +
Sbjct: 262 ---PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 296

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 64/278 (23%), Positives = 118/278 (42%), Gaps = 33/278 (11%)
Query: 71  LFEGTLVDQDRP---ISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETE- 126
           ++ GTL+D D      +V   +  + + +V       +      H N+L L+G CL +E 
Sbjct: 46  VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 105
Query: 127 LPTLVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKAS 183
            P +V   +K+G LR F      +  +   I   +++A  + YL     +  V R + A 
Sbjct: 106 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAAR 162
Query: 184 NVLLDENYSAKLHDFSLSVSIPEGETHV--REEFIKGAYGFIAPEYFATSSFNEMCDVYS 241
           N +LDE ++ K+ DF L+  + + E +    +   K    ++A E   T  F    DV+S
Sbjct: 163 NCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWS 222
Query: 242 FGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEE 301
           FG  L EL+T       +G     D+   +     ++  R   ++ P +  D        
Sbjct: 223 FGVLLWELMT-------RGAPPYPDVNTFDITVYLLQGRR---LLQPEYCPD-------- 264
Query: 302 KLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLSVV 339
               L ++M KC     E RP   ++  ++  ++ + +
Sbjct: 265 ---PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 299

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/278 (23%), Positives = 117/278 (42%), Gaps = 33/278 (11%)
Query: 71  LFEGTLVDQDRP---ISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETE- 126
           ++ GTL+D D      +V   +  + + +V       +      H N+L L+G CL +E 
Sbjct: 45  VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 104
Query: 127 LPTLVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKAS 183
            P +V   +K+G LR F      +  +   I   +++A  + YL     +  V R + A 
Sbjct: 105 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAAR 161
Query: 184 NVLLDENYSAKLHDFSLSVSIPEGETHV--REEFIKGAYGFIAPEYFATSSFNEMCDVYS 241
           N +LDE ++ K+ DF L+  + + E      +   K    ++A E   T  F    DV+S
Sbjct: 162 NCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWS 221
Query: 242 FGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEE 301
           FG  L EL+T       +G     D+   +     ++  R   ++ P +  D        
Sbjct: 222 FGVLLWELMT-------RGAPPYPDVNTFDITVYLLQGRR---LLQPEYCPD-------- 263
Query: 302 KLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLSVV 339
               L ++M KC     E RP   ++  ++  ++ + +
Sbjct: 264 ---PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 298

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 77/292 (26%), Positives = 117/292 (40%), Gaps = 32/292 (10%)
Query: 46  SAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISV--MKFHDNSTLDDVEYCF-N 102
           S +D +      +L + I       + +G  +  + P     +K   N T D V   F  
Sbjct: 1   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQ 60
Query: 103 NIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFA---SLLIAPRIKIAME 159
             +   Q  H +I+KLIG   E  +  ++ E    G LR F      SL +A  I  A +
Sbjct: 61  EALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQ 119
Query: 160 IANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGA 219
           ++ A+AYL     +  V R I A NVL+      KL DF LS  + E  T+ +    K  
Sbjct: 120 LSTALAYLE---SKRFVHRDIAARNVLVSATDCVKLGDFGLSRYM-EDSTYYKASKGKLP 175
Query: 220 YGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIEN 279
             ++APE      F    DV+ FG  + E+L    V  F+G  N+D +  +E  ++    
Sbjct: 176 IKWMAPESINFRRFTSASDVWMFGVCMWEILMH-GVKPFQGVKNNDVIGRIENGER---- 230
Query: 280 NRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQL 331
                            P       +L  LM KC +  P  RP   ++  QL
Sbjct: 231 ----------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQL 266

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/247 (26%), Positives = 108/247 (43%), Gaps = 44/247 (17%)
Query: 110 MKHKNILKLIGCCLETELPTLVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANAVAY 166
           ++H N+LK IG   + +    + E +K GTLRG      +    + R+  A +IA+ +AY
Sbjct: 64  LEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAY 123
Query: 167 LHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSV------SIPEGETHVREEFIKGAY 220
           LH      I+ R + + N L+ EN +  + DF L+       + PEG   +++   K  Y
Sbjct: 124 LH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRY 180
Query: 221 G------FIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAK 274
                  ++APE     S++E  DV+SFG  LCE++         G  N D     +Y  
Sbjct: 181 TVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEII---------GRVNADP----DYLP 227
Query: 275 KSIENNRFGAIVDPIFDE---DNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQL 331
           ++++   FG  V    D     N  P       S   +  +C    PE RP  V +   L
Sbjct: 228 RTMD---FGLNVRGFLDRYCPPNCPP-------SFFPITVRCCDLDPEKRPSFVKLEHWL 277
Query: 332 RQMYLSV 338
             + + +
Sbjct: 278 ETLRMHL 284

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 77/292 (26%), Positives = 117/292 (40%), Gaps = 32/292 (10%)
Query: 46  SAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISV--MKFHDNSTLDDVEYCF-N 102
           S +D +      +L + I       + +G  +  + P     +K   N T D V   F  
Sbjct: 381 STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQ 440
Query: 103 NIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFA---SLLIAPRIKIAME 159
             +   Q  H +I+KLIG   E  +  ++ E    G LR F      SL +A  I  A +
Sbjct: 441 EALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQ 499
Query: 160 IANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGA 219
           ++ A+AYL     +  V R I A NVL+      KL DF LS  + E  T+ +    K  
Sbjct: 500 LSTALAYLE---SKRFVHRDIAARNVLVSATDCVKLGDFGLSRYM-EDSTYYKASKGKLP 555
Query: 220 YGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIEN 279
             ++APE      F    DV+ FG  + E+L    V  F+G  N+D +  +E  ++    
Sbjct: 556 IKWMAPESINFRRFTSASDVWMFGVCMWEILMH-GVKPFQGVKNNDVIGRIENGER---- 610
Query: 280 NRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQL 331
                            P       +L  LM KC +  P  RP   ++  QL
Sbjct: 611 ----------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQL 646

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 76/153 (49%), Gaps = 8/153 (5%)
Query: 104 IVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL-----RGFSFASLLIAPRIKIAM 158
           +    +++H NI+  +G   +    ++V E +  G+L     +  +   L    R+ +A 
Sbjct: 85  VAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAY 144
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           ++A  + YLH   + PIV R +K+ N+L+D+ Y+ K+ DF LS    +    +  +   G
Sbjct: 145 DVAKGMNYLH-NRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KASXFLXSKXAAG 201
Query: 219 AYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT 251
              ++APE       NE  DVYSFG  L EL T
Sbjct: 202 TPEWMAPEVLRDEPSNEKSDVYSFGVILWELAT 234

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/279 (22%), Positives = 118/279 (42%), Gaps = 35/279 (12%)
Query: 71  LFEGTLVDQDRP---ISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETE- 126
           ++ GTL+D D      +V   +  + + +V       +      H N+L L+G CL +E 
Sbjct: 46  VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 105
Query: 127 LPTLVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKAS 183
            P +V   +K+G LR F      +  +   I   +++A  + +L     +  V R + A 
Sbjct: 106 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAAR 162
Query: 184 NVLLDENYSAKLHDFSLSVSIPEGE---THVREEFIKGAYGFIAPEYFATSSFNEMCDVY 240
           N +LDE ++ K+ DF L+  + + E    H  +   K    ++A E   T  F    DV+
Sbjct: 163 NCMLDEKFTVKVADFGLARDMYDKEFDSVH-NKTGAKLPVKWMALESLQTQKFTTKSDVW 221
Query: 241 SFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKE 300
           SFG  L EL+T       +G     D+   +     ++  R   ++ P +  D       
Sbjct: 222 SFGVLLWELMT-------RGAPPYPDVNTFDITVYLLQGRR---LLQPEYCPD------- 264
Query: 301 EKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLSVV 339
                L ++M KC     E RP   ++  ++  ++ + +
Sbjct: 265 ----PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 299

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/279 (22%), Positives = 118/279 (42%), Gaps = 35/279 (12%)
Query: 71  LFEGTLVDQDRP---ISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETE- 126
           ++ GTL+D D      +V   +  + + +V       +      H N+L L+G CL +E 
Sbjct: 44  VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 103
Query: 127 LPTLVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKAS 183
            P +V   +K+G LR F      +  +   I   +++A  + +L     +  V R + A 
Sbjct: 104 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAAR 160
Query: 184 NVLLDENYSAKLHDFSLSVSIPEGE---THVREEFIKGAYGFIAPEYFATSSFNEMCDVY 240
           N +LDE ++ K+ DF L+  + + E    H  +   K    ++A E   T  F    DV+
Sbjct: 161 NCMLDEKFTVKVADFGLARDMYDKEFDSVH-NKTGAKLPVKWMALESLQTQKFTTKSDVW 219
Query: 241 SFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKE 300
           SFG  L EL+T       +G     D+   +     ++  R   ++ P +  D       
Sbjct: 220 SFGVLLWELMT-------RGAPPYPDVNTFDITVYLLQGRR---LLQPEYCPD------- 262
Query: 301 EKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLSVV 339
                L ++M KC     E RP   ++  ++  ++ + +
Sbjct: 263 ----PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 297

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/279 (22%), Positives = 118/279 (42%), Gaps = 35/279 (12%)
Query: 71  LFEGTLVDQDRP---ISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETE- 126
           ++ GTL+D D      +V   +  + + +V       +      H N+L L+G CL +E 
Sbjct: 46  VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 105
Query: 127 LPTLVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKAS 183
            P +V   +K+G LR F      +  +   I   +++A  + +L     +  V R + A 
Sbjct: 106 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAAR 162
Query: 184 NVLLDENYSAKLHDFSLSVSIPEGE---THVREEFIKGAYGFIAPEYFATSSFNEMCDVY 240
           N +LDE ++ K+ DF L+  + + E    H  +   K    ++A E   T  F    DV+
Sbjct: 163 NCMLDEKFTVKVADFGLARDMYDKEFDSVH-NKTGAKLPVKWMALESLQTQKFTTKSDVW 221
Query: 241 SFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKE 300
           SFG  L EL+T       +G     D+   +     ++  R   ++ P +  D       
Sbjct: 222 SFGVLLWELMT-------RGAPPYPDVNTFDITVYLLQGRR---LLQPEYCPD------- 264
Query: 301 EKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLSVV 339
                L ++M KC     E RP   ++  ++  ++ + +
Sbjct: 265 ----PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 299

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/275 (23%), Positives = 116/275 (42%), Gaps = 35/275 (12%)
Query: 71  LFEGTLVDQDRP---ISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETE- 126
           ++ GTL+D D      +V   +  + + +V       +      H N+L L+G CL +E 
Sbjct: 105 VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 164
Query: 127 LPTLVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKAS 183
            P +V   +K+G LR F      +  +   I   +++A  + +L     +  V R + A 
Sbjct: 165 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAAR 221
Query: 184 NVLLDENYSAKLHDFSLSVSIPEGE---THVREEFIKGAYGFIAPEYFATSSFNEMCDVY 240
           N +LDE ++ K+ DF L+  + + E    H  +   K    ++A E   T  F    DV+
Sbjct: 222 NCMLDEKFTVKVADFGLARDMYDKEFDSVH-NKTGAKLPVKWMALESLQTQKFTTKSDVW 280
Query: 241 SFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKE 300
           SFG  L EL+T       +G     D+   +     ++  R   ++ P +  D       
Sbjct: 281 SFGVLLWELMT-------RGAPPYPDVNTFDITVYLLQGRR---LLQPEYCPD------- 323
Query: 301 EKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMY 335
                L ++M KC     E RP   ++  ++  ++
Sbjct: 324 ----PLYEVMLKCWHPKAEMRPSFSELVSRISAIF 354

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/275 (23%), Positives = 116/275 (42%), Gaps = 35/275 (12%)
Query: 71  LFEGTLVDQDRP---ISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETE- 126
           ++ GTL+D D      +V   +  + + +V       +      H N+L L+G CL +E 
Sbjct: 47  VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 106
Query: 127 LPTLVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKAS 183
            P +V   +K+G LR F      +  +   I   +++A  + +L     +  V R + A 
Sbjct: 107 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAAR 163
Query: 184 NVLLDENYSAKLHDFSLSVSIPEGE---THVREEFIKGAYGFIAPEYFATSSFNEMCDVY 240
           N +LDE ++ K+ DF L+  + + E    H  +   K    ++A E   T  F    DV+
Sbjct: 164 NCMLDEKFTVKVADFGLARDMLDKEFDSVH-NKTGAKLPVKWMALESLQTQKFTTKSDVW 222
Query: 241 SFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKE 300
           SFG  L EL+T       +G     D+   +     ++  R   ++ P +  D       
Sbjct: 223 SFGVLLWELMT-------RGAPPYPDVNTFDITVYLLQGRR---LLQPEYCPD------- 265
Query: 301 EKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMY 335
                L ++M KC     E RP   ++  ++  ++
Sbjct: 266 ----PLYEVMLKCWHPKAEMRPSFSELVSRISAIF 296

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/275 (23%), Positives = 116/275 (42%), Gaps = 35/275 (12%)
Query: 71  LFEGTLVDQDRP---ISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETE- 126
           ++ GTL+D D      +V   +  + + +V       +      H N+L L+G CL +E 
Sbjct: 47  VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 106
Query: 127 LPTLVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKAS 183
            P +V   +K+G LR F      +  +   I   +++A  + +L     +  V R + A 
Sbjct: 107 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAAR 163
Query: 184 NVLLDENYSAKLHDFSLSVSIPEGE---THVREEFIKGAYGFIAPEYFATSSFNEMCDVY 240
           N +LDE ++ K+ DF L+  + + E    H  +   K    ++A E   T  F    DV+
Sbjct: 164 NCMLDEKFTVKVADFGLARDMYDKEFDSVH-NKTGAKLPVKWMALESLQTQKFTTKSDVW 222
Query: 241 SFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKE 300
           SFG  L EL+T       +G     D+   +     ++  R   ++ P +  D       
Sbjct: 223 SFGVLLWELMT-------RGAPPYPDVNTFDITVYLLQGRR---LLQPEYCPD------- 265
Query: 301 EKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMY 335
                L ++M KC     E RP   ++  ++  ++
Sbjct: 266 ----PLYEVMLKCWHPKAEMRPSFSELVSRISAIF 296

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 92/221 (41%), Gaps = 30/221 (13%)
Query: 110 MKHKNILKLIGCCLETELPTLVFESVKYGTL----RGFSFASLLIAPRIKIAMEIANAVA 165
           + H+N+++L G  L   +  +V E    G+L    R       L+    + A+++A  + 
Sbjct: 72  LDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMG 129
Query: 166 YLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH-VREEFIKGAYGFIA 224
           YL     +  + R + A N+LL      K+ DF L  ++P+ + H V +E  K  + + A
Sbjct: 130 YLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 186
Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA 284
           PE   T +F+   D + FG  L E+ T                    Y ++         
Sbjct: 187 PESLKTRTFSHASDTWMFGVTLWEMFT--------------------YGQEPWIGLNGSQ 226
Query: 285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMV 325
           I+  I  E    P  E+  Q +  +M +C +  PE RP  V
Sbjct: 227 ILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFV 267

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/279 (22%), Positives = 118/279 (42%), Gaps = 35/279 (12%)
Query: 71  LFEGTLVDQDRP---ISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETE- 126
           ++ GTL+D D      +V   +  + + +V       +      H N+L L+G CL +E 
Sbjct: 51  VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 110
Query: 127 LPTLVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKAS 183
            P +V   +K+G LR F      +  +   I   +++A  + +L     +  V R + A 
Sbjct: 111 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAAR 167
Query: 184 NVLLDENYSAKLHDFSLSVSIPEGE---THVREEFIKGAYGFIAPEYFATSSFNEMCDVY 240
           N +LDE ++ K+ DF L+  + + E    H  +   K    ++A E   T  F    DV+
Sbjct: 168 NCMLDEKFTVKVADFGLARDMYDKEFDSVH-NKTGAKLPVKWMALESLQTQKFTTKSDVW 226
Query: 241 SFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKE 300
           SFG  L EL+T       +G     D+   +     ++  R   ++ P +  D       
Sbjct: 227 SFGVLLWELMT-------RGAPPYPDVNTFDITVYLLQGRR---LLQPEYCPD------- 269
Query: 301 EKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLSVV 339
                L ++M KC     E RP   ++  ++  ++ + +
Sbjct: 270 ----PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 304

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 74/148 (50%), Gaps = 6/148 (4%)
Query: 107 SSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF--SFASLLIAPRIKIAMEIANAV 164
           SSQ+ H+NI+ +I    E +   LV E ++  TL  +  S   L +   I    +I + +
Sbjct: 65  SSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGI 124
Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIA 224
            + H   D  IV R IK  N+L+D N + K+ DF ++ ++ E  +  +   + G   + +
Sbjct: 125 KHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET-SLTQTNHVLGTVQYFS 180
Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLTG 252
           PE     + +E  D+YS G  L E+L G
Sbjct: 181 PEQAKGEATDECTDIYSIGIVLYEMLVG 208

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 92/221 (41%), Gaps = 30/221 (13%)
Query: 110 MKHKNILKLIGCCLETELPTLVFESVKYGTL----RGFSFASLLIAPRIKIAMEIANAVA 165
           + H+N+++L G  L   +  +V E    G+L    R       L+    + A+++A  + 
Sbjct: 72  LDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMG 129
Query: 166 YLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH-VREEFIKGAYGFIA 224
           YL     +  + R + A N+LL      K+ DF L  ++P+ + H V +E  K  + + A
Sbjct: 130 YLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 186
Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA 284
           PE   T +F+   D + FG  L E+ T                    Y ++         
Sbjct: 187 PESLKTRTFSHASDTWMFGVTLWEMFT--------------------YGQEPWIGLNGSQ 226
Query: 285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMV 325
           I+  I  E    P  E+  Q +  +M +C +  PE RP  V
Sbjct: 227 ILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFV 267

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 92/221 (41%), Gaps = 30/221 (13%)
Query: 110 MKHKNILKLIGCCLETELPTLVFESVKYGTL----RGFSFASLLIAPRIKIAMEIANAVA 165
           + H+N+++L G  L   +  +V E    G+L    R       L+    + A+++A  + 
Sbjct: 68  LDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMG 125
Query: 166 YLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH-VREEFIKGAYGFIA 224
           YL     +  + R + A N+LL      K+ DF L  ++P+ + H V +E  K  + + A
Sbjct: 126 YLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182
Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA 284
           PE   T +F+   D + FG  L E+ T                    Y ++         
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMFT--------------------YGQEPWIGLNGSQ 222
Query: 285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMV 325
           I+  I  E    P  E+  Q +  +M +C +  PE RP  V
Sbjct: 223 ILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFV 263

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 92/221 (41%), Gaps = 30/221 (13%)
Query: 110 MKHKNILKLIGCCLETELPTLVFESVKYGTL----RGFSFASLLIAPRIKIAMEIANAVA 165
           + H+N+++L G  L   +  +V E    G+L    R       L+    + A+++A  + 
Sbjct: 68  LDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMG 125
Query: 166 YLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH-VREEFIKGAYGFIA 224
           YL     +  + R + A N+LL      K+ DF L  ++P+ + H V +E  K  + + A
Sbjct: 126 YLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182
Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA 284
           PE   T +F+   D + FG  L E+ T                    Y ++         
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMFT--------------------YGQEPWIGLNGSQ 222
Query: 285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMV 325
           I+  I  E    P  E+  Q +  +M +C +  PE RP  V
Sbjct: 223 ILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFV 263

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 92/221 (41%), Gaps = 30/221 (13%)
Query: 110 MKHKNILKLIGCCLETELPTLVFESVKYGTL----RGFSFASLLIAPRIKIAMEIANAVA 165
           + H+N+++L G  L   +  +V E    G+L    R       L+    + A+++A  + 
Sbjct: 78  LDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMG 135
Query: 166 YLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH-VREEFIKGAYGFIA 224
           YL     +  + R + A N+LL      K+ DF L  ++P+ + H V +E  K  + + A
Sbjct: 136 YLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCA 192
Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA 284
           PE   T +F+   D + FG  L E+ T                    Y ++         
Sbjct: 193 PESLKTRTFSHASDTWMFGVTLWEMFT--------------------YGQEPWIGLNGSQ 232
Query: 285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMV 325
           I+  I  E    P  E+  Q +  +M +C +  PE RP  V
Sbjct: 233 ILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFV 273

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 92/221 (41%), Gaps = 30/221 (13%)
Query: 110 MKHKNILKLIGCCLETELPTLVFESVKYGTL----RGFSFASLLIAPRIKIAMEIANAVA 165
           + H+N+++L G  L   +  +V E    G+L    R       L+    + A+++A  + 
Sbjct: 78  LDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMG 135
Query: 166 YLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH-VREEFIKGAYGFIA 224
           YL     +  + R + A N+LL      K+ DF L  ++P+ + H V +E  K  + + A
Sbjct: 136 YLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 192
Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA 284
           PE   T +F+   D + FG  L E+ T                    Y ++         
Sbjct: 193 PESLKTRTFSHASDTWMFGVTLWEMFT--------------------YGQEPWIGLNGSQ 232
Query: 285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMV 325
           I+  I  E    P  E+  Q +  +M +C +  PE RP  V
Sbjct: 233 ILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFV 273

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 92/221 (41%), Gaps = 30/221 (13%)
Query: 110 MKHKNILKLIGCCLETELPTLVFESVKYGTL----RGFSFASLLIAPRIKIAMEIANAVA 165
           + H+N+++L G  L   +  +V E    G+L    R       L+    + A+++A  + 
Sbjct: 68  LDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMG 125
Query: 166 YLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH-VREEFIKGAYGFIA 224
           YL     +  + R + A N+LL      K+ DF L  ++P+ + H V +E  K  + + A
Sbjct: 126 YLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCA 182
Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA 284
           PE   T +F+   D + FG  L E+ T                    Y ++         
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMFT--------------------YGQEPWIGLNGSQ 222
Query: 285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMV 325
           I+  I  E    P  E+  Q +  +M +C +  PE RP  V
Sbjct: 223 ILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFV 263

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 107/223 (47%), Gaps = 18/223 (8%)
Query: 43  RAFSAKDLKKATNNYDLHKVIQSDTSYR------LFEGTLVDQDRPISVMKFHDNSTLDD 96
            +FS  +LK  TNN+D   +              +++G + +    +  +    + T ++
Sbjct: 13  HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEE 72
Query: 97  VEYCFNN-IVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAP--- 152
           ++  F+  I   ++ +H+N+++L+G   + +   LV+  +  G+L     + L   P   
Sbjct: 73  LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD-RLSCLDGTPPLS 131
Query: 153 ---RIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGET 209
              R KIA   AN + +LH   +   + R IK++N+LLDE ++AK+ DF L+ +  +   
Sbjct: 132 WHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188
Query: 210 HVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
            V    I G   ++APE           D+YSFG  L E++TG
Sbjct: 189 TVMXSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITG 230

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 107/223 (47%), Gaps = 18/223 (8%)
Query: 43  RAFSAKDLKKATNNYDLHKVIQSDTSYR------LFEGTLVDQDRPISVMKFHDNSTLDD 96
            +FS  +LK  TNN+D   +              +++G + +    +  +    + T ++
Sbjct: 7   HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEE 66
Query: 97  VEYCFNN-IVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAP--- 152
           ++  F+  I   ++ +H+N+++L+G   + +   LV+  +  G+L     + L   P   
Sbjct: 67  LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD-RLSCLDGTPPLS 125
Query: 153 ---RIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGET 209
              R KIA   AN + +LH   +   + R IK++N+LLDE ++AK+ DF L+ +  +   
Sbjct: 126 WHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 182
Query: 210 HVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
            V    I G   ++APE           D+YSFG  L E++TG
Sbjct: 183 XVMXXRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITG 224

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 107/223 (47%), Gaps = 18/223 (8%)
Query: 43  RAFSAKDLKKATNNYDLHKVIQSDTSYR------LFEGTLVDQDRPISVMKFHDNSTLDD 96
            +FS  +LK  TNN+D   +              +++G + +    +  +    + T ++
Sbjct: 13  HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEE 72
Query: 97  VEYCFNN-IVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAP--- 152
           ++  F+  I   ++ +H+N+++L+G   + +   LV+  +  G+L     + L   P   
Sbjct: 73  LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD-RLSCLDGTPPLS 131
Query: 153 ---RIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGET 209
              R KIA   AN + +LH   +   + R IK++N+LLDE ++AK+ DF L+ +  +   
Sbjct: 132 WHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188
Query: 210 HVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
            V    I G   ++APE           D+YSFG  L E++TG
Sbjct: 189 TVMXXRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITG 230

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 105/223 (47%), Gaps = 18/223 (8%)
Query: 43  RAFSAKDLKKATNNYDLHKVIQSDTSYR------LFEGTLVDQDRPISVMKFHDNSTLDD 96
            +FS  +LK  TNN+D   +              +++G + +    +  +    + T ++
Sbjct: 4   HSFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEE 63
Query: 97  VEYCFNN-IVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAP--- 152
           ++  F+  I   ++ +H+N+++L+G   + +   LV+     G+L     + L   P   
Sbjct: 64  LKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLD-RLSCLDGTPPLS 122
Query: 153 ---RIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGET 209
              R KIA   AN + +LH   +   + R IK++N+LLDE ++AK+ DF L+ +  +   
Sbjct: 123 WHXRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 179
Query: 210 HVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
            V    I G   + APE           D+YSFG  L E++TG
Sbjct: 180 XVXXSRIVGTTAYXAPEAL-RGEITPKSDIYSFGVVLLEIITG 221

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/298 (22%), Positives = 120/298 (40%), Gaps = 43/298 (14%)
Query: 59  LHKVIQSDTSYRLFEGTLVDQDR-----PISVMKFHDNSTLDDVEYCFNNIVFSSQMKHK 113
           L K++       + EG L  +D       +  MK  DNS+  ++E   +         H 
Sbjct: 38  LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKL-DNSSQREIEEFLSEAACMKDFSHP 96
Query: 114 NILKLIGCCLETE-----LPTLVFESVKYGTLRGFSFASLL-IAPR-------IKIAMEI 160
           N+++L+G C+E        P ++   +KYG L  +   S L   P+       +K  ++I
Sbjct: 97  NVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDI 156
Query: 161 ANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAY 220
           A  + YL    +R  + R + A N +L ++ +  + DF LS  I  G+ + +    K   
Sbjct: 157 ALGMEYLS---NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 213
Query: 221 GFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENN 280
            +IA E  A   +    DV++FG  + E+ T   +  + G  N +    L +  +     
Sbjct: 214 KWIAIESLADRVYTSKSDVWAFGVTMWEIATR-GMTPYPGVQNHEMYDYLLHGHR----- 267
Query: 281 RFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLSV 338
                              E+ L  L ++MY C    P  RP    +  QL ++  S+
Sbjct: 268 ---------------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 101/218 (46%), Gaps = 30/218 (13%)
Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF----SFASLLIAPRIKIAMEIANAV 164
           Q++H+ +++L     +  +  ++ E ++ G+L  F    S   L I   + +A +IA  +
Sbjct: 64  QLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 122
Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIA 224
           A++    +R  + R ++A+N+L+ +  S K+ DF L+  I + E   RE   K    + A
Sbjct: 123 AFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREG-AKFPIKWTA 178
Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA 284
           PE     +F    DV+SFG  L E++T   +  + G  N + +  LE   +         
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRI-PYPGMTNPEVIQNLERGYR--------- 228
Query: 285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
           +V P    DN         + L QLM  C  + PE RP
Sbjct: 229 MVRP----DNC-------PEELYQLMRLCWKERPEDRP 255

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 101/218 (46%), Gaps = 30/218 (13%)
Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF----SFASLLIAPRIKIAMEIANAV 164
           Q++H+ +++L     +  +  ++ E ++ G+L  F    S   L I   + +A +IA  +
Sbjct: 65  QLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 123
Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIA 224
           A++    +R  + R ++A+N+L+ +  S K+ DF L+  I + E   RE   K    + A
Sbjct: 124 AFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREG-AKFPIKWTA 179
Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA 284
           PE     +F    DV+SFG  L E++T   +  + G  N + +  LE   +         
Sbjct: 180 PEAINYGTFTIKSDVWSFGILLTEIVTHGRI-PYPGMTNPEVIQNLERGYR--------- 229
Query: 285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
           +V P    DN         + L QLM  C  + PE RP
Sbjct: 230 MVRP----DNC-------PEELYQLMRLCWKERPEDRP 256

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 101/218 (46%), Gaps = 30/218 (13%)
Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF----SFASLLIAPRIKIAMEIANAV 164
           Q++H+ +++L     +  +  ++ E ++ G+L  F    S   L I   + +A +IA  +
Sbjct: 64  QLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 122
Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIA 224
           A++    +R  + R ++A+N+L+ +  S K+ DF L+  I + E   RE   K    + A
Sbjct: 123 AFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREG-AKFPIKWTA 178
Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA 284
           PE     +F    DV+SFG  L E++T   +  + G  N + +  LE   +         
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRI-PYPGMTNPEVIQNLERGYR--------- 228
Query: 285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
           +V P    DN         + L QLM  C  + PE RP
Sbjct: 229 MVRP----DNC-------PEELYQLMRLCWKERPEDRP 255

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 101/218 (46%), Gaps = 30/218 (13%)
Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF----SFASLLIAPRIKIAMEIANAV 164
           Q++H+ +++L     +  +  ++ E ++ G+L  F    S   L I   + +A +IA  +
Sbjct: 66  QLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 124
Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIA 224
           A++    +R  + R ++A+N+L+ +  S K+ DF L+  I + E   RE   K    + A
Sbjct: 125 AFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREG-AKFPIKWTA 180
Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA 284
           PE     +F    DV+SFG  L E++T   +  + G  N + +  LE   +         
Sbjct: 181 PEAINYGTFTIKSDVWSFGILLTEIVTHGRI-PYPGMTNPEVIQNLERGYR--------- 230
Query: 285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
           +V P    DN         + L QLM  C  + PE RP
Sbjct: 231 MVRP----DNC-------PEELYQLMRLCWKERPEDRP 257

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 101/218 (46%), Gaps = 30/218 (13%)
Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF----SFASLLIAPRIKIAMEIANAV 164
           Q++H+ +++L     +  +  ++ E ++ G+L  F    S   L I   + +A +IA  +
Sbjct: 73  QLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 131
Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIA 224
           A++    +R  + R ++A+N+L+ +  S K+ DF L+  I + E   RE   K    + A
Sbjct: 132 AFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREG-AKFPIKWTA 187
Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA 284
           PE     +F    DV+SFG  L E++T   +  + G  N + +  LE   +         
Sbjct: 188 PEAINYGTFTIKSDVWSFGILLTEIVTHGRI-PYPGMTNPEVIQNLERGYR--------- 237
Query: 285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
           +V P    DN         + L QLM  C  + PE RP
Sbjct: 238 MVRP----DNC-------PEELYQLMRLCWKERPEDRP 264

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 101/218 (46%), Gaps = 30/218 (13%)
Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF----SFASLLIAPRIKIAMEIANAV 164
           Q++H+ +++L     +  +  ++ E ++ G+L  F    S   L I   + +A +IA  +
Sbjct: 72  QLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 130
Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIA 224
           A++    +R  + R ++A+N+L+ +  S K+ DF L+  I + E   RE   K    + A
Sbjct: 131 AFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREG-AKFPIKWTA 186
Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA 284
           PE     +F    DV+SFG  L E++T   +  + G  N + +  LE   +         
Sbjct: 187 PEAINYGTFTIKSDVWSFGILLTEIVTHGRI-PYPGMTNPEVIQNLERGYR--------- 236
Query: 285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
           +V P    DN         + L QLM  C  + PE RP
Sbjct: 237 MVRP----DNC-------PEELYQLMRLCWKERPEDRP 263

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 101/218 (46%), Gaps = 30/218 (13%)
Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF----SFASLLIAPRIKIAMEIANAV 164
           Q++H+ +++L     +  +  ++ E ++ G+L  F    S   L I   + +A +IA  +
Sbjct: 64  QLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 122
Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIA 224
           A++    +R  + R ++A+N+L+ +  S K+ DF L+  I + E   RE   K    + A
Sbjct: 123 AFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREG-AKFPIKWTA 178
Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA 284
           PE     +F    DV+SFG  L E++T   +  + G  N + +  LE   +         
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRI-PYPGMTNPEVIQNLERGYR--------- 228
Query: 285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
           +V P    DN         + L QLM  C  + PE RP
Sbjct: 229 MVRP----DNC-------PEELYQLMRLCWKERPEDRP 255

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 101/218 (46%), Gaps = 30/218 (13%)
Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF----SFASLLIAPRIKIAMEIANAV 164
           Q++H+ +++L     +  +  ++ E ++ G+L  F    S   L I   + +A +IA  +
Sbjct: 70  QLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 128
Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIA 224
           A++    +R  + R ++A+N+L+ +  S K+ DF L+  I + E   RE   K    + A
Sbjct: 129 AFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREG-AKFPIKWTA 184
Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA 284
           PE     +F    DV+SFG  L E++T   +  + G  N + +  LE   +         
Sbjct: 185 PEAINYGTFTIKSDVWSFGILLTEIVTHGRI-PYPGMTNPEVIQNLERGYR--------- 234
Query: 285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
           +V P    DN         + L QLM  C  + PE RP
Sbjct: 235 MVRP----DNC-------PEELYQLMRLCWKERPEDRP 261

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 101/218 (46%), Gaps = 30/218 (13%)
Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF----SFASLLIAPRIKIAMEIANAV 164
           Q++H+ +++L     +  +  ++ E ++ G+L  F    S   L I   + +A +IA  +
Sbjct: 70  QLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 128
Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIA 224
           A++    +R  + R ++A+N+L+ +  S K+ DF L+  I + E   RE   K    + A
Sbjct: 129 AFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG-AKFPIKWTA 184
Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA 284
           PE     +F    DV+SFG  L E++T   +  + G  N + +  LE   +         
Sbjct: 185 PEAINYGTFTIKSDVWSFGILLTEIVTHGRI-PYPGMTNPEVIQNLERGYR--------- 234
Query: 285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
           +V P    DN         + L QLM  C  + PE RP
Sbjct: 235 MVRP----DNC-------PEELYQLMRLCWKERPEDRP 261

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 101/218 (46%), Gaps = 30/218 (13%)
Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF----SFASLLIAPRIKIAMEIANAV 164
           Q++H+ +++L     +  +  ++ E ++ G+L  F    S   L I   + +A +IA  +
Sbjct: 69  QLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 127
Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIA 224
           A++    +R  + R ++A+N+L+ +  S K+ DF L+  I + E   RE   K    + A
Sbjct: 128 AFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG-AKFPIKWTA 183
Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA 284
           PE     +F    DV+SFG  L E++T   +  + G  N + +  LE   +         
Sbjct: 184 PEAINYGTFTIKSDVWSFGILLTEIVTHGRI-PYPGMTNPEVIQNLERGYR--------- 233
Query: 285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
           +V P    DN         + L QLM  C  + PE RP
Sbjct: 234 MVRP----DNC-------PEELYQLMRLCWKERPEDRP 260

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 101/218 (46%), Gaps = 30/218 (13%)
Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF----SFASLLIAPRIKIAMEIANAV 164
           Q++H+ +++L     +  +  ++ E ++ G+L  F    S   L I   + +A +IA  +
Sbjct: 64  QLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 122
Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIA 224
           A++    +R  + R ++A+N+L+ +  S K+ DF L+  I + E   RE   K    + A
Sbjct: 123 AFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG-AKFPIKWTA 178
Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA 284
           PE     +F    DV+SFG  L E++T   +  + G  N + +  LE   +         
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRI-PYPGMTNPEVIQNLERGYR--------- 228
Query: 285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
           +V P    DN         + L QLM  C  + PE RP
Sbjct: 229 MVRP----DNC-------PEELYQLMRLCWKERPEDRP 255

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 101/218 (46%), Gaps = 30/218 (13%)
Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF----SFASLLIAPRIKIAMEIANAV 164
           Q++H+ +++L     +  +  ++ E ++ G+L  F    S   L I   + +A +IA  +
Sbjct: 60  QLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 118
Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIA 224
           A++    +R  + R ++A+N+L+ +  S K+ DF L+  I + E   RE   K    + A
Sbjct: 119 AFIE---ERNYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG-AKFPIKWTA 174
Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA 284
           PE     +F    DV+SFG  L E++T   +  + G  N + +  LE   +         
Sbjct: 175 PEAINYGTFTIKSDVWSFGILLTEIVTHGRI-PYPGMTNPEVIQNLERGYR--------- 224
Query: 285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
           +V P    DN         + L QLM  C  + PE RP
Sbjct: 225 MVRP----DNC-------PEELYQLMRLCWKERPEDRP 251

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 101/218 (46%), Gaps = 30/218 (13%)
Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF----SFASLLIAPRIKIAMEIANAV 164
           Q++H+ +++L     +  +  ++ E ++ G+L  F    S   L I   + +A +IA  +
Sbjct: 59  QLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 117
Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIA 224
           A++    +R  + R ++A+N+L+ +  S K+ DF L+  I + E   RE   K    + A
Sbjct: 118 AFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG-AKFPIKWTA 173
Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA 284
           PE     +F    DV+SFG  L E++T   +  + G  N + +  LE   +         
Sbjct: 174 PEAINYGTFTIKSDVWSFGILLTEIVTHGRI-PYPGMTNPEVIQNLERGYR--------- 223
Query: 285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
           +V P    DN         + L QLM  C  + PE RP
Sbjct: 224 MVRP----DNC-------PEELYQLMRLCWKERPEDRP 250

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 98/213 (46%), Gaps = 20/213 (9%)
Query: 53  ATNNYDLHKVIQSDTSYR----------LFEGTLVDQDRPISVMKFHDNSTLDDVEYCFN 102
            + NYD  ++ ++D + +          ++EG        ++V    +++   +VE    
Sbjct: 1   GSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLK 58
Query: 103 NIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL----RGFSFASLLIAPRIKIAM 158
                 ++KH N+++L+G C       ++ E + YG L    R  +   +     + +A 
Sbjct: 59  EAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 118
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           +I++A+ YL     +  + R + A N L+ EN+  K+ DF LS  +  G+T+      K 
Sbjct: 119 QISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKF 174
Query: 219 AYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT 251
              + APE  A + F+   DV++FG  L E+ T
Sbjct: 175 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 101/218 (46%), Gaps = 30/218 (13%)
Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF----SFASLLIAPRIKIAMEIANAV 164
           Q++H+ +++L     +  +  ++ E ++ G+L  F    S   L I   + +A +IA  +
Sbjct: 74  QLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 132
Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIA 224
           A++    +R  + R ++A+N+L+ +  S K+ DF L+  I + E   RE   K    + A
Sbjct: 133 AFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG-AKFPIKWTA 188
Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA 284
           PE     +F    DV+SFG  L E++T   +  + G  N + +  LE   +         
Sbjct: 189 PEAINYGTFTIKSDVWSFGILLTEIVTHGRI-PYPGMTNPEVIQNLERGYR--------- 238
Query: 285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
           +V P    DN         + L QLM  C  + PE RP
Sbjct: 239 MVRP----DNC-------PEELYQLMRLCWKERPEDRP 265

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 98/213 (46%), Gaps = 20/213 (9%)
Query: 53  ATNNYDLHKVIQSDTSYR----------LFEGTLVDQDRPISVMKFHDNSTLDDVEYCFN 102
            + NYD  ++ ++D + +          ++EG        ++V    +++   +VE    
Sbjct: 1   GSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLK 58
Query: 103 NIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL----RGFSFASLLIAPRIKIAM 158
                 ++KH N+++L+G C       ++ E + YG L    R  +   +     + +A 
Sbjct: 59  EAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 118
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           +I++A+ YL     +  + R + A N L+ EN+  K+ DF LS  +  G+T+      K 
Sbjct: 119 QISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKF 174
Query: 219 AYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT 251
              + APE  A + F+   DV++FG  L E+ T
Sbjct: 175 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 100/216 (46%), Gaps = 20/216 (9%)
Query: 50  LKKATNNYDLHKVIQSDTSYR----------LFEGTLVDQDRPISVMKFHDNSTLDDVEY 99
           +  ++ NYD  ++ ++D + +          ++EG        ++V    +++   +VE 
Sbjct: 3   MDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEE 60
Query: 100 CFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL----RGFSFASLLIAPRIK 155
                    ++KH N+++L+G C       ++ E + YG L    R  +   +     + 
Sbjct: 61  FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLY 120
Query: 156 IAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEF 215
           +A +I++A+ YL     +  + R + A N L+ EN+  K+ DF LS  +  G+T+     
Sbjct: 121 MATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAG 176
Query: 216 IKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT 251
            K    + APE  A + F+   DV++FG  L E+ T
Sbjct: 177 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 100/216 (46%), Gaps = 20/216 (9%)
Query: 50  LKKATNNYDLHKVIQSDTSYR----------LFEGTLVDQDRPISVMKFHDNSTLDDVEY 99
           +  ++ NYD  ++ ++D + +          ++EG        ++V    +++   +VE 
Sbjct: 3   MDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEE 60
Query: 100 CFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL----RGFSFASLLIAPRIK 155
                    ++KH N+++L+G C       ++ E + YG L    R  +   +     + 
Sbjct: 61  FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY 120
Query: 156 IAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEF 215
           +A +I++A+ YL     +  + R + A N L+ EN+  K+ DF LS  +  G+T+     
Sbjct: 121 MATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAG 176
Query: 216 IKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT 251
            K    + APE  A + F+   DV++FG  L E+ T
Sbjct: 177 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/294 (21%), Positives = 122/294 (41%), Gaps = 41/294 (13%)
Query: 56  NYDLHKVIQSDTSYR----------LFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIV 105
           NYD  ++ ++D + +          ++EG        ++V    +++   +VE       
Sbjct: 211 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAA 268
Query: 106 FSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL----RGFSFASLLIAPRIKIAMEIA 161
              ++KH N+++L+G C       ++ E + YG L    R  +   +     + +A +I+
Sbjct: 269 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQIS 328
Query: 162 NAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYG 221
           +A+ YL     +  + R + A N L+ EN+  K+ DF LS  +  G+T+      K    
Sbjct: 329 SAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIK 384
Query: 222 FIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNR 281
           + APE  A + F+   DV++FG  L E+ T   +  + G    D   V E  +K     R
Sbjct: 385 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT-YGMSPYPG---IDLSQVYELLEKDYRMER 440
Query: 282 FGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMY 335
                + ++                 +LM  C   +P  RP   ++ +    M+
Sbjct: 441 PEGCPEKVY-----------------ELMRACWQWNPSDRPSFAEIHQAFETMF 477

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 99/214 (46%), Gaps = 20/214 (9%)
Query: 52  KATNNYDLHKVIQSDTSYR----------LFEGTLVDQDRPISVMKFHDNSTLDDVEYCF 101
           + + NYD  ++ ++D + +          ++EG        ++V    +++   +VE   
Sbjct: 13  QGSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFL 70
Query: 102 NNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL----RGFSFASLLIAPRIKIA 157
                  ++KH N+++L+G C       ++ E + YG L    R  +   +     + +A
Sbjct: 71  KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMA 130
Query: 158 MEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIK 217
            +I++A+ YL     +  + R + A N L+ EN+  K+ DF LS  +  G+T+      K
Sbjct: 131 TQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAK 186
Query: 218 GAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT 251
               + APE  A + F+   DV++FG  L E+ T
Sbjct: 187 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 220

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 98/213 (46%), Gaps = 20/213 (9%)
Query: 53  ATNNYDLHKVIQSDTSYR----------LFEGTLVDQDRPISVMKFHDNSTLDDVEYCFN 102
            + NYD  ++ ++D + +          ++EG        ++V    +++   +VE    
Sbjct: 1   GSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLK 58
Query: 103 NIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL----RGFSFASLLIAPRIKIAM 158
                 ++KH N+++L+G C       ++ E + YG L    R  +   +     + +A 
Sbjct: 59  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 118
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           +I++A+ YL     +  + R + A N L+ EN+  K+ DF LS  +  G+T+      K 
Sbjct: 119 QISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKF 174
Query: 219 AYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT 251
              + APE  A + F+   DV++FG  L E+ T
Sbjct: 175 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 71/335 (21%), Positives = 136/335 (40%), Gaps = 50/335 (14%)
Query: 18  SNMVRNEKLLLQKLIATFN---GKRNPIRAFSAKDLKKATNNYDLHKVIQSDTSYR---- 70
           + +V +   +   LI T +    KRN    +        + NYD  ++ ++D + +    
Sbjct: 215 AELVHHHSTVADGLITTLHYPAPKRNKPTVYGV------SPNYDKWEMERTDITMKHKLG 268
Query: 71  ------LFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLE 124
                 ++EG        ++V    +++   +VE          ++KH N+++L+G C  
Sbjct: 269 GGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTR 326
Query: 125 TELPTLVFESVKYGTL----RGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCI 180
                ++ E + YG L    R  +   +     + +A +I++A+ YL     +  + R +
Sbjct: 327 EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRNL 383
Query: 181 KASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVY 240
            A N L+ EN+  K+ DF LS  +  G+T+      K    + APE  A + F+   DV+
Sbjct: 384 AARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 442
Query: 241 SFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKE 300
           +FG  L E+ T   +  + G    D   V E  +K     R     + +++         
Sbjct: 443 AFGVLLWEIAT-YGMSPYPG---IDLSQVYELLEKDYRMERPEGCPEKVYE--------- 489
Query: 301 EKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMY 335
                   LM  C   +P  RP   ++ +    M+
Sbjct: 490 --------LMRACWQWNPSDRPSFAEIHQAFETMF 516

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 98/213 (46%), Gaps = 20/213 (9%)
Query: 53  ATNNYDLHKVIQSDTSYR----------LFEGTLVDQDRPISVMKFHDNSTLDDVEYCFN 102
            + NYD  ++ ++D + +          ++EG        ++V    +++   +VE    
Sbjct: 1   GSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLK 58
Query: 103 NIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL----RGFSFASLLIAPRIKIAM 158
                 ++KH N+++L+G C       ++ E + YG L    R  +   +     + +A 
Sbjct: 59  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 118
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           +I++A+ YL     +  + R + A N L+ EN+  K+ DF LS  +  G+T+      K 
Sbjct: 119 QISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKF 174
Query: 219 AYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT 251
              + APE  A + F+   DV++FG  L E+ T
Sbjct: 175 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 100/216 (46%), Gaps = 20/216 (9%)
Query: 50  LKKATNNYDLHKVIQSDTSYR----------LFEGTLVDQDRPISVMKFHDNSTLDDVEY 99
           +  ++ NYD  ++ ++D + +          ++EG        ++V    +++   +VE 
Sbjct: 3   MDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEE 60
Query: 100 CFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL----RGFSFASLLIAPRIK 155
                    ++KH N+++L+G C       ++ E + YG L    R  +   +     + 
Sbjct: 61  FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLY 120
Query: 156 IAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEF 215
           +A +I++A+ YL     +  + R + A N L+ EN+  K+ DF LS  +  G+T+     
Sbjct: 121 MATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAG 176
Query: 216 IKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT 251
            K    + APE  A + F+   DV++FG  L E+ T
Sbjct: 177 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 100/216 (46%), Gaps = 20/216 (9%)
Query: 50  LKKATNNYDLHKVIQSDTSYR----------LFEGTLVDQDRPISVMKFHDNSTLDDVEY 99
           +  ++ NYD  ++ ++D + +          ++EG        ++V    +++   +VE 
Sbjct: 3   MDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEE 60
Query: 100 CFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL----RGFSFASLLIAPRIK 155
                    ++KH N+++L+G C       ++ E + YG L    R  +   +     + 
Sbjct: 61  FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLY 120
Query: 156 IAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEF 215
           +A +I++A+ YL     +  + R + A N L+ EN+  K+ DF LS  +  G+T+     
Sbjct: 121 MATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAG 176
Query: 216 IKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT 251
            K    + APE  A + F+   DV++FG  L E+ T
Sbjct: 177 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 97/210 (46%), Gaps = 20/210 (9%)
Query: 56  NYDLHKVIQSDTSYR----------LFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIV 105
           NYD  ++ ++D + +          ++EG        ++V    +++   +VE       
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAA 63
Query: 106 FSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL----RGFSFASLLIAPRIKIAMEIA 161
              ++KH N+++L+G C       ++ E + YG L    R  +   +     + +A +I+
Sbjct: 64  VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 123
Query: 162 NAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYG 221
           +A+ YL     +  + R + A N L+ EN+  K+ DF LS  +  G+T+      K    
Sbjct: 124 SAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIK 179
Query: 222 FIAPEYFATSSFNEMCDVYSFGAFLCELLT 251
           + APE  A + F+   DV++FG  L E+ T
Sbjct: 180 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 97/210 (46%), Gaps = 20/210 (9%)
Query: 56  NYDLHKVIQSDTSYR----------LFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIV 105
           NYD  ++ ++D + +          ++EG        ++V    +++   +VE       
Sbjct: 5   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAA 62
Query: 106 FSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL----RGFSFASLLIAPRIKIAMEIA 161
              ++KH N+++L+G C       ++ E + YG L    R  +   +     + +A +I+
Sbjct: 63  VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 122
Query: 162 NAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYG 221
           +A+ YL     +  + R + A N L+ EN+  K+ DF LS  +  G+T+      K    
Sbjct: 123 SAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAPAGAKFPIK 178
Query: 222 FIAPEYFATSSFNEMCDVYSFGAFLCELLT 251
           + APE  A + F+   DV++FG  L E+ T
Sbjct: 179 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 208

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 97/210 (46%), Gaps = 20/210 (9%)
Query: 56  NYDLHKVIQSDTSYR----------LFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIV 105
           NYD  ++ ++D + +          ++EG        ++V    +++   +VE       
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAA 63
Query: 106 FSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL----RGFSFASLLIAPRIKIAMEIA 161
              ++KH N+++L+G C       ++ E + YG L    R  +   +     + +A +I+
Sbjct: 64  VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 123
Query: 162 NAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYG 221
           +A+ YL     +  + R + A N L+ EN+  K+ DF LS  +  G+T+      K    
Sbjct: 124 SAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIK 179
Query: 222 FIAPEYFATSSFNEMCDVYSFGAFLCELLT 251
           + APE  A + F+   DV++FG  L E+ T
Sbjct: 180 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/269 (22%), Positives = 111/269 (41%), Gaps = 31/269 (11%)
Query: 71  LFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTL 130
           ++EG        ++V    +++   +VE          ++KH N+++L+G C       +
Sbjct: 27  VYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 84
Query: 131 VFESVKYGT----LRGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVL 186
           + E + YG     LR  +   +     + +A +I++A+ YL     +  + R + A N L
Sbjct: 85  IIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCL 141
Query: 187 LDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFL 246
           + EN+  K+ DF LS  +  G+T       K    + APE  A + F+   DV++FG  L
Sbjct: 142 VGENHLVKVADFGLS-RLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLL 200
Query: 247 CELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSL 306
            E+ T   +  + G    D   V E  +K     R     + ++                
Sbjct: 201 WEIAT-YGMSPYPGI---DPSQVYELLEKDYRMERPEGCPEKVY---------------- 240
Query: 307 GQLMYKCLSKSPEHRPLMVDVAKQLRQMY 335
            +LM  C   +P  RP   ++ +    M+
Sbjct: 241 -ELMRACWQWNPSDRPSFAEIHQAFETMF 268

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 99/232 (42%), Gaps = 40/232 (17%)
Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTL-------RGFSFASLLIAPRIKIAMEIA 161
           ++ H  +++L G CLE     LVFE +++G L       RG   A  L+     + +++ 
Sbjct: 58  KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLG----MCLDVC 113
Query: 162 NAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYG 221
             +AYL    +  ++ R + A N L+ EN   K+ DF ++  + + + +      K    
Sbjct: 114 EGMAYLE---EASVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVK 169
Query: 222 FIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNR 281
           + +PE F+ S ++   DV+SFG  + E                    V    K   EN  
Sbjct: 170 WASPEVFSFSRYSSKSDVWSFGVLMWE--------------------VFSEGKIPYENRS 209
Query: 282 FGAIVDPIFDEDNSFPGKEEKLQS--LGQLMYKCLSKSPEHRPLMVDVAKQL 331
              +V+ I      F   + +L S  + Q+M  C  + PE RP    + +QL
Sbjct: 210 NSEVVEDI---STGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQL 258

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 56  NYDLHKVIQSDTSYR----------LFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIV 105
           NYD  ++ ++D + +          ++EG        ++V    +++   +VE       
Sbjct: 5   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAA 62
Query: 106 FSSQMKHKNILKLIGCCLETELPTLVFESVKYGT----LRGFSFASLLIAPRIKIAMEIA 161
              ++KH N+++L+G C       ++ E + YG     LR  +   +     + +A +I+
Sbjct: 63  VMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 122
Query: 162 NAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYG 221
           +A+ YL     +  + R + A N L+ EN+  K+ DF LS  +  G+T       K    
Sbjct: 123 SAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTXTAHAGAKFPIK 178
Query: 222 FIAPEYFATSSFNEMCDVYSFGAFLCELLT 251
           + APE  A + F+   DV++FG  L E+ T
Sbjct: 179 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 208

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 97/210 (46%), Gaps = 20/210 (9%)
Query: 56  NYDLHKVIQSDTSYR----------LFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIV 105
           NYD  ++ ++D + +          ++EG        ++V    +++   +VE       
Sbjct: 8   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAA 65
Query: 106 FSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL----RGFSFASLLIAPRIKIAMEIA 161
              ++KH N+++L+G C       ++ E + YG L    R  +   +     + +A +I+
Sbjct: 66  VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 125
Query: 162 NAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYG 221
           +A+ YL     +  + R + A N L+ EN+  K+ DF LS  +  G+T+      K    
Sbjct: 126 SAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIK 181
Query: 222 FIAPEYFATSSFNEMCDVYSFGAFLCELLT 251
           + APE  A + F+   DV++FG  L E+ T
Sbjct: 182 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 211

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/235 (24%), Positives = 101/235 (42%), Gaps = 40/235 (17%)
Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTL-------RGFSFASLLIAPRIKIAMEIA 161
           ++ H  +++L G CLE     LVFE +++G L       RG   A  L+     + +++ 
Sbjct: 58  KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLG----MCLDVC 113
Query: 162 NAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYG 221
             +AYL    +  ++ R + A N L+ EN   K+ DF ++  + + + +      K    
Sbjct: 114 EGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVK 169
Query: 222 FIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNR 281
           + +PE F+ S ++   DV+SFG  + E                    V    K   EN  
Sbjct: 170 WASPEVFSFSRYSSKSDVWSFGVLMWE--------------------VFSEGKIPYENRS 209
Query: 282 FGAIVDPIFDEDNSFPGKEEKLQS--LGQLMYKCLSKSPEHRPLMVDVAKQLRQM 334
              +V+ I      F   + +L S  + Q+M  C  + PE RP    + +QL ++
Sbjct: 210 NSEVVEDI---STGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 261

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/235 (24%), Positives = 101/235 (42%), Gaps = 40/235 (17%)
Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTL-------RGFSFASLLIAPRIKIAMEIA 161
           ++ H  +++L G CLE     LVFE +++G L       RG   A  L+     + +++ 
Sbjct: 78  KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLG----MCLDVC 133
Query: 162 NAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYG 221
             +AYL    +  ++ R + A N L+ EN   K+ DF ++  + + + +      K    
Sbjct: 134 EGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVK 189
Query: 222 FIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNR 281
           + +PE F+ S ++   DV+SFG  + E                    V    K   EN  
Sbjct: 190 WASPEVFSFSRYSSKSDVWSFGVLMWE--------------------VFSEGKIPYENRS 229
Query: 282 FGAIVDPIFDEDNSFPGKEEKLQS--LGQLMYKCLSKSPEHRPLMVDVAKQLRQM 334
              +V+ I      F   + +L S  + Q+M  C  + PE RP    + +QL ++
Sbjct: 230 NSEVVEDI---STGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 281

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/294 (20%), Positives = 120/294 (40%), Gaps = 41/294 (13%)
Query: 56  NYDLHKVIQSDTSYR----------LFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIV 105
           NYD  ++ ++D + +          ++EG        ++V    +++   +VE       
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAA 61
Query: 106 FSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL----RGFSFASLLIAPRIKIAMEIA 161
              ++KH N+++L+G C       ++ E + YG L    R  +   +     + +A +I+
Sbjct: 62  VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 121
Query: 162 NAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYG 221
           +A+ YL     +  + R + A N L+ EN+  K+ DF LS  +  G+T+      K    
Sbjct: 122 SAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIK 177
Query: 222 FIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNR 281
           + APE  A + F+   DV++FG  L E+ T                    Y         
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT--------------------YGMSPYPGID 217
Query: 282 FGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMY 335
              + + + ++D      E   + + +LM  C   +P  RP   ++ +    M+
Sbjct: 218 LSQVYE-LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 270

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 97/210 (46%), Gaps = 20/210 (9%)
Query: 56  NYDLHKVIQSDTSYR----------LFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIV 105
           NYD  ++ ++D + +          ++EG        ++V    +++   +VE       
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAA 63
Query: 106 FSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL----RGFSFASLLIAPRIKIAMEIA 161
              ++KH N+++L+G C       ++ E + YG L    R  +   +     + +A +I+
Sbjct: 64  VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 123
Query: 162 NAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYG 221
           +A+ YL     +  + R + A N L+ EN+  K+ DF LS  +  G+T+      K    
Sbjct: 124 SAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAPAGAKFPIK 179
Query: 222 FIAPEYFATSSFNEMCDVYSFGAFLCELLT 251
           + APE  A + F+   DV++FG  L E+ T
Sbjct: 180 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 97/210 (46%), Gaps = 20/210 (9%)
Query: 56  NYDLHKVIQSDTSYR----------LFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIV 105
           NYD  ++ ++D + +          ++EG        ++V    +++   +VE       
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAA 61
Query: 106 FSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL----RGFSFASLLIAPRIKIAMEIA 161
              ++KH N+++L+G C       ++ E + YG L    R  +   +     + +A +I+
Sbjct: 62  VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 121
Query: 162 NAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYG 221
           +A+ YL     +  + R + A N L+ EN+  K+ DF LS  +  G+T+      K    
Sbjct: 122 SAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIK 177
Query: 222 FIAPEYFATSSFNEMCDVYSFGAFLCELLT 251
           + APE  A + F+   DV++FG  L E+ T
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/235 (24%), Positives = 101/235 (42%), Gaps = 40/235 (17%)
Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTL-------RGFSFASLLIAPRIKIAMEIA 161
           ++ H  +++L G CLE     LVFE +++G L       RG   A  L+     + +++ 
Sbjct: 61  KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLG----MCLDVC 116
Query: 162 NAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYG 221
             +AYL    +  ++ R + A N L+ EN   K+ DF ++  + + + +      K    
Sbjct: 117 EGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVK 172
Query: 222 FIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNR 281
           + +PE F+ S ++   DV+SFG  + E                    V    K   EN  
Sbjct: 173 WASPEVFSFSRYSSKSDVWSFGVLMWE--------------------VFSEGKIPYENRS 212
Query: 282 FGAIVDPIFDEDNSFPGKEEKLQS--LGQLMYKCLSKSPEHRPLMVDVAKQLRQM 334
              +V+ I      F   + +L S  + Q+M  C  + PE RP    + +QL ++
Sbjct: 213 NSEVVEDI---STGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/235 (24%), Positives = 101/235 (42%), Gaps = 40/235 (17%)
Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTL-------RGFSFASLLIAPRIKIAMEIA 161
           ++ H  +++L G CLE     LVFE +++G L       RG   A  L+     + +++ 
Sbjct: 56  KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLG----MCLDVC 111
Query: 162 NAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYG 221
             +AYL    +  ++ R + A N L+ EN   K+ DF ++  + + + +      K    
Sbjct: 112 EGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVK 167
Query: 222 FIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNR 281
           + +PE F+ S ++   DV+SFG  + E                    V    K   EN  
Sbjct: 168 WASPEVFSFSRYSSKSDVWSFGVLMWE--------------------VFSEGKIPYENRS 207
Query: 282 FGAIVDPIFDEDNSFPGKEEKLQS--LGQLMYKCLSKSPEHRPLMVDVAKQLRQM 334
              +V+ I      F   + +L S  + Q+M  C  + PE RP    + +QL ++
Sbjct: 208 NSEVVEDI---STGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 96/218 (44%), Gaps = 30/218 (13%)
Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTL----RGFSFASLLIAPRIKIAMEIANAV 164
           +++H+ +++L     E  +  +V E +  G+L    +G +   L +   + +A +IA+ +
Sbjct: 59  KLRHEKLVQLYAVVSEEPI-XIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM 117
Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIA 224
           AY+        V R ++A+N+L+ EN   K+ DF L+  I + E   R+   K    + A
Sbjct: 118 AYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQG-AKFPIKWTA 173
Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA 284
           PE      F    DV+SFG  L EL T   V  + G  N + L  +E   +         
Sbjct: 174 PEAALYGRFTIKSDVWSFGILLTELTTKGRV-PYPGMVNREVLDQVERGYR--------- 223
Query: 285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
                       P   E  +SL  LM +C  K PE RP
Sbjct: 224 -----------MPCPPECPESLHDLMCQCWRKEPEERP 250

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 99/216 (45%), Gaps = 20/216 (9%)
Query: 50  LKKATNNYDLHKVIQSDTSYR----------LFEGTLVDQDRPISVMKFHDNSTLDDVEY 99
           +  ++ NYD  ++ ++D + +          ++EG        ++V    +++   +VE 
Sbjct: 3   MDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEE 60
Query: 100 CFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL----RGFSFASLLIAPRIK 155
                    ++KH N+++L+G C       ++ E + YG L    R  +   +     + 
Sbjct: 61  FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLY 120
Query: 156 IAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEF 215
           +A +I++A+ YL     +  + R + A N L+ EN+  K+ DF LS  +  G+T      
Sbjct: 121 MATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTXTAHAG 176
Query: 216 IKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT 251
            K    + APE  A + F+   DV++FG  L E+ T
Sbjct: 177 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 95/218 (43%), Gaps = 30/218 (13%)
Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF---SFASLLIAPR-IKIAMEIANAV 164
           +++H+ +++L     E  +  +V E +  G+L  F        L  P+ + +A +IA+ +
Sbjct: 69  KLRHEKLVQLYAVVSEEPI-YIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGM 127
Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIA 224
           AY+        V R ++A+N+L+ EN   K+ DF L+  I + E   R+   K    + A
Sbjct: 128 AYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQG-AKFPIKWTA 183
Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA 284
           PE      F    DV+SFG  L EL T   V  + G  N + L  +E   +         
Sbjct: 184 PEAALYGRFTIKSDVWSFGILLTELTTKGRV-PYPGMVNREVLDQVERGYR--------- 233
Query: 285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
                       P   E  +SL  LM +C  K PE RP
Sbjct: 234 -----------MPCPPECPESLHDLMCQCWRKDPEERP 260

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/269 (22%), Positives = 111/269 (41%), Gaps = 31/269 (11%)
Query: 71  LFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTL 130
           ++EG        ++V    +++   +VE          ++KH N+++L+G C       +
Sbjct: 27  VYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 84
Query: 131 VFESVKYGTL----RGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVL 186
           + E + YG L    R  +   +     + +A +I++A+ YL     +  + R + A N L
Sbjct: 85  ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCL 141
Query: 187 LDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFL 246
           + EN+  K+ DF LS  +  G+T       K    + APE  A + F+   DV++FG  L
Sbjct: 142 VGENHLVKVADFGLS-RLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLL 200
Query: 247 CELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSL 306
            E+ T   +  + G    D   V E  +K     R     + ++                
Sbjct: 201 WEIAT-YGMSPYPGI---DPSQVYELLEKDYRMERPEGCPEKVY---------------- 240
Query: 307 GQLMYKCLSKSPEHRPLMVDVAKQLRQMY 335
            +LM  C   +P  RP   ++ +    M+
Sbjct: 241 -ELMRACWQWNPSDRPSFAEIHQAFETMF 268

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 80/165 (48%), Gaps = 18/165 (10%)
Query: 94  LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPR 153
           L  VE+  +  +  S + H  I+++ G   + +   ++ + ++ G L    F+ L  + R
Sbjct: 47  LKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGEL----FSLLRKSQR 102
Query: 154 IK------IAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEG 207
                    A E+  A+ YLH    + I++R +K  N+LLD+N   K+ DF  +  +P+ 
Sbjct: 103 FPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 159
Query: 208 ETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
                   + G   +IAPE  +T  +N+  D +SFG  + E+L G
Sbjct: 160 TYX-----LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 96/218 (44%), Gaps = 30/218 (13%)
Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTL----RGFSFASLLIAPRIKIAMEIANAV 164
           +++H+ +++L     E  +  +V E +  G+L    +G +   L +   + +A +IA+ +
Sbjct: 235 KLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM 293
Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIA 224
           AY+        V R ++A+N+L+ EN   K+ DF L+  I + E   R+   K    + A
Sbjct: 294 AYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTA 349
Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA 284
           PE      F    DV+SFG  L EL T   V  + G  N + L  +E   +         
Sbjct: 350 PEAALYGRFTIKSDVWSFGILLTELTTKGRV-PYPGMVNREVLDQVERGYR--------- 399
Query: 285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
                       P   E  +SL  LM +C  K PE RP
Sbjct: 400 -----------MPCPPECPESLHDLMCQCWRKEPEERP 426

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 78/160 (48%), Gaps = 8/160 (5%)
Query: 96  DVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL----RGFSFASLLIA 151
           +VE          ++KH N+++L+G C       +V E + YG L    R  +   +   
Sbjct: 71  EVEEFLKEAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAV 130
Query: 152 PRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHV 211
             + +A +I++A+ YL     +  + R + A N L+ EN+  K+ DF LS  +  G+T+ 
Sbjct: 131 VLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHVVKVADFGLS-RLMTGDTYT 186
Query: 212 REEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT 251
                K    + APE  A ++F+   DV++FG  L E+ T
Sbjct: 187 AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIAT 226

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 96/218 (44%), Gaps = 30/218 (13%)
Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTL----RGFSFASLLIAPRIKIAMEIANAV 164
           +++H+ +++L     E  +  +V E +  G+L    +G +   L +   + +A +IA+ +
Sbjct: 235 KLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM 293
Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIA 224
           AY+        V R ++A+N+L+ EN   K+ DF L+  I + E   R+   K    + A
Sbjct: 294 AYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTA 349
Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA 284
           PE      F    DV+SFG  L EL T   V  + G  N + L  +E   +         
Sbjct: 350 PEAALYGRFTIKSDVWSFGILLTELTTKGRV-PYPGMVNREVLDQVERGYR--------- 399
Query: 285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
                       P   E  +SL  LM +C  K PE RP
Sbjct: 400 -----------MPCPPECPESLHDLMCQCWRKEPEERP 426

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/269 (22%), Positives = 111/269 (41%), Gaps = 31/269 (11%)
Query: 71  LFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTL 130
           ++EG        ++V    +++   +VE          ++KH N+++L+G C       +
Sbjct: 27  VYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 84
Query: 131 VFESVKYGTL----RGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVL 186
           + E + YG L    R  +   +     + +A +I++A+ YL     +  + R + A N L
Sbjct: 85  ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCL 141
Query: 187 LDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFL 246
           + EN+  K+ DF LS  +  G+T       K    + APE  A + F+   DV++FG  L
Sbjct: 142 VGENHLVKVADFGLS-RLMTGDTFTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLL 200
Query: 247 CELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSL 306
            E+ T   +  + G    D   V E  +K     R     + ++                
Sbjct: 201 WEIAT-YGMSPYPGI---DPSQVYELLEKDYRMERPEGCPEKVY---------------- 240
Query: 307 GQLMYKCLSKSPEHRPLMVDVAKQLRQMY 335
            +LM  C   +P  RP   ++ +    M+
Sbjct: 241 -ELMRACWQWNPSDRPSFAEIHQAFETMF 268

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 68/158 (43%), Gaps = 9/158 (5%)
Query: 102 NNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL-RGFSFASLLIAPRIKIAM-E 159
             +   S ++H NIL+L G   +     L+ E    GT+ R     S     R    + E
Sbjct: 61  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITE 120
Query: 160 IANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGA 219
           +ANA++Y H    + ++ R IK  N+LL  N   K+ DF  SV  P      R + + G 
Sbjct: 121 LANALSYCH---SKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSS----RRDTLCGT 173
Query: 220 YGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLE 257
             ++ PE       +E  D++S G    E L G    E
Sbjct: 174 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFE 211

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 96/218 (44%), Gaps = 30/218 (13%)
Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTL----RGFSFASLLIAPRIKIAMEIANAV 164
           +++H+ +++L     E  +  +V E +  G+L    +G +   L +   + +A +IA+ +
Sbjct: 235 KLRHEKLVQLYAVVSEEPI-YIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM 293
Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIA 224
           AY+        V R ++A+N+L+ EN   K+ DF L+  I + E   R+   K    + A
Sbjct: 294 AYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTA 349
Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA 284
           PE      F    DV+SFG  L EL T   V  + G  N + L  +E   +         
Sbjct: 350 PEAALYGRFTIKSDVWSFGILLTELTTKGRV-PYPGMVNREVLDQVERGYR--------- 399
Query: 285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
                       P   E  +SL  LM +C  K PE RP
Sbjct: 400 -----------MPCPPECPESLHDLMCQCWRKEPEERP 426

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 95/218 (43%), Gaps = 30/218 (13%)
Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF---SFASLLIAPR-IKIAMEIANAV 164
           +++H+ +++L     E  +  +V E +  G+L  F        L  P+ + +A +IA+ +
Sbjct: 69  KLRHEKLVQLYAVVSEEPI-YIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGM 127
Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIA 224
           AY+        V R ++A+N+L+ EN   K+ DF L+  I + E   R+   K    + A
Sbjct: 128 AYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTA 183
Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA 284
           PE      F    DV+SFG  L EL T   V  + G  N + L  +E   +         
Sbjct: 184 PEAALYGRFTIKSDVWSFGILLTELTTKGRV-PYPGMVNREVLDQVERGYR--------- 233
Query: 285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
                       P   E  +SL  LM +C  K PE RP
Sbjct: 234 -----------MPCPPECPESLHDLMCQCWRKDPEERP 260

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 96/218 (44%), Gaps = 30/218 (13%)
Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTL----RGFSFASLLIAPRIKIAMEIANAV 164
           +++H+ +++L     E  +  +V E +  G+L    +G +   L +   + +A +IA+ +
Sbjct: 62  KLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM 120
Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIA 224
           AY+        V R ++A+N+L+ EN   K+ DF L+  I + E   R+   K    + A
Sbjct: 121 AYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTA 176
Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA 284
           PE      F    DV+SFG  L EL T   V  + G  N + L  +E   +         
Sbjct: 177 PEAALYGRFTIKSDVWSFGILLTELTTKGRV-PYPGMVNREVLDQVERGYR--------- 226
Query: 285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
                       P   E  +SL  LM +C  K PE RP
Sbjct: 227 -----------MPCPPECPESLHDLMCQCWRKEPEERP 253

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 96/218 (44%), Gaps = 30/218 (13%)
Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTL----RGFSFASLLIAPRIKIAMEIANAV 164
           +++H+ +++L     E  +  +V E +  G+L    +G +   L +   + +A +IA+ +
Sbjct: 318 KLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM 376
Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIA 224
           AY+        V R ++A+N+L+ EN   K+ DF L+  I + E   R+   K    + A
Sbjct: 377 AYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTA 432
Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA 284
           PE      F    DV+SFG  L EL T   V  + G  N + L  +E   +         
Sbjct: 433 PEAALYGRFTIKSDVWSFGILLTELTTKGRV-PYPGMVNREVLDQVERGYR--------- 482
Query: 285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
                       P   E  +SL  LM +C  K PE RP
Sbjct: 483 -----------MPCPPECPESLHDLMCQCWRKEPEERP 509

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 94/218 (43%), Gaps = 30/218 (13%)
Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF---SFASLLIAPR-IKIAMEIANAV 164
           +++H+ +++L     E  +  +V E +  G+L  F        L  P+ + +A +IA+ +
Sbjct: 236 KLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGM 294
Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIA 224
           AY+        V R ++A+N+L+ EN   K+ DF L   I + E   R+   K    + A
Sbjct: 295 AYVE---RMNYVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQG-AKFPIKWTA 350
Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA 284
           PE      F    DV+SFG  L EL T   V  + G  N + L  +E   +         
Sbjct: 351 PEAALYGRFTIKSDVWSFGILLTELTTKGRV-PYPGMVNREVLDQVERGYR--------- 400
Query: 285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
                       P   E  +SL  LM +C  K PE RP
Sbjct: 401 -----------MPCPPECPESLHDLMCQCWRKDPEERP 427

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 90/197 (45%), Gaps = 23/197 (11%)
Query: 127 LPTLVFESVKYGTLRGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVL 186
           LP +V E V   TLR        + P+  I + IA+A   L+      I+ R +K +N++
Sbjct: 90  LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEV-IADACQALNFSHQNGIIHRDVKPANIM 148
Query: 187 LDENYSAKLHDFSLSVSIPE-GETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAF 245
           +    + K+ DF ++ +I + G +  +   + G   +++PE     S +   DVYS G  
Sbjct: 149 ISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCV 208
Query: 246 LCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQS 305
           L E+LTG    E    G+  D    ++ ++           DPI         + E L +
Sbjct: 209 LYEVLTG----EPPFTGDSPDSVAYQHVRE-----------DPIPPS-----ARHEGLSA 248
Query: 306 -LGQLMYKCLSKSPEHR 321
            L  ++ K L+K+PE+R
Sbjct: 249 DLDAVVLKALAKNPENR 265

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 95/218 (43%), Gaps = 30/218 (13%)
Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF---SFASLLIAPR-IKIAMEIANAV 164
           +++H+ +++L     E  +  +V E +  G+L  F        L  P+ + +A +IA+ +
Sbjct: 60  KLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGM 118
Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIA 224
           AY+        V R ++A+N+L+ EN   K+ DF L+  I + E   R+   K    + A
Sbjct: 119 AYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTA 174
Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA 284
           PE      F    DV+SFG  L EL T   V  + G  N + L  +E   +         
Sbjct: 175 PEAALYGRFTIKSDVWSFGILLTELTTKGRV-PYPGMVNREVLDQVERGYR--------- 224
Query: 285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
                       P   E  +SL  LM +C  K PE RP
Sbjct: 225 -----------MPCPPECPESLHDLMCQCWRKDPEERP 251

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 96/218 (44%), Gaps = 30/218 (13%)
Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTL----RGFSFASLLIAPRIKIAMEIANAV 164
           +++H+ +++L     E  +  +V E +  G+L    +G +   L +   + ++ +IA+ +
Sbjct: 66  KLRHEKLVQLYAVVSEEPI-YIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGM 124
Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIA 224
           AY+        V R ++A+N+L+ EN   K+ DF L+  I + E   R+   K    + A
Sbjct: 125 AYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQG-AKFPIKWTA 180
Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA 284
           PE      F    DV+SFG  L EL T   V  + G  N + L  +E   +         
Sbjct: 181 PEAALYGRFTIKSDVWSFGILLTELTTKGRV-PYPGMVNREVLDQVERGYR--------- 230
Query: 285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
                       P   E  +SL  LM +C  K PE RP
Sbjct: 231 -----------MPCPPECPESLHDLMCQCWRKEPEERP 257

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 95/218 (43%), Gaps = 30/218 (13%)
Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF---SFASLLIAPR-IKIAMEIANAV 164
           +++H+ +++L     E  +  +V E +  G+L  F        L  P+ + +A +IA+ +
Sbjct: 58  KLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGM 116
Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIA 224
           AY+        V R ++A+N+L+ EN   K+ DF L+  I + E   R+   K    + A
Sbjct: 117 AYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTA 172
Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA 284
           PE      F    DV+SFG  L EL T   V  + G  N + L  +E   +         
Sbjct: 173 PEAALYGRFTIKSDVWSFGILLTELTTKGRV-PYPGMVNREVLDQVERGYR--------- 222
Query: 285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
                       P   E  +SL  LM +C  K PE RP
Sbjct: 223 -----------MPCPPECPESLHDLMCQCWRKDPEERP 249

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 95/218 (43%), Gaps = 30/218 (13%)
Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF---SFASLLIAPR-IKIAMEIANAV 164
           +++H+ +++L     E  +  +V E +  G+L  F        L  P+ + +A +IA+ +
Sbjct: 69  KLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGM 127
Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIA 224
           AY+        V R ++A+N+L+ EN   K+ DF L+  I + E   R+   K    + A
Sbjct: 128 AYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTA 183
Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA 284
           PE      F    DV+SFG  L EL T   V  + G  N + L  +E   +         
Sbjct: 184 PEAALYGRFTIKSDVWSFGILLTELTTKGRV-PYPGMVNREVLDQVERGYR--------- 233
Query: 285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
                       P   E  +SL  LM +C  K PE RP
Sbjct: 234 -----------MPCPPECPESLHDLMCQCWRKDPEERP 260

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 67/158 (42%), Gaps = 9/158 (5%)
Query: 102 NNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL-RGFSFASLLIAPRIKIAM-E 159
             +   S ++H NIL+L G   +     L+ E    GT+ R     S     R    + E
Sbjct: 61  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITE 120
Query: 160 IANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGA 219
           +ANA++Y H    + ++ R IK  N+LL  N   K+ DF  SV  P      R   + G 
Sbjct: 121 LANALSYCH---SKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSS----RRTTLCGT 173
Query: 220 YGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLE 257
             ++ PE       +E  D++S G    E L G    E
Sbjct: 174 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFE 211

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 94/218 (43%), Gaps = 30/218 (13%)
Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF---SFASLLIAPR-IKIAMEIANAV 164
           +++H+ +++L     E  +  +V E +  G L  F        L  P+ + +A +IA+ +
Sbjct: 69  KLRHEKLVQLYAVVSEEPI-YIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGM 127
Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIA 224
           AY+        V R ++A+N+L+ EN   K+ DF L+  I + E   R+   K    + A
Sbjct: 128 AYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTA 183
Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA 284
           PE      F    DV+SFG  L EL T   V  + G  N + L  +E   +         
Sbjct: 184 PEAALYGRFTIKSDVWSFGILLTELTTKGRV-PYPGMVNREVLDQVERGYR--------- 233
Query: 285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
                       P   E  +SL  LM +C  K PE RP
Sbjct: 234 -----------MPCPPECPESLHDLMCQCWRKDPEERP 260

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 95/218 (43%), Gaps = 30/218 (13%)
Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF---SFASLLIAPR-IKIAMEIANAV 164
           +++H+ +++L     E  +  +V E +  G+L  F        L  P+ + +A +IA+ +
Sbjct: 69  KIRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGM 127
Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIA 224
           AY+        V R ++A+N+L+ EN   K+ DF L+  I + E   R+   K    + A
Sbjct: 128 AYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTA 183
Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA 284
           PE      F    DV+SFG  L EL T   V  + G  N + L  +E   +         
Sbjct: 184 PEAALYGRFTIKSDVWSFGILLTELTTKGRV-PYPGMVNREVLDQVERGYR--------- 233
Query: 285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
                       P   E  +SL  LM +C  K PE RP
Sbjct: 234 -----------MPCPPECPESLHDLMCQCWRKDPEERP 260

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 95/218 (43%), Gaps = 30/218 (13%)
Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF---SFASLLIAPR-IKIAMEIANAV 164
           +++H+ +++L     E  +  +V E +  G+L  F        L  P+ + +A +IA+ +
Sbjct: 69  KLRHEKLVQLYAVVSEEPI-YIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGM 127
Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIA 224
           AY+        V R ++A+N+L+ EN   K+ DF L+  I + E   R+   K    + A
Sbjct: 128 AYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTA 183
Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA 284
           PE      F    DV+SFG  L EL T   V  + G  N + L  +E   +         
Sbjct: 184 PEAALYGRFTIKSDVWSFGILLTELTTKGRV-PYPGMVNREVLDQVERGYR--------- 233
Query: 285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
                       P   E  +SL  LM +C  K PE RP
Sbjct: 234 -----------MPCPPECPESLHDLMCQCWRKDPEERP 260

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 96/218 (44%), Gaps = 30/218 (13%)
Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTL----RGFSFASLLIAPRIKIAMEIANAV 164
           +++H+ +++L     E  +  +V E +  G+L    +G +   L +   + ++ +IA+ +
Sbjct: 66  KLRHEKLVQLYAVVSEEPI-YIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGM 124
Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIA 224
           AY+        V R ++A+N+L+ EN   K+ DF L+  I + E   R+   K    + A
Sbjct: 125 AYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTA 180
Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA 284
           PE      F    DV+SFG  L EL T   V  + G  N + L  +E   +         
Sbjct: 181 PEAALYGRFTIKSDVWSFGILLTELTTKGRV-PYPGMVNREVLDQVERGYR--------- 230
Query: 285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
                       P   E  +SL  LM +C  K PE RP
Sbjct: 231 -----------MPCPPECPESLHDLMCQCWRKEPEERP 257

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/241 (23%), Positives = 98/241 (40%), Gaps = 38/241 (15%)
Query: 96  DVEYCFNNIVFSSQMKHKNILKLIGCCLETE------LPTLVFESVKYGTLRGFSFAS-- 147
           D+E          +  H ++ KL+G  L +       +P ++   +K+G L  F  AS  
Sbjct: 68  DIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRI 127
Query: 148 ------LLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLS 201
                 L +   ++  ++IA  + YL     R  + R + A N +L E+ +  + DF LS
Sbjct: 128 GENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLS 184
Query: 202 VSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGN 261
             I  G+ + +    K    ++A E  A + +    DV++FG  + E++T      + G 
Sbjct: 185 RKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQT-PYAGI 243
Query: 262 GNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHR 321
            N +           I N   G          N      E ++ +  LMY+C S  P+ R
Sbjct: 244 ENAE-----------IYNYLIGG---------NRLKQPPECMEEVYDLMYQCWSADPKQR 283
Query: 322 P 322
           P
Sbjct: 284 P 284

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 78/167 (46%), Gaps = 11/167 (6%)
Query: 92  STLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETE-LPTLVFESVKYGTLRGFSFASLLI 150
           + +  VE      +    + H N+L LIG  L  E LP ++   + +G L  F   S   
Sbjct: 61  TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQF-IRSPQR 119
Query: 151 APRIK----IAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPE 206
            P +K      +++A  + YL    ++  V R + A N +LDE+++ K+ DF L+  I +
Sbjct: 120 NPTVKDLISFGLQVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILD 176
Query: 207 GETHVREE--FIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT 251
            E +  ++    +    + A E   T  F    DV+SFG  L ELLT
Sbjct: 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLT 223

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 94/218 (43%), Gaps = 30/218 (13%)
Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF---SFASLLIAPR-IKIAMEIANAV 164
           +++H+ +++L     E  +  +V E +  G L  F        L  P+ + +A +IA+ +
Sbjct: 69  KLRHEKLVQLYAVVSEEPI-YIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGM 127
Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIA 224
           AY+        V R ++A+N+L+ EN   K+ DF L+  I + E   R+   K    + A
Sbjct: 128 AYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTA 183
Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA 284
           PE      F    DV+SFG  L EL T   V  + G  N + L  +E   +         
Sbjct: 184 PEAALYGRFTIKSDVWSFGILLTELTTKGRV-PYPGMVNREVLDQVERGYR--------- 233
Query: 285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
                       P   E  +SL  LM +C  K PE RP
Sbjct: 234 -----------MPCPPECPESLHDLMCQCWRKDPEERP 260

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 77/173 (44%), Gaps = 33/173 (19%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           +I   V Y+H    + ++ R +K SN+ L +    K+ DF L  S+       R    KG
Sbjct: 144 QITKGVDYIH---SKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRS---KG 197
Query: 219 AYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIE 278
              +++PE  ++  + +  D+Y+ G  L ELL  C+             T  E + K   
Sbjct: 198 TLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD-------------TAFETS-KFFT 243
Query: 279 NNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQL 331
           + R G I D IFD       K+EK      L+ K LSK PE RP   ++ + L
Sbjct: 244 DLRDGIISD-IFD-------KKEK-----TLLQKLLSKKPEDRPNTSEILRTL 283

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/235 (23%), Positives = 100/235 (42%), Gaps = 40/235 (17%)
Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTL-------RGFSFASLLIAPRIKIAMEIA 161
           ++ H  +++L G CLE     LV E +++G L       RG   A  L+     + +++ 
Sbjct: 59  KLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLG----MCLDVC 114
Query: 162 NAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYG 221
             +AYL    +  ++ R + A N L+ EN   K+ DF ++  + + + +      K    
Sbjct: 115 EGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVK 170
Query: 222 FIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNR 281
           + +PE F+ S ++   DV+SFG  + E                    V    K   EN  
Sbjct: 171 WASPEVFSFSRYSSKSDVWSFGVLMWE--------------------VFSEGKIPYENRS 210
Query: 282 FGAIVDPIFDEDNSFPGKEEKLQS--LGQLMYKCLSKSPEHRPLMVDVAKQLRQM 334
              +V+ I      F   + +L S  + Q+M  C  + PE RP    + +QL ++
Sbjct: 211 NSEVVEDI---STGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 94/218 (43%), Gaps = 30/218 (13%)
Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF---SFASLLIAPR-IKIAMEIANAV 164
           +++H+ +++L     E  +  +V E +  G+L  F        L  P+ + +A +IA+ +
Sbjct: 69  KLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGM 127
Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIA 224
           AY+        V R + A+N+L+ EN   K+ DF L+  I + E   R+   K    + A
Sbjct: 128 AYVE---RMNYVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTA 183
Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA 284
           PE      F    DV+SFG  L EL T   V  + G  N + L  +E   +         
Sbjct: 184 PEAALYGRFTIKSDVWSFGILLTELTTKGRV-PYPGMVNREVLDQVERGYR--------- 233
Query: 285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
                       P   E  +SL  LM +C  K PE RP
Sbjct: 234 -----------MPCPPECPESLHDLMCQCWRKDPEERP 260

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 81/176 (46%), Gaps = 11/176 (6%)
Query: 110 MKHKNILKLIGCCLETELPTLVFESVKYGTLRGF----SFASLLIAPRIKIAMEIANAVA 165
           ++H  +++L       E   ++ E +  G+L  F        +L+   I  + +IA  +A
Sbjct: 65  LQHDKLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMA 124
Query: 166 YLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAP 225
           Y+     +  + R ++A+NVL+ E+   K+ DF L+  I + E   RE   K    + AP
Sbjct: 125 YIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREG-AKFPIKWTAP 180
Query: 226 EYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLE--YAKKSIEN 279
           E      F    DV+SFG  L E++T   +  + G  N D +T L   Y    +EN
Sbjct: 181 EAINFGCFTIKSDVWSFGILLYEIVTYGKI-PYPGRTNADVMTALSQGYRMPRVEN 235

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 77/173 (44%), Gaps = 33/173 (19%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           +I   V Y+H    + ++ R +K SN+ L +    K+ DF L  S+       R    KG
Sbjct: 130 QITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRS---KG 183
Query: 219 AYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIE 278
              +++PE  ++  + +  D+Y+ G  L ELL  C+             T  E + K   
Sbjct: 184 TLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD-------------TAFETS-KFFT 229
Query: 279 NNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQL 331
           + R G I D IFD       K+EK      L+ K LSK PE RP   ++ + L
Sbjct: 230 DLRDGIISD-IFD-------KKEK-----TLLQKLLSKKPEDRPNTSEILRTL 269

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 74/319 (23%), Positives = 114/319 (35%), Gaps = 47/319 (14%)
Query: 19  NMVRNEKLLLQKLIATFNGKRNPIRAFSAKDLKKATNNYDLHKVIQSDTSYRLFEGTLV- 77
           N+    KL   +  A  +    P RA  +   +   +   + K+I S  S  +  G L  
Sbjct: 13  NLYFQGKLPEPQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRV 72
Query: 78  --DQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESV 135
              +D P+++       T        +      Q  H NI++L G      L  +V E +
Sbjct: 73  PGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYM 132
Query: 136 KYGTLRGF---SFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYS 192
           + G+L  F         I   + +   +   + YL    D   V R + A NVL+D N  
Sbjct: 133 ENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLV 189
Query: 193 AKLHDFSLSVSIPEGETHVREEFIKGAYG---------FIAPEYFATSSFNEMCDVYSFG 243
            K+ DF LS         V E+    AY          + APE  A  +F+   DV+SFG
Sbjct: 190 CKVSDFGLS--------RVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFG 241
Query: 244 AFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKL 303
             + E                    VL Y ++   N     ++  + +E    P      
Sbjct: 242 VVMWE--------------------VLAYGERPYWNMTNRDVISSV-EEGYRLPAPMGCP 280
Query: 304 QSLGQLMYKCLSKSPEHRP 322
            +L QLM  C  K    RP
Sbjct: 281 HALHQLMLDCWHKDRAQRP 299

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 89/226 (39%), Gaps = 32/226 (14%)
Query: 104 IVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL-RGFSFASLLIAPRIKIAM-EIA 161
           +   S ++H NIL+L G   +     L+ E    GT+ R     S     R    + E+A
Sbjct: 60  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 119
Query: 162 NAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYG 221
           NA++Y H    + ++ R IK  N+LL      K+ DF  SV  P      R + + G   
Sbjct: 120 NALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRDTLCGTLD 172
Query: 222 FIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNR 281
           ++ PE       +E  D++S G    E L G                     K   E N 
Sbjct: 173 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG---------------------KPPFEANT 211
Query: 282 FGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDV 327
           +      I   + +FP  +   +    L+ + L  +P  RP++ +V
Sbjct: 212 YQETYKRISRVEFTFP--DFVTEGARDLISRLLKHNPSQRPMLREV 255

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 100/227 (44%), Gaps = 27/227 (11%)
Query: 102 NNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFAS---LLIAPRIKIAM 158
           N +    + +H NIL  +G   + +L  +V +  +  +L     AS     +   I IA 
Sbjct: 69  NEVGVLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIAR 127
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           + A  + YLH    + I+ R +K++N+ L E+ + K+ DF L+          + E + G
Sbjct: 128 QTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSG 184
Query: 219 AYGFIAPEYFATSSFNE---MCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKK 275
           +  ++APE       N      DVY+FG  L EL+TG   L +    N D +        
Sbjct: 185 SILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ--LPYSNINNRDQI-------- 234
Query: 276 SIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
            IE    G++   +    ++ P +      + +LM +CL K  + RP
Sbjct: 235 -IEMVGRGSLSPDLSKVRSNCPKR------MKRLMAECLKKKRDERP 274

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 72/312 (23%), Positives = 113/312 (36%), Gaps = 33/312 (10%)
Query: 19  NMVRNEKLLLQKLIATFNGKRNPIRAFSAKDLKKATNNYDLHKVIQSDTSYRLFEGTLV- 77
           N+    KL   +  A  +    P RA  +   +   +   + K+I S  S  +  G L  
Sbjct: 13  NLYFQGKLPEPQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRV 72
Query: 78  --DQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESV 135
              +D P+++       T        +      Q  H NI++L G      L  +V E +
Sbjct: 73  PGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYM 132
Query: 136 KYGTLRGF---SFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYS 192
           + G+L  F         I   + +   +   + YL    D   V R + A NVL+D N  
Sbjct: 133 ENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLV 189
Query: 193 AKLHDFSLSVSIPEGETHVREEFIKG--AYGFIAPEYFATSSFNEMCDVYSFGAFLCELL 250
            K+ DF LS  + E +         G     + APE  A  +F+   DV+SFG  + E  
Sbjct: 190 CKVSDFGLS-RVLEDDPDAAXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWE-- 246
Query: 251 TGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLM 310
                             VL Y ++   N     ++  + +E    P       +L QLM
Sbjct: 247 ------------------VLAYGERPYWNMTNRDVISSV-EEGYRLPAPMGCPHALHQLM 287
Query: 311 YKCLSKSPEHRP 322
             C  K    RP
Sbjct: 288 LDCWHKDRAQRP 299

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 66/151 (43%), Gaps = 9/151 (5%)
Query: 104 IVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL-RGFSFASLLIAPRIKIAM-EIA 161
           +   S ++H NIL+L G   +     L+ E    GT+ R     S     R    + E+A
Sbjct: 85  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 144
Query: 162 NAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYG 221
           NA++Y H    + ++ R IK  N+LL      K+ DF  SV  P      R + + G   
Sbjct: 145 NALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRDDLCGTLD 197
Query: 222 FIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
           ++ PE       +E  D++S G    E L G
Sbjct: 198 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 228

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 100/227 (44%), Gaps = 27/227 (11%)
Query: 102 NNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFAS---LLIAPRIKIAM 158
           N +    + +H NIL  +G   + +L  +V +  +  +L     AS     +   I IA 
Sbjct: 57  NEVGVLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIAR 115
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           + A  + YLH    + I+ R +K++N+ L E+ + K+ DF L+          + E + G
Sbjct: 116 QTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSG 172
Query: 219 AYGFIAPEYFATSSFNE---MCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKK 275
           +  ++APE       N      DVY+FG  L EL+TG   L +    N D +        
Sbjct: 173 SILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ--LPYSNINNRDQI-------- 222
Query: 276 SIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
            IE    G++   +    ++ P +      + +LM +CL K  + RP
Sbjct: 223 -IEMVGRGSLSPDLSKVRSNCPKR------MKRLMAECLKKKRDERP 262

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 65/151 (43%), Gaps = 9/151 (5%)
Query: 104 IVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL-RGFSFASLLIAPRIKIAM-EIA 161
           +   S ++H NIL+L G   +     L+ E    GT+ R     S     R    + E+A
Sbjct: 64  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 123
Query: 162 NAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYG 221
           NA++Y H    + ++ R IK  N+LL      K+ DF  SV  P      R   + G   
Sbjct: 124 NALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLD 176
Query: 222 FIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
           ++ PE       +E  D++S G    E L G
Sbjct: 177 YLPPEXIEGRXHDEKVDLWSLGVLCYEFLVG 207

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 66/153 (43%), Gaps = 9/153 (5%)
Query: 102 NNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL-RGFSFASLLIAPRIKIAM-E 159
             +   S ++H NIL+L G   ++    L+ E    GT+ R     S     R    + E
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 116
Query: 160 IANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGA 219
           +ANA++Y H    + ++ R IK  N+LL      K+ DF  SV  P      R   + G 
Sbjct: 117 LANALSYCH---SKKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRAALCGT 169
Query: 220 YGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
             ++ PE       +E  D++S G    E L G
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 202

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 88/226 (38%), Gaps = 32/226 (14%)
Query: 104 IVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL-RGFSFASLLIAPRIKIAM-EIA 161
           +   S ++H NIL+L G   +     L+ E    GT+ R     S     R    + E+A
Sbjct: 61  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 120
Query: 162 NAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYG 221
           NA++Y H    + ++ R IK  N+LL      K+ DF  SV  P      R   + G   
Sbjct: 121 NALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRXXLCGTLD 173
Query: 222 FIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNR 281
           ++ PE       +E  D++S G    E L G                     K   E N 
Sbjct: 174 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG---------------------KPPFEANT 212
Query: 282 FGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDV 327
           +      I   + +FP  +   +    L+ + L  +P  RP++ +V
Sbjct: 213 YQETYKRISRVEFTFP--DFVTEGARDLISRLLKHNPSQRPMLREV 256

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 88/228 (38%), Gaps = 32/228 (14%)
Query: 102 NNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL-RGFSFASLLIAPRIKIAM-E 159
             +   S ++H NIL+L G   +     L+ E    GT+ R     S     R    + E
Sbjct: 60  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 119
Query: 160 IANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGA 219
           +ANA++Y H    + ++ R IK  N+LL      K+ DF  SV  P      R   + G 
Sbjct: 120 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRXXLCGT 172
Query: 220 YGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIEN 279
             ++ PE       +E  D++S G    E L G                     K   E 
Sbjct: 173 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG---------------------KPPFEA 211
Query: 280 NRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDV 327
           N +      I   + +FP  +   +    L+ + L  +P  RP++ +V
Sbjct: 212 NTYQETYKRISRVEFTFP--DFVTEGARDLISRLLKHNPSQRPMLREV 257

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 99/227 (43%), Gaps = 27/227 (11%)
Query: 102 NNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFAS---LLIAPRIKIAM 158
           N +    + +H NIL  +G     +L  +V +  +  +L     AS     +   I IA 
Sbjct: 69  NEVGVLRKTRHVNILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIAR 127
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           + A  + YLH    + I+ R +K++N+ L E+ + K+ DF L+          + E + G
Sbjct: 128 QTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSG 184
Query: 219 AYGFIAPEYFATSSFNE---MCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKK 275
           +  ++APE       N      DVY+FG  L EL+TG   L +    N D +        
Sbjct: 185 SILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ--LPYSNINNRDQI-------- 234
Query: 276 SIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
            IE    G++   +    ++ P +      + +LM +CL K  + RP
Sbjct: 235 -IEMVGRGSLSPDLSKVRSNCPKR------MKRLMAECLKKKRDERP 274

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 88/228 (38%), Gaps = 32/228 (14%)
Query: 102 NNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL-RGFSFASLLIAPRIKIAM-E 159
             +   S ++H NIL+L G   +     L+ E    GT+ R     S     R    + E
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 116
Query: 160 IANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGA 219
           +ANA++Y H    + ++ R IK  N+LL      K+ DF  SV  P      R   + G 
Sbjct: 117 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRXXLCGT 169
Query: 220 YGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIEN 279
             ++ PE       +E  D++S G    E L G                     K   E 
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG---------------------KPPFEA 208
Query: 280 NRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDV 327
           N +      I   + +FP  +   +    L+ + L  +P  RP++ +V
Sbjct: 209 NTYQETYKRISRVEFTFP--DFVTEGARDLISRLLKHNPSQRPMLREV 254

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 65/151 (43%), Gaps = 9/151 (5%)
Query: 104 IVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL-RGFSFASLLIAPRIKIAM-EIA 161
           +   S ++H NIL+L G   +     L+ E    GT+ R     S     R    + E+A
Sbjct: 76  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 135
Query: 162 NAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYG 221
           NA++Y H    + ++ R IK  N+LL      K+ DF  SV  P      R   + G   
Sbjct: 136 NALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLD 188
Query: 222 FIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
           ++ PE       +E  D++S G    E L G
Sbjct: 189 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 219

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 88/228 (38%), Gaps = 32/228 (14%)
Query: 102 NNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL-RGFSFASLLIAPRIKIAM-E 159
             +   S ++H NIL+L G   +     L+ E    GT+ R     S     R    + E
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 116
Query: 160 IANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGA 219
           +ANA++Y H    + ++ R IK  N+LL      K+ DF  SV  P      R   + G 
Sbjct: 117 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTXLCGT 169
Query: 220 YGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIEN 279
             ++ PE       +E  D++S G    E L G                     K   E 
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG---------------------KPPFEA 208
Query: 280 NRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDV 327
           N +      I   + +FP  +   +    L+ + L  +P  RP++ +V
Sbjct: 209 NTYQETYKRISRVEFTFP--DFVTEGARDLISRLLKHNPSQRPMLREV 254

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 89/228 (39%), Gaps = 32/228 (14%)
Query: 102 NNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL-RGFSFASLLIAPRIKIAM-E 159
             +   S ++H NIL+L G   +     L+ E    GT+ R     S     R    + E
Sbjct: 60  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 119
Query: 160 IANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGA 219
           +ANA++Y H    + ++ R IK  N+LL      K+ DF  SV  P      R + + G 
Sbjct: 120 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRDDLCGT 172
Query: 220 YGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIEN 279
             ++ PE       +E  D++S G    E L G                     K   E 
Sbjct: 173 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG---------------------KPPFEA 211
Query: 280 NRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDV 327
           N +      I   + +FP  +   +    L+ + L  +P  RP++ +V
Sbjct: 212 NTYQETYKRISRVEFTFP--DFVTEGARDLISRLLKHNPSQRPMLREV 257

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 88/226 (38%), Gaps = 32/226 (14%)
Query: 104 IVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL-RGFSFASLLIAPRIKIAM-EIA 161
           +   S ++H NIL+L G   +     L+ E    GT+ R     S     R    + E+A
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 121
Query: 162 NAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYG 221
           NA++Y H    + ++ R IK  N+LL      K+ DF  SV  P      R   + G   
Sbjct: 122 NALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLD 174
Query: 222 FIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNR 281
           ++ PE       +E  D++S G    E L G                     K   E N 
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG---------------------KPPFEANT 213
Query: 282 FGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDV 327
           +      I   + +FP  +   +    L+ + L  +P  RP++ +V
Sbjct: 214 YQETYKRISRVEFTFP--DFVTEGARDLISRLLKHNPSQRPMLREV 257

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 88/228 (38%), Gaps = 32/228 (14%)
Query: 102 NNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL-RGFSFASLLIAPRIKIAM-E 159
             +   S ++H NIL+L G   +     L+ E    GT+ R     S     R    + E
Sbjct: 60  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 119
Query: 160 IANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGA 219
           +ANA++Y H    + ++ R IK  N+LL      K+ DF  SV  P      R   + G 
Sbjct: 120 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGT 172
Query: 220 YGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIEN 279
             ++ PE       +E  D++S G    E L G                     K   E 
Sbjct: 173 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG---------------------KPPFEA 211
Query: 280 NRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDV 327
           N +      I   + +FP  +   +    L+ + L  +P  RP++ +V
Sbjct: 212 NTYQETYKRISRVEFTFP--DFVTEGARDLISRLLKHNPSQRPMLREV 257

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 88/226 (38%), Gaps = 32/226 (14%)
Query: 104 IVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL-RGFSFASLLIAPRIKIAM-EIA 161
           +   S ++H NIL+L G   +     L+ E    GT+ R     S     R    + E+A
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 121
Query: 162 NAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYG 221
           NA++Y H    + ++ R IK  N+LL      K+ DF  SV  P      R   + G   
Sbjct: 122 NALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRAALCGTLD 174
Query: 222 FIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNR 281
           ++ PE       +E  D++S G    E L G                     K   E N 
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG---------------------KPPFEANT 213
Query: 282 FGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDV 327
           +      I   + +FP  +   +    L+ + L  +P  RP++ +V
Sbjct: 214 YQETYKRISRVEFTFP--DFVTEGARDLISRLLKHNPSQRPMLREV 257

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 88/226 (38%), Gaps = 32/226 (14%)
Query: 104 IVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL-RGFSFASLLIAPRIKIAM-EIA 161
           +   S ++H NIL+L G   +     L+ E    GT+ R     S     R    + E+A
Sbjct: 64  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 123
Query: 162 NAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYG 221
           NA++Y H    + ++ R IK  N+LL      K+ DF  SV  P      R   + G   
Sbjct: 124 NALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLD 176
Query: 222 FIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNR 281
           ++ PE       +E  D++S G    E L G                     K   E N 
Sbjct: 177 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG---------------------KPPFEANT 215
Query: 282 FGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDV 327
           +      I   + +FP  +   +    L+ + L  +P  RP++ +V
Sbjct: 216 YQETYKRISRVEFTFP--DFVTEGARDLISRLLKHNPSQRPMLREV 259

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 88/228 (38%), Gaps = 32/228 (14%)
Query: 102 NNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL-RGFSFASLLIAPRIKIAM-E 159
             +   S ++H NIL+L G   +     L+ E    GT+ R     S     R    + E
Sbjct: 56  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 115
Query: 160 IANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGA 219
           +ANA++Y H    + ++ R IK  N+LL      K+ DF  SV  P      R   + G 
Sbjct: 116 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGT 168
Query: 220 YGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIEN 279
             ++ PE       +E  D++S G    E L G                     K   E 
Sbjct: 169 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG---------------------KPPFEA 207
Query: 280 NRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDV 327
           N +      I   + +FP  +   +    L+ + L  +P  RP++ +V
Sbjct: 208 NTYQETYKRISRVEFTFP--DFVTEGARDLISRLLKHNPSQRPMLREV 253

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 65/151 (43%), Gaps = 9/151 (5%)
Query: 104 IVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL-RGFSFASLLIAPRIKIAM-EIA 161
           +   S ++H NIL+L G   +     L+ E    GT+ R     S     R    + E+A
Sbjct: 85  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 144
Query: 162 NAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYG 221
           NA++Y H    + ++ R IK  N+LL      K+ DF  SV  P      R   + G   
Sbjct: 145 NALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLD 197
Query: 222 FIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
           ++ PE       +E  D++S G    E L G
Sbjct: 198 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 228

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/205 (22%), Positives = 86/205 (41%), Gaps = 27/205 (13%)
Query: 71  LFEGTLVDQDRP-----ISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLE 124
           + E   +D+D+P     ++V    D++T +D+    + +     + KHKNI+ L+G C +
Sbjct: 53  MAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112
Query: 125 TELPTLVFESVKYGTLRGFSFA------------------SLLIAPRIKIAMEIANAVAY 166
                ++ E    G LR +  A                   +     +    ++A  + Y
Sbjct: 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY 172
Query: 167 LHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPE 226
           L     +  + R + A NVL+ EN   K+ DF L+  I   + + +    +    ++APE
Sbjct: 173 LA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPE 229
Query: 227 YFATSSFNEMCDVYSFGAFLCELLT 251
                 +    DV+SFG  + E+ T
Sbjct: 230 ALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 88/226 (38%), Gaps = 32/226 (14%)
Query: 104 IVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL-RGFSFASLLIAPRIKIAM-EIA 161
           +   S ++H NIL+L G   +     L+ E    GT+ R     S     R    + E+A
Sbjct: 59  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 118
Query: 162 NAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYG 221
           NA++Y H    + ++ R IK  N+LL      K+ DF  SV  P      R   + G   
Sbjct: 119 NALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLD 171
Query: 222 FIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNR 281
           ++ PE       +E  D++S G    E L G                     K   E N 
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG---------------------KPPFEANT 210
Query: 282 FGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDV 327
           +      I   + +FP  +   +    L+ + L  +P  RP++ +V
Sbjct: 211 YQETYKRISRVEFTFP--DFVTEGARDLISRLLKHNPSQRPMLREV 254

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 88/228 (38%), Gaps = 32/228 (14%)
Query: 102 NNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL-RGFSFASLLIAPRIKIAM-E 159
             +   S ++H NIL+L G   +     L+ E    GT+ R     S     R    + E
Sbjct: 54  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 113
Query: 160 IANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGA 219
           +ANA++Y H    + ++ R IK  N+LL      K+ DF  SV  P      R   + G 
Sbjct: 114 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGT 166
Query: 220 YGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIEN 279
             ++ PE       +E  D++S G    E L G                     K   E 
Sbjct: 167 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG---------------------KPPFEA 205
Query: 280 NRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDV 327
           N +      I   + +FP  +   +    L+ + L  +P  RP++ +V
Sbjct: 206 NTYQETYKRISRVEFTFP--DFVTEGARDLISRLLKHNPSQRPMLREV 251

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 39/117 (33%), Positives = 60/117 (51%), Gaps = 9/117 (7%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEF-IK 217
           E+A A+ +LH      I++R +K  N+LLDE    KL DF LS    E   H ++ +   
Sbjct: 134 ELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLS---KESIDHEKKAYSFC 187
Query: 218 GAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAK 274
           G   ++APE        +  D +SFG  + E+LTG   L F+G    + +T++  AK
Sbjct: 188 GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT--LPFQGKDRKETMTMILKAK 242

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 88/228 (38%), Gaps = 32/228 (14%)
Query: 102 NNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL-RGFSFASLLIAPRIKIAM-E 159
             +   S ++H NIL+L G   +     L+ E    GT+ R     S     R    + E
Sbjct: 61  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 120
Query: 160 IANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGA 219
           +ANA++Y H    + ++ R IK  N+LL      K+ DF  SV  P      R   + G 
Sbjct: 121 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGT 173
Query: 220 YGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIEN 279
             ++ PE       +E  D++S G    E L G                     K   E 
Sbjct: 174 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG---------------------KPPFEA 212
Query: 280 NRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDV 327
           N +      I   + +FP  +   +    L+ + L  +P  RP++ +V
Sbjct: 213 NTYQETYKRISRVEFTFP--DFVTEGARDLISRLLKHNPSQRPMLREV 258

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 88/228 (38%), Gaps = 32/228 (14%)
Query: 102 NNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL-RGFSFASLLIAPRIKIAM-E 159
             +   S ++H NIL+L G   +     L+ E    GT+ R     S     R    + E
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 116
Query: 160 IANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGA 219
           +ANA++Y H    + ++ R IK  N+LL      K+ DF  SV  P      R   + G 
Sbjct: 117 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRAALCGT 169
Query: 220 YGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIEN 279
             ++ PE       +E  D++S G    E L G                     K   E 
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG---------------------KPPFEA 208
Query: 280 NRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDV 327
           N +      I   + +FP  +   +    L+ + L  +P  RP++ +V
Sbjct: 209 NTYQETYKRISRVEFTFP--DFVTEGARDLISRLLKHNPSQRPMLREV 254

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 89/197 (45%), Gaps = 23/197 (11%)
Query: 127 LPTLVFESVKYGTLRGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVL 186
           LP +V E V   TLR        + P+  I + IA+A   L+      I+ R +K +N++
Sbjct: 107 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEV-IADACQALNFSHQNGIIHRDVKPANIM 165
Query: 187 LDENYSAKLHDFSLSVSIPE-GETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAF 245
           +    + K+ DF ++ +I + G +  +   + G   +++PE     S +   DVYS G  
Sbjct: 166 ISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCV 225
Query: 246 LCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQS 305
           L E+LTG    E    G+       ++ ++           DPI         + E L +
Sbjct: 226 LYEVLTG----EPPFTGDSPVSVAYQHVRE-----------DPIPPS-----ARHEGLSA 265
Query: 306 -LGQLMYKCLSKSPEHR 321
            L  ++ K L+K+PE+R
Sbjct: 266 DLDAVVLKALAKNPENR 282

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 39/117 (33%), Positives = 60/117 (51%), Gaps = 9/117 (7%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEF-IK 217
           E+A A+ +LH      I++R +K  N+LLDE    KL DF LS    E   H ++ +   
Sbjct: 135 ELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLS---KESIDHEKKAYSFC 188
Query: 218 GAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAK 274
           G   ++APE        +  D +SFG  + E+LTG   L F+G    + +T++  AK
Sbjct: 189 GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT--LPFQGKDRKETMTMILKAK 243

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 89/197 (45%), Gaps = 23/197 (11%)
Query: 127 LPTLVFESVKYGTLRGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVL 186
           LP +V E V   TLR        + P+  I + IA+A   L+      I+ R +K +N++
Sbjct: 90  LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEV-IADACQALNFSHQNGIIHRDVKPANIM 148
Query: 187 LDENYSAKLHDFSLSVSIPE-GETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAF 245
           +    + K+ DF ++ +I + G +  +   + G   +++PE     S +   DVYS G  
Sbjct: 149 ISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCV 208
Query: 246 LCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQS 305
           L E+LTG    E    G+       ++ ++           DPI         + E L +
Sbjct: 209 LYEVLTG----EPPFTGDSPVSVAYQHVRE-----------DPIPPS-----ARHEGLSA 248
Query: 306 -LGQLMYKCLSKSPEHR 321
            L  ++ K L+K+PE+R
Sbjct: 249 DLDAVVLKALAKNPENR 265

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/118 (33%), Positives = 62/118 (52%), Gaps = 11/118 (9%)
Query: 159 EIANAVAYLH-VGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEF-I 216
           E+A A+ +LH +G    I++R +K  N+LLDE    KL DF LS    E   H ++ +  
Sbjct: 134 ELALALDHLHSLG----IIYRDLKPENILLDEEGHIKLTDFGLS---KESIDHEKKAYSF 186
Query: 217 KGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAK 274
            G   ++APE        +  D +SFG  + E+LTG   L F+G    + +T++  AK
Sbjct: 187 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT--LPFQGKDRKETMTMILKAK 242

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 89/197 (45%), Gaps = 23/197 (11%)
Query: 127 LPTLVFESVKYGTLRGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVL 186
           LP +V E V   TLR        + P+  I + IA+A   L+      I+ R +K +N++
Sbjct: 90  LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEV-IADACQALNFSHQNGIIHRDVKPANIM 148
Query: 187 LDENYSAKLHDFSLSVSIPE-GETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAF 245
           +    + K+ DF ++ +I + G +  +   + G   +++PE     S +   DVYS G  
Sbjct: 149 ISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCV 208
Query: 246 LCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQS 305
           L E+LTG    E    G+       ++ ++           DPI         + E L +
Sbjct: 209 LYEVLTG----EPPFTGDSPVSVAYQHVRE-----------DPIPPS-----ARHEGLSA 248
Query: 306 -LGQLMYKCLSKSPEHR 321
            L  ++ K L+K+PE+R
Sbjct: 249 DLDAVVLKALAKNPENR 265

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 89/197 (45%), Gaps = 23/197 (11%)
Query: 127 LPTLVFESVKYGTLRGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVL 186
           LP +V E V   TLR        + P+  I + IA+A   L+      I+ R +K +N++
Sbjct: 90  LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEV-IADACQALNFSHQNGIIHRDVKPANIM 148
Query: 187 LDENYSAKLHDFSLSVSIPE-GETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAF 245
           +    + K+ DF ++ +I + G +  +   + G   +++PE     S +   DVYS G  
Sbjct: 149 ISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCV 208
Query: 246 LCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQS 305
           L E+LTG    E    G+       ++ ++           DPI         + E L +
Sbjct: 209 LYEVLTG----EPPFTGDSPVSVAYQHVRE-----------DPIPPS-----ARHEGLSA 248
Query: 306 -LGQLMYKCLSKSPEHR 321
            L  ++ K L+K+PE+R
Sbjct: 249 DLDAVVLKALAKNPENR 265

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 88/221 (39%), Gaps = 32/221 (14%)
Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANAV 164
            Q  H NI++L G   +++   +V E ++ G+L  F     A   +   + +   IA+ +
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSI---PEGETHVREEFIKGAYG 221
            YL    D   V R + A N+L++ N   K+ DF LS  +   PE     R   I     
Sbjct: 161 KYLS---DMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIR 215
Query: 222 FIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNR 281
           + +PE  A   F    DV+S+G  L E                    V+ Y ++      
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWE--------------------VMSYGERPYWEMS 255
Query: 282 FGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
              ++  + DE    P   +   +L QLM  C  K   +RP
Sbjct: 256 NQDVIKAV-DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRP 295

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 88/226 (38%), Gaps = 32/226 (14%)
Query: 104 IVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL-RGFSFASLLIAPRIKIAM-EIA 161
           +   S ++H NIL+L G   +     L+ E    GT+ R     S     R    + E+A
Sbjct: 59  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 118
Query: 162 NAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYG 221
           NA++Y H    + ++ R IK  N+LL      K+ DF  SV  P      R   + G   
Sbjct: 119 NALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTDLCGTLD 171
Query: 222 FIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNR 281
           ++ PE       +E  D++S G    E L G                     K   E N 
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG---------------------KPPFEANT 210
Query: 282 FGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDV 327
           +      I   + +FP  +   +    L+ + L  +P  RP++ +V
Sbjct: 211 YQETYKRISRVEFTFP--DFVTEGARDLISRLLKHNPSQRPMLREV 254

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 88/226 (38%), Gaps = 32/226 (14%)
Query: 104 IVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL-RGFSFASLLIAPRIKIAM-EIA 161
           +   S ++H NIL+L G   +     L+ E    GT+ R     S     R    + E+A
Sbjct: 60  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 119
Query: 162 NAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYG 221
           NA++Y H    + ++ R IK  N+LL      K+ DF  SV  P      R   + G   
Sbjct: 120 NALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTDLCGTLD 172
Query: 222 FIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNR 281
           ++ PE       +E  D++S G    E L G                     K   E N 
Sbjct: 173 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG---------------------KPPFEANT 211
Query: 282 FGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDV 327
           +      I   + +FP  +   +    L+ + L  +P  RP++ +V
Sbjct: 212 YQETYKRISRVEFTFP--DFVTEGARDLISRLLKHNPSQRPMLREV 255

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 88/226 (38%), Gaps = 32/226 (14%)
Query: 104 IVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL-RGFSFASLLIAPRIKIAM-EIA 161
           +   S ++H NIL+L G   +     L+ E    GT+ R     S     R    + E+A
Sbjct: 64  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 123
Query: 162 NAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYG 221
           NA++Y H    + ++ R IK  N+LL      K+ DF  SV  P      R   + G   
Sbjct: 124 NALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTDLCGTLD 176
Query: 222 FIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNR 281
           ++ PE       +E  D++S G    E L G                     K   E N 
Sbjct: 177 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG---------------------KPPFEANT 215
Query: 282 FGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDV 327
           +      I   + +FP  +   +    L+ + L  +P  RP++ +V
Sbjct: 216 YQETYKRISRVEFTFP--DFVTEGARDLISRLLKHNPSQRPMLREV 259

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 88/226 (38%), Gaps = 32/226 (14%)
Query: 104 IVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL-RGFSFASLLIAPRIKIAM-EIA 161
           +   S ++H NIL+L G   +     L+ E    GT+ R     S     R    + E+A
Sbjct: 59  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 118
Query: 162 NAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYG 221
           NA++Y H    + ++ R IK  N+LL      K+ DF  SV  P      R   + G   
Sbjct: 119 NALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTELCGTLD 171
Query: 222 FIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNR 281
           ++ PE       +E  D++S G    E L G                     K   E N 
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG---------------------KPPFEANT 210
Query: 282 FGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDV 327
           +      I   + +FP  +   +    L+ + L  +P  RP++ +V
Sbjct: 211 YQETYKRISRVEFTFP--DFVTEGARDLISRLLKHNPSQRPMLREV 254

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 89/197 (45%), Gaps = 23/197 (11%)
Query: 127 LPTLVFESVKYGTLRGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVL 186
           LP +V E V   TLR        + P+  I + IA+A   L+      I+ R +K +N+L
Sbjct: 90  LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEV-IADACQALNFSHQNGIIHRDVKPANIL 148
Query: 187 LDENYSAKLHDFSLSVSIPE-GETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAF 245
           +    + K+ DF ++ +I + G +  +   + G   +++PE     S +   DVYS G  
Sbjct: 149 ISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCV 208
Query: 246 LCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQS 305
           L E+LTG    E    G+       ++ ++           DPI         + E L +
Sbjct: 209 LYEVLTG----EPPFTGDSPVSVAYQHVRE-----------DPIPPS-----ARHEGLSA 248
Query: 306 -LGQLMYKCLSKSPEHR 321
            L  ++ K L+K+PE+R
Sbjct: 249 DLDAVVLKALAKNPENR 265

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 88/221 (39%), Gaps = 32/221 (14%)
Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANAV 164
            Q  H NI++L G   +++   +V E ++ G+L  F     A   +   + +   IA+ +
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSI---PEGETHVREEFIKGAYG 221
            YL    D   V R + A N+L++ N   K+ DF LS  +   PE     R   I     
Sbjct: 161 KYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIR 215
Query: 222 FIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNR 281
           + +PE  A   F    DV+S+G  L E                    V+ Y ++      
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWE--------------------VMSYGERPYWEMS 255
Query: 282 FGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
              ++  + DE    P   +   +L QLM  C  K   +RP
Sbjct: 256 NQDVIKAV-DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRP 295

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/256 (24%), Positives = 102/256 (39%), Gaps = 29/256 (11%)
Query: 83  ISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRG 142
           ++V     + TLD+ E   +  V    + H +I+KLIG  +E E   ++ E   YG L  
Sbjct: 55  VAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIG-IIEEEPTWIIMELYPYGELGH 113
Query: 143 F---SFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFS 199
           +   +  SL +   +  +++I  A+AYL        V R I   N+L+      KL DF 
Sbjct: 114 YLERNKNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFG 170
Query: 200 LSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFK 259
           LS  I E E + +    +    +++PE      F    DV+ F   + E+L+      F 
Sbjct: 171 LSRYI-EDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILS-FGKQPFF 228
Query: 260 GNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPE 319
              N D + VLE                    + +  P  +     L  LM +C    P 
Sbjct: 229 WLENKDVIGVLE--------------------KGDRLPKPDLCPPVLYTLMTRCWDYDPS 268
Query: 320 HRPLMVDVAKQLRQMY 335
            RP   ++   L  +Y
Sbjct: 269 DRPRFTELVCSLSDVY 284

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 81/177 (45%), Gaps = 23/177 (12%)
Query: 154 IKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVRE 213
           I IA + A  + YLH    + I+ R +K++N+ L E+ + K+ DF L+          + 
Sbjct: 127 IDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQF 183
Query: 214 EFIKGAYGFIAPEYFATSSFNE---MCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
           E + G+  ++APE       N      DVY+FG  L EL+TG   L +  N N+ D  + 
Sbjct: 184 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ--LPY-SNINNRDQIIF 240
Query: 271 EYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDV 327
              +        G +   +    ++ P      +++ +LM +CL K  + RPL   +
Sbjct: 241 MVGR--------GYLSPDLSKVRSNCP------KAMKRLMAECLKKKRDERPLFPQI 283

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/256 (24%), Positives = 102/256 (39%), Gaps = 29/256 (11%)
Query: 83  ISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRG 142
           ++V     + TLD+ E   +  V    + H +I+KLIG  +E E   ++ E   YG L  
Sbjct: 43  VAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIG-IIEEEPTWIIMELYPYGELGH 101
Query: 143 F---SFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFS 199
           +   +  SL +   +  +++I  A+AYL        V R I   N+L+      KL DF 
Sbjct: 102 YLERNKNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFG 158
Query: 200 LSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFK 259
           LS  I E E + +    +    +++PE      F    DV+ F   + E+L+      F 
Sbjct: 159 LSRYI-EDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILS-FGKQPFF 216
Query: 260 GNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPE 319
              N D + VLE                    + +  P  +     L  LM +C    P 
Sbjct: 217 WLENKDVIGVLE--------------------KGDRLPKPDLCPPVLYTLMTRCWDYDPS 256
Query: 320 HRPLMVDVAKQLRQMY 335
            RP   ++   L  +Y
Sbjct: 257 DRPRFTELVCSLSDVY 272

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/256 (24%), Positives = 102/256 (39%), Gaps = 29/256 (11%)
Query: 83  ISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRG 142
           ++V     + TLD+ E   +  V    + H +I+KLIG  +E E   ++ E   YG L  
Sbjct: 39  VAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIG-IIEEEPTWIIMELYPYGELGH 97
Query: 143 F---SFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFS 199
           +   +  SL +   +  +++I  A+AYL        V R I   N+L+      KL DF 
Sbjct: 98  YLERNKNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFG 154
Query: 200 LSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFK 259
           LS  I E E + +    +    +++PE      F    DV+ F   + E+L+      F 
Sbjct: 155 LSRYI-EDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSF-GKQPFF 212
Query: 260 GNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPE 319
              N D + VLE                    + +  P  +     L  LM +C    P 
Sbjct: 213 WLENKDVIGVLE--------------------KGDRLPKPDLCPPVLYTLMTRCWDYDPS 252
Query: 320 HRPLMVDVAKQLRQMY 335
            RP   ++   L  +Y
Sbjct: 253 DRPRFTELVCSLSDVY 268

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 87/226 (38%), Gaps = 32/226 (14%)
Query: 104 IVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL-RGFSFASLLIAPRIKIAM-EIA 161
           +   S ++H NIL+L G   +     L+ E    GT+ R     S     R    + E+A
Sbjct: 60  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 119
Query: 162 NAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYG 221
           NA++Y H    + ++ R IK  N+LL      K+ DF  S   P      R   + G   
Sbjct: 120 NALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSS----RRTTLSGTLD 172
Query: 222 FIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNR 281
           ++ PE       +E  D++S G    E L G                     K   E N 
Sbjct: 173 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG---------------------KPPFEANT 211
Query: 282 FGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDV 327
           +      I   + +FP  +   +    L+ + L  +P  RP++ +V
Sbjct: 212 YQETYKRISRVEFTFP--DFVTEGARDLISRLLKHNPSQRPMLREV 255

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 88/220 (40%), Gaps = 32/220 (14%)
Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANAVA 165
           Q  H NI++L G   +++   +V E ++ G+L  F     A   +   + +   IA+ + 
Sbjct: 73  QFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMK 132
Query: 166 YLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSI---PEGETHVREEFIKGAYGF 222
           YL    D   V R + A N+L++ N   K+ DF LS  +   PE     R   I     +
Sbjct: 133 YLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRW 187
Query: 223 IAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRF 282
            +PE  A   F    DV+S+G  L E                    V+ Y ++       
Sbjct: 188 TSPEAIAYRKFTSASDVWSYGIVLWE--------------------VMSYGERPYWEMSN 227
Query: 283 GAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
             ++  + DE    P   +   +L QLM  C  K   +RP
Sbjct: 228 QDVIKAV-DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRP 266

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 81/177 (45%), Gaps = 23/177 (12%)
Query: 154 IKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVRE 213
           I IA + A  + YLH    + I+ R +K++N+ L E+ + K+ DF L+          + 
Sbjct: 135 IDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQF 191
Query: 214 EFIKGAYGFIAPEYFATSSFNE---MCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
           E + G+  ++APE       N      DVY+FG  L EL+TG   L +  N N+ D  + 
Sbjct: 192 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ--LPYS-NINNRDQIIF 248
Query: 271 EYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDV 327
              +        G +   +    ++ P      +++ +LM +CL K  + RPL   +
Sbjct: 249 MVGR--------GYLSPDLSKVRSNCP------KAMKRLMAECLKKKRDERPLFPQI 291

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 88/228 (38%), Gaps = 32/228 (14%)
Query: 102 NNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL-RGFSFASLLIAPRIKIAM-E 159
             +   S ++H NIL+L G   +     L+ E    GT+ R     S     R    + E
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 116
Query: 160 IANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGA 219
           +ANA++Y H    + ++ R IK  N+LL      K+ DF  SV  P      R   + G 
Sbjct: 117 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTDLCGT 169
Query: 220 YGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIEN 279
             ++ PE       +E  D++S G    E L G                     K   E 
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG---------------------KPPFEA 208
Query: 280 NRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDV 327
           N +      I   + +FP  +   +    L+ + L  +P  RP++ +V
Sbjct: 209 NTYQETYKRISRVEFTFP--DFVTEGARDLISRLLKHNPSQRPMLREV 254

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 88/221 (39%), Gaps = 32/221 (14%)
Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANAV 164
            Q  H NI++L G   +++   +V E ++ G+L  F     A   +   + +   IA+ +
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSI---PEGETHVREEFIKGAYG 221
            YL    D   V R + A N+L++ N   K+ DF LS  +   PE     R   I     
Sbjct: 161 KYLS---DMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIR 215
Query: 222 FIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNR 281
           + +PE  A   F    DV+S+G  L E                    V+ Y ++      
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWE--------------------VMSYGERPYWEMS 255
Query: 282 FGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
              ++  + DE    P   +   +L QLM  C  K   +RP
Sbjct: 256 NQDVIKAV-DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRP 295

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 73/152 (48%), Gaps = 15/152 (9%)
Query: 112 HKNILKLIGCCLE--TELPTLVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANAVAY 166
           H+NI+K  G C E       L+ E +  G+L+ +   +   + +  ++K A++I   + Y
Sbjct: 82  HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDY 141
Query: 167 LHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIK----GAYGF 222
           L     R  V R + A NVL++  +  K+ DF L+ +I   ET      +K        +
Sbjct: 142 LG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI---ETDKEXXTVKDDRDSPVFW 195
Query: 223 IAPEYFATSSFNEMCDVYSFGAFLCELLTGCN 254
            APE    S F    DV+SFG  L ELLT C+
Sbjct: 196 YAPECLMQSKFYIASDVWSFGVTLHELLTYCD 227

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/205 (22%), Positives = 85/205 (41%), Gaps = 27/205 (13%)
Query: 71  LFEGTLVDQDRP-----ISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLE 124
           + E   +D+D+P     ++V    D++T  D+    + +     + KHKNI+ L+G C +
Sbjct: 42  MAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 101
Query: 125 TELPTLVFESVKYGTLRGFSFA------------------SLLIAPRIKIAMEIANAVAY 166
                ++ E    G LR +  A                   +     +    ++A  + Y
Sbjct: 102 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY 161
Query: 167 LHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPE 226
           L     +  + R + A NVL+ EN   K+ DF L+  I   + + +    +    ++APE
Sbjct: 162 LA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPE 218
Query: 227 YFATSSFNEMCDVYSFGAFLCELLT 251
                 +    DV+SFG  + E+ T
Sbjct: 219 ALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/239 (23%), Positives = 94/239 (39%), Gaps = 42/239 (17%)
Query: 112 HKNILKLIGCCLETELPTLVF-ESVKYGTLRGF------SFASLLIAPR----------- 153
           H N++ L+G C +   P +V  E  K+G L  +       F    +AP            
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 154 -IKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVR 212
            I  + ++A  + +L     R  + R + A N+LL E    K+ DF L+  I +   +VR
Sbjct: 150 LICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 206
Query: 213 EEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEY 272
           +   +    ++APE      +    DV+SFG  L E+ +      + G   D+     E+
Sbjct: 207 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-LGASPYPGVKIDE-----EF 260
Query: 273 AKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQL 331
            ++  E  R  A        D + P        + Q M  C    P  RP   ++ + L
Sbjct: 261 CRRLKEGTRMRA-------PDYTTP-------EMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/205 (22%), Positives = 85/205 (41%), Gaps = 27/205 (13%)
Query: 71  LFEGTLVDQDRP-----ISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLE 124
           + E   +D+D+P     ++V    D++T  D+    + +     + KHKNI+ L+G C +
Sbjct: 40  MAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 99
Query: 125 TELPTLVFESVKYGTLRGFSFA------------------SLLIAPRIKIAMEIANAVAY 166
                ++ E    G LR +  A                   +     +    ++A  + Y
Sbjct: 100 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY 159
Query: 167 LHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPE 226
           L     +  + R + A NVL+ EN   K+ DF L+  I   + + +    +    ++APE
Sbjct: 160 LA---SQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPE 216
Query: 227 YFATSSFNEMCDVYSFGAFLCELLT 251
                 +    DV+SFG  + E+ T
Sbjct: 217 ALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/205 (22%), Positives = 85/205 (41%), Gaps = 27/205 (13%)
Query: 71  LFEGTLVDQDRP-----ISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLE 124
           + E   +D+D+P     ++V    D++T  D+    + +     + KHKNI+ L+G C +
Sbjct: 53  MAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIHLLGACTQ 112
Query: 125 TELPTLVFESVKYGTLRGFSFA------------------SLLIAPRIKIAMEIANAVAY 166
                ++ E    G LR +  A                   +     +    ++A  + Y
Sbjct: 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY 172
Query: 167 LHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPE 226
           L     +  + R + A NVL+ EN   K+ DF L+  I   + + +    +    ++APE
Sbjct: 173 LA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPE 229
Query: 227 YFATSSFNEMCDVYSFGAFLCELLT 251
                 +    DV+SFG  + E+ T
Sbjct: 230 ALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/239 (23%), Positives = 94/239 (39%), Gaps = 42/239 (17%)
Query: 112 HKNILKLIGCCLETELPTLVF-ESVKYGTLRGF------SFASLLIAPR----------- 153
           H N++ L+G C +   P +V  E  K+G L  +       F    +AP            
Sbjct: 127 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 186
Query: 154 -IKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVR 212
            I  + ++A  + +L     R  + R + A N+LL E    K+ DF L+  I +   +VR
Sbjct: 187 LICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 243
Query: 213 EEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEY 272
           +   +    ++APE      +    DV+SFG  L E+ +      + G   D+     E+
Sbjct: 244 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-LGASPYPGVKIDE-----EF 297
Query: 273 AKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQL 331
            ++  E  R  A        D + P        + Q M  C    P  RP   ++ + L
Sbjct: 298 CRRLKEGTRMRA-------PDYTTP-------EMYQTMLDCWHGEPSQRPTFSELVEHL 342

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/205 (22%), Positives = 85/205 (41%), Gaps = 27/205 (13%)
Query: 71  LFEGTLVDQDRP-----ISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLE 124
           + E   +D+D+P     ++V    D++T  D+    + +     + KHKNI+ L+G C +
Sbjct: 45  MAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 104
Query: 125 TELPTLVFESVKYGTLRGFSFA------------------SLLIAPRIKIAMEIANAVAY 166
                ++ E    G LR +  A                   +     +    ++A  + Y
Sbjct: 105 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY 164
Query: 167 LHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPE 226
           L     +  + R + A NVL+ EN   K+ DF L+  I   + + +    +    ++APE
Sbjct: 165 LA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPE 221
Query: 227 YFATSSFNEMCDVYSFGAFLCELLT 251
                 +    DV+SFG  + E+ T
Sbjct: 222 ALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/205 (22%), Positives = 85/205 (41%), Gaps = 27/205 (13%)
Query: 71  LFEGTLVDQDRP-----ISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLE 124
           + E   +D+D+P     ++V    D++T  D+    + +     + KHKNI+ L+G C +
Sbjct: 53  MAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIITLLGACTQ 112
Query: 125 TELPTLVFESVKYGTLRGFSFA------------------SLLIAPRIKIAMEIANAVAY 166
                ++ E    G LR +  A                   +     +    ++A  + Y
Sbjct: 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY 172
Query: 167 LHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPE 226
           L     +  + R + A NVL+ EN   K+ DF L+  I   + + +    +    ++APE
Sbjct: 173 LA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPE 229
Query: 227 YFATSSFNEMCDVYSFGAFLCELLT 251
                 +    DV+SFG  + E+ T
Sbjct: 230 ALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 73/149 (48%), Gaps = 9/149 (6%)
Query: 112 HKNILKLIGCCLE--TELPTLVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANAVAY 166
           H+NI+K  G C E       L+ E +  G+L+ +   +   + +  ++K A++I   + Y
Sbjct: 70  HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDY 129
Query: 167 LHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSI-PEGETHVREEFIKGAYGFIAP 225
           L     R  V R + A NVL++  +  K+ DF L+ +I  + E    ++       + AP
Sbjct: 130 LG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAP 186
Query: 226 EYFATSSFNEMCDVYSFGAFLCELLTGCN 254
           E    S F    DV+SFG  L ELLT C+
Sbjct: 187 ECLMQSKFYIASDVWSFGVTLHELLTYCD 215

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 88/221 (39%), Gaps = 32/221 (14%)
Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANAV 164
            Q  H NI++L G   +++   +V E ++ G+L  F     A   +   + +   IA+ +
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSI---PEGETHVREEFIKGAYG 221
            YL    D   V R + A N+L++ N   K+ DF LS  +   PE     R   I     
Sbjct: 161 KYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIR 215
Query: 222 FIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNR 281
           + +PE  A   F    DV+S+G  L E                    V+ Y ++      
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWE--------------------VMSYGERPYWEMS 255
Query: 282 FGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
              ++  + DE    P   +   +L QLM  C  K   +RP
Sbjct: 256 NQDVIKAV-DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRP 295

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 80/173 (46%), Gaps = 23/173 (13%)
Query: 154 IKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVRE 213
           I IA + A  + YLH    + I+ R +K++N+ L E+ + K+ DF L+          + 
Sbjct: 134 IDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF 190
Query: 214 EFIKGAYGFIAPEYFATSSFNE---MCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
           E + G+  ++APE       N      DVY+FG  L EL+TG   L +  N N+ D  + 
Sbjct: 191 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ--LPY-SNINNRDQIIF 247
Query: 271 EYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPL 323
              +        G +   +    ++ P      +++ +LM +CL K  + RPL
Sbjct: 248 MVGR--------GYLSPDLSKVRSNCP------KAMKRLMAECLKKKRDERPL 286

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/239 (23%), Positives = 94/239 (39%), Gaps = 42/239 (17%)
Query: 112 HKNILKLIGCCLETELPTLVF-ESVKYGTLRGF------SFASLLIAPR----------- 153
           H N++ L+G C +   P +V  E  K+G L  +       F    +AP            
Sbjct: 81  HLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 140
Query: 154 -IKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVR 212
            I  + ++A  + +L     R  + R + A N+LL E    K+ DF L+  I +   +VR
Sbjct: 141 LICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 197
Query: 213 EEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEY 272
           +   +    ++APE      +    DV+SFG  L E+ +      + G   D+     E+
Sbjct: 198 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-LGASPYPGVKIDE-----EF 251
Query: 273 AKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQL 331
            ++  E  R  A        D + P        + Q M  C    P  RP   ++ + L
Sbjct: 252 CRRLKEGTRMRA-------PDYTTP-------EMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 88/221 (39%), Gaps = 32/221 (14%)
Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANAV 164
            Q  H NI++L G   +++   +V E ++ G+L  F     A   +   + +   IA+ +
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSI---PEGETHVREEFIKGAYG 221
            YL    D   V R + A N+L++ N   K+ DF LS  +   PE     R   I     
Sbjct: 161 KYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIR 215
Query: 222 FIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNR 281
           + +PE  A   F    DV+S+G  L E                    V+ Y ++      
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWE--------------------VMSYGERPYWEMS 255
Query: 282 FGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
              ++  + DE    P   +   +L QLM  C  K   +RP
Sbjct: 256 NQDVIKAV-DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRP 295

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 88/221 (39%), Gaps = 32/221 (14%)
Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANAV 164
            Q  H NI++L G   +++   +V E ++ G+L  F     A   +   + +   IA+ +
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSI---PEGETHVREEFIKGAYG 221
            YL    D   V R + A N+L++ N   K+ DF LS  +   PE     R   I     
Sbjct: 161 KYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIR 215
Query: 222 FIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNR 281
           + +PE  A   F    DV+S+G  L E                    V+ Y ++      
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWE--------------------VMSYGERPYWEMS 255
Query: 282 FGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
              ++  + DE    P   +   +L QLM  C  K   +RP
Sbjct: 256 NQDVIKAV-DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRP 295

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/205 (22%), Positives = 85/205 (41%), Gaps = 27/205 (13%)
Query: 71  LFEGTLVDQDRP-----ISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLE 124
           + E   +D+D+P     ++V    D++T  D+    + +     + KHKNI+ L+G C +
Sbjct: 99  MAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158
Query: 125 TELPTLVFESVKYGTLRGFSFA------------------SLLIAPRIKIAMEIANAVAY 166
                ++ E    G LR +  A                   +     +    ++A  + Y
Sbjct: 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY 218
Query: 167 LHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPE 226
           L     +  + R + A NVL+ EN   K+ DF L+  I   + + +    +    ++APE
Sbjct: 219 LA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPE 275
Query: 227 YFATSSFNEMCDVYSFGAFLCELLT 251
                 +    DV+SFG  + E+ T
Sbjct: 276 ALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 80/173 (46%), Gaps = 23/173 (13%)
Query: 154 IKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVRE 213
           I IA + A  + YLH    + I+ R +K++N+ L E+ + K+ DF L+          + 
Sbjct: 135 IDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF 191
Query: 214 EFIKGAYGFIAPEYFATSSFNE---MCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
           E + G+  ++APE       N      DVY+FG  L EL+TG   L +  N N+ D  + 
Sbjct: 192 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ--LPYS-NINNRDQIIF 248
Query: 271 EYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPL 323
              +        G +   +    ++ P      +++ +LM +CL K  + RPL
Sbjct: 249 MVGR--------GYLSPDLSKVRSNCP------KAMKRLMAECLKKKRDERPL 287

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 88/221 (39%), Gaps = 32/221 (14%)
Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANAV 164
            Q  H NI++L G   +++   +V E ++ G+L  F     A   +   + +   IA+ +
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSI---PEGETHVREEFIKGAYG 221
            YL    D   V R + A N+L++ N   K+ DF LS  +   PE     R   I     
Sbjct: 161 KYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIR 215
Query: 222 FIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNR 281
           + +PE  A   F    DV+S+G  L E                    V+ Y ++      
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWE--------------------VMSYGERPYWEMS 255
Query: 282 FGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
              ++  + DE    P   +   +L QLM  C  K   +RP
Sbjct: 256 NQDVIKAV-DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRP 295

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/239 (23%), Positives = 94/239 (39%), Gaps = 42/239 (17%)
Query: 112 HKNILKLIGCCLETELPTLVF-ESVKYGTLRGF------SFASLLIAPR----------- 153
           H N++ L+G C +   P +V  E  K+G L  +       F    +AP            
Sbjct: 81  HLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 140
Query: 154 -IKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVR 212
            I  + ++A  + +L     R  + R + A N+LL E    K+ DF L+  I +   +VR
Sbjct: 141 LICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 197
Query: 213 EEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEY 272
           +   +    ++APE      +    DV+SFG  L E+ +      + G   D+     E+
Sbjct: 198 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-LGASPYPGVKIDE-----EF 251
Query: 273 AKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQL 331
            ++  E  R  A        D + P        + Q M  C    P  RP   ++ + L
Sbjct: 252 CRRLKEGTRMRA-------PDYTTP-------EMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 88/221 (39%), Gaps = 32/221 (14%)
Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANAV 164
            Q  H NI++L G   +++   +V E ++ G+L  F     A   +   + +   IA+ +
Sbjct: 89  GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 148
Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSI---PEGETHVREEFIKGAYG 221
            YL    D   V R + A N+L++ N   K+ DF LS  +   PE     R   I     
Sbjct: 149 KYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIR 203
Query: 222 FIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNR 281
           + +PE  A   F    DV+S+G  L E                    V+ Y ++      
Sbjct: 204 WTSPEAIAYRKFTSASDVWSYGIVLWE--------------------VMSYGERPYWEMS 243
Query: 282 FGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
              ++  + DE    P   +   +L QLM  C  K   +RP
Sbjct: 244 NQDVIKAV-DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRP 283

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/205 (22%), Positives = 84/205 (40%), Gaps = 27/205 (13%)
Query: 71  LFEGTLVDQDRP-----ISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLE 124
           + E   +D+D+P     ++V    D++T  D+    + +     + KHKNI+ L+G C +
Sbjct: 53  MAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112
Query: 125 TELPTLVFESVKYGTLRGFSFA------------------SLLIAPRIKIAMEIANAVAY 166
                ++ E    G LR +  A                   +     +    ++A  + Y
Sbjct: 113 DGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSCTYQLARGMEY 172
Query: 167 LHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPE 226
           L     +  + R + A NVL+ EN   K+ DF L+  I   +   +    +    ++APE
Sbjct: 173 LA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPE 229
Query: 227 YFATSSFNEMCDVYSFGAFLCELLT 251
                 +    DV+SFG  + E+ T
Sbjct: 230 ALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 88/221 (39%), Gaps = 32/221 (14%)
Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANAV 164
            Q  H NI++L G   +++   +V E ++ G+L  F     A   +   + +   IA+ +
Sbjct: 99  GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 158
Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSI---PEGETHVREEFIKGAYG 221
            YL    D   V R + A N+L++ N   K+ DF LS  +   PE     R   I     
Sbjct: 159 KYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIR 213
Query: 222 FIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNR 281
           + +PE  A   F    DV+S+G  L E                    V+ Y ++      
Sbjct: 214 WTSPEAIAYRKFTSASDVWSYGIVLWE--------------------VMSYGERPYWEMS 253
Query: 282 FGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
              ++  + DE    P   +   +L QLM  C  K   +RP
Sbjct: 254 NQDVIKAV-DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRP 293

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 88/220 (40%), Gaps = 32/220 (14%)
Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANAVA 165
           Q  H NI++L G   +++   +V E ++ G+L  F     A   +   + +   IA+ + 
Sbjct: 73  QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMK 132
Query: 166 YLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSI---PEGETHVREEFIKGAYGF 222
           YL    D   V R + A N+L++ N   K+ DF LS  +   PE     R   I     +
Sbjct: 133 YLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRW 187
Query: 223 IAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRF 282
            +PE  A   F    DV+S+G  L E                    V+ Y ++       
Sbjct: 188 TSPEAIAYRKFTSASDVWSYGIVLWE--------------------VMSYGERPYWEMSN 227
Query: 283 GAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
             ++  + DE    P   +   +L QLM  C  K   +RP
Sbjct: 228 QDVIKAV-DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRP 266

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 81/177 (45%), Gaps = 23/177 (12%)
Query: 154 IKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVRE 213
           I IA + A  + YLH    + I+ R +K++N+ L E+ + K+ DF L+          + 
Sbjct: 107 IDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQF 163
Query: 214 EFIKGAYGFIAPEYFATSSFNE---MCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
           E + G+  ++APE       N      DVY+FG  L EL+TG   L +  N N+ D  + 
Sbjct: 164 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ--LPY-SNINNRDQIIF 220
Query: 271 EYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDV 327
              +        G +   +    ++ P      +++ +LM +CL K  + RPL   +
Sbjct: 221 MVGR--------GYLSPDLSKVRSNCP------KAMKRLMAECLKKKRDERPLFPQI 263

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/205 (22%), Positives = 84/205 (40%), Gaps = 27/205 (13%)
Query: 71  LFEGTLVDQDRP-----ISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLE 124
           + E   +D+D+P     ++V    D++T  D+    + +     + KHKNI+ L+G C +
Sbjct: 53  MAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112
Query: 125 TELPTLVFESVKYGTLRGFSFA------------------SLLIAPRIKIAMEIANAVAY 166
                ++ E    G LR +  A                   +     +    ++A  + Y
Sbjct: 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY 172
Query: 167 LHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPE 226
           L     +  + R + A NVL+ EN   K+ DF L+  I   +   +    +    ++APE
Sbjct: 173 LA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPE 229
Query: 227 YFATSSFNEMCDVYSFGAFLCELLT 251
                 +    DV+SFG  + E+ T
Sbjct: 230 ALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/239 (23%), Positives = 93/239 (38%), Gaps = 42/239 (17%)
Query: 112 HKNILKLIGCCLETELPTLVF-ESVKYGTLRGF------SFASLLIAPR----------- 153
           H N++ L+G C +   P +V  E  K+G L  +       F    +AP            
Sbjct: 81  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 140
Query: 154 -IKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVR 212
            I  + ++A  + +L     R  + R + A N+LL E    K+ DF L+  I +    VR
Sbjct: 141 LICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVR 197
Query: 213 EEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEY 272
           +   +    ++APE      +    DV+SFG  L E+ +      + G   D+     E+
Sbjct: 198 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-LGASPYPGVKIDE-----EF 251
Query: 273 AKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQL 331
            ++  E  R  A        D + P        + Q M  C    P  RP   ++ + L
Sbjct: 252 CRRLKEGTRMRA-------PDYTTP-------EMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/239 (23%), Positives = 93/239 (38%), Gaps = 42/239 (17%)
Query: 112 HKNILKLIGCCLETELPTLVF-ESVKYGTLRGF------SFASLLIAPR----------- 153
           H N++ L+G C +   P +V  E  K+G L  +       F    +AP            
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 154 -IKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVR 212
            I  + ++A  + +L     R  + R + A N+LL E    K+ DF L+  I +    VR
Sbjct: 150 LICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVR 206
Query: 213 EEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEY 272
           +   +    ++APE      +    DV+SFG  L E+ +      + G   D+     E+
Sbjct: 207 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-LGASPYPGVKIDE-----EF 260
Query: 273 AKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQL 331
            ++  E  R  A        D + P        + Q M  C    P  RP   ++ + L
Sbjct: 261 CRRLKEGTRMRA-------PDYTTP-------EMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/239 (23%), Positives = 93/239 (38%), Gaps = 42/239 (17%)
Query: 112 HKNILKLIGCCLETELPTLVF-ESVKYGTLRGF------SFASLLIAPR----------- 153
           H N++ L+G C +   P +V  E  K+G L  +       F    +AP            
Sbjct: 81  HLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 140
Query: 154 -IKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVR 212
            I  + ++A  + +L     R  + R + A N+LL E    K+ DF L+  I +    VR
Sbjct: 141 LICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVR 197
Query: 213 EEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEY 272
           +   +    ++APE      +    DV+SFG  L E+ +      + G   D+     E+
Sbjct: 198 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-LGASPYPGVKIDE-----EF 251
Query: 273 AKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQL 331
            ++  E  R  A        D + P        + Q M  C    P  RP   ++ + L
Sbjct: 252 CRRLKEGTRMRA-------PDYTTP-------EMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/235 (22%), Positives = 93/235 (39%), Gaps = 38/235 (16%)
Query: 112 HKNILKLIGCCLETELPTLVF-ESVKYGTLRGFSFAS--------------LLIAPRIKI 156
           H N++ L+G C +   P +V  E  K+G L  +  +               L +   I  
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXY 149
Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI 216
           + ++A  + +L     R  + R + A N+LL E    K+ DF L+  I +   +VR+   
Sbjct: 150 SFQVAKGMEFLA---SRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDA 206
Query: 217 KGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKS 276
           +    ++APE      +    DV+SFG  L E+ +      + G   D+     E+ ++ 
Sbjct: 207 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-LGASPYPGVKIDE-----EFXRRL 260
Query: 277 IENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQL 331
            E  R  A        D + P        + Q M  C    P  RP   ++ + L
Sbjct: 261 KEGTRMRA-------PDYTTP-------EMYQTMLDCWHGEPSQRPTFSELVEHL 301

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 69/148 (46%), Gaps = 9/148 (6%)
Query: 110 MKHKNILKLIGCCLETELPTL--VFESVKYGTLRGFSFASLLIAPRIKI---AMEIANAV 164
           ++H NI+K  G C       L  + E + YG+LR +  A       IK+     +I   +
Sbjct: 71  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGM 130
Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVR-EEFIKGAYGFI 223
            YL  G  R  + R +   N+L++     K+ DF L+  +P+ +   + +E  +    + 
Sbjct: 131 EYL--GTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 187
Query: 224 APEYFATSSFNEMCDVYSFGAFLCELLT 251
           APE    S F+   DV+SFG  L EL T
Sbjct: 188 APESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/205 (21%), Positives = 85/205 (41%), Gaps = 27/205 (13%)
Query: 71  LFEGTLVDQDRP-----ISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLE 124
           + E   +D+D+P     ++V    D++T  D+    + +     + KHKNI+ L+G C +
Sbjct: 53  MAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112
Query: 125 TELPTLVFESVKYGTLRGFSFA------------------SLLIAPRIKIAMEIANAVAY 166
                ++ E    G LR +  A                   +     +    ++A  + Y
Sbjct: 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY 172
Query: 167 LHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPE 226
           L     +  + R + A NVL+ EN   ++ DF L+  I   + + +    +    ++APE
Sbjct: 173 LA---SQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNGRLPVKWMAPE 229
Query: 227 YFATSSFNEMCDVYSFGAFLCELLT 251
                 +    DV+SFG  + E+ T
Sbjct: 230 ALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 88/226 (38%), Gaps = 32/226 (14%)
Query: 104 IVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL-RGFSFASLLIAPRIKIAM-EIA 161
           +   S ++H NIL+L G   +     L+ E    GT+ R     S     R    + E+A
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 121
Query: 162 NAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYG 221
           NA++Y H    + ++ R IK  N+LL      K+ +F  SV  P      R   + G   
Sbjct: 122 NALSYCH---SKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSS----RRTTLCGTLD 174
Query: 222 FIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNR 281
           ++ PE       +E  D++S G    E L G                     K   E N 
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG---------------------KPPFEANT 213
Query: 282 FGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDV 327
           +      I   + +FP  +   +    L+ + L  +P  RP++ +V
Sbjct: 214 YQETYKRISRVEFTFP--DFVTEGARDLISRLLKHNPSQRPMLREV 257

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 81/177 (45%), Gaps = 23/177 (12%)
Query: 154 IKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVRE 213
           I IA + A  + YLH    + I+ R +K++N+ L E+ + K+ DF L+          + 
Sbjct: 109 IDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF 165
Query: 214 EFIKGAYGFIAPEYFATSSFNE---MCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
           E + G+  ++APE       N      DVY+FG  L EL+TG   L +  N N+ D  + 
Sbjct: 166 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ--LPY-SNINNRDQIIF 222
Query: 271 EYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDV 327
              +        G +   +    ++ P      +++ +LM +CL K  + RPL   +
Sbjct: 223 MVGR--------GYLSPDLSKVRSNCP------KAMKRLMAECLKKKRDERPLFPQI 265

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 71/169 (42%), Gaps = 25/169 (14%)
Query: 154 IKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVRE 213
           I  + +IA  +A++     R  + R ++A+N+L+  +   K+ DF L+  I + E   RE
Sbjct: 114 IDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE 170
Query: 214 EFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYA 273
              K    + APE     SF    DV+SFG  L E++T   +  + G  N + +  LE  
Sbjct: 171 G-AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRI-PYPGMSNPEVIRALERG 228
Query: 274 KKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
            +                     P  E   + L  +M +C    PE RP
Sbjct: 229 YR--------------------MPRPENCPEELYNIMMRCWKNRPEERP 257

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 88/226 (38%), Gaps = 32/226 (14%)
Query: 104 IVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL-RGFSFASLLIAPRIKIAM-EIA 161
           +   S ++H NIL+L G   +     L+ E    GT+ R     S     R    + E+A
Sbjct: 61  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 120
Query: 162 NAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYG 221
           NA++Y H    + ++ R IK  N+LL      K+ +F  SV  P      R   + G   
Sbjct: 121 NALSYCH---SKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSS----RRTTLCGTLD 173
Query: 222 FIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNR 281
           ++ PE       +E  D++S G    E L G                     K   E N 
Sbjct: 174 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG---------------------KPPFEANT 212
Query: 282 FGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDV 327
           +      I   + +FP  +   +    L+ + L  +P  RP++ +V
Sbjct: 213 YQETYKRISRVEFTFP--DFVTEGARDLISRLLKHNPSQRPMLREV 256

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/205 (22%), Positives = 84/205 (40%), Gaps = 27/205 (13%)
Query: 71  LFEGTLVDQDRP-----ISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLE 124
           + E   +D+D+P     ++V    D++T  D+    + +     + KHKNI+ L+G C +
Sbjct: 53  MAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112
Query: 125 TELPTLVFESVKYGTLRGFSFA------------------SLLIAPRIKIAMEIANAVAY 166
                ++ E    G LR +  A                   +     +    ++A  + Y
Sbjct: 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY 172
Query: 167 LHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPE 226
           L     +  + R + A NVL+ EN   K+ DF L+  I   + +      +    ++APE
Sbjct: 173 LA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNGRLPVKWMAPE 229
Query: 227 YFATSSFNEMCDVYSFGAFLCELLT 251
                 +    DV+SFG  + E+ T
Sbjct: 230 ALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 65/156 (41%), Gaps = 15/156 (9%)
Query: 102 NNIVFSSQMKHKNILKLIGCCLETELPTLVFESVK----YGTLRGFS-FASLLIAPRIKI 156
             +   S ++H NIL+L G   +     L+ E       Y  L+  S F     A  I  
Sbjct: 62  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYI-- 119
Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI 216
             E+ANA++Y H    + ++ R IK  N+LL      K+ DF  SV  P      R   +
Sbjct: 120 -TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRXXL 171
Query: 217 KGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
            G   ++ PE       +E  D++S G    E L G
Sbjct: 172 XGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 207

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 85/205 (41%), Gaps = 27/205 (13%)
Query: 71  LFEGTLVDQDRP-----ISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLE 124
           L E   +D+D+P     ++V     ++T  D+    + +     + KHKNI+ L+G C +
Sbjct: 46  LAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 105
Query: 125 TELPTLVFESVKYGTLR---------GFSFA---------SLLIAPRIKIAMEIANAVAY 166
                ++ E    G LR         G  F+          L     +  A ++A  + Y
Sbjct: 106 DGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSCAYQVARGMEY 165
Query: 167 LHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPE 226
           L     +  + R + A NVL+ E+   K+ DF L+  I   +   +    +    ++APE
Sbjct: 166 L---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNGRLPVKWMAPE 222
Query: 227 YFATSSFNEMCDVYSFGAFLCELLT 251
                 +    DV+SFG  L E+ T
Sbjct: 223 ALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 81/177 (45%), Gaps = 23/177 (12%)
Query: 154 IKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVRE 213
           I IA + A  + YLH    + I+ R +K++N+ L E+ + K+ DF L+          + 
Sbjct: 112 IDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF 168
Query: 214 EFIKGAYGFIAPEYFATSSFNE---MCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
           E + G+  ++APE       N      DVY+FG  L EL+TG   L +  N N+ D  + 
Sbjct: 169 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ--LPYS-NINNRDQIIF 225
Query: 271 EYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDV 327
              +        G +   +    ++ P      +++ +LM +CL K  + RPL   +
Sbjct: 226 MVGR--------GYLSPDLSKVRSNCP------KAMKRLMAECLKKKRDERPLFPQI 268

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 81/177 (45%), Gaps = 23/177 (12%)
Query: 154 IKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVRE 213
           I IA + A  + YLH    + I+ R +K++N+ L E+ + K+ DF L+          + 
Sbjct: 112 IDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF 168
Query: 214 EFIKGAYGFIAPEYFATSSFNE---MCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
           E + G+  ++APE       N      DVY+FG  L EL+TG   L +  N N+ D  + 
Sbjct: 169 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ--LPYS-NINNRDQIIF 225
Query: 271 EYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDV 327
              +        G +   +    ++ P      +++ +LM +CL K  + RPL   +
Sbjct: 226 MVGR--------GYLSPDLSKVRSNCP------KAMKRLMAECLKKKRDERPLFPQI 268

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 81/177 (45%), Gaps = 23/177 (12%)
Query: 154 IKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVRE 213
           I IA + A  + YLH    + I+ R +K++N+ L E+ + K+ DF L+          + 
Sbjct: 107 IDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF 163
Query: 214 EFIKGAYGFIAPEYFATSSFNE---MCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
           E + G+  ++APE       N      DVY+FG  L EL+TG   L +  N N+ D  + 
Sbjct: 164 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ--LPYS-NINNRDQIIF 220
Query: 271 EYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDV 327
              +        G +   +    ++ P      +++ +LM +CL K  + RPL   +
Sbjct: 221 MVGR--------GYLSPDLSKVRSNCP------KAMKRLMAECLKKKRDERPLFPQI 263

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/239 (23%), Positives = 93/239 (38%), Gaps = 42/239 (17%)
Query: 112 HKNILKLIGCCLETELPTLVF-ESVKYGTLRGF------SFASLLIAPR----------- 153
           H N++ L+G C +   P +V  E  K+G L  +       F    +AP            
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 154 -IKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVR 212
            I  + ++A  + +L     R  + R + A N+LL E    K+ DF L+  I +    VR
Sbjct: 150 LICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVR 206
Query: 213 EEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEY 272
           +   +    ++APE      +    DV+SFG  L E+ +      + G   D+     E+
Sbjct: 207 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-LGASPYPGVKIDE-----EF 260
Query: 273 AKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQL 331
            ++  E  R  A        D + P        + Q M  C    P  RP   ++ + L
Sbjct: 261 CRRLKEGTRMRA-------PDYTTP-------EMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 81/177 (45%), Gaps = 23/177 (12%)
Query: 154 IKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVRE 213
           I IA + A  + YLH    + I+ R +K++N+ L E+ + K+ DF L+          + 
Sbjct: 107 IDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF 163
Query: 214 EFIKGAYGFIAPEYFATSSFNE---MCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
           E + G+  ++APE       N      DVY+FG  L EL+TG   L +  N N+ D  + 
Sbjct: 164 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ--LPYS-NINNRDQIIF 220
Query: 271 EYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDV 327
              +        G +   +    ++ P      +++ +LM +CL K  + RPL   +
Sbjct: 221 MVGR--------GYLSPDLSKVRSNCP------KAMKRLMAECLKKKRDERPLFPQI 263

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/235 (23%), Positives = 97/235 (41%), Gaps = 28/235 (11%)
Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPR--IKIAMEIANAVA 165
            Q+ +  I+++IG C E E   LV E  + G L  +   +  +  +  I++  +++  + 
Sbjct: 63  QQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMK 121
Query: 166 YLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREE-FIKGAYGFIA 224
           YL    +   V R + A NVLL   + AK+ DF LS ++   E + + +   K    + A
Sbjct: 122 YLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 178
Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA 284
           PE      F+   DV+SFG  + E  +                    Y +K     + G+
Sbjct: 179 PECINYYKFSSKSDVWSFGVLMWEAFS--------------------YGQKPYRGMK-GS 217
Query: 285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLSVV 339
            V  + ++           + +  LM  C +   E+RP    V  +LR  Y  VV
Sbjct: 218 EVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 272

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 95/238 (39%), Gaps = 39/238 (16%)
Query: 112 HKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIA--PRIKIAMEIANAVA---Y 166
           H NI+ L+G C       L  E   +G L  F   S ++   P   IA   A+ ++    
Sbjct: 82  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 141
Query: 167 LHVGFD----------RPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI 216
           LH   D          +  + R + A N+L+ ENY AK+ DF LS      E +V++   
Sbjct: 142 LHFAADVARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLSRG---QEVYVKKTMG 198
Query: 217 KGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKS 276
           +    ++A E    S +    DV+S+G  L E+++        G      +T  E  +K 
Sbjct: 199 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS-------LGGTPYCGMTCAELYEKL 251
Query: 277 IENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQM 334
            +  R   +  P+  +D  +            LM +C  + P  RP    +   L +M
Sbjct: 252 PQGYR---LEKPLNCDDEVY-----------DLMRQCWREKPYERPSFAQILVSLNRM 295

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 88/221 (39%), Gaps = 32/221 (14%)
Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANAV 164
            Q  H NI++L G   +++   +V E ++ G+L  F     A   +   + +   IA+ +
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSI---PEGETHVREEFIKGAYG 221
            YL    D   V R + A N+L++ N   K+ DF L+  +   PE     R   I     
Sbjct: 161 KYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKI--PIR 215
Query: 222 FIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNR 281
           + +PE  A   F    DV+S+G  L E                    V+ Y ++      
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWE--------------------VMSYGERPYWEMS 255
Query: 282 FGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
              ++  + DE    P   +   +L QLM  C  K   +RP
Sbjct: 256 NQDVIKAV-DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRP 295

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/235 (23%), Positives = 97/235 (41%), Gaps = 28/235 (11%)
Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPR--IKIAMEIANAVA 165
            Q+ +  I+++IG C E E   LV E  + G L  +   +  +  +  I++  +++  + 
Sbjct: 61  QQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMK 119
Query: 166 YLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREE-FIKGAYGFIA 224
           YL    +   V R + A NVLL   + AK+ DF LS ++   E + + +   K    + A
Sbjct: 120 YLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 176
Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA 284
           PE      F+   DV+SFG  + E  +                    Y +K     + G+
Sbjct: 177 PECINYYKFSSKSDVWSFGVLMWEAFS--------------------YGQKPYRGMK-GS 215
Query: 285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLSVV 339
            V  + ++           + +  LM  C +   E+RP    V  +LR  Y  VV
Sbjct: 216 EVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 270

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 71/169 (42%), Gaps = 25/169 (14%)
Query: 154 IKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVRE 213
           I  + +IA  +A++     R  + R ++A+N+L+  +   K+ DF L+  I + E   RE
Sbjct: 287 IDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE 343
Query: 214 EFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYA 273
              K    + APE     SF    DV+SFG  L E++T   +  + G  N + +  LE  
Sbjct: 344 G-AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRI-PYPGMSNPEVIRALERG 401
Query: 274 KKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
            +                     P  E   + L  +M +C    PE RP
Sbjct: 402 YR--------------------MPRPENCPEELYNIMMRCWKNRPEERP 430

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/205 (23%), Positives = 86/205 (41%), Gaps = 27/205 (13%)
Query: 71  LFEGTLVDQDRP-----ISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLE 124
           L E   +D+D+P     ++V     ++T  D+    + +     + KHKNI+ L+G C +
Sbjct: 35  LAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 94
Query: 125 TELPTLVFESVKYGTLR---------GFSFA---------SLLIAPRIKIAMEIANAVAY 166
                ++ E    G LR         G  ++          L     +  A ++A  + Y
Sbjct: 95  DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEY 154
Query: 167 LHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPE 226
           L     +  + R + A NVL+ E+   K+ DF L+  I   + + +    +    ++APE
Sbjct: 155 L---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPE 211
Query: 227 YFATSSFNEMCDVYSFGAFLCELLT 251
                 +    DV+SFG  L E+ T
Sbjct: 212 ALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/205 (23%), Positives = 86/205 (41%), Gaps = 27/205 (13%)
Query: 71  LFEGTLVDQDRP-----ISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLE 124
           L E   +D+D+P     ++V     ++T  D+    + +     + KHKNI+ L+G C +
Sbjct: 38  LAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 97
Query: 125 TELPTLVFESVKYGTLR---------GFSFA---------SLLIAPRIKIAMEIANAVAY 166
                ++ E    G LR         G  ++          L     +  A ++A  + Y
Sbjct: 98  DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEY 157
Query: 167 LHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPE 226
           L     +  + R + A NVL+ E+   K+ DF L+  I   + + +    +    ++APE
Sbjct: 158 L---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPE 214
Query: 227 YFATSSFNEMCDVYSFGAFLCELLT 251
                 +    DV+SFG  L E+ T
Sbjct: 215 ALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/235 (23%), Positives = 97/235 (41%), Gaps = 28/235 (11%)
Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPR--IKIAMEIANAVA 165
            Q+ +  I+++IG C E E   LV E  + G L  +   +  +  +  I++  +++  + 
Sbjct: 67  QQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMK 125
Query: 166 YLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREE-FIKGAYGFIA 224
           YL    +   V R + A NVLL   + AK+ DF LS ++   E + + +   K    + A
Sbjct: 126 YLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 182
Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA 284
           PE      F+   DV+SFG  + E  +                    Y +K     + G+
Sbjct: 183 PECINYYKFSSKSDVWSFGVLMWEAFS--------------------YGQKPYRGMK-GS 221
Query: 285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLSVV 339
            V  + ++           + +  LM  C +   E+RP    V  +LR  Y  VV
Sbjct: 222 EVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 276

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/205 (23%), Positives = 86/205 (41%), Gaps = 27/205 (13%)
Query: 71  LFEGTLVDQDRP-----ISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLE 124
           L E   +D+D+P     ++V     ++T  D+    + +     + KHKNI+ L+G C +
Sbjct: 46  LAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 105
Query: 125 TELPTLVFESVKYGTLR---------GFSFA---------SLLIAPRIKIAMEIANAVAY 166
                ++ E    G LR         G  ++          L     +  A ++A  + Y
Sbjct: 106 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEY 165
Query: 167 LHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPE 226
           L     +  + R + A NVL+ E+   K+ DF L+  I   + + +    +    ++APE
Sbjct: 166 L---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPE 222
Query: 227 YFATSSFNEMCDVYSFGAFLCELLT 251
                 +    DV+SFG  L E+ T
Sbjct: 223 ALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 107/241 (44%), Gaps = 37/241 (15%)
Query: 104 IVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL--RGFSFA-SLLIAPRIKIAMEI 160
           +   S + H NI+KL G  L    P +V E V  G L  R    A  +  + ++++ ++I
Sbjct: 74  VFIMSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDI 131
Query: 161 ANAVAYLHVGFDRPIVFRCIKASNVLL---DENYS--AKLHDFSLSVSIPEGETHVREEF 215
           A  + Y+    + PIV R +++ N+ L   DEN    AK+ DFSLS    +   H     
Sbjct: 132 ALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLS----QQSVHSVSGL 186
Query: 216 IKGAYGFIAPEYFATS--SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYA 273
           + G + ++APE       S+ E  D YSF   L  +LT        G G  D+ +   Y 
Sbjct: 187 L-GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILT--------GEGPFDEYS---YG 234
Query: 274 KKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQ 333
           K    N      + P   ED        +L+++ +L   C S  P+ RP    + K+L +
Sbjct: 235 KIKFINMIREEGLRPTIPEDCP-----PRLRNVIEL---CWSGDPKKRPHFSYIVKELSE 286
Query: 334 M 334
           +
Sbjct: 287 L 287

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 95/238 (39%), Gaps = 39/238 (16%)
Query: 112 HKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIA--PRIKIAMEIANAVA---Y 166
           H NI+ L+G C       L  E   +G L  F   S ++   P   IA   A+ ++    
Sbjct: 85  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 167 LHVGFD----------RPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI 216
           LH   D          +  + R + A N+L+ ENY AK+ DF LS      E +V++   
Sbjct: 145 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG---QEVYVKKTMG 201
Query: 217 KGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKS 276
           +    ++A E    S +    DV+S+G  L E+++        G      +T  E  +K 
Sbjct: 202 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS-------LGGTPYCGMTCAELYEKL 254
Query: 277 IENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQM 334
            +  R   +  P+  +D  +            LM +C  + P  RP    +   L +M
Sbjct: 255 PQGYR---LEKPLNCDDEVY-----------DLMRQCWREKPYERPSFAQILVSLNRM 298

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/205 (23%), Positives = 86/205 (41%), Gaps = 27/205 (13%)
Query: 71  LFEGTLVDQDRP-----ISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLE 124
           L E   +D+D+P     ++V     ++T  D+    + +     + KHKNI+ L+G C +
Sbjct: 39  LAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 98
Query: 125 TELPTLVFESVKYGTLR---------GFSFA---------SLLIAPRIKIAMEIANAVAY 166
                ++ E    G LR         G  ++          L     +  A ++A  + Y
Sbjct: 99  DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEY 158
Query: 167 LHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPE 226
           L     +  + R + A NVL+ E+   K+ DF L+  I   + + +    +    ++APE
Sbjct: 159 L---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPE 215
Query: 227 YFATSSFNEMCDVYSFGAFLCELLT 251
                 +    DV+SFG  L E+ T
Sbjct: 216 ALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/235 (23%), Positives = 97/235 (41%), Gaps = 28/235 (11%)
Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPR--IKIAMEIANAVA 165
            Q+ +  I+++IG C E E   LV E  + G L  +   +  +  +  I++  +++  + 
Sbjct: 73  QQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMK 131
Query: 166 YLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREE-FIKGAYGFIA 224
           YL    +   V R + A NVLL   + AK+ DF LS ++   E + + +   K    + A
Sbjct: 132 YLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 188
Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA 284
           PE      F+   DV+SFG  + E  +                    Y +K     + G+
Sbjct: 189 PECINYYKFSSKSDVWSFGVLMWEAFS--------------------YGQKPYRGMK-GS 227
Query: 285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLSVV 339
            V  + ++           + +  LM  C +   E+RP    V  +LR  Y  VV
Sbjct: 228 EVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 282

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/235 (23%), Positives = 97/235 (41%), Gaps = 28/235 (11%)
Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPR--IKIAMEIANAVA 165
            Q+ +  I+++IG C E E   LV E  + G L  +   +  +  +  I++  +++  + 
Sbjct: 83  QQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMK 141
Query: 166 YLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREE-FIKGAYGFIA 224
           YL    +   V R + A NVLL   + AK+ DF LS ++   E + + +   K    + A
Sbjct: 142 YLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 198
Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA 284
           PE      F+   DV+SFG  + E  +                    Y +K     + G+
Sbjct: 199 PECINYYKFSSKSDVWSFGVLMWEAFS--------------------YGQKPYRGMK-GS 237
Query: 285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLSVV 339
            V  + ++           + +  LM  C +   E+RP    V  +LR  Y  VV
Sbjct: 238 EVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 292

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/235 (23%), Positives = 97/235 (41%), Gaps = 28/235 (11%)
Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPR--IKIAMEIANAVA 165
            Q+ +  I+++IG C E E   LV E  + G L  +   +  +  +  I++  +++  + 
Sbjct: 83  QQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMK 141
Query: 166 YLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREE-FIKGAYGFIA 224
           YL    +   V R + A NVLL   + AK+ DF LS ++   E + + +   K    + A
Sbjct: 142 YLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 198
Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA 284
           PE      F+   DV+SFG  + E  +                    Y +K     + G+
Sbjct: 199 PECINYYKFSSKSDVWSFGVLMWEAFS--------------------YGQKPYRGMK-GS 237
Query: 285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLSVV 339
            V  + ++           + +  LM  C +   E+RP    V  +LR  Y  VV
Sbjct: 238 EVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 292

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/205 (23%), Positives = 86/205 (41%), Gaps = 27/205 (13%)
Query: 71  LFEGTLVDQDRP-----ISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLE 124
           L E   +D+D+P     ++V     ++T  D+    + +     + KHKNI+ L+G C +
Sbjct: 46  LAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 105
Query: 125 TELPTLVFESVKYGTLR---------GFSFA---------SLLIAPRIKIAMEIANAVAY 166
                ++ E    G LR         G  ++          L     +  A ++A  + Y
Sbjct: 106 DGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEY 165
Query: 167 LHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPE 226
           L     +  + R + A NVL+ E+   K+ DF L+  I   + + +    +    ++APE
Sbjct: 166 L---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPE 222
Query: 227 YFATSSFNEMCDVYSFGAFLCELLT 251
                 +    DV+SFG  L E+ T
Sbjct: 223 ALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 71/159 (44%), Gaps = 18/159 (11%)
Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFA----SLLIA-----------P 152
           + ++H++I+K  G C+E +   +VFE +K+G L  F  A    ++L+A            
Sbjct: 70  TNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQ 129
Query: 153 RIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVR 212
            + IA +IA  + YL     +  V R +   N L+ EN   K+ DF +S  +   + +  
Sbjct: 130 MLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRV 186
Query: 213 EEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT 251
                    ++ PE      F    DV+S G  L E+ T
Sbjct: 187 GGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 225

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/236 (22%), Positives = 91/236 (38%), Gaps = 36/236 (15%)
Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANAV 164
            Q  H N++ L G   ++    ++ E ++ G+L  F   +     +   + +   IA  +
Sbjct: 63  GQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGM 122
Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYG--- 221
            YL    D   V R + A N+L++ N   K+ DF LS  +   E    +     A G   
Sbjct: 123 KYLA---DMNYVHRALAARNILVNSNLVCKVSDFGLSRFL---EDDTSDPTYTSALGGKI 176
Query: 222 ---FIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIE 278
              + APE      F    DV+S+G  + E                    V+ Y ++   
Sbjct: 177 PIRWTAPEAIQYRKFTSASDVWSYGIVMWE--------------------VMSYGERPYW 216
Query: 279 NNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQM 334
           +     +++ I ++D   P   +   +L QLM  C  K   HRP    +   L +M
Sbjct: 217 DMTNQDVINAI-EQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 271

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 87/221 (39%), Gaps = 32/221 (14%)
Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANAV 164
            Q  H NI++L G   +++   +V E ++ G+L  F     A   +   + +   IA+ +
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSI---PEGETHVREEFIKGAYG 221
            YL    D   V R + A N+L++ N   K+ DF L   +   PE     R   I     
Sbjct: 161 KYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKI--PIR 215
Query: 222 FIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNR 281
           + +PE  A   F    DV+S+G  L E                    V+ Y ++      
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWE--------------------VMSYGERPYWEMS 255
Query: 282 FGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
              ++  + DE    P   +   +L QLM  C  K   +RP
Sbjct: 256 NQDVIKAV-DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRP 295

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 95/225 (42%), Gaps = 22/225 (9%)
Query: 46  SAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLD--DVEYCFNN 103
           SA D +    NY L K I      ++     V   R ++V K  D + L+   ++  F  
Sbjct: 6   SATDEQPHIGNYRLQKTIGKGNFAKVKLARHVLTGREVAV-KIIDKTQLNPTSLQKLFRE 64
Query: 104 IVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIKIA------ 157
           +     + H NI+KL       +   LV E    G +    F  L+   R+K        
Sbjct: 65  VRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEV----FDYLVAHGRMKEKEARAKF 120
Query: 158 MEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIK 217
            +I +AV Y H  +   IV R +KA N+LLD + + K+ DF  S     G    + +   
Sbjct: 121 RQIVSAVQYCHQKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGN---KLDTFC 174
Query: 218 GAYGFIAPEYFATSSFN-EMCDVYSFGAFLCELLTGCNVLEFKGN 261
           G+  + APE F    ++    DV+S G  L  L++G   L F G 
Sbjct: 175 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS--LPFDGQ 217

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 69/148 (46%), Gaps = 9/148 (6%)
Query: 110 MKHKNILKLIGCCLETELPTL--VFESVKYGTLRGFSFASLLIAPRIKI---AMEIANAV 164
           ++H NI+K  G C       L  + E + YG+LR +          IK+     +I   +
Sbjct: 69  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 128
Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVR-EEFIKGAYGFI 223
            YL  G  R  + R +   N+L++     K+ DF L+  +P+ + + + +E  +    + 
Sbjct: 129 EYL--GTKR-YIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY 185
Query: 224 APEYFATSSFNEMCDVYSFGAFLCELLT 251
           APE    S F+   DV+SFG  L EL T
Sbjct: 186 APESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 95/238 (39%), Gaps = 39/238 (16%)
Query: 112 HKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIA--PRIKIAMEIANAVA---Y 166
           H NI+ L+G C       L  E   +G L  F   S ++   P   IA   A+ ++    
Sbjct: 75  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 134
Query: 167 LHVGFD----------RPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI 216
           LH   D          +  + R + A N+L+ ENY AK+ DF LS      E +V++   
Sbjct: 135 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG---QEVYVKKTMG 191
Query: 217 KGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKS 276
           +    ++A E    S +    DV+S+G  L E+++        G      +T  E  +K 
Sbjct: 192 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS-------LGGTPYCGMTCAELYEKL 244
Query: 277 IENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQM 334
            +  R   +  P+  +D  +            LM +C  + P  RP    +   L +M
Sbjct: 245 PQGYR---LEKPLNCDDEVY-----------DLMRQCWREKPYERPSFAQILVSLNRM 288

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/235 (23%), Positives = 97/235 (41%), Gaps = 28/235 (11%)
Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPR--IKIAMEIANAVA 165
            Q+ +  I+++IG C E E   LV E  + G L  +   +  +  +  I++  +++  + 
Sbjct: 81  QQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMK 139
Query: 166 YLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREE-FIKGAYGFIA 224
           YL    +   V R + A NVLL   + AK+ DF LS ++   E + + +   K    + A
Sbjct: 140 YLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 196
Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA 284
           PE      F+   DV+SFG  + E  +                    Y +K     + G+
Sbjct: 197 PECINYYKFSSKSDVWSFGVLMWEAFS--------------------YGQKPYRGMK-GS 235
Query: 285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLSVV 339
            V  + ++           + +  LM  C +   E+RP    V  +LR  Y  VV
Sbjct: 236 EVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 290

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 72/151 (47%), Gaps = 18/151 (11%)
Query: 112 HKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIK----IAMEIANAVAYL 167
           H +I+ LI     +    LVF+ ++ G L  F + +  +A   K    I   +  AV++L
Sbjct: 159 HPHIITLIDSYESSSFMFLVFDLMRKGEL--FDYLTEKVALSEKETRSIMRSLLEAVSFL 216
Query: 168 HVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEY 227
           H      IV R +K  N+LLD+N   +L DF  S  +  GE  +RE  + G  G++APE 
Sbjct: 217 HAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK-LRE--LCGTPGYLAPEI 270
Query: 228 FATS------SFNEMCDVYSFGAFLCELLTG 252
              S       + +  D+++ G  L  LL G
Sbjct: 271 LKCSMDETHPGYGKEVDLWACGVILFTLLAG 301

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/205 (23%), Positives = 85/205 (41%), Gaps = 27/205 (13%)
Query: 71  LFEGTLVDQDRP-----ISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLE 124
           L E   +D+D+P     ++V     ++T  D+    + +     + KHKNI+ L+G C +
Sbjct: 31  LAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90
Query: 125 TELPTLVFESVKYGTLRGFSFA------------------SLLIAPRIKIAMEIANAVAY 166
                ++ E    G LR +  A                   L     +  A ++A  + Y
Sbjct: 91  DGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEY 150
Query: 167 LHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPE 226
           L     +  + R + A NVL+ E+   K+ DF L+  I   + + +    +    ++APE
Sbjct: 151 L---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPE 207
Query: 227 YFATSSFNEMCDVYSFGAFLCELLT 251
                 +    DV+SFG  L E+ T
Sbjct: 208 ALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 92/218 (42%), Gaps = 30/218 (13%)
Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF----SFASLLIAPRIKIAMEIANAV 164
           ++KH  +++L     E  +  +V E +  G+L  F       +L +   + +A ++A  +
Sbjct: 60  KLKHDKLVQLYAVVSEEPI-YIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGM 118
Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIA 224
           AY+        + R ++++N+L+      K+ DF L+  I + E   R+   K    + A
Sbjct: 119 AYIE---RMNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQG-AKFPIKWTA 174
Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA 284
           PE      F    DV+SFG  L EL+T   V  + G  N + L  +E   +         
Sbjct: 175 PEAALYGRFTIKSDVWSFGILLTELVTKGRV-PYPGMNNREVLEQVERGYR--------- 224
Query: 285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
                       P  ++   SL +LM  C  K PE RP
Sbjct: 225 -----------MPCPQDCPISLHELMIHCWKKDPEERP 251

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 111/248 (44%), Gaps = 51/248 (20%)
Query: 107 SSQMKHKN---ILKLIGCCLETELPTLVFESVKYGTLRGFSFASL--------LIAP--- 152
           +S MK  N   +++L+G   + +   ++ E +  G L+ +   SL        ++AP   
Sbjct: 101 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSY-LRSLRPEMENNPVLAPPSL 159
Query: 153 --RIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH 210
              I++A EIA+ +AYL+       V R + A N ++ E+++ K+ DF ++  I E +  
Sbjct: 160 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY- 215
Query: 211 VREEFIKGAYG-----FIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDD 265
               + KG  G     +++PE      F    DV+SFG  L E+ T      ++G  N+ 
Sbjct: 216 ----YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE-QPYQGLSNEQ 270
Query: 266 DLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMV 325
            L             RF  +   + D+ ++ P        L +LM  C   +P+ RP  +
Sbjct: 271 VL-------------RF-VMEGGLLDKPDNCP------DMLFELMRMCWQYNPKMRPSFL 310
Query: 326 DVAKQLRQ 333
           ++   +++
Sbjct: 311 EIISSIKE 318

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 111/248 (44%), Gaps = 51/248 (20%)
Query: 107 SSQMKHKN---ILKLIGCCLETELPTLVFESVKYGTLRGFSFASL--------LIAP--- 152
           +S MK  N   +++L+G   + +   ++ E +  G L+ +   SL        ++AP   
Sbjct: 72  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSY-LRSLRPEMENNPVLAPPSL 130
Query: 153 --RIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH 210
              I++A EIA+ +AYL+       V R + A N ++ E+++ K+ DF ++  I E +  
Sbjct: 131 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY- 186
Query: 211 VREEFIKGAYG-----FIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDD 265
               + KG  G     +++PE      F    DV+SFG  L E+ T      ++G  N+ 
Sbjct: 187 ----YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE-QPYQGLSNEQ 241
Query: 266 DLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMV 325
            L             RF  +   + D+ ++ P        L +LM  C   +P+ RP  +
Sbjct: 242 VL-------------RF-VMEGGLLDKPDNCP------DMLFELMRMCWQYNPKMRPSFL 281
Query: 326 DVAKQLRQ 333
           ++   +++
Sbjct: 282 EIISSIKE 289

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 48/205 (23%), Positives = 85/205 (41%), Gaps = 27/205 (13%)
Query: 71  LFEGTLVDQDRP-----ISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLE 124
           L E   +D+D+P     ++V     ++T  D+    + +     + KHKNI+ L+G C +
Sbjct: 46  LAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 105
Query: 125 TELPTLVFESVKYGTLRGFSFA------------------SLLIAPRIKIAMEIANAVAY 166
                ++ E    G LR +  A                   L     +  A ++A  + Y
Sbjct: 106 DGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEY 165
Query: 167 LHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPE 226
           L     +  + R + A NVL+ E+   K+ DF L+  I   + + +    +    ++APE
Sbjct: 166 L---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPE 222
Query: 227 YFATSSFNEMCDVYSFGAFLCELLT 251
                 +    DV+SFG  L E+ T
Sbjct: 223 ALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 93/216 (43%), Gaps = 26/216 (12%)
Query: 130 LVFESVKYGTLRGF--SFASLLIAPRIKI-AMEIANAVAYLHVGFDRPIVFRCIKASNVL 186
           LV E +  G LR F     + L A R+ + + +I   + YL     R  V R + A N+L
Sbjct: 90  LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNIL 146
Query: 187 LDENYSAKLHDFSLSVSIP-EGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAF 245
           ++     K+ DF L+  +P + + +V  E  +    + APE  + + F+   DV+SFG  
Sbjct: 147 VESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVV 206
Query: 246 LCELLTGCN-----VLEF-KGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGK 299
           L EL T C+       EF +  G++ D+  L    + +E                  P  
Sbjct: 207 LYELFTYCDKSCSPSAEFLRMMGSERDVPALSRLLELLEEG-------------QRLPAP 253
Query: 300 EEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMY 335
                 + +LM  C + SP+ RP    +  QL  ++
Sbjct: 254 PACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW 289

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 82/176 (46%), Gaps = 11/176 (6%)
Query: 110 MKHKNILKLIGCCLETELPTLVFESVKYGTLRGF----SFASLLIAPRIKIAMEIANAVA 165
           ++H  +++L     + E   ++ E +  G+L  F        +L+   I  + +IA  +A
Sbjct: 64  LQHDKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMA 123
Query: 166 YLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAP 225
           Y+     +  + R ++A+NVL+ E+   K+ DF L+  I + E   RE   K    + AP
Sbjct: 124 YIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREG-AKFPIKWTAP 179
Query: 226 EYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLE--YAKKSIEN 279
           E      F    +V+SFG  L E++T   +  + G  N D ++ L   Y    +EN
Sbjct: 180 EAINFGCFTIKSNVWSFGILLYEIVTYGKI-PYPGRTNADVMSALSQGYRMPRMEN 234

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 111/248 (44%), Gaps = 51/248 (20%)
Query: 107 SSQMKHKN---ILKLIGCCLETELPTLVFESVKYGTLRGFSFASL--------LIAP--- 152
           +S MK  N   +++L+G   + +   ++ E +  G L+ +   SL        ++AP   
Sbjct: 72  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSY-LRSLRPEMENNPVLAPPSL 130
Query: 153 --RIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH 210
              I++A EIA+ +AYL+       V R + A N ++ E+++ K+ DF ++  I E +  
Sbjct: 131 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY- 186
Query: 211 VREEFIKGAYG-----FIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDD 265
               + KG  G     +++PE      F    DV+SFG  L E+ T      ++G  N+ 
Sbjct: 187 ----YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE-QPYQGLSNEQ 241
Query: 266 DLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMV 325
            L             RF  +   + D+ ++ P        L +LM  C   +P+ RP  +
Sbjct: 242 VL-------------RF-VMEGGLLDKPDNCP------DMLFELMRMCWQYNPKMRPSFL 281
Query: 326 DVAKQLRQ 333
           ++   +++
Sbjct: 282 EIISSIKE 289

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 48/205 (23%), Positives = 86/205 (41%), Gaps = 27/205 (13%)
Query: 71  LFEGTLVDQDRP-----ISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLE 124
           L E   +D+D+P     ++V     ++T  D+    + +     + KHKNI+ L+G C +
Sbjct: 87  LAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146
Query: 125 TELPTLVFESVKYGTLR---------GFSFA---------SLLIAPRIKIAMEIANAVAY 166
                ++ E    G LR         G  ++          L     +  A ++A  + Y
Sbjct: 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEY 206
Query: 167 LHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPE 226
           L     +  + R + A NVL+ E+   K+ DF L+  I   + + +    +    ++APE
Sbjct: 207 LA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPE 263
Query: 227 YFATSSFNEMCDVYSFGAFLCELLT 251
                 +    DV+SFG  L E+ T
Sbjct: 264 ALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 111/248 (44%), Gaps = 51/248 (20%)
Query: 107 SSQMKHKN---ILKLIGCCLETELPTLVFESVKYGTLRGFSFASL--------LIAP--- 152
           +S MK  N   +++L+G   + +   ++ E +  G L+ +   SL        ++AP   
Sbjct: 66  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSY-LRSLRPEMENNPVLAPPSL 124
Query: 153 --RIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH 210
              I++A EIA+ +AYL+       V R + A N ++ E+++ K+ DF ++  I E +  
Sbjct: 125 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY- 180
Query: 211 VREEFIKGAYG-----FIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDD 265
               + KG  G     +++PE      F    DV+SFG  L E+ T      ++G  N+ 
Sbjct: 181 ----YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE-QPYQGLSNEQ 235
Query: 266 DLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMV 325
            L             RF  +   + D+ ++ P        L +LM  C   +P+ RP  +
Sbjct: 236 VL-------------RF-VMEGGLLDKPDNCP------DMLFELMRMCWQYNPKMRPSFL 275
Query: 326 DVAKQLRQ 333
           ++   +++
Sbjct: 276 EIISSIKE 283

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 110/248 (44%), Gaps = 51/248 (20%)
Query: 107 SSQMKHKN---ILKLIGCCLETELPTLVFESVKYGTLRGFSFASL--------LIAP--- 152
           +S MK  N   +++L+G   + +   ++ E +  G L+ +   SL        ++AP   
Sbjct: 64  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSY-LRSLRPEMENNPVLAPPSL 122
Query: 153 --RIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH 210
              I++A EIA+ +AYL+       V R + A N ++ E+++ K+ DF ++  I E +  
Sbjct: 123 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXX 179
Query: 211 VREEFIKGAYG-----FIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDD 265
                 KG  G     +++PE      F    DV+SFG  L E+ T      ++G  N+ 
Sbjct: 180 R-----KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE-QPYQGLSNEQ 233
Query: 266 DLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMV 325
            L             RF  +   + D+ ++ P        L +LM  C   +P+ RP  +
Sbjct: 234 VL-------------RF-VMEGGLLDKPDNCP------DMLLELMRMCWQYNPKMRPSFL 273
Query: 326 DVAKQLRQ 333
           ++   +++
Sbjct: 274 EIISSIKE 281

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 111/248 (44%), Gaps = 51/248 (20%)
Query: 107 SSQMKHKN---ILKLIGCCLETELPTLVFESVKYGTLRGFSFASL--------LIAP--- 152
           +S MK  N   +++L+G   + +   ++ E +  G L+ +   SL        ++AP   
Sbjct: 73  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSY-LRSLRPEMENNPVLAPPSL 131
Query: 153 --RIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH 210
              I++A EIA+ +AYL+       V R + A N ++ E+++ K+ DF ++  I E +  
Sbjct: 132 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY- 187
Query: 211 VREEFIKGAYG-----FIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDD 265
               + KG  G     +++PE      F    DV+SFG  L E+ T      ++G  N+ 
Sbjct: 188 ----YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE-QPYQGLSNEQ 242
Query: 266 DLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMV 325
            L             RF  +   + D+ ++ P        L +LM  C   +P+ RP  +
Sbjct: 243 VL-------------RF-VMEGGLLDKPDNCP------DMLFELMRMCWQYNPKMRPSFL 282
Query: 326 DVAKQLRQ 333
           ++   +++
Sbjct: 283 EIISSIKE 290

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 45/205 (21%), Positives = 84/205 (40%), Gaps = 27/205 (13%)
Query: 71  LFEGTLVDQDRP-----ISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLE 124
           + E   +D+D+P     ++V    D++T  D+    + +     + KHKNI+ L+G C +
Sbjct: 53  MAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112
Query: 125 TELPTLVFESVKYGTLRGFSFA------------------SLLIAPRIKIAMEIANAVAY 166
                ++      G LR +  A                   +     +    ++A  + Y
Sbjct: 113 DGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY 172
Query: 167 LHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPE 226
           L     +  + R + A NVL+ EN   K+ DF L+  I   + + +    +    ++APE
Sbjct: 173 LA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPE 229
Query: 227 YFATSSFNEMCDVYSFGAFLCELLT 251
                 +    DV+SFG  + E+ T
Sbjct: 230 ALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 111/248 (44%), Gaps = 51/248 (20%)
Query: 107 SSQMKHKN---ILKLIGCCLETELPTLVFESVKYGTLRGFSFASL--------LIAP--- 152
           +S MK  N   +++L+G   + +   ++ E +  G L+ +   SL        ++AP   
Sbjct: 70  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSY-LRSLRPEMENNPVLAPPSL 128
Query: 153 --RIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH 210
              I++A EIA+ +AYL+       V R + A N ++ E+++ K+ DF ++  I E +  
Sbjct: 129 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY- 184
Query: 211 VREEFIKGAYG-----FIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDD 265
               + KG  G     +++PE      F    DV+SFG  L E+ T      ++G  N+ 
Sbjct: 185 ----YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE-QPYQGLSNEQ 239
Query: 266 DLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMV 325
            L             RF  +   + D+ ++ P        L +LM  C   +P+ RP  +
Sbjct: 240 VL-------------RF-VMEGGLLDKPDNCP------DMLFELMRMCWQYNPKMRPSFL 279
Query: 326 DVAKQLRQ 333
           ++   +++
Sbjct: 280 EIISSIKE 287

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 110/248 (44%), Gaps = 51/248 (20%)
Query: 107 SSQMKHKN---ILKLIGCCLETELPTLVFESVKYGTLRGFSFASL--------LIAP--- 152
           +S MK  N   +++L+G   + +   ++ E +  G L+ +   SL        ++AP   
Sbjct: 73  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSY-LRSLRPEMENNPVLAPPSL 131
Query: 153 --RIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH 210
              I++A EIA+ +AYL+       V R + A N ++ E+++ K+ DF ++  I E +  
Sbjct: 132 SKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXX 188
Query: 211 VREEFIKGAYG-----FIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDD 265
                 KG  G     +++PE      F    DV+SFG  L E+ T      ++G  N+ 
Sbjct: 189 R-----KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE-QPYQGLSNEQ 242
Query: 266 DLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMV 325
            L             RF  +   + D+ ++ P        L +LM  C   +P+ RP  +
Sbjct: 243 VL-------------RF-VMEGGLLDKPDNCP------DMLFELMRMCWQYNPKMRPSFL 282
Query: 326 DVAKQLRQ 333
           ++   +++
Sbjct: 283 EIISSIKE 290

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 111/248 (44%), Gaps = 51/248 (20%)
Query: 107 SSQMKHKN---ILKLIGCCLETELPTLVFESVKYGTLRGFSFASL--------LIAP--- 152
           +S MK  N   +++L+G   + +   ++ E +  G L+ +   SL        ++AP   
Sbjct: 69  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSY-LRSLRPAMANNPVLAPPSL 127
Query: 153 --RIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH 210
              I++A EIA+ +AYL+       V R + A N ++ E+++ K+ DF ++  I E +  
Sbjct: 128 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY- 183
Query: 211 VREEFIKGAYG-----FIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDD 265
               + KG  G     +++PE      F    DV+SFG  L E+ T      ++G  N+ 
Sbjct: 184 ----YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE-QPYQGLSNEQ 238
Query: 266 DLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMV 325
            L             RF  +   + D+ ++ P        L +LM  C   +P+ RP  +
Sbjct: 239 VL-------------RF-VMEGGLLDKPDNCP------DMLFELMRMCWQYNPKMRPSFL 278
Query: 326 DVAKQLRQ 333
           ++   +++
Sbjct: 279 EIISSIKE 286

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/118 (32%), Positives = 61/118 (51%), Gaps = 11/118 (9%)
Query: 159 EIANAVAYLH-VGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEF-I 216
           E+A  + +LH +G    I++R +K  N+LLDE    KL DF LS    E   H ++ +  
Sbjct: 138 ELALGLDHLHSLG----IIYRDLKPENILLDEEGHIKLTDFGLS---KEAIDHEKKAYSF 190
Query: 217 KGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAK 274
            G   ++APE       +   D +S+G  + E+LTG   L F+G    + +T++  AK
Sbjct: 191 CGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGS--LPFQGKDRKETMTLILKAK 246

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/247 (22%), Positives = 108/247 (43%), Gaps = 49/247 (19%)
Query: 107 SSQMKHKN---ILKLIGCCLETELPTLVFESVKYGTLRGF------------SFASLLIA 151
           +S MK  N   +++L+G   + +   ++ E +  G L+ +              A   ++
Sbjct: 79  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 138
Query: 152 PRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHV 211
             I++A EIA+ +AYL+       V R + A N ++ E+++ K+ DF ++  I E +   
Sbjct: 139 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY-- 193
Query: 212 REEFIKGAYG-----FIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDD 266
              + KG  G     +++PE      F    DV+SFG  L E+ T      ++G  N+  
Sbjct: 194 ---YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE-QPYQGLSNEQV 249
Query: 267 LTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVD 326
           L             RF  +   + D+ ++ P        L +LM  C   +P+ RP  ++
Sbjct: 250 L-------------RF-VMEGGLLDKPDNCP------DMLFELMRMCWQYNPKMRPSFLE 289
Query: 327 VAKQLRQ 333
           +   +++
Sbjct: 290 IISSIKE 296

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/247 (22%), Positives = 108/247 (43%), Gaps = 49/247 (19%)
Query: 107 SSQMKHKN---ILKLIGCCLETELPTLVFESVKYGTLRGF------------SFASLLIA 151
           +S MK  N   +++L+G   + +   ++ E +  G L+ +              A   ++
Sbjct: 79  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 138
Query: 152 PRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHV 211
             I++A EIA+ +AYL+       V R + A N ++ E+++ K+ DF ++  I E +   
Sbjct: 139 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY-- 193
Query: 212 REEFIKGAYG-----FIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDD 266
              + KG  G     +++PE      F    DV+SFG  L E+ T      ++G  N+  
Sbjct: 194 ---YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE-QPYQGLSNEQV 249
Query: 267 LTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVD 326
           L             RF  +   + D+ ++ P        L +LM  C   +P+ RP  ++
Sbjct: 250 L-------------RF-VMEGGLLDKPDNCP------DMLFELMRMCWQYNPKMRPSFLE 289
Query: 327 VAKQLRQ 333
           +   +++
Sbjct: 290 IISSIKE 296

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/205 (21%), Positives = 84/205 (40%), Gaps = 27/205 (13%)
Query: 71  LFEGTLVDQDRP-----ISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLE 124
           + E   +D+D+P     ++V    D++T  D+    + +     + KHKNI+ L+G C +
Sbjct: 53  MAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112
Query: 125 TELPTLVFESVKYGTLRGFSFA------------------SLLIAPRIKIAMEIANAVAY 166
                ++      G LR +  A                   +     +    ++A  + Y
Sbjct: 113 DGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY 172
Query: 167 LHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPE 226
           L     +  + R + A NVL+ EN   K+ DF L+  I   + + +    +    ++APE
Sbjct: 173 LA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPE 229
Query: 227 YFATSSFNEMCDVYSFGAFLCELLT 251
                 +    DV+SFG  + E+ T
Sbjct: 230 ALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/239 (23%), Positives = 93/239 (38%), Gaps = 42/239 (17%)
Query: 112 HKNILKLIGCCLETELPTLVF-ESVKYGTLRGF------SFASLLIAPR----------- 153
           H N++ L+G C +   P +V  E  K+G L  +       F     AP            
Sbjct: 92  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEH 151
Query: 154 -IKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVR 212
            I  + ++A  + +L     R  + R + A N+LL E    K+ DF L+  I +   +VR
Sbjct: 152 LICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 208
Query: 213 EEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEY 272
           +   +    ++APE      +    DV+SFG  L E+ +      + G   D+     E+
Sbjct: 209 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-LGASPYPGVKIDE-----EF 262
Query: 273 AKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQL 331
            ++  E  R  A        D + P        + Q M  C    P  RP   ++ + L
Sbjct: 263 CRRLKEGTRMRA-------PDYTTP-------EMYQTMLDCWHGEPSQRPTFSELVEHL 307

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/235 (23%), Positives = 97/235 (41%), Gaps = 28/235 (11%)
Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPR--IKIAMEIANAVA 165
            Q+ +  I+++IG C E E   LV E  + G L  +   +  +  +  I++  +++  + 
Sbjct: 425 QQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMK 483
Query: 166 YLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREE-FIKGAYGFIA 224
           YL    +   V R + A NVLL   + AK+ DF LS ++   E + + +   K    + A
Sbjct: 484 YLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 540
Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA 284
           PE      F+   DV+SFG  + E  +                    Y +K     + G+
Sbjct: 541 PECINYYKFSSKSDVWSFGVLMWEAFS--------------------YGQKPYRGMK-GS 579
Query: 285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLSVV 339
            V  + ++           + +  LM  C +   E+RP    V  +LR  Y  VV
Sbjct: 580 EVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 634

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/235 (23%), Positives = 96/235 (40%), Gaps = 28/235 (11%)
Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPR--IKIAMEIANAVA 165
            Q+ +  I+++IG C E E   LV E  + G L  +   +  +  +  I++  +++  + 
Sbjct: 67  QQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMK 125
Query: 166 YLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREE-FIKGAYGFIA 224
           YL    +   V R + A NVLL   + AK+ DF LS ++   E   + +   K    + A
Sbjct: 126 YLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYA 182
Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA 284
           PE      F+   DV+SFG  + E  +                    Y +K     + G+
Sbjct: 183 PECINYYKFSSKSDVWSFGVLMWEAFS--------------------YGQKPYRGMK-GS 221
Query: 285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLSVV 339
            V  + ++           + +  LM  C +   E+RP    V  +LR  Y  VV
Sbjct: 222 EVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 276

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 68/148 (45%), Gaps = 9/148 (6%)
Query: 110 MKHKNILKLIGCCLETELPTL--VFESVKYGTLRGFSFASLLIAPRIKI---AMEIANAV 164
           ++H NI+K  G C       L  + E + YG+LR +          IK+     +I   +
Sbjct: 71  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 130
Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVR-EEFIKGAYGFI 223
            YL  G  R  + R +   N+L++     K+ DF L+  +P+ +   + +E  +    + 
Sbjct: 131 EYL--GTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 187
Query: 224 APEYFATSSFNEMCDVYSFGAFLCELLT 251
           APE    S F+   DV+SFG  L EL T
Sbjct: 188 APESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 68/148 (45%), Gaps = 9/148 (6%)
Query: 110 MKHKNILKLIGCCLETELPTL--VFESVKYGTLRGFSFASLLIAPRIKI---AMEIANAV 164
           ++H NI+K  G C       L  + E + YG+LR +          IK+     +I   +
Sbjct: 67  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 126
Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVR-EEFIKGAYGFI 223
            YL  G  R  + R +   N+L++     K+ DF L+  +P+ +   + +E  +    + 
Sbjct: 127 EYL--GTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 183
Query: 224 APEYFATSSFNEMCDVYSFGAFLCELLT 251
           APE    S F+   DV+SFG  L EL T
Sbjct: 184 APESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/235 (23%), Positives = 97/235 (41%), Gaps = 28/235 (11%)
Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPR--IKIAMEIANAVA 165
            Q+ +  I+++IG C E E   LV E  + G L  +   +  +  +  I++  +++  + 
Sbjct: 426 QQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMK 484
Query: 166 YLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREE-FIKGAYGFIA 224
           YL    +   V R + A NVLL   + AK+ DF LS ++   E + + +   K    + A
Sbjct: 485 YLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 541
Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA 284
           PE      F+   DV+SFG  + E  +                    Y +K     + G+
Sbjct: 542 PECINYYKFSSKSDVWSFGVLMWEAFS--------------------YGQKPYRGMK-GS 580
Query: 285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLSVV 339
            V  + ++           + +  LM  C +   E+RP    V  +LR  Y  VV
Sbjct: 581 EVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 635

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 65/156 (41%), Gaps = 15/156 (9%)
Query: 102 NNIVFSSQMKHKNILKLIGCCLETELPTLVFESVK----YGTLRGFS-FASLLIAPRIKI 156
             +   S ++H NIL+L G   +     L+ E       Y  L+  S F     A  I  
Sbjct: 62  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYI-- 119
Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI 216
             E+ANA++Y H    + ++ R IK  N+LL      K+ DF  SV  P      R   +
Sbjct: 120 -TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTL 171
Query: 217 KGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
            G   ++ PE       +E  D++S G    E L G
Sbjct: 172 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 207

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/236 (22%), Positives = 91/236 (38%), Gaps = 36/236 (15%)
Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANAV 164
            Q  H N++ L G   ++    ++ E ++ G+L  F   +     +   + +   IA  +
Sbjct: 89  GQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGM 148
Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYG--- 221
            YL    D   V R + A N+L++ N   K+ DF LS  +   E    +     A G   
Sbjct: 149 KYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL---EDDTSDPTYTSALGGKI 202
Query: 222 ---FIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIE 278
              + APE      F    DV+S+G  + E                    V+ Y ++   
Sbjct: 203 PIRWTAPEAIQYRKFTSASDVWSYGIVMWE--------------------VMSYGERPYW 242
Query: 279 NNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQM 334
           +     +++ I ++D   P   +   +L QLM  C  K   HRP    +   L +M
Sbjct: 243 DMTNQDVINAI-EQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 297

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 68/148 (45%), Gaps = 9/148 (6%)
Query: 110 MKHKNILKLIGCCLETELPTL--VFESVKYGTLRGFSFASLLIAPRIKI---AMEIANAV 164
           ++H NI+K  G C       L  + E + YG+LR +          IK+     +I   +
Sbjct: 68  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 127
Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVR-EEFIKGAYGFI 223
            YL  G  R  + R +   N+L++     K+ DF L+  +P+ +   + +E  +    + 
Sbjct: 128 EYL--GTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 184
Query: 224 APEYFATSSFNEMCDVYSFGAFLCELLT 251
           APE    S F+   DV+SFG  L EL T
Sbjct: 185 APESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 68/148 (45%), Gaps = 9/148 (6%)
Query: 110 MKHKNILKLIGCCLETELPTL--VFESVKYGTLRGFSFASLLIAPRIKI---AMEIANAV 164
           ++H NI+K  G C       L  + E + YG+LR +          IK+     +I   +
Sbjct: 66  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 125
Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVR-EEFIKGAYGFI 223
            YL  G  R  + R +   N+L++     K+ DF L+  +P+ +   + +E  +    + 
Sbjct: 126 EYL--GTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 182
Query: 224 APEYFATSSFNEMCDVYSFGAFLCELLT 251
           APE    S F+   DV+SFG  L EL T
Sbjct: 183 APESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 68/148 (45%), Gaps = 9/148 (6%)
Query: 110 MKHKNILKLIGCCLETELPTL--VFESVKYGTLRGFSFASLLIAPRIKI---AMEIANAV 164
           ++H NI+K  G C       L  + E + YG+LR +          IK+     +I   +
Sbjct: 73  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 132
Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVR-EEFIKGAYGFI 223
            YL  G  R  + R +   N+L++     K+ DF L+  +P+ +   + +E  +    + 
Sbjct: 133 EYL--GTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 189
Query: 224 APEYFATSSFNEMCDVYSFGAFLCELLT 251
           APE    S F+   DV+SFG  L EL T
Sbjct: 190 APESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 68/148 (45%), Gaps = 9/148 (6%)
Query: 110 MKHKNILKLIGCCLETELPTL--VFESVKYGTLRGFSFASLLIAPRIKI---AMEIANAV 164
           ++H NI+K  G C       L  + E + YG+LR +          IK+     +I   +
Sbjct: 68  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 127
Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVR-EEFIKGAYGFI 223
            YL  G  R  + R +   N+L++     K+ DF L+  +P+ +   + +E  +    + 
Sbjct: 128 EYL--GTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 184
Query: 224 APEYFATSSFNEMCDVYSFGAFLCELLT 251
           APE    S F+   DV+SFG  L EL T
Sbjct: 185 APESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 68/148 (45%), Gaps = 9/148 (6%)
Query: 110 MKHKNILKLIGCCLETELPTL--VFESVKYGTLRGFSFASLLIAPRIKI---AMEIANAV 164
           ++H NI+K  G C       L  + E + YG+LR +          IK+     +I   +
Sbjct: 75  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 134
Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVR-EEFIKGAYGFI 223
            YL  G  R  + R +   N+L++     K+ DF L+  +P+ +   + +E  +    + 
Sbjct: 135 EYL--GTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 191
Query: 224 APEYFATSSFNEMCDVYSFGAFLCELLT 251
           APE    S F+   DV+SFG  L EL T
Sbjct: 192 APESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 68/148 (45%), Gaps = 9/148 (6%)
Query: 110 MKHKNILKLIGCCLETELPTL--VFESVKYGTLRGFSFASLLIAPRIKI---AMEIANAV 164
           ++H NI+K  G C       L  + E + YG+LR +          IK+     +I   +
Sbjct: 74  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 133
Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVR-EEFIKGAYGFI 223
            YL  G  R  + R +   N+L++     K+ DF L+  +P+ +   + +E  +    + 
Sbjct: 134 EYL--GTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 190
Query: 224 APEYFATSSFNEMCDVYSFGAFLCELLT 251
           APE    S F+   DV+SFG  L EL T
Sbjct: 191 APESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 68/148 (45%), Gaps = 9/148 (6%)
Query: 110 MKHKNILKLIGCCLETELPTL--VFESVKYGTLRGFSFASLLIAPRIKI---AMEIANAV 164
           ++H NI+K  G C       L  + E + YG+LR +          IK+     +I   +
Sbjct: 72  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 131
Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVR-EEFIKGAYGFI 223
            YL  G  R  + R +   N+L++     K+ DF L+  +P+ +   + +E  +    + 
Sbjct: 132 EYL--GTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 188
Query: 224 APEYFATSSFNEMCDVYSFGAFLCELLT 251
           APE    S F+   DV+SFG  L EL T
Sbjct: 189 APESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 94/225 (41%), Gaps = 32/225 (14%)
Query: 73  EGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVF 132
           +G   D ++ I   KFH        E  +N I     + H NI+KL     + +   LV 
Sbjct: 76  KGRYSDDNKNIE--KFH--------EEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVT 125
Query: 133 ESVKYGTLRGFSFASLLIAPRI------KIAMEIANAVAYLHVGFDRPIVFRCIKASNVL 186
           E  + G L    F  ++   +        I  +I + + YLH      IV R IK  N+L
Sbjct: 126 EFYEGGEL----FEQIINRHKFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENIL 178
Query: 187 LDENYS---AKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFG 243
           L+   S    K+ DF LS S    +  +R+    G   +IAPE      +NE CDV+S G
Sbjct: 179 LENKNSLLNIKIVDFGLS-SFFSKDYKLRDRL--GTAYYIAPEVLK-KKYNEKCDVWSCG 234
Query: 244 AFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDP 288
             +  LL  C    F G  + D +  +E  K   + N +  I D 
Sbjct: 235 VIMYILL--CGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDE 277

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 66/241 (27%), Positives = 106/241 (43%), Gaps = 37/241 (15%)
Query: 104 IVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL--RGFSFA-SLLIAPRIKIAMEI 160
           +   S + H NI+KL G  L    P +V E V  G L  R    A  +  + ++++ ++I
Sbjct: 74  VFIMSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDI 131
Query: 161 ANAVAYLHVGFDRPIVFRCIKASNVLL---DENYS--AKLHDFSLSVSIPEGETHVREEF 215
           A  + Y+    + PIV R +++ N+ L   DEN    AK+ DF LS    +   H     
Sbjct: 132 ALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS----QQSVHSVSGL 186
Query: 216 IKGAYGFIAPEYFATS--SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYA 273
           + G + ++APE       S+ E  D YSF   L  +LT        G G  D+ +   Y 
Sbjct: 187 L-GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILT--------GEGPFDEYS---YG 234
Query: 274 KKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQ 333
           K    N      + P   ED        +L+++ +L   C S  P+ RP    + K+L +
Sbjct: 235 KIKFINMIREEGLRPTIPEDCP-----PRLRNVIEL---CWSGDPKKRPHFSYIVKELSE 286
Query: 334 M 334
           +
Sbjct: 287 L 287

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 68/148 (45%), Gaps = 9/148 (6%)
Query: 110 MKHKNILKLIGCCLETELPTL--VFESVKYGTLRGFSFASLLIAPRIKI---AMEIANAV 164
           ++H NI+K  G C       L  + E + YG+LR +          IK+     +I   +
Sbjct: 86  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 145
Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVR-EEFIKGAYGFI 223
            YL  G  R  + R +   N+L++     K+ DF L+  +P+ +   + +E  +    + 
Sbjct: 146 EYL--GTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 202
Query: 224 APEYFATSSFNEMCDVYSFGAFLCELLT 251
           APE    S F+   DV+SFG  L EL T
Sbjct: 203 APESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/220 (22%), Positives = 93/220 (42%), Gaps = 26/220 (11%)
Query: 43  RAFSAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDR----PISVMKFHDNSTLDDVE 98
           R F   +L+K        KV+ S     + +G  + +      P+ +    D S     +
Sbjct: 26  RIFKETELRKL-------KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQ 78
Query: 99  YCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL-------RGFSFASLLIA 151
              ++++    + H +I++L+G C  + L  LV + +  G+L       RG     LL+ 
Sbjct: 79  AVTDHMLAIGSLDHAHIVRLLGLCPGSSL-QLVTQYLPLGSLLDHVRQHRGALGPQLLL- 136
Query: 152 PRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHV 211
                 ++IA  + YL    +  +V R + A NVLL      ++ DF ++  +P  +  +
Sbjct: 137 ---NWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQL 190
Query: 212 REEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT 251
                K    ++A E      +    DV+S+G  + EL+T
Sbjct: 191 LYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 68/148 (45%), Gaps = 9/148 (6%)
Query: 110 MKHKNILKLIGCCLETELPTL--VFESVKYGTLRGFSFASLLIAPRIKI---AMEIANAV 164
           ++H NI+K  G C       L  + E + YG+LR +          IK+     +I   +
Sbjct: 86  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 145
Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVR-EEFIKGAYGFI 223
            YL  G  R  + R +   N+L++     K+ DF L+  +P+ +   + +E  +    + 
Sbjct: 146 EYL--GTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 202
Query: 224 APEYFATSSFNEMCDVYSFGAFLCELLT 251
           APE    S F+   DV+SFG  L EL T
Sbjct: 203 APESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 92/233 (39%), Gaps = 34/233 (14%)
Query: 102 NNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGT----LRGFSFASLLIAPRIKIA 157
             I   SQ     + K  G  L+     ++ E +  G+    LR   F    IA  +K  
Sbjct: 70  QEITVLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK-- 127
Query: 158 MEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIK 217
            EI   + YLH       + R IKA+NVLL E    KL DF ++  + +  T ++     
Sbjct: 128 -EILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQIKRNTFV 181
Query: 218 GAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSI 277
           G   ++APE    S+++   D++S G    EL         KG   + D+  +       
Sbjct: 182 GTPFWMAPEVIQQSAYDSKADIWSLGITAIELA--------KGEPPNSDMHPMRVLFLIP 233
Query: 278 ENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ 330
           +NN       P    D +        +S  + +  CL+K P  RP   ++ K 
Sbjct: 234 KNN------PPTLVGDFT--------KSFKEFIDACLNKDPSFRPTAKELLKH 272

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 68/148 (45%), Gaps = 9/148 (6%)
Query: 110 MKHKNILKLIGCCLETELPTL--VFESVKYGTLRGFSFASLLIAPRIKI---AMEIANAV 164
           ++H NI+K  G C       L  + E + YG+LR +          IK+     +I   +
Sbjct: 99  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 158
Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVR-EEFIKGAYGFI 223
            YL  G  R  + R +   N+L++     K+ DF L+  +P+ +   + +E  +    + 
Sbjct: 159 EYL--GTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 215
Query: 224 APEYFATSSFNEMCDVYSFGAFLCELLT 251
           APE    S F+   DV+SFG  L EL T
Sbjct: 216 APESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/235 (22%), Positives = 93/235 (39%), Gaps = 38/235 (16%)
Query: 112 HKNILKLIGCCLETELPTLVF-ESVKYGTLRGFSFAS--------------LLIAPRIKI 156
           H N++ L+G C +   P +V  E  K+G L  +  +               L +   I  
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICY 149
Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI 216
           + ++A  + +L     R  + R + A N+LL E    K+ DF L+  I +   +VR+   
Sbjct: 150 SFQVAKGMEFLA---SRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 206
Query: 217 KGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKS 276
           +    ++APE      +    DV+SFG  L E+ +      + G   D+     E+ ++ 
Sbjct: 207 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-LGASPYPGVKIDE-----EFCRRL 260
Query: 277 IENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQL 331
            E  R  A        D + P        + Q M  C    P  RP   ++ + L
Sbjct: 261 KEGTRMRA-------PDYTTP-------EMYQTMLDCWHGEPSQRPTFSELVEHL 301

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/237 (22%), Positives = 92/237 (38%), Gaps = 40/237 (16%)
Query: 112 HKNILKLIGCCLETELPTLVF-ESVKYGTLRGFSFAS----------------LLIAPRI 154
           H N++ L+G C +   P +V  E  K+G L  +  +                 L +   I
Sbjct: 92  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLI 151
Query: 155 KIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREE 214
             + ++A  + +L     R  + R + A N+LL E    K+ DF L+  I +    VR+ 
Sbjct: 152 XYSFQVAKGMEFLA---SRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 208
Query: 215 FIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAK 274
             +    ++APE      +    DV+SFG  L E+ +      + G   D+     E+ +
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-LGASPYPGVKIDE-----EFCR 262
Query: 275 KSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQL 331
           +  E  R  A        D + P        + Q M  C    P  RP   ++ + L
Sbjct: 263 RLKEGTRMRA-------PDYTTP-------EMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/220 (22%), Positives = 93/220 (42%), Gaps = 26/220 (11%)
Query: 43  RAFSAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDR----PISVMKFHDNSTLDDVE 98
           R F   +L+K        KV+ S     + +G  + +      P+ +    D S     +
Sbjct: 8   RIFKETELRKL-------KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQ 60
Query: 99  YCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL-------RGFSFASLLIA 151
              ++++    + H +I++L+G C  + L  LV + +  G+L       RG     LL+ 
Sbjct: 61  AVTDHMLAIGSLDHAHIVRLLGLCPGSSL-QLVTQYLPLGSLLDHVRQHRGALGPQLLL- 118
Query: 152 PRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHV 211
                 ++IA  + YL    +  +V R + A NVLL      ++ DF ++  +P  +  +
Sbjct: 119 ---NWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQL 172
Query: 212 REEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT 251
                K    ++A E      +    DV+S+G  + EL+T
Sbjct: 173 LYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 52/102 (50%), Gaps = 6/102 (5%)
Query: 154 IKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVRE 213
           I IA + A  + YLH    + I+ R +K++N+ L E  + K+ DF L+          + 
Sbjct: 135 IDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQV 191
Query: 214 EFIKGAYGFIAPEYFA---TSSFNEMCDVYSFGAFLCELLTG 252
           E   G+  ++APE       + F+   DVYS+G  L EL+TG
Sbjct: 192 EQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTG 233

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 68/148 (45%), Gaps = 9/148 (6%)
Query: 110 MKHKNILKLIGCCLETELPTL--VFESVKYGTLRGFSFASLLIAPRIKI---AMEIANAV 164
           ++H NI+K  G C       L  + E + YG+LR +          IK+     +I   +
Sbjct: 68  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 127
Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVR-EEFIKGAYGFI 223
            YL  G  R  + R +   N+L++     K+ DF L+  +P+ +   + +E  +    + 
Sbjct: 128 EYL--GTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY 184
Query: 224 APEYFATSSFNEMCDVYSFGAFLCELLT 251
           APE    S F+   DV+SFG  L EL T
Sbjct: 185 APESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/221 (23%), Positives = 100/221 (45%), Gaps = 26/221 (11%)
Query: 42  IRAFSAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDR----PISVMKFHDNSTLD-D 96
           +R     +LK+        KV+ S     +++G  V +      P+++   ++ +    +
Sbjct: 32  LRILKETELKRV-------KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKAN 84
Query: 97  VEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF------SFASLLI 150
           VE+    ++ +S M H ++++L+G CL   +  LV + + +G L  +      +  S L+
Sbjct: 85  VEFMDEALIMAS-MDHPHLVRLLGVCLSPTI-QLVTQLMPHGCLLEYVHEHKDNIGSQLL 142
Query: 151 APRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH 210
              +   ++IA  + YL    +R +V R + A NVL+      K+ DF L+  +   E  
Sbjct: 143 ---LNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE 196
Query: 211 VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT 251
              +  K    ++A E      F    DV+S+G  + EL+T
Sbjct: 197 YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 237

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/229 (22%), Positives = 89/229 (38%), Gaps = 27/229 (11%)
Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANAVA 165
           Q  H NI++LIG C + +   +V E V+ G    F     A L +   +++  + A  + 
Sbjct: 168 QYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGME 227
Query: 166 YLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAP 225
           YL     +  + R + A N L+ E    K+ DF +S    +G         +    + AP
Sbjct: 228 YLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAP 284
Query: 226 EYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAI 285
           E      ++   DV+SFG  L E  +               L    Y   S +  R    
Sbjct: 285 EALNYGRYSSESDVWSFGILLWETFS---------------LGASPYPNLSNQQTR---- 325
Query: 286 VDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQM 334
                ++    P  E    ++ +LM +C +  P  RP    + ++L+ +
Sbjct: 326 --EFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/243 (23%), Positives = 100/243 (41%), Gaps = 37/243 (15%)
Query: 92  STLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF-------- 143
           S  D++++    ++ S ++ H+NI++ IG  L++    ++ E +  G L+ F        
Sbjct: 74  SEQDELDFLMEALIIS-KLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRP 132
Query: 144 -SFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLL---DENYSAKLHDFS 199
              +SL +   + +A +IA    YL    +   + R I A N LL        AK+ DF 
Sbjct: 133 SQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 189
Query: 200 LSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFK 259
           ++  I     + +         ++ PE F    F    D +SFG  L E+ +    + + 
Sbjct: 190 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-LGYMPYP 248
Query: 260 GNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPE 319
              N +   VLE+          G  +DP      + PG       + ++M +C    PE
Sbjct: 249 SKSNQE---VLEFVTS-------GGRMDP----PKNCPG------PVYRIMTQCWQHQPE 288
Query: 320 HRP 322
            RP
Sbjct: 289 DRP 291

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 50/99 (50%), Gaps = 12/99 (12%)
Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI 216
           A EI   +  LH      IV+R +K  N+LLD++   ++ D  L+V +PEG+T      I
Sbjct: 292 AAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT------I 342
Query: 217 K---GAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
           K   G  G++APE      +    D ++ G  L E++ G
Sbjct: 343 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAG 381

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 87/192 (45%), Gaps = 22/192 (11%)
Query: 96  DVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRI- 154
           D E     +    Q+ H NI+KL     +     LV E    G L    F  ++   R  
Sbjct: 93  DKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFS 148
Query: 155 -----KIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLD---ENYSAKLHDFSLSVSIPE 206
                +I  ++ + + Y+H      IV R +K  N+LL+   ++ + ++ DF LS    E
Sbjct: 149 EVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF-E 204
Query: 207 GETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDD 266
               ++++ I  AY +IAPE     +++E CDV+S G  L  LL+GC    F G    D 
Sbjct: 205 ASKKMKDK-IGTAY-YIAPEVLH-GTYDEKCDVWSTGVILYILLSGCP--PFNGANEYDI 259
Query: 267 LTVLEYAKKSIE 278
           L  +E  K + E
Sbjct: 260 LKKVEKGKYTFE 271

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 92/216 (42%), Gaps = 26/216 (12%)
Query: 130 LVFESVKYGTLRGF--SFASLLIAPRIKI-AMEIANAVAYLHVGFDRPIVFRCIKASNVL 186
           LV E +  G LR F     + L A R+ + + +I   + YL     R  V R + A N+L
Sbjct: 103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNIL 159
Query: 187 LDENYSAKLHDFSLSVSIP-EGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAF 245
           ++     K+ DF L+  +P + + +V  E  +    + APE  + + F+   DV+SFG  
Sbjct: 160 VESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVV 219
Query: 246 LCELLTGCN-----VLEF-KGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGK 299
           L EL T C+       EF +  G + D+  L    + +E                  P  
Sbjct: 220 LYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEG-------------QRLPAP 266
Query: 300 EEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMY 335
                 + +LM  C + SP+ RP    +  QL  ++
Sbjct: 267 PACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW 302

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 87/192 (45%), Gaps = 22/192 (11%)
Query: 96  DVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRI- 154
           D E     +    Q+ H NI+KL     +     LV E    G L    F  ++   R  
Sbjct: 69  DKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFS 124
Query: 155 -----KIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLD---ENYSAKLHDFSLSVSIPE 206
                +I  ++ + + Y+H      IV R +K  N+LL+   ++ + ++ DF LS    E
Sbjct: 125 EVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF-E 180
Query: 207 GETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDD 266
               ++++ I  AY +IAPE     +++E CDV+S G  L  LL+GC    F G    D 
Sbjct: 181 ASKKMKDK-IGTAY-YIAPEVLH-GTYDEKCDVWSTGVILYILLSGCP--PFNGANEYDI 235
Query: 267 LTVLEYAKKSIE 278
           L  +E  K + E
Sbjct: 236 LKKVEKGKYTFE 247

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 110/248 (44%), Gaps = 51/248 (20%)
Query: 107 SSQMKHKN---ILKLIGCCLETELPTLVFESVKYGTLRGFSFASL--------LIAP--- 152
           +S MK  N   +++L+G   + +   ++ E +  G L+ +   SL        ++AP   
Sbjct: 66  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSY-LRSLRPEMENNPVLAPPSL 124
Query: 153 --RIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH 210
              I++A EIA+ +AYL+       V R + A N  + E+++ K+ DF ++  I E +  
Sbjct: 125 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDY- 180
Query: 211 VREEFIKGAYG-----FIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDD 265
               + KG  G     +++PE      F    DV+SFG  L E+ T      ++G  N+ 
Sbjct: 181 ----YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE-QPYQGLSNEQ 235
Query: 266 DLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMV 325
            L             RF  +   + D+ ++ P        L +LM  C   +P+ RP  +
Sbjct: 236 VL-------------RF-VMEGGLLDKPDNCP------DMLLELMRMCWQYNPKMRPSFL 275
Query: 326 DVAKQLRQ 333
           ++   +++
Sbjct: 276 EIISSIKE 283

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 87/192 (45%), Gaps = 22/192 (11%)
Query: 96  DVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRI- 154
           D E     +    Q+ H NI+KL     +     LV E    G L    F  ++   R  
Sbjct: 92  DKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFS 147
Query: 155 -----KIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLD---ENYSAKLHDFSLSVSIPE 206
                +I  ++ + + Y+H      IV R +K  N+LL+   ++ + ++ DF LS    E
Sbjct: 148 EVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF-E 203
Query: 207 GETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDD 266
               ++++ I  AY +IAPE     +++E CDV+S G  L  LL+GC    F G    D 
Sbjct: 204 ASKKMKDK-IGTAY-YIAPEVLH-GTYDEKCDVWSTGVILYILLSGCP--PFNGANEYDI 258
Query: 267 LTVLEYAKKSIE 278
           L  +E  K + E
Sbjct: 259 LKKVEKGKYTFE 270

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 68/148 (45%), Gaps = 9/148 (6%)
Query: 110 MKHKNILKLIGCCLETELPTL--VFESVKYGTLRGFSFASLLIAPRIKI---AMEIANAV 164
           ++H NI+K  G C       L  + E + YG+LR +          IK+     +I   +
Sbjct: 71  LQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGM 130
Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVR-EEFIKGAYGFI 223
            YL  G  R  + R +   N+L++     K+ DF L+  +P+ +   + +E  +    + 
Sbjct: 131 EYL--GTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 187
Query: 224 APEYFATSSFNEMCDVYSFGAFLCELLT 251
           APE    S F+   DV+SFG  L EL T
Sbjct: 188 APESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 73/156 (46%), Gaps = 6/156 (3%)
Query: 98  EYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIKIA 157
           E  FN +V     +H N++++    L  E   ++ E ++ G L        L   +I   
Sbjct: 87  ELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATV 146
Query: 158 ME-IANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI 216
            E +  A+AYLH    + ++ R IK+ ++LL  +   KL DF     I + +   R+  +
Sbjct: 147 CEAVLQALAYLHA---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK-DVPKRKXLV 202
Query: 217 KGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
              Y ++APE  + S +    D++S G  + E++ G
Sbjct: 203 GTPY-WMAPEVISRSLYATEVDIWSLGIMVIEMVDG 237

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 50/99 (50%), Gaps = 12/99 (12%)
Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI 216
           A EI   +  LH      IV+R +K  N+LLD++   ++ D  L+V +PEG+T      I
Sbjct: 292 AAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT------I 342
Query: 217 K---GAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
           K   G  G++APE      +    D ++ G  L E++ G
Sbjct: 343 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAG 381

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/229 (22%), Positives = 89/229 (38%), Gaps = 27/229 (11%)
Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANAVA 165
           Q  H NI++LIG C + +   +V E V+ G    F     A L +   +++  + A  + 
Sbjct: 168 QYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGME 227
Query: 166 YLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAP 225
           YL     +  + R + A N L+ E    K+ DF +S    +G         +    + AP
Sbjct: 228 YLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAP 284
Query: 226 EYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAI 285
           E      ++   DV+SFG  L E  +               L    Y   S +  R    
Sbjct: 285 EALNYGRYSSESDVWSFGILLWETFS---------------LGASPYPNLSNQQTR---- 325
Query: 286 VDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQM 334
                ++    P  E    ++ +LM +C +  P  RP    + ++L+ +
Sbjct: 326 --EFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/243 (23%), Positives = 100/243 (41%), Gaps = 37/243 (15%)
Query: 92  STLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF-------- 143
           S  D++++    ++ S ++ H+NI++ IG  L++    ++ E +  G L+ F        
Sbjct: 88  SEQDELDFLMEALIIS-KLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRP 146
Query: 144 -SFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLL---DENYSAKLHDFS 199
              +SL +   + +A +IA    YL    +   + R I A N LL        AK+ DF 
Sbjct: 147 SQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 203
Query: 200 LSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFK 259
           ++  I     + +         ++ PE F    F    D +SFG  L E+ +    + + 
Sbjct: 204 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-LGYMPYP 262
Query: 260 GNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPE 319
              N +   VLE+          G  +DP      + PG       + ++M +C    PE
Sbjct: 263 SKSNQE---VLEFVTS-------GGRMDP----PKNCPG------PVYRIMTQCWQHQPE 302
Query: 320 HRP 322
            RP
Sbjct: 303 DRP 305

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 87/192 (45%), Gaps = 22/192 (11%)
Query: 96  DVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRI- 154
           D E     +    Q+ H NI+KL     +     LV E    G L    F  ++   R  
Sbjct: 75  DKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFS 130
Query: 155 -----KIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLD---ENYSAKLHDFSLSVSIPE 206
                +I  ++ + + Y+H      IV R +K  N+LL+   ++ + ++ DF LS    E
Sbjct: 131 EVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF-E 186
Query: 207 GETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDD 266
               ++++ I  AY +IAPE     +++E CDV+S G  L  LL+GC    F G    D 
Sbjct: 187 ASKKMKDK-IGTAY-YIAPEVLH-GTYDEKCDVWSTGVILYILLSGCP--PFNGANEYDI 241
Query: 267 LTVLEYAKKSIE 278
           L  +E  K + E
Sbjct: 242 LKKVEKGKYTFE 253

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/202 (23%), Positives = 94/202 (46%), Gaps = 19/202 (9%)
Query: 61  KVIQSDTSYRLFEGTLVDQDR----PISVMKFHDNSTLD-DVEYCFNNIVFSSQMKHKNI 115
           KV+ S     +++G  V +      P+++   ++ +    +VE+    ++ +S M H ++
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMAS-MDHPHL 79
Query: 116 LKLIGCCLETELPTLVFESVKYGTLRGF------SFASLLIAPRIKIAMEIANAVAYLHV 169
           ++L+G CL   +  LV + + +G L  +      +  S L+   +   ++IA  + YL  
Sbjct: 80  VRLLGVCLSPTI-QLVTQLMPHGCLLEYVHEHKDNIGSQLL---LNWCVQIAKGMMYLE- 134
Query: 170 GFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFA 229
             +R +V R + A NVL+      K+ DF L+  +   E     +  K    ++A E   
Sbjct: 135 --ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 192
Query: 230 TSSFNEMCDVYSFGAFLCELLT 251
              F    DV+S+G  + EL+T
Sbjct: 193 YRKFTHQSDVWSYGVTIWELMT 214

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/156 (23%), Positives = 73/156 (46%), Gaps = 6/156 (3%)
Query: 98  EYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRI-KI 156
           E  FN +V      H N++ +    L  +   +V E ++ G L      + +   +I  +
Sbjct: 87  ELLFNEVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATV 146
Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI 216
            + +  A++YLH   ++ ++ R IK+ ++LL  +   KL DF     + + E   R+  +
Sbjct: 147 CLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK-EVPKRKXLV 202
Query: 217 KGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
              Y ++APE  +   +    D++S G  + E++ G
Sbjct: 203 GTPY-WMAPEVISRLPYGTEVDIWSLGIMVIEMIDG 237

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/243 (23%), Positives = 99/243 (40%), Gaps = 37/243 (15%)
Query: 92  STLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF-------- 143
           S  D++++    ++ S +  H+NI++ IG  L++    ++ E +  G L+ F        
Sbjct: 100 SEQDELDFLMEALIIS-KFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRP 158
Query: 144 -SFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLL---DENYSAKLHDFS 199
              +SL +   + +A +IA    YL    +   + R I A N LL        AK+ DF 
Sbjct: 159 SQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 215
Query: 200 LSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFK 259
           ++  I     + +         ++ PE F    F    D +SFG  L E+ +    + + 
Sbjct: 216 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-LGYMPYP 274
Query: 260 GNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPE 319
              N +   VLE+          G  +DP      + PG       + ++M +C    PE
Sbjct: 275 SKSNQE---VLEFVTS-------GGRMDP----PKNCPG------PVYRIMTQCWQHQPE 314
Query: 320 HRP 322
            RP
Sbjct: 315 DRP 317

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 31/111 (27%), Positives = 55/111 (49%), Gaps = 6/111 (5%)
Query: 152 PR-IKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH 210
           PR I    +I + + +LH    R I++R +K  NVLLD++ + ++ D  L+V +  G+T 
Sbjct: 289 PRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK 345
Query: 211 VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGN 261
            +     G  GF+APE      ++   D ++ G  L E++        +G 
Sbjct: 346 TKG--YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGE 394

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/234 (23%), Positives = 91/234 (38%), Gaps = 32/234 (13%)
Query: 108 SQMKHKNILKLIGCCLETELPTLVF-ESVKYGTLRGF---SFASLLIAPRIKIAMEIANA 163
            Q +H NI++L G    + +P ++  E ++ G L  F   +     +   + +   IA+ 
Sbjct: 72  GQFEHPNIIRLEGVVTNS-MPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASG 130
Query: 164 VAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGA---Y 220
           + YL    +   V R + A N+L++ N   K+ DF LS  + E  +   E    G     
Sbjct: 131 MRYLA---EMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPI 187
Query: 221 GFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENN 280
            + APE  A   F    D +S+G  + E+++      +    N D +  +E         
Sbjct: 188 RWTAPEAIAFRKFTSASDAWSYGIVMWEVMS-FGERPYWDMSNQDVINAIE--------- 237
Query: 281 RFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQM 334
                      +D   P   +   SL QLM  C  K    RP    V   L +M
Sbjct: 238 -----------QDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKM 280

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 92/221 (41%), Gaps = 22/221 (9%)
Query: 76  LVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESV 135
           L   +R I ++K    +T  +     + +    Q+ H NI+KL     +     LV E  
Sbjct: 44  LTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVY 103
Query: 136 KYGTLRGFSFASLLIAPRIK------IAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDE 189
           + G L    F  +++  +        I  ++ +   YLH      IV R +K  N+LL+ 
Sbjct: 104 RGGEL----FDEIILRQKFSEVDAAVIMKQVLSGTTYLH---KHNIVHRDLKPENLLLES 156
Query: 190 NYS---AKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFL 246
                  K+ DF LS     G     +E +  AY +IAPE      ++E CDV+S G  L
Sbjct: 157 KSRDALIKIVDFGLSAHFEVGGKM--KERLGTAY-YIAPEVL-RKKYDEKCDVWSCGVIL 212
Query: 247 CELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVD 287
             LL  C    F G  + + L  +E  K S +   +  + D
Sbjct: 213 YILL--CGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSD 251

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 31/111 (27%), Positives = 55/111 (49%), Gaps = 6/111 (5%)
Query: 152 PR-IKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH 210
           PR I    +I + + +LH    R I++R +K  NVLLD++ + ++ D  L+V +  G+T 
Sbjct: 289 PRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK 345
Query: 211 VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGN 261
            +     G  GF+APE      ++   D ++ G  L E++        +G 
Sbjct: 346 TKG--YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGE 394

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 77/165 (46%), Gaps = 21/165 (12%)
Query: 110 MKHKNILKLIGC-----CLETELPTLVFESVKYGTLRGFSFASLLIAPRI-KIAMEIANA 163
           MKH+NIL+ IG       ++ +L  L+    + G+L  F  A+++    +  IA  +A  
Sbjct: 75  MKHENILQFIGAEKRGTSVDVDL-WLITAFHEKGSLSDFLKANVVSWNELCHIAETMARG 133
Query: 164 VAYLHV-------GFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI 216
           +AYLH        G    I  R IK+ NVLL  N +A + DF L++    G++       
Sbjct: 134 LAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQ 193
Query: 217 KGAYGFIAPEY------FATSSFNEMCDVYSFGAFLCELLTGCNV 255
            G   ++APE       F   +F  + D+Y+ G  L EL + C  
Sbjct: 194 VGTRRYMAPEVLEGAINFQRDAFLRI-DMYAMGLVLWELASRCTA 237

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 31/111 (27%), Positives = 55/111 (49%), Gaps = 6/111 (5%)
Query: 152 PR-IKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH 210
           PR I    +I + + +LH    R I++R +K  NVLLD++ + ++ D  L+V +  G+T 
Sbjct: 289 PRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK 345
Query: 211 VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGN 261
            +     G  GF+APE      ++   D ++ G  L E++        +G 
Sbjct: 346 TKG--YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGE 394

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 66/268 (24%), Positives = 104/268 (38%), Gaps = 39/268 (14%)
Query: 80  DRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGT 139
           D  I V+K    +   D E          Q+ +  I++LIG C + E   LV E    G 
Sbjct: 39  DVAIKVLK--QGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGP 95
Query: 140 LRGFSFASLLIAPRIKIAMEIANAVAYLH---VGF----DRPIVFRCIKASNVLLDENYS 192
           L  F     L+  R +I   ++N    LH   +G     ++  V R + A NVLL   + 
Sbjct: 96  LHKF-----LVGKREEIP--VSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHY 148
Query: 193 AKLHDFSLSVSIPEGETHVREEFI-KGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT 251
           AK+ DF LS ++   +++       K    + APE      F+   DV+S+G  + E L+
Sbjct: 149 AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 208
Query: 252 GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMY 311
                               Y +K  +  + G  V    ++        E    L  LM 
Sbjct: 209 --------------------YGQKPYKKMK-GPEVMAFIEQGKRMECPPECPPELYALMS 247
Query: 312 KCLSKSPEHRPLMVDVAKQLRQMYLSVV 339
            C     E RP  + V +++R  Y S+ 
Sbjct: 248 DCWIYKWEDRPDFLTVEQRMRACYYSLA 275

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/243 (23%), Positives = 99/243 (40%), Gaps = 37/243 (15%)
Query: 92  STLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF-------- 143
           S  D++++    ++ S +  H+NI++ IG  L++    ++ E +  G L+ F        
Sbjct: 80  SEQDELDFLMEALIIS-KFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRP 138
Query: 144 -SFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLL---DENYSAKLHDFS 199
              +SL +   + +A +IA    YL    +   + R I A N LL        AK+ DF 
Sbjct: 139 SQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 195
Query: 200 LSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFK 259
           ++  I     + +         ++ PE F    F    D +SFG  L E+ +    + + 
Sbjct: 196 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-LGYMPYP 254
Query: 260 GNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPE 319
              N +   VLE+          G  +DP      + PG       + ++M +C    PE
Sbjct: 255 SKSNQE---VLEFVTS-------GGRMDP----PKNCPG------PVYRIMTQCWQHQPE 294
Query: 320 HRP 322
            RP
Sbjct: 295 DRP 297

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/243 (23%), Positives = 99/243 (40%), Gaps = 37/243 (15%)
Query: 92  STLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF-------- 143
           S  D++++    ++ S +  H+NI++ IG  L++    ++ E +  G L+ F        
Sbjct: 74  SEQDELDFLMEALIIS-KFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRP 132
Query: 144 -SFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLL---DENYSAKLHDFS 199
              +SL +   + +A +IA    YL    +   + R I A N LL        AK+ DF 
Sbjct: 133 SQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 189
Query: 200 LSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFK 259
           ++  I     + +         ++ PE F    F    D +SFG  L E+ +    + + 
Sbjct: 190 MAQDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-LGYMPYP 248
Query: 260 GNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPE 319
              N +   VLE+          G  +DP      + PG       + ++M +C    PE
Sbjct: 249 SKSNQE---VLEFVTS-------GGRMDP----PKNCPG------PVYRIMTQCWQHQPE 288
Query: 320 HRP 322
            RP
Sbjct: 289 DRP 291

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 47/96 (48%), Gaps = 5/96 (5%)
Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI 216
           A EI   + +LH    + IV+R +K  N+LLD++   K+ DF +      G+    E   
Sbjct: 125 AAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNE--F 179
Query: 217 KGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
            G   +IAPE      +N   D +SFG  L E+L G
Sbjct: 180 CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIG 215

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 50/97 (51%), Gaps = 9/97 (9%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSL-SVSIPEGE-THVREEFI 216
           EI+ A+ +LH    + I++R +K  N++L+     KL DF L   SI +G  TH      
Sbjct: 129 EISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT----F 181
Query: 217 KGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGC 253
            G   ++APE    S  N   D +S GA + ++LTG 
Sbjct: 182 CGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 31/111 (27%), Positives = 55/111 (49%), Gaps = 6/111 (5%)
Query: 152 PR-IKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH 210
           PR I    +I + + +LH    R I++R +K  NVLLD++ + ++ D  L+V +  G+T 
Sbjct: 289 PRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK 345
Query: 211 VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGN 261
            +     G  GF+APE      ++   D ++ G  L E++        +G 
Sbjct: 346 TKG--YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGE 394

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/243 (23%), Positives = 99/243 (40%), Gaps = 37/243 (15%)
Query: 92  STLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF-------- 143
           S  D++++    ++ S +  H+NI++ IG  L++    ++ E +  G L+ F        
Sbjct: 74  SEQDELDFLMEALIIS-KFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRP 132
Query: 144 -SFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLL---DENYSAKLHDFS 199
              +SL +   + +A +IA    YL    +   + R I A N LL        AK+ DF 
Sbjct: 133 SQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 189
Query: 200 LSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFK 259
           ++  I     + +         ++ PE F    F    D +SFG  L E+ +    + + 
Sbjct: 190 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-LGYMPYP 248
Query: 260 GNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPE 319
              N +   VLE+          G  +DP      + PG       + ++M +C    PE
Sbjct: 249 SKSNQE---VLEFVTS-------GGRMDP----PKNCPG------PVYRIMTQCWQHQPE 288
Query: 320 HRP 322
            RP
Sbjct: 289 DRP 291

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 75/175 (42%), Gaps = 27/175 (15%)
Query: 156 IAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEF 215
           I  EI   + YLH   +R I  R IKA+NVLL E    KL DF ++  +   +T ++   
Sbjct: 121 ILREILKGLDYLHS--ERKI-HRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKRNX 175
Query: 216 IKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKK 275
             G   ++APE    S+++   D++S G    EL         KG   + DL  +     
Sbjct: 176 FVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELA--------KGEPPNSDLHPMRVLFL 227
Query: 276 SIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ 330
             +N+       P  +  +S P KE         +  CL+K P  RP   ++ K 
Sbjct: 228 IPKNS------PPTLEGQHSKPFKE--------FVEACLNKDPRFRPTAKELLKH 268

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/243 (23%), Positives = 99/243 (40%), Gaps = 37/243 (15%)
Query: 92  STLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF-------- 143
           S  D++++    ++ S +  H+NI++ IG  L++    ++ E +  G L+ F        
Sbjct: 90  SEQDELDFLMEALIIS-KFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRP 148
Query: 144 -SFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLL---DENYSAKLHDFS 199
              +SL +   + +A +IA    YL    +   + R I A N LL        AK+ DF 
Sbjct: 149 SQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 205
Query: 200 LSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFK 259
           ++  I     + +         ++ PE F    F    D +SFG  L E+ +    + + 
Sbjct: 206 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-LGYMPYP 264
Query: 260 GNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPE 319
              N +   VLE+          G  +DP      + PG       + ++M +C    PE
Sbjct: 265 SKSNQE---VLEFVTS-------GGRMDP----PKNCPG------PVYRIMTQCWQHQPE 304
Query: 320 HRP 322
            RP
Sbjct: 305 DRP 307

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 93/216 (43%), Gaps = 26/216 (12%)
Query: 130 LVFESVKYGTLRGF--SFASLLIAPRIKI-AMEIANAVAYLHVGFDRPIVFRCIKASNVL 186
           LV E +  G LR F     + L A R+ + + +I   + YL     R  V R + A N+L
Sbjct: 91  LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNIL 147
Query: 187 LDENYSAKLHDFSLSVSIP-EGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAF 245
           ++     K+ DF L+  +P + + +V  E  +    + APE  + + F+   DV+SFG  
Sbjct: 148 VESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVV 207
Query: 246 LCELLTGCN-----VLEF-KGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGK 299
           L EL T C+       EF +  G + D+  L    + +E  +               P  
Sbjct: 208 LYELFTYCDKSCSPSAEFLRMMGCERDVPALCRLLELLEEGQ-------------RLPAP 254
Query: 300 EEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMY 335
                 + +LM  C + SP+ RP    +  QL  ++
Sbjct: 255 PACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW 290

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 35/156 (22%), Positives = 74/156 (47%), Gaps = 6/156 (3%)
Query: 98  EYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIK-I 156
           E  FN +V     +H+N++++    L  +   +V E ++ G L      + +   +I  +
Sbjct: 66  ELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAV 125
Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI 216
            + +  A++ LH    + ++ R IK+ ++LL  +   KL DF     + + E   R+  +
Sbjct: 126 CLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK-EVPRRKXLV 181
Query: 217 KGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
              Y ++APE  +   +    D++S G  + E++ G
Sbjct: 182 GTPY-WMAPELISRLPYGPEVDIWSLGIMVIEMVDG 216

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 69/156 (44%), Gaps = 6/156 (3%)
Query: 98  EYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIK-I 156
           E   N I+   + K+ NI+  +   L  +   +V E +  G+L      + +   +I  +
Sbjct: 62  ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV 121
Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI 216
             E   A+ +LH      ++ R IK+ N+LL  + S KL DF     I   E   R E +
Sbjct: 122 CRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP-EQSKRSEMV 177
Query: 217 KGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
              Y ++APE     ++    D++S G    E++ G
Sbjct: 178 GTPY-WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 35/156 (22%), Positives = 74/156 (47%), Gaps = 6/156 (3%)
Query: 98  EYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIK-I 156
           E  FN +V     +H+N++++    L  +   +V E ++ G L      + +   +I  +
Sbjct: 73  ELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAV 132
Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI 216
            + +  A++ LH    + ++ R IK+ ++LL  +   KL DF     + + E   R+  +
Sbjct: 133 CLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK-EVPRRKXLV 188
Query: 217 KGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
              Y ++APE  +   +    D++S G  + E++ G
Sbjct: 189 GTPY-WMAPELISRLPYGPEVDIWSLGIMVIEMVDG 223

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 35/156 (22%), Positives = 74/156 (47%), Gaps = 6/156 (3%)
Query: 98  EYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIK-I 156
           E  FN +V     +H+N++++    L  +   +V E ++ G L      + +   +I  +
Sbjct: 116 ELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAV 175
Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI 216
            + +  A++ LH    + ++ R IK+ ++LL  +   KL DF     + + E   R+  +
Sbjct: 176 CLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK-EVPRRKXLV 231
Query: 217 KGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
              Y ++APE  +   +    D++S G  + E++ G
Sbjct: 232 GTPY-WMAPELISRLPYGPEVDIWSLGIMVIEMVDG 266

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/265 (22%), Positives = 110/265 (41%), Gaps = 23/265 (8%)
Query: 78  DQDRPISVMKFHDNSTLDDVE-YCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVK 136
           D  R +++ KF ++     V+      I    Q++H+N++ L+  C + +   LVFE V 
Sbjct: 48  DTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVD 107
Query: 137 YGTLRGFSFASLLIAPRI--KIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAK 194
           +  L         +  ++  K   +I N + + H      I+ R IK  N+L+ ++   K
Sbjct: 108 HTILDDLELFPNGLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVK 164
Query: 195 LHDFSLSVSI-PEGETHVREEFIKGAYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTG 252
           L DF  + ++   GE +  E        + APE       + +  DV++ G  + E+  G
Sbjct: 165 LCDFGFARTLAAPGEVYDDE---VATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMG 221
Query: 253 CNVLEFKGNGNDDDL---------TVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKL 303
             +  F G+ + D L          +  + +   +N  F  +  P   E      +  KL
Sbjct: 222 EPL--FPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKL 279
Query: 304 -QSLGQLMYKCLSKSPEHRPLMVDV 327
            + +  L  KCL   P+ RP   ++
Sbjct: 280 SEVVIDLAKKCLHIDPDKRPFCAEL 304

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 50/96 (52%), Gaps = 7/96 (7%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSL-SVSIPEGETHVREEFIK 217
           EI+ A+ +LH    + I++R +K  N++L+     KL DF L   SI +G   V   F  
Sbjct: 129 EISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT--VTHXFC- 182
Query: 218 GAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGC 253
           G   ++APE    S  N   D +S GA + ++LTG 
Sbjct: 183 GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 35/156 (22%), Positives = 74/156 (47%), Gaps = 6/156 (3%)
Query: 98  EYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIK-I 156
           E  FN +V     +H+N++++    L  +   +V E ++ G L      + +   +I  +
Sbjct: 62  ELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAV 121
Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI 216
            + +  A++ LH    + ++ R IK+ ++LL  +   KL DF     + + E   R+  +
Sbjct: 122 CLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK-EVPRRKXLV 177
Query: 217 KGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
              Y ++APE  +   +    D++S G  + E++ G
Sbjct: 178 GTPY-WMAPELISRLPYGPEVDIWSLGIMVIEMVDG 212

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/243 (23%), Positives = 99/243 (40%), Gaps = 37/243 (15%)
Query: 92  STLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF-------- 143
           S  D++++    ++ S +  H+NI++ IG  L++    ++ E +  G L+ F        
Sbjct: 88  SEQDELDFLMEALIIS-KFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRP 146
Query: 144 -SFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLL---DENYSAKLHDFS 199
              +SL +   + +A +IA    YL    +   + R I A N LL        AK+ DF 
Sbjct: 147 SQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 203
Query: 200 LSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFK 259
           ++  I     + +         ++ PE F    F    D +SFG  L E+ +    + + 
Sbjct: 204 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-LGYMPYP 262
Query: 260 GNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPE 319
              N +   VLE+          G  +DP      + PG       + ++M +C    PE
Sbjct: 263 SKSNQE---VLEFVTS-------GGRMDP----PKNCPG------PVYRIMTQCWQHQPE 302
Query: 320 HRP 322
            RP
Sbjct: 303 DRP 305

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 93/221 (42%), Gaps = 22/221 (9%)
Query: 76  LVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESV 135
           L   +R I ++K    +T  +     + +    Q+ H NI+KL     +     LV E  
Sbjct: 27  LTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVY 86
Query: 136 KYGTLRGFSFASLLIAPRIK------IAMEIANAVAYLHVGFDRPIVFRCIKASNVLLD- 188
           + G L    F  +++  +        I  ++ +   YLH      IV R +K  N+LL+ 
Sbjct: 87  RGGEL----FDEIILRQKFSEVDAAVIMKQVLSGTTYLH---KHNIVHRDLKPENLLLES 139
Query: 189 --ENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFL 246
              +   K+ DF LS     G     +E +  AY +IAPE      ++E CDV+S G  L
Sbjct: 140 KSRDALIKIVDFGLSAHFEVGGK--MKERLGTAY-YIAPEVL-RKKYDEKCDVWSCGVIL 195
Query: 247 CELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVD 287
             LL  C    F G  + + L  +E  K S +   +  + D
Sbjct: 196 YILL--CGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSD 234

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 35/156 (22%), Positives = 74/156 (47%), Gaps = 6/156 (3%)
Query: 98  EYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIK-I 156
           E  FN +V     +H+N++++    L  +   +V E ++ G L      + +   +I  +
Sbjct: 71  ELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAV 130
Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI 216
            + +  A++ LH    + ++ R IK+ ++LL  +   KL DF     + + E   R+  +
Sbjct: 131 CLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK-EVPRRKXLV 186
Query: 217 KGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
              Y ++APE  +   +    D++S G  + E++ G
Sbjct: 187 GTPY-WMAPELISRLPYGPEVDIWSLGIMVIEMVDG 221

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 48/97 (49%), Gaps = 5/97 (5%)
Query: 156 IAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEF 215
           I  EI   + YLH       + R IKA+NVLL E+   KL DF ++  +   +T ++   
Sbjct: 124 ILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNX 178
Query: 216 IKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
             G   ++APE    S+++   D++S G    EL  G
Sbjct: 179 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARG 215

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/238 (22%), Positives = 92/238 (38%), Gaps = 41/238 (17%)
Query: 112 HKNILKLIGCCLETELPTLVF-ESVKYGTLRGFSFAS-----------------LLIAPR 153
           H N++ L+G C +   P +V  E  K+G L  +  +                  L +   
Sbjct: 91  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHL 150
Query: 154 IKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVRE 213
           I  + ++A  + +L     R  + R + A N+LL E    K+ DF L+  I +    VR+
Sbjct: 151 ICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRK 207
Query: 214 EFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYA 273
              +    ++APE      +    DV+SFG  L E+ +      + G   D+     E+ 
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-LGASPYPGVKIDE-----EFC 261
Query: 274 KKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQL 331
           ++  E  R  A        D + P        + Q M  C    P  RP   ++ + L
Sbjct: 262 RRLKEGTRMRA-------PDYTTP-------EMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 66/268 (24%), Positives = 104/268 (38%), Gaps = 39/268 (14%)
Query: 80  DRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGT 139
           D  I V+K    +   D E          Q+ +  I++LIG C + E   LV E    G 
Sbjct: 365 DVAIKVLK--QGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGP 421
Query: 140 LRGFSFASLLIAPRIKIAMEIANAVAYLH---VGF----DRPIVFRCIKASNVLLDENYS 192
           L  F     L+  R +I   ++N    LH   +G     ++  V R + A NVLL   + 
Sbjct: 422 LHKF-----LVGKREEIP--VSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHY 474
Query: 193 AKLHDFSLSVSIPEGETHVREEFI-KGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT 251
           AK+ DF LS ++   +++       K    + APE      F+   DV+S+G  + E L+
Sbjct: 475 AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 534
Query: 252 GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMY 311
                               Y +K  +  + G  V    ++        E    L  LM 
Sbjct: 535 --------------------YGQKPYKKMK-GPEVMAFIEQGKRMECPPECPPELYALMS 573
Query: 312 KCLSKSPEHRPLMVDVAKQLRQMYLSVV 339
            C     E RP  + V +++R  Y S+ 
Sbjct: 574 DCWIYKWEDRPDFLTVEQRMRACYYSLA 601

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 105/241 (43%), Gaps = 37/241 (15%)
Query: 104 IVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL--RGFSFA-SLLIAPRIKIAMEI 160
           +   S + H NI+KL G  L    P +V E V  G L  R    A  +  + ++++ ++I
Sbjct: 74  VFIMSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDI 131
Query: 161 ANAVAYLHVGFDRPIVFRCIKASNVLL---DENYS--AKLHDFSLSVSIPEGETHVREEF 215
           A  + Y+    + PIV R +++ N+ L   DEN    AK+ DF  S    +   H     
Sbjct: 132 ALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTS----QQSVHSVSGL 186
Query: 216 IKGAYGFIAPEYFATS--SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYA 273
           + G + ++APE       S+ E  D YSF   L  +LT        G G  D+ +   Y 
Sbjct: 187 L-GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILT--------GEGPFDEYS---YG 234
Query: 274 KKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQ 333
           K    N      + P   ED        +L+++ +L   C S  P+ RP    + K+L +
Sbjct: 235 KIKFINMIREEGLRPTIPEDCP-----PRLRNVIEL---CWSGDPKKRPHFSYIVKELSE 286
Query: 334 M 334
           +
Sbjct: 287 L 287

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 40/162 (24%), Positives = 69/162 (42%), Gaps = 21/162 (12%)
Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFA------------------SLL 149
           + ++H++I+K  G C + +   +VFE +K+G L  F  A                   L 
Sbjct: 72  TNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 131
Query: 150 IAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGET 209
           ++  + IA +IA+ + YL     +  V R +   N L+  N   K+ DF +S  +   + 
Sbjct: 132 LSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY 188
Query: 210 HVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT 251
           +           ++ PE      F    DV+SFG  L E+ T
Sbjct: 189 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 59/301 (19%), Positives = 117/301 (38%), Gaps = 45/301 (14%)
Query: 55  NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMK-----FHDNSTLDDVEYCFNNIVFSSQ 109
           NN    K + +    ++ E T     +  +V+K         +  D+ E   + +   S 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 110 M-KHKNILKLIGCCLETELPTLVFESVKYGTL--------------RGFSFASLLIAPR- 153
           + +H+NI+ L+G C       ++ E   YG L                F+ A+  ++ R 
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRD 165
Query: 154 -IKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVR 212
            +  + ++A  +A+L     +  + R + A NVLL   + AK+ DF L+  I     ++ 
Sbjct: 166 LLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222
Query: 213 EEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEY 272
           +   +    ++APE      +    DV+S+G  L E+ +               L +  Y
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS---------------LGLNPY 267
Query: 273 AKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLR 332
               + +  +  + D       +F  K     ++  +M  C +  P HRP    +   L+
Sbjct: 268 PGILVNSKFYKLVKDGYQMAQPAFAPK-----NIYSIMQACWALEPTHRPTFQQICSFLQ 322
Query: 333 Q 333
           +
Sbjct: 323 E 323

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 48/97 (49%), Gaps = 5/97 (5%)
Query: 156 IAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEF 215
           I  EI   + YLH       + R IKA+NVLL E+   KL DF ++  +   +T ++   
Sbjct: 109 ILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNX 163
Query: 216 IKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
             G   ++APE    S+++   D++S G    EL  G
Sbjct: 164 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARG 200

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 95/225 (42%), Gaps = 22/225 (9%)
Query: 46  SAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDD--VEYCFNN 103
           ++ D +    NY L K I      ++     +   + ++V K  D + L+   ++  F  
Sbjct: 5   TSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAV-KIIDKTQLNSSSLQKLFRE 63
Query: 104 IVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIKIA------ 157
           +     + H NI+KL       +   LV E    G +    F  L+   R+K        
Sbjct: 64  VRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEV----FDYLVAHGRMKEKEARAKF 119
Query: 158 MEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIK 217
            +I +AV Y H  F   IV R +KA N+LLD + + K+ DF  S     G    + +   
Sbjct: 120 RQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGN---KLDAFC 173
Query: 218 GAYGFIAPEYFATSSFN-EMCDVYSFGAFLCELLTGCNVLEFKGN 261
           GA  + APE F    ++    DV+S G  L  L++G   L F G 
Sbjct: 174 GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS--LPFDGQ 216

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/237 (21%), Positives = 105/237 (44%), Gaps = 48/237 (20%)
Query: 114 NILKLIGCCLETELPTLVFESVKYGTLRGF------------SFASLLIAPRIKIAMEIA 161
           ++++L+G   + +   +V E + +G L+ +                  +   I++A EIA
Sbjct: 80  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 139
Query: 162 NAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYG 221
           + +AYL+    +  V R + A N ++  +++ K+ DF ++  I E +      + KG  G
Sbjct: 140 DGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDY-----YRKGGKG 191
Query: 222 -----FIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKS 276
                ++APE      F    D++SFG  L E +T      ++G  N+    VL++    
Sbjct: 192 LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWE-ITSLAEQPYQGLSNEQ---VLKF---- 243
Query: 277 IENNRFGAIVDPIF-DEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLR 332
                   ++D  + D+ ++ P      + +  LM  C   +P+ RP  +++   L+
Sbjct: 244 --------VMDGGYLDQPDNCP------ERVTDLMRMCWQFNPKMRPTFLEIVNLLK 286

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 35/156 (22%), Positives = 73/156 (46%), Gaps = 6/156 (3%)
Query: 98  EYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIK-I 156
           E  FN +V     +H+N++++    L  +   +V E ++ G L      + +   +I  +
Sbjct: 193 ELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAV 252
Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI 216
            + +  A++ LH    + ++ R IK+ ++LL  +   KL DF     +   E   R+  +
Sbjct: 253 CLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV-SKEVPRRKXLV 308
Query: 217 KGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
              Y ++APE  +   +    D++S G  + E++ G
Sbjct: 309 GTPY-WMAPELISRLPYGPEVDIWSLGIMVIEMVDG 343

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/243 (23%), Positives = 99/243 (40%), Gaps = 37/243 (15%)
Query: 92  STLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF-------- 143
           S  D++++    ++ S +  H+NI++ IG  L++    ++ E +  G L+ F        
Sbjct: 88  SEQDELDFLMEALIIS-KFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRP 146
Query: 144 -SFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLL---DENYSAKLHDFS 199
              +SL +   + +A +IA    YL    +   + R I A N LL        AK+ DF 
Sbjct: 147 SQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 203
Query: 200 LSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFK 259
           ++  I     + +         ++ PE F    F    D +SFG  L E+ +    + + 
Sbjct: 204 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-LGYMPYP 262
Query: 260 GNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPE 319
              N +   VLE+          G  +DP      + PG       + ++M +C    PE
Sbjct: 263 SKSNQE---VLEFVTS-------GGRMDP----PKNCPG------PVYRIMTQCWQHQPE 302
Query: 320 HRP 322
            RP
Sbjct: 303 DRP 305

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 91/216 (42%), Gaps = 26/216 (12%)
Query: 130 LVFESVKYGTLRGF--SFASLLIAPRIKI-AMEIANAVAYLHVGFDRPIVFRCIKASNVL 186
           LV E +  G LR F     + L A R+ + + +I   + YL     R  V R + A N+L
Sbjct: 87  LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNIL 143
Query: 187 LDENYSAKLHDFSLSVSIP-EGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAF 245
           ++     K+ DF L+  +P + +  V  E  +    + APE  + + F+   DV+SFG  
Sbjct: 144 VESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVV 203
Query: 246 LCELLTGCN-----VLEF-KGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGK 299
           L EL T C+       EF +  G + D+  L    + +E                  P  
Sbjct: 204 LYELFTYCDKSCSPSAEFLRMMGCERDVPALCRLLELLEEG-------------QRLPAP 250
Query: 300 EEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMY 335
                 + +LM  C + SP+ RP    +  QL  ++
Sbjct: 251 PACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW 286

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/243 (23%), Positives = 99/243 (40%), Gaps = 37/243 (15%)
Query: 92  STLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF-------- 143
           S  D++++    ++ S +  H+NI++ IG  L++    ++ E +  G L+ F        
Sbjct: 73  SEQDELDFLMEALIIS-KFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRP 131
Query: 144 -SFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLL---DENYSAKLHDFS 199
              +SL +   + +A +IA    YL    +   + R I A N LL        AK+ DF 
Sbjct: 132 SQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 188
Query: 200 LSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFK 259
           ++  I     + +         ++ PE F    F    D +SFG  L E+ +    + + 
Sbjct: 189 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-LGYMPYP 247
Query: 260 GNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPE 319
              N +   VLE+          G  +DP      + PG       + ++M +C    PE
Sbjct: 248 SKSNQE---VLEFVTS-------GGRMDP----PKNCPG------PVYRIMTQCWQHQPE 287
Query: 320 HRP 322
            RP
Sbjct: 288 DRP 290

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 56/243 (23%), Positives = 99/243 (40%), Gaps = 37/243 (15%)
Query: 92  STLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF-------- 143
           S  D++++    ++ S +  H+NI++ IG  L++    ++ E +  G L+ F        
Sbjct: 114 SEQDELDFLMEALIIS-KFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRP 172
Query: 144 -SFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLL---DENYSAKLHDFS 199
              +SL +   + +A +IA    YL    +   + R I A N LL        AK+ DF 
Sbjct: 173 SQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 229
Query: 200 LSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFK 259
           ++  I     + +         ++ PE F    F    D +SFG  L E+ +    + + 
Sbjct: 230 MARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-LGYMPYP 288
Query: 260 GNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPE 319
              N +   VLE+          G  +DP      + PG       + ++M +C    PE
Sbjct: 289 SKSNQE---VLEFVTS-------GGRMDP----PKNCPG------PVYRIMTQCWQHQPE 328
Query: 320 HRP 322
            RP
Sbjct: 329 DRP 331

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 56/243 (23%), Positives = 99/243 (40%), Gaps = 37/243 (15%)
Query: 92  STLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF-------- 143
           S  D++++    ++ S +  H+NI++ IG  L++    ++ E +  G L+ F        
Sbjct: 73  SEQDELDFLMEALIIS-KFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRP 131
Query: 144 -SFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLL---DENYSAKLHDFS 199
              +SL +   + +A +IA    YL    +   + R I A N LL        AK+ DF 
Sbjct: 132 SQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 188
Query: 200 LSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFK 259
           ++  I     + +         ++ PE F    F    D +SFG  L E+ +    + + 
Sbjct: 189 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-LGYMPYP 247
Query: 260 GNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPE 319
              N +   VLE+          G  +DP      + PG       + ++M +C    PE
Sbjct: 248 SKSNQE---VLEFVTS-------GGRMDP----PKNCPG------PVYRIMTQCWQHQPE 287
Query: 320 HRP 322
            RP
Sbjct: 288 DRP 290

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 56/243 (23%), Positives = 99/243 (40%), Gaps = 37/243 (15%)
Query: 92  STLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF-------- 143
           S  D++++    ++ S +  H+NI++ IG  L++    ++ E +  G L+ F        
Sbjct: 65  SEQDELDFLMEALIIS-KFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRP 123
Query: 144 -SFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLL---DENYSAKLHDFS 199
              +SL +   + +A +IA    YL    +   + R I A N LL        AK+ DF 
Sbjct: 124 SQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 180
Query: 200 LSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFK 259
           ++  I     + +         ++ PE F    F    D +SFG  L E+ +    + + 
Sbjct: 181 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-LGYMPYP 239
Query: 260 GNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPE 319
              N +   VLE+          G  +DP      + PG       + ++M +C    PE
Sbjct: 240 SKSNQE---VLEFVTS-------GGRMDP----PKNCPG------PVYRIMTQCWQHQPE 279
Query: 320 HRP 322
            RP
Sbjct: 280 DRP 282

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 36/107 (33%), Positives = 50/107 (46%), Gaps = 6/107 (5%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           EI  A+ +LH      I++R IK  N+LLD N    L DF LS      ET    +F  G
Sbjct: 167 EIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC-G 222
Query: 219 AYGFIAPEYF--ATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGN 263
              ++AP+      S  ++  D +S G  + ELLTG +     G  N
Sbjct: 223 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN 269

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/253 (22%), Positives = 99/253 (39%), Gaps = 50/253 (19%)
Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF------------------------ 143
           ++  + NI+KL+G C   +   L+FE + YG L  F                        
Sbjct: 105 AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 164
Query: 144 --SFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLS 201
                 L  A ++ IA ++A  +AYL    +R  V R +   N L+ EN   K+ DF LS
Sbjct: 165 SPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLS 221
Query: 202 VSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGN 261
            +I   + +  +        ++ PE    + +    DV+++G  L E+ +   +  + G 
Sbjct: 222 RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY-GLQPYYGM 280
Query: 262 GNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHR 321
            +++   V+ Y +                 + N     E     L  LM  C SK P  R
Sbjct: 281 AHEE---VIYYVR-----------------DGNILACPENCPLELYNLMRLCWSKLPADR 320
Query: 322 PLMVDVAKQLRQM 334
           P    + + L++M
Sbjct: 321 PSFCSIHRILQRM 333

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 48/97 (49%), Gaps = 5/97 (5%)
Query: 156 IAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEF 215
           I  EI   + YLH       + R IKA+NVLL E+   KL DF ++  +   +T ++   
Sbjct: 109 ILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNT 163
Query: 216 IKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
             G   ++APE    S+++   D++S G    EL  G
Sbjct: 164 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARG 200

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 56/243 (23%), Positives = 99/243 (40%), Gaps = 37/243 (15%)
Query: 92  STLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF-------- 143
           S  D++++    ++ S +  H+NI++ IG  L++    ++ E +  G L+ F        
Sbjct: 91  SEQDELDFLMEALIIS-KFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRP 149
Query: 144 -SFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLL---DENYSAKLHDFS 199
              +SL +   + +A +IA    YL    +   + R I A N LL        AK+ DF 
Sbjct: 150 SQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 206
Query: 200 LSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFK 259
           ++  I     + +         ++ PE F    F    D +SFG  L E+ +    + + 
Sbjct: 207 MARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-LGYMPYP 265
Query: 260 GNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPE 319
              N +   VLE+          G  +DP      + PG       + ++M +C    PE
Sbjct: 266 SKSNQE---VLEFVTS-------GGRMDP----PKNCPG------PVYRIMTQCWQHQPE 305
Query: 320 HRP 322
            RP
Sbjct: 306 DRP 308

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 75/182 (41%), Gaps = 23/182 (12%)
Query: 95  DDVEYCFNNIVFSSQMKHKNILKLIGCCLET-ELPTLVFESVKYGTL-------RGFSFA 146
           DDVE         S  ++   L  + CC +T +    V E V  G L       R F  A
Sbjct: 65  DDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA 124
Query: 147 SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSL-SVSIP 205
                     A EI +A+ +LH   D+ I++R +K  NVLLD     KL DF +    I 
Sbjct: 125 RARF-----YAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176
Query: 206 EGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDD 265
            G T        G   +IAPE      +    D ++ G  L E+L G    E +   N+D
Sbjct: 177 NGVTTAT---FCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAE---NED 230
Query: 266 DL 267
           DL
Sbjct: 231 DL 232

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/237 (21%), Positives = 104/237 (43%), Gaps = 48/237 (20%)
Query: 114 NILKLIGCCLETELPTLVFESVKYGTLRGF------------SFASLLIAPRIKIAMEIA 161
           ++++L+G   + +   +V E + +G L+ +                  +   I++A EIA
Sbjct: 78  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 137
Query: 162 NAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYG 221
           + +AYL+    +  V R + A N ++  +++ K+ DF ++  I E +        KG  G
Sbjct: 138 DGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXR-----KGGKG 189
Query: 222 -----FIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKS 276
                ++APE      F    D++SFG  L E +T      ++G  N+    VL++    
Sbjct: 190 LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWE-ITSLAEQPYQGLSNEQ---VLKF---- 241
Query: 277 IENNRFGAIVDPIF-DEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLR 332
                   ++D  + D+ ++ P      + +  LM  C   +P+ RP  +++   L+
Sbjct: 242 --------VMDGGYLDQPDNCP------ERVTDLMRMCWQFNPKMRPTFLEIVNLLK 284

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 48/97 (49%), Gaps = 5/97 (5%)
Query: 156 IAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEF 215
           I  EI   + YLH       + R IKA+NVLL E+   KL DF ++  +   +T ++   
Sbjct: 129 ILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNT 183
Query: 216 IKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
             G   ++APE    S+++   D++S G    EL  G
Sbjct: 184 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARG 220

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 96/226 (42%), Gaps = 24/226 (10%)
Query: 46  SAKDLKKATNNYDLHKVIQSD--TSYRLFEGTLVDQDRPISVM-KFHDNSTLDDVEYCFN 102
           ++ D +    NY L K I        +L    L  ++  + ++ K   NS+   ++  F 
Sbjct: 5   TSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSS--SLQKLFR 62
Query: 103 NIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIKIA----- 157
            +     + H NI+KL       +   LV E    G +    F  L+   R+K       
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEV----FDYLVAHGRMKEKEARAK 118
Query: 158 -MEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI 216
             +I +AV Y H  F   IV R +KA N+LLD + + K+ DF  S     G     +EF 
Sbjct: 119 FRQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK--LDEFC 173
Query: 217 KGAYGFIAPEYFATSSFN-EMCDVYSFGAFLCELLTGCNVLEFKGN 261
            G+  + APE F    ++    DV+S G  L  L++G   L F G 
Sbjct: 174 -GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS--LPFDGQ 216

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 43/190 (22%), Positives = 79/190 (41%), Gaps = 23/190 (12%)
Query: 142 GFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLS 201
           GF    + +   I  + ++A  + +L     R  + R + A N+LL EN   K+ DF L+
Sbjct: 190 GFYKEPITMEDLISYSFQVARGMEFLS---SRKCIHRDLAARNILLSENNVVKICDFGLA 246
Query: 202 VSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGN 261
             I +   +VR+   +    ++APE      ++   DV+S+G  L E+ +      + G 
Sbjct: 247 RDIYKNPDYVRKGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS-LGGSPYPGV 305
Query: 262 GNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHR 321
             D+D     +  +  E  R  A               E     + Q+M  C  + P+ R
Sbjct: 306 QMDED-----FCSRLREGMRMRA--------------PEYSTPEIYQIMLDCWHRDPKER 346
Query: 322 PLMVDVAKQL 331
           P   ++ ++L
Sbjct: 347 PRFAELVEKL 356

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 50/236 (21%), Positives = 102/236 (43%), Gaps = 46/236 (19%)
Query: 114 NILKLIGCCLETELPTLVFESVKYGTLRGF------------SFASLLIAPRIKIAMEIA 161
           ++++L+G   + +   +V E + +G L+ +                  +   I++A EIA
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 162 NAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYG 221
           + +AYL+    +  V R + A N ++  +++ K+ DF ++  I E +      + KG  G
Sbjct: 141 DGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDY-----YRKGGKG 192
Query: 222 -----FIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKS 276
                ++APE      F    D++SFG  L E +T      ++G  N+  L       K 
Sbjct: 193 LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWE-ITSLAEQPYQGLSNEQVL-------KF 244
Query: 277 IENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLR 332
           + +  +        D+ ++ P      + +  LM  C   +P+ RP  +++   L+
Sbjct: 245 VMDGGY-------LDQPDNCP------ERVTDLMRMCWQFNPKMRPTFLEIVNLLK 287

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 94/225 (41%), Gaps = 22/225 (9%)
Query: 46  SAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLD--DVEYCFNN 103
           S  D +    NY L K I      ++     +   R +++ K  D + L+   ++  F  
Sbjct: 6   SCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAI-KIIDKTQLNPTSLQKLFRE 64
Query: 104 IVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIKIA------ 157
           +     + H NI+KL       +   L+ E    G +    F  L+   R+K        
Sbjct: 65  VRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEV----FDYLVAHGRMKEKEARSKF 120
Query: 158 MEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIK 217
            +I +AV Y H    + IV R +KA N+LLD + + K+ DF  S     G    + +   
Sbjct: 121 RQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG---KLDAFC 174
Query: 218 GAYGFIAPEYFATSSFN-EMCDVYSFGAFLCELLTGCNVLEFKGN 261
           GA  + APE F    ++    DV+S G  L  L++G   L F G 
Sbjct: 175 GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS--LPFDGQ 217

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 50/236 (21%), Positives = 101/236 (42%), Gaps = 46/236 (19%)
Query: 114 NILKLIGCCLETELPTLVFESVKYGTLRGF------------SFASLLIAPRIKIAMEIA 161
           ++++L+G   + +   +V E + +G L+ +                  +   I++A EIA
Sbjct: 82  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 141
Query: 162 NAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYG 221
           + +AYL+    +  V R + A N ++  +++ K+ DF ++  I E +      + KG  G
Sbjct: 142 DGMAYLNA---KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDY-----YRKGGKG 193
Query: 222 -----FIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKS 276
                ++APE      F    D++SFG  L E +T      ++G  N+  L       K 
Sbjct: 194 LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWE-ITSLAEQPYQGLSNEQVL-------KF 245
Query: 277 IENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLR 332
           + +  +        D+ ++ P      + +  LM  C   +P  RP  +++   L+
Sbjct: 246 VMDGGY-------LDQPDNCP------ERVTDLMRMCWQFNPNMRPTFLEIVNLLK 288

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/237 (21%), Positives = 104/237 (43%), Gaps = 48/237 (20%)
Query: 114 NILKLIGCCLETELPTLVFESVKYGTLRGF------------SFASLLIAPRIKIAMEIA 161
           ++++L+G   + +   +V E + +G L+ +                  +   I++A EIA
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 162 NAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYG 221
           + +AYL+    +  V R + A N ++  +++ K+ DF ++  I E +        KG  G
Sbjct: 141 DGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXR-----KGGKG 192
Query: 222 -----FIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKS 276
                ++APE      F    D++SFG  L E +T      ++G  N+    VL++    
Sbjct: 193 LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWE-ITSLAEQPYQGLSNEQ---VLKF---- 244
Query: 277 IENNRFGAIVDPIF-DEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLR 332
                   ++D  + D+ ++ P      + +  LM  C   +P+ RP  +++   L+
Sbjct: 245 --------VMDGGYLDQPDNCP------ERVTDLMRMCWQFNPKMRPTFLEIVNLLK 287

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/236 (21%), Positives = 101/236 (42%), Gaps = 46/236 (19%)
Query: 114 NILKLIGCCLETELPTLVFESVKYGTLRGF------------SFASLLIAPRIKIAMEIA 161
           ++++L+G   + +   +V E + +G L+ +                  +   I++A EIA
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 162 NAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYG 221
           + +AYL+    +  V R + A N ++  +++ K+ DF ++  I E +      + KG  G
Sbjct: 141 DGMAYLNA---KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDY-----YRKGGKG 192
Query: 222 -----FIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKS 276
                ++APE      F    D++SFG  L E +T      ++G  N+  L       K 
Sbjct: 193 LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWE-ITSLAEQPYQGLSNEQVL-------KF 244
Query: 277 IENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLR 332
           + +  +        D+ ++ P      + +  LM  C   +P  RP  +++   L+
Sbjct: 245 VMDGGY-------LDQPDNCP------ERVTDLMRMCWQFNPNMRPTFLEIVNLLK 287

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/147 (27%), Positives = 73/147 (49%), Gaps = 13/147 (8%)
Query: 108 SQMKHKNILKLIGCCLETELPT-LVFESVKYGTL----RGFSFASLLIAPRIKIAMEIAN 162
           +Q++H N+++L+G  +E +    +V E +  G+L    R    + L     +K ++++  
Sbjct: 60  TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 119
Query: 163 AVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGF 222
           A+ YL        V R + A NVL+ E+  AK+ DF L+      E    ++  K    +
Sbjct: 120 AMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLT-----KEASSTQDTGKLPVKW 171
Query: 223 IAPEYFATSSFNEMCDVYSFGAFLCEL 249
            APE    ++F+   DV+SFG  L E+
Sbjct: 172 TAPEALREAAFSTKSDVWSFGILLWEI 198

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 82/176 (46%), Gaps = 31/176 (17%)
Query: 105 VFSSQ-MKHKNILKLI-----GCCLETELPTLVFESVKYGTLRGFSFASLLIAPRI-KIA 157
           +FS+  MKH+N+L+ I     G  LE EL  L+      G+L  +   +++    +  +A
Sbjct: 60  IFSTPGMKHENLLQFIAAEKRGSNLEVEL-WLITAFHDKGSLTDYLKGNIITWNELCHVA 118
Query: 158 MEIANAVAYLHV--------GFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSI----P 205
             ++  ++YLH         G    I  R  K+ NVLL  + +A L DF L+V      P
Sbjct: 119 ETMSRGLSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKP 178
Query: 206 EGETHVREEFIKGAYGFIAPEY------FATSSFNEMCDVYSFGAFLCELLTGCNV 255
            G+TH +     G   ++APE       F   +F  + D+Y+ G  L EL++ C  
Sbjct: 179 PGDTHGQ----VGTRRYMAPEVLEGAINFQRDAFLRI-DMYAMGLVLWELVSRCKA 229

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/301 (19%), Positives = 116/301 (38%), Gaps = 45/301 (14%)
Query: 55  NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMK-----FHDNSTLDDVEYCFNNIVFSSQ 109
           NN    K + +    ++ E T     +  +V+K         +  D+ E   + +   S 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 110 M-KHKNILKLIGCCLETELPTLVFESVKYGTL--------------RGFSFASLLIAPR- 153
           + +H+NI+ L+G C       ++ E   YG L                F+ A+   + R 
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 154 -IKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVR 212
            +  + ++A  +A+L     +  + R + A NVLL   + AK+ DF L+  I     ++ 
Sbjct: 166 LLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222
Query: 213 EEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEY 272
           +   +    ++APE      +    DV+S+G  L E+ +               L +  Y
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS---------------LGLNPY 267
Query: 273 AKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLR 332
               + +  +  + D       +F  K     ++  +M  C +  P HRP    +   L+
Sbjct: 268 PGILVNSKFYKLVKDGYQMAQPAFAPK-----NIYSIMQACWALEPTHRPTFQQICSFLQ 322
Query: 333 Q 333
           +
Sbjct: 323 E 323

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/233 (23%), Positives = 89/233 (38%), Gaps = 30/233 (12%)
Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANAV 164
            Q +H NI++L G    +    ++ E ++ G L  F   +     +   + +   IA+ +
Sbjct: 70  GQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGM 129
Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE---THVREEFIKGAYG 221
            YL    +   V R + A N+L++ N   K+ DF LS  + E     T+      K    
Sbjct: 130 RYLA---EMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIR 186
Query: 222 FIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNR 281
           + APE  A   F    D +S+G  + E+++      +    N D +  +E          
Sbjct: 187 WTAPEAIAFRKFTSASDAWSYGIVMWEVMS-FGERPYWDMSNQDVINAIE---------- 235
Query: 282 FGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQM 334
                     +D   P   +   SL QLM  C  K    RP    V   L +M
Sbjct: 236 ----------QDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKM 278

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/236 (21%), Positives = 99/236 (41%), Gaps = 46/236 (19%)
Query: 114 NILKLIGCCLETELPTLVFESVKYGTLRGF------------SFASLLIAPRIKIAMEIA 161
           ++++L+G   + +   +V E + +G L+ +                  +   I++A EIA
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 162 NAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYG 221
           + +AYL+    +  V R + A N ++  +++ K+ DF ++  I E +        KG  G
Sbjct: 141 DGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXR-----KGGKG 192
Query: 222 -----FIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKS 276
                ++APE      F    D++SFG  L E +T      ++G  N+    VL++    
Sbjct: 193 LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWE-ITSLAEQPYQGLSNEQ---VLKFVMDG 248
Query: 277 IENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLR 332
                         D+ ++ P      + +  LM  C   +P  RP  +++   L+
Sbjct: 249 -----------GYLDQPDNCP------ERVTDLMRMCWQFNPNMRPTFLEIVNLLK 287

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 95/225 (42%), Gaps = 22/225 (9%)
Query: 46  SAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDD--VEYCFNN 103
           ++ D +    NY L K I      ++     +   + ++V K  D + L+   ++  F  
Sbjct: 5   TSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAV-KIIDKTQLNSSSLQKLFRE 63
Query: 104 IVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIKIA------ 157
           +     + H NI+KL       +   LV E    G +    F  L+   R+K        
Sbjct: 64  VRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEV----FDYLVAHGRMKEKEARAKF 119
Query: 158 MEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIK 217
            +I +AV Y H  F   IV R +KA N+LLD + + K+ DF  S     G    + +   
Sbjct: 120 RQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGN---KLDTFC 173
Query: 218 GAYGFIAPEYFATSSFN-EMCDVYSFGAFLCELLTGCNVLEFKGN 261
           G+  + APE F    ++    DV+S G  L  L++G   L F G 
Sbjct: 174 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS--LPFDGQ 216

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/215 (21%), Positives = 88/215 (40%), Gaps = 21/215 (9%)
Query: 55  NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMK-----FHDNSTLDDVEYCFNNIVFSSQ 109
           NN    K + +    ++ E T     +  +V+K         +  D+ E   + +   S 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 110 M-KHKNILKLIGCCLETELPTLVFESVKYGTLRGF------------SFASLLIAPRIKI 156
           + +H+NI+ L+G C       ++ E   YG L  F                L +   +  
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHF 165
Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI 216
           + ++A  +A+L     +  + R + A NVLL   + AK+ DF L+  I     ++ +   
Sbjct: 166 SSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 222
Query: 217 KGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT 251
           +    ++APE      +    DV+S+G  L E+ +
Sbjct: 223 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/241 (24%), Positives = 97/241 (40%), Gaps = 33/241 (13%)
Query: 100 CFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL----RGFSFASLLIAPRI- 154
           C   I    Q+ H N++K     +E     +V E    G L    + F     LI  R  
Sbjct: 79  CIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTV 138
Query: 155 -KIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVRE 213
            K  +++ +A+ ++H    R ++ R IK +NV +      KL D  L        T    
Sbjct: 139 WKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS 195
Query: 214 EFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYA 273
             + G   +++PE    + +N   D++S G  L E+      L+    G+  +L  L   
Sbjct: 196 --LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA----LQSPFYGDKMNLYSL--- 246
Query: 274 KKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP---LMVDVAKQ 330
            K IE   +  +    + E+            L QL+  C++  PE RP    + DVAK+
Sbjct: 247 CKKIEQCDYPPLPSDHYSEE------------LRQLVNMCINPDPEKRPDVTYVYDVAKR 294
Query: 331 L 331
           +
Sbjct: 295 M 295

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 95/225 (42%), Gaps = 22/225 (9%)
Query: 46  SAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDD--VEYCFNN 103
           ++ D +    NY L K I      ++     +   + ++V K  D + L+   ++  F  
Sbjct: 5   TSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAV-KIIDKTQLNSSSLQKLFRE 63
Query: 104 IVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIKIA------ 157
           +     + H NI+KL       +   LV E    G +    F  L+   R+K        
Sbjct: 64  VRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEV----FDYLVAHGRMKEKEARAKF 119
Query: 158 MEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIK 217
            +I +AV Y H  F   IV R +KA N+LLD + + K+ DF  S     G    + +   
Sbjct: 120 RQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGN---KLDTFC 173
Query: 218 GAYGFIAPEYFATSSFN-EMCDVYSFGAFLCELLTGCNVLEFKGN 261
           G+  + APE F    ++    DV+S G  L  L++G   L F G 
Sbjct: 174 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS--LPFDGQ 216

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/297 (19%), Positives = 113/297 (38%), Gaps = 41/297 (13%)
Query: 55  NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMK-----FHDNSTLDDVEYCFNNIVFSSQ 109
           NN    K + +    ++ E T     +  +V+K         +  D+ E   + +   S 
Sbjct: 38  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 97
Query: 110 M-KHKNILKLIGCCLETELPTLVFESVKYGTLRGF------------SFASLLIAPRIKI 156
           + +H+NI+ L+G C       ++ E   YG L  F                L +   +  
Sbjct: 98  LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHF 157
Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI 216
           + ++A  +A+L     +  + R + A NVLL   + AK+ DF L+  I     ++ +   
Sbjct: 158 SSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 214
Query: 217 KGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKS 276
           +    ++APE      +    DV+S+G  L E+ +               L +  Y    
Sbjct: 215 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS---------------LGLNPYPGIL 259
Query: 277 IENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQ 333
           + +  +  + D       +F  K     ++  +M  C +  P HRP    +   L++
Sbjct: 260 VNSKFYKLVKDGYQMAQPAFAPK-----NIYSIMQACWALEPTHRPTFQQICSFLQE 311

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 92/214 (42%), Gaps = 19/214 (8%)
Query: 55  NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKN 114
           ++Y+L +VI S  +  +       +   +++ + +       ++     I   SQ  H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 115 ILKL-IGCCLETELPTL--------VFESVKYGTLRGFSFASLLIAPRI-KIAMEIANAV 164
           I+       ++ EL  +        V + +K+   +G   + +L    I  I  E+   +
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEG----ETHVREEFIKGAY 220
            YLH       + R +KA N+LL E+ S ++ DF +S  +  G       VR+ F+ G  
Sbjct: 135 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV-GTP 190
Query: 221 GFIAPEYF-ATSSFNEMCDVYSFGAFLCELLTGC 253
            ++APE       ++   D++SFG    EL TG 
Sbjct: 191 CWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 71/260 (27%), Positives = 107/260 (41%), Gaps = 30/260 (11%)
Query: 39  RNPIRAFSAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKF-HDNSTLDDV 97
           +N IR  + KD+++      L K +      RL+E    D+     VM+  H    LD +
Sbjct: 61  KNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYE-VYEDEQYICLVMELCHGGHLLDKL 119
Query: 98  EYCFNNIVFSSQMKHKNILKLIGC-CLETELPTLVFESVKYGTLRGFSFASLLIAPRIK- 155
               ++      M   +++K   C C E        E    G++ GF   SL    R K 
Sbjct: 120 NVFIDDSTGKCAM---DVVKTQICPCPECN------EEAINGSIHGFR-ESLDFVQREKL 169
Query: 156 ---IAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDEN--YSAKLHDFSLS---VSIPEG 207
              I  +I +A+ YLH   ++ I  R IK  N L   N  +  KL DF LS     +  G
Sbjct: 170 ISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNG 226
Query: 208 ETHVREEFIKGAYGFIAPEYFATS--SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDD 265
           E +         Y F+APE   T+  S+   CD +S G  L  LL G   + F G  + D
Sbjct: 227 EYYGMTTKAGTPY-FVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMG--AVPFPGVNDAD 283
Query: 266 DLTVLEYAKKSIENNRFGAI 285
            ++ +   K   EN  +  +
Sbjct: 284 TISQVLNKKLCFENPNYNVL 303

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/236 (21%), Positives = 101/236 (42%), Gaps = 46/236 (19%)
Query: 114 NILKLIGCCLETELPTLVFESVKYGTLRGF------------SFASLLIAPRIKIAMEIA 161
           ++++L+G   + +   +V E + +G L+ +                  +   I++A EIA
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 162 NAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYG 221
           + +AYL+    +  V R + A N ++  +++ K+ DF ++  I E        + KG  G
Sbjct: 141 DGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAY-----YRKGGKG 192
Query: 222 -----FIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKS 276
                ++APE      F    D++SFG  L E +T      ++G  N+  L       K 
Sbjct: 193 LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWE-ITSLAEQPYQGLSNEQVL-------KF 244
Query: 277 IENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLR 332
           + +  +        D+ ++ P      + +  LM  C   +P+ RP  +++   L+
Sbjct: 245 VMDGGY-------LDQPDNCP------ERVTDLMRMCWQFNPKMRPTFLEIVNLLK 287

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 47/96 (48%), Gaps = 5/96 (5%)
Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI 216
           A EI   + +LH    + IV+R +K  N+LLD++   K+ DF +      G+   +    
Sbjct: 124 AAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNXF 178
Query: 217 KGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
            G   +IAPE      +N   D +SFG  L E+L G
Sbjct: 179 CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIG 214

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 92/214 (42%), Gaps = 19/214 (8%)
Query: 55  NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKN 114
           ++Y+L +VI S  +  +       +   +++ + +       ++     I   SQ  H N
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 115 ILKL-IGCCLETELPTL--------VFESVKYGTLRGFSFASLLIAPRI-KIAMEIANAV 164
           I+       ++ EL  +        V + +K+   +G   + +L    I  I  E+   +
Sbjct: 70  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 129
Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEG----ETHVREEFIKGAY 220
            YLH       + R +KA N+LL E+ S ++ DF +S  +  G       VR+ F+ G  
Sbjct: 130 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV-GTP 185
Query: 221 GFIAPEYF-ATSSFNEMCDVYSFGAFLCELLTGC 253
            ++APE       ++   D++SFG    EL TG 
Sbjct: 186 CWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 219

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 94/225 (41%), Gaps = 22/225 (9%)
Query: 46  SAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDD--VEYCFNN 103
           ++ D +    NY L K I      ++     +   + ++V K  D + L+   ++  F  
Sbjct: 5   TSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAV-KIIDKTQLNSSSLQKLFRE 63
Query: 104 IVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIKIA------ 157
           +     + H NI+KL       +   LV E    G +    F  L+   R K        
Sbjct: 64  VRIXKVLNHPNIVKLFEVIETEKTLYLVXEYASGGEV----FDYLVAHGRXKEKEARAKF 119
Query: 158 MEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIK 217
            +I +AV Y H  F   IV R +KA N+LLD + + K+ DF  S     G    + +   
Sbjct: 120 RQIVSAVQYCHQKF---IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGN---KLDAFC 173
Query: 218 GAYGFIAPEYFATSSFN-EMCDVYSFGAFLCELLTGCNVLEFKGN 261
           GA  + APE F    ++    DV+S G  L  L++G   L F G 
Sbjct: 174 GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS--LPFDGQ 216

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 79/181 (43%), Gaps = 13/181 (7%)
Query: 86  MKFHDNSTLDD--VEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF 143
           +K  D + L+   ++  F  +     + H NI+KL       +   LV E    G +  +
Sbjct: 37  VKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDY 96
Query: 144 SFASLLIAPRIKIA--MEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLS 201
             A   +  +   A   +I +AV Y H  F   IV R +KA N+LLD + + K+ DF  S
Sbjct: 97  LVAHGWMKEKEARAKFRQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFS 153
Query: 202 VSIPEGETHVREEFIKGAYGFIAPEYFATSSFN-EMCDVYSFGAFLCELLTGCNVLEFKG 260
                G    + +   G+  + APE F    ++    DV+S G  L  L++G   L F G
Sbjct: 154 NEFTFGN---KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS--LPFDG 208
Query: 261 N 261
Sbjct: 209 Q 209

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/153 (25%), Positives = 64/153 (41%), Gaps = 9/153 (5%)
Query: 102 NNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL-RGFSFASLLIAPRIKIAME- 159
             I   S ++H NIL++     + +   L+ E    G L +           R    ME 
Sbjct: 64  REIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE 123
Query: 160 IANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGA 219
           +A+A+ Y H   +R ++ R IK  N+L+      K+ DF  SV  P     +R   + G 
Sbjct: 124 LADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS----LRRRXMCGT 176
Query: 220 YGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
             ++ PE     + +E  D++  G    E L G
Sbjct: 177 LDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 209

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/153 (25%), Positives = 64/153 (41%), Gaps = 9/153 (5%)
Query: 102 NNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL-RGFSFASLLIAPRIKIAME- 159
             I   S ++H NIL++     + +   L+ E    G L +           R    ME 
Sbjct: 63  REIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE 122
Query: 160 IANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGA 219
           +A+A+ Y H   +R ++ R IK  N+L+      K+ DF  SV  P     +R   + G 
Sbjct: 123 LADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS----LRRRXMCGT 175
Query: 220 YGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
             ++ PE     + +E  D++  G    E L G
Sbjct: 176 LDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 208

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 72/149 (48%), Gaps = 13/149 (8%)
Query: 108 SQMKHKNILKLIGCCLETELPT-LVFESVKYGTL----RGFSFASLLIAPRIKIAMEIAN 162
           +Q++H N+++L+G  +E +    +V E +  G+L    R    + L     +K ++++  
Sbjct: 69  TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 128
Query: 163 AVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGF 222
           A+ YL        V R + A NVL+ E+  AK+ DF L+      E    ++  K    +
Sbjct: 129 AMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLT-----KEASSTQDTGKLPVKW 180
Query: 223 IAPEYFATSSFNEMCDVYSFGAFLCELLT 251
            APE      F+   DV+SFG  L E+ +
Sbjct: 181 TAPEALREKKFSTKSDVWSFGILLWEIYS 209

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 95/226 (42%), Gaps = 24/226 (10%)
Query: 46  SAKDLKKATNNYDLHKVIQSD--TSYRLFEGTLVDQDRPISVM-KFHDNSTLDDVEYCFN 102
           ++ D +    NY L K I        +L    L  ++  + ++ K   NS+   ++  F 
Sbjct: 5   TSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSS--SLQKLFR 62
Query: 103 NIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIKIA----- 157
            +     + H NI+KL       +   LV E    G +    F  L+   R+K       
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEV----FDYLVAHGRMKEKEARAK 118
Query: 158 -MEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI 216
             +I +AV Y H  F   IV R +KA N+LLD + + K+ DF  S     G    + +  
Sbjct: 119 FRQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGN---KLDTF 172
Query: 217 KGAYGFIAPEYFATSSFN-EMCDVYSFGAFLCELLTGCNVLEFKGN 261
            G+  + APE F    ++    DV+S G  L  L++G   L F G 
Sbjct: 173 CGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS--LPFDGQ 216

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/147 (27%), Positives = 71/147 (48%), Gaps = 13/147 (8%)
Query: 108 SQMKHKNILKLIGCCLETELPT-LVFESVKYGTL----RGFSFASLLIAPRIKIAMEIAN 162
           +Q++H N+++L+G  +E +    +V E +  G+L    R    + L     +K ++++  
Sbjct: 54  TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 113
Query: 163 AVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGF 222
           A+ YL        V R + A NVL+ E+  AK+ DF L+      E    ++  K    +
Sbjct: 114 AMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLT-----KEASSTQDTGKLPVKW 165
Query: 223 IAPEYFATSSFNEMCDVYSFGAFLCEL 249
            APE      F+   DV+SFG  L E+
Sbjct: 166 TAPEALREKKFSTKSDVWSFGILLWEI 192

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 93/228 (40%), Gaps = 20/228 (8%)
Query: 55  NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKF------HDNSTLDDVEYCFNNIVFSS 108
            ++DL +VI   +  ++    L   DR I  MK       +D+  +D V+      VF  
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDR-IYAMKVVKKELVNDDEDIDWVQT--EKHVFEQ 65
Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIKI---AMEIANAVA 165
              H  ++ L  C         V E V  G L  F        P       + EI+ A+ 
Sbjct: 66  ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLM-FHMQRQRKLPEEHARFYSAEISLALN 124
Query: 166 YLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSL-SVSIPEGETHVREEFIKGAYGFIA 224
           YLH   +R I++R +K  NVLLD     KL D+ +    +  G+T        G   +IA
Sbjct: 125 YLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSXFCGTPNYIA 178
Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEY 272
           PE      +    D ++ G  + E++ G +  +  G+ ++ D    +Y
Sbjct: 179 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDY 226

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 93/228 (40%), Gaps = 20/228 (8%)
Query: 55  NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKF------HDNSTLDDVEYCFNNIVFSS 108
            ++DL +VI   +  ++    L   DR I  MK       +D+  +D V+      VF  
Sbjct: 20  QDFDLLRVIGRGSYAKVLLVRLKKTDR-IYAMKVVKKELVNDDEDIDWVQT--EKHVFEQ 76
Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIKI---AMEIANAVA 165
              H  ++ L  C         V E V  G L  F        P       + EI+ A+ 
Sbjct: 77  ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLM-FHMQRQRKLPEEHARFYSAEISLALN 135
Query: 166 YLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSL-SVSIPEGETHVREEFIKGAYGFIA 224
           YLH   +R I++R +K  NVLLD     KL D+ +    +  G+T        G   +IA
Sbjct: 136 YLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSXFCGTPNYIA 189
Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEY 272
           PE      +    D ++ G  + E++ G +  +  G+ ++ D    +Y
Sbjct: 190 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDY 237

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/233 (22%), Positives = 89/233 (38%), Gaps = 32/233 (13%)
Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANAV 164
            Q  H NI+ L G   + +   ++ E ++ G+L  F   +     +   + +   I + +
Sbjct: 85  GQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGM 144
Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSI---PEGETHVREEFIKGAYG 221
            YL    D   V R + A N+L++ N   K+ DF +S  +   PE     R   I     
Sbjct: 145 KYLS---DMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKI--PIR 199
Query: 222 FIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNR 281
           + APE  A   F    DV+S+G  + E                    V+ Y ++   +  
Sbjct: 200 WTAPEAIAYRKFTSASDVWSYGIVMWE--------------------VMSYGERPYWDMS 239
Query: 282 FGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQM 334
              ++  I +E    P   +   +L QLM  C  K    RP    +   L ++
Sbjct: 240 NQDVIKAI-EEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLDKL 291

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/233 (22%), Positives = 89/233 (38%), Gaps = 32/233 (13%)
Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANAV 164
            Q  H NI+ L G   + +   ++ E ++ G+L  F   +     +   + +   I + +
Sbjct: 70  GQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGM 129
Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSI---PEGETHVREEFIKGAYG 221
            YL    D   V R + A N+L++ N   K+ DF +S  +   PE     R   I     
Sbjct: 130 KYLS---DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKI--PIR 184
Query: 222 FIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNR 281
           + APE  A   F    DV+S+G  + E                    V+ Y ++   +  
Sbjct: 185 WTAPEAIAYRKFTSASDVWSYGIVMWE--------------------VMSYGERPYWDMS 224
Query: 282 FGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQM 334
              ++  I +E    P   +   +L QLM  C  K    RP    +   L ++
Sbjct: 225 NQDVIKAI-EEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLDKL 276

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/156 (25%), Positives = 68/156 (43%), Gaps = 6/156 (3%)
Query: 98  EYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIK-I 156
           E   N I+   + K+ NI+  +   L  +   +V E +  G+L      + +   +I  +
Sbjct: 62  ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV 121
Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI 216
             E   A+ +LH      ++ R IK+ N+LL  + S KL DF     I   E   R   +
Sbjct: 122 CRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP-EQSKRSTMV 177
Query: 217 KGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
              Y ++APE     ++    D++S G    E++ G
Sbjct: 178 GTPY-WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 84/192 (43%), Gaps = 22/192 (11%)
Query: 96  DVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRI- 154
           D E     +    Q+ H NI KL     +     LV E    G L    F  ++   R  
Sbjct: 69  DKESLLREVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFS 124
Query: 155 -----KIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLD---ENYSAKLHDFSLSVSIPE 206
                +I  ++ + + Y H      IV R +K  N+LL+   ++ + ++ DF LS    E
Sbjct: 125 EVDAARIIRQVLSGITYXH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF-E 180
Query: 207 GETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDD 266
                +++ I  AY +IAPE     +++E CDV+S G  L  LL+GC    F G    D 
Sbjct: 181 ASKKXKDK-IGTAY-YIAPEVLH-GTYDEKCDVWSTGVILYILLSGCP--PFNGANEYDI 235
Query: 267 LTVLEYAKKSIE 278
           L  +E  K + E
Sbjct: 236 LKKVEKGKYTFE 247

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/156 (25%), Positives = 68/156 (43%), Gaps = 6/156 (3%)
Query: 98  EYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIK-I 156
           E   N I+   + K+ NI+  +   L  +   +V E +  G+L      + +   +I  +
Sbjct: 63  ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV 122
Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI 216
             E   A+ +LH      ++ R IK+ N+LL  + S KL DF     I   E   R   +
Sbjct: 123 CRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP-EQSKRSXMV 178
Query: 217 KGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
              Y ++APE     ++    D++S G    E++ G
Sbjct: 179 GTPY-WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 213

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 67/158 (42%), Gaps = 15/158 (9%)
Query: 104 IVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF--SFASLLIAPRIKIAM--- 158
           I     +KHKNI++ +G   E     +  E V  G+L     S    L      I     
Sbjct: 70  IALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTK 129
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSA--KLHDFSLSVSIPEGETHVREEFI 216
           +I   + YLH   D  IV R IK  NVL++  YS   K+ DF  S  +  G     E F 
Sbjct: 130 QILEGLKYLH---DNQIVHRDIKGDNVLIN-TYSGVLKISDFGTSKRL-AGINPCTETFT 184
Query: 217 KGAYGFIAPEYF--ATSSFNEMCDVYSFGAFLCELLTG 252
            G   ++APE        + +  D++S G  + E+ TG
Sbjct: 185 -GTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATG 221

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/156 (25%), Positives = 68/156 (43%), Gaps = 6/156 (3%)
Query: 98  EYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIK-I 156
           E   N I+   + K+ NI+  +   L  +   +V E +  G+L      + +   +I  +
Sbjct: 63  ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV 122
Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI 216
             E   A+ +LH      ++ R IK+ N+LL  + S KL DF     I   E   R   +
Sbjct: 123 CRECLQALEFLH---SNQVIHRNIKSDNILLGMDGSVKLTDFGFCAQITP-EQSKRSTMV 178
Query: 217 KGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
              Y ++APE     ++    D++S G    E++ G
Sbjct: 179 GTPY-WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 213

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/156 (25%), Positives = 68/156 (43%), Gaps = 6/156 (3%)
Query: 98  EYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIK-I 156
           E   N I+   + K+ NI+  +   L  +   +V E +  G+L      + +   +I  +
Sbjct: 62  ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV 121
Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI 216
             E   A+ +LH      ++ R IK+ N+LL  + S KL DF     I   E   R   +
Sbjct: 122 CRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP-EQSKRSXMV 177
Query: 217 KGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
              Y ++APE     ++    D++S G    E++ G
Sbjct: 178 GTPY-WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 93/228 (40%), Gaps = 20/228 (8%)
Query: 55  NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKF------HDNSTLDDVEYCFNNIVFSS 108
            ++DL +VI   +  ++    L   DR I  MK       +D+  +D V+      VF  
Sbjct: 5   QDFDLLRVIGRGSYAKVLLVRLKKTDR-IYAMKVVKKELVNDDEDIDWVQT--EKHVFEQ 61
Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIKI---AMEIANAVA 165
              H  ++ L  C         V E V  G L  F        P       + EI+ A+ 
Sbjct: 62  ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLM-FHMQRQRKLPEEHARFYSAEISLALN 120
Query: 166 YLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSL-SVSIPEGETHVREEFIKGAYGFIA 224
           YLH   +R I++R +K  NVLLD     KL D+ +    +  G+T        G   +IA
Sbjct: 121 YLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSXFCGTPNYIA 174
Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEY 272
           PE      +    D ++ G  + E++ G +  +  G+ ++ D    +Y
Sbjct: 175 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDY 222

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/233 (22%), Positives = 89/233 (38%), Gaps = 32/233 (13%)
Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANAV 164
            Q  H NI+ L G   + +   ++ E ++ G+L  F   +     +   + +   I + +
Sbjct: 64  GQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGM 123
Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSI---PEGETHVREEFIKGAYG 221
            YL    D   V R + A N+L++ N   K+ DF +S  +   PE     R   I     
Sbjct: 124 KYLS---DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKI--PIR 178
Query: 222 FIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNR 281
           + APE  A   F    DV+S+G  + E                    V+ Y ++   +  
Sbjct: 179 WTAPEAIAYRKFTSASDVWSYGIVMWE--------------------VMSYGERPYWDMS 218
Query: 282 FGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQM 334
              ++  I +E    P   +   +L QLM  C  K    RP    +   L ++
Sbjct: 219 NQDVIKAI-EEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLDKL 270

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/233 (22%), Positives = 90/233 (38%), Gaps = 32/233 (13%)
Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANAV 164
            Q  H NI+ L G   +++   +V E ++ G+L  F   +     +   + +   I+  +
Sbjct: 78  GQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGM 137
Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSI---PEGETHVREEFIKGAYG 221
            YL    D   V R + A N+L++ N   K+ DF LS  +   PE     R   I     
Sbjct: 138 KYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIR 192
Query: 222 FIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNR 281
           + APE  A   F    DV+S+G  + E                    V+ Y ++      
Sbjct: 193 WTAPEAIAFRKFTSASDVWSYGIVMWE--------------------VVSYGERPYWEMT 232
Query: 282 FGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQM 334
              ++  + +E    P   +   +L QLM  C  K    RP   ++   L ++
Sbjct: 233 NQDVIKAV-EEGYRLPSPMDCPAALYQLMLDCWQKERNSRPKFDEIVNMLDKL 284

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 93/224 (41%), Gaps = 22/224 (9%)
Query: 47  AKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLD--DVEYCFNNI 104
             D +    NY L K I      ++     +   R +++ K  D + L+   ++  F  +
Sbjct: 4   GSDEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAI-KIIDKTQLNPTSLQKLFREV 62
Query: 105 VFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIKIA------M 158
                + H NI+KL       +   L+ E    G +    F  L+   R+K         
Sbjct: 63  RIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEV----FDYLVAHGRMKEKEARSKFR 118
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           +I +AV Y H    + IV R +KA N+LLD + + K+ DF  S     G    + +   G
Sbjct: 119 QIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG---KLDTFCG 172
Query: 219 AYGFIAPEYFATSSFN-EMCDVYSFGAFLCELLTGCNVLEFKGN 261
           +  + APE F    ++    DV+S G  L  L++G   L F G 
Sbjct: 173 SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS--LPFDGQ 214

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/177 (24%), Positives = 78/177 (44%), Gaps = 15/177 (8%)
Query: 82  PISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL- 140
           P+++    +N++    +   +     + +    + +L+G CL + +  LV + + YG L 
Sbjct: 48  PVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRLLGICLTSTV-QLVTQLMPYGCLL 106
Query: 141 ------RGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAK 194
                 RG   +  L+       M+IA  ++YL    D  +V R + A NVL+      K
Sbjct: 107 DHVRENRGRLGSQDLL----NWCMQIAKGMSYLE---DVRLVHRDLAARNVLVKSPNHVK 159
Query: 195 LHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT 251
           + DF L+  +   ET    +  K    ++A E      F    DV+S+G  + EL+T
Sbjct: 160 ITDFGLARLLDIDETEYHADGGKVPIKWMALESILRRRFTHQSDVWSYGVTVWELMT 216

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 72/149 (48%), Gaps = 13/149 (8%)
Query: 108 SQMKHKNILKLIGCCLETELPT-LVFESVKYGTL----RGFSFASLLIAPRIKIAMEIAN 162
           +Q++H N+++L+G  +E +    +V E +  G+L    R    + L     +K ++++  
Sbjct: 241 TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 300
Query: 163 AVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGF 222
           A+ YL        V R + A NVL+ E+  AK+ DF L+      E    ++  K    +
Sbjct: 301 AMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLT-----KEASSTQDTGKLPVKW 352
Query: 223 IAPEYFATSSFNEMCDVYSFGAFLCELLT 251
            APE      F+   DV+SFG  L E+ +
Sbjct: 353 TAPEALREKKFSTKSDVWSFGILLWEIYS 381

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 51/97 (52%), Gaps = 8/97 (8%)
Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI 216
           A EI   + ++H   +R +V+R +K +N+LLDE+   ++ D  L+    + + H      
Sbjct: 297 AAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---- 349
Query: 217 KGAYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTG 252
            G +G++APE      +++   D +S G  L +LL G
Sbjct: 350 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 386

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 51/97 (52%), Gaps = 8/97 (8%)
Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI 216
           A EI   + ++H   +R +V+R +K +N+LLDE+   ++ D  L+    + + H      
Sbjct: 298 AAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---- 350
Query: 217 KGAYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTG 252
            G +G++APE      +++   D +S G  L +LL G
Sbjct: 351 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 51/97 (52%), Gaps = 8/97 (8%)
Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI 216
           A EI   + ++H   +R +V+R +K +N+LLDE+   ++ D  L+    + + H      
Sbjct: 298 AAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---- 350
Query: 217 KGAYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTG 252
            G +G++APE      +++   D +S G  L +LL G
Sbjct: 351 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 51/97 (52%), Gaps = 8/97 (8%)
Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI 216
           A EI   + ++H   +R +V+R +K +N+LLDE+   ++ D  L+    + + H      
Sbjct: 298 AAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---- 350
Query: 217 KGAYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTG 252
            G +G++APE      +++   D +S G  L +LL G
Sbjct: 351 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 67/158 (42%), Gaps = 15/158 (9%)
Query: 104 IVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF--SFASLLIAPRIKIAM--- 158
           I     +KHKNI++ +G   E     +  E V  G+L     S    L      I     
Sbjct: 56  IALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTK 115
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSA--KLHDFSLSVSIPEGETHVREEFI 216
           +I   + YLH   D  IV R IK  NVL++  YS   K+ DF  S  +  G     E F 
Sbjct: 116 QILEGLKYLH---DNQIVHRDIKGDNVLIN-TYSGVLKISDFGTSKRL-AGINPCTETFT 170
Query: 217 KGAYGFIAPEYF--ATSSFNEMCDVYSFGAFLCELLTG 252
            G   ++APE        + +  D++S G  + E+ TG
Sbjct: 171 -GTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATG 207

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 32/117 (27%), Positives = 56/117 (47%), Gaps = 7/117 (5%)
Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSL-SVSIPEGETHVREEF 215
           + EI+ A+ YLH   +R I++R +K  NVLLD     KL D+ +    +  G+T      
Sbjct: 159 SAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TST 212
Query: 216 IKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEY 272
             G   +IAPE      +    D ++ G  + E++ G +  +  G+ ++ D    +Y
Sbjct: 213 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDY 269

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 70/151 (46%), Gaps = 18/151 (11%)
Query: 110 MKHKNILKLIGCCLETELPTLVFESVKYGTL-----RGFSFASLLIAPRIKIAMEIANAV 164
           + H NI+KL     +     LV E  K G L         F  +  A  IK   ++ + V
Sbjct: 93  LDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIK---QVLSGV 149
Query: 165 AYLHVGFDRPIVFRCIKASNVLLD---ENYSAKLHDFSLSVSIPEGETHVREEFIKGAYG 221
            YLH      IV R +K  N+LL+   ++   K+ DF LS ++ E +  ++E    G   
Sbjct: 150 TYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLS-AVFENQKKMKERL--GTAY 203
Query: 222 FIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
           +IAPE      ++E CDV+S G  L  LL G
Sbjct: 204 YIAPEVL-RKKYDEKCDVWSIGVILFILLAG 233

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/228 (20%), Positives = 90/228 (39%), Gaps = 34/228 (14%)
Query: 55  NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMK-----FHDNSTLDDVEYCFNNIVFSSQ 109
           NN    K + +    ++ E T     +  +V+K         +  D+ E   + +   S 
Sbjct: 31  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 90
Query: 110 M-KHKNILKLIGCCLETELPTLVFESVKYGTLRGF--SFASLLIAPRI------------ 154
           + +H+NI+ L+G C       ++ E   YG L  F    A  ++ P +            
Sbjct: 91  LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKE 150
Query: 155 -----------KIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVS 203
                        + ++A  +A+L     +  + R + A NVLL   + AK+ DF L+  
Sbjct: 151 DGRPLELRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARD 207
Query: 204 IPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT 251
           I     ++ +   +    ++APE      +    DV+S+G  L E+ +
Sbjct: 208 IMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 255

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 42/201 (20%), Positives = 90/201 (44%), Gaps = 17/201 (8%)
Query: 61  KVIQSDTSYRLFEGTLVDQDR----PISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNIL 116
           KV+ S     +++G  + +      P+++M+  + ++    +   +     + + + ++ 
Sbjct: 55  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVC 114
Query: 117 KLIGCCLETELPTLVFESVKYGTLRGF------SFASLLIAPRIKIAMEIANAVAYLHVG 170
           +L+G CL + +  L+ + + +G L  +      +  S  +   +   ++IA  + YL   
Sbjct: 115 RLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIGSQYL---LNWCVQIAKGMNYLE-- 168
Query: 171 FDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFAT 230
            DR +V R + A NVL+      K+ DF L+  +   E     E  K    ++A E    
Sbjct: 169 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 227
Query: 231 SSFNEMCDVYSFGAFLCELLT 251
             +    DV+S+G  + EL+T
Sbjct: 228 RIYTHQSDVWSYGVTVWELMT 248

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 51/110 (46%), Gaps = 9/110 (8%)
Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI 216
           A EI+  + +LH    R I++R +K  NV+LD     K+ DF +           RE   
Sbjct: 126 AAEISIGLFFLH---KRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTRE--F 180
Query: 217 KGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDD 266
            G   +IAPE  A   + +  D +++G  L E+L G        +G D+D
Sbjct: 181 CGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPF----DGEDED 226

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 69/161 (42%), Gaps = 20/161 (12%)
Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF-----SFASLL-----IAPR---- 153
           + ++H++I++  G C E     +VFE +++G L  F       A LL     +AP     
Sbjct: 75  TMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGL 134
Query: 154 ---IKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH 210
              + +A ++A  + YL  G     V R +   N L+ +    K+ DF +S  I   + +
Sbjct: 135 GQLLAVASQVAAGMVYL-AGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYY 191
Query: 211 VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT 251
                      ++ PE      F    DV+SFG  L E+ T
Sbjct: 192 RVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 232

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 36/135 (26%), Positives = 60/135 (44%), Gaps = 14/135 (10%)
Query: 126 ELPTLVFESVKYGTLRGF-----SFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCI 180
           +LP L  E  + G LR +     +   L   P   +  +I++A+ YLH   +  I+ R +
Sbjct: 92  DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDL 148
Query: 181 KASNVLLDENYSAKLH---DFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMC 237
           K  N++L       +H   D   +  + +GE     EF+ G   ++APE      +    
Sbjct: 149 KPENIVLQPGPQRLIHKIIDLGYAKELDQGELCT--EFV-GTLQYLAPELLEQKKYTVTV 205
Query: 238 DVYSFGAFLCELLTG 252
           D +SFG    E +TG
Sbjct: 206 DYWSFGTLAFECITG 220

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 90/205 (43%), Gaps = 22/205 (10%)
Query: 96  DVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRI- 154
           D       +    ++ H NI+KL     ++    +V E    G L    F  ++   R  
Sbjct: 64  DTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRKRFS 119
Query: 155 -----KIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLD---ENYSAKLHDFSLSVSIPE 206
                +I  ++ + + Y+H      IV R +K  N+LL+   ++   K+ DF LS    +
Sbjct: 120 EHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176
Query: 207 GETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDD 266
             T +++  I  AY +IAPE     +++E CDV+S G  L  LL+G     F G    D 
Sbjct: 177 N-TKMKDR-IGTAY-YIAPEVLR-GTYDEKCDVWSAGVILYILLSGTP--PFYGKNEYDI 230
Query: 267 LTVLEYAKKSIENNRFGAIVDPIFD 291
           L  +E  K + +  ++  I D   D
Sbjct: 231 LKRVETGKYAFDLPQWRTISDDAKD 255

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 36/135 (26%), Positives = 60/135 (44%), Gaps = 14/135 (10%)
Query: 126 ELPTLVFESVKYGTLRGF-----SFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCI 180
           +LP L  E  + G LR +     +   L   P   +  +I++A+ YLH   +  I+ R +
Sbjct: 91  DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDL 147
Query: 181 KASNVLLDENYSAKLH---DFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMC 237
           K  N++L       +H   D   +  + +GE     EF+ G   ++APE      +    
Sbjct: 148 KPENIVLQPGPQRLIHKIIDLGYAKELDQGELCT--EFV-GTLQYLAPELLEQKKYTVTV 204
Query: 238 DVYSFGAFLCELLTG 252
           D +SFG    E +TG
Sbjct: 205 DYWSFGTLAFECITG 219

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 69/161 (42%), Gaps = 20/161 (12%)
Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF-----SFASLL-----IAPR---- 153
           + ++H++I++  G C E     +VFE +++G L  F       A LL     +AP     
Sbjct: 69  TMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGL 128
Query: 154 ---IKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH 210
              + +A ++A  + YL  G     V R +   N L+ +    K+ DF +S  I   + +
Sbjct: 129 GQLLAVASQVAAGMVYL-AGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYY 185
Query: 211 VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT 251
                      ++ PE      F    DV+SFG  L E+ T
Sbjct: 186 RVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 226

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 69/161 (42%), Gaps = 20/161 (12%)
Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF-----SFASLL-----IAPR---- 153
           + ++H++I++  G C E     +VFE +++G L  F       A LL     +AP     
Sbjct: 98  TMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGL 157
Query: 154 ---IKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH 210
              + +A ++A  + YL  G     V R +   N L+ +    K+ DF +S  I   + +
Sbjct: 158 GQLLAVASQVAAGMVYL-AGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYY 214
Query: 211 VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT 251
                      ++ PE      F    DV+SFG  L E+ T
Sbjct: 215 RVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 56/240 (23%), Positives = 86/240 (35%), Gaps = 46/240 (19%)
Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANAV 164
            Q  H N++ L G     +   +V E ++ G L  F         +   + +   IA  +
Sbjct: 99  GQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGM 158
Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSI---PE-------GETHVREE 214
            YL    D   V R + A N+L++ N   K+ DF LS  I   PE       G+  VR  
Sbjct: 159 RYLA---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVR-- 213
Query: 215 FIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAK 274
                  + APE      F    DV+S+G  + E                    V+ Y +
Sbjct: 214 -------WTAPEAIQYRKFTSASDVWSYGIVMWE--------------------VMSYGE 246
Query: 275 KSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQM 334
           +   +     ++  I +E    P   +    L QLM  C  K    RP    +   L +M
Sbjct: 247 RPYWDMSNQDVIKAI-EEGYRLPAPMDCPAGLHQLMLDCWQKERAERPKFEQIVGILDKM 305

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 35/111 (31%), Positives = 54/111 (48%), Gaps = 11/111 (9%)
Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSL-SVSIPEGETHVREEF 215
           A EIA  + +L     + I++R +K  NV+LD     K+ DF +   +I +G   V  + 
Sbjct: 127 AAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG---VTTKX 180
Query: 216 IKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDD 266
             G   +IAPE  A   + +  D ++FG  L E+L G    E    G D+D
Sbjct: 181 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE----GEDED 227

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 83/203 (40%), Gaps = 11/203 (5%)
Query: 100 CFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAP-RIKIAM 158
               I    ++ H NI+ L+         +LVF+ ++          SL++ P  IK  M
Sbjct: 59  ALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYM 118
Query: 159 EIA-NAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIK 217
            +    + YLH  +   I+ R +K +N+LLDEN   KL DF L+ S          + + 
Sbjct: 119 LMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVT 175
Query: 218 GAYGFIAPE-YFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLT-VLEYAKK 275
             Y   APE  F    +    D+++ G  L ELL     L   G+ + D LT + E    
Sbjct: 176 RWYR--APELLFGARMYGVGVDMWAVGCILAELLLRVPFLP--GDSDLDQLTRIFETLGT 231
Query: 276 SIENNRFGAIVDPIFDEDNSFPG 298
             E         P +    SFPG
Sbjct: 232 PTEEQWPDMCSLPDYVTFKSFPG 254

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 90/213 (42%), Gaps = 30/213 (14%)
Query: 61  KVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNI-VFSSQMKHKNILKLI 119
           KV+++ T+Y L +    D    ++V     ++ L + E   + + V S    H NI+ L+
Sbjct: 54  KVVEA-TAYGLIKS---DAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLL 109
Query: 120 GCCLETELPTLVF-ESVKYGTLRGF------SFASLLIAPRI--------------KIAM 158
           G C     PTLV  E   YG L  F      SF     +P I                + 
Sbjct: 110 GAC-TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSY 168
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           ++A  +A+L     +  + R + A N+LL      K+ DF L+  I     +V +   + 
Sbjct: 169 QVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL 225
Query: 219 AYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT 251
              ++APE      +    DV+S+G FL EL +
Sbjct: 226 PVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 258

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 90/213 (42%), Gaps = 30/213 (14%)
Query: 61  KVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNI-VFSSQMKHKNILKLI 119
           KV+++ T+Y L +    D    ++V     ++ L + E   + + V S    H NI+ L+
Sbjct: 56  KVVEA-TAYGLIKS---DAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLL 111
Query: 120 GCCLETELPTLVF-ESVKYGTLRGF------SFASLLIAPRI--------------KIAM 158
           G C     PTLV  E   YG L  F      SF     +P I                + 
Sbjct: 112 GAC-TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSY 170
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           ++A  +A+L     +  + R + A N+LL      K+ DF L+  I     +V +   + 
Sbjct: 171 QVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL 227
Query: 219 AYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT 251
              ++APE      +    DV+S+G FL EL +
Sbjct: 228 PVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 260

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 48/95 (50%), Gaps = 7/95 (7%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSL-SVSIPEGETHVREEFIK 217
           EI +A+ YLH    R +V+R IK  N++LD++   K+ DF L    I +G T    +   
Sbjct: 118 EIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM---KXFC 171
Query: 218 GAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
           G   ++APE    + +    D +  G  + E++ G
Sbjct: 172 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 206

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/111 (31%), Positives = 54/111 (48%), Gaps = 11/111 (9%)
Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSL-SVSIPEGETHVREEF 215
           A EIA  + +L     + I++R +K  NV+LD     K+ DF +   +I +G   V  + 
Sbjct: 448 AAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG---VTTKX 501
Query: 216 IKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDD 266
             G   +IAPE  A   + +  D ++FG  L E+L G    E    G D+D
Sbjct: 502 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE----GEDED 548

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 90/213 (42%), Gaps = 30/213 (14%)
Query: 61  KVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNI-VFSSQMKHKNILKLI 119
           KV+++ T+Y L +    D    ++V     ++ L + E   + + V S    H NI+ L+
Sbjct: 38  KVVEA-TAYGLIKS---DAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLL 93
Query: 120 GCCLETELPTLVF-ESVKYGTLRGF------SFASLLIAPRI--------------KIAM 158
           G C     PTLV  E   YG L  F      SF     +P I                + 
Sbjct: 94  GAC-TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSY 152
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           ++A  +A+L     +  + R + A N+LL      K+ DF L+  I     +V +   + 
Sbjct: 153 QVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL 209
Query: 219 AYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT 251
              ++APE      +    DV+S+G FL EL +
Sbjct: 210 PVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 48/95 (50%), Gaps = 7/95 (7%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSL-SVSIPEGETHVREEFIK 217
           EI +A+ YLH    R +V+R IK  N++LD++   K+ DF L    I +G T    +   
Sbjct: 113 EIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM---KXFC 166
Query: 218 GAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
           G   ++APE    + +    D +  G  + E++ G
Sbjct: 167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 201

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 67/165 (40%), Gaps = 25/165 (15%)
Query: 98  EYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIKIA 157
           E C N +     + H+N++K  G   E  +  L  E    G L  F      I P I + 
Sbjct: 54  EICINKM-----LNHENVVKFYGHRREGNIQYLFLEYCSGGEL--FD----RIEPDIGMP 102
Query: 158 --------MEIANAVAYLH-VGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE 208
                    ++   V YLH +G    I  R IK  N+LLDE  + K+ DF L+       
Sbjct: 103 EPDAQRFFHQLMAGVVYLHGIG----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 158
Query: 209 THVREEFIKGAYGFIAPEYFATSSFN-EMCDVYSFGAFLCELLTG 252
                  + G   ++APE      F+ E  DV+S G  L  +L G
Sbjct: 159 RERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/239 (24%), Positives = 102/239 (42%), Gaps = 32/239 (13%)
Query: 40  NPIRAFSAKDL---KKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDD 96
           +P R+    DL   +     ++L +++ + T  ++++G  V   + ++ +K  D  T D+
Sbjct: 6   SPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQ-LAAIKVMD-VTGDE 63
Query: 97  VEYCFNNI-VFSSQMKHKNILKLIGCCLETELP------TLVFESVKYGTL-------RG 142
            E     I +      H+NI    G  ++   P       LV E    G++       +G
Sbjct: 64  EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG 123
Query: 143 FSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSV 202
            +     IA    I  EI   +++LH      ++ R IK  NVLL EN   KL DF +S 
Sbjct: 124 NTLKEEWIA---YICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 177
Query: 203 SIPEGETHVREEFIKGAYGFIAPEYFA-----TSSFNEMCDVYSFGAFLCELLTGCNVL 256
            + +     R  FI   Y ++APE  A      ++++   D++S G    E+  G   L
Sbjct: 178 QL-DRTVGRRNTFIGTPY-WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 234

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 48/95 (50%), Gaps = 7/95 (7%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSL-SVSIPEGETHVREEFIK 217
           EI +A+ YLH    R +V+R IK  N++LD++   K+ DF L    I +G T    +   
Sbjct: 113 EIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM---KXFC 166
Query: 218 GAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
           G   ++APE    + +    D +  G  + E++ G
Sbjct: 167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 201

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 48/95 (50%), Gaps = 7/95 (7%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSL-SVSIPEGETHVREEFIK 217
           EI +A+ YLH    R +V+R IK  N++LD++   K+ DF L    I +G T    +   
Sbjct: 113 EIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM---KXFC 166
Query: 218 GAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
           G   ++APE    + +    D +  G  + E++ G
Sbjct: 167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 201

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/105 (32%), Positives = 48/105 (45%), Gaps = 6/105 (5%)
Query: 149 LIAPRIKI-AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEG 207
            + PR +  A EIA+A+ YLH      IV+R +K  N+LLD      L DF L     E 
Sbjct: 136 FLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192
Query: 208 ETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
            +        G   ++APE      ++   D +  GA L E+L G
Sbjct: 193 NSTTST--FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 235

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/263 (20%), Positives = 114/263 (43%), Gaps = 44/263 (16%)
Query: 85  VMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF- 143
           ++K  D +  +  E  F      S++ HK+++   G C+  +   LV E VK+G+L  + 
Sbjct: 44  LLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL 103
Query: 144 --SFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLL--DENYSA------ 193
             +   + I  ++++A ++A A+ +L    +  ++   + A N+LL  +E+         
Sbjct: 104 KKNKNCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFI 160
Query: 194 KLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFAT-SSFNEMCDVYSFGAFLCELLTG 252
           KL D  +S+++      + ++ ++    ++ PE      + N   D +SFG  L E+ + 
Sbjct: 161 KLSDPGISITV------LPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS- 213
Query: 253 CNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYK 312
                    G D  L+ L+  +K              +++ +  P    K   L  L+  
Sbjct: 214 ---------GGDKPLSALDSQRKL-----------QFYEDRHQLPAP--KAAELANLINN 251
Query: 313 CLSKSPEHRPLMVDVAKQLRQMY 335
           C+   P+HRP    + + L  ++
Sbjct: 252 CMDYEPDHRPSFRAIIRDLNSLF 274

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 65/159 (40%), Gaps = 20/159 (12%)
Query: 104 IVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIKIA------ 157
           I  +  + H+N++K  G   E  +  L  E    G L  F      I P I +       
Sbjct: 56  IXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL--FD----RIEPDIGMPEPDAQR 109
Query: 158 --MEIANAVAYLH-VGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREE 214
              ++   V YLH +G    I  R IK  N+LLDE  + K+ DF L+             
Sbjct: 110 FFHQLMAGVVYLHGIG----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 165
Query: 215 FIKGAYGFIAPEYFATSSFN-EMCDVYSFGAFLCELLTG 252
            + G   ++APE      F+ E  DV+S G  L  +L G
Sbjct: 166 KMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 65/159 (40%), Gaps = 20/159 (12%)
Query: 104 IVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIKIA------ 157
           I  +  + H+N++K  G   E  +  L  E    G L  F      I P I +       
Sbjct: 55  IXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL--FD----RIEPDIGMPEPDAQR 108
Query: 158 --MEIANAVAYLH-VGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREE 214
              ++   V YLH +G    I  R IK  N+LLDE  + K+ DF L+             
Sbjct: 109 FFHQLMAGVVYLHGIG----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 164
Query: 215 FIKGAYGFIAPEYFATSSFN-EMCDVYSFGAFLCELLTG 252
            + G   ++APE      F+ E  DV+S G  L  +L G
Sbjct: 165 KMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 90/213 (42%), Gaps = 30/213 (14%)
Query: 61  KVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNI-VFSSQMKHKNILKLI 119
           KV+++ T+Y L +    D    ++V     ++ L + E   + + V S    H NI+ L+
Sbjct: 61  KVVEA-TAYGLIKS---DAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLL 116
Query: 120 GCCLETELPTLVF-ESVKYGTLRGF------SFASLLIAPRI--------------KIAM 158
           G C     PTLV  E   YG L  F      SF     +P I                + 
Sbjct: 117 GAC-TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSY 175
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           ++A  +A+L     +  + R + A N+LL      K+ DF L+  I     +V +   + 
Sbjct: 176 QVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL 232
Query: 219 AYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT 251
              ++APE      +    DV+S+G FL EL +
Sbjct: 233 PVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 67/165 (40%), Gaps = 25/165 (15%)
Query: 98  EYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIKIA 157
           E C N +     + H+N++K  G   E  +  L  E    G L  F      I P I + 
Sbjct: 54  EICINKM-----LNHENVVKFYGHRREGNIQYLFLEYCSGGEL--FD----RIEPDIGMP 102
Query: 158 --------MEIANAVAYLH-VGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE 208
                    ++   V YLH +G    I  R IK  N+LLDE  + K+ DF L+       
Sbjct: 103 EPDAQRFFHQLMAGVVYLHGIG----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 158
Query: 209 THVREEFIKGAYGFIAPEYFATSSFN-EMCDVYSFGAFLCELLTG 252
                  + G   ++APE      F+ E  DV+S G  L  +L G
Sbjct: 159 RERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/169 (24%), Positives = 68/169 (40%), Gaps = 35/169 (20%)
Query: 154 IKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVRE 213
           I  + +IA  +A++     R  + R ++A+N+L+  +   K+ DF L+         V  
Sbjct: 281 IDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLA--------RVGA 329
Query: 214 EFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYA 273
           +F      + APE     SF    DV+SFG  L E++T   +  + G  N + +  LE  
Sbjct: 330 KF---PIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRI-PYPGMSNPEVIRALERG 385
Query: 274 KKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
            +                     P  E   + L  +M +C    PE RP
Sbjct: 386 YR--------------------MPRPENCPEELYNIMMRCWKNRPEERP 414

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 48/95 (50%), Gaps = 7/95 (7%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSL-SVSIPEGETHVREEFIK 217
           EI +A+ YLH    R +V+R IK  N++LD++   K+ DF L    I +G T    +   
Sbjct: 113 EIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM---KTFC 166
Query: 218 GAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
           G   ++APE    + +    D +  G  + E++ G
Sbjct: 167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 201

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 69/162 (42%), Gaps = 26/162 (16%)
Query: 104 IVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIKIA------ 157
           I  ++ + H+N++K  G   E  +  L  E    G L  F      I P I +       
Sbjct: 56  ICINAMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL--FD----RIEPDIGMPEPDAQR 109
Query: 158 --MEIANAVAYLH-VGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREE 214
              ++   V YLH +G    I  R IK  N+LLDE  + K+ DF L+        + RE 
Sbjct: 110 FFHQLMAGVVYLHGIG----ITHRDIKPENLLLDERDNLKISDFGLATVF---RYNNRER 162
Query: 215 FIK---GAYGFIAPEYFATSSFN-EMCDVYSFGAFLCELLTG 252
            +    G   ++APE      F+ E  DV+S G  L  +L G
Sbjct: 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 68/153 (44%), Gaps = 19/153 (12%)
Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLI------APRIKIAMEIAN 162
           +++H NI++L     E     LVF+ V  G L    F  ++       A       +I  
Sbjct: 84  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADASHCIQQILE 139
Query: 163 AVAYLHVGFDRPIVFRCIKASNVLLD---ENYSAKLHDFSLSVSIPEGETHVREEFIKGA 219
           ++AY H      IV R +K  N+LL    +  + KL DF L++ + + E         G 
Sbjct: 140 SIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW---HGFAGT 193
Query: 220 YGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
            G+++PE      +++  D+++ G  L  LL G
Sbjct: 194 PGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 65/252 (25%), Positives = 113/252 (44%), Gaps = 37/252 (14%)
Query: 110 MKHKNILKLI-----GCCLETELPTLVFESVKYGTLRGFSFASLLIAPR-IKIAMEIANA 163
           M+H+NIL  I     G    T+L  L+ +  + G+L  +  ++ L A   +K+A    + 
Sbjct: 88  MRHENILGFIAADIKGTGSWTQL-YLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSG 146
Query: 164 VAYLHVGF----DRP-IVFRCIKASNVLLDENYSAKLHDFSLSVSI--PEGETHVREEFI 216
           + +LH        +P I  R +K+ N+L+ +N +  + D  L+V       E  +     
Sbjct: 147 LCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTR 206
Query: 217 KGAYGFIAPEYFATSSFNE-------MCDVYSFGAFLCEL----LTGCNVLEFKGNGNDD 265
            G   ++ PE     S N        M D+YSFG  L E+    ++G  V E++   +D 
Sbjct: 207 VGTKRYMPPEVL-DESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD- 264
Query: 266 DLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGK---EEKLQSLGQLMYKCLSKSPEHRP 322
               L  +  S E+ R    +  +     SFP +   +E L+ +G+LM +C + +P  R 
Sbjct: 265 ----LVPSDPSYEDMREIVCIKKL---RPSFPNRWSSDECLRQMGKLMTECWAHNPASRL 317
Query: 323 LMVDVAKQLRQM 334
             + V K L +M
Sbjct: 318 TALRVKKTLAKM 329

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 70/168 (41%), Gaps = 31/168 (18%)
Query: 98  EYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIKIA 157
           E C N +     + H+N++K  G   E  +  L  E    G L  F      I P I + 
Sbjct: 54  EICINKM-----LNHENVVKFYGHRREGNIQYLFLEYCSGGEL--FD----RIEPDIGMP 102
Query: 158 --------MEIANAVAYLH-VGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE 208
                    ++   V YLH +G    I  R IK  N+LLDE  + K+ DF L+       
Sbjct: 103 EPDAQRFFHQLMAGVVYLHGIG----ITHRDIKPENLLLDERDNLKISDFGLATVF---R 155
Query: 209 THVREEFIK---GAYGFIAPEYFATSSFN-EMCDVYSFGAFLCELLTG 252
            + RE  +    G   ++APE      F+ E  DV+S G  L  +L G
Sbjct: 156 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 90/213 (42%), Gaps = 30/213 (14%)
Query: 61  KVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNI-VFSSQMKHKNILKLI 119
           KV+++ T+Y L +    D    ++V     ++ L + E   + + V S    H NI+ L+
Sbjct: 61  KVVEA-TAYGLIKS---DAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLL 116
Query: 120 GCCLETELPTLVF-ESVKYGTLRGF------SFASLLIAPRI--------------KIAM 158
           G C     PTLV  E   YG L  F      SF     +P I                + 
Sbjct: 117 GAC-TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSY 175
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           ++A  +A+L     +  + R + A N+LL      K+ DF L+  I     +V +   + 
Sbjct: 176 QVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNARL 232
Query: 219 AYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT 251
              ++APE      +    DV+S+G FL EL +
Sbjct: 233 PVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 70/168 (41%), Gaps = 31/168 (18%)
Query: 98  EYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIKIA 157
           E C N +     + H+N++K  G   E  +  L  E    G L  F      I P I + 
Sbjct: 55  EICINKM-----LNHENVVKFYGHRREGNIQYLFLEYCSGGEL--FD----RIEPDIGMP 103
Query: 158 --------MEIANAVAYLH-VGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE 208
                    ++   V YLH +G    I  R IK  N+LLDE  + K+ DF L+       
Sbjct: 104 EPDAQRFFHQLMAGVVYLHGIG----ITHRDIKPENLLLDERDNLKISDFGLATVF---R 156
Query: 209 THVREEFIK---GAYGFIAPEYFATSSFN-EMCDVYSFGAFLCELLTG 252
            + RE  +    G   ++APE      F+ E  DV+S G  L  +L G
Sbjct: 157 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 87/201 (43%), Gaps = 22/201 (10%)
Query: 96  DVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRI- 154
           D       +    ++ H NI+KL     ++    +V E    G L    F  ++   R  
Sbjct: 64  DTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRKRFS 119
Query: 155 -----KIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLD---ENYSAKLHDFSLSVSIPE 206
                +I  ++ + + Y+H      IV R +K  N+LL+   ++   K+ DF LS    +
Sbjct: 120 EHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176
Query: 207 GETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDD 266
             T +++    G   +IAPE     +++E CDV+S G  L  LL+G     F G    D 
Sbjct: 177 N-TKMKDRI--GTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTP--PFYGKNEYDI 230
Query: 267 LTVLEYAKKSIENNRFGAIVD 287
           L  +E  K + +  ++  I D
Sbjct: 231 LKRVETGKYAFDLPQWRTISD 251

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 68/165 (41%), Gaps = 20/165 (12%)
Query: 97  VEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIK- 155
           V+   N +    Q+KH +IL+L     ++    LV E    G +  +      +  R+K 
Sbjct: 55  VQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRY------LKNRVKP 108
Query: 156 --------IAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEG 207
                      +I   + YLH      I+ R +  SN+LL  N + K+ DF L+  +   
Sbjct: 109 FSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLK-- 163
Query: 208 ETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
             H +   + G   +I+PE    S+     DV+S G     LL G
Sbjct: 164 MPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIG 208

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 87/201 (43%), Gaps = 22/201 (10%)
Query: 96  DVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRI- 154
           D       +    ++ H NI+KL     ++    +V E    G L    F  ++   R  
Sbjct: 64  DTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRKRFS 119
Query: 155 -----KIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLD---ENYSAKLHDFSLSVSIPE 206
                +I  ++ + + Y+H      IV R +K  N+LL+   ++   K+ DF LS    +
Sbjct: 120 EHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176
Query: 207 GETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDD 266
             T +++    G   +IAPE     +++E CDV+S G  L  LL+G     F G    D 
Sbjct: 177 N-TKMKDRI--GTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTP--PFYGKNEYDI 230
Query: 267 LTVLEYAKKSIENNRFGAIVD 287
           L  +E  K + +  ++  I D
Sbjct: 231 LKRVETGKYAFDLPQWRTISD 251

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 48/95 (50%), Gaps = 7/95 (7%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSL-SVSIPEGETHVREEFIK 217
           EI +A+ YLH    R +V+R IK  N++LD++   K+ DF L    I +G T    +   
Sbjct: 113 EIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM---KTFC 166
Query: 218 GAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
           G   ++APE    + +    D +  G  + E++ G
Sbjct: 167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 201

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/201 (20%), Positives = 89/201 (44%), Gaps = 17/201 (8%)
Query: 61  KVIQSDTSYRLFEGTLVDQDR----PISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNIL 116
           KV+ S     +++G  + +      P+++ +  + ++    +   +     + + + ++ 
Sbjct: 28  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 117 KLIGCCLETELPTLVFESVKYGTLRGF------SFASLLIAPRIKIAMEIANAVAYLHVG 170
           +L+G CL + +  L+ + + +G L  +      +  S  +   +   ++IA  + YL   
Sbjct: 88  RLLGICLTSTV-QLIMQLMPFGCLLDYVREHKDNIGSQYL---LNWCVQIAKGMNYLE-- 141
Query: 171 FDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFAT 230
            DR +V R + A NVL+      K+ DF L+  +   E     E  K    ++A E    
Sbjct: 142 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 200
Query: 231 SSFNEMCDVYSFGAFLCELLT 251
             +    DV+S+G  + EL+T
Sbjct: 201 RIYTHQSDVWSYGVTVWELMT 221

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 68/162 (41%), Gaps = 26/162 (16%)
Query: 104 IVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIKIA------ 157
           I  +  + H+N++K  G   E  +  L  E    G L  F      I P I +       
Sbjct: 55  IXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL--FD----RIEPDIGMPEPDAQR 108
Query: 158 --MEIANAVAYLH-VGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREE 214
              ++   V YLH +G    I  R IK  N+LLDE  + K+ DF L+        + RE 
Sbjct: 109 FFHQLMAGVVYLHGIG----ITHRDIKPENLLLDERDNLKISDFGLATVF---RYNNRER 161
Query: 215 FIK---GAYGFIAPEYFATSSFN-EMCDVYSFGAFLCELLTG 252
            +    G   ++APE      F+ E  DV+S G  L  +L G
Sbjct: 162 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 57/107 (53%), Gaps = 14/107 (13%)
Query: 156 IAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEF 215
           I   + N+ +Y+H   ++ I  R +K SN+L+D+N   KL DF       E E  V ++ 
Sbjct: 156 IIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFG------ESEYMVDKKI 207
Query: 216 --IKGAYGFIAPEYFAT-SSFN-EMCDVYSFGAFLCELLTGCNVLEF 258
              +G Y F+ PE+F+  SS+N    D++S G  +C  +   NV+ F
Sbjct: 208 KGSRGTYEFMPPEFFSNESSYNGAKVDIWSLG--ICLYVMFYNVVPF 252

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 67/165 (40%), Gaps = 25/165 (15%)
Query: 98  EYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIKIA 157
           E C N +     + H+N++K  G   E  +  L  E    G L    F    I P I + 
Sbjct: 54  EICINKM-----LNHENVVKFYGHRREGNIQYLFLEYCSGGEL----FDR--IEPDIGMP 102
Query: 158 --------MEIANAVAYLH-VGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE 208
                    ++   V YLH +G    I  R IK  N+LLDE  + K+ DF L+       
Sbjct: 103 EPDAQRFFHQLMAGVVYLHGIG----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 158
Query: 209 THVREEFIKGAYGFIAPEYFATSSFN-EMCDVYSFGAFLCELLTG 252
                  + G   ++APE      F+ E  DV+S G  L  +L G
Sbjct: 159 RERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 48/95 (50%), Gaps = 7/95 (7%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSL-SVSIPEGETHVREEFIK 217
           EI +A+ YLH    R +V+R IK  N++LD++   K+ DF L    I +G T    +   
Sbjct: 116 EIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM---KTFC 169
Query: 218 GAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
           G   ++APE    + +    D +  G  + E++ G
Sbjct: 170 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 204

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/175 (23%), Positives = 71/175 (40%), Gaps = 23/175 (13%)
Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI 216
           + ++A  + +L     R  + R + A N+LL E    K+ DF L+  I +   +VR+   
Sbjct: 199 SFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 255
Query: 217 KGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKS 276
           +    ++APE      +    DV+SFG  L E+ +      + G   D+     E+ ++ 
Sbjct: 256 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-LGASPYPGVKIDE-----EFCRRL 309
Query: 277 IENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQL 331
            E  R  A        D + P        + Q M  C    P  RP   ++ + L
Sbjct: 310 KEGTRMRA-------PDYTTP-------EMYQTMLDCWHGEPSQRPTFSELVEHL 350

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 68/162 (41%), Gaps = 26/162 (16%)
Query: 104 IVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIKIA------ 157
           I  +  + H+N++K  G   E  +  L  E    G L  F      I P I +       
Sbjct: 54  ICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL--FD----RIEPDIGMPEPDAQR 107
Query: 158 --MEIANAVAYLH-VGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREE 214
              ++   V YLH +G    I  R IK  N+LLDE  + K+ DF L+        + RE 
Sbjct: 108 FFHQLMAGVVYLHGIG----ITHRDIKPENLLLDERDNLKISDFGLATVF---RYNNRER 160
Query: 215 FIK---GAYGFIAPEYFATSSFN-EMCDVYSFGAFLCELLTG 252
            +    G   ++APE      F+ E  DV+S G  L  +L G
Sbjct: 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 202

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/175 (23%), Positives = 71/175 (40%), Gaps = 23/175 (13%)
Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI 216
           + ++A  + +L     R  + R + A N+LL E    K+ DF L+  I +   +VR+   
Sbjct: 204 SFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 260
Query: 217 KGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKS 276
           +    ++APE      +    DV+SFG  L E+ +      + G   D+     E+ ++ 
Sbjct: 261 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-LGASPYPGVKIDE-----EFCRRL 314
Query: 277 IENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQL 331
            E  R  A        D + P        + Q M  C    P  RP   ++ + L
Sbjct: 315 KEGTRMRA-------PDYTTP-------EMYQTMLDCWHGEPSQRPTFSELVEHL 355

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 70/168 (41%), Gaps = 31/168 (18%)
Query: 98  EYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIKIA 157
           E C N +     + H+N++K  G   E  +  L  E    G L  F      I P I + 
Sbjct: 55  EICINKM-----LNHENVVKFYGHRREGNIQYLFLEYCSGGEL--FD----RIEPDIGMP 103
Query: 158 --------MEIANAVAYLH-VGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE 208
                    ++   V YLH +G    I  R IK  N+LLDE  + K+ DF L+       
Sbjct: 104 EPDAQRFFHQLMAGVVYLHGIG----ITHRDIKPENLLLDERDNLKISDFGLATVF---R 156
Query: 209 THVREEFIK---GAYGFIAPEYFATSSFN-EMCDVYSFGAFLCELLTG 252
            + RE  +    G   ++APE      F+ E  DV+S G  L  +L G
Sbjct: 157 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 70/168 (41%), Gaps = 31/168 (18%)
Query: 98  EYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIKIA 157
           E C N +     + H+N++K  G   E  +  L  E    G L  F      I P I + 
Sbjct: 55  EICINKM-----LNHENVVKFYGHRREGNIQYLFLEYCSGGEL--FD----RIEPDIGMP 103
Query: 158 --------MEIANAVAYLH-VGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE 208
                    ++   V YLH +G    I  R IK  N+LLDE  + K+ DF L+       
Sbjct: 104 EPDAQRFFHQLMAGVVYLHGIG----ITHRDIKPENLLLDERDNLKISDFGLATVF---R 156
Query: 209 THVREEFIK---GAYGFIAPEYFATSSFN-EMCDVYSFGAFLCELLTG 252
            + RE  +    G   ++APE      F+ E  DV+S G  L  +L G
Sbjct: 157 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 70/168 (41%), Gaps = 31/168 (18%)
Query: 98  EYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIKIA 157
           E C N +     + H+N++K  G   E  +  L  E    G L  F      I P I + 
Sbjct: 55  EICINKM-----LNHENVVKFYGHRREGNIQYLFLEYCSGGEL--FD----RIEPDIGMP 103
Query: 158 --------MEIANAVAYLH-VGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE 208
                    ++   V YLH +G    I  R IK  N+LLDE  + K+ DF L+       
Sbjct: 104 EPDAQRFFHQLMAGVVYLHGIG----ITHRDIKPENLLLDERDNLKISDFGLATVF---R 156
Query: 209 THVREEFIK---GAYGFIAPEYFATSSFN-EMCDVYSFGAFLCELLTG 252
            + RE  +    G   ++APE      F+ E  DV+S G  L  +L G
Sbjct: 157 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/175 (23%), Positives = 71/175 (40%), Gaps = 23/175 (13%)
Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI 216
           + ++A  + +L     R  + R + A N+LL E    K+ DF L+  I +   +VR+   
Sbjct: 197 SFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 253
Query: 217 KGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKS 276
           +    ++APE      +    DV+SFG  L E+ +      + G   D+     E+ ++ 
Sbjct: 254 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-LGASPYPGVKIDE-----EFCRRL 307
Query: 277 IENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQL 331
            E  R  A        D + P        + Q M  C    P  RP   ++ + L
Sbjct: 308 KEGTRMRA-------PDYTTP-------EMYQTMLDCWHGEPSQRPTFSELVEHL 348

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 68/162 (41%), Gaps = 26/162 (16%)
Query: 104 IVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIKIA------ 157
           I  +  + H+N++K  G   E  +  L  E    G L  F      I P I +       
Sbjct: 56  ICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL--FD----RIEPDIGMPEPDAQR 109
Query: 158 --MEIANAVAYLH-VGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREE 214
              ++   V YLH +G    I  R IK  N+LLDE  + K+ DF L+        + RE 
Sbjct: 110 FFHQLMAGVVYLHGIG----ITHRDIKPENLLLDERDNLKISDFGLATVF---RYNNRER 162
Query: 215 FIK---GAYGFIAPEYFATSSFN-EMCDVYSFGAFLCELLTG 252
            +    G   ++APE      F+ E  DV+S G  L  +L G
Sbjct: 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/201 (20%), Positives = 89/201 (44%), Gaps = 17/201 (8%)
Query: 61  KVIQSDTSYRLFEGTLVDQDR----PISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNIL 116
           KV+ S     +++G  + +      P+++ +  + ++    +   +     + + + ++ 
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 81
Query: 117 KLIGCCLETELPTLVFESVKYGTLRGF------SFASLLIAPRIKIAMEIANAVAYLHVG 170
           +L+G CL + +  L+ + + +G L  +      +  S  +   +   ++IA  + YL   
Sbjct: 82  RLLGICLTSTV-QLIMQLMPFGXLLDYVREHKDNIGSQYL---LNWCVQIAKGMNYLE-- 135
Query: 171 FDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFAT 230
            DR +V R + A NVL+      K+ DF L+  +   E     E  K    ++A E    
Sbjct: 136 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 194
Query: 231 SSFNEMCDVYSFGAFLCELLT 251
             +    DV+S+G  + EL+T
Sbjct: 195 RIYTHQSDVWSYGVTVWELMT 215

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 70/168 (41%), Gaps = 31/168 (18%)
Query: 98  EYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIKIA 157
           E C N +     + H+N++K  G   E  +  L  E    G L  F      I P I + 
Sbjct: 54  EICINKM-----LNHENVVKFYGHRREGNIQYLFLEYCSGGEL--FD----RIEPDIGMP 102
Query: 158 --------MEIANAVAYLH-VGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE 208
                    ++   V YLH +G    I  R IK  N+LLDE  + K+ DF L+       
Sbjct: 103 EPDAQRFFHQLMAGVVYLHGIG----ITHRDIKPENLLLDERDNLKISDFGLATVF---R 155
Query: 209 THVREEFIK---GAYGFIAPEYFATSSFN-EMCDVYSFGAFLCELLTG 252
            + RE  +    G   ++APE      F+ E  DV+S G  L  +L G
Sbjct: 156 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 68/162 (41%), Gaps = 26/162 (16%)
Query: 104 IVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIKIA------ 157
           I  +  + H+N++K  G   E  +  L  E    G L    F    I P I +       
Sbjct: 55  ICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL----FDR--IEPDIGMPEPDAQR 108
Query: 158 --MEIANAVAYLH-VGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREE 214
              ++   V YLH +G    I  R IK  N+LLDE  + K+ DF L+        + RE 
Sbjct: 109 FFHQLMAGVVYLHGIG----ITHRDIKPENLLLDERDNLKISDFGLATVF---RYNNRER 161
Query: 215 FIK---GAYGFIAPEYFATSSFN-EMCDVYSFGAFLCELLTG 252
            +    G   ++APE      F+ E  DV+S G  L  +L G
Sbjct: 162 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 70/168 (41%), Gaps = 31/168 (18%)
Query: 98  EYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIKIA 157
           E C N +     + H+N++K  G   E  +  L  E    G L  F      I P I + 
Sbjct: 54  EICINKM-----LNHENVVKFYGHRREGNIQYLFLEYCSGGEL--FD----RIEPDIGMP 102
Query: 158 --------MEIANAVAYLH-VGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE 208
                    ++   V YLH +G    I  R IK  N+LLDE  + K+ DF L+       
Sbjct: 103 EPDAQRFFHQLMAGVVYLHGIG----ITHRDIKPENLLLDERDNLKISDFGLATVF---R 155
Query: 209 THVREEFIK---GAYGFIAPEYFATSSFN-EMCDVYSFGAFLCELLTG 252
            + RE  +    G   ++APE      F+ E  DV+S G  L  +L G
Sbjct: 156 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 64/154 (41%), Gaps = 15/154 (9%)
Query: 104 IVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL-----RGFSFASLLIAPRIKIAM 158
           I   + + H NIL+L     +     L+ E    G L     +  +F     A    I  
Sbjct: 74  IEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTA---TIME 130
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           E+A+A+ Y H    + ++ R IK  N+LL      K+ DF  SV  P     +R + + G
Sbjct: 131 ELADALMYCH---GKKVIHRDIKPENLLLGLKGELKIADFGWSVHAPS----LRRKTMCG 183
Query: 219 AYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
              ++ PE       NE  D++  G    ELL G
Sbjct: 184 TLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVG 217

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/201 (20%), Positives = 89/201 (44%), Gaps = 17/201 (8%)
Query: 61  KVIQSDTSYRLFEGTLVDQDR----PISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNIL 116
           KV+ S     +++G  + +      P+++ +  + ++    +   +     + + + ++ 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 117 KLIGCCLETELPTLVFESVKYGTLRGF------SFASLLIAPRIKIAMEIANAVAYLHVG 170
           +L+G CL + +  L+ + + +G L  +      +  S  +   +   ++IA  + YL   
Sbjct: 84  RLLGICLTSTV-QLIMQLMPFGCLLDYVREHKDNIGSQYL---LNWCVQIAKGMNYLE-- 137
Query: 171 FDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFAT 230
            DR +V R + A NVL+      K+ DF L+  +   E     E  K    ++A E    
Sbjct: 138 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 196
Query: 231 SSFNEMCDVYSFGAFLCELLT 251
             +    DV+S+G  + EL+T
Sbjct: 197 RIYTHQSDVWSYGVTVWELMT 217

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 68/162 (41%), Gaps = 26/162 (16%)
Query: 104 IVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIKIA------ 157
           I  +  + H+N++K  G   E  +  L  E    G L  F      I P I +       
Sbjct: 55  ICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL--FD----RIEPDIGMPEPDAQR 108
Query: 158 --MEIANAVAYLH-VGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREE 214
              ++   V YLH +G    I  R IK  N+LLDE  + K+ DF L+        + RE 
Sbjct: 109 FFHQLMAGVVYLHGIG----ITHRDIKPENLLLDERDNLKISDFGLATVF---RYNNRER 161
Query: 215 FIK---GAYGFIAPEYFATSSFN-EMCDVYSFGAFLCELLTG 252
            +    G   ++APE      F+ E  DV+S G  L  +L G
Sbjct: 162 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/201 (20%), Positives = 89/201 (44%), Gaps = 17/201 (8%)
Query: 61  KVIQSDTSYRLFEGTLVDQDR----PISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNIL 116
           KV+ S     +++G  + +      P+++ +  + ++    +   +     + + + ++ 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 117 KLIGCCLETELPTLVFESVKYGTLRGF------SFASLLIAPRIKIAMEIANAVAYLHVG 170
           +L+G CL + +  L+ + + +G L  +      +  S  +   +   ++IA  + YL   
Sbjct: 83  RLLGICLTSTV-QLIMQLMPFGCLLDYVREHKDNIGSQYL---LNWCVQIAKGMNYLE-- 136
Query: 171 FDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFAT 230
            DR +V R + A NVL+      K+ DF L+  +   E     E  K    ++A E    
Sbjct: 137 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 195
Query: 231 SSFNEMCDVYSFGAFLCELLT 251
             +    DV+S+G  + EL+T
Sbjct: 196 RIYTHQSDVWSYGVTVWELMT 216

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/175 (23%), Positives = 71/175 (40%), Gaps = 23/175 (13%)
Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI 216
           + ++A  + +L     R  + R + A N+LL E    K+ DF L+  I +   +VR+   
Sbjct: 206 SFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 262
Query: 217 KGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKS 276
           +    ++APE      +    DV+SFG  L E+ +      + G   D+     E+ ++ 
Sbjct: 263 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-LGASPYPGVKIDE-----EFCRRL 316
Query: 277 IENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQL 331
            E  R  A        D + P        + Q M  C    P  RP   ++ + L
Sbjct: 317 KEGTRMRA-------PDYTTP-------EMYQTMLDCWHGEPSQRPTFSELVEHL 357

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/201 (20%), Positives = 89/201 (44%), Gaps = 17/201 (8%)
Query: 61  KVIQSDTSYRLFEGTLVDQDR----PISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNIL 116
           KV+ S     +++G  + +      P+++ +  + ++    +   +     + + + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 117 KLIGCCLETELPTLVFESVKYGTLRGF------SFASLLIAPRIKIAMEIANAVAYLHVG 170
           +L+G CL + +  L+ + + +G L  +      +  S  +   +   ++IA  + YL   
Sbjct: 81  RLLGICLTSTV-QLIMQLMPFGCLLDYVREHKDNIGSQYL---LNWCVQIAKGMNYLE-- 134
Query: 171 FDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFAT 230
            DR +V R + A NVL+      K+ DF L+  +   E     E  K    ++A E    
Sbjct: 135 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 231 SSFNEMCDVYSFGAFLCELLT 251
             +    DV+S+G  + EL+T
Sbjct: 194 RIYTHQSDVWSYGVTVWELMT 214

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/263 (20%), Positives = 113/263 (42%), Gaps = 44/263 (16%)
Query: 85  VMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF- 143
           ++K  D +  +  E  F      S++ HK+++   G C   +   LV E VK+G+L  + 
Sbjct: 44  LLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYL 103
Query: 144 --SFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLL--DENYSA------ 193
             +   + I  ++++A ++A A+ +L    +  ++   + A N+LL  +E+         
Sbjct: 104 KKNKNCINILWKLEVAKQLAWAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFI 160
Query: 194 KLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFAT-SSFNEMCDVYSFGAFLCELLTG 252
           KL D  +S+++      + ++ ++    ++ PE      + N   D +SFG  L E+ + 
Sbjct: 161 KLSDPGISITV------LPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS- 213
Query: 253 CNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYK 312
                    G D  L+ L+  +K              +++ +  P    K   L  L+  
Sbjct: 214 ---------GGDKPLSALDSQRKL-----------QFYEDRHQLPAP--KAAELANLINN 251
Query: 313 CLSKSPEHRPLMVDVAKQLRQMY 335
           C+   P+HRP    + + L  ++
Sbjct: 252 CMDYEPDHRPSFRAIIRDLNSLF 274

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 75/164 (45%), Gaps = 22/164 (13%)
Query: 110 MKHKNILKLIGCCLETELPTLVFESVKYGTL---------RGFSFASLLIAPRIKIAMEI 160
           +KH +I++L+       +  +VFE +    L          GF ++  + +  ++   +I
Sbjct: 83  LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR---QI 139
Query: 161 ANAVAYLHVGFDRPIVFRCIKASNVLL---DENYSAKLHDFSLSVSIPEGETHVREEFIK 217
             A+ Y H   D  I+ R +K  NVLL   + +   KL DF +++ +  GE+ +      
Sbjct: 140 LEALRYCH---DNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQL--GESGLVAGGRV 194
Query: 218 GAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGN 261
           G   F+APE      + +  DV+  G  L  LL+GC  L F G 
Sbjct: 195 GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGC--LPFYGT 236

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 68/162 (41%), Gaps = 26/162 (16%)
Query: 104 IVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIKIA------ 157
           I  +  + H+N++K  G   E  +  L  E    G L    F    I P I +       
Sbjct: 55  ICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL----FDR--IEPDIGMPEPDAQR 108
Query: 158 --MEIANAVAYLH-VGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREE 214
              ++   V YLH +G    I  R IK  N+LLDE  + K+ DF L+        + RE 
Sbjct: 109 FFHQLMAGVVYLHGIG----ITHRDIKPENLLLDERDNLKISDFGLATVF---RYNNRER 161
Query: 215 FIK---GAYGFIAPEYFATSSFN-EMCDVYSFGAFLCELLTG 252
            +    G   ++APE      F+ E  DV+S G  L  +L G
Sbjct: 162 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/201 (20%), Positives = 89/201 (44%), Gaps = 17/201 (8%)
Query: 61  KVIQSDTSYRLFEGTLVDQDR----PISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNIL 116
           KV+ S     +++G  + +      P+++ +  + ++    +   +     + + + ++ 
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 81
Query: 117 KLIGCCLETELPTLVFESVKYGTLRGF------SFASLLIAPRIKIAMEIANAVAYLHVG 170
           +L+G CL + +  L+ + + +G L  +      +  S  +   +   ++IA  + YL   
Sbjct: 82  RLLGICLTSTV-QLIMQLMPFGCLLDYVREHKDNIGSQYL---LNWCVQIAKGMNYLE-- 135
Query: 171 FDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFAT 230
            DR +V R + A NVL+      K+ DF L+  +   E     E  K    ++A E    
Sbjct: 136 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 194
Query: 231 SSFNEMCDVYSFGAFLCELLT 251
             +    DV+S+G  + EL+T
Sbjct: 195 RIYTHQSDVWSYGVTVWELMT 215

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 68/162 (41%), Gaps = 26/162 (16%)
Query: 104 IVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIKIA------ 157
           I  +  + H+N++K  G   E  +  L  E    G L    F    I P I +       
Sbjct: 55  ICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL----FDR--IEPDIGMPEPDAQR 108
Query: 158 --MEIANAVAYLH-VGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREE 214
              ++   V YLH +G    I  R IK  N+LLDE  + K+ DF L+        + RE 
Sbjct: 109 FFHQLMAGVVYLHGIG----ITHRDIKPENLLLDERDNLKISDFGLATVF---RYNNRER 161
Query: 215 FIK---GAYGFIAPEYFATSSFN-EMCDVYSFGAFLCELLTG 252
            +    G   ++APE      F+ E  DV+S G  L  +L G
Sbjct: 162 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/201 (20%), Positives = 89/201 (44%), Gaps = 17/201 (8%)
Query: 61  KVIQSDTSYRLFEGTLVDQDR----PISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNIL 116
           KV+ S     +++G  + +      P+++ +  + ++    +   +     + + + ++ 
Sbjct: 25  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 84
Query: 117 KLIGCCLETELPTLVFESVKYGTLRGF------SFASLLIAPRIKIAMEIANAVAYLHVG 170
           +L+G CL + +  L+ + + +G L  +      +  S  +   +   ++IA  + YL   
Sbjct: 85  RLLGICLTSTV-QLIMQLMPFGCLLDYVREHKDNIGSQYL---LNWCVQIAKGMNYLE-- 138
Query: 171 FDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFAT 230
            DR +V R + A NVL+      K+ DF L+  +   E     E  K    ++A E    
Sbjct: 139 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 197
Query: 231 SSFNEMCDVYSFGAFLCELLT 251
             +    DV+S+G  + EL+T
Sbjct: 198 RIYTHQSDVWSYGVTVWELMT 218

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 68/149 (45%), Gaps = 14/149 (9%)
Query: 112 HKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPR--IKIAMEIANAVAYLHV 169
           H NI++L           LVF+ +K G L  +    + ++ +   KI   +   +  LH 
Sbjct: 70  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH- 128
Query: 170 GFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFA 229
                IV R +K  N+LLD++ + KL DF  S  +  GE  +RE  + G   ++APE   
Sbjct: 129 --KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK-LRE--VCGTPSYLAPEIIE 183
Query: 230 TS------SFNEMCDVYSFGAFLCELLTG 252
            S       + +  D++S G  +  LL G
Sbjct: 184 CSMNDNHPGYGKEVDMWSTGVIMYTLLAG 212

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 68/162 (41%), Gaps = 26/162 (16%)
Query: 104 IVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIKIA------ 157
           I  +  + H+N++K  G   E  +  L  E    G L    F    I P I +       
Sbjct: 56  ICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL----FDR--IEPDIGMPEPDAQR 109
Query: 158 --MEIANAVAYLH-VGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREE 214
              ++   V YLH +G    I  R IK  N+LLDE  + K+ DF L+        + RE 
Sbjct: 110 FFHQLMAGVVYLHGIG----ITHRDIKPENLLLDERDNLKISDFGLATVF---RYNNRER 162
Query: 215 FIK---GAYGFIAPEYFATSSFN-EMCDVYSFGAFLCELLTG 252
            +    G   ++APE      F+ E  DV+S G  L  +L G
Sbjct: 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/114 (30%), Positives = 55/114 (48%), Gaps = 7/114 (6%)
Query: 143 FSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSV 202
           +S    +I   I   + +A   A  H+  +  I+ R IK SN+LLD + + KL DF +S 
Sbjct: 115 YSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISG 174
Query: 203 SIPEGETHVREEFIKGAYGFIAPEYFATSS----FNEMCDVYSFGAFLCELLTG 252
            + +     R+    G   ++APE    S+    ++   DV+S G  L EL TG
Sbjct: 175 QLVDSIAKTRD---AGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATG 225

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 26/75 (34%), Positives = 41/75 (54%), Gaps = 2/75 (2%)
Query: 175 IVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFN 234
           ++ R +K +NV LD   + KL DF L+  +   E   +E F+   Y +++PE     S+N
Sbjct: 137 VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKE-FVGTPY-YMSPEQMNRMSYN 194
Query: 235 EMCDVYSFGAFLCEL 249
           E  D++S G  L EL
Sbjct: 195 EKSDIWSLGCLLYEL 209

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/108 (30%), Positives = 49/108 (45%), Gaps = 8/108 (7%)
Query: 150 IAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGET 209
           I  RI   M +A   A  ++     ++ R +K SN+LLDE    KL DF +S  + + + 
Sbjct: 121 IPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA 180
Query: 210 HVREEFIKGAYGFIAPEYF-----ATSSFNEMCDVYSFGAFLCELLTG 252
             R     G   ++APE           ++   DV+S G  L EL TG
Sbjct: 181 KDRSA---GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATG 225

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 68/149 (45%), Gaps = 14/149 (9%)
Query: 112 HKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPR--IKIAMEIANAVAYLHV 169
           H NI++L           LVF+ +K G L  +    + ++ +   KI   +   +  LH 
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH- 141
Query: 170 GFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFA 229
                IV R +K  N+LLD++ + KL DF  S  +  GE  +RE  + G   ++APE   
Sbjct: 142 --KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK-LRE--VCGTPSYLAPEIIE 196
Query: 230 TS------SFNEMCDVYSFGAFLCELLTG 252
            S       + +  D++S G  +  LL G
Sbjct: 197 CSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 68/153 (44%), Gaps = 19/153 (12%)
Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLI------APRIKIAMEIAN 162
           +++H NI++L     E     LVF+ V  G L    F  ++       A       +I  
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADASHCIQQILE 116
Query: 163 AVAYLHVGFDRPIVFRCIKASNVLLD---ENYSAKLHDFSLSVSIPEGETHVREEFIKGA 219
           ++AY H      IV R +K  N+LL    +  + KL DF L++ + + E         G 
Sbjct: 117 SIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW---HGFAGT 170
Query: 220 YGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
            G+++PE      +++  D+++ G  L  LL G
Sbjct: 171 PGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 24/94 (25%), Positives = 47/94 (50%), Gaps = 3/94 (3%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           EI +A+ YLH    + I+ R +K  N+LL+E+   ++ DF  +  +       R     G
Sbjct: 140 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 196
Query: 219 AYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
              +++PE     S ++  D+++ G  + +L+ G
Sbjct: 197 TAQYVSPELLTEKSASKSSDLWALGCIIYQLVAG 230

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 68/153 (44%), Gaps = 19/153 (12%)
Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLI------APRIKIAMEIAN 162
           +++H NI++L     E     LVF+ V  G L    F  ++       A       +I  
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADASHCIQQILE 116
Query: 163 AVAYLHVGFDRPIVFRCIKASNVLLD---ENYSAKLHDFSLSVSIPEGETHVREEFIKGA 219
           ++AY H      IV R +K  N+LL    +  + KL DF L++ + + E         G 
Sbjct: 117 SIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW---HGFAGT 170
Query: 220 YGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
            G+++PE      +++  D+++ G  L  LL G
Sbjct: 171 PGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/250 (20%), Positives = 100/250 (40%), Gaps = 31/250 (12%)
Query: 30  KLIATFNGKR----NPIRAFSAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISV 85
           K+I ++ G      +P +    +  +   NN    K + +    ++ E T     +  +V
Sbjct: 17  KIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAV 76
Query: 86  MK-----FHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLETELPTLVFESVKYGT 139
           +K         +  D+ E   + +   S + +H+NI+ L+G C       ++ E   YG 
Sbjct: 77  LKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGD 136
Query: 140 LRGF-----------SF-------ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIK 181
           L  F           S+         L     +  + ++A  +A+L     +  + R + 
Sbjct: 137 LLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFLA---SKNCIHRDVA 193
Query: 182 ASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYS 241
           A NVLL   + AK+ DF L+  I     ++ +   +    ++APE      +    DV+S
Sbjct: 194 ARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWS 253
Query: 242 FGAFLCELLT 251
           +G  L E+ +
Sbjct: 254 YGILLWEIFS 263

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 68/153 (44%), Gaps = 19/153 (12%)
Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLI------APRIKIAMEIAN 162
           +++H NI++L     E     LVF+ V  G L    F  ++       A       +I  
Sbjct: 60  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADASHCIQQILE 115
Query: 163 AVAYLHVGFDRPIVFRCIKASNVLLD---ENYSAKLHDFSLSVSIPEGETHVREEFIKGA 219
           ++AY H      IV R +K  N+LL    +  + KL DF L++ + + E         G 
Sbjct: 116 SIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW---HGFAGT 169
Query: 220 YGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
            G+++PE      +++  D+++ G  L  LL G
Sbjct: 170 PGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 202

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 24/94 (25%), Positives = 46/94 (48%), Gaps = 3/94 (3%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           EI +A+ YLH    + I+ R +K  N+LL+E+   ++ DF  +  +       R     G
Sbjct: 140 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 219 AYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
              +++PE     S  +  D+++ G  + +L+ G
Sbjct: 197 TAQYVSPELLTEKSAXKSSDLWALGCIIYQLVAG 230

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/201 (20%), Positives = 89/201 (44%), Gaps = 17/201 (8%)
Query: 61  KVIQSDTSYRLFEGTLVDQDR----PISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNIL 116
           KV+ S     +++G  + +      P+++ +  + ++    +   +     + + + ++ 
Sbjct: 28  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 117 KLIGCCLETELPTLVFESVKYGTLRGF------SFASLLIAPRIKIAMEIANAVAYLHVG 170
           +L+G CL + +  L+ + + +G L  +      +  S  +   +   ++IA  + YL   
Sbjct: 88  RLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIGSQYL---LNWCVQIAKGMNYLE-- 141
Query: 171 FDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFAT 230
            DR +V R + A NVL+      K+ DF L+  +   E     E  K    ++A E    
Sbjct: 142 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 200
Query: 231 SSFNEMCDVYSFGAFLCELLT 251
             +    DV+S+G  + EL+T
Sbjct: 201 RIYTHQSDVWSYGVTVWELMT 221

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/201 (20%), Positives = 89/201 (44%), Gaps = 17/201 (8%)
Query: 61  KVIQSDTSYRLFEGTLVDQDR----PISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNIL 116
           KV+ S     +++G  + +      P+++ +  + ++    +   +     + + + ++ 
Sbjct: 21  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 117 KLIGCCLETELPTLVFESVKYGTLRGF------SFASLLIAPRIKIAMEIANAVAYLHVG 170
           +L+G CL + +  L+ + + +G L  +      +  S  +   +   ++IA  + YL   
Sbjct: 81  RLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIGSQYL---LNWCVQIAKGMNYLE-- 134
Query: 171 FDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFAT 230
            DR +V R + A NVL+      K+ DF L+  +   E     E  K    ++A E    
Sbjct: 135 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 231 SSFNEMCDVYSFGAFLCELLT 251
             +    DV+S+G  + EL+T
Sbjct: 194 RIYTHQSDVWSYGVTVWELMT 214

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/201 (20%), Positives = 89/201 (44%), Gaps = 17/201 (8%)
Query: 61  KVIQSDTSYRLFEGTLVDQDR----PISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNIL 116
           KV+ S     +++G  + +      P+++ +  + ++    +   +     + + + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 117 KLIGCCLETELPTLVFESVKYGTLRGF------SFASLLIAPRIKIAMEIANAVAYLHVG 170
           +L+G CL + +  L+ + + +G L  +      +  S  +   +   ++IA  + YL   
Sbjct: 81  RLLGICLTSTV-QLITQLMPFGXLLDYVREHKDNIGSQYL---LNWCVQIAKGMNYLE-- 134
Query: 171 FDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFAT 230
            DR +V R + A NVL+      K+ DF L+  +   E     E  K    ++A E    
Sbjct: 135 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 231 SSFNEMCDVYSFGAFLCELLT 251
             +    DV+S+G  + EL+T
Sbjct: 194 RIYTHQSDVWSYGVTVWELMT 214

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/201 (20%), Positives = 89/201 (44%), Gaps = 17/201 (8%)
Query: 61  KVIQSDTSYRLFEGTLVDQDR----PISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNIL 116
           KV+ S     +++G  + +      P+++ +  + ++    +   +     + + + ++ 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 117 KLIGCCLETELPTLVFESVKYGTLRGF------SFASLLIAPRIKIAMEIANAVAYLHVG 170
           +L+G CL + +  L+ + + +G L  +      +  S  +   +   ++IA  + YL   
Sbjct: 84  RLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIGSQYL---LNWCVQIAKGMNYLE-- 137
Query: 171 FDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFAT 230
            DR +V R + A NVL+      K+ DF L+  +   E     E  K    ++A E    
Sbjct: 138 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 196
Query: 231 SSFNEMCDVYSFGAFLCELLT 251
             +    DV+S+G  + EL+T
Sbjct: 197 RIYTHQSDVWSYGVTVWELMT 217

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/201 (20%), Positives = 89/201 (44%), Gaps = 17/201 (8%)
Query: 61  KVIQSDTSYRLFEGTLVDQDR----PISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNIL 116
           KV+ S     +++G  + +      P+++ +  + ++    +   +     + + + ++ 
Sbjct: 31  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 90
Query: 117 KLIGCCLETELPTLVFESVKYGTLRGF------SFASLLIAPRIKIAMEIANAVAYLHVG 170
           +L+G CL + +  L+ + + +G L  +      +  S  +   +   ++IA  + YL   
Sbjct: 91  RLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIGSQYL---LNWCVQIAKGMNYLE-- 144
Query: 171 FDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFAT 230
            DR +V R + A NVL+      K+ DF L+  +   E     E  K    ++A E    
Sbjct: 145 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 203
Query: 231 SSFNEMCDVYSFGAFLCELLT 251
             +    DV+S+G  + EL+T
Sbjct: 204 RIYTHQSDVWSYGVTVWELMT 224

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/201 (20%), Positives = 89/201 (44%), Gaps = 17/201 (8%)
Query: 61  KVIQSDTSYRLFEGTLVDQDR----PISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNIL 116
           KV+ S     +++G  + +      P+++ +  + ++    +   +     + + + ++ 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 117 KLIGCCLETELPTLVFESVKYGTLRGF------SFASLLIAPRIKIAMEIANAVAYLHVG 170
           +L+G CL + +  L+ + + +G L  +      +  S  +   +   ++IA  + YL   
Sbjct: 84  RLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIGSQYL---LNWCVQIAKGMNYLE-- 137
Query: 171 FDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFAT 230
            DR +V R + A NVL+      K+ DF L+  +   E     E  K    ++A E    
Sbjct: 138 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 196
Query: 231 SSFNEMCDVYSFGAFLCELLT 251
             +    DV+S+G  + EL+T
Sbjct: 197 RIYTHQSDVWSYGVTVWELMT 217

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/201 (20%), Positives = 89/201 (44%), Gaps = 17/201 (8%)
Query: 61  KVIQSDTSYRLFEGTLVDQDR----PISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNIL 116
           KV+ S     +++G  + +      P+++ +  + ++    +   +     + + + ++ 
Sbjct: 28  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 117 KLIGCCLETELPTLVFESVKYGTLRGF------SFASLLIAPRIKIAMEIANAVAYLHVG 170
           +L+G CL + +  L+ + + +G L  +      +  S  +   +   ++IA  + YL   
Sbjct: 88  RLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIGSQYL---LNWCVQIAKGMNYLE-- 141
Query: 171 FDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFAT 230
            DR +V R + A NVL+      K+ DF L+  +   E     E  K    ++A E    
Sbjct: 142 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 200
Query: 231 SSFNEMCDVYSFGAFLCELLT 251
             +    DV+S+G  + EL+T
Sbjct: 201 RIYTHQSDVWSYGVTVWELMT 221

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/201 (20%), Positives = 89/201 (44%), Gaps = 17/201 (8%)
Query: 61  KVIQSDTSYRLFEGTLVDQDR----PISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNIL 116
           KV+ S     +++G  + +      P+++ +  + ++    +   +     + + + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 117 KLIGCCLETELPTLVFESVKYGTLRGF------SFASLLIAPRIKIAMEIANAVAYLHVG 170
           +L+G CL + +  L+ + + +G L  +      +  S  +   +   ++IA  + YL   
Sbjct: 81  RLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIGSQYL---LNWCVQIAKGMNYLE-- 134
Query: 171 FDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFAT 230
            DR +V R + A NVL+      K+ DF L+  +   E     E  K    ++A E    
Sbjct: 135 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 231 SSFNEMCDVYSFGAFLCELLT 251
             +    DV+S+G  + EL+T
Sbjct: 194 RIYTHQSDVWSYGVTVWELMT 214

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 41/201 (20%), Positives = 89/201 (44%), Gaps = 17/201 (8%)
Query: 61  KVIQSDTSYRLFEGTLVDQDR----PISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNIL 116
           KV+ S     +++G  + +      P+++ +  + ++    +   +     + + + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 117 KLIGCCLETELPTLVFESVKYGTLRGF------SFASLLIAPRIKIAMEIANAVAYLHVG 170
           +L+G CL + +  L+ + + +G L  +      +  S  +   +   ++IA  + YL   
Sbjct: 81  RLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIGSQYL---LNWCVQIAKGMNYLE-- 134
Query: 171 FDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFAT 230
            DR +V R + A NVL+      K+ DF L+  +   E     E  K    ++A E    
Sbjct: 135 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 231 SSFNEMCDVYSFGAFLCELLT 251
             +    DV+S+G  + EL+T
Sbjct: 194 RIYTHQSDVWSYGVTVWELMT 214

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 41/201 (20%), Positives = 89/201 (44%), Gaps = 17/201 (8%)
Query: 61  KVIQSDTSYRLFEGTLVDQDR----PISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNIL 116
           KV+ S     +++G  + +      P+++ +  + ++    +   +     + + + ++ 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 117 KLIGCCLETELPTLVFESVKYGTLRGF------SFASLLIAPRIKIAMEIANAVAYLHVG 170
           +L+G CL + +  L+ + + +G L  +      +  S  +   +   ++IA  + YL   
Sbjct: 84  RLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIGSQYL---LNWCVQIAKGMNYLE-- 137
Query: 171 FDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFAT 230
            DR +V R + A NVL+      K+ DF L+  +   E     E  K    ++A E    
Sbjct: 138 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 196
Query: 231 SSFNEMCDVYSFGAFLCELLT 251
             +    DV+S+G  + EL+T
Sbjct: 197 RIYTHQSDVWSYGVTVWELMT 217

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 41/201 (20%), Positives = 89/201 (44%), Gaps = 17/201 (8%)
Query: 61  KVIQSDTSYRLFEGTLVDQDR----PISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNIL 116
           KV+ S     +++G  + +      P+++ +  + ++    +   +     + + + ++ 
Sbjct: 46  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 105
Query: 117 KLIGCCLETELPTLVFESVKYGTLRGF------SFASLLIAPRIKIAMEIANAVAYLHVG 170
           +L+G CL + +  L+ + + +G L  +      +  S  +   +   ++IA  + YL   
Sbjct: 106 RLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIGSQYL---LNWCVQIAKGMNYLE-- 159
Query: 171 FDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFAT 230
            DR +V R + A NVL+      K+ DF L+  +   E     E  K    ++A E    
Sbjct: 160 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 218
Query: 231 SSFNEMCDVYSFGAFLCELLT 251
             +    DV+S+G  + EL+T
Sbjct: 219 RIYTHQSDVWSYGVTVWELMT 239

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 41/201 (20%), Positives = 89/201 (44%), Gaps = 17/201 (8%)
Query: 61  KVIQSDTSYRLFEGTLVDQDR----PISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNIL 116
           KV+ S     +++G  + +      P+++ +  + ++    +   +     + + + ++ 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 117 KLIGCCLETELPTLVFESVKYGTLRGF------SFASLLIAPRIKIAMEIANAVAYLHVG 170
           +L+G CL + +  L+ + + +G L  +      +  S  +   +   ++IA  + YL   
Sbjct: 83  RLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIGSQYL---LNWCVQIAKGMNYLE-- 136
Query: 171 FDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFAT 230
            DR +V R + A NVL+      K+ DF L+  +   E     E  K    ++A E    
Sbjct: 137 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 195
Query: 231 SSFNEMCDVYSFGAFLCELLT 251
             +    DV+S+G  + EL+T
Sbjct: 196 RIYTHQSDVWSYGVTVWELMT 216

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 41/201 (20%), Positives = 89/201 (44%), Gaps = 17/201 (8%)
Query: 61  KVIQSDTSYRLFEGTLVDQDR----PISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNIL 116
           KV+ S     +++G  + +      P+++ +  + ++    +   +     + + + ++ 
Sbjct: 27  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 86
Query: 117 KLIGCCLETELPTLVFESVKYGTLRGF------SFASLLIAPRIKIAMEIANAVAYLHVG 170
           +L+G CL + +  L+ + + +G L  +      +  S  +   +   ++IA  + YL   
Sbjct: 87  RLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIGSQYL---LNWCVQIAKGMNYLE-- 140
Query: 171 FDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFAT 230
            DR +V R + A NVL+      K+ DF L+  +   E     E  K    ++A E    
Sbjct: 141 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 199
Query: 231 SSFNEMCDVYSFGAFLCELLT 251
             +    DV+S+G  + EL+T
Sbjct: 200 RIYTHQSDVWSYGVTVWELMT 220

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 24/94 (25%), Positives = 46/94 (48%), Gaps = 3/94 (3%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           EI +A+ YLH    + I+ R +K  N+LL+E+   ++ DF  +  +       R     G
Sbjct: 116 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 172
Query: 219 AYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
              +++PE     S  +  D+++ G  + +L+ G
Sbjct: 173 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 206

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 68/163 (41%), Gaps = 25/163 (15%)
Query: 102 NNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL------RGFSF---ASLLIAP 152
           N I    ++KH NI+ L           L+ + V  G L      +GF     AS LI  
Sbjct: 65  NEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLI-- 122
Query: 153 RIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVL---LDENYSAKLHDFSLSVSIPEGET 209
                 ++ +AV YLH   D  IV R +K  N+L   LDE+    + DF LS     G  
Sbjct: 123 -----FQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV 174
Query: 210 HVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
                   G  G++APE  A   +++  D +S G     LL G
Sbjct: 175 L---STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 24/94 (25%), Positives = 46/94 (48%), Gaps = 3/94 (3%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           EI +A+ YLH    + I+ R +K  N+LL+E+   ++ DF  +  +       R     G
Sbjct: 118 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 174
Query: 219 AYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
              +++PE     S  +  D+++ G  + +L+ G
Sbjct: 175 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 208

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 26/75 (34%), Positives = 41/75 (54%), Gaps = 2/75 (2%)
Query: 175 IVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFN 234
           ++ R +K +NV LD   + KL DF L+  I   +T   + F+   Y +++PE     S+N
Sbjct: 137 VLHRDLKPANVFLDGKQNVKLGDFGLA-RILNHDTSFAKTFVGTPY-YMSPEQMNRMSYN 194
Query: 235 EMCDVYSFGAFLCEL 249
           E  D++S G  L EL
Sbjct: 195 EKSDIWSLGCLLYEL 209

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 24/94 (25%), Positives = 46/94 (48%), Gaps = 3/94 (3%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           EI +A+ YLH    + I+ R +K  N+LL+E+   ++ DF  +  +       R     G
Sbjct: 117 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 173
Query: 219 AYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
              +++PE     S  +  D+++ G  + +L+ G
Sbjct: 174 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 207

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 24/94 (25%), Positives = 46/94 (48%), Gaps = 3/94 (3%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           EI +A+ YLH    + I+ R +K  N+LL+E+   ++ DF  +  +       R     G
Sbjct: 115 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 171
Query: 219 AYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
              +++PE     S  +  D+++ G  + +L+ G
Sbjct: 172 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 205

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 26/75 (34%), Positives = 41/75 (54%), Gaps = 2/75 (2%)
Query: 175 IVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFN 234
           ++ R +K +NV LD   + KL DF L+  I   +T   + F+   Y +++PE     S+N
Sbjct: 137 VLHRDLKPANVFLDGKQNVKLGDFGLA-RILNHDTSFAKAFVGTPY-YMSPEQMNRMSYN 194
Query: 235 EMCDVYSFGAFLCEL 249
           E  D++S G  L EL
Sbjct: 195 EKSDIWSLGCLLYEL 209

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 24/94 (25%), Positives = 46/94 (48%), Gaps = 3/94 (3%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           EI +A+ YLH    + I+ R +K  N+LL+E+   ++ DF  +  +       R     G
Sbjct: 141 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 197
Query: 219 AYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
              +++PE     S  +  D+++ G  + +L+ G
Sbjct: 198 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 24/94 (25%), Positives = 46/94 (48%), Gaps = 3/94 (3%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           EI +A+ YLH    + I+ R +K  N+LL+E+   ++ DF  +  +       R     G
Sbjct: 140 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 219 AYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
              +++PE     S  +  D+++ G  + +L+ G
Sbjct: 197 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 24/94 (25%), Positives = 46/94 (48%), Gaps = 3/94 (3%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           EI +A+ YLH    + I+ R +K  N+LL+E+   ++ DF  +  +       R     G
Sbjct: 140 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 219 AYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
              +++PE     S  +  D+++ G  + +L+ G
Sbjct: 197 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 24/94 (25%), Positives = 46/94 (48%), Gaps = 3/94 (3%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           EI +A+ YLH    + I+ R +K  N+LL+E+   ++ DF  +  +       R     G
Sbjct: 140 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 219 AYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
              +++PE     S  +  D+++ G  + +L+ G
Sbjct: 197 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 68/163 (41%), Gaps = 25/163 (15%)
Query: 102 NNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL------RGFSF---ASLLIAP 152
           N I    ++KH NI+ L           L+ + V  G L      +GF     AS LI  
Sbjct: 65  NEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLI-- 122
Query: 153 RIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVL---LDENYSAKLHDFSLSVSIPEGET 209
                 ++ +AV YLH   D  IV R +K  N+L   LDE+    + DF LS     G  
Sbjct: 123 -----FQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV 174
Query: 210 HVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
                   G  G++APE  A   +++  D +S G     LL G
Sbjct: 175 L---STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 24/94 (25%), Positives = 46/94 (48%), Gaps = 3/94 (3%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           EI +A+ YLH    + I+ R +K  N+LL+E+   ++ DF  +  +       R     G
Sbjct: 138 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 194
Query: 219 AYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
              +++PE     S  +  D+++ G  + +L+ G
Sbjct: 195 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 24/94 (25%), Positives = 46/94 (48%), Gaps = 3/94 (3%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           EI +A+ YLH    + I+ R +K  N+LL+E+   ++ DF  +  +       R     G
Sbjct: 138 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 194
Query: 219 AYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
              +++PE     S  +  D+++ G  + +L+ G
Sbjct: 195 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 24/94 (25%), Positives = 46/94 (48%), Gaps = 3/94 (3%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           EI +A+ YLH    + I+ R +K  N+LL+E+   ++ DF  +  +       R     G
Sbjct: 138 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 194
Query: 219 AYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
              +++PE     S  +  D+++ G  + +L+ G
Sbjct: 195 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 52/97 (53%), Gaps = 9/97 (9%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           E+  A+ YL    ++ I+ R +K  N+LLDE+    + DF+++  +P  ET +    + G
Sbjct: 123 ELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR-ETQITT--MAG 176
Query: 219 AYGFIAPEYFAT---SSFNEMCDVYSFGAFLCELLTG 252
              ++APE F++   + ++   D +S G    ELL G
Sbjct: 177 TKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRG 213

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 24/94 (25%), Positives = 46/94 (48%), Gaps = 3/94 (3%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           EI +A+ YLH    + I+ R +K  N+LL+E+   ++ DF  +  +       R     G
Sbjct: 140 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 219 AYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
              +++PE     S  +  D+++ G  + +L+ G
Sbjct: 197 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 24/94 (25%), Positives = 46/94 (48%), Gaps = 3/94 (3%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           EI +A+ YLH    + I+ R +K  N+LL+E+   ++ DF  +  +       R     G
Sbjct: 122 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 178
Query: 219 AYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
              +++PE     S  +  D+++ G  + +L+ G
Sbjct: 179 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 212

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 58/120 (48%), Gaps = 19/120 (15%)
Query: 155 KIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREE 214
           ++  +I + V Y H      +V R +K  NVLLD + +AK+ DF LS  + +G      E
Sbjct: 120 RLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG------E 170
Query: 215 FIK---GAYGFIAPEYFATSSF-NEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
           F++   G+  + APE  +   +     D++S G  L  LL  C  L F    +DD +  L
Sbjct: 171 FLRXSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALL--CGTLPF----DDDHVPTL 224

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 41/201 (20%), Positives = 89/201 (44%), Gaps = 17/201 (8%)
Query: 61  KVIQSDTSYRLFEGTLVDQDR----PISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNIL 116
           KV+ S     +++G  + +      P+++ +  + ++    +   +     + + + ++ 
Sbjct: 18  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 77
Query: 117 KLIGCCLETELPTLVFESVKYGTLRGF------SFASLLIAPRIKIAMEIANAVAYLHVG 170
           +L+G CL + +  L+ + + +G L  +      +  S  +   +   ++IA  + YL   
Sbjct: 78  RLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIGSQYL---LNWCVQIAEGMNYLE-- 131
Query: 171 FDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFAT 230
            DR +V R + A NVL+      K+ DF L+  +   E     E  K    ++A E    
Sbjct: 132 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 190
Query: 231 SSFNEMCDVYSFGAFLCELLT 251
             +    DV+S+G  + EL+T
Sbjct: 191 RIYTHQSDVWSYGVTVWELMT 211

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 24/94 (25%), Positives = 46/94 (48%), Gaps = 3/94 (3%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           EI +A+ YLH    + I+ R +K  N+LL+E+   ++ DF  +  +       R     G
Sbjct: 143 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 199
Query: 219 AYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
              +++PE     S  +  D+++ G  + +L+ G
Sbjct: 200 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 233

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 24/94 (25%), Positives = 46/94 (48%), Gaps = 3/94 (3%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           EI +A+ YLH    + I+ R +K  N+LL+E+   ++ DF  +  +       R     G
Sbjct: 145 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 201
Query: 219 AYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
              +++PE     S  +  D+++ G  + +L+ G
Sbjct: 202 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 235

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 41/201 (20%), Positives = 89/201 (44%), Gaps = 17/201 (8%)
Query: 61  KVIQSDTSYRLFEGTLVDQDR----PISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNIL 116
           KV+ S     +++G  + +      P+++ +  + ++    +   +     + + + ++ 
Sbjct: 15  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 117 KLIGCCLETELPTLVFESVKYGTLRGF------SFASLLIAPRIKIAMEIANAVAYLHVG 170
           +L+G CL + +  L+ + + +G L  +      +  S  +   +   ++IA  + YL   
Sbjct: 75  RLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIGSQYL---LNWCVQIAKGMNYLE-- 128
Query: 171 FDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFAT 230
            DR +V R + A NVL+      K+ DF L+  +   E     E  K    ++A E    
Sbjct: 129 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 187
Query: 231 SSFNEMCDVYSFGAFLCELLT 251
             +    DV+S+G  + EL+T
Sbjct: 188 RIYTHQSDVWSYGVTVWELMT 208

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 68/163 (41%), Gaps = 25/163 (15%)
Query: 102 NNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL------RGFSF---ASLLIAP 152
           N I    ++KH NI+ L           L+ + V  G L      +GF     AS LI  
Sbjct: 65  NEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLI-- 122
Query: 153 RIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVL---LDENYSAKLHDFSLSVSIPEGET 209
                 ++ +AV YLH   D  IV R +K  N+L   LDE+    + DF LS     G  
Sbjct: 123 -----FQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV 174
Query: 210 HVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
                   G  G++APE  A   +++  D +S G     LL G
Sbjct: 175 LST---ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 68/163 (41%), Gaps = 25/163 (15%)
Query: 102 NNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL------RGFSF---ASLLIAP 152
           N I    ++KH NI+ L           L+ + V  G L      +GF     AS LI  
Sbjct: 65  NEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLI-- 122
Query: 153 RIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVL---LDENYSAKLHDFSLSVSIPEGET 209
                 ++ +AV YLH   D  IV R +K  N+L   LDE+    + DF LS     G  
Sbjct: 123 -----FQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV 174
Query: 210 HVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
                   G  G++APE  A   +++  D +S G     LL G
Sbjct: 175 LST---ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 24/94 (25%), Positives = 46/94 (48%), Gaps = 3/94 (3%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           EI +A+ YLH    + I+ R +K  N+LL+E+   ++ DF  +  +       R     G
Sbjct: 137 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 193
Query: 219 AYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
              +++PE     S  +  D+++ G  + +L+ G
Sbjct: 194 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 24/94 (25%), Positives = 46/94 (48%), Gaps = 3/94 (3%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           EI +A+ YLH    + I+ R +K  N+LL+E+   ++ DF  +  +       R     G
Sbjct: 138 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVG 194
Query: 219 AYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
              +++PE     S  +  D+++ G  + +L+ G
Sbjct: 195 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 40/151 (26%), Positives = 67/151 (44%), Gaps = 13/151 (8%)
Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF------SFASLLIAPRIKIAMEIA 161
            Q  H NI++L G   + +   ++ E ++ G L  F       F+ L +   ++    IA
Sbjct: 101 GQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLR---GIA 157
Query: 162 NAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEG-ETHVREEFIKGAY 220
             + YL    +   V R + A N+L++ N   K+ DF LS  + +  E        K   
Sbjct: 158 AGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI 214
Query: 221 GFIAPEYFATSSFNEMCDVYSFGAFLCELLT 251
            + APE  +   F    DV+SFG  + E++T
Sbjct: 215 RWTAPEAISYRKFTSASDVWSFGIVMWEVMT 245

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 66/149 (44%), Gaps = 14/149 (9%)
Query: 112 HKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPR--IKIAMEIANAVAYLHV 169
           H NI++L           LVF+ +K G L  +    + ++ +   KI   +   +  LH 
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH- 141
Query: 170 GFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFA 229
                IV R +K  N+LLD++ + KL DF  S  +  GE   +   + G   ++APE   
Sbjct: 142 --KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLRSVCGTPSYLAPEIIE 196
Query: 230 TS------SFNEMCDVYSFGAFLCELLTG 252
            S       + +  D++S G  +  LL G
Sbjct: 197 CSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 24/94 (25%), Positives = 46/94 (48%), Gaps = 3/94 (3%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           EI +A+ YLH    + I+ R +K  N+LL+E+   ++ DF  +  +       R     G
Sbjct: 141 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 197
Query: 219 AYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
              +++PE     S  +  D+++ G  + +L+ G
Sbjct: 198 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 42/170 (24%), Positives = 70/170 (41%), Gaps = 26/170 (15%)
Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKY----------GTLRGFSFASLLIAPRIKIAM 158
           ++KH NI+KL       +   LVFE +            G L   +  S L        +
Sbjct: 56  ELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFL--------L 107
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           ++ N +AY H   DR ++ R +K  N+L++     K+ DF L+ +          E +  
Sbjct: 108 QLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTL 164
Query: 219 AYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDL 267
            Y   AP+    S  ++   D++S G    E++ G  +  F G    D L
Sbjct: 165 WYR--APDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPL--FPGVSEADQL 210

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 28/95 (29%), Positives = 47/95 (49%), Gaps = 7/95 (7%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIP-EGETHVREEFIK 217
           +    V YLH   +  ++ R +K  N+ L+++   K+ DF L+  I  +GE   R++ + 
Sbjct: 150 QTIQGVQYLH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGE---RKKXLC 203
Query: 218 GAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
           G   +IAPE       +   D++S G  L  LL G
Sbjct: 204 GTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVG 238

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 54/108 (50%), Gaps = 15/108 (13%)
Query: 155 KIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREE 214
           ++  +I +AV Y H      +V R +K  NVLLD + +AK+ DF LS  + +G      E
Sbjct: 115 RLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG------E 165
Query: 215 FIK---GAYGFIAPEYFATSSF-NEMCDVYSFGAFLCELLTGCNVLEF 258
           F++   G+  + APE  +   +     D++S G  L  LL  C  L F
Sbjct: 166 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALL--CGTLPF 211

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 42/170 (24%), Positives = 70/170 (41%), Gaps = 26/170 (15%)
Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKY----------GTLRGFSFASLLIAPRIKIAM 158
           ++KH NI+KL       +   LVFE +            G L   +  S L        +
Sbjct: 56  ELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFL--------L 107
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           ++ N +AY H   DR ++ R +K  N+L++     K+ DF L+ +          E +  
Sbjct: 108 QLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTL 164
Query: 219 AYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDL 267
            Y   AP+    S  ++   D++S G    E++ G  +  F G    D L
Sbjct: 165 WYR--APDVLMGSKKYSTTIDIWSVGCIFAEMVNGAPL--FPGVSEADQL 210

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 54/108 (50%), Gaps = 15/108 (13%)
Query: 155 KIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREE 214
           ++  +I +AV Y H      +V R +K  NVLLD + +AK+ DF LS  + +G      E
Sbjct: 115 RLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG------E 165
Query: 215 FIK---GAYGFIAPEYFATSSF-NEMCDVYSFGAFLCELLTGCNVLEF 258
           F++   G+  + APE  +   +     D++S G  L  LL  C  L F
Sbjct: 166 FLRDSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALL--CGTLPF 211

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 40/117 (34%), Positives = 60/117 (51%), Gaps = 11/117 (9%)
Query: 154 IKIAM-EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSA-KLHDFSLSVSIPEGETHV 211
           +K+ M ++  ++AY+H  F   I  R IK  N+LLD + +  KL DF  +  +  GE +V
Sbjct: 160 VKLYMYQLFRSLAYIH-SFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV 216
Query: 212 REEFIKGAYGFIAPEY-FATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDL 267
              +I   Y + APE  F  + +    DV+S G  L ELL G  +  F G+   D L
Sbjct: 217 --SYICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI--FPGDSGVDQL 268

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 40/117 (34%), Positives = 60/117 (51%), Gaps = 11/117 (9%)
Query: 154 IKIAM-EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSA-KLHDFSLSVSIPEGETHV 211
           +K+ M ++  ++AY+H  F   I  R IK  N+LLD + +  KL DF  +  +  GE +V
Sbjct: 158 VKLYMYQLFRSLAYIH-SFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV 214
Query: 212 REEFIKGAYGFIAPEY-FATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDL 267
              +I   Y + APE  F  + +    DV+S G  L ELL G  +  F G+   D L
Sbjct: 215 --SYICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI--FPGDSGVDQL 266

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 27/95 (28%), Positives = 49/95 (51%), Gaps = 6/95 (6%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSL-SVSIPEGETHVREEFIK 217
           EI +A+ YLH   ++ +V+R +K  N++LD++   K+ DF L    I +G T    +   
Sbjct: 259 EIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM---KTFC 313
Query: 218 GAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
           G   ++APE    + +    D +  G  + E++ G
Sbjct: 314 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 348

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 24/94 (25%), Positives = 46/94 (48%), Gaps = 3/94 (3%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           EI +A+ YLH    + I+ R +K  N+LL+E+   ++ DF  +  +       R     G
Sbjct: 137 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 193
Query: 219 AYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
              +++PE     S  +  D+++ G  + +L+ G
Sbjct: 194 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 27/95 (28%), Positives = 49/95 (51%), Gaps = 6/95 (6%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSL-SVSIPEGETHVREEFIK 217
           EI +A+ YLH   ++ +V+R +K  N++LD++   K+ DF L    I +G T    +   
Sbjct: 256 EIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM---KTFC 310
Query: 218 GAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
           G   ++APE    + +    D +  G  + E++ G
Sbjct: 311 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 345

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 40/117 (34%), Positives = 60/117 (51%), Gaps = 11/117 (9%)
Query: 154 IKIAM-EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSA-KLHDFSLSVSIPEGETHV 211
           +K+ M ++  ++AY+H  F   I  R IK  N+LLD + +  KL DF  +  +  GE +V
Sbjct: 162 VKLYMYQLFRSLAYIH-SFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV 218
Query: 212 REEFIKGAYGFIAPEY-FATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDL 267
              +I   Y + APE  F  + +    DV+S G  L ELL G  +  F G+   D L
Sbjct: 219 --SYICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI--FPGDSGVDQL 270

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 40/117 (34%), Positives = 60/117 (51%), Gaps = 11/117 (9%)
Query: 154 IKIAM-EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSA-KLHDFSLSVSIPEGETHV 211
           +K+ M ++  ++AY+H  F   I  R IK  N+LLD + +  KL DF  +  +  GE +V
Sbjct: 203 VKLYMYQLFRSLAYIH-SFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV 259
Query: 212 REEFIKGAYGFIAPEY-FATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDL 267
              +I   Y + APE  F  + +    DV+S G  L ELL G  +  F G+   D L
Sbjct: 260 --SYICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI--FPGDSGVDQL 311

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 46/217 (21%), Positives = 87/217 (40%), Gaps = 28/217 (12%)
Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANAVA 165
           ++ H  ++K  G C +     +V E +  G L  +       L  +  +++  ++   +A
Sbjct: 59  KLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMA 118
Query: 166 YLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAP 225
           +L        + R + A N L+D +   K+ DF ++  + + + +V     K    + AP
Sbjct: 119 FLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD-DQYVSSVGTKFPVKWSAP 174
Query: 226 EYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAI 285
           E F    ++   DV++FG  + E+ +        G    D  T  E   K  + +R   +
Sbjct: 175 EVFHYFKYSSKSDVWAFGILMWEVFS-------LGKMPYDLYTNSEVVLKVSQGHR---L 224
Query: 286 VDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
             P    D  +           Q+MY C  + PE RP
Sbjct: 225 YRPHLASDTIY-----------QIMYSCWHELPEKRP 250

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 40/117 (34%), Positives = 60/117 (51%), Gaps = 11/117 (9%)
Query: 154 IKIAM-EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSA-KLHDFSLSVSIPEGETHV 211
           +K+ M ++  ++AY+H  F   I  R IK  N+LLD + +  KL DF  +  +  GE +V
Sbjct: 137 VKLYMYQLFRSLAYIH-SFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV 193
Query: 212 REEFIKGAYGFIAPEY-FATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDL 267
              +I   Y + APE  F  + +    DV+S G  L ELL G  +  F G+   D L
Sbjct: 194 --SYICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI--FPGDSGVDQL 245

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 27/95 (28%), Positives = 49/95 (51%), Gaps = 6/95 (6%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSL-SVSIPEGETHVREEFIK 217
           EI +A+ YLH   ++ +V+R +K  N++LD++   K+ DF L    I +G T    +   
Sbjct: 116 EIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM---KXFC 170
Query: 218 GAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
           G   ++APE    + +    D +  G  + E++ G
Sbjct: 171 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 205

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 40/201 (19%), Positives = 88/201 (43%), Gaps = 17/201 (8%)
Query: 61  KVIQSDTSYRLFEGTLVDQDR----PISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNIL 116
           KV+ S     +++G  + +      P+++ +  + ++    +   +     + + + ++ 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 117 KLIGCCLETELPTLVFESVKYGTLRGF------SFASLLIAPRIKIAMEIANAVAYLHVG 170
           +L+G CL + +  L+ + + +G L  +      +  S  +   +   ++IA  + YL   
Sbjct: 83  RLLGICLTSTV-QLIMQLMPFGCLLDYVREHKDNIGSQYL---LNWCVQIAKGMNYLE-- 136
Query: 171 FDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFAT 230
            DR +V R + A NVL+      K+ DF  +  +   E     E  K    ++A E    
Sbjct: 137 -DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILH 195
Query: 231 SSFNEMCDVYSFGAFLCELLT 251
             +    DV+S+G  + EL+T
Sbjct: 196 RIYTHQSDVWSYGVTVWELMT 216

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 27/95 (28%), Positives = 49/95 (51%), Gaps = 6/95 (6%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSL-SVSIPEGETHVREEFIK 217
           EI +A+ YLH   ++ +V+R +K  N++LD++   K+ DF L    I +G T    +   
Sbjct: 117 EIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM---KXFC 171
Query: 218 GAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
           G   ++APE    + +    D +  G  + E++ G
Sbjct: 172 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 206

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 27/95 (28%), Positives = 49/95 (51%), Gaps = 6/95 (6%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSL-SVSIPEGETHVREEFIK 217
           EI +A+ YLH   ++ +V+R +K  N++LD++   K+ DF L    I +G T    +   
Sbjct: 118 EIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM---KXFC 172
Query: 218 GAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
           G   ++APE    + +    D +  G  + E++ G
Sbjct: 173 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 207

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 28/95 (29%), Positives = 47/95 (49%), Gaps = 7/95 (7%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIP-EGETHVREEFIK 217
           +    V YLH   +  ++ R +K  N+ L+++   K+ DF L+  I  +GE   R++ + 
Sbjct: 150 QTIQGVQYLH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGE---RKKTLC 203
Query: 218 GAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
           G   +IAPE       +   D++S G  L  LL G
Sbjct: 204 GTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVG 238

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 42/170 (24%), Positives = 70/170 (41%), Gaps = 26/170 (15%)
Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKY----------GTLRGFSFASLLIAPRIKIAM 158
           ++KH NI+KL       +   LVFE +            G L   +  S L        +
Sbjct: 56  ELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFL--------L 107
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           ++ N +AY H   DR ++ R +K  N+L++     K+ DF L+ +          E +  
Sbjct: 108 QLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTL 164
Query: 219 AYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDL 267
            Y   AP+    S  ++   D++S G    E++ G  +  F G    D L
Sbjct: 165 WYR--APDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPL--FPGVSEADQL 210

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 40/117 (34%), Positives = 60/117 (51%), Gaps = 11/117 (9%)
Query: 154 IKIAM-EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSA-KLHDFSLSVSIPEGETHV 211
           +K+ M ++  ++AY+H  F   I  R IK  N+LLD + +  KL DF  +  +  GE +V
Sbjct: 152 VKLYMYQLFRSLAYIH-SFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV 208
Query: 212 REEFIKGAYGFIAPEY-FATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDL 267
              +I   Y + APE  F  + +    DV+S G  L ELL G  +  F G+   D L
Sbjct: 209 --SYICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI--FPGDSGVDQL 260

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/117 (34%), Positives = 60/117 (51%), Gaps = 11/117 (9%)
Query: 154 IKIAM-EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSA-KLHDFSLSVSIPEGETHV 211
           +K+ M ++  ++AY+H  F   I  R IK  N+LLD + +  KL DF  +  +  GE +V
Sbjct: 124 VKLYMYQLFRSLAYIH-SFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV 180
Query: 212 REEFIKGAYGFIAPEY-FATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDL 267
              +I   Y + APE  F  + +    DV+S G  L ELL G  +  F G+   D L
Sbjct: 181 --SYICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI--FPGDSGVDQL 232

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 68/152 (44%), Gaps = 18/152 (11%)
Query: 110 MKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLI------APRIKIAMEIANA 163
           +KH NI++L     E     LVF+ V  G L    F  ++       A       +I  +
Sbjct: 87  LKHPNIVRLHDSISEEGFHYLVFDLVTGGEL----FEDIVAREYYSEADASHCIHQILES 142
Query: 164 VAYLHVGFDRPIVFRCIKASNVLLD---ENYSAKLHDFSLSVSIPEGETHVREEFIKGAY 220
           V ++H      IV R +K  N+LL    +  + KL DF L++ + +GE      F  G  
Sbjct: 143 VNHIH---QHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEV-QGEQQAWFGF-AGTP 197
Query: 221 GFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
           G+++PE      + +  D+++ G  L  LL G
Sbjct: 198 GYLSPEVLRKDPYGKPVDIWACGVILYILLVG 229

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/117 (34%), Positives = 60/117 (51%), Gaps = 11/117 (9%)
Query: 154 IKIAM-EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSA-KLHDFSLSVSIPEGETHV 211
           +K+ M ++  ++AY+H  F   I  R IK  N+LLD + +  KL DF  +  +  GE +V
Sbjct: 124 VKLYMYQLFRSLAYIH-SFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV 180
Query: 212 REEFIKGAYGFIAPEY-FATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDL 267
              +I   Y + APE  F  + +    DV+S G  L ELL G  +  F G+   D L
Sbjct: 181 --SYICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI--FPGDSGVDQL 232

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/201 (19%), Positives = 88/201 (43%), Gaps = 17/201 (8%)
Query: 61  KVIQSDTSYRLFEGTLVDQDR----PISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNIL 116
           KV+ S     +++G  + +      P+++ +  + ++    +   +     + + + ++ 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 117 KLIGCCLETELPTLVFESVKYGTLRGF------SFASLLIAPRIKIAMEIANAVAYLHVG 170
           +L+G CL + +  L+ + + +G L  +      +  S  +   +   ++IA  + YL   
Sbjct: 83  RLLGICLTSTV-QLIMQLMPFGCLLDYVREHKDNIGSQYL---LNWCVQIAKGMNYLE-- 136
Query: 171 FDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFAT 230
            DR +V R + A NVL+      K+ DF  +  +   E     E  K    ++A E    
Sbjct: 137 -DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILH 195
Query: 231 SSFNEMCDVYSFGAFLCELLT 251
             +    DV+S+G  + EL+T
Sbjct: 196 RIYTHQSDVWSYGVTVWELMT 216

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/117 (34%), Positives = 60/117 (51%), Gaps = 11/117 (9%)
Query: 154 IKIAM-EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSA-KLHDFSLSVSIPEGETHV 211
           +K+ M ++  ++AY+H  F   I  R IK  N+LLD + +  KL DF  +  +  GE +V
Sbjct: 129 VKLYMYQLFRSLAYIH-SFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV 185
Query: 212 REEFIKGAYGFIAPEY-FATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDL 267
              +I   Y + APE  F  + +    DV+S G  L ELL G  +  F G+   D L
Sbjct: 186 --SYICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI--FPGDSGVDQL 237

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/117 (34%), Positives = 60/117 (51%), Gaps = 11/117 (9%)
Query: 154 IKIAM-EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSA-KLHDFSLSVSIPEGETHV 211
           +K+ M ++  ++AY+H  F   I  R IK  N+LLD + +  KL DF  +  +  GE +V
Sbjct: 124 VKLYMYQLFRSLAYIH-SFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV 180
Query: 212 REEFIKGAYGFIAPEY-FATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDL 267
              +I   Y + APE  F  + +    DV+S G  L ELL G  +  F G+   D L
Sbjct: 181 --SYICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI--FPGDSGVDQL 232

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/119 (25%), Positives = 55/119 (46%), Gaps = 23/119 (19%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           +I   + Y+H      I+ R +K SN+ ++E+   K+ DF L+        H  +E    
Sbjct: 133 QILRGLKYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLA-------RHTDDEMT-- 180
Query: 219 AYGFIAPEYFATSS-------FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
             G++A  ++           +N+  D++S G  + ELLTG  +  F G  + D L ++
Sbjct: 181 --GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL--FPGTDHIDQLKLI 235

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/119 (25%), Positives = 55/119 (46%), Gaps = 23/119 (19%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           +I   + Y+H      I+ R +K SN+ ++E+   K+ DF L+        H  +E    
Sbjct: 144 QILRGLKYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLA-------RHTDDEMT-- 191
Query: 219 AYGFIAPEYFATSS-------FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
             G++A  ++           +N+  D++S G  + ELLTG  +  F G  + D L ++
Sbjct: 192 --GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL--FPGTDHIDQLKLI 246

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/95 (29%), Positives = 47/95 (49%), Gaps = 7/95 (7%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIP-EGETHVREEFIK 217
           +I     YLH      ++ R +K  N+ L+E+   K+ DF L+  +  +GE   R++ + 
Sbjct: 147 QIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE---RKKVLC 200
Query: 218 GAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
           G   +IAPE  +    +   DV+S G  +  LL G
Sbjct: 201 GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG 235

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 69/163 (42%), Gaps = 26/163 (15%)
Query: 102 NNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL------RGFSF---ASLLIAP 152
           N I    ++KH+NI+ L      T    LV + V  G L      RG      ASL+I  
Sbjct: 55  NEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVI-- 112
Query: 153 RIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLL---DENYSAKLHDFSLSVSIPEGET 209
                 ++ +AV YLH   +  IV R +K  N+L    +EN    + DF LS     G  
Sbjct: 113 -----QQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM 164
Query: 210 HVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
                   G  G++APE  A   +++  D +S G     LL G
Sbjct: 165 STA----CGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/201 (19%), Positives = 88/201 (43%), Gaps = 17/201 (8%)
Query: 61  KVIQSDTSYRLFEGTLVDQDR----PISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNIL 116
           KV+ S     +++G  + +      P+++ +  + ++    +   +     + + + ++ 
Sbjct: 25  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 84
Query: 117 KLIGCCLETELPTLVFESVKYGTLRGF------SFASLLIAPRIKIAMEIANAVAYLHVG 170
           +L+G CL + +  L+ + + +G L  +      +  S  +   +   ++IA  + YL   
Sbjct: 85  RLLGICLTSTV-QLIMQLMPFGCLLDYVREHKDNIGSQYL---LNWCVQIAKGMNYLE-- 138
Query: 171 FDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFAT 230
            DR +V R + A NVL+      K+ DF  +  +   E     E  K    ++A E    
Sbjct: 139 -DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILH 197
Query: 231 SSFNEMCDVYSFGAFLCELLT 251
             +    DV+S+G  + EL+T
Sbjct: 198 RIYTHQSDVWSYGVTVWELMT 218

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/119 (25%), Positives = 55/119 (46%), Gaps = 23/119 (19%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           +I   + Y+H      I+ R +K SN+ ++E+   K+ DF L+        H  +E    
Sbjct: 138 QILRGLKYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLA-------RHTDDEMT-- 185
Query: 219 AYGFIAPEYFATSS-------FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
             G++A  ++           +N+  D++S G  + ELLTG  +  F G  + D L ++
Sbjct: 186 --GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL--FPGTDHIDQLKLI 240

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/119 (25%), Positives = 55/119 (46%), Gaps = 23/119 (19%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           +I   + Y+H      I+ R +K SN+ ++E+   K+ DF L+        H  +E    
Sbjct: 138 QILRGLKYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLA-------RHTDDEMT-- 185
Query: 219 AYGFIAPEYFATSS-------FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
             G++A  ++           +N+  D++S G  + ELLTG  +  F G  + D L ++
Sbjct: 186 --GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL--FPGTDHIDQLKLI 240

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/95 (29%), Positives = 47/95 (49%), Gaps = 7/95 (7%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIP-EGETHVREEFIK 217
           +    V YLH   +  ++ R +K  N+ L+++   K+ DF L+  I  +GE   R++ + 
Sbjct: 134 QTIQGVQYLH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGE---RKKDLC 187
Query: 218 GAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
           G   +IAPE       +   D++S G  L  LL G
Sbjct: 188 GTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVG 222

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/103 (27%), Positives = 51/103 (49%), Gaps = 14/103 (13%)
Query: 154 IKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVRE 213
           + +A++  +++ ++H         R +K  N+LLD++   KL DF   + + + E  VR 
Sbjct: 177 VVLALDAIHSMGFIH---------RDVKPDNMLLDKSGHLKLADFGTCMKMNK-EGMVRC 226
Query: 214 EFIKGAYGFIAPEYFATSS----FNEMCDVYSFGAFLCELLTG 252
           +   G   +I+PE   +      +   CD +S G FL E+L G
Sbjct: 227 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/95 (29%), Positives = 47/95 (49%), Gaps = 7/95 (7%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIP-EGETHVREEFIK 217
           +I     YLH      ++ R +K  N+ L+E+   K+ DF L+  +  +GE   R++ + 
Sbjct: 149 QIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE---RKKVLC 202
Query: 218 GAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
           G   +IAPE  +    +   DV+S G  +  LL G
Sbjct: 203 GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG 237

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/103 (27%), Positives = 51/103 (49%), Gaps = 14/103 (13%)
Query: 154 IKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVRE 213
           + +A++  +++ ++H         R +K  N+LLD++   KL DF   + + + E  VR 
Sbjct: 182 VVLALDAIHSMGFIH---------RDVKPDNMLLDKSGHLKLADFGTCMKMNK-EGMVRC 231
Query: 214 EFIKGAYGFIAPEYFATSS----FNEMCDVYSFGAFLCELLTG 252
           +   G   +I+PE   +      +   CD +S G FL E+L G
Sbjct: 232 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/119 (26%), Positives = 55/119 (46%), Gaps = 23/119 (19%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           +I   + Y+H      I+ R +K SN+ ++E+   K+ DF L+        H  +E    
Sbjct: 133 QILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-------RHTDDEMA-- 180
Query: 219 AYGFIAPEYFATSS-------FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
             GF+A  ++           +N+  D++S G  + ELLTG  +  F G  + D L ++
Sbjct: 181 --GFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL--FPGTDHIDQLKLI 235

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/103 (27%), Positives = 51/103 (49%), Gaps = 14/103 (13%)
Query: 154 IKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVRE 213
           + +A++  +++ ++H         R +K  N+LLD++   KL DF   + + + E  VR 
Sbjct: 182 VVLALDAIHSMGFIH---------RDVKPDNMLLDKSGHLKLADFGTCMKMNK-EGMVRC 231
Query: 214 EFIKGAYGFIAPEYFATSS----FNEMCDVYSFGAFLCELLTG 252
           +   G   +I+PE   +      +   CD +S G FL E+L G
Sbjct: 232 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/119 (26%), Positives = 55/119 (46%), Gaps = 23/119 (19%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           +I   + Y+H      I+ R +K SN+ ++E+   K+ DF L+        H  +E    
Sbjct: 133 QILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-------RHTDDEMA-- 180
Query: 219 AYGFIAPEYFATSS-------FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
             GF+A  ++           +N+  D++S G  + ELLTG  +  F G  + D L ++
Sbjct: 181 --GFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL--FPGTDHIDQLKLI 235

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/95 (29%), Positives = 47/95 (49%), Gaps = 7/95 (7%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIP-EGETHVREEFIK 217
           +    V YLH   +  ++ R +K  N+ L+++   K+ DF L+  I  +GE   R++ + 
Sbjct: 150 QTIQGVQYLH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGE---RKKDLC 203
Query: 218 GAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
           G   +IAPE       +   D++S G  L  LL G
Sbjct: 204 GTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVG 238

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/95 (29%), Positives = 47/95 (49%), Gaps = 7/95 (7%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIP-EGETHVREEFIK 217
           +I     YLH      ++ R +K  N+ L+E+   K+ DF L+  +  +GE   R++ + 
Sbjct: 123 QIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE---RKKVLC 176
Query: 218 GAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
           G   +IAPE  +    +   DV+S G  +  LL G
Sbjct: 177 GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG 211

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/119 (25%), Positives = 55/119 (46%), Gaps = 23/119 (19%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           +I   + Y+H      I+ R +K SN+ ++E+   K+ DF L+        H  +E    
Sbjct: 135 QILRGLKYIHSA---DIIHRDLKPSNLAVNEDSELKILDFGLA-------RHTDDEMT-- 182
Query: 219 AYGFIAPEYFATSS-------FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
             G++A  ++           +N+  D++S G  + ELLTG  +  F G  + D L ++
Sbjct: 183 --GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL--FPGTDHIDQLKLI 237

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/119 (25%), Positives = 55/119 (46%), Gaps = 23/119 (19%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           +I   + Y+H      I+ R +K SN+ ++E+   K+ DF L+        H  +E    
Sbjct: 139 QILRGLKYIHSA---DIIHRDLKPSNLAVNEDSELKILDFGLA-------RHTDDEMT-- 186
Query: 219 AYGFIAPEYFATSS-------FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
             G++A  ++           +N+  D++S G  + ELLTG  +  F G  + D L ++
Sbjct: 187 --GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL--FPGTDHIDQLKLI 241

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/119 (26%), Positives = 55/119 (46%), Gaps = 23/119 (19%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           +I   + Y+H      I+ R +K SN+ ++E+   K+ DF L+        H  +E    
Sbjct: 129 QILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-------RHTDDEMA-- 176
Query: 219 AYGFIAPEYFATSS-------FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
             GF+A  ++           +N+  D++S G  + ELLTG  +  F G  + D L ++
Sbjct: 177 --GFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL--FPGTDHIDQLKLI 231

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/95 (29%), Positives = 47/95 (49%), Gaps = 7/95 (7%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIP-EGETHVREEFIK 217
           +I     YLH      ++ R +K  N+ L+E+   K+ DF L+  +  +GE   R++ + 
Sbjct: 125 QIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE---RKKTLC 178
Query: 218 GAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
           G   +IAPE  +    +   DV+S G  +  LL G
Sbjct: 179 GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG 213

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/95 (29%), Positives = 47/95 (49%), Gaps = 7/95 (7%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIP-EGETHVREEFIK 217
           +I     YLH      ++ R +K  N+ L+E+   K+ DF L+  +  +GE   R++ + 
Sbjct: 125 QIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE---RKKTLC 178
Query: 218 GAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
           G   +IAPE  +    +   DV+S G  +  LL G
Sbjct: 179 GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG 213

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/201 (19%), Positives = 88/201 (43%), Gaps = 17/201 (8%)
Query: 61  KVIQSDTSYRLFEGTLVDQDR----PISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNIL 116
           KV+ S     +++G  + +      P+++ +  + ++    +   +     + + + ++ 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 117 KLIGCCLETELPTLVFESVKYGTLRGF------SFASLLIAPRIKIAMEIANAVAYLHVG 170
           +L+G CL + +  L+ + + +G L  +      +  S  +   +   ++IA  + YL   
Sbjct: 83  RLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIGSQYL---LNWCVQIAKGMNYLE-- 136
Query: 171 FDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFAT 230
            DR +V R + A NVL+      K+ DF  +  +   E     E  K    ++A E    
Sbjct: 137 -DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILH 195
Query: 231 SSFNEMCDVYSFGAFLCELLT 251
             +    DV+S+G  + EL+T
Sbjct: 196 RIYTHQSDVWSYGVTVWELMT 216

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/231 (23%), Positives = 97/231 (41%), Gaps = 40/231 (17%)
Query: 48  KDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFS 107
           K L K T  Y   K ++ D+     EGT     R IS+MK                    
Sbjct: 23  KGLNKTTGVYVALKEVKLDSE----EGTPSTAIREISLMK-------------------- 58
Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPR------IK-IAMEI 160
            ++KH+NI++L          TLVFE +     +     ++   PR      +K    ++
Sbjct: 59  -ELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQL 117
Query: 161 ANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAY 220
              +A+ H   +  I+ R +K  N+L+++    KL DF L+ +          E +   Y
Sbjct: 118 LQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWY 174
Query: 221 GFIAPEYFATS-SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
              AP+    S +++   D++S G  L E++TG  +  F G  +++ L ++
Sbjct: 175 R--APDVLMGSRTYSTSIDIWSCGCILAEMITGKPL--FPGTNDEEQLKLI 221

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/95 (29%), Positives = 47/95 (49%), Gaps = 7/95 (7%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIP-EGETHVREEFIK 217
           +I     YLH      ++ R +K  N+ L+E+   K+ DF L+  +  +GE   R++ + 
Sbjct: 129 QIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE---RKKTLC 182
Query: 218 GAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
           G   +IAPE  +    +   DV+S G  +  LL G
Sbjct: 183 GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG 217

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/201 (19%), Positives = 88/201 (43%), Gaps = 17/201 (8%)
Query: 61  KVIQSDTSYRLFEGTLVDQDR----PISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNIL 116
           KV+ S     +++G  + +      P+++ +  + ++    +   +     + + + ++ 
Sbjct: 28  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 117 KLIGCCLETELPTLVFESVKYGTLRGF------SFASLLIAPRIKIAMEIANAVAYLHVG 170
           +L+G CL + +  L+ + + +G L  +      +  S  +   +   ++IA  + YL   
Sbjct: 88  RLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIGSQYL---LNWCVQIAKGMNYLE-- 141
Query: 171 FDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFAT 230
            DR +V R + A NVL+      K+ DF  +  +   E     E  K    ++A E    
Sbjct: 142 -DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILH 200
Query: 231 SSFNEMCDVYSFGAFLCELLT 251
             +    DV+S+G  + EL+T
Sbjct: 201 RIYTHQSDVWSYGVTVWELMT 221

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/119 (25%), Positives = 55/119 (46%), Gaps = 23/119 (19%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           +I   + Y+H      I+ R +K SN+ ++E+   K+ DF L+        H  +E    
Sbjct: 140 QILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-------RHTADEMT-- 187
Query: 219 AYGFIAPEYFATSS-------FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
             G++A  ++           +N+  D++S G  + ELLTG  +  F G  + D L ++
Sbjct: 188 --GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL--FPGTDHIDQLKLI 242

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 71/166 (42%), Gaps = 24/166 (14%)
Query: 111 KHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIKIAM--EIANAVAYLH 168
           +H NI+ L     + +   +V E +K G L          + R   A+   I   V YLH
Sbjct: 74  QHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLH 133
Query: 169 VGFDRPIVFRCIKASNVL-LDEN---YSAKLHDFSLSVSIPEGETHVREE---FIKGAY- 220
               + +V R +K SN+L +DE+    S ++ DF  +         +R E    +   Y 
Sbjct: 134 A---QGVVHRDLKPSNILYVDESGNPESIRICDFGFA-------KQLRAENGLLMTPCYT 183
Query: 221 -GFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDD 265
             F+APE      ++  CD++S G  L  +LTG        NG DD
Sbjct: 184 ANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPF---ANGPDD 226

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/119 (25%), Positives = 55/119 (46%), Gaps = 23/119 (19%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           +I   + Y+H      I+ R +K SN+ ++E+   K+ DF L+        H  +E    
Sbjct: 133 QILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-------RHTDDEMT-- 180
Query: 219 AYGFIAPEYFATSS-------FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
             G++A  ++           +N+  D++S G  + ELLTG  +  F G  + D L ++
Sbjct: 181 --GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL--FPGTDHIDQLKLI 235

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 69/163 (42%), Gaps = 25/163 (15%)
Query: 102 NNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL------RGF---SFASLLIAP 152
           N I    ++KH+NI+ L           LV + V  G L      +GF     AS LI  
Sbjct: 69  NEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLI-- 126
Query: 153 RIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLL---DENYSAKLHDFSLSVSIPEGET 209
                 ++ +AV YLH      IV R +K  N+L    DE     + DF LS    EG+ 
Sbjct: 127 -----RQVLDAVYYLH---RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKM--EGKG 176
Query: 210 HVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
            V      G  G++APE  A   +++  D +S G     LL G
Sbjct: 177 DVMSTAC-GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 218

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/119 (25%), Positives = 55/119 (46%), Gaps = 23/119 (19%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           +I   + Y+H      I+ R +K SN+ ++E+   K+ DF L+        H  +E    
Sbjct: 140 QILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-------RHTADEMT-- 187
Query: 219 AYGFIAPEYFATSS-------FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
             G++A  ++           +N+  D++S G  + ELLTG  +  F G  + D L ++
Sbjct: 188 --GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL--FPGTDHIDQLKLI 242

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/119 (25%), Positives = 55/119 (46%), Gaps = 23/119 (19%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           +I   + Y+H      I+ R +K SN+ ++E+   K+ DF L+        H  +E    
Sbjct: 156 QILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-------RHTDDEMT-- 203
Query: 219 AYGFIAPEYFATSS-------FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
             G++A  ++           +N+  D++S G  + ELLTG  +  F G  + D L ++
Sbjct: 204 --GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL--FPGTDHIDQLKLI 258

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/119 (25%), Positives = 55/119 (46%), Gaps = 23/119 (19%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           +I   + Y+H      I+ R +K SN+ ++E+   K+ DF L+        H  +E    
Sbjct: 133 QILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-------RHTDDEMT-- 180
Query: 219 AYGFIAPEYFATSS-------FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
             G++A  ++           +N+  D++S G  + ELLTG  +  F G  + D L ++
Sbjct: 181 --GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL--FPGTDHIDQLKLI 235

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/119 (25%), Positives = 55/119 (46%), Gaps = 23/119 (19%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           +I   + Y+H      I+ R +K SN+ ++E+   K+ DF L+        H  +E    
Sbjct: 133 QILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-------RHTDDEMT-- 180
Query: 219 AYGFIAPEYFATSS-------FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
             G++A  ++           +N+  D++S G  + ELLTG  +  F G  + D L ++
Sbjct: 181 --GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL--FPGTDHIDQLKLI 235

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/119 (25%), Positives = 55/119 (46%), Gaps = 23/119 (19%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           +I   + Y+H      I+ R +K SN+ ++E+   K+ DF L+        H  +E    
Sbjct: 140 QILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-------RHTADEMT-- 187
Query: 219 AYGFIAPEYFATSS-------FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
             G++A  ++           +N+  D++S G  + ELLTG  +  F G  + D L ++
Sbjct: 188 --GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL--FPGTDHIDQLKLI 242

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/119 (25%), Positives = 55/119 (46%), Gaps = 23/119 (19%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           +I   + Y+H      I+ R +K SN+ ++E+   K+ DF L+        H  +E    
Sbjct: 133 QILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-------RHTDDEMT-- 180
Query: 219 AYGFIAPEYFATSS-------FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
             G++A  ++           +N+  D++S G  + ELLTG  +  F G  + D L ++
Sbjct: 181 --GYVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGRTL--FPGTDHIDQLKLI 235

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/119 (25%), Positives = 55/119 (46%), Gaps = 23/119 (19%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           +I   + Y+H      I+ R +K SN+ ++E+   K+ DF L+        H  +E    
Sbjct: 133 QILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-------RHTDDEMT-- 180
Query: 219 AYGFIAPEYFATSS-------FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
             G++A  ++           +N+  D++S G  + ELLTG  +  F G  + D L ++
Sbjct: 181 --GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL--FPGTDHIDQLKLI 235

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/201 (19%), Positives = 88/201 (43%), Gaps = 17/201 (8%)
Query: 61  KVIQSDTSYRLFEGTLVDQDR----PISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNIL 116
           KV+ S     +++G  + +      P+++ +  + ++    +   +     + + + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 117 KLIGCCLETELPTLVFESVKYGTLRGF------SFASLLIAPRIKIAMEIANAVAYLHVG 170
           +L+G CL + +  L+ + + +G L  +      +  S  +   +   ++IA  + YL   
Sbjct: 81  RLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIGSQYL---LNWCVQIAKGMNYLE-- 134
Query: 171 FDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFAT 230
            DR +V R + A NVL+      K+ DF  +  +   E     E  K    ++A E    
Sbjct: 135 -DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 231 SSFNEMCDVYSFGAFLCELLT 251
             +    DV+S+G  + EL+T
Sbjct: 194 RIYTHQSDVWSYGVTVWELMT 214

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/119 (25%), Positives = 55/119 (46%), Gaps = 23/119 (19%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           +I   + Y+H      I+ R +K SN+ ++E+   K+ DF L+        H  +E    
Sbjct: 144 QILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-------RHTDDEMT-- 191
Query: 219 AYGFIAPEYFATSS-------FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
             G++A  ++           +N+  D++S G  + ELLTG  +  F G  + D L ++
Sbjct: 192 --GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL--FPGTDHIDQLKLI 246

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/119 (25%), Positives = 55/119 (46%), Gaps = 23/119 (19%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           +I   + Y+H      I+ R +K SN+ ++E+   K+ DF L+        H  +E    
Sbjct: 140 QILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-------RHTDDEMT-- 187
Query: 219 AYGFIAPEYFATSS-------FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
             G++A  ++           +N+  D++S G  + ELLTG  +  F G  + D L ++
Sbjct: 188 --GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL--FPGTDHIDQLKLI 242

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/119 (25%), Positives = 55/119 (46%), Gaps = 23/119 (19%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           +I   + Y+H      I+ R +K SN+ ++E+   K+ DF L+        H  +E    
Sbjct: 133 QILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-------RHTDDEMT-- 180
Query: 219 AYGFIAPEYFATSS-------FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
             G++A  ++           +N+  D++S G  + ELLTG  +  F G  + D L ++
Sbjct: 181 --GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL--FPGTDHIDQLKLI 235

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/119 (25%), Positives = 55/119 (46%), Gaps = 23/119 (19%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           +I   + Y+H      I+ R +K SN+ ++E+   K+ DF L+        H  +E    
Sbjct: 145 QILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-------RHTDDEMT-- 192
Query: 219 AYGFIAPEYFATSS-------FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
             G++A  ++           +N+  D++S G  + ELLTG  +  F G  + D L ++
Sbjct: 193 --GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL--FPGTDHIDQLKLI 247

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/119 (25%), Positives = 55/119 (46%), Gaps = 23/119 (19%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           +I   + Y+H      I+ R +K SN+ ++E+   K+ DF L+        H  +E    
Sbjct: 153 QILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-------RHTDDEMT-- 200
Query: 219 AYGFIAPEYFATSS-------FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
             G++A  ++           +N+  D++S G  + ELLTG  +  F G  + D L ++
Sbjct: 201 --GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL--FPGTDHIDQLKLI 255

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/119 (25%), Positives = 55/119 (46%), Gaps = 23/119 (19%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           +I   + Y+H      I+ R +K SN+ ++E+   K+ DF L+        H  +E    
Sbjct: 133 QILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-------RHTDDEMT-- 180
Query: 219 AYGFIAPEYFATSS-------FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
             G++A  ++           +N+  D++S G  + ELLTG  +  F G  + D L ++
Sbjct: 181 --GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL--FPGTDHIDQLKLI 235

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/119 (25%), Positives = 55/119 (46%), Gaps = 23/119 (19%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           +I   + Y+H      I+ R +K SN+ ++E+   K+ DF L+        H  +E    
Sbjct: 135 QILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-------RHTDDEMT-- 182
Query: 219 AYGFIAPEYFATSS-------FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
             G++A  ++           +N+  D++S G  + ELLTG  +  F G  + D L ++
Sbjct: 183 --GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL--FPGTDHIDQLKLI 237

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/119 (25%), Positives = 55/119 (46%), Gaps = 23/119 (19%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           +I   + Y+H      I+ R +K SN+ ++E+   K+ DF L+        H  +E    
Sbjct: 138 QILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-------RHTDDEMT-- 185
Query: 219 AYGFIAPEYFATSS-------FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
             G++A  ++           +N+  D++S G  + ELLTG  +  F G  + D L ++
Sbjct: 186 --GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL--FPGTDHIDQLKLI 240

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/119 (25%), Positives = 55/119 (46%), Gaps = 23/119 (19%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           +I   + Y+H      I+ R +K SN+ ++E+   K+ DF L+        H  +E    
Sbjct: 145 QILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-------RHTDDEMT-- 192
Query: 219 AYGFIAPEYFATSS-------FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
             G++A  ++           +N+  D++S G  + ELLTG  +  F G  + D L ++
Sbjct: 193 --GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL--FPGTDHIDQLKLI 247

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/119 (25%), Positives = 55/119 (46%), Gaps = 23/119 (19%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           +I   + Y+H      I+ R +K SN+ ++E+   K+ DF L+        H  +E    
Sbjct: 133 QILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-------RHTDDEMT-- 180
Query: 219 AYGFIAPEYFATSS-------FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
             G++A  ++           +N+  D++S G  + ELLTG  +  F G  + D L ++
Sbjct: 181 --GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL--FPGTDHIDQLKLI 235

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/119 (25%), Positives = 55/119 (46%), Gaps = 23/119 (19%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           +I   + Y+H      I+ R +K SN+ ++E+   K+ DF L+        H  +E    
Sbjct: 132 QILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-------RHTDDEMT-- 179
Query: 219 AYGFIAPEYFATSS-------FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
             G++A  ++           +N+  D++S G  + ELLTG  +  F G  + D L ++
Sbjct: 180 --GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL--FPGTDHIDQLKLI 234

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/119 (25%), Positives = 55/119 (46%), Gaps = 23/119 (19%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           +I   + Y+H      I+ R +K SN+ ++E+   K+ DF L+        H  +E    
Sbjct: 145 QILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-------RHTDDEMT-- 192
Query: 219 AYGFIAPEYFATSS-------FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
             G++A  ++           +N+  D++S G  + ELLTG  +  F G  + D L ++
Sbjct: 193 --GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL--FPGTDHIDQLKLI 247

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/119 (25%), Positives = 55/119 (46%), Gaps = 23/119 (19%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           +I   + Y+H      I+ R +K SN+ ++E+   K+ DF L+        H  +E    
Sbjct: 153 QILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-------RHTDDEMT-- 200
Query: 219 AYGFIAPEYFATSS-------FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
             G++A  ++           +N+  D++S G  + ELLTG  +  F G  + D L ++
Sbjct: 201 --GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL--FPGTDHIDQLKLI 255

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/119 (25%), Positives = 55/119 (46%), Gaps = 23/119 (19%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           +I   + Y+H      I+ R +K SN+ ++E+   K+ DF L+        H  +E    
Sbjct: 143 QILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-------RHTDDEMT-- 190
Query: 219 AYGFIAPEYFATSS-------FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
             G++A  ++           +N+  D++S G  + ELLTG  +  F G  + D L ++
Sbjct: 191 --GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL--FPGTDHIDQLKLI 245

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/119 (25%), Positives = 55/119 (46%), Gaps = 23/119 (19%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           +I   + Y+H      I+ R +K SN+ ++E+   K+ DF L+        H  +E    
Sbjct: 152 QILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-------RHTDDEMT-- 199
Query: 219 AYGFIAPEYFATSS-------FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
             G++A  ++           +N+  D++S G  + ELLTG  +  F G  + D L ++
Sbjct: 200 --GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL--FPGTDHIDQLKLI 254

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/119 (25%), Positives = 55/119 (46%), Gaps = 23/119 (19%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           +I   + Y+H      I+ R +K SN+ ++E+   K+ DF L+        H  +E    
Sbjct: 135 QILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-------RHTDDEMT-- 182
Query: 219 AYGFIAPEYFATSS-------FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
             G++A  ++           +N+  D++S G  + ELLTG  +  F G  + D L ++
Sbjct: 183 --GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL--FPGTDHIDQLKLI 237

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/119 (25%), Positives = 55/119 (46%), Gaps = 23/119 (19%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           +I   + Y+H      I+ R +K SN+ ++E+   K+ DF L+        H  +E    
Sbjct: 139 QILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-------RHTDDEMT-- 186
Query: 219 AYGFIAPEYFATSS-------FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
             G++A  ++           +N+  D++S G  + ELLTG  +  F G  + D L ++
Sbjct: 187 --GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL--FPGTDHIDQLKLI 241

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/119 (25%), Positives = 55/119 (46%), Gaps = 23/119 (19%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           +I   + Y+H      I+ R +K SN+ ++E+   K+ DF L+        H  +E    
Sbjct: 135 QILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-------RHTDDEMT-- 182
Query: 219 AYGFIAPEYFATSS-------FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
             G++A  ++           +N+  D++S G  + ELLTG  +  F G  + D L ++
Sbjct: 183 --GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL--FPGTDHIDQLKLI 237

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/119 (25%), Positives = 55/119 (46%), Gaps = 23/119 (19%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           +I   + Y+H      I+ R +K SN+ ++E+   K+ DF L+        H  +E    
Sbjct: 152 QILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-------RHTDDEMT-- 199
Query: 219 AYGFIAPEYFATSS-------FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
             G++A  ++           +N+  D++S G  + ELLTG  +  F G  + D L ++
Sbjct: 200 --GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL--FPGTDHIDQLKLI 254

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 69/167 (41%), Gaps = 9/167 (5%)
Query: 104 IVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRI--KIAMEIA 161
           I    ++KHKNI++L       +  TLVFE       + F   +  + P I      ++ 
Sbjct: 52  ICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLL 111
Query: 162 NAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYG 221
             + + H    R ++ R +K  N+L++ N   KL DF L+ +          E +   Y 
Sbjct: 112 KGLGFCH---SRNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYR 168
Query: 222 FIAPE-YFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDL 267
              P+  F    ++   D++S G    EL      L F GN  DD L
Sbjct: 169 --PPDVLFGAKLYSTSIDMWSAGCIFAELANAARPL-FPGNDVDDQL 212

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/119 (25%), Positives = 55/119 (46%), Gaps = 23/119 (19%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           +I   + Y+H      I+ R +K SN+ ++E+   K+ DF L+        H  +E    
Sbjct: 138 QILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-------RHTDDEMT-- 185
Query: 219 AYGFIAPEYFATSS-------FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
             G++A  ++           +N+  D++S G  + ELLTG  +  F G  + D L ++
Sbjct: 186 --GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL--FPGTDHIDQLKLI 240

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/119 (25%), Positives = 55/119 (46%), Gaps = 23/119 (19%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           +I   + Y+H      I+ R +K SN+ ++E+   K+ DF L+        H  +E    
Sbjct: 133 QILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-------RHTDDEMT-- 180
Query: 219 AYGFIAPEYFATSS-------FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
             G++A  ++           +N+  D++S G  + ELLTG  +  F G  + D L ++
Sbjct: 181 --GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL--FPGTDHIDQLKLI 235

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 57/116 (49%), Gaps = 19/116 (16%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIK- 217
           +I +AV Y H      IV R +K  N+LLDE+ + K+ DF LS  + +G       F+K 
Sbjct: 111 QIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG------NFLKT 161
Query: 218 --GAYGFIAPEYFATSSF-NEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
             G+  + APE  +   +     DV+S G  L  +L  C  L F    +D+ + VL
Sbjct: 162 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVML--CRRLPF----DDESIPVL 211

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 57/116 (49%), Gaps = 19/116 (16%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIK- 217
           +I +AV Y H      IV R +K  N+LLDE+ + K+ DF LS  + +G       F+K 
Sbjct: 121 QIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG------NFLKT 171
Query: 218 --GAYGFIAPEYFATSSF-NEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
             G+  + APE  +   +     DV+S G  L  +L  C  L F    +D+ + VL
Sbjct: 172 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVML--CRRLPF----DDESIPVL 221

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/119 (25%), Positives = 55/119 (46%), Gaps = 23/119 (19%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           +I   + Y+H      I+ R +K SN+ ++E+   K+ DF L+        H  +E    
Sbjct: 139 QILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-------RHTDDEMT-- 186
Query: 219 AYGFIAPEYFATSS-------FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
             G++A  ++           +N+  D++S G  + ELLTG  +  F G  + D L ++
Sbjct: 187 --GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL--FPGTDHIDQLKLI 241

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/119 (25%), Positives = 55/119 (46%), Gaps = 23/119 (19%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           +I   + Y+H      I+ R +K SN+ ++E+   K+ DF L+        H  +E    
Sbjct: 130 QILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-------RHTDDEMT-- 177
Query: 219 AYGFIAPEYFATSS-------FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
             G++A  ++           +N+  D++S G  + ELLTG  +  F G  + D L ++
Sbjct: 178 --GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL--FPGTDHIDQLKLI 232

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/119 (25%), Positives = 55/119 (46%), Gaps = 23/119 (19%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           +I   + Y+H      I+ R +K SN+ ++E+   K+ DF L+        H  +E    
Sbjct: 133 QILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-------RHTDDEMT-- 180
Query: 219 AYGFIAPEYFATSS-------FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
             G++A  ++           +N+  D++S G  + ELLTG  +  F G  + D L ++
Sbjct: 181 --GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL--FPGTDHIDQLKLI 235

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 75/171 (43%), Gaps = 10/171 (5%)
Query: 100 CFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF-SFASLLIAPRIKIAM 158
               I    ++ H NI+ LI         TLVFE ++    +      + L   +IKI +
Sbjct: 66  AIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYL 125
Query: 159 -EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIK 217
            ++   VA+ H      I+ R +K  N+L++ + + KL DF L+ +          E + 
Sbjct: 126 YQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVT 182
Query: 218 GAYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDL 267
             Y   AP+    S  ++   D++S G    E++TG  +  F G  +DD L
Sbjct: 183 LWYR--APDVLMGSKKYSTSVDIWSIGCIFAEMITGKPL--FPGVTDDDQL 229

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 57/116 (49%), Gaps = 19/116 (16%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIK- 217
           +I +AV Y H      IV R +K  N+LLDE+ + K+ DF LS  + +G       F+K 
Sbjct: 120 QIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG------NFLKT 170
Query: 218 --GAYGFIAPEYFATSSF-NEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
             G+  + APE  +   +     DV+S G  L  +L  C  L F    +D+ + VL
Sbjct: 171 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVML--CRRLPF----DDESIPVL 220

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/119 (25%), Positives = 55/119 (46%), Gaps = 23/119 (19%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           +I   + Y+H      I+ R +K SN+ ++E+   K+ DF L+        H  +E    
Sbjct: 129 QILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-------RHTDDEMT-- 176
Query: 219 AYGFIAPEYFATSS-------FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
             G++A  ++           +N+  D++S G  + ELLTG  +  F G  + D L ++
Sbjct: 177 --GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL--FPGTDHIDQLKLI 231

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 40/117 (34%), Positives = 59/117 (50%), Gaps = 11/117 (9%)
Query: 154 IKIAM-EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSA-KLHDFSLSVSIPEGETHV 211
           +K+ M ++  ++AY+H  F   I  R IK  N+LLD + +  KL DF  +  +  GE +V
Sbjct: 158 VKLYMYQLFRSLAYIH-SFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV 214
Query: 212 REEFIKGAYGFIAPEY-FATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDL 267
               I   Y + APE  F  + +    DV+S G  L ELL G  +  F G+   D L
Sbjct: 215 --SXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI--FPGDSGVDQL 266

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 75/171 (43%), Gaps = 10/171 (5%)
Query: 100 CFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF-SFASLLIAPRIKIAM 158
               I    ++ H NI+ LI         TLVFE ++    +      + L   +IKI +
Sbjct: 66  AIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYL 125
Query: 159 -EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIK 217
            ++   VA+ H      I+ R +K  N+L++ + + KL DF L+ +          E + 
Sbjct: 126 YQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVT 182
Query: 218 GAYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDL 267
             Y   AP+    S  ++   D++S G    E++TG  +  F G  +DD L
Sbjct: 183 LWYR--APDVLMGSKKYSTSVDIWSIGCIFAEMITGKPL--FPGVTDDDQL 229

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/119 (25%), Positives = 55/119 (46%), Gaps = 23/119 (19%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           +I   + Y+H      I+ R +K SN+ ++E+   K+ DF L+        H  +E    
Sbjct: 130 QILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-------RHTDDEMT-- 177
Query: 219 AYGFIAPEYFATSS-------FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
             G++A  ++           +N+  D++S G  + ELLTG  +  F G  + D L ++
Sbjct: 178 --GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL--FPGTDHIDQLKLI 232

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 57/116 (49%), Gaps = 19/116 (16%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIK- 217
           +I +AV Y H      IV R +K  N+LLDE+ + K+ DF LS  + +G       F+K 
Sbjct: 115 QIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG------NFLKT 165
Query: 218 --GAYGFIAPEYFATSSF-NEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
             G+  + APE  +   +     DV+S G  L  +L  C  L F    +D+ + VL
Sbjct: 166 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVML--CRRLPF----DDESIPVL 215

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 40/117 (34%), Positives = 59/117 (50%), Gaps = 11/117 (9%)
Query: 154 IKIAM-EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSA-KLHDFSLSVSIPEGETHV 211
           +K+ M ++  ++AY+H  F   I  R IK  N+LLD + +  KL DF  +  +  GE +V
Sbjct: 136 VKLYMYQLFRSLAYIH-SFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV 192
Query: 212 REEFIKGAYGFIAPEY-FATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDL 267
               I   Y + APE  F  + +    DV+S G  L ELL G  +  F G+   D L
Sbjct: 193 --SXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI--FPGDSGVDQL 244

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/119 (25%), Positives = 55/119 (46%), Gaps = 23/119 (19%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           +I   + Y+H      I+ R +K SN+ ++E+   K+ DF L+        H  +E    
Sbjct: 131 QILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-------RHTDDEMT-- 178
Query: 219 AYGFIAPEYFATSS-------FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
             G++A  ++           +N+  D++S G  + ELLTG  +  F G  + D L ++
Sbjct: 179 --GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL--FPGTDHIDQLKLI 233

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/119 (25%), Positives = 55/119 (46%), Gaps = 23/119 (19%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           +I   + Y+H      I+ R +K SN+ ++E+   K+ DF L+        H  +E    
Sbjct: 139 QILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-------RHTDDEMT-- 186
Query: 219 AYGFIAPEYFATSS-------FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
             G++A  ++           +N+  D++S G  + ELLTG  +  F G  + D L ++
Sbjct: 187 --GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL--FPGTDHIDQLKLI 241

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/119 (25%), Positives = 55/119 (46%), Gaps = 23/119 (19%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           +I   + Y+H      I+ R +K SN+ ++E+   K+ DF L+        H  +E    
Sbjct: 129 QILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-------RHTDDEMT-- 176
Query: 219 AYGFIAPEYFATSS-------FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
             G++A  ++           +N+  D++S G  + ELLTG  +  F G  + D L ++
Sbjct: 177 --GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL--FPGTDHIDQLKLI 231

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 40/117 (34%), Positives = 59/117 (50%), Gaps = 11/117 (9%)
Query: 154 IKIAM-EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSA-KLHDFSLSVSIPEGETHV 211
           +K+ M ++  ++AY+H  F   I  R IK  N+LLD + +  KL DF  +  +  GE +V
Sbjct: 143 VKLYMYQLFRSLAYIH-SFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV 199
Query: 212 REEFIKGAYGFIAPEY-FATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDL 267
               I   Y + APE  F  + +    DV+S G  L ELL G  +  F G+   D L
Sbjct: 200 --SXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI--FPGDSGVDQL 251

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/119 (25%), Positives = 55/119 (46%), Gaps = 23/119 (19%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           +I   + Y+H      I+ R +K SN+ ++E+   K+ DF L+        H  +E    
Sbjct: 156 QILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-------RHTDDEMX-- 203
Query: 219 AYGFIAPEYFATSS-------FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
             G++A  ++           +N+  D++S G  + ELLTG  +  F G  + D L ++
Sbjct: 204 --GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL--FPGTDHIDQLKLI 258

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 40/117 (34%), Positives = 59/117 (50%), Gaps = 11/117 (9%)
Query: 154 IKIAM-EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSA-KLHDFSLSVSIPEGETHV 211
           +K+ M ++  ++AY+H  F   I  R IK  N+LLD + +  KL DF  +  +  GE +V
Sbjct: 132 VKLYMYQLFRSLAYIH-SFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV 188
Query: 212 REEFIKGAYGFIAPEY-FATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDL 267
               I   Y + APE  F  + +    DV+S G  L ELL G  +  F G+   D L
Sbjct: 189 --SXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI--FPGDSGVDQL 240

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 40/117 (34%), Positives = 59/117 (50%), Gaps = 11/117 (9%)
Query: 154 IKIAM-EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSA-KLHDFSLSVSIPEGETHV 211
           +K+ M ++  ++AY+H  F   I  R IK  N+LLD + +  KL DF  +  +  GE +V
Sbjct: 124 VKLYMYQLFRSLAYIH-SFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV 180
Query: 212 REEFIKGAYGFIAPEY-FATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDL 267
               I   Y + APE  F  + +    DV+S G  L ELL G  +  F G+   D L
Sbjct: 181 --SXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI--FPGDSGVDQL 232

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/119 (25%), Positives = 54/119 (45%), Gaps = 23/119 (19%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           +I   + Y+H      I+ R +K SN+ ++E+   K+ DF L         H  +E    
Sbjct: 133 QILRGLKYIHSA---DIIHRDLKPSNLAVNEDSELKILDFGLC-------RHTDDEMT-- 180
Query: 219 AYGFIAPEYFATSS-------FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
             G++A  ++           +N+  D++S G  + ELLTG  +  F G  + D L ++
Sbjct: 181 --GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL--FPGTDHIDQLKLI 235

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/119 (25%), Positives = 55/119 (46%), Gaps = 23/119 (19%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           +I   + Y+H      I+ R +K SN+ ++E+   K+ DF L+        H  +E    
Sbjct: 129 QILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-------RHTDDEMT-- 176
Query: 219 AYGFIAPEYFATSS-------FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
             G++A  ++           +N+  D++S G  + ELLTG  +  F G  + D L ++
Sbjct: 177 --GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL--FPGTDHIDQLKLI 231

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 40/117 (34%), Positives = 59/117 (50%), Gaps = 11/117 (9%)
Query: 154 IKIAM-EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSA-KLHDFSLSVSIPEGETHV 211
           +K+ M ++  ++AY+H  F   I  R IK  N+LLD + +  KL DF  +  +  GE +V
Sbjct: 124 VKLYMYQLFRSLAYIH-SFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV 180
Query: 212 REEFIKGAYGFIAPEY-FATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDL 267
               I   Y + APE  F  + +    DV+S G  L ELL G  +  F G+   D L
Sbjct: 181 --SXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI--FPGDSGVDQL 232

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 40/117 (34%), Positives = 59/117 (50%), Gaps = 11/117 (9%)
Query: 154 IKIAM-EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSA-KLHDFSLSVSIPEGETHV 211
           +K+ M ++  ++AY+H  F   I  R IK  N+LLD + +  KL DF  +  +  GE +V
Sbjct: 125 VKLYMYQLFRSLAYIH-SFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV 181
Query: 212 REEFIKGAYGFIAPEY-FATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDL 267
               I   Y + APE  F  + +    DV+S G  L ELL G  +  F G+   D L
Sbjct: 182 --SXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI--FPGDSGVDQL 233

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 40/117 (34%), Positives = 59/117 (50%), Gaps = 11/117 (9%)
Query: 154 IKIAM-EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSA-KLHDFSLSVSIPEGETHV 211
           +K+ M ++  ++AY+H  F   I  R IK  N+LLD + +  KL DF  +  +  GE +V
Sbjct: 136 VKLYMYQLFRSLAYIH-SFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV 192
Query: 212 REEFIKGAYGFIAPEY-FATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDL 267
               I   Y + APE  F  + +    DV+S G  L ELL G  +  F G+   D L
Sbjct: 193 --SXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI--FPGDSGVDQL 244

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 40/117 (34%), Positives = 59/117 (50%), Gaps = 11/117 (9%)
Query: 154 IKIAM-EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSA-KLHDFSLSVSIPEGETHV 211
           +K+ M ++  ++AY+H  F   I  R IK  N+LLD + +  KL DF  +  +  GE +V
Sbjct: 128 VKLYMYQLFRSLAYIH-SFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV 184
Query: 212 REEFIKGAYGFIAPEY-FATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDL 267
               I   Y + APE  F  + +    DV+S G  L ELL G  +  F G+   D L
Sbjct: 185 --SXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI--FPGDSGVDQL 236

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 40/117 (34%), Positives = 59/117 (50%), Gaps = 11/117 (9%)
Query: 154 IKIAM-EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSA-KLHDFSLSVSIPEGETHV 211
           +K+ M ++  ++AY+H  F   I  R IK  N+LLD + +  KL DF  +  +  GE +V
Sbjct: 124 VKLYMYQLFRSLAYIH-SFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV 180
Query: 212 REEFIKGAYGFIAPEY-FATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDL 267
               I   Y + APE  F  + +    DV+S G  L ELL G  +  F G+   D L
Sbjct: 181 --SXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI--FPGDSGVDQL 232

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 28/90 (31%), Positives = 44/90 (48%), Gaps = 5/90 (5%)
Query: 163 AVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGF 222
            + YLH  F R I  R IKA N+LL+    AKL DF ++  +   +   +   + G   +
Sbjct: 137 GLEYLH--FMRKI-HRDIKAGNILLNTEGHAKLADFGVAGQL--TDXMAKRNXVIGTPFW 191
Query: 223 IAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
           +APE      +N + D++S G    E+  G
Sbjct: 192 MAPEVIQEIGYNCVADIWSLGITAIEMAEG 221

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 68/152 (44%), Gaps = 18/152 (11%)
Query: 110 MKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLI------APRIKIAMEIANA 163
           +KH NI++L     E     LVF+ V  G L    F  ++       A       +I  A
Sbjct: 60  LKHSNIVRLHDSISEEGFHYLVFDLVTGGEL----FEDIVAREYYSEADASHCIQQILEA 115
Query: 164 VAYLHVGFDRPIVFRCIKASNVLLD---ENYSAKLHDFSLSVSIPEGETHVREEFIKGAY 220
           V + H      +V R +K  N+LL    +  + KL DF L++ + +G+      F  G  
Sbjct: 116 VLHCH---QMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEV-QGDQQAWFGF-AGTP 170
Query: 221 GFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
           G+++PE     ++ +  D+++ G  L  LL G
Sbjct: 171 GYLSPEVLRKEAYGKPVDIWACGVILYILLVG 202

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 30/119 (25%), Positives = 55/119 (46%), Gaps = 23/119 (19%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           +I   + Y+H      I+ R +K SN+ ++E+   K+ DF L+        H  +E    
Sbjct: 133 QILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFYLA-------RHTDDEMT-- 180
Query: 219 AYGFIAPEYFATSS-------FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
             G++A  ++           +N+  D++S G  + ELLTG  +  F G  + D L ++
Sbjct: 181 --GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL--FPGTDHIDQLKLI 235

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 67/152 (44%), Gaps = 18/152 (11%)
Query: 110 MKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLI------APRIKIAMEIANA 163
           +KH NI++L     E     L+F+ V  G L    F  ++       A       +I  A
Sbjct: 78  LKHPNIVRLHDSISEEGHHYLIFDLVTGGEL----FEDIVAREYYSEADASHCIQQILEA 133
Query: 164 VAYLHVGFDRPIVFRCIKASNVLLD---ENYSAKLHDFSLSVSIPEGETHVREEFIKGAY 220
           V + H      +V R +K  N+LL    +  + KL DF L++ + EGE      F  G  
Sbjct: 134 VLHCH---QMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEV-EGEQQAWFGF-AGTP 188
Query: 221 GFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
           G+++PE      + +  D+++ G  L  LL G
Sbjct: 189 GYLSPEVLRKDPYGKPVDLWACGVILYILLVG 220

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 40/117 (34%), Positives = 59/117 (50%), Gaps = 11/117 (9%)
Query: 154 IKIAM-EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSA-KLHDFSLSVSIPEGETHV 211
           +K+ M ++  ++AY+H  F   I  R IK  N+LLD + +  KL DF  +  +  GE +V
Sbjct: 124 VKLYMYQLFRSLAYIH-SFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV 180
Query: 212 REEFIKGAYGFIAPEY-FATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDL 267
               I   Y + APE  F  + +    DV+S G  L ELL G  +  F G+   D L
Sbjct: 181 --SXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI--FPGDSGVDQL 232

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 52/238 (21%), Positives = 96/238 (40%), Gaps = 34/238 (14%)
Query: 97  VEYCFNNIVFSSQMKHKNILKLIGCCLETELPTL--VFESVKYGTLRGFSFASLLIAPRI 154
           +E  +  I    ++ H N++KL+    +     L  VFE V  G +        L   + 
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQA 139
Query: 155 KIAME-IANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVRE 213
           +   + +   + YLH    + I+ R IK SN+L+ E+   K+ DF +S      +  +  
Sbjct: 140 RFYFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSN 196
Query: 214 EFIKGAYGFIAPEYFATSS---FNEMCDVYSFGAFL-CELLTGCNVLEFKGNGNDDDLTV 269
               G   F+APE  + +      +  DV++ G  L C +   C  +       D+ +  
Sbjct: 197 TV--GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM-------DERIMC 247
Query: 270 LEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDV 327
           L    KS               +   FP + +  + L  L+ + L K+PE R ++ ++
Sbjct: 248 LHSKIKS---------------QALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEI 290

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 67/152 (44%), Gaps = 18/152 (11%)
Query: 110 MKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLI------APRIKIAMEIANA 163
           +KH NI++L     E     L+F+ V  G L    F  ++       A       +I  A
Sbjct: 67  LKHPNIVRLHDSISEEGHHYLIFDLVTGGEL----FEDIVAREYYSEADASHCIQQILEA 122
Query: 164 VAYLHVGFDRPIVFRCIKASNVLLD---ENYSAKLHDFSLSVSIPEGETHVREEFIKGAY 220
           V + H      +V R +K  N+LL    +  + KL DF L++ + EGE      F  G  
Sbjct: 123 VLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV-EGEQQAWFGF-AGTP 177
Query: 221 GFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
           G+++PE      + +  D+++ G  L  LL G
Sbjct: 178 GYLSPEVLRKDPYGKPVDLWACGVILYILLVG 209

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 68/152 (44%), Gaps = 18/152 (11%)
Query: 110 MKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLI------APRIKIAMEIANA 163
           +KH NI++L     E     LVF+ V  G L    F  ++       A       +I  +
Sbjct: 60  LKHPNIVRLHDSISEEGFHYLVFDLVTGGEL----FEDIVAREYYSEADASHCIQQILES 115
Query: 164 VAYLHVGFDRPIVFRCIKASNVLL---DENYSAKLHDFSLSVSIPEGETHVREEFIKGAY 220
           V + H+     IV R +K  N+LL    +  + KL DF L++ + +G+      F  G  
Sbjct: 116 VNHCHLN---GIVHRDLKPENLLLASKSKGAAVKLADFGLAIEV-QGDQQAWFGF-AGTP 170
Query: 221 GFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
           G+++PE      + +  D+++ G  L  LL G
Sbjct: 171 GYLSPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 27/98 (27%), Positives = 49/98 (50%), Gaps = 6/98 (6%)
Query: 155 KIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREE 214
           K+++ +   +AYL       I+ R +K SN+L++     KL DF +S  + +    +   
Sbjct: 118 KVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANS 172
Query: 215 FIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
           F+ G   ++APE    + ++   D++S G  L EL  G
Sbjct: 173 FV-GTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVG 209

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 68/152 (44%), Gaps = 18/152 (11%)
Query: 110 MKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLI------APRIKIAMEIANA 163
           +KH NI++L     E     LVF+ V  G L    F  ++       A       +I  +
Sbjct: 60  LKHPNIVRLHDSISEEGFHYLVFDLVTGGEL----FEDIVAREYYSEADASHCIQQILES 115
Query: 164 VAYLHVGFDRPIVFRCIKASNVLL---DENYSAKLHDFSLSVSIPEGETHVREEFIKGAY 220
           V + H+     IV R +K  N+LL    +  + KL DF L++ + +G+      F  G  
Sbjct: 116 VNHCHLN---GIVHRDLKPENLLLASKSKGAAVKLADFGLAIEV-QGDQQAWFGF-AGTP 170
Query: 221 GFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
           G+++PE      + +  D+++ G  L  LL G
Sbjct: 171 GYLSPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 26/83 (31%), Positives = 41/83 (49%), Gaps = 7/83 (8%)
Query: 175 IVFRCIKASNVLLDENYSAKLHDFSLSVSIPE-GETHVREEFIKGAYGFIAPEYFATSS- 232
           ++ R +K  N+LLD++   KL DF   + + E G  H   +   G   +I+PE   +   
Sbjct: 195 LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHC--DTAVGTPDYISPEVLKSQGG 252
Query: 233 ---FNEMCDVYSFGAFLCELLTG 252
              +   CD +S G FL E+L G
Sbjct: 253 DGYYGRECDWWSVGVFLFEMLVG 275

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 29/119 (24%), Positives = 55/119 (46%), Gaps = 23/119 (19%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           +I   + Y+H      I+ R +K SN+ ++E+   K+ D+ L+        H  +E    
Sbjct: 133 QILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDYGLA-------RHTDDEMT-- 180
Query: 219 AYGFIAPEYFATSS-------FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
             G++A  ++           +N+  D++S G  + ELLTG  +  F G  + D L ++
Sbjct: 181 --GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL--FPGTDHIDQLKLI 235

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 75/168 (44%), Gaps = 32/168 (19%)
Query: 110 MKHKNILKLIGCCLETELPTLVFESVKYGTL---------RGFSFASLLIAPRIKIAMEI 160
           + H NI+K+     +     +V E+ + G L         RG + +   +A  +K  M  
Sbjct: 77  LDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMM-- 134
Query: 161 ANAVAYLHVGFDRPIVFRCIKASNVLLDE---NYSAKLHDFSLSVSIPEGETHVREEFIK 217
            NA+AY H    + +V + +K  N+L  +   +   K+ DF L+      E    +E   
Sbjct: 135 -NALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLA------ELFKSDEHST 184
Query: 218 GAYG---FIAPEYFATS-SFNEMCDVYSFGAFLCELLTGCNVLEFKGN 261
            A G   ++APE F    +F   CD++S G  +  LLTGC  L F G 
Sbjct: 185 NAAGTALYMAPEVFKRDVTFK--CDIWSAGVVMYFLLTGC--LPFTGT 228

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 27/100 (27%), Positives = 49/100 (49%), Gaps = 8/100 (8%)
Query: 156 IAMEIANAVAYLHVGFDRPIVFRCIKASNVLL---DENYSAKLHDFSLSVSIPEGETHVR 212
           I  ++ +AV+++H   D  +V R +K  N+L    ++N   K+ DF  +   P     ++
Sbjct: 111 IMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLK 167
Query: 213 EEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
                  Y   APE    + ++E CD++S G  L  +L+G
Sbjct: 168 TPCFTLHYA--APELLNQNGYDESCDLWSLGVILYTMLSG 205

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 28/107 (26%), Positives = 51/107 (47%), Gaps = 13/107 (12%)
Query: 154 IKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE----- 208
           + I ++IA AV +LH    + ++ R +K SN+    +   K+ DF L  ++ + E     
Sbjct: 121 LHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177
Query: 209 -----THVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELL 250
                 + R     G   +++PE    +S++   D++S G  L ELL
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 31/115 (26%), Positives = 53/115 (46%), Gaps = 15/115 (13%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIK- 217
           +I   + Y+H      I+ R +K SN+ ++E+   K+ DF L+        H  +E    
Sbjct: 133 QILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-------RHTDDEMTGX 182
Query: 218 -GAYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
                + APE       +N+  D++S G  + ELLTG  +  F G  + D L ++
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL--FPGTDHIDQLKLI 235

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 31/115 (26%), Positives = 53/115 (46%), Gaps = 15/115 (13%)
Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIK- 217
           +I   + Y+H      I+ R +K SN+ ++E+   K+ DF L+        H  +E    
Sbjct: 153 QILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-------RHTDDEMXGX 202
Query: 218 -GAYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
                + APE       +N+  D++S G  + ELLTG  +  F G  + D L ++
Sbjct: 203 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL--FPGTDHIDQLKLI 255

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 70/180 (38%), Gaps = 30/180 (16%)
Query: 83  ISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRG 142
           I  M +    + +  +     + F  +++H N ++  GC L      LV E         
Sbjct: 84  IKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC------- 136
Query: 143 FSFASLLIAPRIKIAMEIANA---------VAYLHVGFDRPIVFRCIKASNVLLDENYSA 193
              AS L+    K   E+  A         +AYLH      ++ R +KA N+LL E    
Sbjct: 137 LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLV 193
Query: 194 KLHDF-SLSVSIPEGETHVREEFIKGAYGFIAPEYFAT---SSFNEMCDVYSFGAFLCEL 249
           KL DF S S+  P         F+   Y ++APE         ++   DV+S G    EL
Sbjct: 194 KLGDFGSASIMAPAN------XFVGTPY-WMAPEVILAMDEGQYDGKVDVWSLGITCIEL 246

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 24/96 (25%), Positives = 47/96 (48%), Gaps = 8/96 (8%)
Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI 216
           A +I     YLH      +++R +K  N+++D+    K+ DF L+  + +G T      +
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRV-KGRTWX----L 198
Query: 217 KGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
            G   ++APE   +  +N+  D ++ G  + E+  G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 34/114 (29%), Positives = 51/114 (44%), Gaps = 12/114 (10%)
Query: 156 IAMEIANAVAYLHVGFDRPIVFRCIKASNVL-LDEN---YSAKLHDFSLSVSIPEGETHV 211
           +   I   V YLH    + +V R +K SN+L +DE+    S ++ DF  +  +   E  +
Sbjct: 121 VLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL-RAENGL 176
Query: 212 REEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDD 265
                  A  F+APE      ++  CD++S G  L   LTG        NG DD
Sbjct: 177 LXTPCYTA-NFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTPF---ANGPDD 226

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 70/180 (38%), Gaps = 30/180 (16%)
Query: 83  ISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRG 142
           I  M +    + +  +     + F  +++H N ++  GC L      LV E         
Sbjct: 45  IKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC------- 97
Query: 143 FSFASLLIAPRIKIAMEIANA---------VAYLHVGFDRPIVFRCIKASNVLLDENYSA 193
              AS L+    K   E+  A         +AYLH      ++ R +KA N+LL E    
Sbjct: 98  LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLV 154
Query: 194 KLHDF-SLSVSIPEGETHVREEFIKGAYGFIAPEYFAT---SSFNEMCDVYSFGAFLCEL 249
           KL DF S S+  P         F+   Y ++APE         ++   DV+S G    EL
Sbjct: 155 KLGDFGSASIMAPAN------XFVGTPY-WMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	339
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-55
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	2e-55
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	4e-52
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-41
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	4e-34
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	5e-33
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	8e-33
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-32
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	3e-31
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-31
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	6e-31
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	9e-31
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-30
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-30
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-30
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-30
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	6e-30
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	6e-26
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	4e-19
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	5e-19
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	6e-19
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	7e-19
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	8e-19
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	9e-19
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-18
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-18
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-18
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	3e-18
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	5e-18
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	8e-18
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-17
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	3e-17
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	5e-17
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	5e-17
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	9e-17
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-16
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-16
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-16
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	6e-16
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	7e-16
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	8e-16
4aoj_A	329	High affinity nerve growth factor receptor; transf	9e-16
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-15
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-15
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-15
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-15
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-15
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-15
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-15
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	3e-15
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	3e-15
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	4e-15
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	4e-15
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	5e-15
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	6e-15
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	8e-15
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	8e-15
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-14
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-14
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-14
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	3e-14
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	4e-14
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	6e-14
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	6e-14
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	7e-14
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	7e-14
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	8e-14
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-13
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-13
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	3e-13
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-13
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	4e-13
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	4e-13
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	4e-13
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	4e-13
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	4e-13
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	9e-13
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	9e-13
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-12
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-12
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-12
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-12
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-12
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-12
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	3e-12
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	3e-12
2a19_B	284	Interferon-induced, double-stranded RNA-activated	4e-12
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	4e-12
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	9e-12
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-11
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-11
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	3e-11
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	3e-11
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	4e-11
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	4e-11
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	7e-11
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	7e-11
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	8e-11
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	8e-11
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	9e-11
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	9e-11
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-10
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-10
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-10
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-10
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-10
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-10
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-10
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-10
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-10
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	4e-10
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	4e-10
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	4e-10
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	5e-10
3ork_A	311	Serine/threonine protein kinase; structural genomi	6e-10
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	7e-10
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	7e-10
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	7e-10
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	8e-10
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-09
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-09
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-09
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-09
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-09
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-09
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-09
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-09
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	3e-09
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	3e-09
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	4e-09
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	4e-09
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	5e-09
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	5e-09
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	6e-09
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	7e-09
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	8e-09
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	8e-09
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	9e-09
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-08
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-08
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-08
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-08
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-08
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-08
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-08
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	4e-08
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	5e-08
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	7e-08
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	9e-08
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-07
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-07
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-07
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-07
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-07
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-07
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-07
3an0_A	340	Dual specificity mitogen-activated protein kinase;	3e-07
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	3e-07
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	3e-07
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	3e-07
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	4e-07
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	4e-07
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	5e-07
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	6e-07
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	7e-07
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-06
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-06
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-06
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-06
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-06
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-06
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	3e-06
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	3e-06
3aln_A	327	Dual specificity mitogen-activated protein kinase;	4e-06
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	4e-06
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	4e-06
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	5e-06
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	7e-06
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-05
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-05
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-05
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-05
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-05
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-05
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-05
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-05
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-05
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-05
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-05
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	3e-05
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	3e-05
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	3e-05
3niz_A	311	Rhodanese family protein; structural genomics, str	4e-05
3o0g_A	292	Cell division protein kinase 5; kinase activator c	4e-05
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	4e-05
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	5e-05
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	5e-05
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-04
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-04
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-04
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	3e-04
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	3e-04
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	3e-04
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	3e-04
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	3e-04
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	4e-04
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	4e-04
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	4e-04
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	9e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  183 bits (467), Expect = 1e-55
 Identities = 83/299 (27%), Positives = 150/299 (50%), Gaps = 18/299 (6%)

Query: 42  IRAFSAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTL-DDVEYC 100
           ++ FS ++L+ A++N+    ++      ++++G L D    ++V +  +  T   ++++ 
Sbjct: 17  LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLAD-GTLVAVKRLKEERTQGGELQFQ 75

Query: 101 FNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAP------RI 154
              +   S   H+N+L+L G C+      LV+  +  G++           P      R 
Sbjct: 76  -TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQ 134

Query: 155 KIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHV--R 212
           +IA+  A  +AYLH   D  I+ R +KA+N+LLDE + A + DF L+  +   +THV   
Sbjct: 135 RIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 194

Query: 213 EEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEY 272
              ++G  G IAPEY +T   +E  DV+ +G  L EL+TG    +     NDDD+ +L++
Sbjct: 195 ---VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 251

Query: 273 AKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQL 331
            K  ++  +  A+VD     +  +  +E  ++ L Q+   C   SP  RP M +V + L
Sbjct: 252 VKGLLKEKKLEALVDVDLQGN--YKDEE--VEQLIQVALLCTQSSPMERPKMSEVVRML 306

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  182 bits (465), Expect = 2e-55
 Identities = 89/299 (29%), Positives = 139/299 (46%), Gaps = 25/299 (8%)

Query: 43  RAFSAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFN 102
                 DL++ATNN+D   +I      ++++G L D    +++ +    S+    E  F 
Sbjct: 27  YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD-GAKVALKRRTPESSQGIEE--FE 83

Query: 103 N-IVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLR------GFSFASLLIAPRIK 155
             I   S  +H +++ LIG C E     L+++ ++ G L+           S+    R++
Sbjct: 84  TEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLE 143

Query: 156 IAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEG-ETHV--R 212
           I +  A  + YLH      I+ R +K+ N+LLDEN+  K+ DF +S    E  +TH+   
Sbjct: 144 ICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTV 200

Query: 213 EEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEY 272
              +KG  G+I PEYF      E  DVYSFG  L E+L   + +         +L   E+
Sbjct: 201 ---VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNL--AEW 255

Query: 273 AKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQL 331
           A +S  N +   IVDP   +        E L+  G    KCL+ S E RP M DV  +L
Sbjct: 256 AVESHNNGQLEQIVDPNLADKIR----PESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  173 bits (441), Expect = 4e-52
 Identities = 69/314 (21%), Positives = 137/314 (43%), Gaps = 38/314 (12%)

Query: 43  RAFSAKDLKKATNNYDLHKVIQSDTSY------RLFEGTLVDQDRPISVMKFHDNSTLD- 95
            +FS  +LK  TNN+D   +              +++G +   +  ++V K      +  
Sbjct: 13  HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITT 70

Query: 96  ---DVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAP 152
                ++    I   ++ +H+N+++L+G   + +   LV+  +  G+L           P
Sbjct: 71  EELKQQF-DQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP 129

Query: 153 -----RIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEG 207
                R KIA   AN + +LH   +   + R IK++N+LLDE ++AK+ DF L+ +  + 
Sbjct: 130 LSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKF 186

Query: 208 E-THV--REEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGND 264
             T +  R   I G   ++APE           D+YSFG  L E++TG   ++     + 
Sbjct: 187 AQTVMTSR---IVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDE----HR 238

Query: 265 DDLTVLEYAKKSIENNR-FGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPL 323
           +   +L+  ++  +  +     +D      N        ++++  +  +CL +    RP 
Sbjct: 239 EPQLLLDIKEEIEDEEKTIEDYIDKKM---NDADSTS--VEAMYSVASQCLHEKKNKRPD 293

Query: 324 MVDVAKQLRQMYLS 337
           +  V + L++M  S
Sbjct: 294 IKKVQQLLQEMTAS 307

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  146 bits (369), Expect = 2e-41
 Identities = 64/313 (20%), Positives = 120/313 (38%), Gaps = 33/313 (10%)

Query: 45  FSAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHD-NSTLDDVEYCFNN 103
              ++L   +    L +V        +++  L+++   + +    D  S  ++ E     
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYE----- 68

Query: 104 IVFSSQMKHKNILKLIGCCLETELPT----LVFESVKYGTLRGFSFASLL-IAPRIKIAM 158
           +     MKH+NIL+ IG             L+    + G+L  F  A+++       IA 
Sbjct: 69  VYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAE 128

Query: 159 EIANAVAYLH-------VGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHV 211
            +A  +AYLH        G    I  R IK+ NVLL  N +A + DF L++    G++  
Sbjct: 129 TMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAG 188

Query: 212 REEFIKGAYGFIAPEYF-----ATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDD 266
                 G   ++APE                D+Y+ G  L EL + C       +G  D+
Sbjct: 189 DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTA----ADGPVDE 244

Query: 267 LTVLEYAKKSIENNRFGAIVDPIFDE--DNSFPG---KEEKLQSLGQLMYKCLSKSPEHR 321
             +L + ++  ++     + + +  +           K   +  L + + +C     E R
Sbjct: 245 Y-MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEAR 303

Query: 322 PLMVDVAKQLRQM 334
                V +++ QM
Sbjct: 304 LSAGCVGERITQM 316

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  125 bits (316), Expect = 4e-34
 Identities = 57/290 (19%), Positives = 103/290 (35%), Gaps = 47/290 (16%)

Query: 58  DLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNN-IVFSSQMKHKNIL 116
           +    +  + S  L++G    Q   I V               FN          H N+L
Sbjct: 13  NFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVL 70

Query: 117 KLIGCCLETELPTL--VFESVKYGTLRGF----SFASLLIAPRIKIAMEIANAVAYLHVG 170
            ++G C     P    +   + YG+L       +   +  +  +K A+++A  +A+LH  
Sbjct: 71  PVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-T 129

Query: 171 FDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYF-- 228
            +  I    + + +V++DE+ +A++    +  S               A  ++APE    
Sbjct: 130 LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGR-------MYAPAWVAPEALQK 182

Query: 229 -ATSSFNEMCDVYSFGAFLCELLTGCNVLE--FKGNGNDDDLTVLEYAKKSIENN-RFGA 284
               +     D++SF   L EL+T     E  F       DL+ +E   K      R   
Sbjct: 183 KPEDTNRRSADMWSFAVLLWELVTR----EVPF------ADLSNMEIGMKVALEGLR--- 229

Query: 285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQM 334
              P      S          + +LM  C+++ P  RP    +   L +M
Sbjct: 230 ---PTIPPGIS--------PHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  123 bits (311), Expect = 5e-33
 Identities = 55/238 (23%), Positives = 92/238 (38%), Gaps = 31/238 (13%)

Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF-----SFASLLIAPRIKIAMEIAN 162
            +++H NI+  +G   +    ++V E +  G+L        +   L    R+ +A ++A 
Sbjct: 89  KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAK 148

Query: 163 AVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGF 222
            + YLH   + PIV R +K+ N+L+D+ Y+ K+ DF LS          +     G   +
Sbjct: 149 GMNYLH-NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSA--AGTPEW 205

Query: 223 IAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENN-R 281
           +APE       NE  DVYSFG  L EL T      +        L   +          R
Sbjct: 206 MAPEVLRDEPSNEKSDVYSFGVILWELATLQ--QPWGN------LNPAQVVAAVGFKCKR 257

Query: 282 FGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLSVV 339
                      + +          +  ++  C +  P  RP    +   LR +  S V
Sbjct: 258 ------LEIPRNLN--------PQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  122 bits (309), Expect = 8e-33
 Identities = 61/237 (25%), Positives = 98/237 (41%), Gaps = 33/237 (13%)

Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF-----SFASLLIAPRIKIAMEIAN 162
           S++ H NI+KL G CL      LV E  + G+L               A  +   ++ + 
Sbjct: 56  SRVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQ 113

Query: 163 AVAYLHVGFDRPIVFRCIKASNVLLDENYS-AKLHDFSLSVSIPEGETHVREEFIKGAYG 221
            VAYLH    + ++ R +K  N+LL    +  K+ DF  +  I    T+      KG+  
Sbjct: 114 GVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNN-----KGSAA 168

Query: 222 FIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNR 281
           ++APE F  S+++E CDV+S+G  L E++T      F   G                  R
Sbjct: 169 WMAPEVFEGSNYSEKCDVFSWGIILWEVITRR--KPFDEIGG----PAFRIMWAVHNGTR 222

Query: 282 FGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLSV 338
                 P   ++   P      + +  LM +C SK P  RP M ++ K +  +    
Sbjct: 223 ------PPLIKN--LP------KPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  123 bits (310), Expect = 1e-32
 Identities = 54/328 (16%), Positives = 111/328 (33%), Gaps = 44/328 (13%)

Query: 45  FSAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNN- 103
            +A +     +N  L ++I       +++G+L ++   + V  F +          F N 
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN-------RQNFINE 55

Query: 104 --IVFSSQMKHKNILKLIGCCLETELPT-----LVFESVKYGTLRGFSFASLL-IAPRIK 155
             I     M+H NI + I               LV E    G+L  +            +
Sbjct: 56  KNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCR 115

Query: 156 IAMEIANAVAYLH------VGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGET 209
           +A  +   +AYLH        +   I  R + + NVL+  + +  + DF LS+ +     
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175

Query: 210 HVREEF------IKGAYGFIAPEYF-------ATSSFNEMCDVYSFGAFLCELLTGCNVL 256
               E         G   ++APE            S  +  D+Y+ G    E+   C  L
Sbjct: 176 VRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235

Query: 257 EFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDED------NSFPGKEEKLQSLGQLM 310
               +  +     + +  +   +  F  +   +  E        ++      ++SL + +
Sbjct: 236 FPGESVPE---YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETI 292

Query: 311 YKCLSKSPEHRPLMVDVAKQLRQMYLSV 338
             C  +  E R       +++ ++ +  
Sbjct: 293 EDCWDQDAEARLTAQXAEERMAELMMIW 320

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  119 bits (300), Expect = 3e-31
 Identities = 55/254 (21%), Positives = 99/254 (38%), Gaps = 29/254 (11%)

Query: 104 IVFSSQMKHKNILKLIGCCLETELPT----LVFESVKYGTLRGF-SFASLLIAPRIKIAM 158
           I  +  M+H+NIL  I   ++         L+ +  + G+L  +    +L     +K+A 
Sbjct: 82  IYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAY 141

Query: 159 EIANAVAYLH-----VGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVRE 213
              + + +LH           I  R +K+ N+L+ +N +  + D  L+V        V  
Sbjct: 142 SSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDI 201

Query: 214 EFIK--GAYGFIAPE------YFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDD 265
                 G   ++ PE               M D+YSFG  L E+   C        G   
Sbjct: 202 PPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVS------GGIV 255

Query: 266 DLTVLEYAKKSIENNRFGAIVDPIFDEDN--SFP---GKEEKLQSLGQLMYKCLSKSPEH 320
           +   L Y      +  +  + + +  +    SFP     +E L+ +G+LM +C + +P  
Sbjct: 256 EEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPAS 315

Query: 321 RPLMVDVAKQLRQM 334
           R   + V K L +M
Sbjct: 316 RLTALRVKKTLAKM 329

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  117 bits (295), Expect = 6e-31
 Identities = 61/281 (21%), Positives = 102/281 (36%), Gaps = 43/281 (15%)

Query: 70  RLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFS------SQMKHKNILKLIGCCL 123
            + +G LV     +++       +  + E       F       S + H NI+KL G   
Sbjct: 34  LVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM- 92

Query: 124 ETELPTLVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCI 180
               P +V E V  G L          +  + ++++ ++IA  + Y+    + PIV R +
Sbjct: 93  -HNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ-NQNPPIVHRDL 150

Query: 181 KASNVLLDE-----NYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSS--F 233
           ++ N+ L          AK+ DF LS       + +      G + ++APE        +
Sbjct: 151 RSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLL-----GNFQWMAPETIGAEEESY 205

Query: 234 NEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDED 293
            E  D YSF   L  +LTG     F          +        E  R      P   ED
Sbjct: 206 TEKADTYSFAMILYTILTG--EGPFDEY---SYGKIKFINMIREEGLR------PTIPED 254

Query: 294 NSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQM 334
              P        L  ++  C S  P+ RP    + K+L ++
Sbjct: 255 --CP------PRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  117 bits (295), Expect = 9e-31
 Identities = 60/286 (20%), Positives = 106/286 (37%), Gaps = 43/286 (15%)

Query: 70  RLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPT 129
           +  + T  +    + VMK       +        +     ++H N+LK IG   + +   
Sbjct: 25  QAIKVTHRETGEVM-VMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLN 83

Query: 130 LVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVL 186
            + E +K GTLRG      +    + R+  A +IA+ +AYLH      I+ R + + N L
Sbjct: 84  FITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCL 140

Query: 187 LDENYSAKLHDFSLSVSIPEGETHVREEF------------IKGAYGFIAPEYFATSSFN 234
           + EN +  + DF L+  + + +T                  + G   ++APE     S++
Sbjct: 141 VRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYD 200

Query: 235 EMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL--EYAKKSIENNRFGAIVDPIFDE 292
           E  DV+SFG  LCE++   N         D D      ++                    
Sbjct: 201 EKVDVFSFGIVLCEIIGRVNA--------DPDYLPRTMDFGLNVRGFLD------RYCPP 246

Query: 293 DNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLSV 338
           +           S   +  +C    PE RP  V +   L  + + +
Sbjct: 247 NCP--------PSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  116 bits (292), Expect = 1e-30
 Identities = 66/236 (27%), Positives = 101/236 (42%), Gaps = 34/236 (14%)

Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF-SFASLLIAPRIKIAMEIANAVAY 166
           + +KH NI+ L G CL+     LV E  + G L    S   +     +  A++IA  + Y
Sbjct: 61  AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNY 120

Query: 167 LHVGFDRPIVFRCIKASNVLLDE--------NYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           LH     PI+ R +K+SN+L+ +        N   K+ DF L+                G
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA----AG 176

Query: 219 AYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIE 278
           AY ++APE    S F++  DV+S+G  L ELLTG   + F+G      +  L  A     
Sbjct: 177 AYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTG--EVPFRG------IDGLAVAYGVAM 228

Query: 279 NNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQM 334
           N     I  P     ++ P      +   +LM  C +  P  RP   ++  QL  +
Sbjct: 229 NKLALPI--P-----STCP------EPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  117 bits (294), Expect = 1e-30
 Identities = 55/253 (21%), Positives = 98/253 (38%), Gaps = 35/253 (13%)

Query: 108 SQMKHKNILKLIGCCL-ETELPT---LVFESVKYGTLRGF-SFASLLIAPRIKIAMEIAN 162
             ++H+NIL  I   +      T   L+    + G+L  +    +L     ++I + IA+
Sbjct: 57  VMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIAS 116

Query: 163 AVAYLH-----VGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI- 216
            +A+LH           I  R +K+ N+L+ +N    + D  L+V   +    +      
Sbjct: 117 GLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNP 176

Query: 217 -KGAYGFIAPE------YFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTV 269
             G   ++APE              +  D+++FG  L E+           NG  +D   
Sbjct: 177 RVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVS-----NGIVEDYKP 231

Query: 270 ----LEYAKKSIENNRFGAIVD----PIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHR 321
               +     S E+ R    VD     I +   S P     L SL +LM +C  ++P  R
Sbjct: 232 PFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPT----LTSLAKLMKECWYQNPSAR 287

Query: 322 PLMVDVAKQLRQM 334
              + + K L ++
Sbjct: 288 LTALRIKKTLTKI 300

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  116 bits (293), Expect = 3e-30
 Identities = 46/255 (18%), Positives = 98/255 (38%), Gaps = 29/255 (11%)

Query: 104 IVFSSQMKHKNILKLIGCCLETELPT----LVFESVKYGTLRGF-SFASLLIAPRIKIAM 158
           I  +  ++H+NIL  I    +         LV +  ++G+L  + +  ++ +   IK+A+
Sbjct: 87  IYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLAL 146

Query: 159 EIANAVAYLH-----VGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVRE 213
             A+ +A+LH           I  R +K+ N+L+ +N +  + D  L+V        +  
Sbjct: 147 STASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDI 206

Query: 214 EFI--KGAYGFIAPE------YFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDD 265
                 G   ++APE              +  D+Y+ G    E+   C++      G   
Sbjct: 207 APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI------GGIH 260

Query: 266 DLTVLEYAKKSIENNRFGAIVDPIFDED-----NSFPGKEEKLQSLGQLMYKCLSKSPEH 320
           +   L Y      +     +   + ++       +     E L+ + ++M +C   +   
Sbjct: 261 EDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAA 320

Query: 321 RPLMVDVAKQLRQMY 335
           R   + + K L Q+ 
Sbjct: 321 RLTALRIKKTLSQLS 335

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  114 bits (288), Expect = 6e-30
 Identities = 50/233 (21%), Positives = 100/233 (42%), Gaps = 27/233 (11%)

Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANAV 164
            + +H NIL  +G     +L  +V +  +  +L      S     +   I IA + A  +
Sbjct: 75  RKTRHVNILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGM 133

Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIA 224
            YLH    + I+ R +K++N+ L E+ + K+ DF L+          + E + G+  ++A
Sbjct: 134 DYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMA 190

Query: 225 PE---YFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNR 281
           PE      ++ ++   DVY+FG  L EL+TG   L +        +   +   + +    
Sbjct: 191 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTG--QLPYSN------INNRDQIIEMVGRGS 242

Query: 282 FGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQM 334
               +  +     + P      + + +LM +CL K  + RP    +  ++ ++
Sbjct: 243 LSPDLSKVRS---NCP------KRMKRLMAECLKKKRDERPSFPRILAEIEEL 286

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  104 bits (261), Expect = 6e-26
 Identities = 44/242 (18%), Positives = 85/242 (35%), Gaps = 40/242 (16%)

Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANAV 164
            Q +H+N++  +G C+      ++    K  TL      +   L +    +IA EI   +
Sbjct: 84  RQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGM 143

Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFI- 223
            YLH    + I+ + +K+ NV  D      + DF L       +   RE+ ++   G++ 
Sbjct: 144 GYLH---AKGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLC 199

Query: 224 --APEYFATSS---------FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEY 272
             APE     S         F++  DV++ G    EL        FK    +  +  +  
Sbjct: 200 HLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAR--EWPFKTQPAEAIIWQMG- 256

Query: 273 AKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLR 332
                   +       +              + +  ++  C +   E RP    +   L 
Sbjct: 257 -----TGMKP-----NLSQIGMG--------KEISDILLFCWAFEQEERPTFTKLMDMLE 298

Query: 333 QM 334
           ++
Sbjct: 299 KL 300

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 87.1 bits (216), Expect = 4e-19
 Identities = 54/231 (23%), Positives = 99/231 (42%), Gaps = 29/231 (12%)

Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF----SFASLLIAPRIKIAMEIANAV 164
           ++KH N+++L+G C       ++ E + YG L  +    +   +     + +A +I++A+
Sbjct: 272 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 331

Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIA 224
            YL     +  + R + A N L+ EN+  K+ DF LS  +  G+T+      K    + A
Sbjct: 332 EYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTA 387

Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA 284
           PE  A + F+   DV++FG  L E+ T   +  + G        V E  +K   + R   
Sbjct: 388 PESLAYNKFSIKSDVWAFGVLLWEIAT-YGMSPYPGIDLSQ---VYELLEK---DYR--- 437

Query: 285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMY 335
                          E   + + +LM  C   +P  RP   ++ +    M+
Sbjct: 438 -----------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score = 85.1 bits (211), Expect = 5e-19
 Identities = 49/270 (18%), Positives = 82/270 (30%), Gaps = 43/270 (15%)

Query: 85  VMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPT----LVFESVKYGTL 140
            +K        D E             H NIL+L+  CL          L+    K GTL
Sbjct: 58  ALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTL 117

Query: 141 RGFSFASLLIAPRI------KIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAK 194
                        +       + + I   +  +H    +    R +K +N+LL +     
Sbjct: 118 WNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPV 174

Query: 195 LHDF----SLSVSIPEGETHVREEFIKGAYG---FIAPEYFATSS---FNEMCDVYSFGA 244
           L D        + +      +  +          + APE F+  S    +E  DV+S G 
Sbjct: 175 LMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGC 234

Query: 245 FLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQ 304
            L  ++ G     +       D   L         N+             S P       
Sbjct: 235 VLYAMMFG--EGPYDMVFQKGDSVAL------AVQNQL------------SIPQSPRHSS 274

Query: 305 SLGQLMYKCLSKSPEHRPLMVDVAKQLRQM 334
           +L QL+   ++  P  RP +  +  QL  +
Sbjct: 275 ALWQLLNSMMTVDPHQRPHIPLLLSQLEAL 304

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 85.6 bits (212), Expect = 6e-19
 Identities = 63/277 (22%), Positives = 107/277 (38%), Gaps = 41/277 (14%)

Query: 72  FEGTLVDQDR---PISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELP 128
           + GTL+D D      +V   +  + + +V       +      H N+L L+G CL +E  
Sbjct: 106 YHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 165

Query: 129 TL-VFESVKYGTLRGF---SFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASN 184
            L V   +K+G LR F      +  +   I   +++A  + +L     +  V R + A N
Sbjct: 166 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARN 222

Query: 185 VLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFI-----APEYFATSSFNEMCDV 239
            +LDE ++ K+ DF L+  + + E              +     A E   T  F    DV
Sbjct: 223 CMLDEKFTVKVADFGLARDMYDKEFDSVH---NKTGAKLPVKWMALESLQTQKFTTKSDV 279

Query: 240 YSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPG 298
           +SFG  L EL+T G     +      D   +  Y  +       G  +          P 
Sbjct: 280 WSFGVLLWELMTRGAP--PYPDVNTFD---ITVYLLQ-------GRRLLQ--------P- 318

Query: 299 KEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMY 335
            E     L ++M KC     E RP   ++  ++  ++
Sbjct: 319 -EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 354

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 84.2 bits (209), Expect = 7e-19
 Identities = 64/282 (22%), Positives = 107/282 (37%), Gaps = 51/282 (18%)

Query: 72  FEGTLVDQDR---PISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELP 128
           + GTL+D D      +V   +  + + +V       +      H N+L L+G CL +E  
Sbjct: 42  YHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 101

Query: 129 TL-VFESVKYGTLRGFSFASLLIAPR--------IKIAMEIANAVAYLHVGFDRPIVFRC 179
            L V   +K+G LR F     +            I   +++A  + YL     +  V R 
Sbjct: 102 PLVVLPYMKHGDLRNF-----IRNETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRD 153

Query: 180 IKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFI-----APEYFATSSFN 234
           + A N +LDE ++ K+ DF L+  + + E +            +     A E   T  F 
Sbjct: 154 LAARNCMLDEKFTVKVADFGLARDMYDKEYYSVH---NKTGAKLPVKWMALESLQTQKFT 210

Query: 235 EMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDED 293
              DV+SFG  L EL+T G     +      D   +  Y  +       G  +       
Sbjct: 211 TKSDVWSFGVLLWELMTRGAP--PYPDVNTFD---ITVYLLQ-------GRRLLQ----- 253

Query: 294 NSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMY 335
              P  E     L ++M KC     E RP   ++  ++  ++
Sbjct: 254 ---P--EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 290

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 84.7 bits (210), Expect = 8e-19
 Identities = 47/245 (19%), Positives = 89/245 (36%), Gaps = 37/245 (15%)

Query: 108 SQMKHKNILKLIGCCLET-ELPT-LVFESVKYGTLRGF---SFASLLIAPRIKIAMEIAN 162
             ++H NI+K  G C         L+ E + YG+LR +       +     ++   +I  
Sbjct: 97  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 156

Query: 163 AVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGF 222
            + YL     +  + R +   N+L++     K+ DF L+  +P+ +    E +     G 
Sbjct: 157 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK----EYYKVKEPGE 209

Query: 223 I-----APEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSI 277
                 APE    S F+   DV+SFG  L EL T     +         +   +     +
Sbjct: 210 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG--QM 267

Query: 278 ENNRFGAIVDPIFDEDNSFPGKEEKL-------QSLGQLMYKCLSKSPEHRPLMVDVAKQ 330
                  ++               +L         +  +M +C + +   RP   D+A +
Sbjct: 268 IVFHLIELLK-----------NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR 316

Query: 331 LRQMY 335
           + Q+ 
Sbjct: 317 VDQIR 321

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 85.0 bits (211), Expect = 9e-19
 Identities = 50/236 (21%), Positives = 87/236 (36%), Gaps = 39/236 (16%)

Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANAVA 165
           Q  H NI++LIG C + +   +V E V+ G    F     A L +   +++  + A  + 
Sbjct: 168 QYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGME 227

Query: 166 YLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGF--- 222
           YL     +  + R + A N L+ E    K+ DF +S    +G          G       
Sbjct: 228 YLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASG----GLRQVPVK 280

Query: 223 -IAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGND--DDLTVLEYAKKSIEN 279
             APE      ++   DV+SFG  L E  +          G     +L+  +  +   + 
Sbjct: 281 WTAPEALNYGRYSSESDVWSFGILLWETFS---------LGASPYPNLSNQQTREFVEKG 331

Query: 280 NRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMY 335
            R      P            + +  L   M +C +  P  RP    + ++L+ + 
Sbjct: 332 GRLPC---P--------ELCPDAVFRL---MEQCWAYEPGQRPSFSTIYQELQSIR 373

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 85.5 bits (211), Expect = 1e-18
 Identities = 37/225 (16%), Positives = 69/225 (30%), Gaps = 54/225 (24%)

Query: 115 ILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRP 174
           +   +   L+T    L+  S  + +L            R+++ +++   +A LH      
Sbjct: 183 LYPRMQSNLQTFGEVLLSHSSTHKSLV--------HHARLQLTLQVIRLLASLH---HYG 231

Query: 175 IVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFA----- 229
           +V   ++  +++LD+     L  F   V   +G + V         GF  PE  A     
Sbjct: 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLV--RDGASAVSP----IGRGFAPPETTAERMLP 285

Query: 230 -----TSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA 284
                 +      D ++ G  +  +      L       D  L   E             
Sbjct: 286 FGQHHPTLMTFAFDTWTLGLAIYWIWCA--DLPNTD---DAALGGSE------------- 327

Query: 285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK 329
               IF    + P      Q +  L+   L    E R L +   +
Sbjct: 328 ---WIFRSCKNIP------QPVRALLEGFLRYPKEDRLLPLQAME 363

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 83.9 bits (208), Expect = 1e-18
 Identities = 62/243 (25%), Positives = 100/243 (41%), Gaps = 36/243 (14%)

Query: 108 SQMKHKNILKLIGCCLETELPT--LVFESVKYGTLRGF-SFASLLIAPRIKIAMEIANAV 164
             + H++I+K  GCC +    +  LV E V  G+LR +    S+ +A  +  A +I   +
Sbjct: 88  RTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGM 147

Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFI- 223
           AYLH    +  + R + A NVLLD +   K+ DF L+ ++PEG     E +     G   
Sbjct: 148 AYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH----EYYRVREDGDSP 200

Query: 224 ----APEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIEN 279
               APE      F    DV+SFG  L ELLT C+           +L  +      +  
Sbjct: 201 VFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDS-SQSPPTKFLELIGIAQG--QMTV 257

Query: 280 NRFGAIVDPIFDEDNSFPGKEEKL-------QSLGQLMYKCLSKSPEHRPLMVDVAKQLR 332
            R   +++           + E+L         +  LM  C       RP   ++   L+
Sbjct: 258 LRLTELLE-----------RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILK 306

Query: 333 QMY 335
            ++
Sbjct: 307 TVH 309

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 83.5 bits (207), Expect = 2e-18
 Identities = 49/245 (20%), Positives = 92/245 (37%), Gaps = 37/245 (15%)

Query: 108 SQMKHKNILKLIGCCLET-ELPT-LVFESVKYGTLRGF---SFASLLIAPRIKIAMEIAN 162
             ++H NI+K  G C         L+ E + YG+LR +       +     ++   +I  
Sbjct: 66  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 125

Query: 163 AVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH--VRE--EF-IK 217
            + YL     +  + R +   N+L++     K+ DF L+  +P+ +    V+E  E  I 
Sbjct: 126 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF 182

Query: 218 GAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSI 277
               + APE    S F+   DV+SFG  L EL T     +         +   +     +
Sbjct: 183 ----WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG--QM 236

Query: 278 ENNRFGAIVDPIFDEDNSFPGKEEKL-------QSLGQLMYKCLSKSPEHRPLMVDVAKQ 330
                  ++               +L         +  +M +C + +   RP   D+A +
Sbjct: 237 IVFHLIELLK-----------NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR 285

Query: 331 LRQMY 335
           + Q+ 
Sbjct: 286 VDQIR 290

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 83.2 bits (206), Expect = 3e-18
 Identities = 54/245 (22%), Positives = 86/245 (35%), Gaps = 40/245 (16%)

Query: 109 QMKHKNILKLIGCCLET-ELPT-LVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANA 163
            +    I+K  G           LV E +  G LR F     A L  +  +  + +I   
Sbjct: 80  ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 139

Query: 164 VAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFI 223
           + YL     R  V R + A N+L++     K+ DF L+  +P  +    + ++    G  
Sbjct: 140 MEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK----DYYVVREPGQS 192

Query: 224 -----APEYFATSSFNEMCDVYSFGAFLCELLT-------GCNVLEFKGNGNDDDLTVLE 271
                APE  + + F+   DV+SFG  L EL T                    D   +  
Sbjct: 193 PIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR 252

Query: 272 YAKKSIENNRFGAIVD-PIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ 330
             +   E  R  A    P                 + +LM  C + SP+ RP    +  Q
Sbjct: 253 LLELLEEGQRLPAPPACP---------------AEVHELMKLCWAPSPQDRPSFSALGPQ 297

Query: 331 LRQMY 335
           L  ++
Sbjct: 298 LDMLW 302

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 82.0 bits (203), Expect = 5e-18
 Identities = 57/245 (23%), Positives = 92/245 (37%), Gaps = 40/245 (16%)

Query: 108 SQMKHKNILKLIGCCLETELPT--LVFESVKYGTLRGF---SFASLLIAPRIKIAMEIAN 162
             + H+NI+K  G C E       L+ E +  G+L+ +   +   + +  ++K A++I  
Sbjct: 78  RNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICK 137

Query: 163 AVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGF 222
            + YL     R  V R + A NVL++  +  K+ DF L+ +I   +    E +       
Sbjct: 138 GMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK----EYYTVKDDRD 190

Query: 223 I-----APEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDD-------DLTVL 270
                 APE    S F    DV+SFG  L ELLT C+                   +TV 
Sbjct: 191 SPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVT 250

Query: 271 EYAKKSIENNRFGAIVD-PIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK 329
                  E  R     + P                 + QLM KC    P +R    ++ +
Sbjct: 251 RLVNTLKEGKRLPCPPNCP---------------DEVYQLMRKCWEFQPSNRTSFQNLIE 295

Query: 330 QLRQM 334
               +
Sbjct: 296 GFEAL 300

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 81.6 bits (202), Expect = 8e-18
 Identities = 52/244 (21%), Positives = 104/244 (42%), Gaps = 46/244 (18%)

Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF------------SFASLLIAPRIK 155
            +    ++++L+G   + +   ++ E +  G L+ +              A   ++  I+
Sbjct: 83  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 142

Query: 156 IAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEF 215
           +A EIA+ +AYL+       V R + A N ++ E+++ K+ DF ++  I E + +     
Sbjct: 143 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR---- 195

Query: 216 IKGAYGFI-----APEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
            KG  G +     +PE      F    DV+SFG  L E+ T      ++G  N+    VL
Sbjct: 196 -KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA-EQPYQGLSNEQ---VL 250

Query: 271 EYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ 330
            +  +       G ++D         P  +     L +LM  C   +P+ RP  +++   
Sbjct: 251 RFVME-------GGLLDK--------P--DNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293

Query: 331 LRQM 334
           +++ 
Sbjct: 294 IKEE 297

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 80.4 bits (199), Expect = 2e-17
 Identities = 54/244 (22%), Positives = 93/244 (38%), Gaps = 50/244 (20%)

Query: 108 SQMKHKNILKLIGCCLETELPTL-VFESVKYGTLRGF---SFASLLIAPRIKIAMEIANA 163
             + H N+L LIG  L  E     +   + +G L  F      +  +   I   +++A  
Sbjct: 77  RGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARG 136

Query: 164 VAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFI 223
           + YL    ++  V R + A N +LDE+++ K+ DF L+  I + E +  +   +  +  +
Sbjct: 137 MEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQ---QHRHARL 190

Query: 224 -----APEYFATSSFNEMCDVYSFGAFLCELLT-------GCNVLEFKGNGNDDDLTVLE 271
                A E   T  F    DV+SFG  L ELLT         +  +           +  
Sbjct: 191 PVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD-----------LTH 239

Query: 272 YAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQL 331
           +  +       G  +          P  E    SL Q+M +C    P  RP    +  ++
Sbjct: 240 FLAQ-------GRRLPQ--------P--EYCPDSLYQVMQQCWEADPAVRPTFRVLVGEV 282

Query: 332 RQMY 335
            Q+ 
Sbjct: 283 EQIV 286

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 80.1 bits (198), Expect = 3e-17
 Identities = 52/254 (20%), Positives = 97/254 (38%), Gaps = 62/254 (24%)

Query: 108 SQMKHKNILKLIGCCLETE------LPTLVFESVKYGTLRGF--------SFASLLIAPR 153
            +  H ++ KL+G  L +       +P ++   +K+G L  F        +  +L +   
Sbjct: 80  KEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTL 139

Query: 154 IKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVRE 213
           ++  ++IA  + YL     R  + R + A N +L E+ +  + DF LS  I  G+ +   
Sbjct: 140 VRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYR-- 194

Query: 214 EFIKGAYGFI-----APEYFATSSFNEMCDVYSFGAFLCELLT-------GCNVLEFKGN 261
              +G    +     A E  A + +    DV++FG  + E++T       G    E    
Sbjct: 195 ---QGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE---- 247

Query: 262 GNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHR 321
                  +  Y          G  +          P   E ++ +  LMY+C S  P+ R
Sbjct: 248 -------IYNYLIG-------GNRLKQ--------P--PECMEEVYDLMYQCWSADPKQR 283

Query: 322 PLMVDVAKQLRQMY 335
           P    +  +L  + 
Sbjct: 284 PSFTCLRMELENIL 297

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 79.2 bits (196), Expect = 5e-17
 Identities = 64/294 (21%), Positives = 111/294 (37%), Gaps = 67/294 (22%)

Query: 72  FEGTLVDQD-RPISV----MKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETE 126
            EG L  +D   + V    MK  DNS+  ++E   +         H N+++L+G C+E  
Sbjct: 51  MEGNLKQEDGTSLKVAVKTMK-LDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS 109

Query: 127 -----LPTLVFESVKYGTLRGF--------SFASLLIAPRIKIAMEIANAVAYLHVGFDR 173
                 P ++   +KYG L  +            + +   +K  ++IA  + YL    +R
Sbjct: 110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NR 166

Query: 174 PIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFI-----APEYF 228
             + R + A N +L ++ +  + DF LS  I  G+ +      +G    +     A E  
Sbjct: 167 NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYR-----QGRIAKMPVKWIAIESL 221

Query: 229 ATSSFNEMCDVYSFGAFLCELLT-------GCNVLEFKGNGNDDDLTVLEYAKKSIENNR 281
           A   +    DV++FG  + E+ T       G    E           + +Y         
Sbjct: 222 ADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE-----------MYDYLLH------ 264

Query: 282 FGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMY 335
            G  +          P  E+ L  L ++MY C    P  RP    +  QL ++ 
Sbjct: 265 -GHRLKQ--------P--EDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL 307

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 80.7 bits (199), Expect = 5e-17
 Identities = 62/232 (26%), Positives = 99/232 (42%), Gaps = 32/232 (13%)

Query: 109 QMKHKNILKLIGCCLETELPT-LVFESVKYGTLRGF---SFASLLIAPR-IKIAMEIANA 163
           +++H+ +++L      +E P  +V E +  G+L  F        L  P+ + +A +IA+ 
Sbjct: 318 KLRHEKLVQLYAVV--SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 375

Query: 164 VAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFI 223
           +AY+        V R ++A+N+L+ EN   K+ DF L+  I + E +   +  K    + 
Sbjct: 376 MAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWT 431

Query: 224 APEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFG 283
           APE      F    DV+SFG  L EL T   V  + G  N + L  +E         R  
Sbjct: 432 APEAALYGRFTIKSDVWSFGILLTELTTKGRV-PYPGMVNREVLDQVE------RGYR-- 482

Query: 284 AIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMY 335
                        P   E  +SL  LM +C  K PE RP    +   L   +
Sbjct: 483 ------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 79.3 bits (195), Expect = 9e-17
 Identities = 38/241 (15%), Positives = 73/241 (30%), Gaps = 60/241 (24%)

Query: 115 ILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRP 174
           +   +   L+T    L+  S  + +L            R+++ +++   +A LH      
Sbjct: 178 LYPRMQSNLQTFGEVLLSHSSTHKSLV--------HHARLQLTLQVIRLLASLH---HYG 226

Query: 175 IVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSS-- 232
           +V   ++  +++LD+     L  F   V   +G   V       + GF  PE  A  +  
Sbjct: 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLV--RDGARVV----SSVSRGFEPPELEARRATI 280

Query: 233 ---------FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFG 283
                         D ++ G  +  +      L         D  +              
Sbjct: 281 SYHRDRRTLMTFSFDAWALGLVIYWIWCA--DLPI-----TKDAALGGSEW--------- 324

Query: 284 AIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVA-----KQLRQMYLSV 338
                IF    + P      Q +  L+   L    E R L +        +QLR    + 
Sbjct: 325 -----IFRSCKNIP------QPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAA 373

Query: 339 V 339
           +
Sbjct: 374 L 374

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 79.4 bits (196), Expect = 1e-16
 Identities = 62/232 (26%), Positives = 99/232 (42%), Gaps = 32/232 (13%)

Query: 109 QMKHKNILKLIGCCLETELPT-LVFESVKYGTLRGF---SFASLLIAPR-IKIAMEIANA 163
           +++H+ +++L      +E P  +V E +  G+L  F        L  P+ + +A +IA+ 
Sbjct: 235 KLRHEKLVQLYAVV--SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 292

Query: 164 VAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFI 223
           +AY+        V R ++A+N+L+ EN   K+ DF L+  I + E +   +  K    + 
Sbjct: 293 MAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWT 348

Query: 224 APEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFG 283
           APE      F    DV+SFG  L EL T   V  + G  N + L  +E         R  
Sbjct: 349 APEAALYGRFTIKSDVWSFGILLTELTTKGRV-PYPGMVNREVLDQVE------RGYR-- 399

Query: 284 AIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMY 335
                        P   E  +SL  LM +C  K PE RP    +   L   +
Sbjct: 400 ------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 78.4 bits (194), Expect = 1e-16
 Identities = 47/231 (20%), Positives = 91/231 (39%), Gaps = 30/231 (12%)

Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANAVA 165
            + + ++ +L+G CL + +  L+ + + +G L  +      ++     +   ++IA  + 
Sbjct: 73  SVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 131

Query: 166 YLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAP 225
           YL    DR +V R + A NVL+      K+ DF L+  +   E     E  K    ++A 
Sbjct: 132 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188

Query: 226 EYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA 284
           E      +    DV+S+G  + EL+T G     + G    +  ++LE      +  R   
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFG--SKPYDGIPASEISSILE------KGER--- 237

Query: 285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMY 335
                       P        +  +M KC     + RP   ++  +  +M 
Sbjct: 238 -----------LPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 78.5 bits (194), Expect = 3e-16
 Identities = 40/153 (26%), Positives = 70/153 (45%), Gaps = 23/153 (15%)

Query: 109 QMKHKNILKLIGCCLETELPT-LVFESVKYGTLRGF----SFASLLIAPRIKIAMEIANA 163
           Q++H N+++L+G  +E +    +V E +  G+L  +      + L     +K ++++  A
Sbjct: 242 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 301

Query: 164 VAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFI 223
           + YL        V R + A NVL+ E+  AK+ DF L+          +E       G +
Sbjct: 302 MEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLT----------KEASSTQDTGKL 348

Query: 224 -----APEYFATSSFNEMCDVYSFGAFLCELLT 251
                APE      F+   DV+SFG  L E+ +
Sbjct: 349 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 381

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 77.4 bits (191), Expect = 6e-16
 Identities = 55/234 (23%), Positives = 94/234 (40%), Gaps = 32/234 (13%)

Query: 109 QMKHKNILKLIGCCLETELPT-LVFESVKYGTLRGF----SFASLLIAPRIKIAMEIANA 163
            ++H  ++KL      T+ P  ++ E +  G+L  F      +   +   I  + +IA  
Sbjct: 239 TLQHDKLVKLHAVV--TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEG 296

Query: 164 VAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFI 223
           +A++     R  + R ++A+N+L+  +   K+ DF L+  I E   +   E  K    + 
Sbjct: 297 MAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVI-EDNEYTAREGAKFPIKWT 352

Query: 224 APEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFG 283
           APE     SF    DV+SFG  L E++T   +  + G  N + +  LE         R  
Sbjct: 353 APEAINFGSFTIKSDVWSFGILLMEIVTYGRI-PYPGMSNPEVIRALE------RGYR-- 403

Query: 284 AIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS 337
                        P  E   + L  +M +C    PE RP    +   L   Y +
Sbjct: 404 ------------MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score = 75.8 bits (187), Expect = 7e-16
 Identities = 51/240 (21%), Positives = 86/240 (35%), Gaps = 55/240 (22%)

Query: 108 SQMKHKNILKLIGCCLETEL--PTLVF--ESVKYGTLRGF--SFASLLIAPRIKIAMEIA 161
             ++H NI++       T      +V   E +  GTL+ +   F  + I        +I 
Sbjct: 80  KGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQIL 139

Query: 162 NAVAYLHVGFDRPIVFRCIKASNVLLD-ENYSAKLHDFSLSVSIPEGETHVREEFIKGAY 220
             + +LH     PI+ R +K  N+ +     S K+ D  L+       T  R  F K   
Sbjct: 140 KGLQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA-------TLKRASFAKAVI 191

Query: 221 G---FIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSI 277
           G   F+APE +    ++E  DVY+FG  + E+ T                   EY     
Sbjct: 192 GTPEFMAPEMY-EEKYDESVDVYAFGMCMLEMATS------------------EYPYSEC 232

Query: 278 ENNR--FGAIVD----PIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQL 331
           +N    +  +        FD+      KE        ++  C+ ++ + R       K L
Sbjct: 233 QNAAQIYRRVTSGVKPASFDKVAIPEVKE--------IIEGCIRQNKDERYS----IKDL 280

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 77.3 bits (190), Expect = 8e-16
 Identities = 54/238 (22%), Positives = 94/238 (39%), Gaps = 37/238 (15%)

Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANAVA 165
           Q+ +  I++LIG C   E   LV E    G L  F       + ++   ++  +++  + 
Sbjct: 392 QLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMK 450

Query: 166 YLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEF-----IKGAY 220
           YL    ++  V R + A NVLL   + AK+ DF LS ++   +++          +K   
Sbjct: 451 YLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK--- 504

Query: 221 GFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENN 280
            + APE      F+   DV+S+G  + E L+      +K     + +  +E      +  
Sbjct: 505 -WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK-PYKKMKGPEVMAFIE------QGK 556

Query: 281 RFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLSV 338
           R                   E    L  LM  C     E RP  + V +++R  Y S+
Sbjct: 557 R--------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 600

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 76.2 bits (188), Expect = 9e-16
 Identities = 47/257 (18%), Positives = 89/257 (34%), Gaps = 65/257 (25%)

Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF-----------------SFASLLI 150
           + ++H++I++  G C E     +VFE +++G L  F                 +   L +
Sbjct: 98  TMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGL 157

Query: 151 APRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH 210
              + +A ++A  + YL        V R +   N L+ +    K+ DF +S  I   + +
Sbjct: 158 GQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYY 214

Query: 211 VREEFIKGAYGFI-----APEYFATSSFNEMCDVYSFGAFLCELLT-------GCNVLEF 258
                  G    +      PE      F    DV+SFG  L E+ T         +  E 
Sbjct: 215 R-----VGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE- 268

Query: 259 KGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSP 318
                      ++   +       G  ++         P        +  +M  C  + P
Sbjct: 269 ----------AIDCITQ-------GRELER--------P--RACPPEVYAIMRGCWQREP 301

Query: 319 EHRPLMVDVAKQLRQMY 335
           + R  + DV  +L+ + 
Sbjct: 302 QQRHSIKDVHARLQALA 318

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 75.0 bits (185), Expect = 1e-15
 Identities = 54/239 (22%), Positives = 94/239 (39%), Gaps = 37/239 (15%)

Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANAV 164
            Q+ +  I++LIG C   E   LV E    G L  F       + ++   ++  +++  +
Sbjct: 65  HQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGM 123

Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEF-----IKGA 219
            YL    ++  V R + A NVLL   + AK+ DF LS ++   +++          +K  
Sbjct: 124 KYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK-- 178

Query: 220 YGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIEN 279
             + APE      F+   DV+S+G  + E L+      +K     + +  +E      + 
Sbjct: 179 --WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK-PYKKMKGPEVMAFIE------QG 229

Query: 280 NRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLSV 338
            R                   E    L  LM  C     E RP  + V +++R  Y S+
Sbjct: 230 KR--------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 274

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 75.0 bits (185), Expect = 1e-15
 Identities = 54/235 (22%), Positives = 97/235 (41%), Gaps = 37/235 (15%)

Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF----SFASLLIAPRIKIAMEIANAV 164
           ++KH N+++L+G C       ++ E + YG L  +    +   +     + +A +I++A+
Sbjct: 65  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 124

Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEF---IKGAYG 221
            YL     +  + R + A N L+ EN+  K+ DF LS  +              IK    
Sbjct: 125 EYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK---- 177

Query: 222 FIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENN 280
           + APE  A + F+   DV++FG  L E+ T G +   + G        V E  +K   + 
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP--YPGIDLSQ---VYELLEK---DY 229

Query: 281 RFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMY 335
           R                  E   + + +LM  C   +P  RP   ++ +    M+
Sbjct: 230 R--------------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 270

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 74.6 bits (184), Expect = 2e-15
 Identities = 68/236 (28%), Positives = 97/236 (41%), Gaps = 39/236 (16%)

Query: 108 SQMKHKNILKLIGCCLETELPT-LVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANA 163
            Q  H +I+KLIG    TE P  ++ E    G LR F      SL +A  I  A +++ A
Sbjct: 71  RQFDHPHIVKLIGVI--TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 128

Query: 164 VAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEF---IKGAY 220
           +AYL     +  V R I A NVL+  N   KL DF LS  + +   +   +    IK   
Sbjct: 129 LAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK--- 182

Query: 221 GFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIEN 279
            ++APE      F    DV+ FG  + E+L  G     F+G  N+D +  +E        
Sbjct: 183 -WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP--FQGVKNNDVIGRIE------NG 233

Query: 280 NRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMY 335
            R               P       +L  LM KC +  P  RP   ++  QL  + 
Sbjct: 234 ER--------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 75.1 bits (185), Expect = 2e-15
 Identities = 47/231 (20%), Positives = 91/231 (39%), Gaps = 30/231 (12%)

Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANAVA 165
            + + ++ +L+G CL + +  L+ + + +G L  +      ++     +   ++IA  + 
Sbjct: 73  SVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 131

Query: 166 YLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAP 225
           YL    DR +V R + A NVL+      K+ DF L+  +   E     E  K    ++A 
Sbjct: 132 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188

Query: 226 EYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA 284
           E      +    DV+S+G  + EL+T G     + G    +  ++LE      +  R   
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFG--SKPYDGIPASEISSILE------KGER--- 237

Query: 285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMY 335
                       P        +  +M KC     + RP   ++  +  +M 
Sbjct: 238 -----------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 75.7 bits (186), Expect = 3e-15
 Identities = 68/237 (28%), Positives = 96/237 (40%), Gaps = 41/237 (17%)

Query: 108 SQMKHKNILKLIGCCLETELPT-LVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANA 163
            Q  H +I+KLIG    TE P  ++ E    G LR F      SL +A  I  A +++ A
Sbjct: 446 RQFDHPHIVKLIGVI--TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTA 503

Query: 164 VAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFI 223
           +AYL     +  V R I A NVL+  N   KL DF LS  + +        + K + G +
Sbjct: 504 LAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED------STYYKASKGKL 554

Query: 224 -----APEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIE 278
                APE      F    DV+ FG  + E+L    V  F+G  N+D +  +E       
Sbjct: 555 PIKWMAPESINFRRFTSASDVWMFGVCMWEILM-HGVKPFQGVKNNDVIGRIE------N 607

Query: 279 NNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMY 335
             R               P       +L  LM KC +  P  RP   ++  QL  + 
Sbjct: 608 GER--------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 74.7 bits (183), Expect = 3e-15
 Identities = 21/179 (11%), Positives = 48/179 (26%), Gaps = 24/179 (13%)

Query: 153 RIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVR 212
              +  ++    A L     + +V       N+ +  +    L D S    +       R
Sbjct: 196 LHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----R 247

Query: 213 EEFIKGAYGFIAPEYF--ATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
                    +   E+   +T++F    + +  G  +  +      L F         +  
Sbjct: 248 GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL--FLPFGLVTPGIKGSW- 304

Query: 271 EYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK 329
                   + R        F      P        +  L+ + L+     R L ++  +
Sbjct: 305 -----KRPSLRVPGTDSLAFGSCTPLP------DFVKTLIGRFLNFDRRRRLLPLEAME 352

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 73.8 bits (182), Expect = 3e-15
 Identities = 40/153 (26%), Positives = 70/153 (45%), Gaps = 23/153 (15%)

Query: 109 QMKHKNILKLIGCCLETELPT-LVFESVKYGTLRGF----SFASLLIAPRIKIAMEIANA 163
           Q++H N+++L+G  +E +    +V E +  G+L  +      + L     +K ++++  A
Sbjct: 70  QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 129

Query: 164 VAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFI 223
           + YL        V R + A NVL+ E+  AK+ DF L+          +E       G +
Sbjct: 130 MEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLT----------KEASSTQDTGKL 176

Query: 224 -----APEYFATSSFNEMCDVYSFGAFLCELLT 251
                APE      F+   DV+SFG  L E+ +
Sbjct: 177 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 209

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 73.8 bits (182), Expect = 3e-15
 Identities = 56/239 (23%), Positives = 95/239 (39%), Gaps = 38/239 (15%)

Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF--SFASLLIAPRIKIAMEIANAVAY 166
           Q+ +  I+++IG C   E   LV E  + G L  +      +     I++  +++  + Y
Sbjct: 74  QLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 132

Query: 167 LHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEF-----IKGAYG 221
           L    +   V R + A NVLL   + AK+ DF LS ++   E + + +      +K    
Sbjct: 133 LE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK---- 185

Query: 222 FIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENN 280
           + APE      F+   DV+SFG  + E  + G     ++G    +   +LE      +  
Sbjct: 186 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYG--QKPYRGMKGSEVTAMLE------KGE 237

Query: 281 RFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLSVV 339
           R                      + +  LM  C +   E+RP    V  +LR  Y  VV
Sbjct: 238 R--------------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 282

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 74.7 bits (184), Expect = 3e-15
 Identities = 55/244 (22%), Positives = 94/244 (38%), Gaps = 46/244 (18%)

Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF---------SFASLLIAPRIKIAM 158
           S+  H+NI++ IG  L++    ++ E +  G L+ F           +SL +   + +A 
Sbjct: 129 SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 188

Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLD---ENYSAKLHDFSLSVSIPEGETHVREEF 215
           +IA    YL    +   + R I A N LL        AK+ DF ++  I     +     
Sbjct: 189 DIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYR---- 241

Query: 216 IKGAYGFI-----APEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
            KG    +      PE F    F    D +SFG  L E+ +   +  +    N +   VL
Sbjct: 242 -KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYM-PYPSKSNQE---VL 296

Query: 271 EYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ 330
           E+          G  +DP        P  +     + ++M +C    PE RP    + ++
Sbjct: 297 EFVTS-------GGRMDP--------P--KNCPGPVYRIMTQCWQHQPEDRPNFAIILER 339

Query: 331 LRQM 334
           +   
Sbjct: 340 IEYC 343

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 74.3 bits (183), Expect = 4e-15
 Identities = 55/251 (21%), Positives = 92/251 (36%), Gaps = 60/251 (23%)

Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF---------SFASLLIAPRIKIAM 158
           S+  H+NI++ IG  L++    ++ E +  G L+ F           +SL +   + +A 
Sbjct: 88  SKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 147

Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLD---ENYSAKLHDFSLSVSIPEGETHVREEF 215
           +IA    YL    +   + R I A N LL        AK+ DF ++  I     +     
Sbjct: 148 DIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR---- 200

Query: 216 IKGAYGFI-----APEYFATSSFNEMCDVYSFGAFLCELLT-------GCNVLEFKGNGN 263
            KG    +      PE F    F    D +SFG  L E+ +         +  E      
Sbjct: 201 -KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE------ 253

Query: 264 DDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPL 323
                VLE+          G  +DP        P  +     + ++M +C    PE RP 
Sbjct: 254 -----VLEFVTS-------GGRMDP--------P--KNCPGPVYRIMTQCWQHQPEDRPN 291

Query: 324 MVDVAKQLRQM 334
              + +++   
Sbjct: 292 FAIILERIEYC 302

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 73.9 bits (182), Expect = 4e-15
 Identities = 58/243 (23%), Positives = 86/243 (35%), Gaps = 52/243 (21%)

Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANAVA 165
           Q  H NI++L G      L  +V E ++ G+L  F         I   + +   +   + 
Sbjct: 106 QFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMR 165

Query: 166 YLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFI-- 223
           YL    D   V R + A NVL+D N   K+ DF LS  + +      +       G I  
Sbjct: 166 YLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP----DAAYTTTGGKIPI 218

Query: 224 ---APEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIEN 279
              APE  A  +F+   DV+SFG  + E+L  G     +    N D   V+      +E 
Sbjct: 219 RWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGE--RPYWNMTNRD---VISS----VEE 269

Query: 280 NRFGAIVDPIFDEDNSFPGKEEKL-------QSLGQLMYKCLSKSPEHRPLMVDVAKQLR 332
                                 +L        +L QLM  C  K    RP    +   L 
Sbjct: 270 G--------------------YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLD 309

Query: 333 QMY 335
            + 
Sbjct: 310 ALI 312

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 73.0 bits (180), Expect = 5e-15
 Identities = 37/150 (24%), Positives = 75/150 (50%), Gaps = 13/150 (8%)

Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF--SFASLLIAPR-IKIAMEIANAV 164
            ++ H  +++L G CLE     LV E +++G L  +  +   L  A   + + +++   +
Sbjct: 58  MKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGM 117

Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVRE--EF-IKGAYG 221
           AYL    +  ++ R + A N L+ EN   K+ DF ++  + + +       +F +K    
Sbjct: 118 AYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK---- 170

Query: 222 FIAPEYFATSSFNEMCDVYSFGAFLCELLT 251
           + +PE F+ S ++   DV+SFG  + E+ +
Sbjct: 171 WASPEVFSFSRYSSKSDVWSFGVLMWEVFS 200

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 73.5 bits (181), Expect = 6e-15
 Identities = 37/165 (22%), Positives = 65/165 (39%), Gaps = 32/165 (19%)

Query: 111 KHKNILKLIGCCLETELPTLV-FESVKYGTLRGF-----------------SFASLLIAP 152
            H N++ L+G C +   P +V  E  K+G L  +                  +   L   
Sbjct: 89  HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148

Query: 153 R-IKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHV 211
             I  + ++A  + +L     R  + R + A N+LL E    K+ DF L+  I     + 
Sbjct: 149 HLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDI-----YK 200

Query: 212 REEFIKGAYGFI-----APEYFATSSFNEMCDVYSFGAFLCELLT 251
             ++++     +     APE      +    DV+SFG  L E+ +
Sbjct: 201 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 73.1 bits (180), Expect = 8e-15
 Identities = 34/146 (23%), Positives = 64/146 (43%), Gaps = 7/146 (4%)

Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANAVA 165
            + H +I++L+G C       LV + +  G+L         +L     +   ++IA  + 
Sbjct: 71  SLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMY 129

Query: 166 YLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAP 225
           YL    +  +V R + A NVLL      ++ DF ++  +P  +  +     K    ++A 
Sbjct: 130 YLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMAL 186

Query: 226 EYFATSSFNEMCDVYSFGAFLCELLT 251
           E      +    DV+S+G  + EL+T
Sbjct: 187 ESIHFGKYTHQSDVWSYGVTVWELMT 212

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 72.7 bits (179), Expect = 8e-15
 Identities = 51/258 (19%), Positives = 96/258 (37%), Gaps = 66/258 (25%)

Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF------------------SFASLL 149
           + ++H++I+K  G C + +   +VFE +K+G L  F                  +   L 
Sbjct: 72  TNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 131

Query: 150 IAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGET 209
           ++  + IA +IA+ + YL     +  V R +   N L+  N   K+ DF +S  +   + 
Sbjct: 132 LSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY 188

Query: 210 HVREEFIKGAYGFI-----APEYFATSSFNEMCDVYSFGAFLCELLT-------GCNVLE 257
           +       G +  +      PE      F    DV+SFG  L E+ T         +  E
Sbjct: 189 YR-----VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE 243

Query: 258 FKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKS 317
                      V+E   +       G +++         P      + +  +M  C  + 
Sbjct: 244 -----------VIECITQ-------GRVLER--------P--RVCPKEVYDVMLGCWQRE 275

Query: 318 PEHRPLMVDVAKQLRQMY 335
           P+ R  + ++ K L  + 
Sbjct: 276 PQQRLNIKEIYKILHALG 293

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 71.5 bits (176), Expect = 2e-14
 Identities = 57/244 (23%), Positives = 90/244 (36%), Gaps = 55/244 (22%)

Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANAV 164
             + H +I+KLIG   E E   ++ E   YG L  +   +  SL +   +  +++I  A+
Sbjct: 68  KNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAM 126

Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFI- 223
           AYL        V R I   N+L+      KL DF LS  I +      E++ K +   + 
Sbjct: 127 AYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIED------EDYYKASVTRLP 177

Query: 224 ----APEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIE 278
               +PE      F    DV+ F   + E+L+ G     F    N D   V+      +E
Sbjct: 178 IKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP--FFWLENKD---VIGV----LE 228

Query: 279 NNRFGAIVDPIFDEDNSFPGKEEKL-------QSLGQLMYKCLSKSPEHRPLMVDVAKQL 331
                                 ++L         L  LM +C    P  RP   ++   L
Sbjct: 229 KG--------------------DRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSL 268

Query: 332 RQMY 335
             +Y
Sbjct: 269 SDVY 272

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 71.1 bits (175), Expect = 2e-14
 Identities = 31/150 (20%), Positives = 67/150 (44%), Gaps = 13/150 (8%)

Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF--SFASLLIAPR-IKIAMEIANAV 164
            ++ H  ++K  G C +     +V E +  G L  +  S    L   + +++  ++   +
Sbjct: 58  MKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGM 117

Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVRE--EF-IKGAYG 221
           A+L        + R + A N L+D +   K+ DF ++  + + +       +F +K    
Sbjct: 118 AFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVK---- 170

Query: 222 FIAPEYFATSSFNEMCDVYSFGAFLCELLT 251
           + APE F    ++   DV++FG  + E+ +
Sbjct: 171 WSAPEVFHYFKYSSKSDVWAFGILMWEVFS 200

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 71.5 bits (176), Expect = 2e-14
 Identities = 29/150 (19%), Positives = 65/150 (43%), Gaps = 13/150 (8%)

Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANAV 164
             + H+ +++L G C +     ++ E +  G L  +             +++  ++  A+
Sbjct: 74  MNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAM 133

Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVRE--EF-IKGAYG 221
            YL     +  + R + A N L+++    K+ DF LS  + + E       +F ++    
Sbjct: 134 EYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR---- 186

Query: 222 FIAPEYFATSSFNEMCDVYSFGAFLCELLT 251
           +  PE    S F+   D+++FG  + E+ +
Sbjct: 187 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 71.1 bits (175), Expect = 3e-14
 Identities = 44/151 (29%), Positives = 77/151 (50%), Gaps = 17/151 (11%)

Query: 109 QMKHKNILKLIGCCLETELPTL-VFESVKYGTLRGF----SFASLLIAPRIKIAMEIANA 163
           Q++H+ +++L      T+ P   + E ++ G+L  F    S   L I   + +A +IA  
Sbjct: 64  QLQHQRLVRLYAVV--TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121

Query: 164 VAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEF---IKGAY 220
           +A++    +R  + R ++A+N+L+ +  S K+ DF L+  I + E   RE     IK   
Sbjct: 122 MAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK--- 175

Query: 221 GFIAPEYFATSSFNEMCDVYSFGAFLCELLT 251
            + APE     +F    DV+SFG  L E++T
Sbjct: 176 -WTAPEAINYGTFTIKSDVWSFGILLTEIVT 205

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 71.6 bits (176), Expect = 4e-14
 Identities = 55/237 (23%), Positives = 94/237 (39%), Gaps = 38/237 (16%)

Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANAV 164
            Q  H NI++L G   +++   +V E ++ G+L  F     A   +   + +   IA+ +
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 160

Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFI- 223
            YL    D   V R + A N+L++ N   K+ DF L   + +          +G    I 
Sbjct: 161 KYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTT--RGGKIPIR 215

Query: 224 --APEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENN 280
             +PE  A   F    DV+S+G  L E+++ G     +    N D   V++     ++  
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG--ERPYWEMSNQD---VIKA----VDEG 266

Query: 281 -RFGAIVD-PIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMY 335
            R    +D P                +L QLM  C  K   +RP    +   L ++ 
Sbjct: 267 YRLPPPMDCP---------------AALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 70.8 bits (174), Expect = 6e-14
 Identities = 51/242 (21%), Positives = 89/242 (36%), Gaps = 48/242 (19%)

Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANAV 164
            Q  H NI++L G   + +   ++ E ++ G L  F         +   + +   IA  +
Sbjct: 101 GQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGM 160

Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFI- 223
            YL    +   V R + A N+L++ N   K+ DF LS  + +           G    I 
Sbjct: 161 KYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTT--SGGKIPIR 215

Query: 224 --APEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENN 280
             APE  +   F    DV+SFG  + E++T G     +    N +   V++     I + 
Sbjct: 216 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP--YWELSNHE---VMKA----INDG 266

Query: 281 RFGAIVDPIFDEDNSFPGKEEKL-------QSLGQLMYKCLSKSPEHRPLMVDVAKQLRQ 333
                                +L        ++ QLM +C  +    RP   D+   L +
Sbjct: 267 --------------------FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 306

Query: 334 MY 335
           + 
Sbjct: 307 LI 308

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 70.9 bits (174), Expect = 6e-14
 Identities = 54/255 (21%), Positives = 89/255 (34%), Gaps = 66/255 (25%)

Query: 111 KHKNILKLIGCCLETELPTLVFESVKYGTLRGF-----------SFASLLIAPR------ 153
           KHKNI+ L+G C +     ++ E    G LR +           S+    +         
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204

Query: 154 -IKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVR 212
            +    ++A  + YL     +  + R + A NVL+ EN   K+ DF L+  I     +  
Sbjct: 205 LVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDI-----NNI 256

Query: 213 EEFIKGAYGFI-----APEYFATSSFNEMCDVYSFGAFLCELLT-------GCNVLEFKG 260
           + + K   G +     APE      +    DV+SFG  + E+ T       G  V E   
Sbjct: 257 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--- 313

Query: 261 NGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEH 320
                   + +  K+       G  +D         P        L  +M  C    P  
Sbjct: 314 --------LFKLLKE-------GHRMDK--------P--ANCTNELYMMMRDCWHAVPSQ 348

Query: 321 RPLMVDVAKQLRQMY 335
           RP    + + L ++ 
Sbjct: 349 RPTFKQLVEDLDRIL 363

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 70.9 bits (174), Expect = 7e-14
 Identities = 42/164 (25%), Positives = 66/164 (40%), Gaps = 31/164 (18%)

Query: 111 KHKNILKLIGCCLETELPTLVFESVKYGTLRGF-----------SFASLLIAPR------ 153
           KHKNI+ L+G C +     ++ E    G LR +           S+              
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192

Query: 154 -IKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVR 212
            +  A ++A  + YL     +  + R + A NVL+ E+   K+ DF L+  I     H  
Sbjct: 193 LVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDI-----HHI 244

Query: 213 EEFIKGAYGFI-----APEYFATSSFNEMCDVYSFGAFLCELLT 251
           + + K   G +     APE      +    DV+SFG  L E+ T
Sbjct: 245 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 70.4 bits (173), Expect = 7e-14
 Identities = 54/255 (21%), Positives = 89/255 (34%), Gaps = 66/255 (25%)

Query: 111 KHKNILKLIGCCLETELPTLVFESVKYGTLRGF-----------SFASLLIAPR------ 153
           KHKNI+ L+G C +     ++ E    G LR +           S+    +         
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158

Query: 154 -IKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVR 212
            +    ++A  + YL     +  + R + A NVL+ EN   K+ DF L+  I     +  
Sbjct: 159 LVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDI-----NNI 210

Query: 213 EEFIKGAYGFI-----APEYFATSSFNEMCDVYSFGAFLCELLT-------GCNVLEFKG 260
           + + K   G +     APE      +    DV+SFG  + E+ T       G  V E   
Sbjct: 211 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--- 267

Query: 261 NGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEH 320
                   + +  K+       G  +D         P        L  +M  C    P  
Sbjct: 268 --------LFKLLKE-------GHRMDK--------P--ANCTNELYMMMRDCWHAVPSQ 302

Query: 321 RPLMVDVAKQLRQMY 335
           RP    + + L ++ 
Sbjct: 303 RPTFKQLVEDLDRIL 317

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 70.0 bits (172), Expect = 8e-14
 Identities = 36/166 (21%), Positives = 61/166 (36%), Gaps = 33/166 (19%)

Query: 111 KHKNILKLIGCCLETELPTLVFESVKYGTLRGF--------------------SFASLLI 150
            H NI+ L+G C       ++ E   YG L  F                       +L +
Sbjct: 85  NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144

Query: 151 APRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH 210
              +  + ++A  +A+L     +  + R + A N+LL      K+ DF L+  I      
Sbjct: 145 EDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDI-----K 196

Query: 211 VREEFIKGAYGFI-----APEYFATSSFNEMCDVYSFGAFLCELLT 251
               ++      +     APE      +    DV+S+G FL EL +
Sbjct: 197 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 68.8 bits (169), Expect = 2e-13
 Identities = 42/258 (16%), Positives = 93/258 (36%), Gaps = 66/258 (25%)

Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF------------------SFASLL 149
           ++++H N++ L+G   + +  +++F    +G L  F                    ++L 
Sbjct: 67  ARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALE 126

Query: 150 IAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGET 209
               + +  +IA  + YL       +V + +   NVL+ +  + K+ D  L   +     
Sbjct: 127 PPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREV----- 178

Query: 210 HVREEFIKGAYGFI-----APEYFATSSFNEMCDVYSFGAFLCELLT-------GCNVLE 257
           +  + +       +     APE      F+   D++S+G  L E+ +       G +  +
Sbjct: 179 YAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD 238

Query: 258 FKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKS 317
                      V+E  +          ++          P  ++    +  LM +C ++ 
Sbjct: 239 -----------VVEMIRN-------RQVLPC--------P--DDCPAWVYALMIECWNEF 270

Query: 318 PEHRPLMVDVAKQLRQMY 335
           P  RP   D+  +LR   
Sbjct: 271 PSRRPRFKDIHSRLRAWG 288

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 69.6 bits (170), Expect = 2e-13
 Identities = 40/232 (17%), Positives = 71/232 (30%), Gaps = 35/232 (15%)

Query: 48  KDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPIS----VMKFHDNSTLDDVEYCFNN 103
            + +  +    +H ++      +++E T  D +   +    V+K    +   +       
Sbjct: 58  TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117

Query: 104 IVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL-------RGFSFASLLIAPRIKI 156
           +           +K     L      LV E   YGTL       +      +     I  
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177

Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLL-----------DENYSAKLHDFSLSV--- 202
           AM +   +  +H   D  I+   IK  N +L           D +    L D   S+   
Sbjct: 178 AMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234

Query: 203 SIPEGETHVREEFIK--GAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
             P+G       F       GF   E  +   +N   D +   A +  +L G
Sbjct: 235 LFPKGTI-----FTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFG 281

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 68.5 bits (168), Expect = 3e-13
 Identities = 39/249 (15%), Positives = 83/249 (33%), Gaps = 63/249 (25%)

Query: 108 SQMKHKNILKLIGCCLETELPT-------------LVFESVKYGTL------RGFSFASL 148
           + + H+ +++     LE                  +  E  + GTL         +    
Sbjct: 57  ASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRD 116

Query: 149 LIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE 208
                 ++  +I  A++Y+H    + I+ R +K  N+ +DE+ + K+ DF L+ ++    
Sbjct: 117 EYW---RLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSL 170

Query: 209 THVREEFIK------------GAYGFIAPEYFA-TSSFNEMCDVYSFGAFLCELLTGCNV 255
             ++ +               G   ++A E    T  +NE  D+YS G    E++     
Sbjct: 171 DILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPF-- 228

Query: 256 LEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQS--LGQLMYKC 313
               G     ++      K              +      FP   +  +     +++   
Sbjct: 229 --STGM-ERVNI----LKK--------------LRSVSIEFPPDFDDNKMKVEKKIIRLL 267

Query: 314 LSKSPEHRP 322
           +   P  RP
Sbjct: 268 IDHDPNKRP 276

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 68.8 bits (169), Expect = 3e-13
 Identities = 38/162 (23%), Positives = 66/162 (40%), Gaps = 29/162 (17%)

Query: 111 KHKNILKLIGCCLETELPTLVFESVKYGTLRGF--------------SFASLLIAPR--I 154
           +H+NI+ L+G C       ++ E   YG L  F              + A+   + R  +
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLL 167

Query: 155 KIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREE 214
             + ++A  +A+L     +  + R + A NVLL   + AK+ DF L+  I          
Sbjct: 168 HFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND-----SN 219

Query: 215 FIKGAYGFI-----APEYFATSSFNEMCDVYSFGAFLCELLT 251
           +I      +     APE      +    DV+S+G  L E+ +
Sbjct: 220 YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 68.5 bits (168), Expect = 4e-13
 Identities = 60/266 (22%), Positives = 93/266 (34%), Gaps = 74/266 (27%)

Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF-------------------SFASL 148
           ++  + NI+KL+G C   +   L+FE + YG L  F                        
Sbjct: 105 AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 164

Query: 149 LIAPR-------IKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLS 201
              P        + IA ++A  +AYL    +R  V R +   N L+ EN   K+ DF LS
Sbjct: 165 SPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLS 221

Query: 202 VSIPEGETHVREEFIKGAYGFI-----APEYFATSSFNEMCDVYSFGAFLCELLT----- 251
            +I   + +            I      PE    + +    DV+++G  L E+ +     
Sbjct: 222 RNIYSADYYK-----ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276

Query: 252 --GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQL 309
             G    E           V+ Y +        G I+          P  E     L  L
Sbjct: 277 YYGMAHEE-----------VIYYVRD-------GNILAC--------P--ENCPLELYNL 308

Query: 310 MYKCLSKSPEHRPLMVDVAKQLRQMY 335
           M  C SK P  RP    + + L++M 
Sbjct: 309 MRLCWSKLPADRPSFCSIHRILQRMC 334

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 68.2 bits (167), Expect = 4e-13
 Identities = 37/175 (21%), Positives = 70/175 (40%), Gaps = 26/175 (14%)

Query: 108 SQMKHKNILKLIGCCLETELPT---LVFE----------SVKYGTLRGFSFASLLIAPRI 154
           + +K++  L   G  +         +++E             +  L       + I    
Sbjct: 98  TDIKNEYCLTCEGI-ITN--YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK 154

Query: 155 KIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREE 214
            I   + N+ +Y+H   ++ I  R +K SN+L+D+N   KL DF  S  + + +      
Sbjct: 155 CIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKG--- 209

Query: 215 FIKGAYGFIAPEYFATSSF--NEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDL 267
             +G Y F+ PE+F+  S       D++S G  L  +     V+ F    +  +L
Sbjct: 210 -SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYN--VVPFSLKISLVEL 261

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 67.7 bits (166), Expect = 4e-13
 Identities = 49/242 (20%), Positives = 91/242 (37%), Gaps = 50/242 (20%)

Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANAVA 165
            + H+N+++L G  L   +  +V E    G+L           L+    + A+++A  + 
Sbjct: 77  SLDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 135

Query: 166 YLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFI-- 223
           YL     +  + R + A N+LL      K+ DF L  ++P+ +    + ++   +  +  
Sbjct: 136 YLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND----DHYVMQEHRKVPF 188

Query: 224 ---APEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENN 280
              APE   T +F+   D + FG  L E+ T      + G        +L      I+  
Sbjct: 189 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE-PWIGLNGSQ---ILHK----IDKE 240

Query: 281 RFGAIVDPIFDEDNSFPGKEEKL-------QSLGQLMYKCLSKSPEHRPLMVDVAKQLRQ 333
                               E+L       Q +  +M +C +  PE RP  V +   L +
Sbjct: 241 G-------------------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 281

Query: 334 MY 335
             
Sbjct: 282 AQ 283

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 68.1 bits (167), Expect = 4e-13
 Identities = 42/164 (25%), Positives = 65/164 (39%), Gaps = 34/164 (20%)

Query: 111 KHKNILKLIGCCLETELPTLVFESVKYGTLRGF-----------SFASLLIAPR------ 153
            H NI+ L+G C       L  E   +G L  F           +FA             
Sbjct: 84  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 143

Query: 154 -IKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVR 212
            +  A ++A  + YL     +  + R + A N+L+ ENY AK+ DF LS           
Sbjct: 144 LLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQ-------- 192

Query: 213 EEFIKGAYGFI-----APEYFATSSFNEMCDVYSFGAFLCELLT 251
           E ++K   G +     A E    S +    DV+S+G  L E+++
Sbjct: 193 EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 68.4 bits (167), Expect = 4e-13
 Identities = 42/271 (15%), Positives = 80/271 (29%), Gaps = 45/271 (16%)

Query: 90  DNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLR-------G 142
           +  + + V +    +  S    H NI+      +      +V   + YG+ +        
Sbjct: 63  EACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFM 122

Query: 143 FSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSV 202
                L IA    I   +  A+ Y+H       V R +KAS++L+  +    L     ++
Sbjct: 123 DGMNELAIA---YILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNL 176

Query: 203 SIPEGETHVREEFIKGAYGFI------APEYFA--TSSFNEMCDVYSFGAFLCELLTGC- 253
           S+       +          +      +PE        ++   D+YS G   CEL  G  
Sbjct: 177 SM-ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHV 235

Query: 254 ----------------------NVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFD 291
                                                    A   + ++   +   P   
Sbjct: 236 PFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNG 295

Query: 292 EDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
           +  S P            + +CL ++P+ RP
Sbjct: 296 DSPSHPYHRTFSPHFHHFVEQCLQRNPDARP 326

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 66.9 bits (164), Expect = 9e-13
 Identities = 47/242 (19%), Positives = 99/242 (40%), Gaps = 44/242 (18%)

Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANAV 164
           S++ HK+++   G C+  +   LV E VK+G+L  +   +   + I  ++++A ++A A+
Sbjct: 67  SKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAM 126

Query: 165 AYLHVGFDRPIVFRCIKASNVLLD--------ENYSAKLHDFSLSVSIPEGETHVREEFI 216
            +L    +  ++   + A N+LL              KL D  +S+++      + ++ +
Sbjct: 127 HFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV------LPKDIL 177

Query: 217 KGAYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKK 275
           +    ++ PE      + N   D +SFG  L E+ +G          +      L++   
Sbjct: 178 QERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSG-GDKPLSALDSQR---KLQF--- 230

Query: 276 SIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMY 335
             E+      +          P   E    L  L+  C+   P+HRP    + + L  ++
Sbjct: 231 -YED---RHQLPA--------PKAAE----LANLINNCMDYEPDHRPSFRAIIRDLNSLF 274

Query: 336 LS 337
             
Sbjct: 275 TP 276

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 66.5 bits (163), Expect = 9e-13
 Identities = 50/259 (19%), Positives = 99/259 (38%), Gaps = 42/259 (16%)

Query: 79  QDRPISVMKFHDNSTLD--DVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTL------ 130
            D  I V K  D  ++   + +   + +    ++KH NI++     ++    TL      
Sbjct: 29  SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEY 88

Query: 131 -----VFESVKYGTLRGFSFASLLIAPRIKIAMEIANAVAYLH--VGFDRPIVFRCIKAS 183
                +   +  GT          +   +++  ++  A+   H        ++ R +K +
Sbjct: 89  CEGGDLASVITKGTKERQYLDEEFV---LRVMTQLTLALKECHRRSDGGHTVLHRDLKPA 145

Query: 184 NVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFG 243
           NV LD   + KL DF L+  +   +T   + F+ G   +++PE     S+NE  D++S G
Sbjct: 146 NVFLDGKQNVKLGDFGLARIL-NHDTSFAKTFV-GTPYYMSPEQMNRMSYNEKSDIWSLG 203

Query: 244 AFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKL 303
             L EL     +  F    +  +L         I   +F  I    + ++          
Sbjct: 204 CLLYELCAL--MPPFTAF-SQKELA------GKIREGKFRRI-PYRYSDE---------- 243

Query: 304 QSLGQLMYKCLSKSPEHRP 322
             L +++ + L+    HRP
Sbjct: 244 --LNEIITRMLNLKDYHRP 260

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score = 67.0 bits (164), Expect = 1e-12
 Identities = 51/253 (20%), Positives = 97/253 (38%), Gaps = 39/253 (15%)

Query: 79  QDRPISVMKF--HDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVK 136
           +D    V+K       +  + E     +   + MKH NI++      E     +V +  +
Sbjct: 47  EDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCE 106

Query: 137 YGTL-------RGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDE 189
            G L       +G  F    I   +   ++I  A+ ++H   DR I+ R IK+ N+ L +
Sbjct: 107 GGDLFKRINAQKGVLFQEDQI---LDWFVQICLALKHVH---DRKILHRDIKSQNIFLTK 160

Query: 190 NYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCEL 249
           + + +L DF ++  +    T        G   +++PE      +N   D+++ G  L EL
Sbjct: 161 DGTVQLGDFGIARVL--NSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYEL 218

Query: 250 LTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQL 309
            T  +   F+        ++     K I +  F  +    +  D            L  L
Sbjct: 219 CTLKHA--FEAG------SMKNLVLK-IISGSFPPV-SLHYSYD------------LRSL 256

Query: 310 MYKCLSKSPEHRP 322
           + +   ++P  RP
Sbjct: 257 VSQLFKRNPRDRP 269

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 66.6 bits (163), Expect = 1e-12
 Identities = 46/242 (19%), Positives = 85/242 (35%), Gaps = 54/242 (22%)

Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTL-------RGFSFASLLIAPR------- 153
           ++++H  I++     LE      +  S     L       R  +    +           
Sbjct: 58  AKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERER 117

Query: 154 ---IKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLS--------- 201
              + I ++IA AV +LH    + ++ R +K SN+    +   K+ DF L          
Sbjct: 118 SVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEE 174

Query: 202 -VSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKG 260
              +     + R     G   +++PE    +S++   D++S G  L ELL          
Sbjct: 175 QTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPF------- 227

Query: 261 NGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEH 320
           +   + +  L      + N +F     P+F          +K      ++   LS SP  
Sbjct: 228 STQMERVRTL----TDVRNLKF----PPLFT---------QKYPCEYVMVQDMLSPSPME 270

Query: 321 RP 322
           RP
Sbjct: 271 RP 272

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 66.1 bits (162), Expect = 1e-12
 Identities = 37/151 (24%), Positives = 61/151 (40%), Gaps = 17/151 (11%)

Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRI------KIAMEIA 161
           S ++H NIL++     + +   L+ E    G L    +  L    R           E+A
Sbjct: 69  SHLRHPNILRMYNYFHDRKRIYLMLEFAPRGEL----YKELQKHGRFDEQRSATFMEELA 124

Query: 162 NAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYG 221
           +A+ Y H   +R ++ R IK  N+L+      K+ DF  SV  P          + G   
Sbjct: 125 DALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRT----MCGTLD 177

Query: 222 FIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
           ++ PE     + +E  D++  G    E L G
Sbjct: 178 YLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 208

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 66.6 bits (163), Expect = 2e-12
 Identities = 44/232 (18%), Positives = 77/232 (33%), Gaps = 46/232 (19%)

Query: 108 SQMKHKNILKLIGCCLETELPT-LVFESVKYGTLRGFSFASLLIAPRI------KIAMEI 160
             + H++++   G   E      +V E  +  +L             +          +I
Sbjct: 96  RSLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEARYYLRQI 150

Query: 161 ANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIK--- 217
                YLH      ++ R +K  N+ L+E+   K+ DF L+  +         E  K   
Sbjct: 151 VLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV-----EYDGERKKVLC 202

Query: 218 GAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSI 277
           G   +IAPE  +    +   DV+S G  +  LL G     F        L    Y +  I
Sbjct: 203 GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK--PPF----ETSCLKET-YLR--I 253

Query: 278 ENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK 329
           + N +         +  +             L+ K L   P  RP + ++  
Sbjct: 254 KKNEY------SIPKHINPVAAS--------LIQKMLQTDPTARPTINELLN 291

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 65.7 bits (161), Expect = 2e-12
 Identities = 41/151 (27%), Positives = 63/151 (41%), Gaps = 17/151 (11%)

Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRI------KIAMEIA 161
           S ++H NIL+L G   +     L+ E    GT+    +  L    +           E+A
Sbjct: 64  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELA 119

Query: 162 NAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYG 221
           NA++Y H    + ++ R IK  N+LL      K+ DF  SV  P      R   + G   
Sbjct: 120 NALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTDLCGTLD 172

Query: 222 FIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
           ++ PE       +E  D++S G    E L G
Sbjct: 173 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 203

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score = 66.2 bits (162), Expect = 2e-12
 Identities = 51/246 (20%), Positives = 90/246 (36%), Gaps = 36/246 (14%)

Query: 86  MKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL----- 140
           ++  D         C   I    Q+ H N++K     +E     +V E    G L     
Sbjct: 65  VQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIK 124

Query: 141 ----RGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLH 196
               +        +    K  +++ +A+ ++H    R ++ R IK +NV +      KL 
Sbjct: 125 HFKKQKRLIPERTVW---KYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLG 178

Query: 197 DFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVL 256
           D  L       +T      +   Y +++PE    + +N   D++S G  L E+       
Sbjct: 179 DLGLG-RFFSSKTTAAHSLVGTPY-YMSPERIHENGYNFKSDIWSLGCLLYEMAAL--QS 234

Query: 257 EFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSK 316
            F G    D + +    KK IE   +  +    + E+            L QL+  C++ 
Sbjct: 235 PFYG----DKMNLYSLCKK-IEQCDYPPLPSDHYSEE------------LRQLVNMCINP 277

Query: 317 SPEHRP 322
            PE RP
Sbjct: 278 DPEKRP 283

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 65.7 bits (161), Expect = 3e-12
 Identities = 46/175 (26%), Positives = 73/175 (41%), Gaps = 39/175 (22%)

Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF-------------------SFASL 148
            Q+ H +++KL G C +     L+ E  KYG+LRGF                   S +  
Sbjct: 81  KQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLD 140

Query: 149 LIAPR-------IKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLS 201
               R       I  A +I+  + YL    +  +V R + A N+L+ E    K+ DF LS
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLS 197

Query: 202 VSIPEGETHVREEFIKGAYGFI-----APEYFATSSFNEMCDVYSFGAFLCELLT 251
             +     +  + ++K + G I     A E      +    DV+SFG  L E++T
Sbjct: 198 RDV-----YEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 64.9 bits (159), Expect = 3e-12
 Identities = 44/232 (18%), Positives = 77/232 (33%), Gaps = 46/232 (19%)

Query: 108 SQMKHKNILKLIGCCLETELPT-LVFESVKYGTLRGFSFASLLIAPRI------KIAMEI 160
             + H++++   G   E      +V E  +  +L             +          +I
Sbjct: 70  RSLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEARYYLRQI 124

Query: 161 ANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIK--- 217
                YLH      ++ R +K  N+ L+E+   K+ DF L+  +         E  K   
Sbjct: 125 VLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV-----EYDGERKKVLC 176

Query: 218 GAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSI 277
           G   +IAPE  +    +   DV+S G  +  LL G     F        L    Y +  I
Sbjct: 177 GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK--PPF----ETSCLKET-YLR--I 227

Query: 278 ENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK 329
           + N +         +  +             L+ K L   P  RP + ++  
Sbjct: 228 KKNEY------SIPKHINPVAAS--------LIQKMLQTDPTARPTINELLN 265

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score = 65.0 bits (159), Expect = 4e-12
 Identities = 54/238 (22%), Positives = 85/238 (35%), Gaps = 59/238 (24%)

Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKY----------------GTL-------RGFS 144
           +++ H NI+   GC    +                           GTL       RG  
Sbjct: 59  AKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK 118

Query: 145 FASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSI 204
              +L     ++  +I   V Y+H    + ++ R +K SN+ L +    K+ DF L  S+
Sbjct: 119 LDKVLAL---ELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL 172

Query: 205 PEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGND 264
                  R    KG   +++PE  ++  + +  D+Y+ G  L ELL  C           
Sbjct: 173 KNDGKRTR---SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVC----------- 218

Query: 265 DDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
                     K   + R G I+  IFD+                L+ K LSK PE RP
Sbjct: 219 ---DTAFETSKFFTDLRDG-IISDIFDKK------------EKTLLQKLLSKKPEDRP 260

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 65.0 bits (159), Expect = 4e-12
 Identities = 36/171 (21%), Positives = 60/171 (35%), Gaps = 38/171 (22%)

Query: 111 KHKNILKLIGCCLETELPTLVFESVKYGTLRGF-------------------------SF 145
            H+NI+ L+G C  +    L+FE   YG L  +                           
Sbjct: 107 SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 166

Query: 146 ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIP 205
             L     +  A ++A  + +L     +  V R + A NVL+      K+ DF L+  I 
Sbjct: 167 NVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDI- 222

Query: 206 EGETHVREEFIKGAYGFI-----APEYFATSSFNEMCDVYSFGAFLCELLT 251
                    ++      +     APE      +    DV+S+G  L E+ +
Sbjct: 223 ----MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 63.9 bits (156), Expect = 9e-12
 Identities = 46/228 (20%), Positives = 74/228 (32%), Gaps = 47/228 (20%)

Query: 104 IVFSSQMKHKNILKLIGC-------CLETEL--PTLVFESVKYGTLRGFSFASLLIAPRI 154
                  +H   ++L           L+TEL  P+L      +G       A +      
Sbjct: 108 GSHEKVGQHPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGAS--LPEAQVW----- 160

Query: 155 KIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREE 214
               +   A+A+LH    + +V   +K +N+ L      KL DF L V +  G     E 
Sbjct: 161 GYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL--GTAGAGEV 215

Query: 215 FIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAK 274
              G   ++APE     S+    DV+S G  + E+      L   G G            
Sbjct: 216 QE-GDPRYMAPELLQ-GSYGTAADVFSLGLTILEVACN-MELPHGGEG-----------W 261

Query: 275 KSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
           + +        + P F    S          L  ++   L   P+ R 
Sbjct: 262 QQLRQG----YLPPEFTAGLS--------SELRSVLVMMLEPDPKLRA 297

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 63.6 bits (155), Expect = 1e-11
 Identities = 49/281 (17%), Positives = 90/281 (32%), Gaps = 62/281 (22%)

Query: 85  VMKFHDNSTLDDVEYCFNNIVFSSQMK-HKNILKLIGCCLETELPT-------LVFESVK 136
            +K   ++  +        + F  ++  H NI++        +  +       L+   + 
Sbjct: 57  ALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELC 116

Query: 137 YGTLRGFSFASLLIAPR----------IKIAMEIANAVAYLHVGFDRPIVFRCIKASNVL 186
            G L        L              +KI  +   AV ++H     PI+ R +K  N+L
Sbjct: 117 KGQL-----VEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH-RQKPPIIHRDLKVENLL 170

Query: 187 LDENYSAKLHDF----SLSVSIPEGETHVREEFIKGAYGFI------APEYFATSS---F 233
           L    + KL DF    ++S       +  R   ++             PE     S    
Sbjct: 171 LSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPI 230

Query: 234 NEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDED 293
            E  D+++ G  L  L        F+              K  I N ++           
Sbjct: 231 GEKQDIWALGCILYLLCFR--QHPFEDGA-----------KLRIVNGKY----------- 266

Query: 294 NSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQM 334
            S P  + +      L+   L  +PE R  + +V  QL+++
Sbjct: 267 -SIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEI 306

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 63.1 bits (154), Expect = 2e-11
 Identities = 46/235 (19%), Positives = 84/235 (35%), Gaps = 50/235 (21%)

Query: 108 SQMKHKN--ILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRI-------KIAM 158
           ++++  +  I++L    +  +   +V E    G        S L   +            
Sbjct: 81  NKLQQHSDKIIRLYDYEITDQYIYMVME---CG---NIDLNSWLKKKKSIDPWERKSYWK 134

Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
            +  AV  +H      IV   +K +N L+ +    KL DF ++  +    T V ++   G
Sbjct: 135 NMLEAVHTIH---QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVG 190

Query: 219 AYGFIAPE-----------YFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDL 267
              ++ PE             + S  +   DV+S G  L  +  G     F+   N    
Sbjct: 191 TVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK--TPFQQIINQI-- 246

Query: 268 TVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
                       ++  AI+DP  + +  FP   EK   L  ++  CL + P+ R 
Sbjct: 247 ------------SKLHAIIDP--NHEIEFPDIPEK--DLQDVLKCCLKRDPKQRI 285

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 63.5 bits (154), Expect = 3e-11
 Identities = 44/243 (18%), Positives = 77/243 (31%), Gaps = 49/243 (20%)

Query: 109 QMKHKNILKLIGCCLETE-------LPTLVFESVKYGTLRGFSFASLLIAPRIKIAME-- 159
           ++ H N++       +         LP L  E  + G LR +     L        ++  
Sbjct: 68  KLNHPNVVSAR-EVPDGLQKLAPNDLPLLAMEYCEGGDLRKY-----LNQFENCCGLKEG 121

Query: 160 --------IANAVAYLHVGFDRPIVFRCIKASNVLLDENYSA---KLHDFSLSVSIPEGE 208
                   I++A+ YLH   +  I+ R +K  N++L         K+ D   +  + +GE
Sbjct: 122 PIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE 178

Query: 209 THVREEFIKGAYG---FIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDD 265
                       G   ++APE      +    D +SFG    E +TG     F  N    
Sbjct: 179 ------LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF--RPFLPNWQPV 230

Query: 266 DLTVLEYAKKSIENNRFGAIVDPI------FDEDNSFPGKEEKLQSLGQLMYKCLSKSPE 319
                   K +     +  +   +         ++       KL+   Q M   L     
Sbjct: 231 QWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCM---LMWHQR 287

Query: 320 HRP 322
            R 
Sbjct: 288 QRG 290

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 63.3 bits (154), Expect = 3e-11
 Identities = 44/204 (21%), Positives = 72/204 (35%), Gaps = 41/204 (20%)

Query: 130 LVFESVKYGTLRGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDE 189
           +V E V   +L+      L +A  I   +EI  A++YLH      +V+  +K  N++L E
Sbjct: 161 IVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTE 217

Query: 190 NYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCEL 249
               KL D      I           + G  GF APE    +      D+Y+ G  L  L
Sbjct: 218 E-QLKLIDLGAVSRI--NSFGY----LYGTPGFQAPEI-VRTGPTVATDIYTVGRTLAAL 269

Query: 250 LTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQL 309
                +                           G  VD + ++D      +    S G+L
Sbjct: 270 TLD--LPTRN-----------------------GRYVDGLPEDDPVLKTYD----SYGRL 300

Query: 310 MYKCLSKSPEHRPL-MVDVAKQLR 332
           + + +   P  R     +++ QL 
Sbjct: 301 LRRAIDPDPRQRFTTAEEMSAQLT 324

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 61.8 bits (151), Expect = 4e-11
 Identities = 51/236 (21%), Positives = 79/236 (33%), Gaps = 53/236 (22%)

Query: 108 SQMKHKNILKLIGCCLETELPT-LVFESVKYGTLRGFSFASLLIAPRI-------KIAME 159
            Q+KH +IL+L     E      LV E    G +       L    +            +
Sbjct: 66  CQLKHPSILELYNY-FEDSNYVYLVLEMCHNGEM----NRYLKNRVKPFSENEARHFMHQ 120

Query: 160 IANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIK-- 217
           I   + YLH      I+ R +  SN+LL  N + K+ DF L+  +         E     
Sbjct: 121 IITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP-----HEKHYTL 172

Query: 218 -GAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKS 276
            G   +I+PE    S+     DV+S G     LL G     F    + D +      K  
Sbjct: 173 CGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGR--PPF----DTDTVKNT-LNK-- 223

Query: 277 IENNRFGAIVDPIFDEDNSFPG---KEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK 329
           +    +              P     E K      L+++ L ++P  R  +  V  
Sbjct: 224 VVLADY------------EMPSFLSIEAK-----DLIHQLLRRNPADRLSLSSVLD 262

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 62.1 bits (151), Expect = 4e-11
 Identities = 42/248 (16%), Positives = 77/248 (31%), Gaps = 51/248 (20%)

Query: 109 QMKHKNILKLIGC--CLETELPTLVFESVKYGTLRGFSFASLLIAPR----------IKI 156
           ++ HKNI+KL        T    L+ E    G+L        L  P           + +
Sbjct: 63  KLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTV-----LEEPSNAYGLPESEFLIV 117

Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLL----DENYSAKLHDFSLSVSIPEGETHVR 212
             ++   + +L    +  IV R IK  N++     D     KL DF  +  + + E    
Sbjct: 118 LRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---- 170

Query: 213 EEFIKGAYG---FIAPEYFATS--------SFNEMCDVYSFGAFLCELLTGCNVLEFKGN 261
                  YG   ++ P+ +  +         +    D++S G       TG   L F+  
Sbjct: 171 --QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS--LPFRPF 226

Query: 262 GNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGK--------EEKLQSLGQLMYKC 313
                   + Y   + + +   + V    +    + G               L  ++   
Sbjct: 227 EGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANI 286

Query: 314 LSKSPEHR 321
           L    E  
Sbjct: 287 LEADQEKC 294

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 62.0 bits (151), Expect = 7e-11
 Identities = 58/248 (23%), Positives = 91/248 (36%), Gaps = 55/248 (22%)

Query: 92  STLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIA 151
               D E     +    Q+ H NI+KL     +     LV E    G L  F        
Sbjct: 65  KQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL--FD------- 115

Query: 152 PRI------------KIAMEIANAVAYLHVGFDRPIVFRCIKASNVLL---DENYSAKLH 196
             I            +I  ++ + + Y+H      IV R +K  N+LL    ++ + ++ 
Sbjct: 116 -EIISRKRFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRII 171

Query: 197 DFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVL 256
           DF LS      +         G   +IAPE     +++E CDV+S G  L  LL+G    
Sbjct: 172 DFGLSTHFEASKKMKD---KIGTAYYIAPEVL-HGTYDEKCDVWSTGVILYILLSG--CP 225

Query: 257 EFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLG--QLMYKCL 314
            F G  N+ D+       K +E  ++            +F   + K  S     L+ K L
Sbjct: 226 PFNGA-NEYDI------LKKVEKGKY------------TFELPQWKKVSESAKDLIRKML 266

Query: 315 SKSPEHRP 322
           +  P  R 
Sbjct: 267 TYVPSMRI 274

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 61.7 bits (150), Expect = 7e-11
 Identities = 35/157 (22%), Positives = 61/157 (38%), Gaps = 19/157 (12%)

Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIA------PRIK-IAMEI 160
           + +    I+ L G   E     +  E ++ G     S   L+         R      + 
Sbjct: 105 AGLSSPRIVPLYGAVREGPWVNIFMELLEGG-----SLGQLIKQMGCLPEDRALYYLGQA 159

Query: 161 ANAVAYLHVGFDRPIVFRCIKASNVLLDEN-YSAKLHDFSLSVSIPE---GETHVREEFI 216
              + YLH    R I+   +KA NVLL  +   A L DF  ++ +     G++ +  ++I
Sbjct: 160 LEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYI 216

Query: 217 KGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGC 253
            G    +APE       +   D++S    +  +L GC
Sbjct: 217 PGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC 253

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 61.2 bits (149), Expect = 8e-11
 Identities = 38/159 (23%), Positives = 69/159 (43%), Gaps = 6/159 (3%)

Query: 95  DDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRI 154
              E   N I+   + K+ NI+  +   L  +   +V E +  G+L      + +   +I
Sbjct: 59  PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI 118

Query: 155 -KIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVRE 213
             +  E   A+ +LH      ++ R IK+ N+LL  + S KL DF     I   ++  R 
Sbjct: 119 AAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RS 174

Query: 214 EFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
             +   Y ++APE     ++    D++S G    E++ G
Sbjct: 175 TMVGTPY-WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 61.8 bits (150), Expect = 8e-11
 Identities = 45/235 (19%), Positives = 85/235 (36%), Gaps = 50/235 (21%)

Query: 108 SQMKHKN--ILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPR-------IKIAM 158
           ++++  +  I++L    +  +   +V E    G        S L   +            
Sbjct: 109 NKLQQHSDKIIRLYDYEITDQYIYMVME---CG---NIDLNSWLKKKKSIDPWERKSYWK 162

Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
            +  AV  +H      IV   +K +N L+ +    KL DF ++  +    T V ++   G
Sbjct: 163 NMLEAVHTIH---QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVG 218

Query: 219 AYGFIAPE-----------YFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDL 267
           A  ++ PE             + S  +   DV+S G  L  +  G               
Sbjct: 219 AVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK-------------- 264

Query: 268 TVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
               + +   + ++  AI+DP  + +  FP   EK   L  ++  CL + P+ R 
Sbjct: 265 --TPFQQIINQISKLHAIIDP--NHEIEFPDIPEK--DLQDVLKCCLKRDPKQRI 313

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 61.3 bits (149), Expect = 9e-11
 Identities = 45/232 (19%), Positives = 80/232 (34%), Gaps = 48/232 (20%)

Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPR-------IKIAMEIA 161
           Q     I++L    +  +   +V E    G        S L   +             + 
Sbjct: 65  QQHSDKIIRLYDYEITDQYIYMVME---CG---NIDLNSWLKKKKSIDPWERKSYWKNML 118

Query: 162 NAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYG 221
            AV  +H      IV   +K +N L+ +    KL DF ++  +    T V ++   G   
Sbjct: 119 EAVHTIH---QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVN 174

Query: 222 FIAPE-----------YFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
           ++ PE             + S  +   DV+S G  L  +  G                  
Sbjct: 175 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK----------------T 218

Query: 271 EYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
            + +   + ++  AI+DP  + +  FP   EK   L  ++  CL + P+ R 
Sbjct: 219 PFQQIINQISKLHAIIDP--NHEIEFPDIPEK--DLQDVLKCCLKRDPKQRI 266

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 60.7 bits (148), Expect = 9e-11
 Identities = 55/217 (25%), Positives = 98/217 (45%), Gaps = 24/217 (11%)

Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF--SFASLLIAPRIKIAMEIANAVA 165
           SQ+ H+NI+ +I    E +   LV E ++  TL  +  S   L +   I    +I + + 
Sbjct: 66  SQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIK 125

Query: 166 YLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAP 225
           + H   D  IV R IK  N+L+D N + K+ DF ++ ++ E  +  +   + G   + +P
Sbjct: 126 HAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE-TSLTQTNHVLGTVQYFSP 181

Query: 226 EYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAI 285
           E     + +E  D+YS G  L E+L G     F G   +  +++   A K I++    ++
Sbjct: 182 EQAKGEATDECTDIYSIGIVLYEMLVG--EPPFNG---ETAVSI---AIKHIQD----SV 229

Query: 286 VDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
            +   D     P      QSL  ++ +   K   +R 
Sbjct: 230 PNVTTDVRKDIP------QSLSNVILRATEKDKANRY 260

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 61.3 bits (149), Expect = 1e-10
 Identities = 56/245 (22%), Positives = 82/245 (33%), Gaps = 55/245 (22%)

Query: 95  DDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRI 154
                    +     + H NI+KL     +     LV E  K G L  F          I
Sbjct: 78  SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGEL--FD--------EI 127

Query: 155 ------------KIAMEIANAVAYLHVGFDRPIVFRCIKASNVLL---DENYSAKLHDFS 199
                        I  ++ + V YLH      IV R +K  N+LL   +++   K+ DF 
Sbjct: 128 IHRMKFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFG 184

Query: 200 LSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFK 259
           LS      +         G   +IAPE      ++E CDV+S G  L  LL G     F 
Sbjct: 185 LSAVFENQKKMKE---RLGTAYYIAPEVL-RKKYDEKCDVWSIGVILFILLAG--YPPFG 238

Query: 260 GNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLG--QLMYKCLSKS 317
           G  + +                   I+  +     +F   E K  S G   L+ + L   
Sbjct: 239 GQTDQE-------------------ILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFD 279

Query: 318 PEHRP 322
            + R 
Sbjct: 280 SQRRI 284

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 60.5 bits (147), Expect = 1e-10
 Identities = 42/176 (23%), Positives = 64/176 (36%), Gaps = 35/176 (19%)

Query: 155 KIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREE 214
           K+ + I  A+ YL       ++ R +K SN+LLDE    KL DF   +S    +   ++ 
Sbjct: 128 KMTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERGQIKLCDF--GISGRLVDDKAKDR 183

Query: 215 FIKGAYGFIAPE-----YFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTV 269
              G   ++APE           ++   DV+S G  L EL TG    +F       D  V
Sbjct: 184 SA-GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATG----QFPYKNCKTDFEV 238

Query: 270 LEYAKKSIENNRFGAIVD---PIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
           L              ++    P+      F             +  CL+K    RP
Sbjct: 239 LTK------------VLQEEPPLLPGHMGFS------GDFQSFVKDCLTKDHRKRP 276

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 60.6 bits (147), Expect = 2e-10
 Identities = 42/248 (16%), Positives = 77/248 (31%), Gaps = 51/248 (20%)

Query: 109 QMKHKNILKLIGC--CLETELPTLVFESVKYGTLRGFSFASLLIAPR----------IKI 156
           ++ HKNI+KL        T    L+ E    G+L        L  P           + +
Sbjct: 63  KLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTV-----LEEPSNAYGLPESEFLIV 117

Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLL----DENYSAKLHDFSLSVSIPEGETHVR 212
             ++   + +L    +  IV R IK  N++     D     KL DF  +  + + E    
Sbjct: 118 LRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---- 170

Query: 213 EEFIKGAYG---FIAPEYFATS--------SFNEMCDVYSFGAFLCELLTGCNVLEFKGN 261
                  YG   ++ P+ +  +         +    D++S G       TG   L F+  
Sbjct: 171 --QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS--LPFRPF 226

Query: 262 GNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGK--------EEKLQSLGQLMYKC 313
                   + Y   + + +   + V    +    + G               L  ++   
Sbjct: 227 EGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANI 286

Query: 314 LSKSPEHR 321
           L    E  
Sbjct: 287 LEADQEKC 294

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 60.6 bits (147), Expect = 2e-10
 Identities = 31/157 (19%), Positives = 59/157 (37%), Gaps = 22/157 (14%)

Query: 111 KHKNILKLIGCCLETELPTLVFESVKYGTL------RGFSFASLLIAPRIKIAMEIANAV 164
           +H N+++      + +   +  E     TL      + F+   L       +  +  + +
Sbjct: 76  EHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPI---TLLQQTTSGL 131

Query: 165 AYLHVGFDRPIVFRCIKASNVLLDE-----NYSAKLHDFSLSVSIPEGE-THVREEFIKG 218
           A+LH      IV R +K  N+L+          A + DF L   +  G  +  R   + G
Sbjct: 132 AHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPG 188

Query: 219 AYGFIAPEYFATSSF---NEMCDVYSFGAFLCELLTG 252
             G+IAPE  +           D++S G     +++ 
Sbjct: 189 TEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 60.3 bits (146), Expect = 2e-10
 Identities = 58/334 (17%), Positives = 103/334 (30%), Gaps = 69/334 (20%)

Query: 7   IKR-KSSGEAADSNMVRNEKLLLQKLIATFNGKRNPIRAFSAKDLKKATNNYDLHKVIQS 65
           IKR +          V  E   L KL          +R F+A          +    I  
Sbjct: 36  IKRIRLPNRELAREKVMREVKALAKL-----EHPGIVRYFNAWLETPPEKWQEEMDEIWL 90

Query: 66  DTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLET 125
                 +         P  +          D     N +        K  L      ++ 
Sbjct: 91  KDESTDW-----PLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYL-----YIQM 140

Query: 126 ELPTLVFESVKYGTLRGFSFASLLIAPR-----IKIAMEIANAVAYLHVGFDRPIVFRCI 180
           +L        +   L+ +      +  R     + I ++IA AV +LH    + ++ R +
Sbjct: 141 QL-------CRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH---SKGLMHRDL 190

Query: 181 KASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGF----------IAPEYFAT 230
           K SN+    +   K+ DF L  ++ + E          AY            ++PE    
Sbjct: 191 KPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHG 250

Query: 231 SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAK--KSIENNRFGAIVDP 288
           ++++   D++S G  L ELL   +             T +E  +    + N +F      
Sbjct: 251 NNYSHKVDIFSLGLILFELLYSFS-------------TQMERVRIITDVRNLKF----PL 293

Query: 289 IFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
           +F +                ++   LS SP  RP
Sbjct: 294 LFTQKYP---------QEHMMVQDMLSPSPTERP 318

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 60.0 bits (146), Expect = 2e-10
 Identities = 32/164 (19%), Positives = 61/164 (37%), Gaps = 38/164 (23%)

Query: 110 MKHKNILKLIGCCLETELPT-----LVFESVKYGTL------RGFSF-----ASLLIAPR 153
               +I+ ++    E          ++ E ++ G L      RG        A+ ++   
Sbjct: 79  SGGPHIVCILDVY-ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIM--- 134

Query: 154 IKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLL---DENYSAKLHDFSLSVSIPEGE-- 208
                +I  A+ +LH      I  R +K  N+L    +++   KL DF  +    +    
Sbjct: 135 ----RDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQ 187

Query: 209 THVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
           T            ++APE      +++ CD++S G  +  LL G
Sbjct: 188 TPC------YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 225

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 59.7 bits (145), Expect = 2e-10
 Identities = 39/159 (24%), Positives = 72/159 (45%), Gaps = 6/159 (3%)

Query: 95  DDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRI 154
              E  FN +V     +H N++++    L  E   ++ E ++ G L        L   +I
Sbjct: 84  QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQI 143

Query: 155 -KIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVRE 213
             +   +  A+AYLH    + ++ R IK+ ++LL  +   KL DF     I +     R+
Sbjct: 144 ATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-RK 199

Query: 214 EFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
             +   Y ++APE  + S +    D++S G  + E++ G
Sbjct: 200 SLVGTPY-WMAPEVISRSLYATEVDIWSLGIMVIEMVDG 237

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 59.6 bits (145), Expect = 2e-10
 Identities = 59/261 (22%), Positives = 105/261 (40%), Gaps = 41/261 (15%)

Query: 92  STLDDVEYCFNNI-VFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL------RG-F 143
                    F  + +      H+N+L+LI    E +   LVFE ++ G++      R  F
Sbjct: 49  QPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHF 108

Query: 144 S--FASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLL---DENYSAKLHDF 198
           +   AS+++        ++A+A+ +LH   ++ I  R +K  N+L    ++    K+ DF
Sbjct: 109 NELEASVVV-------QDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDF 158

Query: 199 SLSVSIPEGETHVREEFIK-----GAYGFIAPE-----YFATSSFNEMCDVYSFGAFLCE 248
            L   I            +     G+  ++APE         S +++ CD++S G  L  
Sbjct: 159 DLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYI 218

Query: 249 LLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLG- 307
           LL+G     F G    D       A  + +N  F +I +  ++    FP K+    S   
Sbjct: 219 LLSG--YPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYE----FPDKDWAHISCAA 272

Query: 308 -QLMYKCLSKSPEHRPLMVDV 327
             L+ K L +  + R     V
Sbjct: 273 KDLISKLLVRDAKQRLSAAQV 293

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 59.2 bits (144), Expect = 3e-10
 Identities = 38/160 (23%), Positives = 61/160 (38%), Gaps = 34/160 (21%)

Query: 112 HKNILKLIGCCLETELPTLVFESVKYGTL------RGF---SFASLLIAPRIKIAMEIAN 162
           H NI++L           LVF+ +K G L      +          ++         +  
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIM-------RALLE 135

Query: 163 AVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYG- 221
            +  LH      IV R +K  N+LLD++ + KL DF  S  +  G      E ++   G 
Sbjct: 136 VICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG------EKLREVCGT 186

Query: 222 --FIAPEYFATSSFNEM------CDVYSFGAFLCELLTGC 253
             ++APE    S  +         D++S G  +  LL G 
Sbjct: 187 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 226

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 59.2 bits (144), Expect = 4e-10
 Identities = 37/196 (18%), Positives = 70/196 (35%), Gaps = 28/196 (14%)

Query: 130 LVFESVKYGTLRGF--SFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLL 187
           +    +    L         L     + I  +I +A+   H         R +K  N+L+
Sbjct: 111 VDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILV 167

Query: 188 DENYSAKLHDFSLSVSIPEGETHV-REEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFL 246
             +  A L DF ++ +    +  + +     G   ++APE F+ S      D+Y+    L
Sbjct: 168 SADDFAYLVDFGIASAT--TDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVL 225

Query: 247 CELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSL 306
            E LTG     ++G    D L+V+  A            +          P       + 
Sbjct: 226 YECLTG--SPPYQG----DQLSVM-GA-------HINQAIPRPSTVRPGIP------VAF 265

Query: 307 GQLMYKCLSKSPEHRP 322
             ++ + ++K+PE R 
Sbjct: 266 DAVIARGMAKNPEDRY 281

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 58.7 bits (143), Expect = 4e-10
 Identities = 43/160 (26%), Positives = 70/160 (43%), Gaps = 31/160 (19%)

Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTL------RGF---SFASLLIAPRIKIAME 159
           +++H NI++L     E     LVF+ V  G L      R F   + AS  I        +
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCI-------QQ 113

Query: 160 IANAVAYLHVGFDRPIVFRCIKASNVLL---DENYSAKLHDFSLSVSIPEGETHVREEFI 216
           I  ++AY H      IV R +K  N+LL    +  + KL DF L++ + +       E  
Sbjct: 114 ILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS------EAW 164

Query: 217 KGAYG---FIAPEYFATSSFNEMCDVYSFGAFLCELLTGC 253
            G  G   +++PE      +++  D+++ G  L  LL G 
Sbjct: 165 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGY 204

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 58.7 bits (143), Expect = 4e-10
 Identities = 47/156 (30%), Positives = 67/156 (42%), Gaps = 26/156 (16%)

Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTL------RGF---SFASLLIAPRIKIAME 159
           ++KH+NI+ L      T    LV + V  G L      RG      ASL+I        +
Sbjct: 62  KIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVI-------QQ 114

Query: 160 IANAVAYLHVGFDRPIVFRCIKASNVLL---DENYSAKLHDFSLSVSIPEGETHVREEFI 216
           + +AV YLH   +  IV R +K  N+L    +EN    + DF LS     G         
Sbjct: 115 VLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMST----A 167

Query: 217 KGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
            G  G++APE  A   +++  D +S G     LL G
Sbjct: 168 CGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 58.9 bits (143), Expect = 5e-10
 Identities = 42/156 (26%), Positives = 63/156 (40%), Gaps = 25/156 (16%)

Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTL------RGF---SFASLLIAPRIKIAME 159
           ++ H NI+KL          +LV E V  G L      +G+     A+  +        +
Sbjct: 104 RLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAV-------KQ 156

Query: 160 IANAVAYLHVGFDRPIVFRCIKASNVLL---DENYSAKLHDFSLSVSIPEGETHVREEFI 216
           I  AVAYLH   +  IV R +K  N+L      +   K+ DF LS  +           +
Sbjct: 157 ILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT---V 210

Query: 217 KGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
            G  G+ APE     ++    D++S G     LL G
Sbjct: 211 CGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 58.4 bits (142), Expect = 6e-10
 Identities = 47/202 (23%), Positives = 84/202 (41%), Gaps = 25/202 (12%)

Query: 124 ETELPTLVFESVKYGTLRGF--SFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIK 181
              LP +V E V   TLR    +   +     I++  +   A+ + H      I+ R +K
Sbjct: 87  AGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH---QNGIIHRDVK 143

Query: 182 ASNVLLDENYSAKLHDFSLSVSIPEGETHV-REEFIKGAYGFIAPEYFATSSFNEMCDVY 240
            +N+++    + K+ DF ++ +I +    V +   + G   +++PE     S +   DVY
Sbjct: 144 PANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVY 203

Query: 241 SFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKE 300
           S G  L E+LTG     F G   D  ++V   A + +  +       P            
Sbjct: 204 SLGCVLYEVLTG--EPPFTG---DSPVSV---AYQHVRED-----PIPPSARHEGLS--- 247

Query: 301 EKLQSLGQLMYKCLSKSPEHRP 322
                L  ++ K L+K+PE+R 
Sbjct: 248 ---ADLDAVVLKALAKNPENRY 266

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 58.1 bits (141), Expect = 7e-10
 Identities = 46/164 (28%), Positives = 71/164 (43%), Gaps = 16/164 (9%)

Query: 95  DDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRI 154
           D++E     I   SQ     + K  G  L+     ++ E   Y  L G S   LL    +
Sbjct: 62  DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME---Y--LGGGSALDLLEPGPL 116

Query: 155 K------IAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE 208
                  I  EI   + YLH       + R IKA+NVLL E+   KL DF ++  + + +
Sbjct: 117 DETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173

Query: 209 THVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
              R  F+   + ++APE    S+++   D++S G    EL  G
Sbjct: 174 IK-RNTFVGTPF-WMAPEVIKQSAYDSKADIWSLGITAIELARG 215

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 58.0 bits (141), Expect = 7e-10
 Identities = 62/289 (21%), Positives = 106/289 (36%), Gaps = 52/289 (17%)

Query: 51  KKATNNYDLH----KVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVF 106
           K A N  D      KV+      R          R               +E  +  I  
Sbjct: 30  KLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89

Query: 107 SSQMKHKNILKLIGCCLETELPT-----LVFESVKYGTLRGFSFAS---LLIAPRIKIAM 158
             ++ H N++KL+   L+   P      +VFE V  G +      +   L          
Sbjct: 90  LKKLDHPNVVKLV-EVLDD--PNEDHLYMVFELVNQGPV--MEVPTLKPLSEDQARFYFQ 144

Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           ++   + YLH    + I+ R IK SN+L+ E+   K+ DF +S +  +G     +  +  
Sbjct: 145 DLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVS-NEFKGS----DALLSN 196

Query: 219 AYG---FIAPEYFATSSFN---EMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEY 272
             G   F+APE  + +      +  DV++ G  L   + G     F     D+ +  L +
Sbjct: 197 TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ--CPF----MDERIMCL-H 249

Query: 273 AKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHR 321
           +K              I  +   FP + +  + L  L+ + L K+PE R
Sbjct: 250 SK--------------IKSQALEFPDQPDIAEDLKDLITRMLDKNPESR 284

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 58.5 bits (142), Expect = 7e-10
 Identities = 38/154 (24%), Positives = 62/154 (40%), Gaps = 14/154 (9%)

Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTL------RGFSFASLLIAPRIKIAMEIAN 162
            +KH +I++L+       +  +VFE +    L      R  +      A       +I  
Sbjct: 82  MLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE 141

Query: 163 AVAYLHVGFDRPIVFRCIKASNVLL---DENYSAKLHDFSLSVSIPEGETHVREEFIKGA 219
           A+ Y H   D  I+ R +K   VLL   + +   KL  F +++ + E           G 
Sbjct: 142 ALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG--RVGT 196

Query: 220 YGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGC 253
             F+APE      + +  DV+  G  L  LL+GC
Sbjct: 197 PHFMAPEVVKREPYGKPVDVWGCGVILFILLSGC 230

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 58.1 bits (141), Expect = 8e-10
 Identities = 37/154 (24%), Positives = 67/154 (43%), Gaps = 24/154 (15%)

Query: 112 HKNILKLIGCCLETELPTLVFESVKYGTL------RGF---SFASLLIAPRIKIAMEIAN 162
           H NI+KL     +     LV E +  G L      +     + AS ++        ++ +
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIM-------RKLVS 117

Query: 163 AVAYLHVGFDRPIVFRCIKASNVLL---DENYSAKLHDFSLSVSIPEGETHVREEFIKGA 219
           AV+++H   D  +V R +K  N+L    ++N   K+ DF  +   P     ++       
Sbjct: 118 AVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFT 172

Query: 220 YGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGC 253
             + APE    + ++E CD++S G  L  +L+G 
Sbjct: 173 LHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQ 206

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 58.4 bits (141), Expect = 1e-09
 Identities = 28/97 (28%), Positives = 51/97 (52%), Gaps = 8/97 (8%)

Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI 216
           A EI   + ++H   +R +V+R +K +N+LLDE+   ++ D  L+    + + H      
Sbjct: 298 AAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---- 350

Query: 217 KGAYGFIAPEYFAT-SSFNEMCDVYSFGAFLCELLTG 252
            G +G++APE      +++   D +S G  L +LL G
Sbjct: 351 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 57.8 bits (140), Expect = 1e-09
 Identities = 36/164 (21%), Positives = 58/164 (35%), Gaps = 39/164 (23%)

Query: 111 KHKNILKLIGCCLETELPT-----LVFESVKYGTL------RGFSF-----ASLLIAPRI 154
           +  +I++++    E          +V E +  G L      RG        AS ++    
Sbjct: 113 QCPHIVRIVDVY-ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM---- 167

Query: 155 KIAMEIANAVAYLHVGFDRPIVFRCIKASNVLL---DENYSAKLHDFSLSVSIPEGE--- 208
                I  A+ YLH      I  R +K  N+L      N   KL DF  +          
Sbjct: 168 ---KSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT 221

Query: 209 THVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
           T            ++APE      +++ CD++S G  +  LL G
Sbjct: 222 TPC------YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 259

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 57.4 bits (139), Expect = 1e-09
 Identities = 40/165 (24%), Positives = 66/165 (40%), Gaps = 16/165 (9%)

Query: 95  DDVEYCFNNIVFSSQMKHKNILKLIGCCL-ETELPTLVFESVKYGTL------RGFSFAS 147
            D++     I    Q    +++K  G     T+L  +V E    G++      R  +   
Sbjct: 66  SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDL-WIVMEYCGAGSVSDIIRLRNKTLTE 124

Query: 148 LLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEG 207
             IA    I       + YLH       + R IKA N+LL+    AKL DF ++  + + 
Sbjct: 125 DEIA---TILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178

Query: 208 ETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
               R   I   + ++APE      +N + D++S G    E+  G
Sbjct: 179 MAK-RNTVIGTPF-WMAPEVIQEIGYNCVADIWSLGITAIEMAEG 221

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 58.2 bits (141), Expect = 1e-09
 Identities = 63/247 (25%), Positives = 90/247 (36%), Gaps = 59/247 (23%)

Query: 95  DDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRI 154
              E  +N I     + H NI+KL     + +   LV E  + G L  F         +I
Sbjct: 88  KFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL--FE--------QI 137

Query: 155 ------------KIAMEIANAVAYLHVGFDRPIVFRCIKASNVLL---DENYSAKLHDFS 199
                        I  +I + + YLH      IV R IK  N+LL   +   + K+ DF 
Sbjct: 138 INRHKFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFG 194

Query: 200 LSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFK 259
           LS    +           G   +IAPE      +NE CDV+S G  +  LL G     F 
Sbjct: 195 LSSFFSKDYKLRD---RLGTAYYIAPEVL-KKKYNEKCDVWSCGVIMYILLCG--YPPFG 248

Query: 260 GNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDN----SFPGKEEKLQSLGQLMYKCLS 315
           G  ND D+       K +E  ++       FD ++    S   KE        L+   L+
Sbjct: 249 GQ-NDQDI------IKKVEKGKY------YFDFNDWKNISDEAKE--------LIKLMLT 287

Query: 316 KSPEHRP 322
                R 
Sbjct: 288 YDYNKRC 294

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 57.8 bits (140), Expect = 1e-09
 Identities = 39/180 (21%), Positives = 65/180 (36%), Gaps = 25/180 (13%)

Query: 86  MKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL----- 140
            K      + D E   N I   +Q+ H N+++L           LV E V  G L     
Sbjct: 119 AKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRII 178

Query: 141 -RGFSF----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLL--DENYSA 193
              ++       L +        +I   + ++H      I+   +K  N+L    +    
Sbjct: 179 DESYNLTELDTILFM-------KQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQI 228

Query: 194 KLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGC 253
           K+ DF L+      E  ++  F  G   F+APE       +   D++S G     LL+G 
Sbjct: 229 KIIDFGLARRYKPREK-LKVNF--GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGL 285

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 57.3 bits (139), Expect = 2e-09
 Identities = 43/159 (27%), Positives = 70/159 (44%), Gaps = 31/159 (19%)

Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTL------RGF---SFASLLIAPRIKIAME 159
           +++H NI++L     E     LVF+ V  G L      R F   + AS  I        +
Sbjct: 84  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCI-------QQ 136

Query: 160 IANAVAYLHVGFDRPIVFRCIKASNVLL---DENYSAKLHDFSLSVSIPEGETHVREEFI 216
           I  ++AY H      IV R +K  N+LL    +  + KL DF L++ + +       E  
Sbjct: 137 ILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS------EAW 187

Query: 217 KGAYG---FIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
            G  G   +++PE      +++  D+++ G  L  LL G
Sbjct: 188 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 57.0 bits (138), Expect = 2e-09
 Identities = 38/160 (23%), Positives = 64/160 (40%), Gaps = 34/160 (21%)

Query: 112 HKNILKLIGCCLETELPTLVFESVKYGTL------RGF---SFASLLIAPRIKIAMEIAN 162
           H +I+ LI     +    LVF+ ++ G L      +          ++         +  
Sbjct: 159 HPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIM-------RSLLE 211

Query: 163 AVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYG- 221
           AV++LH      IV R +K  N+LLD+N   +L DF  S  +  G      E ++   G 
Sbjct: 212 AVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG------EKLRELCGT 262

Query: 222 --FIAPE------YFATSSFNEMCDVYSFGAFLCELLTGC 253
             ++APE            + +  D+++ G  L  LL G 
Sbjct: 263 PGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGS 302

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 57.5 bits (139), Expect = 2e-09
 Identities = 32/99 (32%), Positives = 50/99 (50%), Gaps = 12/99 (12%)

Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI 216
           A EI   +  LH      IV+R +K  N+LLD++   ++ D  L+V +PEG+T      I
Sbjct: 292 AAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT------I 342

Query: 217 K---GAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
           K   G  G++APE      +    D ++ G  L E++ G
Sbjct: 343 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAG 381

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 57.0 bits (138), Expect = 3e-09
 Identities = 34/175 (19%), Positives = 63/175 (36%), Gaps = 17/175 (9%)

Query: 86  MKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL----- 140
            KF +     D     N I   +Q+ H  ++ L     +     L+ E +  G L     
Sbjct: 81  AKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIA 140

Query: 141 -RGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLL--DENYSAKLHD 197
              +  +   +   ++   +    + ++H   +  IV   IK  N++    +  S K+ D
Sbjct: 141 AEDYKMSEAEVINYMR---QACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIID 194

Query: 198 FSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
           F L+  +   E  V+         F APE           D+++ G     LL+G
Sbjct: 195 FGLATKLNPDEI-VKVTT--ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 56.2 bits (136), Expect = 3e-09
 Identities = 50/181 (27%), Positives = 78/181 (43%), Gaps = 27/181 (14%)

Query: 86  MKFHDNSTLD--DVEYCFNNIVFSSQMKHKNILKLIGCCLETELPT-LVFESVKYGTLRG 142
           +K  D + L+   ++  F  +     + H NI+KL    +ETE    L+ E    G +  
Sbjct: 45  IKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV-IETEKTLYLIMEYASGGEV-- 101

Query: 143 FSFASLLIAPRI------KIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLH 196
             F  L+   R+          +I +AV Y H    + IV R +KA N+LLD + + K+ 
Sbjct: 102 --FDYLVAHGRMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIA 156

Query: 197 DFSLSVSIPEGETHVREEFIK---GAYGFIAPEYFATSSFN-EMCDVYSFGAFLCELLTG 252
           DF  S     G        +    GA  + APE F    ++    DV+S G  L  L++G
Sbjct: 157 DFGFSNEFTVG------GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 210

Query: 253 C 253
            
Sbjct: 211 S 211

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 56.6 bits (137), Expect = 4e-09
 Identities = 53/245 (21%), Positives = 86/245 (35%), Gaps = 55/245 (22%)

Query: 95  DDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRI 154
            D       +    ++ H NI+KL     ++    +V E    G L  F          I
Sbjct: 63  KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL--FD--------EI 112

Query: 155 ------------KIAMEIANAVAYLHVGFDRPIVFRCIKASNVLL---DENYSAKLHDFS 199
                       +I  ++ + + Y+H      IV R +K  N+LL   +++   K+ DF 
Sbjct: 113 IKRKRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFG 169

Query: 200 LSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFK 259
           LS    +           G   +IAPE     +++E CDV+S G  L  LL+G     F 
Sbjct: 170 LSTCFQQNTKMKD---RIGTAYYIAPEVL-RGTYDEKCDVWSAGVILYILLSG--TPPFY 223

Query: 260 GNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLG--QLMYKCLSKS 317
           G    D                   I+  +     +F   + +  S     L+ K L+  
Sbjct: 224 GKNEYD-------------------ILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFH 264

Query: 318 PEHRP 322
           P  R 
Sbjct: 265 PSLRI 269

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 56.8 bits (137), Expect = 4e-09
 Identities = 32/175 (18%), Positives = 62/175 (35%), Gaps = 17/175 (9%)

Query: 86  MKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL----- 140
            KF       D E     I   S ++H  ++ L     +     +++E +  G L     
Sbjct: 187 AKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVA 246

Query: 141 -RGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLL--DENYSAKLHD 197
                 +       ++   ++   + ++H   +   V   +K  N++     +   KL D
Sbjct: 247 DEHNKMSEDEAVEYMR---QVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLID 300

Query: 198 FSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
           F L+  +   ++ V+     G   F APE           D++S G     LL+G
Sbjct: 301 FGLTAHLDPKQS-VKVTT--GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 56.2 bits (136), Expect = 5e-09
 Identities = 40/156 (25%), Positives = 66/156 (42%), Gaps = 24/156 (15%)

Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTL------RGF---SFASLLIAPRIKIAME 159
            +KH NI++L     E     L+F+ V  G L      R +   + AS  I        +
Sbjct: 66  LLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCI-------QQ 118

Query: 160 IANAVAYLHVGFDRPIVFRCIKASNVLL---DENYSAKLHDFSLSVSIPEGETHVREEFI 216
           I  AV + H      +V R +K  N+LL    +  + KL DF L++ +   +        
Sbjct: 119 ILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG--F 173

Query: 217 KGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
            G  G+++PE      + +  D+++ G  L  LL G
Sbjct: 174 AGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 209

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 55.4 bits (134), Expect = 5e-09
 Identities = 40/176 (22%), Positives = 66/176 (37%), Gaps = 25/176 (14%)

Query: 95  DDVEYCFNNIVFSSQMKHKNILKLIGCCLETE-------------LPTLVFESVKYGTLR 141
             ++     I   SQ  H NI+      +  +             +  ++   V  G  +
Sbjct: 55  TSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHK 114

Query: 142 GFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDF--- 198
                   IA    I  E+   + YLH       + R +KA N+LL E+ S ++ DF   
Sbjct: 115 SGVLDESTIA---TILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVS 168

Query: 199 -SLSVSIPEGETHVREEFIKGAYGFIAPEYFA-TSSFNEMCDVYSFGAFLCELLTG 252
             L+         VR+ F+     ++APE       ++   D++SFG    EL TG
Sbjct: 169 AFLATGGDITRNKVRKTFVGTPC-WMAPEVMEQVRGYDFKADIWSFGITAIELATG 223

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 54.9 bits (133), Expect = 6e-09
 Identities = 39/179 (21%), Positives = 65/179 (36%), Gaps = 26/179 (14%)

Query: 86  MKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL----- 140
            K      ++DV+     I     + H NI++L     +     LV E    G L     
Sbjct: 39  AKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVV 98

Query: 141 -RGF---SFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLL---DENYSA 193
            +     S A+ ++        ++ +AVAY H      +  R +K  N L      +   
Sbjct: 99  HKRVFRESDAARIM-------KDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPL 148

Query: 194 KLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
           KL DF L+     G+         G   +++P+      +   CD +S G  +  LL G
Sbjct: 149 KLIDFGLAARFKPGKMMRT---KVGTPYYVSPQVL-EGLYGPECDEWSAGVMMYVLLCG 203

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 55.6 bits (134), Expect = 7e-09
 Identities = 24/98 (24%), Positives = 48/98 (48%), Gaps = 6/98 (6%)

Query: 155 KIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREE 214
           K+++ +   + YL       I+ R +K SN+L++     KL DF +S  + +    +   
Sbjct: 135 KVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANS 189

Query: 215 FIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
           F+ G   +++PE    + ++   D++S G  L E+  G
Sbjct: 190 FV-GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 226

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 55.4 bits (134), Expect = 8e-09
 Identities = 41/177 (23%), Positives = 68/177 (38%), Gaps = 33/177 (18%)

Query: 111 KHKNILKLIGCCLETELPTLVFESVKYGTL------RGF---SFASLLIAPRIKIAMEIA 161
           +H NI+ L     + +   +V E +K G L      + F     AS ++         I 
Sbjct: 74  QHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVL-------FTIT 126

Query: 162 NAVAYLHVGFDRPIVFRCIKASNVLL---DENYSA-KLHDFSLSVSIPEGETHVREEFIK 217
             V YLH    + +V R +K SN+L      N  + ++ DF  +  +           + 
Sbjct: 127 KTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN-----GLLM 178

Query: 218 GAYG---FIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLE 271
                  F+APE      ++  CD++S G  L  +LTG     F    +D    +L 
Sbjct: 179 TPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG--YTPFANGPDDTPEEILA 233

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 55.6 bits (134), Expect = 8e-09
 Identities = 44/251 (17%), Positives = 79/251 (31%), Gaps = 60/251 (23%)

Query: 112 HKNILKLIGC---------CLE---TELPTLVFESVKYGTLRGFSFASLLIAPRIKIAME 159
           H N+++              LE     L     + V+   +   +         I +  +
Sbjct: 68  HPNVIRYYCSETTDRFLYIALELCNLNL----QDLVESKNVSDENLKLQKEYNPISLLRQ 123

Query: 160 IANAVAYLHVGFDRPIVFRCIKASNVLLD-------------ENYSAKLHDFSLSVSIPE 206
           IA+ VA+LH      I+ R +K  N+L+              EN    + DF L   +  
Sbjct: 124 IASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180

Query: 207 GETHVREEF--IKGAYGFIAPEYFATSSF-------NEMCDVYSFGAFLCELLTGCNVLE 257
           G++  R       G  G+ APE    S+            D++S G     +L+      
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK-GKHP 239

Query: 258 FKGNGNDDDLTVLEYAKKSIENNRF-GAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSK 316
           F    + +          +I    F    +  + D        +        L+ + +  
Sbjct: 240 FGDKYSRE---------SNIIRGIFSLDEMKCLHDRSLIAEATD--------LISQMIDH 282

Query: 317 SPEHRPLMVDV 327
            P  RP  + V
Sbjct: 283 DPLKRPTAMKV 293

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 54.5 bits (132), Expect = 9e-09
 Identities = 41/156 (26%), Positives = 67/156 (42%), Gaps = 26/156 (16%)

Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTL------RGF---SFASLLIAPRIKIAME 159
           ++ H NI+KL     ++    +V E    G L      R       A+ +I        +
Sbjct: 77  KLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARII-------KQ 129

Query: 160 IANAVAYLHVGFDRPIVFRCIKASNVLL---DENYSAKLHDFSLSVSIPEGETHVREEFI 216
           + + + Y+H      IV R +K  N+LL   +++   K+ DF LS    +          
Sbjct: 130 VFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD---R 183

Query: 217 KGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
            G   +IAPE     +++E CDV+S G  L  LL+G
Sbjct: 184 IGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSG 218

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 54.7 bits (132), Expect = 1e-08
 Identities = 39/178 (21%), Positives = 66/178 (37%), Gaps = 20/178 (11%)

Query: 83  ISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFE-----SVKY 137
           I  M +    + +  +     + F  +++H N ++  GC L      LV E     +   
Sbjct: 84  IKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDL 143

Query: 138 GTLRGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHD 197
             +       + IA    +       +AYLH      ++ R +KA N+LL E    KL D
Sbjct: 144 LEVHKKPLQEVEIA---AVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGD 197

Query: 198 FSLSVSIPEGETHVREEFIKGAYGFIAPE---YFATSSFNEMCDVYSFGAFLCELLTG 252
           F  +  +          F+   Y ++APE         ++   DV+S G    EL   
Sbjct: 198 FGSASIMAP-----ANSFVGTPY-WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 249

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 54.2 bits (131), Expect = 1e-08
 Identities = 36/179 (20%), Positives = 73/179 (40%), Gaps = 23/179 (12%)

Query: 87  KFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFA 146
           K  +  + +++E     I   +   H  I+KL+G         ++ E   +    G +  
Sbjct: 50  KVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE---F--CPGGAVD 104

Query: 147 SLLIAPRIK--------IAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDF 198
           ++++             +  ++  A+ +LH    + I+ R +KA NVL+      +L DF
Sbjct: 105 AIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADF 161

Query: 199 SLSVSIPEGETHVREEFIKGAYGFIAPE-----YFATSSFNEMCDVYSFGAFLCELLTG 252
            +S    +     R+ FI   Y ++APE         + ++   D++S G  L E+   
Sbjct: 162 GVSAKNLKTLQK-RDSFIGTPY-WMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQI 218

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 54.5 bits (131), Expect = 2e-08
 Identities = 49/228 (21%), Positives = 77/228 (33%), Gaps = 28/228 (12%)

Query: 38  KRNPIRAFSAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDV 97
            +N IR  + KD+++      L K +      RL+E    D+     VM           
Sbjct: 60  NKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYE-VYEDEQYICLVM----------- 107

Query: 98  EYC-----FNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAP 152
           E C      + +              +        P    E++             +   
Sbjct: 108 ELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQRE 167

Query: 153 R--IKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLL--DENYSAKLHDFSLSVSIPEGE 208
           +    I  +I +A+ YLH   ++ I  R IK  N L   ++++  KL DF LS    +  
Sbjct: 168 KLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLN 224

Query: 209 THVREEFIKGAY--GFIAPE--YFATSSFNEMCDVYSFGAFLCELLTG 252
                     A    F+APE       S+   CD +S G  L  LL G
Sbjct: 225 NGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMG 272

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 54.3 bits (131), Expect = 2e-08
 Identities = 39/162 (24%), Positives = 65/162 (40%), Gaps = 35/162 (21%)

Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTL------RGF---SFASLLIAPRIKIAME 159
           ++ H  I+K+     + E   +V E ++ G L            +   L          +
Sbjct: 196 KLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF-------YQ 247

Query: 160 IANAVAYLHVGFDRPIVFRCIKASNVLL---DENYSAKLHDFSLSVSIPEGETHVREEFI 216
           +  AV YLH   +  I+ R +K  NVLL   +E+   K+ DF  S  + E         +
Sbjct: 248 MLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET------SLM 298

Query: 217 KGAYG---FIAPE---YFATSSFNEMCDVYSFGAFLCELLTG 252
           +   G   ++APE      T+ +N   D +S G  L   L+G
Sbjct: 299 RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 54.4 bits (131), Expect = 2e-08
 Identities = 27/96 (28%), Positives = 51/96 (53%), Gaps = 5/96 (5%)

Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI 216
             +I + + +LH    R I++R +K  NVLLD++ + ++ D  L+V +  G+T  +  + 
Sbjct: 295 TAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK-GYA 350

Query: 217 KGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
            G  GF+APE      ++   D ++ G  L E++  
Sbjct: 351 -GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAA 385

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 53.6 bits (129), Expect = 2e-08
 Identities = 25/217 (11%), Positives = 48/217 (22%), Gaps = 52/217 (23%)

Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIKIAMEIANAVAYL 167
           S++    + +++          +V E ++ G+L+  +  S      I+    +A A    
Sbjct: 86  SRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAA 145

Query: 168 HVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEY 227
           H      +       S V +  +    L                           +    
Sbjct: 146 H---RAGVALSIDHPSRVRVSIDGDVVLAYP----------------------ATMPDAN 180

Query: 228 FATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKS--IENNRFGAI 285
                     D+   GA L  LL           G    L   E       IE       
Sbjct: 181 PQD-------DIRGIGASLYALLVN--RWPLPEAGVRSGLAPAERDTAGQPIEPADIDRD 231

Query: 286 VDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
           +                      +  + +      R 
Sbjct: 232 IPFQISA----------------VAARSVQGDGGIRS 252

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 53.1 bits (128), Expect = 3e-08
 Identities = 39/156 (25%), Positives = 60/156 (38%), Gaps = 19/156 (12%)

Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRG--------FSFASLLIAPRIKIAME 159
             +KHKNI++ +G   E     +  E V  G+L                 I        +
Sbjct: 74  KHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIG---FYTKQ 130

Query: 160 IANAVAYLHVGFDRPIVFRCIKASNVLLD-ENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           I   + YLH   D  IV R IK  NVL++  +   K+ DF  S  +             G
Sbjct: 131 ILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTG 185

Query: 219 AYGFIAPEYF--ATSSFNEMCDVYSFGAFLCELLTG 252
              ++APE        + +  D++S G  + E+ TG
Sbjct: 186 TLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATG 221

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 53.0 bits (127), Expect = 4e-08
 Identities = 41/185 (22%), Positives = 67/185 (36%), Gaps = 31/185 (16%)

Query: 154 IKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVRE 213
           I  + ++A  + +L     R  + R + A N+LL E    K+ DF L+  I +   +VR+
Sbjct: 196 ICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 252

Query: 214 EFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGN----GNDDDLTV 269
              +    ++APE      +    DV+SFG  L E+ +        G     G   D   
Sbjct: 253 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-------LGASPYPGVKIDEEF 305

Query: 270 LEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK 329
               K   E  R               P  +     + Q M  C    P  RP   ++ +
Sbjct: 306 CRRLK---EGTR------------MRAP--DYTTPEMYQTMLDCWHGEPSQRPTFSELVE 348

Query: 330 QLRQM 334
            L  +
Sbjct: 349 HLGNL 353

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 53.1 bits (128), Expect = 5e-08
 Identities = 43/183 (23%), Positives = 64/183 (34%), Gaps = 24/183 (13%)

Query: 83  ISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRG 142
           I   +   +      E     +    Q+ H NI+ L           L+ E V  G L  
Sbjct: 45  IKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGEL-- 102

Query: 143 FSFASLLIAPR--------IKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLL----DEN 190
           F F    +A +             +I + V YLH    + I    +K  N++L       
Sbjct: 103 FDF----LAQKESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPI 155

Query: 191 YSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELL 250
              KL DF L+  I +G    +  F  G   F+APE           D++S G     LL
Sbjct: 156 PHIKLIDFGLAHEIEDGVE-FKNIF--GTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 212

Query: 251 TGC 253
           +G 
Sbjct: 213 SGA 215

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 52.3 bits (126), Expect = 7e-08
 Identities = 42/183 (22%), Positives = 64/183 (34%), Gaps = 24/183 (13%)

Query: 83  ISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRG 142
           I   +   +      E     +    Q+ H N++ L           L+ E V  G L  
Sbjct: 45  IKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGEL-- 102

Query: 143 FSFASLLIAPR--------IKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLL----DEN 190
           F F    +A +             +I + V YLH    + I    +K  N++L       
Sbjct: 103 FDF----LAQKESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPI 155

Query: 191 YSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELL 250
              KL DF L+  I +G    +  F  G   F+APE           D++S G     LL
Sbjct: 156 PHIKLIDFGLAHEIEDGVE-FKNIF--GTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 212

Query: 251 TGC 253
           +G 
Sbjct: 213 SGA 215

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 51.9 bits (125), Expect = 9e-08
 Identities = 31/152 (20%), Positives = 58/152 (38%), Gaps = 17/152 (11%)

Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTL------RGFSFASLLIAPRIKIAMEIAN 162
             +H+NIL L       E   ++FE +    +        F      I   +    ++  
Sbjct: 57  IARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVH---QVCE 113

Query: 163 AVAYLHVGFDRPIVFRCIKASNVLL--DENYSAKLHDFSLSVSIPEGETHVREEFIKGAY 220
           A+ +LH      I    I+  N++     + + K+ +F  +  +  G+   R  F   A 
Sbjct: 114 ALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN-FRLLF--TAP 167

Query: 221 GFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
            + APE       +   D++S G  +  LL+G
Sbjct: 168 EYYAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 51.5 bits (124), Expect = 1e-07
 Identities = 37/175 (21%), Positives = 64/175 (36%), Gaps = 35/175 (20%)

Query: 155 KIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREE 214
           KIA+ I  A+ +LH      ++ R +K SNVL++     K+ DF   +S    +   ++ 
Sbjct: 113 KIAVSIVKALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDF--GISGYLVDDVAKDI 168

Query: 215 FIKGAYGFIAPE----YFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL 270
              G   ++APE          ++   D++S G  + EL        F  +        L
Sbjct: 169 DA-GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAIL----RFPYDSWGTPFQQL 223

Query: 271 EYAKKSIENNRFGAIVD---PIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
           +             +V+   P    D  F               +CL K+ + RP
Sbjct: 224 KQ------------VVEEPSPQLPADK-FS------AEFVDFTSQCLKKNSKERP 259

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 51.0 bits (123), Expect = 1e-07
 Identities = 40/187 (21%), Positives = 64/187 (34%), Gaps = 32/187 (17%)

Query: 83  ISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL-- 140
           I   +   +      E     +    +++H NI+ L           L+ E V  G L  
Sbjct: 38  IKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFD 97

Query: 141 ----RGF---SFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLL----DE 189
               +       A+  +        +I + V YLH    + I    +K  N++L      
Sbjct: 98  FLAEKESLTEDEATQFL-------KQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVP 147

Query: 190 NYSAKLHDFSLSVSIPEGETHVREEFIKGAYG---FIAPEYFATSSFNEMCDVYSFGAFL 246
           N   KL DF ++  I  G         K  +G   F+APE           D++S G   
Sbjct: 148 NPRIKLIDFGIAHKIEAGNE------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201

Query: 247 CELLTGC 253
             LL+G 
Sbjct: 202 YILLSGA 208

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 51.0 bits (123), Expect = 1e-07
 Identities = 48/181 (26%), Positives = 67/181 (37%), Gaps = 36/181 (19%)

Query: 110 MKHKNILKLIGCCLETELPT---LVFESVKYGTLRGFSFASLLIAPRIKIAMEIA----- 161
           + H+N++K  G            L  E    G L  F      I P I +    A     
Sbjct: 62  LNHENVVKFYGH-RRE--GNIQYLFLEYCSGGEL--FDR----IEPDIGMPEPDAQRFFH 112

Query: 162 ---NAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
                V YLH      I  R IK  N+LLDE  + K+ DF L+          RE  +  
Sbjct: 113 QLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN---RERLLNK 166

Query: 219 AYG---FIAPEYFATSSFN-EMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAK 274
             G   ++APE      F+ E  DV+S G  L  +L G   L +    +    +  EY+ 
Sbjct: 167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPW----DQPSDSCQEYSD 220

Query: 275 K 275
            
Sbjct: 221 W 221

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 51.1 bits (123), Expect = 2e-07
 Identities = 39/162 (24%), Positives = 65/162 (40%), Gaps = 35/162 (21%)

Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTL------RGF---SFASLLIAPRIKIAME 159
           ++ H  I+K+     + E   +V E ++ G L            +   L          +
Sbjct: 71  KLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF-------YQ 122

Query: 160 IANAVAYLHVGFDRPIVFRCIKASNVLL---DENYSAKLHDFSLSVSIPEGETHVREEFI 216
           +  AV YLH   +  I+ R +K  NVLL   +E+   K+ DF  S  + E         +
Sbjct: 123 MLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET------SLM 173

Query: 217 KGAYG---FIAPE---YFATSSFNEMCDVYSFGAFLCELLTG 252
           +   G   ++APE      T+ +N   D +S G  L   L+G
Sbjct: 174 RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 50.9 bits (122), Expect = 2e-07
 Identities = 40/158 (25%), Positives = 70/158 (44%), Gaps = 24/158 (15%)

Query: 108 SQMKHKNILKLIGCCLETELPT-LVFESVKYGTLRGFSFASLLIAPRI------KIAMEI 160
           S+++H NI+K++    E +    LV E    G      FA +   PR+       I  ++
Sbjct: 84  SRVEHANIIKVLDI-FENQGFFQLVMEKHGSG---LDLFAFIDRHPRLDEPLASYIFRQL 139

Query: 161 ANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE---THVREEFIK 217
            +AV YL     + I+ R IK  N+++ E+++ KL DF  +  +  G+   T        
Sbjct: 140 VSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC------ 190

Query: 218 GAYGFIAPEYFATSSFN-EMCDVYSFGAFLCELLTGCN 254
           G   + APE    + +     +++S G  L  L+   N
Sbjct: 191 GTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEEN 228

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 50.7 bits (122), Expect = 2e-07
 Identities = 41/183 (22%), Positives = 64/183 (34%), Gaps = 24/183 (13%)

Query: 83  ISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRG 142
           I   +   +      E     +    +++H N++ L           L+ E V  G L  
Sbjct: 44  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGEL-- 101

Query: 143 FSFASLLIAPR--------IKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLL----DEN 190
           F F    +A +         +   +I N V YLH      I    +K  N++L       
Sbjct: 102 FDF----LAEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPK 154

Query: 191 YSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELL 250
              K+ DF L+  I  G    +  F  G   F+APE           D++S G     LL
Sbjct: 155 PRIKIIDFGLAHKIDFGNE-FKNIF--GTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 211

Query: 251 TGC 253
           +G 
Sbjct: 212 SGA 214

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 50.8 bits (122), Expect = 2e-07
 Identities = 27/97 (27%), Positives = 47/97 (48%), Gaps = 9/97 (9%)

Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           E+  A+ YL    ++ I+ R +K  N+LLDE+    + DF+++  +P          + G
Sbjct: 123 ELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT---MAG 176

Query: 219 AYGFIAPEYFATSSF---NEMCDVYSFGAFLCELLTG 252
              ++APE F++      +   D +S G    ELL G
Sbjct: 177 TKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRG 213

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 50.3 bits (121), Expect = 3e-07
 Identities = 39/163 (23%), Positives = 65/163 (39%), Gaps = 36/163 (22%)

Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTL---------RGFSF----ASLLIAPRIK 155
            + H NI+K+     +     +V E+ + G L         RG +      + L+     
Sbjct: 76  SLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELM----- 130

Query: 156 IAMEIANAVAYLHVGFDRPIVFRCIKASNVLL---DENYSAKLHDFSLSVSIPEGETHVR 212
              ++ NA+AY H    + +V + +K  N+L      +   K+ DF L+           
Sbjct: 131 --KQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD----- 180

Query: 213 EEFIKGAYG---FIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
            E    A G   ++APE F        CD++S G  +  LLTG
Sbjct: 181 -EHSTNAAGTALYMAPEVF-KRDVTFKCDIWSAGVVMYFLLTG 221

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 50.5 bits (121), Expect = 3e-07
 Identities = 40/172 (23%), Positives = 60/172 (34%), Gaps = 30/172 (17%)

Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI 216
             EI  A+  +H       V R IK  N+LLD     +L DF   + +    T      +
Sbjct: 168 LAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV 224

Query: 217 KGAYGFIAPE-------YFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTV 269
            G   +++PE          T S+   CD ++ G F  E+  G     F      D    
Sbjct: 225 -GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ--TPFYA----DSTAE 277

Query: 270 LEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHR 321
                       +G IV   + E  S P  +E +    +   + L   PE R
Sbjct: 278 T-----------YGKIVH--YKEHLSLPLVDEGVPEEARDFIQRLLCPPETR 316

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 50.5 bits (121), Expect = 3e-07
 Identities = 27/101 (26%), Positives = 42/101 (41%), Gaps = 9/101 (8%)

Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI 216
             E+  A+  +H       V R IK  N+L+D N   +L DF   + + E  T      +
Sbjct: 181 LAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV 237

Query: 217 KGAYGFIAPE-----YFATSSFNEMCDVYSFGAFLCELLTG 252
            G   +I+PE           +   CD +S G  + E+L G
Sbjct: 238 -GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYG 277

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 50.0 bits (120), Expect = 4e-07
 Identities = 48/181 (26%), Positives = 67/181 (37%), Gaps = 36/181 (19%)

Query: 110 MKHKNILKLIGCCLETELPT---LVFESVKYGTLRGFSFASLLIAPRIKIAMEIA----- 161
           + H+N++K  G            L  E    G L  F      I P I +    A     
Sbjct: 62  LNHENVVKFYGH-RRE--GNIQYLFLEYCSGGEL--FDR----IEPDIGMPEPDAQRFFH 112

Query: 162 ---NAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
                V YLH      I  R IK  N+LLDE  + K+ DF L+          RE  +  
Sbjct: 113 QLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN---RERLLNK 166

Query: 219 AYG---FIAPEYFATSSFN-EMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAK 274
             G   ++APE      F+ E  DV+S G  L  +L G   L +    +    +  EY+ 
Sbjct: 167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPW----DQPSDSCQEYSD 220

Query: 275 K 275
            
Sbjct: 221 W 221

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 49.9 bits (120), Expect = 4e-07
 Identities = 26/96 (27%), Positives = 49/96 (51%), Gaps = 7/96 (7%)

Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF--SFASLLIAPRIKIAM-EIANAVA 165
           Q++H+N++ L+  C + +   LVFE V + T+      F + L    ++  + +I N + 
Sbjct: 80  QLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIG 138

Query: 166 YLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLS 201
           + H      I+ R IK  N+L+ ++   KL DF  +
Sbjct: 139 FCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFA 171

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 49.5 bits (119), Expect = 5e-07
 Identities = 35/101 (34%), Positives = 48/101 (47%), Gaps = 19/101 (18%)

Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLS-VSIPEGETHVREEFIK 217
           E+A A+ +LH      I++R +K  N+LLDE    KL DF LS  SI   +         
Sbjct: 134 ELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK-------- 182

Query: 218 GAYGF------IAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
            AY F      +APE        +  D +SFG  + E+LTG
Sbjct: 183 -AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 49.1 bits (118), Expect = 6e-07
 Identities = 38/119 (31%), Positives = 58/119 (48%), Gaps = 20/119 (16%)

Query: 160 IANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIK-- 217
           I +AV Y H      +V R +K  NVLLD + +AK+ DF LS  + +G      EF++  
Sbjct: 120 ILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG------EFLRTS 170

Query: 218 -GAYGFIAPEYFATSSFN-EMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAK 274
            G+  + APE  +   +     D++S G  L  LL G   L F    +D+ +  L + K
Sbjct: 171 CGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGT--LPF----DDEHVPTL-FKK 222

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 49.7 bits (119), Expect = 7e-07
 Identities = 28/97 (28%), Positives = 49/97 (50%), Gaps = 6/97 (6%)

Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLS-VSIPEGETHVREEF 215
             EI +A+ YLH   +  +V+R +K  N++LD++   K+ DF L    I +G T   + F
Sbjct: 254 GAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKTF 309

Query: 216 IKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
             G   ++APE    + +    D +  G  + E++ G
Sbjct: 310 C-GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 345

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 48.9 bits (117), Expect = 1e-06
 Identities = 47/177 (26%), Positives = 70/177 (39%), Gaps = 27/177 (15%)

Query: 95  DDVEYCFNNIVFSSQM-KHKNILKLIGCCLETELPT------LVFE-----SVK--YGTL 140
           D+ E     I    +   H+NI    G  ++   P       LV E     SV       
Sbjct: 62  DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT 121

Query: 141 RGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSL 200
           +G +     IA    I  EI   +++LH      ++ R IK  NVLL EN   KL DF +
Sbjct: 122 KGNTLKEEWIA---YICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGV 175

Query: 201 SVSIPEGETHVREEFIKGAYGFIAPE-----YFATSSFNEMCDVYSFGAFLCELLTG 252
           S  +       R  FI   Y ++APE         ++++   D++S G    E+  G
Sbjct: 176 SAQLDRTVGR-RNTFIGTPY-WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 48.7 bits (117), Expect = 1e-06
 Identities = 31/101 (30%), Positives = 48/101 (47%), Gaps = 19/101 (18%)

Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLS-VSIPEGETHVREEFIK 217
           EI+ A+ +LH    + I++R +K  N++L+     KL DF L   SI +G          
Sbjct: 129 EISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV-------- 177

Query: 218 GAYGF------IAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
             + F      +APE    S  N   D +S GA + ++LTG
Sbjct: 178 -THTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTG 217

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 48.4 bits (116), Expect = 1e-06
 Identities = 25/102 (24%), Positives = 46/102 (45%), Gaps = 15/102 (14%)

Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI 216
             EI +A+ YLH    + I+ R +K  N+LL+E+   ++ DF  +  +       R    
Sbjct: 136 TAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR---- 188

Query: 217 KGAYGF------IAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
             A  F      ++PE     S  +  D+++ G  + +L+ G
Sbjct: 189 --ANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 47.6 bits (114), Expect = 2e-06
 Identities = 35/179 (19%), Positives = 67/179 (37%), Gaps = 31/179 (17%)

Query: 110 MKHKNILKLIGCCLETELPT---LVFESVKYGTLRGFSFASLLIAPRIKIAM------EI 160
           ++HKN+++L+   L  E      +V E    G          +   R  +        ++
Sbjct: 63  LRHKNVIQLVDV-LYNEEKQKMYMVMEYCVCGMQEMLDS---VPEKRFPVCQAHGYFCQL 118

Query: 161 ANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAY 220
            + + YLH    + IV + IK  N+LL    + K+    ++           ++  + + 
Sbjct: 119 IDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVA-EALHPFA--ADDTCRTSQ 172

Query: 221 G---FIAPEYFATS-SFN-EMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAK 274
           G   F  PE      +F+    D++S G  L  + TG     F      D++  L +  
Sbjct: 173 GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL--YPF----EGDNIYKL-FEN 224

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 47.8 bits (114), Expect = 3e-06
 Identities = 26/100 (26%), Positives = 44/100 (44%), Gaps = 8/100 (8%)

Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI 216
             E+  A+  +H       + R +K  N+LLD++   KL DF   + + +      +  +
Sbjct: 174 TAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV 230

Query: 217 KGAYGFIAPEYF----ATSSFNEMCDVYSFGAFLCELLTG 252
            G   +I+PE          +   CD +S G FL E+L G
Sbjct: 231 -GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 47.2 bits (113), Expect = 3e-06
 Identities = 34/151 (22%), Positives = 51/151 (33%), Gaps = 17/151 (11%)

Query: 112 HKNILKLIGCCLETELPTLVFESVKYGTL------RGFSFASLLIAPRIKIAMEIANAVA 165
              ++ L      T    L+ E    G +            S      I++  +I   V 
Sbjct: 88  CPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDV--IRLIKQILEGVY 145

Query: 166 YLHVGFDRPIVFRCIKASNVLL---DENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGF 222
           YLH      IV   +K  N+LL         K+ DF +S  I      +RE    G   +
Sbjct: 146 YLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE-LREIM--GTPEY 199

Query: 223 IAPEYFATSSFNEMCDVYSFGAFLCELLTGC 253
           +APE           D+++ G     LLT  
Sbjct: 200 LAPEILNYDPITTATDMWNIGIIAYMLLTHT 230

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 47.0 bits (112), Expect = 3e-06
 Identities = 22/97 (22%), Positives = 40/97 (41%), Gaps = 9/97 (9%)

Query: 160 IANAVAYLHVGFDRPIVFRCIKASNVLLDENY-SAKLHDFSLSVSIPEGETHVREEFIKG 218
           +  AV + H   +  ++ R IK  N+L+D N    KL DF     + +      +    G
Sbjct: 158 VLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD----G 210

Query: 219 AYGFIAPEYFATSSFN-EMCDVYSFGAFLCELLTGCN 254
              +  PE+     ++     V+S G  L +++ G  
Sbjct: 211 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI 247

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 46.9 bits (112), Expect = 4e-06
 Identities = 32/105 (30%), Positives = 50/105 (47%), Gaps = 15/105 (14%)

Query: 155 KIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE---THV 211
           KI +    A+ +L    +  I+ R IK SN+LLD + + KL DF +S     G+   +  
Sbjct: 129 KITLATVKALNHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFGIS-----GQLVDSIA 181

Query: 212 REEFIKGAYGFIAPE----YFATSSFNEMCDVYSFGAFLCELLTG 252
           +     G   ++APE      +   ++   DV+S G  L EL TG
Sbjct: 182 KTRDA-GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATG 225

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 46.9 bits (112), Expect = 4e-06
 Identities = 23/97 (23%), Positives = 41/97 (42%), Gaps = 9/97 (9%)

Query: 160 IANAVAYLHVGFDRPIVFRCIKASNVLLD-ENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           +  A+ + H    R +V R IK  N+L+D     AKL DF     + +      +    G
Sbjct: 148 VVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD----G 200

Query: 219 AYGFIAPEYFATSSFN-EMCDVYSFGAFLCELLTGCN 254
              +  PE+ +   ++     V+S G  L +++ G  
Sbjct: 201 TRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDI 237

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 46.9 bits (112), Expect = 4e-06
 Identities = 37/119 (31%), Positives = 55/119 (46%), Gaps = 20/119 (16%)

Query: 160 IANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIK-- 217
           I  A+ Y H      IV R +K  N+LLD+N + K+ DF LS  + +G       F+K  
Sbjct: 117 IICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG------NFLKTS 167

Query: 218 -GAYGFIAPEYFATSSFN-EMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAK 274
            G+  + APE      +     DV+S G  L  +L G   L F    +D+ +  L + K
Sbjct: 168 CGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGR--LPF----DDEFIPNL-FKK 219

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 46.2 bits (110), Expect = 5e-06
 Identities = 33/248 (13%), Positives = 68/248 (27%), Gaps = 66/248 (26%)

Query: 104 IVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRI------KIA 157
              +   +H ++++      E +   +  E    G+L      +  I           + 
Sbjct: 62  YAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLL 121

Query: 158 MEIANAVAYLHVGFDRPIVFRCIKASNVLLDEN-------------------YSAKLHDF 198
           +++   + Y+H      +V   IK SN+ +                         K+ D 
Sbjct: 122 LQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDL 178

Query: 199 SLSVSIPEGETHVREEFIKGAYG---FIAPEYFA-TSSFNEMCDVYSFGAFLCELLTGCN 254
                I   +            G   F+A E      +     D+++    +        
Sbjct: 179 GHVTRISSPQVEE---------GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGA-E 228

Query: 255 VLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCL 314
            L   G+         ++ +  I   R      P   +  S        Q   +L+   +
Sbjct: 229 PLPRNGD---------QWHE--IRQGRL-----PRIPQVLS--------QEFTELLKVMI 264

Query: 315 SKSPEHRP 322
              PE RP
Sbjct: 265 HPDPERRP 272

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 46.6 bits (110), Expect = 7e-06
 Identities = 32/97 (32%), Positives = 50/97 (51%), Gaps = 7/97 (7%)

Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLS-VSIPEGETHVREEF 215
           A EIA  + +L     + I++R +K  NV+LD     K+ DF +   +I +G T   + F
Sbjct: 448 AAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT--TKTF 502

Query: 216 IKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
             G   +IAPE  A   + +  D ++FG  L E+L G
Sbjct: 503 C-GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 538

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 45.7 bits (109), Expect = 1e-05
 Identities = 31/103 (30%), Positives = 47/103 (45%), Gaps = 19/103 (18%)

Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLS-VSIPEGETHVREEF 215
           A EIA  + +L     + I++R +K  NV+LD     K+ DF +   +I +G T      
Sbjct: 127 AAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT------ 177

Query: 216 IKGAYGF------IAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
                 F      IAPE  A   + +  D ++FG  L E+L G
Sbjct: 178 ---TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 217

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 45.7 bits (109), Expect = 1e-05
 Identities = 33/103 (32%), Positives = 44/103 (42%), Gaps = 19/103 (18%)

Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLS-VSIPEGETHVREEF 215
           A EIA+A+ YLH      IV+R +K  N+LLD      L DF L   +I    T      
Sbjct: 145 AAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST------ 195

Query: 216 IKGAYGF------IAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
                 F      +APE      ++   D +  GA L E+L G
Sbjct: 196 ---TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 235

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 45.9 bits (109), Expect = 1e-05
 Identities = 38/119 (31%), Positives = 57/119 (47%), Gaps = 20/119 (16%)

Query: 160 IANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIK-- 217
           I + V Y H      +V R +K  NVLLD + +AK+ DF LS  + +G      EF++  
Sbjct: 125 ILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG------EFLRTS 175

Query: 218 -GAYGFIAPEYFATSSFN-EMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAK 274
            G+  + APE  +   +     D++S G  L  LL G   L F    +DD +  L + K
Sbjct: 176 CGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGT--LPF----DDDHVPTL-FKK 227

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 45.3 bits (108), Expect = 1e-05
 Identities = 29/103 (28%), Positives = 46/103 (44%), Gaps = 19/103 (18%)

Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLS-VSIPEGETHVREEF 215
             EI +A+ YLH    R +V+R IK  N++LD++   K+ DF L    I +G T      
Sbjct: 111 GAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT------ 161

Query: 216 IKGAYGF------IAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
                 F      +APE    + +    D +  G  + E++ G
Sbjct: 162 ---MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 201

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 46.0 bits (108), Expect = 1e-05
 Identities = 66/404 (16%), Positives = 119/404 (29%), Gaps = 106/404 (26%)

Query: 3   SSLNIK-RKSSGEAADSNMVRNEKL---LL-------QKLIATFNGK-------RNP--I 42
            S NIK R  S +A    +++++     LL        K    FN         R     
Sbjct: 219 HSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVT 278

Query: 43  RAFSAKDLKKATNNYDLHKVIQSDTSYRLFEGTL--VDQDRPISVMKFH----------- 89
              SA      + +      +  D    L    L    QD P  V+  +           
Sbjct: 279 DFLSAATTTHISLD-HHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESI 337

Query: 90  --DNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFAS 147
               +T D              +    +  +I   L    P    E  K        F  
Sbjct: 338 RDGLATWD----------NWKHVNCDKLTTIIESSLNVLEPA---EYRKM-------FDR 377

Query: 148 LLIAPR-IKIAMEIANAV-AYLHVGFDRPIVFRCIKASNVLLDEN---YSAKLHDFSLSV 202
           L + P    I   + + +   +       +V +  K S  L+++     +  +    L +
Sbjct: 378 LSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYS--LVEKQPKESTISIPSIYLEL 435

Query: 203 SIP---EGETH--VREEF-IKGAY---GFIAPE---YFA------------TSSFNEMCD 238
            +    E   H  + + + I   +     I P    YF                      
Sbjct: 436 KVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRM 495

Query: 239 VY-SFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENN--RFGAIVDPIFDEDNS 295
           V+  F  FL + +   +          + L  L++ K  I +N  ++  +V+ I D    
Sbjct: 496 VFLDFR-FLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILD---- 550

Query: 296 F-PGKEEKLQSLGQLMYKC-----LSKSPEHRPLMVDVAKQLRQ 333
           F P  EE L     +  K      ++   E   +  +  KQ+++
Sbjct: 551 FLPKIEENL-----ICSKYTDLLRIALMAEDEAIFEEAHKQVQR 589

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 44.9 bits (107), Expect = 2e-05
 Identities = 30/103 (29%), Positives = 45/103 (43%), Gaps = 19/103 (18%)

Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLS-VSIPEGETHVREEF 215
           A EI   + +LH    + IV+R +K  N+LLD++   K+ DF +   ++           
Sbjct: 124 AAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK------ 174

Query: 216 IKGAYGF------IAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
                 F      IAPE      +N   D +SFG  L E+L G
Sbjct: 175 ---TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIG 214

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 44.9 bits (107), Expect = 2e-05
 Identities = 33/103 (32%), Positives = 45/103 (43%), Gaps = 19/103 (18%)

Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLS-VSIPEGETHVREEF 215
           A EI +A+ +LH   D+ I++R +K  NVLLD     KL DF +    I  G T      
Sbjct: 130 AAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT------ 180

Query: 216 IKGAYGF------IAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
                 F      IAPE      +    D ++ G  L E+L G
Sbjct: 181 ---TATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCG 220

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 45.0 bits (107), Expect = 2e-05
 Identities = 29/101 (28%), Positives = 45/101 (44%), Gaps = 19/101 (18%)

Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLS-VSIPEGETHVREEFIK 217
           EI+ A+ YLH   +R I++R +K  NVLLD     KL D+ +    +  G+T        
Sbjct: 161 EISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT-------- 209

Query: 218 GAYGF------IAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
               F      IAPE      +    D ++ G  + E++ G
Sbjct: 210 -TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG 249

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 44.5 bits (106), Expect = 2e-05
 Identities = 26/100 (26%), Positives = 47/100 (47%), Gaps = 10/100 (10%)

Query: 109 QMKHKNILKLIGCCLETELPTLVFESV-----KY-GTLRGFSFASLLIAPRIKIAM-EIA 161
           ++KH+NI++L          TLVFE +     KY  +    +    L    +K    ++ 
Sbjct: 59  ELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118

Query: 162 NAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLS 201
             +A+ H   +  I+ R +K  N+L+++    KL DF L+
Sbjct: 119 QGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLA 155

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 44.4 bits (106), Expect = 2e-05
 Identities = 27/96 (28%), Positives = 46/96 (47%), Gaps = 7/96 (7%)

Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF--SFASLLIAPRIKIAM-EIANAVA 165
           ++KH NI+KL       +   LVFE +    L+         L +   K  + ++ N +A
Sbjct: 56  ELKHSNIVKLYDVIHTKKRLVLVFEHLDQD-LKKLLDVCEGGLESVTAKSFLLQLLNGIA 114

Query: 166 YLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLS 201
           Y H   DR ++ R +K  N+L++     K+ DF L+
Sbjct: 115 YCH---DRRVLHRDLKPQNLLINREGELKIADFGLA 147

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 44.6 bits (106), Expect = 2e-05
 Identities = 34/121 (28%), Positives = 51/121 (42%), Gaps = 22/121 (18%)

Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLS-VSIPEGETHVREEFIK 217
           EI  A+ +LH      I++R IK  N+LLD N    L DF LS   + +          +
Sbjct: 167 EIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET--------E 215

Query: 218 GAYGF------IAPEYFATSS--FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTV 269
            AY F      +AP+         ++  D +S G  + ELLTG     F  +G  +    
Sbjct: 216 RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA--SPFTVDGEKNSQAE 273

Query: 270 L 270
           +
Sbjct: 274 I 274

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 44.5 bits (106), Expect = 3e-05
 Identities = 29/103 (28%), Positives = 46/103 (44%), Gaps = 19/103 (18%)

Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLS-VSIPEGETHVREEF 215
           + EI+ A+ YLH   +R I++R +K  NVLLD     KL D+ +    +  G+T      
Sbjct: 116 SAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT------ 166

Query: 216 IKGAYGF------IAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
                 F      IAPE      +    D ++ G  + E++ G
Sbjct: 167 ---TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG 206

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 44.1 bits (105), Expect = 3e-05
 Identities = 25/96 (26%), Positives = 48/96 (50%), Gaps = 7/96 (7%)

Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF--SFASLLIAPRIKIAM-EIANAVA 165
            +KH NI+ L       +  TLVFE +    L+ +     +++    +K+ + ++   +A
Sbjct: 56  DLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLA 114

Query: 166 YLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLS 201
           Y H    + ++ R +K  N+L++E    KL DF L+
Sbjct: 115 YCH---RQKVLHRDLKPQNLLINERGELKLADFGLA 147

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 44.1 bits (105), Expect = 3e-05
 Identities = 22/95 (23%), Positives = 39/95 (41%), Gaps = 7/95 (7%)

Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF--SFASLLIAPRIKIAM-EIANAVA 165
           Q+KH N++ L+          LVFE   + T+      +   +    +K    +   AV 
Sbjct: 58  QLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVN 116

Query: 166 YLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSL 200
           + H       + R +K  N+L+ ++   KL DF  
Sbjct: 117 FCH---KHNCIHRDVKPENILITKHSVIKLCDFGF 148

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 44.1 bits (105), Expect = 4e-05
 Identities = 28/96 (29%), Positives = 48/96 (50%), Gaps = 7/96 (7%)

Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF--SFASLLIAPRIKIAM-EIANAVA 165
           ++ H NI+ LI         TLVFE ++   L+       + L   +IKI + ++   VA
Sbjct: 75  ELHHPNIVSLIDVIHSERCLTLVFEFMEKD-LKKVLDENKTGLQDSQIKIYLYQLLRGVA 133

Query: 166 YLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLS 201
           + H      I+ R +K  N+L++ + + KL DF L+
Sbjct: 134 HCH---QHRILHRDLKPQNLLINSDGALKLADFGLA 166

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 43.7 bits (104), Expect = 4e-05
 Identities = 43/172 (25%), Positives = 70/172 (40%), Gaps = 29/172 (16%)

Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF--SFASLLIAPRIKIAM-EIANAVA 165
           ++KHKNI++L       +  TLVFE      L+ +  S    L    +K  + ++   + 
Sbjct: 57  ELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115

Query: 166 YLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSL--SVSIPEGE-THV------REEFI 216
           + H    R ++ R +K  N+L++ N   KL +F L  +  IP    +        R    
Sbjct: 116 FCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYR---- 168

Query: 217 KGAYGFIAPEY-FATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDL 267
                   P+  F    ++   D++S G    EL      L F GN  DD L
Sbjct: 169 -------PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL-FPGNDVDDQL 212

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 43.8 bits (104), Expect = 4e-05
 Identities = 29/106 (27%), Positives = 44/106 (41%), Gaps = 21/106 (19%)

Query: 109 QMKHKNILKLIGCCLETELPT--------LVFESV-----KYGTLRGFSFASLLIAPRIK 155
            +KH+N++ LI  C     P         LVF+          +     F        IK
Sbjct: 72  LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFT----LSEIK 127

Query: 156 IAME-IANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSL 200
             M+ + N + Y+H      I+ R +KA+NVL+  +   KL DF L
Sbjct: 128 RVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGL 170

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 43.4 bits (103), Expect = 5e-05
 Identities = 34/161 (21%), Positives = 52/161 (32%), Gaps = 54/161 (33%)

Query: 111 KHKNILKLIGCCLETELPT-----LVFESVKYGTL------RGFSF-----ASLLIAPRI 154
           +  +I++++    E          +V E +  G L      RG        AS ++    
Sbjct: 69  QCPHIVRIVDVY-ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM---- 123

Query: 155 KIAMEIANAVAYLHVGFDRPIVFRCIKASNVLL---DENYSAKLHDFSLSVSIPEGETHV 211
                I  A+ YLH      I  R +K  N+L      N   KL DF  +          
Sbjct: 124 ---KSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA---K------ 168

Query: 212 REEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
             E     Y              + CD++S G  +  LL G
Sbjct: 169 --ETTGEKYD-------------KSCDMWSLGVIMYILLCG 194

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 43.3 bits (103), Expect = 5e-05
 Identities = 42/162 (25%), Positives = 62/162 (38%), Gaps = 32/162 (19%)

Query: 108 SQMKHKNILKLIGCCLETELP-----TLVFESVKYGTLRGF---SFASLLIAPRIKIAM- 158
              +H N+++L+  C  +        TLVFE V    LR +   +    L A  IK  M 
Sbjct: 69  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMR 127

Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSL--SVSIPEGETHV----- 211
           +    + +LH      IV R +K  N+L+    + KL DF L    S     T V     
Sbjct: 128 QFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLW 184

Query: 212 -REEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
            R           APE    S++    D++S G    E+   
Sbjct: 185 YR-----------APEVLLQSTYATPVDMWSVGCIFAEMFRR 215

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 42.6 bits (101), Expect = 1e-04
 Identities = 39/164 (23%), Positives = 58/164 (35%), Gaps = 36/164 (21%)

Query: 108 SQMKHKNILKLIGCCLETELP-----TLVFESV-----KYGTLRGFSFASLLIAPRIKIA 157
              +H N+++L   C  +        TLVFE V      Y           +    IK  
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG---VPTETIKDM 125

Query: 158 M-EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSL--SVSIPEGETHV--- 211
           M ++   + +LH      +V R +K  N+L+  +   KL DF L    S     T V   
Sbjct: 126 MFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVT 182

Query: 212 ---REEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
              R           APE    SS+    D++S G    E+   
Sbjct: 183 LWYR-----------APEVLLQSSYATPVDLWSVGCIFAEMFRR 215

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 42.5 bits (101), Expect = 1e-04
 Identities = 26/97 (26%), Positives = 47/97 (48%), Gaps = 8/97 (8%)

Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF---SFASLLIAPRIKIAM-EIANAV 164
           ++ H NI+KL+          LVFE +    L+ F   S  + +  P IK  + ++   +
Sbjct: 58  ELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGL 116

Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLS 201
           A+ H      ++ R +K  N+L++   + KL DF L+
Sbjct: 117 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLA 150

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 42.3 bits (100), Expect = 1e-04
 Identities = 20/102 (19%), Positives = 41/102 (40%), Gaps = 20/102 (19%)

Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI 216
           A +I     YLH      +++R +K  N+L+D+    ++ DF  +           +   
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA-----------KRVK 192

Query: 217 KGAYGF------IAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
              +        +APE   +  +N+  D ++ G  + E+  G
Sbjct: 193 GRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 41.4 bits (97), Expect = 3e-04
 Identities = 24/99 (24%), Positives = 48/99 (48%), Gaps = 8/99 (8%)

Query: 163 AVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGF 222
            + +LH      I+ R +K SN+++  + + K+ DF L+ +   G + +   ++   Y +
Sbjct: 176 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-Y 229

Query: 223 IAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGN 261
            APE      + E  D++S G  + E++    +L F G 
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRH-KIL-FPGR 266

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 41.1 bits (97), Expect = 3e-04
 Identities = 23/99 (23%), Positives = 45/99 (45%), Gaps = 11/99 (11%)

Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF-SFASLLIAPRIKIAM-EIANAVAY 166
           +++H+NI++L           L+FE  +   L+ +      +    IK  + ++ N V +
Sbjct: 89  ELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNF 147

Query: 167 LHVGFDRPIVFRCIKASNVLLDENYSA-----KLHDFSL 200
            H    R  + R +K  N+LL  + ++     K+ DF L
Sbjct: 148 CH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 41.2 bits (97), Expect = 3e-04
 Identities = 42/162 (25%), Positives = 65/162 (40%), Gaps = 31/162 (19%)

Query: 110 MKHKNILKLIGCCLETELPT------LVFESVK---YGTLRGFSFASLLIAPR-IKIAM- 158
           +KH N++ L                 LV E V    Y   R ++     +    IK+ M 
Sbjct: 89  VKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMY 148

Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSA-KLHDFSLSVSIPEGETHVREEFIK 217
           ++  ++AY+H      I  R IK  N+LLD      KL DF  +  +  GE +V      
Sbjct: 149 QLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSY---- 201

Query: 218 GAYGFI------APE-YFATSSFNEMCDVYSFGAFLCELLTG 252
                I      APE  F  +++    D++S G  + EL+ G
Sbjct: 202 -----ICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQG 238

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 41.2 bits (97), Expect = 3e-04
 Identities = 26/99 (26%), Positives = 49/99 (49%), Gaps = 8/99 (8%)

Query: 163 AVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGF 222
            + +LH      I+ R +K SN+++  + + K+ DF L+ +   G + +   ++   Y +
Sbjct: 139 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-Y 192

Query: 223 IAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGN 261
            APE      + E  D++S G  + E++ G  VL F G 
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMIKG-GVL-FPGT 229

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 41.3 bits (97), Expect = 3e-04
 Identities = 55/252 (21%), Positives = 91/252 (36%), Gaps = 52/252 (20%)

Query: 113 KNILKLIGC-------CLETELPTL-VFESVKYGTLRGFSFASLLIAPRIKIAMEIANAV 164
            N++ ++         C+  EL ++ ++E +K    +GFS    L   R K A  I   +
Sbjct: 159 MNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFS----LPLVR-KFAHSILQCL 213

Query: 165 AYLHVGFDRPIVFRCIKASNVLLDENYSA--KLHDFSLSVSIPEGETHVREEFIKGAYGF 222
             LH      I+   +K  N+LL +   +  K+ DF  S    E +           Y +
Sbjct: 214 DALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRV---------YTY 259

Query: 223 I------APEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLT-------- 268
           I      APE    + +    D++S G  L ELLTG   L   G    D L         
Sbjct: 260 IQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTG-YPL-LPGEDEGDQLACMIELLGM 317

Query: 269 ----VLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLM 324
               +L+ +K++   N   +   P +    +       L   G+     L   PE R   
Sbjct: 318 PSQKLLDASKRA--KNFVSSKGYPRYCTVTTLSDGSVVLNG-GRSRRGKLRGPPESREWG 374

Query: 325 VDVAKQLRQMYL 336
             +      ++L
Sbjct: 375 NALKGCDDPLFL 386

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 40.6 bits (96), Expect = 4e-04
 Identities = 31/102 (30%), Positives = 48/102 (47%), Gaps = 20/102 (19%)

Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFI 216
           A E+  A+ YLH    + I++R +K  N+LLD+N   K+ DF  +           +   
Sbjct: 112 AAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFA-----------KYVP 157

Query: 217 KGAYGF------IAPEYFATSSFNEMCDVYSFGAFLCELLTG 252
              Y        IAPE  +T  +N+  D +SFG  + E+L G
Sbjct: 158 DVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 40.6 bits (96), Expect = 4e-04
 Identities = 29/95 (30%), Positives = 44/95 (46%), Gaps = 7/95 (7%)

Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF--SFASLLIAPRIKIAME-IANAVA 165
           ++ H NI+ L+         +LVF+ ++   L       + +L    IK  M      + 
Sbjct: 68  ELSHPNIIGLLDAFGHKSNISLVFDFMETD-LEVIIKDNSLVLTPSHIKAYMLMTLQGLE 126

Query: 166 YLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSL 200
           YLH      I+ R +K +N+LLDEN   KL DF L
Sbjct: 127 YLH---QHWILHRDLKPNNLLLDENGVLKLADFGL 158

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 40.8 bits (96), Expect = 4e-04
 Identities = 36/168 (21%), Positives = 55/168 (32%), Gaps = 32/168 (19%)

Query: 160 IANAVAYLHVGFDRPIVFRCIKASNVLLDENYSA--KLHDFSLSVSIPEGETHVREEFIK 217
           + + V+Y H      I  R +K  N LLD + +   K+ DF  S S             K
Sbjct: 125 LLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH------SQPK 175

Query: 218 ---GAYGFIAPEYFATSSFN-EMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYA 273
              G   +IAPE      ++ ++ DV+S G  L  +L G     F     D +       
Sbjct: 176 STVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGA--YPF----EDPEEPRD--- 226

Query: 274 KKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHR 321
                   +   +  I     S P           L+ +     P  R
Sbjct: 227 --------YRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATR 266

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 39.8 bits (93), Expect = 9e-04
 Identities = 19/108 (17%), Positives = 39/108 (36%), Gaps = 19/108 (17%)

Query: 109 QMKHKNILKLIGCCLETELP--TLVFESV---------KYGTLRGFSFASLLIAPRIKIA 157
           ++KH N++ L    L        L+F+            +   +       L    +K  
Sbjct: 74  ELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSL 133

Query: 158 M-EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSA----KLHDFSL 200
           + +I + + YLH      ++ R +K +N+L+          K+ D   
Sbjct: 134 LYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGF 178

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	339
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.96
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.94
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.86
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.77
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.47
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.35
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.34
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.09
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.95
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.67
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.65
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.53
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.5
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.22
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.22
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.99
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.93
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.73
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.69
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.57
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.56
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.45
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.41
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.32
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.23
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.23
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.9
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.78
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.45
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.37
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.93
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	92.83
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	90.45
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	85.42

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=8.1e-62  Score=433.50  Aligned_cols=257  Identities=21%  Similarity=0.295  Sum_probs=213.7

Q ss_pred             cCcccCCceeccCCeeEEEEEEc-----CCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLV-----DQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPT  129 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~  129 (339)
                      ++|.+.+.||+|+||+||+|.+.     .++..||||+++... ....+.|.+|+.+|++++|||||+++|+|.+++..+
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~   91 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   91 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC-hHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence            67889999999999999999875     357899999997654 356778999999999999999999999999999999


Q ss_pred             EEEEeccCCccccccc---------------cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceE
Q 019536          130 LVFESVKYGTLRGFSF---------------ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAK  194 (339)
Q Consensus       130 lv~e~~~~g~L~~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~k  194 (339)
                      ||||||++|+|.+++.               ..+++..++.++.||+.||.|||   +++|+||||||+|||+++++.+|
T Consensus        92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~K  168 (299)
T 4asz_A           92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVK  168 (299)
T ss_dssp             EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcEE
Confidence            9999999999999985               25899999999999999999999   89999999999999999999999


Q ss_pred             EecCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHH
Q 019536          195 LHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYA  273 (339)
Q Consensus       195 l~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~  273 (339)
                      |+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||....        ..+..
T Consensus       169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~--------~~~~~  240 (299)
T 4asz_A          169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS--------NNEVI  240 (299)
T ss_dssp             ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC--------HHHHH
T ss_pred             ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC--------HHHHH
Confidence            999999987755544433334568999999999999999999999999999999998 899985321        11222


Q ss_pred             HHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          274 KKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                      ........              .+.+..+++++.+||.+||+.||++|||+.+|++.|+++.+.
T Consensus       241 ~~i~~~~~--------------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~  290 (299)
T 4asz_A          241 ECITQGRV--------------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA  290 (299)
T ss_dssp             HHHHHTCC--------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHcCCC--------------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence            22111111              112234567899999999999999999999999999998753

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=5.4e-61  Score=433.81  Aligned_cols=256  Identities=19%  Similarity=0.264  Sum_probs=205.4

Q ss_pred             cCcccCCceeccCCeeEEEEEEc-----CCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLV-----DQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPT  129 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~  129 (339)
                      ++|.+.+.||+|+||+||+|++.     .++..||||+++... ....+.|.+|+.+|++++|||||+++|+|.+++..+
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~  119 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL  119 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            57888899999999999999975     357899999997653 356778999999999999999999999999999999


Q ss_pred             EEEEeccCCccccccc-----------------cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCc
Q 019536          130 LVFESVKYGTLRGFSF-----------------ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYS  192 (339)
Q Consensus       130 lv~e~~~~g~L~~~~~-----------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~  192 (339)
                      ||||||++|+|.+++.                 ..+++.+++.++.||+.||.|||   +++|+||||||+|||++.++.
T Consensus       120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~~  196 (329)
T 4aoj_A          120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLV  196 (329)
T ss_dssp             EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCCc
Confidence            9999999999999864                 25889999999999999999999   899999999999999999999


Q ss_pred             eEEecCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHH
Q 019536          193 AKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLE  271 (339)
Q Consensus       193 ~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~  271 (339)
                      +||+|||+|+.+.............||+.|||||++.+..|+.++|||||||++|||+| |+.||....        ..+
T Consensus       197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~--------~~~  268 (329)
T 4aoj_A          197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS--------NTE  268 (329)
T ss_dssp             EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC--------HHH
T ss_pred             EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCC--------HHH
Confidence            99999999987755443333334679999999999999999999999999999999999 899985321        112


Q ss_pred             HHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 019536          272 YAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYL  336 (339)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~  336 (339)
                      ..........              .+.+..+++++.+||.+||+.||++|||+.||++.|+.+.+
T Consensus       269 ~~~~i~~g~~--------------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~  319 (329)
T 4aoj_A          269 AIDCITQGRE--------------LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ  319 (329)
T ss_dssp             HHHHHHHTCC--------------CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHcCCC--------------CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence            1121111111              12223456789999999999999999999999999999875

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2.5e-61  Score=432.06  Aligned_cols=255  Identities=18%  Similarity=0.306  Sum_probs=211.0

Q ss_pred             cCcccCCceeccCCeeEEEEEEc-----CCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLV-----DQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPT  129 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~  129 (339)
                      .++++.+.||+|+||+||+|.+.     .+++.||||+++........+.|.+|+.++++++|||||+++|+|.+++..+
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            45677889999999999999974     3578999999987655556788999999999999999999999999999999


Q ss_pred             EEEEeccCCccccccc------------------cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCC
Q 019536          130 LVFESVKYGTLRGFSF------------------ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENY  191 (339)
Q Consensus       130 lv~e~~~~g~L~~~~~------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~  191 (339)
                      ||||||++|+|.+++.                  ..+++..++.++.||+.||.|||   +.+|+||||||+|||+++++
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEECCCC
Confidence            9999999999999873                  35888999999999999999999   89999999999999999999


Q ss_pred             ceEEecCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHH
Q 019536          192 SAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVL  270 (339)
Q Consensus       192 ~~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~  270 (339)
                      .+||+|||+|+.+.............||+.|||||++.+..|+.++|||||||++|||+| |+.||....        ..
T Consensus       183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~--------~~  254 (308)
T 4gt4_A          183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS--------NQ  254 (308)
T ss_dssp             CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC--------HH
T ss_pred             CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC--------HH
Confidence            999999999987654433333334679999999999999999999999999999999998 899975221        11


Q ss_pred             HHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 019536          271 EYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQM  334 (339)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l  334 (339)
                      +..... ..+.             ..|.+..++..+.+||.+||+.||++||||.||++.|+.+
T Consensus       255 ~~~~~i-~~~~-------------~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          255 DVVEMI-RNRQ-------------VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             HHHHHH-HTTC-------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             HHHHHH-HcCC-------------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            111111 1111             1123345667899999999999999999999999999864

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2.2e-60  Score=424.56  Aligned_cols=263  Identities=22%  Similarity=0.295  Sum_probs=205.6

Q ss_pred             HHHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccC-CChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccE
Q 019536           51 KKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDN-STLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPT  129 (339)
Q Consensus        51 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~  129 (339)
                      +...+++.+.+.||+|+||+||+|++.+   .||||+++.. ......+.|.+|+.++++++|||||+++|+|.+ +.++
T Consensus        32 ei~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~  107 (307)
T 3omv_A           32 EIEASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLA  107 (307)
T ss_dssp             BCCTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCE
T ss_pred             EEcHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEE
Confidence            3445788899999999999999998743   4899998754 334566789999999999999999999999865 4579


Q ss_pred             EEEEeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCC
Q 019536          130 LVFESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPE  206 (339)
Q Consensus       130 lv~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~  206 (339)
                      ||||||++|+|.+++.   ..+++..++.|+.||+.||.|||   +++|+||||||+|||+++++.+||+|||+|+....
T Consensus       108 iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~  184 (307)
T 3omv_A          108 IVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR  184 (307)
T ss_dssp             EEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred             EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence            9999999999999884   56899999999999999999999   89999999999999999999999999999987654


Q ss_pred             CCceeeeccccccccccccccccc---CCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCccc
Q 019536          207 GETHVREEFIKGAYGFIAPEYFAT---SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFG  283 (339)
Q Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (339)
                      ..........+||+.|||||++.+   ..|+.++|||||||++|||++|+.||.....     ..   ........+.  
T Consensus       185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~-----~~---~~~~~~~~~~--  254 (307)
T 3omv_A          185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN-----RD---QIIFMVGRGY--  254 (307)
T ss_dssp             ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----HH---HHHHHHHTTC--
T ss_pred             CCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh-----HH---HHHHHHhcCC--
Confidence            333333335689999999999964   3589999999999999999999999853221     11   1111111110  


Q ss_pred             ccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          284 AIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                        ..+...     ..+..++..+.+||.+||+.||++|||+.+|++.|+.|..+
T Consensus       255 --~~p~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~  301 (307)
T 3omv_A          255 --ASPDLS-----KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS  301 (307)
T ss_dssp             --CCCCST-----TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred             --CCCCcc-----cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence              111110     11224566899999999999999999999999999988654

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=3.1e-60  Score=428.92  Aligned_cols=250  Identities=18%  Similarity=0.280  Sum_probs=211.3

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFES  134 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  134 (339)
                      ..|++.+.||+|+||+||+|.+..+|+.||||++..... ...+.+.+|+.+|+.++|||||++++++.+++.+||||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  152 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  152 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence            569999999999999999999999999999999976433 3445678999999999999999999999999999999999


Q ss_pred             ccCCccccccc-cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceeee
Q 019536          135 VKYGTLRGFSF-ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVRE  213 (339)
Q Consensus       135 ~~~g~L~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~  213 (339)
                      |++|+|.+++. ..+++..+..++.||+.||.|||   +++|+||||||+|||++.+|.+||+|||+|+.+......  .
T Consensus       153 ~~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~--~  227 (346)
T 4fih_A          153 LEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--R  227 (346)
T ss_dssp             CTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC--B
T ss_pred             CCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCc--c
Confidence            99999999886 67999999999999999999999   899999999999999999999999999999887554332  2


Q ss_pred             cccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCC
Q 019536          214 EFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDED  293 (339)
Q Consensus       214 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (339)
                      ...+||+.|||||++.+..|+.++||||+||++|||++|++||...  .   ......   .... ..           .
T Consensus       228 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~--~---~~~~~~---~i~~-~~-----------~  287 (346)
T 4fih_A          228 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE--P---PLKAMK---MIRD-NL-----------P  287 (346)
T ss_dssp             CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS--C---HHHHHH---HHHH-SS-----------C
T ss_pred             cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc--C---HHHHHH---HHHc-CC-----------C
Confidence            2468999999999999999999999999999999999999998521  1   111111   1111 10           0


Q ss_pred             CCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          294 NSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       294 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      ...+.+...++++.+||.+||+.||++|||+.|++++
T Consensus       288 ~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H  324 (346)
T 4fih_A          288 PRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  324 (346)
T ss_dssp             CCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            1122234567789999999999999999999999863

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.8e-60  Score=433.77  Aligned_cols=269  Identities=19%  Similarity=0.327  Sum_probs=223.5

Q ss_pred             ccHHHHHHHhcCcccCCceeccCCeeEEEEEEcCC-----CeeEEEEEeccCCChhhHHHHHHHHHHHHhcCC-Cceeee
Q 019536           45 FSAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQ-----DRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKH-KNILKL  118 (339)
Q Consensus        45 ~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H-~niv~~  118 (339)
                      +..++|+...++|++.+.||+|+||+||+|.+...     ++.||||++.........+.|.+|+.+|+++.| ||||++
T Consensus        54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l  133 (353)
T 4ase_A           54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL  133 (353)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence            45567777789999999999999999999998654     368999999887666667889999999999965 999999


Q ss_pred             eeeeee-CCccEEEEEeccCCccccccc------------------cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEcc
Q 019536          119 IGCCLE-TELPTLVFESVKYGTLRGFSF------------------ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRC  179 (339)
Q Consensus       119 ~~~~~~-~~~~~lv~e~~~~g~L~~~~~------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~d  179 (339)
                      +|+|.+ ++.++||||||++|+|.+++.                  ..+++..++.++.||+.||.|||   +++|+|||
T Consensus       134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRD  210 (353)
T 4ase_A          134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRD  210 (353)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSC
T ss_pred             EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCc
Confidence            999976 456899999999999999874                  23788999999999999999999   89999999


Q ss_pred             CCCCCEEeCCCCceEEecCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCcccc
Q 019536          180 IKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEF  258 (339)
Q Consensus       180 lk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~  258 (339)
                      |||+|||+++++.+||+|||+|+.+.............||+.|||||++.+..|+.++|||||||++|||+| |+.||..
T Consensus       211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~  290 (353)
T 4ase_A          211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  290 (353)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence            999999999999999999999998766555444556779999999999999999999999999999999998 9999853


Q ss_pred             CCCCCCCchhHHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          259 KGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                      ....    ....    .....+.             ..+.+..+++++.+||.+||+.||++|||+.+|+++|+++.++
T Consensus       291 ~~~~----~~~~----~~i~~g~-------------~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~  348 (353)
T 4ase_A          291 VKID----EEFC----RRLKEGT-------------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  348 (353)
T ss_dssp             CCCS----HHHH----HHHHHTC-------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCHH----HHHH----HHHHcCC-------------CCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence            2211    1111    1111111             1122234566899999999999999999999999999998764

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.8e-60  Score=431.08  Aligned_cols=249  Identities=19%  Similarity=0.241  Sum_probs=204.1

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS-TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFE  133 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  133 (339)
                      ++|++.+.||+|+||+||+|++..+|+.||||++.... .....+.+.+|+.++++++|||||++++++.+++.+|||||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            68999999999999999999999999999999997653 33456788999999999999999999999999999999999


Q ss_pred             eccCCccccccc----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCc
Q 019536          134 SVKYGTLRGFSF----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGET  209 (339)
Q Consensus       134 ~~~~g~L~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~  209 (339)
                      ||++|+|.+++.    ..+++..++.++.||+.||.|||   +++|+||||||+|||++.+|.+||+|||+|+.+.....
T Consensus       104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~  180 (350)
T 4b9d_A          104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE  180 (350)
T ss_dssp             CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH
T ss_pred             CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeecCCcc
Confidence            999999999985    24678888999999999999999   89999999999999999999999999999987644322


Q ss_pred             eeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCc
Q 019536          210 HVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPI  289 (339)
Q Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (339)
                        .....+||+.|||||++.+..|+.++||||+||++|||++|+.||....        ..+....... +.+.      
T Consensus       181 --~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~--------~~~~~~~i~~-~~~~------  243 (350)
T 4b9d_A          181 --LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS--------MKNLVLKIIS-GSFP------  243 (350)
T ss_dssp             --HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHH-TCCC------
T ss_pred             --cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--------HHHHHHHHHc-CCCC------
Confidence              1224679999999999999999999999999999999999999985221        1111122111 1110      


Q ss_pred             ccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          290 FDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                             +.+...+.++.+||.+||+.||++|||+.|++++
T Consensus       244 -------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  277 (350)
T 4b9d_A          244 -------PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK  277 (350)
T ss_dssp             -------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                   1122456689999999999999999999999863

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=3.5e-61  Score=428.99  Aligned_cols=248  Identities=19%  Similarity=0.279  Sum_probs=210.8

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC--ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS--TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVF  132 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  132 (339)
                      ++|++.+.||+|+||+||+|++..+++.||||++.+..  .....+.+.+|+.+|+.++|||||++++++.+++.+||||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            57999999999999999999999999999999997532  1234677889999999999999999999999999999999


Q ss_pred             EeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCce
Q 019536          133 ESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH  210 (339)
Q Consensus       133 e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~  210 (339)
                      |||++|+|.+++.  +.+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+|+.+......
T Consensus       112 Ey~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~  188 (311)
T 4aw0_A          112 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ  188 (311)
T ss_dssp             CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred             ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence            9999999999986  68999999999999999999999   899999999999999999999999999999987654443


Q ss_pred             eeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcc
Q 019536          211 VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIF  290 (339)
Q Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (339)
                      ......+||+.|||||++.+..|+.++||||+||++|+|++|+.||...  .   .....   .... ..          
T Consensus       189 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~--~---~~~~~---~~i~-~~----------  249 (311)
T 4aw0_A          189 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG--N---EGLIF---AKII-KL----------  249 (311)
T ss_dssp             CCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS--S---HHHHH---HHHH-HT----------
T ss_pred             ccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC--C---HHHHH---HHHH-cC----------
Confidence            3344578999999999999999999999999999999999999998521  1   11111   1111 11          


Q ss_pred             cCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 019536          291 DEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVA  328 (339)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il  328 (339)
                        ...+|  ...++++++|+.+||+.||++|||+.|++
T Consensus       250 --~~~~p--~~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          250 --EYDFP--EKFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             --CCCCC--TTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             --CCCCC--cccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence              11122  23556799999999999999999999864

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=5.4e-60  Score=426.15  Aligned_cols=255  Identities=17%  Similarity=0.192  Sum_probs=209.3

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFE  133 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  133 (339)
                      .+.|++.++||+|+||+||+|++..+|+.||||+++....      ..+|+.+++.++|||||++++++.+++.+|||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmE  130 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFME  130 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            4568888999999999999999999999999999976532      2379999999999999999999999999999999


Q ss_pred             eccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCC-ceEEecCCCccccCCCCce
Q 019536          134 SVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENY-SAKLHDFSLSVSIPEGETH  210 (339)
Q Consensus       134 ~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~-~~kl~dfg~a~~~~~~~~~  210 (339)
                      ||+||+|.+++.  +.+++..+..++.||+.||.|||   +++|+||||||+|||++.+| .+||+|||+|+.+......
T Consensus       131 y~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~  207 (336)
T 4g3f_A          131 LLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG  207 (336)
T ss_dssp             CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred             ccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence            999999999986  67999999999999999999999   99999999999999999887 5999999999887553321


Q ss_pred             ---eeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCccccccc
Q 019536          211 ---VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVD  287 (339)
Q Consensus       211 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (339)
                         ......+||+.|||||++.+..|+.++||||+||++|||++|+.||......  .....   ...  ....+.    
T Consensus       208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~~~~---i~~--~~~~~~----  276 (336)
T 4g3f_A          208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG--PLCLK---IAS--EPPPIR----  276 (336)
T ss_dssp             ------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCS--CCHHH---HHH--SCCGGG----
T ss_pred             cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH--HHHHH---HHc--CCCCch----
Confidence               1223467999999999999999999999999999999999999998532221  11111   111  000000    


Q ss_pred             CcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          288 PIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                               ..+..+++.+.+|+.+||+.||++|||+.|++++|.....+
T Consensus       277 ---------~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~  317 (336)
T 4g3f_A          277 ---------EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE  317 (336)
T ss_dssp             ---------GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---------hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence                     01124566899999999999999999999999999887754

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=5.9e-59  Score=430.55  Aligned_cols=250  Identities=18%  Similarity=0.276  Sum_probs=211.2

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFES  134 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  134 (339)
                      +.|++.+.||+|+||.||+|.+..+|+.||||++..... ...+.+.+|+.+|+.++|||||++++++.+++.+||||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy  229 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  229 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC-SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch-hHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence            569999999999999999999999999999999976543 4456688999999999999999999999999999999999


Q ss_pred             ccCCccccccc-cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceeee
Q 019536          135 VKYGTLRGFSF-ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVRE  213 (339)
Q Consensus       135 ~~~g~L~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~  213 (339)
                      |+||+|.+++. ..+++..+..++.||+.||.|||   +++|+||||||+|||++.+|.+||+|||+|+.+......  .
T Consensus       230 ~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~--~  304 (423)
T 4fie_A          230 LEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--R  304 (423)
T ss_dssp             CTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC--B
T ss_pred             CCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCcc--c
Confidence            99999999886 67999999999999999999999   899999999999999999999999999999887554332  2


Q ss_pred             cccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCC
Q 019536          214 EFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDED  293 (339)
Q Consensus       214 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (339)
                      ...+||+.|||||++.+..|+.++|||||||++|||++|+.||...  .   ......   .... ...           
T Consensus       305 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~--~---~~~~~~---~i~~-~~~-----------  364 (423)
T 4fie_A          305 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE--P---PLKAMK---MIRD-NLP-----------  364 (423)
T ss_dssp             CCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS--C---HHHHHH---HHHH-SCC-----------
T ss_pred             cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc--C---HHHHHH---HHHc-CCC-----------
Confidence            2468999999999999999999999999999999999999998521  1   111111   1111 110           


Q ss_pred             CCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          294 NSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       294 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      ...+.+...+.++.+||.+||+.||++|||+.|++++
T Consensus       365 ~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H  401 (423)
T 4fie_A          365 PRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  401 (423)
T ss_dssp             CCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            0111223456789999999999999999999999873

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=3.4e-59  Score=413.92  Aligned_cols=245  Identities=18%  Similarity=0.274  Sum_probs=198.8

Q ss_pred             ccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeeee----CCccEEEE
Q 019536           58 DLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS-TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLE----TELPTLVF  132 (339)
Q Consensus        58 ~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~----~~~~~lv~  132 (339)
                      .+.+.||+|+||+||+|.+..+++.||+|++.... .....+.|.+|+.++++++|||||+++++|.+    .+.+||||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            66778999999999999999999999999997643 33456779999999999999999999999875    34579999


Q ss_pred             EeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCC--eEEccCCCCCEEeCC-CCceEEecCCCccccCCC
Q 019536          133 ESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRP--IVFRCIKASNVLLDE-NYSAKLHDFSLSVSIPEG  207 (339)
Q Consensus       133 e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~dlk~~Nil~~~-~~~~kl~dfg~a~~~~~~  207 (339)
                      |||++|+|.+++.  ..+++..+..++.||+.||.|||   +++  |+||||||+|||++. ++.+||+|||+|+.....
T Consensus       109 Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~  185 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS  185 (290)
T ss_dssp             ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred             eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC
Confidence            9999999999986  57899999999999999999999   777  999999999999974 789999999999865433


Q ss_pred             CceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCccccccc
Q 019536          208 ETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVD  287 (339)
Q Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (339)
                      ..    ...+||+.|||||++.+ .|+.++|||||||++|||++|+.||.....       ... .......+..     
T Consensus       186 ~~----~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~-------~~~-~~~~i~~~~~-----  247 (290)
T 3fpq_A          186 FA----KAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-------AAQ-IYRRVTSGVK-----  247 (290)
T ss_dssp             SB----EESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-------HHH-HHHHHTTTCC-----
T ss_pred             cc----CCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc-------HHH-HHHHHHcCCC-----
Confidence            22    24679999999999865 699999999999999999999999852211       111 1111111110     


Q ss_pred             CcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          288 PIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                             +...+...++++.+|+.+||+.||++|||+.|++++
T Consensus       248 -------~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H  283 (290)
T 3fpq_A          248 -------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             -------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             -------CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                   000111234578999999999999999999999863

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=3.8e-59  Score=410.29  Aligned_cols=247  Identities=20%  Similarity=0.266  Sum_probs=193.2

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC--hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST--LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLV  131 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  131 (339)
                      .++|++.+.||+|+||+||+|.+..+|+.||||++.....  ......+.+|+.+++.++|||||++++++.+.+..|+|
T Consensus        12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (275)
T 3hyh_A           12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV   91 (275)
T ss_dssp             --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            4789999999999999999999999999999999976532  23456788999999999999999999999999999999


Q ss_pred             EEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCc
Q 019536          132 FESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGET  209 (339)
Q Consensus       132 ~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~  209 (339)
                      |||| +|+|.+++.  ..+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+.......
T Consensus        92 mEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~  167 (275)
T 3hyh_A           92 IEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF  167 (275)
T ss_dssp             EECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred             EeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCc
Confidence            9999 678888875  67999999999999999999999   89999999999999999999999999999987654332


Q ss_pred             eeeecccccccccccccccccCCC-CcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccC
Q 019536          210 HVREEFIKGAYGFIAPEYFATSSF-NEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDP  288 (339)
Q Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (339)
                      .   ...+||+.|+|||++.+..| +.++||||+||++|+|++|+.||....     .....    .......       
T Consensus       168 ~---~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~-----~~~~~----~~i~~~~-------  228 (275)
T 3hyh_A          168 L---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES-----IPVLF----KNISNGV-------  228 (275)
T ss_dssp             ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHH----HHHHHTC-------
T ss_pred             c---CCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC-----HHHHH----HHHHcCC-------
Confidence            2   24679999999999998886 579999999999999999999985211     11111    1111111       


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          289 IFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                           ..+|  ...++++.+|+.+||+.||++|||+.|++++
T Consensus       229 -----~~~p--~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  263 (275)
T 3hyh_A          229 -----YTLP--KFLSPGAAGLIKRMLIVNPLNRISIHEIMQD  263 (275)
T ss_dssp             -----CCCC--TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred             -----CCCC--CCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence                 1111  2355679999999999999999999999873

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.4e-57  Score=408.26  Aligned_cols=267  Identities=20%  Similarity=0.285  Sum_probs=202.7

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHH--HHHHHHHhcCCCceeeeeeeeeeCC----cc
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCF--NNIVFSSQMKHKNILKLIGCCLETE----LP  128 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~--~e~~~l~~l~H~niv~~~~~~~~~~----~~  128 (339)
                      ++|.+.+.||+|+||+||+|++  +|+.||||+++...    ...+.  .|+..+.+++|||||+++|+|.+++    .+
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~----~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~   76 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL   76 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence            4688889999999999999998  68999999997532    23333  4566667889999999999998754    46


Q ss_pred             EEEEEeccCCccccccc-cCCChHHHHHHHHHHHHHHHHHhcCCCC--------CeEEccCCCCCEEeCCCCceEEecCC
Q 019536          129 TLVFESVKYGTLRGFSF-ASLLIAPRIKIAMEIANAVAYLHVGFDR--------PIVFRCIKASNVLLDENYSAKLHDFS  199 (339)
Q Consensus       129 ~lv~e~~~~g~L~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~--------~i~H~dlk~~Nil~~~~~~~kl~dfg  199 (339)
                      +||||||++|+|.+++. ..+++..+..++.|++.||.|||   +.        +|+||||||+|||++.++.+||+|||
T Consensus        77 ~lV~Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH---~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFG  153 (303)
T 3hmm_A           77 WLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLH---MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  153 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHH---CCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             EEEecCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH---HhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCC
Confidence            89999999999999987 67899999999999999999999   55        89999999999999999999999999


Q ss_pred             CccccCCCCcee--eecccccccccccccccccC------CCCcccchHHHHHHHHHHHhCCCccccCCCCCCCch----
Q 019536          200 LSVSIPEGETHV--REEFIKGAYGFIAPEYFATS------SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDL----  267 (339)
Q Consensus       200 ~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~----  267 (339)
                      +|+.........  .....+||+.|||||++.+.      .|+.++|||||||++|||++|++||...........    
T Consensus       154 la~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~  233 (303)
T 3hmm_A          154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP  233 (303)
T ss_dssp             TCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred             CCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccc
Confidence            998775543321  22245799999999999764      367899999999999999999988754332221110    


Q ss_pred             --hHHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          268 --TVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       268 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                        ..............    .++.++..   ......+..+.+|+.+||+.||++||||.+|++.|++|.++
T Consensus       234 ~~~~~~~~~~~~~~~~----~rp~~p~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~  298 (303)
T 3hmm_A          234 SDPSVEEMRKVVCEQK----LRPNIPNR---WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             SSCCHHHHHHHHTTSC----CCCCCCGG---GGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             ccchHHHHHHHHhccc----CCCCCCcc---ccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence              01111111111111    11111110   01125667899999999999999999999999999998754

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=7.3e-59  Score=413.86  Aligned_cols=247  Identities=21%  Similarity=0.229  Sum_probs=197.2

Q ss_pred             cCcccCCceeccCCeeEEEEEEc---CCCeeEEEEEeccCCC-hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLV---DQDRPISVMKFHDNST-LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTL  130 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~---~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  130 (339)
                      ++|++.+.||+|+||+||+|+..   .+++.||+|+++.... ......+.+|+.++++++|||||++++++.+++..|+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            57999999999999999999884   4678999999876421 1234467799999999999999999999999999999


Q ss_pred             EEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCC
Q 019536          131 VFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE  208 (339)
Q Consensus       131 v~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~  208 (339)
                      |||||+||+|.+++.  ..+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+|+......
T Consensus       104 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  180 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE  180 (304)
T ss_dssp             EECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred             EEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence            999999999999986  57899999999999999999999   8999999999999999999999999999998764433


Q ss_pred             ceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccC
Q 019536          209 THVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDP  288 (339)
Q Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (339)
                      ..  ....+||+.|||||++.+..|+.++||||+||++|||++|+.||....        ..+....... .        
T Consensus       181 ~~--~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~--------~~~~~~~i~~-~--------  241 (304)
T 3ubd_A          181 KK--AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD--------RKETMTMILK-A--------  241 (304)
T ss_dssp             CC--CCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHH-C--------
T ss_pred             cc--ccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC--------HHHHHHHHHc-C--------
Confidence            22  224679999999999999999999999999999999999999985221        1111111111 1        


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCH-----HHHHH
Q 019536          289 IFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLM-----VDVAK  329 (339)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~-----~~il~  329 (339)
                          ...+|  ...++++.+|+.+||+.||++|||+     +|+++
T Consensus       242 ----~~~~p--~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          242 ----KLGMP--QFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             ----CCCCC--TTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             ----CCCCC--CcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence                11112  2456689999999999999999995     56664

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=7.4e-57  Score=401.96  Aligned_cols=249  Identities=19%  Similarity=0.283  Sum_probs=191.9

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC-------
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETE-------  126 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~-------  126 (339)
                      .++|++.+.||+|+||+||+|++..+|+.||||++.........+.+.+|+.+|++++|||||++++++.+.+       
T Consensus         4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~   83 (299)
T 4g31_A            4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP   83 (299)
T ss_dssp             HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred             chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence            3569999999999999999999999999999999987665556678999999999999999999999997654       


Q ss_pred             -----ccEEEEEeccCCccccccccC-----CChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEe
Q 019536          127 -----LPTLVFESVKYGTLRGFSFAS-----LLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLH  196 (339)
Q Consensus       127 -----~~~lv~e~~~~g~L~~~~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~  196 (339)
                           .+|+|||||++|+|.+++...     .++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+
T Consensus        84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl~  160 (299)
T 4g31_A           84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVG  160 (299)
T ss_dssp             ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred             cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEEc
Confidence                 368999999999999998632     344557889999999999999   8999999999999999999999999


Q ss_pred             cCCCccccCCCCcee----------eecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCc
Q 019536          197 DFSLSVSIPEGETHV----------REEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDD  266 (339)
Q Consensus       197 dfg~a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~  266 (339)
                      |||+|+.+.......          .....+||+.|||||++.+..|+.++|||||||++|||++   ||..       .
T Consensus       161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~-------~  230 (299)
T 4g31_A          161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST-------Q  230 (299)
T ss_dssp             CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS-------H
T ss_pred             cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC-------c
Confidence            999998875432211          1223579999999999999999999999999999999996   6531       1


Q ss_pred             hhHHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          267 LTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                      ......... .....+             .|.....++.+.+|+.+||+.||++|||+.|+++
T Consensus       231 ~~~~~~~~~-~~~~~~-------------p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          231 MERVRTLTD-VRNLKF-------------PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             HHHHHHHHH-HHTTCC-------------CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             cHHHHHHHH-HhcCCC-------------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            111111111 111110             0112344556789999999999999999999987

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=3.8e-55  Score=400.92  Aligned_cols=271  Identities=17%  Similarity=0.199  Sum_probs=202.7

Q ss_pred             HHhcCcccCCceeccCCeeEEEEEEc---CCCeeEEEEEeccCCChhhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCc
Q 019536           52 KATNNYDLHKVIQSDTSYRLFEGTLV---DQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLETEL  127 (339)
Q Consensus        52 ~~~~~~~~~~~ig~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~  127 (339)
                      ...++|++.+.||+|+||+||+|++.   .+++.||+|++....   ....+.+|+.+|+.+ +||||+++++++.+.+.
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~---~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~   94 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS---HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH   94 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS---CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc---CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence            45578999999999999999999875   467899999987653   345678999999998 69999999999999999


Q ss_pred             cEEEEEeccCCccccccccCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCC-CceEEecCCCccccCC
Q 019536          128 PTLVFESVKYGTLRGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDEN-YSAKLHDFSLSVSIPE  206 (339)
Q Consensus       128 ~~lv~e~~~~g~L~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~-~~~kl~dfg~a~~~~~  206 (339)
                      .|+|||||++|+|.+++ ..+++.++..++.|++.||.|||   +++|+||||||+|||++.+ +.+||+|||+|+....
T Consensus        95 ~~lvmE~~~g~~L~~~~-~~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~  170 (361)
T 4f9c_A           95 VVIAMPYLEHESFLDIL-NSLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD  170 (361)
T ss_dssp             EEEEEECCCCCCHHHHH-TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred             EEEEEeCCCcccHHHHH-cCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence            99999999999999988 46899999999999999999999   9999999999999999876 7999999999986543


Q ss_pred             CCce--------------------------eeecccccccccccccccccC-CCCcccchHHHHHHHHHHHhCCCccccC
Q 019536          207 GETH--------------------------VREEFIKGAYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTGCNVLEFK  259 (339)
Q Consensus       207 ~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~  259 (339)
                      ....                          ......+||+.|+|||++.+. .|+.++||||+||++|||++|+.||. .
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~-~  249 (361)
T 4f9c_A          171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY-K  249 (361)
T ss_dssp             CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS-C
T ss_pred             ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC-C
Confidence            2110                          011234799999999999876 58999999999999999999999984 3


Q ss_pred             CCCCCCchhHHHHHHHHhhcCc---------------------------------ccccccCcccCCCCCCCcHHHHHHH
Q 019536          260 GNGNDDDLTVLEYAKKSIENNR---------------------------------FGAIVDPIFDEDNSFPGKEEKLQSL  306 (339)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~---------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~  306 (339)
                      +.++.+.+..+...........                                 ...............+.....++++
T Consensus       250 ~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a  329 (361)
T 4f9c_A          250 ASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEA  329 (361)
T ss_dssp             CSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHH
T ss_pred             CCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHH
Confidence            3322222221111110000000                                 0000000000000001112345678


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHHH
Q 019536          307 GQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       307 ~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      .+|+.+||++||++|||+.|++++
T Consensus       330 ~DLl~~lL~~dP~~R~ta~eaL~H  353 (361)
T 4f9c_A          330 YDLLDKLLDLNPASRITAEEALLH  353 (361)
T ss_dssp             HHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             HHHHHHHCcCChhHCcCHHHHhcC
Confidence            999999999999999999999863

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.3e-55  Score=402.91  Aligned_cols=269  Identities=14%  Similarity=0.199  Sum_probs=203.0

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeeee------CCc
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS-TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLE------TEL  127 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~------~~~  127 (339)
                      ++|++.+.||+|+||+||+|.+..+|+.||||++.... .....+.+.+|+.+|+.++|||||++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            57999999999999999999999999999999997653 33456778899999999999999999998764      356


Q ss_pred             cEEEEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccC
Q 019536          128 PTLVFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIP  205 (339)
Q Consensus       128 ~~lv~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~  205 (339)
                      .|||||||+ |+|.+++.  ..+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+|+.+.
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~  209 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLC  209 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred             EEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecceeeecc
Confidence            899999996 67888876  57999999999999999999999   8999999999999999999999999999998764


Q ss_pred             CCCc--eeeecccccccccccccccccC-CCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcc
Q 019536          206 EGET--HVREEFIKGAYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRF  282 (339)
Q Consensus       206 ~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (339)
                      ....  .......+||+.|+|||++.+. .|+.++||||+||++|||++|++||..  ....+.+..+............
T Consensus       210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g--~~~~~~l~~I~~~~g~p~~~~~  287 (398)
T 4b99_A          210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPG--KNYVHQLQLIMMVLGTPSPAVI  287 (398)
T ss_dssp             ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCC--SSHHHHHHHHHHHHCCCCGGGT
T ss_pred             cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCC--CCHHHHHHHHHHhcCCCChHHh
Confidence            4321  1122246899999999998875 568999999999999999999999753  2221111111111111111000


Q ss_pred             ccccc-------CcccCCCCCCCc---HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          283 GAIVD-------PIFDEDNSFPGK---EEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       283 ~~~~~-------~~~~~~~~~~~~---~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                      ..+..       ..+....+.+..   ...+.++.+||.+||++||++|||+.|+++
T Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          288 QAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             C-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             hhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            00000       000011111100   123567899999999999999999999986

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=5.8e-53  Score=408.35  Aligned_cols=251  Identities=15%  Similarity=0.177  Sum_probs=210.1

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFE  133 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  133 (339)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|++..... ...+.+.+|+.+|+.++|||||++++++.+.+.++||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~-~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E  234 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE-SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE  234 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccch-hhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            4689999999999999999999999999999999976543 456778899999999999999999999999999999999


Q ss_pred             eccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCC--CceEEecCCCccccCCCC
Q 019536          134 SVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDEN--YSAKLHDFSLSVSIPEGE  208 (339)
Q Consensus       134 ~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~--~~~kl~dfg~a~~~~~~~  208 (339)
                      ||+||+|.+++.   ..+++..+..++.||+.||.|||   +++|+||||||+|||++.+  +.+||+|||+|+.+....
T Consensus       235 ~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~  311 (573)
T 3uto_A          235 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ  311 (573)
T ss_dssp             CCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred             ecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence            999999999875   46889999999999999999999   8999999999999999854  889999999999886654


Q ss_pred             ceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccC
Q 019536          209 THVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDP  288 (339)
Q Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (339)
                      ...   ..+||+.|||||++.+..|+.++||||+||++|+|++|++||....        ..+...... ...+      
T Consensus       312 ~~~---~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~--------~~~~~~~i~-~~~~------  373 (573)
T 3uto_A          312 SVK---VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN--------DDETLRNVK-SCDW------  373 (573)
T ss_dssp             EEE---EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS--------HHHHHHHHH-TTCC------
T ss_pred             cee---eeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--------HHHHHHHHH-hCCC------
Confidence            332   3579999999999999999999999999999999999999985221        111111111 1110      


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          289 IFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                          ....+.....+.++.+||.+||+.||.+|||+.|++++
T Consensus       374 ----~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H  411 (573)
T 3uto_A          374 ----NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  411 (573)
T ss_dssp             ----CCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ----CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                00111122456789999999999999999999999873

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.8e-52  Score=404.13  Aligned_cols=248  Identities=17%  Similarity=0.254  Sum_probs=202.3

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC--hhhHHHHH---HHHHHHHhcCCCceeeeeeeeeeCCccE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST--LDDVEYCF---NNIVFSSQMKHKNILKLIGCCLETELPT  129 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~---~e~~~l~~l~H~niv~~~~~~~~~~~~~  129 (339)
                      ++|++.++||+|+||+||+|+...+|+.||||++.+...  ......+.   .++.+++.++|||||++++++.+.+.+|
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            689999999999999999999999999999999975311  12223333   3466777789999999999999999999


Q ss_pred             EEEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCC
Q 019536          130 LVFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEG  207 (339)
Q Consensus       130 lv~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~  207 (339)
                      +|||||+||+|.+++.  ..+++..+..++.||+.||.|||   +++|+||||||+|||++.+|.+||+|||+|+.+...
T Consensus       269 lVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~  345 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK  345 (689)
T ss_dssp             EEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeeecCCC
Confidence            9999999999999986  67999999999999999999999   999999999999999999999999999999887554


Q ss_pred             Cceeeeccccccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccc
Q 019536          208 ETHVREEFIKGAYGFIAPEYFAT-SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIV  286 (339)
Q Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (339)
                      ..    ...+||+.|||||++.+ ..|+.++||||+||++|||++|++||......+  .....   .....        
T Consensus       346 ~~----~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~--~~~i~---~~i~~--------  408 (689)
T 3v5w_A          346 KP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--KHEID---RMTLT--------  408 (689)
T ss_dssp             CC----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC--HHHHH---HHHHH--------
T ss_pred             CC----CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHH---HhhcC--------
Confidence            32    24689999999999964 579999999999999999999999985332221  11111   11111        


Q ss_pred             cCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 019536          287 DPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPL-----MVDVAK  329 (339)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps-----~~~il~  329 (339)
                           ....+|  ...+.++.+||.+||+.||.+|++     +.||++
T Consensus       409 -----~~~~~p--~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          409 -----MAVELP--DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             -----CCCCCC--TTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             -----CCCCCC--ccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence                 111112  245678999999999999999998     677764

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=7.1e-51  Score=368.12  Aligned_cols=282  Identities=30%  Similarity=0.477  Sum_probs=232.2

Q ss_pred             cccHHHHHHHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeee
Q 019536           44 AFSAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCL  123 (339)
Q Consensus        44 ~~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~  123 (339)
                      .+...++...+++|++.+.||+|+||+||+|.+. +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.
T Consensus        28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  105 (321)
T 2qkw_B           28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESS-QGIEEFETEIETLSFCRHPHLVSLIGFCD  105 (321)
T ss_dssp             --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCS-SHHHHHHHHHHGGGSCCCTTBCCEEEECC
T ss_pred             eecHHHHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccCh-HHHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence            3444566678899999999999999999999975 789999999876644 55778899999999999999999999999


Q ss_pred             eCCccEEEEEeccCCcccccccc------CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEec
Q 019536          124 ETELPTLVFESVKYGTLRGFSFA------SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHD  197 (339)
Q Consensus       124 ~~~~~~lv~e~~~~g~L~~~~~~------~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~d  197 (339)
                      +++..++||||+++|+|.+++..      .+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+||+|
T Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~D  182 (321)
T 2qkw_B          106 ERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITD  182 (321)
T ss_dssp             CTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECC
T ss_pred             CCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEee
Confidence            99999999999999999999862      4788999999999999999999   89999999999999999999999999


Q ss_pred             CCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHh
Q 019536          198 FSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSI  277 (339)
Q Consensus       198 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  277 (339)
                      ||+++...............||+.|+|||++.+..++.++||||||+++|+|++|+.||.....  ........+.....
T Consensus       183 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~--~~~~~~~~~~~~~~  260 (321)
T 2qkw_B          183 FGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP--REMVNLAEWAVESH  260 (321)
T ss_dssp             CTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSS--SSCCCHHHHTHHHH
T ss_pred             cccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCc--HHHHHHHHHhhhcc
Confidence            9999875443322222245689999999999989999999999999999999999999764332  33444555544444


Q ss_pred             hcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 019536          278 ENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYL  336 (339)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~  336 (339)
                      ....+..+.++....    ..+...+..+.+++.+||+.||++|||+.++++.|+.+.+
T Consensus       261 ~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~  315 (321)
T 2qkw_B          261 NNGQLEQIVDPNLAD----KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR  315 (321)
T ss_dssp             TTTCCCSSSSSSCTT----CSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ccccHHHhcChhhcc----ccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence            444444444433222    2335778899999999999999999999999999998864

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=4.4e-51  Score=370.11  Aligned_cols=285  Identities=29%  Similarity=0.495  Sum_probs=233.9

Q ss_pred             CcccccHHHHHHHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeee
Q 019536           41 PIRAFSAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIG  120 (339)
Q Consensus        41 ~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~  120 (339)
                      ....++..++....++|++.+.||+|+||+||+|... +++.||+|++...........+.+|+.+++.++||||+++++
T Consensus        16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~   94 (326)
T 3uim_A           16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG   94 (326)
T ss_dssp             CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred             ccceecHHHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence            4567899999999999999999999999999999865 689999999987644334446889999999999999999999


Q ss_pred             eeeeCCccEEEEEeccCCcccccccc------CCChHHHHHHHHHHHHHHHHHhcCCCC---CeEEccCCCCCEEeCCCC
Q 019536          121 CCLETELPTLVFESVKYGTLRGFSFA------SLLIAPRIKIAMEIANAVAYLHVGFDR---PIVFRCIKASNVLLDENY  191 (339)
Q Consensus       121 ~~~~~~~~~lv~e~~~~g~L~~~~~~------~~~~~~~~~i~~~i~~~l~~LH~~~~~---~i~H~dlk~~Nil~~~~~  191 (339)
                      ++.+++..++||||+++|+|.+++..      .+++..+..++.|++.||.|||   +.   +|+||||||+||+++.++
T Consensus        95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~ivH~Dlkp~Nil~~~~~  171 (326)
T 3uim_A           95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLH---DHCDPKIIHRDVKAANILLDEEF  171 (326)
T ss_dssp             EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHH---HSSSSCEECCCCSGGGEEECTTC
T ss_pred             EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCeEeCCCchhhEEECCCC
Confidence            99999999999999999999998762      3888999999999999999999   67   999999999999999999


Q ss_pred             ceEEecCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHH
Q 019536          192 SAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLE  271 (339)
Q Consensus       192 ~~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~  271 (339)
                      .+||+|||+++.......... ....||+.|+|||++.+..++.++||||||+++|+|++|+.||...............
T Consensus       172 ~~kl~Dfg~~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~  250 (326)
T 3uim_A          172 EAVVGDFGLAKLMDYKDTHVT-TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD  250 (326)
T ss_dssp             CEEECCCSSCEECCSSSSCEE-CCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHH
T ss_pred             CEEeccCccccccCccccccc-ccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHH
Confidence            999999999987754443322 2456899999999999889999999999999999999999999644333333444555


Q ss_pred             HHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 019536          272 YAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQM  334 (339)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l  334 (339)
                      +............+.+....    ...+...+..+.+++.+||+.||++|||+.+|+++|+..
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          251 WVKGLLKEKKLEALVDVDLQ----GNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             HHTTTTSSCCSTTSSCTTCT----TSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             HHHHHhhchhhhhhcChhhc----cccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence            54444444444444333322    223357788999999999999999999999999999853

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.7e-49  Score=357.24  Aligned_cols=260  Identities=22%  Similarity=0.290  Sum_probs=213.5

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFE  133 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  133 (339)
                      .++|.+.+.||+|+||+||+|.+..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   87 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD-EETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITE   87 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEE
Confidence            367999999999999999999999999999999986543 3567788999999999999999999999999999999999


Q ss_pred             eccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCce
Q 019536          134 SVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH  210 (339)
Q Consensus       134 ~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~  210 (339)
                      |+++|+|.+++.   ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++........
T Consensus        88 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  164 (310)
T 3s95_A           88 YIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ  164 (310)
T ss_dssp             CCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred             ecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence            999999999985   56899999999999999999999   899999999999999999999999999999876443321


Q ss_pred             ee------------ecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhh
Q 019536          211 VR------------EEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIE  278 (339)
Q Consensus       211 ~~------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  278 (339)
                      ..            .....||+.|+|||++.+..++.++||||||+++|+|++|..|+..................... 
T Consensus       165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~-  243 (310)
T 3s95_A          165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRY-  243 (310)
T ss_dssp             ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHT-
T ss_pred             ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccccc-
Confidence            10            11356899999999999999999999999999999999999997643332221111111100000 


Q ss_pred             cCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          279 NNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                                 .        +..++..+.+|+.+||+.||++|||+.++++.|+.+...
T Consensus       244 -----------~--------~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~  283 (310)
T 3s95_A          244 -----------C--------PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH  283 (310)
T ss_dssp             -----------C--------CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -----------C--------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence                       0        012334588999999999999999999999999998764

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=5.5e-50  Score=369.32  Aligned_cols=259  Identities=20%  Similarity=0.328  Sum_probs=213.9

Q ss_pred             hcCcccCCceeccCCeeEEEEEEc-------CCCeeEEEEEeccCCChhhHHHHHHHHHHHHhc-CCCceeeeeeeeeeC
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLV-------DQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLET  125 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~  125 (339)
                      .++|++.+.||+|+||+||+|.+.       .++..||+|++.........+.+.+|+.+++.+ +||||++++++|.+.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            478999999999999999999975       245689999998776656678899999999999 899999999999999


Q ss_pred             CccEEEEEeccCCcccccccc------------------CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEe
Q 019536          126 ELPTLVFESVKYGTLRGFSFA------------------SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLL  187 (339)
Q Consensus       126 ~~~~lv~e~~~~g~L~~~~~~------------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~  187 (339)
                      +..++||||+++|+|.+++..                  .+++..++.++.||+.||.|||   +.+|+||||||+|||+
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEEE
Confidence            999999999999999998752                  3678889999999999999999   8999999999999999


Q ss_pred             CCCCceEEecCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCc
Q 019536          188 DENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDD  266 (339)
Q Consensus       188 ~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~  266 (339)
                      +.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||.....     
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~-----  311 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-----  311 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG-----
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH-----
Confidence            9999999999999987655433222223457788999999999999999999999999999999 9999753211     


Q ss_pred             hhHHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          267 LTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                      ......    .....             ..+.+..++..+.+|+.+||+.||++|||+.++++.|+++...
T Consensus       312 ~~~~~~----~~~~~-------------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~  365 (370)
T 2psq_A          312 EELFKL----LKEGH-------------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL  365 (370)
T ss_dssp             GGHHHH----HHTTC-------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHH----HhcCC-------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            111111    11110             0111224556799999999999999999999999999998753

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=2.8e-49  Score=354.00  Aligned_cols=250  Identities=19%  Similarity=0.277  Sum_probs=209.9

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFE  133 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  133 (339)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   97 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc-cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence            4789999999999999999999998999999999876543 345678899999999999999999999999999999999


Q ss_pred             eccCCccccccc-cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceee
Q 019536          134 SVKYGTLRGFSF-ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVR  212 (339)
Q Consensus       134 ~~~~g~L~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~  212 (339)
                      |+++|+|.+++. ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||++.......... 
T Consensus        98 ~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-  173 (297)
T 3fxz_A           98 YLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-  173 (297)
T ss_dssp             CCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCB-
T ss_pred             CCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccccc-
Confidence            999999999986 56889999999999999999999   8999999999999999999999999999998765543322 


Q ss_pred             ecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccC
Q 019536          213 EEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDE  292 (339)
Q Consensus       213 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (339)
                       ....||+.|+|||++.+..++.++||||+||++|+|++|+.||....        .............           
T Consensus       174 -~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--------~~~~~~~~~~~~~-----------  233 (297)
T 3fxz_A          174 -STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN--------PLRALYLIATNGT-----------  233 (297)
T ss_dssp             -CCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHHCS-----------
T ss_pred             -CCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCC-----------
Confidence             24579999999999999999999999999999999999999985221        1111111111111           


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          293 DNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       293 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                       ...+.+...+..+.+|+.+||+.||++|||+.++++
T Consensus       234 -~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          234 -PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             -CCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -CCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence             111223355667999999999999999999999986

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=5.3e-50  Score=370.42  Aligned_cols=264  Identities=21%  Similarity=0.300  Sum_probs=216.9

Q ss_pred             HHHHHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCcc
Q 019536           49 DLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELP  128 (339)
Q Consensus        49 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~  128 (339)
                      .+....++|.+.+.||+|+||.||+|.+..+++.||||.+.........+.+.+|+.+++.++||||+++++++.+++..
T Consensus       108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  187 (377)
T 3cbl_A          108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPI  187 (377)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             ccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCc
Confidence            34445578999999999999999999999899999999998765545556788999999999999999999999999999


Q ss_pred             EEEEEeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccC
Q 019536          129 TLVFESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIP  205 (339)
Q Consensus       129 ~lv~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~  205 (339)
                      ++||||+++|+|.+++.   ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus       188 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~  264 (377)
T 3cbl_A          188 YIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEA  264 (377)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence            99999999999999986   35899999999999999999999   8999999999999999999999999999998754


Q ss_pred             CCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCcccc
Q 019536          206 EGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA  284 (339)
Q Consensus       206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (339)
                      ............++..|+|||++.+..++.++|||||||++|||++ |..||.....        .+.........    
T Consensus       265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~--------~~~~~~~~~~~----  332 (377)
T 3cbl_A          265 DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN--------QQTREFVEKGG----  332 (377)
T ss_dssp             TSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH--------HHHHHHHHTTC----
T ss_pred             CCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCC----
Confidence            4322211112335778999999998899999999999999999998 9999753211        11111111111    


Q ss_pred             cccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                                ..+.+..++..+.+||.+||+.||++|||+.+|++.|+++...
T Consensus       333 ----------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~  375 (377)
T 3cbl_A          333 ----------RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR  375 (377)
T ss_dssp             ----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----------CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence                      1122234556799999999999999999999999999998753

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=2.2e-49  Score=358.64  Aligned_cols=271  Identities=22%  Similarity=0.251  Sum_probs=210.9

Q ss_pred             HhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCc----c
Q 019536           53 ATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETEL----P  128 (339)
Q Consensus        53 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~----~  128 (339)
                      ..++|++.+.||+|+||+||+|.+  .++.||||++....  .....+.+|+.+++.++||||+++++++.+...    .
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   97 (322)
T 3soc_A           22 QSMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQD--KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDL   97 (322)
T ss_dssp             TTEEEEEEEEEECSTTCEEEEEEE--TTEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             chhhchhhheecccCceEEEEEEE--CCCEEEEEEeecCc--hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceE
Confidence            347899999999999999999988  58999999996542  333445678999999999999999999987553    6


Q ss_pred             EEEEEeccCCccccccc-cCCChHHHHHHHHHHHHHHHHHhcCCCC----------CeEEccCCCCCEEeCCCCceEEec
Q 019536          129 TLVFESVKYGTLRGFSF-ASLLIAPRIKIAMEIANAVAYLHVGFDR----------PIVFRCIKASNVLLDENYSAKLHD  197 (339)
Q Consensus       129 ~lv~e~~~~g~L~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~----------~i~H~dlk~~Nil~~~~~~~kl~d  197 (339)
                      ++||||+++|+|.+++. ..+++..+..++.|++.||.|||   +.          +|+||||||+|||++.++.+||+|
T Consensus        98 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~D  174 (322)
T 3soc_A           98 WLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD  174 (322)
T ss_dssp             EEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCEEECC
T ss_pred             EEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeEEEcc
Confidence            99999999999999987 57899999999999999999999   88          999999999999999999999999


Q ss_pred             CCCccccCCCCceeeecccccccccccccccccC-----CCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhH---
Q 019536          198 FSLSVSIPEGETHVREEFIKGAYGFIAPEYFATS-----SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTV---  269 (339)
Q Consensus       198 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~---  269 (339)
                      ||+++...............||+.|+|||++.+.     .++.++|||||||++|+|++|+.||.............   
T Consensus       175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  254 (322)
T 3soc_A          175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG  254 (322)
T ss_dssp             CTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHC
T ss_pred             CCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhc
Confidence            9999877654443333345789999999999863     46678999999999999999999986443322211110   


Q ss_pred             ----HHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          270 ----LEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       270 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                          ............    ..+.....   ......+..+.+|+.+||+.||++|||+.+|++.|++|.+.
T Consensus       255 ~~~~~~~~~~~~~~~~----~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~  319 (322)
T 3soc_A          255 QHPSLEDMQEVVVHKK----KRPVLRDY---WQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL  319 (322)
T ss_dssp             SSCCHHHHHHHHTTSC----CCCCCCGG---GGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cCCchhhhhhhhhccc----CCCCcccc---ccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence                000011000000    00000000   01124567799999999999999999999999999998764

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.8e-50  Score=369.50  Aligned_cols=270  Identities=19%  Similarity=0.338  Sum_probs=220.4

Q ss_pred             cccHHHHHHHhcCcccCCceeccCCeeEEEEEE-----cCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhc-CCCceee
Q 019536           44 AFSAKDLKKATNNYDLHKVIQSDTSYRLFEGTL-----VDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILK  117 (339)
Q Consensus        44 ~~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~  117 (339)
                      .+....+....++|++.+.||+|+||.||+|.+     ..+++.||||++.........+.+.+|+.+++.+ +||||++
T Consensus        11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~   90 (359)
T 3vhe_A           11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN   90 (359)
T ss_dssp             CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence            355667777789999999999999999999994     4566899999998776656677899999999999 7999999


Q ss_pred             eeeeeeeCC-ccEEEEEeccCCccccccccC-------------------------------------------------
Q 019536          118 LIGCCLETE-LPTLVFESVKYGTLRGFSFAS-------------------------------------------------  147 (339)
Q Consensus       118 ~~~~~~~~~-~~~lv~e~~~~g~L~~~~~~~-------------------------------------------------  147 (339)
                      +++++.+.+ ..++||||+++|+|.+++...                                                 
T Consensus        91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (359)
T 3vhe_A           91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE  170 (359)
T ss_dssp             EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred             eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence            999998754 489999999999999887521                                                 


Q ss_pred             -------------------CChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCC
Q 019536          148 -------------------LLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE  208 (339)
Q Consensus       148 -------------------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~  208 (339)
                                         +++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++......
T Consensus       171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~  247 (359)
T 3vhe_A          171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP  247 (359)
T ss_dssp             -------------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred             cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence                               788889999999999999999   8999999999999999999999999999998765544


Q ss_pred             ceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCccccccc
Q 019536          209 THVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVD  287 (339)
Q Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (339)
                      .........||+.|+|||++.+..++.++|||||||++|+|++ |+.||.......    ....    ......      
T Consensus       248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~----~~~~----~~~~~~------  313 (359)
T 3vhe_A          248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE----EFCR----RLKEGT------  313 (359)
T ss_dssp             TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH----HHHH----HHHHTC------
T ss_pred             cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH----HHHH----HHHcCC------
Confidence            4333335668899999999999999999999999999999998 999975322211    1111    111110      


Q ss_pred             CcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          288 PIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                             ..+.+...+..+.+++.+||+.||++|||+.+++++|+++..+
T Consensus       314 -------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  356 (359)
T 3vhe_A          314 -------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  356 (359)
T ss_dssp             -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -------CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence                   0111123456799999999999999999999999999999865

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1e-49  Score=358.85  Aligned_cols=263  Identities=21%  Similarity=0.315  Sum_probs=205.5

Q ss_pred             HHHHHHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC
Q 019536           48 KDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS-TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETE  126 (339)
Q Consensus        48 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~  126 (339)
                      .++....++|++.+.||+|+||+||+|.+  ++..||+|++.... .....+.+.+|+.++++++||||+++++++.+.+
T Consensus        30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  107 (309)
T 3p86_A           30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP  107 (309)
T ss_dssp             --CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred             ccccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence            34445568899999999999999999988  68899999987654 3345577889999999999999999999999999


Q ss_pred             ccEEEEEeccCCcccccccc-----CCChHHHHHHHHHHHHHHHHHhcCCCCC--eEEccCCCCCEEeCCCCceEEecCC
Q 019536          127 LPTLVFESVKYGTLRGFSFA-----SLLIAPRIKIAMEIANAVAYLHVGFDRP--IVFRCIKASNVLLDENYSAKLHDFS  199 (339)
Q Consensus       127 ~~~lv~e~~~~g~L~~~~~~-----~~~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~dlk~~Nil~~~~~~~kl~dfg  199 (339)
                      ..++||||+++|+|.+++..     .+++..++.++.|++.||.|||   +.+  |+||||||+||+++.++.+||+|||
T Consensus       108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg  184 (309)
T 3p86_A          108 NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCDFG  184 (309)
T ss_dssp             CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECCCC
T ss_pred             ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECCCC
Confidence            99999999999999999863     3888999999999999999999   888  9999999999999999999999999


Q ss_pred             CccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhc
Q 019536          200 LSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIEN  279 (339)
Q Consensus       200 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  279 (339)
                      +++........  .....||+.|+|||++.+..++.++|||||||++|+|++|+.||....        ..+........
T Consensus       185 ~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~--------~~~~~~~~~~~  254 (309)
T 3p86_A          185 LSRLKASTFLS--SKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLN--------PAQVVAAVGFK  254 (309)
T ss_dssp             -------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSC--------HHHHHHHHHHS
T ss_pred             CCccccccccc--cccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhc
Confidence            99765433221  224568999999999999999999999999999999999999985221        11111111100


Q ss_pred             CcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhc
Q 019536          280 NRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLSV  338 (339)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~~  338 (339)
                      ..             ..+.+...+..+.+|+.+||+.||++|||+.++++.|+.+..+.
T Consensus       255 ~~-------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~  300 (309)
T 3p86_A          255 CK-------------RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA  300 (309)
T ss_dssp             CC-------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred             CC-------------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence            00             01112245567999999999999999999999999999988653

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=4.1e-49  Score=357.33  Aligned_cols=259  Identities=25%  Similarity=0.324  Sum_probs=212.1

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCC---eeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQD---RPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTL  130 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  130 (339)
                      .++|++.+.||+|+||+||+|.+..++   ..||||++.........+.+.+|+.+++.++||||+++++++.+++..++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            367999999999999999999997544   46999999877665667789999999999999999999999999999999


Q ss_pred             EEEeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCC
Q 019536          131 VFESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEG  207 (339)
Q Consensus       131 v~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~  207 (339)
                      ||||+++|+|.+++.   ..+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus       128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  204 (325)
T 3kul_A          128 VTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD  204 (325)
T ss_dssp             EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred             EeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence            999999999999985   47899999999999999999999   899999999999999999999999999999877543


Q ss_pred             Cce-eeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCccccc
Q 019536          208 ETH-VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAI  285 (339)
Q Consensus       208 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (339)
                      ... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.....        ..........      
T Consensus       205 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~--------~~~~~~~~~~------  270 (325)
T 3kul_A          205 PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN--------RDVISSVEEG------  270 (325)
T ss_dssp             --CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH--------HHHHHHHHTT------
T ss_pred             ccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH--------HHHHHHHHcC------
Confidence            322 12223446778999999998999999999999999999999 9999752211        1111111111      


Q ss_pred             ccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          286 VDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                              ...+.+..++..+.+|+.+||+.||++|||+.+|++.|+.+..+
T Consensus       271 --------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~  314 (325)
T 3kul_A          271 --------YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS  314 (325)
T ss_dssp             --------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             --------CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence                    11122234556799999999999999999999999999998754

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.3e-49  Score=360.77  Aligned_cols=249  Identities=22%  Similarity=0.318  Sum_probs=208.9

Q ss_pred             HhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 019536           53 ATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS-TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLV  131 (339)
Q Consensus        53 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  131 (339)
                      ..++|++.+.||+|+||.||+|.+..+|+.||||++.... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   92 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI   92 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence            3578999999999999999999999899999999997653 334567788999999999999999999999999999999


Q ss_pred             EEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCc
Q 019536          132 FESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGET  209 (339)
Q Consensus       132 ~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~  209 (339)
                      |||+++|+|.+++.  ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus        93 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  169 (328)
T 3fe3_A           93 MEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK  169 (328)
T ss_dssp             ECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCG
T ss_pred             EECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCc
Confidence            99999999999885  67899999999999999999999   89999999999999999999999999999987654432


Q ss_pred             eeeecccccccccccccccccCCCC-cccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccC
Q 019536          210 HVREEFIKGAYGFIAPEYFATSSFN-EMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDP  288 (339)
Q Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (339)
                      .   ....||+.|+|||++.+..++ .++||||+||++|+|++|+.||....        .......... +.       
T Consensus       170 ~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--------~~~~~~~i~~-~~-------  230 (328)
T 3fe3_A          170 L---DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN--------LKELRERVLR-GK-------  230 (328)
T ss_dssp             G---GTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHH-CC-------
T ss_pred             c---ccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC--------HHHHHHHHHh-CC-------
Confidence            2   245799999999999988775 78999999999999999999985321        1111111111 11       


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          289 IFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                           ...|  ...+..+.+|+.+||+.||.+|||+.+++++
T Consensus       231 -----~~~p--~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          231 -----YRIP--FYMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             -----CCCC--TTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             -----CCCC--CCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                 1111  2345678999999999999999999999863

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=5.7e-48  Score=346.66  Aligned_cols=283  Identities=24%  Similarity=0.359  Sum_probs=226.3

Q ss_pred             CcccccHHHHHHHhcCcccC------CceeccCCeeEEEEEEcCCCeeEEEEEeccCC---ChhhHHHHHHHHHHHHhcC
Q 019536           41 PIRAFSAKDLKKATNNYDLH------KVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS---TLDDVEYCFNNIVFSSQMK  111 (339)
Q Consensus        41 ~~~~~~~~~~~~~~~~~~~~------~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~  111 (339)
                      ....|+..++...+++|...      +.||+|+||+||+|..  ++..||+|++....   .....+.+.+|+.+++.++
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~   88 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ   88 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC
Confidence            46779999999999998877      8999999999999987  68899999987642   2244677889999999999


Q ss_pred             CCceeeeeeeeeeCCccEEEEEeccCCccccccc-----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEE
Q 019536          112 HKNILKLIGCCLETELPTLVFESVKYGTLRGFSF-----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVL  186 (339)
Q Consensus       112 H~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~-----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil  186 (339)
                      ||||+++++++.+++..++||||+++|+|.+++.     ..+++..+..++.|++.||.|||   +.+|+||||||+||+
T Consensus        89 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil  165 (307)
T 2nru_A           89 HENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANIL  165 (307)
T ss_dssp             CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEE
T ss_pred             CCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEE
Confidence            9999999999999999999999999999998875     35888999999999999999999   899999999999999


Q ss_pred             eCCCCceEEecCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCc
Q 019536          187 LDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDD  266 (339)
Q Consensus       187 ~~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~  266 (339)
                      ++.++.+||+|||+++...............||+.|+|||.+.+ .++.++||||||+++|+|++|+.||.......  .
T Consensus       166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~  242 (307)
T 2nru_A          166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ--L  242 (307)
T ss_dssp             ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS--B
T ss_pred             EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH--H
Confidence            99999999999999987655433333334578999999998865 58899999999999999999999986433221  1


Q ss_pred             hhHHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          267 LTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                      ......... .....+....+....     +.+...+..+.+++.+||+.||.+|||+.++++.|+++..+
T Consensus       243 ~~~~~~~~~-~~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~s  307 (307)
T 2nru_A          243 LLDIKEEIE-DEEKTIEDYIDKKMN-----DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS  307 (307)
T ss_dssp             TTHHHHHHH-TTSCCHHHHSCSSCS-----CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC--
T ss_pred             HHHHHHHhh-hhhhhhhhhcccccc-----ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhcC
Confidence            111111100 111111222222111     12346778899999999999999999999999999998653

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=4.5e-49  Score=356.78  Aligned_cols=254  Identities=21%  Similarity=0.245  Sum_probs=206.4

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFE  133 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  133 (339)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++.........+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            47899999999999999999999999999999999766443445678899999999999999999999999999999999


Q ss_pred             eccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCcee
Q 019536          134 SVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHV  211 (339)
Q Consensus       134 ~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~  211 (339)
                      |+++|+|.+++.  ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++.+.......
T Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  162 (323)
T 3tki_A           86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER  162 (323)
T ss_dssp             CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred             cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence            999999999987  46899999999999999999999   8999999999999999999999999999998765443332


Q ss_pred             eecccccccccccccccccCCC-CcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcc
Q 019536          212 REEFIKGAYGFIAPEYFATSSF-NEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIF  290 (339)
Q Consensus       212 ~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (339)
                      ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.......   .....    .....          
T Consensus       163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~~----~~~~~----------  225 (323)
T 3tki_A          163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC---QEYSD----WKEKK----------  225 (323)
T ss_dssp             CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS---HHHHH----HHTTC----------
T ss_pred             ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH---HHHHH----Hhccc----------
Confidence            2334679999999999988775 788999999999999999999986433221   11110    00000          


Q ss_pred             cCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          291 DEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                         ...+.....+..+.+|+.+||+.||++|||+.|++++
T Consensus       226 ---~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          226 ---TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             ---TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ---ccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence               0011122455678999999999999999999999863

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=6.9e-49  Score=350.74  Aligned_cols=267  Identities=19%  Similarity=0.309  Sum_probs=208.7

Q ss_pred             hcCcccCCceeccCCeeEEEEE----EcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeee--CCc
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGT----LVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLE--TEL  127 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~--~~~  127 (339)
                      .++|++.+.||+|+||+||+|+    ...+++.||+|++..... ...+.+.+|+.+++.++||||+++++++..  ...
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   87 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE-EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN   87 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCH-HHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence            3789999999999999999999    456889999999976543 556778899999999999999999999865  456


Q ss_pred             cEEEEEeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCcccc
Q 019536          128 PTLVFESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSI  204 (339)
Q Consensus       128 ~~lv~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~  204 (339)
                      .++||||+++|+|.+++.   ..+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++..
T Consensus        88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~  164 (295)
T 3ugc_A           88 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVL  164 (295)
T ss_dssp             CEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred             eEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence            899999999999999986   35899999999999999999999   899999999999999999999999999999876


Q ss_pred             CCCCce-eeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCC--------CCCCCchhHHHHHHH
Q 019536          205 PEGETH-VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKG--------NGNDDDLTVLEYAKK  275 (339)
Q Consensus       205 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~--------~~~~~~~~~~~~~~~  275 (339)
                      ...... .......++..|+|||++.+..++.++||||||+++|+|++|..|+....        ......... .....
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  243 (295)
T 3ugc_A          165 PQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV-FHLIE  243 (295)
T ss_dssp             -----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHH-HHHHH
T ss_pred             cCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhH-HHHHH
Confidence            543322 11223456778999999999999999999999999999999998875321        111000000 01111


Q ss_pred             HhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhc
Q 019536          276 SIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLSV  338 (339)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~~  338 (339)
                      ...             .....+.+..++..+.+|+.+||+.||++|||+.++++.|+++.+++
T Consensus       244 ~~~-------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l  293 (295)
T 3ugc_A          244 LLK-------------NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM  293 (295)
T ss_dssp             HHH-------------TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             HHh-------------ccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence            111             11122223355678999999999999999999999999999998865

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=6.6e-48  Score=348.34  Aligned_cols=273  Identities=17%  Similarity=0.211  Sum_probs=214.2

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC--ccEEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETE--LPTLVF  132 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~--~~~lv~  132 (339)
                      ++|.+.+.||+|+||+||+|.+..+++.||||++.........+.+.+|+.+++.++||||+++++++...+  ..++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence            679999999999999999999998999999999987554455677889999999999999999999998755  679999


Q ss_pred             EeccCCcccccccc-----CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEe----CCCCceEEecCCCccc
Q 019536          133 ESVKYGTLRGFSFA-----SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLL----DENYSAKLHDFSLSVS  203 (339)
Q Consensus       133 e~~~~g~L~~~~~~-----~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~----~~~~~~kl~dfg~a~~  203 (339)
                      ||+++|+|.+++..     .+++..++.++.|++.||.|||   +.+|+||||||+||++    +.++.+||+|||+++.
T Consensus        89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~  165 (319)
T 4euu_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (319)
T ss_dssp             ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred             eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence            99999999999862     2899999999999999999999   8999999999999999    7888899999999987


Q ss_pred             cCCCCceeeecccccccccccccccc--------cCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHH
Q 019536          204 IPEGETHVREEFIKGAYGFIAPEYFA--------TSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKK  275 (339)
Q Consensus       204 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  275 (339)
                      ........   ...||+.|+|||++.        +..++.++|||||||++|+|++|+.||....... ...........
T Consensus       166 ~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~  241 (319)
T 4euu_A          166 LEDDEQFV---SLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR-RNKEVMYKIIT  241 (319)
T ss_dssp             CCTTCCBC---CCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGG-GCHHHHHHHHH
T ss_pred             cCCCCcee---ecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccc-hhHHHHHHHhc
Confidence            75544322   346899999999986        4678999999999999999999999986332222 11122222111


Q ss_pred             HhhcCccccc---ccCcccC----CCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 019536          276 SIENNRFGAI---VDPIFDE----DNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQM  334 (339)
Q Consensus       276 ~~~~~~~~~~---~~~~~~~----~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l  334 (339)
                      ......+..+   ....+..    ..........+..+.+++.+||+.||++|||+.|++++..+-
T Consensus       242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~  307 (319)
T 4euu_A          242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (319)
T ss_dssp             HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence            1111111111   0000000    011122346788899999999999999999999999987753

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=9.3e-49  Score=363.09  Aligned_cols=252  Identities=21%  Similarity=0.298  Sum_probs=203.0

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC--hhhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCccEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST--LDDVEYCFNNIVFSSQM-KHKNILKLIGCCLETELPTL  130 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~~l  130 (339)
                      .++|++.++||+|+||+||+|+...+++.||+|++.+...  ......+.+|..++.++ +||||+++++++.+.+..++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            4689999999999999999999999999999999986422  23345577899999887 89999999999999999999


Q ss_pred             EEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCC
Q 019536          131 VFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE  208 (339)
Q Consensus       131 v~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~  208 (339)
                      ||||+++|+|..++.  ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+|+......
T Consensus       131 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~  207 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG  207 (396)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeeecccCC
Confidence            999999999998886  57899999999999999999999   8999999999999999999999999999998643322


Q ss_pred             ceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccC
Q 019536          209 THVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDP  288 (339)
Q Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (339)
                      ..  ....+||+.|+|||++.+..|+.++|+|||||++|||++|+.||...+................+...        
T Consensus       208 ~~--~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~--------  277 (396)
T 4dc2_A          208 DT--TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--------  277 (396)
T ss_dssp             CC--BCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC--------
T ss_pred             Cc--cccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc--------
Confidence            21  22467999999999999999999999999999999999999998654433221111111112111111        


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCH
Q 019536          289 IFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLM  324 (339)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~  324 (339)
                          ...+|  ...+.++.+|+.+||+.||++||++
T Consensus       278 ----~~~~p--~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          278 ----QIRIP--RSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             ----CCCCC--TTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             ----ccCCC--CcCCHHHHHHHHHHhcCCHhHcCCC
Confidence                11122  2355679999999999999999996

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=2e-49  Score=357.01  Aligned_cols=261  Identities=24%  Similarity=0.399  Sum_probs=216.4

Q ss_pred             HHhcCcccCCceeccCCeeEEEEEEc-----CCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC
Q 019536           52 KATNNYDLHKVIQSDTSYRLFEGTLV-----DQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETE  126 (339)
Q Consensus        52 ~~~~~~~~~~~ig~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~  126 (339)
                      ...++|.+.+.||+|+||.||+|.+.     .++..||+|++.........+.+.+|+.+++.++||||+++++++.+++
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   99 (314)
T 2ivs_A           20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG   99 (314)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Confidence            34578999999999999999999983     3558999999987666566788999999999999999999999999999


Q ss_pred             ccEEEEEeccCCcccccccc--------------------------CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccC
Q 019536          127 LPTLVFESVKYGTLRGFSFA--------------------------SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCI  180 (339)
Q Consensus       127 ~~~lv~e~~~~g~L~~~~~~--------------------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dl  180 (339)
                      ..++||||+++|+|.+++..                          .+++..++.++.|++.||.|||   +.+|+||||
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~di  176 (314)
T 2ivs_A          100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDL  176 (314)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCC
T ss_pred             ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCccccc
Confidence            99999999999999998752                          2788889999999999999999   899999999


Q ss_pred             CCCCEEeCCCCceEEecCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccC
Q 019536          181 KASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFK  259 (339)
Q Consensus       181 k~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~  259 (339)
                      ||+||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|+|++ |..||...
T Consensus       177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  256 (314)
T 2ivs_A          177 AARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI  256 (314)
T ss_dssp             SGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             chheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999987765444333334557788999999999899999999999999999999 99997532


Q ss_pred             CCCCCCchhHHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          260 GNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                      ..     ......    .....             ..+.+...+..+.+|+.+||+.||++|||+.++++.|+++..+
T Consensus       257 ~~-----~~~~~~----~~~~~-------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  312 (314)
T 2ivs_A          257 PP-----ERLFNL----LKTGH-------------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK  312 (314)
T ss_dssp             CG-----GGHHHH----HHTTC-------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CH-----HHHHHH----hhcCC-------------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence            21     111111    11110             0011124456799999999999999999999999999998764

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=7.9e-48  Score=348.29  Aligned_cols=262  Identities=18%  Similarity=0.259  Sum_probs=215.6

Q ss_pred             ccccHHHHHHHhcC----------cccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCC
Q 019536           43 RAFSAKDLKKATNN----------YDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKH  112 (339)
Q Consensus        43 ~~~~~~~~~~~~~~----------~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H  112 (339)
                      ..++.++++.+++.          |+..+.||+|+||+||+|....+|+.||||++..... ...+.+.+|+.+++.++|
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h  101 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ-QRRELLFNEVVIMRDYQH  101 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CSHHHHHHHHHHHTTCCC
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch-hHHHHHHHHHHHHHhCCC
Confidence            45778888877754          7777899999999999999998999999999976543 456778899999999999


Q ss_pred             CceeeeeeeeeeCCccEEEEEeccCCccccccc-cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCC
Q 019536          113 KNILKLIGCCLETELPTLVFESVKYGTLRGFSF-ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENY  191 (339)
Q Consensus       113 ~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~  191 (339)
                      |||+++++++..++..++||||+++|+|.+++. ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++
T Consensus       102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~  178 (321)
T 2c30_A          102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLDG  178 (321)
T ss_dssp             TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTC
T ss_pred             CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCC
Confidence            999999999999999999999999999999886 57899999999999999999999   89999999999999999999


Q ss_pred             ceEEecCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHH
Q 019536          192 SAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLE  271 (339)
Q Consensus       192 ~~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~  271 (339)
                      .+||+|||+++.........  ....||+.|+|||++.+..++.++||||||+++|+|++|+.||....     ..... 
T Consensus       179 ~~kl~Dfg~~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~-----~~~~~-  250 (321)
T 2c30_A          179 RVKLSDFGFCAQISKDVPKR--KSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS-----PVQAM-  250 (321)
T ss_dssp             CEEECCCTTCEECCSSSCCB--CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-----HHHHH-
T ss_pred             cEEEeeeeeeeecccCcccc--ccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHH-
Confidence            99999999998765433221  24579999999999999999999999999999999999999985221     11111 


Q ss_pred             HHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          272 YAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                        ..... ...           .........+..+.+++.+||+.||++|||+.+++++
T Consensus       251 --~~~~~-~~~-----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          251 --KRLRD-SPP-----------PKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDH  295 (321)
T ss_dssp             --HHHHH-SSC-----------CCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             --HHHhc-CCC-----------CCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              11111 100           0111122445679999999999999999999999874

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.5e-49  Score=363.58  Aligned_cols=258  Identities=21%  Similarity=0.298  Sum_probs=209.6

Q ss_pred             hcCcccCCceeccCCeeEEEEEE-----cCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCcc
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTL-----VDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELP  128 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~  128 (339)
                      .++|++.+.||+|+||+||+|.+     ..+++.||||++...........+.+|+.+++.++||||+++++++.++...
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            36899999999999999999994     4467899999998766656677889999999999999999999999999999


Q ss_pred             EEEEEeccCCccccccc---------cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCC---ceEEe
Q 019536          129 TLVFESVKYGTLRGFSF---------ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENY---SAKLH  196 (339)
Q Consensus       129 ~lv~e~~~~g~L~~~~~---------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~---~~kl~  196 (339)
                      ++||||+++|+|.+++.         ..+++..++.++.|++.||.|||   +.+|+||||||+|||++.++   .+||+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEEC
Confidence            99999999999999976         24888899999999999999999   89999999999999999554   59999


Q ss_pred             cCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHH
Q 019536          197 DFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKK  275 (339)
Q Consensus       197 dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~  275 (339)
                      |||+++...............+|+.|+|||++.+..++.++|||||||++|+|++ |..||....        ..+....
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~--------~~~~~~~  298 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS--------NQEVLEF  298 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--------HHHHHHH
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHH
Confidence            9999976533222222223567889999999999999999999999999999998 999975321        1111111


Q ss_pred             HhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 019536          276 SIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYL  336 (339)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~  336 (339)
                      ......              .+.+..++..+.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus       299 i~~~~~--------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~  345 (367)
T 3l9p_A          299 VTSGGR--------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  345 (367)
T ss_dssp             HHTTCC--------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHcCCC--------------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence            111110              01112345579999999999999999999999999998865

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=2.5e-49  Score=358.97  Aligned_cols=256  Identities=18%  Similarity=0.311  Sum_probs=202.2

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCee----EEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRP----ISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTL  130 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~----vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  130 (339)
                      ++|++.+.||+|+||+||+|.+..+++.    ||+|.+...........+.+|+.+++.++||||++++++|.++. .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~   93 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence            6799999999999999999998766654    58888766554456678999999999999999999999998765 689


Q ss_pred             EEEeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCC
Q 019536          131 VFESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEG  207 (339)
Q Consensus       131 v~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~  207 (339)
                      |+||+++|+|.+++.   ..+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus        94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~  170 (327)
T 3poz_A           94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  170 (327)
T ss_dssp             EEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTT
T ss_pred             EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcceeEccCC
Confidence            999999999999875   46889999999999999999999   899999999999999999999999999999887655


Q ss_pred             CceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCcccccc
Q 019536          208 ETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIV  286 (339)
Q Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (339)
                      ..........+|..|+|||++.+..++.++|||||||++|+|++ |+.||......     .......    ..      
T Consensus       171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-----~~~~~~~----~~------  235 (327)
T 3poz_A          171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-----EISSILE----KG------  235 (327)
T ss_dssp             CC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-----GHHHHHH----TT------
T ss_pred             cccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH-----HHHHHHH----cC------
Confidence            44333334557889999999999999999999999999999999 99997532211     1111111    10      


Q ss_pred             cCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 019536          287 DPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYL  336 (339)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~  336 (339)
                             ...+.+...+..+.+++.+||+.||++|||+.++++.|+++..
T Consensus       236 -------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          236 -------ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             -------CCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             -------CCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                   0111222455679999999999999999999999999998864

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=8.7e-49  Score=356.57  Aligned_cols=249  Identities=19%  Similarity=0.223  Sum_probs=206.9

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC--ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS--TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLV  131 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  131 (339)
                      .++|++.+.||+|+||+||+|....+++.||+|++....  .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            468999999999999999999999999999999997542  123456788999999999999999999999999999999


Q ss_pred             EEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCc
Q 019536          132 FESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGET  209 (339)
Q Consensus       132 ~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~  209 (339)
                      |||+++|+|.+++.  ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus        84 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~  160 (337)
T 1o6l_A           84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA  160 (337)
T ss_dssp             EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC
Confidence            99999999998886  57899999999999999999999   89999999999999999999999999999986433322


Q ss_pred             eeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCc
Q 019536          210 HVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPI  289 (339)
Q Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (339)
                      .  ....+||+.|+|||++.+..|+.++|+|||||++|+|++|+.||....        .......... .         
T Consensus       161 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--------~~~~~~~i~~-~---------  220 (337)
T 1o6l_A          161 T--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HERLFELILM-E---------  220 (337)
T ss_dssp             C--BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHH-C---------
T ss_pred             c--ccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC--------HHHHHHHHHc-C---------
Confidence            1  224679999999999999999999999999999999999999985211        1111111111 1         


Q ss_pred             ccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 019536          290 FDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP-----LMVDVAKQ  330 (339)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~il~~  330 (339)
                         ...+|  ...+.++.+|+.+||+.||++||     ++.+|+++
T Consensus       221 ---~~~~p--~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          221 ---EIRFP--RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             ---CCCCC--TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             ---CCCCC--CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence               11112  23456799999999999999999     89998764

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=7.3e-49  Score=353.15  Aligned_cols=265  Identities=20%  Similarity=0.313  Sum_probs=218.4

Q ss_pred             HHHHhcCcccCCceeccCCeeEEEEEE-----cCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhc-CCCceeeeeeeee
Q 019536           50 LKKATNNYDLHKVIQSDTSYRLFEGTL-----VDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCCL  123 (339)
Q Consensus        50 ~~~~~~~~~~~~~ig~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~  123 (339)
                      +....++|++.+.||+|+||+||+|.+     ..+++.||+|++.........+.+.+|+.+++++ +||||+++++++.
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   97 (313)
T 1t46_A           18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT   97 (313)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence            334457899999999999999999996     3467899999998776656678889999999999 9999999999999


Q ss_pred             eCCccEEEEEeccCCcccccccc--------------------CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCC
Q 019536          124 ETELPTLVFESVKYGTLRGFSFA--------------------SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKAS  183 (339)
Q Consensus       124 ~~~~~~lv~e~~~~g~L~~~~~~--------------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~  183 (339)
                      +++..++||||+++|+|.+++..                    .+++..++.++.|++.||.|||   +.+|+||||||+
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~  174 (313)
T 1t46_A           98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAAR  174 (313)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGG
T ss_pred             cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccc
Confidence            99999999999999999998752                    3788999999999999999999   899999999999


Q ss_pred             CEEeCCCCceEEecCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCC
Q 019536          184 NVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNG  262 (339)
Q Consensus       184 Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~  262 (339)
                      ||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|+|++ |+.||......
T Consensus       175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~  254 (313)
T 1t46_A          175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD  254 (313)
T ss_dssp             GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred             eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch
Confidence            99999999999999999987765544333334567888999999999999999999999999999998 99997532211


Q ss_pred             CCCchhHHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhc
Q 019536          263 NDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLSV  338 (339)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~~  338 (339)
                          ......    .....             ..+.+...+..+.+|+.+||+.||.+|||+.++++.|+++.++.
T Consensus       255 ----~~~~~~----~~~~~-------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  309 (313)
T 1t46_A          255 ----SKFYKM----IKEGF-------------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES  309 (313)
T ss_dssp             ----HHHHHH----HHHTC-------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             ----hHHHHH----hccCC-------------CCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence                111111    11110             00111234567999999999999999999999999999998764

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.5e-48  Score=358.24  Aligned_cols=250  Identities=21%  Similarity=0.213  Sum_probs=207.5

Q ss_pred             HhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCCh-----hhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCc
Q 019536           53 ATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTL-----DDVEYCFNNIVFSSQMKHKNILKLIGCCLETEL  127 (339)
Q Consensus        53 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~  127 (339)
                      ..+.|++.+.||+|+||+||+|.+..+|+.||+|.+......     ...+.+.+|+.+++.++||||+++++++.+.+.
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~   89 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD   89 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence            347899999999999999999999999999999999875432     135778899999999999999999999999999


Q ss_pred             cEEEEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCC----ceEEecCCCc
Q 019536          128 PTLVFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENY----SAKLHDFSLS  201 (339)
Q Consensus       128 ~~lv~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~----~~kl~dfg~a  201 (339)
                      .++||||+++|+|.+++.  ..+++..+..++.||+.||.|||   +.+|+||||||+||+++.++    .+||+|||++
T Consensus        90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a  166 (361)
T 2yab_A           90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (361)
T ss_dssp             EEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred             EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence            999999999999999986  56889999999999999999999   89999999999999998776    7999999999


Q ss_pred             cccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCc
Q 019536          202 VSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNR  281 (339)
Q Consensus       202 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (339)
                      +........   ....||+.|+|||++.+..|+.++||||+||++|+|++|..||....        ..+.... +....
T Consensus       167 ~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~--------~~~~~~~-i~~~~  234 (361)
T 2yab_A          167 HEIEDGVEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--------KQETLAN-ITAVS  234 (361)
T ss_dssp             EECCTTCCC---CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS--------HHHHHHH-HHTTC
T ss_pred             eEcCCCCcc---ccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHH-HHhcC
Confidence            877554322   13569999999999999899999999999999999999999985221        1111111 11111


Q ss_pred             ccccccCcccCCCCCCC--cHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          282 FGAIVDPIFDEDNSFPG--KEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       282 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                                  ..++.  ....+..+.+|+.+||+.||++|||+.++++
T Consensus       235 ------------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          235 ------------YDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             ------------CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ------------CCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                        01110  1134567999999999999999999999985

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.1e-49  Score=357.81  Aligned_cols=264  Identities=21%  Similarity=0.294  Sum_probs=212.0

Q ss_pred             HHHHhcCcccCCceeccCCeeEEEEEEc-----CCCeeEEEEEeccCCChhhHHHHHHHHHHHHhc-CCCceeeeeeeee
Q 019536           50 LKKATNNYDLHKVIQSDTSYRLFEGTLV-----DQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCCL  123 (339)
Q Consensus        50 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~  123 (339)
                      ++...++|.+.+.||+|+||+||+|.+.     .++..||+|++.........+.+.+|+.+++++ +||||+++++++.
T Consensus        40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  119 (344)
T 1rjb_A           40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT  119 (344)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            4445688999999999999999999973     456789999998665445567788999999999 8999999999999


Q ss_pred             eCCccEEEEEeccCCcccccccc-------------------------CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEc
Q 019536          124 ETELPTLVFESVKYGTLRGFSFA-------------------------SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFR  178 (339)
Q Consensus       124 ~~~~~~lv~e~~~~g~L~~~~~~-------------------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~  178 (339)
                      .++..++||||+++|+|.+++..                         .+++..++.++.|++.||.|||   +.+|+||
T Consensus       120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~  196 (344)
T 1rjb_A          120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHR  196 (344)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEET
T ss_pred             eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccC
Confidence            99999999999999999998752                         2688889999999999999999   8999999


Q ss_pred             cCCCCCEEeCCCCceEEecCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccc
Q 019536          179 CIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLE  257 (339)
Q Consensus       179 dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~  257 (339)
                      ||||+||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|+|++ |..||.
T Consensus       197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  276 (344)
T 1rjb_A          197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP  276 (344)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence            9999999999999999999999987655444333434567889999999999999999999999999999998 999975


Q ss_pred             cCCCCCCCchhHHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          258 FKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                      .....    ...    ........             ..+.+...+..+.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus       277 ~~~~~----~~~----~~~~~~~~-------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  335 (344)
T 1rjb_A          277 GIPVD----ANF----YKLIQNGF-------------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD  335 (344)
T ss_dssp             TCCCS----HHH----HHHHHTTC-------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             cCCcH----HHH----HHHHhcCC-------------CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence            33211    111    11111110             0111123456799999999999999999999999999998754

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.7e-48  Score=348.75  Aligned_cols=251  Identities=21%  Similarity=0.312  Sum_probs=200.6

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCCh-------------------------hhHHHHHHHHHHHH
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTL-------------------------DDVEYCFNNIVFSS  108 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------------------------~~~~~~~~e~~~l~  108 (339)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++......                         ...+.+.+|+.+++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            47899999999999999999999999999999998765321                         12356889999999


Q ss_pred             hcCCCceeeeeeeeee--CCccEEEEEeccCCccccccc-cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCE
Q 019536          109 QMKHKNILKLIGCCLE--TELPTLVFESVKYGTLRGFSF-ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNV  185 (339)
Q Consensus       109 ~l~H~niv~~~~~~~~--~~~~~lv~e~~~~g~L~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Ni  185 (339)
                      .++||||+++++++.+  .+..++||||+++++|.++.. ..+++..+..++.|++.||.|||   +.+|+||||||+||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Ni  168 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNL  168 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGE
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHE
Confidence            9999999999999987  567899999999999998876 57899999999999999999999   89999999999999


Q ss_pred             EeCCCCceEEecCCCccccCCCCceeeecccccccccccccccccCC---CCcccchHHHHHHHHHHHhCCCccccCCCC
Q 019536          186 LLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSS---FNEMCDVYSFGAFLCELLTGCNVLEFKGNG  262 (339)
Q Consensus       186 l~~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~~l~el~~g~~p~~~~~~~  262 (339)
                      +++.++.+||+|||+++.........  ....||+.|+|||++.+..   ++.++|||||||++|+|++|+.||....  
T Consensus       169 l~~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~--  244 (298)
T 2zv2_A          169 LVGEDGHIKIADFGVSNEFKGSDALL--SNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER--  244 (298)
T ss_dssp             EECTTSCEEECCCTTCEECSSSSCEE--CCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS--
T ss_pred             EECCCCCEEEecCCCccccccccccc--cCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc--
Confidence            99999999999999998775543322  2356899999999997765   4788999999999999999999985211  


Q ss_pred             CCCchhHHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          263 NDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                            ....... .....            ..+|.....+..+.+|+.+||+.||++|||+.+++++
T Consensus       245 ------~~~~~~~-~~~~~------------~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h  293 (298)
T 2zv2_A          245 ------IMCLHSK-IKSQA------------LEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH  293 (298)
T ss_dssp             ------HHHHHHH-HHHCC------------CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred             ------HHHHHHH-Hhccc------------CCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence                  1111111 11111            1111112345679999999999999999999999763

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.7e-48  Score=359.63  Aligned_cols=258  Identities=22%  Similarity=0.308  Sum_probs=200.9

Q ss_pred             cCcccCCceeccCCeeEEEEEEc---CCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLV---DQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLV  131 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  131 (339)
                      ++|++.+.||+|+||.||+|.+.   .++..||||++.........+.+.+|+.++++++||||+++++++.+++..++|
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV  124 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence            58999999999999999999986   467789999998765556677899999999999999999999999999999999


Q ss_pred             EEeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCC
Q 019536          132 FESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE  208 (339)
Q Consensus       132 ~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~  208 (339)
                      |||+++|+|.+++.   ..+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus       125 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  201 (373)
T 2qol_A          125 TEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP  201 (373)
T ss_dssp             EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCccccccccCC
Confidence            99999999999986   36889999999999999999999   8999999999999999999999999999998765432


Q ss_pred             ce-eeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCcccccc
Q 019536          209 TH-VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIV  286 (339)
Q Consensus       209 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (339)
                      .. .......+++.|+|||++.+..++.++||||||+++|||++ |+.||....        ............      
T Consensus       202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~--------~~~~~~~i~~~~------  267 (373)
T 2qol_A          202 EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS--------NQDVIKAVDEGY------  267 (373)
T ss_dssp             ------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC--------HHHHHHHHHTTE------
T ss_pred             ccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHHcCC------
Confidence            21 11112345678999999999999999999999999999998 999975221        111111111110      


Q ss_pred             cCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          287 DPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                              ..+.+..++..+.+|+.+||+.||++|||+.+|++.|+++...
T Consensus       268 --------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  310 (373)
T 2qol_A          268 --------RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN  310 (373)
T ss_dssp             --------ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             --------CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence                    0111224456799999999999999999999999999998753

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.4e-48  Score=357.61  Aligned_cols=262  Identities=21%  Similarity=0.311  Sum_probs=215.9

Q ss_pred             HHHhcCcccCCceeccCCeeEEEEEEcC-------CCeeEEEEEeccCCChhhHHHHHHHHHHHHhc-CCCceeeeeeee
Q 019536           51 KKATNNYDLHKVIQSDTSYRLFEGTLVD-------QDRPISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCC  122 (339)
Q Consensus        51 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~  122 (339)
                      ....++|.+.+.||+|+||+||+|.+..       .+..||+|++...........+.+|+.+++.+ +||||+++++++
T Consensus        65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  144 (382)
T 3tt0_A           65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC  144 (382)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence            3345789999999999999999999753       33579999998876666778899999999999 999999999999


Q ss_pred             eeCCccEEEEEeccCCcccccccc------------------CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCC
Q 019536          123 LETELPTLVFESVKYGTLRGFSFA------------------SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASN  184 (339)
Q Consensus       123 ~~~~~~~lv~e~~~~g~L~~~~~~------------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~N  184 (339)
                      .+++..++||||+++|+|.+++..                  .+++..++.++.|++.||.|||   +.+|+||||||+|
T Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~N  221 (382)
T 3tt0_A          145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARN  221 (382)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGG
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcce
Confidence            999999999999999999998752                  3888999999999999999999   8999999999999


Q ss_pred             EEeCCCCceEEecCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCC
Q 019536          185 VLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGN  263 (339)
Q Consensus       185 il~~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~  263 (339)
                      ||++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|+|++ |..||....   
T Consensus       222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~---  298 (382)
T 3tt0_A          222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP---  298 (382)
T ss_dssp             EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---
T ss_pred             EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC---
Confidence            9999999999999999987655433223334567889999999999999999999999999999999 999975221   


Q ss_pred             CCchhHHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          264 DDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                           ..+... .......             .+.+..++..+.+|+.+||+.||++|||+.+|++.|+++...
T Consensus       299 -----~~~~~~-~~~~~~~-------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  353 (382)
T 3tt0_A          299 -----VEELFK-LLKEGHR-------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL  353 (382)
T ss_dssp             -----HHHHHH-HHHTTCC-------------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -----HHHHHH-HHHcCCC-------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence                 111111 1111110             011123456799999999999999999999999999998753

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-48  Score=355.02  Aligned_cols=262  Identities=24%  Similarity=0.325  Sum_probs=214.1

Q ss_pred             HHHhcCcccCCceeccCCeeEEEEEEc-----CCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeC
Q 019536           51 KKATNNYDLHKVIQSDTSYRLFEGTLV-----DQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLET  125 (339)
Q Consensus        51 ~~~~~~~~~~~~ig~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~  125 (339)
                      ....++|++.+.||+|+||.||+|.+.     .+++.||+|.+.........+.+.+|+.+++.++||||+++++++.++
T Consensus        43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~  122 (343)
T 1luf_A           43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG  122 (343)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence            344589999999999999999999997     345899999998776656677889999999999999999999999999


Q ss_pred             CccEEEEEeccCCccccccc--------------------------cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEcc
Q 019536          126 ELPTLVFESVKYGTLRGFSF--------------------------ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRC  179 (339)
Q Consensus       126 ~~~~lv~e~~~~g~L~~~~~--------------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~d  179 (339)
                      +..++||||+++|+|.+++.                          ..+++..++.++.|++.||.|||   +.+|+|||
T Consensus       123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~D  199 (343)
T 1luf_A          123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRD  199 (343)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSC
T ss_pred             CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCC
Confidence            99999999999999999875                          35788889999999999999999   89999999


Q ss_pred             CCCCCEEeCCCCceEEecCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCcccc
Q 019536          180 IKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEF  258 (339)
Q Consensus       180 lk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~  258 (339)
                      |||+||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|+|++ |..||..
T Consensus       200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  279 (343)
T 1luf_A          200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG  279 (343)
T ss_dssp             CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence            999999999999999999999987644332222224567889999999998899999999999999999999 9999752


Q ss_pred             CCCCCCCchhHHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          259 KGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                      ..        ..+.... .......             +.+..++..+.+|+.+||+.||++|||+.++++.|+++.+.
T Consensus       280 ~~--------~~~~~~~-~~~~~~~-------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~  336 (343)
T 1luf_A          280 MA--------HEEVIYY-VRDGNIL-------------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER  336 (343)
T ss_dssp             SC--------HHHHHHH-HHTTCCC-------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred             CC--------hHHHHHH-HhCCCcC-------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence            21        1111111 1111110             11124456799999999999999999999999999998754

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=3.9e-48  Score=353.55  Aligned_cols=252  Identities=21%  Similarity=0.299  Sum_probs=204.1

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC--ChhhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCccEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS--TLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLETELPTL  130 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~~l  130 (339)
                      .++|++.+.||+|+||.||+|++..+++.||+|++....  .....+.+.+|..++..+ +||||+++++++.+.+..++
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            367999999999999999999999999999999998653  234556788999999988 89999999999999999999


Q ss_pred             EEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCC
Q 019536          131 VFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE  208 (339)
Q Consensus       131 v~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~  208 (339)
                      ||||+++|+|.+++.  ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus        88 v~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~  164 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG  164 (345)
T ss_dssp             EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence            999999999998886  57899999999999999999999   8999999999999999999999999999998643322


Q ss_pred             ceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccC
Q 019536          209 THVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDP  288 (339)
Q Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (339)
                      ..  ....+||+.|+|||++.+..|+.++|+||+||++|+|++|+.||...+................+....       
T Consensus       165 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~-------  235 (345)
T 3a8x_A          165 DT--TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-------  235 (345)
T ss_dssp             CC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC-------
T ss_pred             Cc--ccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC-------
Confidence            21  224579999999999999999999999999999999999999986543322111111111111111111       


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCH
Q 019536          289 IFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLM  324 (339)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~  324 (339)
                           ..+|  ...+..+.+|+.+||+.||++||++
T Consensus       236 -----~~~p--~~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          236 -----IRIP--RSLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             -----CCCC--TTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             -----CCCC--CCCCHHHHHHHHHHhcCCHhHCCCC
Confidence                 1112  2345679999999999999999996

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-48  Score=352.23  Aligned_cols=248  Identities=15%  Similarity=0.167  Sum_probs=207.2

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFE  133 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  133 (339)
                      .++|++.+.||+|+||+||+|.+..+++.||+|.+....  .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   81 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc--ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence            478999999999999999999999999999999987543  445668899999999999999999999999999999999


Q ss_pred             eccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCC--CCceEEecCCCccccCCCC
Q 019536          134 SVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDE--NYSAKLHDFSLSVSIPEGE  208 (339)
Q Consensus       134 ~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~--~~~~kl~dfg~a~~~~~~~  208 (339)
                      |+++|+|.+++.   ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.  ++.+||+|||+++......
T Consensus        82 ~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~  158 (321)
T 1tki_A           82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD  158 (321)
T ss_dssp             CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred             eCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence            999999999886   35889999999999999999999   899999999999999987  7899999999998876544


Q ss_pred             ceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccC
Q 019536          209 THVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDP  288 (339)
Q Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (339)
                      ...   ...||+.|+|||++.+..++.++||||+||++|+|++|..||....        .......... ..       
T Consensus       159 ~~~---~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~~i~~-~~-------  219 (321)
T 1tki_A          159 NFR---LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET--------NQQIIENIMN-AE-------  219 (321)
T ss_dssp             EEE---EEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHH-TC-------
T ss_pred             ccc---cccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC--------HHHHHHHHHc-CC-------
Confidence            322   3568999999999998889999999999999999999999985221        1111111111 11       


Q ss_pred             cccCCCCCCC--cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          289 IFDEDNSFPG--KEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       289 ~~~~~~~~~~--~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                           ..++.  ....+.++.+|+.+||+.||++|||+.|++++
T Consensus       220 -----~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h  258 (321)
T 1tki_A          220 -----YTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             -----CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             -----CCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                 01110  11345679999999999999999999999873

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=6.1e-48  Score=344.76  Aligned_cols=261  Identities=20%  Similarity=0.291  Sum_probs=208.1

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC--ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS--TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLV  131 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  131 (339)
                      .++|++.+.||+|+||+||+|.+..+++.||+|.+....  .....+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            368999999999999999999999999999999986543  234457788999999999999999999999999999999


Q ss_pred             EEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCc
Q 019536          132 FESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGET  209 (339)
Q Consensus       132 ~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~  209 (339)
                      |||+++|+|.+++.  ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus        90 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  166 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL  166 (294)
T ss_dssp             EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred             EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccc
Confidence            99999999999986  56899999999999999999999   89999999999999999999999999999987654332


Q ss_pred             eeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCc
Q 019536          210 HVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPI  289 (339)
Q Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (339)
                      .. .....||+.|+|||++.+..++.++||||+|+++|+|++|+.||....        .............. ..    
T Consensus       167 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~--------~~~~~~~~~~~~~~-~~----  232 (294)
T 4eqm_A          167 TQ-TNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET--------AVSIAIKHIQDSVP-NV----  232 (294)
T ss_dssp             ---------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC--------HHHHHHHHHSSCCC-CH----
T ss_pred             cc-cCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHhhccCC-Cc----
Confidence            21 223568999999999999999999999999999999999999985321        11111111111100 00    


Q ss_pred             ccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHHHHh
Q 019536          290 FDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP-LMVDVAKQLRQMYL  336 (339)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-s~~~il~~L~~l~~  336 (339)
                       ..    ..+...+..+.+++.+||+.||++|| ++.++.+.|+.+..
T Consensus       233 -~~----~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~  275 (294)
T 4eqm_A          233 -TT----DVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH  275 (294)
T ss_dssp             -HH----HSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred             -ch----hcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence             00    00113456799999999999999998 89999999987653

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=8.7e-48  Score=338.83  Aligned_cols=255  Identities=19%  Similarity=0.300  Sum_probs=210.6

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFE  133 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  133 (339)
                      .++|++.+.||+|+||+||+|.+. ++..||+|++.....  ..+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM--SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE   83 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             hhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC--cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence            478999999999999999999886 677899999976543  34668899999999999999999999999999999999


Q ss_pred             eccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCce
Q 019536          134 SVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH  210 (339)
Q Consensus       134 ~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~  210 (339)
                      |+++++|.+++.   ..+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||++.........
T Consensus        84 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  160 (268)
T 3sxs_A           84 YISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV  160 (268)
T ss_dssp             CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred             ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence            999999999986   35899999999999999999999   899999999999999999999999999999876554433


Q ss_pred             eeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCc
Q 019536          211 VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPI  289 (339)
Q Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (339)
                      . .....+|+.|+|||++.+..++.++||||+|+++|+|++ |+.||.....        ............        
T Consensus       161 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~--------  223 (268)
T 3sxs_A          161 S-SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN--------SEVVLKVSQGHR--------  223 (268)
T ss_dssp             E-CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH--------HHHHHHHHTTCC--------
T ss_pred             c-ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh--------HHHHHHHHcCCC--------
Confidence            2 223456778999999998899999999999999999999 9999752211        111111111110        


Q ss_pred             ccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          290 FDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                            .+.+...+..+.+++.+||+.||++|||+.++++.|+.+.+.
T Consensus       224 ------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          224 ------LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             ------CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             ------CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence                  011123445799999999999999999999999999998653

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=3.3e-48  Score=364.87  Aligned_cols=255  Identities=20%  Similarity=0.248  Sum_probs=207.8

Q ss_pred             HHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC-hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 019536           52 KATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST-LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTL  130 (339)
Q Consensus        52 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  130 (339)
                      ...++|++.+.||+|+||+||+|.+..+|+.||+|++..... ....+.+.+|+.+++.++||||+++++++.+++..++
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l   87 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL   87 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence            345789999999999999999999999999999999987543 2445678899999999999999999999999999999


Q ss_pred             EEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeC---CCCceEEecCCCccccC
Q 019536          131 VFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLD---ENYSAKLHDFSLSVSIP  205 (339)
Q Consensus       131 v~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~---~~~~~kl~dfg~a~~~~  205 (339)
                      ||||+++|+|.+.+.  ..+++..+..++.||+.||.|||   +.+|+||||||+|||++   .++.+||+|||+++...
T Consensus        88 v~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~  164 (444)
T 3soa_A           88 IFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE  164 (444)
T ss_dssp             EECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred             EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence            999999999988876  57889999999999999999999   89999999999999998   46789999999998775


Q ss_pred             CCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCccccc
Q 019536          206 EGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAI  285 (339)
Q Consensus       206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (339)
                      ......  ....||+.|+|||++.+..|+.++||||+||++|+|++|++||....     ......    ....+..   
T Consensus       165 ~~~~~~--~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~-----~~~~~~----~i~~~~~---  230 (444)
T 3soa_A          165 GEQQAW--FGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED-----QHRLYQ----QIKAGAY---  230 (444)
T ss_dssp             TTCCBC--CCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHH----HHHHTCC---
T ss_pred             CCCcee--ecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc-----HHHHHH----HHHhCCC---
Confidence            543321  13579999999999999899999999999999999999999984211     111111    1111111   


Q ss_pred             ccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          286 VDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                             ..+.+.....+.++.+|+.+||+.||++|||+.+++++
T Consensus       231 -------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          231 -------DFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             -------CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             -------CCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence                   00111112455689999999999999999999999873

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=4.2e-48  Score=341.11  Aligned_cols=255  Identities=20%  Similarity=0.323  Sum_probs=210.5

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFE  133 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  133 (339)
                      .++|++.+.||+|+||+||+|.+. +++.||+|++.....  ..+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE   85 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB--CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             hhhceeeheecCCCccEEEEEEec-CCCeEEEEEeccccc--CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEE
Confidence            468999999999999999999987 678899999986543  34668899999999999999999999999999999999


Q ss_pred             eccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCce
Q 019536          134 SVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH  210 (339)
Q Consensus       134 ~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~  210 (339)
                      |+++|+|.+++.   ..+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++........
T Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  162 (269)
T 4hcu_A           86 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT  162 (269)
T ss_dssp             CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred             eCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEeccccccccccccccc
Confidence            999999999985   45888999999999999999999   899999999999999999999999999999876443221


Q ss_pred             eeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCc
Q 019536          211 VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPI  289 (339)
Q Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (339)
                       ......+|+.|+|||++.+..++.++||||+|+++|+|++ |+.||....        ............         
T Consensus       163 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~--------~~~~~~~~~~~~---------  224 (269)
T 4hcu_A          163 -SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--------NSEVVEDISTGF---------  224 (269)
T ss_dssp             -STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHHHHHHTTC---------
T ss_pred             -cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC--------HHHHHHHHhcCc---------
Confidence             1113456778999999998999999999999999999999 999975221        111111111110         


Q ss_pred             ccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          290 FDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                           ....+...+..+.+++.+||+.||++|||+.++++.|+++.++
T Consensus       225 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~  267 (269)
T 4hcu_A          225 -----RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  267 (269)
T ss_dssp             -----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             -----cCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence                 0111123456799999999999999999999999999999875

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=6.6e-49  Score=355.90  Aligned_cols=256  Identities=20%  Similarity=0.290  Sum_probs=205.9

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCee----EEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRP----ISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTL  130 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~----vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  130 (339)
                      ++|++.+.||+|+||+||+|.+..++..    ||+|.+...........+.+|+.+++.++||||+++++++. ++..++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            6799999999999999999999877765    78888765544344556778999999999999999999986 456889


Q ss_pred             EEEeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCC
Q 019536          131 VFESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEG  207 (339)
Q Consensus       131 v~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~  207 (339)
                      ||||+++|+|.+++.   ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  168 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD  168 (325)
T ss_dssp             EEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred             EEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence            999999999999875   46889999999999999999999   899999999999999999999999999999887655


Q ss_pred             CceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCcccccc
Q 019536          208 ETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIV  286 (339)
Q Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (339)
                      ..........+|..|+|||++.+..++.++|||||||++|+|++ |+.||......     .....    ......    
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-----~~~~~----~~~~~~----  235 (325)
T 3kex_A          169 DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA-----EVPDL----LEKGER----  235 (325)
T ss_dssp             TTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT-----HHHHH----HHTTCB----
T ss_pred             cccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH-----HHHHH----HHcCCC----
Confidence            44333334567889999999999999999999999999999999 99998632211     11111    111100    


Q ss_pred             cCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 019536          287 DPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYL  336 (339)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~  336 (339)
                               .+.+...+..+.+++.+||+.||++|||+.++++.|+++..
T Consensus       236 ---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~  276 (325)
T 3kex_A          236 ---------LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR  276 (325)
T ss_dssp             ---------CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred             ---------CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                     01111233458899999999999999999999999998864

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.9e-48  Score=345.57  Aligned_cols=259  Identities=25%  Similarity=0.340  Sum_probs=201.0

Q ss_pred             HHhcCcccCCceeccCCeeEEEEEEcCC---CeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCcc
Q 019536           52 KATNNYDLHKVIQSDTSYRLFEGTLVDQ---DRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELP  128 (339)
Q Consensus        52 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~  128 (339)
                      ...++|++.+.||+|+||+||+|.+..+   +..||+|.+.........+.+.+|+.+++.++||||+++++++. ++..
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~   90 (281)
T 1mp8_A           12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV   90 (281)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred             EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCcc
Confidence            3457899999999999999999998643   46799999887665566778899999999999999999999985 4568


Q ss_pred             EEEEEeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccC
Q 019536          129 TLVFESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIP  205 (339)
Q Consensus       129 ~lv~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~  205 (339)
                      ++||||+++|+|.+++.   ..+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++...
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  167 (281)
T 1mp8_A           91 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  167 (281)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECccccccccC
Confidence            99999999999999986   35889999999999999999999   8999999999999999999999999999998765


Q ss_pred             CCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCcccc
Q 019536          206 EGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA  284 (339)
Q Consensus       206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (339)
                      ...... .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||......     ......    ....   
T Consensus       168 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~-----~~~~~i----~~~~---  234 (281)
T 1mp8_A          168 DSTYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-----DVIGRI----ENGE---  234 (281)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-----GHHHHH----HTTC---
T ss_pred             cccccc-cccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH-----HHHHHH----HcCC---
Confidence            433221 123456788999999998999999999999999999996 99997532211     111111    1110   


Q ss_pred             cccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                                ..+.+...+..+.+++.+||+.||++|||+.++++.|+++.++
T Consensus       235 ----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  277 (281)
T 1mp8_A          235 ----------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  277 (281)
T ss_dssp             ----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence                      0111224556799999999999999999999999999999764

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=3.9e-48  Score=355.89  Aligned_cols=254  Identities=20%  Similarity=0.285  Sum_probs=208.5

Q ss_pred             HHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 019536           52 KATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS-TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTL  130 (339)
Q Consensus        52 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  130 (339)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l  105 (362)
T 2bdw_A           26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL  105 (362)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            34578999999999999999999999999999999997653 33456778899999999999999999999999999999


Q ss_pred             EEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCC---CceEEecCCCccccC
Q 019536          131 VFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDEN---YSAKLHDFSLSVSIP  205 (339)
Q Consensus       131 v~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~---~~~kl~dfg~a~~~~  205 (339)
                      ||||+++|+|.+++.  ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.+   +.+||+|||+++...
T Consensus       106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~  182 (362)
T 2bdw_A          106 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  182 (362)
T ss_dssp             EECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred             EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence            999999999988876  56888999999999999999999   8999999999999999865   459999999998775


Q ss_pred             CCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCccccc
Q 019536          206 EGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAI  285 (339)
Q Consensus       206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (339)
                      .....   ....||+.|+|||++.+..|+.++|||||||++|+|++|+.||....     ......    ....+..   
T Consensus       183 ~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~-----~~~~~~----~i~~~~~---  247 (362)
T 2bdw_A          183 DSEAW---HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED-----QHRLYA----QIKAGAY---  247 (362)
T ss_dssp             TCCSC---CCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHH----HHHHTCC---
T ss_pred             CCccc---ccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC-----HHHHHH----HHHhCCC---
Confidence            44322   13579999999999999899999999999999999999999985211     111111    1111111   


Q ss_pred             ccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          286 VDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                             ..+.+.....+.++.+|+.+||+.||++|||+.+++++
T Consensus       248 -------~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          248 -------DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             -------CCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             -------CCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                   00111122456689999999999999999999999864

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=3e-48  Score=347.57  Aligned_cols=265  Identities=22%  Similarity=0.296  Sum_probs=209.5

Q ss_pred             cCcccCCceeccCCeeEEEEEE----cCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeC--Ccc
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTL----VDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLET--ELP  128 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~--~~~  128 (339)
                      +.|++.+.||+|+||.||+|.+    ..+++.||+|++.........+.+.+|+.+++.++||||+++++++.+.  +..
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            5689999999999999999994    5688999999998765545667889999999999999999999999876  668


Q ss_pred             EEEEEeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccC
Q 019536          129 TLVFESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIP  205 (339)
Q Consensus       129 ~lv~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~  205 (339)
                      ++||||+++|+|.+++.   ..+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++...
T Consensus       101 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  177 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE  177 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECccccccccc
Confidence            99999999999999984   46899999999999999999999   8999999999999999999999999999998776


Q ss_pred             CCCce-eeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCC------CCCCchhHHHHHHHHhh
Q 019536          206 EGETH-VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGN------GNDDDLTVLEYAKKSIE  278 (339)
Q Consensus       206 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~------~~~~~~~~~~~~~~~~~  278 (339)
                      ..... .......+|..|+|||++.+..++.++||||+|+++|+|++|+.|+.....      .................
T Consensus       178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (302)
T 4e5w_A          178 TDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLK  257 (302)
T ss_dssp             TTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHH
T ss_pred             CCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHh
Confidence            54432 222235678889999999999999999999999999999999988642110      00000011111111111


Q ss_pred             cCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 019536          279 NNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMY  335 (339)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~  335 (339)
                                   .....+.+...+..+.+|+.+||+.||++|||+.++++.|+++.
T Consensus       258 -------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          258 -------------EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             -------------TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -------------ccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence                         11112222345668999999999999999999999999999886

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.1e-48  Score=358.13  Aligned_cols=249  Identities=21%  Similarity=0.278  Sum_probs=201.9

Q ss_pred             HhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC--ChhhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCccE
Q 019536           53 ATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS--TLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLETELPT  129 (339)
Q Consensus        53 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~~  129 (339)
                      ..++|++.+.||+|+||+||+|++..+++.||+|++....  .....+.+.+|..+++.+ +||||+++++++.+.+..+
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  100 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF  100 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence            3578999999999999999999999999999999997642  123456678999999988 7999999999999999999


Q ss_pred             EEEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCC
Q 019536          130 LVFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEG  207 (339)
Q Consensus       130 lv~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~  207 (339)
                      +||||+++|+|.+++.  ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+|+.....
T Consensus       101 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~  177 (353)
T 3txo_A          101 FVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN  177 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence            9999999999999886  67899999999999999999999   899999999999999999999999999999764333


Q ss_pred             CceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCccccccc
Q 019536          208 ETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVD  287 (339)
Q Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (339)
                      ..  .....+||+.|+|||++.+..|+.++||||+||++|+|++|+.||....        ..+....... .       
T Consensus       178 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~--------~~~~~~~i~~-~-------  239 (353)
T 3txo_A          178 GV--TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN--------EDDLFEAILN-D-------  239 (353)
T ss_dssp             ----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHH-C-------
T ss_pred             Cc--cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC--------HHHHHHHHHc-C-------
Confidence            22  2224679999999999998899999999999999999999999985221        1111111111 1       


Q ss_pred             CcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCH------HHHHH
Q 019536          288 PIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLM------VDVAK  329 (339)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~------~~il~  329 (339)
                           ...+|  ...+..+.+|+.+||+.||++||++      .+|++
T Consensus       240 -----~~~~p--~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          240 -----EVVYP--TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             -----CCCCC--TTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             -----CCCCC--CCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence                 11112  2345678999999999999999998      67765

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=3e-48  Score=352.45  Aligned_cols=265  Identities=20%  Similarity=0.320  Sum_probs=216.4

Q ss_pred             HHHHHhcCcccCCceeccCCeeEEEEEEcCCCe-----eEEEEEeccCCChhhHHHHHHHHHHHHhc-CCCceeeeeeee
Q 019536           49 DLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDR-----PISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCC  122 (339)
Q Consensus        49 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~  122 (339)
                      ++....++|++.+.||+|+||+||+|.+..++.     .||+|.+.........+.+.+|+.+++.+ +||||+++++++
T Consensus        40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  119 (333)
T 2i1m_A           40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC  119 (333)
T ss_dssp             GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            344456889999999999999999999976554     79999998776656678899999999999 899999999999


Q ss_pred             eeCCccEEEEEeccCCccccccc----------------cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEE
Q 019536          123 LETELPTLVFESVKYGTLRGFSF----------------ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVL  186 (339)
Q Consensus       123 ~~~~~~~lv~e~~~~g~L~~~~~----------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil  186 (339)
                      .+++..++||||+++|+|.+++.                ..+++..++.++.|++.||.|||   +.+|+||||||+||+
T Consensus       120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl  196 (333)
T 2i1m_A          120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVL  196 (333)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCE
T ss_pred             ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEE
Confidence            99999999999999999999875                24688889999999999999999   899999999999999


Q ss_pred             eCCCCceEEecCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCC
Q 019536          187 LDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDD  265 (339)
Q Consensus       187 ~~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~  265 (339)
                      ++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|+|++ |..||......   
T Consensus       197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---  273 (333)
T 2i1m_A          197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN---  273 (333)
T ss_dssp             EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS---
T ss_pred             ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh---
Confidence            99999999999999987654443333334557888999999999999999999999999999998 99997532211   


Q ss_pred             chhHHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          266 DLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                       .....    ......             ..+.+...+..+.+|+.+||+.||.+|||+.++++.|+++..+
T Consensus       274 -~~~~~----~~~~~~-------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~  327 (333)
T 2i1m_A          274 -SKFYK----LVKDGY-------------QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE  327 (333)
T ss_dssp             -HHHHH----HHHHTC-------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -HHHHH----HHhcCC-------------CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence             11111    111110             0011123345789999999999999999999999999998754

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=2.1e-47  Score=347.32  Aligned_cols=259  Identities=22%  Similarity=0.332  Sum_probs=213.1

Q ss_pred             HhcCcccCCceeccCCeeEEEEEEc-------CCCeeEEEEEeccCCChhhHHHHHHHHHHHHhc-CCCceeeeeeeeee
Q 019536           53 ATNNYDLHKVIQSDTSYRLFEGTLV-------DQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLE  124 (339)
Q Consensus        53 ~~~~~~~~~~ig~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~  124 (339)
                      ..++|++.+.||+|+||+||+|.+.       .++..||+|++...........+.+|+.+++.+ +||||+++++++.+
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  112 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  112 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence            4578999999999999999999985       356789999998776656678889999999999 89999999999999


Q ss_pred             CCccEEEEEeccCCcccccccc------------------CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEE
Q 019536          125 TELPTLVFESVKYGTLRGFSFA------------------SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVL  186 (339)
Q Consensus       125 ~~~~~lv~e~~~~g~L~~~~~~------------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil  186 (339)
                      .+..++||||+++|+|.+++..                  .+++..++.++.|++.||.|||   +.+|+||||||+||+
T Consensus       113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIl  189 (334)
T 2pvf_A          113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVL  189 (334)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEE
T ss_pred             CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceEE
Confidence            9999999999999999998752                  2788889999999999999999   899999999999999


Q ss_pred             eCCCCceEEecCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCC
Q 019536          187 LDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDD  265 (339)
Q Consensus       187 ~~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~  265 (339)
                      ++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|+|++ |..||....     
T Consensus       190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~-----  264 (334)
T 2pvf_A          190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-----  264 (334)
T ss_dssp             ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC-----
T ss_pred             EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC-----
Confidence            99999999999999987765443333334457788999999998899999999999999999999 999975221     


Q ss_pred             chhHHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 019536          266 DLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYL  336 (339)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~  336 (339)
                         ..+.... ......             .+.+..++..+.+++.+||+.||.+|||+.++++.|+++..
T Consensus       265 ---~~~~~~~-~~~~~~-------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~  318 (334)
T 2pvf_A          265 ---VEELFKL-LKEGHR-------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT  318 (334)
T ss_dssp             ---HHHHHHH-HHHTCC-------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---HHHHHHH-HhcCCC-------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence               1111111 111110             01112345679999999999999999999999999999875

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=2.7e-48  Score=349.94  Aligned_cols=269  Identities=19%  Similarity=0.329  Sum_probs=218.8

Q ss_pred             ccHHHHHHHhcCcccCCceeccCCeeEEEEEEc-----CCCeeEEEEEeccCCChhhHHHHHHHHHHHHhc-CCCceeee
Q 019536           45 FSAKDLKKATNNYDLHKVIQSDTSYRLFEGTLV-----DQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKL  118 (339)
Q Consensus        45 ~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~  118 (339)
                      +...++....++|.+.+.||+|+||+||+|.+.     .+++.||+|++...........+.+|+.++..+ +||||+++
T Consensus        17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~   96 (316)
T 2xir_A           17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   96 (316)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence            445566666789999999999999999999863     467899999998776656667889999999999 79999999


Q ss_pred             eeeeeeCC-ccEEEEEeccCCccccccccC------------------CChHHHHHHHHHHHHHHHHHhcCCCCCeEEcc
Q 019536          119 IGCCLETE-LPTLVFESVKYGTLRGFSFAS------------------LLIAPRIKIAMEIANAVAYLHVGFDRPIVFRC  179 (339)
Q Consensus       119 ~~~~~~~~-~~~lv~e~~~~g~L~~~~~~~------------------~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~d  179 (339)
                      ++++...+ ..++||||+++|+|.+++...                  +++..++.++.|++.||.|||   +.+|+|||
T Consensus        97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~d  173 (316)
T 2xir_A           97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRD  173 (316)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCSC
T ss_pred             EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCccccc
Confidence            99988754 589999999999999987621                  678889999999999999999   89999999


Q ss_pred             CCCCCEEeCCCCceEEecCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCcccc
Q 019536          180 IKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEF  258 (339)
Q Consensus       180 lk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~  258 (339)
                      |||+||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|+|++ |..||..
T Consensus       174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~  253 (316)
T 2xir_A          174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  253 (316)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence            999999999999999999999987755544334445567889999999999999999999999999999998 9999753


Q ss_pred             CCCCCCCchhHHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          259 KGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                      ....    ......    ......             .+.+...+..+.+++.+||+.||.+|||+.++++.|+.+..+
T Consensus       254 ~~~~----~~~~~~----~~~~~~-------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  311 (316)
T 2xir_A          254 VKID----EEFCRR----LKEGTR-------------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  311 (316)
T ss_dssp             CCCS----HHHHHH----HHHTCC-------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cchh----HHHHHH----hccCcc-------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence            2211    111111    111110             011123445799999999999999999999999999998864

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=4e-48  Score=351.96  Aligned_cols=247  Identities=19%  Similarity=0.228  Sum_probs=205.0

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC--hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST--LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLV  131 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  131 (339)
                      .++|.+.+.||+|+||+||+|.+..+++.||+|++.....  ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            4789999999999999999999999999999999865311  12235678999999999999999999999999999999


Q ss_pred             EEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCc
Q 019536          132 FESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGET  209 (339)
Q Consensus       132 ~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~  209 (339)
                      |||+ +|+|.+++.  ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||++........
T Consensus        88 ~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~  163 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF  163 (336)
T ss_dssp             ECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT
T ss_pred             EECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCcc
Confidence            9999 678888775  67899999999999999999999   89999999999999999999999999999987655432


Q ss_pred             eeeecccccccccccccccccCCC-CcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccC
Q 019536          210 HVREEFIKGAYGFIAPEYFATSSF-NEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDP  288 (339)
Q Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (339)
                      ..   ..+||+.|+|||++.+..+ +.++||||+||++|+|++|+.||.......                     +...
T Consensus       164 ~~---~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~---------------------~~~~  219 (336)
T 3h4j_B          164 LK---TSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN---------------------LFKK  219 (336)
T ss_dssp             TC---CCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT---------------------CBCC
T ss_pred             cc---cccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH---------------------HHHH
Confidence            21   3569999999999988876 689999999999999999999986322211                     1111


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          289 IFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      ........  +...+..+.+|+.+||+.||.+|||+.|++++
T Consensus       220 i~~~~~~~--p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  259 (336)
T 3h4j_B          220 VNSCVYVM--PDFLSPGAQSLIRRMIVADPMQRITIQEIRRD  259 (336)
T ss_dssp             CCSSCCCC--CTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred             HHcCCCCC--cccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence            11111112  22456679999999999999999999999863

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=4.9e-48  Score=349.02  Aligned_cols=245  Identities=20%  Similarity=0.318  Sum_probs=205.7

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC--hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST--LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLV  131 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  131 (339)
                      .++|++.+.||+|+||+||+|....+|+.||+|++.....  ....+.+.+|..+++.++||||+++++++.+.+..++|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            4689999999999999999999999999999999976421  13456778999999999999999999999999999999


Q ss_pred             EEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCc
Q 019536          132 FESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGET  209 (339)
Q Consensus       132 ~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~  209 (339)
                      |||+++|+|.+++.  ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus        85 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~~  161 (318)
T 1fot_A           85 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY  161 (318)
T ss_dssp             ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCBC
T ss_pred             EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecCCccc
Confidence            99999999999986  56889999999999999999999   99999999999999999999999999999987644321


Q ss_pred             eeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCc
Q 019536          210 HVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPI  289 (339)
Q Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (339)
                           ..+||+.|+|||++.+..++.++|+||+||++|+|++|+.||....        .......... .         
T Consensus       162 -----~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--------~~~~~~~i~~-~---------  218 (318)
T 1fot_A          162 -----TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN--------TMKTYEKILN-A---------  218 (318)
T ss_dssp             -----CCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHH-C---------
T ss_pred             -----cccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC--------HHHHHHHHHh-C---------
Confidence                 3579999999999999999999999999999999999999985211        1111111111 1         


Q ss_pred             ccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 019536          290 FDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP-----LMVDVAK  329 (339)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~il~  329 (339)
                         ...+|  ...+.++.+|+.+||+.||++||     ++.++++
T Consensus       219 ---~~~~p--~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          219 ---ELRFP--PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             ---CCCCC--TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             ---CCCCC--CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence               11111  23456799999999999999999     8888875

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.8e-47  Score=346.52  Aligned_cols=250  Identities=19%  Similarity=0.280  Sum_probs=201.0

Q ss_pred             HhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC------
Q 019536           53 ATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETE------  126 (339)
Q Consensus        53 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~------  126 (339)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++.........+.+.+|+.+++.++||||++++++|.+.+      
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   83 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE   83 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence            35789999999999999999999999999999999987655556788999999999999999999999986644      


Q ss_pred             ---------------------------------------------------ccEEEEEeccCCcccccccc-----CCCh
Q 019536          127 ---------------------------------------------------LPTLVFESVKYGTLRGFSFA-----SLLI  150 (339)
Q Consensus       127 ---------------------------------------------------~~~lv~e~~~~g~L~~~~~~-----~~~~  150 (339)
                                                                         ..++||||+++|+|.+++..     ..++
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~  163 (332)
T 3qd2_B           84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH  163 (332)
T ss_dssp             HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred             hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence                                                               27899999999999999863     3455


Q ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCce----------eeeccccccc
Q 019536          151 APRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH----------VREEFIKGAY  220 (339)
Q Consensus       151 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~----------~~~~~~~gt~  220 (339)
                      ..++.++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++........          .......||+
T Consensus       164 ~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  240 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK  240 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred             HHHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence            567899999999999999   899999999999999999999999999999877654221          1112346899


Q ss_pred             ccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCCCCCC-Cc
Q 019536          221 GFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFP-GK  299 (339)
Q Consensus       221 ~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  299 (339)
                      .|+|||++.+..++.++|||||||++|+|++|..|+.          ........ .....              .| ..
T Consensus       241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~----------~~~~~~~~-~~~~~--------------~~~~~  295 (332)
T 3qd2_B          241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM----------ERVRIITD-VRNLK--------------FPLLF  295 (332)
T ss_dssp             GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH----------HHHHHHHH-HHTTC--------------CCHHH
T ss_pred             CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh----------HHHHHHHH-hhccC--------------CCccc
Confidence            9999999999999999999999999999999877642          11111111 11111              11 11


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          300 EEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       300 ~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      ...+..+.+|+.+||+.||++|||+.+++++
T Consensus       296 ~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~  326 (332)
T 3qd2_B          296 TQKYPQEHMMVQDMLSPSPTERPEATDIIEN  326 (332)
T ss_dssp             HHHCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred             ccCChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence            2455678999999999999999999999873

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=4e-47  Score=339.47  Aligned_cols=262  Identities=13%  Similarity=0.092  Sum_probs=212.3

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCccEEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLETELPTLVF  132 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~~lv~  132 (339)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++.....   .+.+.+|+.+++.+ +|+|++++++++.++...++||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~   85 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI   85 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc---cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence            3679999999999999999999988999999999876533   23466899999999 7999999999999999999999


Q ss_pred             EeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCc-----eEEecCCCcccc
Q 019536          133 ESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYS-----AKLHDFSLSVSI  204 (339)
Q Consensus       133 e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~-----~kl~dfg~a~~~  204 (339)
                      ||+ +++|.+++.   ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.     +||+|||+++..
T Consensus        86 e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~  161 (298)
T 1csn_A           86 DLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  161 (298)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             Eec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence            999 999999986   35899999999999999999999   999999999999999987765     999999999877


Q ss_pred             CCCCce-----eeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhc
Q 019536          205 PEGETH-----VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIEN  279 (339)
Q Consensus       205 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  279 (339)
                      ......     .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.......  ..............
T Consensus       162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~  239 (298)
T 1csn_A          162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT--NKQKYERIGEKKQS  239 (298)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCC--HHHHHHHHHHHHHH
T ss_pred             ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccc--cHHHHHHHHhhccC
Confidence            554321     11224568999999999999999999999999999999999999986433221  22222221111111


Q ss_pred             CcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          280 NRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                      .....+             ....+..+.+|+.+||+.||++|||+.+|++.|+++..+
T Consensus       240 ~~~~~~-------------~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~  284 (298)
T 1csn_A          240 TPLREL-------------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER  284 (298)
T ss_dssp             SCHHHH-------------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             ccHHHH-------------HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHh
Confidence            111000             012345799999999999999999999999999998865

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=8.2e-48  Score=348.94  Aligned_cols=250  Identities=20%  Similarity=0.208  Sum_probs=206.5

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCCh-----hhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCcc
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTL-----DDVEYCFNNIVFSSQMKHKNILKLIGCCLETELP  128 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~  128 (339)
                      .+.|.+.+.||+|+||.||+|.+..+++.||+|.+......     ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            36799999999999999999999999999999998765331     1467788999999999999999999999999999


Q ss_pred             EEEEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCC----ceEEecCCCcc
Q 019536          129 TLVFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENY----SAKLHDFSLSV  202 (339)
Q Consensus       129 ~lv~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~----~~kl~dfg~a~  202 (339)
                      ++||||+++|+|.+++.  ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++    .+||+|||+++
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~  166 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH  166 (326)
T ss_dssp             EEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             EEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence            99999999999999986  56889999999999999999999   89999999999999998877    79999999998


Q ss_pred             ccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcc
Q 019536          203 SIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRF  282 (339)
Q Consensus       203 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (339)
                      ........   ....||+.|+|||++.+..++.++|||||||++|+|++|+.||....        ..+....... .. 
T Consensus       167 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~~~~~-~~-  233 (326)
T 2y0a_A          167 KIDFGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--------KQETLANVSA-VN-  233 (326)
T ss_dssp             ECCTTSCC---CCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS--------HHHHHHHHHH-TC-
T ss_pred             ECCCCCcc---ccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC--------HHHHHHHHHh-cC-
Confidence            77543322   13568999999999998899999999999999999999999975211        1111111111 00 


Q ss_pred             cccccCcccCCCCCCC--cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          283 GAIVDPIFDEDNSFPG--KEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       283 ~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                                 ..++.  ....+..+.+|+.+||+.||++|||+.+++++
T Consensus       234 -----------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  272 (326)
T 2y0a_A          234 -----------YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  272 (326)
T ss_dssp             -----------CCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             -----------CCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                       00010  11334678999999999999999999999873

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=9.1e-48  Score=343.10  Aligned_cols=267  Identities=17%  Similarity=0.216  Sum_probs=203.9

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC-hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST-LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFE  133 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  133 (339)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++..... ......+.+|+.+++.++||||+++++++.+++..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            579999999999999999999999999999999976543 2345778899999999999999999999999999999999


Q ss_pred             eccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCcee
Q 019536          134 SVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHV  211 (339)
Q Consensus       134 ~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~  211 (339)
                      |++++.+..+..  ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++.........
T Consensus        82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  158 (292)
T 3o0g_A           82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY  158 (292)
T ss_dssp             CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCC
T ss_pred             cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccccc
Confidence            998644443332  57899999999999999999999   8999999999999999999999999999998765433221


Q ss_pred             eecccccccccccccccccCC-CCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhh---cCccccccc
Q 019536          212 REEFIKGAYGFIAPEYFATSS-FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIE---NNRFGAIVD  287 (339)
Q Consensus       212 ~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  287 (339)
                        ....||+.|+|||++.+.. ++.++||||+||++|+|++|..||. .+...   ............   ...+.....
T Consensus       159 --~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~-~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~  232 (292)
T 3o0g_A          159 --SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF-PGNDV---DDQLKRIFRLLGTPTEEQWPSMTK  232 (292)
T ss_dssp             --CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSC-CCSSH---HHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred             --cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCc-CCCCH---HHHHHHHHHHhCCCChhhhhhhcc
Confidence              2356899999999997765 8999999999999999999888863 22211   112222111111   111111000


Q ss_pred             -------CcccCCCC-CCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          288 -------PIFDEDNS-FPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       288 -------~~~~~~~~-~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                             +....... .......+..+.+|+.+||+.||++|||+.|++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  283 (292)
T 3o0g_A          233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence                   00000000 00112355678999999999999999999999863

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.9e-48  Score=352.03  Aligned_cols=257  Identities=18%  Similarity=0.308  Sum_probs=203.5

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCee----EEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRP----ISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPT  129 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~----vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~  129 (339)
                      .++|++.+.||+|+||+||+|.+..+++.    ||+|.+...........+.+|+.+++.++||||+++++++..+. .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            36899999999999999999999877764    57777766555566788999999999999999999999998765 78


Q ss_pred             EEEEeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCC
Q 019536          130 LVFESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPE  206 (339)
Q Consensus       130 lv~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~  206 (339)
                      +|+||+++|+|.+++.   ..+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus        93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~  169 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence            9999999999999875   46889999999999999999999   89999999999999999999999999999987755


Q ss_pred             CCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCccccc
Q 019536          207 GETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAI  285 (339)
Q Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (339)
                      ...........+|+.|+|||++.+..++.++|||||||++|+|++ |+.||......     .......    .      
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-----~~~~~~~----~------  234 (327)
T 3lzb_A          170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-----EISSILE----K------  234 (327)
T ss_dssp             ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-----GHHHHHH----T------
T ss_pred             ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH-----HHHHHHH----c------
Confidence            443333334456788999999999999999999999999999999 99997532211     1111111    0      


Q ss_pred             ccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 019536          286 VDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYL  336 (339)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~  336 (339)
                             ....+.+...+..+.+|+.+||+.||.+|||+.++++.|+++..
T Consensus       235 -------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  278 (327)
T 3lzb_A          235 -------GERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             -------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred             -------CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence                   01112223455679999999999999999999999999999874

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=2.4e-48  Score=371.40  Aligned_cols=260  Identities=21%  Similarity=0.340  Sum_probs=215.2

Q ss_pred             HHHHHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCcc
Q 019536           49 DLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELP  128 (339)
Q Consensus        49 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~  128 (339)
                      .++...++|++.+.||+|+||.||+|.+..++..||||.+....  ...+.+.+|+.++++++||||++++++|.+.+..
T Consensus       214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  291 (495)
T 1opk_A          214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF  291 (495)
T ss_dssp             CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             ccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc--cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcE
Confidence            34445578999999999999999999999889999999997653  3467789999999999999999999999999999


Q ss_pred             EEEEEeccCCccccccc----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCcccc
Q 019536          129 TLVFESVKYGTLRGFSF----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSI  204 (339)
Q Consensus       129 ~lv~e~~~~g~L~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~  204 (339)
                      ++||||+++|+|.+++.    ..+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       292 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  368 (495)
T 1opk_A          292 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLM  368 (495)
T ss_dssp             EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred             EEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceec
Confidence            99999999999999985    35788889999999999999999   899999999999999999999999999999876


Q ss_pred             CCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCccc
Q 019536          205 PEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFG  283 (339)
Q Consensus       205 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (339)
                      ...... ......++..|+|||++.+..++.++|||||||++|||++ |..||.....     ........    ..   
T Consensus       369 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~-----~~~~~~~~----~~---  435 (495)
T 1opk_A          369 TGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----SQVYELLE----KD---  435 (495)
T ss_dssp             TTCCEE-CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG-----GGHHHHHH----TT---
T ss_pred             cCCcee-ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHH----cC---
Confidence            543322 2223446778999999998999999999999999999999 9999753221     11111111    10   


Q ss_pred             ccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 019536          284 AIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYL  336 (339)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~  336 (339)
                                ...+.+..++..+.+||.+||+.||++|||+.+|++.|+.+..
T Consensus       436 ----------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~  478 (495)
T 1opk_A          436 ----------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  478 (495)
T ss_dssp             ----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred             ----------CCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence                      1112223455679999999999999999999999999998764

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=4.2e-48  Score=350.04  Aligned_cols=262  Identities=23%  Similarity=0.366  Sum_probs=195.2

Q ss_pred             HHHhcCcccCCceeccCCeeEEEEEEcCCCe---eEEEEEeccCC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC
Q 019536           51 KKATNNYDLHKVIQSDTSYRLFEGTLVDQDR---PISVMKFHDNS-TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETE  126 (339)
Q Consensus        51 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~---~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~  126 (339)
                      ....++|++.+.||+|+||+||+|.+..++.   .||+|++.... .....+.+.+|+.+++.++||||+++++++....
T Consensus        19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   98 (323)
T 3qup_A           19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR   98 (323)
T ss_dssp             BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred             ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence            3345789999999999999999999876665   89999987653 2355678899999999999999999999998776


Q ss_pred             cc------EEEEEeccCCcccccccc--------CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCc
Q 019536          127 LP------TLVFESVKYGTLRGFSFA--------SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYS  192 (339)
Q Consensus       127 ~~------~lv~e~~~~g~L~~~~~~--------~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~  192 (339)
                      ..      ++||||+++|+|.+++..        .+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.
T Consensus        99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~  175 (323)
T 3qup_A           99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMT  175 (323)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSC
T ss_pred             cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCCC
Confidence            55      899999999999998751        5888999999999999999999   899999999999999999999


Q ss_pred             eEEecCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHH
Q 019536          193 AKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLE  271 (339)
Q Consensus       193 ~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~  271 (339)
                      +||+|||+++...............+++.|+|||.+.+..++.++|||||||++|+|++ |..||.....     .....
T Consensus       176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~-----~~~~~  250 (323)
T 3qup_A          176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN-----AEIYN  250 (323)
T ss_dssp             EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----GGHHH
T ss_pred             EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccCh-----HHHHH
Confidence            99999999987655433322223456788999999999999999999999999999999 8999753221     11111


Q ss_pred             HHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          272 YAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                      .   .....              ..+.+...+..+.+|+.+||+.||++|||+.++++.|+++...
T Consensus       251 ~---~~~~~--------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~  299 (323)
T 3qup_A          251 Y---LIGGN--------------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH  299 (323)
T ss_dssp             H---HHTTC--------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             H---HhcCC--------------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            1   11110              0111224456799999999999999999999999999998753

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2.2e-47  Score=346.58  Aligned_cols=261  Identities=13%  Similarity=0.118  Sum_probs=211.2

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCccEEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLETELPTLVF  132 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~~lv~  132 (339)
                      .++|++.+.||+|+||+||+|.+..+++.||||.+.....   .+.+.+|+.+++.+ +||||+++++++.+++..++||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~   84 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR---APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL   84 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS---SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc---hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence            3689999999999999999999988999999999876543   23467899999999 9999999999999999999999


Q ss_pred             EeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCc-----eEEecCCCcccc
Q 019536          133 ESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYS-----AKLHDFSLSVSI  204 (339)
Q Consensus       133 e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~-----~kl~dfg~a~~~  204 (339)
                      ||+ +++|.+++.   ..+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.     +||+|||+++.+
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~  160 (330)
T 2izr_A           85 ELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY  160 (330)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred             EeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence            999 999999876   57899999999999999999999   899999999999999998887     999999999876


Q ss_pred             CCCCcee-----eecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhc
Q 019536          205 PEGETHV-----REEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIEN  279 (339)
Q Consensus       205 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  279 (339)
                      .......     ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......  ...............
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~--~~~~~~~~i~~~~~~  238 (330)
T 2izr_A          161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKAD--TLKERYQKIGDTKRA  238 (330)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCS--SHHHHHHHHHHHHHH
T ss_pred             ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccc--cHHHHHHHHHhhhcc
Confidence            5433211     112467999999999999999999999999999999999999998643221  222222221111111


Q ss_pred             CcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          280 NRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                      ......             ....+ ++.+++..||+.||.+||++.+|++.|+++...
T Consensus       239 ~~~~~~-------------~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~  282 (330)
T 2izr_A          239 TPIEVL-------------CENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDR  282 (330)
T ss_dssp             SCHHHH-------------TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             CCHHHH-------------hccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHH
Confidence            000000             00123 799999999999999999999999999988754

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.7e-47  Score=361.55  Aligned_cols=250  Identities=21%  Similarity=0.308  Sum_probs=206.6

Q ss_pred             HhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC-ccEEE
Q 019536           53 ATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETE-LPTLV  131 (339)
Q Consensus        53 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~-~~~lv  131 (339)
                      ..++|++.+.||+|+||.||+|.+  .++.||||+++...   ..+.+.+|+.++++++||||+++++++.+.. ..++|
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv  265 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV  265 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEE
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEE
Confidence            447899999999999999999998  57899999998653   4567889999999999999999999987765 78999


Q ss_pred             EEeccCCcccccccc----CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCC
Q 019536          132 FESVKYGTLRGFSFA----SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEG  207 (339)
Q Consensus       132 ~e~~~~g~L~~~~~~----~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~  207 (339)
                      |||+++|+|.+++..    .++...++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus       266 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  342 (450)
T 1k9a_A          266 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  342 (450)
T ss_dssp             EECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc
Confidence            999999999999862    3688889999999999999999   899999999999999999999999999999865332


Q ss_pred             CceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCcccccc
Q 019536          208 ETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIV  286 (339)
Q Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (339)
                      ..     ...++..|+|||++.+..++.++|||||||++|||++ |+.||.......     .....    ..+      
T Consensus       343 ~~-----~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-----~~~~i----~~~------  402 (450)
T 1k9a_A          343 QD-----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-----VVPRV----EKG------  402 (450)
T ss_dssp             ---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT-----HHHHH----HTT------
T ss_pred             cc-----CCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHH----HcC------
Confidence            21     2356788999999999999999999999999999998 999986332211     11111    111      


Q ss_pred             cCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          287 DPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                             ...+.+..++..+.+||.+||+.||++|||+.++++.|+.+...
T Consensus       403 -------~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~  446 (450)
T 1k9a_A          403 -------YKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH  446 (450)
T ss_dssp             -------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             -------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence                   11122234566899999999999999999999999999998764

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=2.1e-48  Score=346.18  Aligned_cols=259  Identities=22%  Similarity=0.343  Sum_probs=216.2

Q ss_pred             HHHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 019536           51 KKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTL  130 (339)
Q Consensus        51 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  130 (339)
                      ....++|++.+.||+|+||+||+|.+..++..||+|.+....  ...+.+.+|+.+++.++||||+++++++.+++..++
T Consensus         9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   86 (288)
T 3kfa_A            9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI   86 (288)
T ss_dssp             BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS--THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred             cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEE
Confidence            345678999999999999999999999899999999997643  456778899999999999999999999999999999


Q ss_pred             EEEeccCCccccccc----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCC
Q 019536          131 VFESVKYGTLRGFSF----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPE  206 (339)
Q Consensus       131 v~e~~~~g~L~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~  206 (339)
                      ||||+++++|.+++.    ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||++.....
T Consensus        87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~  163 (288)
T 3kfa_A           87 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG  163 (288)
T ss_dssp             EEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred             EEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence            999999999999985    45888899999999999999999   89999999999999999999999999999987755


Q ss_pred             CCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCccccc
Q 019536          207 GETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAI  285 (339)
Q Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (339)
                      .... ......+|+.|+|||++.+..++.++||||+|+++|+|++ |..||.....     .........    .     
T Consensus       164 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~-----~~~~~~~~~----~-----  228 (288)
T 3kfa_A          164 DTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----SQVYELLEK----D-----  228 (288)
T ss_dssp             SSSE-EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG-----GGHHHHHHT----T-----
T ss_pred             Cccc-cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHhc----c-----
Confidence            4432 2224557888999999999999999999999999999999 9999753221     111111111    0     


Q ss_pred             ccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          286 VDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                              ...+.+...+..+.+|+.+||+.||.+|||+.++++.|+++..+
T Consensus       229 --------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~  272 (288)
T 3kfa_A          229 --------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  272 (288)
T ss_dssp             --------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --------CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence                    01111224456799999999999999999999999999998764

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=5.1e-48  Score=349.26  Aligned_cols=266  Identities=18%  Similarity=0.320  Sum_probs=217.6

Q ss_pred             ccHHHHHHHhcCcccCCceeccCCeeEEEEEEc-----CCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeee
Q 019536           45 FSAKDLKKATNNYDLHKVIQSDTSYRLFEGTLV-----DQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLI  119 (339)
Q Consensus        45 ~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~  119 (339)
                      +..+++....++|++.+.||+|+||.||+|.+.     .+++.||+|.+...........+.+|+.+++.++||||++++
T Consensus        15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~   94 (322)
T 1p4o_A           15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL   94 (322)
T ss_dssp             CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred             cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence            444566667789999999999999999999876     357889999998766556667789999999999999999999


Q ss_pred             eeeeeCCccEEEEEeccCCccccccc------------cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEe
Q 019536          120 GCCLETELPTLVFESVKYGTLRGFSF------------ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLL  187 (339)
Q Consensus       120 ~~~~~~~~~~lv~e~~~~g~L~~~~~------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~  187 (339)
                      +++.+++..++||||+++|+|.+++.            ..+++..++.++.|++.||.|||   +.+|+||||||+||++
T Consensus        95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli  171 (322)
T 1p4o_A           95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMV  171 (322)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEE
T ss_pred             EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEE
Confidence            99999999999999999999999875            24578889999999999999999   8999999999999999


Q ss_pred             CCCCceEEecCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCc
Q 019536          188 DENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDD  266 (339)
Q Consensus       188 ~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~  266 (339)
                      +.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|+|++ |..||....      
T Consensus       172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~------  245 (322)
T 1p4o_A          172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS------  245 (322)
T ss_dssp             CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC------
T ss_pred             cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC------
Confidence            9999999999999987654433322223456888999999999999999999999999999999 888875221      


Q ss_pred             hhHHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 019536          267 LTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMY  335 (339)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~  335 (339)
                        .......... ...             .+.+...+..+.+|+.+||+.||++|||+.++++.|+++.
T Consensus       246 --~~~~~~~~~~-~~~-------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~  298 (322)
T 1p4o_A          246 --NEQVLRFVME-GGL-------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM  298 (322)
T ss_dssp             --HHHHHHHHHT-TCC-------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred             --HHHHHHHHHc-CCc-------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence              1111111111 110             0111244567999999999999999999999999998875

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=5.3e-48  Score=354.94  Aligned_cols=252  Identities=19%  Similarity=0.206  Sum_probs=196.9

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFE  133 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  133 (339)
                      .++|++.+.||+|+||+||+|....+++.||+|++.....  ..+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e   96 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME   96 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT--SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc--ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence            4789999999999999999999999999999999976532  23567799999999999999999999999999999999


Q ss_pred             eccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCc--eEEecCCCccccCCCCc
Q 019536          134 SVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYS--AKLHDFSLSVSIPEGET  209 (339)
Q Consensus       134 ~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~--~kl~dfg~a~~~~~~~~  209 (339)
                      |+++|+|.+++.  ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.  +||+|||+++.......
T Consensus        97 ~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~  173 (361)
T 3uc3_A           97 YASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ  173 (361)
T ss_dssp             CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred             eCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCC
Confidence            999999999875  67899999999999999999999   899999999999999987765  99999999875433222


Q ss_pred             eeeecccccccccccccccccCCCCcc-cchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccC
Q 019536          210 HVREEFIKGAYGFIAPEYFATSSFNEM-CDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDP  288 (339)
Q Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (339)
                      .   ....||+.|+|||++.+..++.+ +||||+||++|+|++|+.||.......  .  ..........          
T Consensus       174 ~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~--~~~~~~~~~~----------  236 (361)
T 3uc3_A          174 P---KSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR--D--YRKTIQRILS----------  236 (361)
T ss_dssp             ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC--C--HHHHHHHHHT----------
T ss_pred             C---CCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH--H--HHHHHHHHhc----------
Confidence            1   23569999999999988887655 899999999999999999986433221  1  1111111111          


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          289 IFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                         .....|.....+..+.+|+.+||+.||++|||+.+++++
T Consensus       237 ---~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          237 ---VKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             ---TCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             ---CCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence               111122222345678999999999999999999999874

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=6.9e-48  Score=352.50  Aligned_cols=245  Identities=17%  Similarity=0.225  Sum_probs=206.3

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC--ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS--TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLV  131 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  131 (339)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++....  .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            378999999999999999999999999999999986542  113456788999999999999999999999999999999


Q ss_pred             EEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCc
Q 019536          132 FESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGET  209 (339)
Q Consensus       132 ~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~  209 (339)
                      |||+++|+|.+++.  ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus       120 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~~  196 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW  196 (350)
T ss_dssp             EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCBC
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceeccCCcc
Confidence            99999999999986  57899999999999999999999   89999999999999999999999999999987654322


Q ss_pred             eeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCc
Q 019536          210 HVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPI  289 (339)
Q Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (339)
                           ...||+.|+|||++.+..++.++|||||||++|+|++|+.||....        .......... +.        
T Consensus       197 -----~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--------~~~~~~~i~~-~~--------  254 (350)
T 1rdq_E          197 -----TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ--------PIQIYEKIVS-GK--------  254 (350)
T ss_dssp             -----CCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHH-CC--------
T ss_pred             -----cccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC--------HHHHHHHHHc-CC--------
Confidence                 3579999999999999999999999999999999999999985221        1111111111 11        


Q ss_pred             ccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 019536          290 FDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPL-----MVDVAK  329 (339)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps-----~~~il~  329 (339)
                          ..+|  ...+..+.+|+.+||+.||++||+     +.+|++
T Consensus       255 ----~~~p--~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          255 ----VRFP--SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             ----CCCC--TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             ----CCCC--CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence                1111  234567999999999999999998     788775

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=4.9e-47  Score=339.35  Aligned_cols=261  Identities=20%  Similarity=0.308  Sum_probs=202.6

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHh--cCCCceeeeeeeeeeC----Cc
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQ--MKHKNILKLIGCCLET----EL  127 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~--l~H~niv~~~~~~~~~----~~  127 (339)
                      .++|++.+.||+|+||+||+|.+  +++.||||++..    .....+.+|.+++..  ++||||+++++++.+.    ..
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~----~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~   80 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSS----RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ   80 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECG----GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecc----ccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence            47899999999999999999998  789999999865    334556677777766  7999999999997653    45


Q ss_pred             cEEEEEeccCCccccccc-cCCChHHHHHHHHHHHHHHHHHhcCC-----CCCeEEccCCCCCEEeCCCCceEEecCCCc
Q 019536          128 PTLVFESVKYGTLRGFSF-ASLLIAPRIKIAMEIANAVAYLHVGF-----DRPIVFRCIKASNVLLDENYSAKLHDFSLS  201 (339)
Q Consensus       128 ~~lv~e~~~~g~L~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~-----~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a  201 (339)
                      .++||||+++|+|.+++. ..+++..++.++.|++.||.|||...     +.+|+||||||+|||++.++.+||+|||++
T Consensus        81 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  160 (301)
T 3q4u_A           81 LWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA  160 (301)
T ss_dssp             EEEEECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             eEEehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCe
Confidence            789999999999999987 57899999999999999999999321     468999999999999999999999999999


Q ss_pred             cccCCCCceee--ecccccccccccccccccC------CCCcccchHHHHHHHHHHHhC----------CCccccCCCCC
Q 019536          202 VSIPEGETHVR--EEFIKGAYGFIAPEYFATS------SFNEMCDVYSFGAFLCELLTG----------CNVLEFKGNGN  263 (339)
Q Consensus       202 ~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~~l~el~~g----------~~p~~~~~~~~  263 (339)
                      +..........  .....||+.|+|||++.+.      .++.++|||||||++|+|++|          +.||.......
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~  240 (301)
T 3q4u_A          161 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND  240 (301)
T ss_dssp             EEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             eecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCC
Confidence            87655433211  1234689999999999876      455799999999999999999          77764332222


Q ss_pred             CCchhHHHHHHHHhhcCcccccccCcccCCCCCC---CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 019536          264 DDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFP---GKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQM  334 (339)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l  334 (339)
                      ... ...  ..........           ...|   .....+..+.+|+.+||+.||++|||+.+|++.|+++
T Consensus       241 ~~~-~~~--~~~~~~~~~~-----------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          241 PSF-EDM--RKVVCVDQQR-----------PNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             CCH-HHH--HHHHTTSCCC-----------CCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cch-hhh--hHHHhccCCC-----------CCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            111 111  1111111100           0111   1125678899999999999999999999999999976

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.4e-47  Score=353.89  Aligned_cols=277  Identities=17%  Similarity=0.216  Sum_probs=217.0

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC--ccEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETE--LPTLV  131 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~--~~~lv  131 (339)
                      .++|.+.+.||+|+||+||+|.+..+++.||||++.........+.+.+|+.+++.++||||+++++++.+.+  ..++|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            3679999999999999999999998999999999987554455677889999999999999999999998755  67999


Q ss_pred             EEeccCCcccccccc-----CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEe----CCCCceEEecCCCcc
Q 019536          132 FESVKYGTLRGFSFA-----SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLL----DENYSAKLHDFSLSV  202 (339)
Q Consensus       132 ~e~~~~g~L~~~~~~-----~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~----~~~~~~kl~dfg~a~  202 (339)
                      |||+++|+|.+++..     .+++..++.++.|++.||.|||   +.+|+||||||+||++    +.++.+||+|||+++
T Consensus        88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            999999999999862     2899999999999999999999   8999999999999999    778889999999998


Q ss_pred             ccCCCCceeeeccccccccccccccccc--------CCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHH
Q 019536          203 SIPEGETHVREEFIKGAYGFIAPEYFAT--------SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAK  274 (339)
Q Consensus       203 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~  274 (339)
                      .........   ...||..|+|||++.+        ..++.++|||||||++|+|++|+.||........ .........
T Consensus       165 ~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~-~~~~~~~~~  240 (396)
T 4eut_A          165 ELEDDEQFV---SLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR-NKEVMYKII  240 (396)
T ss_dssp             ECCCGGGSS---CSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTT-CHHHHHHHH
T ss_pred             EccCCCccc---cccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccc-hHHHHHHHh
Confidence            765543221   3568999999999865        5678899999999999999999999864333221 222222211


Q ss_pred             HHhhcCccccc---ccCccc--CC--CCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          275 KSIENNRFGAI---VDPIFD--ED--NSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       275 ~~~~~~~~~~~---~~~~~~--~~--~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                      .......+..+   ....+.  ..  .........+..+.+++.+||+.||++|||+.++++.++++...
T Consensus       241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence            11111111100   000000  00  11122356788899999999999999999999999999988753

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1e-47  Score=338.88  Aligned_cols=251  Identities=26%  Similarity=0.367  Sum_probs=195.4

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC---hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST---LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTL  130 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  130 (339)
                      .++|++.+.||+|+||+||+|.+  .+..||+|++.....   ....+.+.+|+.+++.++||||+++++++.+++..++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL   83 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence            46899999999999999999998  589999999876432   2335678899999999999999999999999999999


Q ss_pred             EEEeccCCccccccc-cCCChHHHHHHHHHHHHHHHHHhcCCCCC---eEEccCCCCCEEeCC--------CCceEEecC
Q 019536          131 VFESVKYGTLRGFSF-ASLLIAPRIKIAMEIANAVAYLHVGFDRP---IVFRCIKASNVLLDE--------NYSAKLHDF  198 (339)
Q Consensus       131 v~e~~~~g~L~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~---i~H~dlk~~Nil~~~--------~~~~kl~df  198 (339)
                      ||||+++++|.+++. ..+++..+..++.|++.||.|||   +.+   |+||||||+||+++.        ++.+||+||
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           84 VMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             EEECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EEEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            999999999999886 67899999999999999999999   777   999999999999985        678999999


Q ss_pred             CCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhh
Q 019536          199 SLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIE  278 (339)
Q Consensus       199 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  278 (339)
                      |+++........    ...||+.|+|||.+.+..++.++||||||+++|+|++|+.||....        ..........
T Consensus       161 g~~~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~~~~~~~~~~  228 (271)
T 3dtc_A          161 GLAREWHRTTKM----SAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID--------GLAVAYGVAM  228 (271)
T ss_dssp             CC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSC--------HHHHHHHHHT
T ss_pred             Cccccccccccc----CCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHhhhc
Confidence            999866543322    3468999999999999999999999999999999999999985221        1111111111


Q ss_pred             cCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 019536          279 NNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQM  334 (339)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l  334 (339)
                      ..             ...+.+...+..+.+++.+||+.||++|||+.++++.|++|
T Consensus       229 ~~-------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          229 NK-------------LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             SC-------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             CC-------------CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            10             11112234556799999999999999999999999999864

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=3e-48  Score=361.46  Aligned_cols=259  Identities=17%  Similarity=0.241  Sum_probs=209.2

Q ss_pred             HHHHHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC--hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC
Q 019536           49 DLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST--LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETE  126 (339)
Q Consensus        49 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~  126 (339)
                      ++....++|++.+.||+|+||+||+|.+..+++.||+|++.....  ......+.+|+.+++.++||||+++++++.+++
T Consensus        63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~  142 (410)
T 3v8s_A           63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR  142 (410)
T ss_dssp             HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence            344456899999999999999999999999999999999865211  122344778999999999999999999999999


Q ss_pred             ccEEEEEeccCCccccccc-cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccC
Q 019536          127 LPTLVFESVKYGTLRGFSF-ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIP  205 (339)
Q Consensus       127 ~~~lv~e~~~~g~L~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~  205 (339)
                      ..++||||+++|+|.+++. ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+|+...
T Consensus       143 ~~~lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~  219 (410)
T 3v8s_A          143 YLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN  219 (410)
T ss_dssp             EEEEEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEeccceeEeec
Confidence            9999999999999999886 57889999999999999999999   8999999999999999999999999999998775


Q ss_pred             CCCceeeecccccccccccccccccCC----CCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCc
Q 019536          206 EGETHVREEFIKGAYGFIAPEYFATSS----FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNR  281 (339)
Q Consensus       206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (339)
                      ..... .....+||+.|+|||++.+..    |+.++|||||||++|||++|+.||....     ......   .......
T Consensus       220 ~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-----~~~~~~---~i~~~~~  290 (410)
T 3v8s_A          220 KEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS-----LVGTYS---KIMNHKN  290 (410)
T ss_dssp             TTSEE-ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHH---HHHTHHH
T ss_pred             cCCcc-cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC-----hhhHHH---HHHhccc
Confidence            54432 222467999999999998665    8899999999999999999999985211     111111   1111000


Q ss_pred             ccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 019536          282 FGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEH--RPLMVDVAKQ  330 (339)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~--Rps~~~il~~  330 (339)
                                 ...+|.....+.++.+|+.+||+.+|.+  ||++.||+++
T Consensus       291 -----------~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          291 -----------SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             -----------HCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             -----------cccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence                       0111222245567999999999999998  9999999864

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=5.4e-48  Score=365.37  Aligned_cols=260  Identities=22%  Similarity=0.313  Sum_probs=213.3

Q ss_pred             HHHHHHHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC
Q 019536           47 AKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETE  126 (339)
Q Consensus        47 ~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~  126 (339)
                      .++++...++|.+.+.||+|+||+||+|.+. ++..||||++....  ...+.+.+|+.+++.++||||+++++++. .+
T Consensus       180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~  255 (454)
T 1qcf_A          180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KE  255 (454)
T ss_dssp             TTCSBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS--BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred             ccceeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC--ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CC
Confidence            4455666788999999999999999999986 57889999997653  34678999999999999999999999987 56


Q ss_pred             ccEEEEEeccCCccccccc----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCcc
Q 019536          127 LPTLVFESVKYGTLRGFSF----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSV  202 (339)
Q Consensus       127 ~~~lv~e~~~~g~L~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~  202 (339)
                      ..++||||+++|+|.+++.    ..+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus       256 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~  332 (454)
T 1qcf_A          256 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLAR  332 (454)
T ss_dssp             SCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGG
T ss_pred             ccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCce
Confidence            7899999999999999986    26888899999999999999999   8999999999999999999999999999998


Q ss_pred             ccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCc
Q 019536          203 SIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNR  281 (339)
Q Consensus       203 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (339)
                      ......... .....++..|+|||++.+..++.++|||||||++|||++ |+.||....        ..+......... 
T Consensus       333 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~--------~~~~~~~i~~~~-  402 (454)
T 1qcf_A          333 VIEDNEYTA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS--------NPEVIRALERGY-  402 (454)
T ss_dssp             GBCCHHHHT-TCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--------HHHHHHHHHHTC-
T ss_pred             EcCCCceec-cCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHHcCC-
Confidence            764432111 112346778999999998999999999999999999999 999975221        111111111111 


Q ss_pred             ccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 019536          282 FGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYL  336 (339)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~  336 (339)
                                   ..+.+..++..+.+||.+||+.||++|||+.+|++.|+.+..
T Consensus       403 -------------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~  444 (454)
T 1qcf_A          403 -------------RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT  444 (454)
T ss_dssp             -------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred             -------------CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence                         112223456689999999999999999999999999998864

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2.8e-48  Score=354.23  Aligned_cols=251  Identities=22%  Similarity=0.298  Sum_probs=205.0

Q ss_pred             HHHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC--hhhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCc
Q 019536           51 KKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST--LDDVEYCFNNIVFSSQM-KHKNILKLIGCCLETEL  127 (339)
Q Consensus        51 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~  127 (339)
                      ....++|.+.+.||+|+||.||+|.+..+++.||+|++.....  ......+.+|..++..+ +||||+++++++.+.+.
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            3456899999999999999999999999999999999976421  13456678899999877 99999999999999999


Q ss_pred             cEEEEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccC
Q 019536          128 PTLVFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIP  205 (339)
Q Consensus       128 ~~lv~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~  205 (339)
                      .++||||+++|+|.+++.  ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        93 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  169 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM  169 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence            999999999999999986  57899999999999999999999   8999999999999999999999999999997653


Q ss_pred             CCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCccccc
Q 019536          206 EGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAI  285 (339)
Q Consensus       206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (339)
                      .....  ....+||+.|+|||++.+..|+.++|+||+||++|+|++|+.||....        ........ ...     
T Consensus       170 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--------~~~~~~~i-~~~-----  233 (345)
T 1xjd_A          170 LGDAK--TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD--------EEELFHSI-RMD-----  233 (345)
T ss_dssp             CTTCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHH-HHC-----
T ss_pred             cCCCc--ccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC--------HHHHHHHH-HhC-----
Confidence            32221  224679999999999999999999999999999999999999985221        11111111 111     


Q ss_pred             ccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHH-HHHH
Q 019536          286 VDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMV-DVAK  329 (339)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~-~il~  329 (339)
                             ...+|  ...+..+.+|+.+||+.||++||++. +|++
T Consensus       234 -------~~~~p--~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~  269 (345)
T 1xjd_A          234 -------NPFYP--RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  269 (345)
T ss_dssp             -------CCCCC--TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             -------CCCCC--cccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence                   11111  13456799999999999999999987 6653

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2.7e-47  Score=338.34  Aligned_cols=257  Identities=16%  Similarity=0.244  Sum_probs=208.4

Q ss_pred             HHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 019536           52 KATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLV  131 (339)
Q Consensus        52 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  131 (339)
                      ...++|++.+.||+|+||+||+|.+. ++..||+|++.....  ..+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   97 (283)
T 3gen_A           21 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII   97 (283)
T ss_dssp             CCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB--CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred             CCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC--CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEE
Confidence            34578999999999999999999887 678899999986543  346688999999999999999999999999999999


Q ss_pred             EEeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCC
Q 019536          132 FESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE  208 (339)
Q Consensus       132 ~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~  208 (339)
                      |||+++|+|.+++.   ..+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++......
T Consensus        98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  174 (283)
T 3gen_A           98 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE  174 (283)
T ss_dssp             ECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred             EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence            99999999999875   56899999999999999999999   8999999999999999999999999999998764432


Q ss_pred             ceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCccccccc
Q 019536          209 THVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVD  287 (339)
Q Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (339)
                      .. ......+|+.|+|||++.+..++.++||||+|+++|+|++ |+.||....        ............       
T Consensus       175 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~--------~~~~~~~~~~~~-------  238 (283)
T 3gen_A          175 YT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT--------NSETAEHIAQGL-------  238 (283)
T ss_dssp             HH-STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSC--------HHHHHHHHHTTC-------
T ss_pred             cc-cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccC--------hhHHHHHHhccc-------
Confidence            21 1113446778999999998899999999999999999998 999975321        111111111110       


Q ss_pred             CcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          288 PIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                             ....+...+..+.+|+.+||+.||++|||+.++++.|+++.++
T Consensus       239 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~  281 (283)
T 3gen_A          239 -------RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE  281 (283)
T ss_dssp             -------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -------CCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence                   0011123345799999999999999999999999999999864

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=3.5e-47  Score=351.28  Aligned_cols=250  Identities=19%  Similarity=0.302  Sum_probs=205.3

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC--ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS--TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLV  131 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  131 (339)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++....  .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            378999999999999999999999999999999987532  123456788999999999999999999999999999999


Q ss_pred             EEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCc
Q 019536          132 FESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGET  209 (339)
Q Consensus       132 ~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~  209 (339)
                      |||+++|+|.+++.  ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus        94 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~  170 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ  170 (384)
T ss_dssp             ECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred             EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeeccCCCc
Confidence            99999999999886  46889999999999999999999   89999999999999999999999999999987654432


Q ss_pred             eeeeccccccccccccccccc---CCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccc
Q 019536          210 HVREEFIKGAYGFIAPEYFAT---SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIV  286 (339)
Q Consensus       210 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (339)
                      .   ....||+.|+|||++.+   ..|+.++|||||||++|+|++|+.||.......  ......   . .....     
T Consensus       171 ~---~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~--~~~~~~---~-~~~~~-----  236 (384)
T 4fr4_A          171 I---TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS--SKEIVH---T-FETTV-----  236 (384)
T ss_dssp             B---CCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC--HHHHHH---H-HHHCC-----
T ss_pred             e---eccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc--HHHHHH---H-Hhhcc-----
Confidence            2   24679999999999974   458999999999999999999999986433221  111111   1 11110     


Q ss_pred             cCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCC-HHHHHH
Q 019536          287 DPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPL-MVDVAK  329 (339)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps-~~~il~  329 (339)
                             ..+  +...+..+.+|+.+||+.||++||+ +.++++
T Consensus       237 -------~~~--p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          237 -------VTY--PSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             -------CCC--CTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             -------cCC--CCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence                   111  1245567999999999999999998 666653

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=2.1e-47  Score=339.72  Aligned_cols=252  Identities=23%  Similarity=0.362  Sum_probs=203.1

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhh------HHHHHHHHHHHHhcCCCceeeeeeeeeeCCc
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDD------VEYCFNNIVFSSQMKHKNILKLIGCCLETEL  127 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~------~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~  127 (339)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++........      .+.+.+|+.+++.++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            3789999999999999999999999999999999876533221      167889999999999999999999997655 


Q ss_pred             cEEEEEeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCC--eEEccCCCCCEEeCCCCc-----eEEec
Q 019536          128 PTLVFESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRP--IVFRCIKASNVLLDENYS-----AKLHD  197 (339)
Q Consensus       128 ~~lv~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~dlk~~Nil~~~~~~-----~kl~d  197 (339)
                       ++||||+++|+|.+++.   ..+++..++.++.|++.||.|||   +.+  |+||||||+||+++.++.     +||+|
T Consensus        97 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D  172 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD  172 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred             -eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence             79999999999988774   46889999999999999999999   888  999999999999987776     99999


Q ss_pred             CCCccccCCCCceeeecccccccccccccccc--cCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHH
Q 019536          198 FSLSVSIPEGETHVREEFIKGAYGFIAPEYFA--TSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKK  275 (339)
Q Consensus       198 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  275 (339)
                      ||+++......     ....||+.|+|||++.  ...++.++||||+||++|+|++|+.||.......      ......
T Consensus       173 fg~~~~~~~~~-----~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~------~~~~~~  241 (287)
T 4f0f_A          173 FGLSQQSVHSV-----SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK------IKFINM  241 (287)
T ss_dssp             CTTCBCCSSCE-----ECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH------HHHHHH
T ss_pred             CCccccccccc-----cccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH------HHHHHH
Confidence            99997543321     1356899999999984  4567899999999999999999999985332211      111111


Q ss_pred             HhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 019536          276 SIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQM  334 (339)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l  334 (339)
                      ......             ..+.+...+..+.+|+.+||+.||++|||+.++++.|++|
T Consensus       242 ~~~~~~-------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          242 IREEGL-------------RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             HHHSCC-------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             HhccCC-------------CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            111110             0011124456799999999999999999999999999864

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.7e-47  Score=350.38  Aligned_cols=251  Identities=20%  Similarity=0.200  Sum_probs=203.4

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC----ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS----TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPT  129 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~  129 (339)
                      .+.|++.+.||+|+||+||+|.+..+++.||||++....    .....+.+.+|+.+++.++||||+++++++.+++..+
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            367999999999999999999999999999999986421    1124577889999999999999999999999999999


Q ss_pred             EEEEeccCCccccccc------cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCc---eEEecCCC
Q 019536          130 LVFESVKYGTLRGFSF------ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYS---AKLHDFSL  200 (339)
Q Consensus       130 lv~e~~~~g~L~~~~~------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~---~kl~dfg~  200 (339)
                      +||||+++|+|.+.+.      ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            9999999999987764      24788899999999999999999   899999999999999986554   99999999


Q ss_pred             ccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcC
Q 019536          201 SVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENN  280 (339)
Q Consensus       201 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  280 (339)
                      ++........  .....||+.|+|||++.+..++.++||||+||++|+|++|+.||....         ...... ....
T Consensus       180 a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---------~~~~~~-i~~~  247 (351)
T 3c0i_A          180 AIQLGESGLV--AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK---------ERLFEG-IIKG  247 (351)
T ss_dssp             CEECCTTSCB--CCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH---------HHHHHH-HHHT
T ss_pred             eeEecCCCee--ecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH---------HHHHHH-HHcC
Confidence            9877654322  123569999999999999999999999999999999999999985210         111111 1111


Q ss_pred             cccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          281 RFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                      ...  ..        .+.....+..+.+|+.+||+.||++|||+.++++
T Consensus       248 ~~~--~~--------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          248 KYK--MN--------PRQWSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             CCC--CC--------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCC--CC--------ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            100  00        0000134567999999999999999999999986

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=8.6e-47  Score=349.50  Aligned_cols=251  Identities=18%  Similarity=0.183  Sum_probs=207.3

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFE  133 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  133 (339)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E  128 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP-LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE  128 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch-hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence            4789999999999999999999999999999999876543 445678899999999999999999999999999999999


Q ss_pred             eccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCC--CCceEEecCCCccccCCCC
Q 019536          134 SVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDE--NYSAKLHDFSLSVSIPEGE  208 (339)
Q Consensus       134 ~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~--~~~~kl~dfg~a~~~~~~~  208 (339)
                      |+++|+|.+++.   ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.  ++.+||+|||+++......
T Consensus       129 ~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~  205 (387)
T 1kob_A          129 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE  205 (387)
T ss_dssp             CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred             cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence            999999999886   36889999999999999999999   899999999999999974  5779999999998876544


Q ss_pred             ceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccC
Q 019536          209 THVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDP  288 (339)
Q Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (339)
                      ...   ...||+.|+|||++.+..++.++|||||||++|+|++|+.||....     .....   ..... ..+.     
T Consensus       206 ~~~---~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~-----~~~~~---~~i~~-~~~~-----  268 (387)
T 1kob_A          206 IVK---VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED-----DLETL---QNVKR-CDWE-----  268 (387)
T ss_dssp             CEE---EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS-----HHHHH---HHHHH-CCCC-----
T ss_pred             cee---eeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC-----HHHHH---HHHHh-CCCC-----
Confidence            322   3468999999999999999999999999999999999999985221     11111   11111 1100     


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          289 IFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                           ...+.....+.++.+|+.+||+.||++|||+.+++++
T Consensus       269 -----~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          269 -----FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             -----CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             -----CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence                 0001112345679999999999999999999999874

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=4.5e-47  Score=341.86  Aligned_cols=268  Identities=18%  Similarity=0.196  Sum_probs=200.8

Q ss_pred             HhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC-hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 019536           53 ATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST-LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLV  131 (339)
Q Consensus        53 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  131 (339)
                      ..++|++.+.||+|+||+||+|.+. +++.||+|++..... ......+.+|+.+++.++||||+++++++.+++..++|
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   97 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV   97 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence            3478999999999999999999996 689999999976533 23356788999999999999999999999999999999


Q ss_pred             EEeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCC
Q 019536          132 FESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE  208 (339)
Q Consensus       132 ~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~  208 (339)
                      |||+++ +|.+++.   ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus        98 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  173 (311)
T 3niz_A           98 FEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV  173 (311)
T ss_dssp             EECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred             EcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence            999985 6666654   35888999999999999999999   8999999999999999999999999999998765433


Q ss_pred             ceeeeccccccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCccccccc
Q 019536          209 THVREEFIKGAYGFIAPEYFAT-SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVD  287 (339)
Q Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (339)
                      ...  ....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||......  +................+....+
T Consensus       174 ~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~  249 (311)
T 3niz_A          174 RSY--THEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDD--DQLPKIFSILGTPNPREWPQVQE  249 (311)
T ss_dssp             C-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTT--THHHHHHHHHCCCCTTTSGGGTT
T ss_pred             ccc--cCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHHCCCChHHhhhhhc
Confidence            222  13468999999999876 46899999999999999999999998643322  22222111111111111111000


Q ss_pred             ------CcccCCCCCC---CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          288 ------PIFDEDNSFP---GKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       288 ------~~~~~~~~~~---~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                            .........+   .....+.++.+|+.+||+.||++|||+.|+++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          250 LPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             SHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             cchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                  0000000000   00123467899999999999999999999987

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.7e-47  Score=345.47  Aligned_cols=265  Identities=17%  Similarity=0.243  Sum_probs=191.1

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFE  133 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  133 (339)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++.........+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            46899999999999999999999989999999999866544455678899999999999999999999999999999999


Q ss_pred             eccCCccccccc--------cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccC
Q 019536          134 SVKYGTLRGFSF--------ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIP  205 (339)
Q Consensus       134 ~~~~g~L~~~~~--------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~  205 (339)
                      |++ |+|.+++.        ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++...
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            998 58888764        24788889999999999999999   8999999999999999999999999999998765


Q ss_pred             CCCceeeecccccccccccccccccC-CCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHh---hcCc
Q 019536          206 EGETHVREEFIKGAYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSI---ENNR  281 (339)
Q Consensus       206 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~  281 (339)
                      ......  ....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.....     ...........   ....
T Consensus       160 ~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~i~~~~~~~~~~~  232 (317)
T 2pmi_A          160 IPVNTF--SSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND-----EEQLKLIFDIMGTPNESL  232 (317)
T ss_dssp             SCCCCC--CCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHHHCSCCTTT
T ss_pred             CCcccC--CCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHHHhCCCChhH
Confidence            432221  134689999999999764 689999999999999999999999853221     11111111111   0000


Q ss_pred             ccccc-----cCcccCCCCCC--------CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          282 FGAIV-----DPIFDEDNSFP--------GKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       282 ~~~~~-----~~~~~~~~~~~--------~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                      +..+.     .+.+.......        .....+..+.+|+.+||+.||++|||+.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          233 WPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             CGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence            10000     00000000000        00123457999999999999999999999986

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.7e-47  Score=339.03  Aligned_cols=260  Identities=23%  Similarity=0.327  Sum_probs=208.8

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCe---eEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCcc-EE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDR---PISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELP-TL  130 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~-~l  130 (339)
                      ..|...+.||+|+||+||+|.+..++.   .||+|.+.........+.+.+|+.+++.++||||+++++++.+.+.. ++
T Consensus        21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  100 (298)
T 3pls_A           21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV  100 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence            356677899999999999999765444   79999998766656778899999999999999999999999876654 99


Q ss_pred             EEEeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCC
Q 019536          131 VFESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEG  207 (339)
Q Consensus       131 v~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~  207 (339)
                      ||||+.+|+|.+++.   ..+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus       101 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  177 (298)
T 3pls_A          101 LLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDR  177 (298)
T ss_dssp             EECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred             EEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence            999999999999986   46788889999999999999999   899999999999999999999999999999866443


Q ss_pred             Cce--eeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCccccc
Q 019536          208 ETH--VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAI  285 (339)
Q Consensus       208 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (339)
                      ...  .......+|..|+|||.+.+..++.++||||||+++|+|++|..|+.. +..   .........    ..     
T Consensus       178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~-~~~---~~~~~~~~~----~~-----  244 (298)
T 3pls_A          178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYR-HID---PFDLTHFLA----QG-----  244 (298)
T ss_dssp             GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTT-TSC---GGGHHHHHH----TT-----
T ss_pred             cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCc-cCC---HHHHHHHhh----cC-----
Confidence            211  112235678899999999999999999999999999999996665421 111   111111111    00     


Q ss_pred             ccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhc
Q 019536          286 VDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLSV  338 (339)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~~  338 (339)
                              ...+.+...+..+.+++.+||+.||.+|||+.++++.|+++...+
T Consensus       245 --------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l  289 (298)
T 3pls_A          245 --------RRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL  289 (298)
T ss_dssp             --------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             --------CCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence                    011112244567999999999999999999999999999998765

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=6.8e-47  Score=334.30  Aligned_cols=254  Identities=20%  Similarity=0.246  Sum_probs=209.0

Q ss_pred             HhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 019536           53 ATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVF  132 (339)
Q Consensus        53 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  132 (339)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++.........+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence            34789999999999999999999998999999999976544455678889999999999999999999999999999999


Q ss_pred             EeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCce
Q 019536          133 ESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH  210 (339)
Q Consensus       133 e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~  210 (339)
                      ||+++++|.+++.  ..++...+..++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||++.........
T Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~  161 (276)
T 2yex_A           85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  161 (276)
T ss_dssp             ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             EecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence            9999999999987  46888999999999999999999   899999999999999999999999999999876443322


Q ss_pred             eeecccccccccccccccccCCC-CcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCc
Q 019536          211 VREEFIKGAYGFIAPEYFATSSF-NEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPI  289 (339)
Q Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (339)
                      .......||..|+|||++.+..+ +.++||||||+++|+|++|+.||.......   .....     .....        
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~-----~~~~~--------  225 (276)
T 2yex_A          162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC---QEYSD-----WKEKK--------  225 (276)
T ss_dssp             CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS---HHHHH-----HHTTC--------
T ss_pred             hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH---HHHHH-----hhhcc--------
Confidence            22234568999999999987765 688999999999999999999986433211   11100     00000        


Q ss_pred             ccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          290 FDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                          ...+.....+..+.+|+.+||+.||++|||+.++++
T Consensus       226 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          226 ----TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             ----TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ----cccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence                001112245567899999999999999999999986

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=4.3e-47  Score=341.93  Aligned_cols=263  Identities=23%  Similarity=0.404  Sum_probs=201.3

Q ss_pred             HHHhcCcccCCceeccCCeeEEEEEEcC---CCeeEEEEEeccCC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC
Q 019536           51 KKATNNYDLHKVIQSDTSYRLFEGTLVD---QDRPISVMKFHDNS-TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETE  126 (339)
Q Consensus        51 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~  126 (339)
                      ....++|.+.+.||+|+||.||+|....   ++..||+|.+.... .....+.+.+|+.+++.++||||+++++++.+.+
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  109 (313)
T 3brb_A           30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS  109 (313)
T ss_dssp             BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred             ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence            3445789999999999999999998864   45689999987653 3345677889999999999999999999998755


Q ss_pred             -----ccEEEEEeccCCccccccc--------cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCce
Q 019536          127 -----LPTLVFESVKYGTLRGFSF--------ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSA  193 (339)
Q Consensus       127 -----~~~lv~e~~~~g~L~~~~~--------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~  193 (339)
                           ..++||||+++|+|.+++.        ..+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+
T Consensus       110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~  186 (313)
T 3brb_A          110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTV  186 (313)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTSCE
T ss_pred             ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcE
Confidence                 3499999999999998872        45889999999999999999999   9999999999999999999999


Q ss_pred             EEecCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHH
Q 019536          194 KLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEY  272 (339)
Q Consensus       194 kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~  272 (339)
                      ||+|||+++...............+++.|+|||.+.+..++.++||||||+++|+|++ |..||......     .....
T Consensus       187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-----~~~~~  261 (313)
T 3brb_A          187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH-----EMYDY  261 (313)
T ss_dssp             EECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-----GHHHH
T ss_pred             EEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH-----HHHHH
Confidence            9999999987654433222224457888999999999999999999999999999999 88887532211     11111


Q ss_pred             HHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhc
Q 019536          273 AKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLSV  338 (339)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~~  338 (339)
                      .   ....              ..+.+...+..+.+++.+||+.||.+|||+.++++.|+++.+++
T Consensus       262 ~---~~~~--------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l  310 (313)
T 3brb_A          262 L---LHGH--------------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL  310 (313)
T ss_dssp             H---HTTC--------------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             H---HcCC--------------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence            1   1100              01112244567999999999999999999999999999998764

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=2.7e-47  Score=338.09  Aligned_cols=257  Identities=24%  Similarity=0.375  Sum_probs=207.4

Q ss_pred             HhcCcccCCceeccCCeeEEEEEEcC---CCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccE
Q 019536           53 ATNNYDLHKVIQSDTSYRLFEGTLVD---QDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPT  129 (339)
Q Consensus        53 ~~~~~~~~~~ig~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~  129 (339)
                      ..++|.+.+.||+|+||+||+|.+..   ++..||+|.+.........+.+.+|+.+++.++||||+++++++.++ ..+
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~   88 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTW   88 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCE
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCE
Confidence            35789999999999999999999753   34569999998776656678899999999999999999999998754 568


Q ss_pred             EEEEeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCC
Q 019536          130 LVFESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPE  206 (339)
Q Consensus       130 lv~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~  206 (339)
                      +||||+++++|.+++.   ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||++.....
T Consensus        89 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  165 (281)
T 3cc6_A           89 IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIED  165 (281)
T ss_dssp             EEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred             EEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence            9999999999999986   45889999999999999999999   89999999999999999999999999999987654


Q ss_pred             CCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCccccc
Q 019536          207 GETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAI  285 (339)
Q Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (339)
                      ..... .....+++.|+|||++.+..++.++||||||+++|+|++ |+.||......     ........   ..     
T Consensus       166 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~-----~~~~~~~~---~~-----  231 (281)
T 3cc6_A          166 EDYYK-ASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK-----DVIGVLEK---GD-----  231 (281)
T ss_dssp             --------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG-----GHHHHHHH---TC-----
T ss_pred             ccccc-cccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH-----HHHHHHhc---CC-----
Confidence            33221 123456788999999998899999999999999999998 99998532221     11111111   00     


Q ss_pred             ccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 019536          286 VDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYL  336 (339)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~  336 (339)
                               ..+.+...+..+.+++.+||+.||++|||+.++++.|+++..
T Consensus       232 ---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~  273 (281)
T 3cc6_A          232 ---------RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ  273 (281)
T ss_dssp             ---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---------CCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence                     011112345679999999999999999999999999999874

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.3e-47  Score=350.82  Aligned_cols=249  Identities=20%  Similarity=0.256  Sum_probs=204.8

Q ss_pred             HhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC--ChhhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCccE
Q 019536           53 ATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS--TLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLETELPT  129 (339)
Q Consensus        53 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~~  129 (339)
                      ..++|++.+.||+|+||+||+|....+++.||+|++....  .....+.+.+|..++..+ +||||+++++++.+.+..+
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            3578999999999999999999999889999999997642  113456778999999888 8999999999999999999


Q ss_pred             EEEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCC
Q 019536          130 LVFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEG  207 (339)
Q Consensus       130 lv~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~  207 (339)
                      +||||+++|+|.+++.  ..+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus        98 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  174 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD  174 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence            9999999999999986  57899999999999999999999   899999999999999999999999999999864332


Q ss_pred             CceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCccccccc
Q 019536          208 ETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVD  287 (339)
Q Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (339)
                      ...  ....+||+.|+|||++.+..++.++|+|||||++|||++|+.||....        ..+....... .       
T Consensus       175 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~--------~~~~~~~i~~-~-------  236 (353)
T 2i0e_A          175 GVT--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED--------EDELFQSIME-H-------  236 (353)
T ss_dssp             TCC--BCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHH-C-------
T ss_pred             Ccc--cccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC--------HHHHHHHHHh-C-------
Confidence            221  224679999999999999999999999999999999999999985221        1111111111 1       


Q ss_pred             CcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 019536          288 PIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPL-----MVDVAK  329 (339)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps-----~~~il~  329 (339)
                           ...+|  ...+.++.+|+.+||+.||++||+     +.+|++
T Consensus       237 -----~~~~p--~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          237 -----NVAYP--KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             -----CCCCC--TTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             -----CCCCC--CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence                 11112  244567999999999999999996     466654

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.2e-46  Score=356.67  Aligned_cols=265  Identities=18%  Similarity=0.205  Sum_probs=198.8

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC------
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS-TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETE------  126 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~------  126 (339)
                      .++|++.+.||+|+||+||+|.+..+++.||||++.... .......+.+|+.+++.++||||+++++++....      
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            478999999999999999999999999999999997642 2345677889999999999999999999997654      


Q ss_pred             ccEEEEEeccCCccccccccCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCC
Q 019536          127 LPTLVFESVKYGTLRGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPE  206 (339)
Q Consensus       127 ~~~lv~e~~~~g~L~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~  206 (339)
                      ..++||||++++ |.+.+...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+|+....
T Consensus       141 ~~~lv~E~~~~~-l~~~~~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  216 (464)
T 3ttj_A          141 DVYLVMELMDAN-LCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  216 (464)
T ss_dssp             EEEEEEECCSEE-HHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred             eEEEEEeCCCCC-HHHHHhhcCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence            469999999764 66666677999999999999999999999   89999999999999999999999999999987654


Q ss_pred             CCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcC---ccc
Q 019536          207 GETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENN---RFG  283 (339)
Q Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~  283 (339)
                      ....   ....||+.|+|||++.+..|+.++||||+||++|+|++|+.||...  ..   ..............   .+.
T Consensus       217 ~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~--~~---~~~~~~i~~~lg~p~~~~~~  288 (464)
T 3ttj_A          217 SFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR--DY---IDQWNKVIEQLGTPCPEFMK  288 (464)
T ss_dssp             CCCC-------CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS--SH---HHHHHHHHHHHCSCCHHHHT
T ss_pred             Cccc---CCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCC--CH---HHHHHHHHHhcCCCCHHHHH
Confidence            3221   2357899999999999999999999999999999999999997532  21   11111111100000   000


Q ss_pred             -------ccccC----------cccCCCCCCC----cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          284 -------AIVDP----------IFDEDNSFPG----KEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       284 -------~~~~~----------~~~~~~~~~~----~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                             .+...          .......++.    ....+.++.+|+.+||++||++|||+.|++++
T Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                   00000          0000000000    01236779999999999999999999999874

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-46  Score=341.86  Aligned_cols=258  Identities=22%  Similarity=0.292  Sum_probs=204.0

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCC----eeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQD----RPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTL  130 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  130 (339)
                      ++|++.+.||+|+||+||+|.+..++    ..||+|.+...........+.+|+.+++.++||||+++++++.+.+..++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            57888899999999999999986543    46999999876655666778999999999999999999999999999999


Q ss_pred             EEEeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCC
Q 019536          131 VFESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEG  207 (339)
Q Consensus       131 v~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~  207 (339)
                      ||||+++|+|.+++.   ..+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus       124 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~  200 (333)
T 1mqb_A          124 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  200 (333)
T ss_dssp             EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchhhccc
Confidence            999999999999986   46889999999999999999999   899999999999999999999999999999876543


Q ss_pred             Cce-eeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCccccc
Q 019536          208 ETH-VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAI  285 (339)
Q Consensus       208 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (339)
                      ... .......+|..|+|||++.+..++.++||||||+++|+|++ |+.||....        ..+.........     
T Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~--------~~~~~~~~~~~~-----  267 (333)
T 1mqb_A          201 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS--------NHEVMKAINDGF-----  267 (333)
T ss_dssp             ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHHHHHHTTC-----
T ss_pred             cccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCC--------HHHHHHHHHCCC-----
Confidence            221 11112345778999999998899999999999999999998 999974221        111111111110     


Q ss_pred             ccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          286 VDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                               ..+.+...+..+.+|+.+||+.||++|||+.++++.|+++...
T Consensus       268 ---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~  310 (333)
T 1mqb_A          268 ---------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  310 (333)
T ss_dssp             ---------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             ---------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence                     1111224456799999999999999999999999999998753

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.6e-46  Score=338.97  Aligned_cols=267  Identities=21%  Similarity=0.301  Sum_probs=203.0

Q ss_pred             HHHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhc--CCCceeeeeeeeeeC---
Q 019536           51 KKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQM--KHKNILKLIGCCLET---  125 (339)
Q Consensus        51 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l--~H~niv~~~~~~~~~---  125 (339)
                      ....++|++.+.||+|+||.||+|.+  +++.||||++...    ....+.+|..++..+  +||||+++++++.+.   
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~  106 (337)
T 3mdy_A           33 RTIAKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTT----EEASWFRETEIYQTVLMRHENILGFIAADIKGTGS  106 (337)
T ss_dssp             TTHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred             cccccceEEEeEeecCCCeEEEEEEE--CCceEEEEEEecc----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence            34457899999999999999999998  5899999998653    334455666666554  899999999999887   


Q ss_pred             -CccEEEEEeccCCccccccc-cCCChHHHHHHHHHHHHHHHHHhcCCCC--------CeEEccCCCCCEEeCCCCceEE
Q 019536          126 -ELPTLVFESVKYGTLRGFSF-ASLLIAPRIKIAMEIANAVAYLHVGFDR--------PIVFRCIKASNVLLDENYSAKL  195 (339)
Q Consensus       126 -~~~~lv~e~~~~g~L~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~--------~i~H~dlk~~Nil~~~~~~~kl  195 (339)
                       ...++||||+++|+|.+++. ..+++..++.++.|++.||.|||   +.        +|+||||||+||+++.++.+||
T Consensus       107 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl  183 (337)
T 3mdy_A          107 WTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI  183 (337)
T ss_dssp             GCEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred             CCceEEEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence             67899999999999999986 57899999999999999999999   77        9999999999999999999999


Q ss_pred             ecCCCccccCCCCcee--eecccccccccccccccccCCCCcc------cchHHHHHHHHHHHhC----------CCccc
Q 019536          196 HDFSLSVSIPEGETHV--REEFIKGAYGFIAPEYFATSSFNEM------CDVYSFGAFLCELLTG----------CNVLE  257 (339)
Q Consensus       196 ~dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------~DiwslG~~l~el~~g----------~~p~~  257 (339)
                      +|||+++.+.......  ......||+.|+|||++.+..++..      +|||||||++|||++|          ..||.
T Consensus       184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~  263 (337)
T 3mdy_A          184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH  263 (337)
T ss_dssp             CCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             EeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence            9999997765433221  1123468999999999987766654      9999999999999999          44443


Q ss_pred             cCCCCCCCchhHHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          258 FKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                      .........    ............    .+....   ......++..+.+|+.+||+.||++|||+.++++.|+++.++
T Consensus       264 ~~~~~~~~~----~~~~~~~~~~~~----~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~  332 (337)
T 3mdy_A          264 DLVPSDPSY----EDMREIVCIKKL----RPSFPN---RWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES  332 (337)
T ss_dssp             TTSCSSCCH----HHHHHHHTTSCC----CCCCCG---GGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             hhcCCCCch----hhhHHHHhhhcc----Cccccc---cchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence            222211111    111111111000    000000   001236788899999999999999999999999999999865

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=3.9e-47  Score=352.62  Aligned_cols=271  Identities=17%  Similarity=0.266  Sum_probs=205.3

Q ss_pred             HhcCcccCCceecc--CCeeEEEEEEcCCCeeEEEEEeccCC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccE
Q 019536           53 ATNNYDLHKVIQSD--TSYRLFEGTLVDQDRPISVMKFHDNS-TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPT  129 (339)
Q Consensus        53 ~~~~~~~~~~ig~G--~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~  129 (339)
                      ..++|++.+.||+|  +||+||+|.+..+++.||||++.... .....+.+.+|+.+++.++||||+++++++.+++..+
T Consensus        23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  102 (389)
T 3gni_B           23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW  102 (389)
T ss_dssp             CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence            35789999999999  99999999999999999999997653 2344567788999999999999999999999999999


Q ss_pred             EEEEeccCCccccccc----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccC
Q 019536          130 LVFESVKYGTLRGFSF----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIP  205 (339)
Q Consensus       130 lv~e~~~~g~L~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~  205 (339)
                      +||||+++|+|.+++.    ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||.+....
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~  179 (389)
T 3gni_B          103 VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMI  179 (389)
T ss_dssp             EEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred             EEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence            9999999999999875    46888999999999999999999   8999999999999999999999999999886543


Q ss_pred             CCCce-----eeeccccccccccccccccc--CCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhh
Q 019536          206 EGETH-----VREEFIKGAYGFIAPEYFAT--SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIE  278 (339)
Q Consensus       206 ~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  278 (339)
                      .....     .......||+.|+|||++.+  ..|+.++|||||||++|+|++|+.||.......  ..  .........
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~--~~~~~~~~~  255 (389)
T 3gni_B          180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ--ML--LEKLNGTVP  255 (389)
T ss_dssp             ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTT--HH--HHC------
T ss_pred             cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHH--HH--HHHhcCCCC
Confidence            22111     11123468899999999987  579999999999999999999999985432211  11  000000000


Q ss_pred             ---------cCcc----------ccccc--------CcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          279 ---------NNRF----------GAIVD--------PIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       279 ---------~~~~----------~~~~~--------~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                               ....          ..+.+        +........+.+...+..+.+|+.+||+.||++|||+.+++++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             --------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             ccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence                     0000          00000        0000000111222455679999999999999999999999864

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.4e-47  Score=342.18  Aligned_cols=267  Identities=17%  Similarity=0.221  Sum_probs=200.8

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCCh-hhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTL-DDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVF  132 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  132 (339)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++...... ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF   81 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence            36899999999999999999999989999999998765432 33566789999999999999999999999999999999


Q ss_pred             EeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCce
Q 019536          133 ESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH  210 (339)
Q Consensus       133 e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~  210 (339)
                      ||+++++|.++..  ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++........
T Consensus        82 e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  158 (311)
T 4agu_A           82 EYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY  158 (311)
T ss_dssp             ECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             EeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc
Confidence            9999999988865  56889999999999999999999   899999999999999999999999999999876543322


Q ss_pred             eeeccccccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcC--------c
Q 019536          211 VREEFIKGAYGFIAPEYFAT-SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENN--------R  281 (339)
Q Consensus       211 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------~  281 (339)
                      .  ....||..|+|||++.+ ..++.++||||+|+++|+|++|+.||.....     ..............        .
T Consensus       159 ~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~  231 (311)
T 4agu_A          159 Y--DDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSD-----VDQLYLIRKTLGDLIPRHQQVFS  231 (311)
T ss_dssp             ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHHHCSCCHHHHHHHH
T ss_pred             c--CCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHhcccccccccccc
Confidence            1  13468999999999976 5689999999999999999999999753221     11111111110000        0


Q ss_pred             ccccc-cCcccCCCCCCC----cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          282 FGAIV-DPIFDEDNSFPG----KEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       282 ~~~~~-~~~~~~~~~~~~----~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      ..... ............    ....+..+.+|+.+||+.||++|||+.+++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          232 TNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             TCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             cccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            00000 000000000000    01345678999999999999999999999863

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.4e-47  Score=337.24  Aligned_cols=258  Identities=23%  Similarity=0.322  Sum_probs=210.3

Q ss_pred             hcCcccCC-ceeccCCeeEEEEEEc--CCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 019536           54 TNNYDLHK-VIQSDTSYRLFEGTLV--DQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTL  130 (339)
Q Consensus        54 ~~~~~~~~-~ig~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  130 (339)
                      .++|.+.. .||+|+||+||+|.+.  .++..||+|++.........+.+.+|+.+++.++||||+++++++ ..+..++
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l   86 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML   86 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence            35666666 9999999999999864  467889999998876656778899999999999999999999999 5556899


Q ss_pred             EEEeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCC
Q 019536          131 VFESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEG  207 (339)
Q Consensus       131 v~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~  207 (339)
                      ||||+++++|.+++.   ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~  163 (287)
T 1u59_A           87 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  163 (287)
T ss_dssp             EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence            999999999999875   45899999999999999999999   899999999999999999999999999999877544


Q ss_pred             Ccee-eecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCccccc
Q 019536          208 ETHV-REEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAI  285 (339)
Q Consensus       208 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (339)
                      .... ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.....     .....    .......   
T Consensus       164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-----~~~~~----~i~~~~~---  231 (287)
T 1u59_A          164 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-----PEVMA----FIEQGKR---  231 (287)
T ss_dssp             SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT-----HHHHH----HHHTTCC---
T ss_pred             cceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH-----HHHHH----HHhcCCc---
Confidence            3321 1223446788999999998899999999999999999998 9999753221     11111    1111110   


Q ss_pred             ccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          286 VDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                                .+.+...+..+.+++.+||+.||++|||+.++++.|+.++.+
T Consensus       232 ----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  273 (287)
T 1u59_A          232 ----------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  273 (287)
T ss_dssp             ----------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----------CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence                      011124456799999999999999999999999999999865

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.3e-47  Score=359.76  Aligned_cols=260  Identities=18%  Similarity=0.209  Sum_probs=208.5

Q ss_pred             HHHHHHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC--hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeC
Q 019536           48 KDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST--LDDVEYCFNNIVFSSQMKHKNILKLIGCCLET  125 (339)
Q Consensus        48 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~  125 (339)
                      .++...+++|++.++||+|+||+||+|.+..+++.||+|++.....  ......+.+|..++..++||||++++++|.++
T Consensus        67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~  146 (437)
T 4aw2_A           67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDD  146 (437)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred             hcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC
Confidence            3444556899999999999999999999999999999999975311  11223477899999999999999999999999


Q ss_pred             CccEEEEEeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCcc
Q 019536          126 ELPTLVFESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSV  202 (339)
Q Consensus       126 ~~~~lv~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~  202 (339)
                      +..++||||+++|+|.+++.   ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+|+
T Consensus       147 ~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~DFGla~  223 (437)
T 4aw2_A          147 NNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCL  223 (437)
T ss_dssp             SEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             CEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEcchhhhh
Confidence            99999999999999999985   47899999999999999999999   8999999999999999999999999999998


Q ss_pred             ccCCCCceeeecccccccccccccccc-----cCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHh
Q 019536          203 SIPEGETHVREEFIKGAYGFIAPEYFA-----TSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSI  277 (339)
Q Consensus       203 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  277 (339)
                      ......... ....+||+.|+|||++.     +..|+.++|||||||++|||++|+.||....        ..+......
T Consensus       224 ~~~~~~~~~-~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~--------~~~~~~~i~  294 (437)
T 4aw2_A          224 KLMEDGTVQ-SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES--------LVETYGKIM  294 (437)
T ss_dssp             ECCTTSCEE-CCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHH
T ss_pred             hcccCCCcc-cccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC--------hhHHHHhhh
Confidence            775544332 22457999999999987     4578999999999999999999999985221        111111111


Q ss_pred             hcCcccccccCcccCCCCCCC-cHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 019536          278 ENNRFGAIVDPIFDEDNSFPG-KEEKLQSLGQLMYKCLSKSPEH--RPLMVDVAKQ  330 (339)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~cl~~dP~~--Rps~~~il~~  330 (339)
                      ....           ...+|. ....+.++.+||.+||..+|++  ||++.|++++
T Consensus       295 ~~~~-----------~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          295 NHKE-----------RFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             THHH-----------HCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred             hccc-----------cccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence            1000           000111 0134567999999999998888  9999999863

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=2.8e-47  Score=344.23  Aligned_cols=265  Identities=23%  Similarity=0.312  Sum_probs=211.3

Q ss_pred             cccCCceeccCCeeEEEEEEc----CCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeC--CccEE
Q 019536           57 YDLHKVIQSDTSYRLFEGTLV----DQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLET--ELPTL  130 (339)
Q Consensus        57 ~~~~~~ig~G~~g~V~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~--~~~~l  130 (339)
                      |++.+.||+|+||+||++.+.    .+++.||||++.........+.+.+|+.+++.++||||+++++++.+.  ...++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            499999999999999888653    478899999998876656677899999999999999999999999874  56799


Q ss_pred             EEEeccCCccccccc-cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCc
Q 019536          131 VFESVKYGTLRGFSF-ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGET  209 (339)
Q Consensus       131 v~e~~~~g~L~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~  209 (339)
                      ||||+++|+|.+++. ..+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  189 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE  189 (318)
T ss_dssp             EECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCS
T ss_pred             EEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCcccccccccccc
Confidence            999999999999987 56899999999999999999999   89999999999999999999999999999988765433


Q ss_pred             e-eeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCC------CCCchhHHHHHHHHhhcCcc
Q 019536          210 H-VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNG------NDDDLTVLEYAKKSIENNRF  282 (339)
Q Consensus       210 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~~~~~  282 (339)
                      . .......+|..|+|||++.+..++.++||||||+++|+|++|+.||......      ................    
T Consensus       190 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----  265 (318)
T 3lxp_A          190 YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE----  265 (318)
T ss_dssp             EEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH----
T ss_pred             ccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh----
Confidence            2 1222345788899999999989999999999999999999999998532110      0000000000111111    


Q ss_pred             cccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          283 GAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                               .....+.+..++..+.+|+.+||+.||++|||+.++++.|+++.+.
T Consensus       266 ---------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~  311 (318)
T 3lxp_A          266 ---------RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK  311 (318)
T ss_dssp             ---------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---------cccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHh
Confidence                     1111122234566899999999999999999999999999998765

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=3.8e-47  Score=334.70  Aligned_cols=250  Identities=20%  Similarity=0.268  Sum_probs=205.1

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeC--CccEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS-TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLET--ELPTL  130 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~--~~~~l  130 (339)
                      .++|++.+.||+|+||+||+|.+  ++..||+|++.... .....+.+.+|+.+++.++||||+++++++.+.  +..++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   86 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL   86 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence            46899999999999999999998  58999999998754 334567788999999999999999999999887  77899


Q ss_pred             EEEeccCCcccccccc----CCChHHHHHHHHHHHHHHHHHhcCCCCC--eEEccCCCCCEEeCCCCceEEecCCCcccc
Q 019536          131 VFESVKYGTLRGFSFA----SLLIAPRIKIAMEIANAVAYLHVGFDRP--IVFRCIKASNVLLDENYSAKLHDFSLSVSI  204 (339)
Q Consensus       131 v~e~~~~g~L~~~~~~----~~~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~  204 (339)
                      ||||+++|+|.+++..    .+++..++.++.|++.||.|||   +.+  |+||||||+||+++.++.++++|||++...
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~  163 (271)
T 3kmu_A           87 ITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF  163 (271)
T ss_dssp             EEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred             eecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccceeee
Confidence            9999999999999863    4789999999999999999999   888  999999999999999999999998887553


Q ss_pred             CCCCceeeecccccccccccccccccCCCCc---ccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCc
Q 019536          205 PEGETHVREEFIKGAYGFIAPEYFATSSFNE---MCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNR  281 (339)
Q Consensus       205 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (339)
                      ...       ...||+.|+|||++.+..++.   ++||||||+++|+|++|+.||....        .............
T Consensus       164 ~~~-------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--------~~~~~~~~~~~~~  228 (271)
T 3kmu_A          164 QSP-------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS--------NMEIGMKVALEGL  228 (271)
T ss_dssp             SCT-------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSC--------HHHHHHHHHHSCC
T ss_pred             ccc-------CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccC--------hHHHHHHHHhcCC
Confidence            322       235789999999998766554   7999999999999999999985221        1111111111111


Q ss_pred             ccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 019536          282 FGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYL  336 (339)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~  336 (339)
                                   ..+.+...+..+.+++.+||+.||++|||+.++++.|+++.+
T Consensus       229 -------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          229 -------------RPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             -------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             -------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence                         001112445679999999999999999999999999999864

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=7.3e-47  Score=338.01  Aligned_cols=260  Identities=25%  Similarity=0.394  Sum_probs=206.6

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCC---CeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeee-eCCccE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQ---DRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCL-ETELPT  129 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~-~~~~~~  129 (339)
                      ..+|++.+.||+|+||+||+|.+..+   ...||+|.+.........+.+.+|+.++++++||||+++++++. .++..+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            46789999999999999999997533   34699999987766567788999999999999999999999865 456789


Q ss_pred             EEEEeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCC
Q 019536          130 LVFESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPE  206 (339)
Q Consensus       130 lv~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~  206 (339)
                      +||||+++|+|.+++.   ..+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus       104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~  180 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  180 (298)
T ss_dssp             EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred             EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence            9999999999999985   45788899999999999999999   89999999999999999999999999999987654


Q ss_pred             CCce--eeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCccc
Q 019536          207 GETH--VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFG  283 (339)
Q Consensus       207 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (339)
                      ....  .......+|+.|+|||.+.+..++.++||||+|+++|+|++ |.+||......  .   .....   .. ..  
T Consensus       181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~--~---~~~~~---~~-~~--  249 (298)
T 3f66_A          181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--D---ITVYL---LQ-GR--  249 (298)
T ss_dssp             GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT--T---HHHHH---HT-TC--
T ss_pred             cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH--H---HHHHH---hc-CC--
Confidence            3221  11223457788999999999999999999999999999999 55554322211  1   11111   00 00  


Q ss_pred             ccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhc
Q 019536          284 AIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLSV  338 (339)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~~  338 (339)
                                 ..+.+...+..+.+++.+||+.||++|||+.++++.|+++..+.
T Consensus       250 -----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~  293 (298)
T 3f66_A          250 -----------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF  293 (298)
T ss_dssp             -----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred             -----------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence                       00111234457999999999999999999999999999998754

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.1e-46  Score=343.73  Aligned_cols=260  Identities=21%  Similarity=0.202  Sum_probs=204.0

Q ss_pred             HHHHHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC----ChhhHHHHHHHHHHHHhcCCCceeeeeeeeee
Q 019536           49 DLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS----TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLE  124 (339)
Q Consensus        49 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~  124 (339)
                      ++....++|++.+.||+|+||+||+|.+..+++.||+|++....    .....+.+.+|+.+++.++||||+++++++.+
T Consensus        20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   99 (345)
T 3hko_A           20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED   99 (345)
T ss_dssp             CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence            45667789999999999999999999999999999999986531    22456778899999999999999999999999


Q ss_pred             CCccEEEEEeccCCcccccccc------------------------------------------CCChHHHHHHHHHHHH
Q 019536          125 TELPTLVFESVKYGTLRGFSFA------------------------------------------SLLIAPRIKIAMEIAN  162 (339)
Q Consensus       125 ~~~~~lv~e~~~~g~L~~~~~~------------------------------------------~~~~~~~~~i~~~i~~  162 (339)
                      .+..++||||+++|+|.+++..                                          .+++..+..++.|++.
T Consensus       100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~  179 (345)
T 3hko_A          100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS  179 (345)
T ss_dssp             SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence            9999999999999999888741                                          1245567789999999


Q ss_pred             HHHHHhcCCCCCeEEccCCCCCEEeCCCC--ceEEecCCCccccCCCCc--eeeeccccccccccccccccc--CCCCcc
Q 019536          163 AVAYLHVGFDRPIVFRCIKASNVLLDENY--SAKLHDFSLSVSIPEGET--HVREEFIKGAYGFIAPEYFAT--SSFNEM  236 (339)
Q Consensus       163 ~l~~LH~~~~~~i~H~dlk~~Nil~~~~~--~~kl~dfg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~--~~~~~~  236 (339)
                      ||.|||   +.+|+||||||+||+++.++  .+||+|||+++.+.....  ........||+.|+|||++.+  ..++.+
T Consensus       180 ~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~  256 (345)
T 3hko_A          180 ALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK  256 (345)
T ss_dssp             HHHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred             HHHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence            999999   89999999999999998766  899999999986543211  111224568999999999975  578999


Q ss_pred             cchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhcc
Q 019536          237 CDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSK  316 (339)
Q Consensus       237 ~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  316 (339)
                      +|||||||++|+|++|+.||....        .............           ....+.....+..+.+|+.+||+.
T Consensus       257 ~DiwslG~il~el~~g~~pf~~~~--------~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~li~~~l~~  317 (345)
T 3hko_A          257 CDAWSAGVLLHLLLMGAVPFPGVN--------DADTISQVLNKKL-----------CFENPNYNVLSPLARDLLSNLLNR  317 (345)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCCC-----------CTTSGGGGGSCHHHHHHHHHHSCS
T ss_pred             HHHHHHHHHHHHHHHCCCCCCCCC--------hHHHHHHHHhccc-----------ccCCcccccCCHHHHHHHHHHcCC
Confidence            999999999999999999985221        1111111111110           001111223566899999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 019536          317 SPEHRPLMVDVAKQ  330 (339)
Q Consensus       317 dP~~Rps~~~il~~  330 (339)
                      ||.+|||+.+++++
T Consensus       318 ~p~~Rps~~~~l~h  331 (345)
T 3hko_A          318 NVDERFDAMRALQH  331 (345)
T ss_dssp             CTTTSCCHHHHHHS
T ss_pred             ChhHCCCHHHHhcC
Confidence            99999999999883

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1e-47  Score=362.78  Aligned_cols=248  Identities=17%  Similarity=0.211  Sum_probs=196.5

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccC--CChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDN--STLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLV  131 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  131 (339)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++...  ........+.+|+.+++.++||||+++++++.+.+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            36899999999999999999999999999999999753  2224456678899999999999999999999999999999


Q ss_pred             EEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCC-CCeEEccCCCCCEEeCCCCceEEecCCCccccCCCC
Q 019536          132 FESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFD-RPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE  208 (339)
Q Consensus       132 ~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~  208 (339)
                      |||+++|+|.+++.  ..+++..+..++.|++.||.|||   + .+|+||||||+|||++.++.+||+|||+|+......
T Consensus       227 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  303 (446)
T 4ejn_A          227 MEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG  303 (446)
T ss_dssp             ECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred             EeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCC
Confidence            99999999998886  57889999999999999999999   7 899999999999999999999999999997654332


Q ss_pred             ceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccC
Q 019536          209 THVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDP  288 (339)
Q Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (339)
                      ..  .....||+.|+|||++.+..|+.++|||||||++|+|++|+.||....        .......... .        
T Consensus       304 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--------~~~~~~~i~~-~--------  364 (446)
T 4ejn_A          304 AT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HEKLFELILM-E--------  364 (446)
T ss_dssp             -----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHH-C--------
T ss_pred             cc--cccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC--------HHHHHHHHHh-C--------
Confidence            22  224679999999999999999999999999999999999999985221        1111111111 1        


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 019536          289 IFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP-----LMVDVAK  329 (339)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~il~  329 (339)
                          ...+|  ...+..+.+|+.+||+.||++||     |+.++++
T Consensus       365 ----~~~~p--~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          365 ----EIRFP--RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             ----CCCCC--TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ----CCCCC--ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence                11111  13456799999999999999999     9999986

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=8.8e-47  Score=345.29  Aligned_cols=252  Identities=20%  Similarity=0.252  Sum_probs=191.4

Q ss_pred             HHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 019536           52 KATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLV  131 (339)
Q Consensus        52 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  131 (339)
                      ...++|++.+.||+|+||+||+|.+..+++.||+|++....   ..+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus        50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  126 (349)
T 2w4o_A           50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV  126 (349)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence            34578999999999999999999999899999999998653   345677999999999999999999999999999999


Q ss_pred             EEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCC---CCceEEecCCCccccCC
Q 019536          132 FESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDE---NYSAKLHDFSLSVSIPE  206 (339)
Q Consensus       132 ~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~---~~~~kl~dfg~a~~~~~  206 (339)
                      |||+++|+|.+++.  ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.   ++.+||+|||+++....
T Consensus       127 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~  203 (349)
T 2w4o_A          127 LELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH  203 (349)
T ss_dssp             ECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred             EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence            99999999999876  46889999999999999999999   899999999999999975   88999999999987644


Q ss_pred             CCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccc
Q 019536          207 GETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIV  286 (339)
Q Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (339)
                      ....   ....||+.|+|||++.+..++.++|||||||++|+|++|+.||......        ............    
T Consensus       204 ~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--------~~~~~~i~~~~~----  268 (349)
T 2w4o_A          204 QVLM---KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD--------QFMFRRILNCEY----  268 (349)
T ss_dssp             ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH--------HHHHHHHHTTCC----
T ss_pred             cccc---ccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc--------HHHHHHHHhCCC----
Confidence            3221   2356899999999999989999999999999999999999998522110        001111111110    


Q ss_pred             cCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          287 DPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                          .  ...+.....+..+.+|+.+||+.||++|||+.+++++
T Consensus       269 ----~--~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  306 (349)
T 2w4o_A          269 ----Y--FISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH  306 (349)
T ss_dssp             ----C--CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ----c--cCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                0  0001112455679999999999999999999999873

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=9.8e-47  Score=349.83  Aligned_cols=270  Identities=21%  Similarity=0.275  Sum_probs=195.1

Q ss_pred             HHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccC-CChhhHHHHHHHHHHHHhcC-CCceeeeeeeeeeCC--c
Q 019536           52 KATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDN-STLDDVEYCFNNIVFSSQMK-HKNILKLIGCCLETE--L  127 (339)
Q Consensus        52 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~-H~niv~~~~~~~~~~--~  127 (339)
                      ...++|++.+.||+|+||+||+|.+..+++.||||++... ........+.+|+.+++.+. ||||+++++++...+  .
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            3458999999999999999999999999999999998754 23355677889999999997 999999999997544  6


Q ss_pred             cEEEEEeccCCccccccc-cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCC
Q 019536          128 PTLVFESVKYGTLRGFSF-ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPE  206 (339)
Q Consensus       128 ~~lv~e~~~~g~L~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~  206 (339)
                      .++||||++ |+|.+++. ..++...+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+|+.+..
T Consensus        86 ~~lv~e~~~-~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  161 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIRANILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVN  161 (388)
T ss_dssp             EEEEEECCS-EEHHHHHHHTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEESSS
T ss_pred             EEEEecccC-cCHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCcccccccc
Confidence            899999997 57877776 57888889999999999999999   89999999999999999999999999999987643


Q ss_pred             CCc-------------------eeeeccccccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCc
Q 019536          207 GET-------------------HVREEFIKGAYGFIAPEYFAT-SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDD  266 (339)
Q Consensus       207 ~~~-------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~  266 (339)
                      ...                   .......+||+.|+|||++.+ ..|+.++||||+||++|+|++|++||...  ..   
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~--~~---  236 (388)
T 3oz6_A          162 IRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS--ST---  236 (388)
T ss_dssp             CCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS--SH---
T ss_pred             cccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC--CH---
Confidence            110                   111123579999999999986 57999999999999999999999997532  21   


Q ss_pred             hhHHHHHHHHhhcCcc---cccccC----------------cccCCCCCC----------CcHHHHHHHHHHHHHhhccC
Q 019536          267 LTVLEYAKKSIENNRF---GAIVDP----------------IFDEDNSFP----------GKEEKLQSLGQLMYKCLSKS  317 (339)
Q Consensus       267 ~~~~~~~~~~~~~~~~---~~~~~~----------------~~~~~~~~~----------~~~~~~~~~~~li~~cl~~d  317 (339)
                      ................   ..+..+                .......++          .....+..+.+|+.+||+.|
T Consensus       237 ~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~d  316 (388)
T 3oz6_A          237 MNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFN  316 (388)
T ss_dssp             HHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSS
T ss_pred             HHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccC
Confidence            1111111111100000   000000                000000000          00023457899999999999


Q ss_pred             CCCCCCHHHHHHH
Q 019536          318 PEHRPLMVDVAKQ  330 (339)
Q Consensus       318 P~~Rps~~~il~~  330 (339)
                      |++|||+.|++++
T Consensus       317 P~~R~t~~e~l~H  329 (388)
T 3oz6_A          317 PNKRISANDALKH  329 (388)
T ss_dssp             GGGSCCHHHHTTS
T ss_pred             cccCCCHHHHhCC
Confidence            9999999999875

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=8.5e-47  Score=336.38  Aligned_cols=259  Identities=21%  Similarity=0.335  Sum_probs=195.7

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS-TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVF  132 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  132 (339)
                      .++|++.+.||+|+||+||+|.+..   .||+|++.... .....+.+.+|+.+++.++||||+++++++ ..+..++||
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~   98 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT   98 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence            4789999999999999999998743   49999987653 335567788999999999999999999966 455689999


Q ss_pred             EeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCc
Q 019536          133 ESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGET  209 (339)
Q Consensus       133 e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~  209 (339)
                      ||+++++|.+++.   ..+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus        99 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  175 (289)
T 3og7_A           99 QWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG  175 (289)
T ss_dssp             ECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred             EecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceeccccccccc
Confidence            9999999998875   56888999999999999999999   89999999999999999999999999999976644322


Q ss_pred             eeeecccccccccccccccc---cCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccc
Q 019536          210 HVREEFIKGAYGFIAPEYFA---TSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIV  286 (339)
Q Consensus       210 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (339)
                      ........||+.|+|||++.   +..++.++||||||+++|+|++|+.||......    .....    ........   
T Consensus       176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~----~~~~~~~~---  244 (289)
T 3og7_A          176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR----DQIIE----MVGRGSLS---  244 (289)
T ss_dssp             --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH----HHHHH----HHHHTSCC---
T ss_pred             cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH----HHHHH----HhcccccC---
Confidence            22222456899999999986   567889999999999999999999998532211    11111    11111110   


Q ss_pred             cCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 019536          287 DPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYL  336 (339)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~  336 (339)
                       +...     .....++..+.+|+.+||+.||++|||+.++++.|+++.+
T Consensus       245 -~~~~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          245 -PDLS-----KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             -CCTT-----SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             -cchh-----hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence             0000     0012345679999999999999999999999999999865

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=3.1e-47  Score=345.15  Aligned_cols=266  Identities=22%  Similarity=0.291  Sum_probs=211.0

Q ss_pred             cCcccCCceeccCCeeEEEEEE----cCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeee--eCCcc
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTL----VDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCL--ETELP  128 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~--~~~~~  128 (339)
                      ++|++.+.||+|+||.||+|.+    ..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.  +.+..
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  101 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGP-DQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL  101 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCH-HHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCH-HHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence            6899999999999999999994    56889999999976543 55677889999999999999999999987  45668


Q ss_pred             EEEEEeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccC
Q 019536          129 TLVFESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIP  205 (339)
Q Consensus       129 ~lv~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~  205 (339)
                      ++||||+++++|.+++.   ..+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++...
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  178 (327)
T 3lxl_A          102 RLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLP  178 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred             EEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccccceecc
Confidence            99999999999999986   45899999999999999999999   8999999999999999999999999999998775


Q ss_pred             CCCcee-eecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCC------CCchhHHHHHHHHhh
Q 019536          206 EGETHV-REEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGN------DDDLTVLEYAKKSIE  278 (339)
Q Consensus       206 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~  278 (339)
                      ...... ......+|..|+|||++.+..++.++||||||+++|+|++|+.||.......      ...............
T Consensus       179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (327)
T 3lxl_A          179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLE  258 (327)
T ss_dssp             TTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHH
T ss_pred             cCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhh
Confidence            443321 2223457888999999999999999999999999999999999975321100      000000011111111


Q ss_pred             cCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          279 NNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                                   .....+.+..++..+.+|+.+||+.||++|||+.++++.|+.++..
T Consensus       259 -------------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  304 (327)
T 3lxl_A          259 -------------EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG  304 (327)
T ss_dssp             -------------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred             -------------cccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence                         1111122235567899999999999999999999999999998753

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=7.8e-47  Score=357.15  Aligned_cols=260  Identities=24%  Similarity=0.300  Sum_probs=207.1

Q ss_pred             HHHHHHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCc
Q 019536           48 KDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETEL  127 (339)
Q Consensus        48 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~  127 (339)
                      +.++...++|++.+.||+|+||.||+|.+. .+..||||++....  ...+.+.+|+.+++.++||||+++++++.+ +.
T Consensus       177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~  252 (452)
T 1fmk_A          177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP  252 (452)
T ss_dssp             TCSBCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEECCTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred             cccccChhHceeeeeecCCCCeEEEEEEEC-CCceEEEEEeccCC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cc
Confidence            345555678999999999999999999997 45779999998654  235678999999999999999999999976 66


Q ss_pred             cEEEEEeccCCccccccc----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccc
Q 019536          128 PTLVFESVKYGTLRGFSF----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVS  203 (339)
Q Consensus       128 ~~lv~e~~~~g~L~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~  203 (339)
                      .++||||+++|+|.+++.    ..+++..++.++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++.
T Consensus       253 ~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~  329 (452)
T 1fmk_A          253 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARL  329 (452)
T ss_dssp             CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred             eEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCcccee
Confidence            899999999999999986    35889999999999999999999   89999999999999999999999999999987


Q ss_pred             cCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCcc
Q 019536          204 IPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRF  282 (339)
Q Consensus       204 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (339)
                      ........ .....++..|+|||++.+..++.++||||||+++|||++ |+.||....        ..+........   
T Consensus       330 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~--------~~~~~~~i~~~---  397 (452)
T 1fmk_A          330 IEDNEYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--------NREVLDQVERG---  397 (452)
T ss_dssp             --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--------HHHHHHHHHTT---
T ss_pred             cCCCceec-ccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHHcC---
Confidence            65432221 113456788999999999999999999999999999999 999975221        11111111111   


Q ss_pred             cccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          283 GAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                                 ...+.+..++..+.+||.+||+.||++|||+.+|++.|+.+..+
T Consensus       398 -----------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~  441 (452)
T 1fmk_A          398 -----------YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  441 (452)
T ss_dssp             -----------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             -----------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence                       11122234566899999999999999999999999999988643

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-47  Score=350.57  Aligned_cols=258  Identities=24%  Similarity=0.389  Sum_probs=197.8

Q ss_pred             CcccCCceeccCCeeEEEEEEcCC---CeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeee-CCccEEE
Q 019536           56 NYDLHKVIQSDTSYRLFEGTLVDQ---DRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLE-TELPTLV  131 (339)
Q Consensus        56 ~~~~~~~ig~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~-~~~~~lv  131 (339)
                      .|.+.+.||+|+||+||+|.+..+   +..||+|.+.........+.+.+|+.+++.++||||++++++|.+ ++..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            467778999999999999997533   246899998776555677889999999999999999999998754 5678999


Q ss_pred             EEeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCC
Q 019536          132 FESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE  208 (339)
Q Consensus       132 ~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~  208 (339)
                      |||+++|+|.+++.   ..+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++......
T Consensus       170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~  246 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  246 (373)
T ss_dssp             EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence            99999999999986   35778888999999999999999   8999999999999999999999999999998664432


Q ss_pred             cee--eecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCccccc
Q 019536          209 THV--REEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAI  285 (339)
Q Consensus       209 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (339)
                      ...  ......+|+.|+|||++.+..++.++|||||||++|+|++ |.+||.......     .....    ..+.    
T Consensus       247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~-----~~~~~----~~~~----  313 (373)
T 3c1x_A          247 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-----ITVYL----LQGR----  313 (373)
T ss_dssp             -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC-----HHHHH----HTTC----
T ss_pred             cccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH-----HHHHH----HcCC----
Confidence            211  1123456788999999999999999999999999999999 677764322211     11111    1110    


Q ss_pred             ccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhc
Q 019536          286 VDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLSV  338 (339)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~~  338 (339)
                               ..+.+..++..+.+++.+||+.||++|||+.++++.|+++..+.
T Consensus       314 ---------~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~  357 (373)
T 3c1x_A          314 ---------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF  357 (373)
T ss_dssp             ---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             ---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence                     00111234567999999999999999999999999999998653

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=7.1e-47  Score=342.76  Aligned_cols=258  Identities=21%  Similarity=0.296  Sum_probs=204.6

Q ss_pred             hcCcccCCceeccCCeeEEEEE-----EcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCcc
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGT-----LVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELP  128 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~  128 (339)
                      .++|++.+.||+|+||.||+|.     ...++..||+|.+...........+.+|+.+++.++||||+++++++.+.+..
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            4789999999999999999999     44577899999998765556677889999999999999999999999999999


Q ss_pred             EEEEEeccCCcccccccc---------CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCC---CCceEEe
Q 019536          129 TLVFESVKYGTLRGFSFA---------SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDE---NYSAKLH  196 (339)
Q Consensus       129 ~lv~e~~~~g~L~~~~~~---------~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~---~~~~kl~  196 (339)
                      ++||||+++|+|.+++..         .+++..++.++.|++.||.|||   +.+|+||||||+||+++.   +..+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEEEC
Confidence            999999999999999762         3788889999999999999999   899999999999999984   4569999


Q ss_pred             cCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHH
Q 019536          197 DFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKK  275 (339)
Q Consensus       197 dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~  275 (339)
                      |||+++...............+|+.|+|||++.+..++.++||||||+++|+|++ |+.||....        .......
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~--------~~~~~~~  257 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS--------NQEVLEF  257 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--------HHHHHHH
T ss_pred             ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC--------HHHHHHH
Confidence            9999876544333222224567889999999998899999999999999999998 989975221        1111111


Q ss_pred             HhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 019536          276 SIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYL  336 (339)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~  336 (339)
                      ......              .+.+...+..+.+|+.+||+.||.+|||+.++++.|+.+..
T Consensus       258 ~~~~~~--------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  304 (327)
T 2yfx_A          258 VTSGGR--------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  304 (327)
T ss_dssp             HHTTCC--------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HhcCCC--------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence            111110              01112345578999999999999999999999999998864

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=7.1e-47  Score=358.26  Aligned_cols=248  Identities=24%  Similarity=0.264  Sum_probs=206.5

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC--hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST--LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLV  131 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  131 (339)
                      .++|.+.+.||+|+||.||+|.+..+|+.||||++.....  ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            3789999999999999999999999999999999975321  12356788999999999999999999999999999999


Q ss_pred             EEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCc
Q 019536          132 FESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGET  209 (339)
Q Consensus       132 ~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~  209 (339)
                      |||+++|+|.+++.  ..+++..+..++.||+.||.|||   +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus        95 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~  171 (476)
T 2y94_A           95 MEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF  171 (476)
T ss_dssp             EECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhcccccc
Confidence            99999999999986  56899999999999999999999   99999999999999999999999999999987755432


Q ss_pred             eeeecccccccccccccccccCCC-CcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccC
Q 019536          210 HVREEFIKGAYGFIAPEYFATSSF-NEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDP  288 (339)
Q Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (339)
                      .   ...+||+.|+|||++.+..+ +.++||||+||++|+|++|+.||.....     ....   .. ...+.       
T Consensus       172 ~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~-----~~~~---~~-i~~~~-------  232 (476)
T 2y94_A          172 L---RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV-----PTLF---KK-ICDGI-------  232 (476)
T ss_dssp             B---CCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS-----HHHH---HH-HHTTC-------
T ss_pred             c---cccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH-----HHHH---HH-HhcCC-------
Confidence            2   13569999999999988776 6899999999999999999999853211     1111   11 11111       


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          289 IFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                           .  ..+...+.++.+|+.+||+.||++|||+.+++++
T Consensus       233 -----~--~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h  267 (476)
T 2y94_A          233 -----F--YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH  267 (476)
T ss_dssp             -----C--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             -----c--CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence                 0  1112344578999999999999999999999873

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.1e-46  Score=339.55  Aligned_cols=266  Identities=20%  Similarity=0.332  Sum_probs=212.0

Q ss_pred             cCcccCCceeccCCeeEEEEEE----cCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC--cc
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTL----VDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETE--LP  128 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~--~~  128 (339)
                      ++|++.+.||+|+||.||+|.+    ..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++...+  ..
T Consensus        41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE-EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCS-HHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCH-HHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            6799999999999999999994    45789999999987543 56678899999999999999999999987644  78


Q ss_pred             EEEEEeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccC
Q 019536          129 TLVFESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIP  205 (339)
Q Consensus       129 ~lv~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~  205 (339)
                      ++||||+++++|.+++.   ..+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++...
T Consensus       120 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~  196 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP  196 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence            99999999999999986   35889999999999999999999   8999999999999999999999999999998775


Q ss_pred             CCCceee-ecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccC--------CCCCCCchhHHHHHHHH
Q 019536          206 EGETHVR-EEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFK--------GNGNDDDLTVLEYAKKS  276 (339)
Q Consensus       206 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~--------~~~~~~~~~~~~~~~~~  276 (339)
                      ....... .....++..|+|||++.+..++.++||||||+++|+|++|..|+...        +....... ........
T Consensus       197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  275 (326)
T 2w1i_A          197 QDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM-IVFHLIEL  275 (326)
T ss_dssp             SSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHH-HHHHHHHH
T ss_pred             ccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhh-hHHHHHHH
Confidence            5433211 12245677899999999888999999999999999999999987522        11110000 00011111


Q ss_pred             hhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhc
Q 019536          277 IENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLSV  338 (339)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~~  338 (339)
                      ...             ....+.+..++..+.+|+.+||+.||++|||+.++++.|+++.+.+
T Consensus       276 ~~~-------------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l  324 (326)
T 2w1i_A          276 LKN-------------NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM  324 (326)
T ss_dssp             HHT-------------TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             hhc-------------CCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence            111             1111222345668999999999999999999999999999998865

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.6e-46  Score=332.67  Aligned_cols=259  Identities=22%  Similarity=0.314  Sum_probs=211.0

Q ss_pred             HHHHHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCcc
Q 019536           49 DLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELP  128 (339)
Q Consensus        49 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~  128 (339)
                      ++....++|++.+.||+|+||+||+|.+. ++..||+|.+....  ...+.+.+|+.+++.++||||+++++++.+ +..
T Consensus         7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~   82 (279)
T 1qpc_A            7 EWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPI   82 (279)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             hcccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc--ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCc
Confidence            44445678999999999999999999986 67889999997654  235678899999999999999999999874 458


Q ss_pred             EEEEEeccCCcccccccc----CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCcccc
Q 019536          129 TLVFESVKYGTLRGFSFA----SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSI  204 (339)
Q Consensus       129 ~lv~e~~~~g~L~~~~~~----~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~  204 (339)
                      ++||||+++++|.+++..    .+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++..
T Consensus        83 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  159 (279)
T 1qpc_A           83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI  159 (279)
T ss_dssp             EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccc
Confidence            999999999999999873    6899999999999999999999   899999999999999999999999999999877


Q ss_pred             CCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCccc
Q 019536          205 PEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFG  283 (339)
Q Consensus       205 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (339)
                      ...... ......++..|+|||++.+..++.++||||||+++|+|++ |+.||....        ..+.........   
T Consensus       160 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--------~~~~~~~~~~~~---  227 (279)
T 1qpc_A          160 EDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--------NPEVIQNLERGY---  227 (279)
T ss_dssp             SSSCEE-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC--------HHHHHHHHHTTC---
T ss_pred             cCcccc-cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccC--------HHHHHHHHhccc---
Confidence            554322 2223456778999999998899999999999999999999 898975221        111111111110   


Q ss_pred             ccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          284 AIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                                 ..+.+...+..+.+|+.+||+.||++|||+.++++.|+++...
T Consensus       228 -----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  270 (279)
T 1qpc_A          228 -----------RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (279)
T ss_dssp             -----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -----------CCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence                       0011123456799999999999999999999999999998765

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.1e-46  Score=331.28  Aligned_cols=255  Identities=20%  Similarity=0.318  Sum_probs=209.9

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFE  133 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  133 (339)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++.....  ..+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTE   83 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB--CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEC
T ss_pred             hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEe
Confidence            367999999999999999999997 678999999987543  34678899999999999999999999999999999999


Q ss_pred             eccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCce
Q 019536          134 SVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH  210 (339)
Q Consensus       134 ~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~  210 (339)
                      |+++++|.+++.   ..+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++........
T Consensus        84 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~  160 (267)
T 3t9t_A           84 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT  160 (267)
T ss_dssp             CCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred             CCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEccccccccccccccc
Confidence            999999999986   35788999999999999999999   899999999999999999999999999998766432211


Q ss_pred             eeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCc
Q 019536          211 VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPI  289 (339)
Q Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (339)
                       ......++..|+|||++.+..++.++||||+|+++|+|++ |+.||....        .............        
T Consensus       161 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--------~~~~~~~i~~~~~--------  223 (267)
T 3t9t_A          161 -SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--------NSEVVEDISTGFR--------  223 (267)
T ss_dssp             -STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHHHHHHTTCC--------
T ss_pred             -ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC--------HHHHHHHHhcCCc--------
Confidence             1113456778999999998899999999999999999999 899975221        1111111111100        


Q ss_pred             ccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          290 FDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                            .+.+...+..+.+++.+||+.||++|||+.++++.|+++.++
T Consensus       224 ------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (267)
T 3t9t_A          224 ------LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  265 (267)
T ss_dssp             ------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             ------CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence                  011123455789999999999999999999999999999875

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=6.8e-47  Score=342.76  Aligned_cols=247  Identities=21%  Similarity=0.249  Sum_probs=181.8

Q ss_pred             CCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcC-CCceeeeeeeeeeCCccEEEEEeccCC
Q 019536           60 HKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMK-HKNILKLIGCCLETELPTLVFESVKYG  138 (339)
Q Consensus        60 ~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~g  138 (339)
                      .+.||+|+||+||+|.+..+++.||||++..    .....+.+|+.+++.+. ||||+++++++.++...++||||+++|
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~   91 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK----RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGG   91 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEG----GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEECh----hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCC
Confidence            3789999999999999999999999999965    34566779999999997 999999999999999999999999999


Q ss_pred             ccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCC---ceEEecCCCccccCCCCceeee
Q 019536          139 TLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENY---SAKLHDFSLSVSIPEGETHVRE  213 (339)
Q Consensus       139 ~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~---~~kl~dfg~a~~~~~~~~~~~~  213 (339)
                      +|.+++.  ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++   .+||+|||+++.........  
T Consensus        92 ~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~--  166 (325)
T 3kn6_A           92 ELFERIKKKKHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL--  166 (325)
T ss_dssp             BHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcc--
Confidence            9999886  56899999999999999999999   89999999999999997665   79999999998765443322  


Q ss_pred             cccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCC
Q 019536          214 EFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDED  293 (339)
Q Consensus       214 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (339)
                      ....||+.|+|||++.+..++.++||||+||++|+|++|+.||........ .....+.... +..+            .
T Consensus       167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~~~~-i~~~------------~  232 (325)
T 3kn6_A          167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLT-CTSAVEIMKK-IKKG------------D  232 (325)
T ss_dssp             -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC--------CCCHHHHHHH-HTTT------------C
T ss_pred             cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccc-cccHHHHHHH-HHcC------------C
Confidence            235689999999999999999999999999999999999999864332111 1111111111 1111            1


Q ss_pred             CCCCCc--HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          294 NSFPGK--EEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       294 ~~~~~~--~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                      ..++..  ...+.++.+|+.+||+.||++|||+.++++
T Consensus       233 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          233 FSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             CCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             CCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence            111111  234678999999999999999999999874

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=7.8e-47  Score=343.47  Aligned_cols=268  Identities=20%  Similarity=0.313  Sum_probs=200.1

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHH--HHhcCCCceeeeeeeeee-----CC
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVF--SSQMKHKNILKLIGCCLE-----TE  126 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~--l~~l~H~niv~~~~~~~~-----~~  126 (339)
                      .++|++.+.||+|+||+||+|..  +++.||||++...    ....+..|..+  +..++||||+++++.+..     ..
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~   85 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFA----NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM   85 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred             hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeecc----chhhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence            47899999999999999999987  7899999999753    23444445444  455899999999986543     23


Q ss_pred             ccEEEEEeccCCccccccc-cCCChHHHHHHHHHHHHHHHHHhcCCCC---------CeEEccCCCCCEEeCCCCceEEe
Q 019536          127 LPTLVFESVKYGTLRGFSF-ASLLIAPRIKIAMEIANAVAYLHVGFDR---------PIVFRCIKASNVLLDENYSAKLH  196 (339)
Q Consensus       127 ~~~lv~e~~~~g~L~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~---------~i~H~dlk~~Nil~~~~~~~kl~  196 (339)
                      ..++||||+++|+|.+++. ...++..+..++.|++.||.|||   +.         +|+||||||+|||++.++.+||+
T Consensus        86 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~  162 (336)
T 3g2f_A           86 EYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS  162 (336)
T ss_dssp             EEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred             eEEEEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCcEEEe
Confidence            5689999999999999986 56788889999999999999999   78         99999999999999999999999


Q ss_pred             cCCCccccCCCCc------eeeeccccccccccccccccc-------CCCCcccchHHHHHHHHHHHhCCCccccCCCCC
Q 019536          197 DFSLSVSIPEGET------HVREEFIKGAYGFIAPEYFAT-------SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGN  263 (339)
Q Consensus       197 dfg~a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~  263 (339)
                      |||+++.+.....      ........||+.|+|||++.+       ..++.++|||||||++|||++|..||. .+...
T Consensus       163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~-~~~~~  241 (336)
T 3g2f_A          163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF-PGESV  241 (336)
T ss_dssp             CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGS-TTSCC
T ss_pred             eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCC-Cccch
Confidence            9999987654321      111223468999999999976       456788999999999999999987763 22221


Q ss_pred             CCchhHHH----------HHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 019536          264 DDDLTVLE----------YAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQ  333 (339)
Q Consensus       264 ~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~  333 (339)
                      ........          ..........    ..+.+.  ..++.....+..+.+|+.+||+.||++|||+.++++.|++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~  315 (336)
T 3g2f_A          242 PEYQMAFQTEVGNHPTFEDMQVLVSREK----QRPKFP--EAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAE  315 (336)
T ss_dssp             CCCCCTTHHHHCSSCCHHHHHHHHTTSC----CCCCCC--TTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             hHHHHhhhcccCCCchHHHHHhhhcccc----cCCCCC--cccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHH
Confidence            11111100          0000000000    011111  1122233577889999999999999999999999999999


Q ss_pred             HHhh
Q 019536          334 MYLS  337 (339)
Q Consensus       334 l~~~  337 (339)
                      +...
T Consensus       316 ll~~  319 (336)
T 3g2f_A          316 LMMI  319 (336)
T ss_dssp             HHHC
T ss_pred             HHHH
Confidence            8753

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.8e-46  Score=337.22  Aligned_cols=252  Identities=23%  Similarity=0.370  Sum_probs=197.3

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFE  133 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  133 (339)
                      .++|++.+.||+|+||+||+|.+  .++.||+|++...   ...+.+.+|+.+++.++||||+++++++.+  ..++|||
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e   79 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESE---SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVME   79 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSST---THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEE
T ss_pred             HhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecCh---hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEE
Confidence            36789999999999999999998  5789999998654   446778899999999999999999999874  4799999


Q ss_pred             eccCCcccccccc-----CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCc-eEEecCCCccccCCC
Q 019536          134 SVKYGTLRGFSFA-----SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYS-AKLHDFSLSVSIPEG  207 (339)
Q Consensus       134 ~~~~g~L~~~~~~-----~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~-~kl~dfg~a~~~~~~  207 (339)
                      |+++|+|.+++..     .++...++.++.|++.||.|||+....+|+||||||+||+++.++. +||+|||+++.....
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~  159 (307)
T 2eva_A           80 YAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH  159 (307)
T ss_dssp             CCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------
T ss_pred             cCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc
Confidence            9999999999862     3677888999999999999999211189999999999999988876 799999998765432


Q ss_pred             CceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCccccccc
Q 019536          208 ETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVD  287 (339)
Q Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (339)
                      ..     ...||+.|+|||++.+..++.++||||||+++|+|++|+.||...+..      .......... ...     
T Consensus       160 ~~-----~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~-~~~-----  222 (307)
T 2eva_A          160 MT-----NNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP------AFRIMWAVHN-GTR-----  222 (307)
T ss_dssp             ----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS------HHHHHHHHHT-TCC-----
T ss_pred             cc-----cCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc------HHHHHHHHhc-CCC-----
Confidence            21     245899999999999989999999999999999999999998633221      1111111111 100     


Q ss_pred             CcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          288 PIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                              .+.+...+..+.+|+.+||+.||++|||+.++++.|+.+.+.
T Consensus       223 --------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  264 (307)
T 2eva_A          223 --------PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY  264 (307)
T ss_dssp             --------CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGG
T ss_pred             --------CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence                    011123455789999999999999999999999999998754

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.7e-46  Score=333.27  Aligned_cols=252  Identities=20%  Similarity=0.284  Sum_probs=206.8

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS-TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVF  132 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  132 (339)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++.... .....+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            578999999999999999999999999999999987653 3345677889999999999999999999999999999999


Q ss_pred             EeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCc---eEEecCCCccccCCC
Q 019536          133 ESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYS---AKLHDFSLSVSIPEG  207 (339)
Q Consensus       133 e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~---~kl~dfg~a~~~~~~  207 (339)
                      ||+++|+|.+.+.  ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.   +||+|||++......
T Consensus        85 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~  161 (284)
T 3kk8_A           85 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS  161 (284)
T ss_dssp             CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred             ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence            9999999988775  56889999999999999999999   899999999999999976655   999999999776544


Q ss_pred             CceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCccccccc
Q 019536          208 ETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVD  287 (339)
Q Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (339)
                      ...   ....||+.|+|||++.+..++.++||||+|+++|+|++|+.||....     .....   . .......     
T Consensus       162 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~-----~~~~~---~-~~~~~~~-----  224 (284)
T 3kk8_A          162 EAW---HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED-----QHRLY---A-QIKAGAY-----  224 (284)
T ss_dssp             CBC---CCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHH---H-HHHHTCC-----
T ss_pred             ccc---cCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc-----hhHHH---H-HHHhccc-----
Confidence            322   13568999999999999999999999999999999999999985211     11111   1 1111111     


Q ss_pred             CcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          288 PIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                           ..+.+.....+..+.+|+.+||+.||++|||+.+++++
T Consensus       225 -----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (284)
T 3kk8_A          225 -----DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  262 (284)
T ss_dssp             -----CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             -----cCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence                 00111112445679999999999999999999999873

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=9.5e-47  Score=341.92  Aligned_cols=255  Identities=21%  Similarity=0.320  Sum_probs=205.7

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeE--EEEEeccCCChhhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCccEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPI--SVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLETELPTLV  131 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~v--avK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~~lv  131 (339)
                      ++|++.+.||+|+||.||+|.+..++..+  |+|.+.........+.+.+|+.+++.+ +||||+++++++.+.+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            68999999999999999999998888755  999988655445667788999999999 899999999999999999999


Q ss_pred             EEeccCCcccccccc------------------CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCce
Q 019536          132 FESVKYGTLRGFSFA------------------SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSA  193 (339)
Q Consensus       132 ~e~~~~g~L~~~~~~------------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~  193 (339)
                      |||+++|+|.+++..                  .+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCCeE
Confidence            999999999998752                  5888999999999999999999   8999999999999999999999


Q ss_pred             EEecCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHH
Q 019536          194 KLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEY  272 (339)
Q Consensus       194 kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~  272 (339)
                      ||+|||+++.......   .....+++.|+|||++.+..++.++||||||+++|+|++ |+.||....        ....
T Consensus       182 kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~--------~~~~  250 (327)
T 1fvr_A          182 KIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--------CAEL  250 (327)
T ss_dssp             EECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHH
T ss_pred             EEcccCcCcccccccc---ccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc--------HHHH
Confidence            9999999874322111   113456788999999998889999999999999999998 999975221        1111


Q ss_pred             HHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          273 AKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                      ...... .             ...+.+...+..+.+|+.+||+.||++|||+.++++.|+++.++
T Consensus       251 ~~~~~~-~-------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  301 (327)
T 1fvr_A          251 YEKLPQ-G-------------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  301 (327)
T ss_dssp             HHHGGG-T-------------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             HHHhhc-C-------------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            111111 1             00111123456799999999999999999999999999998764

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=6.7e-47  Score=343.06  Aligned_cols=248  Identities=21%  Similarity=0.245  Sum_probs=194.3

Q ss_pred             hcCcccCCceeccCCeeEEEEEEc---CCCeeEEEEEeccCCC---hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCc
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLV---DQDRPISVMKFHDNST---LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETEL  127 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~---~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~  127 (339)
                      .++|++.+.||+|+||.||+|...   .+++.||+|++.....   ......+.+|+.+++.++||||+++++++.+++.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            478999999999999999999985   5889999999986532   2344567789999999999999999999999999


Q ss_pred             cEEEEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccC
Q 019536          128 PTLVFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIP  205 (339)
Q Consensus       128 ~~lv~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~  205 (339)
                      .++||||+++|+|.+++.  ..++...+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~  172 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI  172 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred             EEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence            999999999999999886  56888899999999999999999   8999999999999999999999999999987653


Q ss_pred             CCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCccccc
Q 019536          206 EGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAI  285 (339)
Q Consensus       206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (339)
                      .....  .....||+.|+|||++.+..++.++|||||||++|+|++|+.||....        ........... .    
T Consensus       173 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--------~~~~~~~i~~~-~----  237 (327)
T 3a62_A          173 HDGTV--THTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN--------RKKTIDKILKC-K----  237 (327)
T ss_dssp             --------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHHT-C----
T ss_pred             cCCcc--ccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHhC-C----
Confidence            33221  224578999999999999899999999999999999999999985221        11111111111 0    


Q ss_pred             ccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 019536          286 VDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP-----LMVDVAK  329 (339)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~il~  329 (339)
                              ..+|  ...+..+.+|+.+||+.||++||     ++.++++
T Consensus       238 --------~~~p--~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          238 --------LNLP--PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             --------CCCC--TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             --------CCCC--CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence                    1111  23456799999999999999999     7778775

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=9.5e-47  Score=335.69  Aligned_cols=250  Identities=20%  Similarity=0.361  Sum_probs=203.0

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCC-------eeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQD-------RPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETE  126 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~  126 (339)
                      .++|.+.+.||+|+||+||+|.+..++       ..||+|.+..... ...+.+.+|+.+++.++||||+++++++.+++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR-NYSESFFEAASMMSKLSHKHLVLNYGVCVCGD   85 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGG-GGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence            367999999999999999999998666       5799999866433 55677899999999999999999999999999


Q ss_pred             ccEEEEEeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCc--------eEE
Q 019536          127 LPTLVFESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYS--------AKL  195 (339)
Q Consensus       127 ~~~lv~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~--------~kl  195 (339)
                      ..++||||+++|+|.+++.   ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.        +||
T Consensus        86 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl  162 (289)
T 4fvq_A           86 ENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKL  162 (289)
T ss_dssp             CCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred             CCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccceeee
Confidence            9999999999999999986   33889999999999999999999   899999999999999988876        999


Q ss_pred             ecCCCccccCCCCceeeeccccccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHH
Q 019536          196 HDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFAT-SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAK  274 (339)
Q Consensus       196 ~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~  274 (339)
                      +|||++.......      ...+|+.|+|||++.+ ..++.++||||||+++|+|++|..|+... .      .......
T Consensus       163 ~Dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~-~------~~~~~~~  229 (289)
T 4fvq_A          163 SDPGISITVLPKD------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSA-L------DSQRKLQ  229 (289)
T ss_dssp             CCCCSCTTTSCHH------HHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTT-S------CHHHHHH
T ss_pred             ccCcccccccCcc------ccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccc-c------chHHHHH
Confidence            9999986653321      3458889999999987 67899999999999999999965553211 1      1111111


Q ss_pred             HHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 019536          275 KSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYL  336 (339)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~  336 (339)
                      ........              +  ...+..+.+|+.+||+.||++|||+.++++.|+++..
T Consensus       230 ~~~~~~~~--------------~--~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~  275 (289)
T 4fvq_A          230 FYEDRHQL--------------P--APKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT  275 (289)
T ss_dssp             HHHTTCCC--------------C--CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred             HhhccCCC--------------C--CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            11111100              0  0112358899999999999999999999999998864

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=9.5e-47  Score=333.77  Aligned_cols=247  Identities=21%  Similarity=0.247  Sum_probs=205.1

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFE  133 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  133 (339)
                      .++|++.+.||+|+||+||+|.+..++..||+|++..... ...+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV-EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME   86 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc-chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence            4679999999999999999999999999999999976543 446778899999999999999999999999999999999


Q ss_pred             eccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEe---CCCCceEEecCCCccccCCCC
Q 019536          134 SVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLL---DENYSAKLHDFSLSVSIPEGE  208 (339)
Q Consensus       134 ~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~---~~~~~~kl~dfg~a~~~~~~~  208 (339)
                      |+++++|.+++.  ..+++..+..++.|++.||.|||   +.+|+||||||+||++   +.++.+||+|||++.......
T Consensus        87 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~  163 (277)
T 3f3z_A           87 LCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK  163 (277)
T ss_dssp             CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred             ccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence            999999988875  56899999999999999999999   8999999999999999   788899999999998765543


Q ss_pred             ceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccC
Q 019536          209 THVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDP  288 (339)
Q Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (339)
                      ...   ...||+.|+|||++.+. ++.++||||+|+++|+|++|+.||....        ......... ...       
T Consensus       164 ~~~---~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~~~~~~~~~-~~~-------  223 (277)
T 3f3z_A          164 MMR---TKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPT--------DSEVMLKIR-EGT-------  223 (277)
T ss_dssp             CBC---CCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHH-HCC-------
T ss_pred             chh---ccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCC--------HHHHHHHHH-hCC-------
Confidence            321   35689999999998654 8999999999999999999999985321        111111111 111       


Q ss_pred             cccCCCCCCCc--HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          289 IFDEDNSFPGK--EEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       289 ~~~~~~~~~~~--~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                           ...|..  ...+..+.+|+.+||+.||++|||+.++++
T Consensus       224 -----~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          224 -----FTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             -----CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             -----CCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                 011110  134567999999999999999999999986

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=3.5e-46  Score=332.92  Aligned_cols=263  Identities=14%  Similarity=0.165  Sum_probs=205.7

Q ss_pred             HhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeee-eeCCccEEE
Q 019536           53 ATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCC-LETELPTLV  131 (339)
Q Consensus        53 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~-~~~~~~~lv  131 (339)
                      ..++|++.+.||+|+||+||+|.+..+++.||+|++.....   .+.+.+|+.+++.++|+|++..++.+ .+++..++|
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   83 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   83 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc---chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence            45789999999999999999999988999999998766533   23466899999999988877766665 567778999


Q ss_pred             EEeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEe---CCCCceEEecCCCccccC
Q 019536          132 FESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLL---DENYSAKLHDFSLSVSIP  205 (339)
Q Consensus       132 ~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~---~~~~~~kl~dfg~a~~~~  205 (339)
                      |||+ +++|.+++.   ..+++..+..++.|++.||.|||   +.+|+||||||+||++   +.++.+||+|||+++...
T Consensus        84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~  159 (296)
T 4hgt_A           84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             EECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             EEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence            9999 999999875   57899999999999999999999   8999999999999999   788999999999998775


Q ss_pred             CCCcee-----eecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcC
Q 019536          206 EGETHV-----REEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENN  280 (339)
Q Consensus       206 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  280 (339)
                      ......     ......||+.|+|||++.+..++.++|||||||++|+|++|+.||........  ..............
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~  237 (296)
T 4hgt_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK--RQKYERISEKKMST  237 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSS--SSHHHHHHHHHHHS
T ss_pred             CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhh--hhhhhhhhcccccc
Confidence            543211     12245689999999999999999999999999999999999999865433322  22222111111110


Q ss_pred             cccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          281 RFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                      .....             ....+..+.+|+.+||+.||++|||+.++++.|+++..+
T Consensus       238 ~~~~~-------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~  281 (296)
T 4hgt_A          238 PIEVL-------------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  281 (296)
T ss_dssp             CHHHH-------------TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             hhhhh-------------hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHH
Confidence            00000             012345799999999999999999999999999998864

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=5.5e-47  Score=348.58  Aligned_cols=268  Identities=15%  Similarity=0.148  Sum_probs=204.4

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCC-----CeeEEEEEeccCCChhh----------HHHHHHHHHHHHhcCCCceeee
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQ-----DRPISVMKFHDNSTLDD----------VEYCFNNIVFSSQMKHKNILKL  118 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~----------~~~~~~e~~~l~~l~H~niv~~  118 (339)
                      .++|++.+.||+|+||+||+|.+..+     ++.||||++........          ...+..|+..++.++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            46899999999999999999998754     57899999876532100          1123345566777889999999


Q ss_pred             eeeeeeC----CccEEEEEeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeC--C
Q 019536          119 IGCCLET----ELPTLVFESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLD--E  189 (339)
Q Consensus       119 ~~~~~~~----~~~~lv~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~--~  189 (339)
                      ++++...    ...++||||+ +++|.+++.   ..+++..++.++.||+.||.|||   +.+|+||||||+|||++  .
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill~~~~  189 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKN  189 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEESSC
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEEecCC
Confidence            9999875    4579999999 999999986   46899999999999999999999   89999999999999998  8


Q ss_pred             CCceEEecCCCccccCCCCcee-----eecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCC
Q 019536          190 NYSAKLHDFSLSVSIPEGETHV-----REEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGND  264 (339)
Q Consensus       190 ~~~~kl~dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~  264 (339)
                      ++.+||+|||+++.+.......     ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......  
T Consensus       190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~--  267 (364)
T 3op5_A          190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD--  267 (364)
T ss_dssp             TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC--
T ss_pred             CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC--
Confidence            8999999999998765432111     112345999999999999999999999999999999999999998643221  


Q ss_pred             CchhHHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          265 DDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                        ............. ....+.+..+..       ...+.++.+++..||+.||++|||+.+|++.|+++..+
T Consensus       268 --~~~~~~~~~~~~~-~~~~~~~~~~~~-------~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  330 (364)
T 3op5_A          268 --PKYVRDSKIRYRE-NIASLMDKCFPA-------ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKA  330 (364)
T ss_dssp             --HHHHHHHHHHHHH-CHHHHHHHHSCT-------TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             --HHHHHHHHHHhhh-hHHHHHHHhccc-------ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Confidence              1111111111111 111112211110       12345799999999999999999999999999998764

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=3.1e-46  Score=333.04  Aligned_cols=260  Identities=22%  Similarity=0.289  Sum_probs=207.5

Q ss_pred             HhcCcccCC-ceeccCCeeEEEEEE--cCCCeeEEEEEeccCCC-hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCcc
Q 019536           53 ATNNYDLHK-VIQSDTSYRLFEGTL--VDQDRPISVMKFHDNST-LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELP  128 (339)
Q Consensus        53 ~~~~~~~~~-~ig~G~~g~V~~~~~--~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~  128 (339)
                      ..++|.+.+ .||+|+||+||+|.+  ..+++.||+|++..... ....+.+.+|+.+++.++||||+++++++ ..+..
T Consensus        14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~   92 (291)
T 1xbb_A           14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW   92 (291)
T ss_dssp             CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred             cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence            346788888 999999999999965  45678999999976533 23467788999999999999999999999 56678


Q ss_pred             EEEEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCC
Q 019536          129 TLVFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPE  206 (339)
Q Consensus       129 ~lv~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~  206 (339)
                      ++||||+++++|.+++.  ..++...++.++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus        93 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  169 (291)
T 1xbb_A           93 MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA  169 (291)
T ss_dssp             EEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred             EEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence            99999999999999986  45889999999999999999999   89999999999999999999999999999987755


Q ss_pred             CCceee-ecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCcccc
Q 019536          207 GETHVR-EEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA  284 (339)
Q Consensus       207 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (339)
                      ...... .....+++.|+|||++.+..++.++||||||+++|+|++ |+.||.....        ..... .......  
T Consensus       170 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~-~~~~~~~--  238 (291)
T 1xbb_A          170 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--------SEVTA-MLEKGER--  238 (291)
T ss_dssp             TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHHH-HHHTTCC--
T ss_pred             CCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH--------HHHHH-HHHcCCC--
Confidence            443221 222346788999999998889999999999999999999 9999753211        11111 1111110  


Q ss_pred             cccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhc
Q 019536          285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLSV  338 (339)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~~  338 (339)
                                 .+.+...+..+.+++.+||+.||++|||+.++++.|++++.+.
T Consensus       239 -----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~  281 (291)
T 1xbb_A          239 -----------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV  281 (291)
T ss_dssp             -----------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             -----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence                       0111244567999999999999999999999999999998653

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=8.8e-47  Score=348.19  Aligned_cols=244  Identities=18%  Similarity=0.168  Sum_probs=196.4

Q ss_pred             CCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeccCCc
Q 019536           60 HKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGT  139 (339)
Q Consensus        60 ~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~g~  139 (339)
                      .+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..++||||+++|+
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~  172 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM-KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE  172 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence            5679999999999999998999999999987543 456778899999999999999999999999999999999999999


Q ss_pred             cccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEe--CCCCceEEecCCCccccCCCCceeeec
Q 019536          140 LRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLL--DENYSAKLHDFSLSVSIPEGETHVREE  214 (339)
Q Consensus       140 L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~--~~~~~~kl~dfg~a~~~~~~~~~~~~~  214 (339)
                      |.+++.   ..+++..+..++.|++.||.|||   +.+|+||||||+|||+  +.++.+||+|||+++.........   
T Consensus       173 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~---  246 (373)
T 2x4f_A          173 LFDRIIDESYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLK---  246 (373)
T ss_dssp             EHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCC---
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccc---
Confidence            988875   35889999999999999999999   8999999999999999  567889999999998775543321   


Q ss_pred             ccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCCC
Q 019536          215 FIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDN  294 (339)
Q Consensus       215 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (339)
                      ...||+.|+|||++.+..++.++|||||||++|+|++|+.||....        ........... .+.          .
T Consensus       247 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~--------~~~~~~~i~~~-~~~----------~  307 (373)
T 2x4f_A          247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN--------DAETLNNILAC-RWD----------L  307 (373)
T ss_dssp             CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHHT-CCC----------S
T ss_pred             cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhc-cCC----------C
Confidence            3468999999999998899999999999999999999999985221        11111111111 000          0


Q ss_pred             CCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          295 SFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       295 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                      ..+.....+.++.+|+.+||+.||++|||+.++++
T Consensus       308 ~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          308 EDEEFQDISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            00111234567999999999999999999999997

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=5.5e-47  Score=344.76  Aligned_cols=243  Identities=20%  Similarity=0.253  Sum_probs=204.4

Q ss_pred             HhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCCh-------hhHHHHHHHHHHHHhcCCCceeeeeeeeeeC
Q 019536           53 ATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTL-------DDVEYCFNNIVFSSQMKHKNILKLIGCCLET  125 (339)
Q Consensus        53 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~  125 (339)
                      ..++|++.+.||+|+||+||+|.+..+++.||||++......       .....+.+|+.+++.++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            457899999999999999999999999999999999875321       1334566899999999999999999999999


Q ss_pred             CccEEEEEeccCC-ccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCcc
Q 019536          126 ELPTLVFESVKYG-TLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSV  202 (339)
Q Consensus       126 ~~~~lv~e~~~~g-~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~  202 (339)
                      +..++||||+.+| +|.+++.  ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~  178 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAA  178 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             CEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEeecccce
Confidence            9999999999777 8988876  46899999999999999999999   8999999999999999999999999999998


Q ss_pred             ccCCCCceeeecccccccccccccccccCCC-CcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCc
Q 019536          203 SIPEGETHVREEFIKGAYGFIAPEYFATSSF-NEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNR  281 (339)
Q Consensus       203 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (339)
                      .........   ...||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.....                    
T Consensus       179 ~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------------------  235 (335)
T 3dls_A          179 YLERGKLFY---TFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE--------------------  235 (335)
T ss_dssp             ECCTTCCBC---EECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG--------------------
T ss_pred             ECCCCCcee---ccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH--------------------
Confidence            775544322   3568999999999988876 7899999999999999999999852110                    


Q ss_pred             ccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          282 FGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                         ......      ..+...+.++.+|+.+||+.||++|||+.+++++
T Consensus       236 ---~~~~~~------~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          236 ---TVEAAI------HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             ---GTTTCC------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             ---HHhhcc------CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               001100      1111345679999999999999999999999974

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=7.4e-47  Score=340.34  Aligned_cols=259  Identities=19%  Similarity=0.278  Sum_probs=198.6

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC--hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCcc---
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST--LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELP---  128 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~---  128 (339)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++.....  ......+.+|+.+++.++||||+++++++......   
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            4789999999999999999999998999999999987532  23456788999999999999999999999876544   


Q ss_pred             -EEEEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccC
Q 019536          129 -TLVFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIP  205 (339)
Q Consensus       129 -~lv~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~  205 (339)
                       ++||||+++|+|.+++.  ..+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++.+.
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  167 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIA  167 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred             cEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence             99999999999999986  57899999999999999999999   8999999999999999999999999999998765


Q ss_pred             CCCce-eeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccc
Q 019536          206 EGETH-VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA  284 (339)
Q Consensus       206 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (339)
                      ..... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||....        ............... 
T Consensus       168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~--------~~~~~~~~~~~~~~~-  238 (311)
T 3ork_A          168 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS--------PVSVAYQHVREDPIP-  238 (311)
T ss_dssp             --------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHHCCCCC-
T ss_pred             ccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHhcCCCCC-
Confidence            43222 12223568999999999999999999999999999999999999985221        111111111111000 


Q ss_pred             cccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHH-HHHHHH
Q 019536          285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVA-KQLRQM  334 (339)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il-~~L~~l  334 (339)
                         +.       ......+..+.+++.+||+.||++||++.+++ ..+.++
T Consensus       239 ---~~-------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  279 (311)
T 3ork_A          239 ---PS-------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  279 (311)
T ss_dssp             ---HH-------HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             ---cc-------cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence               00       00013456799999999999999999766655 444443

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.8e-47  Score=351.12  Aligned_cols=248  Identities=20%  Similarity=0.222  Sum_probs=195.0

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC--hhhHHHHHHHHHH-HHhcCCCceeeeeeeeeeCCccEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST--LDDVEYCFNNIVF-SSQMKHKNILKLIGCCLETELPTL  130 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~-l~~l~H~niv~~~~~~~~~~~~~l  130 (339)
                      .++|++.+.||+|+||.||+|+...+++.||+|++.....  ......+.+|..+ ++.++||||+++++++.+.+..|+
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            4789999999999999999999999999999999976532  2334556677766 577899999999999999999999


Q ss_pred             EEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCC
Q 019536          131 VFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE  208 (339)
Q Consensus       131 v~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~  208 (339)
                      ||||+++|+|.+++.  ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus       117 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~  193 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN  193 (373)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCccccccccCC
Confidence            999999999999886  56888999999999999999999   8999999999999999999999999999998643322


Q ss_pred             ceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccC
Q 019536          209 THVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDP  288 (339)
Q Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (339)
                      ..  ....+||+.|+|||++.+..|+.++|+|||||++|||++|+.||....        ..+....... .        
T Consensus       194 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~--------~~~~~~~i~~-~--------  254 (373)
T 2r5t_A          194 ST--TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN--------TAEMYDNILN-K--------  254 (373)
T ss_dssp             CC--CCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB--------HHHHHHHHHH-S--------
T ss_pred             Cc--cccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC--------HHHHHHHHHh-c--------
Confidence            21  224679999999999999999999999999999999999999985211        1111111111 1        


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          289 IFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                          ...++  ...+..+.+|+.+||+.||.+||++.+.++
T Consensus       255 ----~~~~~--~~~~~~~~~li~~lL~~dp~~R~~~~~~~~  289 (373)
T 2r5t_A          255 ----PLQLK--PNITNSARHLLEGLLQKDRTKRLGAKDDFM  289 (373)
T ss_dssp             ----CCCCC--SSSCHHHHHHHHHHTCSSGGGSTTTTTTHH
T ss_pred             ----ccCCC--CCCCHHHHHHHHHHcccCHHhCCCCCCCHH
Confidence                11111  134557999999999999999999864433

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.3e-46  Score=338.82  Aligned_cols=243  Identities=18%  Similarity=0.178  Sum_probs=194.2

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC-ChhhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCccEEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS-TLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLETELPTLVF  132 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~~lv~  132 (339)
                      ++|++.++||+|+||+||+|.+..+++.||||++.... .......+..|+..+..+ +||||++++++|.+++..++||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            67999999999999999999999999999999987653 224445566676666555 8999999999999999999999


Q ss_pred             EeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCc
Q 019536          133 ESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGET  209 (339)
Q Consensus       133 e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~  209 (339)
                      ||+ +++|.+++.   ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||++........
T Consensus       137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~  212 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA  212 (311)
T ss_dssp             ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred             ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeeecccCCC
Confidence            999 668887765   46899999999999999999999   89999999999999999999999999999887654332


Q ss_pred             eeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCc
Q 019536          210 HVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPI  289 (339)
Q Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (339)
                      .   ....||+.|+|||++.+ .++.++|||||||++|+|++|..|+...        ...    ........    .+ 
T Consensus       213 ~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~--------~~~----~~~~~~~~----~~-  271 (311)
T 3p1a_A          213 G---EVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG--------EGW----QQLRQGYL----PP-  271 (311)
T ss_dssp             -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH--------HHH----HHHTTTCC----CH-
T ss_pred             C---cccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc--------cHH----HHHhccCC----Cc-
Confidence            2   23568999999999876 7999999999999999999997765311        000    00111100    00 


Q ss_pred             ccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          290 FDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                             ..+...+..+.+|+.+||+.||++|||+.++++
T Consensus       272 -------~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          272 -------EFTAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             -------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             -------ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence                   001134567999999999999999999999986

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2.7e-46  Score=331.34  Aligned_cols=248  Identities=21%  Similarity=0.313  Sum_probs=202.8

Q ss_pred             HhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC--hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 019536           53 ATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST--LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTL  130 (339)
Q Consensus        53 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  130 (339)
                      ..++|++.+.||+|+||+||+|.+..++..||+|++.....  ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   86 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence            34789999999999999999999999999999999865321  1234667899999999999999999999999999999


Q ss_pred             EEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCC
Q 019536          131 VFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE  208 (339)
Q Consensus       131 v~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~  208 (339)
                      ||||+++|+|.+++.  ..++...+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||++.......
T Consensus        87 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~  163 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR  163 (279)
T ss_dssp             EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred             EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCCccc
Confidence            999999999998876  57889999999999999999999   9999999999999999999999999999986554332


Q ss_pred             ceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccC
Q 019536          209 THVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDP  288 (339)
Q Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (339)
                      .    ....||+.|+|||.+.+..++.++||||+|+++|+|++|+.||....        ....... .....       
T Consensus       164 ~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~-~~~~~-------  223 (279)
T 3fdn_A          164 R----TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT--------YQETYKR-ISRVE-------  223 (279)
T ss_dssp             --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHH-HHHTC-------
T ss_pred             c----cccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc--------HHHHHHH-HHhCC-------
Confidence            2    13568999999999999899999999999999999999999985221        1111111 11110       


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          289 IFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                           ...  +...+..+.+|+.+||+.||++|||+.+++++
T Consensus       224 -----~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          224 -----FTF--PDFVTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             -----CCC--CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             -----CCC--CCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence                 011  12345578999999999999999999999974

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2.9e-46  Score=347.82  Aligned_cols=250  Identities=16%  Similarity=0.226  Sum_probs=193.7

Q ss_pred             hcCcccC-CceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHH-hcCCCceeeeeeeeee----CCc
Q 019536           54 TNNYDLH-KVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSS-QMKHKNILKLIGCCLE----TEL  127 (339)
Q Consensus        54 ~~~~~~~-~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~-~l~H~niv~~~~~~~~----~~~  127 (339)
                      .++|.+. +.||+|+||+||+|.+..+++.||||++...      ..+.+|+.++. ..+||||+++++++..    ...
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~  133 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC  133 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence            4567776 6899999999999999999999999999642      34668888874 4589999999999875    567


Q ss_pred             cEEEEEeccCCcccccccc----CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCC---CCceEEecCCC
Q 019536          128 PTLVFESVKYGTLRGFSFA----SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDE---NYSAKLHDFSL  200 (339)
Q Consensus       128 ~~lv~e~~~~g~L~~~~~~----~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~---~~~~kl~dfg~  200 (339)
                      .++||||+++|+|.+++..    .+++..+..++.||+.||.|||   +.+|+||||||+|||++.   ++.+||+|||+
T Consensus       134 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~  210 (400)
T 1nxk_A          134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGF  210 (400)
T ss_dssp             EEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEeccc
Confidence            8999999999999999863    4889999999999999999999   899999999999999997   78899999999


Q ss_pred             ccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcC
Q 019536          201 SVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENN  280 (339)
Q Consensus       201 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  280 (339)
                      ++........   ...+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.......... ......    ..+
T Consensus       211 a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-~~~~~i----~~~  282 (400)
T 1nxk_A          211 AKETTSHNSL---TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-GMKTRI----RMG  282 (400)
T ss_dssp             CEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCC-SHHHHH----HHT
T ss_pred             ccccCCCCcc---ccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccH-HHHHHH----HcC
Confidence            9876543221   24568999999999999999999999999999999999999986433221111 111111    111


Q ss_pred             cccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          281 RFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      .+          ....+.....+.++.+||.+||+.||++|||+.+++++
T Consensus       283 ~~----------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          283 QY----------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             CC----------CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             cc----------cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            10          00111112456689999999999999999999999974

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.3e-46  Score=367.79  Aligned_cols=257  Identities=23%  Similarity=0.323  Sum_probs=204.3

Q ss_pred             CcccCC-ceeccCCeeEEEEEEc--CCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 019536           56 NYDLHK-VIQSDTSYRLFEGTLV--DQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVF  132 (339)
Q Consensus        56 ~~~~~~-~ig~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  132 (339)
                      ++.+.. .||+|+||.||+|.+.  .++..||||+++........+.+.+|+.+++.++||||++++++|.+ +..++||
T Consensus       336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~  414 (613)
T 2ozo_A          336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM  414 (613)
T ss_dssp             SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred             ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence            333333 7999999999999886  35668999999876555677889999999999999999999999976 4589999


Q ss_pred             EeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCc
Q 019536          133 ESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGET  209 (339)
Q Consensus       133 e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~  209 (339)
                      ||+++|+|.+++.   ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus       415 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~  491 (613)
T 2ozo_A          415 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS  491 (613)
T ss_dssp             ECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----
T ss_pred             EeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCc
Confidence            9999999999885   45899999999999999999999   89999999999999999999999999999987654332


Q ss_pred             ee-eecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCccccccc
Q 019536          210 HV-REEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVD  287 (339)
Q Consensus       210 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (339)
                      .. ......+++.|+|||++.+..++.++|||||||++|||++ |+.||.....     .....   . ...+.      
T Consensus       492 ~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~-----~~~~~---~-i~~~~------  556 (613)
T 2ozo_A          492 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-----PEVMA---F-IEQGK------  556 (613)
T ss_dssp             ----------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS-----HHHHH---H-HHTTC------
T ss_pred             eeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH-----HHHHH---H-HHcCC------
Confidence            21 1112345678999999999999999999999999999998 9999853221     11111   1 11111      


Q ss_pred             CcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhc
Q 019536          288 PIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLSV  338 (339)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~~  338 (339)
                             ..+.+..++..+.+||.+||+.||++|||+.+|++.|+.++.++
T Consensus       557 -------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~  600 (613)
T 2ozo_A          557 -------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  600 (613)
T ss_dssp             -------CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             -------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence                   11122345668999999999999999999999999999988653

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=4.9e-47  Score=348.31  Aligned_cols=263  Identities=16%  Similarity=0.209  Sum_probs=207.1

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFES  134 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  134 (339)
                      ++|++.+.||+|+||+||+|.+..++..||+|++.........+.+.+|+.+++.++||||+++++++.+++..++||||
T Consensus        33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  112 (360)
T 3eqc_A           33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH  112 (360)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence            68999999999999999999999999999999998776556677889999999999999999999999999999999999


Q ss_pred             ccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCC-CeEEccCCCCCEEeCCCCceEEecCCCccccCCCCcee
Q 019536          135 VKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDR-PIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHV  211 (339)
Q Consensus       135 ~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~  211 (339)
                      +++|+|.+++.  ..+++..+..++.|++.||.|||   +. +|+||||||+||+++.++.+||+|||++........  
T Consensus       113 ~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  187 (360)
T 3eqc_A          113 MDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--  187 (360)
T ss_dssp             CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC---
T ss_pred             CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccccc--
Confidence            99999999986  47889999999999999999999   75 899999999999999999999999999876533211  


Q ss_pred             eecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHh--------------
Q 019536          212 REEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSI--------------  277 (339)
Q Consensus       212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--------------  277 (339)
                        ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.......      ........              
T Consensus       188 --~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~  259 (360)
T 3eqc_A          188 --NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE------LELMFGCQVEGDAAETPPRPRT  259 (360)
T ss_dssp             -----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHH------HHHHHC----------------
T ss_pred             --cCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHhcccccccCCCCCCCccc
Confidence              13568999999999999999999999999999999999999985322100      00000000              


Q ss_pred             -------------hcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          278 -------------ENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       278 -------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                                   .........+...............+.++.+|+.+||+.||++|||+.+++++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  325 (360)
T 3eqc_A          260 PGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  325 (360)
T ss_dssp             --------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             CCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence                         00000000000000100101111345679999999999999999999999873

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.8e-46  Score=339.31  Aligned_cols=250  Identities=20%  Similarity=0.224  Sum_probs=206.3

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChh-----hHHHHHHHHHHHHhcCCCceeeeeeeeeeCCcc
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLD-----DVEYCFNNIVFSSQMKHKNILKLIGCCLETELP  128 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~  128 (339)
                      .++|++.+.||+|+||.||+|.+..+++.||+|.+.......     ..+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            467999999999999999999999999999999997753321     367788999999999999999999999999999


Q ss_pred             EEEEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCC----ceEEecCCCcc
Q 019536          129 TLVFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENY----SAKLHDFSLSV  202 (339)
Q Consensus       129 ~lv~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~----~~kl~dfg~a~  202 (339)
                      ++||||+++++|.+++.  ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++    .+||+|||+++
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~  167 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH  167 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence            99999999999999986  46788899999999999999999   89999999999999999887    79999999998


Q ss_pred             ccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcc
Q 019536          203 SIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRF  282 (339)
Q Consensus       203 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (339)
                      ........   ....||+.|+|||++.+..++.++||||||+++|+|++|+.||....        ........ .....
T Consensus       168 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~~~~~~~i-~~~~~  235 (321)
T 2a2a_A          168 EIEDGVEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--------KQETLANI-TSVSY  235 (321)
T ss_dssp             ECCTTCCC---CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS--------HHHHHHHH-HTTCC
T ss_pred             ecCccccc---cccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHH-Hhccc
Confidence            76554322   13468999999999999999999999999999999999999985221        11111111 11100


Q ss_pred             cccccCcccCCCCCCC--cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          283 GAIVDPIFDEDNSFPG--KEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       283 ~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                                  ..+.  ....+..+.+|+.+||+.||++|||+.+++++
T Consensus       236 ------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h  273 (321)
T 2a2a_A          236 ------------DFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (321)
T ss_dssp             ------------CCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred             ------------ccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                        0000  01234578999999999999999999999873

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=4.3e-46  Score=331.27  Aligned_cols=248  Identities=20%  Similarity=0.259  Sum_probs=199.1

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFES  134 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  134 (339)
                      ++|.+.+.||+|+||+||+|.+..++..||+|++.........+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  101 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET  101 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence            67999999999999999999999999999999998765545678889999999999999999999999999999999999


Q ss_pred             ccCCccccccc------cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEe---CCCCceEEecCCCccccC
Q 019536          135 VKYGTLRGFSF------ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLL---DENYSAKLHDFSLSVSIP  205 (339)
Q Consensus       135 ~~~g~L~~~~~------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~---~~~~~~kl~dfg~a~~~~  205 (339)
                      +++|+|.+++.      ..+++..+..++.|++.||.|||   +.+|+||||||+||++   +.++.+||+|||+++...
T Consensus       102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~  178 (285)
T 3is5_A          102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK  178 (285)
T ss_dssp             CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred             CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence            99999998874      46889999999999999999999   8999999999999999   456789999999997765


Q ss_pred             CCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCccccc
Q 019536          206 EGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAI  285 (339)
Q Consensus       206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (339)
                      .....   ....||+.|+|||++. ..++.++||||||+++|+|++|+.||....        .............    
T Consensus       179 ~~~~~---~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~--------~~~~~~~~~~~~~----  242 (285)
T 3is5_A          179 SDEHS---TNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS--------LEEVQQKATYKEP----  242 (285)
T ss_dssp             -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCCC----
T ss_pred             CcccC---cCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCC--------HHHHHhhhccCCc----
Confidence            43322   2356899999999985 568899999999999999999999985321        1111111111000    


Q ss_pred             ccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          286 VDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                         ....     .....++.+.+|+.+||+.||++|||+.|+++
T Consensus       243 ---~~~~-----~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          243 ---NYAV-----ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             ---CCCC-------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             ---cccc-----ccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence               0000     00123457889999999999999999999986

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.3e-47  Score=355.75  Aligned_cols=259  Identities=19%  Similarity=0.191  Sum_probs=206.9

Q ss_pred             HHHHHHHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC--hhhHHHHHHHHHHHHhcCCCceeeeeeeeee
Q 019536           47 AKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST--LDDVEYCFNNIVFSSQMKHKNILKLIGCCLE  124 (339)
Q Consensus        47 ~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~  124 (339)
                      ..++....++|++.+.||+|+||+||+|....+++.||+|++.+...  ....+.+.+|..++..++||||+++++++.+
T Consensus        53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  132 (412)
T 2vd5_A           53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD  132 (412)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence            34445556899999999999999999999999999999999975321  1233457789999999999999999999999


Q ss_pred             CCccEEEEEeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCc
Q 019536          125 TELPTLVFESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLS  201 (339)
Q Consensus       125 ~~~~~lv~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a  201 (339)
                      .+..|+||||+++|+|.+++.   ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus       133 ~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~DFGla  209 (412)
T 2vd5_A          133 ENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSC  209 (412)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEeechhh
Confidence            999999999999999999986   36899999999999999999999   899999999999999999999999999999


Q ss_pred             cccCCCCceeeecccccccccccccccc-------cCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHH
Q 019536          202 VSIPEGETHVREEFIKGAYGFIAPEYFA-------TSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAK  274 (339)
Q Consensus       202 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~  274 (339)
                      +......... ....+||+.|+|||++.       +..|+.++|+|||||++|||++|+.||....     .........
T Consensus       210 ~~~~~~~~~~-~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~-----~~~~~~~i~  283 (412)
T 2vd5_A          210 LKLRADGTVR-SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS-----TAETYGKIV  283 (412)
T ss_dssp             EECCTTSCEE-CSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHHHHH
T ss_pred             eeccCCCccc-cceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCC-----HHHHHHHHH
Confidence            8775544322 22457999999999987       3568999999999999999999999985221     111111111


Q ss_pred             HHhhcCcccccccCcccCCCCCCC-cHHHHHHHHHHHHHhhccCCCCC---CCHHHHHH
Q 019536          275 KSIENNRFGAIVDPIFDEDNSFPG-KEEKLQSLGQLMYKCLSKSPEHR---PLMVDVAK  329 (339)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~cl~~dP~~R---ps~~~il~  329 (339)
                      ......              .+|. +...+.++.+||.+||. +|.+|   |++.+|++
T Consensus       284 ~~~~~~--------------~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          284 HYKEHL--------------SLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             THHHHC--------------CCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             hcccCc--------------CCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence            000000              0110 12345679999999999 99998   58988875

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=9e-47  Score=336.06  Aligned_cols=264  Identities=19%  Similarity=0.249  Sum_probs=199.0

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCCh-hhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTL-DDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFE  133 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  133 (339)
                      ++|++.+.||+|+||+||+|.+ .+++.||+|++...... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence            5799999999999999999998 57899999999765322 234667899999999999999999999999999999999


Q ss_pred             eccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCce
Q 019536          134 SVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH  210 (339)
Q Consensus       134 ~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~  210 (339)
                      |+++ +|.+++.   ..++...+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++........
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  156 (288)
T 1ob3_A           81 HLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK  156 (288)
T ss_dssp             CCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred             ecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCccccc
Confidence            9975 7877764   56888899999999999999999   899999999999999999999999999999876543221


Q ss_pred             eeecccccccccccccccccC-CCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhc---Cccccc-
Q 019536          211 VREEFIKGAYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIEN---NRFGAI-  285 (339)
Q Consensus       211 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~-  285 (339)
                      .  ....||+.|+|||++.+. .++.++||||+||++|+|++|+.||....     ..............   ..+..+ 
T Consensus       157 ~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~  229 (288)
T 1ob3_A          157 Y--THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS-----EADQLMRIFRILGTPNSKNWPNVT  229 (288)
T ss_dssp             -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred             c--ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHHHCCCChhhchhhh
Confidence            1  134689999999999764 58999999999999999999999985321     11111111111110   000000 


Q ss_pred             ----ccCcccCCCCCCC---cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          286 ----VDPIFDEDNSFPG---KEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       286 ----~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                          .++.+....+.+.   ....+..+.+|+.+||+.||++|||+.+++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  281 (288)
T 1ob3_A          230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (288)
T ss_dssp             GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence                0111110000000   01345678999999999999999999999863

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=3.1e-46  Score=335.89  Aligned_cols=261  Identities=21%  Similarity=0.311  Sum_probs=201.8

Q ss_pred             HhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC--ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 019536           53 ATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS--TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTL  130 (339)
Q Consensus        53 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  130 (339)
                      ..++|++.+.||+|+||.||+|....+++.||+|++....  .......+.+|+.+++.++||||+++++++.+++..++
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l  109 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI  109 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence            3468999999999999999999998899999999997632  33456778899999999999999999999999999999


Q ss_pred             EEEeccCCccccccc------cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCcccc
Q 019536          131 VFESVKYGTLRGFSF------ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSI  204 (339)
Q Consensus       131 v~e~~~~g~L~~~~~------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~  204 (339)
                      ||||+++|+|.+++.      ..++...++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++..
T Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~  186 (310)
T 2wqm_A          110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF  186 (310)
T ss_dssp             EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred             EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence            999999999998875      45888999999999999999999   899999999999999999999999999998776


Q ss_pred             CCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccc
Q 019536          205 PEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA  284 (339)
Q Consensus       205 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (339)
                      ......  .....|+..|+|||++.+..++.++||||||+++|+|++|+.||.....      ........ ........
T Consensus       187 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~-~~~~~~~~  257 (310)
T 2wqm_A          187 SSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM------NLYSLCKK-IEQCDYPP  257 (310)
T ss_dssp             --------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C------CHHHHHHH-HHTTCSCC
T ss_pred             cCCCcc--ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch------hHHHHHHH-hhcccCCC
Confidence            543322  1134689999999999998999999999999999999999999752211      11111111 11111100


Q ss_pred             cccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                                 .+ ....+..+.+|+.+||+.||++|||+.++++.|+++...
T Consensus       258 -----------~~-~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~  298 (310)
T 2wqm_A          258 -----------LP-SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHAC  298 (310)
T ss_dssp             -----------CC-TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -----------Cc-ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence                       00 123456799999999999999999999999999998753

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.2e-46  Score=331.57  Aligned_cols=249  Identities=18%  Similarity=0.286  Sum_probs=185.5

Q ss_pred             HhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC--hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 019536           53 ATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST--LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTL  130 (339)
Q Consensus        53 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  130 (339)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|.+.....  ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus         9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   88 (278)
T 3cok_A            9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL   88 (278)
T ss_dssp             SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred             ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence            34789999999999999999999988999999999865321  1234678899999999999999999999999999999


Q ss_pred             EEEeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCC
Q 019536          131 VFESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEG  207 (339)
Q Consensus       131 v~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~  207 (339)
                      ||||+++++|.+++.   ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||++......
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~  165 (278)
T 3cok_A           89 VLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP  165 (278)
T ss_dssp             EEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred             EEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence            999999999999876   45889999999999999999999   899999999999999999999999999999876533


Q ss_pred             CceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCccccccc
Q 019536          208 ETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVD  287 (339)
Q Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (339)
                      ....  ....||+.|+|||++.+..++.++||||||+++|+|++|+.||.......  .                   ..
T Consensus       166 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~-------------------~~  222 (278)
T 3cok_A          166 HEKH--YTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN--T-------------------LN  222 (278)
T ss_dssp             ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------------------------
T ss_pred             CCcc--eeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH--H-------------------HH
Confidence            2211  13568999999999998899999999999999999999999986332211  0                   00


Q ss_pred             CcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          288 PIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                      .........  +...+..+.+|+.+||+.||++|||+.++++
T Consensus       223 ~~~~~~~~~--~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          223 KVVLADYEM--PSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             -CCSSCCCC--CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             HHhhcccCC--ccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence            001111111  1234567899999999999999999999986

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.2e-46  Score=344.10  Aligned_cols=245  Identities=20%  Similarity=0.264  Sum_probs=201.0

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC--hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST--LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVF  132 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  132 (339)
                      +.|+..+.||+|+||+||+|.+..+++.||||++.....  ....+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            558999999999999999999988999999999976532  234567889999999999999999999999999999999


Q ss_pred             EeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCc
Q 019536          133 ESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGET  209 (339)
Q Consensus       133 e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~  209 (339)
                      ||++ |+|.+++.   ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++...... 
T Consensus       134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~-  208 (348)
T 1u5q_A          134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN-  208 (348)
T ss_dssp             ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBC-
T ss_pred             ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCCC-
Confidence            9997 57766653   57899999999999999999999   8999999999999999999999999999997764322 


Q ss_pred             eeeecccccccccccccccc---cCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccc
Q 019536          210 HVREEFIKGAYGFIAPEYFA---TSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIV  286 (339)
Q Consensus       210 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (339)
                           ...||+.|+|||++.   +..++.++|||||||++|+|++|+.||....        .............     
T Consensus       209 -----~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~--------~~~~~~~~~~~~~-----  270 (348)
T 1u5q_A          209 -----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--------AMSALYHIAQNES-----  270 (348)
T ss_dssp             -----CCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHSCC-----
T ss_pred             -----cccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHHhcCC-----
Confidence                 346899999999985   4678999999999999999999999975221        1111111111110     


Q ss_pred             cCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          287 DPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                       +       ...+...+..+.+|+.+||+.||++|||+.+++++
T Consensus       271 -~-------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          271 -P-------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             -C-------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             -C-------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence             0       00112345578999999999999999999999864

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.4e-47  Score=347.04  Aligned_cols=264  Identities=16%  Similarity=0.192  Sum_probs=194.8

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFES  134 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  134 (339)
                      ++|.+.+.||+|+||+||+|.+..+++.||+|++...........+.+|+.+++.++||||+++++++.+++..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            57999999999999999999999999999999997654322223455799999999999999999999999999999999


Q ss_pred             ccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCcee
Q 019536          135 VKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHV  211 (339)
Q Consensus       135 ~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~  211 (339)
                      ++ |+|.+++.   ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++.........
T Consensus        82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~  157 (324)
T 3mtl_A           82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY  157 (324)
T ss_dssp             CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred             cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcccc
Confidence            97 57877765   45888899999999999999999   8999999999999999999999999999987654332221


Q ss_pred             eeccccccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHh---hcCccccccc
Q 019536          212 REEFIKGAYGFIAPEYFAT-SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSI---ENNRFGAIVD  287 (339)
Q Consensus       212 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  287 (339)
                        ....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||....  .   ...........   ....+.....
T Consensus       158 --~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--~---~~~~~~i~~~~~~~~~~~~~~~~~  230 (324)
T 3mtl_A          158 --DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGST--V---EEQLHFIFRILGTPTEETWPGILS  230 (324)
T ss_dssp             -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--H---HHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             --ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--H---HHHHHHHHHHhCCCChHhchhhhc
Confidence              13468999999999876 568999999999999999999999985321  1   11111111111   1111111100


Q ss_pred             CcccCCCCC---------CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          288 PIFDEDNSF---------PGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       288 ~~~~~~~~~---------~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                      .........         +.....+..+.+|+.+||+.||++|||+.|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          231 NEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             CHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             chhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            000000000         001134567899999999999999999999987

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1e-45  Score=329.96  Aligned_cols=262  Identities=14%  Similarity=0.165  Sum_probs=208.8

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeee-eeCCccEEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCC-LETELPTLVF  132 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~-~~~~~~~lv~  132 (339)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++.....   .+.+.+|+.+++.++|++++..++.+ .+++..++||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS---CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc---hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence            4789999999999999999999988999999999876543   23577999999999988876666655 5677789999


Q ss_pred             EeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEe---CCCCceEEecCCCccccCC
Q 019536          133 ESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLL---DENYSAKLHDFSLSVSIPE  206 (339)
Q Consensus       133 e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~---~~~~~~kl~dfg~a~~~~~  206 (339)
                      ||+ +++|.+++.   ..+++..+..++.|++.||.|||   +.+|+||||||+||++   +.++.+||+|||+++....
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  160 (296)
T 3uzp_A           85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  160 (296)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             Eec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence            999 899999875   56899999999999999999999   8999999999999999   4788999999999987655


Q ss_pred             CCcee-----eecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCc
Q 019536          207 GETHV-----REEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNR  281 (339)
Q Consensus       207 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (339)
                      .....     ......||+.|+|||++.+..++.++|||||||++|+|++|+.||........  ...............
T Consensus       161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~  238 (296)
T 3uzp_A          161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK--RQKYERISEKKMSTP  238 (296)
T ss_dssp             TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSS--SSHHHHHHHHHHHSC
T ss_pred             cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhh--hhhhhhhcccccCCc
Confidence            43211     11245689999999999999999999999999999999999999864433221  122221111111000


Q ss_pred             ccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          282 FGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                      ...+             ....+..+.+|+.+||+.||++|||+.++++.|+++..+
T Consensus       239 ~~~~-------------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  281 (296)
T 3uzp_A          239 IEVL-------------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  281 (296)
T ss_dssp             HHHH-------------TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             hHHH-------------HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHh
Confidence            0000             012345799999999999999999999999999999865

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=8e-46  Score=333.32  Aligned_cols=262  Identities=15%  Similarity=0.157  Sum_probs=201.4

Q ss_pred             HHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC--hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccE
Q 019536           52 KATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST--LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPT  129 (339)
Q Consensus        52 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~  129 (339)
                      ...++|.+.+.||+|+||+||+|.+..+++.||+|++.....  ....+.+.+|+.+++.++||||+++++++.+++..+
T Consensus        31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~  110 (309)
T 2h34_A           31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLY  110 (309)
T ss_dssp             ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred             cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEE
Confidence            345899999999999999999999998999999999876532  233477889999999999999999999999999999


Q ss_pred             EEEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCC
Q 019536          130 LVFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEG  207 (339)
Q Consensus       130 lv~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~  207 (339)
                      +||||+++++|.+++.  ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||++......
T Consensus       111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  187 (309)
T 2h34_A          111 VDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTDE  187 (309)
T ss_dssp             EEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred             EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence            9999999999999986  56899999999999999999999   899999999999999999999999999998776543


Q ss_pred             CceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCccccccc
Q 019536          208 ETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVD  287 (339)
Q Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (339)
                      .... .....|++.|+|||++.+..++.++||||||+++|+|++|+.||....      .   ............    .
T Consensus       188 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~---~~~~~~~~~~~~----~  253 (309)
T 2h34_A          188 KLTQ-LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ------L---SVMGAHINQAIP----R  253 (309)
T ss_dssp             ----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCH------H---HHHHHHHHSCCC----C
T ss_pred             cccc-ccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCch------H---HHHHHHhccCCC----C
Confidence            3221 123568999999999998899999999999999999999999985211      1   111111111100    0


Q ss_pred             CcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHHHHhh
Q 019536          288 PIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP-LMVDVAKQLRQMYLS  337 (339)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-s~~~il~~L~~l~~~  337 (339)
                      + .      ..+...+..+.+++.+||+.||++|| |+.++++.|++...+
T Consensus       254 ~-~------~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~  297 (309)
T 2h34_A          254 P-S------TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT  297 (309)
T ss_dssp             G-G------GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred             c-c------ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence            0 0      00113345689999999999999999 999999999987643

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=4.3e-46  Score=341.93  Aligned_cols=205  Identities=22%  Similarity=0.252  Sum_probs=180.3

Q ss_pred             cccccHHHHHHHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcC-----CCcee
Q 019536           42 IRAFSAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMK-----HKNIL  116 (339)
Q Consensus        42 ~~~~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-----H~niv  116 (339)
                      ...++.++.....++|.+.+.||+|+||+||+|.+..+++.||||++...  ......+..|+.+++.+.     ||||+
T Consensus        22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~h~~iv   99 (360)
T 3llt_A           22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI--KKYTRSAKIEADILKKIQNDDINNNNIV   99 (360)
T ss_dssp             GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--HHHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred             ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc--hhhhhhhHHHHHHHHHhcccCCCCCCee
Confidence            44455555566678999999999999999999999999999999999743  244566778999999996     99999


Q ss_pred             eeeeeeeeCCccEEEEEeccCCccccccc----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCC---
Q 019536          117 KLIGCCLETELPTLVFESVKYGTLRGFSF----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDE---  189 (339)
Q Consensus       117 ~~~~~~~~~~~~~lv~e~~~~g~L~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~---  189 (339)
                      ++++++...+..++||||+ +++|.+++.    ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.   
T Consensus       100 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~  175 (360)
T 3llt_A          100 KYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYF  175 (360)
T ss_dssp             CEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTTC
T ss_pred             cccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEccccc
Confidence            9999999999999999999 899999876    24888999999999999999999   899999999999999975   


Q ss_pred             ----------------------CCceEEecCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHH
Q 019536          190 ----------------------NYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLC  247 (339)
Q Consensus       190 ----------------------~~~~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~  247 (339)
                                            ++.+||+|||+++.......     ...||+.|+|||++.+..++.++|||||||++|
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~  250 (360)
T 3llt_A          176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHG-----SIINTRQYRAPEVILNLGWDVSSDMWSFGCVLA  250 (360)
T ss_dssp             CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCCC-----SCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHH
T ss_pred             cccccchhcccccccccccccCCCCEEEEeccCceecCCCCc-----CccCcccccCcHHHcCCCCCCccchHHHHHHHH
Confidence                                  78899999999986544322     356899999999999999999999999999999


Q ss_pred             HHHhCCCccc
Q 019536          248 ELLTGCNVLE  257 (339)
Q Consensus       248 el~~g~~p~~  257 (339)
                      +|++|+.||.
T Consensus       251 ell~g~~pf~  260 (360)
T 3llt_A          251 ELYTGSLLFR  260 (360)
T ss_dssp             HHHHSSCSCC
T ss_pred             HHHHCCCCCC
Confidence            9999999985

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=3.2e-47  Score=347.13  Aligned_cols=252  Identities=20%  Similarity=0.241  Sum_probs=201.5

Q ss_pred             HhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCccEEE
Q 019536           53 ATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLETELPTLV  131 (339)
Q Consensus        53 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~~lv  131 (339)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++.....     ...+|+.++.++ +||||+++++++.+++..++|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv   94 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV   94 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence            35789999999999999999999999999999999976532     134688888887 799999999999999999999


Q ss_pred             EEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCC----CceEEecCCCccccC
Q 019536          132 FESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDEN----YSAKLHDFSLSVSIP  205 (339)
Q Consensus       132 ~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~----~~~kl~dfg~a~~~~  205 (339)
                      |||+++|+|.+++.  ..+++..+..++.||+.||.|||   +.+|+||||||+|||+...    +.+||+|||+++...
T Consensus        95 ~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~  171 (342)
T 2qr7_A           95 TELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR  171 (342)
T ss_dssp             ECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred             EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence            99999999999875  56889999999999999999999   8999999999999998432    359999999998765


Q ss_pred             CCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCccccc
Q 019536          206 EGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAI  285 (339)
Q Consensus       206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (339)
                      ......  ....||+.|+|||++.+..|+.++|||||||++|+|++|+.||......  .......    .+..+.+.  
T Consensus       172 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~~~----~i~~~~~~--  241 (342)
T 2qr7_A          172 AENGLL--MTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD--TPEEILA----RIGSGKFS--  241 (342)
T ss_dssp             CTTCCB--CCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS--CHHHHHH----HHHHCCCC--
T ss_pred             CCCCce--eccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC--CHHHHHH----HHccCCcc--
Confidence            443221  2356899999999998888999999999999999999999998632211  1111111    11111110  


Q ss_pred             ccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          286 VDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                              ...+.+...+..+.+|+.+||+.||++|||+.+++++
T Consensus       242 --------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  278 (342)
T 2qr7_A          242 --------LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH  278 (342)
T ss_dssp             --------CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             --------cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                    0000112455679999999999999999999999863

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1e-45  Score=331.51  Aligned_cols=250  Identities=22%  Similarity=0.274  Sum_probs=209.7

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFE  133 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  133 (339)
                      .+.|++.+.||+|+||.||+|.+..+++.||+|++.........+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            36799999999999999999999989999999999876555667889999999999999999999999999999999999


Q ss_pred             eccCCccccccc-cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceee
Q 019536          134 SVKYGTLRGFSF-ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVR  212 (339)
Q Consensus       134 ~~~~g~L~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~  212 (339)
                      |+++++|.+++. ..+++..+..++.|++.||.|||   +.+|+|+||||+||+++.++.+||+|||++.........  
T Consensus       101 ~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--  175 (303)
T 3a7i_A          101 YLGGGSALDLLEPGPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK--  175 (303)
T ss_dssp             CCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCC--
T ss_pred             eCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCccccc--
Confidence            999999999886 57889999999999999999999   899999999999999999999999999999876543322  


Q ss_pred             ecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccC
Q 019536          213 EEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDE  292 (339)
Q Consensus       213 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (339)
                      .....||+.|+|||++.+..++.++||||||+++|+|++|+.||....        .......... ...     +.+  
T Consensus       176 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~-~~~-----~~~--  239 (303)
T 3a7i_A          176 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH--------PMKVLFLIPK-NNP-----PTL--  239 (303)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHH-SCC-----CCC--
T ss_pred             cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC--------HHHHHHHhhc-CCC-----CCC--
Confidence            123568999999999999899999999999999999999999975221        1111111111 110     000  


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          293 DNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       293 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                            +...+..+.+|+.+||+.||++|||+.+++++
T Consensus       240 ------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          240 ------EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             ------CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             ------ccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence                  11334578999999999999999999999875

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=6.2e-46  Score=333.73  Aligned_cols=266  Identities=18%  Similarity=0.216  Sum_probs=198.7

Q ss_pred             HhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC----hhhHHHHHHHHHHHHhcC---CCceeeeeeeeeeC
Q 019536           53 ATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST----LDDVEYCFNNIVFSSQMK---HKNILKLIGCCLET  125 (339)
Q Consensus        53 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~e~~~l~~l~---H~niv~~~~~~~~~  125 (339)
                      ..++|++.+.||+|+||+||+|.+..+++.||+|++.....    ......+.+|+.+++.++   ||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            35799999999999999999999988999999999874321    112345567777776664   99999999999876


Q ss_pred             C-----ccEEEEEeccCCcccccccc----CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEe
Q 019536          126 E-----LPTLVFESVKYGTLRGFSFA----SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLH  196 (339)
Q Consensus       126 ~-----~~~lv~e~~~~g~L~~~~~~----~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~  196 (339)
                      .     ..++||||++ |+|.+++..    .+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~  162 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLA  162 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEEEC
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEEe
Confidence            5     4789999997 588888762    3899999999999999999999   8999999999999999999999999


Q ss_pred             cCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHH
Q 019536          197 DFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKS  276 (339)
Q Consensus       197 dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  276 (339)
                      |||+++........   ....||+.|+|||++.+..++.++|||||||++|+|++|+.||....  .   ..........
T Consensus       163 Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--~---~~~~~~i~~~  234 (308)
T 3g33_A          163 DFGLARIYSYQMAL---TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS--E---ADQLGKIFDL  234 (308)
T ss_dssp             SCSCTTTSTTCCCS---GGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSS--H---HHHHHHHHHH
T ss_pred             eCccccccCCCccc---CCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCC--H---HHHHHHHHHH
Confidence            99999876543322   24578999999999999999999999999999999999999975321  1   1111111111


Q ss_pred             hh---cCccccc---ccCcccCCCCCCC---cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          277 IE---NNRFGAI---VDPIFDEDNSFPG---KEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       277 ~~---~~~~~~~---~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      ..   ...+...   ....+......+.   ....+..+.+|+.+||+.||++|||+.+++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  297 (308)
T 3g33_A          235 IGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH  297 (308)
T ss_dssp             HCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence            11   0101000   0000000000000   01345678999999999999999999999863

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2.7e-46  Score=354.21  Aligned_cols=194  Identities=20%  Similarity=0.287  Sum_probs=155.6

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeC-----Cc
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS-TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLET-----EL  127 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~-----~~  127 (339)
                      .++|++.+.||+|+||+||+|.+..+++.||||++.... .....+.+.+|+.+++.++||||+++++++...     ..
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            378999999999999999999999999999999997643 334567788999999999999999999999543     46


Q ss_pred             cEEEEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccC
Q 019536          128 PTLVFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIP  205 (339)
Q Consensus       128 ~~lv~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~  205 (339)
                      .|+||||+ +|+|.+++.  ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+|+...
T Consensus       132 ~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~  207 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVD  207 (458)
T ss_dssp             EEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred             EEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence            89999998 568888876  45889999999999999999999   8999999999999999999999999999998764


Q ss_pred             CCCce-------------------------eeeccccccccccccccc-ccCCCCcccchHHHHHHHHHHHh
Q 019536          206 EGETH-------------------------VREEFIKGAYGFIAPEYF-ATSSFNEMCDVYSFGAFLCELLT  251 (339)
Q Consensus       206 ~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~~l~el~~  251 (339)
                      .....                         ......+||+.|+|||++ .+..|+.++|||||||++|||++
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt  279 (458)
T 3rp9_A          208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN  279 (458)
T ss_dssp             SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred             CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence            32210                         012235689999999986 45679999999999999999999

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=7e-46  Score=334.37  Aligned_cols=261  Identities=21%  Similarity=0.285  Sum_probs=200.8

Q ss_pred             hcCcccC-CceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCccEEE
Q 019536           54 TNNYDLH-KVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLETELPTLV  131 (339)
Q Consensus        54 ~~~~~~~-~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~~lv  131 (339)
                      .+.|.+. +.||+|+||+||+|.+..+++.||||++..... ...+.+.+|+.++.++ +||||+++++++.+++..++|
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv   89 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG-HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV   89 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS-CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc-hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence            3678884 789999999999999998999999999976543 4567788999999885 799999999999999999999


Q ss_pred             EEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCc---eEEecCCCccccCC
Q 019536          132 FESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYS---AKLHDFSLSVSIPE  206 (339)
Q Consensus       132 ~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~---~kl~dfg~a~~~~~  206 (339)
                      |||+++|+|.+++.  ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.   +||+|||++.....
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  166 (316)
T 2ac3_A           90 FEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL  166 (316)
T ss_dssp             EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred             EEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence            99999999999986  56899999999999999999999   899999999999999987765   99999999876543


Q ss_pred             CCce-----eeeccccccccccccccccc-----CCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchh------HH
Q 019536          207 GETH-----VREEFIKGAYGFIAPEYFAT-----SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLT------VL  270 (339)
Q Consensus       207 ~~~~-----~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~------~~  270 (339)
                      ....     .......||+.|+|||++.+     ..++.++|||||||++|+|++|+.||............      ..
T Consensus       167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  246 (316)
T 2ac3_A          167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ  246 (316)
T ss_dssp             ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred             CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence            2111     11113458999999999875     45889999999999999999999998644332211110      00


Q ss_pred             HHHHHHhhcCcccccccCcccCCCCCCCc--HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          271 EYAKKSIENNRFGAIVDPIFDEDNSFPGK--EEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      ...........            ..+|..  ...+..+.+|+.+||+.||++|||+.+++++
T Consensus       247 ~~~~~~i~~~~------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  296 (316)
T 2ac3_A          247 NMLFESIQEGK------------YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH  296 (316)
T ss_dssp             HHHHHHHHHCC------------CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHHHHhccC------------cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            11111111111            111111  1245679999999999999999999999873

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=7.3e-47  Score=334.77  Aligned_cols=250  Identities=21%  Similarity=0.309  Sum_probs=199.3

Q ss_pred             HhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeC-CccEEE
Q 019536           53 ATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLET-ELPTLV  131 (339)
Q Consensus        53 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~-~~~~lv  131 (339)
                      ..++|++.+.||+|+||+||+|.+  +++.||+|.+....   ..+.+.+|+.+++.++||||+++++++.+. +..++|
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv   93 (278)
T 1byg_A           19 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV   93 (278)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred             ChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh---HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEE
Confidence            357899999999999999999988  58999999987653   456788999999999999999999997654 578999


Q ss_pred             EEeccCCcccccccc----CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCC
Q 019536          132 FESVKYGTLRGFSFA----SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEG  207 (339)
Q Consensus       132 ~e~~~~g~L~~~~~~----~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~  207 (339)
                      |||+++|+|.+++..    .+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++......
T Consensus        94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  170 (278)
T 1byg_A           94 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  170 (278)
T ss_dssp             ECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             EecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence            999999999999862    3788889999999999999999   899999999999999999999999999998765433


Q ss_pred             CceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCcccccc
Q 019536          208 ETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIV  286 (339)
Q Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (339)
                      ..     ...++..|+|||.+.+..++.++||||||+++|+|++ |+.||.....     .....   . ....      
T Consensus       171 ~~-----~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-----~~~~~---~-~~~~------  230 (278)
T 1byg_A          171 QD-----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----KDVVP---R-VEKG------  230 (278)
T ss_dssp             ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG-----GGHHH---H-HTTT------
T ss_pred             cc-----CCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHH---H-HhcC------
Confidence            21     2357888999999998899999999999999999998 9999753221     11111   1 1110      


Q ss_pred             cCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          287 DPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                             ...+.+...+..+.+++.+||+.||++|||+.++++.|+++...
T Consensus       231 -------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~  274 (278)
T 1byg_A          231 -------YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  274 (278)
T ss_dssp             -------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -------CCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence                   00111124456799999999999999999999999999998754

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.1e-46  Score=343.86  Aligned_cols=251  Identities=19%  Similarity=0.264  Sum_probs=195.6

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC-ChhhHHHHHHHHHHHHhcCC--CceeeeeeeeeeCCccEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS-TLDDVEYCFNNIVFSSQMKH--KNILKLIGCCLETELPTL  130 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H--~niv~~~~~~~~~~~~~l  130 (339)
                      .++|++.+.||+|+||+||+|.+. +++.||||++.... .....+.+.+|+.+++.++|  |||+++++++.+++..++
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l   86 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM   86 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence            367999999999999999999885 68899999987653 33455778899999999976  999999999999999999


Q ss_pred             EEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCC
Q 019536          131 VFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE  208 (339)
Q Consensus       131 v~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~  208 (339)
                      ||| +.+|+|.+++.  ..+++..+..++.|++.||.|||   +.+|+||||||+|||++ ++.+||+|||+++.+....
T Consensus        87 v~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~  161 (343)
T 3dbq_A           87 VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  161 (343)
T ss_dssp             EEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred             EEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence            999 56889999886  56888999999999999999999   89999999999999997 6789999999998775544


Q ss_pred             ceeeeccccccccccccccccc-----------CCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHh
Q 019536          209 THVREEFIKGAYGFIAPEYFAT-----------SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSI  277 (339)
Q Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  277 (339)
                      .........||+.|+|||++.+           ..++.++|||||||++|+|++|+.||....       ..........
T Consensus       162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-------~~~~~~~~~~  234 (343)
T 3dbq_A          162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-------NQISKLHAII  234 (343)
T ss_dssp             --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC-------SHHHHHHHHH
T ss_pred             ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh-------hHHHHHHHHh
Confidence            3323334679999999999865           678899999999999999999999985211       1111111111


Q ss_pred             hcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          278 ENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      ....         .  ..+|  ...+..+.+|+.+||+.||++|||+.+++++
T Consensus       235 ~~~~---------~--~~~~--~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          235 DPNH---------E--IEFP--DIPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             CTTS---------C--CCCC--CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cCCc---------c--cCCc--ccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence            1110         0  0111  1223568999999999999999999999874

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=2.8e-46  Score=346.93  Aligned_cols=250  Identities=20%  Similarity=0.266  Sum_probs=195.9

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC-ChhhHHHHHHHHHHHHhcC--CCceeeeeeeeeeCCccEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS-TLDDVEYCFNNIVFSSQMK--HKNILKLIGCCLETELPTLV  131 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~--H~niv~~~~~~~~~~~~~lv  131 (339)
                      ++|++.+.||+|+||+||+|.+. +++.||||++.... .....+.+.+|+.+++.++  ||||+++++++..++..++|
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  134 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  134 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcC-CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence            46999999999999999999987 48999999997653 3345677899999999996  59999999999999999999


Q ss_pred             EEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCc
Q 019536          132 FESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGET  209 (339)
Q Consensus       132 ~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~  209 (339)
                      || +.+++|.+++.  ..+++..+..++.||+.||.|||   +.+|+||||||+|||++ ++.+||+|||+++.+.....
T Consensus       135 ~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~  209 (390)
T 2zmd_A          135 ME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT  209 (390)
T ss_dssp             EE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred             Ee-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence            99 56889999886  56788889999999999999999   99999999999999996 57899999999987755433


Q ss_pred             eeeeccccccccccccccccc-----------CCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhh
Q 019536          210 HVREEFIKGAYGFIAPEYFAT-----------SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIE  278 (339)
Q Consensus       210 ~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  278 (339)
                      ........||+.|+|||++.+           ..++.++|||||||++|+|++|+.||....       ...........
T Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~-------~~~~~~~~~~~  282 (390)
T 2zmd_A          210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-------NQISKLHAIID  282 (390)
T ss_dssp             ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC-------CHHHHHHHHHC
T ss_pred             cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh-------HHHHHHHHHhC
Confidence            322234579999999999865           368899999999999999999999985221       11111111111


Q ss_pred             cCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          279 NNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      ..         ..  ..+|  ...+..+.+|+.+||+.||++|||+.+++++
T Consensus       283 ~~---------~~--~~~~--~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          283 PN---------HE--IEFP--DIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             TT---------SC--CCCC--CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cc---------cc--CCCC--ccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence            11         00  0111  1224578999999999999999999999864

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=9.9e-46  Score=352.84  Aligned_cols=252  Identities=21%  Similarity=0.282  Sum_probs=205.3

Q ss_pred             HhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 019536           53 ATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS-TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLV  131 (339)
Q Consensus        53 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  131 (339)
                      ..++|++.+.||+|+||+||+|.+..+++.||||++.... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   99 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence            3478999999999999999999999999999999986531 123467788999999999999999999999999999999


Q ss_pred             EEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeC---CCCceEEecCCCccccCC
Q 019536          132 FESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLD---ENYSAKLHDFSLSVSIPE  206 (339)
Q Consensus       132 ~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~---~~~~~kl~dfg~a~~~~~  206 (339)
                      |||+++|+|.+.+.  ..+++..+..++.|++.||.|||   +.+|+||||||+|||++   .++.+||+|||+++....
T Consensus       100 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~  176 (486)
T 3mwu_A          100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ  176 (486)
T ss_dssp             ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred             EEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence            99999999988875  67899999999999999999999   89999999999999995   456799999999987654


Q ss_pred             CCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccc
Q 019536          207 GETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIV  286 (339)
Q Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (339)
                      ....   ....||+.|+|||++.+ .|+.++||||+||++|+|++|+.||....        ..+..... .....    
T Consensus       177 ~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~~i-~~~~~----  239 (486)
T 3mwu_A          177 NTKM---KDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN--------EYDILKRV-ETGKY----  239 (486)
T ss_dssp             C-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHH-HHTCC----
T ss_pred             CCcc---CCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHH-HhCCC----
Confidence            4322   13569999999999975 59999999999999999999999985221        11111111 11111    


Q ss_pred             cCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          287 DPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                            ....|.....+..+.+|+.+||+.||++|||+.+++++
T Consensus       240 ------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          240 ------AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             ------CSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             ------CCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                  01112223556789999999999999999999999974

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=9.9e-46  Score=340.30  Aligned_cols=253  Identities=16%  Similarity=0.188  Sum_probs=204.2

Q ss_pred             HHHHhcCcccCCceeccCCeeEEEEE-----EcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcC---CCceeeeeee
Q 019536           50 LKKATNNYDLHKVIQSDTSYRLFEGT-----LVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMK---HKNILKLIGC  121 (339)
Q Consensus        50 ~~~~~~~~~~~~~ig~G~~g~V~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~---H~niv~~~~~  121 (339)
                      +....++|.+.+.||+|+||+||+|.     ...+++.||+|++...    ....+.+|+.+++.++   |+||++++++
T Consensus        60 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~  135 (365)
T 3e7e_A           60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA----NPWEFYIGTQLMERLKPSMQHMFMKFYSA  135 (365)
T ss_dssp             EECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC----CHHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred             EEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC----ChhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence            33445789999999999999999994     5668899999999764    3455678888888886   9999999999


Q ss_pred             eeeCCccEEEEEeccCCccccccc-------cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCC-----
Q 019536          122 CLETELPTLVFESVKYGTLRGFSF-------ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDE-----  189 (339)
Q Consensus       122 ~~~~~~~~lv~e~~~~g~L~~~~~-------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~-----  189 (339)
                      +..++..++||||+++|+|.+++.       ..+++..++.++.|++.||.|||   +.+|+||||||+|||++.     
T Consensus       136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~  212 (365)
T 3e7e_A          136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQ  212 (365)
T ss_dssp             EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC
T ss_pred             eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCc
Confidence            999999999999999999999984       46899999999999999999999   899999999999999998     


Q ss_pred             ------CCceEEecCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCC
Q 019536          190 ------NYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGN  263 (339)
Q Consensus       190 ------~~~~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~  263 (339)
                            ++.+||+|||+|+.+.............||+.|+|||++.+..|+.++|||||||++|+|++|+.||.......
T Consensus       213 ~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~  292 (365)
T 3e7e_A          213 DDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE  292 (365)
T ss_dssp             ------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE
T ss_pred             cccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc
Confidence                  89999999999976543222223335679999999999999999999999999999999999999985322110


Q ss_pred             CCchhHHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCC-CCHHHHHHHHHHHHh
Q 019536          264 DDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHR-PLMVDVAKQLRQMYL  336 (339)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~R-ps~~~il~~L~~l~~  336 (339)
                                      ..    ....+.   ..    ...+.+.+++..||+.+|.+| |++.++.+.|+++..
T Consensus       293 ----------------~~----~~~~~~---~~----~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~  339 (365)
T 3e7e_A          293 ----------------CK----PEGLFR---RL----PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ  339 (365)
T ss_dssp             ----------------EE----ECSCCT---TC----SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred             ----------------ee----echhcc---cc----CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence                            00    001110   01    124567889999999999998 578888888888764

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.1e-45  Score=347.49  Aligned_cols=199  Identities=19%  Similarity=0.261  Sum_probs=168.4

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeC-----Cc
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS-TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLET-----EL  127 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~-----~~  127 (339)
                      .++|++.+.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+++.++||||+++++++...     +.
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            478999999999999999999999999999999997653 334567788999999999999999999999876     56


Q ss_pred             cEEEEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccC
Q 019536          128 PTLVFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIP  205 (339)
Q Consensus       128 ~~lv~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~  205 (339)
                      .|+||||++ |+|.+++.  ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+|+...
T Consensus       105 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~  180 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTIN  180 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred             EEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence            899999996 58988876  35899999999999999999999   8999999999999999999999999999998765


Q ss_pred             CCCce--------------------eeeccccccccccccccc-ccCCCCcccchHHHHHHHHHHHhCCCcc
Q 019536          206 EGETH--------------------VREEFIKGAYGFIAPEYF-ATSSFNEMCDVYSFGAFLCELLTGCNVL  256 (339)
Q Consensus       206 ~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~~l~el~~g~~p~  256 (339)
                      .....                    ......+||+.|+|||++ .+..|+.++||||+||++|||++|..||
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             ------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             ccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence            43211                    011245789999999986 5567999999999999999999854443

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=2.1e-45  Score=338.86  Aligned_cols=264  Identities=18%  Similarity=0.239  Sum_probs=196.4

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC------
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS-TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETE------  126 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~------  126 (339)
                      .++|++.+.||+|+||+||+|.+..+++.||||++.... .......+.+|+.+++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            478999999999999999999999999999999997653 3345567889999999999999999999998665      


Q ss_pred             ccEEEEEeccCCccccccccCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCC
Q 019536          127 LPTLVFESVKYGTLRGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPE  206 (339)
Q Consensus       127 ~~~lv~e~~~~g~L~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~  206 (339)
                      ..++||||++ |+|.+.+...++...+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus       104 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~  179 (371)
T 2xrw_A          104 DVYIVMELMD-ANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  179 (371)
T ss_dssp             EEEEEEECCS-EEHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC------
T ss_pred             ceEEEEEcCC-CCHHHHHhhccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence            6799999997 4787777778999999999999999999999   89999999999999999999999999999987644


Q ss_pred             CCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHH----------
Q 019536          207 GETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKS----------  276 (339)
Q Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~----------  276 (339)
                      ...   .....||+.|+|||++.+..++.++||||+||++|+|++|+.||.....     ..........          
T Consensus       180 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~i~~~~~~~~~~~~~  251 (371)
T 2xrw_A          180 SFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH-----IDQWNKVIEQLGTPCPEFMK  251 (371)
T ss_dssp             -------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHC-CCCCCHHHHT
T ss_pred             ccc---cCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHhCCCCHHHHH
Confidence            321   1135689999999999999999999999999999999999999853211     1111100000          


Q ss_pred             ---------hhc-Cccccc-ccCcccCCCCCCC----cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          277 ---------IEN-NRFGAI-VDPIFDEDNSFPG----KEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       277 ---------~~~-~~~~~~-~~~~~~~~~~~~~----~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                               ... ..+... ....+ ....+|.    ....+..+.+|+.+||+.||++|||+.+++++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  319 (371)
T 2xrw_A          252 KLQPTVRTYVENRPKYAGYSFEKLF-PDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  319 (371)
T ss_dssp             TSCHHHHHHHHSSCCCCCCCHHHHS-CGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             HhhhHHHHHHhhCccccccchhhhc-ccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence                     000 000000 00000 0000111    12346789999999999999999999999873

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.5e-46  Score=343.58  Aligned_cols=263  Identities=16%  Similarity=0.163  Sum_probs=197.3

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC------
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS-TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETE------  126 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~------  126 (339)
                      .++|++.+.||+|+||.||+|.+..+|+.||||++.... .....+.+.+|+.+++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            478999999999999999999999999999999986643 3344567889999999999999999999998653      


Q ss_pred             ccEEEEEeccCCccccccc-cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccC
Q 019536          127 LPTLVFESVKYGTLRGFSF-ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIP  205 (339)
Q Consensus       127 ~~~lv~e~~~~g~L~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~  205 (339)
                      ..++||||+ +++|.+++. ..++...+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++...
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  179 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD  179 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             eEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence            359999999 789988876 67889999999999999999999   8999999999999999999999999999998764


Q ss_pred             CCCceeeeccccccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcC---c
Q 019536          206 EGETHVREEFIKGAYGFIAPEYFAT-SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENN---R  281 (339)
Q Consensus       206 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~  281 (339)
                      ....     ...+|+.|+|||++.+ ..++.++||||+||++|+|++|+.||...  ..   ..............   .
T Consensus       180 ~~~~-----~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~--~~---~~~l~~i~~~~g~~~~~~  249 (367)
T 1cm8_A          180 SEMT-----GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS--DH---LDQLKEIMKVTGTPPAEF  249 (367)
T ss_dssp             SSCC-----SSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS--SH---HHHHHHHHHHHCCCCHHH
T ss_pred             cccC-----cCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCC--CH---HHHHHHHHHhcCCCCHHH
Confidence            4322     3468999999999887 67999999999999999999999997532  11   11111111100000   0


Q ss_pred             cccccc-------CcccC--CCCCC-CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          282 FGAIVD-------PIFDE--DNSFP-GKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       282 ~~~~~~-------~~~~~--~~~~~-~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      ...+..       ..+..  ...+. .....+..+.+|+.+||+.||++|||+.+++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h  308 (367)
T 1cm8_A          250 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  308 (367)
T ss_dssp             HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence            000000       00000  00000 011345679999999999999999999999873

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.1e-46  Score=348.31  Aligned_cols=239  Identities=15%  Similarity=0.145  Sum_probs=188.8

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccC--CChhhHHHHHHHH---HHHHhcCCCceeeee-------ee
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDN--STLDDVEYCFNNI---VFSSQMKHKNILKLI-------GC  121 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~---~~l~~l~H~niv~~~-------~~  121 (339)
                      .++|.+.+.||+|+||+||+|.+..+|+.||||++...  ......+.+.+|+   .+++.++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            36788899999999999999999889999999999754  2234567788999   555566899999998       55


Q ss_pred             eeeCC-----------------ccEEEEEeccCCccccccc--cCCCh-------HHHHHHHHHHHHHHHHHhcCCCCCe
Q 019536          122 CLETE-----------------LPTLVFESVKYGTLRGFSF--ASLLI-------APRIKIAMEIANAVAYLHVGFDRPI  175 (339)
Q Consensus       122 ~~~~~-----------------~~~lv~e~~~~g~L~~~~~--~~~~~-------~~~~~i~~~i~~~l~~LH~~~~~~i  175 (339)
                      +.+.+                 ..++||||+ +|+|.+++.  ..++.       ..++.++.||+.||.|||   +.+|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGL  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCCe
Confidence            55443                 278999999 689999986  23444       677789999999999999   8999


Q ss_pred             EEccCCCCCEEeCCCCceEEecCCCccccCCCCceeeecccccccccccccccccC-----------CCCcccchHHHHH
Q 019536          176 VFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATS-----------SFNEMCDVYSFGA  244 (339)
Q Consensus       176 ~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DiwslG~  244 (339)
                      +||||||+|||++.++.+||+|||+|+.....     .....| +.|+|||++.+.           .++.++|||||||
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~  301 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR-----VVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL  301 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTCE-----EECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCCc-----ccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence            99999999999999999999999999864331     113457 899999999887           8999999999999


Q ss_pred             HHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCH
Q 019536          245 FLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLM  324 (339)
Q Consensus       245 ~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~  324 (339)
                      ++|+|++|+.||.......                 ....+    ....      ...+..+.+|+.+||+.||++|||+
T Consensus       302 il~elltg~~Pf~~~~~~~-----------------~~~~~----~~~~------~~~~~~~~~li~~~L~~dp~~Rpt~  354 (377)
T 3byv_A          302 VIYWIWCADLPITKDAALG-----------------GSEWI----FRSC------KNIPQPVRALLEGFLRYPKEDRLLP  354 (377)
T ss_dssp             HHHHHHHSSCCC------C-----------------CSGGG----GSSC------CCCCHHHHHHHHHHTCSSGGGCCCH
T ss_pred             HHHHHHHCCCCCccccccc-----------------chhhh----hhhc------cCCCHHHHHHHHHHcCCCchhCCCH
Confidence            9999999999985322211                 01111    1111      1334579999999999999999999


Q ss_pred             HHHHH
Q 019536          325 VDVAK  329 (339)
Q Consensus       325 ~~il~  329 (339)
                      .++++
T Consensus       355 ~e~l~  359 (377)
T 3byv_A          355 LQAME  359 (377)
T ss_dssp             HHHHT
T ss_pred             HHHhh
Confidence            99986

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=2.4e-46  Score=341.94  Aligned_cols=265  Identities=17%  Similarity=0.148  Sum_probs=199.7

Q ss_pred             cCcccCCceeccCCeeEEEEEEcC---CCeeEEEEEeccCCChh----------hHHHHHHHHHHHHhcCCCceeeeeee
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVD---QDRPISVMKFHDNSTLD----------DVEYCFNNIVFSSQMKHKNILKLIGC  121 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~----------~~~~~~~e~~~l~~l~H~niv~~~~~  121 (339)
                      ++|.+.+.||+|+||+||+|.+..   ++..+|+|++.......          ....+.+|+.+++.++||||++++++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~  116 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS  116 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence            679999999999999999999986   78899999988654311          11235678889999999999999999


Q ss_pred             eee----CCccEEEEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCC--ce
Q 019536          122 CLE----TELPTLVFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENY--SA  193 (339)
Q Consensus       122 ~~~----~~~~~lv~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~--~~  193 (339)
                      +..    ....++||||+ +++|.+++.  ..+++..++.++.|++.||.|||   +.+|+||||||+||+++.++  .+
T Consensus       117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~  192 (345)
T 2v62_A          117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQV  192 (345)
T ss_dssp             EEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESSSTTSE
T ss_pred             cccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccCCCCcE
Confidence            988    67889999999 999999987  47899999999999999999999   89999999999999998877  99


Q ss_pred             EEecCCCccccCCCCce-----eeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchh
Q 019536          194 KLHDFSLSVSIPEGETH-----VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLT  268 (339)
Q Consensus       194 kl~dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~  268 (339)
                      ||+|||+++.+......     .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......    .
T Consensus       193 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~----~  268 (345)
T 2v62_A          193 YLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP----V  268 (345)
T ss_dssp             EECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH----H
T ss_pred             EEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc----H
Confidence            99999999876432211     01123568999999999999999999999999999999999999985322111    1


Q ss_pred             HHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 019536          269 VLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMY  335 (339)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~  335 (339)
                      ................ ......       ....+..+.+++.+||+.||++|||+.+|++.|+++.
T Consensus       269 ~~~~~~~~~~~~~~~~-~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  327 (345)
T 2v62_A          269 AVQTAKTNLLDELPQS-VLKWAP-------SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG  327 (345)
T ss_dssp             HHHHHHHHHHHTTTHH-HHHHSC-------TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred             HHHHHHHhhcccccHH-HHhhcc-------ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence            1111111111110000 000000       0033457999999999999999999999999998753

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=8.5e-46  Score=362.91  Aligned_cols=253  Identities=23%  Similarity=0.293  Sum_probs=202.0

Q ss_pred             CceeccCCeeEEEEEEc--CCCeeEEEEEeccCCC-hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeccC
Q 019536           61 KVIQSDTSYRLFEGTLV--DQDRPISVMKFHDNST-LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKY  137 (339)
Q Consensus        61 ~~ig~G~~g~V~~~~~~--~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~  137 (339)
                      +.||+|+||+||+|.+.  .+++.||||+++.... ....+.+.+|+.+++.++||||+++++++.+ +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            37999999999999664  4568999999976532 2446789999999999999999999999965 457899999999


Q ss_pred             Cccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCce-eeec
Q 019536          138 GTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH-VREE  214 (339)
Q Consensus       138 g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~-~~~~  214 (339)
                      |+|.+++.  ..+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+...... ....
T Consensus       454 g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~  530 (635)
T 4fl3_A          454 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT  530 (635)
T ss_dssp             EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---------
T ss_pred             CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccccc
Confidence            99999986  56889999999999999999999   899999999999999999999999999999877554322 1122


Q ss_pred             ccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCC
Q 019536          215 FIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDED  293 (339)
Q Consensus       215 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (339)
                      ...+|+.|+|||++.+..++.++|||||||++|||++ |+.||.....        .+.... ...+.            
T Consensus       531 ~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~--------~~~~~~-i~~~~------------  589 (635)
T 4fl3_A          531 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--------SEVTAM-LEKGE------------  589 (635)
T ss_dssp             ----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHHHH-HHTTC------------
T ss_pred             CCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHH-HHcCC------------
Confidence            3456788999999999999999999999999999998 9999753211        111111 11111            


Q ss_pred             CCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhcC
Q 019536          294 NSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLSVV  339 (339)
Q Consensus       294 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~~~  339 (339)
                       ..+.+..++.++.+||.+||+.||++|||+.+|++.|++++.+++
T Consensus       590 -~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l~  634 (635)
T 4fl3_A          590 -RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV  634 (635)
T ss_dssp             -CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHC
T ss_pred             -CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhc
Confidence             111122455689999999999999999999999999999998764

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=5.7e-46  Score=357.30  Aligned_cols=251  Identities=19%  Similarity=0.280  Sum_probs=206.7

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC--ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS--TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLV  131 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  131 (339)
                      .++|++.+.||+|+||.||+|....+|+.||+|++....  .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            367999999999999999999999999999999986532  113456688999999999999999999999999999999


Q ss_pred             EEeccCCccccccc----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCC
Q 019536          132 FESVKYGTLRGFSF----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEG  207 (339)
Q Consensus       132 ~e~~~~g~L~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~  207 (339)
                      |||+++|+|.+++.    ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus       263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~  339 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  339 (576)
T ss_dssp             ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence            99999999998875    23889999999999999999999   899999999999999999999999999999887554


Q ss_pred             CceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCccccccc
Q 019536          208 ETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVD  287 (339)
Q Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (339)
                      ....   ...||+.|+|||++.+..|+.++|||||||++|+|++|+.||.......  ....+   ........      
T Consensus       340 ~~~~---~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~--~~~~i---~~~i~~~~------  405 (576)
T 2acx_A          340 QTIK---GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI--KREEV---ERLVKEVP------  405 (576)
T ss_dssp             CCEE---CCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCC--CHHHH---HHHHHHCC------
T ss_pred             cccc---ccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccch--hHHHH---HHHhhccc------
Confidence            3321   3579999999999999899999999999999999999999986432211  11111   11111110      


Q ss_pred             CcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 019536          288 PIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP-----LMVDVAK  329 (339)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~il~  329 (339)
                            ..+|  ...+.++.+|+.+||+.||++||     ++.||++
T Consensus       406 ------~~~p--~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          406 ------EEYS--ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             ------CCCC--TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             ------ccCC--ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence                  1111  23456799999999999999999     7788875

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=8.5e-45  Score=330.73  Aligned_cols=271  Identities=19%  Similarity=0.275  Sum_probs=209.2

Q ss_pred             HHHHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHh--cCCCceeeeeeeeeeCC-
Q 019536           50 LKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQ--MKHKNILKLIGCCLETE-  126 (339)
Q Consensus        50 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~--l~H~niv~~~~~~~~~~-  126 (339)
                      -....++|.+.+.||+|+||+||+|.+  +++.||||++..    .....+.+|..++..  ++||||+++++++...+ 
T Consensus        37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~----~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~  110 (342)
T 1b6c_B           37 QRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSS----REERSWFREAEIYQTVMLRHENILGFIAADNKDNG  110 (342)
T ss_dssp             HHHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECG----GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS
T ss_pred             cccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCc----hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC
Confidence            344567899999999999999999998  689999999964    345667789888887  78999999999998876 


Q ss_pred             ---ccEEEEEeccCCccccccc-cCCChHHHHHHHHHHHHHHHHHhcCC-----CCCeEEccCCCCCEEeCCCCceEEec
Q 019536          127 ---LPTLVFESVKYGTLRGFSF-ASLLIAPRIKIAMEIANAVAYLHVGF-----DRPIVFRCIKASNVLLDENYSAKLHD  197 (339)
Q Consensus       127 ---~~~lv~e~~~~g~L~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~-----~~~i~H~dlk~~Nil~~~~~~~kl~d  197 (339)
                         ..++||||+++|+|.+++. ..+++..++.++.|++.||.|||...     +.+|+||||||+||+++.++.+||+|
T Consensus       111 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~D  190 (342)
T 1b6c_B          111 TWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD  190 (342)
T ss_dssp             SCCCEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECC
T ss_pred             ccceeEEEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEE
Confidence               7899999999999999986 57899999999999999999999311     36899999999999999999999999


Q ss_pred             CCCccccCCCCcee--eecccccccccccccccccC------CCCcccchHHHHHHHHHHHhC----------CCccccC
Q 019536          198 FSLSVSIPEGETHV--REEFIKGAYGFIAPEYFATS------SFNEMCDVYSFGAFLCELLTG----------CNVLEFK  259 (339)
Q Consensus       198 fg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~~l~el~~g----------~~p~~~~  259 (339)
                      ||+++.........  ......||+.|+|||++.+.      .++.++|||||||++|+|++|          ..||...
T Consensus       191 fg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~  270 (342)
T 1b6c_B          191 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL  270 (342)
T ss_dssp             CTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred             CCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcccc
Confidence            99998765543321  12245689999999999765      234789999999999999999          5565432


Q ss_pred             CCCCCCchhHHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          260 GNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                      ......   .... .........    .+.+...  + ........+.+|+.+||+.||++|||+.+|++.|+++.++
T Consensus       271 ~~~~~~---~~~~-~~~~~~~~~----~~~~~~~--~-~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~  337 (342)
T 1b6c_B          271 VPSDPS---VEEM-RKVVCEQKL----RPNIPNR--W-QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  337 (342)
T ss_dssp             SCSSCC---HHHH-HHHHTTSCC----CCCCCGG--G-GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CcCccc---HHHH-HHHHHHHHh----CCCCccc--c-cchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence            221111   1111 111111110    1111100  0 0125677899999999999999999999999999999864

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=7.2e-46  Score=355.32  Aligned_cols=252  Identities=21%  Similarity=0.234  Sum_probs=202.8

Q ss_pred             HhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCCh------------hhHHHHHHHHHHHHhcCCCceeeeee
Q 019536           53 ATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTL------------DDVEYCFNNIVFSSQMKHKNILKLIG  120 (339)
Q Consensus        53 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------------~~~~~~~~e~~~l~~l~H~niv~~~~  120 (339)
                      ..++|.+.+.||+|+||+||+|.+..++..||+|++......            ...+.+.+|+.+++.++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            457899999999999999999999999999999998764321            23567889999999999999999999


Q ss_pred             eeeeCCccEEEEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCC---ceEE
Q 019536          121 CCLETELPTLVFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENY---SAKL  195 (339)
Q Consensus       121 ~~~~~~~~~lv~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~---~~kl  195 (339)
                      ++.++...++|||||++|+|.+++.  ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++   .+||
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl  190 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKI  190 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCCSSEEE
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCCccEEE
Confidence            9999999999999999999988875  67899999999999999999999   89999999999999998775   6999


Q ss_pred             ecCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHH
Q 019536          196 HDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKK  275 (339)
Q Consensus       196 ~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  275 (339)
                      +|||+++........   ....||+.|+|||++. ..|+.++||||+||++|+|++|+.||....        ..+....
T Consensus       191 ~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~~  258 (504)
T 3q5i_A          191 VDFGLSSFFSKDYKL---RDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQN--------DQDIIKK  258 (504)
T ss_dssp             CCCTTCEECCTTSCB---CCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHH
T ss_pred             EECCCCEEcCCCCcc---ccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHH
Confidence            999999877554322   1356999999999986 469999999999999999999999985321        1111111


Q ss_pred             HhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          276 SIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      .. .+..          ....+.....+..+.+|+.+||+.||.+|||+.+++++
T Consensus       259 i~-~~~~----------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h  302 (504)
T 3q5i_A          259 VE-KGKY----------YFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS  302 (504)
T ss_dssp             HH-HCCC----------CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HH-cCCC----------CCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            11 1110          00001112345679999999999999999999999863

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=2.7e-46  Score=337.26  Aligned_cols=260  Identities=19%  Similarity=0.214  Sum_probs=205.0

Q ss_pred             HhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeee----CCcc
Q 019536           53 ATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLE----TELP  128 (339)
Q Consensus        53 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~----~~~~  128 (339)
                      ..++|++.+.||+|+||.||+|....+++.||+|++..... ...+.+.+|+.+++.++||||+++++++..    ....
T Consensus        27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  105 (317)
T 2buj_A           27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQ-QDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA  105 (317)
T ss_dssp             TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSH-HHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred             CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCH-HHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence            34789999999999999999999988999999999876432 566778899999999999999999999973    3467


Q ss_pred             EEEEEeccCCccccccc------cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCcc
Q 019536          129 TLVFESVKYGTLRGFSF------ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSV  202 (339)
Q Consensus       129 ~lv~e~~~~g~L~~~~~------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~  202 (339)
                      ++||||+++|+|.+++.      ..+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++
T Consensus       106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~  182 (317)
T 2buj_A          106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMN  182 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred             EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence            89999999999998875      45889999999999999999999   8999999999999999999999999999987


Q ss_pred             ccCCCCcee-------eecccccccccccccccccCC---CCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHH
Q 019536          203 SIPEGETHV-------REEFIKGAYGFIAPEYFATSS---FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEY  272 (339)
Q Consensus       203 ~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~  272 (339)
                      .........       ......||+.|+|||++.+..   ++.++||||||+++|+|++|+.||.........   ....
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~---~~~~  259 (317)
T 2buj_A          183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS---VALA  259 (317)
T ss_dssp             ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC---HHHH
T ss_pred             hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch---hhHH
Confidence            653211100       001234689999999987654   789999999999999999999998532111100   0000


Q ss_pred             HHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 019536          273 AKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYL  336 (339)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~  336 (339)
                          ...             ....|.....+..+.+|+.+||+.||.+|||+.++++.|+.+..
T Consensus       260 ----~~~-------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~  306 (317)
T 2buj_A          260 ----VQN-------------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP  306 (317)
T ss_dssp             ----HHC-------------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred             ----hhc-------------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence                000             11112222445679999999999999999999999999998753

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=5.5e-46  Score=354.45  Aligned_cols=251  Identities=22%  Similarity=0.297  Sum_probs=207.6

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC--hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST--LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLV  131 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  131 (339)
                      .++|++.+.||+|+||+||+|.+..+++.||||++.....  ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            4679999999999999999999999999999999876532  24567788999999999999999999999999999999


Q ss_pred             EEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEe---CCCCceEEecCCCccccCC
Q 019536          132 FESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLL---DENYSAKLHDFSLSVSIPE  206 (339)
Q Consensus       132 ~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~---~~~~~~kl~dfg~a~~~~~  206 (339)
                      |||+.+|+|.+++.  ..+++..+..++.|++.||.|||   +.+|+||||||+|||+   +.++.+||+|||+++.+..
T Consensus       105 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~  181 (484)
T 3nyv_A          105 GEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA  181 (484)
T ss_dssp             ECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred             EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence            99999999988875  57888999999999999999999   8999999999999999   5678899999999987755


Q ss_pred             CCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccc
Q 019536          207 GETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIV  286 (339)
Q Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (339)
                      ....   ....||+.|+|||++.+ .|+.++||||+||++|+|++|++||....        ..+...... ....    
T Consensus       182 ~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~~i~-~~~~----  244 (484)
T 3nyv_A          182 SKKM---KDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN--------EYDILKKVE-KGKY----  244 (484)
T ss_dssp             CCSH---HHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHH-HCCC----
T ss_pred             cccc---ccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHH-cCCC----
Confidence            4322   23569999999999876 69999999999999999999999985321        111111111 1111    


Q ss_pred             cCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          287 DPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                            ....|.....+..+.+|+.+||+.||++|||+.+++++
T Consensus       245 ------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  282 (484)
T 3nyv_A          245 ------TFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH  282 (484)
T ss_dssp             ------CCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ------CCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence                  11122223556789999999999999999999999873

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=7.1e-46  Score=329.46  Aligned_cols=246  Identities=20%  Similarity=0.270  Sum_probs=205.0

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC--hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST--LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLV  131 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  131 (339)
                      .++|++.+.||+|+||.||+|.+..++..||+|++.....  ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            3789999999999999999999999999999999865321  12346688999999999999999999999999999999


Q ss_pred             EEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCc
Q 019536          132 FESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGET  209 (339)
Q Consensus       132 ~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~  209 (339)
                      |||+++|+|.+++.  ..++...+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||++........
T Consensus        93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~  169 (284)
T 2vgo_A           93 LEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR  169 (284)
T ss_dssp             ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSCB
T ss_pred             EEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCccccc
Confidence            99999999999886  56889999999999999999999   99999999999999999999999999999876544322


Q ss_pred             eeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCc
Q 019536          210 HVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPI  289 (339)
Q Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (339)
                          ....|++.|+|||++.+..++.++||||||+++|+|++|+.||....        ......... ..         
T Consensus       170 ----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~~~~~~~~~-~~---------  227 (284)
T 2vgo_A          170 ----RTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS--------HTETHRRIV-NV---------  227 (284)
T ss_dssp             ----CCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHH-TT---------
T ss_pred             ----ccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC--------HhHHHHHHh-cc---------
Confidence                13568999999999999899999999999999999999999985321        111111111 11         


Q ss_pred             ccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          290 FDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                         ...+|  ...+..+.+++.+||+.||.+|||+.++++
T Consensus       228 ---~~~~~--~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          228 ---DLKFP--PFLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             ---CCCCC--TTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ---ccCCC--CcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence               01111  234567899999999999999999999987

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=5.9e-46  Score=333.24  Aligned_cols=250  Identities=22%  Similarity=0.248  Sum_probs=202.9

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFE  133 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  133 (339)
                      .++|.+.+.||+|+||+||+|.+..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA-FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ   86 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc-cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence            4679999999999999999999998999999999986543 334567899999999999999999999999999999999


Q ss_pred             eccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEe---CCCCceEEecCCCccccCCCC
Q 019536          134 SVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLL---DENYSAKLHDFSLSVSIPEGE  208 (339)
Q Consensus       134 ~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~---~~~~~~kl~dfg~a~~~~~~~  208 (339)
                      |+++++|.+++.  ..++...+..++.|++.||.|||   +.+|+||||||+||++   +.++.+||+|||++.......
T Consensus        87 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~  163 (304)
T 2jam_A           87 LVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI  163 (304)
T ss_dssp             CCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBT
T ss_pred             cCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCc
Confidence            999999998875  57889999999999999999999   8999999999999999   778899999999987654322


Q ss_pred             ceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccC
Q 019536          209 THVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDP  288 (339)
Q Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (339)
                      .    ....||+.|+|||++.+..++.++||||+|+++|+|++|+.||....        ....... ......      
T Consensus       164 ~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~~~~~~~-i~~~~~------  224 (304)
T 2jam_A          164 M----STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET--------ESKLFEK-IKEGYY------  224 (304)
T ss_dssp             T----HHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHH-HHHCCC------
T ss_pred             c----ccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC--------HHHHHHH-HHcCCC------
Confidence            1    13568999999999999999999999999999999999999975221        1111111 111110      


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          289 IFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                        .  ...+.....+..+.+|+.+||+.||++|||+.+++++
T Consensus       225 --~--~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (304)
T 2jam_A          225 --E--FESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH  262 (304)
T ss_dssp             --C--CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             --C--CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence              0  0011112445679999999999999999999999873

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=4.3e-46  Score=343.49  Aligned_cols=252  Identities=9%  Similarity=0.064  Sum_probs=186.3

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC--hhhHHHHHHHHHHHHhc--CCCceeeee-------eee
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST--LDDVEYCFNNIVFSSQM--KHKNILKLI-------GCC  122 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l--~H~niv~~~-------~~~  122 (339)
                      ..+|.+.+.||+|+||+||+|.+..+++.||+|++.....  ....+.+.+|+.+++.+  +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            4569999999999999999999999999999999988643  23456677885555544  699988755       444


Q ss_pred             eeC-----------------CccEEEEEeccCCccccccc---cCCChHHH------HHHHHHHHHHHHHHhcCCCCCeE
Q 019536          123 LET-----------------ELPTLVFESVKYGTLRGFSF---ASLLIAPR------IKIAMEIANAVAYLHVGFDRPIV  176 (339)
Q Consensus       123 ~~~-----------------~~~~lv~e~~~~g~L~~~~~---~~~~~~~~------~~i~~~i~~~l~~LH~~~~~~i~  176 (339)
                      ...                 ...++||||++ |+|.+++.   ..++...+      ..++.||+.||.|||   +.+|+
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~iv  216 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLV  216 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHH---HCCCc
Confidence            332                 23799999998 89999986   24566666      677899999999999   89999


Q ss_pred             EccCCCCCEEeCCCCceEEecCCCccccCCCCceeeeccccccccccccccccc--CCCCcccchHHHHHHHHHHHhCCC
Q 019536          177 FRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFAT--SSFNEMCDVYSFGAFLCELLTGCN  254 (339)
Q Consensus       177 H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~g~~  254 (339)
                      ||||||+|||++.++.+||+|||+|+.......     ...+|+.|+|||++.+  ..++.++|||||||++|+|++|+.
T Consensus       217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~-----~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~  291 (371)
T 3q60_A          217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGP-----ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL  291 (371)
T ss_dssp             ETTCSGGGEEECTTSCEEECCGGGEEETTCEEE-----GGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred             cCcCCHHHEEECCCCCEEEEecceeeecCCCcc-----CccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence            999999999999999999999999987643211     3456799999999987  679999999999999999999999


Q ss_pred             ccccCCCCCCCchhHHHHHHHHhhcCccccc-ccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          255 VLEFKGNGNDDDLTVLEYAKKSIENNRFGAI-VDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       255 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                      ||.........               .+... ..........++.....+..+.+|+.+||+.||++|||+.++++
T Consensus       292 Pf~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          292 PFGLVTPGIKG---------------SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             STTBCCTTCTT---------------CCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             CCCCcCccccc---------------chhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            98644322111               00000 01111112222322355678999999999999999999999975

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1e-45  Score=329.38  Aligned_cols=248  Identities=17%  Similarity=0.272  Sum_probs=200.2

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeeee----CCccE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS-TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLE----TELPT  129 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~----~~~~~  129 (339)
                      ..|.+.+.||+|+||+||+|.+..++..||+|.+.... .....+.+.+|+.+++.++||||+++++++..    ....+
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  105 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence            45888889999999999999999999999999987653 33456778899999999999999999999875    35589


Q ss_pred             EEEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCC--eEEccCCCCCEEeC-CCCceEEecCCCcccc
Q 019536          130 LVFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRP--IVFRCIKASNVLLD-ENYSAKLHDFSLSVSI  204 (339)
Q Consensus       130 lv~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~dlk~~Nil~~-~~~~~kl~dfg~a~~~  204 (339)
                      +||||+++|+|.+++.  ..+++..+..++.|++.||.|||   +.+  |+||||||+||+++ .++.+||+|||++...
T Consensus       106 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~  182 (290)
T 1t4h_A          106 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  182 (290)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             EEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence            9999999999999987  57889999999999999999999   888  99999999999997 7899999999999765


Q ss_pred             CCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccc
Q 019536          205 PEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA  284 (339)
Q Consensus       205 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (339)
                      ......    ...||+.|+|||++. ..++.++||||+|+++|+|++|+.||.....       ....... ....... 
T Consensus       183 ~~~~~~----~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-------~~~~~~~-~~~~~~~-  248 (290)
T 1t4h_A          183 RASFAK----AVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN-------AAQIYRR-VTSGVKP-  248 (290)
T ss_dssp             CTTSBE----ESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-------HHHHHHH-HTTTCCC-
T ss_pred             cccccc----cccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCc-------HHHHHHH-HhccCCc-
Confidence            443322    346899999999886 4589999999999999999999999853211       1111111 1111000 


Q ss_pred             cccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                         .        ..+...+..+.+|+.+||+.||++|||+.+++++
T Consensus       249 ---~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  283 (290)
T 1t4h_A          249 ---A--------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             ---G--------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ---c--------ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence               0        0011233578999999999999999999999863

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=3.3e-46  Score=359.70  Aligned_cols=260  Identities=24%  Similarity=0.299  Sum_probs=211.5

Q ss_pred             HHHHHHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCc
Q 019536           48 KDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETEL  127 (339)
Q Consensus        48 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~  127 (339)
                      +.++...++|++.+.||+|+||.||+|.+. .+..||||++....  ...+.+.+|+.+++.++||||+++++++.+ +.
T Consensus       260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~  335 (535)
T 2h8h_A          260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP  335 (535)
T ss_dssp             TCSBCCGGGEEEEEEEEECSSEEEEEEEET-TTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred             cceecchhhhhhheecccCCCeEEEEEEEC-CCceEEEEEeCCCC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-cc
Confidence            445555678999999999999999999997 45779999998654  235678999999999999999999999976 66


Q ss_pred             cEEEEEeccCCccccccc----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccc
Q 019536          128 PTLVFESVKYGTLRGFSF----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVS  203 (339)
Q Consensus       128 ~~lv~e~~~~g~L~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~  203 (339)
                      .++||||+++|+|.+++.    ..+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++.
T Consensus       336 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~  412 (535)
T 2h8h_A          336 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARL  412 (535)
T ss_dssp             CEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTT
T ss_pred             ceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEccccccee
Confidence            899999999999999987    35889999999999999999999   89999999999999999999999999999987


Q ss_pred             cCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCcc
Q 019536          204 IPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRF  282 (339)
Q Consensus       204 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (339)
                      ....... ......++..|+|||++.+..++.++|||||||++|||++ |+.||....        ..+.........  
T Consensus       413 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~--------~~~~~~~i~~~~--  481 (535)
T 2h8h_A          413 IEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--------NREVLDQVERGY--  481 (535)
T ss_dssp             CCCHHHH-TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCC--------HHHHHHHHHTTC--
T ss_pred             cCCCcee-cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHHcCC--
Confidence            6432211 1112346778999999999999999999999999999999 899975221        111111111111  


Q ss_pred             cccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          283 GAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                                  ..+.+..++..+.+||.+||+.||++|||+.+|++.|+.+..+
T Consensus       482 ------------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  524 (535)
T 2h8h_A          482 ------------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  524 (535)
T ss_dssp             ------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred             ------------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence                        1122234556799999999999999999999999999988643

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=3.1e-46  Score=349.73  Aligned_cols=253  Identities=19%  Similarity=0.201  Sum_probs=193.8

Q ss_pred             HHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC-------hhhHHHHHHHHHHHHhcCCCceeeeeeeeee
Q 019536           52 KATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST-------LDDVEYCFNNIVFSSQMKHKNILKLIGCCLE  124 (339)
Q Consensus        52 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~  124 (339)
                      ...++|.+.+.||+|+||+||+|.+..+++.||+|++.....       ......+.+|+.++++++||||+++++++..
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  211 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA  211 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            456899999999999999999999999999999999875321       1122347799999999999999999999864


Q ss_pred             CCccEEEEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCC---CceEEecCC
Q 019536          125 TELPTLVFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDEN---YSAKLHDFS  199 (339)
Q Consensus       125 ~~~~~lv~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~---~~~kl~dfg  199 (339)
                      + ..++||||+++|+|.+++.  ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.+   +.+||+|||
T Consensus       212 ~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG  287 (419)
T 3i6u_A          212 E-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFG  287 (419)
T ss_dssp             S-EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred             C-ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEEEeecc
Confidence            4 5789999999999999876  57889999999999999999999   8999999999999999754   459999999


Q ss_pred             CccccCCCCceeeeccccccccccccccccc---CCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHH
Q 019536          200 LSVSIPEGETHVREEFIKGAYGFIAPEYFAT---SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKS  276 (339)
Q Consensus       200 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  276 (339)
                      +++........   ....||+.|+|||++.+   ..|+.++|||||||++|+|++|+.||.......    .....    
T Consensus       288 ~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~----~~~~~----  356 (419)
T 3i6u_A          288 HSKILGETSLM---RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV----SLKDQ----  356 (419)
T ss_dssp             TTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC----CHHHH----
T ss_pred             cceecCCCccc---cccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH----HHHHH----
Confidence            99876543321   24579999999999863   568899999999999999999999986322211    11111    


Q ss_pred             hhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          277 IENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                      ........          ..+.....+..+.+|+.+||+.||++|||+.++++
T Consensus       357 i~~~~~~~----------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          357 ITSGKYNF----------IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             HHTTCCCC----------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HhcCCCCC----------CchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            11111000          00000134567999999999999999999999987

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=7e-46  Score=336.78  Aligned_cols=257  Identities=21%  Similarity=0.268  Sum_probs=190.9

Q ss_pred             HHHHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcC-CCceeeeeeeee-----
Q 019536           50 LKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMK-HKNILKLIGCCL-----  123 (339)
Q Consensus        50 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~~~~~~~-----  123 (339)
                      +.....+|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.+. ||||+++++++.     
T Consensus        23 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~  101 (337)
T 3ll6_A           23 VELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEE-EKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEE  101 (337)
T ss_dssp             EEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSH-HHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTT
T ss_pred             eeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCch-HHHHHHHHHHHHHHHhccCCChhhccccccccccc
Confidence            33445689999999999999999999999999999999866533 55677889999999996 999999999994     


Q ss_pred             ---eCCccEEEEEeccCCccccccc-----cCCChHHHHHHHHHHHHHHHHHhcCCCCC--eEEccCCCCCEEeCCCCce
Q 019536          124 ---ETELPTLVFESVKYGTLRGFSF-----ASLLIAPRIKIAMEIANAVAYLHVGFDRP--IVFRCIKASNVLLDENYSA  193 (339)
Q Consensus       124 ---~~~~~~lv~e~~~~g~L~~~~~-----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~dlk~~Nil~~~~~~~  193 (339)
                         .....++||||++ |+|.+++.     ..+++..++.++.|++.||.|||   +.+  |+||||||+||+++.++.+
T Consensus       102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~  177 (337)
T 3ll6_A          102 SDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTI  177 (337)
T ss_dssp             STTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCE
T ss_pred             cccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCE
Confidence               3344789999996 78888764     46899999999999999999999   888  9999999999999999999


Q ss_pred             EEecCCCccccCCCCcee----------eeccccccccccccccc---ccCCCCcccchHHHHHHHHHHHhCCCccccCC
Q 019536          194 KLHDFSLSVSIPEGETHV----------REEFIKGAYGFIAPEYF---ATSSFNEMCDVYSFGAFLCELLTGCNVLEFKG  260 (339)
Q Consensus       194 kl~dfg~a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~  260 (339)
                      ||+|||+++.........          ......||+.|+|||++   .+..++.++|||||||++|+|++|+.||....
T Consensus       178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~  257 (337)
T 3ll6_A          178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA  257 (337)
T ss_dssp             EBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             EEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence            999999998765432211          11134589999999998   56678999999999999999999999985221


Q ss_pred             CCCCCchhHHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 019536          261 NGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYL  336 (339)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~  336 (339)
                      ...                     +....    ...+.....+..+.+|+.+||+.||++|||+.++++.|+.+..
T Consensus       258 ~~~---------------------~~~~~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~  308 (337)
T 3ll6_A          258 KLR---------------------IVNGK----YSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA  308 (337)
T ss_dssp             ---------------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHH---------------------hhcCc----ccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            100                     00000    0011111223358899999999999999999999999998875

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.8e-45  Score=351.76  Aligned_cols=251  Identities=21%  Similarity=0.241  Sum_probs=200.4

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC-hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST-LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVF  132 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  132 (339)
                      .++|++.+.||+|+||+||+|.+..++..||+|++..... ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            4579999999999999999999999999999999976532 234567889999999999999999999999999999999


Q ss_pred             EeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCC---CCceEEecCCCccccCCC
Q 019536          133 ESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDE---NYSAKLHDFSLSVSIPEG  207 (339)
Q Consensus       133 e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~---~~~~kl~dfg~a~~~~~~  207 (339)
                      |||++|+|.+.+.  ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.   ++.+||+|||+++.....
T Consensus       116 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~  192 (494)
T 3lij_A          116 ECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ  192 (494)
T ss_dssp             ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred             ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence            9999999988875  57888999999999999999999   899999999999999976   455999999999877554


Q ss_pred             CceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCccccccc
Q 019536          208 ETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVD  287 (339)
Q Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (339)
                      ...   ....||+.|+|||++. ..|+.++||||+||++|+|++|+.||....        ..+...... ....     
T Consensus       193 ~~~---~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~~i~-~~~~-----  254 (494)
T 3lij_A          193 KKM---KERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQT--------DQEILRKVE-KGKY-----  254 (494)
T ss_dssp             BCB---CCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHH-HTCC-----
T ss_pred             ccc---cccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHH-hCCC-----
Confidence            322   1356999999999986 569999999999999999999999985321        111111111 1111     


Q ss_pred             CcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          288 PIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                           ....+.....+..+.+|+.+||+.||++|||+.+++++
T Consensus       255 -----~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          255 -----TFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             -----CCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             -----CCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence                 00111112445679999999999999999999999863

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.3e-45  Score=334.49  Aligned_cols=264  Identities=18%  Similarity=0.230  Sum_probs=202.7

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcC-CCceeeeeeeeee--CCccEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMK-HKNILKLIGCCLE--TELPTLV  131 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~~~~~~~~--~~~~~lv  131 (339)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++...    ..+.+.+|+.+++.++ ||||+++++++.+  ....++|
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            7899999999999999999999999999999999753    3466889999999997 9999999999987  6678999


Q ss_pred             EEeccCCccccccccCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCC-ceEEecCCCccccCCCCce
Q 019536          132 FESVKYGTLRGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENY-SAKLHDFSLSVSIPEGETH  210 (339)
Q Consensus       132 ~e~~~~g~L~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~-~~kl~dfg~a~~~~~~~~~  210 (339)
                      |||+++++|.+++. .++...+..++.|++.||.|||   +.+|+||||||+|||++.++ .+||+|||+++........
T Consensus       112 ~e~~~~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~  187 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQ-TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY  187 (330)
T ss_dssp             EECCCCCCHHHHGG-GCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCC
T ss_pred             EeccCchhHHHHHH-hCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCcc
Confidence            99999999988874 5888899999999999999999   89999999999999999776 8999999999876544332


Q ss_pred             eeeccccccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHH------HHhhcCcc-
Q 019536          211 VREEFIKGAYGFIAPEYFAT-SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAK------KSIENNRF-  282 (339)
Q Consensus       211 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~------~~~~~~~~-  282 (339)
                      .   ...||..|+|||++.+ ..++.++|||||||++|+|++|+.||.. +....+.+.......      ........ 
T Consensus       188 ~---~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  263 (330)
T 3nsz_A          188 N---VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH-GHDNYDQLVRIAKVLGTEDLYDYIDKYNIE  263 (330)
T ss_dssp             C---SCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSC-CSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred             c---cccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCccc-CCchHHHHHHHHHhcCCchhhhHHHHhccc
Confidence            1   3468899999999877 5789999999999999999999999842 221111111100000      00000000 


Q ss_pred             -----ccc----ccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          283 -----GAI----VDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       283 -----~~~----~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                           ..+    ....+............+..+.+|+.+||+.||++|||+.+++++
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h  320 (330)
T 3nsz_A          264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  320 (330)
T ss_dssp             CCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             cccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence                 000    000000001111122356789999999999999999999999873

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=3.5e-46  Score=357.70  Aligned_cols=251  Identities=18%  Similarity=0.280  Sum_probs=205.5

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC--hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST--LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVF  132 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  132 (339)
                      ++|.+.+.||+|+||.||+|.+..+|+.||+|++.....  ......+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            679999999999999999999999999999999975421  134567889999999999999999999999999999999


Q ss_pred             EeccCCccccccc------cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCC
Q 019536          133 ESVKYGTLRGFSF------ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPE  206 (339)
Q Consensus       133 e~~~~g~L~~~~~------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~  206 (339)
                      ||+++|+|.+++.      ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.+|.+||+|||+++.+..
T Consensus       265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~  341 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA  341 (543)
T ss_dssp             CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence            9999999988874      25888999999999999999999   89999999999999999999999999999987755


Q ss_pred             CCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccc
Q 019536          207 GETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIV  286 (339)
Q Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (339)
                      ....  ....+||+.|+|||++.+..|+.++|+|||||++|||++|+.||.......    ........... .      
T Consensus       342 ~~~~--~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~----~~~~~~~~i~~-~------  408 (543)
T 3c4z_A          342 GQTK--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV----ENKELKQRVLE-Q------  408 (543)
T ss_dssp             TCCC--BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC----CHHHHHHHHHH-C------
T ss_pred             CCcc--cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch----hHHHHHHHHhh-c------
Confidence            4322  123579999999999999999999999999999999999999986432211    11111111111 1      


Q ss_pred             cCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCH-----HHHHH
Q 019536          287 DPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLM-----VDVAK  329 (339)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~-----~~il~  329 (339)
                            ...+|  ...+..+.+|+.+||+.||++||++     .+|++
T Consensus       409 ------~~~~p--~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          409 ------AVTYP--DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             ------CCCCC--TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             ------ccCCC--cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence                  11111  2455679999999999999999975     56654

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=2.3e-45  Score=325.64  Aligned_cols=247  Identities=21%  Similarity=0.310  Sum_probs=204.9

Q ss_pred             HhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeee--------
Q 019536           53 ATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLE--------  124 (339)
Q Consensus        53 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~--------  124 (339)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++....     +.+.+|+.+++.++||||+++++++..        
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   83 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS   83 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence            4477999999999999999999999899999999997643     345689999999999999999999864        


Q ss_pred             --------CCccEEEEEeccCCccccccc----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCc
Q 019536          125 --------TELPTLVFESVKYGTLRGFSF----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYS  192 (339)
Q Consensus       125 --------~~~~~lv~e~~~~g~L~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~  192 (339)
                              ....++||||+++|+|.+++.    ..+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.
T Consensus        84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~  160 (284)
T 2a19_B           84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQ  160 (284)
T ss_dssp             -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTE
T ss_pred             cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCCCC
Confidence                    345799999999999999985    46888899999999999999999   899999999999999999999


Q ss_pred             eEEecCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHH
Q 019536          193 AKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEY  272 (339)
Q Consensus       193 ~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~  272 (339)
                      +||+|||++..........   ...||+.|+|||++.+..++.++||||||+++|+|++|..|+...          .. 
T Consensus       161 ~kl~Dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----------~~-  226 (284)
T 2a19_B          161 VKIGDFGLVTSLKNDGKRT---RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET----------SK-  226 (284)
T ss_dssp             EEECCCTTCEESSCCSCCC---CCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH----------HH-
T ss_pred             EEECcchhheecccccccc---ccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH----------HH-
Confidence            9999999998775543221   346899999999999999999999999999999999999886410          11 


Q ss_pred             HHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          273 AKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                      .........        +.        ...+..+.+++.+||+.||++|||+.++++.|+.+..+
T Consensus       227 ~~~~~~~~~--------~~--------~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~  275 (284)
T 2a19_B          227 FFTDLRDGI--------IS--------DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS  275 (284)
T ss_dssp             HHHHHHTTC--------CC--------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred             HHHHhhccc--------cc--------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence            111111111        10        12334688999999999999999999999999987643

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2.5e-45  Score=327.48  Aligned_cols=249  Identities=19%  Similarity=0.259  Sum_probs=207.4

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC--ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS--TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLV  131 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  131 (339)
                      .++|.+.+.||+|+||+||+|.+..+++.||+|.+....  .....+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            478999999999999999999999999999999987642  234567788999999999999999999999999999999


Q ss_pred             EEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCc
Q 019536          132 FESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGET  209 (339)
Q Consensus       132 ~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~  209 (339)
                      |||+++++|.+++.  ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus        94 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  170 (294)
T 2rku_A           94 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE  170 (294)
T ss_dssp             EECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceecccCcc
Confidence            99999999999876  57899999999999999999999   89999999999999999999999999999987654332


Q ss_pred             eeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCc
Q 019536          210 HVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPI  289 (339)
Q Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (339)
                      ..  ....||+.|+|||++.+..++.++||||+|+++|+|++|+.||....        ..+..... ....        
T Consensus       171 ~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~~~~~~~~-~~~~--------  231 (294)
T 2rku_A          171 RK--KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC--------LKETYLRI-KKNE--------  231 (294)
T ss_dssp             CB--CCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHH-HTTC--------
T ss_pred             cc--ccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHH-hhcc--------
Confidence            21  23568999999999998889999999999999999999999985321        11111111 1110        


Q ss_pred             ccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          290 FDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                          ...  +...+..+.+++.+||+.||++|||+.+++++
T Consensus       232 ----~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          232 ----YSI--PKHINPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             ----CCC--CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             ----CCC--ccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence                011  12344578999999999999999999999874

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.9e-46  Score=340.53  Aligned_cols=267  Identities=19%  Similarity=0.307  Sum_probs=202.2

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCCh-hhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTL-DDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVF  132 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  132 (339)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++...... ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            47899999999999999999999989999999998765432 34556779999999999999999999999999999999


Q ss_pred             EeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCce
Q 019536          133 ESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH  210 (339)
Q Consensus       133 e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~  210 (339)
                      ||+++++|.++..  ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++........
T Consensus       104 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  180 (331)
T 4aaa_A          104 EFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV  180 (331)
T ss_dssp             ECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred             ecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCccc
Confidence            9999999988754  67899999999999999999999   899999999999999999999999999999776543322


Q ss_pred             eeecccccccccccccccccC-CCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHH------------h
Q 019536          211 VREEFIKGAYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKS------------I  277 (339)
Q Consensus       211 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~------------~  277 (339)
                      .  ....||..|+|||++.+. .++.++||||+||++|+|++|+.||.....     ..........            .
T Consensus       181 ~--~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~  253 (331)
T 4aaa_A          181 Y--DDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSD-----IDQLYHIMMCLGNLIPRHQELFN  253 (331)
T ss_dssp             -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHHHCSCCHHHHHHHH
T ss_pred             c--CCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCc-----HHHHHHHHHHhCCCChhhhhHhh
Confidence            1  134689999999999875 689999999999999999999999753221     1111111000            0


Q ss_pred             hcCcccccccCcccCCCCCC-CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          278 ENNRFGAIVDPIFDEDNSFP-GKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      ..........+......... .....+..+.+|+.+||+.||++|||+.|++++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  307 (331)
T 4aaa_A          254 KNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH  307 (331)
T ss_dssp             HCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             hccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            01111111111111100000 001345679999999999999999999999863

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=3.1e-46  Score=338.93  Aligned_cols=268  Identities=14%  Similarity=0.194  Sum_probs=195.1

Q ss_pred             HHHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCCh-hhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccE
Q 019536           51 KKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTL-DDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPT  129 (339)
Q Consensus        51 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~  129 (339)
                      ....++|++.+.||+|+||+||+|.+..+++.||+|++...... .....+.+|+.+++.++||||+++++++.+++..+
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (329)
T 3gbz_A           30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH  109 (329)
T ss_dssp             --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred             ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence            34558999999999999999999999999999999999765332 23456779999999999999999999999999999


Q ss_pred             EEEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEe-----CCCCceEEecCCCcc
Q 019536          130 LVFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLL-----DENYSAKLHDFSLSV  202 (339)
Q Consensus       130 lv~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~-----~~~~~~kl~dfg~a~  202 (339)
                      +||||++ |+|.+++.  ..+++..+..++.|++.||.|||   +.+|+||||||+|||+     +..+.+||+|||+++
T Consensus       110 lv~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~  185 (329)
T 3gbz_A          110 LIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR  185 (329)
T ss_dssp             EEEECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred             EEEecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence            9999997 58888876  46889999999999999999999   8999999999999999     455569999999998


Q ss_pred             ccCCCCceeeecccccccccccccccccC-CCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHh---h
Q 019536          203 SIPEGETHVREEFIKGAYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSI---E  278 (339)
Q Consensus       203 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~  278 (339)
                      .........  ....||+.|+|||++.+. .++.++|||||||++|+|++|+.||....  .   ...........   .
T Consensus       186 ~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--~---~~~~~~~~~~~~~~~  258 (329)
T 3gbz_A          186 AFGIPIRQF--THEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDS--E---IDQLFKIFEVLGLPD  258 (329)
T ss_dssp             HHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--H---HHHHHHHHHHHCCCC
T ss_pred             ccCCccccc--CCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCC--H---HHHHHHHHHHhCCCc
Confidence            765433221  134679999999999875 58999999999999999999999975321  1   11111111111   0


Q ss_pred             cCcccccc-cCcccCCCC-C--CC-----cHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          279 NNRFGAIV-DPIFDEDNS-F--PG-----KEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       279 ~~~~~~~~-~~~~~~~~~-~--~~-----~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                      ...+.... .+.+....+ .  ..     +...+.++.+|+.+||+.||++|||+.|+++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          259 DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             TTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            00000000 000000000 0  00     0114567899999999999999999999986

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=4.5e-46  Score=329.68  Aligned_cols=252  Identities=19%  Similarity=0.261  Sum_probs=203.7

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeeee--CCccEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS-TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLE--TELPTL  130 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~--~~~~~l  130 (339)
                      .++|++.+.||+|+||+||+|.+..+++.||+|.+.... .....+.+.+|+.+++.++||||+++++++.+  ++..++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            478999999999999999999999999999999998654 33456778899999999999999999998854  567899


Q ss_pred             EEEeccCCccccccc------cCCChHHHHHHHHHHHHHHHHHhcCCCCC-----eEEccCCCCCEEeCCCCceEEecCC
Q 019536          131 VFESVKYGTLRGFSF------ASLLIAPRIKIAMEIANAVAYLHVGFDRP-----IVFRCIKASNVLLDENYSAKLHDFS  199 (339)
Q Consensus       131 v~e~~~~g~L~~~~~------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~-----i~H~dlk~~Nil~~~~~~~kl~dfg  199 (339)
                      ||||+++|+|.+++.      ..+++..++.++.|++.||.|||   +.+     |+||||||+||+++.++.+||+|||
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            999999999999986      23899999999999999999999   777     9999999999999999999999999


Q ss_pred             CccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhc
Q 019536          200 LSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIEN  279 (339)
Q Consensus       200 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  279 (339)
                      +++........  .....||..|+|||++.+..++.++||||||+++|+|++|+.||....        ...... ....
T Consensus       162 ~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~-~i~~  230 (279)
T 2w5a_A          162 LARILNHDTSF--AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS--------QKELAG-KIRE  230 (279)
T ss_dssp             HHHHC---CHH--HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHH-HHHH
T ss_pred             hheeecccccc--ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC--------HHHHHH-HHhh
Confidence            98876543321  113468999999999998899999999999999999999999975321        111111 1111


Q ss_pred             CcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 019536          280 NRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLR  332 (339)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~  332 (339)
                      +...             +.+...+..+.+++.+||+.||++|||+.++++.+.
T Consensus       231 ~~~~-------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~  270 (279)
T 2w5a_A          231 GKFR-------------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL  270 (279)
T ss_dssp             TCCC-------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred             cccc-------------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence            1110             011134567999999999999999999999998654

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.7e-45  Score=331.61  Aligned_cols=250  Identities=19%  Similarity=0.256  Sum_probs=201.9

Q ss_pred             HHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 019536           52 KATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLV  131 (339)
Q Consensus        52 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  131 (339)
                      ...++|++.+.||+|+||+||+|.+..+|+.||+|.+....   ..+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  102 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES---DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV  102 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS---CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH---HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence            34578999999999999999999999899999999997653   346678999999999999999999999999999999


Q ss_pred             EEeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCC
Q 019536          132 FESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE  208 (339)
Q Consensus       132 ~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~  208 (339)
                      |||+++|+|.+++.   ..+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||++.......
T Consensus       103 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  179 (314)
T 3com_A          103 MEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM  179 (314)
T ss_dssp             EECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred             eecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence            99999999999875   57899999999999999999999   8999999999999999999999999999998765432


Q ss_pred             ceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccC
Q 019536          209 THVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDP  288 (339)
Q Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (339)
                      ..  .....||..|+|||++.+..++.++||||||+++|+|++|+.||....        ............        
T Consensus       180 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~~--------  241 (314)
T 3com_A          180 AK--RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH--------PMRAIFMIPTNP--------  241 (314)
T ss_dssp             SC--BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHSC--------
T ss_pred             cc--cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHhcCC--------
Confidence            22  123568999999999998899999999999999999999999985221        111111111110        


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          289 IFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                          ...+..+...+..+.+|+.+||+.||++|||+.++++
T Consensus       242 ----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          242 ----PPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             ----CCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ----CcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence                0111122345567999999999999999999999986

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=9e-46  Score=338.74  Aligned_cols=271  Identities=18%  Similarity=0.217  Sum_probs=200.4

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC-hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeC-------
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST-LDDVEYCFNNIVFSSQMKHKNILKLIGCCLET-------  125 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~-------  125 (339)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++..... ......+.+|+.+++.++||||+++++++...       
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            4789999999999999999999998999999999866533 23345677999999999999999999999873       


Q ss_pred             -CccEEEEEeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCc
Q 019536          126 -ELPTLVFESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLS  201 (339)
Q Consensus       126 -~~~~lv~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a  201 (339)
                       +..++||||+++ +|.+.+.   ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||++
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  171 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA  171 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence             467999999975 5555543   46899999999999999999999   899999999999999999999999999999


Q ss_pred             cccCCCCce--eeeccccccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhh
Q 019536          202 VSIPEGETH--VREEFIKGAYGFIAPEYFAT-SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIE  278 (339)
Q Consensus       202 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  278 (339)
                      +.+......  .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....  .......+........
T Consensus       172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--~~~~~~~i~~~~~~~~  249 (351)
T 3mi9_A          172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT--EQHQLALISQLCGSIT  249 (351)
T ss_dssp             EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCCCC
T ss_pred             ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHHhCCCC
Confidence            876532211  11223568999999999876 458999999999999999999999975321  1111111111111111


Q ss_pred             cCcccccccCcccCCC-----CCCCcHH------HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          279 NNRFGAIVDPIFDEDN-----SFPGKEE------KLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       279 ~~~~~~~~~~~~~~~~-----~~~~~~~------~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      ...+..+.........     ..+....      .+..+.+|+.+||+.||++|||+.|++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence            1111111000000000     0000001      13568899999999999999999999873

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.7e-45  Score=326.58  Aligned_cols=256  Identities=19%  Similarity=0.227  Sum_probs=205.2

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCCh-----hhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTL-----DDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPT  129 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~  129 (339)
                      ++|++.+.||+|+||+||+|.+..+++.||+|.+......     ...+.+.+|+.+++.++||||+++++++.+++..+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            5799999999999999999999989999999998765321     23677889999999999999999999999999999


Q ss_pred             EEEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCC----ceEEecCCCccc
Q 019536          130 LVFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENY----SAKLHDFSLSVS  203 (339)
Q Consensus       130 lv~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~----~~kl~dfg~a~~  203 (339)
                      +||||+++++|.+++.  ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++    .+||+|||++..
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~  161 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK  161 (283)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred             EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence            9999999999999986  57899999999999999999999   89999999999999998877    799999999987


Q ss_pred             cCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCccc
Q 019536          204 IPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFG  283 (339)
Q Consensus       204 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (339)
                      .......   ....||+.|+|||++.+..++.++||||||+++|+|++|+.||....        ....... ...... 
T Consensus       162 ~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~-~~~~~~-  228 (283)
T 3bhy_A          162 IEAGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET--------KQETLTN-ISAVNY-  228 (283)
T ss_dssp             CC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHH-HHTTCC-
T ss_pred             ccCCCcc---cccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc--------hHHHHHH-hHhccc-
Confidence            6543322   13468999999999998899999999999999999999999975321        1111111 111100 


Q ss_pred             ccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHHHHH
Q 019536          284 AIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK--QLRQMY  335 (339)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~--~L~~l~  335 (339)
                               ....+.....+..+.+|+.+||+.||++|||+.++++  .++.+.
T Consensus       229 ---------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  273 (283)
T 3bhy_A          229 ---------DFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR  273 (283)
T ss_dssp             ---------CCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred             ---------CCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence                     0000000123457899999999999999999999998  345443

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-45  Score=337.27  Aligned_cols=269  Identities=19%  Similarity=0.205  Sum_probs=197.0

Q ss_pred             HHHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChh----hHHHHHHHHHHHHhcCCCceeeeeeeeeeCC
Q 019536           51 KKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLD----DVEYCFNNIVFSSQMKHKNILKLIGCCLETE  126 (339)
Q Consensus        51 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~  126 (339)
                      ....++|++.+.||+|+||.||+|.+..+|+.||+|++.......    ....+.+|+.+++.++||||+++++++.+.+
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (346)
T 1ua2_A            6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS   85 (346)
T ss_dssp             -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence            345688999999999999999999999899999999987643211    1245779999999999999999999999999


Q ss_pred             ccEEEEEeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccc
Q 019536          127 LPTLVFESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVS  203 (339)
Q Consensus       127 ~~~lv~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~  203 (339)
                      ..++||||+++ +|.+++.   ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus        86 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (346)
T 1ua2_A           86 NISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKS  161 (346)
T ss_dssp             CCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred             ceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence            99999999986 7777765   35888899999999999999999   89999999999999999999999999999987


Q ss_pred             cCCCCceeeecccccccccccccccccC-CCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhh---c
Q 019536          204 IPEGETHVREEFIKGAYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIE---N  279 (339)
Q Consensus       204 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~  279 (339)
                      +.......  ....||+.|+|||++.+. .++.++|||||||++|+|++|.+||....  .   ............   .
T Consensus       162 ~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~--~---~~~~~~i~~~~~~~~~  234 (346)
T 1ua2_A          162 FGSPNRAY--THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS--D---LDQLTRIFETLGTPTE  234 (346)
T ss_dssp             TTSCCCCC--CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS--H---HHHHHHHHHHHCCCCT
T ss_pred             ccCCcccC--CcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCC--H---HHHHHHHHHHcCCCCh
Confidence            65433221  135689999999999764 58999999999999999999999975321  1   111111111111   1


Q ss_pred             Cccccc---ccCcccCC-CCCCC---cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          280 NRFGAI---VDPIFDED-NSFPG---KEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       280 ~~~~~~---~~~~~~~~-~~~~~---~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      ..+...   .+...... ...|.   ....+..+.+|+.+||+.||++|||+.|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          235 EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             TTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            111110   00000000 00000   01335689999999999999999999999864

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=3.7e-45  Score=331.59  Aligned_cols=260  Identities=19%  Similarity=0.170  Sum_probs=206.7

Q ss_pred             cHHHHHHHhcCcccC-CceeccCCeeEEEEEEcCCCeeEEEEEeccCCC-hhhHHHHHHHHHHHHhc-CCCceeeeeeee
Q 019536           46 SAKDLKKATNNYDLH-KVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST-LDDVEYCFNNIVFSSQM-KHKNILKLIGCC  122 (339)
Q Consensus        46 ~~~~~~~~~~~~~~~-~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~~~~~~  122 (339)
                      .++......+.|.+. +.||+|+||+||+|.+..+++.||+|++..... ......+.+|+.++..+ +||||+++++++
T Consensus        19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~   98 (327)
T 3lm5_A           19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY   98 (327)
T ss_dssp             CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred             HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence            334445666788887 889999999999999999999999999876432 24467788999999999 569999999999


Q ss_pred             eeCCccEEEEEeccCCccccccc----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCC---CCceEE
Q 019536          123 LETELPTLVFESVKYGTLRGFSF----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDE---NYSAKL  195 (339)
Q Consensus       123 ~~~~~~~lv~e~~~~g~L~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~---~~~~kl  195 (339)
                      .+.+..++||||+++|+|.+++.    ..+++..++.++.|++.||.|||   +.+|+||||||+||+++.   ++.+||
T Consensus        99 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~~kL  175 (327)
T 3lm5_A           99 ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKI  175 (327)
T ss_dssp             ECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCCEEE
T ss_pred             EeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCcEEE
Confidence            99999999999999999999874    46889999999999999999999   899999999999999987   789999


Q ss_pred             ecCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHH
Q 019536          196 HDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKK  275 (339)
Q Consensus       196 ~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  275 (339)
                      +|||+++........   ....||+.|+|||++.+..++.++||||||+++|+|++|+.||.....        ......
T Consensus       176 ~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~  244 (327)
T 3lm5_A          176 VDFGMSRKIGHACEL---REIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN--------QETYLN  244 (327)
T ss_dssp             CCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHH
T ss_pred             eeCccccccCCcccc---ccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--------hHHHHH
Confidence            999999876543321   135689999999999999999999999999999999999999853211        111111


Q ss_pred             HhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          276 SIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      .. ....          ....+.....+..+.+|+.+||+.||++|||+.+++++
T Consensus       245 i~-~~~~----------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          245 IS-QVNV----------DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             HH-HTCC----------CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             HH-hccc----------ccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence            11 1000          00111112445679999999999999999999999863

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.6e-45  Score=326.98  Aligned_cols=244  Identities=14%  Similarity=0.182  Sum_probs=200.3

Q ss_pred             HhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC-ChhhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCccEE
Q 019536           53 ATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS-TLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLETELPTL  130 (339)
Q Consensus        53 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~~l  130 (339)
                      ..++|++.+.||+|+||+||+|.+..+++.||+|++.... .......+.+|+..+..+ +||||+++++++.+++..++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            4578999999999999999999999899999999998653 234567788999999999 99999999999999999999


Q ss_pred             EEEeccCCccccccc------cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCC--------------
Q 019536          131 VFESVKYGTLRGFSF------ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDEN--------------  190 (339)
Q Consensus       131 v~e~~~~g~L~~~~~------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~--------------  190 (339)
                      ||||+++|+|.+++.      ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.+              
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC----------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence            999999999999986      45899999999999999999999   8999999999999999844              


Q ss_pred             -----CceEEecCCCccccCCCCceeeecccccccccccccccccC-CCCcccchHHHHHHHHHHHhCCCccccCCCCCC
Q 019536          191 -----YSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGND  264 (339)
Q Consensus       191 -----~~~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~  264 (339)
                           ..+||+|||.+........      ..||..|+|||++.+. .++.++|||||||++|+|++|.+|+...     
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~~~------~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-----  234 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSPQV------EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG-----  234 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCSCC------CCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS-----
T ss_pred             ccCCceEEEEcccccccccCCccc------cCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch-----
Confidence                 4799999999987654332      3589999999999876 5678999999999999999998775311     


Q ss_pred             CchhHHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          265 DDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                         ....    ........           ..  +...+..+.+|+.+||+.||++|||+.+++++
T Consensus       235 ---~~~~----~~~~~~~~-----------~~--~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  280 (289)
T 1x8b_A          235 ---DQWH----EIRQGRLP-----------RI--PQVLSQEFTELLKVMIHPDPERRPSAMALVKH  280 (289)
T ss_dssp             ---HHHH----HHHTTCCC-----------CC--SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             ---hHHH----HHHcCCCC-----------CC--CcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence               1111    11111110           01  11345679999999999999999999999863

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=2.8e-45  Score=333.48  Aligned_cols=250  Identities=19%  Similarity=0.275  Sum_probs=207.9

Q ss_pred             HhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC--ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 019536           53 ATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS--TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTL  130 (339)
Q Consensus        53 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  130 (339)
                      ..++|.+.+.||+|+||.||++.+..+++.||+|++....  .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  118 (335)
T 2owb_A           39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV  118 (335)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence            3478999999999999999999999999999999987642  23456778899999999999999999999999999999


Q ss_pred             EEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCC
Q 019536          131 VFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE  208 (339)
Q Consensus       131 v~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~  208 (339)
                      ||||+++++|.+++.  ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++......
T Consensus       119 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  195 (335)
T 2owb_A          119 VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  195 (335)
T ss_dssp             EECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             EEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence            999999999999876  57899999999999999999999   8999999999999999999999999999998765433


Q ss_pred             ceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccC
Q 019536          209 THVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDP  288 (339)
Q Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (339)
                      ...  ....||..|+|||++.+..++.++||||||+++|+|++|+.||....        ..+...... ....      
T Consensus       196 ~~~--~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~~~~~~~~~-~~~~------  258 (335)
T 2owb_A          196 ERK--KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC--------LKETYLRIK-KNEY------  258 (335)
T ss_dssp             CCB--CCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHH-HTCC------
T ss_pred             ccc--cccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC--------HHHHHHHHh-cCCC------
Confidence            221  23568999999999999899999999999999999999999985221        111111111 1110      


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          289 IFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                            ..|  ...+..+.+|+.+||+.||++|||+.+++++
T Consensus       259 ------~~~--~~~~~~~~~li~~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          259 ------SIP--KHINPVAASLIQKMLQTDPTARPTINELLND  292 (335)
T ss_dssp             ------CCC--TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             ------CCC--ccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                  111  1334578999999999999999999999873

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=3.3e-45  Score=336.81  Aligned_cols=256  Identities=23%  Similarity=0.326  Sum_probs=206.3

Q ss_pred             HHHHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCCh-------hhHHHHHHHHHHHHhc-CCCceeeeeee
Q 019536           50 LKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTL-------DDVEYCFNNIVFSSQM-KHKNILKLIGC  121 (339)
Q Consensus        50 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~e~~~l~~l-~H~niv~~~~~  121 (339)
                      .....++|.+.+.||+|+||.||+|.+..+|+.||||++......       ...+.+.+|+.+++.+ .||||++++++
T Consensus        89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  168 (365)
T 2y7j_A           89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS  168 (365)
T ss_dssp             HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence            344557899999999999999999999889999999998765321       1245677999999999 79999999999


Q ss_pred             eeeCCccEEEEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCC
Q 019536          122 CLETELPTLVFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFS  199 (339)
Q Consensus       122 ~~~~~~~~lv~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg  199 (339)
                      +...+..++||||+++++|.+++.  ..+++..+..++.|++.||.|||   +.+|+|+||||+||+++.++.+||+|||
T Consensus       169 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ikl~DfG  245 (365)
T 2y7j_A          169 YESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFG  245 (365)
T ss_dssp             EEBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             EeeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEEecC
Confidence            999999999999999999999886  57899999999999999999999   8999999999999999999999999999


Q ss_pred             CccccCCCCceeeeccccccccccccccccc------CCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHH
Q 019536          200 LSVSIPEGETHVREEFIKGAYGFIAPEYFAT------SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYA  273 (339)
Q Consensus       200 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~  273 (339)
                      ++..+......   ....||+.|+|||++.+      ..++.++|||||||++|+|++|+.||....        .....
T Consensus       246 ~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~--------~~~~~  314 (365)
T 2y7j_A          246 FSCHLEPGEKL---RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR--------QILML  314 (365)
T ss_dssp             TCEECCTTCCB---CCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHH
T ss_pred             cccccCCCccc---ccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC--------HHHHH
Confidence            99877554322   13578999999999864      358899999999999999999999985211        11111


Q ss_pred             HHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          274 KKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      .. .......          ...|.....+..+.+|+.+||+.||++|||+.+++++
T Consensus       315 ~~-i~~~~~~----------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  360 (365)
T 2y7j_A          315 RM-IMEGQYQ----------FSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH  360 (365)
T ss_dssp             HH-HHHTCCC----------CCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HH-HHhCCCC----------CCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            11 1111100          0000011234579999999999999999999999873

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.7e-46  Score=341.51  Aligned_cols=262  Identities=16%  Similarity=0.201  Sum_probs=205.0

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcC--------CCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceee--------
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVD--------QDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILK--------  117 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~--------  117 (339)
                      .++|.+.+.||+|+||+||+|.+..        .++.||+|.+...      +.+.+|+.+++.++||||++        
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~  114 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYST  114 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhccC
Confidence            3689999999999999999999986        4889999998754      35678999999999999988        


Q ss_pred             -------eeeeeee-CCccEEEEEeccCCccccccc----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCE
Q 019536          118 -------LIGCCLE-TELPTLVFESVKYGTLRGFSF----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNV  185 (339)
Q Consensus       118 -------~~~~~~~-~~~~~lv~e~~~~g~L~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Ni  185 (339)
                             +++++.. ++..++||||+ +++|.+++.    ..+++..++.++.|++.||.|||   +.+|+||||||+||
T Consensus       115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NI  190 (352)
T 2jii_A          115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENI  190 (352)
T ss_dssp             TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGGGE
T ss_pred             CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHE
Confidence                   5677765 67789999999 999999986    45899999999999999999999   89999999999999


Q ss_pred             EeCCCC--ceEEecCCCccccCCCCcee-----eecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCcccc
Q 019536          186 LLDENY--SAKLHDFSLSVSIPEGETHV-----REEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEF  258 (339)
Q Consensus       186 l~~~~~--~~kl~dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~  258 (339)
                      +++.++  .+||+|||+++.+.......     ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus       191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  270 (352)
T 2jii_A          191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN  270 (352)
T ss_dssp             EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred             EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            999988  89999999998765432111     11234689999999999998999999999999999999999999864


Q ss_pred             CCCCCCCchhHHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          259 KGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                      .....   ............ . ...+....       ......+..+.+|+.+||+.||++|||+.++++.|+++..+
T Consensus       271 ~~~~~---~~~~~~~~~~~~-~-~~~~~~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  337 (352)
T 2jii_A          271 CLPNT---EDIMKQKQKFVD-K-PGPFVGPC-------GHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQD  337 (352)
T ss_dssp             GTTCH---HHHHHHHHHHHH-S-CCCEECTT-------SCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             CCcCH---HHHHHHHHhccC-C-hhhhhhhc-------cccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHh
Confidence            43211   111111111111 1 11111100       00112346799999999999999999999999999999864

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=7.4e-46  Score=365.68  Aligned_cols=249  Identities=20%  Similarity=0.257  Sum_probs=206.1

Q ss_pred             HhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC--ChhhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCccE
Q 019536           53 ATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS--TLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLETELPT  129 (339)
Q Consensus        53 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~~  129 (339)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++....  .....+.+.+|..++..+ +||||+++++++.+.+.+|
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            4578999999999999999999999999999999987531  123456678899999887 7999999999999999999


Q ss_pred             EEEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCC
Q 019536          130 LVFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEG  207 (339)
Q Consensus       130 lv~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~  207 (339)
                      +||||+++|+|.+++.  ..+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+|+.....
T Consensus       419 lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~  495 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD  495 (674)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCT
T ss_pred             EEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceeeccccC
Confidence            9999999999999987  67899999999999999999999   899999999999999999999999999999864433


Q ss_pred             CceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCccccccc
Q 019536          208 ETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVD  287 (339)
Q Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (339)
                      ...  .....||+.|+|||++.+..|+.++|||||||++|||++|+.||....        ..+.......         
T Consensus       496 ~~~--~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~--------~~~~~~~i~~---------  556 (674)
T 3pfq_A          496 GVT--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED--------EDELFQSIME---------  556 (674)
T ss_dssp             TCC--BCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHS---------
T ss_pred             Ccc--cccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC--------HHHHHHHHHh---------
Confidence            222  224679999999999999999999999999999999999999985321        1111111111         


Q ss_pred             CcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCH-----HHHHH
Q 019536          288 PIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLM-----VDVAK  329 (339)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~-----~~il~  329 (339)
                          ....+|  ...+.++.+||.+||+.||++||++     .+|++
T Consensus       557 ----~~~~~p--~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          557 ----HNVAYP--KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             ----SCCCCC--TTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             ----CCCCCC--ccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence                111222  2456689999999999999999997     66654

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=7.7e-46  Score=330.03  Aligned_cols=258  Identities=21%  Similarity=0.330  Sum_probs=198.8

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcC-CC--eeEEEEEeccCC--ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCcc
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVD-QD--RPISVMKFHDNS--TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELP  128 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~-~~--~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~  128 (339)
                      .++|++.+.||+|+||+||+|.+.. ++  ..||+|++....  .....+.+.+|+.+++.++||||+++++++.+++ .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            3689999999999999999998743 22  369999987652  2245677889999999999999999999998765 7


Q ss_pred             EEEEEeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccC
Q 019536          129 TLVFESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIP  205 (339)
Q Consensus       129 ~lv~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~  205 (339)
                      ++||||+++|+|.+++.   ..+++..+..++.|++.||.|||   +.+|+|+||||+||+++.++.+||+|||+++...
T Consensus        96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  172 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP  172 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence            89999999999999886   46899999999999999999999   8999999999999999999999999999998775


Q ss_pred             CCCcee-eecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCccc
Q 019536          206 EGETHV-REEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFG  283 (339)
Q Consensus       206 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (339)
                      ...... ......+|..|+|||++.+..++.++||||||+++|+|++ |+.||....        ............   
T Consensus       173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--------~~~~~~~~~~~~---  241 (291)
T 1u46_A          173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN--------GSQILHKIDKEG---  241 (291)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHHHHHHTSC---
T ss_pred             ccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC--------HHHHHHHHHccC---
Confidence            543321 2223457788999999998889999999999999999999 999975221        111111111110   


Q ss_pred             ccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 019536          284 AIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYL  336 (339)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~  336 (339)
                                ...+.+...+..+.+++.+||+.||++|||+.++++.|+++..
T Consensus       242 ----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          242 ----------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             ----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             ----------CCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence                      1112223455679999999999999999999999999998764

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=5.8e-46  Score=341.96  Aligned_cols=263  Identities=17%  Similarity=0.203  Sum_probs=187.2

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeC------C
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS-TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLET------E  126 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~------~  126 (339)
                      .++|++.+.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+++.++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            378999999999999999999999999999999997643 334567788999999999999999999998754      5


Q ss_pred             ccEEEEEeccCCccccccc-cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccC
Q 019536          127 LPTLVFESVKYGTLRGFSF-ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIP  205 (339)
Q Consensus       127 ~~~lv~e~~~~g~L~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~  205 (339)
                      ..++|+|++ +++|.+++. ..+++..+..++.||+.||.|||   +.+|+||||||+||+++.++.+||+|||+++...
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~  183 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTA  183 (367)
T ss_dssp             CCEEEEECC-CEECC-----CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC--------
T ss_pred             eEEEEeccc-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence            579999999 789988876 57899999999999999999999   8999999999999999999999999999998754


Q ss_pred             CCCceeeeccccccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhc---Cc
Q 019536          206 EGETHVREEFIKGAYGFIAPEYFAT-SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIEN---NR  281 (339)
Q Consensus       206 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~  281 (339)
                      ....     ...||..|+|||++.+ ..++.++||||+||++|+|++|+.||...  ..   .............   ..
T Consensus       184 ~~~~-----~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~--~~---~~~l~~i~~~~g~p~~~~  253 (367)
T 2fst_X          184 DEMT-----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT--DH---IDQLKLILRLVGTPGAEL  253 (367)
T ss_dssp             ------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCS--SH---HHHHHHHHHHHCSCCHHH
T ss_pred             ccCC-----CcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCC--CH---HHHHHHHHHHhCCCCHHH
Confidence            3221     3568999999999887 67999999999999999999999997532  11   1111111111100   00


Q ss_pred             ccccccC-------cccCCCCCCCc---HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          282 FGAIVDP-------IFDEDNSFPGK---EEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       282 ~~~~~~~-------~~~~~~~~~~~---~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      +..+...       .+......+..   ...+..+.+|+.+||+.||++|||+.+++++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          254 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             HTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence            0000000       00000000000   1234578999999999999999999999863

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=2.7e-45  Score=337.36  Aligned_cols=268  Identities=16%  Similarity=0.158  Sum_probs=204.9

Q ss_pred             HhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeC-----Cc
Q 019536           53 ATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLET-----EL  127 (339)
Q Consensus        53 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~-----~~  127 (339)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+|+.+++.++||||+++++++...     ..
T Consensus        25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  104 (364)
T 3qyz_A           25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD  104 (364)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence            3578999999999999999999999999999999998765555667889999999999999999999999765     35


Q ss_pred             cEEEEEeccCCccccccc-cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCC
Q 019536          128 PTLVFESVKYGTLRGFSF-ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPE  206 (339)
Q Consensus       128 ~~lv~e~~~~g~L~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~  206 (339)
                      .++||||++ |+|.+++. ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus       105 ~~iv~e~~~-~~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~  180 (364)
T 3qyz_A          105 VYIVQDLME-TDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP  180 (364)
T ss_dssp             EEEEEECCS-EEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred             EEEEEcccC-cCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcceEecCC
Confidence            799999997 58888776 67899999999999999999999   89999999999999999999999999999987654


Q ss_pred             CCcee-eeccccccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCc---
Q 019536          207 GETHV-REEFIKGAYGFIAPEYFAT-SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNR---  281 (339)
Q Consensus       207 ~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---  281 (339)
                      ..... ......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||....  ..   ..............   
T Consensus       181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--~~---~~~~~i~~~~~~~~~~~  255 (364)
T 3qyz_A          181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH--YL---DQLNHILGILGSPSQED  255 (364)
T ss_dssp             GGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSS--GG---GHHHHHHHHHCSCCHHH
T ss_pred             CCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCC--hH---HHHHHHHHHhCCCCHHH
Confidence            32211 1123468999999998754 458999999999999999999999975322  11   12221111110000   


Q ss_pred             cccccc-------CcccCCCCCCC---cHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          282 FGAIVD-------PIFDEDNSFPG---KEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       282 ~~~~~~-------~~~~~~~~~~~---~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                      +..+.+       .........+.   ....+..+.+|+.+||+.||++|||+.++++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            000000       00000000000   0123567899999999999999999999986

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=5.5e-45  Score=358.45  Aligned_cols=262  Identities=25%  Similarity=0.329  Sum_probs=209.4

Q ss_pred             HHHHHhcCcccCCceeccCCeeEEEEEEcC---CCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeC
Q 019536           49 DLKKATNNYDLHKVIQSDTSYRLFEGTLVD---QDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLET  125 (339)
Q Consensus        49 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~  125 (339)
                      ++....++|++.+.||+|+||+||+|.+..   .+..||+|++.........+.+.+|+.+++.++||||+++++++.+ 
T Consensus       384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-  462 (656)
T 2j0j_A          384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-  462 (656)
T ss_dssp             GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-
Confidence            344445789999999999999999999864   3567999998876655666789999999999999999999999854 


Q ss_pred             CccEEEEEeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCcc
Q 019536          126 ELPTLVFESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSV  202 (339)
Q Consensus       126 ~~~~lv~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~  202 (339)
                      +..++||||+++|+|.+++.   ..+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus       463 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a~  539 (656)
T 2j0j_A          463 NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR  539 (656)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred             CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCCe
Confidence            56899999999999999986   35888899999999999999999   8999999999999999999999999999998


Q ss_pred             ccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCc
Q 019536          203 SIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNR  281 (339)
Q Consensus       203 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (339)
                      ......... .....+|+.|+|||++.+..++.++|||||||++|||++ |..||....        ..+..........
T Consensus       540 ~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~--------~~~~~~~i~~~~~  610 (656)
T 2j0j_A          540 YMEDSTYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK--------NNDVIGRIENGER  610 (656)
T ss_dssp             SCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHHHHHHHTCC
T ss_pred             ecCCCccee-ccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCC--------HHHHHHHHHcCCC
Confidence            765443222 223456788999999998999999999999999999997 999975221        1111111111110


Q ss_pred             ccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          282 FGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                                    .+.+..++..+.+|+.+||+.||++|||+.++++.|+++.++
T Consensus       611 --------------~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~  652 (656)
T 2j0j_A          611 --------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  652 (656)
T ss_dssp             --------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --------------CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence                          111224456799999999999999999999999999999754

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.7e-45  Score=329.71  Aligned_cols=251  Identities=16%  Similarity=0.232  Sum_probs=200.3

Q ss_pred             HhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 019536           53 ATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVF  132 (339)
Q Consensus        53 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  132 (339)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   95 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE-EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI   95 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH-HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence            34789999999999999999999998999999999876543 55678889999999999999999999999999999999


Q ss_pred             EeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCc
Q 019536          133 ESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGET  209 (339)
Q Consensus       133 e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~  209 (339)
                      ||+++++|.+++.   ..+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++........
T Consensus        96 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  172 (302)
T 2j7t_A           96 EFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ  172 (302)
T ss_dssp             ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH
T ss_pred             EeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCcccccccc
Confidence            9999999998865   56899999999999999999999   89999999999999999999999999998754322111


Q ss_pred             eeeecccccccccccccccc-----cCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccc
Q 019536          210 HVREEFIKGAYGFIAPEYFA-----TSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA  284 (339)
Q Consensus       210 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (339)
                        ......||..|+|||++.     +..++.++||||||+++|+|++|+.||....        .............   
T Consensus       173 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~~~---  239 (302)
T 2j7t_A          173 --KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN--------PMRVLLKIAKSDP---  239 (302)
T ss_dssp             --C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHSCC---
T ss_pred             --ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC--------HHHHHHHHhccCC---
Confidence              111346899999999983     5678899999999999999999999975321        1111111111110   


Q ss_pred             cccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                               .....+...+..+.+|+.+||+.||++|||+.++++
T Consensus       240 ---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          240 ---------PTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             ---------CCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             ---------cccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence                     011122345667999999999999999999999986

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=8.9e-46  Score=329.43  Aligned_cols=249  Identities=16%  Similarity=0.224  Sum_probs=187.5

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHH-HHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCF-NNIVFSSQMKHKNILKLIGCCLETELPTLVF  132 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~-~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  132 (339)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++...........+. ++...++.++||||+++++++.+++..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            478999999999999999999999999999999998764434444444 4455678889999999999999999999999


Q ss_pred             EeccCCccccccc------cCCChHHHHHHHHHHHHHHHHHhcCCCC-CeEEccCCCCCEEeCCCCceEEecCCCccccC
Q 019536          133 ESVKYGTLRGFSF------ASLLIAPRIKIAMEIANAVAYLHVGFDR-PIVFRCIKASNVLLDENYSAKLHDFSLSVSIP  205 (339)
Q Consensus       133 e~~~~g~L~~~~~------~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~  205 (339)
                      ||++ |+|.+++.      ..+++..+..++.|++.||.|||   +. +|+||||||+||+++.++.+||+|||+++...
T Consensus        86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            9997 47766653      47899999999999999999999   77 99999999999999999999999999998765


Q ss_pred             CCCceeeeccccccccccccccc----ccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCc
Q 019536          206 EGETHVREEFIKGAYGFIAPEYF----ATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNR  281 (339)
Q Consensus       206 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (339)
                      .....   ....||+.|+|||++    .+..++.++||||+|+++|+|++|+.||...+.       .............
T Consensus       162 ~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~  231 (290)
T 3fme_A          162 DDVAK---DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT-------PFQQLKQVVEEPS  231 (290)
T ss_dssp             -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC-------HHHHHHHHHHSCC
T ss_pred             ccccc---cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc-------hHHHHHHHhccCC
Confidence            43322   134689999999996    456789999999999999999999999853221       1111111111111


Q ss_pred             ccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          282 FGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                      .            ..+ ....+..+.+|+.+||+.||++|||+.++++
T Consensus       232 ~------------~~~-~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          232 P------------QLP-ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             C------------CCC-TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             C------------Ccc-cccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence            0            001 1134567999999999999999999999987

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=5.9e-45  Score=324.91  Aligned_cols=249  Identities=21%  Similarity=0.290  Sum_probs=197.4

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFES  134 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  134 (339)
                      ++|.....||+|+||+||+|.+..+++.||+|.+..... ...+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  100 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS-RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQ  100 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC----HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch-HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEe
Confidence            445556699999999999999998999999999977643 4567788999999999999999999999999999999999


Q ss_pred             ccCCcccccccc-----CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCC-CCceEEecCCCccccCCCC
Q 019536          135 VKYGTLRGFSFA-----SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDE-NYSAKLHDFSLSVSIPEGE  208 (339)
Q Consensus       135 ~~~g~L~~~~~~-----~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~-~~~~kl~dfg~a~~~~~~~  208 (339)
                      +++++|.+++..     .+++..+..++.|++.||.|||   +.+|+|+||||+||+++. ++.+||+|||+++......
T Consensus       101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~  177 (295)
T 2clq_A          101 VPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN  177 (295)
T ss_dssp             CSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred             CCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence            999999998762     3457778889999999999999   899999999999999987 8999999999998765432


Q ss_pred             ceeeecccccccccccccccccCC--CCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccc
Q 019536          209 THVREEFIKGAYGFIAPEYFATSS--FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIV  286 (339)
Q Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (339)
                      ..  .....||+.|+|||++.+..  ++.++||||||+++|+|++|+.||...+..     .  ...........     
T Consensus       178 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~--~~~~~~~~~~~-----  243 (295)
T 2clq_A          178 PC--TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP-----Q--AAMFKVGMFKV-----  243 (295)
T ss_dssp             -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH-----H--HHHHHHHHHCC-----
T ss_pred             Cc--ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCch-----h--HHHHhhccccc-----
Confidence            21  12356899999999997654  889999999999999999999998532211     0  00000000000     


Q ss_pred             cCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          287 DPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                      .+      .  .+...+..+.+|+.+||+.||++|||+.++++
T Consensus       244 ~~------~--~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          244 HP------E--IPESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             CC------C--CCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             cc------c--ccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            00      1  11234567899999999999999999999986

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=2e-45  Score=324.94  Aligned_cols=248  Identities=25%  Similarity=0.293  Sum_probs=197.3

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC--ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS--TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLV  131 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  131 (339)
                      .++|.+.+.||+|+||.||+|.+..+++.||+|++....  .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            378999999999999999999999899999999986532  113356788999999999999999999999999999999


Q ss_pred             EEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCc
Q 019536          132 FESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGET  209 (339)
Q Consensus       132 ~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~  209 (339)
                      |||+++++|.+++.  ..++...+..++.|++.||.|||   +.+|+|+||||+||+++.++.+||+|||++........
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  166 (276)
T 2h6d_A           90 MEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF  166 (276)
T ss_dssp             EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---
T ss_pred             EeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccccCCCcc
Confidence            99999999999986  57889999999999999999999   89999999999999999999999999999987654332


Q ss_pred             eeeecccccccccccccccccCCC-CcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccC
Q 019536          210 HVREEFIKGAYGFIAPEYFATSSF-NEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDP  288 (339)
Q Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (339)
                      .   ....+|+.|+|||.+.+..+ +.++||||||+++|+|++|+.||....        .... .........      
T Consensus       167 ~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~~~~-~~~~~~~~~------  228 (276)
T 2h6d_A          167 L---RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH--------VPTL-FKKIRGGVF------  228 (276)
T ss_dssp             -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHH-HHHHHHCCC------
T ss_pred             e---ecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc--------HHHH-HHHhhcCcc------
Confidence            1   13468899999999988765 689999999999999999999975211        1111 111111110      


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          289 IFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                            ..  +...+..+.+++.+||+.||++|||+.+++++
T Consensus       229 ------~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          229 ------YI--PEYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             ------CC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             ------cC--chhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                  01  11334578999999999999999999999984

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.5e-44  Score=342.96  Aligned_cols=262  Identities=15%  Similarity=0.195  Sum_probs=208.9

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCC-CceeeeeeeeeeCCccEEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKH-KNILKLIGCCLETELPTLVF  132 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H-~niv~~~~~~~~~~~~~lv~  132 (339)
                      .++|.+.+.||+|+||.||+|.+..+++.||||++......   ..+.+|+.+++.++| +++..+..++.+++..++||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm   82 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM   82 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS---CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc---HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence            47899999999999999999999989999999998765432   346789999999976 56666667777888899999


Q ss_pred             EeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEe---CCCCceEEecCCCccccCC
Q 019536          133 ESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLL---DENYSAKLHDFSLSVSIPE  206 (339)
Q Consensus       133 e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~---~~~~~~kl~dfg~a~~~~~  206 (339)
                      ||+ +++|.+++.   ..+++..++.++.||+.||.|||   +.+|+||||||+|||+   +.++.+||+|||+++.+..
T Consensus        83 e~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~  158 (483)
T 3sv0_A           83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD  158 (483)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             ECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence            999 999999875   57999999999999999999999   8999999999999999   5789999999999987765


Q ss_pred             CCcee-----eecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCc
Q 019536          207 GETHV-----REEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNR  281 (339)
Q Consensus       207 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (339)
                      .....     ......||..|+|||++.+..++.++|||||||++|+|++|+.||......  .................
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~--~~~~~~~~i~~~~~~~~  236 (483)
T 3sv0_A          159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG--TKKQKYEKISEKKVATS  236 (483)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS--SHHHHHHHHHHHHHHSC
T ss_pred             CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccch--hHHHHHHHHhhcccccc
Confidence            43221     112457899999999999999999999999999999999999998643322  12222222111111111


Q ss_pred             ccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          282 FGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                      ...+.             ..++.++.+|+..||+.||++||++.+|++.|+++...
T Consensus       237 ~~~l~-------------~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~  279 (483)
T 3sv0_A          237 IEALC-------------RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR  279 (483)
T ss_dssp             HHHHH-------------TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             HHHHh-------------cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence            10000             12345799999999999999999999999999998753

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=6e-45  Score=326.55  Aligned_cols=251  Identities=16%  Similarity=0.216  Sum_probs=198.3

Q ss_pred             HhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC---hhhHHHHHHHHHHHHhcCCCceeeeeeeee--eCCc
Q 019536           53 ATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST---LDDVEYCFNNIVFSSQMKHKNILKLIGCCL--ETEL  127 (339)
Q Consensus        53 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~~~~~~~--~~~~  127 (339)
                      ..++|.+.+.||+|+||.||+|.+..+++.||+|++.....   ......+.+|+.+++.++||||+++++++.  +.+.
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK   82 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence            45789999999999999999999998999999999875421   234577889999999999999999999984  4567


Q ss_pred             cEEEEEeccCCccccccc----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccc
Q 019536          128 PTLVFESVKYGTLRGFSF----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVS  203 (339)
Q Consensus       128 ~~lv~e~~~~g~L~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~  203 (339)
                      .++||||++++ |.+++.    ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||++..
T Consensus        83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~  158 (305)
T 2wtk_C           83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEA  158 (305)
T ss_dssp             EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeeccccccc
Confidence            89999999877 544443    56889999999999999999999   89999999999999999999999999999987


Q ss_pred             cCCCCceeeecccccccccccccccccCC--CCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCc
Q 019536          204 IPEGETHVREEFIKGAYGFIAPEYFATSS--FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNR  281 (339)
Q Consensus       204 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (339)
                      ..............||..|+|||++.+..  ++.++||||||+++|+|++|+.||....        ....... .....
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~-i~~~~  229 (305)
T 2wtk_C          159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN--------IYKLFEN-IGKGS  229 (305)
T ss_dssp             CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHH-HHHCC
T ss_pred             cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch--------HHHHHHH-HhcCC
Confidence            65433322333456899999999997644  4789999999999999999999975211        1111111 11111


Q ss_pred             ccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          282 FGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      .            ..+  ...+..+.+|+.+||+.||++|||+.+++++
T Consensus       230 ~------------~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          230 Y------------AIP--GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             C------------CCC--SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             C------------CCC--CccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            0            111  1344578999999999999999999999974

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=4.7e-45  Score=338.79  Aligned_cols=266  Identities=15%  Similarity=0.197  Sum_probs=201.8

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcC--------CCceeeeeeeee--
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMK--------HKNILKLIGCCL--  123 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~--------H~niv~~~~~~~--  123 (339)
                      .++|++.+.||+|+||+||+|.+..+++.||||++...  ....+.+.+|+.+++.++        |+||+++++++.  
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~  113 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA--EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS  113 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC--CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence            47899999999999999999999999999999999754  244567889999999986        788999999998  


Q ss_pred             --eCCccEEEEEeccCCccccccc----cCCChHHHHHHHHHHHHHHHHHhcCCCC-CeEEccCCCCCEEeCCCC-----
Q 019536          124 --ETELPTLVFESVKYGTLRGFSF----ASLLIAPRIKIAMEIANAVAYLHVGFDR-PIVFRCIKASNVLLDENY-----  191 (339)
Q Consensus       124 --~~~~~~lv~e~~~~g~L~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~i~H~dlk~~Nil~~~~~-----  191 (339)
                        ++...++||||+. ++|.+.+.    ..+++..+..++.||+.||.|||   +. +|+||||||+|||++.++     
T Consensus       114 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~~~~~  189 (397)
T 1wak_A          114 GVNGTHICMVFEVLG-HHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQYIRR  189 (397)
T ss_dssp             ETTEEEEEEEECCCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHHHHHH
T ss_pred             CCCCceEEEEEeccC-ccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccchhhhh
Confidence              5567899999995 45544443    35899999999999999999999   77 999999999999998775     


Q ss_pred             --------------------------------------------ceEEecCCCccccCCCCceeeecccccccccccccc
Q 019536          192 --------------------------------------------SAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEY  227 (339)
Q Consensus       192 --------------------------------------------~~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~  227 (339)
                                                                  .+||+|||+++.......     ...||+.|+|||+
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~-----~~~gt~~y~aPE~  264 (397)
T 1wak_A          190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFT-----EDIQTRQYRSLEV  264 (397)
T ss_dssp             HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSC-----SCCSCGGGCCHHH
T ss_pred             hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCc-----cCCCCCcccCChh
Confidence                                                        799999999987654322     3468999999999


Q ss_pred             cccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCc-hhHHHHHHHHhhc--------Ccc-cccccC-----cccC
Q 019536          228 FATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDD-LTVLEYAKKSIEN--------NRF-GAIVDP-----IFDE  292 (339)
Q Consensus       228 ~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~--------~~~-~~~~~~-----~~~~  292 (339)
                      +.+..++.++|||||||++|+|++|+.||.......... .............        ... ..++..     .+..
T Consensus       265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  344 (397)
T 1wak_A          265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK  344 (397)
T ss_dssp             HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred             hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence            999999999999999999999999999986433322111 1111111111000        000 000000     0000


Q ss_pred             CC----------CCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          293 DN----------SFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       293 ~~----------~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      ..          ....+...+..+.+|+.+||+.||++|||+.|++++
T Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  392 (397)
T 1wak_A          345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH  392 (397)
T ss_dssp             CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred             cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence            00          011234667889999999999999999999999863

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.5e-45  Score=338.86  Aligned_cols=262  Identities=18%  Similarity=0.226  Sum_probs=194.5

Q ss_pred             HHHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeee------
Q 019536           51 KKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLE------  124 (339)
Q Consensus        51 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~------  124 (339)
                      ....++|++.+.||+|+||+||+|.+..+|+.||+|++.....     ...+|+.+++.++||||+++++++..      
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~   77 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP   77 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-----hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence            4556899999999999999999999999999999999876532     12379999999999999999999854      


Q ss_pred             --------------------------------CCccEEEEEeccCCccccccc------cCCChHHHHHHHHHHHHHHHH
Q 019536          125 --------------------------------TELPTLVFESVKYGTLRGFSF------ASLLIAPRIKIAMEIANAVAY  166 (339)
Q Consensus       125 --------------------------------~~~~~lv~e~~~~g~L~~~~~------~~~~~~~~~~i~~~i~~~l~~  166 (339)
                                                      ....++||||++ |+|.+.+.      ..+++..+..++.|++.||.|
T Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~  156 (383)
T 3eb0_A           78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF  156 (383)
T ss_dssp             --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence                                            334789999998 47666553      568899999999999999999


Q ss_pred             HhcCCCCCeEEccCCCCCEEeC-CCCceEEecCCCccccCCCCceeeecccccccccccccccccC-CCCcccchHHHHH
Q 019536          167 LHVGFDRPIVFRCIKASNVLLD-ENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATS-SFNEMCDVYSFGA  244 (339)
Q Consensus       167 LH~~~~~~i~H~dlk~~Nil~~-~~~~~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~  244 (339)
                      ||   +.+|+||||||+||+++ .++.+||+|||+|+.+.......   ...+|+.|+|||++.+. .++.++||||+||
T Consensus       157 LH---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~  230 (383)
T 3eb0_A          157 IH---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSV---AYICSRFYRAPELMLGATEYTPSIDLWSIGC  230 (383)
T ss_dssp             HH---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCC---CCCCCSSCCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred             HH---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCc---CcccCCCccCHHHhcCCCCCCcchhhhhHHH
Confidence            99   99999999999999997 68899999999998765543322   34679999999998775 4899999999999


Q ss_pred             HHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhc----------CcccccccCcccC-CCCCCCcHHHHHHHHHHHHHh
Q 019536          245 FLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIEN----------NRFGAIVDPIFDE-DNSFPGKEEKLQSLGQLMYKC  313 (339)
Q Consensus       245 ~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~c  313 (339)
                      ++|+|++|+.||....  .   .............          .......-+.... ......+...+..+.+|+.+|
T Consensus       231 il~ell~g~~pf~~~~--~---~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  305 (383)
T 3eb0_A          231 VFGELILGKPLFSGET--S---IDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQI  305 (383)
T ss_dssp             HHHHHHHSSCSSCCSS--H---HHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHH
T ss_pred             HHHHHHhCCCCCCCCC--h---HHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHH
Confidence            9999999999975321  1   1111111111000          0000000000000 000000113456799999999


Q ss_pred             hccCCCCCCCHHHHHH
Q 019536          314 LSKSPEHRPLMVDVAK  329 (339)
Q Consensus       314 l~~dP~~Rps~~~il~  329 (339)
                      |+.||++|||+.|+++
T Consensus       306 L~~dP~~R~t~~e~l~  321 (383)
T 3eb0_A          306 LRYEPDLRINPYEAMA  321 (383)
T ss_dssp             CCSSGGGSCCHHHHHT
T ss_pred             ccCChhhCCCHHHHhc
Confidence            9999999999999986

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-45  Score=339.01  Aligned_cols=254  Identities=21%  Similarity=0.271  Sum_probs=202.7

Q ss_pred             hcCcccCCceeccCCeeEEEEEEc---CCCeeEEEEEeccCCC---hhhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCC
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLV---DQDRPISVMKFHDNST---LDDVEYCFNNIVFSSQM-KHKNILKLIGCCLETE  126 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~---~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~  126 (339)
                      .++|++.+.||+|+||+||+|...   .+++.||||++.....   ....+.+.+|+.+++.+ +||||+++++++.+.+
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            378999999999999999999984   4789999999875321   12345566899999999 6999999999999999


Q ss_pred             ccEEEEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCcccc
Q 019536          127 LPTLVFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSI  204 (339)
Q Consensus       127 ~~~lv~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~  204 (339)
                      ..++||||+++|+|.+++.  ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~  209 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  209 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred             eEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence            9999999999999999986  57889999999999999999999   899999999999999999999999999999876


Q ss_pred             CCCCceeeecccccccccccccccccC--CCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcc
Q 019536          205 PEGETHVREEFIKGAYGFIAPEYFATS--SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRF  282 (339)
Q Consensus       205 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (339)
                      ....... .....||+.|+|||++.+.  .++.++|||||||++|+|++|+.||...+...  .  ...........   
T Consensus       210 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--~--~~~~~~~~~~~---  281 (355)
T 1vzo_A          210 VADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN--S--QAEISRRILKS---  281 (355)
T ss_dssp             CGGGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC--C--HHHHHHHHHHC---
T ss_pred             ccCCCCc-ccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc--h--HHHHHHHHhcc---
Confidence            4433221 1235699999999999863  47899999999999999999999986433322  1  11111111110   


Q ss_pred             cccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 019536          283 GAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP-----LMVDVAKQ  330 (339)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~il~~  330 (339)
                                ..  +.+...+..+.+|+.+||+.||++||     |+.+++++
T Consensus       282 ----------~~--~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h  322 (355)
T 1vzo_A          282 ----------EP--PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  322 (355)
T ss_dssp             ----------CC--CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             ----------CC--CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence                      00  11123456789999999999999999     99999874

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=2.3e-44  Score=331.97  Aligned_cols=263  Identities=16%  Similarity=0.177  Sum_probs=200.9

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC-hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCcc----
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST-LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELP----  128 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~----  128 (339)
                      .++|.+.+.||+|+||+||+|.+..+|+.||+|++..... ......+.+|+.+++.++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            4789999999999999999999999999999999986533 23457788999999999999999999999877654    


Q ss_pred             --EEEEEeccCCccccccccCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCC
Q 019536          129 --TLVFESVKYGTLRGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPE  206 (339)
Q Consensus       129 --~lv~e~~~~g~L~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~  206 (339)
                        ++||||++ ++|.+++...+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus       121 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~  196 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMGMEFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA  196 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTCC-----
T ss_pred             eEEEEEcccc-ccHHHHhhcCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCccccccc
Confidence              99999997 6888888888999999999999999999999   89999999999999999999999999999976543


Q ss_pred             CCceeeeccccccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcC---cc
Q 019536          207 GETHVREEFIKGAYGFIAPEYFAT-SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENN---RF  282 (339)
Q Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~  282 (339)
                      ...     ...||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....     ...............   ..
T Consensus       197 ~~~-----~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-----~~~~~~~i~~~~~~~~~~~~  266 (371)
T 4exu_A          197 EMT-----GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD-----YLDQLTQILKVTGVPGTEFV  266 (371)
T ss_dssp             --------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHHHCCCCHHHH
T ss_pred             CcC-----CcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHHHhCCCcHHHH
Confidence            321     3568999999999987 679999999999999999999999985321     111111111110000   00


Q ss_pred             ccccc-------CcccCCCCCC---CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          283 GAIVD-------PIFDEDNSFP---GKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       283 ~~~~~-------~~~~~~~~~~---~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      ..+.+       ..........   .....+..+.+|+.+||+.||++|||+.+++++
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          267 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             TTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence            00000       0000000000   001235679999999999999999999999863

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1e-44  Score=332.00  Aligned_cols=263  Identities=16%  Similarity=0.191  Sum_probs=201.3

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC-hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCc-----
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST-LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETEL-----  127 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~-----  127 (339)
                      .++|.+.+.||+|+||+||+|.+..+|+.||||++..... ......+.+|+.+++.++||||+++++++...+.     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            3689999999999999999999999999999999976533 2345678899999999999999999999987654     


Q ss_pred             -cEEEEEeccCCccccccccCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCC
Q 019536          128 -PTLVFESVKYGTLRGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPE  206 (339)
Q Consensus       128 -~~lv~e~~~~g~L~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~  206 (339)
                       .++||||++ |+|.+++...+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  178 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMGLKFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA  178 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred             eEEEEecccc-CCHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence             499999997 6999988888999999999999999999999   89999999999999999999999999999976543


Q ss_pred             CCceeeeccccccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcC---cc
Q 019536          207 GETHVREEFIKGAYGFIAPEYFAT-SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENN---RF  282 (339)
Q Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~  282 (339)
                      ...     ...+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.....     ..............   ..
T Consensus       179 ~~~-----~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~~~~~~i~~~~~~~~~~~~  248 (353)
T 3coi_A          179 EMT-----GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY-----LDQLTQILKVTGVPGTEFV  248 (353)
T ss_dssp             ----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCH-----HHHHHHHHHHHCBCCHHHH
T ss_pred             Ccc-----ccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHhCCCCHHHH
Confidence            221     3468999999999877 6789999999999999999999999853221     11111111110000   00


Q ss_pred             cccccC-------cccC--CCCC-CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          283 GAIVDP-------IFDE--DNSF-PGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       283 ~~~~~~-------~~~~--~~~~-~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      ..+.+.       .+..  ...+ ......+..+.+|+.+||+.||++|||+.+++++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  306 (353)
T 3coi_A          249 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  306 (353)
T ss_dssp             TTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            000000       0000  0000 0112446689999999999999999999999863

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.5e-45  Score=331.18  Aligned_cols=257  Identities=21%  Similarity=0.270  Sum_probs=198.9

Q ss_pred             ccHHHHHHHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhc-CCCceeeeeeeee
Q 019536           45 FSAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCCL  123 (339)
Q Consensus        45 ~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~  123 (339)
                      ++..++....++|++.+.||+|+||.||+|.+..+++.||+|++....  ...+.+.+|+.+++.+ +||||+++++++.
T Consensus        14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   91 (326)
T 2x7f_A           14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFI   91 (326)
T ss_dssp             --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--STTHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred             ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc--ccHHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence            333444556789999999999999999999999899999999987653  3346788999999999 8999999999998


Q ss_pred             e------CCccEEEEEeccCCccccccc----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCce
Q 019536          124 E------TELPTLVFESVKYGTLRGFSF----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSA  193 (339)
Q Consensus       124 ~------~~~~~lv~e~~~~g~L~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~  193 (339)
                      .      .+..++||||+++|+|.+++.    ..++...+..++.|++.||.|||   +.+|+|+||||+||+++.++.+
T Consensus        92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~  168 (326)
T 2x7f_A           92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEV  168 (326)
T ss_dssp             ECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCE
T ss_pred             eccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCCE
Confidence            7      457899999999999999976    45888889999999999999999   8999999999999999999999


Q ss_pred             EEecCCCccccCCCCceeeecccccccccccccccc-----cCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchh
Q 019536          194 KLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFA-----TSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLT  268 (339)
Q Consensus       194 kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~  268 (339)
                      ||+|||++.........  .....||+.|+|||++.     +..++.++|||||||++|+|++|+.||....        
T Consensus       169 kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------  238 (326)
T 2x7f_A          169 KLVDFGVSAQLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH--------  238 (326)
T ss_dssp             EECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC--------
T ss_pred             EEeeCcCceecCcCccc--cccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc--------
Confidence            99999998776433221  12356899999999987     4568899999999999999999999974221        


Q ss_pred             HHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          269 VLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                      ............ ...            ......+..+.+|+.+||+.||++|||+.++++
T Consensus       239 ~~~~~~~~~~~~-~~~------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          239 PMRALFLIPRNP-APR------------LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             HHHHHHHHHHSC-CCC------------CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHhhcCc-ccc------------CCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            111111111111 000            001134457999999999999999999999987

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=4.3e-44  Score=319.90  Aligned_cols=253  Identities=20%  Similarity=0.284  Sum_probs=205.9

Q ss_pred             HHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC--------hhhHHHHHHHHHHHHhcC-CCceeeeeeee
Q 019536           52 KATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST--------LDDVEYCFNNIVFSSQMK-HKNILKLIGCC  122 (339)
Q Consensus        52 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~e~~~l~~l~-H~niv~~~~~~  122 (339)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|++.....        ....+.+.+|+.+++++. ||||+++++++
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY   93 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence            345889999999999999999999999999999999976531        123456789999999995 99999999999


Q ss_pred             eeCCccEEEEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCC
Q 019536          123 LETELPTLVFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSL  200 (339)
Q Consensus       123 ~~~~~~~lv~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~  200 (339)
                      .+++..++||||+++++|.+++.  ..++...+..++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||+
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~  170 (298)
T 1phk_A           94 ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGF  170 (298)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             ccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEecccc
Confidence            99999999999999999999986  47889999999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCCCceeeecccccccccccccccc------cCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHH
Q 019536          201 SVSIPEGETHVREEFIKGAYGFIAPEYFA------TSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAK  274 (339)
Q Consensus       201 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~  274 (339)
                      +.........   ....|++.|+|||++.      ...++.++||||||+++|+|++|+.||....        ......
T Consensus       171 ~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~~~~~~  239 (298)
T 1phk_A          171 SCQLDPGEKL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK--------QMLMLR  239 (298)
T ss_dssp             CEECCTTCCB---CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHH
T ss_pred             hhhcCCCccc---ccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc--------HHHHHH
Confidence            9876544322   1356899999999985      4468899999999999999999999975221        111111


Q ss_pred             HHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          275 KSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                      ... ....          ....+.....+..+.+|+.+||+.||++|||+.++++
T Consensus       240 ~~~-~~~~----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          240 MIM-SGNY----------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             HHH-HTCC----------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHh-cCCc----------ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            111 1110          0111222345668999999999999999999999986

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=3.3e-45  Score=331.07  Aligned_cols=252  Identities=20%  Similarity=0.219  Sum_probs=197.6

Q ss_pred             HhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC-------hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeC
Q 019536           53 ATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST-------LDDVEYCFNNIVFSSQMKHKNILKLIGCCLET  125 (339)
Q Consensus        53 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~  125 (339)
                      ..++|.+.+.||+|+||.||+|.+..+++.||||++.....       ......+.+|+.+++.++||||+++++++..+
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            34789999999999999999999999999999999875421       12234577999999999999999999999766


Q ss_pred             CccEEEEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCc---eEEecCCC
Q 019536          126 ELPTLVFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYS---AKLHDFSL  200 (339)
Q Consensus       126 ~~~~lv~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~---~kl~dfg~  200 (339)
                      + .++||||+++|+|.+++.  ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.   +||+|||+
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~  163 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGH  163 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred             c-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence            5 799999999999998876  56888899999999999999999   899999999999999987654   99999999


Q ss_pred             ccccCCCCceeeecccccccccccccccc---cCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHh
Q 019536          201 SVSIPEGETHVREEFIKGAYGFIAPEYFA---TSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSI  277 (339)
Q Consensus       201 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  277 (339)
                      ++........   ....||+.|+|||++.   +..++.++|||||||++|+|++|..||.......    .......   
T Consensus       164 ~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~~~~---  233 (322)
T 2ycf_A          164 SKILGETSLM---RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV----SLKDQIT---  233 (322)
T ss_dssp             CEECCCCHHH---HHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS----CHHHHHH---
T ss_pred             ceeccccccc---ccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH----HHHHHHH---
Confidence            9876543221   1356899999999974   4578999999999999999999999986332211    1111111   


Q ss_pred             hcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          278 ENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                       ......  .+        ......+..+.+|+.+||+.||++|||+.++++
T Consensus       234 -~~~~~~--~~--------~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          234 -SGKYNF--IP--------EVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             -HTCCCC--CH--------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             -hCcccc--Cc--------hhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence             111000  00        000133567899999999999999999999985

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.3e-44  Score=339.77  Aligned_cols=194  Identities=19%  Similarity=0.204  Sum_probs=170.6

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhc------CCCceeeeeeeeeeCCc
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQM------KHKNILKLIGCCLETEL  127 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l------~H~niv~~~~~~~~~~~  127 (339)
                      ..+|++.+.||+|+||+||+|.+..+++.||||++....  .....+.+|+.+++.+      .|+||+++++++...+.
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  173 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK--RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH  173 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc--chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence            467999999999999999999999999999999997542  3445677888888887      57799999999999999


Q ss_pred             cEEEEEeccCCccccccc----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCc--eEEecCCCc
Q 019536          128 PTLVFESVKYGTLRGFSF----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYS--AKLHDFSLS  201 (339)
Q Consensus       128 ~~lv~e~~~~g~L~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~--~kl~dfg~a  201 (339)
                      .++||||+. ++|.+++.    ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.  +||+|||+|
T Consensus       174 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a  249 (429)
T 3kvw_A          174 ICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS  249 (429)
T ss_dssp             EEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             EEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeecccc
Confidence            999999996 68887765    34889999999999999999999   899999999999999999887  999999999


Q ss_pred             cccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCcccc
Q 019536          202 VSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEF  258 (339)
Q Consensus       202 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~  258 (339)
                      +.......     ...||+.|+|||++.+..|+.++|||||||++|+|++|++||..
T Consensus       250 ~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~  301 (429)
T 3kvw_A          250 CYEHQRVY-----TYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPG  301 (429)
T ss_dssp             EETTCCCC-----SSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             eecCCccc-----ccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCC
Confidence            76544322     35689999999999999999999999999999999999999753

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.6e-44  Score=330.47  Aligned_cols=267  Identities=18%  Similarity=0.165  Sum_probs=201.9

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeC-----Ccc
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLET-----ELP  128 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~-----~~~  128 (339)
                      .++|++.+.||+|+||+||+|.+..+|+.||||++...........+.+|+.+++.++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            478999999999999999999999899999999997665555667788999999999999999999998764     568


Q ss_pred             EEEEEeccCCccccccc-cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCC
Q 019536          129 TLVFESVKYGTLRGFSF-ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEG  207 (339)
Q Consensus       129 ~lv~e~~~~g~L~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~  207 (339)
                      ++||||++ |+|.+++. ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus        90 ~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  165 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVISTQMLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES  165 (353)
T ss_dssp             EEEECCCS-EEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred             EEEEeccC-ccHHHHHhhcCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEecccccccccc
Confidence            99999997 58888776 57899999999999999999999   899999999999999999999999999999876543


Q ss_pred             Ccee--------eeccccccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhh
Q 019536          208 ETHV--------REEFIKGAYGFIAPEYFAT-SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIE  278 (339)
Q Consensus       208 ~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  278 (339)
                      ....        ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.....     ............
T Consensus       166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~~  240 (353)
T 2b9h_A          166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY-----RHQLLLIFGIIG  240 (353)
T ss_dssp             --------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHHHC
T ss_pred             cccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCc-----HHHHHHHHHHhC
Confidence            2111        1112468999999998765 6789999999999999999999999853221     111111111110


Q ss_pred             cCc----ccccccC-------cccCCCCCC---CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          279 NNR----FGAIVDP-------IFDEDNSFP---GKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       279 ~~~----~~~~~~~-------~~~~~~~~~---~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                      ...    ...+...       ........+   .....+..+.+|+.+||+.||++|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            000    0000000       000000000   00134567899999999999999999999987

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=4.9e-45  Score=333.22  Aligned_cols=258  Identities=19%  Similarity=0.282  Sum_probs=202.2

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChh----------------hHHHHHHHHHHHHhcCCCceee
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLD----------------DVEYCFNNIVFSSQMKHKNILK  117 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----------------~~~~~~~e~~~l~~l~H~niv~  117 (339)
                      .++|.+.+.||+|+||.||+|.+  +++.||+|++.......                ..+.+.+|+.+++.++||||++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~  107 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT  107 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence            47899999999999999999999  89999999987542111                1277889999999999999999


Q ss_pred             eeeeeeeCCccEEEEEeccCCccccc------cc----cCCChHHHHHHHHHHHHHHHHHhcCCC-CCeEEccCCCCCEE
Q 019536          118 LIGCCLETELPTLVFESVKYGTLRGF------SF----ASLLIAPRIKIAMEIANAVAYLHVGFD-RPIVFRCIKASNVL  186 (339)
Q Consensus       118 ~~~~~~~~~~~~lv~e~~~~g~L~~~------~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~i~H~dlk~~Nil  186 (339)
                      +++++.+.+..++||||+++|+|.++      +.    ..+++..+..++.|++.||.|||   + .+|+||||||+||+
T Consensus       108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~Nil  184 (348)
T 2pml_X          108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPSNIL  184 (348)
T ss_dssp             CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGGGEE
T ss_pred             EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChHhEE
Confidence            99999999999999999999999998      54    46888999999999999999999   7 99999999999999


Q ss_pred             eCCCCceEEecCCCccccCCCCceeeecccccccccccccccccC-CCCc-ccchHHHHHHHHHHHhCCCccccCCCCCC
Q 019536          187 LDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATS-SFNE-MCDVYSFGAFLCELLTGCNVLEFKGNGND  264 (339)
Q Consensus       187 ~~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DiwslG~~l~el~~g~~p~~~~~~~~~  264 (339)
                      ++.++.+||+|||++.......    .....||..|+|||++.+. .++. ++||||||+++|+|++|+.||......  
T Consensus       185 ~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--  258 (348)
T 2pml_X          185 MDKNGRVKLSDFGESEYMVDKK----IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL--  258 (348)
T ss_dssp             ECTTSCEEECCCTTCEECBTTE----ECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS--
T ss_pred             EcCCCcEEEecccccccccccc----ccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH--
Confidence            9999999999999998764431    2245689999999999877 6766 999999999999999999998632221  


Q ss_pred             CchhHHHHHHHHhhcCccccc------ccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          265 DDLTVLEYAKKSIENNRFGAI------VDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                        ....   .. ........-      ..+..... ........+..+.+|+.+||+.||++|||+.++++
T Consensus       259 --~~~~---~~-i~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          259 --VELF---NN-IRTKNIEYPLDRNHFLYPLTNKK-STCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             --HHHH---HH-HTSCCCCCCCSSSSSTTTTCC---------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             --HHHH---HH-HhccCcCCccchhhhhccccccc-cccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence              1111   11 111111000      00000000 00000234567999999999999999999999987

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=6.6e-46  Score=332.19  Aligned_cols=263  Identities=21%  Similarity=0.297  Sum_probs=185.0

Q ss_pred             HHHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 019536           51 KKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTL  130 (339)
Q Consensus        51 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  130 (339)
                      ....++|.+.+.||+|+||+||+|.+..+++.||+|++.........+.+.+|+.+++.++||||+++++++...+..++
T Consensus        11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   90 (303)
T 2vwi_A           11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL   90 (303)
T ss_dssp             --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred             ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence            34458999999999999999999999888999999998765444556778899999999999999999999999999999


Q ss_pred             EEEeccCCccccccc----------cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCC
Q 019536          131 VFESVKYGTLRGFSF----------ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSL  200 (339)
Q Consensus       131 v~e~~~~g~L~~~~~----------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~  200 (339)
                      ||||+++++|.+++.          ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+
T Consensus        91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~  167 (303)
T 2vwi_A           91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGV  167 (303)
T ss_dssp             EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred             EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEeccc
Confidence            999999999999874          34888999999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCCCce---eeeccccccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHH
Q 019536          201 SVSIPEGETH---VREEFIKGAYGFIAPEYFAT-SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKS  276 (339)
Q Consensus       201 a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  276 (339)
                      +.........   .......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||......     ....   ..
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~---~~  239 (303)
T 2vwi_A          168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM-----KVLM---LT  239 (303)
T ss_dssp             HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGG-----GHHH---HH
T ss_pred             hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchh-----hHHH---HH
Confidence            8766433211   11123568999999999876 56899999999999999999999998533211     1111   11


Q ss_pred             hhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          277 IENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                      .... ....... ....   ......+..+.+|+.+||+.||.+|||+.++++
T Consensus       240 ~~~~-~~~~~~~-~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          240 LQND-PPSLETG-VQDK---EMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             HTSS-CCCTTC---------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             hccC-CCccccc-cccc---hhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            1110 0000000 0000   001134457899999999999999999999987

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.5e-44  Score=328.03  Aligned_cols=267  Identities=18%  Similarity=0.225  Sum_probs=204.1

Q ss_pred             hcCcccCCceeccCCeeEEEEEE-cCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCc------eeeeeeeeeeCC
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTL-VDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKN------ILKLIGCCLETE  126 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~n------iv~~~~~~~~~~  126 (339)
                      .++|++.+.||+|+||+||+|.+ ..+++.||+|++...  ....+.+.+|+.+++.++|+|      ++++++++.+.+
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~   90 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV--DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG   90 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC--CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence            36899999999999999999998 567899999999753  244567889999999987665      999999999999


Q ss_pred             ccEEEEEeccCCccccccc----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCC-------------
Q 019536          127 LPTLVFESVKYGTLRGFSF----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDE-------------  189 (339)
Q Consensus       127 ~~~lv~e~~~~g~L~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~-------------  189 (339)
                      ..++||||+ +++|.+++.    ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.             
T Consensus        91 ~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~  166 (339)
T 1z57_A           91 HICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKR  166 (339)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred             cEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCcccc
Confidence            999999999 889988876    25788899999999999999999   899999999999999987             


Q ss_pred             ------CCceEEecCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCC
Q 019536          190 ------NYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGN  263 (339)
Q Consensus       190 ------~~~~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~  263 (339)
                            ++.+||+|||+++.......     ...||+.|+|||++.+..++.++|||||||++|+|++|+.||.....  
T Consensus       167 ~~~~~~~~~~kl~Dfg~~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--  239 (339)
T 1z57_A          167 DERTLINPDIKVVDFGSATYDDEHHS-----TLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS--  239 (339)
T ss_dssp             EEEEESCCCEEECCCSSCEETTSCCC-----SSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH--
T ss_pred             ccccccCCCceEeeCcccccCccccc-----cccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh--
Confidence                  66799999999987544322     35689999999999999999999999999999999999999863221  


Q ss_pred             CCchhHHHHHHHHhhc--------Cccccccc-CcccCC-----------------CCCCCcHHHHHHHHHHHHHhhccC
Q 019536          264 DDDLTVLEYAKKSIEN--------NRFGAIVD-PIFDED-----------------NSFPGKEEKLQSLGQLMYKCLSKS  317 (339)
Q Consensus       264 ~~~~~~~~~~~~~~~~--------~~~~~~~~-~~~~~~-----------------~~~~~~~~~~~~~~~li~~cl~~d  317 (339)
                         .............        ........ ......                 .........+..+.+|+.+||+.|
T Consensus       240 ---~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d  316 (339)
T 1z57_A          240 ---KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYD  316 (339)
T ss_dssp             ---HHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred             ---HHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcC
Confidence               1111111111100        00000000 000000                 000112256778999999999999


Q ss_pred             CCCCCCHHHHHHH--HHHHHh
Q 019536          318 PEHRPLMVDVAKQ--LRQMYL  336 (339)
Q Consensus       318 P~~Rps~~~il~~--L~~l~~  336 (339)
                      |++|||+.|++++  ++.+.+
T Consensus       317 P~~Rpt~~ell~hp~f~~~~~  337 (339)
T 1z57_A          317 PAKRITLREALKHPFFDLLKK  337 (339)
T ss_dssp             TTTSCCHHHHTTSGGGGGGGC
T ss_pred             cccccCHHHHhcCHHHHHHhc
Confidence            9999999999864  444433

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=5.8e-44  Score=317.67  Aligned_cols=252  Identities=21%  Similarity=0.279  Sum_probs=204.8

Q ss_pred             HHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 019536           52 KATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS-TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTL  130 (339)
Q Consensus        52 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  130 (339)
                      ...++|++.+.||+|+||+||+|.+..+++.||+|++.... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   98 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI   98 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence            44578999999999999999999999899999999987642 22456778899999999999999999999999999999


Q ss_pred             EEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCC---CceEEecCCCccccC
Q 019536          131 VFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDEN---YSAKLHDFSLSVSIP  205 (339)
Q Consensus       131 v~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~---~~~kl~dfg~a~~~~  205 (339)
                      ||||+++++|.+++.  ..+++..+..++.|++.||.|||   +.+++|+||||+||+++.+   +.+||+|||++....
T Consensus        99 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~  175 (287)
T 2wei_A           99 VGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (287)
T ss_dssp             EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred             EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence            999999999988875  57899999999999999999999   8999999999999999754   469999999988765


Q ss_pred             CCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCccccc
Q 019536          206 EGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAI  285 (339)
Q Consensus       206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (339)
                      ......   ...+|+.|+|||.+.+ .++.++||||||+++|+|++|+.||....        ....... ......   
T Consensus       176 ~~~~~~---~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~~~~~~~-~~~~~~---  239 (287)
T 2wei_A          176 QNTKMK---DRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN--------EYDILKR-VETGKY---  239 (287)
T ss_dssp             CCSSCS---CHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHH-HHHCCC---
T ss_pred             CCCccc---cccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCC--------HHHHHHH-HHcCCC---
Confidence            443221   3458899999999875 48999999999999999999999975321        1111111 111111   


Q ss_pred             ccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          286 VDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                             ....+.....+..+.+++.+||+.||++|||+.++++
T Consensus       240 -------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          240 -------AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             -------CCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------CCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence                   0011111244567999999999999999999999998

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=4e-44  Score=324.59  Aligned_cols=253  Identities=19%  Similarity=0.190  Sum_probs=181.6

Q ss_pred             HhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHH-HHHhcCCCceeeeeeeeeeCCccEEE
Q 019536           53 ATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIV-FSSQMKHKNILKLIGCCLETELPTLV  131 (339)
Q Consensus        53 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~-~l~~l~H~niv~~~~~~~~~~~~~lv  131 (339)
                      ..++|.+.+.||+|+||.||+|.+..+++.||||++...........+..|+. +++.++||||+++++++.+++..++|
T Consensus        20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv   99 (327)
T 3aln_A           20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC   99 (327)
T ss_dssp             CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence            34789999999999999999999998999999999987655455566666766 77778999999999999999999999


Q ss_pred             EEeccCCccccccc-------cCCChHHHHHHHHHHHHHHHHHhcCCCC-CeEEccCCCCCEEeCCCCceEEecCCCccc
Q 019536          132 FESVKYGTLRGFSF-------ASLLIAPRIKIAMEIANAVAYLHVGFDR-PIVFRCIKASNVLLDENYSAKLHDFSLSVS  203 (339)
Q Consensus       132 ~e~~~~g~L~~~~~-------~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~  203 (339)
                      |||+++ +|.+++.       ..+++..+..++.|++.||.|||   +. +|+||||||+||+++.++.+||+|||+++.
T Consensus       100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~  175 (327)
T 3aln_A          100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQ  175 (327)
T ss_dssp             ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred             EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence            999985 6666543       56888899999999999999999   77 999999999999999999999999999987


Q ss_pred             cCCCCceeeeccccccccccccccc----ccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhc
Q 019536          204 IPEGETHVREEFIKGAYGFIAPEYF----ATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIEN  279 (339)
Q Consensus       204 ~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  279 (339)
                      .......   ....||+.|+|||++    .+..++.++||||||+++|+|++|+.||.......                
T Consensus       176 ~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----------------  236 (327)
T 3aln_A          176 LVDSIAK---TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF----------------  236 (327)
T ss_dssp             ---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------------------
T ss_pred             ccccccc---ccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH----------------
Confidence            6543322   124689999999998    45678999999999999999999999985322110                


Q ss_pred             CcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          280 NRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                      .....+..... ...........+..+.+|+.+||+.||++|||+.++++
T Consensus       237 ~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          237 DQLTQVVKGDP-PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             ---CCCCCSCC-CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHHhcCCC-CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            00001111000 00000111234567999999999999999999999987

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.2e-44  Score=336.39  Aligned_cols=259  Identities=20%  Similarity=0.250  Sum_probs=192.0

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCc------c
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETEL------P  128 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~------~  128 (339)
                      .+|++.+.||+|+||+||+|.+..++. ||+|++.....     ...+|+.+++.++||||+++++++...+.      .
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~-----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~  113 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR-----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL  113 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc-----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence            579999999999999999999985555 88888865432     12279999999999999999999965433      7


Q ss_pred             EEEEEeccCCcccccc-----ccCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeC-CCCceEEecCCCcc
Q 019536          129 TLVFESVKYGTLRGFS-----FASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLD-ENYSAKLHDFSLSV  202 (339)
Q Consensus       129 ~lv~e~~~~g~L~~~~-----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~-~~~~~kl~dfg~a~  202 (339)
                      ++||||++++.+....     ...+++..+..++.|++.||.|||   +.+|+||||||+|||++ .++.+||+|||+|+
T Consensus       114 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~  190 (394)
T 4e7w_A          114 NLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAK  190 (394)
T ss_dssp             EEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence            8999999876554432     257889999999999999999999   89999999999999998 79999999999998


Q ss_pred             ccCCCCceeeecccccccccccccccccC-CCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCc
Q 019536          203 SIPEGETHVREEFIKGAYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNR  281 (339)
Q Consensus       203 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (339)
                      .........   ...+|+.|+|||++.+. .|+.++||||+||++|+|++|+.||....  .   ...............
T Consensus       191 ~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~--~---~~~l~~i~~~~g~p~  262 (394)
T 4e7w_A          191 ILIAGEPNV---SYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGES--G---IDQLVEIIKVLGTPS  262 (394)
T ss_dssp             ECCTTCCCC---SSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS--H---HHHHHHHHHHHCCCC
T ss_pred             cccCCCCCc---ccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--H---HHHHHHHHHHhCCCC
Confidence            765443321   34689999999998765 58999999999999999999999975321  1   111111111100000


Q ss_pred             -------ccccccCcccCCCCCC----CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          282 -------FGAIVDPIFDEDNSFP----GKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       282 -------~~~~~~~~~~~~~~~~----~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                             ........+......+    .+...+.++.+|+.+||+.||++|||+.+++++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          263 REQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             HHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence                   0000111111100000    011245689999999999999999999999864

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.6e-44  Score=338.21  Aligned_cols=257  Identities=21%  Similarity=0.258  Sum_probs=191.6

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeC------Ccc
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLET------ELP  128 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~------~~~  128 (339)
                      .+|++.+.||+|+||.||+|.+..+++.||||++.....     ...+|+.+++.++||||+++++++...      ...
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~  128 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL  128 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence            479999999999999999999998999999999875432     123799999999999999999998542      236


Q ss_pred             EEEEEeccCCccccccc------cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCC-CceEEecCCCc
Q 019536          129 TLVFESVKYGTLRGFSF------ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDEN-YSAKLHDFSLS  201 (339)
Q Consensus       129 ~lv~e~~~~g~L~~~~~------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~-~~~kl~dfg~a  201 (339)
                      ++||||+++ ++.+.+.      ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.+ +.+||+|||++
T Consensus       129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a  204 (420)
T 1j1b_A          129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSA  204 (420)
T ss_dssp             EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhh
Confidence            799999986 4444432      56889999999999999999999   9999999999999999955 67899999999


Q ss_pred             cccCCCCceeeecccccccccccccccccC-CCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhh--
Q 019536          202 VSIPEGETHVREEFIKGAYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIE--  278 (339)
Q Consensus       202 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--  278 (339)
                      +.+.......   ...||+.|+|||++.+. .|+.++|||||||++|||++|+.||...  ..   ............  
T Consensus       205 ~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~--~~---~~~l~~i~~~lg~p  276 (420)
T 1j1b_A          205 KQLVRGEPNV---SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SG---VDQLVEIIKVLGTP  276 (420)
T ss_dssp             EECCTTCCCC---SCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS--SH---HHHHHHHHHHHCSC
T ss_pred             hhcccCCCce---eeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCC--CH---HHHHHHHHHHhCCC
Confidence            8765433221   34689999999998765 7999999999999999999999997532  11   111111111100  


Q ss_pred             --------cCcccccccCcccCCCCCC--CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          279 --------NNRFGAIVDPIFDEDNSFP--GKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       279 --------~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                              ...+..+..+.+.. ..+.  .+...+.++.+|+.+||+.||.+|||+.|+++
T Consensus       277 ~~~~~~~~~~~~~~~~~p~~~~-~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          277 TREQIREMNPNYTEFKFPQIKA-HPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             CHHHHHHHCSCCCCCCCCCCCC-CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CHHHHHhhChhhhhhccCccCC-CCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence                    00011110000000 0000  00123567999999999999999999999986

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.8e-44  Score=331.00  Aligned_cols=272  Identities=16%  Similarity=0.170  Sum_probs=190.2

Q ss_pred             HHHHHHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCc
Q 019536           48 KDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETEL  127 (339)
Q Consensus        48 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~  127 (339)
                      .......++|++.+.||+|+||+||+|.+..+++.||||++.....  ....+.+++..++.++||||+++++++...+.
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~   93 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR--FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE   93 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT--CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc--ccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence            4556777999999999999999999999998999999999866432  23345678888899999999999999976443


Q ss_pred             -------cEEEEEeccCCcccccc---c--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCC-CCceE
Q 019536          128 -------PTLVFESVKYGTLRGFS---F--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDE-NYSAK  194 (339)
Q Consensus       128 -------~~lv~e~~~~g~L~~~~---~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~-~~~~k  194 (339)
                             .++||||++++.+..+.   .  ..++...+..++.|++.||.|||.+ +.+|+||||||+|||++. ++.+|
T Consensus        94 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~ivH~Dlkp~NIll~~~~~~~k  172 (360)
T 3e3p_A           94 RDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLK  172 (360)
T ss_dssp             SCTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTST-TTCCBCSCCCGGGEEEETTTTEEE
T ss_pred             ccccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCC-CCCeecCcCCHHHEEEeCCCCcEE
Confidence                   78999999875333221   1  4678888899999999999999943 578999999999999996 89999


Q ss_pred             EecCCCccccCCCCceeeecccccccccccccccccC-CCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHH
Q 019536          195 LHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYA  273 (339)
Q Consensus       195 l~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~  273 (339)
                      |+|||+++.........   ...||+.|+|||++.+. .++.++|||||||++|+|++|+.||.....     .......
T Consensus       173 l~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~-----~~~~~~~  244 (360)
T 3e3p_A          173 LCDFGSAKKLSPSEPNV---AYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS-----AGQLHEI  244 (360)
T ss_dssp             ECCCTTCBCCCTTSCCC---STTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHH
T ss_pred             EeeCCCceecCCCCCcc---cccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCCh-----HHHHHHH
Confidence            99999998775543321   35689999999998765 489999999999999999999999853211     1111111


Q ss_pred             HHHhhcC---ccccc----ccCcccCCCCCC-------CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          274 KKSIENN---RFGAI----VDPIFDEDNSFP-------GKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       274 ~~~~~~~---~~~~~----~~~~~~~~~~~~-------~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      .......   .+..+    .+.........+       .....+..+.+|+.+||+.||++|||+.|++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  315 (360)
T 3e3p_A          245 VRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH  315 (360)
T ss_dssp             HHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            1110000   00000    000000000000       011246789999999999999999999999863

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2e-44  Score=331.02  Aligned_cols=272  Identities=15%  Similarity=0.176  Sum_probs=196.9

Q ss_pred             cHHHHHHHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCCh----------hhHHHHHHHHHHHHhcCCCce
Q 019536           46 SAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTL----------DDVEYCFNNIVFSSQMKHKNI  115 (339)
Q Consensus        46 ~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----------~~~~~~~~e~~~l~~l~H~ni  115 (339)
                      ...++....++|.+.+.||+|+||.||+|.+. ++..||||++......          ...+.+.+|+.+++.++||||
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   91 (362)
T 3pg1_A           13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI   91 (362)
T ss_dssp             HHHHHHHTTCSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             HHHHHHHhccceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence            35577788899999999999999999999986 5999999998654221          123778899999999999999


Q ss_pred             eeeeeeeeeC-----CccEEEEEeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEe
Q 019536          116 LKLIGCCLET-----ELPTLVFESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLL  187 (339)
Q Consensus       116 v~~~~~~~~~-----~~~~lv~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~  187 (339)
                      +++++++...     ...++||||++ |+|.+++.   ..+++..+..++.|++.||.|||   +.+|+||||||+||++
T Consensus        92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~  167 (362)
T 3pg1_A           92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILL  167 (362)
T ss_dssp             CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEE
T ss_pred             cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHEEE
Confidence            9999998543     35799999997 57766654   35889999999999999999999   8999999999999999


Q ss_pred             CCCCceEEecCCCccccCCCCceeeeccccccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCc
Q 019536          188 DENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFAT-SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDD  266 (339)
Q Consensus       188 ~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~  266 (339)
                      +.++.+||+|||+++........   ....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||....     .
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-----~  239 (362)
T 3pg1_A          168 ADNNDITICDFNLAREDTADANK---THYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST-----F  239 (362)
T ss_dssp             CTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----H
T ss_pred             cCCCCEEEEecCccccccccccc---ceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC-----H
Confidence            99999999999999755433222   13568899999999877 678999999999999999999999985321     1


Q ss_pred             hhHHHHHHHHhhcCcc-----------cccccCcccCCCCCC---CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          267 LTVLEYAKKSIENNRF-----------GAIVDPIFDEDNSFP---GKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       267 ~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      ................           ...............   .....+..+.+|+.+||+.||++|||+.+++++
T Consensus       240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  317 (362)
T 3pg1_A          240 YNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH  317 (362)
T ss_dssp             HHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence            1111111111100000           000000000000000   001234678999999999999999999999873

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.4e-43  Score=327.93  Aligned_cols=198  Identities=17%  Similarity=0.214  Sum_probs=170.9

Q ss_pred             HHHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcC-CC-----ceeeeeeeeee
Q 019536           51 KKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMK-HK-----NILKLIGCCLE  124 (339)
Q Consensus        51 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-H~-----niv~~~~~~~~  124 (339)
                      ....++|++.+.||+|+||+||+|.+..+++.||||++...  ......+.+|+.+++.+. |+     +|+++++++..
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~  127 (382)
T 2vx3_A           50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK--KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF  127 (382)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE
T ss_pred             CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc--HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc
Confidence            34468999999999999999999999999999999999753  234566778899888885 55     49999999999


Q ss_pred             CCccEEEEEeccCCccccccc----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeC--CCCceEEecC
Q 019536          125 TELPTLVFESVKYGTLRGFSF----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLD--ENYSAKLHDF  198 (339)
Q Consensus       125 ~~~~~lv~e~~~~g~L~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~--~~~~~kl~df  198 (339)
                      .+..++||||++ |+|.+++.    ..+++..+..++.|++.||.|||+. ..+|+||||||+|||++  .++.+||+||
T Consensus       128 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DF  205 (382)
T 2vx3_A          128 RNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDF  205 (382)
T ss_dssp             TTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred             CCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence            999999999996 58888875    3588999999999999999999932 36899999999999994  5788999999


Q ss_pred             CCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccc
Q 019536          199 SLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLE  257 (339)
Q Consensus       199 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~  257 (339)
                      |+++.......     ...||+.|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus       206 G~a~~~~~~~~-----~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~  259 (382)
T 2vx3_A          206 GSSCQLGQRIY-----QYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFS  259 (382)
T ss_dssp             TTCEETTCCCC-----SSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             cCceecccccc-----cccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            99987754322     3568999999999999999999999999999999999999986

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=4.8e-44  Score=333.60  Aligned_cols=270  Identities=14%  Similarity=0.191  Sum_probs=183.5

Q ss_pred             hcCccc-CCceeccCCeeEEEEEEc--CCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeee--CCcc
Q 019536           54 TNNYDL-HKVIQSDTSYRLFEGTLV--DQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLE--TELP  128 (339)
Q Consensus        54 ~~~~~~-~~~ig~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~--~~~~  128 (339)
                      .+.|.+ .++||+|+||+||+|.+.  .+++.||+|++.....   ...+.+|+.+++.++||||+++++++..  +...
T Consensus        19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   95 (405)
T 3rgf_A           19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHADRKV   95 (405)
T ss_dssp             HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC---CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred             hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC---CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence            355766 568999999999999976  4688999999976533   2457799999999999999999999954  6678


Q ss_pred             EEEEEeccCCccccccc-----------cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEe----CCCCce
Q 019536          129 TLVFESVKYGTLRGFSF-----------ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLL----DENYSA  193 (339)
Q Consensus       129 ~lv~e~~~~g~L~~~~~-----------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~----~~~~~~  193 (339)
                      ++||||+++ +|.+++.           ..+++..++.++.||+.||.|||   +.+|+||||||+|||+    +.++.+
T Consensus        96 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~  171 (405)
T 3rgf_A           96 WLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRV  171 (405)
T ss_dssp             EEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCE
T ss_pred             EEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcE
Confidence            999999964 6666653           13888999999999999999999   8999999999999999    677899


Q ss_pred             EEecCCCccccCCCCce-eeecccccccccccccccccC-CCCcccchHHHHHHHHHHHhCCCccccCCCCCC----Cch
Q 019536          194 KLHDFSLSVSIPEGETH-VREEFIKGAYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGND----DDL  267 (339)
Q Consensus       194 kl~dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~----~~~  267 (339)
                      ||+|||+|+.+...... .......||+.|+|||++.+. .++.++|||||||++|+|++|++||........    ...
T Consensus       172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~  251 (405)
T 3rgf_A          172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH  251 (405)
T ss_dssp             EECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCH
T ss_pred             EEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchH
Confidence            99999999876543211 122245789999999999874 589999999999999999999999864332110    011


Q ss_pred             hHHHHHHHHhh---cCcccccccC---------cccCCCCCCCc--------HHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 019536          268 TVLEYAKKSIE---NNRFGAIVDP---------IFDEDNSFPGK--------EEKLQSLGQLMYKCLSKSPEHRPLMVDV  327 (339)
Q Consensus       268 ~~~~~~~~~~~---~~~~~~~~~~---------~~~~~~~~~~~--------~~~~~~~~~li~~cl~~dP~~Rps~~~i  327 (339)
                      ...........   ...+..+..-         ...........        ...+..+.+|+.+||+.||.+|||+.|+
T Consensus       252 ~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~  331 (405)
T 3rgf_A          252 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA  331 (405)
T ss_dssp             HHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             HHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence            11111111110   0001000000         00000000000        0013468899999999999999999999


Q ss_pred             HHH
Q 019536          328 AKQ  330 (339)
Q Consensus       328 l~~  330 (339)
                      +++
T Consensus       332 L~h  334 (405)
T 3rgf_A          332 MQD  334 (405)
T ss_dssp             HTS
T ss_pred             hcC
Confidence            863

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=9.6e-44  Score=320.41  Aligned_cols=266  Identities=17%  Similarity=0.198  Sum_probs=193.9

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeee----------
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCL----------  123 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~----------  123 (339)
                      .++|.+.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.          
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   88 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD-PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV   88 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC-hHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence            378999999999999999999999899999999987653 356677889999999999999999999874          


Q ss_pred             ----eCCccEEEEEeccCCccccccc-cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeC-CCCceEEec
Q 019536          124 ----ETELPTLVFESVKYGTLRGFSF-ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLD-ENYSAKLHD  197 (339)
Q Consensus       124 ----~~~~~~lv~e~~~~g~L~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~-~~~~~kl~d  197 (339)
                          +.+..++||||++ |+|.+++. ..++...+..++.|++.||.|||   +.+|+||||||+||+++ .++.+||+|
T Consensus        89 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~D  164 (320)
T 2i6l_A           89 GSLTELNSVYIVQEYME-TDLANVLEQGPLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGD  164 (320)
T ss_dssp             --CCSCSEEEEEEECCS-EEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTEEEECC
T ss_pred             ccccccCceeEEeeccC-CCHHHHhhcCCccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCeEEEcc
Confidence                3467799999997 68988876 57888999999999999999999   89999999999999997 567999999


Q ss_pred             CCCccccCCCCce-eeeccccccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHH
Q 019536          198 FSLSVSIPEGETH-VREEFIKGAYGFIAPEYFAT-SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKK  275 (339)
Q Consensus       198 fg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  275 (339)
                      ||+++........ .......+|..|+|||.+.+ ..++.++||||||+++|+|++|+.||.....     .........
T Consensus       165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~~~~~~~~~  239 (320)
T 2i6l_A          165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE-----LEQMQLILE  239 (320)
T ss_dssp             CTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHH
T ss_pred             CccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHH
Confidence            9999876432211 11123457889999998865 6789999999999999999999999853221     111111111


Q ss_pred             HhhcC----------cccccccCcccCCCCCC---CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          276 SIENN----------RFGAIVDPIFDEDNSFP---GKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       276 ~~~~~----------~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      .....          ............. ..+   .....+..+.+|+.+||+.||++|||+.+++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (320)
T 2i6l_A          240 SIPVVHEEDRQELLSVIPVYIRNDMTEP-HKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH  306 (320)
T ss_dssp             HSCCCCHHHHHHHHTTSCHHHHHHTTSC-CCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             hcCCCchhhhhhhhhcCcccccccccCC-CCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence            00000          0000000000000 000   001245679999999999999999999999873

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=2.5e-45  Score=331.02  Aligned_cols=264  Identities=17%  Similarity=0.245  Sum_probs=201.2

Q ss_pred             cHHHHHHHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC-hhhHHHHHHHHHHHHhcCCCceeeeeeeeee
Q 019536           46 SAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST-LDDVEYCFNNIVFSSQMKHKNILKLIGCCLE  124 (339)
Q Consensus        46 ~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~  124 (339)
                      ..+++....++|++.+.||+|+||+||+|.+..   .+|+|++..... ....+.+.+|+.+++.++||||+++++++.+
T Consensus        24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  100 (319)
T 2y4i_B           24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS  100 (319)
T ss_dssp             CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC
T ss_pred             ccccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec
Confidence            345555667899999999999999999999853   499999875422 2334556789999999999999999999999


Q ss_pred             CCccEEEEEeccCCcccccccc---CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCc
Q 019536          125 TELPTLVFESVKYGTLRGFSFA---SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLS  201 (339)
Q Consensus       125 ~~~~~lv~e~~~~g~L~~~~~~---~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a  201 (339)
                      .+..++||||+++++|.+++..   .+++..+..++.|++.||.|||   +.+|+||||||+||+++ ++.+||+|||++
T Consensus       101 ~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~  176 (319)
T 2y4i_B          101 PPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLF  176 (319)
T ss_dssp             SSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCSCC
T ss_pred             CCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecCCc
Confidence            9999999999999999999873   5889999999999999999999   89999999999999998 679999999998


Q ss_pred             cccCCCCc---eeeeccccccccccccccccc---------CCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhH
Q 019536          202 VSIPEGET---HVREEFIKGAYGFIAPEYFAT---------SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTV  269 (339)
Q Consensus       202 ~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~  269 (339)
                      +.......   ........||+.|+|||++.+         ..++.++||||||+++|+|++|+.||.....        
T Consensus       177 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--------  248 (319)
T 2y4i_B          177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA--------  248 (319)
T ss_dssp             C----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH--------
T ss_pred             cccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------
Confidence            76532111   111123458899999999864         3578899999999999999999999852211        


Q ss_pred             HHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          270 LEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                      ...... ......     +...       ....+..+.+|+.+||+.||++|||+.++++.|+++...
T Consensus       249 ~~~~~~-~~~~~~-----~~~~-------~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~  303 (319)
T 2y4i_B          249 EAIIWQ-MGTGMK-----PNLS-------QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR  303 (319)
T ss_dssp             HHHHHH-HHTTCC-----CCCC-------CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred             HHHHHH-hccCCC-----CCCC-------cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence            111111 111110     0000       012233589999999999999999999999999987643

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2e-43  Score=315.77  Aligned_cols=251  Identities=17%  Similarity=0.286  Sum_probs=192.4

Q ss_pred             HhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeee--------
Q 019536           53 ATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLE--------  124 (339)
Q Consensus        53 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~--------  124 (339)
                      ..++|++.+.||+|+||+||+|.+..+++.||+|++...  ....+.+.+|+.+++.++||||+++++++.+        
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   81 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT--EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM   81 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc--HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence            357899999999999999999999989999999998653  2456778899999999999999999999865        


Q ss_pred             -----CCccEEEEEeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEe
Q 019536          125 -----TELPTLVFESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLH  196 (339)
Q Consensus       125 -----~~~~~lv~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~  196 (339)
                           .+..++||||+++|+|.+++.   ..++...++.++.|++.||.|||   +.+|+||||||+||+++.++.+||+
T Consensus        82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~kl~  158 (303)
T 1zy4_A           82 TAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIG  158 (303)
T ss_dssp             ----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEEC
T ss_pred             cccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCEEEe
Confidence                 345789999999999999986   35677888999999999999999   8999999999999999999999999


Q ss_pred             cCCCccccCCCCc------------eeeecccccccccccccccccC-CCCcccchHHHHHHHHHHHhCCCccccCCCCC
Q 019536          197 DFSLSVSIPEGET------------HVREEFIKGAYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGN  263 (339)
Q Consensus       197 dfg~a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~  263 (339)
                      |||+++.......            ........||..|+|||++.+. .++.++|||||||++|+|++   ||..     
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~-----  230 (303)
T 1zy4_A          159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFST-----  230 (303)
T ss_dssp             CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSS-----
T ss_pred             eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCC-----
Confidence            9999977643210            1111235688999999999765 68999999999999999998   3320     


Q ss_pred             CCchhHHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          264 DDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                        .......... .....      ..+...    .+...+..+.+|+.+||+.||++|||+.++++
T Consensus       231 --~~~~~~~~~~-~~~~~------~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          231 --GMERVNILKK-LRSVS------IEFPPD----FDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             --HHHHHHHHHH-HHSTT------CCCCTT----CCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --chhHHHHHHh-ccccc------cccCcc----ccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence              1111111111 11110      000111    11234456899999999999999999999987

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=7.5e-44  Score=328.25  Aligned_cols=263  Identities=15%  Similarity=0.185  Sum_probs=199.0

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcC-----------CCceeeeeeee
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMK-----------HKNILKLIGCC  122 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-----------H~niv~~~~~~  122 (339)
                      .++|++.+.||+|+||+||+|.+..+++.||||++....  ...+.+.+|+.+++.+.           ||||+++++++
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~   95 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF   95 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc--cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence            368999999999999999999999899999999997532  34566789999998886           89999999999


Q ss_pred             eeCC----ccEEEEEeccCCccccccc----cCCChHHHHHHHHHHHHHHHHHhcCCCC-CeEEccCCCCCEEeC-----
Q 019536          123 LETE----LPTLVFESVKYGTLRGFSF----ASLLIAPRIKIAMEIANAVAYLHVGFDR-PIVFRCIKASNVLLD-----  188 (339)
Q Consensus       123 ~~~~----~~~lv~e~~~~g~L~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~i~H~dlk~~Nil~~-----  188 (339)
                      ...+    ..++||||+ +++|.+++.    ..+++..+..++.||+.||.|||   +. +|+||||||+|||++     
T Consensus        96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~~~  171 (373)
T 1q8y_A           96 NHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSP  171 (373)
T ss_dssp             EEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETT
T ss_pred             hccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccCCC
Confidence            8654    689999999 889988875    35889999999999999999999   77 999999999999994     


Q ss_pred             -CCCceEEecCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCc-
Q 019536          189 -ENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDD-  266 (339)
Q Consensus       189 -~~~~~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~-  266 (339)
                       ..+.+||+|||+++.......     ...||+.|+|||++.+..++.++|||||||++|+|++|+.||.......... 
T Consensus       172 ~~~~~~kl~Dfg~a~~~~~~~~-----~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~  246 (373)
T 1q8y_A          172 ENLIQIKIADLGNACWYDEHYT-----NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD  246 (373)
T ss_dssp             TTEEEEEECCCTTCEETTBCCC-----SCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred             cCcceEEEcccccccccCCCCC-----CCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence             445799999999987654322     3468999999999999999999999999999999999999986433221111 


Q ss_pred             hhHHHHHHHHhhc--------C-----------ccccccc-------CcccCCCCCCCcHHHHHHHHHHHHHhhccCCCC
Q 019536          267 LTVLEYAKKSIEN--------N-----------RFGAIVD-------PIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEH  320 (339)
Q Consensus       267 ~~~~~~~~~~~~~--------~-----------~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~  320 (339)
                      .............        .           .+..+..       ......  ...+...+..+.+|+.+||+.||++
T Consensus       247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~  324 (373)
T 1q8y_A          247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEK--YKFSKDEAKEISDFLSPMLQLDPRK  324 (373)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHT--TCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred             HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhc--ccCCcchHHHHHHHHHHHhccCccc
Confidence            1111111110000        0           0000000       000001  1123467788999999999999999


Q ss_pred             CCCHHHHHH
Q 019536          321 RPLMVDVAK  329 (339)
Q Consensus       321 Rps~~~il~  329 (339)
                      |||+.++++
T Consensus       325 Rpt~~ell~  333 (373)
T 1q8y_A          325 RADAGGLVN  333 (373)
T ss_dssp             CBCHHHHHT
T ss_pred             cCCHHHHhh
Confidence            999999986

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.4e-44  Score=325.52  Aligned_cols=260  Identities=19%  Similarity=0.259  Sum_probs=197.9

Q ss_pred             ccHHHHHHHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC-ChhhHHHHHHHHHHHHhcC--CCceeeeeee
Q 019536           45 FSAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS-TLDDVEYCFNNIVFSSQMK--HKNILKLIGC  121 (339)
Q Consensus        45 ~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~--H~niv~~~~~  121 (339)
                      +.++.+....++|++.+.||+|+||.||+|.+. +++.||+|++.... .....+.+.+|+.+++.++  ||||++++++
T Consensus        18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~   96 (313)
T 3cek_A           18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY   96 (313)
T ss_dssp             --CCEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEE
T ss_pred             CCeeeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEE
Confidence            334444455678999999999999999999986 58899999997653 3345677889999999997  5999999999


Q ss_pred             eeeCCccEEEEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCC
Q 019536          122 CLETELPTLVFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFS  199 (339)
Q Consensus       122 ~~~~~~~~lv~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg  199 (339)
                      +.+++..++||| +.+++|.+++.  ..++...+..++.|++.||.|||   +.+|+||||||+||+++. +.+||+|||
T Consensus        97 ~~~~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~~kL~Dfg  171 (313)
T 3cek_A           97 EITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GMLKLIDFG  171 (313)
T ss_dssp             EECSSEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TEEEECCCS
T ss_pred             eecCCEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-CeEEEeecc
Confidence            999999999999 56889999876  56888899999999999999999   899999999999999974 899999999


Q ss_pred             CccccCCCCceeeeccccccccccccccccc-----------CCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchh
Q 019536          200 LSVSIPEGETHVREEFIKGAYGFIAPEYFAT-----------SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLT  268 (339)
Q Consensus       200 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~  268 (339)
                      +++...............||+.|+|||++.+           ..++.++||||||+++|+|++|+.||.....       
T Consensus       172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-------  244 (313)
T 3cek_A          172 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-------  244 (313)
T ss_dssp             SSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS-------
T ss_pred             ccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH-------
Confidence            9987655433222224568999999999875           4688899999999999999999999852211       


Q ss_pred             HHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          269 VLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      .............         .  ..++  ...+..+.+++.+||+.||++|||+.+++++
T Consensus       245 ~~~~~~~~~~~~~---------~--~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  293 (313)
T 3cek_A          245 QISKLHAIIDPNH---------E--IEFP--DIPEKDLQDVLKCCLKRDPKQRISIPELLAH  293 (313)
T ss_dssp             HHHHHHHHHCTTS---------C--CCCC--CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHHHHHHhccc---------c--cCCc--ccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence            1111111111110         0  0111  1224578999999999999999999999874

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=8e-44  Score=324.02  Aligned_cols=250  Identities=18%  Similarity=0.221  Sum_probs=175.1

Q ss_pred             HhcCcccCC-ceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHH-HHHHHhcCCCceeeeeeeeee----CC
Q 019536           53 ATNNYDLHK-VIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNN-IVFSSQMKHKNILKLIGCCLE----TE  126 (339)
Q Consensus        53 ~~~~~~~~~-~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e-~~~l~~l~H~niv~~~~~~~~----~~  126 (339)
                      ..++|.+.+ .||+|+||+||+|.+..+++.||+|++....      ...+| ...++.+.||||+++++++..    +.
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~   99 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP------KARQEVDHHWQASGGPHIVCILDVYENMHHGKR   99 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH------HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH------HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence            457899855 6999999999999999999999999986531      12233 334567799999999999976    44


Q ss_pred             ccEEEEEeccCCcccccccc----CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCC---CCceEEecCC
Q 019536          127 LPTLVFESVKYGTLRGFSFA----SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDE---NYSAKLHDFS  199 (339)
Q Consensus       127 ~~~lv~e~~~~g~L~~~~~~----~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~---~~~~kl~dfg  199 (339)
                      ..++||||+++|+|.+++..    .+++..++.++.|++.||.|||   +.+|+||||||+||+++.   ++.+||+|||
T Consensus       100 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg  176 (336)
T 3fhr_A          100 CLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFG  176 (336)
T ss_dssp             EEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEeccc
Confidence            58999999999999999862    5889999999999999999999   899999999999999976   4559999999


Q ss_pred             CccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhc
Q 019536          200 LSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIEN  279 (339)
Q Consensus       200 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  279 (339)
                      +++........    ...+|+.|+|||++.+..++.++||||||+++|+|++|+.||...........     .......
T Consensus       177 ~~~~~~~~~~~----~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-----~~~~~~~  247 (336)
T 3fhr_A          177 FAKETTQNALQ----TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG-----MKRRIRL  247 (336)
T ss_dssp             TCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------------
T ss_pred             cceeccccccc----cCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh-----HHHhhhc
Confidence            99866443221    35689999999999888899999999999999999999999853322110000     0000000


Q ss_pred             CcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          280 NRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      ..          .....+.....+..+.+|+.+||+.||++|||+.+++++
T Consensus       248 ~~----------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  288 (336)
T 3fhr_A          248 GQ----------YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH  288 (336)
T ss_dssp             -------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             cc----------cccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            00          001111122456679999999999999999999999973

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=8.3e-44  Score=322.07  Aligned_cols=266  Identities=18%  Similarity=0.261  Sum_probs=198.5

Q ss_pred             HHhcCcccCCceeccCCeeEEEEEEc-CCCeeEEEEEeccCCCh-hhHHHHHHHHHHHHhc---CCCceeeeeeeee---
Q 019536           52 KATNNYDLHKVIQSDTSYRLFEGTLV-DQDRPISVMKFHDNSTL-DDVEYCFNNIVFSSQM---KHKNILKLIGCCL---  123 (339)
Q Consensus        52 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l---~H~niv~~~~~~~---  123 (339)
                      ...++|++.+.||+|+||+||+|.+. .+++.||+|++...... .....+.+|+.+++.+   .||||+++++++.   
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   87 (326)
T 1blx_A            8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   87 (326)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence            34588999999999999999999995 67899999998754221 1223455777777666   8999999999987   


Q ss_pred             --eCCccEEEEEeccCCccccccc----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEec
Q 019536          124 --ETELPTLVFESVKYGTLRGFSF----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHD  197 (339)
Q Consensus       124 --~~~~~~lv~e~~~~g~L~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~d  197 (339)
                        .....++||||++ |+|.+++.    ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl~D  163 (326)
T 1blx_A           88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLAD  163 (326)
T ss_dssp             CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECS
T ss_pred             cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEEec
Confidence              4567899999997 68888875    34889999999999999999999   89999999999999999999999999


Q ss_pred             CCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHh
Q 019536          198 FSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSI  277 (339)
Q Consensus       198 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  277 (339)
                      ||+++........   ....||..|+|||++.+..++.++||||||+++|+|++|+.||.....     ...........
T Consensus       164 fg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~i~~~~  235 (326)
T 1blx_A          164 FGLARIYSFQMAL---TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD-----VDQLGKILDVI  235 (326)
T ss_dssp             CCSCCCCCGGGGG---CCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHHH
T ss_pred             CcccccccCCCCc---cccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH-----HHHHHHHHHHc
Confidence            9999766433211   135689999999999988999999999999999999999999753211     11111111111


Q ss_pred             h---cCcccccc---cCcccCCCCCC---CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          278 E---NNRFGAIV---DPIFDEDNSFP---GKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       278 ~---~~~~~~~~---~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                      .   ...+....   ...+......+   .....+..+.+|+.+||+.||++|||+.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          236 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             CCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            0   00000000   00000000000   01134567899999999999999999999985

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2.1e-43  Score=322.69  Aligned_cols=260  Identities=17%  Similarity=0.172  Sum_probs=198.4

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCC-eeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCc------eeeeeeeeeeCC
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQD-RPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKN------ILKLIGCCLETE  126 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~n------iv~~~~~~~~~~  126 (339)
                      .++|++.+.||+|+||+||+|.+..++ ..||+|++...  ....+.+.+|+.+++.++|+|      ++.+++++...+
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~   95 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV--GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG   95 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc--ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence            478999999999999999999998766 79999999753  244567788999999998766      899999999999


Q ss_pred             ccEEEEEeccCCccccccc----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEe---------------
Q 019536          127 LPTLVFESVKYGTLRGFSF----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLL---------------  187 (339)
Q Consensus       127 ~~~lv~e~~~~g~L~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~---------------  187 (339)
                      ..++||||+ ++++.+++.    ..+++..+..++.||+.||.|||   +.+|+||||||+|||+               
T Consensus        96 ~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~  171 (355)
T 2eu9_A           96 HMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSC  171 (355)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred             eEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecccccccccccccc
Confidence            999999999 555555543    35889999999999999999999   9999999999999999               


Q ss_pred             ----CCCCceEEecCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCC
Q 019536          188 ----DENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGN  263 (339)
Q Consensus       188 ----~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~  263 (339)
                          +.++.+||+|||+++.......     ...||+.|+|||++.+..++.++|||||||++|+|++|+.||.....  
T Consensus       172 ~~~~~~~~~~kl~Dfg~~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--  244 (355)
T 2eu9_A          172 EEKSVKNTSIRVADFGSATFDHEHHT-----TIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN--  244 (355)
T ss_dssp             CEEEESCCCEEECCCTTCEETTSCCC-----SSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--
T ss_pred             cccccCCCcEEEeecCcccccccccc-----CCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH--
Confidence                5678899999999986544322     35689999999999999999999999999999999999999853221  


Q ss_pred             CCchhHHHHHHHHhhc--------Cccccc-ccCcccC-----------------CCCCCCcHHHHHHHHHHHHHhhccC
Q 019536          264 DDDLTVLEYAKKSIEN--------NRFGAI-VDPIFDE-----------------DNSFPGKEEKLQSLGQLMYKCLSKS  317 (339)
Q Consensus       264 ~~~~~~~~~~~~~~~~--------~~~~~~-~~~~~~~-----------------~~~~~~~~~~~~~~~~li~~cl~~d  317 (339)
                         .............        ...... .......                 ..........+..+.+|+.+||+.|
T Consensus       245 ---~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d  321 (355)
T 2eu9_A          245 ---REHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFD  321 (355)
T ss_dssp             ---HHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred             ---HHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCC
Confidence               1111111111100        000000 0000000                 0000111245678999999999999


Q ss_pred             CCCCCCHHHHHH
Q 019536          318 PEHRPLMVDVAK  329 (339)
Q Consensus       318 P~~Rps~~~il~  329 (339)
                      |++|||+.++++
T Consensus       322 P~~Rpt~~e~l~  333 (355)
T 2eu9_A          322 PAQRITLAEALL  333 (355)
T ss_dssp             TTTSCCHHHHTT
T ss_pred             hhhCcCHHHHhc
Confidence            999999999985

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=2.2e-44  Score=325.49  Aligned_cols=245  Identities=18%  Similarity=0.290  Sum_probs=200.3

Q ss_pred             HHHHHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCCh-----hhHHHHHHHHHHHHhcC--CCceeeeeee
Q 019536           49 DLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTL-----DDVEYCFNNIVFSSQMK--HKNILKLIGC  121 (339)
Q Consensus        49 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~l~--H~niv~~~~~  121 (339)
                      +.....++|++.+.||+|+||+||+|.+..+++.||||++......     .....+.+|+.+++.+.  ||||++++++
T Consensus        37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~  116 (320)
T 3a99_A           37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW  116 (320)
T ss_dssp             ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred             ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence            3445568899999999999999999999999999999998764321     12244668999999996  5999999999


Q ss_pred             eeeCCccEEEEEeccC-Cccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeC-CCCceEEec
Q 019536          122 CLETELPTLVFESVKY-GTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLD-ENYSAKLHD  197 (339)
Q Consensus       122 ~~~~~~~~lv~e~~~~-g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~-~~~~~kl~d  197 (339)
                      +.+++..++|||++.+ ++|.+++.  ..+++..+..++.|++.||.|||   +.+|+||||||+||+++ .++.+||+|
T Consensus       117 ~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~kL~D  193 (320)
T 3a99_A          117 FERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLID  193 (320)
T ss_dssp             EECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECC
T ss_pred             EecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCCEEEee
Confidence            9999999999999976 89998876  57889999999999999999999   89999999999999999 788999999


Q ss_pred             CCCccccCCCCceeeecccccccccccccccccCCC-CcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHH
Q 019536          198 FSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSF-NEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKS  276 (339)
Q Consensus       198 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  276 (339)
                      ||+++........    ...||+.|+|||++.+..+ +.++||||||+++|+|++|+.||....          .    .
T Consensus       194 fg~~~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~----------~----~  255 (320)
T 3a99_A          194 FGSGALLKDTVYT----DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----------E----I  255 (320)
T ss_dssp             CTTCEECCSSCBC----CCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----------H----H
T ss_pred             Ccccccccccccc----CCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh----------h----h
Confidence            9999876543321    3468999999999987766 688999999999999999999985210          0    0


Q ss_pred             hhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          277 IENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                      ... ..            ..  +...+..+.+|+.+||+.||++|||+.++++
T Consensus       256 ~~~-~~------------~~--~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          256 IRG-QV------------FF--RQRVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             HHC-CC------------CC--SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hcc-cc------------cc--cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            000 00            00  0123457899999999999999999999987

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4e-43  Score=347.60  Aligned_cols=244  Identities=20%  Similarity=0.282  Sum_probs=200.6

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcC-CCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCc-----
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVD-QDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETEL-----  127 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~-----  127 (339)
                      .++|++.+.||+|+||+||+|.+.. +++.||||++...........+.+|+.+++.++||||+++++++.+.+.     
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            3789999999999999999999975 7899999998776555666778899999999999999999999987665     


Q ss_pred             cEEEEEeccCCccccccccCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCC
Q 019536          128 PTLVFESVKYGTLRGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEG  207 (339)
Q Consensus       128 ~~lv~e~~~~g~L~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~  207 (339)
                      .|+||||+++++|.+++...+++..++.++.||+.||.|||   +.+|+||||||+|||++.+ .+||+|||+++.....
T Consensus       159 ~~lv~E~~~g~~L~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~  234 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF  234 (681)
T ss_dssp             EEEEEECCCCEECC----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC
T ss_pred             eEEEEEeCCCCcHHHHHhCCCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecccchhcccC
Confidence            69999999999999998889999999999999999999999   8999999999999999975 8999999999876543


Q ss_pred             CceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCccccccc
Q 019536          208 ETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVD  287 (339)
Q Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (339)
                      .      ...||+.|+|||++.+.. +.++|||||||++|+|++|.+||.......                        
T Consensus       235 ~------~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~------------------------  283 (681)
T 2pzi_A          235 G------YLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG------------------------  283 (681)
T ss_dssp             S------CCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS------------------------
T ss_pred             C------ccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc------------------------
Confidence            2      356999999999987654 889999999999999999988864211100                        


Q ss_pred             CcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCC-HHHHHHHHHHHHhh
Q 019536          288 PIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPL-MVDVAKQLRQMYLS  337 (339)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps-~~~il~~L~~l~~~  337 (339)
                        +.   ........+..+.+|+.+||+.||++||+ ++++.+.|..+..+
T Consensus       284 --~~---~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~  329 (681)
T 2pzi_A          284 --LP---EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLRE  329 (681)
T ss_dssp             --CC---TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHH
T ss_pred             --cc---ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHH
Confidence              00   00011134467899999999999999995 66777777766543

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.3e-44  Score=321.09  Aligned_cols=245  Identities=21%  Similarity=0.315  Sum_probs=192.4

Q ss_pred             HHHHHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCCh-----hhHHHHHHHHHHHHhc----CCCceeeee
Q 019536           49 DLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTL-----DDVEYCFNNIVFSSQM----KHKNILKLI  119 (339)
Q Consensus        49 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~l----~H~niv~~~  119 (339)
                      +.....++|++.+.||+|+||.||+|.+..+++.||+|++......     .....+.+|+.++..+    +||||++++
T Consensus        25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~  104 (312)
T 2iwi_A           25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL  104 (312)
T ss_dssp             --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred             chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence            4455668999999999999999999999989999999999765321     1223355799999998    899999999


Q ss_pred             eeeeeCCccEEEEEe-ccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeC-CCCceEE
Q 019536          120 GCCLETELPTLVFES-VKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLD-ENYSAKL  195 (339)
Q Consensus       120 ~~~~~~~~~~lv~e~-~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~-~~~~~kl  195 (339)
                      +++.+.+..++|||+ +++++|.+++.  ..+++..++.++.|++.||.|||   +.+|+||||||+||+++ .++.+||
T Consensus       105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl  181 (312)
T 2iwi_A          105 DWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKL  181 (312)
T ss_dssp             EEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTTEEEE
T ss_pred             EEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCCeEEE
Confidence            999999999999999 78999999986  56899999999999999999999   89999999999999999 8899999


Q ss_pred             ecCCCccccCCCCceeeecccccccccccccccccCCCC-cccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHH
Q 019536          196 HDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFN-EMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAK  274 (339)
Q Consensus       196 ~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~  274 (339)
                      +|||+++........    ...||..|+|||++.+..+. .++||||||+++|+|++|+.||...        .  ..  
T Consensus       182 ~dfg~~~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~--------~--~~--  245 (312)
T 2iwi_A          182 IDFGSGALLHDEPYT----DFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD--------Q--EI--  245 (312)
T ss_dssp             CCCSSCEECCSSCBC----CCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH--------H--HH--
T ss_pred             EEcchhhhcccCccc----ccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh--------H--HH--
Confidence            999999877543322    34689999999999877764 5899999999999999999997521        0  00  


Q ss_pred             HHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          275 KSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                        . ...            ..++  ...+..+.+|+.+||+.||++|||+.++++
T Consensus       246 --~-~~~------------~~~~--~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          246 --L-EAE------------LHFP--AHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             --H-HTC------------CCCC--TTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             --h-hhc------------cCCc--ccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              0 000            0011  134457899999999999999999999987

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.8e-43  Score=318.68  Aligned_cols=252  Identities=19%  Similarity=0.266  Sum_probs=183.6

Q ss_pred             HHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHH-HHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 019536           52 KATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCF-NNIVFSSQMKHKNILKLIGCCLETELPTL  130 (339)
Q Consensus        52 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~-~e~~~l~~l~H~niv~~~~~~~~~~~~~l  130 (339)
                      ...++|++.+.||+|+||.||+|.+..+++.||||++...........+. .+..+++.++||||+++++++.+++..++
T Consensus        22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~l  101 (318)
T 2dyl_A           22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFI  101 (318)
T ss_dssp             CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEE
Confidence            34578999999999999999999999899999999998765444444444 44557888899999999999999999999


Q ss_pred             EEEeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCC-CeEEccCCCCCEEeCCCCceEEecCCCccccCC
Q 019536          131 VFESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDR-PIVFRCIKASNVLLDENYSAKLHDFSLSVSIPE  206 (339)
Q Consensus       131 v~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~  206 (339)
                      ||||+ ++.+..+..   ..+++..+..++.|++.||.|||   +. +|+||||||+||+++.++.+||+|||++.....
T Consensus       102 v~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  177 (318)
T 2dyl_A          102 AMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD  177 (318)
T ss_dssp             EECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             EEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence            99999 445544443   57889999999999999999999   75 999999999999999999999999999876644


Q ss_pred             CCceeeecccccccccccccccc-----cCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCc
Q 019536          207 GETHVREEFIKGAYGFIAPEYFA-----TSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNR  281 (339)
Q Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (339)
                      ....   ....||+.|+|||++.     +..++.++||||||+++|+|++|+.||.....       .............
T Consensus       178 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~~~~~~~~~  247 (318)
T 2dyl_A          178 DKAK---DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT-------DFEVLTKVLQEEP  247 (318)
T ss_dssp             ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS-------HHHHHHHHHHSCC
T ss_pred             Cccc---cccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc-------cHHHHHHHhccCC
Confidence            3322   1346899999999984     45688999999999999999999999853211       1111111111110


Q ss_pred             ccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          282 FGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                                  ...+.....+..+.+|+.+||+.||.+|||+.++++
T Consensus       248 ------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          248 ------------PLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             ------------CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ------------CCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence                        011111134457999999999999999999999987

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=2.1e-43  Score=343.04  Aligned_cols=269  Identities=17%  Similarity=0.218  Sum_probs=204.0

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeee------CCc
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLE------TEL  127 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~------~~~  127 (339)
                      .++|++.+.||+|+||+||+|.+..+|+.||||++.........+.+.+|+.+++.++||||+++++++..      ++.
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            47899999999999999999999989999999999876665667889999999999999999999999765      667


Q ss_pred             cEEEEEeccCCcccccccc-----CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCc---eEEecCC
Q 019536          128 PTLVFESVKYGTLRGFSFA-----SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYS---AKLHDFS  199 (339)
Q Consensus       128 ~~lv~e~~~~g~L~~~~~~-----~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~---~kl~dfg  199 (339)
                      .++||||+++|+|.+++..     .+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.   +||+|||
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence            8999999999999999863     5888999999999999999999   899999999999999986654   8999999


Q ss_pred             CccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhc
Q 019536          200 LSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIEN  279 (339)
Q Consensus       200 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  279 (339)
                      +++........   ....||+.|+|||++.+..++.++||||+||++|+|++|..||.....       ...+.......
T Consensus       170 ~a~~~~~~~~~---~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~-------~~~~~~~i~~~  239 (676)
T 3qa8_A          170 YAKELDQGELC---TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ-------PVQWHGKVREK  239 (676)
T ss_dssp             CCCBTTSCCCC---CCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH-------HHHSSTTCC--
T ss_pred             ccccccccccc---ccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc-------hhhhhhhhhcc
Confidence            99877554322   135689999999999999999999999999999999999999853210       00000000000


Q ss_pred             ----CcccccccCccc--CCCCCC--CcHHHHHHHHHHHHHhhccCCCCCCCHHHH-----HHHHHHHH
Q 019536          280 ----NRFGAIVDPIFD--EDNSFP--GKEEKLQSLGQLMYKCLSKSPEHRPLMVDV-----AKQLRQMY  335 (339)
Q Consensus       280 ----~~~~~~~~~~~~--~~~~~~--~~~~~~~~~~~li~~cl~~dP~~Rps~~~i-----l~~L~~l~  335 (339)
                          ............  ...+.|  .....+..+.+|+.+||++||++|||+.++     .+.++.+.
T Consensus       240 ~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL  308 (676)
T 3qa8_A          240 SNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSIL  308 (676)
T ss_dssp             ----CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHH
T ss_pred             cchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHH
Confidence                000000011111  111111  123577889999999999999999999884     44555544

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=6.6e-43  Score=328.62  Aligned_cols=248  Identities=18%  Similarity=0.253  Sum_probs=184.8

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCccEEEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLETELPTLVFE  133 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e  133 (339)
                      +.|...+.||+|+||+||.+.. .+|+.||||++...    ..+.+.+|+.++..+ +||||+++++++.+++..++|||
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~-~~g~~vAvK~~~~~----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E   89 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGS-FQGRPVAVKRMLID----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE   89 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEE-SSSSEEEEEEEEGG----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred             heeeccCeEeeCCCeEEEEEEE-ECCeEEEEEEEcHH----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence            3455678899999999987544 47999999998653    345677999999876 89999999999999999999999


Q ss_pred             eccCCccccccccCC---------ChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCC-------------C
Q 019536          134 SVKYGTLRGFSFASL---------LIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDEN-------------Y  191 (339)
Q Consensus       134 ~~~~g~L~~~~~~~~---------~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~-------------~  191 (339)
                      |++ |+|.+++....         .+..++.++.||+.||.|||   +.+|+||||||+|||++.+             +
T Consensus        90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~  165 (434)
T 2rio_A           90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENL  165 (434)
T ss_dssp             CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred             cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCce
Confidence            995 69999876321         22234679999999999999   8999999999999999654             4


Q ss_pred             ceEEecCCCccccCCCCcee--eeccccccccccccccccc-------CCCCcccchHHHHHHHHHHHh-CCCccccCCC
Q 019536          192 SAKLHDFSLSVSIPEGETHV--REEFIKGAYGFIAPEYFAT-------SSFNEMCDVYSFGAFLCELLT-GCNVLEFKGN  261 (339)
Q Consensus       192 ~~kl~dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~  261 (339)
                      .+||+|||+++.........  ......||+.|+|||++.+       ..++.++|||||||++|+|++ |+.||.....
T Consensus       166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~  245 (434)
T 2rio_A          166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS  245 (434)
T ss_dssp             EEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred             EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence            79999999998876543221  1223579999999999975       568899999999999999999 9999752211


Q ss_pred             CCCCchhHHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          262 GNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                            ......    . ...    .  . ...........+.++.+|+.+||+.||++|||+.+|++
T Consensus       246 ------~~~~i~----~-~~~----~--~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          246 ------RESNII----R-GIF----S--L-DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             ------HHHHHH----H-TCC----C--C-CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ------hHHHHh----c-CCC----C--c-ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence                  001110    0 000    0  0 00111123467788999999999999999999999986

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=5.5e-42  Score=305.00  Aligned_cols=231  Identities=13%  Similarity=0.072  Sum_probs=188.5

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC--hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST--LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVF  132 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  132 (339)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.....  ....+.+.+|+.+++.++||||+++++++.+++..|+||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            679999999999999999999998899999999987643  244577889999999999999999999999999999999


Q ss_pred             EeccCCccccccccCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceee
Q 019536          133 ESVKYGTLRGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVR  212 (339)
Q Consensus       133 e~~~~g~L~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~  212 (339)
                      ||+++++|.+++.......+...++.|++.||.|||   +.+|+||||||+|||++.++.+||+++|             
T Consensus       111 e~~~g~~L~~~l~~~~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~-------------  174 (286)
T 3uqc_A          111 EWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPA-------------  174 (286)
T ss_dssp             ECCCEEEHHHHHTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCC-------------
T ss_pred             EecCCCCHHHHHhcCCChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEecc-------------
Confidence            999999999999866666678889999999999999   8999999999999999999999998554             


Q ss_pred             ecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccC
Q 019536          213 EEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDE  292 (339)
Q Consensus       213 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (339)
                               |++       .++.++|||||||++|+|++|+.||.........  .                ........
T Consensus       175 ---------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~--~----------------~~~~~~~~  220 (286)
T 3uqc_A          175 ---------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGL--A----------------PAERDTAG  220 (286)
T ss_dssp             ---------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCS--E----------------ECCBCTTS
T ss_pred             ---------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhh--H----------------HHHHHhcc
Confidence                     222       3688999999999999999999998643221100  0                00000001


Q ss_pred             CCCCC--CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 019536          293 DNSFP--GKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYL  336 (339)
Q Consensus       293 ~~~~~--~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~  336 (339)
                      ....+  .....+..+.+|+.+||+.||++| |+.++++.|+++..
T Consensus       221 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~  265 (286)
T 3uqc_A          221 QPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA  265 (286)
T ss_dssp             CBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred             CCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence            00000  001345679999999999999999 99999999998764

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.2e-42  Score=326.26  Aligned_cols=246  Identities=18%  Similarity=0.271  Sum_probs=183.4

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCccEEEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLETELPTLVFE  133 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~~lv~e  133 (339)
                      .+|.+.+.||+|+||+|+.... .+++.||||++.....    ..+.+|+.+++.+ +||||+++++++.+....++|||
T Consensus        24 ~~y~~~~~LG~G~~G~V~~~~~-~~~~~vAvK~~~~~~~----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E   98 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVYRGM-FDNRDVAVKRILPECF----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE   98 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEEEEE-SSSSEEEEEEECTTTE----EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             EEEecCCeeecCcCEEEEEEEE-eCCeEEEEEEECHHHH----HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence            5699999999999999654333 3789999999976432    2245899999999 79999999999999999999999


Q ss_pred             eccCCcccccccc---CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCC-----CCceEEecCCCccccC
Q 019536          134 SVKYGTLRGFSFA---SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDE-----NYSAKLHDFSLSVSIP  205 (339)
Q Consensus       134 ~~~~g~L~~~~~~---~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~-----~~~~kl~dfg~a~~~~  205 (339)
                      |++ |+|.+++..   ......++.++.||+.||.|||   +.+|+||||||+|||++.     ...+||+|||+|+...
T Consensus        99 ~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~  174 (432)
T 3p23_A           99 LCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA  174 (432)
T ss_dssp             CCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred             CCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence            996 688888752   3445566789999999999999   899999999999999953     3358899999998775


Q ss_pred             CCCce-eeecccccccccccccccc---cCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcC
Q 019536          206 EGETH-VREEFIKGAYGFIAPEYFA---TSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENN  280 (339)
Q Consensus       206 ~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  280 (339)
                      ..... .......||+.|+|||++.   +..++.++|||||||++|+|++ |..||.....      ..   ........
T Consensus       175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~------~~---~~~~~~~~  245 (432)
T 3p23_A          175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ------RQ---ANILLGAC  245 (432)
T ss_dssp             -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT------HH---HHHHTTCC
T ss_pred             CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH------HH---HHHHhccC
Confidence            43221 1222457999999999997   3567889999999999999999 8888742111      00   01111100


Q ss_pred             cccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          281 RFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                      ..          . ........+..+.+|+.+||+.||++|||+.+|++
T Consensus       246 ~~----------~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          246 SL----------D-CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             CC----------T-TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             Cc----------c-ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            00          0 01111245667899999999999999999999985

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=4e-41  Score=301.24  Aligned_cols=227  Identities=17%  Similarity=0.254  Sum_probs=180.3

Q ss_pred             hcCcccC-CceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHH-HhcCCCceeeeeeeeee----CCc
Q 019536           54 TNNYDLH-KVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFS-SQMKHKNILKLIGCCLE----TEL  127 (339)
Q Consensus        54 ~~~~~~~-~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l-~~l~H~niv~~~~~~~~----~~~  127 (339)
                      .++|.+. +.||+|+||.||+|.+..+++.||+|++...      ..+.+|+.++ +..+||||+++++++..    +..
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~   89 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC   89 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence            4678777 7899999999999999999999999999642      3466888887 55699999999999987    667


Q ss_pred             cEEEEEeccCCccccccc----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCC---CCceEEecCCC
Q 019536          128 PTLVFESVKYGTLRGFSF----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDE---NYSAKLHDFSL  200 (339)
Q Consensus       128 ~~lv~e~~~~g~L~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~---~~~~kl~dfg~  200 (339)
                      .++||||+++|+|.+++.    ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.   ++.+||+|||+
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~  166 (299)
T 3m2w_A           90 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGF  166 (299)
T ss_dssp             EEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence            899999999999999986    25889999999999999999999   899999999999999998   78899999998


Q ss_pred             ccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcC
Q 019536          201 SVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENN  280 (339)
Q Consensus       201 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  280 (339)
                      +....                        +..++.++||||+||++|+|++|+.||........                
T Consensus       167 a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~----------------  206 (299)
T 3m2w_A          167 AKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI----------------  206 (299)
T ss_dssp             CEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC----------------------
T ss_pred             ccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh----------------
Confidence            85432                        24567889999999999999999999853221110                


Q ss_pred             cccccccCcccCCCCCCCc--HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          281 RFGAIVDPIFDEDNSFPGK--EEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                       ...............+.+  ...+.++.+|+.+||+.||++|||+.+++++
T Consensus       207 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h  257 (299)
T 3m2w_A          207 -SPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  257 (299)
T ss_dssp             --CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             -hHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence             000011111111112211  2356789999999999999999999999873

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.4e-41  Score=317.70  Aligned_cols=239  Identities=16%  Similarity=0.164  Sum_probs=179.8

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC--hhhHHHHHHHHHHHHhcCC-Cceee--------------
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST--LDDVEYCFNNIVFSSQMKH-KNILK--------------  117 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H-~niv~--------------  117 (339)
                      ..|...+.||+|+||+||+|.+..+|+.||||++.....  ....+.+.+|+.+++.+.| +|...              
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            457788999999999999999999999999999884432  1335778899999999977 32211              


Q ss_pred             -------eeeeeee-----CCccEEEEEeccCCccccccc---------cCCChHHHHHHHHHHHHHHHHHhcCCCCCeE
Q 019536          118 -------LIGCCLE-----TELPTLVFESVKYGTLRGFSF---------ASLLIAPRIKIAMEIANAVAYLHVGFDRPIV  176 (339)
Q Consensus       118 -------~~~~~~~-----~~~~~lv~e~~~~g~L~~~~~---------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~  176 (339)
                             +..++..     ....+++|+++ +++|.+++.         ..+++..++.++.|++.||.|||   +.+|+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ii  233 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLV  233 (413)
T ss_dssp             ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred             ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcc
Confidence                   1111111     12346677765 688988873         44677788889999999999999   89999


Q ss_pred             EccCCCCCEEeCCCCceEEecCCCccccCCCCceeeeccccccccccccccc----------ccCCCCcccchHHHHHHH
Q 019536          177 FRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYF----------ATSSFNEMCDVYSFGAFL  246 (339)
Q Consensus       177 H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DiwslG~~l  246 (339)
                      ||||||+|||++.++.+||+|||+++.....     .....| +.|+|||++          .+..++.++|||||||++
T Consensus       234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil  307 (413)
T 3dzo_A          234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI  307 (413)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred             cCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence            9999999999999999999999998765432     223567 999999999          555688999999999999


Q ss_pred             HHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 019536          247 CELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVD  326 (339)
Q Consensus       247 ~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~  326 (339)
                      |+|++|+.||.......                     ..+..+....      ..+..+.+|+.+||+.||++|||+.+
T Consensus       308 ~elltg~~Pf~~~~~~~---------------------~~~~~~~~~~------~~~~~~~~li~~~l~~dP~~Rpt~~~  360 (413)
T 3dzo_A          308 YWIWCADLPNTDDAALG---------------------GSEWIFRSCK------NIPQPVRALLEGFLRYPKEDRLLPLQ  360 (413)
T ss_dssp             HHHHHSSCCCCTTGGGS---------------------CSGGGGSSCC------CCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HHHHHCCCCCCCcchhh---------------------hHHHHHhhcc------cCCHHHHHHHHHHccCChhhCcCHHH
Confidence            99999999985322111                     1111122111      22357999999999999999999988


Q ss_pred             HHHH
Q 019536          327 VAKQ  330 (339)
Q Consensus       327 il~~  330 (339)
                      +++.
T Consensus       361 ~l~~  364 (413)
T 3dzo_A          361 AMET  364 (413)
T ss_dssp             HTTS
T ss_pred             HHhC
Confidence            8653

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.7e-41  Score=308.64  Aligned_cols=242  Identities=14%  Similarity=0.128  Sum_probs=184.0

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC-------hhhHHHHHHHHHHHHhcC---------CCceee
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST-------LDDVEYCFNNIVFSSQMK---------HKNILK  117 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~e~~~l~~l~---------H~niv~  117 (339)
                      .++|++.+.||+|+||+||+|++  +++.||||++.....       ....+.+.+|+.+++.++         ||||++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            46799999999999999999998  789999999986532       234477889999999886         555555


Q ss_pred             eeee-----------------eee-------------CCccEEEEEeccCCcccccc-ccCCChHHHHHHHHHHHHHHHH
Q 019536          118 LIGC-----------------CLE-------------TELPTLVFESVKYGTLRGFS-FASLLIAPRIKIAMEIANAVAY  166 (339)
Q Consensus       118 ~~~~-----------------~~~-------------~~~~~lv~e~~~~g~L~~~~-~~~~~~~~~~~i~~~i~~~l~~  166 (339)
                      +.++                 +.+             .+..++||||+++|++.+.+ ...+++..+..++.||+.||.|
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL~~  176 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAV  176 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence            5554                 433             67899999999999655554 4678999999999999999999


Q ss_pred             HhcCCCCCeEEccCCCCCEEeCCCC--------------------ceEEecCCCccccCCCCceeeeccccccccccccc
Q 019536          167 LHVGFDRPIVFRCIKASNVLLDENY--------------------SAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPE  226 (339)
Q Consensus       167 LH~~~~~~i~H~dlk~~Nil~~~~~--------------------~~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE  226 (339)
                      ||+  +.+|+||||||+|||++.++                    .+||+|||+|+.....       ...||+.|+|||
T Consensus       177 lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y~aPE  247 (336)
T 2vuw_A          177 AEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVSMDED  247 (336)
T ss_dssp             HHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCTTCSG
T ss_pred             HHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecccChh
Confidence            993  37899999999999999887                    8999999999876432       246899999999


Q ss_pred             ccccCCCCcccchHHHHHH-HHHHHhCCCccccCCCCCCCchhHHHHH-HHHhhcCcccccccCcccCCCCCCCcHHHHH
Q 019536          227 YFATSSFNEMCDVYSFGAF-LCELLTGCNVLEFKGNGNDDDLTVLEYA-KKSIENNRFGAIVDPIFDEDNSFPGKEEKLQ  304 (339)
Q Consensus       227 ~~~~~~~~~~~DiwslG~~-l~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (339)
                      ++.+.. +.++||||+|++ .+++++|..||..        ....... .........        ......+.+...+.
T Consensus       248 ~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~--------~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~s~  310 (336)
T 2vuw_A          248 LFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN--------VLWLHYLTDKMLKQMTF--------KTKCNTPAMKQIKR  310 (336)
T ss_dssp             GGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH--------HHHHHHHHHHHHHTCCC--------SSCCCSHHHHHHHH
T ss_pred             hhcCCC-ccceehhhhhCCCCcccccccCCCcc--------hhhhhHHHHhhhhhhcc--------CcccchhhhhhcCH
Confidence            998776 889999998776 7778889988741        0000001 111111000        11111122346788


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHH
Q 019536          305 SLGQLMYKCLSKSPEHRPLMVDVA  328 (339)
Q Consensus       305 ~~~~li~~cl~~dP~~Rps~~~il  328 (339)
                      ++.+|+.+||++|     |+.|++
T Consensus       311 ~~~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          311 KIQEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHHHHHGGGSS-----SHHHHH
T ss_pred             HHHHHHHHHhccC-----CHHHHH
Confidence            9999999999977     999988

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=2.2e-34  Score=278.36  Aligned_cols=186  Identities=16%  Similarity=0.030  Sum_probs=130.7

Q ss_pred             eeccCCeeEEEEEEcCCCeeEEEEEeccCCC---------hhhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCccEEEE
Q 019536           63 IQSDTSYRLFEGTLVDQDRPISVMKFHDNST---------LDDVEYCFNNIVFSSQM-KHKNILKLIGCCLETELPTLVF  132 (339)
Q Consensus        63 ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~~lv~  132 (339)
                      .+.|++|.+..++....|+.+++|.+.....         ....+.+.+|+.+|+++ .|+||+++++++++++..||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            3455666666666656788999999976421         13346689999999999 7999999999999999999999


Q ss_pred             EeccCCccccccccCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceee
Q 019536          133 ESVKYGTLRGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVR  212 (339)
Q Consensus       133 e~~~~g~L~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~  212 (339)
                      ||++|++|.+++...-+... ..|+.||+.||.|+|   ++||+||||||+|||++.+|.+||+|||+|+........  
T Consensus       322 Eyv~G~~L~d~i~~~~~l~~-~~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~--  395 (569)
T 4azs_A          322 EKLPGRLLSDMLAAGEEIDR-EKILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSW--  395 (569)
T ss_dssp             ECCCSEEHHHHHHTTCCCCH-HHHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CC--
T ss_pred             ecCCCCcHHHHHHhCCCCCH-HHHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCcc--
Confidence            99999999999874333322 358999999999999   999999999999999999999999999999877554332  


Q ss_pred             ecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCc
Q 019536          213 EEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNV  255 (339)
Q Consensus       213 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p  255 (339)
                      ....+||+.|+|||++.+. +..++|+||+|++++++.++..+
T Consensus       396 ~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          396 PTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             SHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             ccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence            2246799999999999754 56779999999988877665444

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.96  E-value=2.9e-30  Score=248.23  Aligned_cols=186  Identities=11%  Similarity=0.075  Sum_probs=146.5

Q ss_pred             ccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCCh-h------hHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 019536           58 DLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTL-D------DVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTL  130 (339)
Q Consensus        58 ~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~------~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  130 (339)
                      ...+.||+|+||+||+|..  .+..+++|+....... .      ..+.+.+|+.++++++||||+++..++...+..++
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l  416 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI  416 (540)
T ss_dssp             ---------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred             CCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence            4467899999999999955  6788899986553221 1      13457899999999999999977666667788899


Q ss_pred             EEEeccCCccccccccCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCce
Q 019536          131 VFESVKYGTLRGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH  210 (339)
Q Consensus       131 v~e~~~~g~L~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~  210 (339)
                      ||||+++++|.+++..      +..++.|++.||.|||   +.+|+||||||+|||++.  .+||+|||+|+........
T Consensus       417 VmE~~~ggsL~~~l~~------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~  485 (540)
T 3en9_A          417 MMSYINGKLAKDVIED------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDK  485 (540)
T ss_dssp             EEECCCSEEHHHHSTT------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHH
T ss_pred             EEECCCCCCHHHHHHH------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEECCCcccc
Confidence            9999999999999876      5579999999999999   899999999999999998  9999999999887553221


Q ss_pred             e-----eeccccccccccccccccc--CCCCcccchHHHHHHHHHHHhCCCcc
Q 019536          211 V-----REEFIKGAYGFIAPEYFAT--SSFNEMCDVYSFGAFLCELLTGCNVL  256 (339)
Q Consensus       211 ~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~g~~p~  256 (339)
                      .     ......||+.|+|||++..  ..|+..+|+|+..+-..+-+.++.+|
T Consensus       486 ~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          486 AVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             ccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            1     1124679999999999987  56888999999999888888776664

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.94  E-value=1.3e-26  Score=205.10  Aligned_cols=161  Identities=16%  Similarity=0.069  Sum_probs=126.4

Q ss_pred             HHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCCh-----------------hhHHHHHHHHHHHHhcCCCc
Q 019536           52 KATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTL-----------------DDVEYCFNNIVFSSQMKHKN  114 (339)
Q Consensus        52 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~~e~~~l~~l~H~n  114 (339)
                      .....|.+.+.||+|+||.||+|.+ .+|+.||+|.+......                 .....+.+|+.+++.++  |
T Consensus        87 ~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~  163 (282)
T 1zar_A           87 RSGKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G  163 (282)
T ss_dssp             HTTSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T
T ss_pred             hCCeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C
Confidence            3345666779999999999999999 78999999999754221                 13566889999999998  5


Q ss_pred             eeeeeeeeeeCCccEEEEEeccCCccccccccCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceE
Q 019536          115 ILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAK  194 (339)
Q Consensus       115 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~k  194 (339)
                       +++.+++.. +..++||||+++|+|.+ +.    ......++.|++.||.|||   +.+|+||||||+|||++ ++.+|
T Consensus       164 -~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~----~~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl~-~~~vk  232 (282)
T 1zar_A          164 -LAVPKVYAW-EGNAVLMELIDAKELYR-VR----VENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVS-EEGIW  232 (282)
T ss_dssp             -SSSCCEEEE-ETTEEEEECCCCEEGGG-CC----CSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE-TTEEE
T ss_pred             -CCcCeEEec-cceEEEEEecCCCcHHH-cc----hhhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEEE-CCcEE
Confidence             666665544 55799999999999988 32    2334579999999999999   89999999999999999 99999


Q ss_pred             EecCCCccccCCCCceeeeccccccccccccccccc----------CCCCcccchHH
Q 019536          195 LHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFAT----------SSFNEMCDVYS  241 (339)
Q Consensus       195 l~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~~Diws  241 (339)
                      |+|||+|+.               +..++|||++..          ..|...+|+|+
T Consensus       233 l~DFG~a~~---------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~  274 (282)
T 1zar_A          233 IIDFPQSVE---------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS  274 (282)
T ss_dssp             ECCCTTCEE---------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred             EEECCCCeE---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence            999999853               334688988753          33455566654

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.86  E-value=1.6e-21  Score=170.20  Aligned_cols=140  Identities=14%  Similarity=0.106  Sum_probs=107.3

Q ss_pred             CcccCCceeccCCeeEEEEEEcCCCee--EEEEEeccCCCh-----------------------hhHHHHHHHHHHHHhc
Q 019536           56 NYDLHKVIQSDTSYRLFEGTLVDQDRP--ISVMKFHDNSTL-----------------------DDVEYCFNNIVFSSQM  110 (339)
Q Consensus        56 ~~~~~~~ig~G~~g~V~~~~~~~~~~~--vavK~~~~~~~~-----------------------~~~~~~~~e~~~l~~l  110 (339)
                      -|++...||+|+||.||+|.+..+|+.  ||||+++.....                       .....+.+|+.++..+
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            367889999999999999999668888  999987654211                       1123678999999999


Q ss_pred             CCCce--eeeeeeeeeCCccEEEEEeccC-C----ccccccccCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCC
Q 019536          111 KHKNI--LKLIGCCLETELPTLVFESVKY-G----TLRGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKAS  183 (339)
Q Consensus       111 ~H~ni--v~~~~~~~~~~~~~lv~e~~~~-g----~L~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~  183 (339)
                      .|+++  +.++++    +..+|||||+.+ |    +|.+... ..+......++.|++.||.|||.  +.+|+||||||+
T Consensus       128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~-~~~~~~~~~i~~qi~~~l~~lH~--~~givHrDlkp~  200 (258)
T 1zth_A          128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGR-ELKELDVEGIFNDVVENVKRLYQ--EAELVHADLSEY  200 (258)
T ss_dssp             HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGG-GGGGSCHHHHHHHHHHHHHHHHH--TSCEECSSCSTT
T ss_pred             HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhh-ccChHHHHHHHHHHHHHHHHHHH--HCCEEeCCCCHH
Confidence            88764  344432    356899999953 4    4444432 22345677899999999999994  478999999999


Q ss_pred             CEEeCCCCceEEecCCCcccc
Q 019536          184 NVLLDENYSAKLHDFSLSVSI  204 (339)
Q Consensus       184 Nil~~~~~~~kl~dfg~a~~~  204 (339)
                      |||++.  .++|+|||+|...
T Consensus       201 NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          201 NIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SEEESS--SEEECCCTTCEET
T ss_pred             HEEEcC--cEEEEECcccccC
Confidence            999998  8999999998654

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.77  E-value=3.3e-19  Score=162.39  Aligned_cols=137  Identities=12%  Similarity=0.107  Sum_probs=99.9

Q ss_pred             CcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCCh-------------hhHH--------HHHHHHHHHHhcCCCc
Q 019536           56 NYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTL-------------DDVE--------YCFNNIVFSSQMKHKN  114 (339)
Q Consensus        56 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------------~~~~--------~~~~e~~~l~~l~H~n  114 (339)
                      -|++...||+|++|.||+|... +|+.||||+++.....             ....        ...+|...|.++.+.+
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g  174 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG  174 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence            4999999999999999999986 7999999987642110             0011        1234566666664443


Q ss_pred             ee--eeeeeeeeCCccEEEEEeccCCccccccccCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCC-
Q 019536          115 IL--KLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENY-  191 (339)
Q Consensus       115 iv--~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~-  191 (339)
                      +.  ..+++    ...+|||||++|++|..+...    .....++.|++.+|.|||   ..+|+||||||.|||++.++ 
T Consensus       175 v~vp~p~~~----~~~~LVME~i~G~~L~~l~~~----~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl~~dgd  243 (397)
T 4gyi_A          175 FPVPEPIAQ----SRHTIVMSLVDALPMRQVSSV----PDPASLYADLIALILRLA---KHGLIHGDFNEFNILIREEKD  243 (397)
T ss_dssp             CSCCCEEEE----ETTEEEEECCSCEEGGGCCCC----SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEEEEEC
T ss_pred             CCCCeeeec----cCceEEEEecCCccHhhhccc----HHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeCCCC
Confidence            32  22221    124799999999988776432    234568899999999999   89999999999999998766 


Q ss_pred             ---------ceEEecCCCcccc
Q 019536          192 ---------SAKLHDFSLSVSI  204 (339)
Q Consensus       192 ---------~~kl~dfg~a~~~  204 (339)
                               .+.|+||+-+...
T Consensus       244 ~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          244 AEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             SSCTTSEEEEEEECCCTTCEET
T ss_pred             cccccccccceEEEEeCCcccC
Confidence                     3899999977554

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.47  E-value=1.5e-13  Score=119.69  Aligned_cols=146  Identities=10%  Similarity=0.000  Sum_probs=112.9

Q ss_pred             HHHHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcC-CCceeeeeeeeeeCCcc
Q 019536           50 LKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMK-HKNILKLIGCCLETELP  128 (339)
Q Consensus        50 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~~~~~~~~~~~~  128 (339)
                      +......|.+...++.|+.+.||++..  .+..+++|....... .....+.+|+.+++.+. +.++.++++++.+.+..
T Consensus         9 l~~~l~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~-~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~   85 (263)
T 3tm0_A            9 LKKLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS   85 (263)
T ss_dssp             HHHHHTTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             HHHHhccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccC-CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCce
Confidence            344557788888888889999999975  468899999875311 11234778999999884 67888999999988889


Q ss_pred             EEEEEeccCCccccccccCCChHHHHHHHHHHHHHHHHHhcCC-------------------------------------
Q 019536          129 TLVFESVKYGTLRGFSFASLLIAPRIKIAMEIANAVAYLHVGF-------------------------------------  171 (339)
Q Consensus       129 ~lv~e~~~~g~L~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-------------------------------------  171 (339)
                      ++||||++|.+|.+...   +......++.+++.+|..||...                                     
T Consensus        86 ~lv~e~i~G~~l~~~~~---~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (263)
T 3tm0_A           86 NLLMSEADGVLCSEEYE---DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT  162 (263)
T ss_dssp             EEEEECCSSEEHHHHCC---TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred             EEEEEecCCeehhhccC---CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence            99999999999877632   12234468889999999999410                                     


Q ss_pred             -------------------CCCeEEccCCCCCEEeCCCCceEEecCCCc
Q 019536          172 -------------------DRPIVFRCIKASNVLLDENYSAKLHDFSLS  201 (339)
Q Consensus       172 -------------------~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a  201 (339)
                                         ...++|+|++|.||+++.+..+.|+||+.+
T Consensus       163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a  211 (263)
T 3tm0_A          163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRS  211 (263)
T ss_dssp             SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTC
T ss_pred             cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhc
Confidence                               045899999999999987656679999976

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.35  E-value=1.5e-12  Score=112.82  Aligned_cols=138  Identities=13%  Similarity=0.025  Sum_probs=100.2

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCc--eeeeeeeeeeCCccEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKN--ILKLIGCCLETELPTLV  131 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~n--iv~~~~~~~~~~~~~lv  131 (339)
                      ...+.+....+.|..+.||++.. .+|..+++|......    ...+.+|+.+++.+.+.+  +.+++++..+++..++|
T Consensus        19 ~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v   93 (264)
T 1nd4_A           19 LFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL   93 (264)
T ss_dssp             TTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred             cCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEE
Confidence            34565544444666799999965 367789999976541    234568999998886444  56788888887788999


Q ss_pred             EEeccCCccccccccCCChHHHHHHHHHHHHHHHHHhcCC----------------------------------------
Q 019536          132 FESVKYGTLRGFSFASLLIAPRIKIAMEIANAVAYLHVGF----------------------------------------  171 (339)
Q Consensus       132 ~e~~~~g~L~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~----------------------------------------  171 (339)
                      |||++|.++.  .. ..   ....++.+++..|..||...                                        
T Consensus        94 ~e~i~G~~l~--~~-~~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (264)
T 1nd4_A           94 LGEVPGQDLL--SS-HL---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAP  167 (264)
T ss_dssp             EECCSSEETT--TS-CC---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCH
T ss_pred             EEecCCcccC--cC-cC---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccH
Confidence            9999998884  21 11   12357788888888888321                                        


Q ss_pred             ---------------CCCeEEccCCCCCEEeCCCCceEEecCCCcc
Q 019536          172 ---------------DRPIVFRCIKASNVLLDENYSAKLHDFSLSV  202 (339)
Q Consensus       172 ---------------~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~  202 (339)
                                     ...++|+|++|.||+++.++.+.|+|||.+.
T Consensus       168 ~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          168 AELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             HHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                           0129999999999999877667799999863

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.34  E-value=5.4e-12  Score=114.99  Aligned_cols=142  Identities=15%  Similarity=0.107  Sum_probs=106.8

Q ss_pred             CCceeccCCeeEEEEEEcCCCeeEEEEEec--cCCChhhHHHHHHHHHHHHhcC--CCceeeeeeeeeeC---CccEEEE
Q 019536           60 HKVIQSDTSYRLFEGTLVDQDRPISVMKFH--DNSTLDDVEYCFNNIVFSSQMK--HKNILKLIGCCLET---ELPTLVF  132 (339)
Q Consensus        60 ~~~ig~G~~g~V~~~~~~~~~~~vavK~~~--~~~~~~~~~~~~~e~~~l~~l~--H~niv~~~~~~~~~---~~~~lv~  132 (339)
                      .+.++.|.++.||+....  +..+++|+..  ..........+.+|..+++.+.  +..+++++.++.+.   +..++||
T Consensus        43 ~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             EEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            467889999999998874  4678888876  3322223445778999999986  45688999998876   3479999


Q ss_pred             EeccCCccccccccCCChHHHHHHHHHHHHHHHHHhcCC-----------------------------------------
Q 019536          133 ESVKYGTLRGFSFASLLIAPRIKIAMEIANAVAYLHVGF-----------------------------------------  171 (339)
Q Consensus       133 e~~~~g~L~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-----------------------------------------  171 (339)
                      ||++|.++.+.....++......++.+++..|..||...                                         
T Consensus       121 e~v~G~~l~~~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  200 (359)
T 3dxp_A          121 EFVSGRVLWDQSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSL  200 (359)
T ss_dssp             ECCCCBCCCCTTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHH
T ss_pred             EecCCeecCCCccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHH
Confidence            999998886654456777788889999999999999520                                         


Q ss_pred             --------------CCCeEEccCCCCCEEeCCCCc--eEEecCCCccc
Q 019536          172 --------------DRPIVFRCIKASNVLLDENYS--AKLHDFSLSVS  203 (339)
Q Consensus       172 --------------~~~i~H~dlk~~Nil~~~~~~--~kl~dfg~a~~  203 (339)
                                    ...++|+|+++.||+++.++.  +.++||+.+..
T Consensus       201 ~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          201 MDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                          246999999999999987653  68999998764

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.09  E-value=2e-10  Score=102.09  Aligned_cols=186  Identities=13%  Similarity=0.122  Sum_probs=121.7

Q ss_pred             CCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcC-CCc--eeeeeeeeeeCC---ccEEEEE
Q 019536           60 HKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMK-HKN--ILKLIGCCLETE---LPTLVFE  133 (339)
Q Consensus        60 ~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-H~n--iv~~~~~~~~~~---~~~lv~e  133 (339)
                      .+.++.|....||+..     ..+++|.....   .....+.+|..+++.+. +..  +.+++.....++   ..|+|||
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~---~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~   96 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS---RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFT   96 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSH---HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEE
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCc---chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEc
Confidence            3568899999999863     45788876432   34566789999998883 333  445555544333   3589999


Q ss_pred             eccCCccccccccCCChHHHHHHHHHHHHHHHHHhcCC------------------------------------------
Q 019536          134 SVKYGTLRGFSFASLLIAPRIKIAMEIANAVAYLHVGF------------------------------------------  171 (339)
Q Consensus       134 ~~~~g~L~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~------------------------------------------  171 (339)
                      +++|.++.+.....++..+...++.+++..+..||...                                          
T Consensus        97 ~i~G~~l~~~~~~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  176 (304)
T 3sg8_A           97 KIKGVPLTPLLLNNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDF  176 (304)
T ss_dssp             CCCCEECCHHHHHTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHH
T ss_pred             ccCCeECCccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHH
Confidence            99998887654456677777788888888888888410                                          


Q ss_pred             -------------CCCeEEccCCCCCEEeCC--CCceEEecCCCccccCCCCceeeecc-------------cccccccc
Q 019536          172 -------------DRPIVFRCIKASNVLLDE--NYSAKLHDFSLSVSIPEGETHVREEF-------------IKGAYGFI  223 (339)
Q Consensus       172 -------------~~~i~H~dlk~~Nil~~~--~~~~kl~dfg~a~~~~~~~~~~~~~~-------------~~gt~~y~  223 (339)
                                   ...++|+|++|.||+++.  ...+.++||+.+...... .......             .....+..
T Consensus       177 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~-~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~  255 (304)
T 3sg8_A          177 YRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD-NDFISLMEDDEEYGMEFVSKILNHYKHK  255 (304)
T ss_dssp             HHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT-HHHHTTCCTTTSCCHHHHHHHHHHHTCS
T ss_pred             HHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH-HHHHHHHhhccccCHHHHHHHHHHcCCC
Confidence                         134799999999999997  556889999987654321 1100000             00000011


Q ss_pred             c-ccccccCCCCcccchHHHHHHHHHHHhCCCcc
Q 019536          224 A-PEYFATSSFNEMCDVYSFGAFLCELLTGCNVL  256 (339)
Q Consensus       224 a-PE~~~~~~~~~~~DiwslG~~l~el~~g~~p~  256 (339)
                      . |+....  .....+.|++|.++|.+.+|..+|
T Consensus       256 ~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          256 DIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             CHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             CcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence            1 221110  112257899999999999998775

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.67  E-value=1.6e-07  Score=83.39  Aligned_cols=135  Identities=10%  Similarity=0.031  Sum_probs=91.6

Q ss_pred             CceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCC---ceeeeeeeee-eCCccEEEEEecc
Q 019536           61 KVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHK---NILKLIGCCL-ETELPTLVFESVK  136 (339)
Q Consensus        61 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~---niv~~~~~~~-~~~~~~lv~e~~~  136 (339)
                      ..++.|....||+.     +..+++|+...   ......+.+|..+++.+.+.   .+.+.+.++. ..+..++|||+++
T Consensus        25 ~~l~~G~~n~v~~v-----g~~~VlR~~~~---~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~   96 (306)
T 3tdw_A           25 ESLGEGFRNYAILV-----NGDWVFRFPKS---QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ   96 (306)
T ss_dssp             EEEEECSSEEEEEE-----TTTEEEEEESS---HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred             eecCCCcceeEEEE-----CCEEEEEecCC---chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence            45778888889987     45677887432   23456788999999999642   3566676664 3455789999999


Q ss_pred             CCccccccccCCChHHHHHHHHHHHHHHHHHhcC----------------------------------------------
Q 019536          137 YGTLRGFSFASLLIAPRIKIAMEIANAVAYLHVG----------------------------------------------  170 (339)
Q Consensus       137 ~g~L~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~----------------------------------------------  170 (339)
                      |.++.+.....++......++.++...|..||..                                              
T Consensus        97 G~~l~~~~~~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~  176 (306)
T 3tdw_A           97 GQILGEDGMAVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRF  176 (306)
T ss_dssp             SEECHHHHHTTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHH
T ss_pred             CeECchhhhhhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHH
Confidence            9888663323334444444455555555544421                                              


Q ss_pred             -----------CCCCeEEccCCCCCEEeCC---CCc-eEEecCCCccc
Q 019536          171 -----------FDRPIVFRCIKASNVLLDE---NYS-AKLHDFSLSVS  203 (339)
Q Consensus       171 -----------~~~~i~H~dlk~~Nil~~~---~~~-~kl~dfg~a~~  203 (339)
                                 ....++|+|+.+.||+++.   ++. +.|+||+.+..
T Consensus       177 ~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          177 QSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                       1345799999999999987   345 58999998754

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.65  E-value=3.3e-07  Score=79.57  Aligned_cols=142  Identities=10%  Similarity=-0.059  Sum_probs=97.3

Q ss_pred             hcCcccCCceeccCCe-eEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcC-CCceeeeeeeeeeCCccEEE
Q 019536           54 TNNYDLHKVIQSDTSY-RLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMK-HKNILKLIGCCLETELPTLV  131 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g-~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~~~~~~~~~~~~~lv  131 (339)
                      ...|+. +.+..|..+ .||+......+..+.+|.-..    .....+.+|...|+.+. +--+.++++++.+++..++|
T Consensus        24 l~g~~~-~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lv   98 (272)
T 4gkh_A           24 LYGYRW-ARDNVGQSGATIYRLYGKPNAPELFLKHGKG----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLL   98 (272)
T ss_dssp             HTTCEE-EEEECSSSSCEEEEEECCTTCCCEEEEEEET----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred             ccCCeE-EEccCCCcCCeEEEEEecCCCeEEEEEECCC----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEE
Confidence            334443 344555555 689887766677888998654    33455778999988884 33477889999999999999


Q ss_pred             EEeccCCccccccccCCChHHHHHHHHHHHHHHHHHhcCC----------------------------------------
Q 019536          132 FESVKYGTLRGFSFASLLIAPRIKIAMEIANAVAYLHVGF----------------------------------------  171 (339)
Q Consensus       132 ~e~~~~g~L~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~----------------------------------------  171 (339)
                      ||+++|.++.+....  .......+..+++..|.-||...                                        
T Consensus        99 me~l~G~~~~~~~~~--~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  176 (272)
T 4gkh_A           99 TTAIPGKTAFQVLEE--YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV  176 (272)
T ss_dssp             EECCCSEEHHHHHHH--CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred             EEeeCCccccccccC--CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence            999999876654321  11222345555556666666210                                        


Q ss_pred             ---------------CCCeEEccCCCCCEEeCCCCceEEecCCCcc
Q 019536          172 ---------------DRPIVFRCIKASNVLLDENYSAKLHDFSLSV  202 (339)
Q Consensus       172 ---------------~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~  202 (339)
                                     ...++|+|+.+.||+++.++.+-|+||+.+.
T Consensus       177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                           1137899999999999987777799999764

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.22  E-value=1.4e-05  Score=72.26  Aligned_cols=82  Identities=5%  Similarity=-0.140  Sum_probs=54.4

Q ss_pred             Cce-eccCCeeEEEEEEc--C----CCeeEEEEEeccCCC--hhhHHHHHHHHHHHHhcC-C--CceeeeeeeeeeC---
Q 019536           61 KVI-QSDTSYRLFEGTLV--D----QDRPISVMKFHDNST--LDDVEYCFNNIVFSSQMK-H--KNILKLIGCCLET---  125 (339)
Q Consensus        61 ~~i-g~G~~g~V~~~~~~--~----~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~-H--~niv~~~~~~~~~---  125 (339)
                      +.| +.|....+|+....  .    ++..+++|.......  ......+.+|..+++.+. +  -.+.+++.++.++   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            456 77888899988753  1    156788887654320  001134567888888774 2  3577888887665   


Q ss_pred             CccEEEEEeccCCcccc
Q 019536          126 ELPTLVFESVKYGTLRG  142 (339)
Q Consensus       126 ~~~~lv~e~~~~g~L~~  142 (339)
                      +..++||||++|.++.+
T Consensus       106 g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             SSCEEEEECCCCBCCCB
T ss_pred             CCceEEEEecCCCChhh
Confidence            34689999999877764

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.22  E-value=7.3e-06  Score=75.30  Aligned_cols=77  Identities=10%  Similarity=0.023  Sum_probs=49.7

Q ss_pred             CCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC------hhhHHHHHHHHHHHHhcCC--C-ceeeeeeeeeeCCccEE
Q 019536           60 HKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST------LDDVEYCFNNIVFSSQMKH--K-NILKLIGCCLETELPTL  130 (339)
Q Consensus        60 ~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~e~~~l~~l~H--~-niv~~~~~~~~~~~~~l  130 (339)
                      .+.||.|..+.||++.....++.+++|.......      ....+++..|..+++.+..  | .+.+++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            3578999999999997655678899998654211      1123456678888887742  3 34456644  3455689


Q ss_pred             EEEeccCC
Q 019536          131 VFESVKYG  138 (339)
Q Consensus       131 v~e~~~~g  138 (339)
                      |||++++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.99  E-value=8.7e-05  Score=66.26  Aligned_cols=31  Identities=19%  Similarity=0.162  Sum_probs=27.7

Q ss_pred             CCCeEEccCCCCCEEeCCCCceEEecCCCcc
Q 019536          172 DRPIVFRCIKASNVLLDENYSAKLHDFSLSV  202 (339)
Q Consensus       172 ~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~  202 (339)
                      ...++|+|+.+.||+++.++.+.++||+.+.
T Consensus       221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             SCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             cCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            5789999999999999877889999999764

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.93  E-value=8.5e-05  Score=65.81  Aligned_cols=75  Identities=8%  Similarity=-0.049  Sum_probs=58.9

Q ss_pred             CCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcC---CCceeeeeeeeeeCCccEEEEEecc
Q 019536           60 HKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMK---HKNILKLIGCCLETELPTLVFESVK  136 (339)
Q Consensus        60 ~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~---H~niv~~~~~~~~~~~~~lv~e~~~  136 (339)
                      .+.|+.|....+|+...  ++..+++|.....    ....+..|...|+.+.   ...++++++++...+..++||||++
T Consensus        41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~  114 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND--EVQTVFVKINERS----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN  114 (312)
T ss_dssp             EEEECCSSSSEEEEEES--SSCEEEEEEEEGG----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred             eEEeCCccceeeeEEEE--CCCeEEEEeCCcc----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence            35688899999999875  5677888887542    3556778988888873   3568889998887788999999999


Q ss_pred             CCcc
Q 019536          137 YGTL  140 (339)
Q Consensus       137 ~g~L  140 (339)
                      +..+
T Consensus       115 G~~~  118 (312)
T 3jr1_A          115 KSKN  118 (312)
T ss_dssp             CCCC
T ss_pred             CCCC
Confidence            8765

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.73  E-value=0.00011  Score=68.05  Aligned_cols=32  Identities=9%  Similarity=0.201  Sum_probs=28.1

Q ss_pred             CCCeEEccCCCCCEEeCCCCceEEecCCCcccc
Q 019536          172 DRPIVFRCIKASNVLLDENYSAKLHDFSLSVSI  204 (339)
Q Consensus       172 ~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~  204 (339)
                      ...++|+|+.+.|||++.++ +.++||+.+..-
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G  262 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG  262 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence            67899999999999998776 999999987653

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.69  E-value=0.00061  Score=60.30  Aligned_cols=155  Identities=13%  Similarity=0.093  Sum_probs=85.7

Q ss_pred             ccccHHHHHHHhcCcccC-----CceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCc--e
Q 019536           43 RAFSAKDLKKATNNYDLH-----KVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKN--I  115 (339)
Q Consensus        43 ~~~~~~~~~~~~~~~~~~-----~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~n--i  115 (339)
                      ..++.+++......|.+.     +.|+.|....+|+....  +..+++|.......   .+.+..|+.++..+...+  +
T Consensus         5 ~~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~~~---~~~l~~e~~~l~~L~~~g~~v   79 (322)
T 2ppq_A            5 TDITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTT--KDPLILTLYEKRVE---KNDLPFFLGLMQHLAAKGLSC   79 (322)
T ss_dssp             CCCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEES--SCCEEEEEECC------CCHHHHHHHHHHHHHHTTCCC
T ss_pred             ccCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeC--CccEEEEEeCCCCC---HHHHHHHHHHHHHHHHCCCCC
Confidence            345666776666667653     33556777889998764  33688898876322   123446777776663212  3


Q ss_pred             eeeeee------eeeCCccEEEEEeccCCccccc--------------cc---cCC--------C---hHHHHH------
Q 019536          116 LKLIGC------CLETELPTLVFESVKYGTLRGF--------------SF---ASL--------L---IAPRIK------  155 (339)
Q Consensus       116 v~~~~~------~~~~~~~~lv~e~~~~g~L~~~--------------~~---~~~--------~---~~~~~~------  155 (339)
                      .+++..      ....+..+++++|++|..+...              +.   ..+        .   |.....      
T Consensus        80 P~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~  159 (322)
T 2ppq_A           80 PLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERA  159 (322)
T ss_dssp             CCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGG
T ss_pred             CcccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHH
Confidence            344422      1223456899999998665321              00   000        0   111000      


Q ss_pred             ------HHHHHHHHHHHHhc----CCCCCeEEccCCCCCEEeCCCCceEEecCCCcc
Q 019536          156 ------IAMEIANAVAYLHV----GFDRPIVFRCIKASNVLLDENYSAKLHDFSLSV  202 (339)
Q Consensus       156 ------i~~~i~~~l~~LH~----~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~  202 (339)
                            +...+...+..+..    ....+++|+|+.+.||+++.+..+.++||+.+.
T Consensus       160 ~~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          160 DEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             GGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HhhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence                  00113334444442    113568999999999999877666899999763

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.57  E-value=0.00038  Score=63.30  Aligned_cols=136  Identities=18%  Similarity=0.132  Sum_probs=79.5

Q ss_pred             CceeccCCeeEEEEEEcC-------CCeeEEEEEeccCCChhhHHHHHHHHHHHHhcC-CCceeeeeeeeeeCCccEEEE
Q 019536           61 KVIQSDTSYRLFEGTLVD-------QDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMK-HKNILKLIGCCLETELPTLVF  132 (339)
Q Consensus        61 ~~ig~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~~~~~~~~~~~~~lv~  132 (339)
                      +.+..|-...+|+....+       +++.+.+++....  ........+|..+++.+. +.-..++++.+.++    +||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~--~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~  129 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI--LQGVDSLVLESVMFAILAERSLGPQLYGVFPEG----RLE  129 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc--cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEE
Confidence            456667788899988742       3467888886332  133455668988888874 33346777776543    899


Q ss_pred             EeccCCcccccc-c-----------------------cCC--ChHHHHHHHHHHHH-------------------HHHH-
Q 019536          133 ESVKYGTLRGFS-F-----------------------ASL--LIAPRIKIAMEIAN-------------------AVAY-  166 (339)
Q Consensus       133 e~~~~g~L~~~~-~-----------------------~~~--~~~~~~~i~~~i~~-------------------~l~~-  166 (339)
                      ||++|.+|..-- .                       ...  .+.+...+..++..                   .+.. 
T Consensus       130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L  209 (379)
T 3feg_A          130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL  209 (379)
T ss_dssp             ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred             EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence            999986654210 0                       001  12233333333211                   1222 


Q ss_pred             ---Hhc-CCCCCeEEccCCCCCEEeCCC----CceEEecCCCcc
Q 019536          167 ---LHV-GFDRPIVFRCIKASNVLLDEN----YSAKLHDFSLSV  202 (339)
Q Consensus       167 ---LH~-~~~~~i~H~dlk~~Nil~~~~----~~~kl~dfg~a~  202 (339)
                         |.. .....++|+|+.+.||+++.+    +.+.++||..|.
T Consensus       210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence               221 113458999999999999876    689999999864

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.56  E-value=0.00044  Score=60.32  Aligned_cols=79  Identities=13%  Similarity=0.058  Sum_probs=54.9

Q ss_pred             CcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCC---CceeeeeeeeeeCCccEEEE
Q 019536           56 NYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKH---KNILKLIGCCLETELPTLVF  132 (339)
Q Consensus        56 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H---~niv~~~~~~~~~~~~~lv~  132 (339)
                      ...-.+.+|.|..+.||+.+.. +|+.|.+|+...... .....+..|...|+.+.-   --+++++++.    ..++||
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~-~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~   89 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAP-ALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAM   89 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCC-CCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEE
T ss_pred             CeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCc-chhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEE
Confidence            4555677899999999999986 788999998654432 223346689888888842   1344555542    247899


Q ss_pred             EeccCCcc
Q 019536          133 ESVKYGTL  140 (339)
Q Consensus       133 e~~~~g~L  140 (339)
                      ||++++..
T Consensus        90 e~l~~~~~   97 (288)
T 3f7w_A           90 EWVDERPP   97 (288)
T ss_dssp             ECCCCCCC
T ss_pred             EeecccCC
Confidence            99987654

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.45  E-value=0.00064  Score=59.69  Aligned_cols=128  Identities=12%  Similarity=0.022  Sum_probs=73.4

Q ss_pred             CCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCce-eeeeeeeeeCCccEEEEEec-cC
Q 019536           60 HKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNI-LKLIGCCLETELPTLVFESV-KY  137 (339)
Q Consensus        60 ~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~ni-v~~~~~~~~~~~~~lv~e~~-~~  137 (339)
                      .+.|+.|....+|+.      ..+++|+...... . .....+|..+++.+...++ .++++.+  .+.-++++||+ ++
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~-~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g   92 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTE-E-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGA   92 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTC
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCcc-c-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCC
Confidence            577888999999998      4577888765321 1 1112367777776642222 4666554  33346899999 65


Q ss_pred             CccccccccCCChHHHHHHHHHHHHHHHHHhc------------------------------------------------
Q 019536          138 GTLRGFSFASLLIAPRIKIAMEIANAVAYLHV------------------------------------------------  169 (339)
Q Consensus       138 g~L~~~~~~~~~~~~~~~i~~~i~~~l~~LH~------------------------------------------------  169 (339)
                      .++......     ..-.++.+++..|.-||.                                                
T Consensus        93 ~~l~~~~~~-----~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~  167 (301)
T 3dxq_A           93 QTMSPEKFK-----TRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALA  167 (301)
T ss_dssp             EECCHHHHH-----HSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHH
T ss_pred             ccCCHhhHh-----hhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHH
Confidence            555320000     000012222222222221                                                


Q ss_pred             --CCCCCeEEccCCCCCEEeCCCCceEEecCCCccc
Q 019536          170 --GFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVS  203 (339)
Q Consensus       170 --~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~  203 (339)
                        .....++|+|+.+.||+ ..++.+.++||..+..
T Consensus       168 ~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          168 AHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             SSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             hcCCCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence              11334899999999999 5566789999998754

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.41  E-value=0.0034  Score=55.59  Aligned_cols=158  Identities=12%  Similarity=0.077  Sum_probs=88.4

Q ss_pred             CCcccccHHHHHHHhcCccc-----CCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCC-
Q 019536           40 NPIRAFSAKDLKKATNNYDL-----HKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHK-  113 (339)
Q Consensus        40 ~~~~~~~~~~~~~~~~~~~~-----~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~-  113 (339)
                      .++...+.+++......|.+     ...++ |....||+.... +|+.+++|.......  ....+..|..++..+... 
T Consensus         6 ~~~~~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~--~~~~~~~E~~~~~~L~~~g   81 (328)
T 1zyl_A            6 FTFQTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDE-DRRRFVVKFYRPERW--TADQILEEHQFALQLVNDE   81 (328)
T ss_dssp             CCCCCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCT-TCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTT
T ss_pred             CCCCCCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcC-CCCEEEEEEcCCCCC--CHHHHHHHHHHHHHHHHcC
Confidence            34555666666555554433     22355 777889987653 466789999874421  234556788877777421 


Q ss_pred             -ceeeeeee-----eeeCCccEEEEEeccCCccccc--------------cc---c--------CCChHHH----H----
Q 019536          114 -NILKLIGC-----CLETELPTLVFESVKYGTLRGF--------------SF---A--------SLLIAPR----I----  154 (339)
Q Consensus       114 -niv~~~~~-----~~~~~~~~lv~e~~~~g~L~~~--------------~~---~--------~~~~~~~----~----  154 (339)
                       .+++++..     ...++..++||++++|.++...              +.   .        .......    .    
T Consensus        82 ~~vp~~~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~  161 (328)
T 1zyl_A           82 VPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFE  161 (328)
T ss_dssp             CSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHH
T ss_pred             CeecceeecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHh
Confidence             24445443     1123455789999988654311              00   0        0111110    0    


Q ss_pred             --------------HHHHHHHHHHHHHhc-CCCCCeEEccCCCCCEEeCCCCceEEecCCCccc
Q 019536          155 --------------KIAMEIANAVAYLHV-GFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVS  203 (339)
Q Consensus       155 --------------~i~~~i~~~l~~LH~-~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~  203 (339)
                                    ..+..++..+.-+-. .....++|+|+.+.||+++ + .+.++||+.+..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          162 DATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             TCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             hcCcCCHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence                          011112222221110 0145689999999999999 4 899999987644

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.32  E-value=0.0019  Score=59.72  Aligned_cols=74  Identities=16%  Similarity=0.114  Sum_probs=49.7

Q ss_pred             CCceeccCCeeEEEEEEcC-------CCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCc-eeeeeeeeeeCCccEEE
Q 019536           60 HKVIQSDTSYRLFEGTLVD-------QDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKN-ILKLIGCCLETELPTLV  131 (339)
Q Consensus        60 ~~~ig~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~n-iv~~~~~~~~~~~~~lv  131 (339)
                      .+.|+.|-...+|+....+       ++..+.+|+......   .+.+.+|..+++.+...+ ..++++.+.+    .+|
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v  150 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL  150 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEE
Confidence            3467778888999998753       256788998844211   144557888888884333 3677776543    289


Q ss_pred             EEeccCCcc
Q 019536          132 FESVKYGTL  140 (339)
Q Consensus       132 ~e~~~~g~L  140 (339)
                      +||++|-++
T Consensus       151 ~e~l~G~~l  159 (429)
T 1nw1_A          151 EEYIPSRPL  159 (429)
T ss_dssp             ECCCCEEEC
T ss_pred             EEEeCCccc
Confidence            999987554

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.23  E-value=0.0011  Score=59.09  Aligned_cols=33  Identities=24%  Similarity=0.137  Sum_probs=27.9

Q ss_pred             CCCeEEccCCCCCEEeCCC----CceEEecCCCcccc
Q 019536          172 DRPIVFRCIKASNVLLDEN----YSAKLHDFSLSVSI  204 (339)
Q Consensus       172 ~~~i~H~dlk~~Nil~~~~----~~~kl~dfg~a~~~  204 (339)
                      ...++|+|+.+.||+++.+    +.+.++||+.+..-
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            4579999999999999874    67899999987553

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.23  E-value=0.0023  Score=59.64  Aligned_cols=75  Identities=12%  Similarity=0.053  Sum_probs=47.9

Q ss_pred             CceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCce-eeeeeeeeeCCccEEEEEeccCCc
Q 019536           61 KVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNI-LKLIGCCLETELPTLVFESVKYGT  139 (339)
Q Consensus        61 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~ni-v~~~~~~~~~~~~~lv~e~~~~g~  139 (339)
                      +.|+.|-...+|+....+.+..+.+|+...... . .-...+|..+++.+...++ .++++.+..    .+|+||++|-+
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~-~-~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~  187 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTD-E-IINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYA  187 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-CC-S-CSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEE
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCChh-h-hcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCcc
Confidence            457778888999998854357888988754321 1 1112478888888864444 577777632    25999998865


Q ss_pred             cc
Q 019536          140 LR  141 (339)
Q Consensus       140 L~  141 (339)
                      |.
T Consensus       188 l~  189 (458)
T 2qg7_A          188 LS  189 (458)
T ss_dssp             CC
T ss_pred             CC
Confidence            53

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.90  E-value=0.0055  Score=55.31  Aligned_cols=74  Identities=16%  Similarity=0.129  Sum_probs=43.1

Q ss_pred             CceeccCCeeEEEEEEcC--------CCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCc-eeeeeeeeeeCCccEEE
Q 019536           61 KVIQSDTSYRLFEGTLVD--------QDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKN-ILKLIGCCLETELPTLV  131 (339)
Q Consensus        61 ~~ig~G~~g~V~~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~n-iv~~~~~~~~~~~~~lv  131 (339)
                      ..|+.|..-.+|+....+        .+..+++|+.....  ........|..+++.+...+ +.++++..  .  -++|
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v  112 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV--DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI  112 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG--GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc--cceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence            456677788899988743        12678888765432  11112346777787774223 44666554  2  3689


Q ss_pred             EEeccCCcc
Q 019536          132 FESVKYGTL  140 (339)
Q Consensus       132 ~e~~~~g~L  140 (339)
                      |||++|.++
T Consensus       113 ~e~i~G~~l  121 (369)
T 3c5i_A          113 EEWLYGDPL  121 (369)
T ss_dssp             EECCCSEEC
T ss_pred             EEEecCCcC
Confidence            999987654

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.78  E-value=0.0061  Score=50.38  Aligned_cols=95  Identities=13%  Similarity=0.035  Sum_probs=58.6

Q ss_pred             ccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceeeecc
Q 019536          139 TLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEF  215 (339)
Q Consensus       139 ~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~~~  215 (339)
                      +|.+++.   +++.+.+++.++.|.+.+|.-+-.  ...-..+=..|..|++..+|.+.+.+ +.+.             
T Consensus        34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~--~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------   97 (229)
T 2yle_A           34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAAR--RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------------   97 (229)
T ss_dssp             EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred             cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhh--cccCCceecCCcceEEecCCceeccc-cccc-------------
Confidence            5666665   799999999999999999877621  11111223456888888888887764 1110             


Q ss_pred             cccccccccccccccCCCCcccchHHHHHHHHHHHh
Q 019536          216 IKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT  251 (339)
Q Consensus       216 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~  251 (339)
                       .....+.|||... ...+.+.=|||+|+++|.-+-
T Consensus        98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD  131 (229)
T 2yle_A           98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD  131 (229)
T ss_dssp             ----------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred             -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence             0122356888763 234456679999999998774

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.37  E-value=0.037  Score=49.32  Aligned_cols=32  Identities=22%  Similarity=0.227  Sum_probs=27.6

Q ss_pred             CCCeEEccCCCCCEEeCCCCceEEecCCCccc
Q 019536          172 DRPIVFRCIKASNVLLDENYSAKLHDFSLSVS  203 (339)
Q Consensus       172 ~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~  203 (339)
                      ...++|+|+.+.||+++.++.+.++||+.+..
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            35689999999999999878899999987654

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.93  E-value=0.027  Score=51.90  Aligned_cols=74  Identities=14%  Similarity=0.033  Sum_probs=46.6

Q ss_pred             CceeccCCeeEEEEEEcCC-------CeeEEEEEeccCCChhhHHHHHHHHHHHHhcC-CCceeeeeeeeeeCCccEEEE
Q 019536           61 KVIQSDTSYRLFEGTLVDQ-------DRPISVMKFHDNSTLDDVEYCFNNIVFSSQMK-HKNILKLIGCCLETELPTLVF  132 (339)
Q Consensus        61 ~~ig~G~~g~V~~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~~~~~~~~~~~~~lv~  132 (339)
                      +.+..|-...+|+......       +..+.+++.....  ...-...+|..+++.+. +.-..++++.+.    -++|+
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t--~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~  149 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV--GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE  149 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC---CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc--chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence            4566677888999987521       5778888865432  11112246778777774 333456665432    36899


Q ss_pred             EeccCCcc
Q 019536          133 ESVKYGTL  140 (339)
Q Consensus       133 e~~~~g~L  140 (339)
                      ||++|.+|
T Consensus       150 efI~G~~l  157 (424)
T 3mes_A          150 EFIDGEPL  157 (424)
T ss_dssp             ECCCSEEC
T ss_pred             EEeCCccC
Confidence            99998665

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=92.83  E-value=0.1  Score=47.55  Aligned_cols=28  Identities=29%  Similarity=0.350  Sum_probs=24.0

Q ss_pred             eEEccCCCCCEEe------CCCCceEEecCCCcc
Q 019536          175 IVFRCIKASNVLL------DENYSAKLHDFSLSV  202 (339)
Q Consensus       175 i~H~dlk~~Nil~------~~~~~~kl~dfg~a~  202 (339)
                      ++|+|+.+.|||+      +++..+.++||..|.
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~  279 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS  279 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence            5799999999999      456779999999874

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=90.45  E-value=0.03  Score=52.21  Aligned_cols=64  Identities=5%  Similarity=-0.021  Sum_probs=18.9

Q ss_pred             ccCCceeccCCeeEEEEEEcCCCeeEEE------EEeccCCC-hhhHHHHHHHHHHHHhcCCCceeeeeeeeee
Q 019536           58 DLHKVIQSDTSYRLFEGTLVDQDRPISV------MKFHDNST-LDDVEYCFNNIVFSSQMKHKNILKLIGCCLE  124 (339)
Q Consensus        58 ~~~~~ig~G~~g~V~~~~~~~~~~~vav------K~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~  124 (339)
                      .+.+.+|   ||.||+|.+.....+||+      |....... .+....+.+|..+++.++|||+++.+++...
T Consensus       145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~  215 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH  215 (463)
T ss_dssp             CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred             cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence            4456676   999999999755568888      76655322 2334567889999999999999999887653

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=85.42  E-value=2.5  Score=34.68  Aligned_cols=115  Identities=5%  Similarity=-0.016  Sum_probs=75.5

Q ss_pred             CCCceeeeeeeeeeCCccEEEEEeccCCccccccc-cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCC
Q 019536          111 KHKNILKLIGCCLETELPTLVFESVKYGTLRGFSF-ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDE  189 (339)
Q Consensus       111 ~H~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~  189 (339)
                      .||+.+.. .+-.+.+.  +++.|-.......+-. ...+...+++++..|+....+++     .-+|--|.|+|++++.
T Consensus        43 ~~~~Fl~~-~I~e~eD~--v~~~y~~~~~~~~f~~ik~~~~~eKlr~l~ni~~l~~~~~-----~r~tf~L~P~NL~f~~  114 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDS--FQIHYDINDNHTPFDNIKSFTKNEKLRYLLNIKNLEEVNR-----TRYTFVLAPDELFFTR  114 (215)
T ss_dssp             CCTTBCCE-EEEECSSE--EEEEECCCTTSEEGGGGGGSCHHHHHHHHHHGGGGGGGGG-----SSEECCCSGGGEEECT
T ss_pred             cCCcccce-EEEEcccE--EEEEEEcCcccCCHHHHHhcCHHHHHHHHHHHHHHHHHhc-----CceEEEEecceEEEcC
Confidence            57877755 44455554  4445544444444433 67888889999999988776655     2467789999999999


Q ss_pred             CCceEEecCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccc
Q 019536          190 NYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLE  257 (339)
Q Consensus       190 ~~~~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~  257 (339)
                      ++.+++.--|+...+++..              +.+|.          =.-.+=|++..+++++..|.
T Consensus       115 ~~~p~i~~RGik~~l~P~~--------------~~ee~----------fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          115 DGLPIAKTRGLQNVVDPLP--------------VSEAE----------FLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             TSCEEESCCEETTTBSCCC--------------CCHHH----------HHHHHHHHHHHHHCTTCCHH
T ss_pred             CCCEEEEEccCccCCCCCC--------------CCHHH----------HHHHHHHHHHHHHcCCCCHH
Confidence            9999999888643322211              01111          12255677888888888775

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	339
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	9e-39
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	8e-38
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-35
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-35
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	4e-35
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	7e-35
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-34
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-34
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	9e-34
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-33
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	4e-33
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	4e-33
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	5e-33
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	6e-33
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	8e-33
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-32
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	3e-32
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	3e-32
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	5e-32
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	9e-32
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	9e-32
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	3e-31
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	8e-31
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-30
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-30
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-30
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-29
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-29
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	3e-29
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-29
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	5e-29
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	6e-29
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	5e-28
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-26
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-26
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-25
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	3e-25
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	4e-25
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	7e-25
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-23
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-23
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	8e-23
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-22
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-22
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-22
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	4e-22
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	3e-21
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	4e-21
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-20
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	5e-20
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-19
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-19
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-19
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-19
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	6e-19
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	6e-18
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-17
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-16
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-15
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	6e-15
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	4e-14
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	7e-12

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 9e-39
 Identities = 55/286 (19%), Positives = 113/286 (39%), Gaps = 29/286 (10%)

Query: 55  NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKN 114
               + + I S +   +++G     D  + ++     +    ++   N +    + +H N
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKW-HGDVAVKMLNVTAPTP-QQLQAFKNEVGVLRKTRHVN 65

Query: 115 ILKLIGCCLETELPTLVFESVKYGTLRGFSFA---SLLIAPRIKIAMEIANAVAYLHVGF 171
           IL  +G     +L  +V +  +  +L            +   I IA + A  + YLH   
Sbjct: 66  ILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH--- 121

Query: 172 DRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATS 231
            + I+ R +K++N+ L E+ + K+ DF L+          + E + G+  ++APE     
Sbjct: 122 AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181

Query: 232 S---FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDP 288
               ++   DVY+FG  L EL+TG             ++   +     +        + P
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPY--------SNINNRDQIIFMVGRG----YLSP 229

Query: 289 IFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQM 334
              +  S        +++ +LM +CL K  + RPL   +   +  +
Sbjct: 230 DLSKVRS-----NCPKAMKRLMAECLKKKRDERPLFPQILASIELL 270

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  134 bits (339), Expect = 8e-38
 Identities = 59/308 (19%), Positives = 108/308 (35%), Gaps = 42/308 (13%)

Query: 45  FSAKDLKKATNN---------YDLHKVIQSDTSYRLFEGTLVDQDR---PISVMKFHDNS 92
           F+ +D  +A              + +VI +     +  G L    +    +++       
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 93  TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAP 152
           T        +      Q  H N++ L G   ++    ++ E ++ G+L  F   +     
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126

Query: 153 ---RIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE- 208
               + +   IA  + YL    D   V R + A N+L++ N   K+ DF LS  + +   
Sbjct: 127 VIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183

Query: 209 --THVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDD 266
             T+      K    + APE      F    DV+S+G  + E+++      +    N D 
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS-YGERPYWDMTNQDV 242

Query: 267 LTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVD 326
           +  +                    ++D   P   +   +L QLM  C  K   HRP    
Sbjct: 243 INAI--------------------EQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQ 282

Query: 327 VAKQLRQM 334
           +   L +M
Sbjct: 283 IVNTLDKM 290

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 1e-35
 Identities = 42/301 (13%), Positives = 95/301 (31%), Gaps = 29/301 (9%)

Query: 50  LKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQ 109
           ++   ++++    + +     +F+ +       ++    H              +    +
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60

Query: 110 MKHKNILKLIGCCLETELPTLVFESVKYGTLRGF--SFASLLIAPRIKIAMEIANAVAYL 167
                I+   G        ++  E +  G+L         +      K+++ +   + YL
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 120

Query: 168 HVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEY 227
                  I+ R +K SN+L++     KL DF +S  + +   +       G   +++PE 
Sbjct: 121 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF----VGTRSYMSPER 174

Query: 228 FATSSFNEMCDVYSFGAFLCELLTGC---------------------NVLEFKGNGNDDD 266
              + ++   D++S G  L E+  G                      +  E         
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234

Query: 267 LTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVD 326
             +  Y   S        ++D I +E                 + KCL K+P  R  +  
Sbjct: 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 294

Query: 327 V 327
           +
Sbjct: 295 L 295

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (322), Expect = 2e-35
 Identities = 50/300 (16%), Positives = 112/300 (37%), Gaps = 27/300 (9%)

Query: 55  NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKN 114
               L + I       ++ G    ++  + +    +    +   +    I  +  ++H+N
Sbjct: 3   RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHEN 58

Query: 115 ILKLIGCCLETELPT----LVFESVKYGTLRGF-SFASLLIAPRIKIAMEIANAVAYLHV 169
           IL  I    +         LV +  ++G+L  + +  ++ +   IK+A+  A+ +A+LH+
Sbjct: 59  ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHM 118

Query: 170 GF-----DRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE--THVREEFIKGAYGF 222
                     I  R +K+ N+L+ +N +  + D  L+V          +      G   +
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 178

Query: 223 IAPEYFATS------SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGND--DDLTVLEYAK 274
           +APE    S         +  D+Y+ G    E+   C++     +      DL   + + 
Sbjct: 179 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238

Query: 275 KSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQM 334
           + +        + P            E L+ + ++M +C   +   R   + + K L Q+
Sbjct: 239 EEMRKVVCEQKLRPNIPNRWQSC---EALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (318), Expect = 4e-35
 Identities = 53/283 (18%), Positives = 114/283 (40%), Gaps = 31/283 (10%)

Query: 55  NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKN 114
           +     + I S     +  G  +++D+ +++    + +  +  E          ++ H  
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSE--EDFIEEAEVMMKLSHPK 61

Query: 115 ILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAP---RIKIAMEIANAVAYLHVGF 171
           +++L G CLE     LVFE +++G L  +      +      + + +++   +AYL    
Sbjct: 62  LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE--- 118

Query: 172 DRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATS 231
           +  ++ R + A N L+ EN   K+ DF ++  + + +        K    + +PE F+ S
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS-TGTKFPVKWASPEVFSFS 177

Query: 232 SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFD 291
            ++   DV+SFG  + E+ +        G    ++ +  E  +      R   +  P   
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSE-------GKIPYENRSNSEVVEDISTGFR---LYKP--- 224

Query: 292 EDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQM 334
                         + Q+M  C  + PE RP    + +QL ++
Sbjct: 225 --------RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (317), Expect = 7e-35
 Identities = 51/277 (18%), Positives = 95/277 (34%), Gaps = 34/277 (12%)

Query: 55  NNYDLHKVIQSDTSYRLFEGTLVDQDRP--ISVMKFHDNSTLDDVEYCFNNIVFSSQMKH 112
            ++++ + +       ++            + V+                 +   S ++H
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 113 KNILKLIGCCLETELPTLVFESVKYGTLRGF--SFASLLIAPRIKIAMEIANAVAYLHVG 170
            NIL+L G   +     L+ E    GT+       +            E+ANA++Y H  
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH-- 123

Query: 171 FDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFAT 230
             + ++ R IK  N+LL      K+ DF  SV  P          + G   ++ PE    
Sbjct: 124 -SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----TLCGTLDYLPPEMIEG 178

Query: 231 SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIF 290
              +E  D++S G    E L G     F+ N   +                       I 
Sbjct: 179 RMHDEKVDLWSLGVLCYEFLVGKPP--FEANTYQE-------------------TYKRIS 217

Query: 291 DEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDV 327
             + +FP  +   +    L+ + L  +P  RP++ +V
Sbjct: 218 RVEFTFP--DFVTEGARDLISRLLKHNPSQRPMLREV 252

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (315), Expect = 1e-34
 Identities = 58/287 (20%), Positives = 112/287 (39%), Gaps = 33/287 (11%)

Query: 55  NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKN 114
               L + + +     ++ G        ++V      S     +          Q++H+ 
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQR 69

Query: 115 ILKLIGCCLETELPTLVFESVKYGT----LRGFSFASLLIAPRIKIAMEIANAVAYLHVG 170
           +++L     +  +  ++ E ++ G+    L+  S   L I   + +A +IA  +A++   
Sbjct: 70  LVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE-- 126

Query: 171 FDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFAT 230
            +R  + R ++A+N+L+ +  S K+ DF L+  I + E   RE   K    + APE    
Sbjct: 127 -ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKFPIKWTAPEAINY 184

Query: 231 SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIF 290
            +F    DV+SFG  L E++T        G      +T  E  +      R       + 
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTH-------GRIPYPGMTNPEVIQNLERGYR------MVR 231

Query: 291 DEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS 337
            ++          + L QLM  C  + PE RP    +   L   + +
Sbjct: 232 PDNCP--------EELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (312), Expect = 3e-34
 Identities = 52/285 (18%), Positives = 107/285 (37%), Gaps = 39/285 (13%)

Query: 55  NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKN 114
               L + I       +  G    +   ++V    +++T              +Q++H N
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFL---AEASVMTQLRHSN 61

Query: 115 ILKLIGCCLETE-LPTLVFESVKYGTLRGF----SFASLLIAPRIKIAMEIANAVAYLHV 169
           +++L+G  +E +    +V E +  G+L  +      + L     +K ++++  A+ YL  
Sbjct: 62  LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE- 120

Query: 170 GFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFA 229
                 V R + A NVL+ E+  AK+ DF L+      +   +         + APE   
Sbjct: 121 --GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK-----LPVKWTAPEALR 173

Query: 230 TSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPI 289
              F+   DV+SFG  L E+ +        G      + + +   +  +  +        
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSF-------GRVPYPRIPLKDVVPRVEKGYK-------- 218

Query: 290 FDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQM 334
            D  +  P       ++ ++M  C       RP  + + +QL  +
Sbjct: 219 MDAPDGCP------PAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (310), Expect = 9e-34
 Identities = 56/265 (21%), Positives = 99/265 (37%), Gaps = 29/265 (10%)

Query: 78  DQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKY 137
            +   +++      +   D E          Q+ +  I++LIG C    L  LV E    
Sbjct: 34  KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGG 92

Query: 138 GTLRGFSFA---SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAK 194
           G L  F       + ++   ++  +++  + YL    ++  V R + A NVLL   + AK
Sbjct: 93  GPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAK 149

Query: 195 LHDFSLSVSIPEGETHVREEF-IKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGC 253
           + DF LS ++   +++       K    + APE      F+   DV+S+G  + E L+  
Sbjct: 150 ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS-Y 208

Query: 254 NVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKC 313
               +K     + +         IE  +          E             L  LM  C
Sbjct: 209 GQKPYKKMKGPEVM-------AFIEQGKRMECPPECPPE-------------LYALMSDC 248

Query: 314 LSKSPEHRPLMVDVAKQLRQMYLSV 338
                E RP  + V +++R  Y S+
Sbjct: 249 WIYKWEDRPDFLTVEQRMRACYYSL 273

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (308), Expect = 1e-33
 Identities = 56/278 (20%), Positives = 97/278 (34%), Gaps = 26/278 (9%)

Query: 55  NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKN 114
            ++DL + +       +        +  ++V        +D  E     I  +  + H+N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 115 ILKLIGCCLETELPTLVFESVKYGTLRGF--SFASLLIAPRIKIAMEIANAVAYLHVGFD 172
           ++K  G   E  +  L  E    G L         +      +   ++   V YLH    
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---G 121

Query: 173 RPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSS 232
             I  R IK  N+LLDE  + K+ DF L+              + G   ++APE      
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181

Query: 233 FN-EMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFD 291
           F+ E  DV+S G  L  +L G    +     +D      ++ +K    N +  I      
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWD---QPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 238

Query: 292 EDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK 329
                            L++K L ++P  R  + D+ K
Sbjct: 239 -----------------LLHKILVENPSARITIPDIKK 259

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (304), Expect = 4e-33
 Identities = 41/283 (14%), Positives = 97/283 (34%), Gaps = 31/283 (10%)

Query: 55  NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKN 114
            +    K + +     +  G    Q   +++    + S  +D             + H+ 
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGSMSED--EFIEEAKVMMNLSHEK 60

Query: 115 ILKLIGCCLETELPTLVFESVKYGTLRGFSFAS---LLIAPRIKIAMEIANAVAYLHVGF 171
           +++L G C +     ++ E +  G L  +             +++  ++  A+ YL    
Sbjct: 61  LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE--- 117

Query: 172 DRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATS 231
            +  + R + A N L+++    K+ DF LS  + + E        K    +  PE    S
Sbjct: 118 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS-VGSKFPVRWSPPEVLMYS 176

Query: 232 SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFD 291
            F+   D+++FG  + E+ +    + ++   N +                   I   +  
Sbjct: 177 KFSSKSDIWAFGVLMWEIYS-LGKMPYERFTNSETAE---------------HIAQGLRL 220

Query: 292 EDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQM 334
                  ++     +  +MY C  +  + RP    +   +  +
Sbjct: 221 YRPHLASEK-----VYTIMYSCWHEKADERPTFKILLSNILDV 258

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (307), Expect = 4e-33
 Identities = 59/270 (21%), Positives = 101/270 (37%), Gaps = 27/270 (10%)

Query: 72  FEGTLVDQDR---PISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETE-L 127
           + GTL+D D      +V   +  + + +V       +      H N+L L+G CL +E  
Sbjct: 44  YHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 103

Query: 128 PTLVFESVKYGTLRGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLL 187
           P +V   +K+G LR F            +          +     +  V R + A N +L
Sbjct: 104 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML 163

Query: 188 DENYSAKLHDFSLSVSIPEGETHVREEF--IKGAYGFIAPEYFATSSFNEMCDVYSFGAF 245
           DE ++ K+ DF L+  + + E          K    ++A E   T  F    DV+SFG  
Sbjct: 164 DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVL 223

Query: 246 LCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQS 305
           L EL+T        G     D+   +     ++  R       +  E             
Sbjct: 224 LWELMTR-------GAPPYPDVNTFDITVYLLQGRR------LLQPEYCP--------DP 262

Query: 306 LGQLMYKCLSKSPEHRPLMVDVAKQLRQMY 335
           L ++M KC     E RP   ++  ++  ++
Sbjct: 263 LYEVMLKCWHPKAEMRPSFSELVSRISAIF 292

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (307), Expect = 5e-33
 Identities = 53/311 (17%), Positives = 101/311 (32%), Gaps = 54/311 (17%)

Query: 55  NNYDLHKVIQSDTSYRLFEGTLVDQDR-----PISVMKFHDNSTLDDVEYCFNNIVFSSQ 109
            N +  KV+ S    ++   T     +      ++V    + +   + E   + +   +Q
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 110 M-KHKNILKLIGCCLETELPTLVFESVKYGTLRGF------------------------- 143
           +  H+NI+ L+G C  +    L+FE   YG L  +                         
Sbjct: 97  LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 144 SFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVS 203
               L     +  A ++A  + +L     +  V R + A NVL+      K+ DF L+  
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARD 213

Query: 204 IPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGN 263
           I     +V     +    ++APE      +    DV+S+G  L E+ +   V  + G   
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS-LGVNPYPGIPV 272

Query: 264 DDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPL 323
           D +                      +              + +  +M  C +     RP 
Sbjct: 273 DANF-------------------YKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPS 313

Query: 324 MVDVAKQLRQM 334
             ++   L   
Sbjct: 314 FPNLTSFLGCQ 324

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (304), Expect = 6e-33
 Identities = 64/286 (22%), Positives = 107/286 (37%), Gaps = 32/286 (11%)

Query: 55  NNYDLHKVIQSDTSYRLFEGTLVDQDRP---ISVMKFHDNSTLDDVEYCFNNIVFSSQMK 111
              +L + I       + +G  +  + P   +++    + ++    E      +   Q  
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 112 HKNILKLIGCCLETELPTLVFESVKYGTLRGFSFA---SLLIAPRIKIAMEIANAVAYLH 168
           H +I+KLIG   E  +  ++ E    G LR F      SL +A  I  A +++ A+AYL 
Sbjct: 67  HPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125

Query: 169 VGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYF 228
               +  V R I A NVL+  N   KL DF LS  + +   + +    K    ++APE  
Sbjct: 126 ---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESI 181

Query: 229 ATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDP 288
               F    DV+ FG  + E+L         G      +   +   +     R       
Sbjct: 182 NFRRFTSASDVWMFGVCMWEILMH-------GVKPFQGVKNNDVIGRIENGER------L 228

Query: 289 IFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQM 334
               +           +L  LM KC +  P  RP   ++  QL  +
Sbjct: 229 PMPPNCP--------PTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  121 bits (304), Expect = 8e-33
 Identities = 55/285 (19%), Positives = 109/285 (38%), Gaps = 31/285 (10%)

Query: 55  NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKN 114
            +  +   +       ++EG        ++V    +++   +VE          ++KH N
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPN 74

Query: 115 ILKLIGCCLETELPTLVFESVKYGTLRGF----SFASLLIAPRIKIAMEIANAVAYLHVG 170
           +++L+G C       ++ E + YG L  +    +   +     + +A +I++A+ YL   
Sbjct: 75  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-- 132

Query: 171 FDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFAT 230
             +  + R + A N L+ EN+  K+ DF LS  +            K    + APE  A 
Sbjct: 133 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH-AGAKFPIKWTAPESLAY 190

Query: 231 SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIF 290
           + F+   DV++FG  L E+ T      + G                         V  + 
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGM-SPYPGIDLSQ--------------------VYELL 229

Query: 291 DEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMY 335
           ++D      E   + + +LM  C   +P  RP   ++ +    M+
Sbjct: 230 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  121 bits (303), Expect = 1e-32
 Identities = 63/318 (19%), Positives = 117/318 (36%), Gaps = 55/318 (17%)

Query: 48  KDLKKATNNYDLHKVIQSDTSYRLFEGTL-----VDQDRPISVMKFHDNSTLDDVEYCFN 102
             L+   NN +  + I      R+F+         +    ++V    + ++ D       
Sbjct: 6   LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQR 65

Query: 103 NIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF------------------- 143
                ++  + NI+KL+G C   +   L+FE + YG L  F                   
Sbjct: 66  EAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLST 125

Query: 144 -------SFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLH 196
                      L  A ++ IA ++A  +AYL    +R  V R +   N L+ EN   K+ 
Sbjct: 126 RARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIA 182

Query: 197 DFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVL 256
           DF LS +I   + +  +        ++ PE    + +    DV+++G  L E+ +   + 
Sbjct: 183 DFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG-LQ 241

Query: 257 EFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSK 316
            + G  +++ +         + +    A  +    E             L  LM  C SK
Sbjct: 242 PYYGMAHEEVI-------YYVRDGNILACPENCPLE-------------LYNLMRLCWSK 281

Query: 317 SPEHRPLMVDVAKQLRQM 334
            P  RP    + + L++M
Sbjct: 282 LPADRPSFCSIHRILQRM 299

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (300), Expect = 3e-32
 Identities = 64/287 (22%), Positives = 109/287 (37%), Gaps = 33/287 (11%)

Query: 55  NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKN 114
            +  L   +       ++ GT     R +++      +     E          +++H+ 
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGT--MSPEAFLQEAQVMKKLRHEK 73

Query: 115 ILKLIGCCLETELPTLVFESVKYGTL----RGFSFASLLIAPRIKIAMEIANAVAYLHVG 170
           +++L     E  +  +V E +  G+L    +G +   L +   + +A +IA+ +AY+   
Sbjct: 74  LVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE-- 130

Query: 171 FDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFAT 230
                V R ++A+N+L+ EN   K+ DF L+  I + E   R+   K    + APE    
Sbjct: 131 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA-KFPIKWTAPEAALY 188

Query: 231 SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIF 290
             F    DV+SFG  L EL T        G      +   E   +     R         
Sbjct: 189 GRFTIKSDVWSFGILLTELTTK-------GRVPYPGMVNREVLDQVERGYR--------- 232

Query: 291 DEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS 337
                 P   E  +SL  LM +C  K PE RP    +   L   + S
Sbjct: 233 -----MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (301), Expect = 3e-32
 Identities = 51/285 (17%), Positives = 109/285 (38%), Gaps = 32/285 (11%)

Query: 57  YDLHKVIQSDTSYRLFEGTLVDQDR----PISVMKFHDNSTLDDVEYCFNNIVFSSQMKH 112
           +   KV+ S     +++G  + +      P+++ +  + ++    +   +     + + +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 113 KNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAP---RIKIAMEIANAVAYLHV 169
            ++ +L+G CL + +  L+ + + +G L  +             +   ++IA  + YL  
Sbjct: 71  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 128

Query: 170 GFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFA 229
             DR +V R + A NVL+      K+ DF L+  +   E     E  K    ++A E   
Sbjct: 129 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 186

Query: 230 TSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPI 289
              +    DV+S+G  + EL+T        G+   D +   E +    +  R        
Sbjct: 187 HRIYTHQSDVWSYGVTVWELMTF-------GSKPYDGIPASEISSILEKGER-------- 231

Query: 290 FDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQM 334
                  P        +  +M KC     + RP   ++  +  +M
Sbjct: 232 ------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (297), Expect = 5e-32
 Identities = 58/288 (20%), Positives = 108/288 (37%), Gaps = 33/288 (11%)

Query: 55  NNYDLHKVIQSDTSYRLFEGTLVDQDRP-----ISVMKFHDNSTLDDVEYCFNNIVFSSQ 109
            +  L + +   +   +  G             +  +K    S  + ++     +     
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 110 MKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFA---SLLIAPRIKIAMEIANAVAY 166
           + H+N+++L G  L   +  +V E    G+L           L+    + A+++A  + Y
Sbjct: 68  LDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126

Query: 167 LHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH-VREEFIKGAYGFIAP 225
           L     +  + R + A N+LL      K+ DF L  ++P+ + H V +E  K  + + AP
Sbjct: 127 LE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183

Query: 226 EYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAI 285
           E   T +F+   D + FG  L E+ T      + G                        I
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFT-YGQEPWIGLNGSQ-------------------I 223

Query: 286 VDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQ 333
           +  I  E    P  E+  Q +  +M +C +  PE RP  V +   L +
Sbjct: 224 LHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (297), Expect = 9e-32
 Identities = 46/282 (16%), Positives = 95/282 (33%), Gaps = 34/282 (12%)

Query: 54  TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHK 113
            + +++   +      ++++    +        K  D  + +++E     I   +   H 
Sbjct: 11  EDFWEIIGELGDGAFGKVYKAQNKETSVLA-AAKVIDTKSEEELEDYMVEIDILASCDHP 69

Query: 114 NILKLIGCCLETELPTLVFESVKYGTLRGFSFA---SLLIAPRIKIAMEIANAVAYLHVG 170
           NI+KL+          ++ E    G +          L  +    +  +  +A+ YLH  
Sbjct: 70  NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH-- 127

Query: 171 FDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFAT 230
            D  I+ R +KA N+L   +   KL DF +S                G   ++APE    
Sbjct: 128 -DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVMC 184

Query: 231 SS-----FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAI 285
            +     ++   DV+S G  L E+                +L  +    K  ++      
Sbjct: 185 ETSKDRPYDYKADVWSLGITLIEMAEIEPPH--------HELNPMRVLLKIAKSEP---- 232

Query: 286 VDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDV 327
             P   + + +        +    + KCL K+ + R     +
Sbjct: 233 --PTLAQPSRWS------SNFKDFLKKCLEKNVDARWTTSQL 266

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (297), Expect = 9e-32
 Identities = 50/276 (18%), Positives = 92/276 (33%), Gaps = 30/276 (10%)

Query: 51  KKATNNYDLHKVIQSDTSYRLFEGTLVDQDRP--ISVMKFHDNSTLDDVEYCFNNIVFSS 108
           KK   ++   K++   +   +     +   R   I +++       + V Y        S
Sbjct: 4   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63

Query: 109 QMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF--SFASLLIAPRIKIAMEIANAVAY 166
           ++ H   +KL     + E         K G L  +     S           EI +A+ Y
Sbjct: 64  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 123

Query: 167 LHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPE 226
           LH    + I+ R +K  N+LL+E+   ++ DF  +  +       R     G   +++PE
Sbjct: 124 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 180

Query: 227 YFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIV 286
                S  +  D+++ G  + +L+ G     F+                         I 
Sbjct: 181 LLTEKSACKSSDLWALGCIIYQLVAGL--PPFRAGNEYL-------------------IF 219

Query: 287 DPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
             I   +  FP  E+       L+ K L      R 
Sbjct: 220 QKIIKLEYDFP--EKFFPKARDLVEKLLVLDATKRL 253

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (293), Expect = 3e-31
 Identities = 55/235 (23%), Positives = 95/235 (40%), Gaps = 28/235 (11%)

Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFAS--LLIAPRIKIAMEIANAVA 165
            Q+ +  I+++IG C E E   LV E  + G L  +   +  +     I++  +++  + 
Sbjct: 63  QQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMK 121

Query: 166 YLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVR-EEFIKGAYGFIA 224
           YL    +   V R + A NVLL   + AK+ DF LS ++   E + + +   K    + A
Sbjct: 122 YLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 178

Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA 284
           PE      F+   DV+SFG  + E  +      ++G    +   +LE  ++         
Sbjct: 179 PECINYYKFSSKSDVWSFGVLMWEAFS-YGQKPYRGMKGSEVTAMLEKGER--------- 228

Query: 285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLSVV 339
                              + +  LM  C +   E+RP    V  +LR  Y  VV
Sbjct: 229 ---MGCPAGCP--------REMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 272

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (289), Expect = 8e-31
 Identities = 58/288 (20%), Positives = 103/288 (35%), Gaps = 32/288 (11%)

Query: 55  NNYDLHKVIQSDTSYRLFEGTLVDQD----RPISVMKFHDNSTLDDVEYCFNNIVFSSQM 110
           +     KVI +     +++G L         P+++       T               Q 
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 111 KHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFAS---LLIAPRIKIAMEIANAVAYL 167
            H NI++L G   + +   ++ E ++ G L  F         +   + +   IA  + YL
Sbjct: 67  SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126

Query: 168 HVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEF-IKGAYGFIAPE 226
               +   V R + A N+L++ N   K+ DF LS  + +           K    + APE
Sbjct: 127 A---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 183

Query: 227 YFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIV 286
             +   F    DV+SFG  + E++T        G     +L+  E  K   +  R     
Sbjct: 184 AISYRKFTSASDVWSFGIVMWEVMTY-------GERPYWELSNHEVMKAINDGFR----- 231

Query: 287 DPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQM 334
                     P   +   ++ QLM +C  +    RP   D+   L ++
Sbjct: 232 ---------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (289), Expect = 2e-30
 Identities = 56/306 (18%), Positives = 104/306 (33%), Gaps = 49/306 (16%)

Query: 55  NNYDLHKVIQSDTSYRLFEGTLV-----DQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQ 109
           N     K + +    ++ E T       D    ++V     ++ L + E   + +   S 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 110 MK-HKNILKLIGCCLETELPTLVFESVKYGTLRGF--------------------SFASL 148
           +  H NI+ L+G C       ++ E   YG L  F                       +L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 149 LIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE 208
            +   +  + ++A  +A+L     +  + R + A N+LL      K+ DF L+  I    
Sbjct: 143 DLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 209 THVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLT 268
            +V +   +    ++APE      +    DV+S+G FL EL +        G+     + 
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSL-------GSSPYPGMP 252

Query: 269 VLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVA 328
           V     K             +  E       E     +  +M  C    P  RP    + 
Sbjct: 253 VDSKFYK-------------MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299

Query: 329 KQLRQM 334
           + + + 
Sbjct: 300 QLIEKQ 305

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (287), Expect = 2e-30
 Identities = 48/275 (17%), Positives = 93/275 (33%), Gaps = 27/275 (9%)

Query: 54  TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHK 113
              Y   + I    S  ++    V   + +++ +  +       E   N I+   + K+ 
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAI-RQMNLQQQPKKELIINEILVMRENKNP 77

Query: 114 NILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIK-IAMEIANAVAYLHVGFD 172
           NI+  +   L  +   +V E +  G+L      + +   +I  +  E   A+ +LH    
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH---S 134

Query: 173 RPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSS 232
             ++ R IK+ N+LL  + S KL DF     I   ++      + G   ++APE     +
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS--TMVGTPYWMAPEVVTRKA 192

Query: 233 FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDE 292
           +    D++S G    E++ G     +        L           N        P    
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGE--PPYLNENPLRAL------YLIATNGT------PELQN 238

Query: 293 DNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDV 327
                            + +CL    E R    ++
Sbjct: 239 PEKLS------AIFRDFLNRCLDMDVEKRGSAKEL 267

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  115 bits (288), Expect = 3e-30
 Identities = 56/290 (19%), Positives = 95/290 (32%), Gaps = 40/290 (13%)

Query: 45  FSAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRP--ISVMKFHDNSTLDDVEYCFN 102
           F   D +K    +   + I   +   ++    V       I  M +    + +  +    
Sbjct: 8   FFKDDPEK---LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIK 64

Query: 103 NIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFAS--LLIAPRIKIAMEI 160
            + F  +++H N ++  GC L      LV E                L       +    
Sbjct: 65  EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGA 124

Query: 161 ANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAY 220
              +AYLH      ++ R +KA N+LL E    KL DF  +  +    + V      G  
Sbjct: 125 LQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV------GTP 175

Query: 221 GFIAPEYFATSS---FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSI 277
            ++APE         ++   DV+S G    EL      L      N + ++ L +    I
Sbjct: 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF-----NMNAMSALYH----I 226

Query: 278 ENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDV 327
             N   A+    + E                 +  CL K P+ RP    +
Sbjct: 227 AQNESPALQSGHWSEY------------FRNFVDSCLQKIPQDRPTSEVL 264

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  114 bits (286), Expect = 1e-29
 Identities = 46/278 (16%), Positives = 95/278 (34%), Gaps = 31/278 (11%)

Query: 55  NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKN 114
           ++YD+H+ + +     +   T           KF       D E     I   S ++H  
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNF-AAKFVMTPHESDKETVRKEIQTMSVLRHPT 84

Query: 115 ILKLIGCCLETELPTLVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANAVAYLHVGF 171
           ++ L     +     +++E +  G L          +     ++   ++   + ++H   
Sbjct: 85  LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH--- 141

Query: 172 DRPIVFRCIKASNVLL--DENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFA 229
           +   V   +K  N++     +   KL DF L+  +   ++    +   G   F APE   
Sbjct: 142 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV---KVTTGTAEFAAPEVAE 198

Query: 230 TSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPI 289
                   D++S G     LL+G     F G  +D+ L  ++    +++++ F  I +  
Sbjct: 199 GKPVGYYTDMWSVGVLSYILLSGL--SPFGGENDDETLRNVKSCDWNMDDSAFSGISEDG 256

Query: 290 FDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDV 327
            D                  + K L   P  R  +   
Sbjct: 257 KD-----------------FIRKLLLADPNTRMTIHQA 277

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (282), Expect = 1e-29
 Identities = 55/305 (18%), Positives = 106/305 (34%), Gaps = 48/305 (15%)

Query: 55  NNYDLHKVIQSDTSYRLFEGTLVDQD-----RPISVMKFHDNSTLDDVEYCFNNI-VFSS 108
           +   L K +      ++ E      D     R ++V    + +T  +     + + +   
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 109 QMKHKNILKLIGCCLETELP-TLVFESVKYGTLRGF------------------SFASLL 149
              H N++ L+G C +   P  ++ E  K+G L  +                      L 
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 150 IAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGET 209
           +   I  + ++A  + +L     R  + R + A N+LL E    K+ DF L+  I +   
Sbjct: 133 LEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 210 HVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTV 269
           +VR+   +    ++APE      +    DV+SFG  L E+ +               + +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-------PYPGVKI 242

Query: 270 LEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK 329
            E   + ++        D    E             + Q M  C    P  RP   ++ +
Sbjct: 243 DEEFCRRLKEGTRMRAPDYTTPE-------------MYQTMLDCWHGEPSQRPTFSELVE 289

Query: 330 QLRQM 334
            L  +
Sbjct: 290 HLGNL 294

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (280), Expect = 3e-29
 Identities = 59/301 (19%), Positives = 107/301 (35%), Gaps = 48/301 (15%)

Query: 55  NNYDLHKVIQSDTSYRLFEGTLVD--QDRPISVMKFHDNSTLDDVEYCFNNI-VFSSQMK 111
           N+     VI      ++ +  +         ++ +  + ++ DD       + V      
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 112 HKNILKLIGCCLETELPTLVFESVKYGTLRGF------------------SFASLLIAPR 153
           H NI+ L+G C       L  E   +G L  F                  + ++L     
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 154 IKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVRE 213
           +  A ++A  + YL     +  + R + A N+L+ ENY AK+ DF LS      E +V++
Sbjct: 130 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQ---EVYVKK 183

Query: 214 EFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYA 273
              +    ++A E    S +    DV+S+G  L E+++        G      +T  E  
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSL-------GGTPYCGMTCAELY 236

Query: 274 KKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQ 333
           +K  +  R                        +  LM +C  + P  RP    +   L +
Sbjct: 237 EKLPQGYR--------------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 282

Query: 334 M 334
           M
Sbjct: 283 M 283

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (278), Expect = 3e-29
 Identities = 49/283 (17%), Positives = 101/283 (35%), Gaps = 35/283 (12%)

Query: 56  NYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNN-IVFSSQMKHKN 114
           +Y++   I + +  R  +       + +   +    S  +  +    + +    ++KH N
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64

Query: 115 ILKLIGCCLETE--LPTLVFESVKYGTLRGF------SFASLLIAPRIKIAMEIANAVAY 166
           I++     ++       +V E  + G L             L     +++  ++  A+  
Sbjct: 65  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124

Query: 167 LH--VGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIA 224
            H        ++ R +K +NV LD   + KL DF L+  +    +  +     G   +++
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA--FVGTPYYMS 182

Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA 284
           PE     S+NE  D++S G  L EL        F      +           I   +F  
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPP--FTAFSQKELA-------GKIREGKFRR 233

Query: 285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDV 327
           I     DE             L +++ + L+    HRP + ++
Sbjct: 234 IPYRYSDE-------------LNEIITRMLNLKDYHRPSVEEI 263

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (276), Expect = 5e-29
 Identities = 47/279 (16%), Positives = 98/279 (35%), Gaps = 34/279 (12%)

Query: 57  YDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNN-IVFSSQMKHKNI 115
                 I   +   +++G   +    ++  +  D          F         ++H NI
Sbjct: 11  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70

Query: 116 LKLIGCCLET----ELPTLVFESVKYGTLRGF--SFASLLIAPRIKIAMEIANAVAYLHV 169
           ++       T    +   LV E +  GTL+ +   F  + I        +I   + +LH 
Sbjct: 71  VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT 130

Query: 170 GFDRPIVFRCIKASNVLL-DENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYF 228
               PI+ R +K  N+ +     S K+ D  L+              + G   F+APE +
Sbjct: 131 R-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----VIGTPEFMAPEMY 185

Query: 229 ATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDP 288
               ++E  DVY+FG  + E+ T      +    N   +       + + +    A  D 
Sbjct: 186 -EEKYDESVDVYAFGMCMLEMATSE--YPYSECQNAAQI------YRRVTSGVKPASFDK 236

Query: 289 IFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDV 327
           +   +            + +++  C+ ++ + R  + D+
Sbjct: 237 VAIPE------------VKEIIEGCIRQNKDERYSIKDL 263

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (278), Expect = 6e-29
 Identities = 54/313 (17%), Positives = 123/313 (39%), Gaps = 47/313 (15%)

Query: 45  FSAKDLKKA------TNNYDLHKVIQSDTSYRLFEGTL-----VDQDRPISVMKFHDNST 93
           FSA D+              + + +   +   ++EG        + +  +++   ++ ++
Sbjct: 4   FSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS 63

Query: 94  LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF---------- 143
           + +     N      +    ++++L+G   + +   ++ E +  G L+ +          
Sbjct: 64  MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMAN 123

Query: 144 --SFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLS 201
               A   ++  I++A EIA+ +AYL+       V R + A N ++ E+++ K+ DF ++
Sbjct: 124 NPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMT 180

Query: 202 VSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGN 261
             I E + + +         +++PE      F    DV+SFG  L E+ T      ++G 
Sbjct: 181 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE-QPYQGL 239

Query: 262 GNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHR 321
            N+  L       + +         D   D              L +LM  C   +P+ R
Sbjct: 240 SNEQVL-------RFVMEGGLLDKPDNCPDM-------------LFELMRMCWQYNPKMR 279

Query: 322 PLMVDVAKQLRQM 334
           P  +++   +++ 
Sbjct: 280 PSFLEIISSIKEE 292

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (271), Expect = 5e-28
 Identities = 58/306 (18%), Positives = 105/306 (34%), Gaps = 50/306 (16%)

Query: 55  NNYDLHKVIQSDTSYRLFEGTLVDQDR-------PISVMKFHDNSTLDDVEYCFNNI-VF 106
           +   L K +      ++     +  D+        ++V     ++T  D+    + + + 
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 107 SSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF------------------SFASL 148
               KHKNI+ L+G C +     ++ E    G LR +                      L
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 149 LIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE 208
                +  A ++A  + YL     +  + R + A NVL+ E+   K+ DF L+  I   +
Sbjct: 133 SSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189

Query: 209 THVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLT 268
            + +    +    ++APE      +    DV+SFG  L E+ T        G      + 
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL-------GGSPYPGVP 242

Query: 269 VLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVA 328
           V E  K   E +R                        L  +M  C    P  RP    + 
Sbjct: 243 VEELFKLLKEGHR--------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 288

Query: 329 KQLRQM 334
           + L ++
Sbjct: 289 EDLDRI 294

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  106 bits (265), Expect = 1e-26
 Identities = 50/278 (17%), Positives = 92/278 (33%), Gaps = 31/278 (11%)

Query: 55  NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKN 114
           + YD+ + + S     +         R   V KF +     D     N I   +Q+ H  
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVF-VAKFINTPYPLDKYTVKNEISIMNQLHHPK 87

Query: 115 ILKLIGCCLETELPTLVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANAVAYLHVGF 171
           ++ L     +     L+ E +  G L          +  A  I    +    + ++H   
Sbjct: 88  LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH--- 144

Query: 172 DRPIVFRCIKASNVLLD--ENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFA 229
           +  IV   IK  N++ +  +  S K+ DF L+  +   E     +       F APE   
Sbjct: 145 EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV---KVTTATAEFAAPEIVD 201

Query: 230 TSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPI 289
                   D+++ G     LL+G  +  F G  + + L  ++      + + F ++    
Sbjct: 202 REPVGFYTDMWAIGVLGYVLLSG--LSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEA 259

Query: 290 FDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDV 327
            D                  +   L K P  R  + D 
Sbjct: 260 KD-----------------FIKNLLQKEPRKRLTVHDA 280

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  104 bits (260), Expect = 1e-26
 Identities = 50/292 (17%), Positives = 108/292 (36%), Gaps = 32/292 (10%)

Query: 54  TNNYDLHKVIQSDTSYRLFEGTLVDQDRP--ISVMKFHDNSTLDDVEYCFNNIVFSSQMK 111
           ++ Y+L +++       +     +   R   + V++                   ++ + 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 112 HKNILKLIGCCLETE----LPTLVFESVKYGTLRGF--SFASLLIAPRIKIAMEIANAVA 165
           H  I+ +            LP +V E V   TLR    +   +     I++  +   A+ 
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 125

Query: 166 YLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEF-IKGAYGFIA 224
           + H      I+ R +K +N+++    + K+ DF ++ +I +    V +   + G   +++
Sbjct: 126 FSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182

Query: 225 PEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA 284
           PE     S +   DVYS G  L E+LTG               + +  A + +  +    
Sbjct: 183 PEQARGDSVDARSDVYSLGCVLYEVLTGEPPF--------TGDSPVSVAYQHVREDPI-- 232

Query: 285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPL-MVDVAKQLRQMY 335
              P                 L  ++ K L+K+PE+R     ++   L +++
Sbjct: 233 ---PPSARHEGLS------ADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (255), Expect = 1e-25
 Identities = 61/281 (21%), Positives = 104/281 (37%), Gaps = 33/281 (11%)

Query: 55  NNYDLHKVIQSDTSYRLFEGTLVDQDRP--ISVMKFHDNSTLDDVEYCFNNI-VFSSQMK 111
            ++ LHK++   +  ++F       ++   I  +K       DDVE       V S   +
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 112 HKNILKLIGCCLETELPTLVFESVKYGTLRGF--SFASLLIAPRIKIAMEIANAVAYLHV 169
           H  +  +       E    V E +  G L     S     ++     A EI   + +LH 
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH- 120

Query: 170 GFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFA 229
              + IV+R +K  N+LLD++   K+ DF +      G+   +     G   +IAPE   
Sbjct: 121 --SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNTFCGTPDYIAPEILL 176

Query: 230 TSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPI 289
              +N   D +SFG  L E+L G +   F G    D+  +    +            +P 
Sbjct: 177 GQKYNHSVDWWSFGVLLYEMLIGQSP--FHG---QDEEELFHSIRMD----------NPF 221

Query: 290 FDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ 330
           +        K+        L+ K   + PE R  +    +Q
Sbjct: 222 YPRWLEKEAKD--------LLVKLFVREPEKRLGVRGDIRQ 254

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  101 bits (252), Expect = 3e-25
 Identities = 49/282 (17%), Positives = 86/282 (30%), Gaps = 24/282 (8%)

Query: 48  KDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFS 107
           K  +   + YD   V+ +     +         + +++      +         N I   
Sbjct: 2   KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61

Query: 108 SQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGF--SFASLLIAPRIKIAMEIANAVA 165
            ++KH NI+ L           L+ + V  G L                ++  ++ +AV 
Sbjct: 62  HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVK 121

Query: 166 YLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAP 225
           YLH         +        LDE+    + DF LS     G          G  G++AP
Sbjct: 122 YLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL---STACGTPGYVAP 178

Query: 226 EYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAI 285
           E  A   +++  D +S G     LL G     F    +      +  A+   ++  +  I
Sbjct: 179 EVLAQKPYSKAVDCWSIGVIAYILLCGY--PPFYDENDAKLFEQILKAEYEFDSPYWDDI 236

Query: 286 VDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDV 327
            D   D                  +   + K PE R      
Sbjct: 237 SDSAKD-----------------FIRHLMEKDPEKRFTCEQA 261

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  102 bits (254), Expect = 4e-25
 Identities = 45/288 (15%), Positives = 102/288 (35%), Gaps = 36/288 (12%)

Query: 55  NNYDLHKVIQSDTSYRLFEGTLVDQDRP--ISVMKFHDNSTLDDVEYCFNNIVFSSQMK- 111
           N++ +H++I       ++     D  +   +  +               N  +  S +  
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 112 --HKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPR--IKIAMEIANAVAYL 167
                I+ +       +  + + + +  G L        + +       A EI   + ++
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 123

Query: 168 HVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEY 227
           H   +R +V+R +K +N+LLDE+   ++ D  L+    + + H       G +G++APE 
Sbjct: 124 H---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH----ASVGTHGYMAPEV 176

Query: 228 FATS-SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIV 286
                +++   D +S G  L +LL G +   F+ +   D   +                 
Sbjct: 177 LQKGVAYDSSADWFSLGCMLFKLLRGHS--PFRQHKTKDKHEIDRMTLTM---------- 224

Query: 287 DPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP-LMVDVAKQLRQ 333
                +  S          L  L+   L +    R   +   A+++++
Sbjct: 225 AVELPDSFS--------PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  100 bits (250), Expect = 7e-25
 Identities = 52/284 (18%), Positives = 113/284 (39%), Gaps = 36/284 (12%)

Query: 55  NNYDLHKVIQSDTSYRLFEGTLVDQDRP--ISVMKFHDNSTLDDVEYCFNNIVFSSQMKH 112
            ++ + + + + +  R+         R   + V+K      L  VE+  +  +  S + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 113 KNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRI--KIAMEIANAVAYLHVG 170
             I+++ G   + +   ++ + ++ G L      S      +    A E+  A+ YLH  
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH-- 121

Query: 171 FDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFAT 230
             + I++R +K  N+LLD+N   K+ DF  +  +P+    +      G   +IAPE  +T
Sbjct: 122 -SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTL-----CGTPDYIAPEVVST 175

Query: 231 SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIF 290
             +N+  D +SFG  + E+L G     F  +                         + I 
Sbjct: 176 KPYNKSIDWWSFGILIYEMLAGY--TPFYDSNTMK-------------------TYEKIL 214

Query: 291 DEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP-LMVDVAKQLRQ 333
           + +  FP      + +  L+ + +++    R   + +  + ++ 
Sbjct: 215 NAELRFP--PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.6 bits (237), Expect = 2e-23
 Identities = 56/294 (19%), Positives = 95/294 (32%), Gaps = 39/294 (13%)

Query: 45  FSAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRP-----ISVMKFHDNSTLDDVEY 99
           F  +++    + YD  + + S     + +              I   +   +      E 
Sbjct: 3   FRQENVD---DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED 59

Query: 100 CFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFA--SLLIAPRIKIA 157
               +    +++H N++ L           L+ E V  G L  F     SL      +  
Sbjct: 60  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFL 119

Query: 158 MEIANAVAYLHVGFDRPIVFRCIKASNVLLDEN----YSAKLHDFSLSVSIPEGETHVRE 213
            +I N V YLH      I    +K  N++L +        K+ DF L+  I  G      
Sbjct: 120 KQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--- 173

Query: 214 EFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYA 273
           + I G   F+APE           D++S G     LL+G +   F G+   + L  +   
Sbjct: 174 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP--FLGDTKQETLANVSAV 231

Query: 274 KKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDV 327
               E+  F        D                  + + L K P+ R  + D 
Sbjct: 232 NYEFEDEYFSNTSALAKD-----------------FIRRLLVKDPKKRMTIQDS 268

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.9 bits (238), Expect = 3e-23
 Identities = 44/282 (15%), Positives = 88/282 (31%), Gaps = 32/282 (11%)

Query: 51  KKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQM 110
           K+    Y + + +       +         +           T  D       I   +  
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT--DQVLVKKEISILNIA 58

Query: 111 KHKNILKLIGCCLETELPTLVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANAVAYL 167
           +H+NIL L       E   ++FE +    +      S   L     +    ++  A+ +L
Sbjct: 59  RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFL 118

Query: 168 HVGFDRPIVFRCIKASNVLLD--ENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAP 225
           H      I    I+  N++     + + K+ +F  +  +  G+       +  A  + AP
Sbjct: 119 H---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLFTAPEYYAP 172

Query: 226 EYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAI 285
           E       +   D++S G  +  LL+G N   F    N   +  +  A+ + +   F  I
Sbjct: 173 EVHQHDVVSTATDMWSLGTLVYVLLSGINP--FLAETNQQIIENIMNAEYTFDEEAFKEI 230

Query: 286 VDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDV 327
                D                  + + L K  + R    + 
Sbjct: 231 SIEAMD-----------------FVDRLLVKERKSRMTASEA 255

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.5 bits (234), Expect = 8e-23
 Identities = 55/251 (21%), Positives = 85/251 (33%), Gaps = 17/251 (6%)

Query: 83  ISVMKFHDNSTLDD--VEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTL 140
           I  +K    S   D         I    ++ H NI+ L+         +LVF+ ++    
Sbjct: 28  IKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLE 87

Query: 141 RGFSFASLLIAP--RIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDF 198
                 SL++ P       +     + YLH      I+ R +K +N+LLDEN   KL DF
Sbjct: 88  VIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADF 144

Query: 199 SLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEF 258
            L+ S            +   +       F    +    D+++ G  L ELL        
Sbjct: 145 GLAKSFGS-PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPF--L 201

Query: 259 KGNGNDDDLT-VLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKL------QSLGQLMY 311
            G+ + D LT + E      E         P +    SFPG             L  L+ 
Sbjct: 202 PGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQ 261

Query: 312 KCLSKSPEHRP 322
                +P  R 
Sbjct: 262 GLFLFNPCARI 272

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.1 bits (233), Expect = 2e-22
 Identities = 48/291 (16%), Positives = 90/291 (30%), Gaps = 22/291 (7%)

Query: 54  TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHK 113
              Y     I       +           +++ K          +     I    + +H+
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 114 NILKLIGCCLETELPT-----LVFESVKYGTLRGFSFASLLIAPRIKIAMEIANAVAYLH 168
           NI+ +        +       LV   +     +      L          +I   + Y+H
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126

Query: 169 VGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSI-PEGETHVREEFIKGAYGFIAPEY 227
                 ++ R +K SN+LL+     K+ DF L+    P+ +             + APE 
Sbjct: 127 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183

Query: 228 FATS-SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLT-VLEYAKKSIENNRFGAI 285
              S  + +  D++S G  L E+L+   +  F G    D L  +L       + +    I
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPI--FPGKHYLDQLNHILGILGSPSQEDLNCII 241

Query: 286 VDPIFDEDNSFPGKEEKL---------QSLGQLMYKCLSKSPEHRPLMVDV 327
                +   S P K +                L+ K L+ +P  R  +   
Sbjct: 242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 93.4 bits (231), Expect = 2e-22
 Identities = 49/295 (16%), Positives = 101/295 (34%), Gaps = 27/295 (9%)

Query: 52  KATNNYDLHKVIQSDTSYRLFEGT-LVDQDRPISVMKFHDNSTLDDVEYCFNNIV----F 106
           +A   Y+    I      ++F+   L +  R +++ +    +  + +       V     
Sbjct: 4   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63

Query: 107 SSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPR--------IKIAM 158
               +H N+++L   C  +        ++ +  +       L   P           +  
Sbjct: 64  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123

Query: 159 EIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKG 218
           ++   + +LH      +V R +K  N+L+  +   KL DF L+              +  
Sbjct: 124 QLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS---VVV 177

Query: 219 AYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLT-VLEYAKKSI 277
              + APE    SS+    D++S G    E+     +  F+G+ + D L  +L+      
Sbjct: 178 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL--FRGSSDVDQLGKILDVIGLPG 235

Query: 278 ENNRFGAIVDPIFDEDNSFPGKEEKL-----QSLGQLMYKCLSKSPEHRPLMVDV 327
           E +    +  P     +      EK      +    L+ KCL+ +P  R      
Sbjct: 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 93.0 bits (230), Expect = 2e-22
 Identities = 42/294 (14%), Positives = 89/294 (30%), Gaps = 32/294 (10%)

Query: 55  NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKN 114
           N Y L + I S +   ++ GT +     +++      +    +            M+   
Sbjct: 7   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLH---IESKIYKMMQGGV 63

Query: 115 ILKLIG-CCLETELPTLVFESVKYGTLRGFSFAS--LLIAPRIKIAMEIANAVAYLHVGF 171
            +  I  C  E +   +V E +       F+F S    +   + +A ++ + + Y+H   
Sbjct: 64  GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH--- 120

Query: 172 DRPIVFRCIKASNVL---LDENYSAKLHDFSLSVSIPEGETHVREEF-----IKGAYGFI 223
            +  + R +K  N L     +     + DF L+    +  TH    +     + G   + 
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180

Query: 224 APEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFG 283
           +         +   D+ S G  L     G    +                    E     
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK---------YERISEK 231

Query: 284 AIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS 337
            +  PI      +P            +  C S   + +P    + +  R ++  
Sbjct: 232 KMSTPIEVLCKGYP------SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 92.3 bits (228), Expect = 4e-22
 Identities = 53/284 (18%), Positives = 103/284 (36%), Gaps = 16/284 (5%)

Query: 55  NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFH-DNSTLDDVEYCFNNIVFSSQMKHK 113
             Y+  + I   T   +F+    +    +++ +   D+            I    ++KHK
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 114 NILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRI--KIAMEIANAVAYLHVGF 171
           NI++L       +  TLVFE       + F   +  + P I      ++   + + H   
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH--- 118

Query: 172 DRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATS 231
            R ++ R +K  N+L++ N   KL +F L+ +            +   +       F   
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC-YSAEVVTLWYRPPDVLFGAK 177

Query: 232 SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVD---- 287
            ++   D++S G    EL      L F GN  DD L  +     +    ++ ++      
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPL-FPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236

Query: 288 ---PIFDEDNSFPGKEEKLQSLGQ-LMYKCLSKSPEHRPLMVDV 327
              P++    S      KL + G+ L+   L  +P  R    + 
Sbjct: 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score = 89.7 bits (222), Expect = 3e-21
 Identities = 49/224 (21%), Positives = 82/224 (36%), Gaps = 33/224 (14%)

Query: 112 HKNILKLIGCCLETELPTLVFESVKYGTLRGF--SFASLLIAPRIKIAMEIANAVAYLHV 169
           H NI++L           LVF+ +K G L  +     +L      KI   +   +  LH 
Sbjct: 69  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH- 127

Query: 170 GFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFA 229
                IV R +K  N+LLD++ + KL DF  S  +  GE       + G   ++APE   
Sbjct: 128 --KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE---VCGTPSYLAPEIIE 182

Query: 230 TS------SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFG 283
            S       + +  D++S G  +  LL G     F        L       + I +  + 
Sbjct: 183 CSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP--FWHRKQMLML-------RMIMSGNY- 232

Query: 284 AIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDV 327
                   E + +        ++  L+ + L   P+ R    + 
Sbjct: 233 ---QFGSPEWDDYS------DTVKDLVSRFLVVQPQKRYTAEEA 267

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 89.5 bits (221), Expect = 4e-21
 Identities = 36/293 (12%), Positives = 91/293 (31%), Gaps = 32/293 (10%)

Query: 55  NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKN 114
            +Y + + I   +   +FEGT +  ++ +++      S    +   +    +        
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYR--TYKLLAGCTG 62

Query: 115 ILKLIGCCLETELPTLVFESVKYGTLRGFSFAS--LLIAPRIKIAMEIANAVAYLHVGFD 172
           I  +     E     LV + +                +      A ++   V  +H   +
Sbjct: 63  IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---E 119

Query: 173 RPIVFRCIKASNVLLDENYS-----AKLHDFSLSVSIPEGETHV-----REEFIKGAYGF 222
           + +V+R IK  N L+    S       + DF +     +  T        ++ + G   +
Sbjct: 120 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 179

Query: 223 IAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRF 282
           ++         +   D+ + G      L G     ++G     +    E   +  ++   
Sbjct: 180 MSINTHLGREQSRRDDLEALGHVFMYFLRGSL--PWQGLKAATNKQKYERIGEKKQST-- 235

Query: 283 GAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMY 335
                P+ +    FP      +   + M+   + + +  P    +     ++ 
Sbjct: 236 -----PLRELCAGFP------EEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 277

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.7 bits (219), Expect = 1e-20
 Identities = 59/287 (20%), Positives = 102/287 (35%), Gaps = 32/287 (11%)

Query: 56  NYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNI 115
           +Y   KVI + +   +++  L D    +++ K   +    + E     +    ++ H NI
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE-----LQIMRKLDHCNI 75

Query: 116 LKLIGCCLETELPT------LVFESVKYGTLR-----GFSFASLLIAPRIKIAMEIANAV 164
           ++L      +          LV + V     R       +  +L +        ++  ++
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135

Query: 165 AYLHVGFDRPIVFRCIKASNVLLD-ENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFI 223
           AY+H      I  R IK  N+LLD +    KL DF  +  +  GE +V   +I   Y   
Sbjct: 136 AYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YICSRYYRA 190

Query: 224 APEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLT----VLEYAKKSIEN 279
               F  + +    DV+S G  L ELL G     F G+   D L     VL    +    
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQ--PIFPGDSGVDQLVEIIKVLGTPTREQIR 248

Query: 280 NRFGAIVDPIFDEDNSFPGKEEKLQSLGQ----LMYKCLSKSPEHRP 322
                  +  F +  + P  +            L  + L  +P  R 
Sbjct: 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL 295

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 87.1 bits (215), Expect = 5e-20
 Identities = 49/282 (17%), Positives = 94/282 (33%), Gaps = 29/282 (10%)

Query: 55  NNYDLHKVIQSDTSYRLFEGTLVDQDRP--ISVMKFHDNSTLDDVEYCFNNIVFSSQMKH 112
           N++D  K++   T  ++         R   + +++       D+V +           +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 113 KNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIKIAMEIANAVAYLHVGFD 172
             +  L       +    V E    G L        +     +     A  V+ L     
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE-RARFYGAEIVSALEYLHS 123

Query: 173 RPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSS 232
           R +V+R IK  N++LD++   K+ DF L          ++     G   ++APE    + 
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK--TFCGTPEYLAPEVLEDND 181

Query: 233 FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDE 292
           +    D +  G  + E++ G   L F    ++                    + + I  E
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGR--LPFYNQDHER-------------------LFELILME 220

Query: 293 DNSFPGKEEKLQSLGQLMYKCLSKSPEHRP-LMVDVAKQLRQ 333
           +  FP           L+   L K P+ R       AK++ +
Sbjct: 221 EIRFP--RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 85.3 bits (210), Expect = 1e-19
 Identities = 47/284 (16%), Positives = 93/284 (32%), Gaps = 18/284 (6%)

Query: 55  NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFH-DNSTLDDVEYCFNNIVFSSQMKHK 113
             Y   + I   T   +++    +     ++ K   +             I    ++KH 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60

Query: 114 NILKLIGCCLETELPTLVFESVKYGTLRGFSFAS--LLIAPRIKIAMEIANAVAYLHVGF 171
           NI+KL       +   LVFE +     +        L         +++ N +AY H   
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH--- 117

Query: 172 DRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATS 231
           DR ++ R +K  N+L++     K+ DF L+ +            I   +         + 
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK-YTHEIVTLWYRAPDVLMGSK 176

Query: 232 SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFD 291
            ++   D++S G    E++ G     F G    D L  +     +  +  +  + +    
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGT--PLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234

Query: 292 EDNSFPGKEEKLQSLGQ--------LMYKCLSKSPEHRPLMVDV 327
           + N    +    +S  +        L+ K L   P  R      
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 84.9 bits (209), Expect = 2e-19
 Identities = 44/285 (15%), Positives = 93/285 (32%), Gaps = 20/285 (7%)

Query: 56  NYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFH-DNSTLDDVEYCFNNIVFSSQMKHKN 114
           N+   + I   T   +++         +++ K   D  T          I    ++ H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 115 ILKLIGCCLETELPTLVFESVKYGT---LRGFSFASLLIAPRIKIAMEIANAVAYLHVGF 171
           I+KL+          LVFE +       +   +   + +        ++   +A+ H   
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH--- 119

Query: 172 DRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATS 231
              ++ R +K  N+L++   + KL DF L+ +            +   +           
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCK 178

Query: 232 SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFD 291
            ++   D++S G    E++T      F G+   D L  +     + +   +  +   + D
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRR--ALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS-MPD 235

Query: 292 EDNSFPGKEEKL---------QSLGQLMYKCLSKSPEHRPLMVDV 327
              SFP    +          +    L+ + L   P  R      
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 85.5 bits (211), Expect = 2e-19
 Identities = 39/234 (16%), Positives = 76/234 (32%), Gaps = 32/234 (13%)

Query: 105 VFSSQMKHKNILKLIGCC----LETELPTLVFESVKYGTLRGF----SFASLLIAPRIKI 156
           +     +  +I++++          +   +V E +  G L          +       +I
Sbjct: 57  LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 116

Query: 157 AMEIANAVAYLHVGFDRPIVFRCIKASNVLLD---ENYSAKLHDFSLSVSIPEGETHVRE 213
              I  A+ YLH      I  R +K  N+L      N   KL DF  +       +    
Sbjct: 117 MKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL--- 170

Query: 214 EFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYA 273
                   ++APE      +++ CD++S G  +  LL G          ++  L +    
Sbjct: 171 TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFY-----SNHGLAISPGM 225

Query: 274 KKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDV 327
           K  I   ++    +    E +         + +  L+   L   P  R  + + 
Sbjct: 226 KTRIRMGQY----EFPNPEWSEVS------EEVKMLIRNLLKTEPTQRMTITEF 269

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 84.9 bits (209), Expect = 2e-19
 Identities = 53/296 (17%), Positives = 99/296 (33%), Gaps = 26/296 (8%)

Query: 55  NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFH-DNSTLDDVEYCFNNIVFSSQMKHK 113
           + Y+    I   T   +F+       + +++ K   +N            I     +KH+
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69

Query: 114 NILKLIGCCLETELPT--------LVFESVKYGTLRGFSFASLLIAPRIKIAMEIANAVA 165
           N++ LI  C     P         LVF+  ++    G     L+     +I   +   + 
Sbjct: 70  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLA-GLLSNVLVKFTLSEIKRVMQMLLN 128

Query: 166 YLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLS--VSIPEGETHVREEFIKGAYGFI 223
            L+      I+ R +KA+NVL+  +   KL DF L+   S+ +     R         + 
Sbjct: 129 GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR 188

Query: 224 APEYFATS-SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRF 282
            PE       +    D++  G  + E+ T   +   +GN     L ++     SI    +
Sbjct: 189 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI--MQGNTEQHQLALISQLCGSITPEVW 246

Query: 283 GAIVDPIFDEDNSFPGKEEKLQSLG-----------QLMYKCLSKSPEHRPLMVDV 327
             + +    E       +++                 L+ K L   P  R    D 
Sbjct: 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 83.2 bits (205), Expect = 6e-19
 Identities = 43/285 (15%), Positives = 90/285 (31%), Gaps = 48/285 (16%)

Query: 55  NNYDLHKVIQSDTSYRLFEGTLVDQDRP-----ISVMKFHDNSTLDDVEYCFNNIVFSSQ 109
           + Y +  ++ S     ++ G  V  + P     +   +  D   L +       +V   +
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63

Query: 110 MK--HKNILKLIGCCLETELPTLVFESVKYGTLRGF---SFASLLIAPRIKIAMEIANAV 164
           +      +++L+      +   L+ E  +             +L          ++  AV
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123

Query: 165 AYLHVGFDRPIVFRCIKASNVLLDEN-YSAKLHDFSLSVSIPEGETHVREEFIKGAYGFI 223
            + H   +  ++ R IK  N+L+D N    KL DF     + +           G   + 
Sbjct: 124 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD----FDGTRVYS 176

Query: 224 APEYFATSSF-NEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRF 282
            PE+     +      V+S G  L +++ G   + F+ +                     
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGD--IPFEHD--------------------- 213

Query: 283 GAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDV 327
               + I      F   +        L+  CL+  P  RP   ++
Sbjct: 214 ----EEIIRGQVFFR--QRVSSECQHLIRWCLALRPSDRPTFEEI 252

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 81.4 bits (200), Expect = 6e-18
 Identities = 42/284 (14%), Positives = 88/284 (30%), Gaps = 36/284 (12%)

Query: 55  NNYDLHKVIQSDTSYRLFEGTLVDQDRP--ISVMKFHDNSTLDDVEYCFNNIVFSSQMKH 112
           + +D  K + + +  R+      +      + ++       L  +E+  N       +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 113 KNILKLIGCCLETELPTLVFESVKYGTLRGFSFAS--LLIAPRIKIAMEIANAVAYLHVG 170
             ++KL     +     +V E V  G +                  A +I     YLH  
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH-- 158

Query: 171 FDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFAT 230
               +++R +K  N+L+D+    ++ DF  +  +      +      G    +APE   +
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC-----GTPEALAPEIILS 212

Query: 231 SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIF 290
             +N+  D ++ G  + E+  G     F  +                       I + I 
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGY--PPFFADQPIQ-------------------IYEKIV 251

Query: 291 DEDNSFPGKEEKLQSLGQLMYKCLSKSPEHR-PLMVDVAKQLRQ 333
                FP        L  L+   L      R   + +    ++ 
Sbjct: 252 SGKVRFP--SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 79.5 bits (195), Expect = 2e-17
 Identities = 55/291 (18%), Positives = 100/291 (34%), Gaps = 35/291 (12%)

Query: 55  NNYDLHKVIQSDTS---YRLFEGTLVDQDRPISVMKFHDNSTLDD---VEYCFNNIVFSS 108
            N++L KV+ +      + + + +  D  +  ++      + +      E+         
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 109 QMKHK-NILKLIGCCLETELPTLVFESVKYGTLRGF--SFASLLIAPRIKIAMEIANAVA 165
            ++    ++ L           L+ + +  G L                    EI  A+ 
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALE 143

Query: 166 YLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAP 225
           +LH      I++R IK  N+LLD N    L DF LS      ET        G   ++AP
Sbjct: 144 HLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERA-YDFCGTIEYMAP 199

Query: 226 EYF--ATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFG 283
           +      S  ++  D +S G  + ELLTG     F  +G  +                  
Sbjct: 200 DIVRGGDSGHDKAVDWWSLGVLMYELLTGA--SPFTVDGEKNSQA--------------- 242

Query: 284 AIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP-LMVDVAKQLRQ 333
            I   I   +  +P  +E       L+ + L K P+ R       A ++++
Sbjct: 243 EISRRILKSEPPYP--QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 76.4 bits (187), Expect = 2e-16
 Identities = 47/287 (16%), Positives = 92/287 (32%), Gaps = 29/287 (10%)

Query: 55  NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKN 114
           ++Y L + +       +FE   +  +  + V+K         ++      +  +     N
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKV-VVKILKPVKKKKIKREIK--ILENLRGGPN 91

Query: 115 ILKLIGCCLE--TELPTLVFESVKYGTLRGFSFASLLIAPRIKIAMEIANAVAYLHVGFD 172
           I+ L     +  +  P LVFE V     +   + +L          EI  A+ Y H    
Sbjct: 92  IITLADIVKDPVSRTPALVFEHVNNTDFKQL-YQTLTDYDIRFYMYEILKALDYCH---S 147

Query: 173 RPIVFRCIKASNVLLD-ENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATS 231
             I+ R +K  NV++D E+   +L D+ L+     G+ +     +   Y           
Sbjct: 148 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV--RVASRYFKGPELLVDYQ 205

Query: 232 SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVL----------------EYAKK 275
            ++   D++S G  L  ++       F G+ N D L  +                     
Sbjct: 206 MYDYSLDMWSLGCMLASMIFRKEPF-FHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264

Query: 276 SIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
              N+  G      ++       +          + K L    + R 
Sbjct: 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRL 311

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 74.9 bits (183), Expect = 1e-15
 Identities = 41/297 (13%), Positives = 96/297 (32%), Gaps = 26/297 (8%)

Query: 45  FSAKDLKKAT----NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFH-DNSTLDDVEY 99
           F  +++ K        Y   + + S     +           +++ K +    +    + 
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63

Query: 100 CFNNIVFSSQMKHKNILKLIGCCLETELPT------LVFESVKYGTLRGFSFASLLIAPR 153
            +  +     M+H+N++ L+      E         LV   +     +      L     
Sbjct: 64  AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123

Query: 154 IKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVRE 213
             +  ++   + Y+H      I+ R +K  N+ ++E+   K+ DF L+       T    
Sbjct: 124 QFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTG--- 177

Query: 214 EFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG------CNVLEFKGNGNDDDL 267
            ++   +            + +  D++S G  + E++TG       + L+          
Sbjct: 178 -YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 236

Query: 268 TVLEYAKKSIENNRFGAIVDPIFD-EDNSFPGKEEKLQSLGQ-LMYKCLSKSPEHRP 322
           T      + ++++     +  + + E   F         L   L+ K L    E R 
Sbjct: 237 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV 293

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 72.6 bits (177), Expect = 6e-15
 Identities = 48/293 (16%), Positives = 94/293 (32%), Gaps = 28/293 (9%)

Query: 48  KDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFH-DNSTLDDVEYCFNNIVF 106
           K + +    Y     + S     +           ++V K      ++   +  +  +  
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 70

Query: 107 SSQMKHKNILKLIGCCL------ETELPTLVFESVKYGTLRGFSFASLLIAPRIKIAMEI 160
              MKH+N++ L+          E     LV   +            L       +  +I
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 130

Query: 161 ANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAY 220
              + Y+H      I+ R +K SN+ ++E+   K+ DF L+    +  T     ++   +
Sbjct: 131 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG----YVATRW 183

Query: 221 GFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLE-----------FKGNGNDDDLTV 269
                       +N+  D++S G  + ELLTG  +              +  G      +
Sbjct: 184 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243

Query: 270 LEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP 322
            + + +S  N        P  +  N F G          L+ K L    + R 
Sbjct: 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVD---LLEKMLVLDSDKRI 293

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 70.0 bits (170), Expect = 4e-14
 Identities = 52/294 (17%), Positives = 98/294 (33%), Gaps = 33/294 (11%)

Query: 55  NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFH-DNSTLDDVEYCFNNIVFSSQMKHK 113
             Y   K I S     +        DR +++ K           +  +  +V    + HK
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 114 NILKLIGCCL------ETELPTLVFESVKYGTLRGFSFASLLIAPRIKIAMEIANAVAYL 167
           NI+ L+          E +   LV E +     +              +  ++   + +L
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDH-ERMSYLLYQMLCGIKHL 135

Query: 168 HVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEY 227
           H      I+ R +K SN+++  + + K+ DF L+ +                  + APE 
Sbjct: 136 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM---TPYVVTRYYRAPEV 189

Query: 228 FATSSFNEMCDVYSFGAFLCELLTGC-------------NVLEFKGNGNDDDLTVLEYAK 274
                + E  D++S G  + E++                 V+E  G    + +  L+   
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249

Query: 275 KSIENNR--FGAIVDPIFDEDNSFPGKEEKLQSLGQ----LMYKCLSKSPEHRP 322
           ++   NR  +  +  P    D+ FP   E  +        L+ K L   P  R 
Sbjct: 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 303

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 63.5 bits (153), Expect = 7e-12
 Identities = 34/253 (13%), Positives = 72/253 (28%), Gaps = 35/253 (13%)

Query: 103 NIVFSSQMKHKNILKLIGCCLETELPTLVFESVKYGTLRGFSFASLLIAPR-------IK 155
           +      M   +ILKL+          +    V                 R        +
Sbjct: 70  DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ 129

Query: 156 IAMEIANAVAYLHVGFDRPIVFRCIKASNVLLD-ENYSAKLHDFSLSVSIPEGETHVREE 214
           I+ ++   + Y+H      I+   IK  NVL++  +    L    ++             
Sbjct: 130 ISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 187

Query: 215 FIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLE-FKGNGNDDDLTVLEYA 273
                  + +PE    + +    D++S    + EL+TG  + E  +G+    D   +   
Sbjct: 188 NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 247

Query: 274 KKSI-----ENNRFGAIVDPIFDEDN-------------------SFPGKEEKLQSLGQL 309
            + +        R G      F+                       +   +++ + +   
Sbjct: 248 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDF 307

Query: 310 MYKCLSKSPEHRP 322
           +   L   P  R 
Sbjct: 308 LSPMLQLDPRKRA 320

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	339
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.93
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.75
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.2
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.92
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.34
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.12
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.05

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-60  Score=414.71  Aligned_cols=253  Identities=21%  Similarity=0.246  Sum_probs=207.9

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFE  133 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  133 (339)
                      .++|++.+.||+|+||+||+|.+..+|+.||||++.........+.+.+|+.++++++||||+++++++.+++..|+|||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            46799999999999999999999999999999999876544455678899999999999999999999999999999999


Q ss_pred             eccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCcee
Q 019536          134 SVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHV  211 (339)
Q Consensus       134 ~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~  211 (339)
                      ||++|+|.+++.  ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+|+.+.......
T Consensus        84 y~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~  160 (271)
T d1nvra_          84 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER  160 (271)
T ss_dssp             CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred             ccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence            999999999986  57899999999999999999999   8999999999999999999999999999998875544333


Q ss_pred             eecccccccccccccccccCCC-CcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcc
Q 019536          212 REEFIKGAYGFIAPEYFATSSF-NEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIF  290 (339)
Q Consensus       212 ~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (339)
                      .....+||+.|+|||++.+..+ +.++||||+||++|+|++|+.||.......    ....   ......          
T Consensus       161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~----~~~~---~~~~~~----------  223 (271)
T d1nvra_         161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC----QEYS---DWKEKK----------  223 (271)
T ss_dssp             CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS----HHHH---HHHTTC----------
T ss_pred             cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH----HHHH---HHhcCC----------
Confidence            3335679999999999988876 578999999999999999999986433211    1100   000000          


Q ss_pred             cCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          291 DEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                         ...+.....++++.+|+.+||+.||++|||+.|+++
T Consensus       224 ---~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         224 ---TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             ---TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---CCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence               001112245668899999999999999999999976

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.5e-58  Score=411.66  Aligned_cols=257  Identities=21%  Similarity=0.286  Sum_probs=201.9

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCe---eEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDR---PISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLV  131 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  131 (339)
                      ++|++.+.||+|+||+||+|.+..+++   .||||++.........+.|.+|+.+|++++|||||+++|+|.+++..++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            567788999999999999999876554   68999988776666778899999999999999999999999999999999


Q ss_pred             EEeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCC
Q 019536          132 FESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE  208 (339)
Q Consensus       132 ~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~  208 (339)
                      ||||++|+|.+++.   ..+++.++..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+|+.+....
T Consensus       106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~  182 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  182 (299)
T ss_dssp             EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEECCCCcEEECCcccceEccCCC
Confidence            99999999999775   46899999999999999999999   8999999999999999999999999999998775443


Q ss_pred             cee---eecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCcccc
Q 019536          209 THV---REEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA  284 (339)
Q Consensus       209 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (339)
                      ...   ......||+.|+|||++.+..|+.++|||||||++|||++ |+.||....        ..+........     
T Consensus       183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~--------~~~~~~~i~~~-----  249 (299)
T d1jpaa_         183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT--------NQDVINAIEQD-----  249 (299)
T ss_dssp             -------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHHHHHHTT-----
T ss_pred             CcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC--------HHHHHHHHHcC-----
Confidence            221   1112457889999999999999999999999999999998 899975221        11111111111     


Q ss_pred             cccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 019536          285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYL  336 (339)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~  336 (339)
                               ...|.+..++..+.+|+.+||+.||++|||+.+|++.|+++.+
T Consensus       250 ---------~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~  292 (299)
T d1jpaa_         250 ---------YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR  292 (299)
T ss_dssp             ---------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             ---------CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence                     1112233556789999999999999999999999999999874

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-59  Score=409.57  Aligned_cols=263  Identities=21%  Similarity=0.310  Sum_probs=205.5

Q ss_pred             HHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 019536           52 KATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS-TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTL  130 (339)
Q Consensus        52 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  130 (339)
                      ...++|++.+.||+|+||+||+|+..   ..||||+++... .....+.|.+|+.++++++|||||++++++.+ +..++
T Consensus         5 i~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~l   80 (276)
T d1uwha_           5 IPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAI   80 (276)
T ss_dssp             CCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred             cccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEE
Confidence            34578999999999999999999864   359999987543 33567889999999999999999999999865 45799


Q ss_pred             EEEeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCC
Q 019536          131 VFESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEG  207 (339)
Q Consensus       131 v~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~  207 (339)
                      |||||++|+|.+++.   ..+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+|+.....
T Consensus        81 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~  157 (276)
T d1uwha_          81 VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW  157 (276)
T ss_dssp             EEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred             EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence            999999999999874   56899999999999999999999   899999999999999999999999999999877554


Q ss_pred             CceeeecccccccccccccccccC---CCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccc
Q 019536          208 ETHVREEFIKGAYGFIAPEYFATS---SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA  284 (339)
Q Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (339)
                      ..........||+.|+|||++.+.   .|+.++|||||||++|||++|+.||.....     ..   ........+..  
T Consensus       158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~-----~~---~~~~~~~~~~~--  227 (276)
T d1uwha_         158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN-----RD---QIIFMVGRGYL--  227 (276)
T ss_dssp             --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----HH---HHHHHHHHTSC--
T ss_pred             CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh-----HH---HHHHHHhcCCC--
Confidence            433333356799999999998643   589999999999999999999999853211     11   11111111110  


Q ss_pred             cccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhc
Q 019536          285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLSV  338 (339)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~~  338 (339)
                        .+...     ..+..+++++.+|+.+||+.||++|||+.+|++.|+.|.+++
T Consensus       228 --~p~~~-----~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~  274 (276)
T d1uwha_         228 --SPDLS-----KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL  274 (276)
T ss_dssp             --CCCGG-----GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             --CCcch-----hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence              01000     011244567999999999999999999999999999998764

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-58  Score=407.57  Aligned_cols=249  Identities=19%  Similarity=0.278  Sum_probs=211.0

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFES  134 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  134 (339)
                      ++|++.+.||+|+||+||+|.+..+|+.||||++..... ...+.+.+|+.+++.++|||||++++++.+++..|+||||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy   98 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC-hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence            579999999999999999999999999999999876533 3457788999999999999999999999999999999999


Q ss_pred             ccCCccccccc-cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceeee
Q 019536          135 VKYGTLRGFSF-ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVRE  213 (339)
Q Consensus       135 ~~~g~L~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~  213 (339)
                      |++|+|.+++. ..+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+|+.+.......  
T Consensus        99 ~~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~--  173 (293)
T d1yhwa1          99 LAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--  173 (293)
T ss_dssp             CTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCB--
T ss_pred             cCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeeccccccc--
Confidence            99999998876 67899999999999999999999   8999999999999999999999999999998875543322  


Q ss_pred             cccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCC
Q 019536          214 EFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDED  293 (339)
Q Consensus       214 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (339)
                      ....||+.|+|||++.+..|+.++||||+||++|+|++|+.||....        .............            
T Consensus       174 ~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~--------~~~~~~~~~~~~~------------  233 (293)
T d1yhwa1         174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN--------PLRALYLIATNGT------------  233 (293)
T ss_dssp             CCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHHCS------------
T ss_pred             cccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCC--------HHHHHHHHHhCCC------------
Confidence            24579999999999999999999999999999999999999985221        1111111111111            


Q ss_pred             CCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          294 NSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       294 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                      ...+.+...++.+.+|+.+||+.||++|||+.|+++
T Consensus       234 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         234 PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             CCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            112223456678999999999999999999999986

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-59  Score=405.96  Aligned_cols=245  Identities=21%  Similarity=0.333  Sum_probs=207.9

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC--ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS--TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVF  132 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  132 (339)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++....  .....+.+.+|+.+++.++|||||++++++.+++..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            67999999999999999999999999999999986532  1134567889999999999999999999999999999999


Q ss_pred             EeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCce
Q 019536          133 ESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH  210 (339)
Q Consensus       133 e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~  210 (339)
                      |||++|+|.+++.  ..+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+|+........
T Consensus        86 Ey~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~~~  162 (263)
T d2j4za1          86 EYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT  162 (263)
T ss_dssp             ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCCCE
T ss_pred             eecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecCCCccc
Confidence            9999999999986  67899999999999999999999   899999999999999999999999999999876544322


Q ss_pred             eeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcc
Q 019536          211 VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIF  290 (339)
Q Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (339)
                          ...||+.|+|||++.+..|+.++|||||||++|+|++|+.||....        ..+.... ....          
T Consensus       163 ----~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~--------~~~~~~~-i~~~----------  219 (263)
T d2j4za1         163 ----TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT--------YQETYKR-ISRV----------  219 (263)
T ss_dssp             ----ETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHH-HHTT----------
T ss_pred             ----ccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC--------HHHHHHH-HHcC----------
Confidence                4579999999999999999999999999999999999999985221        1111111 1111          


Q ss_pred             cCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          291 DEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                        ...+|  ...++++.+|+.+||+.||++|||+.|+++
T Consensus       220 --~~~~p--~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         220 --EFTFP--DFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             --CCCCC--TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --CCCCC--ccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence              11111  245568999999999999999999999987

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-58  Score=402.57  Aligned_cols=254  Identities=20%  Similarity=0.316  Sum_probs=200.0

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFES  134 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  134 (339)
                      ++|++.+.||+|+||+||+|.+. ++..||||+++...  ...+.+.+|+.++++++|||||+++|+|.+++..++||||
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~   81 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF   81 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCc--CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence            57889999999999999999987 67889999997654  3356789999999999999999999999999999999999


Q ss_pred             ccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCcee
Q 019536          135 VKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHV  211 (339)
Q Consensus       135 ~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~  211 (339)
                      +++|+|.+++.   ..+++..++.++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+|+.........
T Consensus        82 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~  158 (263)
T d1sm2a_          82 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS  158 (263)
T ss_dssp             CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred             cCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence            99999999875   45788899999999999999999   8999999999999999999999999999998775543322


Q ss_pred             eecccccccccccccccccCCCCcccchHHHHHHHHHHHhC-CCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcc
Q 019536          212 REEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTG-CNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIF  290 (339)
Q Consensus       212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (339)
                       .....||+.|+|||++.+..|+.++|||||||++|||+++ .+||..  .      ...+..........         
T Consensus       159 -~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~--~------~~~~~~~~i~~~~~---------  220 (263)
T d1sm2a_         159 -STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN--R------SNSEVVEDISTGFR---------  220 (263)
T ss_dssp             -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS--C------CHHHHHHHHHHTCC---------
T ss_pred             -ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCC--C------CHHHHHHHHHhcCC---------
Confidence             2235689999999999999999999999999999999995 444321  1      11111111111110         


Q ss_pred             cCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          291 DEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                           .+.+..+++++.+|+.+||+.||++|||+.+|+++|++|.++
T Consensus       221 -----~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es  262 (263)
T d1sm2a_         221 -----LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES  262 (263)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -----CCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence                 111224456799999999999999999999999999999865

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.8e-59  Score=413.94  Aligned_cols=261  Identities=21%  Similarity=0.325  Sum_probs=216.6

Q ss_pred             HHHHHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCcc
Q 019536           49 DLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELP  128 (339)
Q Consensus        49 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~  128 (339)
                      +|+...++|++.+.||+|+||+||+|.+..+++.||||+++...  ...+.+.+|+.++++++|||||+++|+|.+++..
T Consensus        11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (287)
T d1opja_          11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF   88 (287)
T ss_dssp             TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc--chHHHHHHHHHHHHhCCCCCEecCCccEeeCCee
Confidence            34445578999999999999999999999999999999987653  3456789999999999999999999999999999


Q ss_pred             EEEEEeccCCccccccc----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCcccc
Q 019536          129 TLVFESVKYGTLRGFSF----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSI  204 (339)
Q Consensus       129 ~lv~e~~~~g~L~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~  204 (339)
                      ++|||||++|+|.+++.    ..+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+|+..
T Consensus        89 ~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~  165 (287)
T d1opja_          89 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM  165 (287)
T ss_dssp             EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred             EEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceeec
Confidence            99999999999999875    46888899999999999999999   899999999999999999999999999999887


Q ss_pred             CCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccc
Q 019536          205 PEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA  284 (339)
Q Consensus       205 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (339)
                      ...... ......||+.|+|||++.+..|+.++|||||||++|||++|..||. .+..   ....    ......+    
T Consensus       166 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~-~~~~---~~~~----~~~i~~~----  232 (287)
T d1opja_         166 TGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY-PGID---LSQV----YELLEKD----  232 (287)
T ss_dssp             CSSSSE-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSS-TTCC---HHHH----HHHHHTT----
T ss_pred             CCCCce-eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCC-Ccch---HHHH----HHHHhcC----
Confidence            654433 2234568899999999999999999999999999999999777753 1111   1111    1111111    


Q ss_pred             cccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 019536          285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYL  336 (339)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~  336 (339)
                               ...+.+..+++.+.+|+.+||+.||++|||+.+|++.|+++..
T Consensus       233 ---------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         233 ---------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             ---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             ---------CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                     1112223456689999999999999999999999999998764

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-58  Score=415.88  Aligned_cols=269  Identities=15%  Similarity=0.213  Sum_probs=209.0

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFE  133 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  133 (339)
                      .++|++.+.||+|+||+||+|.+..+|+.||+|+++..........+.+|+.+|+.++|||||+++++|.+++..++|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            47899999999999999999999999999999999876554566788999999999999999999999999999999999


Q ss_pred             eccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCC-CCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCce
Q 019536          134 SVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFD-RPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH  210 (339)
Q Consensus       134 ~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~  210 (339)
                      |+++|+|.+++.  ..+++..+..++.|++.||.|||   + ++|+||||||+|||++.++.+||+|||+|+.+..... 
T Consensus        85 y~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH---~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~-  160 (322)
T d1s9ja_          85 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA-  160 (322)
T ss_dssp             CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHTC-
T ss_pred             cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCcc-
Confidence            999999999986  57999999999999999999999   6 4899999999999999999999999999987643222 


Q ss_pred             eeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHh-------------
Q 019536          211 VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSI-------------  277 (339)
Q Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------------  277 (339)
                         ...+||+.|+|||++.+..|+.++||||+||++|||++|+.||.....................             
T Consensus       161 ---~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (322)
T d1s9ja_         161 ---NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL  237 (322)
T ss_dssp             ------CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------------
T ss_pred             ---ccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccc
Confidence               1357999999999999999999999999999999999999998532211100000000000000             


Q ss_pred             hc--------CcccccccCcccC-CCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          278 EN--------NRFGAIVDPIFDE-DNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       278 ~~--------~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      ..        ....+..+..... ....+. ...+.++.+|+.+||+.||++|||+.|++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H  298 (322)
T d1s9ja_         238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPS-GVFSLEFQDFVNKCLIKNPAERADLKQLMVH  298 (322)
T ss_dssp             --------CCCCHHHHHHHHHTSCCCCCCB-TTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccccccchhHHHHHhhhhccCCccCcc-ccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence            00        0000000000000 001111 1345679999999999999999999999873

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-58  Score=412.04  Aligned_cols=257  Identities=21%  Similarity=0.317  Sum_probs=209.6

Q ss_pred             HhcCcccCCceeccCCeeEEEEEEcCCCe-----eEEEEEeccCCChhhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCC
Q 019536           53 ATNNYDLHKVIQSDTSYRLFEGTLVDQDR-----PISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLETE  126 (339)
Q Consensus        53 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~  126 (339)
                      ..++|++.+.||+|+||+||+|++...++     .||+|.+...........+.+|+.++.++ +|||||+++++|.+.+
T Consensus        35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~  114 (325)
T d1rjba_          35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  114 (325)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence            34789999999999999999999875543     69999987765545567788999999998 8999999999999999


Q ss_pred             ccEEEEEeccCCcccccccc-------------------------CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCC
Q 019536          127 LPTLVFESVKYGTLRGFSFA-------------------------SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIK  181 (339)
Q Consensus       127 ~~~lv~e~~~~g~L~~~~~~-------------------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk  181 (339)
                      ..++|||||++|+|.+++..                         .+++..++.++.||+.||.|||   +++|+|||||
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDlK  191 (325)
T d1rjba_         115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLA  191 (325)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCS
T ss_pred             eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCc
Confidence            99999999999999998752                         3788889999999999999999   8999999999


Q ss_pred             CCCEEeCCCCceEEecCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCC
Q 019536          182 ASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKG  260 (339)
Q Consensus       182 ~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~  260 (339)
                      |+|||++.++.+||+|||+|+...............||+.|+|||++.+..|+.++|||||||++|||++ |+.||....
T Consensus       192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~  271 (325)
T d1rjba_         192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  271 (325)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999999987766554444445678999999999999999999999999999999997 899975322


Q ss_pred             CCCCCchhHHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 019536          261 NGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQ  333 (339)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~  333 (339)
                      ..    ....    .....+             ..++.+..+++++.+||.+||+.||++|||+.||+++|..
T Consensus       272 ~~----~~~~----~~~~~~-------------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~  323 (325)
T d1rjba_         272 VD----ANFY----KLIQNG-------------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC  323 (325)
T ss_dssp             CS----HHHH----HHHHTT-------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HH----HHHH----HHHhcC-------------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence            21    1111    111111             1112223456689999999999999999999999999964

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-57  Score=402.92  Aligned_cols=258  Identities=22%  Similarity=0.337  Sum_probs=211.7

Q ss_pred             cCcccCCc-eeccCCeeEEEEEEc--CCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 019536           55 NNYDLHKV-IQSDTSYRLFEGTLV--DQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLV  131 (339)
Q Consensus        55 ~~~~~~~~-ig~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  131 (339)
                      ++|.+.+. ||+|+||+||+|.+.  .++..||||+++........+.|.+|+.++++++|||||+++|+|.++ ..++|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eEEEE
Confidence            56677774 999999999999875  345689999998776666778899999999999999999999999654 57899


Q ss_pred             EEeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCC
Q 019536          132 FESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE  208 (339)
Q Consensus       132 ~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~  208 (339)
                      ||||++|+|.+++.   ..+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+|+.+....
T Consensus        87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~  163 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD  163 (285)
T ss_dssp             EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred             EEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhcccccc
Confidence            99999999999864   46899999999999999999999   8999999999999999999999999999999876544


Q ss_pred             ce-eeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCcccccc
Q 019536          209 TH-VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIV  286 (339)
Q Consensus       209 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (339)
                      .. .......||+.|+|||++.+..++.++|||||||++|||++ |+.||.....     ......    ...+.     
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~-----~~~~~~----i~~~~-----  229 (285)
T d1u59a_         164 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-----PEVMAF----IEQGK-----  229 (285)
T ss_dssp             CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT-----HHHHHH----HHTTC-----
T ss_pred             cccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH-----HHHHHH----HHcCC-----
Confidence            32 22224568899999999999999999999999999999998 8999853221     111111    11111     


Q ss_pred             cCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhc
Q 019536          287 DPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLSV  338 (339)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~~  338 (339)
                              ..+.+..++.++.+||.+||+.||++|||+.+|++.|+.++.++
T Consensus       230 --------~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~  273 (285)
T d1u59a_         230 --------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  273 (285)
T ss_dssp             --------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             --------CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence                    11122345668999999999999999999999999999887543

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-57  Score=399.14  Aligned_cols=260  Identities=22%  Similarity=0.316  Sum_probs=211.3

Q ss_pred             HHHHHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCcc
Q 019536           49 DLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELP  128 (339)
Q Consensus        49 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~  128 (339)
                      +|+...++|++.+.||+|+||+||+|.+. ++..||||+++...  ...+.|.+|+.++++++|||||+++|++.+ +..
T Consensus         7 ~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~   82 (272)
T d1qpca_           7 EWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPI   82 (272)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             CeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc--CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCe
Confidence            34444578999999999999999999986 67899999997654  345678999999999999999999998865 457


Q ss_pred             EEEEEeccCCccccccc----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCcccc
Q 019536          129 TLVFESVKYGTLRGFSF----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSI  204 (339)
Q Consensus       129 ~lv~e~~~~g~L~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~  204 (339)
                      ++||||+++|+|.+++.    ..+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+|+.+
T Consensus        83 ~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~  159 (272)
T d1qpca_          83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI  159 (272)
T ss_dssp             EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEc
Confidence            89999999999998765    35899999999999999999999   899999999999999999999999999999987


Q ss_pred             CCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccc
Q 019536          205 PEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA  284 (339)
Q Consensus       205 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (339)
                      ....... .....||+.|+|||++.+..|+.++|||||||++|||++|..|+.. ...      ..+....... +    
T Consensus       160 ~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~-~~~------~~~~~~~i~~-~----  226 (272)
T d1qpca_         160 EDNEYTA-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP-GMT------NPEVIQNLER-G----  226 (272)
T ss_dssp             SSSCEEC-CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSST-TCC------HHHHHHHHHT-T----
T ss_pred             cCCcccc-ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCC-CCC------HHHHHHHHHh-c----
Confidence            6544332 2345689999999999999999999999999999999996655421 111      1111111111 1    


Q ss_pred             cccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                               ...+.+..+++++.+|+.+||+.||++|||+.+|++.|+++..+
T Consensus       227 ---------~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         227 ---------YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             ---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---------CCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence                     11112234556799999999999999999999999999998754

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-58  Score=400.65  Aligned_cols=248  Identities=20%  Similarity=0.274  Sum_probs=195.5

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeeee--CCccEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS-TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLE--TELPTLV  131 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~--~~~~~lv  131 (339)
                      ++|++.+.||+|+||+||+|++..+|+.||+|++.... .....+.+.+|+.++++++|||||++++++.+  ++.+|+|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            67999999999999999999999999999999997764 33456778899999999999999999999865  4568999


Q ss_pred             EEeccCCccccccc------cCCChHHHHHHHHHHHHHHHHHhcCCCCC-----eEEccCCCCCEEeCCCCceEEecCCC
Q 019536          132 FESVKYGTLRGFSF------ASLLIAPRIKIAMEIANAVAYLHVGFDRP-----IVFRCIKASNVLLDENYSAKLHDFSL  200 (339)
Q Consensus       132 ~e~~~~g~L~~~~~------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~-----i~H~dlk~~Nil~~~~~~~kl~dfg~  200 (339)
                      ||||++|+|.+++.      ..+++..++.++.|++.||.|||   +.+     |+||||||+|||++.++.+||+|||+
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH---~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~  160 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL  160 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HHCC---------CCGGGEEECTTSCEEECCHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccc
Confidence            99999999999875      46899999999999999999999   544     99999999999999999999999999


Q ss_pred             ccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcC
Q 019536          201 SVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENN  280 (339)
Q Consensus       201 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  280 (339)
                      |+.+.......  ....||+.|+|||++.+..|+.++|||||||++|||++|+.||....        ..+.... +...
T Consensus       161 a~~~~~~~~~~--~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~--------~~~~~~~-i~~~  229 (269)
T d2java1         161 ARILNHDTSFA--KAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS--------QKELAGK-IREG  229 (269)
T ss_dssp             HHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHH-HHHT
T ss_pred             eeecccCCCcc--ccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC--------HHHHHHH-HHcC
Confidence            98875543322  24679999999999999999999999999999999999999985221        1111111 1111


Q ss_pred             cccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          281 RFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                      ...             +.+...++++.+|+.+||+.||++|||+.|+++
T Consensus       230 ~~~-------------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         230 KFR-------------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             CCC-------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCC-------------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            111             111245568999999999999999999999986

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-58  Score=405.62  Aligned_cols=249  Identities=18%  Similarity=0.236  Sum_probs=207.3

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFES  134 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  134 (339)
                      +.|++.+.||+|+||+||+|.+..+++.||||++..... ...+.+.+|+.++++++|||||++++++.+++..++||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy   90 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE-EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF   90 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS-GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH-HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence            569999999999999999999999999999999976543 5567788999999999999999999999999999999999


Q ss_pred             ccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCcee
Q 019536          135 VKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHV  211 (339)
Q Consensus       135 ~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~  211 (339)
                      |++|+|.+++.   ..+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+|+.......  
T Consensus        91 ~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~--  165 (288)
T d2jfla1          91 CAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--  165 (288)
T ss_dssp             CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH--
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCCCcc--
Confidence            99999999864   46899999999999999999999   89999999999999999999999999999976533211  


Q ss_pred             eecccccccccccccccc-----cCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccc
Q 019536          212 REEFIKGAYGFIAPEYFA-----TSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIV  286 (339)
Q Consensus       212 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (339)
                      ......||+.|+|||++.     +..|+.++||||+||++|+|++|+.||.....     .......   ....      
T Consensus       166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~-----~~~~~~i---~~~~------  231 (288)
T d2jfla1         166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP-----MRVLLKI---AKSE------  231 (288)
T ss_dssp             HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG-----GGHHHHH---HHSC------
T ss_pred             cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCH-----HHHHHHH---HcCC------
Confidence            112357999999999984     45689999999999999999999999853221     1111111   1110      


Q ss_pred             cCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          287 DPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                            ....+.+...++++.+|+.+||+.||++|||+.|+++
T Consensus       232 ------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         232 ------PPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             ------CCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ------CCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                  0112223456778999999999999999999999987

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-58  Score=406.78  Aligned_cols=249  Identities=18%  Similarity=0.266  Sum_probs=205.2

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC--ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS--TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVF  132 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  132 (339)
                      ++|++.+.||+|+||+||+|.+..+++.||||++....  .....+.+.+|+.++++++||||+++++++.+++..|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            57999999999999999999999999999999987532  1234567889999999999999999999999999999999


Q ss_pred             EeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCce
Q 019536          133 ESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH  210 (339)
Q Consensus       133 e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~  210 (339)
                      |||++|+|.+++.  +.+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+|+.+......
T Consensus        88 Ey~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~  164 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ  164 (288)
T ss_dssp             CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             EccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence            9999999999876  68999999999999999999999   899999999999999999999999999999887654433


Q ss_pred             eeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcc
Q 019536          211 VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIF  290 (339)
Q Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (339)
                      .......||+.|+|||++.+..|+.++||||+||++|+|++|+.||....        ......... ..          
T Consensus       165 ~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------~~~~~~~i~-~~----------  225 (288)
T d1uu3a_         165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN--------EYLIFQKII-KL----------  225 (288)
T ss_dssp             -----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHH-TT----------
T ss_pred             cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC--------HHHHHHHHH-cC----------
Confidence            33334679999999999999999999999999999999999999985221        111111111 11          


Q ss_pred             cCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          291 DEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                        ...+|  ...++.+.+||.+||+.||++|||+.|++.
T Consensus       226 --~~~~p--~~~s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         226 --EYDFP--EKFFPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             --CCCCC--TTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             --CCCCC--ccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence              11122  244567999999999999999999998754

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-56  Score=395.80  Aligned_cols=258  Identities=22%  Similarity=0.298  Sum_probs=204.5

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCC----eeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQD----RPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTL  130 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  130 (339)
                      +.|++.++||+|+||+||+|.+..++    ..||||++...........|.+|+.++++++|||||+++|+|.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            57889999999999999999987554    47999999877665666779999999999999999999999999999999


Q ss_pred             EEEeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCC
Q 019536          131 VFESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEG  207 (339)
Q Consensus       131 v~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~  207 (339)
                      ||||+.+|++.+++.   ..+++..++.++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+|+.+...
T Consensus        87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~  163 (283)
T d1mqba_          87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  163 (283)
T ss_dssp             EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence            999999999988765   57899999999999999999999   899999999999999999999999999999876543


Q ss_pred             Cce-eeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccc
Q 019536          208 ETH-VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIV  286 (339)
Q Consensus       208 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (339)
                      ... .......||+.|+|||++.+..|+.++|||||||++|||++|..|+.....       ..+.... ...+      
T Consensus       164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~-------~~~~~~~-i~~~------  229 (283)
T d1mqba_         164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-------NHEVMKA-INDG------  229 (283)
T ss_dssp             ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-------HHHHHHH-HHTT------
T ss_pred             CccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC-------HHHHHHH-Hhcc------
Confidence            322 222235689999999999999999999999999999999997666532111       1111111 1111      


Q ss_pred             cCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 019536          287 DPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYL  336 (339)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~  336 (339)
                             ...+.+..++..+.+|+.+||+.||++|||+.+|++.|+++.+
T Consensus       230 -------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~  272 (283)
T d1mqba_         230 -------FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR  272 (283)
T ss_dssp             -------CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             -------CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence                   1112223455679999999999999999999999999998864

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-56  Score=389.50  Aligned_cols=251  Identities=16%  Similarity=0.257  Sum_probs=210.2

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFES  134 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~  134 (339)
                      ++|++.+.||+|+||+||+|+++ +++.||||+++....  ..+.+.+|+.++++++||||++++|+|.+++..++||||
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey   80 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY   80 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS--CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred             HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC--CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence            68999999999999999999986 788999999987543  356799999999999999999999999999999999999


Q ss_pred             ccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCcee
Q 019536          135 VKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHV  211 (339)
Q Consensus       135 ~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~  211 (339)
                      +++|+|.+++.   ..+++..+..++.|++.||.|||   +++|+||||||+||+++.++.+||+|||+|+.+.......
T Consensus        81 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~  157 (258)
T d1k2pa_          81 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS  157 (258)
T ss_dssp             CTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred             cCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence            99999988854   56888999999999999999999   8999999999999999999999999999998765543332


Q ss_pred             eecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcc
Q 019536          212 REEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIF  290 (339)
Q Consensus       212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (339)
                       .....||+.|+|||.+.+..|+.++|||||||++|||++ |+.||....        ..+...... .+.         
T Consensus       158 -~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~--------~~~~~~~i~-~~~---------  218 (258)
T d1k2pa_         158 -SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT--------NSETAEHIA-QGL---------  218 (258)
T ss_dssp             -CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC--------HHHHHHHHH-TTC---------
T ss_pred             -ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCC--------HHHHHHHHH-hCC---------
Confidence             224568999999999999999999999999999999998 898975221        111111111 110         


Q ss_pred             cCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 019536          291 DEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQM  334 (339)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l  334 (339)
                          ..+.+...++++.+|+.+||+.||++|||+.+|+++|.++
T Consensus       219 ----~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         219 ----RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             ----CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             ----CCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence                1122234556899999999999999999999999998653

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-56  Score=393.45  Aligned_cols=252  Identities=22%  Similarity=0.276  Sum_probs=202.9

Q ss_pred             CceeccCCeeEEEEEEcC--CCeeEEEEEeccCCC-hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeccC
Q 019536           61 KVIQSDTSYRLFEGTLVD--QDRPISVMKFHDNST-LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESVKY  137 (339)
Q Consensus        61 ~~ig~G~~g~V~~~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~  137 (339)
                      +.||+|+||+||+|.+..  +++.||||+++.... ....+.+.+|+.++++++|||||+++|+|.++ ..+||||||++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence            469999999999998753  457899999976432 24457799999999999999999999999654 57899999999


Q ss_pred             Cccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCcee-eec
Q 019536          138 GTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHV-REE  214 (339)
Q Consensus       138 g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~-~~~  214 (339)
                      |+|.+++.  ..+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+|++|||+|+.+....... ...
T Consensus        92 g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~  168 (277)
T d1xbba_          92 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT  168 (277)
T ss_dssp             EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC--
T ss_pred             CcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhcccccccccccc
Confidence            99999886  56899999999999999999999   8999999999999999999999999999998876544332 223


Q ss_pred             ccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCC
Q 019536          215 FIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDED  293 (339)
Q Consensus       215 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (339)
                      ...||+.|+|||++.+..|+.++|||||||++|||++ |+.||....        ..+.... ...+.            
T Consensus       169 ~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~--------~~~~~~~-i~~~~------------  227 (277)
T d1xbba_         169 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK--------GSEVTAM-LEKGE------------  227 (277)
T ss_dssp             --CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC--------HHHHHHH-HHTTC------------
T ss_pred             ccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC--------HHHHHHH-HHcCC------------
Confidence            4568999999999999999999999999999999998 899975221        1111111 11111            


Q ss_pred             CCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhc
Q 019536          294 NSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLSV  338 (339)
Q Consensus       294 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~~  338 (339)
                       ..+.+..++.++.+||.+||+.||++|||+.+|++.|+..+.++
T Consensus       228 -~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~  271 (277)
T d1xbba_         228 -RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV  271 (277)
T ss_dssp             -CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             -CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhhc
Confidence             11222345678999999999999999999999999999987654

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-57  Score=394.12  Aligned_cols=244  Identities=18%  Similarity=0.275  Sum_probs=197.9

Q ss_pred             ccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeeee----CCccEEEE
Q 019536           58 DLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS-TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLE----TELPTLVF  132 (339)
Q Consensus        58 ~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~----~~~~~lv~  132 (339)
                      ++.+.||+|+||+||+|.+..+++.||+|++.... .....+.+.+|++++++++|||||++++++.+    +..+++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            56678999999999999999999999999987653 33456778999999999999999999999875    34579999


Q ss_pred             EeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCC--eEEccCCCCCEEeC-CCCceEEecCCCccccCCC
Q 019536          133 ESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRP--IVFRCIKASNVLLD-ENYSAKLHDFSLSVSIPEG  207 (339)
Q Consensus       133 e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~dlk~~Nil~~-~~~~~kl~dfg~a~~~~~~  207 (339)
                      ||+++|+|.+++.  ..+++..+..++.||+.||+|||   +++  |+||||||+|||++ .++.+||+|||+|+.....
T Consensus        92 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~  168 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS  168 (270)
T ss_dssp             ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred             eCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC
Confidence            9999999999986  57899999999999999999999   777  99999999999996 5789999999999865443


Q ss_pred             CceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCccccccc
Q 019536          208 ETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVD  287 (339)
Q Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (339)
                      ...    ...||+.|+|||++.+ .|+.++||||+||++|||++|+.||.....       ... .......+..    .
T Consensus       169 ~~~----~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~-------~~~-~~~~i~~~~~----~  231 (270)
T d1t4ha_         169 FAK----AVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-------AAQ-IYRRVTSGVK----P  231 (270)
T ss_dssp             SBE----ESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-------HHH-HHHHHTTTCC----C
T ss_pred             ccC----CcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc-------HHH-HHHHHHcCCC----C
Confidence            322    3579999999999865 599999999999999999999999852211       111 1111111110    0


Q ss_pred             CcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          288 PIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                      .        ..+...++++.+|+.+||+.||++|||+.|+++
T Consensus       232 ~--------~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         232 A--------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             G--------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             c--------ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence            0        011123457899999999999999999999986

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.2e-57  Score=405.11  Aligned_cols=252  Identities=20%  Similarity=0.249  Sum_probs=192.8

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFE  133 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  133 (339)
                      .+.|++.+.||+|+||+||+|.+..+++.||||++...........+.+|+.+++.++|||||++++++.+++..|+|||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            46799999999999999999999999999999999876544445667899999999999999999999999999999999


Q ss_pred             eccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeC---CCCceEEecCCCccccCCCC
Q 019536          134 SVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLD---ENYSAKLHDFSLSVSIPEGE  208 (339)
Q Consensus       134 ~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~---~~~~~kl~dfg~a~~~~~~~  208 (339)
                      ||++|+|.+++.  ..+++..+..++.||+.||.|||   +++|+||||||+|||+.   .++.+||+|||+|+......
T Consensus        88 ~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~  164 (307)
T d1a06a_          88 LVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS  164 (307)
T ss_dssp             CCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred             ccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence            999999999986  57999999999999999999999   89999999999999994   57899999999998765443


Q ss_pred             ceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccC
Q 019536          209 THVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDP  288 (339)
Q Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (339)
                      ..   ...+||+.|+|||++.+..|+.++||||+||++|+|++|+.||....        ..+....... ...      
T Consensus       165 ~~---~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------~~~~~~~i~~-~~~------  226 (307)
T d1a06a_         165 VL---STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN--------DAKLFEQILK-AEY------  226 (307)
T ss_dssp             -----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHT-TCC------
T ss_pred             ee---eeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC--------HHHHHHHHhc-cCC------
Confidence            22   23579999999999999999999999999999999999999985211        1111111111 100      


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          289 IFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                          ....+.....++++.+|+.+||+.||++|||+.|++++
T Consensus       227 ----~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         227 ----EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             ----CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             ----CCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence                01112223456789999999999999999999999873

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7e-57  Score=402.01  Aligned_cols=245  Identities=19%  Similarity=0.240  Sum_probs=204.0

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC--hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST--LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVF  132 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  132 (339)
                      ..|+..+.||+|+||+||+|.+..+++.||||++.....  ....+.+.+|+.++++++|||||++++++.+++..++||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            349999999999999999999999999999999976543  234567889999999999999999999999999999999


Q ss_pred             EeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCce
Q 019536          133 ESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH  210 (339)
Q Consensus       133 e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~  210 (339)
                      |||++|+|..+..  ..+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+|+......  
T Consensus        95 E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~~--  169 (309)
T d1u5ra_          95 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN--  169 (309)
T ss_dssp             ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBC--
T ss_pred             EecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccCCCC--
Confidence            9999999876654  67899999999999999999999   8999999999999999999999999999998764422  


Q ss_pred             eeeccccccccccccccccc---CCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCccccccc
Q 019536          211 VREEFIKGAYGFIAPEYFAT---SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVD  287 (339)
Q Consensus       211 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (339)
                          ...||+.|+|||++.+   ..|+.++|||||||++|||++|+.||....        .............      
T Consensus       170 ----~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~--------~~~~~~~i~~~~~------  231 (309)
T d1u5ra_         170 ----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--------AMSALYHIAQNES------  231 (309)
T ss_dssp             ----CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHSCC------
T ss_pred             ----ccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHhCCC------
Confidence                3569999999999864   358999999999999999999999985221        1111222111111      


Q ss_pred             CcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          288 PIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                             +.+.+..+++.+.+|+.+||+.||++|||+.++++
T Consensus       232 -------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         232 -------PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             -------CCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             -------CCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence                   01111245568999999999999999999999986

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-57  Score=396.02  Aligned_cols=257  Identities=26%  Similarity=0.346  Sum_probs=201.8

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCC---CeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQ---DRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTL  130 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  130 (339)
                      .++|++.+.||+|+||+||+|.+..+   +..||||++.........+.+.+|+.++++++||||++++|++.+ +..++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEE
Confidence            46899999999999999999998644   457999998776665667789999999999999999999999964 56899


Q ss_pred             EEEeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCC
Q 019536          131 VFESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEG  207 (339)
Q Consensus       131 v~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~  207 (339)
                      ||||+++|+|.+++.   ..+++..++.++.||+.||.|||   +.+|+||||||+||+++.++.+||+|||+|+.+...
T Consensus        85 v~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~  161 (273)
T d1mp8a_          85 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  161 (273)
T ss_dssp             EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred             EEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhheeccCC
Confidence            999999999998764   46899999999999999999999   899999999999999999999999999999876544


Q ss_pred             CceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCcccccc
Q 019536          208 ETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIV  286 (339)
Q Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (339)
                      .... .....||+.|+|||++.+..|+.++|||||||++|||++ |.+||.....     .......    ..+.     
T Consensus       162 ~~~~-~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~-----~~~~~~i----~~~~-----  226 (273)
T d1mp8a_         162 TYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-----NDVIGRI----ENGE-----  226 (273)
T ss_dssp             ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----GGHHHHH----HTTC-----
T ss_pred             ccee-ccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH-----HHHHHHH----HcCC-----
Confidence            3322 224568999999999999999999999999999999998 8888753322     1111111    1111     


Q ss_pred             cCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          287 DPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                              ..+.+..+++.+.+||.+||+.||++|||+.+|++.|+++.++
T Consensus       227 --------~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  269 (273)
T d1mp8a_         227 --------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  269 (273)
T ss_dssp             --------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --------CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence                    1122235567899999999999999999999999999998754

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=3.5e-56  Score=403.94  Aligned_cols=251  Identities=15%  Similarity=0.178  Sum_probs=209.7

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFE  133 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  133 (339)
                      .++|++.+.||+|+||+||+|.+..+|+.||||++..... ...+.+.+|+.++++++|||||++++++.+++..++|||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE  103 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE-SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE  103 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH-HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch-hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            4689999999999999999999999999999999976543 556778899999999999999999999999999999999


Q ss_pred             eccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeC--CCCceEEecCCCccccCCCC
Q 019536          134 SVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLD--ENYSAKLHDFSLSVSIPEGE  208 (339)
Q Consensus       134 ~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~--~~~~~kl~dfg~a~~~~~~~  208 (339)
                      ||++|+|.+++.   ..+++..+..++.||+.||.|||   +.+|+||||||+|||++  .++.+||+|||+|+.+....
T Consensus       104 ~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~  180 (350)
T d1koaa2         104 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ  180 (350)
T ss_dssp             CCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred             cCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence            999999999874   46899999999999999999999   89999999999999995  46789999999998876554


Q ss_pred             ceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccC
Q 019536          209 THVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDP  288 (339)
Q Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (339)
                      ...   ...||+.|+|||++.+..|+.++||||+||++|+|++|+.||...  .      ..+...... ....      
T Consensus       181 ~~~---~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~--~------~~~~~~~i~-~~~~------  242 (350)
T d1koaa2         181 SVK---VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE--N------DDETLRNVK-SCDW------  242 (350)
T ss_dssp             CEE---EECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS--S------HHHHHHHHH-HTCC------
T ss_pred             ccc---eecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC--C------HHHHHHHHH-hCCC------
Confidence            432   357999999999999999999999999999999999999998522  1      111111111 1110      


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          289 IFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                          ....+.....++++.+||.+||+.||++|||+.|++++
T Consensus       243 ----~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         243 ----NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             ----CSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             ----CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                00011112456789999999999999999999999874

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-56  Score=400.24  Aligned_cols=256  Identities=19%  Similarity=0.318  Sum_probs=204.9

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCe----eEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDR----PISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTL  130 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~l  130 (339)
                      ++|++.++||+|+||+||+|.+..+|+    +||+|++.........+.+.+|+.++++++|||||+++|+|.+++ .++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS-EEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-eeE
Confidence            469999999999999999999987765    689999877655566788999999999999999999999998764 678


Q ss_pred             EEEeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCC
Q 019536          131 VFESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEG  207 (339)
Q Consensus       131 v~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~  207 (339)
                      ++||+.+|+|.+++.   ..+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+|+.+...
T Consensus        88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~  164 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  164 (317)
T ss_dssp             EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred             EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence            899999999988765   56889999999999999999999   899999999999999999999999999999987665


Q ss_pred             CceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCcccccc
Q 019536          208 ETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIV  286 (339)
Q Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (339)
                      ..........||+.|+|||++.+..|+.++|||||||++|||++ |.+||.....     ........    .+      
T Consensus       165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~-----~~~~~~i~----~~------  229 (317)
T d1xkka_         165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-----SEISSILE----KG------  229 (317)
T ss_dssp             CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG-----GGHHHHHH----HT------
T ss_pred             cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH-----HHHHHHHH----cC------
Confidence            54444445568999999999999999999999999999999998 7888653221     11111111    11      


Q ss_pred             cCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 019536          287 DPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYL  336 (339)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~  336 (339)
                             ...+.+..++..+.+|+.+||+.||++|||+.+|+++|+++..
T Consensus       230 -------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~  272 (317)
T d1xkka_         230 -------ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  272 (317)
T ss_dssp             -------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -------CCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence                   1112233556689999999999999999999999999998864

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=7e-56  Score=402.29  Aligned_cols=251  Identities=18%  Similarity=0.175  Sum_probs=209.4

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFE  133 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  133 (339)
                      .++|++.+.||+|+||+||+|.+..+|+.||||++..... .....+.+|+.++++++|||||++++++.+++..|+|||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE  106 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP-LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE  106 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            3679999999999999999999999999999999976543 455678899999999999999999999999999999999


Q ss_pred             eccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeC--CCCceEEecCCCccccCCCC
Q 019536          134 SVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLD--ENYSAKLHDFSLSVSIPEGE  208 (339)
Q Consensus       134 ~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~--~~~~~kl~dfg~a~~~~~~~  208 (339)
                      ||++|+|.+++.   ..+++..++.++.||+.||.|||   +++|+||||||+|||++  .++.+||+|||+|+.+....
T Consensus       107 ~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~  183 (352)
T d1koba_         107 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE  183 (352)
T ss_dssp             CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred             cCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceecCCCC
Confidence            999999988765   36899999999999999999999   89999999999999997  67899999999999886654


Q ss_pred             ceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccC
Q 019536          209 THVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDP  288 (339)
Q Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (339)
                      ...   ...||+.|+|||++.+..|+.++||||+||++|+|++|+.||....        .......... ...      
T Consensus       184 ~~~---~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~--------~~~~~~~i~~-~~~------  245 (352)
T d1koba_         184 IVK---VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED--------DLETLQNVKR-CDW------  245 (352)
T ss_dssp             CEE---EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS--------HHHHHHHHHH-CCC------
T ss_pred             cee---eccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHh-CCC------
Confidence            432   3568999999999999999999999999999999999999985211        1111111111 110      


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          289 IFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                          ..+.+.....+.++.+||.+||+.||.+|||+.|++++
T Consensus       246 ----~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         246 ----EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             ----CCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             ----CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                00111112456689999999999999999999999873

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.1e-56  Score=395.12  Aligned_cols=262  Identities=24%  Similarity=0.317  Sum_probs=214.9

Q ss_pred             HHHHHhcCcccCCceeccCCeeEEEEEEcC-----CCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeee
Q 019536           49 DLKKATNNYDLHKVIQSDTSYRLFEGTLVD-----QDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCL  123 (339)
Q Consensus        49 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~  123 (339)
                      +++...++|++.+.||+|+||+||+|++.+     ++..||||+++........+.+.+|+.++++++||||++++++|.
T Consensus         7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~   86 (301)
T d1lufa_           7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA   86 (301)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence            344456789999999999999999999863     557899999987766566788999999999999999999999999


Q ss_pred             eCCccEEEEEeccCCccccccc--------------------------cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEE
Q 019536          124 ETELPTLVFESVKYGTLRGFSF--------------------------ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVF  177 (339)
Q Consensus       124 ~~~~~~lv~e~~~~g~L~~~~~--------------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H  177 (339)
                      +.+..++||||+++|+|.+++.                          ..+++..++.++.|++.||+|||   +++|+|
T Consensus        87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~ivH  163 (301)
T d1lufa_          87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVH  163 (301)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCC
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeEe
Confidence            9999999999999999998874                          13788889999999999999999   899999


Q ss_pred             ccCCCCCEEeCCCCceEEecCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCC-Ccc
Q 019536          178 RCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGC-NVL  256 (339)
Q Consensus       178 ~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~-~p~  256 (339)
                      |||||+|||++.++.+||+|||+|+...............||+.|+|||.+.+..|+.++|||||||++|||++|. +||
T Consensus       164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~  243 (301)
T d1lufa_         164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY  243 (301)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence            9999999999999999999999998765544433333567889999999999999999999999999999999986 455


Q ss_pred             ccCCCCCCCchhHHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 019536          257 EFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMY  335 (339)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~  335 (339)
                      ...        ...+....... +..             .+.+..+++++.+|+.+||+.||++||||.||++.|++|-
T Consensus       244 ~~~--------~~~e~~~~v~~-~~~-------------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         244 YGM--------AHEEVIYYVRD-GNI-------------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             TTS--------CHHHHHHHHHT-TCC-------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCC--------CHHHHHHHHHc-CCC-------------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            421        11122222111 111             1112245567999999999999999999999999999874

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-56  Score=395.51  Aligned_cols=268  Identities=19%  Similarity=0.312  Sum_probs=206.2

Q ss_pred             cHHHHHHHhcCcccCCceeccCCeeEEEEEEcC-----CCeeEEEEEeccCCChhhHHHHHHHHHHHHhc-CCCceeeee
Q 019536           46 SAKDLKKATNNYDLHKVIQSDTSYRLFEGTLVD-----QDRPISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLI  119 (339)
Q Consensus        46 ~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~  119 (339)
                      ....|+...++|++.+.||+|+||.||+|.+..     +++.||||+++........+.+.+|..++.++ +|+||+.++
T Consensus         4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~   83 (299)
T d1ywna1           4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   83 (299)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence            344555555789999999999999999999854     34689999998776656677788888888777 689999999


Q ss_pred             eeeeeC-CccEEEEEeccCCccccccc------------------cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccC
Q 019536          120 GCCLET-ELPTLVFESVKYGTLRGFSF------------------ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCI  180 (339)
Q Consensus       120 ~~~~~~-~~~~lv~e~~~~g~L~~~~~------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dl  180 (339)
                      +++.+. +..++|||||++|+|.+++.                  ..+++..++.++.||+.||.|||   +++|+||||
T Consensus        84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDl  160 (299)
T d1ywna1          84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDL  160 (299)
T ss_dssp             EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCC
T ss_pred             eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcC
Confidence            998764 46899999999999999874                  23788899999999999999999   899999999


Q ss_pred             CCCCEEeCCCCceEEecCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCC-CccccC
Q 019536          181 KASNVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGC-NVLEFK  259 (339)
Q Consensus       181 k~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~-~p~~~~  259 (339)
                      ||+|||++.++.+||+|||+|+...............||+.|+|||++.+..|+.++|||||||++|||++|. +||...
T Consensus       161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~  240 (299)
T d1ywna1         161 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  240 (299)
T ss_dssp             CGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             CccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC
Confidence            9999999999999999999998765544433333567999999999999999999999999999999999875 565422


Q ss_pred             CCCCCCchhHHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          260 GNGNDDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                      ..    .......    ...+.             ..+.+...++++.+|+.+||+.||++|||+.||+++|+++.++
T Consensus       241 ~~----~~~~~~~----~~~~~-------------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~  297 (299)
T d1ywna1         241 KI----DEEFCRR----LKEGT-------------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  297 (299)
T ss_dssp             CC----SHHHHHH----HHHTC-------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CH----HHHHHHH----HhcCC-------------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            11    1111111    11111             1111224556799999999999999999999999999998754

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-55  Score=391.44  Aligned_cols=249  Identities=20%  Similarity=0.197  Sum_probs=207.6

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC-----hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCcc
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST-----LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELP  128 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~  128 (339)
                      .++|++.+.||+|+||+||+|.+..+|+.||||++.....     ....+.+.+|+.++++++|||||++++++.+.+..
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            3679999999999999999999999999999999876422     12467789999999999999999999999999999


Q ss_pred             EEEEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCC----ceEEecCCCcc
Q 019536          129 TLVFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENY----SAKLHDFSLSV  202 (339)
Q Consensus       129 ~lv~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~----~~kl~dfg~a~  202 (339)
                      ++|||||++|+|.+++.  ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++    .+|++|||+|+
T Consensus        89 ~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~  165 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH  165 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             EEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecchhhhh
Confidence            99999999999999986  57999999999999999999999   89999999999999998776    49999999998


Q ss_pred             ccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcc
Q 019536          203 SIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRF  282 (339)
Q Consensus       203 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (339)
                      .........   ...||+.|+|||++.+..|+.++||||+||++|+|++|+.||....        ..+..... .... 
T Consensus       166 ~~~~~~~~~---~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------~~~~~~~i-~~~~-  232 (293)
T d1jksa_         166 KIDFGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--------KQETLANV-SAVN-  232 (293)
T ss_dssp             ECTTSCBCS---CCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHH-HTTC-
T ss_pred             hcCCCcccc---ccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC--------HHHHHHHH-HhcC-
Confidence            875543322   3568999999999999999999999999999999999999985221        11111111 1110 


Q ss_pred             cccccCcccCCCCCC--CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          283 GAIVDPIFDEDNSFP--GKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       283 ~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                                 ..++  .+...+..+.+||.+||+.||++|||+.|+++
T Consensus       233 -----------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         233 -----------YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             -----------CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -----------CCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                       1111  11234567899999999999999999999986

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-55  Score=398.32  Aligned_cols=248  Identities=19%  Similarity=0.222  Sum_probs=208.7

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC--ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS--TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLV  131 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  131 (339)
                      .++|++.+.||+|+||+||+|++..+|+.||||++.+..  .....+.+.+|+.+|+.++||||+++++++.+++.+|+|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            368999999999999999999999999999999997542  123467788999999999999999999999999999999


Q ss_pred             EEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCc
Q 019536          132 FESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGET  209 (339)
Q Consensus       132 ~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~  209 (339)
                      ||||++|+|.+++.  ..+++..+..++.|++.||.|||   +++|+||||||+|||++.+|.+||+|||+|+.......
T Consensus        84 ~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~  160 (337)
T d1o6la_          84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA  160 (337)
T ss_dssp             EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred             eeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence            99999999999887  67889999999999999999999   99999999999999999999999999999987654332


Q ss_pred             eeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCc
Q 019536          210 HVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPI  289 (339)
Q Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (339)
                      .  ....+||+.|+|||++.+..|+.++||||+||++|||++|++||....        ..+.... ....         
T Consensus       161 ~--~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~--------~~~~~~~-i~~~---------  220 (337)
T d1o6la_         161 T--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HERLFEL-ILME---------  220 (337)
T ss_dssp             C--BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHH-HHHC---------
T ss_pred             c--cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC--------HHHHHHH-HhcC---------
Confidence            2  224679999999999999999999999999999999999999985321        1111111 1111         


Q ss_pred             ccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 019536          290 FDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPL-----MVDVAK  329 (339)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps-----~~~il~  329 (339)
                         ...+|  ...++++.+||.+||+.||++||+     +.++++
T Consensus       221 ---~~~~p--~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         221 ---EIRFP--RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             ---CCCCC--TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ---CCCCC--ccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence               11122  245668999999999999999995     788876

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.9e-55  Score=392.94  Aligned_cols=246  Identities=20%  Similarity=0.307  Sum_probs=207.1

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC--ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS--TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLV  131 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv  131 (339)
                      .++|++.+.||+|+||+||+|++..+|+.||||+++...  .....+.+.+|+.+++.++||||+++++++.+++..|+|
T Consensus         3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   82 (316)
T d1fota_           3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   82 (316)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence            367999999999999999999999999999999987532  123467788999999999999999999999999999999


Q ss_pred             EEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCc
Q 019536          132 FESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGET  209 (339)
Q Consensus       132 ~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~  209 (339)
                      ||||++|+|..++.  ..++...+..++.||+.||.|||   +++|+||||||+|||++.+|.+||+|||+|+.......
T Consensus        83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~~  159 (316)
T d1fota_          83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY  159 (316)
T ss_dssp             ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCBC
T ss_pred             eeecCCccccccccccccccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEeccccc
Confidence            99999999988876  56788888899999999999999   99999999999999999999999999999988755432


Q ss_pred             eeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCc
Q 019536          210 HVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPI  289 (339)
Q Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (339)
                           ..+||+.|+|||++.+..|+.++||||+||++|+|++|+.||....        ..+....... .         
T Consensus       160 -----~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~--------~~~~~~~i~~-~---------  216 (316)
T d1fota_         160 -----TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN--------TMKTYEKILN-A---------  216 (316)
T ss_dssp             -----CCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHH-C---------
T ss_pred             -----cccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC--------HHHHHHHHHc-C---------
Confidence                 4679999999999999999999999999999999999999985221        1111111111 1         


Q ss_pred             ccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 019536          290 FDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP-----LMVDVAKQ  330 (339)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~il~~  330 (339)
                         ...+  +...++++.+++.+||+.||.+|+     |+.+++++
T Consensus       217 ---~~~~--p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         217 ---ELRF--PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             ---CCCC--CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             ---CCCC--CCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence               1111  124456799999999999999996     89999863

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-55  Score=386.95  Aligned_cols=256  Identities=24%  Similarity=0.295  Sum_probs=202.9

Q ss_pred             HhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 019536           53 ATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVF  132 (339)
Q Consensus        53 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  132 (339)
                      ..++|++.+.||+|+||+||+|.+. ++..||||+++...  ...+.|.+|+.++++++|||||+++|+|.++ ..++||
T Consensus        15 ~~~~~~i~~~iG~G~fg~Vy~~~~~-~~~~vAiK~l~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~-~~~lv~   90 (285)
T d1fmka3          15 PRESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVT   90 (285)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEECCTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCEEEE
T ss_pred             CHHHEEEeeEEeeCCCeEEEEEEEC-CCCEEEEEEECccc--CCHHHHHHHHHHHHhcccCCEeEEEEEEecC-CeEEEE
Confidence            3578999999999999999999997 45679999997654  3456799999999999999999999999654 578999


Q ss_pred             EeccCCccccccc----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCC
Q 019536          133 ESVKYGTLRGFSF----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE  208 (339)
Q Consensus       133 e~~~~g~L~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~  208 (339)
                      ||+++|+|..++.    ..+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+|+.+....
T Consensus        91 Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~  167 (285)
T d1fmka3          91 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  167 (285)
T ss_dssp             CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred             EecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence            9999999988875    46899999999999999999999   8999999999999999999999999999998765443


Q ss_pred             ceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccC
Q 019536          209 THVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDP  288 (339)
Q Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (339)
                      ... .....||+.|+|||++.+..++.++|||||||++|||++|..|+... ..      ..+........         
T Consensus       168 ~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~-~~------~~~~~~~i~~~---------  230 (285)
T d1fmka3         168 YTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG-MV------NREVLDQVERG---------  230 (285)
T ss_dssp             ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT-CC------HHHHHHHHHTT---------
T ss_pred             cee-eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCC-CC------HHHHHHHHHhc---------
Confidence            322 22456899999999999999999999999999999999977665321 11      11111111111         


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          289 IFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                           ...+.+..+++++.+|+.+||+.||++|||+.+|++.|++...+
T Consensus       231 -----~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~  274 (285)
T d1fmka3         231 -----YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  274 (285)
T ss_dssp             -----CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             -----CCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence                 11122235567899999999999999999999999999886643

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=4.3e-54  Score=379.24  Aligned_cols=261  Identities=19%  Similarity=0.290  Sum_probs=206.0

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC--hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC----c
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST--LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETE----L  127 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~----~  127 (339)
                      .++|++.+.||+|+||+||+|.+..+|+.||||+++....  ....+.+.+|+.+++.++||||+++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            4679999999999999999999999999999999976533  344567899999999999999999999998654    3


Q ss_pred             cEEEEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccC
Q 019536          128 PTLVFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIP  205 (339)
Q Consensus       128 ~~lv~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~  205 (339)
                      .|+||||+++|+|.+++.  ..+++.+++.++.||+.||.|||   +.+|+||||||+|||++.++..+++|||.+....
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~  162 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIA  162 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCEECC
T ss_pred             EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhhhhhc
Confidence            789999999999998876  57999999999999999999999   8999999999999999999999999999987654


Q ss_pred             CCCc-eeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccc
Q 019536          206 EGET-HVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA  284 (339)
Q Consensus       206 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (339)
                      .... ........||+.|+|||++.+..|+.++||||+||++|+|++|+.||...        ...+............ 
T Consensus       163 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~--------~~~~~~~~~~~~~~~~-  233 (277)
T d1o6ya_         163 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD--------SPVSVAYQHVREDPIP-  233 (277)
T ss_dssp             ----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS--------SHHHHHHHHHHCCCCC-
T ss_pred             cccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCc--------CHHHHHHHHHhcCCCC-
Confidence            3321 12223467999999999999999999999999999999999999998521        1122222222211100 


Q ss_pred             cccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHHHHh
Q 019536          285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP-LMVDVAKQLRQMYL  336 (339)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-s~~~il~~L~~l~~  336 (339)
                         +       .......++++.+++.+||+.||++|| |++++++.|.++..
T Consensus       234 ---~-------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n  276 (277)
T d1o6ya_         234 ---P-------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  276 (277)
T ss_dssp             ---G-------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred             ---C-------chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence               0       001123456799999999999999999 89999999998753

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-55  Score=380.61  Aligned_cols=248  Identities=21%  Similarity=0.301  Sum_probs=197.9

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeee-CCccEEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLE-TELPTLVF  132 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~-~~~~~lv~  132 (339)
                      -++|++.+.||+|+||+||+|.+  .|..||||+++..   ...+.+.+|+.++++++||||++++|+|.+ .+.+++||
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~   80 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT   80 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC---C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred             HHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEE
Confidence            36788999999999999999998  5789999999765   335678899999999999999999999865 45689999


Q ss_pred             EeccCCccccccc----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCC
Q 019536          133 ESVKYGTLRGFSF----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE  208 (339)
Q Consensus       133 e~~~~g~L~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~  208 (339)
                      ||+++|+|.+++.    ..+++..++.++.||+.||.|||   +.+|+||||||+||+++.++.+|++|||+++......
T Consensus        81 ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~  157 (262)
T d1byga_          81 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ  157 (262)
T ss_dssp             CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred             eccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCCCC
Confidence            9999999999986    34899999999999999999999   8999999999999999999999999999997654332


Q ss_pred             ceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCccccccc
Q 019536          209 THVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVD  287 (339)
Q Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (339)
                      .     ...+|..|+|||++.+..++.++|||||||++|||++ |++||.....     .......    ..+       
T Consensus       158 ~-----~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~-----~~~~~~i----~~~-------  216 (262)
T d1byga_         158 D-----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----KDVVPRV----EKG-------  216 (262)
T ss_dssp             ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG-----GGHHHHH----TTT-------
T ss_pred             c-----cccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH-----HHHHHHH----HcC-------
Confidence            2     3457889999999999999999999999999999998 6777643211     1121111    111       


Q ss_pred             CcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 019536          288 PIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYL  336 (339)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~  336 (339)
                            ...+.+...++++.+|+.+||+.||++|||+.++++.|++|..
T Consensus       217 ------~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~  259 (262)
T d1byga_         217 ------YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  259 (262)
T ss_dssp             ------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------CCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence                  0111122445679999999999999999999999999999875

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-54  Score=387.78  Aligned_cols=265  Identities=21%  Similarity=0.309  Sum_probs=217.8

Q ss_pred             HHHHhcCcccCCceeccCCeeEEEEEEc-----CCCeeEEEEEeccCCChhhHHHHHHHHHHHHhc-CCCceeeeeeeee
Q 019536           50 LKKATNNYDLHKVIQSDTSYRLFEGTLV-----DQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCCL  123 (339)
Q Consensus        50 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~  123 (339)
                      |+...++|++.+.||+|+||.||+|++.     .+++.||||+++..........+.+|+.+++.+ +|||||+++|+|.
T Consensus        18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~   97 (311)
T d1t46a_          18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT   97 (311)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe
Confidence            4444589999999999999999999874     466799999998876666777899999999999 6999999999999


Q ss_pred             eCCccEEEEEeccCCcccccccc--------------------CCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCC
Q 019536          124 ETELPTLVFESVKYGTLRGFSFA--------------------SLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKAS  183 (339)
Q Consensus       124 ~~~~~~lv~e~~~~g~L~~~~~~--------------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~  183 (339)
                      +++..++|||||++|+|.+++..                    .+++..+..++.||+.||.|||   +++++||||||+
T Consensus        98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~  174 (311)
T d1t46a_          98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAAR  174 (311)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGG
T ss_pred             eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccccc
Confidence            99999999999999999988641                    4788899999999999999999   899999999999


Q ss_pred             CEEeCCCCceEEecCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCC
Q 019536          184 NVLLDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGN  263 (339)
Q Consensus       184 Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~  263 (339)
                      ||+++.++.+|++|||+++...............||+.|+|||++.+..++.++|||||||++|||+++..|+. .+...
T Consensus       175 NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~-~~~~~  253 (311)
T d1t46a_         175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY-PGMPV  253 (311)
T ss_dssp             GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSS-TTCCS
T ss_pred             cccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCC-CCCCH
Confidence            99999999999999999998776555545556789999999999999999999999999999999999544432 11111


Q ss_pred             CCchhHHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          264 DDDLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                      .   ..   .......+.             ..+.+...+..+.+||.+||+.||.+|||+.+|++.|+++..+
T Consensus       254 ~---~~---~~~~i~~~~-------------~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~  308 (311)
T d1t46a_         254 D---SK---FYKMIKEGF-------------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (311)
T ss_dssp             S---HH---HHHHHHHTC-------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             H---HH---HHHHHhcCC-------------CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence            1   11   111111111             1111224556799999999999999999999999999987765

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-55  Score=382.38  Aligned_cols=255  Identities=22%  Similarity=0.342  Sum_probs=198.1

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCC---CeeEEEEEeccCC--ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQ---DRPISVMKFHDNS--TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPT  129 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~---~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~  129 (339)
                      ++|++.+.||+|+||+||+|++..+   ...||||++....  .....+.|.+|+.++++++||||++++|+|.++ ..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chh
Confidence            5799999999999999999987533   3479999987652  224467899999999999999999999999764 678


Q ss_pred             EEEEeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCC
Q 019536          130 LVFESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPE  206 (339)
Q Consensus       130 lv~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~  206 (339)
                      +||||+++|++.+.+.   ..+++..++.++.|++.||.|||   +++|+||||||+||+++.++.+||+|||+++.+..
T Consensus        87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~  163 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  163 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence            9999999999988765   56999999999999999999999   89999999999999999999999999999998765


Q ss_pred             CCce-eeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCCchhHHHHHHHHhhcCcccc
Q 019536          207 GETH-VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGA  284 (339)
Q Consensus       207 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (339)
                      .... .......|+..|+|||++.+..++.++|||||||++|||++ |+.||...        ...+........+    
T Consensus       164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~--------~~~~~~~~i~~~~----  231 (273)
T d1u46a_         164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL--------NGSQILHKIDKEG----  231 (273)
T ss_dssp             -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC--------CHHHHHHHHHTSC----
T ss_pred             CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCc--------CHHHHHHHHHhCC----
Confidence            4433 22334567889999999999999999999999999999998 89997522        1111112211111    


Q ss_pred             cccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 019536          285 IVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQM  334 (339)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l  334 (339)
                               ...+.+..++..+.+|+.+||+.||++|||+.+|++.|.+.
T Consensus       232 ---------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         232 ---------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             ---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                     11222334566899999999999999999999999988864

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-54  Score=383.27  Aligned_cols=259  Identities=21%  Similarity=0.307  Sum_probs=210.3

Q ss_pred             HhcCcccCCceeccCCeeEEEEEEcCCC-------eeEEEEEeccCCChhhHHHHHHHHHHHHhc-CCCceeeeeeeeee
Q 019536           53 ATNNYDLHKVIQSDTSYRLFEGTLVDQD-------RPISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLE  124 (339)
Q Consensus        53 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~  124 (339)
                      ..++|++.+.||+|+||.||+|+...++       ..||||+++..........+.+|...+.++ +|||||+++++|.+
T Consensus        11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~   90 (299)
T d1fgka_          11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ   90 (299)
T ss_dssp             CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence            3478999999999999999999986544       479999998877666778889999999888 89999999999999


Q ss_pred             CCccEEEEEeccCCccccccc------------------cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEE
Q 019536          125 TELPTLVFESVKYGTLRGFSF------------------ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVL  186 (339)
Q Consensus       125 ~~~~~lv~e~~~~g~L~~~~~------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil  186 (339)
                      ++..++||||+++|+|.+++.                  ..+++.+++.++.|++.||.|||   +.+|+||||||+|||
T Consensus        91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiL  167 (299)
T d1fgka_          91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVL  167 (299)
T ss_dssp             SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEE
T ss_pred             CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeeccccee
Confidence            999999999999999999975                  24789999999999999999999   899999999999999


Q ss_pred             eCCCCceEEecCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHh-CCCccccCCCCCCC
Q 019536          187 LDENYSAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLT-GCNVLEFKGNGNDD  265 (339)
Q Consensus       187 ~~~~~~~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~  265 (339)
                      ++.++.+||+|||+++...............+|+.|+|||.+.+..|+.++|||||||++|||++ |.+||.....    
T Consensus       168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~----  243 (299)
T d1fgka_         168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV----  243 (299)
T ss_dssp             ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH----
T ss_pred             ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH----
Confidence            99999999999999987765544433445678999999999999999999999999999999998 6777642111    


Q ss_pred             chhHHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 019536          266 DLTVLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYL  336 (339)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~  336 (339)
                       .    ........+.             ..+.+...++++.+|+.+||+.||++|||+.||++.|++|..
T Consensus       244 -~----~~~~~i~~~~-------------~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a  296 (299)
T d1fgka_         244 -E----ELFKLLKEGH-------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  296 (299)
T ss_dssp             -H----HHHHHHHTTC-------------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -H----HHHHHHHcCC-------------CCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence             1    1111111111             111122445679999999999999999999999999999864

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-54  Score=388.75  Aligned_cols=255  Identities=22%  Similarity=0.321  Sum_probs=205.8

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCe--eEEEEEeccCCChhhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCccEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDR--PISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLETELPTLV  131 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~~~~~~lv  131 (339)
                      ++|++.+.||+|+||+||+|.+..++.  .||||++.........+.+.+|+.+++++ +|||||+++|+|.+++..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            688999999999999999999987776  57888887665545677899999999999 799999999999999999999


Q ss_pred             EEeccCCccccccc------------------cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCce
Q 019536          132 FESVKYGTLRGFSF------------------ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSA  193 (339)
Q Consensus       132 ~e~~~~g~L~~~~~------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~  193 (339)
                      |||+++|+|.+++.                  ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCCce
Confidence            99999999999874                  45889999999999999999999   8999999999999999999999


Q ss_pred             EEecCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCC-ccccCCCCCCCchhHHHH
Q 019536          194 KLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCN-VLEFKGNGNDDDLTVLEY  272 (339)
Q Consensus       194 kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~-p~~~~~~~~~~~~~~~~~  272 (339)
                      ||+|||+|+........   ....||..|+|||.+.+..|+.++|||||||++|||++|.. ||.  +.      ...+.
T Consensus       167 kl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~--~~------~~~~~  235 (309)
T d1fvra_         167 KIADFGLSRGQEVYVKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC--GM------TCAEL  235 (309)
T ss_dssp             EECCTTCEESSCEECCC-------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT--TC------CHHHH
T ss_pred             EEccccccccccccccc---cceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCC--CC------CHHHH
Confidence            99999999765432221   23468999999999999999999999999999999999765 543  21      11111


Q ss_pred             HHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          273 AKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                      ...... +             ...+.+..+++++.+||.+||+.||++|||+.+|++.|+++.++
T Consensus       236 ~~~i~~-~-------------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~  286 (309)
T d1fvra_         236 YEKLPQ-G-------------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  286 (309)
T ss_dssp             HHHGGG-T-------------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             HHHHHh-c-------------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence            111111 1             11122234566899999999999999999999999999998753

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.1e-54  Score=390.56  Aligned_cols=244  Identities=16%  Similarity=0.216  Sum_probs=206.8

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC--ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS--TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVF  132 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~  132 (339)
                      ++|++.+.||+|+||+||+|.+..+|+.||||++....  .....+.+.+|+.+|+.++|||||++++++.+.+..++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            68999999999999999999999999999999986532  1234567889999999999999999999999999999999


Q ss_pred             EeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCce
Q 019536          133 ESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH  210 (339)
Q Consensus       133 e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~  210 (339)
                      ||+.+|+|..++.  ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+|+.+..... 
T Consensus       121 e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~~-  196 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW-  196 (350)
T ss_dssp             ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCBC-
T ss_pred             ccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeecccccc-
Confidence            9999999998886  57999999999999999999999   89999999999999999999999999999988754322 


Q ss_pred             eeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcc
Q 019536          211 VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIF  290 (339)
Q Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (339)
                          ...||+.|+|||++.+..|+.++|||||||++|+|++|+.||...  .      .......... ..         
T Consensus       197 ----~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~--~------~~~~~~~i~~-~~---------  254 (350)
T d1rdqe_         197 ----TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--Q------PIQIYEKIVS-GK---------  254 (350)
T ss_dssp             ----CCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--S------HHHHHHHHHH-CC---------
T ss_pred             ----cccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc--C------HHHHHHHHhc-CC---------
Confidence                357999999999999999999999999999999999999998521  1      1111111111 11         


Q ss_pred             cCCCCCCCcHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 019536          291 DEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRP-----LMVDVAK  329 (339)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~il~  329 (339)
                         ...  +...++++.+|+.+||+.||.+|+     |+.++++
T Consensus       255 ---~~~--p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         255 ---VRF--PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             ---CCC--CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             ---CCC--CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence               111  124556799999999999999994     8999886

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2.2e-53  Score=373.71  Aligned_cols=251  Identities=20%  Similarity=0.290  Sum_probs=207.7

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCCh--------hhHHHHHHHHHHHHhcC-CCceeeeeeeeeeC
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTL--------DDVEYCFNNIVFSSQMK-HKNILKLIGCCLET  125 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~e~~~l~~l~-H~niv~~~~~~~~~  125 (339)
                      ++|++.+.||+|+||+||+|++..+|+.||||++......        ...+.+.+|+.++++++ ||||+++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            6899999999999999999999999999999998765321        12346889999999996 99999999999999


Q ss_pred             CccEEEEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccc
Q 019536          126 ELPTLVFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVS  203 (339)
Q Consensus       126 ~~~~lv~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~  203 (339)
                      +..|+|||||++|+|.+++.  ..+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++.
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~  159 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ  159 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             cceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccchheeE
Confidence            99999999999999999985  68999999999999999999999   89999999999999999999999999999988


Q ss_pred             cCCCCceeeeccccccccccccccccc------CCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHh
Q 019536          204 IPEGETHVREEFIKGAYGFIAPEYFAT------SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSI  277 (339)
Q Consensus       204 ~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  277 (339)
                      +......   ....||+.|+|||.+.+      ..++.++||||+||++|+|++|+.||....        .........
T Consensus       160 ~~~~~~~---~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~--------~~~~~~~i~  228 (277)
T d1phka_         160 LDPGEKL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK--------QMLMLRMIM  228 (277)
T ss_dssp             CCTTCCB---CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHH
T ss_pred             ccCCCce---eeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC--------HHHHHHHHH
Confidence            7654322   24579999999999863      347889999999999999999999985221        111111111


Q ss_pred             hcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          278 ENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      . +..          ....+.....++++++|+.+||+.||++|||+.||+++
T Consensus       229 ~-~~~----------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         229 S-GNY----------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             H-TCC----------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             h-CCC----------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            1 110          11122233567789999999999999999999999864

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-54  Score=386.18  Aligned_cols=248  Identities=15%  Similarity=0.174  Sum_probs=206.5

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFE  133 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  133 (339)
                      .++|++.+.||+|+||+||+|.+..+++.||||+++...  .....+.+|+.+|+.++|||||++++++.+++.+|+|||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~--~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE   81 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc--ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            478999999999999999999999999999999997653  334567899999999999999999999999999999999


Q ss_pred             eccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCC--CCceEEecCCCccccCCCC
Q 019536          134 SVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDE--NYSAKLHDFSLSVSIPEGE  208 (339)
Q Consensus       134 ~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~--~~~~kl~dfg~a~~~~~~~  208 (339)
                      ||++|+|.+++.   ..+++.++..++.||+.||.|||   +.+|+||||||+|||++.  .+.+||+|||+++......
T Consensus        82 ~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~  158 (321)
T d1tkia_          82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD  158 (321)
T ss_dssp             CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred             cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence            999999999886   26899999999999999999999   899999999999999985  4579999999998875544


Q ss_pred             ceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccC
Q 019536          209 THVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDP  288 (339)
Q Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (339)
                      ...   ...+|+.|+|||.+.+..|+.++||||+||++|+|++|+.||....        ......... ..        
T Consensus       159 ~~~---~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~--------~~~~~~~i~-~~--------  218 (321)
T d1tkia_         159 NFR---LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET--------NQQIIENIM-NA--------  218 (321)
T ss_dssp             EEE---EEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHH-HT--------
T ss_pred             ccc---ccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCC--------HHHHHHHHH-hC--------
Confidence            322   3568999999999999999999999999999999999999985321        111111111 11        


Q ss_pred             cccCCCCCCC--cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          289 IFDEDNSFPG--KEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       289 ~~~~~~~~~~--~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                          ...++.  ....+.++.+|+.+||+.||++|||+.|++++
T Consensus       219 ----~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  258 (321)
T d1tkia_         219 ----EYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             ----CCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ----CCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                111111  11345679999999999999999999999873

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=8.2e-54  Score=390.54  Aligned_cols=249  Identities=17%  Similarity=0.239  Sum_probs=201.1

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC--hhhHHHHH---HHHHHHHhcCCCceeeeeeeeeeCCcc
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST--LDDVEYCF---NNIVFSSQMKHKNILKLIGCCLETELP  128 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~---~e~~~l~~l~H~niv~~~~~~~~~~~~  128 (339)
                      .++|++.+.||+|+||+||+|++..+|+.||||++.....  ......+.   +|+.+++.++|||||++++++.+.+..
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence            3689999999999999999999999999999999864311  11223333   446677778899999999999999999


Q ss_pred             EEEEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCC
Q 019536          129 TLVFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPE  206 (339)
Q Consensus       129 ~lv~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~  206 (339)
                      |+|||||++|+|.+++.  ..+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+|+.+..
T Consensus        83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~  159 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK  159 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred             EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence            99999999999999986  57888899999999999999999   99999999999999999999999999999987765


Q ss_pred             CCceeeeccccccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCccccc
Q 019536          207 GETHVREEFIKGAYGFIAPEYFAT-SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAI  285 (339)
Q Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (339)
                      ....    ...||+.|+|||++.+ ..|+.++||||+||++|+|++|+.||.......     ....... .        
T Consensus       160 ~~~~----~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-----~~~~~~~-~--------  221 (364)
T d1omwa3         160 KKPH----ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-----KHEIDRM-T--------  221 (364)
T ss_dssp             SCCC----SCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC-----HHHHHHH-S--------
T ss_pred             Cccc----ccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHh-c--------
Confidence            4332    4579999999999974 569999999999999999999999986432221     1111111 0        


Q ss_pred             ccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 019536          286 VDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPL-----MVDVAK  329 (339)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps-----~~~il~  329 (339)
                          ......  .+...++++.+||.+||+.||++|||     +.|+++
T Consensus       222 ----~~~~~~--~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         222 ----LTMAVE--LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             ----SSCCCC--CCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             ----ccCCCC--CCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence                001111  11245667999999999999999999     688875

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-54  Score=384.93  Aligned_cols=263  Identities=18%  Similarity=0.307  Sum_probs=217.3

Q ss_pred             HHHHHhcCcccCCceeccCCeeEEEEEEcC-----CCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeee
Q 019536           49 DLKKATNNYDLHKVIQSDTSYRLFEGTLVD-----QDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCL  123 (339)
Q Consensus        49 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~  123 (339)
                      +|+...++|++.+.||+|+||+||+|.++.     ++..||||+++..........+.+|+.++++++||||++++|+|.
T Consensus        14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~   93 (308)
T d1p4oa_          14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS   93 (308)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred             ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe
Confidence            455556899999999999999999999852     357899999987766566677999999999999999999999999


Q ss_pred             eCCccEEEEEeccCCccccccc------------cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCC
Q 019536          124 ETELPTLVFESVKYGTLRGFSF------------ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENY  191 (339)
Q Consensus       124 ~~~~~~lv~e~~~~g~L~~~~~------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~  191 (339)
                      ..+..++||||+++|+|.+++.            ..+++..+..++.|++.||.|||   +++|+||||||+|||++.++
T Consensus        94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~  170 (308)
T d1p4oa_          94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDF  170 (308)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTC
T ss_pred             cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCc
Confidence            9999999999999999999865            23678889999999999999999   89999999999999999999


Q ss_pred             ceEEecCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCC-CccccCCCCCCCchhHH
Q 019536          192 SAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGC-NVLEFKGNGNDDDLTVL  270 (339)
Q Consensus       192 ~~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~-~p~~~~~~~~~~~~~~~  270 (339)
                      .+||+|||+|+.+.............||+.|+|||.+.+..++.++|||||||++|||++|. +||...        ...
T Consensus       171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~--------~~~  242 (308)
T d1p4oa_         171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL--------SNE  242 (308)
T ss_dssp             CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS--------CHH
T ss_pred             eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC--------CHH
Confidence            99999999998776555444444557899999999999999999999999999999999985 555321        122


Q ss_pred             HHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 019536          271 EYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYL  336 (339)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~  336 (339)
                      +..........              .+.+..++..+.+||.+||+.||++|||+.+|++.|++..+
T Consensus       243 ~~~~~i~~~~~--------------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         243 QVLRFVMEGGL--------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             HHHHHHHTTCC--------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHHHHHHhCCC--------------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            22222111111              11222455679999999999999999999999999988654

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-53  Score=385.12  Aligned_cols=248  Identities=17%  Similarity=0.234  Sum_probs=201.0

Q ss_pred             hcCcccCC-ceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhc-CCCceeeeeeeeee----CCc
Q 019536           54 TNNYDLHK-VIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQM-KHKNILKLIGCCLE----TEL  127 (339)
Q Consensus        54 ~~~~~~~~-~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~~~~~~~~----~~~  127 (339)
                      .++|.+.. +||+|+||+||+|.+..+++.||||+++..      ..+.+|+.++.++ +|||||++++++.+    +..
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~   83 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC   83 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence            47898865 699999999999999999999999998642      4566899987655 89999999999875    456


Q ss_pred             cEEEEEeccCCccccccc----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCC---CCceEEecCCC
Q 019536          128 PTLVFESVKYGTLRGFSF----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDE---NYSAKLHDFSL  200 (339)
Q Consensus       128 ~~lv~e~~~~g~L~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~---~~~~kl~dfg~  200 (339)
                      +|+|||||+||+|.+++.    ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.   .+.+||+|||+
T Consensus        84 ~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~  160 (335)
T d2ozaa1          84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGF  160 (335)
T ss_dssp             EEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH---HcCCccccccccccccccccccccccccccce
Confidence            899999999999999985    25889999999999999999999   899999999999999985   56799999999


Q ss_pred             ccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcC
Q 019536          201 SVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENN  280 (339)
Q Consensus       201 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  280 (339)
                      |+........   ....||+.|+|||++.+..|+.++||||+||++|+|++|+.||........  .             
T Consensus       161 a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~--~-------------  222 (335)
T d2ozaa1         161 AKETTSHNSL---TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI--S-------------  222 (335)
T ss_dssp             CEECCCCCCC---CCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------------
T ss_pred             eeeccCCCcc---ccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH--H-------------
Confidence            9877654432   245799999999999999999999999999999999999999864332210  0             


Q ss_pred             cccccccCcccCCCCCCC--cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          281 RFGAIVDPIFDEDNSFPG--KEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                        ..+..........+|.  ....++++.+|+.+||+.||++|||+.|++++
T Consensus       223 --~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         223 --PGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             -------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             --HHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence              0011111122222332  23567789999999999999999999999874

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-53  Score=380.24  Aligned_cols=254  Identities=25%  Similarity=0.389  Sum_probs=204.1

Q ss_pred             CCceeccCCeeEEEEEEcCCC---eeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeee-CCccEEEEEec
Q 019536           60 HKVIQSDTSYRLFEGTLVDQD---RPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLE-TELPTLVFESV  135 (339)
Q Consensus        60 ~~~ig~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~-~~~~~lv~e~~  135 (339)
                      .++||+|+||+||+|.+..++   ..||||+++........++|.+|+.++++++||||++++|+|.+ ++..++|||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            468999999999999986543   36999999876666677889999999999999999999999876 45789999999


Q ss_pred             cCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCcee-
Q 019536          136 KYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHV-  211 (339)
Q Consensus       136 ~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~-  211 (339)
                      ++|+|.+++.   ...++..++.++.|++.||.|||   +.+|+||||||+|||+++++.+||+|||+++.+....... 
T Consensus       112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~  188 (311)
T d1r0pa_         112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV  188 (311)
T ss_dssp             TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred             ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence            9999999876   34667888999999999999999   8999999999999999999999999999998765443221 


Q ss_pred             -eecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCcc
Q 019536          212 -REEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPIF  290 (339)
Q Consensus       212 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (339)
                       ......||+.|+|||.+.+..++.++||||||+++|||++|..||..... ..+   .   ...... +.         
T Consensus       189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~-~~~---~---~~~i~~-g~---------  251 (311)
T d1r0pa_         189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-TFD---I---TVYLLQ-GR---------  251 (311)
T ss_dssp             TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC----------C---HHHHHT-TC---------
T ss_pred             eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC-HHH---H---HHHHHc-CC---------
Confidence             12234688999999999999999999999999999999998888642211 111   1   111111 11         


Q ss_pred             cCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          291 DEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                          ..+.+..+++.+.+||.+||+.||++|||+.||+++|+++..+
T Consensus       252 ----~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~  294 (311)
T d1r0pa_         252 ----RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  294 (311)
T ss_dssp             ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             ----CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence                1111224456799999999999999999999999999999865

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-54  Score=387.54  Aligned_cols=247  Identities=22%  Similarity=0.312  Sum_probs=204.2

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC--ChhhHHHHHHHHHHHH-hcCCCceeeeeeeeeeCCccEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS--TLDDVEYCFNNIVFSS-QMKHKNILKLIGCCLETELPTLV  131 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~-~l~H~niv~~~~~~~~~~~~~lv  131 (339)
                      ++|++.+.||+|+||+||+|++..+++.||||++++..  .....+.+.+|..++. .++|||||++++++.+++..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            68999999999999999999999999999999997532  1234566777777665 68999999999999999999999


Q ss_pred             EEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCc
Q 019536          132 FESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGET  209 (339)
Q Consensus       132 ~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~  209 (339)
                      |||+++|+|.+++.  ..+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+|+.......
T Consensus        82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~  158 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA  158 (320)
T ss_dssp             EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred             EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhcccccc
Confidence            99999999999986  67899999999999999999999   89999999999999999999999999999987654333


Q ss_pred             eeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcccccccCc
Q 019536          210 HVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFGAIVDPI  289 (339)
Q Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (339)
                      ..  ....||+.|+|||++.+..|+.++||||+||++|+|++|+.||....        ..+.... ....         
T Consensus       159 ~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~--------~~~~~~~-i~~~---------  218 (320)
T d1xjda_         159 KT--NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD--------EEELFHS-IRMD---------  218 (320)
T ss_dssp             CB--CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHH-HHHC---------
T ss_pred             cc--cccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC--------HHHHHHH-HHcC---------
Confidence            22  24679999999999999999999999999999999999999985221        1111111 1111         


Q ss_pred             ccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHH-HHHH
Q 019536          290 FDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMV-DVAK  329 (339)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~-~il~  329 (339)
                         ...+|  ...++++.+|+.+||+.||++|||+. ++++
T Consensus       219 ---~~~~p--~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         219 ---NPFYP--RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             ---CCCCC--TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             ---CCCCC--ccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence               11111  24456799999999999999999985 6754

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-53  Score=374.94  Aligned_cols=270  Identities=20%  Similarity=0.276  Sum_probs=202.7

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHH--HHHHHHHhcCCCceeeeeeeeeeCC----cc
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCF--NNIVFSSQMKHKNILKLIGCCLETE----LP  128 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~--~e~~~l~~l~H~niv~~~~~~~~~~----~~  128 (339)
                      .+|.+.+.||+|+||+||+|++  +|+.||||+++..    ....+.  .|+..+.+++||||++++++|.+.+    ..
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~----~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~   76 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL   76 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc----chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence            4678889999999999999997  7899999998653    233344  4455556789999999999998654    47


Q ss_pred             EEEEEeccCCccccccc-cCCChHHHHHHHHHHHHHHHHHhcC-----CCCCeEEccCCCCCEEeCCCCceEEecCCCcc
Q 019536          129 TLVFESVKYGTLRGFSF-ASLLIAPRIKIAMEIANAVAYLHVG-----FDRPIVFRCIKASNVLLDENYSAKLHDFSLSV  202 (339)
Q Consensus       129 ~lv~e~~~~g~L~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~-----~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~  202 (339)
                      ++||||+++|+|.+++. ..+++..++.++.|++.||.|||+.     ..++|+||||||+|||++.++.+||+|||+++
T Consensus        77 ~lv~Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~  156 (303)
T d1vjya_          77 WLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence            89999999999999987 5789999999999999999999931     12699999999999999999999999999998


Q ss_pred             ccCCCCcee--eecccccccccccccccccCC------CCcccchHHHHHHHHHHHhCCCccccCCCCCCCchh------
Q 019536          203 SIPEGETHV--REEFIKGAYGFIAPEYFATSS------FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLT------  268 (339)
Q Consensus       203 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~------  268 (339)
                      .........  ......||+.|+|||++.+..      ++.++|||||||++|||++|..||............      
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~  236 (303)
T d1vjya_         157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  236 (303)
T ss_dssp             EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence            775543321  223467999999999987643      677899999999999999999887543322211110      


Q ss_pred             HHHHHHHHhhcCcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          269 VLEYAKKSIENNRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                      .............    ..+.+..   ..........+.+|+.+||+.||++|||+.||++.|+++.+.
T Consensus       237 ~~~~~~~~~~~~~----~~p~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  298 (303)
T d1vjya_         237 SVEEMRKVVCEQK----LRPNIPN---RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             CHHHHHHHHTTSC----CCCCCCG---GGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHhccc----cCCCCCc---ccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence            1111111111111    1111110   011124566799999999999999999999999999999864

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-53  Score=379.40  Aligned_cols=260  Identities=19%  Similarity=0.205  Sum_probs=197.1

Q ss_pred             CCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChh----hHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEec
Q 019536           60 HKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLD----DVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFESV  135 (339)
Q Consensus        60 ~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~  135 (339)
                      .++||+|+||+||+|.+..+|+.||||+++......    ....+.+|+.++++++|||||++++++.+++..++||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            468999999999999999999999999987643211    1245789999999999999999999999999999999999


Q ss_pred             cCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCceeee
Q 019536          136 KYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHVRE  213 (339)
Q Consensus       136 ~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~~~  213 (339)
                      +++++..+..  ..+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+|+.........  
T Consensus        83 ~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~--  157 (299)
T d1ua2a_          83 ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--  157 (299)
T ss_dssp             SEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCC--
T ss_pred             cchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCCcccc--
Confidence            9988877765  56888999999999999999999   8999999999999999999999999999998765543322  


Q ss_pred             cccccccccccccccccC-CCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhh---cCcccccccCc
Q 019536          214 EFIKGAYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIE---NNRFGAIVDPI  289 (339)
Q Consensus       214 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  289 (339)
                      ...+||+.|+|||++.+. .|+.++||||+||++|||++|.+||...  .+   ............   ...+.......
T Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~--~~---~~~l~~i~~~~~~~~~~~~~~~~~~~  232 (299)
T d1ua2a_         158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD--SD---LDQLTRIFETLGTPTEEQWPDMCSLP  232 (299)
T ss_dssp             CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS--SH---HHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred             cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCC--CH---HHHHHHHHHhcCCCChhhccchhccc
Confidence            235689999999998654 6899999999999999999999997532  21   112221111111   11110000000


Q ss_pred             -ccCCCCCCCc------HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          290 -FDEDNSFPGK------EEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       290 -~~~~~~~~~~------~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                       .......+..      ...++++.+|+.+||+.||++|||+.|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence             0000001100      123567999999999999999999999986

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-52  Score=372.94  Aligned_cols=266  Identities=15%  Similarity=0.194  Sum_probs=201.2

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC-hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST-LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFE  133 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  133 (339)
                      ++|++.+.||+|+||+||+|.+..+|+.||||+++.... ....+.+.+|+.++++++|||||++++++.+++..++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            689999999999999999999999999999999976432 1235678899999999999999999999999999999999


Q ss_pred             eccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCce
Q 019536          134 SVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETH  210 (339)
Q Consensus       134 ~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~  210 (339)
                      |+.++.+.....   ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+|+........
T Consensus        82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~  158 (298)
T d1gz8a_          82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT  158 (298)
T ss_dssp             CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC
T ss_pred             ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccCCccc
Confidence            997654443322   56899999999999999999999   899999999999999999999999999999877543322


Q ss_pred             eeecccccccccccccccccCC-CCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHh---hcCcccccc
Q 019536          211 VREEFIKGAYGFIAPEYFATSS-FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSI---ENNRFGAIV  286 (339)
Q Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  286 (339)
                        .....||+.|+|||++.... ++.++||||+||++|+|++|+.||....  .   ...........   ....+....
T Consensus       159 --~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~--~---~~~~~~i~~~~~~~~~~~~~~~~  231 (298)
T d1gz8a_         159 --YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS--E---IDQLFRIFRTLGTPDEVVWPGVT  231 (298)
T ss_dssp             --TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS--H---HHHHHHHHHHHCCCCTTTSTTGG
T ss_pred             --ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCC--H---HHHHHHHHHhcCCCchhhccccc
Confidence              22357999999999987765 5789999999999999999999985321  1   11111111111   111010000


Q ss_pred             -cCcccCCCC-C--CC----cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          287 -DPIFDEDNS-F--PG----KEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       287 -~~~~~~~~~-~--~~----~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                       .+....... .  ..    ....+.++.+|+.+||+.||++|||+.|++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             GSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence             000000000 0  00    01335678999999999999999999999975

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-53  Score=371.66  Aligned_cols=241  Identities=17%  Similarity=0.281  Sum_probs=197.5

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCCh-----hhHHHHHHHHHHHHhcC--CCceeeeeeeeeeCC
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTL-----DDVEYCFNNIVFSSQMK--HKNILKLIGCCLETE  126 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~l~--H~niv~~~~~~~~~~  126 (339)
                      .++|++.+.||+|+||+||+|++..+|+.||||++......     .....+.+|+.++++++  |||||++++++.+++
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            36899999999999999999999999999999998753211     12233568999999996  899999999999999


Q ss_pred             ccEEEEEeccC-Cccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCC-CCceEEecCCCcc
Q 019536          127 LPTLVFESVKY-GTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDE-NYSAKLHDFSLSV  202 (339)
Q Consensus       127 ~~~lv~e~~~~-g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~-~~~~kl~dfg~a~  202 (339)
                      ..++||||+.+ +++.+++.  ..+++..+..++.|++.||.|||   +++|+||||||+|||++. ++.+||+|||+|+
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~  159 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGA  159 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECccccce
Confidence            99999999976 56666664  67899999999999999999999   899999999999999985 4789999999998


Q ss_pred             ccCCCCceeeecccccccccccccccccCCC-CcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCc
Q 019536          203 SIPEGETHVREEFIKGAYGFIAPEYFATSSF-NEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNR  281 (339)
Q Consensus       203 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (339)
                      .......    ....||+.|+|||++.+..+ +.++||||+||++|+|++|+.||...        .      .... ..
T Consensus       160 ~~~~~~~----~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~--------~------~i~~-~~  220 (273)
T d1xwsa_         160 LLKDTVY----TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD--------E------EIIR-GQ  220 (273)
T ss_dssp             ECCSSCB----CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH--------H------HHHH-CC
T ss_pred             ecccccc----cccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc--------h------HHhh-cc
Confidence            7644322    13579999999999987765 57799999999999999999998521        0      0000 00


Q ss_pred             ccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          282 FGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                                  ..++  ...++++.+|+.+||+.||++|||+.|++++
T Consensus       221 ------------~~~~--~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  255 (273)
T d1xwsa_         221 ------------VFFR--QRVSSECQHLIRWCLALRPSDRPTFEEIQNH  255 (273)
T ss_dssp             ------------CCCS--SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ------------cCCC--CCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence                        0111  1345679999999999999999999999873

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-51  Score=366.96  Aligned_cols=266  Identities=17%  Similarity=0.235  Sum_probs=197.3

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCC-CeeEEEEEeccCCC-hhhHHHHHHHHHHHHhc---CCCceeeeeeeeee----
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQ-DRPISVMKFHDNST-LDDVEYCFNNIVFSSQM---KHKNILKLIGCCLE----  124 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~-~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l---~H~niv~~~~~~~~----  124 (339)
                      .++|++.+.||+|+||+||+|.+..+ ++.||||++..... ......+.+|+.+++.+   +||||++++++|..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            47899999999999999999999654 67899999865422 12233455777776665   79999999999863    


Q ss_pred             -CCccEEEEEeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCC
Q 019536          125 -TELPTLVFESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSL  200 (339)
Q Consensus       125 -~~~~~lv~e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~  200 (339)
                       ....+++|||+++|++.....   ..+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~dfg~  162 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGL  162 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred             cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecchhh
Confidence             346799999999887654432   56889999999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHh---
Q 019536          201 SVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSI---  277 (339)
Q Consensus       201 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~---  277 (339)
                      ++........   ....||+.|+|||++.+..|+.++||||+||++|||++|++||...  ..   ...........   
T Consensus       163 ~~~~~~~~~~---~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~--~~---~~~~~~i~~~~~~~  234 (305)
T d1blxa_         163 ARIYSFQMAL---TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS--SD---VDQLGKILDVIGLP  234 (305)
T ss_dssp             CCCCCGGGGG---CCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS--SH---HHHHHHHHHHHCCC
T ss_pred             hhhhcccccC---CCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCC--CH---HHHHHHHHHhhCCC
Confidence            8765443322   2467999999999999999999999999999999999999998522  11   11111111111   


Q ss_pred             hcCccccc---ccCcccCCCCCC---CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          278 ENNRFGAI---VDPIFDEDNSFP---GKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       278 ~~~~~~~~---~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      ....+...   ...........+   .....++.+.+|+.+||++||++|||+.|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H  293 (305)
T d1blxa_         235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  293 (305)
T ss_dssp             CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             chhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            00000000   000000000000   112345678999999999999999999999864

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=3.3e-51  Score=362.39  Aligned_cols=264  Identities=19%  Similarity=0.234  Sum_probs=201.4

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC-hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST-LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFE  133 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  133 (339)
                      ++|++.+.||+|+||+||+|.+. +|+.||||++..... ....+.+.+|+.++++++||||+++++++.+++..+++||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e   80 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence            58999999999999999999986 789999999976532 2335778899999999999999999999999999999999


Q ss_pred             eccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCcee
Q 019536          134 SVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHV  211 (339)
Q Consensus       134 ~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~  211 (339)
                      |+.++.+..+..  ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+|++|||.|......... 
T Consensus        81 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~-  156 (286)
T d1ob3a_          81 HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK-  156 (286)
T ss_dssp             CCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             eehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccCccc-
Confidence            998887777755  67899999999999999999999   899999999999999999999999999999876543322 


Q ss_pred             eecccccccccccccccccC-CCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhc---Ccccccc-
Q 019536          212 REEFIKGAYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIEN---NRFGAIV-  286 (339)
Q Consensus       212 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~-  286 (339)
                       .....+++.|+|||.+.+. .++.++||||+||++|||++|+.||....  .   .............   ..+.... 
T Consensus       157 -~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~--~---~~~~~~i~~~~~~~~~~~~~~~~~  230 (286)
T d1ob3a_         157 -YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS--E---ADQLMRIFRILGTPNSKNWPNVTE  230 (286)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS--H---HHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             -cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCC--H---HHHHHHHHHhhCCCChhhccchhh
Confidence             2234688999999998765 57899999999999999999999985321  1   1111111111110   0000000 


Q ss_pred             ----cCcccCCCCCC---CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          287 ----DPIFDEDNSFP---GKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       287 ----~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                          ..........+   .....++.+.+|+.+||+.||++|||+.|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                00000000000   01234568899999999999999999999985

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-50  Score=364.00  Aligned_cols=269  Identities=17%  Similarity=0.187  Sum_probs=198.5

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC-hhhHHHHHHHHHHHHhcCCCceeeeeeeeee--------
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST-LDDVEYCFNNIVFSSQMKHKNILKLIGCCLE--------  124 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~--------  124 (339)
                      .++|++.+.||+|+||+||+|.+..+|+.||||++..... ......+.+|+.+|+.++||||+++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            4789999999999999999999999999999999865432 2345678899999999999999999999865        


Q ss_pred             CCccEEEEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCcc
Q 019536          125 TELPTLVFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSV  202 (339)
Q Consensus       125 ~~~~~lv~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~  202 (339)
                      .+..++||||++++.+.....  ..++...+..++.|++.||.|||   +.+|+||||||+|||++.++.+|++|||+++
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~  165 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLAR  165 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeecceee
Confidence            345789999998887765544  57888899999999999999999   8999999999999999999999999999998


Q ss_pred             ccCCCCcee--eecccccccccccccccccC-CCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHh--
Q 019536          203 SIPEGETHV--REEFIKGAYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSI--  277 (339)
Q Consensus       203 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--  277 (339)
                      .+.......  ......||+.|+|||++.+. .|+.++||||+||++|||++|+.||..  ..+   ...........  
T Consensus       166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~--~~~---~~~~~~i~~~~~~  240 (318)
T d3blha1         166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG--NTE---QHQLALISQLCGS  240 (318)
T ss_dssp             ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCC--SSH---HHHHHHHHHHHCC
T ss_pred             ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCC--CCH---HHHHHHHHHhcCC
Confidence            765432221  12235689999999998765 689999999999999999999999752  211   11111111111  


Q ss_pred             -hcCcccccccCcccC----CCCCC-CcH------HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          278 -ENNRFGAIVDPIFDE----DNSFP-GKE------EKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       278 -~~~~~~~~~~~~~~~----~~~~~-~~~------~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                       ...............    ....+ ...      ..+..+.+|+.+||++||++|||+.|++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             CCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence             111111110000000    00000 000      124567899999999999999999999874

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=4.8e-50  Score=361.73  Aligned_cols=263  Identities=18%  Similarity=0.234  Sum_probs=201.5

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcC-CCceeeeeeeeee--CCccEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMK-HKNILKLIGCCLE--TELPTLV  131 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~~~~~~~~--~~~~~lv  131 (339)
                      ++|++.+.||+|+||+||+|++..+|+.||||+++..    ..+.+.+|+.+|+.+. ||||+++++++..  ....++|
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v  110 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  110 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH----HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence            6899999999999999999999999999999999753    3466889999999995 9999999999974  4568999


Q ss_pred             EEeccCCccccccccCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCC-ceEEecCCCccccCCCCce
Q 019536          132 FESVKYGTLRGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENY-SAKLHDFSLSVSIPEGETH  210 (339)
Q Consensus       132 ~e~~~~g~L~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~-~~kl~dfg~a~~~~~~~~~  210 (339)
                      ||||++|+|..+. ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++ .+||+|||+|+........
T Consensus       111 ~e~~~~~~L~~~~-~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~  186 (328)
T d3bqca1         111 FEHVNNTDFKQLY-QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY  186 (328)
T ss_dssp             EECCCSCBGGGTT-TSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCC
T ss_pred             EeecCCCcHHHHh-cCCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccceeccCCCcc
Confidence            9999999998764 57999999999999999999999   99999999999999998654 6999999999877654332


Q ss_pred             eeecccccccccccccccccC-CCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHH------HHhhcCc--
Q 019536          211 VREEFIKGAYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAK------KSIENNR--  281 (339)
Q Consensus       211 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~------~~~~~~~--  281 (339)
                         ....+|+.|+|||.+.+. .++.++||||+||++|+|++|+.||..... ..+.........      .......  
T Consensus       187 ---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~-~~~~~~~i~~~~g~~~~~~~~~~~~~~  262 (328)
T d3bqca1         187 ---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD-NYDQLVRIAKVLGTEDLYDYIDKYNIE  262 (328)
T ss_dssp             ---CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS-HHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred             ---cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCch-hHHHHHHHHHHHCCchhhhhhhhcccc
Confidence               245689999999998765 589999999999999999999999853221 111111111000      0000000  


Q ss_pred             ----cccccc----CcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          282 ----FGAIVD----PIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       282 ----~~~~~~----~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                          +.....    .........+.....++++.+||.+||++||++|||+.|+++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                000000    000001111222345678999999999999999999999986

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-50  Score=366.70  Aligned_cols=263  Identities=16%  Similarity=0.160  Sum_probs=196.3

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCC-ChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC------
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNS-TLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETE------  126 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~------  126 (339)
                      .++|++.+.||+|+||+||+|.+..+|+.||||+++... .....+.+.+|+.+|++++|||||+++++|...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            478999999999999999999999999999999997653 3345677889999999999999999999998654      


Q ss_pred             ccEEEEEeccCCccccccc-cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccC
Q 019536          127 LPTLVFESVKYGTLRGFSF-ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIP  205 (339)
Q Consensus       127 ~~~lv~e~~~~g~L~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~  205 (339)
                      ..++||||+ +++|..+.. ..+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+|++|||+|+...
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~  172 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD  172 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             eEEEEEecc-cccHHHHHHhccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhcccccccccccccceeccC
Confidence            469999999 556766654 68999999999999999999999   8999999999999999999999999999998765


Q ss_pred             CCCceeeecccccccccccccccccC-CCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCc---
Q 019536          206 EGETHVREEFIKGAYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNR---  281 (339)
Q Consensus       206 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---  281 (339)
                      ....     ...||+.|+|||++.+. .++.++||||+||++|+|++|+.||....  .   ...............   
T Consensus       173 ~~~~-----~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~--~---~~~~~~~~~~~~~~~~~~  242 (346)
T d1cm8a_         173 SEMT-----GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD--H---LDQLKEIMKVTGTPPAEF  242 (346)
T ss_dssp             SSCC-----SSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS--H---HHHHHHHHHHHCCCCHHH
T ss_pred             Cccc-----cccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCC--h---HHHHHHHHhccCCCcHHH
Confidence            4332     35689999999998765 57899999999999999999999975321  1   111111111000000   


Q ss_pred             cccc-------ccCcccC--CCCC-CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          282 FGAI-------VDPIFDE--DNSF-PGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       282 ~~~~-------~~~~~~~--~~~~-~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                      ....       .......  ...+ ......++.+.+|+.+||+.||++|||+.|++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H  301 (346)
T d1cm8a_         243 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  301 (346)
T ss_dssp             HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            0000       0000000  0000 0011345678999999999999999999999974

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-50  Score=356.90  Aligned_cols=267  Identities=17%  Similarity=0.213  Sum_probs=207.6

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC-hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST-LDDVEYCFNNIVFSSQMKHKNILKLIGCCLETELPTLVFE  133 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~~~lv~e  133 (339)
                      ++|++.+.||+|+||+||+|++..+++.||||+++.... ......+.+|+.+++.++||||+++++++.+....++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            579999999999999999999999999999999976533 3456788999999999999999999999999999999999


Q ss_pred             eccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCCcee
Q 019536          134 SVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGETHV  211 (339)
Q Consensus       134 ~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~~~~  211 (339)
                      ++.++++..+..  ..+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||.|+.........
T Consensus        82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~  158 (292)
T d1unla_          82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY  158 (292)
T ss_dssp             CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCC
T ss_pred             eccccccccccccccccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccCCCccc
Confidence            999999887765  57888999999999999999999   8999999999999999999999999999998875543322


Q ss_pred             eecccccccccccccccccCC-CCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhc---Cccccc--
Q 019536          212 REEFIKGAYGFIAPEYFATSS-FNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIEN---NRFGAI--  285 (339)
Q Consensus       212 ~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~--  285 (339)
                      .  ...++..|+|||++.+.. ++.++||||+||++|||++|+.||. .+...   .............   ..+...  
T Consensus       159 ~--~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~-~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  232 (292)
T d1unla_         159 S--AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF-PGNDV---DDQLKRIFRLLGTPTEEQWPSMTK  232 (292)
T ss_dssp             C--SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSC-CCSSH---HHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred             e--eeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCC-CCCCH---HHHHHHHHhhcCCCChhhhhhhhh
Confidence            1  345778899999987665 6899999999999999999999973 33322   1122211111111   000000  


Q ss_pred             -cc----CcccCC-CCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          286 -VD----PIFDED-NSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       286 -~~----~~~~~~-~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                       .+    +..... .........++.+.+|+.+||+.||++||||.|++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H  283 (292)
T d1unla_         233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             cccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             00    000000 0001112445678999999999999999999999863

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-50  Score=366.71  Aligned_cols=269  Identities=15%  Similarity=0.137  Sum_probs=200.5

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCc----cE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLETEL----PT  129 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~~~----~~  129 (339)
                      +.+|++.+.||+|+||+||+|.+..+|+.||||++.........+.+++|+.+|++++||||+++++++.....    .+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            35799999999999999999999999999999999876655667789999999999999999999999976542    34


Q ss_pred             EEEEeccCCccccccc-cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCCC
Q 019536          130 LVFESVKYGTLRGFSF-ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEGE  208 (339)
Q Consensus       130 lv~e~~~~g~L~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~~  208 (339)
                      ++++|+.+|+|.+++. ..+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+|+......
T Consensus        87 ~l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~  163 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH  163 (345)
T ss_dssp             EEEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred             EEEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCC
Confidence            5556677999999986 68999999999999999999999   8999999999999999999999999999998764432


Q ss_pred             ce-eeeccccccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCccc---
Q 019536          209 TH-VREEFIKGAYGFIAPEYFAT-SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFG---  283 (339)
Q Consensus       209 ~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  283 (339)
                      .. .......||+.|+|||++.. ..++.++||||+||++|+|++|+.||.....  .   ................   
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~--~---~~~~~~~~~~~~~~~~~~~  238 (345)
T d1pmea_         164 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY--L---DQLNHILGILGSPSQEDLN  238 (345)
T ss_dssp             CBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSH--H---HHHHHHHHHHCSCCHHHHH
T ss_pred             ccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCH--H---HHHHHHhhhccCCChhhhh
Confidence            21 11224568999999999854 4678999999999999999999999753221  1   1111111100000000   


Q ss_pred             -----cccc--CcccCCCCCCC---cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          284 -----AIVD--PIFDEDNSFPG---KEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       284 -----~~~~--~~~~~~~~~~~---~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                           ....  .........+.   ....+.++.+|+.+||+.||++|||+.|++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                 0000  00000000000   01234578999999999999999999999974

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-50  Score=364.08  Aligned_cols=259  Identities=21%  Similarity=0.248  Sum_probs=194.1

Q ss_pred             CcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCceeeeeeeeeeC------CccE
Q 019536           56 NYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNILKLIGCCLET------ELPT  129 (339)
Q Consensus        56 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~------~~~~  129 (339)
                      +|+..++||+|+||+||+|++..+|+.||||++.....     ...+|+.+|++++||||++++++|...      .+.+
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~   95 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN   95 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence            68889999999999999999999999999999976532     123799999999999999999998543      3468


Q ss_pred             EEEEeccCCccccccc-----cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCC-ceEEecCCCccc
Q 019536          130 LVFESVKYGTLRGFSF-----ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENY-SAKLHDFSLSVS  203 (339)
Q Consensus       130 lv~e~~~~g~L~~~~~-----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~-~~kl~dfg~a~~  203 (339)
                      +|||||++|.+..+..     ..+++..+..++.||+.||+|||   +++|+||||||+|||++.++ .+||+|||+++.
T Consensus        96 lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~  172 (350)
T d1q5ka_          96 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ  172 (350)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred             EEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchhh
Confidence            9999998775444322     46899999999999999999999   99999999999999999775 899999999987


Q ss_pred             cCCCCceeeeccccccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcC--
Q 019536          204 IPEGETHVREEFIKGAYGFIAPEYFAT-SSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENN--  280 (339)
Q Consensus       204 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--  280 (339)
                      +.......   ...||..|+|||.+.+ ..|+.++||||+||++|||++|++||.....     ..............  
T Consensus       173 ~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~-----~~~l~~i~~~~g~~~~  244 (350)
T d1q5ka_         173 LVRGEPNV---SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG-----VDQLVEIIKVLGTPTR  244 (350)
T ss_dssp             CCTTSCCC---SCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSH-----HHHHHHHHHHHCCCCH
T ss_pred             ccCCcccc---cccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCH-----HHHHHHHHHHhCCChH
Confidence            75544322   3568999999998765 4689999999999999999999999853221     11111111100000  


Q ss_pred             -c----ccccccCcccCCCCCC----CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          281 -R----FGAIVDPIFDEDNSFP----GKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       281 -~----~~~~~~~~~~~~~~~~----~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                       .    .....+..+......+    .....++++.+|+.+||++||++|||+.|++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  303 (350)
T d1q5ka_         245 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  303 (350)
T ss_dssp             HHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             0    0000000111000000    011345679999999999999999999999963

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.8e-49  Score=353.34  Aligned_cols=260  Identities=14%  Similarity=0.166  Sum_probs=199.7

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCcee-eeeeeeeeCCccEEEEE
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNIL-KLIGCCLETELPTLVFE  133 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv-~~~~~~~~~~~~~lv~e  133 (339)
                      ++|++.+.||+|+||+||+|.+..+|+.||||++.....   .+.+.+|+++++.++|+|++ .+.+++.+++..++|||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme   83 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   83 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT---SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc---CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence            579999999999999999999999999999999876533   23467899999999877655 55566677888899999


Q ss_pred             eccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCC---CCceEEecCCCccccCCC
Q 019536          134 SVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDE---NYSAKLHDFSLSVSIPEG  207 (339)
Q Consensus       134 ~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~---~~~~kl~dfg~a~~~~~~  207 (339)
                      |+++ ++.+.+.   ..+++..+..++.|++.||+|||   +++|+||||||+|||++.   +..+|++|||+|+.+...
T Consensus        84 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~  159 (299)
T d1ckia_          84 LLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  159 (299)
T ss_dssp             CCCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred             EcCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence            9954 5544433   57899999999999999999999   899999999999999863   457999999999887553


Q ss_pred             Cce-----eeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcc
Q 019536          208 ETH-----VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRF  282 (339)
Q Consensus       208 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (339)
                      ...     .......||+.|+|||.+.+..++.++|||||||++|||++|+.||........... .......... ...
T Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~-~~~~~~~~~~-~~~  237 (299)
T d1ckia_         160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK-YERISEKKMS-TPI  237 (299)
T ss_dssp             TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC--------HHHHHHHHHH-SCH
T ss_pred             ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHH-HHHhhcccCC-CCh
Confidence            322     122245799999999999999999999999999999999999999864433221111 1111111110 000


Q ss_pred             cccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 019536          283 GAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYL  336 (339)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~  336 (339)
                      ..+             ...+++++.+++.+||+.||++||++.++.+.|+.++.
T Consensus       238 ~~~-------------~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~  278 (299)
T d1ckia_         238 EVL-------------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  278 (299)
T ss_dssp             HHH-------------TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred             hHh-------------ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence            000             01344679999999999999999999999999988764

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=6.7e-49  Score=348.40  Aligned_cols=262  Identities=12%  Similarity=0.093  Sum_probs=207.7

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCC-CceeeeeeeeeeCCccEEEE
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKH-KNILKLIGCCLETELPTLVF  132 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H-~niv~~~~~~~~~~~~~lv~  132 (339)
                      .++|++.+.||+|+||+||+|++..+|+.||||++.....   .+.+.+|++.++.++| +|++.+++++.++...++||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm   80 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI   80 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC---cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence            3689999999999999999999999999999999866533   2345678889999965 89999999999999999999


Q ss_pred             EeccCCccccccc---cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCC-----CCceEEecCCCcccc
Q 019536          133 ESVKYGTLRGFSF---ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDE-----NYSAKLHDFSLSVSI  204 (339)
Q Consensus       133 e~~~~g~L~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~-----~~~~kl~dfg~a~~~  204 (339)
                      ||+ +|+|.+++.   ..++..++..++.|++.||.|||   +.+|+||||||+|||++.     ++.+||+|||+|+.+
T Consensus        81 e~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~  156 (293)
T d1csna_          81 DLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  156 (293)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             Eec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence            999 688888865   56889999999999999999999   999999999999999974     567999999999876


Q ss_pred             CCCCce-----eeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhc
Q 019536          205 PEGETH-----VREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIEN  279 (339)
Q Consensus       205 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  279 (339)
                      ......     .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......  ..............
T Consensus       157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~--~~~~~~~i~~~~~~  234 (293)
T d1csna_         157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT--NKQKYERIGEKKQS  234 (293)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCC--HHHHHHHHHHHHHH
T ss_pred             ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchh--HHHHHHHHHhccCC
Confidence            543211     12224579999999999999999999999999999999999999986333222  22222211111111


Q ss_pred             CcccccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 019536          280 NRFGAIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQLRQMYLS  337 (339)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~L~~l~~~  337 (339)
                      ....++.             ..+++++.+++..||+.+|++||++..+.+.|+++.+.
T Consensus       235 ~~~~~l~-------------~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~  279 (293)
T d1csna_         235 TPLRELC-------------AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER  279 (293)
T ss_dssp             SCHHHHT-------------TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             CChHHhc-------------CCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHH
Confidence            1111100             12335789999999999999999999999998887653

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-49  Score=359.36  Aligned_cols=264  Identities=18%  Similarity=0.205  Sum_probs=194.4

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC-hhhHHHHHHHHHHHHhcCCCceeeeeeeeee------CCc
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST-LDDVEYCFNNIVFSSQMKHKNILKLIGCCLE------TEL  127 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~------~~~  127 (339)
                      ++|++.++||+|+||+||+|.+..+|+.||||++..... ......+.+|+.++++++||||++++++|..      ...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            679999999999999999999999999999999986533 3455678899999999999999999999964      357


Q ss_pred             cEEEEEeccCCccccccccCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCCC
Q 019536          128 PTLVFESVKYGTLRGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPEG  207 (339)
Q Consensus       128 ~~lv~e~~~~g~L~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~~  207 (339)
                      .|+|||||.++.+ +.+...+++..++.++.||+.||.|||   +.||+||||||+|||++.++.+|++|||+++.....
T Consensus        97 ~~iv~Ey~~~~l~-~~~~~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~  172 (355)
T d2b1pa1          97 VYLVMELMDANLC-QVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS  172 (355)
T ss_dssp             EEEEEECCSEEHH-HHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             eEEEEeccchHHH-HhhhcCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhhhhccccc
Confidence            8999999976544 455678999999999999999999999   899999999999999999999999999998776543


Q ss_pred             CceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHh----------
Q 019536          208 ETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSI----------  277 (339)
Q Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~----------  277 (339)
                      ...   ....+|+.|+|||++.+..++.++||||+||++|+|++|+.||....  .   ...........          
T Consensus       173 ~~~---~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~--~---~~~~~~i~~~~~~~~~~~~~~  244 (355)
T d2b1pa1         173 FMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD--Y---IDQWNKVIEQLGTPCPEFMKK  244 (355)
T ss_dssp             -----------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS--H---HHHHHHHHHHHCCCCHHHHTT
T ss_pred             ccc---ccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCC--H---HHHHHHHHHhccCCCHHHHHH
Confidence            322   24568999999999999999999999999999999999999975322  1   11111100000          


Q ss_pred             ---------hcC-cccccccC-cc---cCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019536          278 ---------ENN-RFGAIVDP-IF---DEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMVDVAKQ  330 (339)
Q Consensus       278 ---------~~~-~~~~~~~~-~~---~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~il~~  330 (339)
                               ... .......+ .+   ......+.....+..+.+|+.+||+.||++||||.||+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence                     000 00000000 00   0000111123467789999999999999999999999864

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-49  Score=357.08  Aligned_cols=252  Identities=21%  Similarity=0.270  Sum_probs=202.0

Q ss_pred             cCcccCCceeccCCeeEEEEEEc---CCCeeEEEEEeccCC---ChhhHHHHHHHHHHHHhcCC-CceeeeeeeeeeCCc
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLV---DQDRPISVMKFHDNS---TLDDVEYCFNNIVFSSQMKH-KNILKLIGCCLETEL  127 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~---~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~H-~niv~~~~~~~~~~~  127 (339)
                      ++|++.+.||+|+||+||+|...   .+|+.||||+++...   .....+.+.+|+.++++++| |||+++++++.+.+.
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            67999999999999999999873   468999999986532   11234567799999999976 899999999999999


Q ss_pred             cEEEEEeccCCccccccc--cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccC
Q 019536          128 PTLVFESVKYGTLRGFSF--ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIP  205 (339)
Q Consensus       128 ~~lv~e~~~~g~L~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~  205 (339)
                      .++||||+.+|+|.+++.  ..++......++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+|+.+.
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~  180 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV  180 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred             eeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccchhhhc
Confidence            999999999999999986  57788888899999999999999   8999999999999999999999999999998775


Q ss_pred             CCCceeeecccccccccccccccccC--CCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCccc
Q 019536          206 EGETHVREEFIKGAYGFIAPEYFATS--SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRFG  283 (339)
Q Consensus       206 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (339)
                      ....... ....|++.|+|||.+.+.  .++.++||||+||++|+|++|+.||...+...  ......  ......    
T Consensus       181 ~~~~~~~-~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~--~~~~i~--~~~~~~----  251 (322)
T d1vzoa_         181 ADETERA-YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN--SQAEIS--RRILKS----  251 (322)
T ss_dssp             GGGGGGG-CGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC--CHHHHH--HHHHHC----
T ss_pred             ccccccc-cccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHH--HhcccC----
Confidence            4433322 246789999999999765  46789999999999999999999986443322  221111  111110    


Q ss_pred             ccccCcccCCCCCCCcHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 019536          284 AIVDPIFDEDNSFPGKEEKLQSLGQLMYKCLSKSPEHRPL-----MVDVAK  329 (339)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps-----~~~il~  329 (339)
                               .  .+.+...++++.+|+.+||++||++|||     ++|+++
T Consensus       252 ---------~--~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         252 ---------E--PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             ---------C--CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             ---------C--CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence                     0  0112245678999999999999999994     788876

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-48  Score=354.97  Aligned_cols=263  Identities=16%  Similarity=0.176  Sum_probs=197.3

Q ss_pred             hcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCC-hhhHHHHHHHHHHHHhcCCCceeeeeeeeeeC-----Cc
Q 019536           54 TNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNST-LDDVEYCFNNIVFSSQMKHKNILKLIGCCLET-----EL  127 (339)
Q Consensus        54 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~~~~~~~~~-----~~  127 (339)
                      .++|++.+.||+|+||+||+|.+..+|+.||||++..... ....+.+.+|+.+|++++|||||++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            4689999999999999999999999999999999986532 34556788999999999999999999998643     23


Q ss_pred             cEEEEEeccCCccccccc-cCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCCCccccCC
Q 019536          128 PTLVFESVKYGTLRGFSF-ASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSVSIPE  206 (339)
Q Consensus       128 ~~lv~e~~~~g~L~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~~~~  206 (339)
                      .+++++|+.+|+|.+++. ..+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+|++|||+|.....
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~  173 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD  173 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC----CCTG
T ss_pred             eEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccchhcccCc
Confidence            466778888999999886 67999999999999999999999   89999999999999999999999999999876543


Q ss_pred             CCceeeecccccccccccccccccC-CCCcccchHHHHHHHHHHHhCCCccccCCCCCCCchhHHHHHHHHhhcCcc---
Q 019536          207 GETHVREEFIKGAYGFIAPEYFATS-SFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDDDLTVLEYAKKSIENNRF---  282 (339)
Q Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---  282 (339)
                      ...     ...||+.|+|||.+.+. .++.++||||+||++|+|++|+.||...  ..   ................   
T Consensus       174 ~~~-----~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~--~~---~~~~~~i~~~~~~~~~~~~  243 (348)
T d2gfsa1         174 EMT-----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT--DH---IDQLKLILRLVGTPGAELL  243 (348)
T ss_dssp             GGS-----SSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS--SH---HHHHHHHHHHHCCCCHHHH
T ss_pred             ccc-----cccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCC--CH---HHHHHHHHHhcCCCChHHh
Confidence            222     35689999999987765 4689999999999999999999997522  11   1111111111100000   


Q ss_pred             ccc-------ccCcccCCCCCCC---cHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019536          283 GAI-------VDPIFDEDNSFPG---KEEKLQSLGQLMYKCLSKSPEHRPLMVDVAK  329 (339)
Q Consensus       283 ~~~-------~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~dP~~Rps~~~il~  329 (339)
                      ...       ...........+.   ....++++++||.+||+.||++|||+.|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             TTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence            000       0000000000000   0123567899999999999999999999987

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=5.3e-43  Score=319.55  Aligned_cols=267  Identities=14%  Similarity=0.144  Sum_probs=191.0

Q ss_pred             cCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcC-----------CCceeeeeeeee
Q 019536           55 NNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMK-----------HKNILKLIGCCL  123 (339)
Q Consensus        55 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-----------H~niv~~~~~~~  123 (339)
                      ++|++.++||+|+||+||+|++..+|+.||||+++...  ...+.+.+|+.+++.++           |+||+++++++.
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~--~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~   90 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   90 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc--cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEee
Confidence            45999999999999999999999999999999997642  23456778999888875           578999999886


Q ss_pred             e--CCccEEEEEeccCCcccccc-----ccCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCC-----
Q 019536          124 E--TELPTLVFESVKYGTLRGFS-----FASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENY-----  191 (339)
Q Consensus       124 ~--~~~~~lv~e~~~~g~L~~~~-----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~-----  191 (339)
                      .  ....+++++++..+......     ...+++..+..++.||+.||.|||+  ..+|+||||||+|||++.++     
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          91 HKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             EEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTE
T ss_pred             eccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCccccc
Confidence            5  34566777777655433221     1567888899999999999999993  38899999999999997654     


Q ss_pred             -ceEEecCCCccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHHHHHHHhCCCccccCCCCCCC-chhH
Q 019536          192 -SAKLHDFSLSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAFLCELLTGCNVLEFKGNGNDD-DLTV  269 (339)
Q Consensus       192 -~~kl~dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~-~~~~  269 (339)
                       .++++|||.|........     ...||+.|+|||++.+..|+.++|+||+||++++|++|+.||......... ....
T Consensus       169 ~~~kl~dfg~s~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~  243 (362)
T d1q8ya_         169 IQIKIADLGNACWYDEHYT-----NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH  243 (362)
T ss_dssp             EEEEECCCTTCEETTBCCC-----SCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred             ceeeEeecccccccccccc-----cccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence             389999999976644322     356999999999999999999999999999999999999998533221111 1111


Q ss_pred             HHHHHHHh--------hcCcc-ccccc-----CcccCC----------CCCCCcHHHHHHHHHHHHHhhccCCCCCCCHH
Q 019536          270 LEYAKKSI--------ENNRF-GAIVD-----PIFDED----------NSFPGKEEKLQSLGQLMYKCLSKSPEHRPLMV  325 (339)
Q Consensus       270 ~~~~~~~~--------~~~~~-~~~~~-----~~~~~~----------~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~  325 (339)
                      ........        ..... ....+     ..+...          .........++.+.+|+.+||++||.+|||+.
T Consensus       244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~  323 (362)
T d1q8ya_         244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG  323 (362)
T ss_dssp             HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred             HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence            11100000        00000 00000     000000          01112246678899999999999999999999


Q ss_pred             HHHHH
Q 019536          326 DVAKQ  330 (339)
Q Consensus       326 ~il~~  330 (339)
                      |+|++
T Consensus       324 e~L~H  328 (362)
T d1q8ya_         324 GLVNH  328 (362)
T ss_dssp             HHHTC
T ss_pred             HHhcC
Confidence            99874

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.93  E-value=7.2e-26  Score=186.94  Aligned_cols=170  Identities=16%  Similarity=0.095  Sum_probs=122.0

Q ss_pred             cccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCCh-----------------hhHHHHHHHHHHHHhcCCCceeeee
Q 019536           57 YDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTL-----------------DDVEYCFNNIVFSSQMKHKNILKLI  119 (339)
Q Consensus        57 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~~e~~~l~~l~H~niv~~~  119 (339)
                      +.+.+.||+|+||+||+|.+. +|+.||||+++.....                 .....+.+|...+.++.|++++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            356789999999999999986 7899999987642110                 0123345788899999999999888


Q ss_pred             eeeeeCCccEEEEEeccCCccccccccCCChHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCEEeCCCCceEEecCC
Q 019536          120 GCCLETELPTLVFESVKYGTLRGFSFASLLIAPRIKIAMEIANAVAYLHVGFDRPIVFRCIKASNVLLDENYSAKLHDFS  199 (339)
Q Consensus       120 ~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg  199 (339)
                      ++.    ..+++|||++++.+.+     ++......++.|++.++.|||   ..+|+||||||+|||++++ .++|+|||
T Consensus        81 ~~~----~~~lvme~~~~~~~~~-----l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~~~liDFG  147 (191)
T d1zara2          81 AWE----GNAVLMELIDAKELYR-----VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-GIWIIDFP  147 (191)
T ss_dssp             EEE----TTEEEEECCCCEEGGG-----CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-EEEECCCT
T ss_pred             Eec----CCEEEEEeeccccccc-----hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC-CEEEEECC
Confidence            663    2479999998876644     344556679999999999999   8999999999999999965 58999999


Q ss_pred             CccccCCCCceeeecccccccccccccccccCCCCcccchHHHHHH
Q 019536          200 LSVSIPEGETHVREEFIKGAYGFIAPEYFATSSFNEMCDVYSFGAF  245 (339)
Q Consensus       200 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~  245 (339)
                      +|.....+....   ....... .-.+.+ ...|+.++|+||..--
T Consensus       148 ~a~~~~~~~~~~---~l~rd~~-~~~~~f-~r~y~~~~d~~s~~~~  188 (191)
T d1zara2         148 QSVEVGEEGWRE---ILERDVR-NIITYF-SRTYRTEKDINSAIDR  188 (191)
T ss_dssp             TCEETTSTTHHH---HHHHHHH-HHHHHH-HHHHCCCCCHHHHHHH
T ss_pred             CcccCCCCCcHH---HHHHHHH-HHHHHH-cCCCCCcccHHHHHHH
Confidence            997664332210   0000000 001112 3568889999997643

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.75  E-value=2.1e-08  Score=84.77  Aligned_cols=149  Identities=10%  Similarity=0.009  Sum_probs=101.0

Q ss_pred             HHHHHHhcCcccCCceeccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcC-CCceeeeeeeeeeCC
Q 019536           48 KDLKKATNNYDLHKVIQSDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMK-HKNILKLIGCCLETE  126 (339)
Q Consensus        48 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~~~~~~~~~~  126 (339)
                      .++......|+..+..+.++.+.||+...  ++..+.+|+...... .....+.+|...+..+. +--+.+++.++.+++
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~-~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~   83 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDG   83 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETT
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcc-cchhhHHHHHHHHHHHhccCCCCcEEEEEecCC
Confidence            46777778888776655555678998764  666777888765432 22334567888877773 444678888888888


Q ss_pred             ccEEEEEeccCCccccccccCCChHHHHHHHHHHHHHHHHHhcCC-----------------------------------
Q 019536          127 LPTLVFESVKYGTLRGFSFASLLIAPRIKIAMEIANAVAYLHVGF-----------------------------------  171 (339)
Q Consensus       127 ~~~lv~e~~~~g~L~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-----------------------------------  171 (339)
                      ..++||++++|.++.+......   ....++.+++..+..||...                                   
T Consensus        84 ~~~lv~~~l~G~~~~~~~~~~~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (263)
T d1j7la_          84 WSNLLMSEADGVLCSEEYEDEQ---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE  160 (263)
T ss_dssp             EEEEEEECCSSEEHHHHTTTCS---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred             ceEEEEEecccccccccccccc---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccc
Confidence            8999999999987754432111   12234445555555555210                                   


Q ss_pred             ---------------------CCCeEEccCCCCCEEeCCCCceEEecCCCcc
Q 019536          172 ---------------------DRPIVFRCIKASNVLLDENYSAKLHDFSLSV  202 (339)
Q Consensus       172 ---------------------~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~  202 (339)
                                           ...++|+|+.|.||++++++.+-|+||+.+.
T Consensus       161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                 1137899999999999977667799999763

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.20  E-value=2.3e-06  Score=71.32  Aligned_cols=128  Identities=12%  Similarity=0.006  Sum_probs=80.9

Q ss_pred             eeccC-CeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCC--CceeeeeeeeeeCCccEEEEEeccCCc
Q 019536           63 IQSDT-SYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKH--KNILKLIGCCLETELPTLVFESVKYGT  139 (339)
Q Consensus        63 ig~G~-~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H--~niv~~~~~~~~~~~~~lv~e~~~~g~  139 (339)
                      +..|. .+.||+.... .+..+.+|.......    ..+..|...++.+..  -.+.+++.++.+++..++||++++|-+
T Consensus        18 ~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~~----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~   92 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGAL----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD   92 (255)
T ss_dssp             CSCTTSSCEEEEEECT-TSCCEEEEEECSCTT----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred             cCCcccCCeEEEEEeC-CCCEEEEEeCCccCH----hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence            33444 4678988764 566678887655432    234567777776632  336778888888888899999998877


Q ss_pred             cccccccCCChHHHHHHHHHHHHHHHHHh---------------------------------------------------
Q 019536          140 LRGFSFASLLIAPRIKIAMEIANAVAYLH---------------------------------------------------  168 (339)
Q Consensus       140 L~~~~~~~~~~~~~~~i~~~i~~~l~~LH---------------------------------------------------  168 (339)
                      +.+...   ..   ...+.++...|.-||                                                   
T Consensus        93 ~~~~~~---~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  166 (255)
T d1nd4a_          93 LLSSHL---AP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLK  166 (255)
T ss_dssp             TTTSCC---CH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHH
T ss_pred             cccccc---cH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHH
Confidence            644311   00   011122222222222                                                   


Q ss_pred             c----CCCCCeEEccCCCCCEEeCCCCceEEecCCCc
Q 019536          169 V----GFDRPIVFRCIKASNVLLDENYSAKLHDFSLS  201 (339)
Q Consensus       169 ~----~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a  201 (339)
                      .    .....++|+|+.|.|||++.+..+-|+||+.+
T Consensus       167 ~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~  203 (255)
T d1nd4a_         167 ARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRL  203 (255)
T ss_dssp             HTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTC
T ss_pred             HhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhc
Confidence            1    00223799999999999998766789999976

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.92  E-value=3.7e-05  Score=68.33  Aligned_cols=77  Identities=13%  Similarity=0.047  Sum_probs=49.1

Q ss_pred             CceeccCCeeEEEEEEcCCCeeEEEEEeccC------CChhhHHHHHHHHHHHHhcC-C--CceeeeeeeeeeCCccEEE
Q 019536           61 KVIQSDTSYRLFEGTLVDQDRPISVMKFHDN------STLDDVEYCFNNIVFSSQMK-H--KNILKLIGCCLETELPTLV  131 (339)
Q Consensus        61 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~~~~~e~~~l~~l~-H--~niv~~~~~~~~~~~~~lv  131 (339)
                      +.||.|....||+.....+++.+.+|...+.      .......+...|...|+.+. +  ..+++++.+  +....++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence            4688899999999988767888999975431      11223345557877777662 2  345666655  44556899


Q ss_pred             EEeccCCc
Q 019536          132 FESVKYGT  139 (339)
Q Consensus       132 ~e~~~~g~  139 (339)
                      ||++++..
T Consensus       110 mE~L~~~~  117 (392)
T d2pula1         110 MEDLSHLK  117 (392)
T ss_dssp             ECCCTTSE
T ss_pred             EeccCCcc
Confidence            99997654

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.34  E-value=0.0004  Score=59.26  Aligned_cols=154  Identities=10%  Similarity=0.046  Sum_probs=83.3

Q ss_pred             cccHHHHHHHhcCcccCCcee-----ccCCeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCce--e
Q 019536           44 AFSAKDLKKATNNYDLHKVIQ-----SDTSYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNI--L  116 (339)
Q Consensus        44 ~~~~~~~~~~~~~~~~~~~ig-----~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~ni--v  116 (339)
                      ..+.+|+.....+|.+.+...     .|---+.|.....  +..+++|++.......   .+..|+.++..+...++  .
T Consensus         2 ~ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~--~g~yVLri~~~~~~~~---~l~~~~~~l~~L~~~g~pvp   76 (316)
T d2ppqa1           2 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTT--KDPLILTLYEKRVEKN---DLPFFLGLMQHLAAKGLSCP   76 (316)
T ss_dssp             CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEES--SCCEEEEEECC---CC---HHHHHHHHHHHHHHTTCCCC
T ss_pred             CCCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEEC--CCcEEEEEcCCCCCHH---HHHHHHHHHHhhhhcccccc
Confidence            356788888888898865554     4445678988764  4458899886543323   23356666666642222  1


Q ss_pred             eeeee------eeeCCccEEEEEeccCCccccccc-------------------------cCCChH--------------
Q 019536          117 KLIGC------CLETELPTLVFESVKYGTLRGFSF-------------------------ASLLIA--------------  151 (339)
Q Consensus       117 ~~~~~------~~~~~~~~lv~e~~~~g~L~~~~~-------------------------~~~~~~--------------  151 (339)
                      ..+..      ..-......++.+..+........                         ......              
T Consensus        77 ~pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (316)
T d2ppqa1          77 LPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERAD  156 (316)
T ss_dssp             CBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGG
T ss_pred             ccceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhh
Confidence            11111      112334556777776654432200                         000000              


Q ss_pred             ----HHHHHHHHHHHHHHHHh-cCCCCCeEEccCCCCCEEeCCCCceEEecCCCcc
Q 019536          152 ----PRIKIAMEIANAVAYLH-VGFDRPIVFRCIKASNVLLDENYSAKLHDFSLSV  202 (339)
Q Consensus       152 ----~~~~i~~~i~~~l~~LH-~~~~~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~  202 (339)
                          .....+......+.-.+ ..-..++||+|+.+.|++++.+...-++||+.+.
T Consensus       157 ~~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         157 EVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             GTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hcchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence                00112222333333322 1124679999999999999988777899999763

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.12  E-value=0.0015  Score=57.49  Aligned_cols=74  Identities=15%  Similarity=0.085  Sum_probs=48.9

Q ss_pred             CceeccCCeeEEEEEEcC-------CCeeEEEEEeccCCChhhHHHHHHHHHHHHhcC-CCceeeeeeeeeeCCccEEEE
Q 019536           61 KVIQSDTSYRLFEGTLVD-------QDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMK-HKNILKLIGCCLETELPTLVF  132 (339)
Q Consensus        61 ~~ig~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~~~~~~~~~~~~~lv~  132 (339)
                      +.|+.|-.=.+|+.....       .+..|.+++.-...   ......+|..+++.+. +.-..++++++.+    .+|+
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~---~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~  120 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE---TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  120 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC---CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc---hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence            567778788899988753       23456666654322   2234558888888884 4444578887753    5899


Q ss_pred             EeccCCccc
Q 019536          133 ESVKYGTLR  141 (339)
Q Consensus       133 e~~~~g~L~  141 (339)
                      ||++|.++.
T Consensus       121 efi~g~~l~  129 (395)
T d1nw1a_         121 EYIPSRPLS  129 (395)
T ss_dssp             CCCCEEECC
T ss_pred             EEeccccCC
Confidence            999876553

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.05  E-value=0.001  Score=57.00  Aligned_cols=131  Identities=14%  Similarity=0.116  Sum_probs=75.6

Q ss_pred             CeeEEEEEEcCCCeeEEEEEeccCCChhhHHHHHHHHHHHHhcCCCce--eeeee-----eeeeCCccEEEEEeccCCcc
Q 019536           68 SYRLFEGTLVDQDRPISVMKFHDNSTLDDVEYCFNNIVFSSQMKHKNI--LKLIG-----CCLETELPTLVFESVKYGTL  140 (339)
Q Consensus        68 ~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~ni--v~~~~-----~~~~~~~~~lv~e~~~~g~L  140 (339)
                      --.||++... +|..+++|..++...  ..+.+..|...+..|....+  +..+.     ....++..+.++++++|..+
T Consensus        35 EN~vy~v~~~-dg~~~VlK~~rp~~~--s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~  111 (325)
T d1zyla1          35 ENRVYQFQDE-DRRRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF  111 (325)
T ss_dssp             SSEEEEECCT-TCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred             cceeEEEEcC-CCCEEEEEEeCCCCC--CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCC
Confidence            3479999875 788899999876532  34556678888877743222  11111     12345567889999987554


Q ss_pred             ccccc-------------------------cCCChH----------------------HHHHHHHHHHHHHHHH-hcCCC
Q 019536          141 RGFSF-------------------------ASLLIA----------------------PRIKIAMEIANAVAYL-HVGFD  172 (339)
Q Consensus       141 ~~~~~-------------------------~~~~~~----------------------~~~~i~~~i~~~l~~L-H~~~~  172 (339)
                      .....                         ......                      .....+..+...+.-+ .....
T Consensus       112 ~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p  191 (325)
T d1zyla1         112 EADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFT  191 (325)
T ss_dssp             CSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSC
T ss_pred             CCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCC
Confidence            32100                         011111                      0111223333333222 12224


Q ss_pred             CCeEEccCCCCCEEeCCCCceEEecCCCccc
Q 019536          173 RPIVFRCIKASNVLLDENYSAKLHDFSLSVS  203 (339)
Q Consensus       173 ~~i~H~dlk~~Nil~~~~~~~kl~dfg~a~~  203 (339)
                      .+++|+|+.+.|||++.+  ..++||+-++.
T Consensus       192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         192 VLRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             ceeecCCCCcccEEEeCC--ceEEechhccc
Confidence            568999999999999743  45899998753